PGSC0003DMG200031198	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMG200031198	K00517	ko00626	Naphthalene and anthracene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMG200031198	K00517	ko00903	Limonene and pinene degradation	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMG200031198	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMG200031198	K00517	ko01110	Biosynthesis of secondary metabolites	1979	2.6e-103	0.46	0.68	0.99
PGSC0003DMG200031199	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMG200031199	K00517	ko00626	Naphthalene and anthracene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMG200031199	K00517	ko00903	Limonene and pinene degradation	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMG200031199	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMG200031199	K00517	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.50	0.67	0.99
PGSC0003DMG200031202	K00558	ko00270	Cysteine and methionine metabolism	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMG200031202	K00558	ko01100	Metabolic pathways	250	9.3e-07	0.60	0.77	0.80
PGSC0003DMG200031204	K12929	ko00904	Diterpenoid biosynthesis	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMG200031204	K12929	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.49	0.75	0.96
PGSC0003DMG200031204	K12929	ko00904	Diterpenoid biosynthesis	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMG200031204	K12929	ko01110	Biosynthesis of secondary metabolites	371	1.6e-14	0.46	0.69	0.84
PGSC0003DMG200031213	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.3e-09	0.36	0.52	0.60
PGSC0003DMG200031213	K11294	ko05130	Pathogenic Escherichia coli infection	399	3.6e-16	0.28	0.50	0.85
PGSC0003DMG200030787	K01692	ko00071	Fatty acid metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00280	Valine, leucine and isoleucine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00281	Geraniol degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00310	Lysine degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00380	Tryptophan metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00410	beta-Alanine metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00632	Benzoate degradation via CoA ligation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00640	Propanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00650	Butanoate metabolism	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00903	Limonene and pinene degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00930	Caprolactam degradation	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko01100	Metabolic pathways	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.38	0.54	0.91
PGSC0003DMG200030787	K01692	ko00071	Fatty acid metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00280	Valine, leucine and isoleucine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00281	Geraniol degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00310	Lysine degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00380	Tryptophan metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00410	beta-Alanine metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00632	Benzoate degradation via CoA ligation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00640	Propanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00650	Butanoate metabolism	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00903	Limonene and pinene degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00930	Caprolactam degradation	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko01100	Metabolic pathways	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.43	0.66	0.77
PGSC0003DMG200030787	K01692	ko00071	Fatty acid metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00280	Valine, leucine and isoleucine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00281	Geraniol degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00310	Lysine degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00380	Tryptophan metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00410	beta-Alanine metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00632	Benzoate degradation via CoA ligation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00640	Propanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00650	Butanoate metabolism	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00903	Limonene and pinene degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko00930	Caprolactam degradation	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko01100	Metabolic pathways	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030787	K01692	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.43	0.65	0.73
PGSC0003DMG200030788	K00472	ko00330	Arginine and proline metabolism	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMG200030788	K00472	ko01100	Metabolic pathways	1487	3.5e-76	0.63	0.78	0.92
PGSC0003DMG200024133	K03108	ko03060	Protein export	412	1.0e-16	0.90	0.97	0.67
PGSC0003DMG200024135	K11778	ko00900	Terpenoid backbone biosynthesis	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMG200024135	K11778	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.53	0.69	0.83
PGSC0003DMG200024137	K04120	ko00904	Diterpenoid biosynthesis	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMG200024137	K04120	ko01100	Metabolic pathways	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMG200024137	K04120	ko01110	Biosynthesis of secondary metabolites	2269	2.6e-119	0.50	0.66	0.98
PGSC0003DMG200024138	K13065	ko00940	Phenylpropanoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMG200024138	K13065	ko00941	Flavonoid biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMG200024138	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMG200024138	K13065	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.38	0.59	0.62
PGSC0003DMG200024139	K13065	ko00940	Phenylpropanoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMG200024139	K13065	ko00941	Flavonoid biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMG200024139	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMG200024139	K13065	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.32	0.48	0.98
PGSC0003DMG200024140	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMG200024140	K11866	ko04144	Endocytosis	601	8.0e-27	0.30	0.46	0.91
PGSC0003DMG200024140	K11866	ko04144	Endocytosis	600	9.2e-27	0.30	0.46	0.91
PGSC0003DMG200024140	K11866	ko04144	Endocytosis	578	1.6e-25	0.30	0.46	0.90
PGSC0003DMG200024144	K04121	ko00904	Diterpenoid biosynthesis	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMG200024144	K04121	ko01100	Metabolic pathways	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMG200024144	K04121	ko01110	Biosynthesis of secondary metabolites	895	7.5e-51	0.38	0.56	0.78
PGSC0003DMG200024145	K01177	ko00500	Starch and sucrose metabolism	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMG200024145	K01177	ko01100	Metabolic pathways	1297	1.1e-65	0.42	0.58	0.50
PGSC0003DMG200024147	K04733	ko04210	Apoptosis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMG200024147	K04733	ko04620	Toll-like receptor signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMG200024147	K04733	ko04722	Neurotrophin signaling pathway	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMG200024147	K04733	ko05140	Leishmaniasis	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMG200024147	K04733	ko05142	Chagas disease	405	1.7e-16	0.43	0.62	0.51
PGSC0003DMG200028577	K00826	ko00280	Valine, leucine and isoleucine degradation	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMG200028577	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMG200028577	K00826	ko00770	Pantothenate and CoA biosynthesis	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMG200028577	K00826	ko01100	Metabolic pathways	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMG200028577	K00826	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.74	0.87	0.81
PGSC0003DMG200028577	K00826	ko00280	Valine, leucine and isoleucine degradation	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMG200028577	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMG200028577	K00826	ko00770	Pantothenate and CoA biosynthesis	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMG200028577	K00826	ko01100	Metabolic pathways	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMG200028577	K00826	ko01110	Biosynthesis of secondary metabolites	2768	7.8e-147	0.77	0.89	0.74
PGSC0003DMG200028579	K10601	ko04120	Ubiquitin mediated proteolysis	313	2.0e-11	0.28	0.42	0.63
PGSC0003DMG200028580	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMG200028580	K10604	ko04120	Ubiquitin mediated proteolysis	572	1.0e-25	0.34	0.51	0.79
PGSC0003DMG200028586	K00869	ko00900	Terpenoid backbone biosynthesis	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMG200028586	K00869	ko01100	Metabolic pathways	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMG200028586	K00869	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMG200028586	K00869	ko04146	Peroxisome	2212	3.6e-116	0.77	0.89	0.99
PGSC0003DMG200028586	K00869	ko00900	Terpenoid backbone biosynthesis	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMG200028586	K00869	ko01100	Metabolic pathways	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMG200028586	K00869	ko01110	Biosynthesis of secondary metabolites	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMG200028586	K00869	ko04146	Peroxisome	2448	3.5e-129	0.76	0.90	0.97
PGSC0003DMG200028588	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3380	1.4e-180	0.87	0.95	1.00
PGSC0003DMG200017999	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMG200017999	K00517	ko00626	Naphthalene and anthracene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMG200017999	K00517	ko00903	Limonene and pinene degradation	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMG200017999	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMG200017999	K00517	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.39	0.58	0.95
PGSC0003DMG200017999	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMG200017999	K00517	ko00626	Naphthalene and anthracene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMG200017999	K00517	ko00903	Limonene and pinene degradation	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMG200017999	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMG200017999	K00517	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.57	0.70	0.93
PGSC0003DMG200044366	K02703	ko00195	Photosynthesis	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMG200044366	K02703	ko01100	Metabolic pathways	1192	6.5e-60	0.99	1.00	0.99
PGSC0003DMG200014510	K11816	ko00380	Tryptophan metabolism	2400	1.5e-126	0.69	0.81	0.99
PGSC0003DMG200014514	K00558	ko00270	Cysteine and methionine metabolism	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMG200014514	K00558	ko01100	Metabolic pathways	1475	1.6e-75	0.52	0.66	0.85
PGSC0003DMG200014514	K00558	ko00270	Cysteine and methionine metabolism	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMG200014514	K00558	ko01100	Metabolic pathways	1616	2.7e-83	0.43	0.55	0.99
PGSC0003DMG200014521	K01899	ko00020	Citrate cycle (TCA cycle)	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMG200014521	K01899	ko00640	Propanoate metabolism	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMG200014521	K01899	ko01100	Metabolic pathways	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMG200014521	K01899	ko01110	Biosynthesis of secondary metabolites	2358	3.2e-124	0.75	0.80	1.00
PGSC0003DMG200014521	K01899	ko00020	Citrate cycle (TCA cycle)	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMG200014521	K01899	ko00640	Propanoate metabolism	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMG200014521	K01899	ko01100	Metabolic pathways	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMG200014521	K01899	ko01110	Biosynthesis of secondary metabolites	2473	1.5e-130	0.87	0.93	1.00
PGSC0003DMG200010496	K10879	ko03440	Homologous recombination	215	5.0e-06	0.44	0.65	0.52
PGSC0003DMG200010497	K10879	ko03440	Homologous recombination	510	2.7e-22	0.49	0.60	0.82
PGSC0003DMG200010511	K06062	ko04330	Notch signaling pathway	1349	1.4e-68	0.70	0.79	0.89
PGSC0003DMG200010511	K06062	ko04330	Notch signaling pathway	1211	5.9e-61	0.84	0.90	0.75
PGSC0003DMG200010511	K06062	ko04330	Notch signaling pathway	3448	2.4e-184	0.79	0.88	1.00
PGSC0003DMG200010511	K06062	ko04330	Notch signaling pathway	1277	1.3e-64	0.72	0.82	0.97
PGSC0003DMG200010511	K06062	ko04330	Notch signaling pathway	3429	2.7e-183	0.79	0.87	1.00
PGSC0003DMG200022638	K05757	ko04666	Fc gamma R-mediated phagocytosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMG200022638	K05757	ko04810	Regulation of actin cytoskeleton	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMG200022638	K05757	ko05100	Bacterial invasion of epithelial cells	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMG200022638	K05757	ko05130	Pathogenic Escherichia coli infection	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMG200022638	K05757	ko05131	Shigellosis	2240	1.0e-117	0.73	0.83	0.88
PGSC0003DMG200022638	K05757	ko04666	Fc gamma R-mediated phagocytosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMG200022638	K05757	ko04810	Regulation of actin cytoskeleton	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMG200022638	K05757	ko05100	Bacterial invasion of epithelial cells	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMG200022638	K05757	ko05130	Pathogenic Escherichia coli infection	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMG200022638	K05757	ko05131	Shigellosis	2649	2.8e-140	0.80	0.88	1.00
PGSC0003DMG200022638	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko04666	Fc gamma R-mediated phagocytosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko04810	Regulation of actin cytoskeleton	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05100	Bacterial invasion of epithelial cells	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05130	Pathogenic Escherichia coli infection	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022638	K05757	ko05131	Shigellosis	1952	7.9e-102	0.86	0.92	0.99
PGSC0003DMG200022639	K04512	ko04310	Wnt signaling pathway	630	1.3e-28	0.27	0.48	0.77
PGSC0003DMG200022640	K12131	ko04712	Circadian rhythm - plant	302	8.8e-11	0.31	0.51	0.90
PGSC0003DMG200022641	K08243	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMG200022641	K08243	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.65	0.89	0.69
PGSC0003DMG200022641	K08243	ko00941	Flavonoid biosynthesis	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMG200022641	K08243	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.56	0.78	0.98
PGSC0003DMG200022652	K03354	ko04110	Cell cycle	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022652	K03354	ko04111	Cell cycle - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022652	K03354	ko04113	Meiosis - yeast	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022652	K03354	ko04114	Oocyte meiosis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022652	K03354	ko04120	Ubiquitin mediated proteolysis	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022652	K03354	ko04914	Progesterone-mediated oocyte maturation	4011	2.2e-215	0.85	0.93	1.00
PGSC0003DMG200022655	K01046	ko00561	Glycerolipid metabolism	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMG200022655	K01046	ko01100	Metabolic pathways	538	7.7e-24	0.32	0.48	0.85
PGSC0003DMG200022656	K10144	ko04115	p53 signaling pathway	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMG200022656	K10144	ko04120	Ubiquitin mediated proteolysis	1702	4.9e-88	0.82	0.90	0.99
PGSC0003DMG200022656	K10144	ko04115	p53 signaling pathway	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMG200022656	K10144	ko04120	Ubiquitin mediated proteolysis	2070	2.5e-108	0.82	0.90	1.00
PGSC0003DMG200036680	K00021	ko00900	Terpenoid backbone biosynthesis	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMG200036680	K00021	ko01100	Metabolic pathways	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMG200036680	K00021	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.81	0.94	0.89
PGSC0003DMG200034534	K11644	ko05016	Huntington's disease	422	1.8e-16	0.32	0.48	0.73
PGSC0003DMG200019574	K01501	ko00380	Tryptophan metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019574	K01501	ko00460	Cyanoamino acid metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019574	K01501	ko00632	Benzoate degradation via CoA ligation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019574	K01501	ko00643	Styrene degradation	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019574	K01501	ko00910	Nitrogen metabolism	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019574	K01501	ko01100	Metabolic pathways	849	5.4e-41	0.51	0.71	0.89
PGSC0003DMG200019579	K01255	ko00480	Glutathione metabolism	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMG200019579	K01255	ko01100	Metabolic pathways	915	1.2e-44	0.76	0.86	0.66
PGSC0003DMG200019584	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMG200019584	K01602	ko00710	Carbon fixation in photosynthetic organisms	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMG200019584	K01602	ko01100	Metabolic pathways	1216	3.1e-61	0.78	0.89	0.98
PGSC0003DMG200019585	K12655	ko04622	RIG-I-like receptor signaling pathway	222	6.5e-06	0.31	0.45	0.87
PGSC0003DMG200019587	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04110	Cell cycle	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04114	Oocyte meiosis	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04722	Neurotrophin signaling pathway	1909	1.9e-99	0.91	0.96	0.98
PGSC0003DMG200019587	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019587	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019587	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019587	K06630	ko04110	Cell cycle	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019587	K06630	ko04114	Oocyte meiosis	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019587	K06630	ko04722	Neurotrophin signaling pathway	1792	5.3e-93	0.93	0.97	0.90
PGSC0003DMG200019588	K12886	ko03040	Spliceosome	402	2.4e-16	0.29	0.43	0.55
PGSC0003DMG200019588	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMG200019588	K12886	ko03040	Spliceosome	402	4.8e-16	0.29	0.43	0.46
PGSC0003DMG200029485	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMG200029486	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029486	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029486	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029486	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029486	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029486	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.38	0.50	0.90
PGSC0003DMG200029487	K00100	ko00051	Fructose and mannose metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029487	K00100	ko00363	Bisphenol A degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029487	K00100	ko00591	Linoleic acid metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029487	K00100	ko00625	Tetrachloroethene degradation	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029487	K00100	ko00650	Butanoate metabolism	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029487	K00100	ko01100	Metabolic pathways	900	8.3e-44	0.42	0.57	0.99
PGSC0003DMG200029489	K12356	ko00940	Phenylpropanoid biosynthesis	745	3.0e-35	0.50	0.62	0.51
PGSC0003DMG200029490	K12356	ko00940	Phenylpropanoid biosynthesis	538	7.7e-24	0.31	0.52	0.94
PGSC0003DMG200029491	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.46	0.59	0.77
PGSC0003DMG200029493	K13228	ko00402	Benzoxazinoid biosynthesis	230	8.0e-11	0.35	0.54	0.70
PGSC0003DMG200029495	K12356	ko00940	Phenylpropanoid biosynthesis	285	8.7e-10	0.33	0.53	0.86
PGSC0003DMG200029497	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.53	0.93
PGSC0003DMG200029500	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMG200029500	K01078	ko00740	Riboflavin metabolism	1529	1.7e-78	0.66	0.83	0.95
PGSC0003DMG200029501	K04498	ko04110	Cell cycle	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04310	Wnt signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04330	Notch signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04350	TGF-beta signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04520	Adherens junction	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04630	Jak-STAT signaling pathway	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04720	Long-term potentiation	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko04916	Melanogenesis	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko05016	Huntington's disease	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko05200	Pathways in cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko05211	Renal cell carcinoma	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200029501	K04498	ko05215	Prostate cancer	248	9.0e-07	0.32	0.44	0.83
PGSC0003DMG200000805	K11091	ko03040	Spliceosome	269	3.7e-08	0.41	0.49	0.08
PGSC0003DMG200000814	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko04115	p53 signaling pathway	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko04210	Apoptosis	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05010	Alzheimer's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05012	Parkinson's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05016	Huntington's disease	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200000814	K02084	ko05222	Small cell lung cancer	356	2.1e-10	0.27	0.45	0.53
PGSC0003DMG200042623	K10643	ko03018	RNA degradation	264	1.1e-06	0.27	0.44	0.92
PGSC0003DMG200042631	K10591	ko04120	Ubiquitin mediated proteolysis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMG200042631	K10591	ko04144	Endocytosis	258	6.6e-10	0.50	0.63	0.42
PGSC0003DMG200015726	K00799	ko00480	Glutathione metabolism	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMG200015726	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMG200015726	K00799	ko00982	Drug metabolism - cytochrome P450	857	2.0e-41	0.46	0.64	0.98
PGSC0003DMG200015728	K00117	ko00030	Pentose phosphate pathway	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMG200015728	K00117	ko01100	Metabolic pathways	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMG200015728	K00117	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.32	0.52	0.72
PGSC0003DMG200015728	K00117	ko00030	Pentose phosphate pathway	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMG200015728	K00117	ko01100	Metabolic pathways	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMG200015728	K00117	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.33	0.50	0.62
PGSC0003DMG200015728	K00117	ko00030	Pentose phosphate pathway	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMG200015728	K00117	ko01100	Metabolic pathways	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMG200015728	K00117	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.37	0.55	0.81
PGSC0003DMG200015730	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMG200015730	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMG200015730	K00737	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMG200015730	K00737	ko01100	Metabolic pathways	367	2.1e-14	0.29	0.43	0.81
PGSC0003DMG200015732	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMG200015732	K00430	ko00680	Methane metabolism	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMG200015732	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMG200015732	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMG200015732	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.62	0.74	0.47
PGSC0003DMG200015733	K07199	ko04910	Insulin signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMG200015733	K07199	ko04920	Adipocytokine signaling pathway	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMG200015733	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	492	2.7e-21	0.60	0.74	0.96
PGSC0003DMG200015733	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015733	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015733	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015733	K07199	ko04910	Insulin signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015733	K07199	ko04920	Adipocytokine signaling pathway	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015733	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	494	2.1e-21	0.60	0.74	0.84
PGSC0003DMG200015736	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMG200015736	K02894	ko03010	Ribosome	591	9.2e-27	0.96	0.97	0.97
PGSC0003DMG200005899	K12581	ko03018	RNA degradation	1253	2.8e-63	0.59	0.76	0.99
PGSC0003DMG200005907	K03012	ko00230	Purine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMG200005907	K03012	ko00240	Pyrimidine metabolism	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMG200005907	K03012	ko01100	Metabolic pathways	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMG200005907	K03012	ko03020	RNA polymerase	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMG200005907	K03012	ko05016	Huntington's disease	818	2.8e-39	0.77	0.80	0.99
PGSC0003DMG200005907	K03012	ko00230	Purine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMG200005907	K03012	ko00240	Pyrimidine metabolism	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMG200005907	K03012	ko01100	Metabolic pathways	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMG200005907	K03012	ko03020	RNA polymerase	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMG200005907	K03012	ko05016	Huntington's disease	1057	1.8e-52	0.92	0.95	0.99
PGSC0003DMG200005909	K02183	ko04020	Calcium signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04070	Phosphatidylinositol signaling system	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04114	Oocyte meiosis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04270	Vascular smooth muscle contraction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04626	Plant-pathogen interaction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04720	Long-term potentiation	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04722	Neurotrophin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04740	Olfactory transduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04744	Phototransduction	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04745	Phototransduction - fly	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04910	Insulin signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04912	GnRH signaling pathway	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04916	Melanogenesis	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04970	Salivary secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko04971	Gastric acid secretion	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko05010	Alzheimer's disease	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005909	K02183	ko05214	Glioma	355	9.6e-14	0.32	0.55	0.97
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1197	3.5e-60	0.91	0.93	0.84
PGSC0003DMG200002879	K07297	ko04920	Adipocytokine signaling pathway	1729	1.6e-89	0.61	0.77	0.98
PGSC0003DMG200002879	K07297	ko04920	Adipocytokine signaling pathway	1213	4.5e-61	0.67	0.82	0.94
PGSC0003DMG200002890	K06653	ko04111	Cell cycle - yeast	324	3.9e-11	0.30	0.48	0.93
PGSC0003DMG200002891	K00510	ko00860	Porphyrin and chlorophyll metabolism	1655	1.9e-85	0.85	0.92	0.99
PGSC0003DMG200002895	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMG200002895	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMG200002895	K00695	ko00500	Starch and sucrose metabolism	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMG200002895	K00695	ko01100	Metabolic pathways	5571	2.0e-301	0.81	0.90	1.00
PGSC0003DMG200012732	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMG200012732	K00766	ko01100	Metabolic pathways	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMG200012732	K00766	ko01110	Biosynthesis of secondary metabolites	370	1.5e-14	0.27	0.47	0.64
PGSC0003DMG200012742	K10245	ko01040	Biosynthesis of unsaturated fatty acids	419	2.8e-17	0.38	0.56	0.69
PGSC0003DMG200012752	K04514	ko04062	Chemokine signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04270	Vascular smooth muscle contraction	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04310	Wnt signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04350	TGF-beta signaling pathway	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04360	Axon guidance	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04510	Focal adhesion	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04670	Leukocyte transendothelial migration	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko04810	Regulation of actin cytoskeleton	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko05130	Pathogenic Escherichia coli infection	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K04514	ko05131	Shigellosis	379	1.9e-11	0.28	0.45	0.56
PGSC0003DMG200012752	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMG200012752	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMG200012752	K10352	ko04530	Tight junction	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMG200012752	K10352	ko05416	Viral myocarditis	387	1.1e-11	0.26	0.48	0.55
PGSC0003DMG200008297	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200008297	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200008298	K08912	ko00196	Photosynthesis - antenna proteins	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMG200008298	K08912	ko01100	Metabolic pathways	2061	7.7e-108	0.90	0.95	1.00
PGSC0003DMG200008299	K08912	ko00196	Photosynthesis - antenna proteins	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMG200008299	K08912	ko01100	Metabolic pathways	2029	4.5e-106	0.90	0.95	1.00
PGSC0003DMG200008300	K08912	ko00196	Photosynthesis - antenna proteins	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMG200008300	K08912	ko01100	Metabolic pathways	1993	4.3e-104	0.89	0.94	1.00
PGSC0003DMG200008301	K08912	ko00196	Photosynthesis - antenna proteins	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMG200008301	K08912	ko01100	Metabolic pathways	1996	3.0e-104	0.89	0.94	1.00
PGSC0003DMG200008306	K02084	ko04115	p53 signaling pathway	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko04210	Apoptosis	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko05010	Alzheimer's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko05012	Parkinson's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko05016	Huntington's disease	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008306	K02084	ko05222	Small cell lung cancer	305	2.8e-07	0.28	0.44	0.33
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	315	1.5e-11	0.38	0.51	0.64
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	305	5.5e-11	0.37	0.50	0.55
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	303	7.1e-11	0.37	0.51	0.55
PGSC0003DMG200008307	K00356	ko00190	Oxidative phosphorylation	295	2.0e-10	0.37	0.49	0.55
PGSC0003DMG200008308	K02541	ko03030	DNA replication	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMG200008308	K02541	ko04110	Cell cycle	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMG200008308	K02541	ko04111	Cell cycle - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMG200008308	K02541	ko04113	Meiosis - yeast	274	1.3e-08	0.45	0.65	0.99
PGSC0003DMG200008308	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko03030	DNA replication	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04110	Cell cycle	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04111	Cell cycle - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008308	K02541	ko04113	Meiosis - yeast	4744	8.0e-256	0.74	0.84	1.00
PGSC0003DMG200008309	K08912	ko00196	Photosynthesis - antenna proteins	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMG200008309	K08912	ko01100	Metabolic pathways	2042	8.6e-107	0.89	0.94	1.00
PGSC0003DMG200008310	K03015	ko00230	Purine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMG200008310	K03015	ko00240	Pyrimidine metabolism	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMG200008310	K03015	ko01100	Metabolic pathways	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMG200008310	K03015	ko03020	RNA polymerase	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMG200008310	K03015	ko05016	Huntington's disease	1136	8.0e-57	0.73	0.90	0.97
PGSC0003DMG200008311	K09458	ko00061	Fatty acid biosynthesis	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMG200008311	K09458	ko01100	Metabolic pathways	3491	1.0e-186	0.88	0.93	1.00
PGSC0003DMG200023391	K02639	ko00195	Photosynthesis	849	5.4e-41	0.68	0.81	0.99
PGSC0003DMG200023392	K11099	ko03040	Spliceosome	604	1.8e-27	0.90	0.96	0.99
PGSC0003DMG200023394	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMG200023394	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMG200023394	K02962	ko03010	Ribosome	1013	4.9e-50	0.86	0.92	0.99
PGSC0003DMG200023398	K03885	ko00190	Oxidative phosphorylation	367	2.1e-14	0.28	0.47	0.96
PGSC0003DMG200023398	K03885	ko00190	Oxidative phosphorylation	318	1.1e-11	0.28	0.46	0.88
PGSC0003DMG200023399	K12198	ko04144	Endocytosis	1583	1.8e-81	0.84	0.94	0.96
PGSC0003DMG200023399	K12198	ko04144	Endocytosis	900	8.3e-44	0.84	0.91	0.99
PGSC0003DMG200023399	K12198	ko04144	Endocytosis	1699	7.1e-88	0.84	0.94	1.00
PGSC0003DMG200023399	K12198	ko04144	Endocytosis	784	2.1e-37	0.84	0.91	0.92
PGSC0003DMG200035475	K00430	ko00360	Phenylalanine metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMG200035475	K00430	ko00680	Methane metabolism	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMG200035475	K00430	ko00940	Phenylpropanoid biosynthesis	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMG200035475	K00430	ko01100	Metabolic pathways	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMG200035475	K00430	ko01110	Biosynthesis of secondary metabolites	1115	1.2e-55	0.46	0.62	0.99
PGSC0003DMG200035480	K03469	ko03030	DNA replication	268	6.0e-09	0.52	0.70	0.63
PGSC0003DMG200035491	K00058	ko00260	Glycine, serine and threonine metabolism	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMG200035491	K00058	ko01100	Metabolic pathways	379	4.5e-15	0.34	0.55	0.94
PGSC0003DMG200035492	K01184	ko00040	Pentose and glucuronate interconversions	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMG200035492	K01184	ko00500	Starch and sucrose metabolism	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMG200035492	K01184	ko01100	Metabolic pathways	1445	7.3e-74	0.55	0.73	0.48
PGSC0003DMG200030184	K05658	ko02010	ABC transporters	3516	4.3e-188	0.38	0.58	0.96
PGSC0003DMG200030184	K05658	ko02010	ABC transporters	3583	8.7e-192	0.38	0.59	0.96
PGSC0003DMG200030185	K02918	ko03010	Ribosome	922	5.1e-45	0.93	0.98	0.99
PGSC0003DMG200030187	K12830	ko03040	Spliceosome	9560	0.	0.91	0.97	1.00
PGSC0003DMG200030191	K01051	ko00040	Pentose and glucuronate interconversions	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMG200030191	K01051	ko00500	Starch and sucrose metabolism	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMG200030191	K01051	ko01100	Metabolic pathways	671	3.6e-31	0.44	0.60	0.96
PGSC0003DMG200030193	K00412	ko00190	Oxidative phosphorylation	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030193	K00412	ko01100	Metabolic pathways	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030193	K00412	ko04260	Cardiac muscle contraction	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030193	K00412	ko05010	Alzheimer's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030193	K00412	ko05012	Parkinson's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030193	K00412	ko05016	Huntington's disease	318	1.1e-11	0.88	0.91	0.61
PGSC0003DMG200030197	K02006	ko02010	ABC transporters	746	2.6e-35	0.46	0.65	0.81
PGSC0003DMG200030197	K02006	ko02010	ABC transporters	357	7.4e-14	0.40	0.59	0.70
PGSC0003DMG200030197	K02006	ko02010	ABC transporters	745	3.0e-35	0.46	0.65	0.81
PGSC0003DMG200030197	K02006	ko02010	ABC transporters	416	4.1e-17	0.46	0.62	0.88
PGSC0003DMG200030208	K00889	ko00562	Inositol phosphate metabolism	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200030208	K00889	ko01100	Metabolic pathways	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200030208	K00889	ko04070	Phosphatidylinositol signaling system	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200030208	K00889	ko04144	Endocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200030208	K00889	ko04666	Fc gamma R-mediated phagocytosis	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200030208	K00889	ko04810	Regulation of actin cytoskeleton	3611	1.8e-196	0.37	0.54	0.95
PGSC0003DMG200020252	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko00360	Phenylalanine metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMG200020252	K00430	ko00680	Methane metabolism	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMG200020252	K00430	ko00940	Phenylpropanoid biosynthesis	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMG200020252	K00430	ko01100	Metabolic pathways	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMG200020252	K00430	ko01110	Biosynthesis of secondary metabolites	1661	8.9e-86	0.64	0.77	0.98
PGSC0003DMG200020252	K00430	ko00360	Phenylalanine metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko00680	Methane metabolism	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko00940	Phenylpropanoid biosynthesis	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko01100	Metabolic pathways	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020252	K00430	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.63	0.79	0.99
PGSC0003DMG200020253	K10808	ko00230	Purine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMG200020253	K10808	ko00240	Pyrimidine metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMG200020253	K10808	ko00480	Glutathione metabolism	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMG200020253	K10808	ko01100	Metabolic pathways	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMG200020253	K10808	ko04115	p53 signaling pathway	2505	2.5e-132	0.88	0.94	1.00
PGSC0003DMG200020259	K01046	ko00561	Glycerolipid metabolism	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMG200020259	K01046	ko01100	Metabolic pathways	903	5.7e-44	0.35	0.55	0.96
PGSC0003DMG200020261	K02183	ko04020	Calcium signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04070	Phosphatidylinositol signaling system	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04114	Oocyte meiosis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04270	Vascular smooth muscle contraction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04626	Plant-pathogen interaction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04720	Long-term potentiation	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04722	Neurotrophin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04740	Olfactory transduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04744	Phototransduction	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04745	Phototransduction - fly	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04910	Insulin signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04912	GnRH signaling pathway	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04916	Melanogenesis	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04970	Salivary secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko04971	Gastric acid secretion	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko05010	Alzheimer's disease	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200020261	K02183	ko05214	Glioma	340	6.4e-13	0.38	0.59	0.94
PGSC0003DMG200025733	K07203	ko04012	ErbB signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko04150	mTOR signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko04910	Insulin signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko04920	Adipocytokine signaling pathway	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko04930	Type II diabetes mellitus	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko05200	Pathways in cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko05214	Glioma	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko05215	Prostate cancer	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko05221	Acute myeloid leukemia	341	6.2e-12	0.83	0.92	0.86
PGSC0003DMG200025733	K07203	ko04012	ErbB signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko04150	mTOR signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko04910	Insulin signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko04920	Adipocytokine signaling pathway	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko04930	Type II diabetes mellitus	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko05200	Pathways in cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko05214	Glioma	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko05215	Prostate cancer	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko05221	Acute myeloid leukemia	404	4.0e-15	0.92	0.96	0.77
PGSC0003DMG200025733	K07203	ko04012	ErbB signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko04150	mTOR signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko04910	Insulin signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko04920	Adipocytokine signaling pathway	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko04930	Type II diabetes mellitus	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko05200	Pathways in cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko05214	Glioma	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko05215	Prostate cancer	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025733	K07203	ko05221	Acute myeloid leukemia	466	1.5e-18	0.81	0.90	0.99
PGSC0003DMG200025734	K00873	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko00230	Purine metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko00620	Pyruvate metabolism	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko00710	Carbon fixation in photosynthetic organisms	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko01100	Metabolic pathways	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.41	0.63	0.84
PGSC0003DMG200025734	K00873	ko00010	Glycolysis / Gluconeogenesis	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko00230	Purine metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko00620	Pyruvate metabolism	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko00710	Carbon fixation in photosynthetic organisms	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko01100	Metabolic pathways	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko04930	Type II diabetes mellitus	1047	6.5e-52	0.42	0.64	0.99
PGSC0003DMG200025734	K00873	ko00010	Glycolysis / Gluconeogenesis	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko00230	Purine metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko00620	Pyruvate metabolism	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko01100	Metabolic pathways	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko01110	Biosynthesis of secondary metabolites	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025734	K00873	ko04930	Type II diabetes mellitus	726	3.3e-34	0.43	0.66	0.98
PGSC0003DMG200025742	K12478	ko04144	Endocytosis	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMG200025742	K12478	ko04145	Phagosome	365	4.7e-11	0.26	0.45	0.96
PGSC0003DMG200016448	K01759	ko00620	Pyruvate metabolism	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMG200016448	K01759	ko04011	MAPK signaling pathway - yeast	660	1.4e-30	0.55	0.73	0.86
PGSC0003DMG200016453	K00430	ko00360	Phenylalanine metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMG200016453	K00430	ko00680	Methane metabolism	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMG200016453	K00430	ko00940	Phenylpropanoid biosynthesis	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMG200016453	K00430	ko01100	Metabolic pathways	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMG200016453	K00430	ko01110	Biosynthesis of secondary metabolites	2260	8.1e-119	0.80	0.88	1.00
PGSC0003DMG200005204	K01184	ko00040	Pentose and glucuronate interconversions	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMG200005204	K01184	ko00500	Starch and sucrose metabolism	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMG200005204	K01184	ko01100	Metabolic pathways	1517	7.8e-78	0.45	0.62	0.96
PGSC0003DMG200005206	K01051	ko00040	Pentose and glucuronate interconversions	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMG200005206	K01051	ko00500	Starch and sucrose metabolism	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMG200005206	K01051	ko01100	Metabolic pathways	1302	5.6e-66	0.48	0.67	0.99
PGSC0003DMG200005206	K01051	ko00040	Pentose and glucuronate interconversions	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMG200005206	K01051	ko00500	Starch and sucrose metabolism	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMG200005206	K01051	ko01100	Metabolic pathways	1385	1.5e-70	0.48	0.67	0.92
PGSC0003DMG200005206	K01051	ko00040	Pentose and glucuronate interconversions	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMG200005206	K01051	ko00500	Starch and sucrose metabolism	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMG200005206	K01051	ko01100	Metabolic pathways	336	1.1e-12	0.55	0.73	0.93
PGSC0003DMG200005207	K13065	ko00940	Phenylpropanoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMG200005207	K13065	ko00941	Flavonoid biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMG200005207	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMG200005207	K13065	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.27	0.47	0.90
PGSC0003DMG200005208	K01051	ko00040	Pentose and glucuronate interconversions	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMG200005208	K01051	ko00500	Starch and sucrose metabolism	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMG200005208	K01051	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.60	0.99
PGSC0003DMG200005214	K06573	ko04966	Collecting duct acid secretion	701	7.9e-33	0.29	0.44	0.82
PGSC0003DMG200005214	K06573	ko04966	Collecting duct acid secretion	736	9.3e-35	0.29	0.44	0.83
PGSC0003DMG200005217	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMG200015176	K08066	ko04612	Antigen processing and presentation	472	3.4e-20	0.41	0.63	0.66
PGSC0003DMG200015177	K08066	ko04612	Antigen processing and presentation	452	4.3e-19	0.51	0.76	0.46
PGSC0003DMG200015177	K08066	ko04612	Antigen processing and presentation	456	2.6e-19	0.37	0.58	0.56
PGSC0003DMG200012082	K01823	ko00900	Terpenoid backbone biosynthesis	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMG200012082	K01823	ko01100	Metabolic pathways	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMG200012082	K01823	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.57	0.64	0.77
PGSC0003DMG200012088	K12879	ko03040	Spliceosome	408	2.0e-15	0.32	0.62	0.77
PGSC0003DMG200012093	K04507	ko04310	Wnt signaling pathway	1384	1.7e-70	0.76	0.88	0.97
PGSC0003DMG200012098	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.51	0.66	0.89
PGSC0003DMG200012101	K02917	ko03010	Ribosome	895	1.6e-43	0.90	0.95	0.99
PGSC0003DMG200012102	K05741	ko04810	Regulation of actin cytoskeleton	340	4.1e-11	0.26	0.42	0.87
PGSC0003DMG200002237	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMG200002237	K02367	ko01100	Metabolic pathways	281	7.6e-07	0.27	0.46	0.51
PGSC0003DMG200002239	K12813	ko03040	Spliceosome	5131	3.6e-277	0.73	0.83	0.99
PGSC0003DMG200002248	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMG200002248	K11294	ko05130	Pathogenic Escherichia coli infection	272	3.7e-06	0.32	0.48	0.27
PGSC0003DMG200002248	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMG200002248	K11294	ko05130	Pathogenic Escherichia coli infection	272	8.6e-06	0.32	0.48	0.17
PGSC0003DMG200002249	K12489	ko04144	Endocytosis	5103	1.3e-275	0.78	0.87	0.96
PGSC0003DMG200002249	K12489	ko04144	Endocytosis	5539	1.1e-299	0.80	0.89	1.00
PGSC0003DMG200000149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00626	Naphthalene and anthracene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00903	Limonene and pinene degradation	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000151	K09480	ko00561	Glycerolipid metabolism	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMG200000151	K09480	ko01100	Metabolic pathways	2177	3.1e-114	0.61	0.76	0.98
PGSC0003DMG200000151	K09480	ko00561	Glycerolipid metabolism	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMG200000151	K09480	ko01100	Metabolic pathways	1985	1.2e-103	0.63	0.78	0.97
PGSC0003DMG200000151	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMG200000151	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMG200000151	K09480	ko00561	Glycerolipid metabolism	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMG200000151	K09480	ko01100	Metabolic pathways	2538	3.8e-134	0.65	0.79	0.98
PGSC0003DMG200000152	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMG200000152	K01491	ko00670	One carbon pool by folate	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMG200000152	K01491	ko01100	Metabolic pathways	2232	2.8e-117	0.72	0.81	1.00
PGSC0003DMG200000158	K05765	ko04360	Axon guidance	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMG200000158	K05765	ko04666	Fc gamma R-mediated phagocytosis	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMG200000158	K05765	ko04810	Regulation of actin cytoskeleton	886	4.9e-43	0.76	0.88	0.99
PGSC0003DMG200000162	K12604	ko03018	RNA degradation	782	3.8e-36	0.48	0.63	0.94
PGSC0003DMG200000164	K11752	ko00740	Riboflavin metabolism	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMG200000164	K11752	ko01100	Metabolic pathways	2040	1.1e-106	0.67	0.81	0.85
PGSC0003DMG200032520	K13228	ko00402	Benzoxazinoid biosynthesis	294	2.2e-10	0.33	0.51	0.73
PGSC0003DMG200032527	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	232	5.8e-07	0.44	0.52	0.97
PGSC0003DMG200032529	K01046	ko00561	Glycerolipid metabolism	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMG200032529	K01046	ko01100	Metabolic pathways	270	7.8e-09	0.31	0.46	0.44
PGSC0003DMG200032537	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMG200032537	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMG200032537	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.56	0.71	0.76
PGSC0003DMG200032537	K00799	ko00480	Glutathione metabolism	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMG200032537	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMG200032537	K00799	ko00982	Drug metabolism - cytochrome P450	1063	8.5e-53	0.57	0.72	0.75
PGSC0003DMG200032537	K00799	ko00480	Glutathione metabolism	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMG200032537	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMG200032537	K00799	ko00982	Drug metabolism - cytochrome P450	1064	7.5e-53	0.57	0.72	0.76
PGSC0003DMG200032538	K02717	ko00195	Photosynthesis	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMG200032538	K02717	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.54	0.71
PGSC0003DMG200032540	K12816	ko03040	Spliceosome	688	4.1e-32	0.34	0.55	0.70
PGSC0003DMG200032541	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00340	Histidine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00350	Tyrosine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00360	Phenylalanine metabolism	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00401	Novobiocin biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01100	Metabolic pathways	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.76	0.84	1.00
PGSC0003DMG200032541	K00817	ko00340	Histidine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko00350	Tyrosine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko00360	Phenylalanine metabolism	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko00401	Novobiocin biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko01100	Metabolic pathways	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032541	K00817	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.85	0.93	0.99
PGSC0003DMG200032544	K12859	ko03040	Spliceosome	1208	8.6e-61	0.96	1.00	0.99
PGSC0003DMG200017276	K01087	ko00500	Starch and sucrose metabolism	4897	2.9e-264	0.76	0.89	0.98
PGSC0003DMG200017276	K01087	ko00500	Starch and sucrose metabolism	5427	1.7e-293	0.75	0.89	0.98
PGSC0003DMG200017280	K07424	ko00140	Steroid hormone biosynthesis	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00591	Linoleic acid metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00830	Retinol metabolism	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00982	Drug metabolism - cytochrome P450	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko00983	Drug metabolism - other enzymes	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017280	K07424	ko01100	Metabolic pathways	2042	8.6e-107	0.50	0.70	0.97
PGSC0003DMG200017281	K07424	ko00140	Steroid hormone biosynthesis	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00591	Linoleic acid metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00830	Retinol metabolism	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00982	Drug metabolism - cytochrome P450	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko00983	Drug metabolism - other enzymes	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017281	K07424	ko01100	Metabolic pathways	2154	5.7e-113	0.51	0.71	1.00
PGSC0003DMG200017283	K06685	ko04111	Cell cycle - yeast	424	4.1e-15	0.30	0.46	0.65
PGSC0003DMG200017288	K01757	ko00901	Indole alkaloid biosynthesis	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMG200017288	K01757	ko01100	Metabolic pathways	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMG200017288	K01757	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.37	0.55	0.98
PGSC0003DMG200027940	K04733	ko04210	Apoptosis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMG200027940	K04733	ko04620	Toll-like receptor signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMG200027940	K04733	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMG200027940	K04733	ko05140	Leishmaniasis	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMG200027940	K04733	ko05142	Chagas disease	914	1.4e-44	0.40	0.57	0.72
PGSC0003DMG200027943	K10949	ko05110	Vibrio cholerae infection	426	1.2e-17	0.35	0.61	0.75
PGSC0003DMG200027943	K10949	ko05110	Vibrio cholerae infection	518	9.8e-23	0.36	0.59	0.77
PGSC0003DMG200027943	K10949	ko05110	Vibrio cholerae infection	399	3.6e-16	0.34	0.55	0.95
PGSC0003DMG200027946	K06628	ko04110	Cell cycle	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMG200027946	K06628	ko04111	Cell cycle - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMG200027946	K06628	ko04113	Meiosis - yeast	4018	8.9e-216	0.80	0.91	1.00
PGSC0003DMG200027950	K00754	ko00051	Fructose and mannose metabolism	797	4.0e-38	0.36	0.46	0.74
PGSC0003DMG200027950	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.54
PGSC0003DMG200027950	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMG200027950	K00754	ko00051	Fructose and mannose metabolism	681	1.0e-31	0.60	0.77	0.59
PGSC0003DMG200027954	K02154	ko00190	Oxidative phosphorylation	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko01100	Metabolic pathways	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko04142	Lysosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko04145	Phagosome	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko04966	Collecting duct acid secretion	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko05110	Vibrio cholerae infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5577	9.1e-302	0.81	0.90	0.99
PGSC0003DMG200027954	K02154	ko00190	Oxidative phosphorylation	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko01100	Metabolic pathways	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko04142	Lysosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko04145	Phagosome	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko04966	Collecting duct acid secretion	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko05110	Vibrio cholerae infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200027954	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	896	1.4e-43	0.86	0.93	0.99
PGSC0003DMG200013807	K12356	ko00940	Phenylpropanoid biosynthesis	354	1.1e-13	0.36	0.51	0.96
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	1248	5.3e-63	0.59	0.73	0.93
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	1357	5.2e-69	0.59	0.72	0.98
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	1727	2.0e-89	0.61	0.74	0.98
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	811	6.8e-39	0.55	0.68	0.84
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	2294	1.1e-120	0.60	0.74	0.98
PGSC0003DMG200013808	K00485	ko00982	Drug metabolism - cytochrome P450	2009	5.7e-105	0.62	0.75	0.98
PGSC0003DMG200013809	K01087	ko00500	Starch and sucrose metabolism	1454	2.3e-74	0.60	0.75	0.88
PGSC0003DMG200013809	K01087	ko00500	Starch and sucrose metabolism	1134	1.0e-56	0.49	0.65	0.95
PGSC0003DMG200013816	K00287	ko00670	One carbon pool by folate	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMG200013816	K00287	ko00790	Folate biosynthesis	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMG200013816	K00287	ko01100	Metabolic pathways	353	1.2e-13	0.33	0.48	0.98
PGSC0003DMG200013816	K00287	ko00670	One carbon pool by folate	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMG200013816	K00287	ko00790	Folate biosynthesis	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMG200013816	K00287	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.45	0.96
PGSC0003DMG200013342	K13066	ko00940	Phenylpropanoid biosynthesis	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMG200013342	K13066	ko01110	Biosynthesis of secondary metabolites	1482	6.6e-76	0.54	0.70	0.96
PGSC0003DMG200013343	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMG200013343	K01870	ko00970	Aminoacyl-tRNA biosynthesis	8273	0.	0.81	0.90	1.00
PGSC0003DMG200013343	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMG200013343	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6925	0.	0.80	0.90	1.00
PGSC0003DMG200013344	K03138	ko03022	Basal transcription factors	2460	7.6e-130	0.75	0.85	0.99
PGSC0003DMG200013344	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMG200013344	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMG200013344	K03138	ko03022	Basal transcription factors	3175	2.8e-169	0.75	0.86	0.99
PGSC0003DMG200013345	K03955	ko00190	Oxidative phosphorylation	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMG200013345	K03955	ko01100	Metabolic pathways	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMG200013345	K03955	ko05010	Alzheimer's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMG200013345	K03955	ko05012	Parkinson's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMG200013345	K03955	ko05016	Huntington's disease	642	1.4e-29	0.63	0.78	0.99
PGSC0003DMG200013346	K03020	ko00230	Purine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMG200013346	K03020	ko00240	Pyrimidine metabolism	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMG200013346	K03020	ko01100	Metabolic pathways	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMG200013346	K03020	ko03020	RNA polymerase	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMG200013346	K03020	ko04623	Cytosolic DNA-sensing pathway	694	1.9e-32	0.74	0.88	0.99
PGSC0003DMG200013348	K12462	ko04722	Neurotrophin signaling pathway	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMG200013348	K12462	ko04962	Vasopressin-regulated water reabsorption	1454	2.3e-74	0.72	0.81	0.94
PGSC0003DMG200013351	K10591	ko04120	Ubiquitin mediated proteolysis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMG200013351	K10591	ko04144	Endocytosis	1559	3.8e-80	0.58	0.77	0.99
PGSC0003DMG200006638	K09561	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.72	0.86	0.82
PGSC0003DMG200006638	K09561	ko04120	Ubiquitin mediated proteolysis	1069	4.0e-53	0.67	0.81	0.86
PGSC0003DMG200006638	K09561	ko04120	Ubiquitin mediated proteolysis	597	4.3e-27	0.58	0.72	0.76
PGSC0003DMG200006644	K00962	ko00230	Purine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMG200006644	K00962	ko00240	Pyrimidine metabolism	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMG200006644	K00962	ko03018	RNA degradation	4687	1.1e-252	0.71	0.82	1.00
PGSC0003DMG200006645	K08905	ko00195	Photosynthesis	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMG200006645	K08905	ko01100	Metabolic pathways	416	4.1e-17	0.80	0.86	0.88
PGSC0003DMG200011189	K13065	ko00940	Phenylpropanoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMG200011189	K13065	ko00941	Flavonoid biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMG200011189	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMG200011189	K13065	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.57	0.74	0.99
PGSC0003DMG200011189	K13065	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMG200011189	K13065	ko00941	Flavonoid biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMG200011189	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMG200011189	K13065	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.59	0.76	0.99
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1004	1.5e-49	0.51	0.74	0.92
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	781	3.1e-37	0.53	0.73	0.80
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.84
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1072	2.7e-53	0.53	0.74	0.72
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1070	3.5e-53	0.51	0.72	0.84
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1049	5.1e-52	0.52	0.74	0.85
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1040	1.6e-51	0.52	0.73	0.93
PGSC0003DMG200011192	K03260	ko05416	Viral myocarditis	1035	3.0e-51	0.52	0.74	0.93
PGSC0003DMG200011194	K02943	ko03010	Ribosome	600	2.9e-27	0.71	0.81	0.98
PGSC0003DMG200011196	K03260	ko05416	Viral myocarditis	2356	4.1e-124	0.48	0.63	0.88
PGSC0003DMG200001463	K02924	ko03010	Ribosome	445	1.0e-18	0.96	0.98	0.98
PGSC0003DMG200001467	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMG200001467	K10614	ko04120	Ubiquitin mediated proteolysis	639	4.9e-29	0.33	0.48	0.94
PGSC0003DMG200001470	K04733	ko04210	Apoptosis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMG200001470	K04733	ko04620	Toll-like receptor signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMG200001470	K04733	ko04722	Neurotrophin signaling pathway	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMG200001470	K04733	ko05140	Leishmaniasis	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMG200001470	K04733	ko05142	Chagas disease	444	3.9e-18	0.40	0.58	0.70
PGSC0003DMG200043363	K12356	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.42	0.61	0.90
PGSC0003DMG200043373	K00033	ko00030	Pentose phosphate pathway	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMG200043373	K00033	ko00480	Glutathione metabolism	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMG200043373	K00033	ko01100	Metabolic pathways	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMG200043373	K00033	ko01110	Biosynthesis of secondary metabolites	3529	8.3e-189	0.86	0.93	0.98
PGSC0003DMG200039968	K05282	ko00904	Diterpenoid biosynthesis	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMG200039968	K05282	ko01100	Metabolic pathways	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMG200039968	K05282	ko01110	Biosynthesis of secondary metabolites	1992	4.9e-104	0.66	0.78	0.95
PGSC0003DMG200039977	K10760	ko00908	Zeatin biosynthesis	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMG200039977	K10760	ko01100	Metabolic pathways	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMG200039977	K10760	ko01110	Biosynthesis of secondary metabolites	947	2.1e-46	0.46	0.62	0.95
PGSC0003DMG200039990	K05282	ko00904	Diterpenoid biosynthesis	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMG200039990	K05282	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMG200039990	K05282	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.63	0.97
PGSC0003DMG200043827	K09658	ko00510	N-Glycan biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMG200043827	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMG200043827	K09658	ko01100	Metabolic pathways	408	1.1e-16	0.65	0.76	0.99
PGSC0003DMG200043836	K04733	ko04210	Apoptosis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMG200043836	K04733	ko04620	Toll-like receptor signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMG200043836	K04733	ko04722	Neurotrophin signaling pathway	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMG200043836	K04733	ko05140	Leishmaniasis	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMG200043836	K04733	ko05142	Chagas disease	2168	9.7e-114	0.41	0.58	0.91
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	1887	3.0e-98	0.38	0.52	0.99
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	338	6.5e-12	0.82	0.92	0.82
PGSC0003DMG200001521	K11778	ko00900	Terpenoid backbone biosynthesis	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMG200001521	K11778	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.60	0.91	0.90
PGSC0003DMG200001523	K05868	ko04110	Cell cycle	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMG200001523	K05868	ko04115	p53 signaling pathway	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMG200001523	K05868	ko04914	Progesterone-mediated oocyte maturation	2353	6.0e-124	0.66	0.80	1.00
PGSC0003DMG200001524	K00831	ko00260	Glycine, serine and threonine metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMG200001524	K00831	ko00750	Vitamin B6 metabolism	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMG200001524	K00831	ko01100	Metabolic pathways	2782	1.3e-147	0.77	0.85	0.99
PGSC0003DMG200001525	K00030	ko00020	Citrate cycle (TCA cycle)	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMG200001525	K00030	ko01100	Metabolic pathways	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMG200001525	K00030	ko01110	Biosynthesis of secondary metabolites	2403	1.1e-126	0.77	0.86	1.00
PGSC0003DMG200001528	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1185	1.6e-59	0.57	0.72	0.89
PGSC0003DMG200001529	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1294	1.6e-65	0.64	0.75	0.89
PGSC0003DMG200013696	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMG200013696	K00517	ko00626	Naphthalene and anthracene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMG200013696	K00517	ko00903	Limonene and pinene degradation	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMG200013696	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMG200013696	K00517	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.63	0.78	0.99
PGSC0003DMG200013698	K12598	ko03018	RNA degradation	6159	0.	0.86	0.93	0.99
PGSC0003DMG200013698	K12598	ko03018	RNA degradation	7232	0.	0.85	0.93	1.00
PGSC0003DMG200013700	K03678	ko03018	RNA degradation	2544	1.8e-134	0.68	0.81	1.00
PGSC0003DMG200013700	K03678	ko03018	RNA degradation	2594	3.1e-137	0.68	0.80	1.00
PGSC0003DMG200013702	K01840	ko00051	Fructose and mannose metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMG200013702	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMG200013702	K01840	ko01100	Metabolic pathways	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMG200013702	K01840	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.79	0.86	0.97
PGSC0003DMG200013702	K01840	ko00051	Fructose and mannose metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMG200013702	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMG200013702	K01840	ko01100	Metabolic pathways	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMG200013702	K01840	ko01110	Biosynthesis of secondary metabolites	772	9.6e-37	0.80	0.91	0.82
PGSC0003DMG200013702	K01840	ko00051	Fructose and mannose metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMG200013702	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMG200013702	K01840	ko01100	Metabolic pathways	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMG200013702	K01840	ko01110	Biosynthesis of secondary metabolites	1736	6.5e-90	0.82	0.91	0.97
PGSC0003DMG200013703	K00967	ko00440	Phosphonate and phosphinate metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMG200013703	K00967	ko00564	Glycerophospholipid metabolism	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMG200013703	K00967	ko01100	Metabolic pathways	2762	1.7e-146	0.76	0.86	1.00
PGSC0003DMG200013703	K00967	ko00440	Phosphonate and phosphinate metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMG200013703	K00967	ko00564	Glycerophospholipid metabolism	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMG200013703	K00967	ko01100	Metabolic pathways	1383	1.9e-70	0.60	0.75	0.89
PGSC0003DMG200013709	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMG200013709	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMG200013709	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMG200013709	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMG200013709	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.50	0.71	0.86
PGSC0003DMG200013709	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200013709	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200013709	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200013709	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200013709	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200007545	K01046	ko00561	Glycerolipid metabolism	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMG200007545	K01046	ko01100	Metabolic pathways	258	2.1e-08	0.33	0.44	0.48
PGSC0003DMG200007545	K01046	ko00561	Glycerolipid metabolism	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMG200007545	K01046	ko01100	Metabolic pathways	258	4.0e-08	0.33	0.44	0.38
PGSC0003DMG200007555	K11866	ko04144	Endocytosis	861	1.2e-41	0.53	0.66	0.96
PGSC0003DMG200007555	K11866	ko04144	Endocytosis	2621	1.0e-138	0.66	0.74	1.00
PGSC0003DMG200007564	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007564	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007564	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007564	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007564	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007564	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200007565	K09843	ko00906	Carotenoid biosynthesis	1012	5.5e-50	0.34	0.53	0.98
PGSC0003DMG200004397	K04733	ko04210	Apoptosis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMG200004397	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMG200004397	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMG200004397	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMG200004397	K04733	ko05142	Chagas disease	783	2.4e-37	0.30	0.48	0.81
PGSC0003DMG200004403	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.3e-12	0.32	0.49	0.42
PGSC0003DMG200004410	K03514	ko03018	RNA degradation	274	5.7e-06	0.29	0.48	0.24
PGSC0003DMG200013424	K00599	ko00340	Histidine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMG200013424	K00599	ko00350	Tyrosine metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMG200013424	K00599	ko00450	Selenoamino acid metabolism	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMG200013424	K00599	ko00626	Naphthalene and anthracene degradation	2954	4.3e-157	0.70	0.81	0.98
PGSC0003DMG200013424	K00599	ko00340	Histidine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMG200013424	K00599	ko00350	Tyrosine metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMG200013424	K00599	ko00450	Selenoamino acid metabolism	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMG200013424	K00599	ko00626	Naphthalene and anthracene degradation	2824	6.3e-150	0.69	0.81	0.84
PGSC0003DMG200013425	K01052	ko00100	Steroid biosynthesis	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMG200013425	K01052	ko04142	Lysosome	997	3.7e-49	0.39	0.56	0.92
PGSC0003DMG200013427	K02183	ko04020	Calcium signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04070	Phosphatidylinositol signaling system	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04114	Oocyte meiosis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04270	Vascular smooth muscle contraction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04626	Plant-pathogen interaction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04720	Long-term potentiation	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04722	Neurotrophin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04740	Olfactory transduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04744	Phototransduction	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04745	Phototransduction - fly	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04910	Insulin signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04912	GnRH signaling pathway	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04916	Melanogenesis	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04970	Salivary secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko04971	Gastric acid secretion	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko05010	Alzheimer's disease	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013427	K02183	ko05214	Glioma	342	5.0e-13	0.39	0.59	0.96
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.73	0.88	0.99
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	3028	3.6e-161	0.74	0.87	0.97
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.82	0.93	0.97
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	652	4.0e-30	0.82	0.93	0.88
PGSC0003DMG200013429	K00231	ko00860	Porphyrin and chlorophyll metabolism	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMG200013429	K00231	ko01100	Metabolic pathways	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMG200013429	K00231	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.70	0.84	0.86
PGSC0003DMG200013431	K12386	ko04142	Lysosome	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMG200013432	K00276	ko00260	Glycine, serine and threonine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko00350	Tyrosine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko00360	Phenylalanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko00410	beta-Alanine metabolism	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko00950	Isoquinoline alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko01100	Metabolic pathways	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013432	K00276	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.45	0.60	0.97
PGSC0003DMG200013436	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.91	0.92	0.99
PGSC0003DMG200013437	K00958	ko00230	Purine metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko00450	Selenoamino acid metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko00920	Sulfur metabolism	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko01100	Metabolic pathways	3200	1.2e-170	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko00230	Purine metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko00450	Selenoamino acid metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko00920	Sulfur metabolism	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMG200013437	K00958	ko01100	Metabolic pathways	3210	3.3e-171	0.80	0.89	1.00
PGSC0003DMG200013440	K05748	ko04520	Adherens junction	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMG200013440	K05748	ko04666	Fc gamma R-mediated phagocytosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMG200013440	K05748	ko04810	Regulation of actin cytoskeleton	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMG200013440	K05748	ko05100	Bacterial invasion of epithelial cells	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMG200013440	K05748	ko05131	Shigellosis	244	2.2e-07	0.38	0.46	0.90
PGSC0003DMG200013443	K00660	ko00941	Flavonoid biosynthesis	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMG200013443	K00660	ko01100	Metabolic pathways	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMG200013443	K00660	ko01110	Biosynthesis of secondary metabolites	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMG200013443	K00660	ko04712	Circadian rhythm - plant	239	2.6e-07	0.28	0.42	0.66
PGSC0003DMG200013443	K00660	ko00941	Flavonoid biosynthesis	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMG200013443	K00660	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMG200013443	K00660	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMG200013443	K00660	ko04712	Circadian rhythm - plant	363	3.5e-14	0.30	0.47	0.59
PGSC0003DMG200006586	K12869	ko03040	Spliceosome	1216	3.1e-61	0.34	0.47	0.98
PGSC0003DMG200006590	K00873	ko00010	Glycolysis / Gluconeogenesis	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko00230	Purine metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko00620	Pyruvate metabolism	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko00710	Carbon fixation in photosynthetic organisms	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko01100	Metabolic pathways	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko01110	Biosynthesis of secondary metabolites	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006590	K00873	ko04930	Type II diabetes mellitus	4146	7.7e-223	0.86	0.92	1.00
PGSC0003DMG200006591	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1762	2.4e-91	0.68	0.83	0.97
PGSC0003DMG200006594	K05666	ko02010	ABC transporters	2670	2.0e-141	0.33	0.52	0.97
PGSC0003DMG200006594	K05673	ko02010	ABC transporters	290	4.0e-09	0.49	0.71	0.83
PGSC0003DMG200006598	K10595	ko04120	Ubiquitin mediated proteolysis	275	1.2e-07	0.40	0.55	0.98
PGSC0003DMG200024362	K13065	ko00940	Phenylpropanoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMG200024362	K13065	ko00941	Flavonoid biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMG200024362	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMG200024362	K13065	ko01110	Biosynthesis of secondary metabolites	251	7.3e-06	0.27	0.45	0.64
PGSC0003DMG200024368	K04725	ko04120	Ubiquitin mediated proteolysis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko04210	Apoptosis	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko04510	Focal adhesion	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko04621	NOD-like receptor signaling pathway	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko05200	Pathways in cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko05222	Small cell lung cancer	261	2.5e-08	0.29	0.43	0.90
PGSC0003DMG200024368	K04725	ko04120	Ubiquitin mediated proteolysis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200024368	K04725	ko04210	Apoptosis	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200024368	K04725	ko04510	Focal adhesion	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200024368	K04725	ko04621	NOD-like receptor signaling pathway	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200024368	K04725	ko05200	Pathways in cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200024368	K04725	ko05222	Small cell lung cancer	242	3.3e-07	0.36	0.52	0.38
PGSC0003DMG200021121	K01054	ko00561	Glycerolipid metabolism	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMG200021121	K01054	ko01100	Metabolic pathways	498	1.2e-21	0.29	0.47	0.93
PGSC0003DMG200021123	K04506	ko04115	p53 signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMG200021123	K04506	ko04120	Ubiquitin mediated proteolysis	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMG200021123	K04506	ko04310	Wnt signaling pathway	2460	7.6e-130	0.91	0.94	1.00
PGSC0003DMG200021123	K04506	ko04115	p53 signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMG200021123	K04506	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMG200021123	K04506	ko04310	Wnt signaling pathway	714	1.5e-33	0.94	0.98	0.99
PGSC0003DMG200021124	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.41	0.58	0.85
PGSC0003DMG200021124	K08064	ko04612	Antigen processing and presentation	455	2.9e-19	0.58	0.75	0.81
PGSC0003DMG200021130	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMG200021130	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.78
PGSC0003DMG200021130	K00866	ko00564	Glycerophospholipid metabolism	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMG200021130	K00866	ko01100	Metabolic pathways	1766	1.4e-91	0.60	0.76	0.95
PGSC0003DMG200032204	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2743	1.9e-145	0.78	0.89	0.99
PGSC0003DMG200032207	K00454	ko00591	Linoleic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMG200032207	K00454	ko00592	alpha-Linolenic acid metabolism	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMG200032207	K00454	ko01100	Metabolic pathways	769	1.4e-36	0.66	0.76	0.93
PGSC0003DMG200032207	K00454	ko00591	Linoleic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMG200032207	K00454	ko00592	alpha-Linolenic acid metabolism	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMG200032207	K00454	ko01100	Metabolic pathways	4204	4.9e-226	0.57	0.73	0.94
PGSC0003DMG200032210	K00423	ko00053	Ascorbate and aldarate metabolism	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMG200032210	K00423	ko01100	Metabolic pathways	3185	7.8e-170	0.66	0.79	0.98
PGSC0003DMG200032222	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	760	4.4e-36	0.38	0.45	0.89
PGSC0003DMG200032223	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	909	2.7e-44	0.36	0.44	0.93
PGSC0003DMG200032242	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMG200032242	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMG200032242	K04424	ko04010	MAPK signaling pathway	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMG200032242	K04424	ko04530	Tight junction	658	8.8e-30	0.33	0.53	0.82
PGSC0003DMG200032243	K00547	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMG200032243	K00547	ko01100	Metabolic pathways	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMG200032243	K00547	ko01110	Biosynthesis of secondary metabolites	2114	9.2e-111	0.74	0.88	0.97
PGSC0003DMG200040962	K12356	ko00940	Phenylpropanoid biosynthesis	373	9.7e-15	0.39	0.49	0.61
PGSC0003DMG200040970	K10760	ko00908	Zeatin biosynthesis	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMG200040970	K10760	ko01100	Metabolic pathways	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMG200040970	K10760	ko01110	Biosynthesis of secondary metabolites	565	2.5e-25	0.54	0.70	0.96
PGSC0003DMG200005256	K02134	ko00190	Oxidative phosphorylation	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMG200005256	K02134	ko01100	Metabolic pathways	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMG200005256	K02134	ko05010	Alzheimer's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMG200005256	K02134	ko05012	Parkinson's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMG200005256	K02134	ko05016	Huntington's disease	1271	2.9e-64	0.82	0.91	0.97
PGSC0003DMG200005257	K03363	ko04110	Cell cycle	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMG200005257	K03363	ko04111	Cell cycle - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMG200005257	K03363	ko04113	Meiosis - yeast	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMG200005257	K03363	ko04114	Oocyte meiosis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMG200005257	K03363	ko04120	Ubiquitin mediated proteolysis	1526	2.5e-78	0.45	0.64	0.90
PGSC0003DMG200005261	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko00908	Zeatin biosynthesis	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMG200005261	K10717	ko01100	Metabolic pathways	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMG200005261	K10717	ko01110	Biosynthesis of secondary metabolites	527	3.1e-23	0.39	0.62	0.97
PGSC0003DMG200005261	K10717	ko00908	Zeatin biosynthesis	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko01100	Metabolic pathways	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko01110	Biosynthesis of secondary metabolites	1119	7.0e-56	0.39	0.63	0.94
PGSC0003DMG200005261	K10717	ko00908	Zeatin biosynthesis	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMG200005261	K10717	ko01100	Metabolic pathways	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMG200005261	K10717	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.36	0.60	0.95
PGSC0003DMG200005271	K03950	ko00190	Oxidative phosphorylation	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMG200005271	K03950	ko01100	Metabolic pathways	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMG200005271	K03950	ko05010	Alzheimer's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMG200005271	K03950	ko05012	Parkinson's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMG200005271	K03950	ko05016	Huntington's disease	568	1.7e-25	0.71	0.85	0.99
PGSC0003DMG200005272	K00430	ko00360	Phenylalanine metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMG200005272	K00430	ko00680	Methane metabolism	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMG200005272	K00430	ko00940	Phenylpropanoid biosynthesis	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMG200005272	K00430	ko01100	Metabolic pathways	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMG200005272	K00430	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.59	0.75	0.99
PGSC0003DMG200005273	K00430	ko00360	Phenylalanine metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMG200005273	K00430	ko00680	Methane metabolism	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMG200005273	K00430	ko00940	Phenylpropanoid biosynthesis	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMG200005273	K00430	ko01100	Metabolic pathways	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMG200005273	K00430	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.71	0.84	0.94
PGSC0003DMG200005273	K00430	ko00360	Phenylalanine metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMG200005273	K00430	ko00680	Methane metabolism	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMG200005273	K00430	ko00940	Phenylpropanoid biosynthesis	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMG200005273	K00430	ko01100	Metabolic pathways	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMG200005273	K00430	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.71	0.87	0.92
PGSC0003DMG200009109	K01087	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.53	0.73	0.95
PGSC0003DMG200015258	K03010	ko00230	Purine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMG200015258	K03010	ko00240	Pyrimidine metabolism	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMG200015258	K03010	ko01100	Metabolic pathways	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMG200015258	K03010	ko03020	RNA polymerase	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMG200015258	K03010	ko05016	Huntington's disease	1877	1.1e-97	0.89	0.94	1.00
PGSC0003DMG200015258	K03010	ko00230	Purine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMG200015258	K03010	ko00240	Pyrimidine metabolism	7907	0.	0.76	0.87	1.00
PGSC0003DMG200015258	K03010	ko01100	Metabolic pathways	7907	0.	0.76	0.87	1.00
PGSC0003DMG200015258	K03010	ko03020	RNA polymerase	7907	0.	0.76	0.87	1.00
PGSC0003DMG200015258	K03010	ko05016	Huntington's disease	7907	0.	0.76	0.87	1.00
PGSC0003DMG200015259	K08066	ko04612	Antigen processing and presentation	685	6.0e-32	0.44	0.56	0.87
PGSC0003DMG200015260	K08066	ko04612	Antigen processing and presentation	420	2.5e-17	0.44	0.64	0.79
PGSC0003DMG200015265	K01114	ko00562	Inositol phosphate metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMG200015265	K01114	ko00564	Glycerophospholipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMG200015265	K01114	ko00565	Ether lipid metabolism	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMG200015265	K01114	ko01100	Metabolic pathways	3617	1.2e-193	0.80	0.88	1.00
PGSC0003DMG200015265	K01114	ko00562	Inositol phosphate metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMG200015265	K01114	ko00564	Glycerophospholipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMG200015265	K01114	ko00565	Ether lipid metabolism	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMG200015265	K01114	ko01100	Metabolic pathways	2989	5.0e-159	0.80	0.89	0.95
PGSC0003DMG200015268	K10684	ko04120	Ubiquitin mediated proteolysis	2068	3.2e-108	0.75	0.88	0.98
PGSC0003DMG200015270	K05681	ko02010	ABC transporters	1119	7.0e-56	0.34	0.51	0.92
PGSC0003DMG200015271	K02998	ko03010	Ribosome	1850	3.3e-96	0.73	0.79	1.00
PGSC0003DMG200015273	K07407	ko00052	Galactose metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMG200015273	K07407	ko00561	Glycerolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMG200015273	K07407	ko00600	Sphingolipid metabolism	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMG200015273	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1749	1.2e-90	0.58	0.69	0.90
PGSC0003DMG200015273	K07407	ko00052	Galactose metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMG200015273	K07407	ko00561	Glycerolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMG200015273	K07407	ko00600	Sphingolipid metabolism	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMG200015273	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1996	3.0e-104	0.60	0.72	0.95
PGSC0003DMG200011994	K02433	ko00970	Aminoacyl-tRNA biosynthesis	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMG200011994	K02433	ko01100	Metabolic pathways	353	1.2e-13	0.51	0.64	0.91
PGSC0003DMG200011994	K02433	ko00970	Aminoacyl-tRNA biosynthesis	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMG200011994	K02433	ko01100	Metabolic pathways	254	7.9e-15	0.36	0.50	0.78
PGSC0003DMG200011994	K02433	ko00970	Aminoacyl-tRNA biosynthesis	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMG200011994	K02433	ko01100	Metabolic pathways	758	5.7e-36	0.37	0.54	0.93
PGSC0003DMG200011994	K02433	ko00970	Aminoacyl-tRNA biosynthesis	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMG200011994	K02433	ko01100	Metabolic pathways	647	7.5e-30	0.38	0.56	0.95
PGSC0003DMG200011994	K02433	ko00970	Aminoacyl-tRNA biosynthesis	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMG200011994	K02433	ko01100	Metabolic pathways	765	2.3e-36	0.38	0.54	0.93
PGSC0003DMG200011997	K04077	ko03018	RNA degradation	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMG200011997	K04077	ko04940	Type I diabetes mellitus	2504	2.8e-132	0.58	0.78	0.91
PGSC0003DMG200011999	K05681	ko02010	ABC transporters	573	9.1e-26	0.35	0.54	0.77
PGSC0003DMG200011999	K05681	ko02010	ABC transporters	651	4.5e-30	0.31	0.51	0.87
PGSC0003DMG200011999	K05681	ko02010	ABC transporters	676	1.9e-31	0.31	0.51	0.82
PGSC0003DMG200011999	K05683	ko02010	ABC transporters	739	6.3e-35	0.31	0.52	0.83
PGSC0003DMG200011999	K05683	ko02010	ABC transporters	838	2.2e-40	0.31	0.51	0.83
PGSC0003DMG200011999	K05683	ko02010	ABC transporters	638	2.4e-29	0.37	0.57	0.71
PGSC0003DMG200018699	K13065	ko00940	Phenylpropanoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMG200018699	K13065	ko00941	Flavonoid biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMG200018699	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMG200018699	K13065	ko01110	Biosynthesis of secondary metabolites	570	1.3e-25	0.31	0.49	0.84
PGSC0003DMG200018700	K13065	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMG200018700	K13065	ko00941	Flavonoid biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMG200018700	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMG200018700	K13065	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.32	0.51	0.99
PGSC0003DMG200018700	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMG200018700	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMG200018700	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMG200018700	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.99
PGSC0003DMG200018701	K02908	ko03010	Ribosome	920	6.6e-45	0.96	1.00	0.99
PGSC0003DMG200018704	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.90
PGSC0003DMG200018704	K01199	ko00500	Starch and sucrose metabolism	765	2.3e-36	0.36	0.57	0.92
PGSC0003DMG200018706	K01426	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00360	Phenylalanine metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00380	Tryptophan metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00632	Benzoate degradation via CoA ligation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00643	Styrene degradation	1016	3.3e-50	0.47	0.65	0.91
PGSC0003DMG200018706	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00330	Arginine and proline metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00360	Phenylalanine metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00380	Tryptophan metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00460	Cyanoamino acid metabolism	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00632	Benzoate degradation via CoA ligation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200018706	K01426	ko00643	Styrene degradation	1349	1.4e-68	0.43	0.61	0.93
PGSC0003DMG200023436	K00249	ko00071	Fatty acid metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko00280	Valine, leucine and isoleucine degradation	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko00410	beta-Alanine metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko00640	Propanoate metabolism	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko01100	Metabolic pathways	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko01110	Biosynthesis of secondary metabolites	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko03320	PPAR signaling pathway	4497	3.4e-242	0.66	0.77	1.00
PGSC0003DMG200023436	K00249	ko00071	Fatty acid metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko00280	Valine, leucine and isoleucine degradation	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko00410	beta-Alanine metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko00640	Propanoate metabolism	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko01100	Metabolic pathways	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko01110	Biosynthesis of secondary metabolites	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023436	K00249	ko03320	PPAR signaling pathway	5066	1.4e-273	0.71	0.84	1.00
PGSC0003DMG200023437	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMG200023437	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMG200023437	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.62	0.76	0.99
PGSC0003DMG200023439	K10594	ko04120	Ubiquitin mediated proteolysis	367	1.0e-12	0.40	0.56	0.46
PGSC0003DMG200023439	K10615	ko04120	Ubiquitin mediated proteolysis	681	1.8e-31	0.33	0.52	0.89
PGSC0003DMG200023439	K10615	ko04120	Ubiquitin mediated proteolysis	545	1.2e-23	0.35	0.54	0.84
PGSC0003DMG200023439	K10615	ko04120	Ubiquitin mediated proteolysis	674	4.7e-31	0.33	0.52	0.89
PGSC0003DMG200023439	K10615	ko04120	Ubiquitin mediated proteolysis	483	3.9e-20	0.35	0.54	0.80
PGSC0003DMG200027180	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMG200027180	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMG200027180	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMG200027180	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.31	0.47	0.84
PGSC0003DMG200027181	K13065	ko00940	Phenylpropanoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMG200027181	K13065	ko00941	Flavonoid biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMG200027181	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMG200027181	K13065	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.31	0.48	0.84
PGSC0003DMG200027186	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMG200027186	K02917	ko03010	Ribosome	892	2.3e-43	0.90	0.94	0.99
PGSC0003DMG200027186	K02917	ko03010	Ribosome	901	7.4e-44	0.91	0.95	0.99
PGSC0003DMG200030097	K00681	ko00430	Taurine and hypotaurine metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko00450	Selenoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko00460	Cyanoamino acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko00480	Glutathione metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko00590	Arachidonic acid metabolism	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko01100	Metabolic pathways	1956	4.8e-102	0.65	0.78	0.99
PGSC0003DMG200030097	K00681	ko00430	Taurine and hypotaurine metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030097	K00681	ko00450	Selenoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030097	K00681	ko00460	Cyanoamino acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030097	K00681	ko00480	Glutathione metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030097	K00681	ko00590	Arachidonic acid metabolism	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030097	K00681	ko01100	Metabolic pathways	3297	5.2e-176	0.67	0.79	0.99
PGSC0003DMG200030104	K03013	ko00230	Purine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMG200030104	K03013	ko00240	Pyrimidine metabolism	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMG200030104	K03013	ko01100	Metabolic pathways	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMG200030104	K03013	ko03020	RNA polymerase	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMG200030104	K03013	ko05016	Huntington's disease	1486	4.0e-76	0.83	0.94	1.00
PGSC0003DMG200009755	K03660	ko03410	Base excision repair	270	2.6e-08	0.41	0.55	0.71
PGSC0003DMG200009757	K12192	ko04144	Endocytosis	1157	5.6e-58	0.74	0.89	0.85
PGSC0003DMG200009757	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMG200009757	K12192	ko04144	Endocytosis	886	4.9e-43	0.72	0.87	0.99
PGSC0003DMG200009757	K12192	ko04144	Endocytosis	1338	5.8e-68	0.75	0.90	1.00
PGSC0003DMG200009759	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMG200009759	K00517	ko00626	Naphthalene and anthracene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMG200009759	K00517	ko00903	Limonene and pinene degradation	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMG200009759	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMG200009759	K00517	ko01110	Biosynthesis of secondary metabolites	722	5.5e-34	0.54	0.70	0.95
PGSC0003DMG200009760	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMG200009760	K00517	ko00626	Naphthalene and anthracene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMG200009760	K00517	ko00903	Limonene and pinene degradation	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMG200009760	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMG200009760	K00517	ko01110	Biosynthesis of secondary metabolites	293	2.5e-18	0.40	0.60	0.92
PGSC0003DMG200009761	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMG200009761	K00517	ko00626	Naphthalene and anthracene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMG200009761	K00517	ko00903	Limonene and pinene degradation	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMG200009761	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMG200009761	K00517	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.37	0.61	1.00
PGSC0003DMG200009761	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMG200009761	K00517	ko00626	Naphthalene and anthracene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMG200009761	K00517	ko00903	Limonene and pinene degradation	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMG200009761	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMG200009761	K00517	ko01110	Biosynthesis of secondary metabolites	755	8.3e-36	0.56	0.71	0.95
PGSC0003DMG200009762	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMG200009762	K00517	ko00626	Naphthalene and anthracene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMG200009762	K00517	ko00903	Limonene and pinene degradation	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMG200009762	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMG200009762	K00517	ko01110	Biosynthesis of secondary metabolites	769	1.4e-36	0.38	0.56	0.95
PGSC0003DMG200009762	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMG200009762	K00517	ko00626	Naphthalene and anthracene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMG200009762	K00517	ko00903	Limonene and pinene degradation	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMG200009762	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMG200009762	K00517	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.43	0.61	0.97
PGSC0003DMG200009763	K00558	ko00270	Cysteine and methionine metabolism	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMG200009763	K00558	ko01100	Metabolic pathways	336	1.3e-11	0.39	0.54	0.62
PGSC0003DMG200009766	K12606	ko03018	RNA degradation	273	3.2e-09	0.62	0.71	0.80
PGSC0003DMG200009767	K12606	ko03018	RNA degradation	187	6.3e-13	0.56	0.66	0.83
PGSC0003DMG200005939	K05864	ko04020	Calcium signaling pathway	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMG200005939	K05864	ko05012	Parkinson's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMG200005939	K05864	ko05016	Huntington's disease	292	6.4e-10	0.31	0.51	0.28
PGSC0003DMG200005942	K01188	ko00460	Cyanoamino acid metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMG200005942	K01188	ko00500	Starch and sucrose metabolism	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMG200005942	K01188	ko00940	Phenylpropanoid biosynthesis	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMG200005942	K01188	ko01110	Biosynthesis of secondary metabolites	2402	1.2e-126	0.51	0.66	0.95
PGSC0003DMG200005942	K01188	ko00460	Cyanoamino acid metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMG200005942	K01188	ko00500	Starch and sucrose metabolism	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMG200005942	K01188	ko00940	Phenylpropanoid biosynthesis	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMG200005942	K01188	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.57	0.75	0.99
PGSC0003DMG200005943	K01188	ko00460	Cyanoamino acid metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMG200005943	K01188	ko00500	Starch and sucrose metabolism	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMG200005943	K01188	ko00940	Phenylpropanoid biosynthesis	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMG200005943	K01188	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.54	0.71	0.99
PGSC0003DMG200005943	K01188	ko00460	Cyanoamino acid metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMG200005943	K01188	ko00500	Starch and sucrose metabolism	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMG200005943	K01188	ko00940	Phenylpropanoid biosynthesis	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMG200005943	K01188	ko01110	Biosynthesis of secondary metabolites	1805	1.0e-93	0.57	0.74	0.89
PGSC0003DMG200005943	K01188	ko00460	Cyanoamino acid metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMG200005943	K01188	ko00500	Starch and sucrose metabolism	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMG200005943	K01188	ko00940	Phenylpropanoid biosynthesis	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMG200005943	K01188	ko01110	Biosynthesis of secondary metabolites	2846	3.9e-151	0.57	0.73	0.97
PGSC0003DMG200005944	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.57	0.89
PGSC0003DMG200005946	K03361	ko04111	Cell cycle - yeast	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMG200005946	K03361	ko04120	Ubiquitin mediated proteolysis	305	2.2e-08	0.28	0.48	0.50
PGSC0003DMG200005948	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04110	Cell cycle	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04115	p53 signaling pathway	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04914	Progesterone-mediated oocyte maturation	1440	1.4e-73	0.74	0.88	0.95
PGSC0003DMG200005948	K05868	ko04110	Cell cycle	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMG200005948	K05868	ko04115	p53 signaling pathway	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMG200005948	K05868	ko04914	Progesterone-mediated oocyte maturation	2116	7.1e-111	0.61	0.74	0.98
PGSC0003DMG200012654	K10839	ko03420	Nucleotide excision repair	2396	2.6e-126	0.76	0.85	1.00
PGSC0003DMG200012654	K10839	ko03420	Nucleotide excision repair	1128	2.2e-56	0.71	0.84	0.95
PGSC0003DMG200012654	K10839	ko03420	Nucleotide excision repair	2464	4.6e-130	0.77	0.86	1.00
PGSC0003DMG200012656	K10615	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.49	0.96
PGSC0003DMG200012657	K10579	ko04120	Ubiquitin mediated proteolysis	1200	2.4e-60	0.72	0.83	0.73
PGSC0003DMG200012657	K10579	ko04120	Ubiquitin mediated proteolysis	1219	2.1e-61	0.77	0.85	0.99
PGSC0003DMG200012658	K12356	ko00940	Phenylpropanoid biosynthesis	1238	1.9e-62	0.57	0.72	0.96
PGSC0003DMG200012658	K12356	ko00940	Phenylpropanoid biosynthesis	1953	7.0e-102	0.51	0.71	0.98
PGSC0003DMG200012659	K04427	ko04010	MAPK signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04310	Wnt signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04520	Adherens junction	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04620	Toll-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04621	NOD-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04622	RIG-I-like receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko04660	T cell receptor signaling pathway	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012659	K04427	ko05140	Leishmaniasis	667	5.9e-31	0.39	0.53	0.74
PGSC0003DMG200012663	K01939	ko00230	Purine metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMG200012663	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMG200012663	K01939	ko01100	Metabolic pathways	3427	3.5e-183	0.81	0.89	0.99
PGSC0003DMG200012666	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMG200012666	K01602	ko00710	Carbon fixation in photosynthetic organisms	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMG200012666	K01602	ko01100	Metabolic pathways	1168	1.4e-58	0.83	0.92	0.97
PGSC0003DMG200012666	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko00710	Carbon fixation in photosynthetic organisms	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012666	K01602	ko01100	Metabolic pathways	1251	3.6e-63	0.80	0.92	0.98
PGSC0003DMG200012667	K00430	ko00360	Phenylalanine metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMG200012667	K00430	ko00680	Methane metabolism	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMG200012667	K00430	ko00940	Phenylpropanoid biosynthesis	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMG200012667	K00430	ko01100	Metabolic pathways	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMG200012667	K00430	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.30	0.44	0.79
PGSC0003DMG200012668	K00430	ko00360	Phenylalanine metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMG200012668	K00430	ko00680	Methane metabolism	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMG200012668	K00430	ko00940	Phenylpropanoid biosynthesis	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMG200012668	K00430	ko01100	Metabolic pathways	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMG200012668	K00430	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.38	0.55	0.87
PGSC0003DMG200046752	K10760	ko00908	Zeatin biosynthesis	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMG200046752	K10760	ko01100	Metabolic pathways	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMG200046752	K10760	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.52	0.72	0.95
PGSC0003DMG200046771	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2561	2.0e-135	0.72	0.84	0.99
PGSC0003DMG200042158	K05282	ko00904	Diterpenoid biosynthesis	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMG200042158	K05282	ko01100	Metabolic pathways	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMG200042158	K05282	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.59	0.72	0.95
PGSC0003DMG200042168	K13248	ko00750	Vitamin B6 metabolism	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMG200042168	K13248	ko01100	Metabolic pathways	414	5.3e-17	0.33	0.48	0.96
PGSC0003DMG200000742	K05280	ko00941	Flavonoid biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMG200000742	K05280	ko00944	Flavone and flavonol biosynthesis	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMG200000742	K05280	ko01100	Metabolic pathways	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMG200000742	K05280	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.48	0.70	0.99
PGSC0003DMG200000743	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMG200000743	K00517	ko00626	Naphthalene and anthracene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMG200000743	K00517	ko00903	Limonene and pinene degradation	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMG200000743	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMG200000743	K00517	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.52	0.69	0.99
PGSC0003DMG200000744	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMG200000744	K00517	ko00626	Naphthalene and anthracene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMG200000744	K00517	ko00903	Limonene and pinene degradation	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMG200000744	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMG200000744	K00517	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.47	0.65	0.99
PGSC0003DMG200000744	K05280	ko00941	Flavonoid biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMG200000744	K05280	ko00944	Flavone and flavonol biosynthesis	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMG200000744	K05280	ko01100	Metabolic pathways	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMG200000744	K05280	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.50	0.69	0.99
PGSC0003DMG200000745	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMG200000745	K00517	ko00626	Naphthalene and anthracene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMG200000745	K00517	ko00903	Limonene and pinene degradation	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMG200000745	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMG200000745	K00517	ko01110	Biosynthesis of secondary metabolites	1664	6.1e-86	0.46	0.66	0.95
PGSC0003DMG200000746	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMG200000746	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMG200000746	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMG200000746	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMG200000746	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.45	0.65	0.98
PGSC0003DMG200000747	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMG200000747	K00517	ko00626	Naphthalene and anthracene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMG200000747	K00517	ko00903	Limonene and pinene degradation	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMG200000747	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMG200000747	K00517	ko01110	Biosynthesis of secondary metabolites	1024	1.2e-50	0.46	0.63	0.98
PGSC0003DMG200000749	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMG200000749	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMG200000749	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMG200000749	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMG200000749	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.46	0.65	0.95
PGSC0003DMG200000752	K11228	ko04011	MAPK signaling pathway - yeast	960	4.1e-47	0.34	0.49	0.79
PGSC0003DMG200000752	K11228	ko04011	MAPK signaling pathway - yeast	956	6.8e-47	0.35	0.49	0.79
PGSC0003DMG200000753	K01834	ko00010	Glycolysis / Gluconeogenesis	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMG200000753	K01834	ko01100	Metabolic pathways	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMG200000753	K01834	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.73	0.84	0.66
PGSC0003DMG200000753	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko00010	Glycolysis / Gluconeogenesis	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko01100	Metabolic pathways	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko01110	Biosynthesis of secondary metabolites	1263	7.9e-64	0.68	0.83	0.90
PGSC0003DMG200000753	K01834	ko00010	Glycolysis / Gluconeogenesis	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMG200000753	K01834	ko01100	Metabolic pathways	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMG200000753	K01834	ko01110	Biosynthesis of secondary metabolites	933	1.3e-45	0.55	0.67	0.88
PGSC0003DMG200000753	K01834	ko00010	Glycolysis / Gluconeogenesis	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMG200000753	K01834	ko01100	Metabolic pathways	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMG200000753	K01834	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.78	0.86	0.76
PGSC0003DMG200000755	K08233	ko00901	Indole alkaloid biosynthesis	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMG200000755	K08233	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.49	0.69	0.99
PGSC0003DMG200000756	K08233	ko00901	Indole alkaloid biosynthesis	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMG200000756	K08233	ko01110	Biosynthesis of secondary metabolites	1082	7.6e-54	0.52	0.69	0.99
PGSC0003DMG200000757	K08233	ko00901	Indole alkaloid biosynthesis	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMG200000757	K08233	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.53	0.69	0.99
PGSC0003DMG200000758	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMG200000758	K00517	ko00626	Naphthalene and anthracene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMG200000758	K00517	ko00903	Limonene and pinene degradation	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMG200000758	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMG200000758	K00517	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.99
PGSC0003DMG200000758	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMG200000758	K00517	ko00626	Naphthalene and anthracene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMG200000758	K00517	ko00903	Limonene and pinene degradation	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMG200000758	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMG200000758	K00517	ko01110	Biosynthesis of secondary metabolites	1732	1.1e-89	0.48	0.66	0.95
PGSC0003DMG200000759	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMG200000759	K00517	ko00626	Naphthalene and anthracene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMG200000759	K00517	ko00903	Limonene and pinene degradation	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMG200000759	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMG200000759	K00517	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.46	0.66	0.92
PGSC0003DMG200000759	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMG200000759	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMG200000759	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMG200000759	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMG200000759	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.66	0.95
PGSC0003DMG200026494	K10781	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMG200026494	K10781	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.76	0.74
PGSC0003DMG200026500	K08916	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMG200026500	K08916	ko01100	Metabolic pathways	2019	1.6e-105	0.84	0.90	1.00
PGSC0003DMG200026502	K02145	ko00190	Oxidative phosphorylation	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026502	K02145	ko01100	Metabolic pathways	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026502	K02145	ko04145	Phagosome	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026502	K02145	ko04966	Collecting duct acid secretion	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026502	K02145	ko05110	Vibrio cholerae infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026502	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5063	2.0e-273	0.95	0.98	1.00
PGSC0003DMG200026505	K01230	ko00510	N-Glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMG200026505	K01230	ko00513	High-mannose type N-glycan biosynthesis	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMG200026505	K01230	ko01100	Metabolic pathways	3149	7.5e-168	0.66	0.78	0.99
PGSC0003DMG200026505	K01230	ko00510	N-Glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMG200026505	K01230	ko00513	High-mannose type N-glycan biosynthesis	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMG200026505	K01230	ko01100	Metabolic pathways	2165	1.4e-113	0.67	0.82	0.96
PGSC0003DMG200026505	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026505	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026505	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026505	K01230	ko00510	N-Glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMG200026505	K01230	ko00513	High-mannose type N-glycan biosynthesis	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMG200026505	K01230	ko01100	Metabolic pathways	3415	1.6e-182	0.70	0.83	0.99
PGSC0003DMG200026505	K01230	ko00510	N-Glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026505	K01230	ko00513	High-mannose type N-glycan biosynthesis	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026505	K01230	ko01100	Metabolic pathways	2342	2.4e-123	0.67	0.82	1.00
PGSC0003DMG200026508	K02135	ko00190	Oxidative phosphorylation	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMG200026508	K02135	ko01100	Metabolic pathways	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMG200026508	K02135	ko05010	Alzheimer's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMG200026508	K02135	ko05012	Parkinson's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMG200026508	K02135	ko05016	Huntington's disease	505	5.1e-22	0.78	0.93	0.97
PGSC0003DMG200022693	K02183	ko04020	Calcium signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04070	Phosphatidylinositol signaling system	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04114	Oocyte meiosis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04270	Vascular smooth muscle contraction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04626	Plant-pathogen interaction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04720	Long-term potentiation	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04722	Neurotrophin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04740	Olfactory transduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04744	Phototransduction	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04745	Phototransduction - fly	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04910	Insulin signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04912	GnRH signaling pathway	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04916	Melanogenesis	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04970	Salivary secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko04971	Gastric acid secretion	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko05010	Alzheimer's disease	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022693	K02183	ko05214	Glioma	1245	7.8e-63	0.99	1.00	0.99
PGSC0003DMG200022694	K08101	ko00860	Porphyrin and chlorophyll metabolism	1562	2.6e-80	0.56	0.72	0.97
PGSC0003DMG200022694	K08101	ko00860	Porphyrin and chlorophyll metabolism	655	2.7e-30	0.49	0.64	0.90
PGSC0003DMG200022694	K08101	ko00860	Porphyrin and chlorophyll metabolism	910	2.3e-44	0.66	0.83	0.93
PGSC0003DMG200022694	K08101	ko00860	Porphyrin and chlorophyll metabolism	1472	2.4e-75	0.64	0.81	0.94
PGSC0003DMG200022699	K12796	ko04621	NOD-like receptor signaling pathway	422	1.3e-13	0.29	0.47	0.33
PGSC0003DMG200022702	K05868	ko04110	Cell cycle	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMG200022702	K05868	ko04115	p53 signaling pathway	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMG200022702	K05868	ko04914	Progesterone-mediated oocyte maturation	2165	1.4e-113	0.66	0.75	0.97
PGSC0003DMG200034671	K09757	ko00940	Phenylpropanoid biosynthesis	252	4.6e-08	0.65	0.77	0.57
PGSC0003DMG200034672	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.40	0.56	0.56
PGSC0003DMG200029406	K05298	ko00710	Carbon fixation in photosynthetic organisms	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMG200029406	K05298	ko01100	Metabolic pathways	3264	3.4e-174	0.86	0.92	1.00
PGSC0003DMG200029408	K03781	ko00380	Tryptophan metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMG200029408	K03781	ko00680	Methane metabolism	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMG200029408	K03781	ko01100	Metabolic pathways	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMG200029408	K03781	ko04146	Peroxisome	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMG200029408	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	3515	4.9e-188	0.79	0.89	1.00
PGSC0003DMG200029409	K08332	ko04140	Regulation of autophagy	326	1.4e-09	0.29	0.51	0.42
PGSC0003DMG200029412	K00121	ko00010	Glycolysis / Gluconeogenesis	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00071	Fatty acid metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00350	Tyrosine metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00641	3-Chloroacrylic acid degradation	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00680	Methane metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00830	Retinol metabolism	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00982	Drug metabolism - cytochrome P450	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko01100	Metabolic pathways	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko01110	Biosynthesis of secondary metabolites	1202	1.8e-60	0.77	0.87	0.95
PGSC0003DMG200029412	K00121	ko00010	Glycolysis / Gluconeogenesis	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00071	Fatty acid metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00350	Tyrosine metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00641	3-Chloroacrylic acid degradation	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00680	Methane metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00830	Retinol metabolism	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00982	Drug metabolism - cytochrome P450	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko01100	Metabolic pathways	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko01110	Biosynthesis of secondary metabolites	1396	3.7e-71	0.78	0.93	1.00
PGSC0003DMG200029412	K00121	ko00010	Glycolysis / Gluconeogenesis	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00071	Fatty acid metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00350	Tyrosine metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00641	3-Chloroacrylic acid degradation	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00680	Methane metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00830	Retinol metabolism	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko00982	Drug metabolism - cytochrome P450	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko01100	Metabolic pathways	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029412	K00121	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.78	0.90	0.97
PGSC0003DMG200029414	K00423	ko00053	Ascorbate and aldarate metabolism	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMG200029414	K00423	ko01100	Metabolic pathways	2370	7.0e-125	0.55	0.68	0.98
PGSC0003DMG200029415	K06685	ko04111	Cell cycle - yeast	350	2.2e-10	0.31	0.48	0.42
PGSC0003DMG200029415	K06685	ko04111	Cell cycle - yeast	350	6.8e-10	0.31	0.48	0.28
PGSC0003DMG200029416	K00799	ko00480	Glutathione metabolism	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMG200029416	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMG200029416	K00799	ko00982	Drug metabolism - cytochrome P450	802	2.1e-38	0.48	0.68	0.97
PGSC0003DMG200029416	K00799	ko00480	Glutathione metabolism	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMG200029416	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMG200029416	K00799	ko00982	Drug metabolism - cytochrome P450	383	2.7e-15	0.54	0.75	0.86
PGSC0003DMG200029422	K12619	ko03018	RNA degradation	6012	0.	0.67	0.76	0.98
PGSC0003DMG200029422	K12619	ko03018	RNA degradation	5999	0.	0.67	0.76	0.98
PGSC0003DMG200014422	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMG200014423	K12188	ko04144	Endocytosis	1076	1.6e-53	0.83	0.95	0.96
PGSC0003DMG200014423	K12188	ko04144	Endocytosis	1892	1.6e-98	0.88	0.96	0.99
PGSC0003DMG200014430	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	0.99
PGSC0003DMG200014430	K08770	ko03320	PPAR signaling pathway	3122	2.3e-166	1.00	1.00	1.00
PGSC0003DMG200014431	K08770	ko03320	PPAR signaling pathway	4360	1.2e-234	1.00	1.00	1.00
PGSC0003DMG200014436	K08770	ko03320	PPAR signaling pathway	331	2.0e-12	0.76	0.88	0.95
PGSC0003DMG200003700	K04371	ko04010	MAPK signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04012	ErbB signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04013	MAPK signaling pathway - fly	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04062	Chemokine signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04114	Oocyte meiosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04150	mTOR signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04270	Vascular smooth muscle contraction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04320	Dorso-ventral axis formation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04350	TGF-beta signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04360	Axon guidance	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04370	VEGF signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04510	Focal adhesion	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04520	Adherens junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04540	Gap junction	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04620	Toll-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04621	NOD-like receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04650	Natural killer cell mediated cytotoxicity	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04660	T cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04662	B cell receptor signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04664	Fc epsilon RI signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04666	Fc gamma R-mediated phagocytosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04720	Long-term potentiation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04722	Neurotrophin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04730	Long-term depression	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04810	Regulation of actin cytoskeleton	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04910	Insulin signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04912	GnRH signaling pathway	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04914	Progesterone-mediated oocyte maturation	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04916	Melanogenesis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04930	Type II diabetes mellitus	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko04960	Aldosterone-regulated sodium reabsorption	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05010	Alzheimer's disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05020	Prion diseases	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05131	Shigellosis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05140	Leishmaniasis	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05142	Chagas disease	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05200	Pathways in cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05210	Colorectal cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05211	Renal cell carcinoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05212	Pancreatic cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05213	Endometrial cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05214	Glioma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05215	Prostate cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05216	Thyroid cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05218	Melanoma	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05219	Bladder cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05220	Chronic myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05221	Acute myeloid leukemia	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003700	K04371	ko05223	Non-small cell lung cancer	1430	4.9e-73	0.91	0.97	0.96
PGSC0003DMG200003701	K04371	ko04010	MAPK signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04012	ErbB signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04013	MAPK signaling pathway - fly	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04062	Chemokine signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04114	Oocyte meiosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04150	mTOR signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04270	Vascular smooth muscle contraction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04320	Dorso-ventral axis formation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04360	Axon guidance	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04370	VEGF signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04510	Focal adhesion	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04520	Adherens junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04540	Gap junction	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04620	Toll-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04621	NOD-like receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04650	Natural killer cell mediated cytotoxicity	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04660	T cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04662	B cell receptor signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04664	Fc epsilon RI signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04666	Fc gamma R-mediated phagocytosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04720	Long-term potentiation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04722	Neurotrophin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04730	Long-term depression	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04810	Regulation of actin cytoskeleton	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04910	Insulin signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04912	GnRH signaling pathway	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04914	Progesterone-mediated oocyte maturation	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04916	Melanogenesis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04930	Type II diabetes mellitus	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko04960	Aldosterone-regulated sodium reabsorption	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05010	Alzheimer's disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05020	Prion diseases	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05131	Shigellosis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05140	Leishmaniasis	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05142	Chagas disease	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05200	Pathways in cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05210	Colorectal cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05211	Renal cell carcinoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05212	Pancreatic cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05213	Endometrial cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05214	Glioma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05215	Prostate cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05216	Thyroid cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05218	Melanoma	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05219	Bladder cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05220	Chronic myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05221	Acute myeloid leukemia	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003701	K04371	ko05223	Non-small cell lung cancer	714	1.5e-33	0.62	0.75	0.99
PGSC0003DMG200003703	K01190	ko00052	Galactose metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMG200003703	K01190	ko00511	Other glycan degradation	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMG200003703	K01190	ko00600	Sphingolipid metabolism	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMG200003703	K01190	ko01100	Metabolic pathways	2787	7.0e-148	0.58	0.73	0.99
PGSC0003DMG200003704	K01338	ko04112	Cell cycle - Caulobacter	805	1.4e-38	0.51	0.68	0.74
PGSC0003DMG200003715	K04618	ko00052	Galactose metabolism	468	6.4e-20	0.29	0.44	0.81
PGSC0003DMG200003716	K04618	ko00052	Galactose metabolism	437	4.6e-18	0.29	0.44	0.81
PGSC0003DMG200003717	K04618	ko00052	Galactose metabolism	470	4.8e-20	0.29	0.46	0.81
PGSC0003DMG200006859	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMG200006861	K04457	ko04010	MAPK signaling pathway	558	3.6e-24	0.35	0.51	0.24
PGSC0003DMG200006862	K01184	ko00040	Pentose and glucuronate interconversions	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMG200006862	K01184	ko00500	Starch and sucrose metabolism	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMG200006862	K01184	ko01100	Metabolic pathways	993	6.2e-49	0.40	0.57	0.95
PGSC0003DMG200006863	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.52	0.67	0.65
PGSC0003DMG200006863	K08064	ko04612	Antigen processing and presentation	591	9.2e-27	0.40	0.55	0.75
PGSC0003DMG200006869	K02137	ko00190	Oxidative phosphorylation	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMG200006869	K02137	ko01100	Metabolic pathways	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMG200006869	K02137	ko05010	Alzheimer's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMG200006869	K02137	ko05012	Parkinson's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMG200006869	K02137	ko05016	Huntington's disease	1298	9.3e-66	0.66	0.82	1.00
PGSC0003DMG200038771	K01955	ko00240	Pyrimidine metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMG200038771	K01955	ko00250	Alanine, aspartate and glutamate metabolism	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMG200038771	K01955	ko01100	Metabolic pathways	398	3.7e-15	0.49	0.67	0.81
PGSC0003DMG200021820	K01087	ko00500	Starch and sucrose metabolism	1309	2.3e-66	0.69	0.81	0.98
PGSC0003DMG200021822	K05658	ko02010	ABC transporters	342	4.7e-12	0.57	0.77	0.95
PGSC0003DMG200021822	K05658	ko02010	ABC transporters	324	4.7e-11	0.55	0.71	0.99
PGSC0003DMG200021822	K05658	ko02010	ABC transporters	544	2.3e-23	0.54	0.73	0.97
PGSC0003DMG200021831	K01858	ko00521	Streptomycin biosynthesis	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMG200021831	K01858	ko00562	Inositol phosphate metabolism	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMG200021831	K01858	ko01100	Metabolic pathways	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMG200021831	K01858	ko01110	Biosynthesis of secondary metabolites	4020	6.9e-216	0.92	0.97	1.00
PGSC0003DMG200024984	K10151	ko04110	Cell cycle	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMG200024984	K10151	ko04115	p53 signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMG200024984	K10151	ko04310	Wnt signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMG200024984	K10151	ko04510	Focal adhesion	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMG200024984	K10151	ko04630	Jak-STAT signaling pathway	322	6.3e-12	0.30	0.48	0.70
PGSC0003DMG200024985	K01110	ko00562	Inositol phosphate metabolism	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko04070	Phosphatidylinositol signaling system	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko04115	p53 signaling pathway	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko04510	Focal adhesion	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko04530	Tight junction	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05200	Pathways in cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05213	Endometrial cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05214	Glioma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05215	Prostate cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05218	Melanoma	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko05222	Small cell lung cancer	3316	4.6e-177	0.67	0.76	1.00
PGSC0003DMG200024985	K01110	ko00562	Inositol phosphate metabolism	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko04070	Phosphatidylinositol signaling system	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko04115	p53 signaling pathway	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko04510	Focal adhesion	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko04530	Tight junction	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05200	Pathways in cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05213	Endometrial cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05214	Glioma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05215	Prostate cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05218	Melanoma	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko05222	Small cell lung cancer	673	2.8e-31	0.52	0.65	0.99
PGSC0003DMG200024985	K01110	ko00562	Inositol phosphate metabolism	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko04070	Phosphatidylinositol signaling system	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko04115	p53 signaling pathway	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko04510	Focal adhesion	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko04530	Tight junction	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05200	Pathways in cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05213	Endometrial cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05214	Glioma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05215	Prostate cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05218	Melanoma	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024985	K01110	ko05222	Small cell lung cancer	2171	6.6e-114	0.73	0.81	0.90
PGSC0003DMG200024990	K05849	ko04020	Calcium signaling pathway	413	1.6e-16	0.35	0.52	0.51
PGSC0003DMG200024993	K00851	ko00030	Pentose phosphate pathway	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMG200024993	K00851	ko01100	Metabolic pathways	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMG200024993	K00851	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.66	0.82	0.98
PGSC0003DMG200024993	K00851	ko00030	Pentose phosphate pathway	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMG200024993	K00851	ko01100	Metabolic pathways	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMG200024993	K00851	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.68	0.78	0.98
PGSC0003DMG200031123	K00963	ko00040	Pentose and glucuronate interconversions	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko00052	Galactose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko00500	Starch and sucrose metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko01100	Metabolic pathways	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko01110	Biosynthesis of secondary metabolites	1504	4.1e-77	0.49	0.65	0.65
PGSC0003DMG200031123	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00040	Pentose and glucuronate interconversions	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko00052	Galactose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko00500	Starch and sucrose metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko01100	Metabolic pathways	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.51	0.71	0.49
PGSC0003DMG200031123	K00963	ko00040	Pentose and glucuronate interconversions	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00052	Galactose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00500	Starch and sucrose metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031123	K00963	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.51	0.68	0.47
PGSC0003DMG200031128	K12373	ko00511	Other glycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko00531	Glycosaminoglycan degradation	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko01100	Metabolic pathways	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko04142	Lysosome	2028	5.1e-106	0.74	0.88	0.99
PGSC0003DMG200031128	K12373	ko00511	Other glycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko00531	Glycosaminoglycan degradation	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko01100	Metabolic pathways	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031128	K12373	ko04142	Lysosome	3511	8.1e-188	0.69	0.84	0.98
PGSC0003DMG200031130	K04382	ko04111	Cell cycle - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04113	Meiosis - yeast	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04114	Oocyte meiosis	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04310	Wnt signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04350	TGF-beta signaling pathway	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04530	Tight junction	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04730	Long-term depression	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko05142	Chagas disease	2627	4.7e-139	0.95	0.98	1.00
PGSC0003DMG200031130	K04382	ko04111	Cell cycle - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04113	Meiosis - yeast	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04114	Oocyte meiosis	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04310	Wnt signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04350	TGF-beta signaling pathway	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04530	Tight junction	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko04730	Long-term depression	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200031130	K04382	ko05142	Chagas disease	1020	2.0e-50	0.96	0.99	0.99
PGSC0003DMG200030865	K06685	ko04111	Cell cycle - yeast	1620	1.6e-83	0.96	0.98	0.99
PGSC0003DMG200030865	K06685	ko04111	Cell cycle - yeast	1816	2.5e-94	0.97	0.99	1.00
PGSC0003DMG200030866	K11422	ko00310	Lysine degradation	288	1.3e-06	0.30	0.41	0.63
PGSC0003DMG200030866	K04512	ko04310	Wnt signaling pathway	833	4.1e-40	0.33	0.57	0.97
PGSC0003DMG200030867	K08762	ko03320	PPAR signaling pathway	606	1.4e-27	0.82	0.91	0.97
PGSC0003DMG200030868	K02873	ko03010	Ribosome	1563	2.3e-80	0.88	0.95	1.00
PGSC0003DMG200030869	K02948	ko03010	Ribosome	795	5.2e-38	0.61	0.77	0.99
PGSC0003DMG200030869	K02948	ko03010	Ribosome	854	2.9e-41	0.50	0.66	0.97
PGSC0003DMG200030873	K02895	ko03010	Ribosome	424	1.5e-17	0.53	0.72	0.61
PGSC0003DMG200030880	K03010	ko00230	Purine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMG200030880	K03010	ko00240	Pyrimidine metabolism	7637	0.	0.72	0.83	0.99
PGSC0003DMG200030880	K03010	ko01100	Metabolic pathways	7637	0.	0.72	0.83	0.99
PGSC0003DMG200030880	K03010	ko03020	RNA polymerase	7637	0.	0.72	0.83	0.99
PGSC0003DMG200030880	K03010	ko05016	Huntington's disease	7637	0.	0.72	0.83	0.99
PGSC0003DMG200030880	K03010	ko00230	Purine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMG200030880	K03010	ko00240	Pyrimidine metabolism	6880	0.	0.79	0.89	1.00
PGSC0003DMG200030880	K03010	ko01100	Metabolic pathways	6880	0.	0.79	0.89	1.00
PGSC0003DMG200030880	K03010	ko03020	RNA polymerase	6880	0.	0.79	0.89	1.00
PGSC0003DMG200030880	K03010	ko05016	Huntington's disease	6880	0.	0.79	0.89	1.00
PGSC0003DMG200024071	K12669	ko00510	N-Glycan biosynthesis	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMG200024071	K12669	ko01100	Metabolic pathways	1746	1.8e-90	0.61	0.79	1.00
PGSC0003DMG200024074	K02917	ko03010	Ribosome	838	2.2e-40	0.85	0.90	0.99
PGSC0003DMG200024449	K03039	ko03050	Proteasome	2881	4.6e-153	0.89	0.96	1.00
PGSC0003DMG200024450	K00059	ko00061	Fatty acid biosynthesis	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMG200024450	K00059	ko01040	Biosynthesis of unsaturated fatty acids	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMG200024450	K00059	ko01100	Metabolic pathways	486	5.7e-21	0.62	0.78	0.97
PGSC0003DMG200024452	K01581	ko00330	Arginine and proline metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMG200024452	K01581	ko00480	Glutathione metabolism	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMG200024452	K01581	ko01100	Metabolic pathways	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMG200024452	K01581	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.39	0.50	0.84
PGSC0003DMG200024458	K00100	ko00051	Fructose and mannose metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024458	K00100	ko00363	Bisphenol A degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024458	K00100	ko00591	Linoleic acid metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024458	K00100	ko00625	Tetrachloroethene degradation	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024458	K00100	ko00650	Butanoate metabolism	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024458	K00100	ko01100	Metabolic pathways	672	3.1e-31	0.32	0.46	0.84
PGSC0003DMG200024459	K00117	ko00030	Pentose phosphate pathway	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMG200024459	K00117	ko01100	Metabolic pathways	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMG200024459	K00117	ko01110	Biosynthesis of secondary metabolites	918	8.5e-45	0.33	0.48	0.73
PGSC0003DMG200024462	K10418	ko04962	Vasopressin-regulated water reabsorption	337	9.4e-13	0.52	0.66	0.32
PGSC0003DMG200024463	K12126	ko04712	Circadian rhythm - plant	274	5.1e-09	0.35	0.48	0.61
PGSC0003DMG200024463	K12126	ko04712	Circadian rhythm - plant	302	1.1e-10	0.34	0.52	0.62
PGSC0003DMG200024466	K12843	ko03040	Spliceosome	1429	5.6e-73	0.35	0.56	0.91
PGSC0003DMG200024467	K10643	ko03018	RNA degradation	266	1.3e-08	0.46	0.73	0.15
PGSC0003DMG200021392	K12850	ko03040	Spliceosome	349	2.1e-13	0.24	0.48	0.98
PGSC0003DMG200021400	K10352	ko04530	Tight junction	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMG200021400	K10352	ko05416	Viral myocarditis	681	6.1e-29	0.29	0.49	0.80
PGSC0003DMG200021405	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMG200021405	K02893	ko03010	Ribosome	578	4.8e-26	0.52	0.66	0.65
PGSC0003DMG200039869	K04121	ko00904	Diterpenoid biosynthesis	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMG200039869	K04121	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMG200039869	K04121	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.39	0.57	0.98
PGSC0003DMG200001387	K04371	ko04010	MAPK signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04012	ErbB signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04013	MAPK signaling pathway - fly	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04062	Chemokine signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04114	Oocyte meiosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04150	mTOR signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04270	Vascular smooth muscle contraction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04320	Dorso-ventral axis formation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04350	TGF-beta signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04360	Axon guidance	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04370	VEGF signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04510	Focal adhesion	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04520	Adherens junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04540	Gap junction	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04620	Toll-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04621	NOD-like receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04650	Natural killer cell mediated cytotoxicity	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04660	T cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04662	B cell receptor signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04664	Fc epsilon RI signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04666	Fc gamma R-mediated phagocytosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04720	Long-term potentiation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04722	Neurotrophin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04730	Long-term depression	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04810	Regulation of actin cytoskeleton	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04910	Insulin signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04912	GnRH signaling pathway	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04914	Progesterone-mediated oocyte maturation	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04916	Melanogenesis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04930	Type II diabetes mellitus	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko04960	Aldosterone-regulated sodium reabsorption	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05010	Alzheimer's disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05020	Prion diseases	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05131	Shigellosis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05140	Leishmaniasis	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05142	Chagas disease	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05200	Pathways in cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05210	Colorectal cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05211	Renal cell carcinoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05212	Pancreatic cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05213	Endometrial cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05214	Glioma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05215	Prostate cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05216	Thyroid cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05218	Melanoma	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05219	Bladder cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05220	Chronic myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05221	Acute myeloid leukemia	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001387	K04371	ko05223	Non-small cell lung cancer	326	6.1e-12	0.51	0.77	0.48
PGSC0003DMG200001388	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMG200001388	K00754	ko00051	Fructose and mannose metabolism	3711	7.6e-199	0.77	0.87	1.00
PGSC0003DMG200007616	K01187	ko00052	Galactose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMG200007616	K01187	ko00500	Starch and sucrose metabolism	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMG200007616	K01187	ko01100	Metabolic pathways	1371	8.8e-70	0.40	0.57	0.61
PGSC0003DMG200007616	K01187	ko00052	Galactose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMG200007616	K01187	ko00500	Starch and sucrose metabolism	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMG200007616	K01187	ko01100	Metabolic pathways	1855	1.8e-96	0.40	0.57	0.59
PGSC0003DMG200007619	K02890	ko03010	Ribosome	387	1.6e-15	0.44	0.66	0.47
PGSC0003DMG200007620	K12872	ko03040	Spliceosome	3548	7.4e-190	0.83	0.91	0.99
PGSC0003DMG200007623	K01633	ko00790	Folate biosynthesis	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMG200007623	K01633	ko01100	Metabolic pathways	451	4.9e-19	0.72	0.83	0.99
PGSC0003DMG200007625	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMG200007625	K03860	ko01100	Metabolic pathways	538	7.7e-24	0.37	0.57	0.83
PGSC0003DMG200007625	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMG200007625	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.67
PGSC0003DMG200007625	K03860	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMG200007625	K03860	ko01100	Metabolic pathways	558	6.1e-25	0.31	0.51	0.55
PGSC0003DMG200007628	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200007628	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200007628	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200007628	K00962	ko00230	Purine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200007628	K00962	ko00240	Pyrimidine metabolism	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200007628	K00962	ko03018	RNA degradation	5447	1.3e-294	0.74	0.84	1.00
PGSC0003DMG200004676	K05185	ko04080	Neuroactive ligand-receptor interaction	908	3.0e-44	0.30	0.33	0.96
PGSC0003DMG200004677	K05185	ko04080	Neuroactive ligand-receptor interaction	841	1.5e-40	0.31	0.34	0.85
PGSC0003DMG200004679	K01081	ko00230	Purine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMG200004679	K01081	ko00240	Pyrimidine metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMG200004679	K01081	ko00760	Nicotinate and nicotinamide metabolism	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMG200004679	K01081	ko01100	Metabolic pathways	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMG200004679	K01081	ko01110	Biosynthesis of secondary metabolites	870	3.8e-42	0.32	0.49	0.65
PGSC0003DMG200004681	K05658	ko02010	ABC transporters	6786	0.	0.64	0.80	1.00
PGSC0003DMG200004682	K02881	ko03010	Ribosome	1026	9.4e-51	0.77	0.86	0.98
PGSC0003DMG200004684	K01139	ko00230	Purine metabolism	797	4.0e-38	0.38	0.56	0.80
PGSC0003DMG200004684	K01139	ko00230	Purine metabolism	853	3.3e-41	0.39	0.57	0.65
PGSC0003DMG200004686	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMG200004686	K02977	ko03010	Ribosome	1328	2.1e-67	1.00	1.00	0.99
PGSC0003DMG200004688	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko00270	Cysteine and methionine metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko00450	Selenoamino acid metabolism	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko01100	Metabolic pathways	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200004688	K00789	ko01110	Biosynthesis of secondary metabolites	3252	1.6e-173	0.96	0.99	0.99
PGSC0003DMG200013299	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMG200013299	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMG200013299	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.73	0.87	0.96
PGSC0003DMG200013299	K07199	ko04910	Insulin signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMG200013299	K07199	ko04920	Adipocytokine signaling pathway	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMG200013299	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1496	1.1e-76	0.75	0.90	1.00
PGSC0003DMG200013302	K08065	ko04612	Antigen processing and presentation	451	4.9e-19	0.54	0.73	0.79
PGSC0003DMG200013304	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04010	MAPK signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04011	MAPK signaling pathway - yeast	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04012	ErbB signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04020	Calcium signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04070	Phosphatidylinositol signaling system	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04270	Vascular smooth muscle contraction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04310	Wnt signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04370	VEGF signaling pathway	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04510	Focal adhesion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04530	Tight junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04540	Gap junction	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04650	Natural killer cell mediated cytotoxicity	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04666	Fc gamma R-mediated phagocytosis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04670	Leukocyte transendothelial migration	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04720	Long-term potentiation	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04730	Long-term depression	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04745	Phototransduction - fly	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04916	Melanogenesis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04960	Aldosterone-regulated sodium reabsorption	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04970	Salivary secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko04971	Gastric acid secretion	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05110	Vibrio cholerae infection	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05146	Amoebiasis	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05200	Pathways in cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05214	Glioma	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K02677	ko05223	Non-small cell lung cancer	237	6.7e-07	0.36	0.50	0.72
PGSC0003DMG200013304	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMG200013304	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMG200013304	K12478	ko04144	Endocytosis	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMG200013304	K12478	ko04145	Phagosome	311	1.3e-08	0.28	0.46	0.83
PGSC0003DMG200013306	K06678	ko04111	Cell cycle - yeast	3346	1.0e-178	0.63	0.78	1.00
PGSC0003DMG200013309	K03934	ko00190	Oxidative phosphorylation	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMG200013309	K03934	ko01100	Metabolic pathways	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMG200013309	K03934	ko05010	Alzheimer's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMG200013309	K03934	ko05012	Parkinson's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMG200013309	K03934	ko05016	Huntington's disease	2039	1.3e-106	0.82	0.89	1.00
PGSC0003DMG200013309	K03934	ko00190	Oxidative phosphorylation	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMG200013309	K03934	ko01100	Metabolic pathways	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMG200013309	K03934	ko05010	Alzheimer's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMG200013309	K03934	ko05012	Parkinson's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMG200013309	K03934	ko05016	Huntington's disease	5456	4.3e-295	0.86	0.92	1.00
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	1174	6.4e-59	0.79	0.87	0.93
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	3430	2.4e-183	0.71	0.83	1.00
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	3889	1.2e-208	0.69	0.82	1.00
PGSC0003DMG200018775	K10872	ko04113	Meiosis - yeast	256	9.8e-08	0.30	0.45	0.87
PGSC0003DMG200018775	K10872	ko04113	Meiosis - yeast	252	1.7e-07	0.35	0.56	0.67
PGSC0003DMG200018775	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.86
PGSC0003DMG200018775	K10872	ko04113	Meiosis - yeast	272	1.2e-08	0.31	0.47	0.76
PGSC0003DMG200018777	K05894	ko00592	alpha-Linolenic acid metabolism	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMG200018777	K05894	ko01100	Metabolic pathways	2545	1.6e-134	0.78	0.87	1.00
PGSC0003DMG200018777	K05894	ko00592	alpha-Linolenic acid metabolism	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMG200018777	K05894	ko01100	Metabolic pathways	821	1.9e-39	0.73	0.84	0.99
PGSC0003DMG200018777	K05894	ko00592	alpha-Linolenic acid metabolism	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMG200018777	K05894	ko01100	Metabolic pathways	1187	1.2e-59	0.76	0.86	0.99
PGSC0003DMG200018778	K05894	ko00592	alpha-Linolenic acid metabolism	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMG200018778	K05894	ko01100	Metabolic pathways	1112	1.7e-55	0.69	0.84	0.99
PGSC0003DMG200018779	K05894	ko00592	alpha-Linolenic acid metabolism	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMG200018779	K05894	ko01100	Metabolic pathways	2233	2.5e-117	0.74	0.85	0.95
PGSC0003DMG200023310	K12347	ko04142	Lysosome	2945	1.3e-156	0.72	0.86	0.93
PGSC0003DMG200023317	K11294	ko05130	Pathogenic Escherichia coli infection	308	4.0e-08	0.28	0.48	0.30
PGSC0003DMG200023319	K00001	ko00010	Glycolysis / Gluconeogenesis	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00071	Fatty acid metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00350	Tyrosine metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00641	3-Chloroacrylic acid degradation	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00830	Retinol metabolism	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00982	Drug metabolism - cytochrome P450	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko01100	Metabolic pathways	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko01110	Biosynthesis of secondary metabolites	1605	1.1e-82	0.73	0.85	0.97
PGSC0003DMG200023319	K00001	ko00010	Glycolysis / Gluconeogenesis	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00071	Fatty acid metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00350	Tyrosine metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00641	3-Chloroacrylic acid degradation	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00830	Retinol metabolism	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko00982	Drug metabolism - cytochrome P450	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko01100	Metabolic pathways	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023319	K00001	ko01110	Biosynthesis of secondary metabolites	2590	5.1e-137	0.73	0.84	0.98
PGSC0003DMG200023321	K01082	ko00920	Sulfur metabolism	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMG200023321	K01082	ko01100	Metabolic pathways	2223	8.9e-117	0.77	0.87	1.00
PGSC0003DMG200023321	K01082	ko00920	Sulfur metabolism	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMG200023321	K01082	ko01100	Metabolic pathways	321	7.2e-12	0.74	0.90	0.94
PGSC0003DMG200023322	K12843	ko03040	Spliceosome	1417	2.5e-72	0.39	0.60	0.81
PGSC0003DMG200023326	K00901	ko00561	Glycerolipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMG200023326	K00901	ko00564	Glycerophospholipid metabolism	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMG200023326	K00901	ko01100	Metabolic pathways	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMG200023326	K00901	ko04070	Phosphatidylinositol signaling system	4474	6.3e-241	0.73	0.84	1.00
PGSC0003DMG200026987	K02900	ko03010	Ribosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200026988	K00276	ko00260	Glycine, serine and threonine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko00350	Tyrosine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko00360	Phenylalanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko00410	beta-Alanine metabolism	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko00950	Isoquinoline alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko01100	Metabolic pathways	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026988	K00276	ko01110	Biosynthesis of secondary metabolites	4534	3.1e-244	0.69	0.77	1.00
PGSC0003DMG200026989	K06067	ko04110	Cell cycle	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMG200026989	K06067	ko04330	Notch signaling pathway	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMG200026989	K06067	ko05016	Huntington's disease	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMG200026989	K06067	ko05200	Pathways in cancer	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMG200026989	K06067	ko05220	Chronic myeloid leukemia	2940	2.5e-156	0.89	0.95	0.98
PGSC0003DMG200026989	K06067	ko04110	Cell cycle	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMG200026989	K06067	ko04330	Notch signaling pathway	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMG200026989	K06067	ko05016	Huntington's disease	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMG200026989	K06067	ko05200	Pathways in cancer	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMG200026989	K06067	ko05220	Chronic myeloid leukemia	3407	4.4e-182	0.85	0.93	0.95
PGSC0003DMG200026991	K12393	ko04142	Lysosome	1001	2.2e-49	0.89	0.95	0.98
PGSC0003DMG200026992	K12854	ko03040	Spliceosome	1505	8.2e-77	0.54	0.69	1.00
PGSC0003DMG200026995	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMG200026995	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMG200026995	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.98
PGSC0003DMG200026995	K04728	ko04110	Cell cycle	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMG200026995	K04728	ko04115	p53 signaling pathway	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMG200026995	K04728	ko04210	Apoptosis	971	2.9e-46	0.29	0.46	0.82
PGSC0003DMG200026996	K03143	ko03022	Basal transcription factors	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMG200026996	K03143	ko03420	Nucleotide excision repair	881	9.3e-43	0.68	0.81	0.93
PGSC0003DMG200026996	K03143	ko03022	Basal transcription factors	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMG200026996	K03143	ko03420	Nucleotide excision repair	1862	7.3e-97	0.75	0.86	0.99
PGSC0003DMG200026997	K04424	ko04010	MAPK signaling pathway	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMG200026997	K04424	ko04530	Tight junction	682	3.8e-31	0.32	0.54	0.88
PGSC0003DMG200027000	K05278	ko00941	Flavonoid biosynthesis	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMG200027000	K05278	ko01100	Metabolic pathways	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMG200027000	K05278	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.39	0.57	0.58
PGSC0003DMG200027003	K02604	ko04110	Cell cycle	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMG200027003	K02604	ko04111	Cell cycle - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMG200027003	K02604	ko04113	Meiosis - yeast	1417	2.5e-72	0.79	0.89	0.99
PGSC0003DMG200027003	K02604	ko04110	Cell cycle	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMG200027003	K02604	ko04111	Cell cycle - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMG200027003	K02604	ko04113	Meiosis - yeast	2273	1.6e-119	0.75	0.87	0.98
PGSC0003DMG200020353	K12343	ko00140	Steroid hormone biosynthesis	1649	4.1e-85	0.71	0.83	0.99
PGSC0003DMG200020355	K00368	ko00910	Nitrogen metabolism	1577	3.8e-81	0.41	0.56	0.95
PGSC0003DMG200020355	K00368	ko00910	Nitrogen metabolism	1640	1.3e-84	0.43	0.57	0.89
PGSC0003DMG200020356	K08769	ko03320	PPAR signaling pathway	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMG200020356	K08769	ko05016	Huntington's disease	953	1.0e-46	0.45	0.61	0.88
PGSC0003DMG200020356	K08769	ko03320	PPAR signaling pathway	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMG200020356	K08769	ko05016	Huntington's disease	963	2.8e-47	0.45	0.61	0.97
PGSC0003DMG200020361	K00847	ko00051	Fructose and mannose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMG200020361	K00847	ko00500	Starch and sucrose metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMG200020361	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMG200020361	K00847	ko01100	Metabolic pathways	773	8.4e-37	0.37	0.53	0.90
PGSC0003DMG200020363	K03841	ko00010	Glycolysis / Gluconeogenesis	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko00030	Pentose phosphate pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko00051	Fructose and mannose metabolism	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko00710	Carbon fixation in photosynthetic organisms	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko01100	Metabolic pathways	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko01110	Biosynthesis of secondary metabolites	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200020363	K03841	ko04910	Insulin signaling pathway	2856	1.1e-151	0.83	0.90	1.00
PGSC0003DMG200041325	K12837	ko03040	Spliceosome	362	1.9e-13	0.25	0.53	0.99
PGSC0003DMG200041330	K10592	ko04120	Ubiquitin mediated proteolysis	397	1.1e-14	0.28	0.46	0.95
PGSC0003DMG200041332	K03469	ko03030	DNA replication	270	1.7e-08	0.35	0.59	0.65
PGSC0003DMG200041346	K00368	ko00910	Nitrogen metabolism	1684	4.8e-87	0.44	0.57	0.91
PGSC0003DMG200005120	K00026	ko00020	Citrate cycle (TCA cycle)	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005120	K00026	ko00620	Pyruvate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005120	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005120	K00026	ko00710	Carbon fixation in photosynthetic organisms	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005120	K00026	ko01100	Metabolic pathways	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005120	K00026	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.89	0.94	0.99
PGSC0003DMG200005125	K12489	ko04144	Endocytosis	772	9.6e-37	0.55	0.69	0.90
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	468	5.6e-20	0.92	0.95	0.95
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2036	1.8e-106	0.84	0.91	0.97
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	3232	2.0e-172	0.76	0.85	0.99
PGSC0003DMG200005133	K01876	ko00970	Aminoacyl-tRNA biosynthesis	2785	9.0e-148	0.86	0.93	0.99
PGSC0003DMG200005138	K01199	ko00500	Starch and sucrose metabolism	834	3.6e-40	0.38	0.55	0.76
PGSC0003DMG200008911	K03850	ko00510	N-Glycan biosynthesis	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMG200008911	K03850	ko01100	Metabolic pathways	718	9.1e-34	0.75	0.86	0.99
PGSC0003DMG200008911	K03850	ko00510	N-Glycan biosynthesis	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMG200008911	K03850	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.82	0.87
PGSC0003DMG200008911	K03850	ko00510	N-Glycan biosynthesis	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMG200008911	K03850	ko01100	Metabolic pathways	2082	5.3e-109	0.62	0.75	1.00
PGSC0003DMG200008911	K03850	ko00510	N-Glycan biosynthesis	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMG200008911	K03850	ko01100	Metabolic pathways	2748	9.9e-146	0.63	0.78	1.00
PGSC0003DMG200008911	K03850	ko00510	N-Glycan biosynthesis	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMG200008911	K03850	ko01100	Metabolic pathways	628	8.4e-29	0.72	0.82	0.99
PGSC0003DMG200008914	K06053	ko04330	Notch signaling pathway	233	2.6e-06	0.31	0.43	0.65
PGSC0003DMG200008915	K09392	ko04110	Cell cycle	600	2.9e-27	0.42	0.61	0.72
PGSC0003DMG200008915	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMG200008915	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMG200015106	K00430	ko00360	Phenylalanine metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMG200015106	K00430	ko00680	Methane metabolism	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMG200015106	K00430	ko00940	Phenylpropanoid biosynthesis	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMG200015106	K00430	ko01100	Metabolic pathways	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMG200015106	K00430	ko01110	Biosynthesis of secondary metabolites	1683	5.4e-87	0.67	0.81	0.99
PGSC0003DMG200015106	K00430	ko00360	Phenylalanine metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMG200015106	K00430	ko00680	Methane metabolism	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMG200015106	K00430	ko00940	Phenylpropanoid biosynthesis	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMG200015106	K00430	ko01100	Metabolic pathways	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMG200015106	K00430	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.66	0.80	0.97
PGSC0003DMG200015106	K00430	ko00360	Phenylalanine metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMG200015106	K00430	ko00680	Methane metabolism	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMG200015106	K00430	ko00940	Phenylpropanoid biosynthesis	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMG200015106	K00430	ko01100	Metabolic pathways	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMG200015106	K00430	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.68	0.81	0.99
PGSC0003DMG200015106	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMG200015106	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMG200015106	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMG200015106	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMG200015106	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.68	0.82	0.98
PGSC0003DMG200015109	K05745	ko04810	Regulation of actin cytoskeleton	334	1.1e-11	0.40	0.55	0.54
PGSC0003DMG200015113	K09561	ko04120	Ubiquitin mediated proteolysis	224	2.7e-06	0.36	0.56	0.22
PGSC0003DMG200002321	K05933	ko00270	Cysteine and methionine metabolism	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMG200002321	K05933	ko01110	Biosynthesis of secondary metabolites	1508	2.4e-77	0.66	0.82	0.98
PGSC0003DMG200002328	K01053	ko00030	Pentose phosphate pathway	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMG200002328	K01053	ko00053	Ascorbate and aldarate metabolism	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMG200002328	K01053	ko00930	Caprolactam degradation	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMG200002328	K01053	ko01100	Metabolic pathways	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMG200002328	K01053	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.35	0.52	0.95
PGSC0003DMG200002328	K01053	ko00030	Pentose phosphate pathway	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMG200002328	K01053	ko00053	Ascorbate and aldarate metabolism	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMG200002328	K01053	ko00930	Caprolactam degradation	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMG200002328	K01053	ko01100	Metabolic pathways	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMG200002328	K01053	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.40	0.57	0.97
PGSC0003DMG200002328	K01053	ko00030	Pentose phosphate pathway	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMG200002328	K01053	ko00053	Ascorbate and aldarate metabolism	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMG200002328	K01053	ko00930	Caprolactam degradation	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMG200002328	K01053	ko01100	Metabolic pathways	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMG200002328	K01053	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.36	0.53	0.97
PGSC0003DMG200002333	K13229	ko00402	Benzoxazinoid biosynthesis	480	1.2e-20	0.41	0.58	0.81
PGSC0003DMG200002336	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.50	0.67	0.97
PGSC0003DMG200002336	K00100	ko00051	Fructose and mannose metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko00363	Bisphenol A degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko00591	Linoleic acid metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko00625	Tetrachloroethene degradation	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko00650	Butanoate metabolism	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko01100	Metabolic pathways	956	6.8e-47	0.48	0.65	0.93
PGSC0003DMG200002336	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002336	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002336	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002336	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002336	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002336	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.65	0.92
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMG200026307	K12456	ko04110	Cell cycle	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMG200026307	K12456	ko04114	Oocyte meiosis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMG200026307	K12456	ko04120	Ubiquitin mediated proteolysis	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMG200026307	K12456	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.47	0.68	0.91
PGSC0003DMG200026308	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMG200026308	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMG200026308	K00648	ko00061	Fatty acid biosynthesis	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMG200026308	K00648	ko01100	Metabolic pathways	845	9.0e-41	0.77	0.89	0.99
PGSC0003DMG200026308	K00648	ko00061	Fatty acid biosynthesis	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMG200026308	K00648	ko01100	Metabolic pathways	2171	6.6e-114	0.72	0.84	0.94
PGSC0003DMG200026311	K12128	ko04712	Circadian rhythm - plant	219	6.0e-06	0.52	0.67	0.57
PGSC0003DMG200026311	K12135	ko04712	Circadian rhythm - plant	598	3.8e-27	0.38	0.62	0.54
PGSC0003DMG200026319	K12896	ko03040	Spliceosome	1435	2.6e-73	0.89	0.95	0.99
PGSC0003DMG200026320	K00301	ko00260	Glycine, serine and threonine metabolism	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMG200026320	K00301	ko01100	Metabolic pathways	2090	1.9e-109	0.61	0.77	0.97
PGSC0003DMG200022548	K08492	ko04130	SNARE interactions in vesicular transport	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMG200022548	K08492	ko04145	Phagosome	1646	6.0e-85	0.73	0.87	0.93
PGSC0003DMG200022548	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMG200022548	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMG200022548	K08492	ko04130	SNARE interactions in vesicular transport	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMG200022548	K08492	ko04145	Phagosome	860	1.3e-41	0.88	0.95	0.97
PGSC0003DMG200022550	K12897	ko03040	Spliceosome	301	9.1e-11	0.50	0.54	0.81
PGSC0003DMG200022555	K06689	ko04120	Ubiquitin mediated proteolysis	1176	5.0e-59	0.88	0.97	0.99
PGSC0003DMG200022558	K03029	ko03050	Proteasome	1884	4.5e-98	0.65	0.79	0.86
PGSC0003DMG200022558	K03029	ko03050	Proteasome	2069	2.8e-108	0.65	0.79	0.99
PGSC0003DMG200022558	K03029	ko03050	Proteasome	2020	1.4e-105	0.62	0.75	1.00
PGSC0003DMG200022561	K10772	ko03410	Base excision repair	2944	1.5e-156	0.59	0.70	0.99
PGSC0003DMG200034444	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMG200034444	K01657	ko01100	Metabolic pathways	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMG200034444	K01657	ko01110	Biosynthesis of secondary metabolites	254	2.7e-14	0.62	0.77	0.90
PGSC0003DMG200019652	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMG200019652	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.32	0.50	0.78
PGSC0003DMG200019653	K03135	ko03022	Basal transcription factors	573	9.1e-26	0.54	0.70	0.98
PGSC0003DMG200019653	K03135	ko03022	Basal transcription factors	1070	3.5e-53	0.62	0.77	1.00
PGSC0003DMG200019656	K01246	ko03410	Base excision repair	576	6.2e-26	0.43	0.46	0.78
PGSC0003DMG200019656	K01246	ko03410	Base excision repair	689	3.6e-32	0.80	0.92	0.98
PGSC0003DMG200019657	K12356	ko00940	Phenylpropanoid biosynthesis	692	2.5e-32	0.33	0.50	0.97
PGSC0003DMG200019659	K12126	ko04712	Circadian rhythm - plant	277	3.4e-09	0.37	0.52	0.54
PGSC0003DMG200019659	K12126	ko04712	Circadian rhythm - plant	311	3.8e-09	0.28	0.45	0.72
PGSC0003DMG200019659	K12126	ko04712	Circadian rhythm - plant	307	6.7e-09	0.27	0.44	0.70
PGSC0003DMG200019662	K05683	ko02010	ABC transporters	825	1.1e-39	0.29	0.50	0.84
PGSC0003DMG200019663	K06685	ko04111	Cell cycle - yeast	440	8.5e-15	0.27	0.40	0.85
PGSC0003DMG200009545	K04733	ko04210	Apoptosis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMG200009545	K04733	ko04620	Toll-like receptor signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMG200009545	K04733	ko04722	Neurotrophin signaling pathway	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMG200009545	K04733	ko05140	Leishmaniasis	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMG200009545	K04733	ko05142	Chagas disease	737	8.2e-35	0.41	0.59	0.78
PGSC0003DMG200005805	K02701	ko00195	Photosynthesis	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMG200005805	K02701	ko01100	Metabolic pathways	768	1.6e-36	0.80	0.87	0.66
PGSC0003DMG200005806	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMG200005806	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMG200005806	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMG200005806	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.82	0.89	0.96
PGSC0003DMG200005806	K01840	ko00051	Fructose and mannose metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMG200005806	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMG200005806	K01840	ko01100	Metabolic pathways	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMG200005806	K01840	ko01110	Biosynthesis of secondary metabolites	803	1.9e-38	0.84	0.91	0.99
PGSC0003DMG200005806	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko00051	Fructose and mannose metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko01100	Metabolic pathways	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005806	K01840	ko01110	Biosynthesis of secondary metabolites	1068	4.5e-53	0.85	0.95	0.77
PGSC0003DMG200005808	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMG200005808	K08680	ko01100	Metabolic pathways	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMG200005808	K08680	ko01110	Biosynthesis of secondary metabolites	233	9.7e-07	0.28	0.45	0.57
PGSC0003DMG200005810	K01838	ko00500	Starch and sucrose metabolism	509	3.1e-22	0.45	0.64	0.95
PGSC0003DMG200005810	K01838	ko00500	Starch and sucrose metabolism	307	4.3e-11	0.47	0.59	0.94
PGSC0003DMG200005810	K01838	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.43	0.64	0.67
PGSC0003DMG200005810	K01838	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.43	0.62	0.77
PGSC0003DMG200005811	K12356	ko00940	Phenylpropanoid biosynthesis	716	1.2e-33	0.32	0.51	0.90
PGSC0003DMG200005815	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005815	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005815	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005816	K12638	ko00905	Brassinosteroid biosynthesis	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005816	K12638	ko01100	Metabolic pathways	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005816	K12638	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.47	0.69	0.91
PGSC0003DMG200005817	K09587	ko00905	Brassinosteroid biosynthesis	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMG200005817	K09587	ko01100	Metabolic pathways	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMG200005817	K09587	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.37	0.56	0.99
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	2022	1.1e-105	0.72	0.85	0.99
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMG200002980	K06685	ko04111	Cell cycle - yeast	464	3.9e-16	0.25	0.41	0.86
PGSC0003DMG200002989	K01757	ko00901	Indole alkaloid biosynthesis	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMG200002989	K01757	ko01100	Metabolic pathways	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMG200002989	K01757	ko01110	Biosynthesis of secondary metabolites	687	4.7e-32	0.37	0.53	0.82
PGSC0003DMG200046285	K10760	ko00908	Zeatin biosynthesis	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMG200046285	K10760	ko01100	Metabolic pathways	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMG200046285	K10760	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.46	0.58	0.96
PGSC0003DMG200042537	K00993	ko00440	Phosphonate and phosphinate metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMG200042537	K00993	ko00564	Glycerophospholipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMG200042537	K00993	ko00565	Ether lipid metabolism	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMG200042537	K00993	ko01100	Metabolic pathways	349	2.1e-13	0.71	0.81	0.88
PGSC0003DMG200042541	K01051	ko00040	Pentose and glucuronate interconversions	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMG200042541	K01051	ko00500	Starch and sucrose metabolism	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMG200042541	K01051	ko01100	Metabolic pathways	582	2.9e-26	0.56	0.68	0.94
PGSC0003DMG200022148	K05692	ko04145	Phagosome	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04510	Focal adhesion	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04520	Adherens junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04530	Tight junction	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04670	Leukocyte transendothelial migration	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04745	Phototransduction - fly	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko04810	Regulation of actin cytoskeleton	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05100	Bacterial invasion of epithelial cells	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05110	Vibrio cholerae infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05130	Pathogenic Escherichia coli infection	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05131	Shigellosis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05414	Dilated cardiomyopathy	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022148	K05692	ko05416	Viral myocarditis	557	6.9e-25	0.30	0.50	0.74
PGSC0003DMG200022149	K12880	ko03040	Spliceosome	2486	2.8e-131	0.90	0.96	1.00
PGSC0003DMG200022149	K12880	ko03040	Spliceosome	1245	7.8e-63	0.93	0.97	0.91
PGSC0003DMG200022150	K06699	ko03050	Proteasome	5875	0.	0.74	0.86	1.00
PGSC0003DMG200022150	K06699	ko03050	Proteasome	5243	2.4e-283	0.74	0.86	1.00
PGSC0003DMG200022150	K06699	ko03050	Proteasome	8480	0.	0.74	0.86	1.00
PGSC0003DMG200022150	K06699	ko03050	Proteasome	5997	0.	0.75	0.86	0.99
PGSC0003DMG200022150	K06699	ko03050	Proteasome	346	4.4e-12	0.49	0.67	0.81
PGSC0003DMG200025057	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMG200025057	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMG200025057	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.51
PGSC0003DMG200025057	K01099	ko00562	Inositol phosphate metabolism	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMG200025057	K01099	ko01100	Metabolic pathways	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMG200025057	K01099	ko04070	Phosphatidylinositol signaling system	739	5.6e-43	0.39	0.57	0.53
PGSC0003DMG200025057	K01099	ko00562	Inositol phosphate metabolism	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMG200025057	K01099	ko01100	Metabolic pathways	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMG200025057	K01099	ko04070	Phosphatidylinositol signaling system	739	6.3e-35	0.40	0.58	0.49
PGSC0003DMG200025058	K01528	ko04144	Endocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMG200025058	K01528	ko04666	Fc gamma R-mediated phagocytosis	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMG200025058	K01528	ko05100	Bacterial invasion of epithelial cells	631	5.7e-29	0.42	0.59	0.84
PGSC0003DMG200025059	K01834	ko00010	Glycolysis / Gluconeogenesis	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMG200025059	K01834	ko01100	Metabolic pathways	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMG200025059	K01834	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.78	0.87	0.98
PGSC0003DMG200025059	K01834	ko00010	Glycolysis / Gluconeogenesis	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMG200025059	K01834	ko01100	Metabolic pathways	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMG200025059	K01834	ko01110	Biosynthesis of secondary metabolites	616	3.9e-28	0.80	0.87	0.96
PGSC0003DMG200025063	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1519	6.0e-78	0.66	0.75	0.98
PGSC0003DMG200025063	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	886	4.9e-43	0.70	0.81	0.99
PGSC0003DMG200025064	K12124	ko04712	Circadian rhythm - plant	7647	0.	0.79	0.86	1.00
PGSC0003DMG200025064	K12124	ko04712	Circadian rhythm - plant	6348	0.	0.79	0.87	0.99
PGSC0003DMG200025066	K09841	ko00906	Carotenoid biosynthesis	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMG200025066	K09841	ko01100	Metabolic pathways	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMG200025066	K09841	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.71	0.81	0.99
PGSC0003DMG200025067	K09841	ko00906	Carotenoid biosynthesis	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMG200025067	K09841	ko01100	Metabolic pathways	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMG200025067	K09841	ko01110	Biosynthesis of secondary metabolites	1766	1.4e-91	0.75	0.86	1.00
PGSC0003DMG200025067	K09841	ko00906	Carotenoid biosynthesis	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMG200025067	K09841	ko01100	Metabolic pathways	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMG200025067	K09841	ko01110	Biosynthesis of secondary metabolites	1213	4.5e-61	0.79	0.87	0.99
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	263	1.1e-08	0.28	0.47	0.59
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.29	0.46	0.59
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	252	4.6e-08	0.33	0.52	0.39
PGSC0003DMG200030730	K00485	ko00982	Drug metabolism - cytochrome P450	443	1.3e-18	0.34	0.49	0.75
PGSC0003DMG200030733	K12852	ko03040	Spliceosome	7668	0.	0.90	0.96	1.00
PGSC0003DMG200003981	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko00330	Arginine and proline metabolism	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01100	Metabolic pathways	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003981	K00930	ko01110	Biosynthesis of secondary metabolites	2044	6.7e-107	0.76	0.84	0.99
PGSC0003DMG200003984	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMG200003984	K08770	ko03320	PPAR signaling pathway	4363	8.3e-235	1.00	1.00	1.00
PGSC0003DMG200003988	K12622	ko03018	RNA degradation	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMG200003988	K12622	ko03040	Spliceosome	772	9.6e-37	0.97	0.98	0.98
PGSC0003DMG200006935	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMG200006935	K10573	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.93	0.97	0.99
PGSC0003DMG200006936	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMG200006936	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMG200006937	K01728	ko00040	Pentose and glucuronate interconversions	1615	3.1e-83	0.53	0.69	0.92
PGSC0003DMG200006938	K01728	ko00040	Pentose and glucuronate interconversions	1819	1.7e-94	0.58	0.70	0.86
PGSC0003DMG200006944	K01184	ko00040	Pentose and glucuronate interconversions	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMG200006944	K01184	ko00500	Starch and sucrose metabolism	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMG200006944	K01184	ko01100	Metabolic pathways	2013	3.4e-105	0.61	0.76	0.99
PGSC0003DMG200043882	K11251	ko05322	Systemic lupus erythematosus	471	3.8e-20	0.66	0.82	0.77
PGSC0003DMG200014380	K12741	ko03040	Spliceosome	1355	6.7e-69	0.44	0.56	0.98
PGSC0003DMG200014380	K12741	ko03040	Spliceosome	874	2.3e-42	0.39	0.52	0.93
PGSC0003DMG200014381	K02995	ko03010	Ribosome	1624	9.8e-84	0.87	0.93	0.99
PGSC0003DMG200014385	K12606	ko03018	RNA degradation	258	2.1e-08	0.60	0.68	0.80
PGSC0003DMG200014386	K08908	ko00196	Photosynthesis - antenna proteins	1319	6.5e-67	0.95	0.98	0.99
PGSC0003DMG200014396	K01696	ko00260	Glycine, serine and threonine metabolism	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMG200014396	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMG200014396	K01696	ko01100	Metabolic pathways	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMG200014396	K01696	ko01110	Biosynthesis of secondary metabolites	3159	2.1e-168	0.92	0.98	0.98
PGSC0003DMG200010774	K05658	ko02010	ABC transporters	3916	3.7e-210	0.44	0.64	0.99
PGSC0003DMG200010788	K03841	ko00010	Glycolysis / Gluconeogenesis	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko00030	Pentose phosphate pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko00051	Fructose and mannose metabolism	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko00710	Carbon fixation in photosynthetic organisms	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko01100	Metabolic pathways	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko04910	Insulin signaling pathway	2551	7.2e-135	0.88	0.93	0.99
PGSC0003DMG200010788	K03841	ko00010	Glycolysis / Gluconeogenesis	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko00030	Pentose phosphate pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko00051	Fructose and mannose metabolism	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko00710	Carbon fixation in photosynthetic organisms	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko01100	Metabolic pathways	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010788	K03841	ko04910	Insulin signaling pathway	2705	2.3e-143	0.93	0.98	0.99
PGSC0003DMG200010792	K03364	ko04110	Cell cycle	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMG200010792	K03364	ko04111	Cell cycle - yeast	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMG200010792	K03364	ko04120	Ubiquitin mediated proteolysis	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMG200010792	K03364	ko04914	Progesterone-mediated oocyte maturation	3068	2.2e-163	0.74	0.84	1.00
PGSC0003DMG200010797	K03801	ko00785	Lipoic acid metabolism	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMG200010797	K03801	ko01100	Metabolic pathways	1414	3.7e-72	0.79	0.89	0.98
PGSC0003DMG200031084	K00975	ko00500	Starch and sucrose metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMG200031084	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMG200031084	K00975	ko01100	Metabolic pathways	3796	1.6e-203	0.87	0.94	1.00
PGSC0003DMG200023999	K05712	ko00360	Phenylalanine metabolism	289	5.5e-10	0.33	0.46	0.74
PGSC0003DMG200023999	K05712	ko00360	Phenylalanine metabolism	254	6.5e-08	0.31	0.45	0.74
PGSC0003DMG200023999	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.87
PGSC0003DMG200023999	K05712	ko00360	Phenylalanine metabolism	284	1.7e-09	0.29	0.43	0.88
PGSC0003DMG200024003	K00104	ko00630	Glyoxylate and dicarboxylate metabolism	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMG200024003	K00104	ko01100	Metabolic pathways	258	7.9e-06	0.33	0.46	0.34
PGSC0003DMG200024011	K04077	ko03018	RNA degradation	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMG200024011	K04077	ko04940	Type I diabetes mellitus	3794	2.0e-203	0.78	0.87	1.00
PGSC0003DMG200018080	K10712	ko00430	Taurine and hypotaurine metabolism	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMG200018080	K10712	ko01100	Metabolic pathways	325	4.3e-12	0.32	0.46	0.96
PGSC0003DMG200018082	K10573	ko04120	Ubiquitin mediated proteolysis	1318	7.4e-67	0.97	0.99	0.99
PGSC0003DMG200018083	K05645	ko02010	ABC transporters	986	1.4e-47	0.38	0.57	0.96
PGSC0003DMG200018083	K05645	ko02010	ABC transporters	980	3.1e-47	0.38	0.58	0.96
PGSC0003DMG200018084	K01785	ko00010	Glycolysis / Gluconeogenesis	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMG200018084	K01785	ko01110	Biosynthesis of secondary metabolites	2015	2.7e-105	0.69	0.83	0.94
PGSC0003DMG200018094	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMG200000658	K01895	ko00010	Glycolysis / Gluconeogenesis	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko00620	Pyruvate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko00640	Propanoate metabolism	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko01100	Metabolic pathways	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.51	0.67	0.98
PGSC0003DMG200000658	K01895	ko00010	Glycolysis / Gluconeogenesis	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko00620	Pyruvate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko00640	Propanoate metabolism	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko01100	Metabolic pathways	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko01110	Biosynthesis of secondary metabolites	2985	8.4e-159	0.54	0.68	0.97
PGSC0003DMG200000658	K01895	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000658	K01895	ko00620	Pyruvate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000658	K01895	ko00640	Propanoate metabolism	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000658	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000658	K01895	ko01100	Metabolic pathways	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000658	K01895	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.60	0.72	0.95
PGSC0003DMG200000662	K04459	ko04010	MAPK signaling pathway	1564	2.0e-80	0.73	0.86	0.94
PGSC0003DMG200000663	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMG200000663	K08332	ko04140	Regulation of autophagy	349	3.1e-11	0.32	0.47	0.58
PGSC0003DMG200000667	K00799	ko00480	Glutathione metabolism	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMG200000667	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMG200000667	K00799	ko00982	Drug metabolism - cytochrome P450	508	3.5e-22	0.36	0.49	0.99
PGSC0003DMG200000667	K00799	ko00480	Glutathione metabolism	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMG200000667	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMG200000667	K00799	ko00982	Drug metabolism - cytochrome P450	239	2.4e-07	0.53	0.74	0.60
PGSC0003DMG200000668	K01179	ko00500	Starch and sucrose metabolism	1757	4.5e-91	0.48	0.63	0.96
PGSC0003DMG200000669	K00895	ko00051	Fructose and mannose metabolism	3818	9.5e-205	0.81	0.89	1.00
PGSC0003DMG200016043	K05280	ko00941	Flavonoid biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMG200016043	K05280	ko00944	Flavone and flavonol biosynthesis	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMG200016043	K05280	ko01100	Metabolic pathways	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMG200016043	K05280	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.49	0.67	0.99
PGSC0003DMG200016044	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMG200016044	K00517	ko00626	Naphthalene and anthracene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMG200016044	K00517	ko00903	Limonene and pinene degradation	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMG200016044	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMG200016044	K00517	ko01110	Biosynthesis of secondary metabolites	260	2.8e-08	0.41	0.62	0.99
PGSC0003DMG200016051	K12356	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.45	0.95
PGSC0003DMG200009810	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMG200009810	K00517	ko00626	Naphthalene and anthracene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMG200009810	K00517	ko00903	Limonene and pinene degradation	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMG200009810	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMG200009810	K00517	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.54	0.70	0.92
PGSC0003DMG200009811	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMG200009811	K00517	ko00626	Naphthalene and anthracene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMG200009811	K00517	ko00903	Limonene and pinene degradation	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMG200009811	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMG200009811	K00517	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.42	0.56	0.98
PGSC0003DMG200009812	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMG200009812	K00517	ko00626	Naphthalene and anthracene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMG200009812	K00517	ko00903	Limonene and pinene degradation	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMG200009812	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMG200009812	K00517	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.38	0.58	0.97
PGSC0003DMG200009814	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMG200009814	K00517	ko00626	Naphthalene and anthracene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMG200009814	K00517	ko00903	Limonene and pinene degradation	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMG200009814	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMG200009814	K00517	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.58	0.75	0.97
PGSC0003DMG200009822	K09755	ko00940	Phenylpropanoid biosynthesis	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMG200009822	K09755	ko01100	Metabolic pathways	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMG200009822	K09755	ko01110	Biosynthesis of secondary metabolites	1488	3.1e-76	0.38	0.61	0.98
PGSC0003DMG200009823	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMG200009823	K00517	ko00626	Naphthalene and anthracene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMG200009823	K00517	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMG200009823	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMG200009823	K00517	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.35	0.57	0.93
PGSC0003DMG200009825	K09755	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMG200009825	K09755	ko01100	Metabolic pathways	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMG200009825	K09755	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.53	0.71	0.96
PGSC0003DMG200009827	K02997	ko03010	Ribosome	1593	5.0e-82	0.94	0.99	0.99
PGSC0003DMG200002703	K08232	ko00053	Ascorbate and aldarate metabolism	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMG200002703	K08232	ko01100	Metabolic pathways	2532	8.1e-134	0.73	0.81	1.00
PGSC0003DMG200002703	K08232	ko00053	Ascorbate and aldarate metabolism	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMG200002703	K08232	ko01100	Metabolic pathways	2929	1.0e-155	0.79	0.88	1.00
PGSC0003DMG200002707	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMG200012606	K04424	ko04010	MAPK signaling pathway	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMG200012606	K04424	ko04530	Tight junction	644	1.1e-29	0.38	0.59	0.76
PGSC0003DMG200008359	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMG200008359	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMG200008359	K03842	ko00510	N-Glycan biosynthesis	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMG200008359	K03842	ko01100	Metabolic pathways	2431	3.0e-128	0.73	0.82	0.99
PGSC0003DMG200008359	K03842	ko00510	N-Glycan biosynthesis	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMG200008359	K03842	ko01100	Metabolic pathways	2949	8.1e-157	0.73	0.85	0.98
PGSC0003DMG200008363	K00059	ko00061	Fatty acid biosynthesis	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMG200008363	K00059	ko01040	Biosynthesis of unsaturated fatty acids	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMG200008363	K00059	ko01100	Metabolic pathways	519	8.6e-23	0.55	0.75	0.78
PGSC0003DMG200008363	K00059	ko00061	Fatty acid biosynthesis	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMG200008363	K00059	ko01040	Biosynthesis of unsaturated fatty acids	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMG200008363	K00059	ko01100	Metabolic pathways	770	1.2e-36	0.56	0.77	0.91
PGSC0003DMG200008364	K00059	ko00061	Fatty acid biosynthesis	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMG200008364	K00059	ko01040	Biosynthesis of unsaturated fatty acids	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMG200008364	K00059	ko01100	Metabolic pathways	540	6.0e-24	0.58	0.77	0.86
PGSC0003DMG200008365	K02896	ko03010	Ribosome	312	2.3e-11	0.78	0.88	0.59
PGSC0003DMG200008365	K02896	ko03010	Ribosome	361	4.5e-14	0.82	0.89	0.98
PGSC0003DMG200008365	K02896	ko03010	Ribosome	1239	1.7e-62	0.90	0.93	0.80
PGSC0003DMG200008365	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMG200008365	K02896	ko03010	Ribosome	1289	2.9e-65	0.90	0.93	0.99
PGSC0003DMG200008368	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.34	0.55	0.72
PGSC0003DMG200008368	K01199	ko00500	Starch and sucrose metabolism	618	3.0e-28	0.34	0.55	0.92
PGSC0003DMG200008369	K00889	ko00562	Inositol phosphate metabolism	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008369	K00889	ko01100	Metabolic pathways	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008369	K00889	ko04070	Phosphatidylinositol signaling system	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008369	K00889	ko04144	Endocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008369	K00889	ko04666	Fc gamma R-mediated phagocytosis	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008369	K00889	ko04810	Regulation of actin cytoskeleton	4610	2.0e-248	0.70	0.81	1.00
PGSC0003DMG200008371	K12625	ko03018	RNA degradation	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMG200008371	K12625	ko03040	Spliceosome	727	2.9e-34	0.96	0.97	0.99
PGSC0003DMG200008373	K04683	ko04110	Cell cycle	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMG200008373	K04683	ko04350	TGF-beta signaling pathway	871	3.3e-42	0.44	0.60	0.86
PGSC0003DMG200008373	K04683	ko04110	Cell cycle	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMG200008373	K04683	ko04350	TGF-beta signaling pathway	874	2.3e-42	0.44	0.60	0.86
PGSC0003DMG200008374	K13034	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMG200008374	K13034	ko00450	Selenoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMG200008374	K13034	ko00460	Cyanoamino acid metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMG200008374	K13034	ko00920	Sulfur metabolism	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMG200008374	K13034	ko01100	Metabolic pathways	544	3.6e-24	0.65	0.69	0.83
PGSC0003DMG200026541	K00791	ko00908	Zeatin biosynthesis	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMG200026541	K00791	ko01100	Metabolic pathways	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMG200026541	K00791	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.64	0.77	0.91
PGSC0003DMG200026541	K00791	ko00908	Zeatin biosynthesis	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMG200026541	K00791	ko01100	Metabolic pathways	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMG200026541	K00791	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.64	0.76	0.89
PGSC0003DMG200026541	K00791	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMG200026541	K00791	ko01100	Metabolic pathways	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMG200026541	K00791	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.58	0.76	0.97
PGSC0003DMG200026541	K00791	ko00908	Zeatin biosynthesis	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMG200026541	K00791	ko01100	Metabolic pathways	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMG200026541	K00791	ko01110	Biosynthesis of secondary metabolites	1052	3.5e-52	0.56	0.67	0.90
PGSC0003DMG200026544	K12873	ko03040	Spliceosome	1148	1.8e-57	0.86	0.92	0.99
PGSC0003DMG200037159	K12796	ko04621	NOD-like receptor signaling pathway	326	9.8e-09	0.32	0.49	0.32
PGSC0003DMG200037166	K10760	ko00908	Zeatin biosynthesis	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMG200037166	K10760	ko01100	Metabolic pathways	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMG200037166	K10760	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.48	0.64	0.96
PGSC0003DMG200019352	K01968	ko00280	Valine, leucine and isoleucine degradation	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMG200019352	K01968	ko01100	Metabolic pathways	500	9.6e-22	0.66	0.81	0.85
PGSC0003DMG200019352	K01968	ko00280	Valine, leucine and isoleucine degradation	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMG200019352	K01968	ko01100	Metabolic pathways	1787	1.0e-92	0.70	0.84	0.93
PGSC0003DMG200019360	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMG200019362	K12817	ko03040	Spliceosome	2608	5.2e-138	0.77	0.87	1.00
PGSC0003DMG200019372	K02291	ko00906	Carotenoid biosynthesis	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMG200019372	K02291	ko01100	Metabolic pathways	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMG200019372	K02291	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.82	0.89	0.92
PGSC0003DMG200029356	K01184	ko00040	Pentose and glucuronate interconversions	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMG200029356	K01184	ko00500	Starch and sucrose metabolism	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMG200029356	K01184	ko01100	Metabolic pathways	741	4.9e-35	0.65	0.80	0.98
PGSC0003DMG200029356	K01184	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMG200029356	K01184	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMG200029356	K01184	ko01100	Metabolic pathways	1369	1.1e-69	0.67	0.80	1.00
PGSC0003DMG200029357	K01184	ko00040	Pentose and glucuronate interconversions	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMG200029357	K01184	ko00500	Starch and sucrose metabolism	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMG200029357	K01184	ko01100	Metabolic pathways	1999	2.0e-104	0.63	0.76	0.99
PGSC0003DMG200029359	K01099	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMG200029359	K01099	ko01100	Metabolic pathways	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMG200029359	K01099	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.34	0.51	0.64
PGSC0003DMG200029359	K01099	ko00562	Inositol phosphate metabolism	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMG200029359	K01099	ko01100	Metabolic pathways	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMG200029359	K01099	ko04070	Phosphatidylinositol signaling system	356	8.4e-14	0.43	0.60	0.80
PGSC0003DMG200029359	K12195	ko04144	Endocytosis	1518	6.8e-78	0.82	0.91	1.00
PGSC0003DMG200029360	K01239	ko00230	Purine metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMG200029360	K01239	ko00760	Nicotinate and nicotinamide metabolism	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMG200029360	K01239	ko01100	Metabolic pathways	949	1.7e-46	0.59	0.79	0.93
PGSC0003DMG200029360	K01239	ko00230	Purine metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMG200029360	K01239	ko00760	Nicotinate and nicotinamide metabolism	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMG200029360	K01239	ko01100	Metabolic pathways	1024	1.2e-50	0.56	0.77	0.87
PGSC0003DMG200029360	K01239	ko00230	Purine metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMG200029360	K01239	ko00760	Nicotinate and nicotinamide metabolism	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMG200029360	K01239	ko01100	Metabolic pathways	1046	7.4e-52	0.51	0.68	0.81
PGSC0003DMG200029363	K01516	ko00230	Purine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMG200029363	K01516	ko00730	Thiamine metabolism	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMG200029363	K01516	ko01100	Metabolic pathways	935	9.8e-46	0.73	0.83	0.96
PGSC0003DMG200029363	K01516	ko00230	Purine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMG200029363	K01516	ko00730	Thiamine metabolism	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMG200029363	K01516	ko01100	Metabolic pathways	2492	1.3e-131	0.67	0.79	0.97
PGSC0003DMG200029365	K12135	ko04712	Circadian rhythm - plant	588	1.3e-26	0.35	0.55	0.95
PGSC0003DMG200029365	K12135	ko04712	Circadian rhythm - plant	584	2.2e-26	0.40	0.60	0.54
PGSC0003DMG200029368	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMG200029368	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMG200029368	K00734	ko01100	Metabolic pathways	372	1.1e-14	0.32	0.50	0.69
PGSC0003DMG200016730	K00695	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMG200016730	K00695	ko01100	Metabolic pathways	4870	9.0e-263	0.68	0.83	0.99
PGSC0003DMG200016730	K00695	ko00500	Starch and sucrose metabolism	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMG200016730	K00695	ko01100	Metabolic pathways	3321	2.5e-177	0.68	0.84	1.00
PGSC0003DMG200016731	K02876	ko03010	Ribosome	592	8.1e-27	0.41	0.55	0.78
PGSC0003DMG200016734	K09658	ko00510	N-Glycan biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMG200016734	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMG200016734	K09658	ko01100	Metabolic pathways	319	9.3e-12	0.69	0.85	0.48
PGSC0003DMG200016744	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMG200016744	K08081	ko01100	Metabolic pathways	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMG200016744	K08081	ko01110	Biosynthesis of secondary metabolites	1401	1.9e-71	0.65	0.75	0.98
PGSC0003DMG200016744	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMG200016744	K08081	ko01100	Metabolic pathways	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMG200016744	K08081	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.70	0.83	0.98
PGSC0003DMG200016746	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMG200016746	K08081	ko01100	Metabolic pathways	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMG200016746	K08081	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.73	0.85	0.93
PGSC0003DMG200009147	K00889	ko00562	Inositol phosphate metabolism	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko01100	Metabolic pathways	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04070	Phosphatidylinositol signaling system	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04144	Endocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04666	Fc gamma R-mediated phagocytosis	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04810	Regulation of actin cytoskeleton	9580	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko00562	Inositol phosphate metabolism	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko01100	Metabolic pathways	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04070	Phosphatidylinositol signaling system	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04144	Endocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04666	Fc gamma R-mediated phagocytosis	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko04810	Regulation of actin cytoskeleton	9591	0.	0.65	0.76	1.00
PGSC0003DMG200009147	K00889	ko00562	Inositol phosphate metabolism	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009147	K00889	ko01100	Metabolic pathways	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009147	K00889	ko04070	Phosphatidylinositol signaling system	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009147	K00889	ko04144	Endocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009147	K00889	ko04666	Fc gamma R-mediated phagocytosis	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009147	K00889	ko04810	Regulation of actin cytoskeleton	2258	1.0e-118	0.61	0.70	0.99
PGSC0003DMG200009150	K04554	ko04120	Ubiquitin mediated proteolysis	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMG200009150	K04554	ko05012	Parkinson's disease	1193	5.8e-60	0.47	0.53	1.00
PGSC0003DMG200009150	K04554	ko04120	Ubiquitin mediated proteolysis	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMG200009150	K04554	ko05012	Parkinson's disease	321	7.2e-12	0.97	1.00	0.65
PGSC0003DMG200009150	K04554	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMG200009150	K04554	ko05012	Parkinson's disease	1639	1.5e-84	0.79	0.89	1.00
PGSC0003DMG200009150	K04554	ko04120	Ubiquitin mediated proteolysis	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMG200009150	K04554	ko05012	Parkinson's disease	1019	2.3e-50	0.97	1.00	0.48
PGSC0003DMG200009154	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.98	1.00
PGSC0003DMG200009154	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.64
PGSC0003DMG200009156	K02293	ko00906	Carotenoid biosynthesis	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMG200009156	K02293	ko01100	Metabolic pathways	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMG200009156	K02293	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.78	0.87	0.96
PGSC0003DMG200009156	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200009156	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200009156	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200011926	K02084	ko04115	p53 signaling pathway	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko04210	Apoptosis	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko05010	Alzheimer's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko05012	Parkinson's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko05016	Huntington's disease	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011926	K02084	ko05222	Small cell lung cancer	296	7.2e-07	0.28	0.48	0.36
PGSC0003DMG200011929	K00475	ko00941	Flavonoid biosynthesis	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMG200011929	K00475	ko01100	Metabolic pathways	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMG200011929	K00475	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.43	0.65	0.89
PGSC0003DMG200011929	K05277	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMG200011929	K05277	ko01100	Metabolic pathways	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMG200011929	K05277	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.37	0.56	0.79
PGSC0003DMG200011929	K05278	ko00941	Flavonoid biosynthesis	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMG200011929	K05278	ko01100	Metabolic pathways	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMG200011929	K05278	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.39	0.59	0.94
PGSC0003DMG200011929	K05278	ko00941	Flavonoid biosynthesis	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMG200011929	K05278	ko01100	Metabolic pathways	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMG200011929	K05278	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.38	0.58	0.88
PGSC0003DMG200011935	K12356	ko00940	Phenylpropanoid biosynthesis	721	6.2e-34	0.34	0.51	0.83
PGSC0003DMG200011937	K05857	ko00562	Inositol phosphate metabolism	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMG200011937	K05857	ko01100	Metabolic pathways	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMG200011937	K05857	ko04020	Calcium signaling pathway	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMG200011937	K05857	ko04070	Phosphatidylinositol signaling system	2095	1.0e-109	0.42	0.50	0.99
PGSC0003DMG200011937	K05857	ko00562	Inositol phosphate metabolism	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMG200011937	K05857	ko01100	Metabolic pathways	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMG200011937	K05857	ko04020	Calcium signaling pathway	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMG200011937	K05857	ko04070	Phosphatidylinositol signaling system	3382	1.1e-180	0.60	0.72	1.00
PGSC0003DMG200011937	K05857	ko00562	Inositol phosphate metabolism	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMG200011937	K05857	ko01100	Metabolic pathways	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMG200011937	K05857	ko04020	Calcium signaling pathway	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMG200011937	K05857	ko04070	Phosphatidylinositol signaling system	3033	1.9e-161	0.48	0.57	1.00
PGSC0003DMG200011941	K01190	ko00052	Galactose metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMG200011941	K01190	ko00511	Other glycan degradation	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMG200011941	K01190	ko00600	Sphingolipid metabolism	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMG200011941	K01190	ko01100	Metabolic pathways	2532	8.1e-134	0.46	0.63	0.84
PGSC0003DMG200002037	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00270	Cysteine and methionine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00350	Tyrosine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00360	Phenylalanine metabolism	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00401	Novobiocin biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko01100	Metabolic pathways	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002037	K00815	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.63	0.77	0.94
PGSC0003DMG200002041	K01610	ko00010	Glycolysis / Gluconeogenesis	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002041	K01610	ko00020	Citrate cycle (TCA cycle)	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002041	K01610	ko00620	Pyruvate metabolism	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002041	K01610	ko00710	Carbon fixation in photosynthetic organisms	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002041	K01610	ko01100	Metabolic pathways	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002041	K01610	ko01110	Biosynthesis of secondary metabolites	4538	1.8e-244	0.81	0.88	1.00
PGSC0003DMG200002042	K01610	ko00010	Glycolysis / Gluconeogenesis	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200002042	K01610	ko00020	Citrate cycle (TCA cycle)	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200002042	K01610	ko00620	Pyruvate metabolism	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200002042	K01610	ko00710	Carbon fixation in photosynthetic organisms	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200002042	K01610	ko01100	Metabolic pathways	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200002042	K01610	ko01110	Biosynthesis of secondary metabolites	1811	4.7e-94	0.63	0.71	0.91
PGSC0003DMG200027227	K00754	ko00051	Fructose and mannose metabolism	1841	1.0e-95	0.49	0.70	0.83
PGSC0003DMG200027227	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMG200027227	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMG200027227	K00754	ko00051	Fructose and mannose metabolism	1843	8.1e-96	0.45	0.65	0.79
PGSC0003DMG200027230	K00914	ko00562	Inositol phosphate metabolism	6073	0.	0.86	0.92	1.00
PGSC0003DMG200027230	K00914	ko01100	Metabolic pathways	6073	0.	0.86	0.92	1.00
PGSC0003DMG200027230	K00914	ko04070	Phosphatidylinositol signaling system	6073	0.	0.86	0.92	1.00
PGSC0003DMG200027230	K00914	ko04140	Regulation of autophagy	6073	0.	0.86	0.92	1.00
PGSC0003DMG200027230	K00914	ko04145	Phagosome	6073	0.	0.86	0.92	1.00
PGSC0003DMG200027230	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko00562	Inositol phosphate metabolism	6138	0.	0.89	0.94	1.00
PGSC0003DMG200027230	K00914	ko01100	Metabolic pathways	6138	0.	0.89	0.94	1.00
PGSC0003DMG200027230	K00914	ko04070	Phosphatidylinositol signaling system	6138	0.	0.89	0.94	1.00
PGSC0003DMG200027230	K00914	ko04140	Regulation of autophagy	6138	0.	0.89	0.94	1.00
PGSC0003DMG200027230	K00914	ko04145	Phagosome	6138	0.	0.89	0.94	1.00
PGSC0003DMG200027230	K00914	ko00562	Inositol phosphate metabolism	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko01100	Metabolic pathways	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04070	Phosphatidylinositol signaling system	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04140	Regulation of autophagy	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027230	K00914	ko04145	Phagosome	2931	8.0e-156	0.86	0.91	0.97
PGSC0003DMG200027233	K04733	ko04210	Apoptosis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMG200027233	K04733	ko04620	Toll-like receptor signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMG200027233	K04733	ko04722	Neurotrophin signaling pathway	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMG200027233	K04733	ko05140	Leishmaniasis	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMG200027233	K04733	ko05142	Chagas disease	792	7.6e-38	0.34	0.51	0.52
PGSC0003DMG200027235	K03405	ko00860	Porphyrin and chlorophyll metabolism	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMG200027235	K03405	ko01100	Metabolic pathways	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMG200027235	K03405	ko01110	Biosynthesis of secondary metabolites	2511	1.2e-132	0.78	0.86	0.98
PGSC0003DMG200027235	K03405	ko00860	Porphyrin and chlorophyll metabolism	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMG200027235	K03405	ko01100	Metabolic pathways	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMG200027235	K03405	ko01110	Biosynthesis of secondary metabolites	5249	1.1e-283	0.83	0.90	1.00
PGSC0003DMG200027239	K01184	ko00040	Pentose and glucuronate interconversions	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMG200027239	K01184	ko00500	Starch and sucrose metabolism	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMG200027239	K01184	ko01100	Metabolic pathways	982	2.5e-48	0.42	0.60	0.73
PGSC0003DMG200027239	K01184	ko00040	Pentose and glucuronate interconversions	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMG200027239	K01184	ko00500	Starch and sucrose metabolism	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMG200027239	K01184	ko01100	Metabolic pathways	1149	1.5e-57	0.41	0.58	0.92
PGSC0003DMG200027240	K01188	ko00460	Cyanoamino acid metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMG200027240	K01188	ko00500	Starch and sucrose metabolism	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMG200027240	K01188	ko00940	Phenylpropanoid biosynthesis	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMG200027240	K01188	ko01110	Biosynthesis of secondary metabolites	2500	4.7e-132	0.52	0.66	0.95
PGSC0003DMG200035974	K01307	ko00790	Folate biosynthesis	1800	1.9e-93	0.63	0.78	0.98
PGSC0003DMG200030038	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.97
PGSC0003DMG200030038	K03103	ko00562	Inositol phosphate metabolism	625	1.2e-28	0.29	0.49	0.93
PGSC0003DMG200030052	K02960	ko03010	Ribosome	1151	1.2e-57	0.91	0.94	0.99
PGSC0003DMG200030058	K04371	ko04010	MAPK signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04012	ErbB signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04013	MAPK signaling pathway - fly	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04062	Chemokine signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04114	Oocyte meiosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04270	Vascular smooth muscle contraction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04320	Dorso-ventral axis formation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04350	TGF-beta signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04360	Axon guidance	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04370	VEGF signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04520	Adherens junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04540	Gap junction	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04620	Toll-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04621	NOD-like receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04650	Natural killer cell mediated cytotoxicity	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04660	T cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04662	B cell receptor signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04664	Fc epsilon RI signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04666	Fc gamma R-mediated phagocytosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04720	Long-term potentiation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04722	Neurotrophin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04730	Long-term depression	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04810	Regulation of actin cytoskeleton	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04912	GnRH signaling pathway	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04914	Progesterone-mediated oocyte maturation	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04916	Melanogenesis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04930	Type II diabetes mellitus	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05010	Alzheimer's disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05020	Prion diseases	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05131	Shigellosis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05140	Leishmaniasis	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05142	Chagas disease	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05200	Pathways in cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05210	Colorectal cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05211	Renal cell carcinoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05212	Pancreatic cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05214	Glioma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05216	Thyroid cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05218	Melanoma	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05219	Bladder cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05220	Chronic myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05221	Acute myeloid leukemia	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.91	1.00
PGSC0003DMG200030058	K04371	ko04010	MAPK signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04012	ErbB signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04013	MAPK signaling pathway - fly	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04062	Chemokine signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04114	Oocyte meiosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04150	mTOR signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04270	Vascular smooth muscle contraction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04320	Dorso-ventral axis formation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04350	TGF-beta signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04360	Axon guidance	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04370	VEGF signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04510	Focal adhesion	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04520	Adherens junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04540	Gap junction	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04620	Toll-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04621	NOD-like receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04650	Natural killer cell mediated cytotoxicity	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04660	T cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04662	B cell receptor signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04664	Fc epsilon RI signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04666	Fc gamma R-mediated phagocytosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04720	Long-term potentiation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04722	Neurotrophin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04730	Long-term depression	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04810	Regulation of actin cytoskeleton	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04910	Insulin signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04912	GnRH signaling pathway	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04914	Progesterone-mediated oocyte maturation	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04916	Melanogenesis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04930	Type II diabetes mellitus	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05010	Alzheimer's disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05020	Prion diseases	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05131	Shigellosis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05140	Leishmaniasis	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05142	Chagas disease	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05200	Pathways in cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05210	Colorectal cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05211	Renal cell carcinoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05212	Pancreatic cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05213	Endometrial cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05214	Glioma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05215	Prostate cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05216	Thyroid cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05218	Melanoma	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05219	Bladder cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05220	Chronic myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05221	Acute myeloid leukemia	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030058	K04371	ko05223	Non-small cell lung cancer	2357	3.6e-124	0.84	0.92	0.97
PGSC0003DMG200030059	K10643	ko03018	RNA degradation	1364	2.1e-69	0.39	0.56	0.95
PGSC0003DMG200030059	K10643	ko03018	RNA degradation	1160	3.8e-58	0.38	0.54	0.94
PGSC0003DMG200030059	K10643	ko03018	RNA degradation	2747	1.1e-145	0.46	0.61	0.99
PGSC0003DMG200030059	K10643	ko03018	RNA degradation	4216	1.1e-226	0.53	0.67	1.00
PGSC0003DMG200020086	K03062	ko03050	Proteasome	3588	4.6e-192	0.97	0.98	1.00
PGSC0003DMG200020091	K03024	ko00230	Purine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMG200020091	K03024	ko00240	Pyrimidine metabolism	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMG200020091	K03024	ko01100	Metabolic pathways	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMG200020091	K03024	ko03020	RNA polymerase	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMG200020091	K03024	ko04623	Cytosolic DNA-sensing pathway	716	1.2e-33	0.47	0.62	1.00
PGSC0003DMG200020091	K03024	ko00230	Purine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMG200020091	K03024	ko00240	Pyrimidine metabolism	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMG200020091	K03024	ko01100	Metabolic pathways	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMG200020091	K03024	ko03020	RNA polymerase	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMG200020091	K03024	ko04623	Cytosolic DNA-sensing pathway	439	2.2e-18	0.44	0.57	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1475	1.6e-75	0.71	0.82	0.95
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.67	0.79	0.95
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.66	0.79	0.95
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.66	0.79	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1358	4.6e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.65	0.79	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.72	0.82	0.94
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.72	0.82	0.95
PGSC0003DMG200020092	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMG200020092	K08081	ko01100	Metabolic pathways	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMG200020092	K08081	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.65	0.79	0.95
PGSC0003DMG200025785	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko04144	Endocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMG200025785	K01528	ko04666	Fc gamma R-mediated phagocytosis	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMG200025785	K01528	ko05100	Bacterial invasion of epithelial cells	326	1.6e-11	0.84	0.92	0.88
PGSC0003DMG200025785	K01528	ko04144	Endocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko04666	Fc gamma R-mediated phagocytosis	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko05100	Bacterial invasion of epithelial cells	319	4.1e-11	0.62	0.80	0.78
PGSC0003DMG200025785	K01528	ko04144	Endocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMG200025785	K01528	ko04666	Fc gamma R-mediated phagocytosis	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMG200025785	K01528	ko05100	Bacterial invasion of epithelial cells	267	3.5e-08	0.58	0.77	0.88
PGSC0003DMG200025789	K00753	ko00510	N-Glycan biosynthesis	1682	6.2e-87	0.76	0.91	0.99
PGSC0003DMG200025789	K00753	ko00510	N-Glycan biosynthesis	2269	2.6e-119	0.78	0.89	0.97
PGSC0003DMG200025789	K00753	ko00510	N-Glycan biosynthesis	2996	2.1e-159	0.69	0.83	0.99
PGSC0003DMG200025789	K00753	ko00510	N-Glycan biosynthesis	2380	2.0e-125	0.79	0.90	1.00
PGSC0003DMG200013638	K00384	ko00240	Pyrimidine metabolism	2442	7.4e-129	0.79	0.88	0.99
PGSC0003DMG200013639	K12741	ko03040	Spliceosome	318	1.1e-11	0.43	0.60	0.34
PGSC0003DMG200013642	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	412	2.6e-16	0.36	0.51	0.45
PGSC0003DMG200013648	K08139	ko04113	Meiosis - yeast	611	5.5e-53	0.38	0.59	0.60
PGSC0003DMG200006481	K10577	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.92	0.96	0.99
PGSC0003DMG200006485	K13065	ko00940	Phenylpropanoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMG200006485	K13065	ko00941	Flavonoid biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMG200006485	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMG200006485	K13065	ko01110	Biosynthesis of secondary metabolites	290	2.4e-08	0.25	0.42	0.88
PGSC0003DMG200006488	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	549	3.6e-24	0.35	0.50	0.88
PGSC0003DMG200006489	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	498	3.3e-21	0.34	0.47	0.99
PGSC0003DMG200006489	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMG200006489	K12567	ko05414	Dilated cardiomyopathy	305	2.0e-08	0.41	0.48	0.75
PGSC0003DMG200006490	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMG200006490	K12567	ko05414	Dilated cardiomyopathy	495	6.5e-19	0.30	0.43	0.95
PGSC0003DMG200006491	K02903	ko03010	Ribosome	971	1.0e-47	0.83	0.92	0.99
PGSC0003DMG200006493	K02957	ko03010	Ribosome	835	3.2e-40	0.72	0.90	0.99
PGSC0003DMG200006499	K01178	ko00500	Starch and sucrose metabolism	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMG200006499	K01178	ko01100	Metabolic pathways	304	6.6e-10	0.30	0.42	0.92
PGSC0003DMG200011436	K00208	ko00061	Fatty acid biosynthesis	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMG200011436	K00208	ko01100	Metabolic pathways	2349	1.0e-123	0.89	0.94	0.99
PGSC0003DMG200011444	K03021	ko00230	Purine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMG200011444	K03021	ko00240	Pyrimidine metabolism	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMG200011444	K03021	ko01100	Metabolic pathways	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMG200011444	K03021	ko03020	RNA polymerase	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMG200011444	K03021	ko04623	Cytosolic DNA-sensing pathway	4441	4.1e-239	0.87	0.95	1.00
PGSC0003DMG200011444	K03021	ko00230	Purine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMG200011444	K03021	ko00240	Pyrimidine metabolism	8032	0.	0.82	0.91	0.98
PGSC0003DMG200011444	K03021	ko01100	Metabolic pathways	8032	0.	0.82	0.91	0.98
PGSC0003DMG200011444	K03021	ko03020	RNA polymerase	8032	0.	0.82	0.91	0.98
PGSC0003DMG200011444	K03021	ko04623	Cytosolic DNA-sensing pathway	8032	0.	0.82	0.91	0.98
PGSC0003DMG200011445	K03021	ko00230	Purine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMG200011445	K03021	ko00240	Pyrimidine metabolism	7627	0.	0.79	0.89	0.98
PGSC0003DMG200011445	K03021	ko01100	Metabolic pathways	7627	0.	0.79	0.89	0.98
PGSC0003DMG200011445	K03021	ko03020	RNA polymerase	7627	0.	0.79	0.89	0.98
PGSC0003DMG200011445	K03021	ko04623	Cytosolic DNA-sensing pathway	7627	0.	0.79	0.89	0.98
PGSC0003DMG200011448	K12603	ko03018	RNA degradation	4537	2.1e-244	0.87	0.94	1.00
PGSC0003DMG200011449	K02889	ko03010	Ribosome	1223	1.3e-61	0.85	0.92	0.99
PGSC0003DMG200043726	K00799	ko00480	Glutathione metabolism	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMG200043726	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMG200043726	K00799	ko00982	Drug metabolism - cytochrome P450	598	3.8e-27	0.38	0.61	0.99
PGSC0003DMG200045082	K10591	ko04120	Ubiquitin mediated proteolysis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMG200045082	K10591	ko04144	Endocytosis	439	1.6e-28	0.54	0.69	0.88
PGSC0003DMG200045089	K00901	ko00561	Glycerolipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMG200045089	K00901	ko00564	Glycerophospholipid metabolism	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMG200045089	K00901	ko01100	Metabolic pathways	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMG200045089	K00901	ko04070	Phosphatidylinositol signaling system	295	1.5e-08	0.38	0.61	0.23
PGSC0003DMG200045095	K07385	ko00902	Monoterpenoid biosynthesis	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMG200045095	K07385	ko01100	Metabolic pathways	981	2.8e-48	0.33	0.51	0.99
PGSC0003DMG200032154	K00008	ko00051	Fructose and mannose metabolism	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMG200032154	K00008	ko01100	Metabolic pathways	2610	4.0e-138	0.87	0.95	1.00
PGSC0003DMG200032154	K00008	ko00051	Fructose and mannose metabolism	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMG200032154	K00008	ko01100	Metabolic pathways	2602	1.1e-137	0.87	0.94	0.99
PGSC0003DMG200032155	K00454	ko00591	Linoleic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMG200032155	K00454	ko00592	alpha-Linolenic acid metabolism	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMG200032155	K00454	ko01100	Metabolic pathways	4304	1.5e-231	0.59	0.75	0.94
PGSC0003DMG200032155	K00454	ko00591	Linoleic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMG200032155	K00454	ko00592	alpha-Linolenic acid metabolism	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMG200032155	K00454	ko01100	Metabolic pathways	657	2.1e-30	0.67	0.75	0.99
PGSC0003DMG200032159	K10418	ko04962	Vasopressin-regulated water reabsorption	307	4.3e-11	0.46	0.62	0.66
PGSC0003DMG200017340	K04460	ko04010	MAPK signaling pathway	3733	4.6e-200	0.89	0.95	1.00
PGSC0003DMG200017341	K00754	ko00051	Fructose and mannose metabolism	779	3.9e-37	0.34	0.53	0.72
PGSC0003DMG200017341	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMG200017341	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.98
PGSC0003DMG200017341	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMG200017341	K00754	ko00051	Fructose and mannose metabolism	1060	1.2e-52	0.35	0.54	0.79
PGSC0003DMG200017346	K00948	ko00030	Pentose phosphate pathway	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMG200017346	K00948	ko00230	Purine metabolism	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMG200017346	K00948	ko01100	Metabolic pathways	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMG200017346	K00948	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.34	0.50	0.86
PGSC0003DMG200017347	K10955	ko05110	Vibrio cholerae infection	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMG200017347	K10955	ko05146	Amoebiasis	280	4.3e-08	0.32	0.45	0.80
PGSC0003DMG200017348	K01213	ko00040	Pentose and glucuronate interconversions	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMG200017348	K01213	ko00500	Starch and sucrose metabolism	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMG200017348	K01213	ko01100	Metabolic pathways	1252	3.2e-63	0.45	0.61	0.92
PGSC0003DMG200017354	K12639	ko00905	Brassinosteroid biosynthesis	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMG200017354	K12639	ko01100	Metabolic pathways	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMG200017354	K12639	ko01110	Biosynthesis of secondary metabolites	2541	2.6e-134	0.63	0.80	0.98
PGSC0003DMG200017367	K01835	ko00010	Glycolysis / Gluconeogenesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00030	Pentose phosphate pathway	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00052	Galactose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00230	Purine metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00500	Starch and sucrose metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko00521	Streptomycin biosynthesis	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko01100	Metabolic pathways	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200017367	K01835	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.51	0.55	1.00
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.59	0.77	0.97
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	1220	1.9e-61	0.57	0.75	0.98
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.61	0.79	0.94
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.59	0.78	0.85
PGSC0003DMG200028224	K09835	ko00906	Carotenoid biosynthesis	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMG200028224	K09835	ko01100	Metabolic pathways	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMG200028224	K09835	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.92	0.96	0.99
PGSC0003DMG200028224	K09835	ko00906	Carotenoid biosynthesis	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMG200028224	K09835	ko01100	Metabolic pathways	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMG200028224	K09835	ko01110	Biosynthesis of secondary metabolites	3254	1.2e-173	0.76	0.85	0.98
PGSC0003DMG200028224	K09835	ko00906	Carotenoid biosynthesis	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMG200028224	K09835	ko01100	Metabolic pathways	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMG200028224	K09835	ko01110	Biosynthesis of secondary metabolites	2312	1.1e-121	0.87	0.94	1.00
PGSC0003DMG200028224	K09835	ko00906	Carotenoid biosynthesis	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMG200028224	K09835	ko01100	Metabolic pathways	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMG200028224	K09835	ko01110	Biosynthesis of secondary metabolites	4022	5.3e-216	0.79	0.87	0.99
PGSC0003DMG200028228	K03504	ko00230	Purine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko00240	Pyrimidine metabolism	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko01100	Metabolic pathways	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko03030	DNA replication	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko03410	Base excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko03420	Nucleotide excision repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko03430	Mismatch repair	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028228	K03504	ko03440	Homologous recombination	268	1.1e-06	0.28	0.45	0.61
PGSC0003DMG200028232	K09480	ko00561	Glycerolipid metabolism	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMG200028232	K09480	ko01100	Metabolic pathways	545	3.3e-24	0.77	0.91	0.95
PGSC0003DMG200028233	K09480	ko00561	Glycerolipid metabolism	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMG200028233	K09480	ko01100	Metabolic pathways	906	3.9e-44	0.68	0.82	0.99
PGSC0003DMG200028233	K09480	ko00561	Glycerolipid metabolism	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMG200028233	K09480	ko01100	Metabolic pathways	4467	1.5e-240	0.67	0.79	0.99
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	732	1.5e-34	0.77	0.88	0.96
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	1003	1.7e-49	0.78	0.90	0.97
PGSC0003DMG200023705	K04506	ko04115	p53 signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023705	K04506	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023705	K04506	ko04310	Wnt signaling pathway	1753	7.5e-91	0.79	0.90	0.98
PGSC0003DMG200023706	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMG200023706	K03652	ko03410	Base excision repair	863	9.2e-42	0.85	0.91	0.98
PGSC0003DMG200023706	K03652	ko03410	Base excision repair	1514	1.1e-77	0.69	0.77	0.99
PGSC0003DMG200023708	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04145	Phagosome	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04510	Focal adhesion	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04520	Adherens junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04530	Tight junction	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04670	Leukocyte transendothelial migration	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04745	Phototransduction - fly	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko04810	Regulation of actin cytoskeleton	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05100	Bacterial invasion of epithelial cells	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05110	Vibrio cholerae infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05130	Pathogenic Escherichia coli infection	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05131	Shigellosis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05414	Dilated cardiomyopathy	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023708	K05692	ko05416	Viral myocarditis	3179	1.7e-169	0.99	1.00	1.00
PGSC0003DMG200023714	K04124	ko00904	Diterpenoid biosynthesis	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMG200023714	K04124	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.31	0.47	0.91
PGSC0003DMG200023715	K13082	ko00941	Flavonoid biosynthesis	839	1.9e-40	0.38	0.57	0.98
PGSC0003DMG200023716	K02999	ko00230	Purine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMG200023716	K02999	ko00240	Pyrimidine metabolism	8494	0.	0.62	0.77	1.00
PGSC0003DMG200023716	K02999	ko01100	Metabolic pathways	8494	0.	0.62	0.77	1.00
PGSC0003DMG200023716	K02999	ko03020	RNA polymerase	8494	0.	0.62	0.77	1.00
PGSC0003DMG200019951	K12599	ko03018	RNA degradation	4266	1.9e-229	0.68	0.78	0.98
PGSC0003DMG200019951	K12599	ko03018	RNA degradation	3887	1.5e-208	0.68	0.79	0.97
PGSC0003DMG200019951	K12599	ko03018	RNA degradation	4529	5.8e-244	0.70	0.80	0.99
PGSC0003DMG200019951	K12599	ko03018	RNA degradation	4112	5.8e-221	0.69	0.79	0.99
PGSC0003DMG200019952	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMG200019952	K01657	ko01100	Metabolic pathways	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMG200019952	K01657	ko01110	Biosynthesis of secondary metabolites	2995	2.3e-159	0.70	0.81	0.93
PGSC0003DMG200019955	K04733	ko04210	Apoptosis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMG200019955	K04733	ko04620	Toll-like receptor signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMG200019955	K04733	ko04722	Neurotrophin signaling pathway	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMG200019955	K04733	ko05140	Leishmaniasis	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMG200019955	K04733	ko05142	Chagas disease	236	2.2e-06	0.30	0.48	0.96
PGSC0003DMG200019956	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMG200019956	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMG200019956	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.45	0.62	0.90
PGSC0003DMG200030531	K04733	ko04210	Apoptosis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMG200030531	K04733	ko04620	Toll-like receptor signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMG200030531	K04733	ko04722	Neurotrophin signaling pathway	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMG200030531	K04733	ko05140	Leishmaniasis	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMG200030531	K04733	ko05142	Chagas disease	695	1.7e-32	0.41	0.59	0.89
PGSC0003DMG200030531	K04733	ko04210	Apoptosis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMG200030531	K04733	ko04620	Toll-like receptor signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMG200030531	K04733	ko04722	Neurotrophin signaling pathway	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMG200030531	K04733	ko05140	Leishmaniasis	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMG200030531	K04733	ko05142	Chagas disease	875	2.0e-42	0.39	0.56	0.56
PGSC0003DMG200030531	K04733	ko04210	Apoptosis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMG200030531	K04733	ko04620	Toll-like receptor signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMG200030531	K04733	ko04722	Neurotrophin signaling pathway	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMG200030531	K04733	ko05140	Leishmaniasis	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMG200030531	K04733	ko05142	Chagas disease	877	1.5e-42	0.38	0.56	0.85
PGSC0003DMG200030531	K04733	ko04210	Apoptosis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMG200030531	K04733	ko04620	Toll-like receptor signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMG200030531	K04733	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMG200030531	K04733	ko05140	Leishmaniasis	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMG200030531	K04733	ko05142	Chagas disease	848	6.2e-41	0.42	0.59	0.72
PGSC0003DMG200030531	K04733	ko04210	Apoptosis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMG200030531	K04733	ko04620	Toll-like receptor signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMG200030531	K04733	ko04722	Neurotrophin signaling pathway	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMG200030531	K04733	ko05140	Leishmaniasis	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMG200030531	K04733	ko05142	Chagas disease	754	9.4e-36	0.41	0.58	0.83
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	693	2.2e-32	0.42	0.60	0.83
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.45
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	852	3.7e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	841	1.5e-40	0.43	0.61	0.76
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	851	4.2e-41	0.43	0.60	0.49
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	690	3.2e-32	0.42	0.59	0.95
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	666	6.7e-31	0.39	0.57	0.95
PGSC0003DMG200030532	K04733	ko04210	Apoptosis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMG200030532	K04733	ko04620	Toll-like receptor signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMG200030532	K04733	ko04722	Neurotrophin signaling pathway	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMG200030532	K04733	ko05140	Leishmaniasis	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMG200030532	K04733	ko05142	Chagas disease	811	6.8e-39	0.40	0.58	0.73
PGSC0003DMG200030533	K04733	ko04210	Apoptosis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMG200030533	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMG200030533	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMG200030533	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMG200030533	K04733	ko05142	Chagas disease	675	2.1e-31	0.42	0.61	0.79
PGSC0003DMG200030535	K04733	ko04210	Apoptosis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMG200030535	K04733	ko04620	Toll-like receptor signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMG200030535	K04733	ko04722	Neurotrophin signaling pathway	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMG200030535	K04733	ko05140	Leishmaniasis	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMG200030535	K04733	ko05142	Chagas disease	870	3.8e-42	0.40	0.57	0.60
PGSC0003DMG200030536	K04733	ko04210	Apoptosis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMG200030536	K04733	ko04620	Toll-like receptor signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMG200030536	K04733	ko04722	Neurotrophin signaling pathway	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMG200030536	K04733	ko05140	Leishmaniasis	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMG200030536	K04733	ko05142	Chagas disease	672	3.1e-31	0.40	0.57	0.91
PGSC0003DMG200030537	K02910	ko03010	Ribosome	717	1.0e-33	0.92	0.97	0.92
PGSC0003DMG200030537	K02910	ko03010	Ribosome	940	5.2e-46	0.93	0.97	0.99
PGSC0003DMG200022177	K01692	ko00071	Fatty acid metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00280	Valine, leucine and isoleucine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00281	Geraniol degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00310	Lysine degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00380	Tryptophan metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00410	beta-Alanine metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00632	Benzoate degradation via CoA ligation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00640	Propanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00650	Butanoate metabolism	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00903	Limonene and pinene degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00930	Caprolactam degradation	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko01100	Metabolic pathways	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.44	0.60	0.90
PGSC0003DMG200022177	K01692	ko00071	Fatty acid metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00280	Valine, leucine and isoleucine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00281	Geraniol degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00310	Lysine degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00380	Tryptophan metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00410	beta-Alanine metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00632	Benzoate degradation via CoA ligation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00640	Propanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00650	Butanoate metabolism	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00903	Limonene and pinene degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko00930	Caprolactam degradation	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko01100	Metabolic pathways	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022177	K01692	ko01110	Biosynthesis of secondary metabolites	232	7.5e-07	0.48	0.64	0.80
PGSC0003DMG200022181	K00640	ko00270	Cysteine and methionine metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMG200022181	K00640	ko00920	Sulfur metabolism	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMG200022181	K00640	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.87	1.00
PGSC0003DMG200022183	K05665	ko02010	ABC transporters	3210	3.3e-171	0.38	0.58	0.95
PGSC0003DMG200000493	K01673	ko00910	Nitrogen metabolism	1970	8.0e-103	0.74	0.84	1.00
PGSC0003DMG200000496	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMG200000496	K00122	ko00680	Methane metabolism	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMG200000496	K00122	ko01100	Metabolic pathways	2672	1.5e-141	0.83	0.89	1.00
PGSC0003DMG200000500	K04733	ko04210	Apoptosis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMG200000500	K04733	ko04620	Toll-like receptor signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMG200000500	K04733	ko04722	Neurotrophin signaling pathway	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMG200000500	K04733	ko05140	Leishmaniasis	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMG200000500	K04733	ko05142	Chagas disease	785	1.8e-37	0.41	0.59	0.52
PGSC0003DMG200046993	K12831	ko03040	Spliceosome	370	3.5e-28	0.66	0.83	0.82
PGSC0003DMG200047004	K01051	ko00040	Pentose and glucuronate interconversions	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMG200047004	K01051	ko00500	Starch and sucrose metabolism	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMG200047004	K01051	ko01100	Metabolic pathways	460	1.5e-19	0.43	0.60	0.95
PGSC0003DMG200047007	K11644	ko05016	Huntington's disease	777	1.4e-36	0.44	0.58	0.56
PGSC0003DMG200005571	K03965	ko00190	Oxidative phosphorylation	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMG200005571	K03965	ko01100	Metabolic pathways	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMG200005571	K03965	ko05010	Alzheimer's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMG200005571	K03965	ko05012	Parkinson's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMG200005571	K03965	ko05016	Huntington's disease	574	8.0e-26	0.76	0.88	0.54
PGSC0003DMG200005571	K03965	ko00190	Oxidative phosphorylation	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMG200005571	K03965	ko01100	Metabolic pathways	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMG200005571	K03965	ko05010	Alzheimer's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMG200005571	K03965	ko05012	Parkinson's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMG200005571	K03965	ko05016	Huntington's disease	817	3.2e-39	0.78	0.90	0.96
PGSC0003DMG200005573	K04079	ko04612	Antigen processing and presentation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko04621	NOD-like receptor signaling pathway	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko04626	Plant-pathogen interaction	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko04914	Progesterone-mediated oocyte maturation	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko05200	Pathways in cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko05215	Prostate cancer	939	9.9e-64	0.54	0.70	0.97
PGSC0003DMG200005573	K04079	ko04612	Antigen processing and presentation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005573	K04079	ko04621	NOD-like receptor signaling pathway	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005573	K04079	ko04626	Plant-pathogen interaction	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005573	K04079	ko04914	Progesterone-mediated oocyte maturation	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005573	K04079	ko05200	Pathways in cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005573	K04079	ko05215	Prostate cancer	2110	1.5e-110	0.91	0.96	0.95
PGSC0003DMG200005580	K05280	ko00941	Flavonoid biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMG200005580	K05280	ko00944	Flavone and flavonol biosynthesis	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMG200005580	K05280	ko01100	Metabolic pathways	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMG200005580	K05280	ko01110	Biosynthesis of secondary metabolites	1480	8.5e-76	0.40	0.58	0.98
PGSC0003DMG200005581	K09754	ko00360	Phenylalanine metabolism	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005581	K09754	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005581	K09754	ko00941	Flavonoid biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005581	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005581	K09754	ko01100	Metabolic pathways	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005581	K09754	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.45	0.64	0.97
PGSC0003DMG200005582	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMG200005582	K00517	ko00626	Naphthalene and anthracene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMG200005582	K00517	ko00903	Limonene and pinene degradation	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMG200005582	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMG200005582	K00517	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.39	0.59	0.93
PGSC0003DMG200016151	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMG200016153	K10352	ko04530	Tight junction	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMG200016153	K10352	ko05416	Viral myocarditis	437	2.9e-16	0.28	0.46	0.97
PGSC0003DMG200016157	K00599	ko00340	Histidine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMG200016157	K00599	ko00350	Tyrosine metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMG200016157	K00599	ko00450	Selenoamino acid metabolism	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMG200016157	K00599	ko00626	Naphthalene and anthracene degradation	2001	1.6e-104	0.37	0.55	0.91
PGSC0003DMG200016157	K00599	ko00340	Histidine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMG200016157	K00599	ko00350	Tyrosine metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMG200016157	K00599	ko00450	Selenoamino acid metabolism	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMG200016157	K00599	ko00626	Naphthalene and anthracene degradation	690	3.2e-32	0.49	0.66	0.79
PGSC0003DMG200016157	K00599	ko00340	Histidine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMG200016157	K00599	ko00350	Tyrosine metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMG200016157	K00599	ko00450	Selenoamino acid metabolism	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMG200016157	K00599	ko00626	Naphthalene and anthracene degradation	938	6.7e-46	0.34	0.49	0.93
PGSC0003DMG200001918	K12126	ko04712	Circadian rhythm - plant	342	7.2e-12	0.26	0.43	0.76
PGSC0003DMG200001919	K12126	ko04712	Circadian rhythm - plant	251	2.2e-07	0.33	0.50	0.49
PGSC0003DMG200001921	K03469	ko03030	DNA replication	370	1.4e-14	0.43	0.63	0.34
PGSC0003DMG200001922	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.48	0.97
PGSC0003DMG200001922	K10260	ko04120	Ubiquitin mediated proteolysis	446	9.2e-19	0.29	0.49	0.79
PGSC0003DMG200001927	K00161	ko00010	Glycolysis / Gluconeogenesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko00020	Citrate cycle (TCA cycle)	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko00620	Pyruvate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko00650	Butanoate metabolism	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko01100	Metabolic pathways	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001927	K00161	ko01110	Biosynthesis of secondary metabolites	2602	1.1e-137	0.78	0.88	1.00
PGSC0003DMG200001929	K04382	ko04111	Cell cycle - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04113	Meiosis - yeast	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04114	Oocyte meiosis	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04310	Wnt signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04350	TGF-beta signaling pathway	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04530	Tight junction	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04730	Long-term depression	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko05142	Chagas disease	2625	6.0e-139	0.96	0.99	1.00
PGSC0003DMG200001929	K04382	ko04111	Cell cycle - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04113	Meiosis - yeast	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04114	Oocyte meiosis	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04310	Wnt signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04350	TGF-beta signaling pathway	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04530	Tight junction	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko04730	Long-term depression	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001929	K04382	ko05142	Chagas disease	1031	5.0e-51	0.98	0.99	0.99
PGSC0003DMG200001930	K12126	ko04712	Circadian rhythm - plant	298	2.0e-10	0.34	0.54	0.80
PGSC0003DMG200001932	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko00030	Pentose phosphate pathway	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko00480	Glutathione metabolism	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01100	Metabolic pathways	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001932	K00033	ko01110	Biosynthesis of secondary metabolites	3675	7.3e-197	0.89	0.95	1.00
PGSC0003DMG200001934	K00558	ko00270	Cysteine and methionine metabolism	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMG200001934	K00558	ko01100	Metabolic pathways	267	1.5e-06	0.38	0.54	0.40
PGSC0003DMG200001934	K00558	ko00270	Cysteine and methionine metabolism	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMG200001934	K00558	ko01100	Metabolic pathways	267	8.2e-06	0.38	0.54	0.30
PGSC0003DMG200001934	K00558	ko00270	Cysteine and methionine metabolism	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMG200001934	K00558	ko01100	Metabolic pathways	267	2.9e-06	0.38	0.54	0.38
PGSC0003DMG200012406	K12893	ko03040	Spliceosome	305	1.3e-10	0.33	0.47	0.40
PGSC0003DMG200012406	K12893	ko03040	Spliceosome	305	1.2e-10	0.33	0.47	0.41
PGSC0003DMG200012409	K00074	ko00632	Benzoate degradation via CoA ligation	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMG200012409	K00074	ko00650	Butanoate metabolism	1905	3.1e-99	0.78	0.89	1.00
PGSC0003DMG200012412	K09880	ko00270	Cysteine and methionine metabolism	3448	2.4e-184	0.78	0.88	1.00
PGSC0003DMG200012414	K09880	ko00270	Cysteine and methionine metabolism	226	1.7e-10	0.78	0.90	0.43
PGSC0003DMG200012415	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012415	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012415	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012415	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012415	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012415	K00771	ko01100	Metabolic pathways	463	3.0e-19	0.31	0.49	0.80
PGSC0003DMG200012416	K02435	ko00970	Aminoacyl-tRNA biosynthesis	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMG200012416	K02435	ko01100	Metabolic pathways	656	2.4e-30	0.60	0.74	0.99
PGSC0003DMG200012418	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMG200012418	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMG200012418	K02260	ko00190	Oxidative phosphorylation	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMG200012418	K02260	ko01100	Metabolic pathways	424	1.5e-17	0.65	0.79	0.91
PGSC0003DMG200033641	K05673	ko02010	ABC transporters	1594	4.4e-82	0.32	0.50	0.80
PGSC0003DMG200033641	K05673	ko02010	ABC transporters	1655	1.9e-85	0.32	0.50	0.81
PGSC0003DMG200033641	K05666	ko02010	ABC transporters	2909	1.3e-154	0.34	0.55	0.92
PGSC0003DMG200033642	K00059	ko00061	Fatty acid biosynthesis	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMG200033642	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMG200033642	K00059	ko01100	Metabolic pathways	1320	5.7e-67	0.59	0.78	1.00
PGSC0003DMG200033642	K00059	ko00061	Fatty acid biosynthesis	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMG200033642	K00059	ko01040	Biosynthesis of unsaturated fatty acids	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMG200033642	K00059	ko01100	Metabolic pathways	835	3.2e-40	0.56	0.79	0.97
PGSC0003DMG200033646	K01190	ko00052	Galactose metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMG200033646	K01190	ko00511	Other glycan degradation	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMG200033646	K01190	ko00600	Sphingolipid metabolism	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMG200033646	K01190	ko01100	Metabolic pathways	4160	1.3e-223	0.68	0.82	1.00
PGSC0003DMG200033646	K01190	ko00052	Galactose metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMG200033646	K01190	ko00511	Other glycan degradation	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMG200033646	K01190	ko00600	Sphingolipid metabolism	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMG200033646	K01190	ko01100	Metabolic pathways	593	7.1e-27	0.74	0.88	0.42
PGSC0003DMG200033646	K01190	ko00052	Galactose metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMG200033646	K01190	ko00511	Other glycan degradation	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMG200033646	K01190	ko00600	Sphingolipid metabolism	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMG200033646	K01190	ko01100	Metabolic pathways	4412	1.6e-237	0.69	0.82	0.86
PGSC0003DMG200033647	K00558	ko00270	Cysteine and methionine metabolism	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMG200033647	K00558	ko01100	Metabolic pathways	998	1.7e-48	0.39	0.56	0.65
PGSC0003DMG200033649	K06130	ko00564	Glycerophospholipid metabolism	213	6.5e-06	0.38	0.49	0.75
PGSC0003DMG200033649	K06130	ko00564	Glycerophospholipid metabolism	551	1.5e-24	0.37	0.55	0.85
PGSC0003DMG200027602	K01599	ko00860	Porphyrin and chlorophyll metabolism	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMG200027602	K01599	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.81	0.91	1.00
PGSC0003DMG200027611	K03283	ko03040	Spliceosome	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMG200027611	K03283	ko04010	MAPK signaling pathway	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMG200027611	K03283	ko04144	Endocytosis	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMG200027611	K03283	ko04612	Antigen processing and presentation	1638	1.6e-84	0.76	0.82	0.99
PGSC0003DMG200027614	K00430	ko00360	Phenylalanine metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMG200027614	K00430	ko00680	Methane metabolism	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMG200027614	K00430	ko00940	Phenylpropanoid biosynthesis	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMG200027614	K00430	ko01100	Metabolic pathways	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMG200027614	K00430	ko01110	Biosynthesis of secondary metabolites	1676	1.3e-86	0.68	0.81	0.99
PGSC0003DMG200027619	K00654	ko00600	Sphingolipid metabolism	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMG200027619	K00654	ko01100	Metabolic pathways	3226	4.3e-172	0.81	0.90	0.98
PGSC0003DMG200027622	K01933	ko00230	Purine metabolism	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMG200027622	K01933	ko01100	Metabolic pathways	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMG200027622	K01933	ko01110	Biosynthesis of secondary metabolites	1408	8.0e-72	0.69	0.81	0.72
PGSC0003DMG200027624	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMG200027624	K00015	ko01100	Metabolic pathways	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMG200027624	K00058	ko00260	Glycine, serine and threonine metabolism	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMG200027624	K00058	ko01100	Metabolic pathways	339	7.3e-13	0.40	0.58	0.70
PGSC0003DMG200027624	K00058	ko00260	Glycine, serine and threonine metabolism	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMG200027624	K00058	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.52	0.83
PGSC0003DMG200027624	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMG200027624	K00015	ko01100	Metabolic pathways	549	1.9e-24	0.33	0.53	0.90
PGSC0003DMG200017617	K07199	ko04910	Insulin signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMG200017617	K07199	ko04920	Adipocytokine signaling pathway	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMG200017617	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	235	9.6e-07	0.44	0.64	0.14
PGSC0003DMG200046191	K04508	ko04310	Wnt signaling pathway	422	1.9e-17	0.42	0.52	0.71
PGSC0003DMG200014177	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMG200014178	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014178	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014178	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014178	K01711	ko00051	Fructose and mannose metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014178	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014178	K01711	ko01100	Metabolic pathways	2849	2.7e-151	0.89	0.95	1.00
PGSC0003DMG200014189	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMG200014189	K01553	ko00230	Purine metabolism	255	2.4e-07	0.27	0.50	0.98
PGSC0003DMG200014189	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMG200014189	K11423	ko00310	Lysine degradation	338	2.9e-09	0.28	0.49	0.64
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	330	2.3e-12	0.39	0.55	0.75
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	952	1.1e-46	0.47	0.60	0.71
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	959	4.6e-47	0.47	0.60	0.91
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	922	5.1e-45	0.46	0.61	0.71
PGSC0003DMG200010056	K12135	ko04712	Circadian rhythm - plant	327	3.4e-12	0.40	0.55	0.48
PGSC0003DMG200010060	K05864	ko04020	Calcium signaling pathway	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMG200010060	K05864	ko05012	Parkinson's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMG200010060	K05864	ko05016	Huntington's disease	2357	3.6e-124	0.75	0.87	1.00
PGSC0003DMG200010060	K05864	ko04020	Calcium signaling pathway	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMG200010060	K05864	ko05012	Parkinson's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMG200010060	K05864	ko05016	Huntington's disease	2195	3.1e-115	0.75	0.87	1.00
PGSC0003DMG200010061	K00430	ko00360	Phenylalanine metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMG200010061	K00430	ko00680	Methane metabolism	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMG200010061	K00430	ko00940	Phenylpropanoid biosynthesis	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMG200010061	K00430	ko01100	Metabolic pathways	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMG200010061	K00430	ko01110	Biosynthesis of secondary metabolites	1370	1.0e-69	0.64	0.74	0.98
PGSC0003DMG200010061	K00430	ko00360	Phenylalanine metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMG200010061	K00430	ko00680	Methane metabolism	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMG200010061	K00430	ko00940	Phenylpropanoid biosynthesis	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMG200010061	K00430	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMG200010061	K00430	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.59	0.73	0.99
PGSC0003DMG200010064	K00430	ko00360	Phenylalanine metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMG200010064	K00430	ko00680	Methane metabolism	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMG200010064	K00430	ko00940	Phenylpropanoid biosynthesis	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMG200010064	K00430	ko01100	Metabolic pathways	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMG200010064	K00430	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.61	0.73	0.98
PGSC0003DMG200010065	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMG200010065	K11228	ko04011	MAPK signaling pathway - yeast	979	3.7e-48	0.36	0.51	0.72
PGSC0003DMG200010066	K02897	ko03010	Ribosome	1277	1.3e-64	0.63	0.78	1.00
PGSC0003DMG200010066	K02897	ko03010	Ribosome	1300	7.2e-66	0.65	0.81	1.00
PGSC0003DMG200010878	K02918	ko03010	Ribosome	719	8.0e-34	0.89	0.96	0.44
PGSC0003DMG200010878	K02918	ko03010	Ribosome	913	1.6e-44	0.92	0.96	0.99
PGSC0003DMG200010879	K07195	ko04910	Insulin signaling pathway	2086	3.2e-109	0.47	0.67	0.94
PGSC0003DMG200010882	K04123	ko00904	Diterpenoid biosynthesis	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMG200010882	K04123	ko01100	Metabolic pathways	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMG200010882	K04123	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.32	0.50	0.97
PGSC0003DMG200031733	K01718	ko00240	Pyrimidine metabolism	778	4.5e-37	0.41	0.58	0.99
PGSC0003DMG200031733	K01718	ko00240	Pyrimidine metabolism	1059	1.4e-52	0.41	0.58	0.91
PGSC0003DMG200031736	K00648	ko00061	Fatty acid biosynthesis	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMG200031736	K00648	ko01100	Metabolic pathways	2571	5.7e-136	0.77	0.88	0.91
PGSC0003DMG200031749	K07466	ko03030	DNA replication	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMG200031749	K07466	ko03420	Nucleotide excision repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMG200031749	K07466	ko03430	Mismatch repair	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMG200031749	K07466	ko03440	Homologous recombination	751	1.4e-35	0.65	0.76	0.89
PGSC0003DMG200027482	K04731	ko04210	Apoptosis	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMG200027482	K04731	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.39	0.55	0.54
PGSC0003DMG200027498	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	318	2.2e-09	0.28	0.44	0.63
PGSC0003DMG200027500	K12190	ko04144	Endocytosis	1875	1.4e-97	0.70	0.82	0.87
PGSC0003DMG200027500	K12190	ko04144	Endocytosis	2563	1.6e-135	0.70	0.82	1.00
PGSC0003DMG200027500	K12190	ko04144	Endocytosis	735	1.1e-34	0.72	0.89	0.87
PGSC0003DMG200018342	K04852	ko04010	MAPK signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMG200018342	K04852	ko04020	Calcium signaling pathway	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMG200018342	K04852	ko04930	Type II diabetes mellitus	413	2.3e-13	0.27	0.45	0.60
PGSC0003DMG200028305	K07424	ko00140	Steroid hormone biosynthesis	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00591	Linoleic acid metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00830	Retinol metabolism	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00982	Drug metabolism - cytochrome P450	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00983	Drug metabolism - other enzymes	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko01100	Metabolic pathways	1103	5.3e-55	0.41	0.61	0.96
PGSC0003DMG200028305	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00140	Steroid hormone biosynthesis	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00591	Linoleic acid metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00830	Retinol metabolism	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00982	Drug metabolism - cytochrome P450	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00983	Drug metabolism - other enzymes	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko01100	Metabolic pathways	1249	4.7e-63	0.39	0.60	0.99
PGSC0003DMG200028305	K07424	ko00140	Steroid hormone biosynthesis	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00591	Linoleic acid metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00830	Retinol metabolism	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00982	Drug metabolism - cytochrome P450	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00983	Drug metabolism - other enzymes	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko01100	Metabolic pathways	586	1.7e-26	0.39	0.58	0.88
PGSC0003DMG200028305	K07424	ko00140	Steroid hormone biosynthesis	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00591	Linoleic acid metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00830	Retinol metabolism	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00982	Drug metabolism - cytochrome P450	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko00983	Drug metabolism - other enzymes	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028305	K07424	ko01100	Metabolic pathways	411	7.8e-17	0.38	0.55	0.84
PGSC0003DMG200028310	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	368	1.8e-14	0.38	0.62	0.93
PGSC0003DMG200028311	K00847	ko00051	Fructose and mannose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMG200028311	K00847	ko00500	Starch and sucrose metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMG200028311	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMG200028311	K00847	ko01100	Metabolic pathways	683	7.8e-32	0.36	0.57	0.44
PGSC0003DMG200028311	K00847	ko00051	Fructose and mannose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMG200028311	K00847	ko00500	Starch and sucrose metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMG200028311	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMG200028311	K00847	ko01100	Metabolic pathways	692	2.5e-32	0.35	0.54	0.49
PGSC0003DMG200028317	K01940	ko00250	Alanine, aspartate and glutamate metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMG200028317	K01940	ko00330	Arginine and proline metabolism	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMG200028317	K01940	ko01100	Metabolic pathways	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMG200028317	K01940	ko01110	Biosynthesis of secondary metabolites	3297	5.2e-176	0.81	0.89	1.00
PGSC0003DMG200014851	K02516	ko04111	Cell cycle - yeast	273	1.0e-08	0.49	0.60	0.95
PGSC0003DMG200014851	K02516	ko04111	Cell cycle - yeast	4430	1.7e-238	0.78	0.87	1.00
PGSC0003DMG200014852	K00999	ko00562	Inositol phosphate metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMG200014852	K00999	ko00564	Glycerophospholipid metabolism	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMG200014852	K00999	ko01100	Metabolic pathways	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMG200014852	K00999	ko04070	Phosphatidylinositol signaling system	318	1.1e-11	0.52	0.71	0.42
PGSC0003DMG200014852	K00999	ko00562	Inositol phosphate metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMG200014852	K00999	ko00564	Glycerophospholipid metabolism	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMG200014852	K00999	ko01100	Metabolic pathways	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMG200014852	K00999	ko04070	Phosphatidylinositol signaling system	654	3.1e-30	0.71	0.85	0.99
PGSC0003DMG200014852	K00999	ko00562	Inositol phosphate metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMG200014852	K00999	ko00564	Glycerophospholipid metabolism	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMG200014852	K00999	ko01100	Metabolic pathways	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMG200014852	K00999	ko04070	Phosphatidylinositol signaling system	426	1.2e-17	0.70	0.87	0.77
PGSC0003DMG200014852	K00999	ko00562	Inositol phosphate metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMG200014852	K00999	ko00564	Glycerophospholipid metabolism	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMG200014852	K00999	ko01100	Metabolic pathways	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMG200014852	K00999	ko04070	Phosphatidylinositol signaling system	1428	6.3e-73	0.75	0.88	1.00
PGSC0003DMG200014854	K06675	ko04111	Cell cycle - yeast	280	1.4e-06	0.25	0.47	0.84
PGSC0003DMG200014854	K06675	ko04111	Cell cycle - yeast	285	5.3e-07	0.26	0.49	0.83
PGSC0003DMG200014855	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200014855	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200014855	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200014857	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMG200014857	K02366	ko01100	Metabolic pathways	486	6.3e-21	0.31	0.50	0.90
PGSC0003DMG200010168	K01924	ko00471	D-Glutamine and D-glutamate metabolism	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMG200010168	K01924	ko00550	Peptidoglycan biosynthesis	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMG200010168	K01924	ko01100	Metabolic pathways	1197	3.5e-60	0.37	0.53	0.91
PGSC0003DMG200010168	K01924	ko00471	D-Glutamine and D-glutamate metabolism	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMG200010168	K01924	ko00550	Peptidoglycan biosynthesis	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMG200010168	K01924	ko01100	Metabolic pathways	960	4.1e-47	0.40	0.57	0.98
PGSC0003DMG200010168	K01924	ko00471	D-Glutamine and D-glutamate metabolism	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMG200010168	K01924	ko00550	Peptidoglycan biosynthesis	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMG200010168	K01924	ko01100	Metabolic pathways	373	9.7e-15	0.37	0.58	0.67
PGSC0003DMG200010169	K02294	ko00906	Carotenoid biosynthesis	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMG200010169	K02294	ko01100	Metabolic pathways	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMG200010169	K02294	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.63	0.74	0.99
PGSC0003DMG200036103	K08967	ko00270	Cysteine and methionine metabolism	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMG200036103	K08967	ko01100	Metabolic pathways	1236	2.5e-62	0.72	0.87	0.85
PGSC0003DMG200036118	K02896	ko03010	Ribosome	333	1.6e-12	0.56	0.71	0.96
PGSC0003DMG200036124	K11251	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.54	0.68	0.92
PGSC0003DMG200022960	K01046	ko00561	Glycerolipid metabolism	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMG200022960	K01046	ko01100	Metabolic pathways	327	3.4e-12	0.32	0.47	0.58
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	385	2.1e-15	0.36	0.45	0.72
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	601	2.6e-27	0.46	0.59	0.92
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMG200022976	K01500	ko00791	Atrazine degradation	387	1.6e-15	0.47	0.62	0.89
PGSC0003DMG200029807	K06268	ko04010	MAPK signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04020	Calcium signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04114	Oocyte meiosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04210	Apoptosis	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04310	Wnt signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04360	Axon guidance	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04370	VEGF signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04650	Natural killer cell mediated cytotoxicity	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04660	T cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04662	B cell receptor signaling pathway	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko04720	Long-term potentiation	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko05010	Alzheimer's disease	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029807	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1667	4.1e-86	0.90	0.94	1.00
PGSC0003DMG200029822	K07466	ko03030	DNA replication	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMG200029822	K07466	ko03420	Nucleotide excision repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMG200029822	K07466	ko03430	Mismatch repair	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMG200029822	K07466	ko03440	Homologous recombination	266	2.3e-06	0.23	0.43	0.84
PGSC0003DMG200029822	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03030	DNA replication	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03420	Nucleotide excision repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03430	Mismatch repair	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200029822	K07466	ko03440	Homologous recombination	276	9.5e-07	0.23	0.43	0.75
PGSC0003DMG200019246	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMG200019246	K06096	ko04530	Tight junction	226	1.3e-06	0.31	0.52	0.57
PGSC0003DMG200019247	K10418	ko04962	Vasopressin-regulated water reabsorption	389	1.3e-15	0.56	0.73	0.73
PGSC0003DMG200019248	K08914	ko00196	Photosynthesis - antenna proteins	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMG200019248	K08914	ko01100	Metabolic pathways	2024	8.5e-106	0.88	0.94	1.00
PGSC0003DMG200019248	K08914	ko00196	Photosynthesis - antenna proteins	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMG200019248	K08914	ko01100	Metabolic pathways	1316	9.5e-67	0.94	0.98	0.99
PGSC0003DMG200006214	K00588	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko00941	Flavonoid biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko01100	Metabolic pathways	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.86	0.95	0.98
PGSC0003DMG200006214	K00588	ko00360	Phenylalanine metabolism	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006214	K00588	ko00940	Phenylpropanoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006214	K00588	ko00941	Flavonoid biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006214	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006214	K00588	ko01100	Metabolic pathways	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006214	K00588	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.81	0.90	0.96
PGSC0003DMG200006217	K05402	ko04620	Toll-like receptor signaling pathway	262	1.3e-08	0.29	0.41	0.93
PGSC0003DMG200006217	K00933	ko00330	Arginine and proline metabolism	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMG200006217	K00933	ko01100	Metabolic pathways	283	2.3e-09	0.35	0.48	0.51
PGSC0003DMG200006218	K12869	ko03040	Spliceosome	1106	3.6e-55	0.43	0.59	0.93
PGSC0003DMG200006220	K02184	ko04320	Dorso-ventral axis formation	979	2.3e-47	0.43	0.50	0.99
PGSC0003DMG200006223	K00753	ko00510	N-Glycan biosynthesis	1316	9.5e-67	0.62	0.74	0.89
PGSC0003DMG200006223	K00753	ko00510	N-Glycan biosynthesis	1405	1.2e-71	0.73	0.88	0.93
PGSC0003DMG200006223	K00753	ko00510	N-Glycan biosynthesis	2979	1.8e-158	0.68	0.81	0.97
PGSC0003DMG200006223	K00753	ko00510	N-Glycan biosynthesis	2247	4.2e-118	0.77	0.89	0.85
PGSC0003DMG200015407	K02926	ko03010	Ribosome	1940	3.6e-101	0.78	0.84	1.00
PGSC0003DMG200015407	K02926	ko03010	Ribosome	1963	2.0e-102	0.80	0.86	1.00
PGSC0003DMG200015412	K01046	ko00561	Glycerolipid metabolism	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMG200015412	K01046	ko01100	Metabolic pathways	345	3.4e-13	0.33	0.47	0.65
PGSC0003DMG200015412	K01046	ko00561	Glycerolipid metabolism	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMG200015412	K01046	ko01100	Metabolic pathways	350	1.8e-13	0.34	0.47	0.57
PGSC0003DMG200015421	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMG200015421	K00517	ko00626	Naphthalene and anthracene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMG200015421	K00517	ko00903	Limonene and pinene degradation	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMG200015421	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMG200015421	K00517	ko01110	Biosynthesis of secondary metabolites	2595	2.7e-137	0.65	0.82	0.99
PGSC0003DMG200015422	K12815	ko03040	Spliceosome	5735	0.	0.73	0.83	0.94
PGSC0003DMG200015422	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMG200015422	K12815	ko03040	Spliceosome	5712	0.	0.75	0.84	0.97
PGSC0003DMG200015423	K10579	ko04120	Ubiquitin mediated proteolysis	1427	7.2e-73	0.87	0.96	0.99
PGSC0003DMG200015426	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMG200015426	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	514	1.6e-22	0.34	0.53	0.84
PGSC0003DMG200013065	K02906	ko03010	Ribosome	751	1.4e-35	0.72	0.84	0.65
PGSC0003DMG200013065	K02906	ko03010	Ribosome	272	3.6e-09	0.51	0.66	0.83
PGSC0003DMG200013065	K02906	ko03010	Ribosome	947	2.1e-46	0.50	0.59	0.75
PGSC0003DMG200013065	K02906	ko03010	Ribosome	1542	3.2e-79	0.71	0.83	0.81
PGSC0003DMG200013067	K01051	ko00040	Pentose and glucuronate interconversions	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMG200013067	K01051	ko00500	Starch and sucrose metabolism	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMG200013067	K01051	ko01100	Metabolic pathways	1168	1.4e-58	0.53	0.72	0.98
PGSC0003DMG200013067	K01051	ko00040	Pentose and glucuronate interconversions	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMG200013067	K01051	ko00500	Starch and sucrose metabolism	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMG200013067	K01051	ko01100	Metabolic pathways	1756	5.1e-91	0.43	0.61	0.99
PGSC0003DMG200013074	K01046	ko00561	Glycerolipid metabolism	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMG200013074	K01046	ko01100	Metabolic pathways	273	3.2e-09	0.33	0.47	0.47
PGSC0003DMG200013078	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMG200013078	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.32	0.51	0.43
PGSC0003DMG200013079	K01046	ko00561	Glycerolipid metabolism	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMG200013079	K01046	ko01100	Metabolic pathways	262	1.3e-08	0.32	0.48	0.44
PGSC0003DMG200002590	K01190	ko00052	Galactose metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMG200002590	K01190	ko00511	Other glycan degradation	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMG200002590	K01190	ko00600	Sphingolipid metabolism	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMG200002590	K01190	ko01100	Metabolic pathways	4297	3.6e-231	0.68	0.82	0.85
PGSC0003DMG200002590	K01190	ko00052	Galactose metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMG200002590	K01190	ko00511	Other glycan degradation	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMG200002590	K01190	ko00600	Sphingolipid metabolism	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMG200002590	K01190	ko01100	Metabolic pathways	1902	4.5e-99	0.66	0.80	1.00
PGSC0003DMG200002592	K01115	ko00564	Glycerophospholipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002592	K01115	ko00565	Ether lipid metabolism	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002592	K01115	ko01100	Metabolic pathways	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002592	K01115	ko04144	Endocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002592	K01115	ko04666	Fc gamma R-mediated phagocytosis	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002592	K01115	ko04912	GnRH signaling pathway	3185	7.8e-170	0.65	0.78	0.99
PGSC0003DMG200002593	K00558	ko00270	Cysteine and methionine metabolism	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMG200002593	K00558	ko01100	Metabolic pathways	1053	1.3e-51	0.40	0.56	0.53
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	511	2.4e-22	0.36	0.53	0.83
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	521	6.7e-23	0.36	0.54	0.83
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	533	1.5e-23	0.38	0.52	0.84
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	539	6.8e-24	0.38	0.54	0.84
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	506	4.5e-22	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	493	2.3e-21	0.35	0.54	0.83
PGSC0003DMG200002594	K13248	ko00750	Vitamin B6 metabolism	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMG200002594	K13248	ko01100	Metabolic pathways	355	9.6e-14	0.32	0.52	0.92
PGSC0003DMG200002594	K01112	ko00051	Fructose and mannose metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMG200002594	K01112	ko00730	Thiamine metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMG200002594	K01112	ko00740	Riboflavin metabolism	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMG200002594	K01112	ko01100	Metabolic pathways	523	5.2e-23	0.36	0.54	0.84
PGSC0003DMG200002596	K12197	ko04144	Endocytosis	1509	2.1e-77	0.91	0.97	1.00
PGSC0003DMG200002597	K02903	ko03010	Ribosome	980	3.2e-48	0.84	0.91	0.99
PGSC0003DMG200002602	K04733	ko04210	Apoptosis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMG200002602	K04733	ko04620	Toll-like receptor signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMG200002602	K04733	ko04722	Neurotrophin signaling pathway	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMG200002602	K04733	ko05140	Leishmaniasis	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMG200002602	K04733	ko05142	Chagas disease	955	7.7e-47	0.29	0.48	0.98
PGSC0003DMG200004735	K01051	ko00040	Pentose and glucuronate interconversions	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMG200004735	K01051	ko00500	Starch and sucrose metabolism	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMG200004735	K01051	ko01100	Metabolic pathways	373	1.1e-14	0.32	0.60	0.95
PGSC0003DMG200004739	K01369	ko04142	Lysosome	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMG200004739	K01369	ko04612	Antigen processing and presentation	2624	6.8e-139	0.71	0.85	1.00
PGSC0003DMG200040616	K03006	ko00230	Purine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMG200040616	K03006	ko00240	Pyrimidine metabolism	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMG200040616	K03006	ko01100	Metabolic pathways	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMG200040616	K03006	ko03020	RNA polymerase	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMG200040616	K03006	ko05016	Huntington's disease	553	1.5e-23	0.41	0.60	0.98
PGSC0003DMG200040619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMG200040619	K00517	ko00626	Naphthalene and anthracene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMG200040619	K00517	ko00903	Limonene and pinene degradation	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMG200040619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMG200040619	K00517	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.65	0.80	0.44
PGSC0003DMG200001179	K01066	ko00623	2,4-Dichlorobenzoate degradation	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMG200001179	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	240	2.1e-07	0.38	0.57	0.46
PGSC0003DMG200001183	K00754	ko00051	Fructose and mannose metabolism	310	5.0e-11	0.30	0.50	0.67
PGSC0003DMG200001191	K11294	ko05130	Pathogenic Escherichia coli infection	2615	2.1e-138	0.54	0.64	1.00
PGSC0003DMG200001193	K01051	ko00040	Pentose and glucuronate interconversions	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMG200001193	K01051	ko00500	Starch and sucrose metabolism	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMG200001193	K01051	ko01100	Metabolic pathways	1741	3.4e-90	0.44	0.59	0.95
PGSC0003DMG200001079	K00748	ko00540	Lipopolysaccharide biosynthesis	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMG200001079	K00748	ko01100	Metabolic pathways	2343	2.1e-123	0.64	0.76	0.97
PGSC0003DMG200001079	K00748	ko00540	Lipopolysaccharide biosynthesis	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMG200001079	K00748	ko01100	Metabolic pathways	412	6.9e-17	0.60	0.74	0.97
PGSC0003DMG200001079	K00748	ko00540	Lipopolysaccharide biosynthesis	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMG200001079	K00748	ko01100	Metabolic pathways	716	1.2e-33	0.69	0.78	0.94
PGSC0003DMG200001082	K02153	ko00190	Oxidative phosphorylation	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001082	K02153	ko01100	Metabolic pathways	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001082	K02153	ko04145	Phagosome	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001082	K02153	ko04966	Collecting duct acid secretion	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001082	K02153	ko05110	Vibrio cholerae infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001082	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	532	1.7e-23	0.84	0.94	0.99
PGSC0003DMG200001085	K12606	ko03018	RNA degradation	547	2.5e-24	0.48	0.68	0.82
PGSC0003DMG200001086	K12606	ko03018	RNA degradation	606	1.4e-27	0.36	0.49	0.66
PGSC0003DMG200001092	K12356	ko00940	Phenylpropanoid biosynthesis	633	4.4e-29	0.31	0.46	0.93
PGSC0003DMG200011523	K02084	ko04115	p53 signaling pathway	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko04210	Apoptosis	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko05010	Alzheimer's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko05012	Parkinson's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko05016	Huntington's disease	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011523	K02084	ko05222	Small cell lung cancer	308	1.2e-07	0.27	0.42	0.68
PGSC0003DMG200011525	K02084	ko04115	p53 signaling pathway	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko04210	Apoptosis	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko05010	Alzheimer's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko05012	Parkinson's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko05016	Huntington's disease	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011525	K02084	ko05222	Small cell lung cancer	304	2.5e-07	0.26	0.46	0.42
PGSC0003DMG200011527	K02084	ko04115	p53 signaling pathway	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko04210	Apoptosis	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko05010	Alzheimer's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko05012	Parkinson's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko05016	Huntington's disease	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011527	K02084	ko05222	Small cell lung cancer	300	4.5e-07	0.26	0.44	0.57
PGSC0003DMG200011530	K05298	ko00710	Carbon fixation in photosynthetic organisms	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMG200011530	K05298	ko01100	Metabolic pathways	2831	2.6e-150	0.86	0.92	0.98
PGSC0003DMG200011531	K12855	ko03040	Spliceosome	236	2.4e-06	0.28	0.48	0.97
PGSC0003DMG200011531	K12869	ko03040	Spliceosome	306	4.2e-08	0.25	0.44	0.70
PGSC0003DMG200006298	K12891	ko03040	Spliceosome	218	3.4e-06	0.43	0.66	0.53
PGSC0003DMG200006298	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMG200006298	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMG200006298	K12900	ko03040	Spliceosome	415	4.7e-17	0.45	0.58	0.80
PGSC0003DMG200006298	K12900	ko03040	Spliceosome	570	1.3e-25	0.43	0.53	0.87
PGSC0003DMG200006298	K12900	ko03040	Spliceosome	349	2.1e-13	0.51	0.63	0.64
PGSC0003DMG200006306	K05663	ko02010	ABC transporters	839	1.9e-40	0.52	0.65	0.98
PGSC0003DMG200006306	K05663	ko02010	ABC transporters	2998	1.6e-159	0.73	0.83	0.96
PGSC0003DMG200009395	K03028	ko03050	Proteasome	6579	0.	0.88	0.95	0.99
PGSC0003DMG200009396	K09561	ko04120	Ubiquitin mediated proteolysis	318	5.5e-11	0.32	0.46	0.68
PGSC0003DMG200009396	K12581	ko03018	RNA degradation	408	2.7e-14	0.29	0.44	0.75
PGSC0003DMG200009396	K12581	ko03018	RNA degradation	297	1.2e-07	0.30	0.45	0.59
PGSC0003DMG200009396	K12581	ko03018	RNA degradation	341	3.8e-10	0.29	0.44	0.71
PGSC0003DMG200013009	K06685	ko04111	Cell cycle - yeast	1629	5.2e-84	0.87	0.94	0.99
PGSC0003DMG200013009	K06685	ko04111	Cell cycle - yeast	959	4.6e-47	0.86	0.94	0.98
PGSC0003DMG200013009	K06685	ko04111	Cell cycle - yeast	919	7.5e-45	0.83	0.92	0.79
PGSC0003DMG200013011	K01213	ko00040	Pentose and glucuronate interconversions	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMG200013011	K01213	ko00500	Starch and sucrose metabolism	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMG200013011	K01213	ko01100	Metabolic pathways	776	5.8e-37	0.46	0.65	0.95
PGSC0003DMG200013014	K03097	ko04310	Wnt signaling pathway	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMG200013014	K03097	ko04520	Adherens junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMG200013014	K03097	ko04530	Tight junction	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMG200013014	K03097	ko04712	Circadian rhythm - plant	2943	1.7e-156	0.80	0.86	0.99
PGSC0003DMG200013014	K03097	ko04310	Wnt signaling pathway	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMG200013014	K03097	ko04520	Adherens junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMG200013014	K03097	ko04530	Tight junction	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMG200013014	K03097	ko04712	Circadian rhythm - plant	3082	3.7e-164	0.84	0.90	0.99
PGSC0003DMG200013016	K12857	ko03040	Spliceosome	261	1.5e-08	0.28	0.48	0.58
PGSC0003DMG200013016	K10140	ko03420	Nucleotide excision repair	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMG200013016	K10140	ko04115	p53 signaling pathway	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMG200013016	K10140	ko04120	Ubiquitin mediated proteolysis	272	3.6e-09	0.29	0.45	0.72
PGSC0003DMG200013016	K12857	ko03040	Spliceosome	216	4.4e-06	0.28	0.47	0.81
PGSC0003DMG200013016	K12857	ko03040	Spliceosome	261	6.9e-08	0.28	0.48	0.33
PGSC0003DMG200013016	K12857	ko03040	Spliceosome	261	5.2e-08	0.28	0.48	0.38
PGSC0003DMG200013017	K01066	ko00623	2,4-Dichlorobenzoate degradation	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMG200013017	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	677	1.7e-31	0.36	0.59	0.92
PGSC0003DMG200000049	K12604	ko03018	RNA degradation	812	6.1e-38	0.51	0.70	1.00
PGSC0003DMG200000049	K12604	ko03018	RNA degradation	572	1.4e-24	0.51	0.70	0.94
PGSC0003DMG200000050	K12604	ko03018	RNA degradation	493	4.3e-20	0.50	0.67	0.84
PGSC0003DMG200000050	K12604	ko03018	RNA degradation	379	9.1e-14	0.55	0.74	0.59
PGSC0003DMG200000057	K04371	ko04010	MAPK signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04012	ErbB signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04013	MAPK signaling pathway - fly	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04062	Chemokine signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04114	Oocyte meiosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04150	mTOR signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04270	Vascular smooth muscle contraction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04320	Dorso-ventral axis formation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04350	TGF-beta signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04360	Axon guidance	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04370	VEGF signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04510	Focal adhesion	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04520	Adherens junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04540	Gap junction	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04620	Toll-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04621	NOD-like receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04650	Natural killer cell mediated cytotoxicity	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04660	T cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04662	B cell receptor signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04664	Fc epsilon RI signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04666	Fc gamma R-mediated phagocytosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04720	Long-term potentiation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04722	Neurotrophin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04730	Long-term depression	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04810	Regulation of actin cytoskeleton	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04910	Insulin signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04912	GnRH signaling pathway	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04914	Progesterone-mediated oocyte maturation	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04916	Melanogenesis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04930	Type II diabetes mellitus	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05010	Alzheimer's disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05020	Prion diseases	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05131	Shigellosis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05140	Leishmaniasis	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05142	Chagas disease	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05200	Pathways in cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05210	Colorectal cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05211	Renal cell carcinoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05212	Pancreatic cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05213	Endometrial cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05214	Glioma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05215	Prostate cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05216	Thyroid cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05218	Melanoma	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05219	Bladder cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05220	Chronic myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05221	Acute myeloid leukemia	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko05223	Non-small cell lung cancer	2199	1.9e-115	0.72	0.77	0.99
PGSC0003DMG200000057	K04371	ko04010	MAPK signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04012	ErbB signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04013	MAPK signaling pathway - fly	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04062	Chemokine signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04114	Oocyte meiosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04150	mTOR signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04270	Vascular smooth muscle contraction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04320	Dorso-ventral axis formation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04350	TGF-beta signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04360	Axon guidance	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04370	VEGF signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04510	Focal adhesion	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04520	Adherens junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04540	Gap junction	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04620	Toll-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04621	NOD-like receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04650	Natural killer cell mediated cytotoxicity	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04660	T cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04662	B cell receptor signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04664	Fc epsilon RI signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04666	Fc gamma R-mediated phagocytosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04720	Long-term potentiation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04722	Neurotrophin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04730	Long-term depression	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04810	Regulation of actin cytoskeleton	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04910	Insulin signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04912	GnRH signaling pathway	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04914	Progesterone-mediated oocyte maturation	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04916	Melanogenesis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04930	Type II diabetes mellitus	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05010	Alzheimer's disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05020	Prion diseases	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05131	Shigellosis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05140	Leishmaniasis	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05142	Chagas disease	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05200	Pathways in cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05210	Colorectal cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05211	Renal cell carcinoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05212	Pancreatic cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05213	Endometrial cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05214	Glioma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05215	Prostate cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05216	Thyroid cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05218	Melanoma	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05219	Bladder cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05220	Chronic myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05221	Acute myeloid leukemia	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000057	K04371	ko05223	Non-small cell lung cancer	2884	3.1e-153	0.88	0.94	1.00
PGSC0003DMG200000059	K12356	ko00940	Phenylpropanoid biosynthesis	557	6.9e-25	0.30	0.47	0.90
PGSC0003DMG200023066	K00901	ko00561	Glycerolipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMG200023066	K00901	ko00564	Glycerophospholipid metabolism	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMG200023066	K00901	ko01100	Metabolic pathways	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMG200023066	K00901	ko04070	Phosphatidylinositol signaling system	323	5.0e-10	0.39	0.62	0.17
PGSC0003DMG200023068	K03111	ko03030	DNA replication	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMG200023068	K03111	ko03430	Mismatch repair	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMG200023068	K03111	ko03440	Homologous recombination	871	3.3e-42	0.73	0.90	0.99
PGSC0003DMG200023068	K03111	ko03030	DNA replication	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMG200023068	K03111	ko03430	Mismatch repair	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMG200023068	K03111	ko03440	Homologous recombination	1095	1.5e-54	0.59	0.76	1.00
PGSC0003DMG200023076	K06100	ko04530	Tight junction	4555	2.1e-245	0.53	0.67	0.98
PGSC0003DMG200023076	K06100	ko04530	Tight junction	5034	8.1e-272	0.53	0.67	0.99
PGSC0003DMG200026166	K01177	ko00500	Starch and sucrose metabolism	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMG200026166	K01177	ko01100	Metabolic pathways	317	1.7e-11	0.39	0.57	0.85
PGSC0003DMG200026170	K06654	ko04111	Cell cycle - yeast	295	2.0e-10	0.35	0.49	0.69
PGSC0003DMG200029760	K02925	ko03010	Ribosome	3182	1.1e-169	0.94	0.98	1.00
PGSC0003DMG200029765	K13289	ko04142	Lysosome	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMG200029765	K13289	ko04614	Renin-angiotensin system	1656	1.7e-85	0.47	0.67	0.91
PGSC0003DMG200038200	K02992	ko03010	Ribosome	1060	1.2e-52	0.98	0.98	0.99
PGSC0003DMG200038209	K05282	ko00904	Diterpenoid biosynthesis	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMG200038209	K05282	ko01100	Metabolic pathways	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMG200038209	K05282	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.42	0.54	0.98
PGSC0003DMG200038217	K12356	ko00940	Phenylpropanoid biosynthesis	648	6.6e-30	0.30	0.48	0.98
PGSC0003DMG200007207	K12486	ko04144	Endocytosis	466	1.1e-19	0.27	0.41	0.69
PGSC0003DMG200007208	K05870	ko04612	Antigen processing and presentation	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMG200007208	K05870	ko04916	Melanogenesis	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMG200007208	K05870	ko04962	Vasopressin-regulated water reabsorption	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMG200007208	K05870	ko05016	Huntington's disease	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMG200007208	K05870	ko05215	Prostate cancer	248	7.6e-08	0.25	0.45	0.89
PGSC0003DMG200007215	K01046	ko00561	Glycerolipid metabolism	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMG200007215	K01046	ko01100	Metabolic pathways	394	6.8e-16	0.38	0.52	0.72
PGSC0003DMG200007224	K00697	ko00500	Starch and sucrose metabolism	5931	0.	0.78	0.87	0.97
PGSC0003DMG200003331	K01762	ko00270	Cysteine and methionine metabolism	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMG200003331	K01762	ko01110	Biosynthesis of secondary metabolites	2692	1.2e-142	0.76	0.85	1.00
PGSC0003DMG200003335	K03040	ko00230	Purine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMG200003335	K03040	ko00240	Pyrimidine metabolism	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMG200003335	K03040	ko01100	Metabolic pathways	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMG200003335	K03040	ko03020	RNA polymerase	1933	8.8e-101	0.76	0.87	0.98
PGSC0003DMG200003340	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMG200003340	K00517	ko00626	Naphthalene and anthracene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMG200003340	K00517	ko00903	Limonene and pinene degradation	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMG200003340	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMG200003340	K00517	ko01110	Biosynthesis of secondary metabolites	1876	1.2e-97	0.45	0.65	0.97
PGSC0003DMG200003341	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMG200003341	K00517	ko00626	Naphthalene and anthracene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMG200003341	K00517	ko00903	Limonene and pinene degradation	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMG200003341	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMG200003341	K00517	ko01110	Biosynthesis of secondary metabolites	1939	4.1e-101	0.46	0.67	1.00
PGSC0003DMG200003342	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMG200003342	K00517	ko00626	Naphthalene and anthracene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMG200003342	K00517	ko00903	Limonene and pinene degradation	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMG200003342	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMG200003342	K00517	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.50	0.69	0.99
PGSC0003DMG200003345	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMG200003345	K00517	ko00626	Naphthalene and anthracene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMG200003345	K00517	ko00903	Limonene and pinene degradation	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMG200003345	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMG200003345	K00517	ko01110	Biosynthesis of secondary metabolites	2054	1.9e-107	0.49	0.68	1.00
PGSC0003DMG200003346	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMG200003346	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMG200003346	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMG200003346	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMG200003346	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.49	0.68	1.00
PGSC0003DMG200003347	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMG200003347	K00517	ko00626	Naphthalene and anthracene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMG200003347	K00517	ko00903	Limonene and pinene degradation	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMG200003347	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMG200003347	K00517	ko01110	Biosynthesis of secondary metabolites	2098	7.0e-110	0.49	0.70	1.00
PGSC0003DMG200003347	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMG200003347	K00517	ko00626	Naphthalene and anthracene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMG200003347	K00517	ko00903	Limonene and pinene degradation	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMG200003347	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMG200003347	K00517	ko01110	Biosynthesis of secondary metabolites	2100	5.4e-110	0.50	0.70	0.98
PGSC0003DMG200003347	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMG200003347	K00517	ko00626	Naphthalene and anthracene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMG200003347	K00517	ko00903	Limonene and pinene degradation	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMG200003347	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMG200003347	K00517	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.48	0.69	0.99
PGSC0003DMG200014796	K00630	ko00561	Glycerolipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMG200014796	K00630	ko00564	Glycerophospholipid metabolism	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMG200014796	K00630	ko01100	Metabolic pathways	399	3.6e-16	0.34	0.52	0.62
PGSC0003DMG200014797	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04020	Calcium signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04070	Phosphatidylinositol signaling system	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04114	Oocyte meiosis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04270	Vascular smooth muscle contraction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04626	Plant-pathogen interaction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04720	Long-term potentiation	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04740	Olfactory transduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04744	Phototransduction	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04745	Phototransduction - fly	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04910	Insulin signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04912	GnRH signaling pathway	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04916	Melanogenesis	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04970	Salivary secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko04971	Gastric acid secretion	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05010	Alzheimer's disease	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014797	K02183	ko05214	Glioma	595	5.5e-27	0.49	0.72	0.90
PGSC0003DMG200014799	K08488	ko04130	SNARE interactions in vesicular transport	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMG200014799	K08488	ko04145	Phagosome	1735	7.4e-90	0.79	0.90	1.00
PGSC0003DMG200014801	K02830	ko04111	Cell cycle - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMG200014801	K02830	ko04113	Meiosis - yeast	1786	1.1e-92	0.77	0.90	0.88
PGSC0003DMG200014801	K02830	ko04111	Cell cycle - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMG200014801	K02830	ko04113	Meiosis - yeast	610	8.3e-28	0.77	0.88	0.94
PGSC0003DMG200014807	K11229	ko04011	MAPK signaling pathway - yeast	532	1.4e-22	0.35	0.52	0.95
PGSC0003DMG200014810	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMG200014810	K07541	ko01100	Metabolic pathways	349	2.1e-13	0.50	0.63	0.98
PGSC0003DMG200014810	K07541	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMG200014810	K07541	ko01100	Metabolic pathways	825	1.1e-39	0.47	0.62	0.86
PGSC0003DMG200016830	K09680	ko00770	Pantothenate and CoA biosynthesis	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMG200016830	K09680	ko01100	Metabolic pathways	917	9.6e-45	0.38	0.55	0.98
PGSC0003DMG200016830	K09680	ko00770	Pantothenate and CoA biosynthesis	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMG200016830	K09680	ko01100	Metabolic pathways	746	2.6e-35	0.38	0.54	0.93
PGSC0003DMG200016832	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.67
PGSC0003DMG200016832	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.64
PGSC0003DMG200016832	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.63
PGSC0003DMG200016832	K00754	ko00051	Fructose and mannose metabolism	954	8.8e-47	0.33	0.53	0.61
PGSC0003DMG200016839	K11816	ko00380	Tryptophan metabolism	676	1.9e-31	0.47	0.64	0.96
PGSC0003DMG200016839	K11816	ko00380	Tryptophan metabolism	355	9.6e-14	0.44	0.70	0.98
PGSC0003DMG200016839	K11816	ko00380	Tryptophan metabolism	652	4.0e-30	0.47	0.65	0.96
PGSC0003DMG200016839	K11816	ko00380	Tryptophan metabolism	412	6.9e-17	0.60	0.79	0.94
PGSC0003DMG200016839	K11816	ko00380	Tryptophan metabolism	649	5.8e-30	0.49	0.72	0.98
PGSC0003DMG200016843	K08769	ko03320	PPAR signaling pathway	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMG200016843	K08769	ko05016	Huntington's disease	620	2.3e-28	0.35	0.54	0.89
PGSC0003DMG200031515	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031515	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031515	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031515	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMG200031515	K00517	ko00626	Naphthalene and anthracene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMG200031515	K00517	ko00903	Limonene and pinene degradation	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMG200031515	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMG200031515	K00517	ko01110	Biosynthesis of secondary metabolites	877	1.5e-42	0.57	0.73	0.94
PGSC0003DMG200031515	K11818	ko00380	Tryptophan metabolism	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031515	K11818	ko00966	Glucosinolate biosynthesis	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031515	K11818	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.47	0.67	0.65
PGSC0003DMG200031516	K11818	ko00380	Tryptophan metabolism	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMG200031516	K11818	ko00966	Glucosinolate biosynthesis	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMG200031516	K11818	ko01110	Biosynthesis of secondary metabolites	1975	4.3e-103	0.50	0.71	0.96
PGSC0003DMG200031516	K11818	ko00380	Tryptophan metabolism	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMG200031516	K11818	ko00966	Glucosinolate biosynthesis	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMG200031516	K11818	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.48	0.71	0.97
PGSC0003DMG200031518	K11818	ko00380	Tryptophan metabolism	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMG200031518	K11818	ko00966	Glucosinolate biosynthesis	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMG200031518	K11818	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.49	0.69	0.99
PGSC0003DMG200031518	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMG200031518	K00517	ko00626	Naphthalene and anthracene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMG200031518	K00517	ko00903	Limonene and pinene degradation	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMG200031518	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMG200031518	K00517	ko01110	Biosynthesis of secondary metabolites	858	1.7e-41	0.54	0.73	0.98
PGSC0003DMG200031519	K11818	ko00380	Tryptophan metabolism	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMG200031519	K11818	ko00966	Glucosinolate biosynthesis	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMG200031519	K11818	ko01110	Biosynthesis of secondary metabolites	1945	1.9e-101	0.49	0.69	0.99
PGSC0003DMG200031519	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMG200031519	K00517	ko00626	Naphthalene and anthracene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMG200031519	K00517	ko00903	Limonene and pinene degradation	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMG200031519	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMG200031519	K00517	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.54	0.73	0.98
PGSC0003DMG200031520	K11818	ko00380	Tryptophan metabolism	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMG200031520	K11818	ko00966	Glucosinolate biosynthesis	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMG200031520	K11818	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.46	0.68	0.88
PGSC0003DMG200031520	K11818	ko00380	Tryptophan metabolism	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMG200031520	K11818	ko00966	Glucosinolate biosynthesis	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMG200031520	K11818	ko01110	Biosynthesis of secondary metabolites	1995	3.4e-104	0.51	0.71	0.96
PGSC0003DMG200031520	K11818	ko00380	Tryptophan metabolism	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMG200031520	K11818	ko00966	Glucosinolate biosynthesis	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMG200031520	K11818	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.49	0.70	0.97
PGSC0003DMG200031520	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMG200031520	K00517	ko00626	Naphthalene and anthracene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMG200031520	K00517	ko00903	Limonene and pinene degradation	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMG200031520	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMG200031520	K00517	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.53	0.73	0.97
PGSC0003DMG200031520	K11818	ko00380	Tryptophan metabolism	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMG200031520	K11818	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMG200031520	K11818	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.45	0.65	0.82
PGSC0003DMG200031520	K11818	ko00380	Tryptophan metabolism	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMG200031520	K11818	ko00966	Glucosinolate biosynthesis	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMG200031520	K11818	ko01110	Biosynthesis of secondary metabolites	1881	6.5e-98	0.50	0.69	0.93
PGSC0003DMG200031521	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko04115	p53 signaling pathway	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko04210	Apoptosis	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05010	Alzheimer's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05012	Parkinson's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05016	Huntington's disease	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031521	K02084	ko05222	Small cell lung cancer	293	3.2e-07	0.27	0.46	0.68
PGSC0003DMG200031524	K12823	ko03040	Spliceosome	253	1.0e-07	0.59	0.62	0.75
PGSC0003DMG200025354	K03018	ko00230	Purine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMG200025354	K03018	ko00240	Pyrimidine metabolism	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMG200025354	K03018	ko01100	Metabolic pathways	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMG200025354	K03018	ko03020	RNA polymerase	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMG200025354	K03018	ko04623	Cytosolic DNA-sensing pathway	4794	1.4e-258	0.72	0.83	0.99
PGSC0003DMG200025354	K03018	ko00230	Purine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMG200025354	K03018	ko00240	Pyrimidine metabolism	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMG200025354	K03018	ko01100	Metabolic pathways	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMG200025354	K03018	ko03020	RNA polymerase	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMG200025354	K03018	ko04623	Cytosolic DNA-sensing pathway	317	1.3e-10	0.82	0.90	0.78
PGSC0003DMG200025354	K03018	ko00230	Purine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMG200025354	K03018	ko00240	Pyrimidine metabolism	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMG200025354	K03018	ko01100	Metabolic pathways	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMG200025354	K03018	ko03020	RNA polymerase	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMG200025354	K03018	ko04623	Cytosolic DNA-sensing pathway	390	1.1e-14	0.82	0.96	0.90
PGSC0003DMG200025357	K07512	ko00062	Fatty acid elongation in mitochondria	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMG200025357	K07512	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.86	0.98
PGSC0003DMG200025357	K07512	ko00062	Fatty acid elongation in mitochondria	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMG200025357	K07512	ko01100	Metabolic pathways	1095	1.5e-54	0.68	0.80	0.76
PGSC0003DMG200025357	K07512	ko00062	Fatty acid elongation in mitochondria	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMG200025357	K07512	ko01100	Metabolic pathways	1349	1.4e-68	0.67	0.80	0.94
PGSC0003DMG200025357	K07512	ko00062	Fatty acid elongation in mitochondria	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMG200025357	K07512	ko01100	Metabolic pathways	2335	5.9e-123	0.71	0.84	1.00
PGSC0003DMG200025362	K01627	ko00540	Lipopolysaccharide biosynthesis	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMG200025362	K01627	ko01100	Metabolic pathways	1511	1.7e-77	0.91	0.96	0.98
PGSC0003DMG200025362	K01627	ko00540	Lipopolysaccharide biosynthesis	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMG200025362	K01627	ko01100	Metabolic pathways	2178	2.7e-114	0.88	0.95	1.00
PGSC0003DMG200025362	K01627	ko00540	Lipopolysaccharide biosynthesis	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMG200025362	K01627	ko01100	Metabolic pathways	1979	2.6e-103	0.82	0.89	1.00
PGSC0003DMG200025362	K01627	ko00540	Lipopolysaccharide biosynthesis	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMG200025362	K01627	ko01100	Metabolic pathways	1151	1.2e-57	0.91	0.97	0.99
PGSC0003DMG200025366	K04371	ko04010	MAPK signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04012	ErbB signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04013	MAPK signaling pathway - fly	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04062	Chemokine signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04114	Oocyte meiosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04150	mTOR signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04270	Vascular smooth muscle contraction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04320	Dorso-ventral axis formation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04350	TGF-beta signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04360	Axon guidance	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04370	VEGF signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04510	Focal adhesion	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04520	Adherens junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04540	Gap junction	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04620	Toll-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04621	NOD-like receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04650	Natural killer cell mediated cytotoxicity	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04660	T cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04662	B cell receptor signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04664	Fc epsilon RI signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04666	Fc gamma R-mediated phagocytosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04720	Long-term potentiation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04722	Neurotrophin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04730	Long-term depression	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04810	Regulation of actin cytoskeleton	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04910	Insulin signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04912	GnRH signaling pathway	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04914	Progesterone-mediated oocyte maturation	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04916	Melanogenesis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04930	Type II diabetes mellitus	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05010	Alzheimer's disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05020	Prion diseases	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05131	Shigellosis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05140	Leishmaniasis	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05142	Chagas disease	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05200	Pathways in cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05210	Colorectal cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05211	Renal cell carcinoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05212	Pancreatic cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05213	Endometrial cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05214	Glioma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05215	Prostate cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05216	Thyroid cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05218	Melanoma	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05219	Bladder cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05220	Chronic myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05221	Acute myeloid leukemia	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025366	K04371	ko05223	Non-small cell lung cancer	2719	3.9e-144	0.84	0.95	0.98
PGSC0003DMG200025371	K10352	ko04530	Tight junction	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko05416	Viral myocarditis	491	4.3e-20	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko04530	Tight junction	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko05416	Viral myocarditis	489	1.7e-19	0.26	0.46	0.84
PGSC0003DMG200025371	K10352	ko04530	Tight junction	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMG200025371	K10352	ko05416	Viral myocarditis	343	7.2e-12	0.28	0.50	0.83
PGSC0003DMG200021446	K00860	ko00230	Purine metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMG200021446	K00860	ko00450	Selenoamino acid metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMG200021446	K00860	ko00920	Sulfur metabolism	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMG200021446	K00860	ko01100	Metabolic pathways	1392	6.1e-71	0.62	0.76	0.87
PGSC0003DMG200021448	K05862	ko04020	Calcium signaling pathway	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMG200021448	K05862	ko05012	Parkinson's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMG200021448	K05862	ko05016	Huntington's disease	1194	5.1e-60	0.55	0.71	1.00
PGSC0003DMG200021449	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.76
PGSC0003DMG200021449	K05741	ko04810	Regulation of actin cytoskeleton	695	2.2e-32	0.29	0.42	0.66
PGSC0003DMG200021459	K12134	ko04712	Circadian rhythm - plant	656	2.4e-30	0.38	0.52	0.63
PGSC0003DMG200021461	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.71
PGSC0003DMG200021461	K06027	ko04962	Vasopressin-regulated water reabsorption	632	5.0e-29	0.37	0.58	0.43
PGSC0003DMG200021461	K06027	ko04962	Vasopressin-regulated water reabsorption	345	1.1e-12	0.40	0.60	0.53
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	1407	9.1e-72	0.66	0.80	0.81
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	1719	5.6e-89	0.71	0.81	0.88
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	2544	1.8e-134	0.72	0.84	0.98
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	1320	5.7e-67	0.64	0.79	0.96
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	2819	1.2e-149	0.68	0.80	0.91
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	1109	2.5e-55	0.63	0.77	0.95
PGSC0003DMG200021462	K01578	ko00410	beta-Alanine metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMG200021462	K01578	ko00640	Propanoate metabolism	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMG200021462	K01578	ko01100	Metabolic pathways	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMG200021462	K01578	ko04146	Peroxisome	282	1.5e-09	0.66	0.82	0.85
PGSC0003DMG200020612	K00235	ko00020	Citrate cycle (TCA cycle)	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko00190	Oxidative phosphorylation	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko01100	Metabolic pathways	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko05010	Alzheimer's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko05012	Parkinson's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020612	K00235	ko05016	Huntington's disease	1564	2.0e-80	0.74	0.85	0.92
PGSC0003DMG200020618	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMG200020618	K08081	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMG200020618	K08081	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.53	0.73	0.88
PGSC0003DMG200020618	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMG200020618	K08081	ko01100	Metabolic pathways	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMG200020618	K08081	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.56	0.75	0.97
PGSC0003DMG200020619	K01087	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.76	0.86	0.79
PGSC0003DMG200020619	K01087	ko00500	Starch and sucrose metabolism	1903	4.0e-99	0.78	0.86	0.82
PGSC0003DMG200020619	K01087	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.77	0.86	0.78
PGSC0003DMG200020620	K00232	ko00071	Fatty acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020620	K00232	ko00592	alpha-Linolenic acid metabolism	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020620	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020620	K00232	ko01100	Metabolic pathways	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020620	K00232	ko03320	PPAR signaling pathway	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020620	K00232	ko04146	Peroxisome	4874	5.4e-263	0.82	0.93	0.98
PGSC0003DMG200020628	K01099	ko00562	Inositol phosphate metabolism	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMG200020628	K01099	ko01100	Metabolic pathways	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMG200020628	K01099	ko04070	Phosphatidylinositol signaling system	675	1.7e-38	0.37	0.55	0.75
PGSC0003DMG200020629	K01834	ko00010	Glycolysis / Gluconeogenesis	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMG200020629	K01834	ko01100	Metabolic pathways	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMG200020629	K01834	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.73	0.88	0.98
PGSC0003DMG200020629	K01834	ko00010	Glycolysis / Gluconeogenesis	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMG200020629	K01834	ko01100	Metabolic pathways	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMG200020629	K01834	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.60	0.75	0.98
PGSC0003DMG200004020	K09838	ko00906	Carotenoid biosynthesis	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMG200004020	K09838	ko01100	Metabolic pathways	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMG200004020	K09838	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.70	0.81	0.93
PGSC0003DMG200004020	K09838	ko00906	Carotenoid biosynthesis	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMG200004020	K09838	ko01100	Metabolic pathways	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMG200004020	K09838	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.58	0.69	0.99
PGSC0003DMG200004021	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3188	5.3e-170	0.78	0.85	0.99
PGSC0003DMG200004021	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3551	5.1e-190	0.84	0.91	0.99
PGSC0003DMG200004023	K10840	ko03420	Nucleotide excision repair	784	2.1e-37	0.56	0.85	0.92
PGSC0003DMG200004029	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMG200004029	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMG200004029	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMG200004029	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.30	0.46	0.88
PGSC0003DMG200004030	K03360	ko04111	Cell cycle - yeast	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMG200004030	K03360	ko04120	Ubiquitin mediated proteolysis	290	8.4e-10	0.31	0.51	0.89
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1322	4.4e-67	0.86	0.97	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.81	0.94	0.97
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00360	Phenylalanine metabolism	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00940	Phenylpropanoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00941	Flavonoid biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01100	Metabolic pathways	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004031	K00588	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.85	0.95	0.99
PGSC0003DMG200004032	K02320	ko00230	Purine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMG200004032	K02320	ko00240	Pyrimidine metabolism	8469	0.	0.66	0.79	1.00
PGSC0003DMG200004032	K02320	ko01100	Metabolic pathways	8469	0.	0.66	0.79	1.00
PGSC0003DMG200004032	K02320	ko03030	DNA replication	8469	0.	0.66	0.79	1.00
PGSC0003DMG200007950	K10577	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.87	0.94	0.99
PGSC0003DMG200007952	K13065	ko00940	Phenylpropanoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMG200007952	K13065	ko00941	Flavonoid biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMG200007952	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMG200007952	K13065	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.28	0.47	0.93
PGSC0003DMG200007955	K12126	ko04712	Circadian rhythm - plant	422	1.9e-17	0.52	0.65	0.59
PGSC0003DMG200007955	K12126	ko04712	Circadian rhythm - plant	467	6.4e-20	0.40	0.55	0.71
PGSC0003DMG200007955	K12126	ko04712	Circadian rhythm - plant	485	6.5e-21	0.40	0.54	0.70
PGSC0003DMG200007965	K01046	ko00561	Glycerolipid metabolism	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMG200007965	K01046	ko01100	Metabolic pathways	400	3.2e-16	0.34	0.51	0.58
PGSC0003DMG200007965	K01046	ko00561	Glycerolipid metabolism	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMG200007965	K01046	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.50
PGSC0003DMG200014136	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3749	6.1e-201	0.84	0.93	0.98
PGSC0003DMG200014144	K00864	ko00561	Glycerolipid metabolism	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMG200014144	K00864	ko01100	Metabolic pathways	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMG200014144	K00864	ko03320	PPAR signaling pathway	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMG200014144	K00864	ko04626	Plant-pathogen interaction	3749	6.1e-201	0.83	0.94	1.00
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1000	2.5e-49	0.84	0.96	0.98
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1843	8.1e-96	0.82	0.95	0.98
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1587	1.1e-81	0.80	0.91	0.93
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	1734	8.4e-90	0.79	0.91	0.96
PGSC0003DMG200014146	K10563	ko03410	Base excision repair	2288	2.3e-120	0.65	0.80	0.97
PGSC0003DMG200003231	K12126	ko04712	Circadian rhythm - plant	293	3.9e-10	0.35	0.56	0.74
PGSC0003DMG200003238	K00029	ko00620	Pyruvate metabolism	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMG200003238	K00029	ko00710	Carbon fixation in photosynthetic organisms	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMG200003238	K00029	ko01100	Metabolic pathways	965	2.2e-47	0.73	0.83	0.59
PGSC0003DMG200003238	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003238	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003238	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003238	K00029	ko00620	Pyruvate metabolism	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003238	K00029	ko00710	Carbon fixation in photosynthetic organisms	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003238	K00029	ko01100	Metabolic pathways	463	1.1e-19	0.68	0.76	0.78
PGSC0003DMG200003241	K09756	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.43	0.60	0.98
PGSC0003DMG200003246	K09489	ko04612	Antigen processing and presentation	423	5.5e-17	0.66	0.81	0.51
PGSC0003DMG200003246	K09489	ko04612	Antigen processing and presentation	474	6.5e-20	0.72	0.84	0.86
PGSC0003DMG200039407	K01051	ko00040	Pentose and glucuronate interconversions	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMG200039407	K01051	ko00500	Starch and sucrose metabolism	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMG200039407	K01051	ko01100	Metabolic pathways	1215	3.5e-61	0.49	0.67	0.93
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2079	7.8e-109	0.56	0.75	0.88
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2494	1.0e-131	0.55	0.74	0.93
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	350	2.6e-13	0.39	0.59	0.80
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	937	7.6e-46	0.63	0.80	0.88
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2316	6.6e-122	0.53	0.71	0.89
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2370	7.0e-125	0.53	0.73	0.91
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	1587	1.1e-81	0.53	0.74	0.87
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2055	1.6e-107	0.55	0.75	0.88
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2027	5.8e-106	0.55	0.74	0.88
PGSC0003DMG200033573	K07385	ko00902	Monoterpenoid biosynthesis	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMG200033573	K07385	ko01100	Metabolic pathways	2449	3.1e-129	0.54	0.74	0.93
PGSC0003DMG200033576	K12127	ko04712	Circadian rhythm - plant	250	2.8e-07	0.39	0.58	0.29
PGSC0003DMG200033576	K12127	ko04712	Circadian rhythm - plant	250	1.4e-07	0.39	0.58	0.33
PGSC0003DMG200020696	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko00052	Galactose metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko01100	Metabolic pathways	1949	1.2e-101	0.71	0.85	1.00
PGSC0003DMG200020696	K00849	ko00052	Galactose metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMG200020696	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMG200020696	K00849	ko01100	Metabolic pathways	573	9.1e-26	0.66	0.79	0.96
PGSC0003DMG200020696	K00849	ko00052	Galactose metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMG200020696	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMG200020696	K00849	ko01100	Metabolic pathways	571	1.2e-25	0.67	0.78	0.91
PGSC0003DMG200020696	K00849	ko00052	Galactose metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMG200020696	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMG200020696	K00849	ko01100	Metabolic pathways	323	5.6e-12	0.75	0.83	0.90
PGSC0003DMG200020698	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	312	2.3e-11	0.60	0.77	0.92
PGSC0003DMG200020700	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMG200020700	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMG200020700	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMG200020700	K05288	ko01100	Metabolic pathways	1199	4.7e-64	0.37	0.56	0.90
PGSC0003DMG200020703	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	297	1.5e-10	0.60	0.71	0.62
PGSC0003DMG200020705	K12836	ko03040	Spliceosome	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMG200020705	K12836	ko05131	Shigellosis	350	1.8e-13	0.49	0.64	0.27
PGSC0003DMG200020705	K12836	ko03040	Spliceosome	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMG200020705	K12836	ko05131	Shigellosis	564	2.8e-25	0.43	0.63	0.33
PGSC0003DMG200020705	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMG200020705	K12850	ko03040	Spliceosome	310	4.5e-11	0.29	0.44	0.69
PGSC0003DMG200024707	K09490	ko03060	Protein export	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMG200024707	K09490	ko05020	Prion diseases	668	5.2e-31	0.67	0.87	0.99
PGSC0003DMG200024709	K01358	ko04112	Cell cycle - Caulobacter	824	1.3e-39	0.48	0.70	0.67
PGSC0003DMG200024711	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMG200024711	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMG200024711	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMG200024711	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMG200024711	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.39	0.58	0.51
PGSC0003DMG200024711	K00680	ko00350	Tyrosine metabolism	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMG200024711	K00680	ko00624	1- and 2-Methylnaphthalene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMG200024711	K00680	ko00632	Benzoate degradation via CoA ligation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMG200024711	K00680	ko00642	Ethylbenzene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMG200024711	K00680	ko00903	Limonene and pinene degradation	565	2.5e-25	0.35	0.58	0.49
PGSC0003DMG200024711	K00680	ko00350	Tyrosine metabolism	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMG200024711	K00680	ko00624	1- and 2-Methylnaphthalene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMG200024711	K00680	ko00632	Benzoate degradation via CoA ligation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMG200024711	K00680	ko00642	Ethylbenzene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMG200024711	K00680	ko00903	Limonene and pinene degradation	496	1.6e-21	0.38	0.58	0.63
PGSC0003DMG200024713	K10532	ko00531	Glycosaminoglycan degradation	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMG200024713	K10532	ko01100	Metabolic pathways	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMG200024713	K10532	ko04142	Lysosome	2782	1.3e-147	0.72	0.82	0.71
PGSC0003DMG200024714	K12623	ko03018	RNA degradation	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMG200024714	K12623	ko03040	Spliceosome	238	2.7e-07	0.65	0.75	0.28
PGSC0003DMG200024715	K03065	ko03050	Proteasome	3408	3.9e-182	0.96	0.99	1.00
PGSC0003DMG200024719	K02891	ko03010	Ribosome	897	1.2e-43	0.84	0.94	0.99
PGSC0003DMG200008758	K07203	ko04012	ErbB signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko04150	mTOR signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko04910	Insulin signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko04920	Adipocytokine signaling pathway	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko04930	Type II diabetes mellitus	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko05200	Pathways in cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko05214	Glioma	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko05215	Prostate cancer	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008758	K07203	ko05221	Acute myeloid leukemia	778	2.1e-36	0.43	0.48	0.70
PGSC0003DMG200008759	K12478	ko04144	Endocytosis	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMG200008759	K12478	ko04145	Phagosome	314	3.8e-09	0.27	0.49	0.81
PGSC0003DMG200008760	K02921	ko03010	Ribosome	631	5.7e-29	0.88	0.94	0.99
PGSC0003DMG200008771	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008771	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008771	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008771	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008771	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008771	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200008772	K10747	ko03030	DNA replication	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMG200008772	K10747	ko03410	Base excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMG200008772	K10747	ko03420	Nucleotide excision repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMG200008772	K10747	ko03430	Mismatch repair	265	9.5e-06	0.28	0.43	0.82
PGSC0003DMG200005659	K12861	ko03040	Spliceosome	1593	5.0e-82	0.75	0.87	0.99
PGSC0003DMG200005666	K03211	ko04013	MAPK signaling pathway - fly	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMG200005666	K03211	ko04320	Dorso-ventral axis formation	280	1.7e-06	0.28	0.39	0.48
PGSC0003DMG200005667	K02563	ko00550	Peptidoglycan biosynthesis	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMG200005667	K02563	ko01100	Metabolic pathways	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMG200005667	K02563	ko04112	Cell cycle - Caulobacter	1386	1.3e-70	0.61	0.79	0.88
PGSC0003DMG200005667	K02563	ko00550	Peptidoglycan biosynthesis	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMG200005667	K02563	ko01100	Metabolic pathways	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMG200005667	K02563	ko04112	Cell cycle - Caulobacter	2120	4.3e-111	0.66	0.81	0.91
PGSC0003DMG200005668	K03821	ko00650	Butanoate metabolism	281	1.3e-09	0.24	0.41	0.87
PGSC0003DMG200012344	K00432	ko00480	Glutathione metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMG200012344	K00432	ko00590	Arachidonic acid metabolism	1206	1.1e-60	0.82	0.93	0.99
PGSC0003DMG200012346	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMG200012346	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMG200012346	K01598	ko00770	Pantothenate and CoA biosynthesis	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMG200012346	K01598	ko01100	Metabolic pathways	1407	9.1e-72	0.80	0.92	0.96
PGSC0003DMG200041536	K12606	ko03018	RNA degradation	618	3.0e-28	0.43	0.65	0.94
PGSC0003DMG200000417	K04565	ko04146	Peroxisome	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMG200000417	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMG200000417	K04565	ko05016	Huntington's disease	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMG200000417	K04565	ko05020	Prion diseases	1326	2.7e-67	0.75	0.87	1.00
PGSC0003DMG200000417	K04565	ko04146	Peroxisome	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMG200000417	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMG200000417	K04565	ko05016	Huntington's disease	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMG200000417	K04565	ko05020	Prion diseases	1331	1.4e-67	0.76	0.87	1.00
PGSC0003DMG200000420	K11252	ko05322	Systemic lupus erythematosus	1034	3.4e-51	0.89	0.94	0.99
PGSC0003DMG200000425	K13083	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMG200000425	K13083	ko00944	Flavone and flavonol biosynthesis	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMG200000425	K13083	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.78	0.90	0.99
PGSC0003DMG200000425	K13083	ko00941	Flavonoid biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMG200000425	K13083	ko00944	Flavone and flavonol biosynthesis	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMG200000425	K13083	ko01110	Biosynthesis of secondary metabolites	2573	4.4e-136	0.77	0.89	0.99
PGSC0003DMG200028919	K08008	ko04145	Phagosome	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	797	4.0e-38	0.38	0.58	0.97
PGSC0003DMG200028919	K08008	ko04145	Phagosome	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	317	1.2e-11	0.51	0.72	0.85
PGSC0003DMG200028919	K08008	ko04145	Phagosome	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	790	9.7e-38	0.38	0.58	0.97
PGSC0003DMG200028919	K08008	ko04145	Phagosome	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	453	3.8e-19	0.35	0.54	0.94
PGSC0003DMG200028919	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMG200028929	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMG200028929	K01904	ko00360	Phenylalanine metabolism	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMG200028929	K01904	ko00940	Phenylpropanoid biosynthesis	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMG200028929	K01904	ko01100	Metabolic pathways	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMG200028929	K01904	ko01110	Biosynthesis of secondary metabolites	3700	3.1e-198	0.79	0.90	0.99
PGSC0003DMG200028932	K08054	ko04145	Phagosome	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMG200028932	K08054	ko04612	Antigen processing and presentation	814	4.6e-39	0.62	0.78	0.99
PGSC0003DMG200028932	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMG200028932	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMG200028932	K08054	ko04145	Phagosome	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMG200028932	K08054	ko04612	Antigen processing and presentation	3464	3.2e-185	0.72	0.85	0.99
PGSC0003DMG200028933	K02978	ko03010	Ribosome	588	1.3e-26	0.82	0.89	0.85
PGSC0003DMG200026835	K01199	ko00500	Starch and sucrose metabolism	736	9.3e-35	0.32	0.56	0.85
PGSC0003DMG200026837	K05759	ko04810	Regulation of actin cytoskeleton	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMG200026837	K05759	ko05131	Shigellosis	904	5.0e-44	0.76	0.89	0.99
PGSC0003DMG200023788	K10245	ko01040	Biosynthesis of unsaturated fatty acids	479	1.4e-20	0.35	0.49	0.87
PGSC0003DMG200023793	K00889	ko00562	Inositol phosphate metabolism	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko01100	Metabolic pathways	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko04070	Phosphatidylinositol signaling system	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko04144	Endocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko04666	Fc gamma R-mediated phagocytosis	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko04810	Regulation of actin cytoskeleton	4638	5.6e-250	0.69	0.83	1.00
PGSC0003DMG200023793	K00889	ko00562	Inositol phosphate metabolism	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023793	K00889	ko01100	Metabolic pathways	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023793	K00889	ko04070	Phosphatidylinositol signaling system	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023793	K00889	ko04144	Endocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023793	K00889	ko04666	Fc gamma R-mediated phagocytosis	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023793	K00889	ko04810	Regulation of actin cytoskeleton	742	4.3e-35	0.80	0.94	0.98
PGSC0003DMG200023799	K00600	ko00260	Glycine, serine and threonine metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023799	K00600	ko00460	Cyanoamino acid metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023799	K00600	ko00670	One carbon pool by folate	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023799	K00600	ko00680	Methane metabolism	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023799	K00600	ko01100	Metabolic pathways	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023799	K00600	ko01110	Biosynthesis of secondary metabolites	3925	1.2e-210	0.78	0.88	1.00
PGSC0003DMG200023802	K10901	ko03440	Homologous recombination	1531	1.3e-78	0.63	0.81	0.98
PGSC0003DMG200030491	K08311	ko03018	RNA degradation	554	1.0e-24	0.46	0.65	0.83
PGSC0003DMG200030493	K03655	ko03440	Homologous recombination	334	1.3e-11	0.57	0.71	0.91
PGSC0003DMG200030493	K03655	ko03440	Homologous recombination	2856	1.1e-151	0.77	0.88	0.94
PGSC0003DMG200030493	K03655	ko03440	Homologous recombination	3680	3.9e-197	0.62	0.73	1.00
PGSC0003DMG200030493	K03655	ko03440	Homologous recombination	5420	4.2e-293	0.67	0.77	1.00
PGSC0003DMG200030493	K03655	ko03440	Homologous recombination	1562	2.6e-80	0.85	0.92	1.00
PGSC0003DMG200030501	K00767	ko00760	Nicotinate and nicotinamide metabolism	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMG200030501	K00767	ko01100	Metabolic pathways	2186	9.8e-115	0.84	0.92	0.99
PGSC0003DMG200030502	K00889	ko00562	Inositol phosphate metabolism	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko01100	Metabolic pathways	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko04070	Phosphatidylinositol signaling system	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko04144	Endocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko04666	Fc gamma R-mediated phagocytosis	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko04810	Regulation of actin cytoskeleton	8412	0.	0.60	0.74	1.00
PGSC0003DMG200030502	K00889	ko00562	Inositol phosphate metabolism	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200030502	K00889	ko01100	Metabolic pathways	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200030502	K00889	ko04070	Phosphatidylinositol signaling system	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200030502	K00889	ko04144	Endocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200030502	K00889	ko04666	Fc gamma R-mediated phagocytosis	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200030502	K00889	ko04810	Regulation of actin cytoskeleton	2039	1.3e-106	0.62	0.77	0.78
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	723	4.8e-34	0.74	0.86	0.91
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	927	2.7e-45	0.68	0.83	0.87
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1824	9.1e-95	0.62	0.77	0.98
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1782	1.9e-92	0.60	0.77	0.98
PGSC0003DMG200022903	K08517	ko04130	SNARE interactions in vesicular transport	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMG200022903	K08517	ko04145	Phagosome	1154	8.2e-58	0.67	0.72	0.99
PGSC0003DMG200022903	K08517	ko04130	SNARE interactions in vesicular transport	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMG200022903	K08517	ko04145	Phagosome	1670	2.8e-86	0.89	0.94	1.00
PGSC0003DMG200022905	K05658	ko02010	ABC transporters	3808	3.4e-204	0.43	0.62	0.80
PGSC0003DMG200022906	K12893	ko03040	Spliceosome	310	2.9e-08	0.28	0.42	0.55
PGSC0003DMG200022911	K08233	ko00901	Indole alkaloid biosynthesis	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMG200022911	K08233	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.45	0.63	0.93
PGSC0003DMG200022914	K10260	ko04120	Ubiquitin mediated proteolysis	402	2.4e-16	0.28	0.45	0.68
PGSC0003DMG200022918	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMG200022918	K00224	ko00364	Fluorobenzoate degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMG200022918	K00224	ko00628	Fluorene degradation	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMG200022918	K00224	ko00640	Propanoate metabolism	1173	7.3e-59	0.49	0.69	0.98
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.60	0.79	0.86
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.59	0.80	0.80
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	405	1.7e-16	0.46	0.59	0.98
PGSC0003DMG200025967	K01051	ko00040	Pentose and glucuronate interconversions	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMG200025967	K01051	ko00500	Starch and sucrose metabolism	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMG200025967	K01051	ko01100	Metabolic pathways	2847	3.4e-151	0.66	0.78	1.00
PGSC0003DMG200025968	K08495	ko04130	SNARE interactions in vesicular transport	1720	4.9e-89	0.89	0.95	0.98
PGSC0003DMG200025971	K06096	ko04530	Tight junction	411	7.8e-17	0.34	0.54	0.94
PGSC0003DMG200025976	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.76
PGSC0003DMG200025976	K12126	ko04712	Circadian rhythm - plant	524	4.6e-23	0.28	0.44	0.80
PGSC0003DMG200025979	K01692	ko00071	Fatty acid metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00280	Valine, leucine and isoleucine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00281	Geraniol degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00310	Lysine degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00380	Tryptophan metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00410	beta-Alanine metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00632	Benzoate degradation via CoA ligation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00640	Propanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00650	Butanoate metabolism	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko00930	Caprolactam degradation	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko01100	Metabolic pathways	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025979	K01692	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.50	0.70	0.90
PGSC0003DMG200025981	K01509	ko00230	Purine metabolism	948	3.9e-46	0.42	0.59	0.90
PGSC0003DMG200019289	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00260	Glycine, serine and threonine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00270	Cysteine and methionine metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00450	Selenoamino acid metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00910	Nitrogen metabolism	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko01100	Metabolic pathways	452	4.3e-19	0.52	0.73	0.89
PGSC0003DMG200019289	K01758	ko00260	Glycine, serine and threonine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMG200019289	K01758	ko00270	Cysteine and methionine metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMG200019289	K01758	ko00450	Selenoamino acid metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMG200019289	K01758	ko00910	Nitrogen metabolism	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMG200019289	K01758	ko01100	Metabolic pathways	1807	7.9e-94	0.56	0.73	0.88
PGSC0003DMG200019295	K05681	ko02010	ABC transporters	1336	7.5e-68	0.37	0.55	0.97
PGSC0003DMG200019301	K00008	ko00051	Fructose and mannose metabolism	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMG200019301	K00008	ko01100	Metabolic pathways	258	5.8e-08	0.41	0.62	0.62
PGSC0003DMG200019301	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMG200019301	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMG200019301	K00008	ko00051	Fructose and mannose metabolism	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMG200019301	K00008	ko01100	Metabolic pathways	642	1.4e-29	0.39	0.59	0.79
PGSC0003DMG200019301	K00008	ko00051	Fructose and mannose metabolism	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMG200019301	K00008	ko01100	Metabolic pathways	248	2.2e-07	0.41	0.64	0.56
PGSC0003DMG200019303	K03943	ko00190	Oxidative phosphorylation	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMG200019303	K03943	ko01100	Metabolic pathways	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMG200019303	K03943	ko05010	Alzheimer's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMG200019303	K03943	ko05012	Parkinson's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMG200019303	K03943	ko05016	Huntington's disease	1861	8.3e-97	0.84	0.91	0.99
PGSC0003DMG200019305	K00648	ko00061	Fatty acid biosynthesis	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMG200019305	K00648	ko01100	Metabolic pathways	301	9.1e-11	0.28	0.44	0.84
PGSC0003DMG200019306	K11251	ko05322	Systemic lupus erythematosus	1025	1.1e-50	0.91	0.96	0.99
PGSC0003DMG200019308	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMG200019308	K12502	ko01100	Metabolic pathways	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMG200019308	K12502	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.78	0.90	1.00
PGSC0003DMG200019309	K01047	ko00564	Glycerophospholipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko00565	Ether lipid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko00590	Arachidonic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko00591	Linoleic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko00592	alpha-Linolenic acid metabolism	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko01100	Metabolic pathways	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04010	MAPK signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04270	Vascular smooth muscle contraction	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04370	VEGF signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04664	Fc epsilon RI signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04730	Long-term depression	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200019309	K01047	ko04912	GnRH signaling pathway	369	1.6e-14	0.29	0.42	0.88
PGSC0003DMG200043087	K10601	ko04120	Ubiquitin mediated proteolysis	261	4.2e-08	0.31	0.41	0.93
PGSC0003DMG200043111	K00472	ko00330	Arginine and proline metabolism	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMG200043111	K00472	ko01100	Metabolic pathways	451	4.9e-19	0.45	0.62	0.75
PGSC0003DMG200011780	K09526	ko04144	Endocytosis	327	1.8e-11	0.40	0.59	0.64
PGSC0003DMG200011782	K00858	ko00760	Nicotinate and nicotinamide metabolism	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMG200011782	K00858	ko01100	Metabolic pathways	969	1.3e-47	0.66	0.84	0.99
PGSC0003DMG200011782	K00858	ko00760	Nicotinate and nicotinamide metabolism	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMG200011782	K00858	ko01100	Metabolic pathways	1440	1.4e-73	0.57	0.74	1.00
PGSC0003DMG200011782	K00858	ko00760	Nicotinate and nicotinamide metabolism	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMG200011782	K00858	ko01100	Metabolic pathways	1692	1.7e-87	0.54	0.73	0.35
PGSC0003DMG200011782	K00858	ko00760	Nicotinate and nicotinamide metabolism	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMG200011782	K00858	ko01100	Metabolic pathways	625	1.2e-28	0.66	0.83	0.97
PGSC0003DMG200011783	K12929	ko00904	Diterpenoid biosynthesis	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMG200011783	K12929	ko01110	Biosynthesis of secondary metabolites	1675	1.5e-86	0.44	0.63	0.97
PGSC0003DMG200011785	K04506	ko04115	p53 signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMG200011785	K04506	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMG200011785	K04506	ko04310	Wnt signaling pathway	308	3.7e-11	0.54	0.72	0.95
PGSC0003DMG200011790	K05863	ko04020	Calcium signaling pathway	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMG200011790	K05863	ko05012	Parkinson's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMG200011790	K05863	ko05016	Huntington's disease	613	5.6e-28	0.37	0.55	0.66
PGSC0003DMG200006157	K00943	ko00240	Pyrimidine metabolism	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMG200006157	K00943	ko01100	Metabolic pathways	1360	3.5e-69	0.68	0.77	0.87
PGSC0003DMG200006157	K00943	ko00240	Pyrimidine metabolism	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMG200006157	K00943	ko01100	Metabolic pathways	1387	1.2e-70	0.71	0.79	0.87
PGSC0003DMG200006167	K03033	ko03050	Proteasome	3555	3.0e-190	0.87	0.92	1.00
PGSC0003DMG200006167	K03033	ko03050	Proteasome	2690	1.6e-142	0.73	0.84	0.92
PGSC0003DMG200006167	K03033	ko03050	Proteasome	3578	1.6e-191	0.88	0.93	1.00
PGSC0003DMG200006168	K10581	ko04120	Ubiquitin mediated proteolysis	5128	3.2e-279	0.63	0.74	0.94
PGSC0003DMG200006168	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMG200006168	K10581	ko04120	Ubiquitin mediated proteolysis	5510	4.5e-298	0.62	0.74	0.95
PGSC0003DMG200006173	K01190	ko00052	Galactose metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMG200006173	K01190	ko00511	Other glycan degradation	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMG200006173	K01190	ko00600	Sphingolipid metabolism	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMG200006173	K01190	ko01100	Metabolic pathways	583	2.5e-26	0.46	0.63	0.93
PGSC0003DMG200009210	K12876	ko03040	Spliceosome	1160	3.8e-58	0.74	0.84	0.78
PGSC0003DMG200009210	K12876	ko03040	Spliceosome	1290	2.6e-65	0.76	0.86	0.99
PGSC0003DMG200009211	K13065	ko00940	Phenylpropanoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMG200009211	K13065	ko00941	Flavonoid biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMG200009211	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMG200009211	K13065	ko01110	Biosynthesis of secondary metabolites	334	1.4e-12	0.26	0.44	0.95
PGSC0003DMG200009217	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	238	2.7e-07	0.30	0.42	0.70
PGSC0003DMG200009217	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1028	7.3e-51	0.42	0.56	0.89
PGSC0003DMG200009217	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	374	8.6e-15	0.32	0.50	0.81
PGSC0003DMG200009217	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	327	3.4e-12	0.52	0.69	0.99
PGSC0003DMG200002629	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMG200002629	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.89
PGSC0003DMG200002629	K05993	ko01053	Biosynthesis of siderophore group nonribosomal peptides	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMG200002629	K05993	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.37	0.58	0.81
PGSC0003DMG200002631	K06664	ko04146	Peroxisome	902	6.5e-44	0.47	0.53	0.71
PGSC0003DMG200002631	K06664	ko04146	Peroxisome	411	7.8e-17	0.81	0.84	0.57
PGSC0003DMG200002631	K06664	ko04146	Peroxisome	746	2.6e-35	0.77	0.85	0.86
PGSC0003DMG200002640	K03843	ko00510	N-Glycan biosynthesis	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMG200002640	K03843	ko01100	Metabolic pathways	270	2.3e-06	0.33	0.47	0.31
PGSC0003DMG200025430	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025430	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025430	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025430	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025430	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025430	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200025431	K07195	ko04910	Insulin signaling pathway	464	9.3e-20	0.71	0.84	0.66
PGSC0003DMG200025438	K13229	ko00402	Benzoxazinoid biosynthesis	1271	2.9e-64	0.45	0.65	0.98
PGSC0003DMG200025438	K13229	ko00402	Benzoxazinoid biosynthesis	1249	4.7e-63	0.45	0.64	0.99
PGSC0003DMG200025438	K13229	ko00402	Benzoxazinoid biosynthesis	1063	8.5e-53	0.47	0.66	0.95
PGSC0003DMG200025439	K13229	ko00402	Benzoxazinoid biosynthesis	1066	5.8e-53	0.48	0.66	0.96
PGSC0003DMG200021723	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021723	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021723	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021723	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021723	K07385	ko00902	Monoterpenoid biosynthesis	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021723	K07385	ko01100	Metabolic pathways	1417	2.5e-72	0.40	0.62	1.00
PGSC0003DMG200021724	K07385	ko00902	Monoterpenoid biosynthesis	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMG200021724	K07385	ko01100	Metabolic pathways	1145	3.2e-73	0.38	0.59	1.00
PGSC0003DMG200021727	K08901	ko00195	Photosynthesis	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMG200021727	K08901	ko01100	Metabolic pathways	1255	2.2e-63	0.67	0.84	1.00
PGSC0003DMG200021729	K04733	ko04210	Apoptosis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMG200021729	K04733	ko04620	Toll-like receptor signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMG200021729	K04733	ko04722	Neurotrophin signaling pathway	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMG200021729	K04733	ko05140	Leishmaniasis	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMG200021729	K04733	ko05142	Chagas disease	836	2.8e-40	0.36	0.55	0.59
PGSC0003DMG200021729	K04733	ko04210	Apoptosis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMG200021729	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMG200021729	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMG200021729	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMG200021729	K04733	ko05142	Chagas disease	887	4.4e-43	0.37	0.54	0.60
PGSC0003DMG200021729	K04733	ko04210	Apoptosis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMG200021729	K04733	ko04620	Toll-like receptor signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMG200021729	K04733	ko04722	Neurotrophin signaling pathway	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMG200021729	K04733	ko05140	Leishmaniasis	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMG200021729	K04733	ko05142	Chagas disease	851	4.2e-41	0.36	0.55	0.89
PGSC0003DMG200021729	K04733	ko04210	Apoptosis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMG200021729	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMG200021729	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMG200021729	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMG200021729	K04733	ko05142	Chagas disease	843	1.2e-40	0.37	0.55	0.59
PGSC0003DMG200021729	K00558	ko00270	Cysteine and methionine metabolism	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMG200021729	K00558	ko01100	Metabolic pathways	441	2.3e-17	0.57	0.75	0.26
PGSC0003DMG200021736	K05933	ko00270	Cysteine and methionine metabolism	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMG200021736	K05933	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.42	0.61	0.83
PGSC0003DMG200021736	K05278	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMG200021736	K05278	ko01100	Metabolic pathways	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMG200021736	K05278	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.33	0.54	0.94
PGSC0003DMG200021738	K11820	ko00380	Tryptophan metabolism	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMG200021738	K11820	ko00966	Glucosinolate biosynthesis	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMG200021738	K11820	ko01110	Biosynthesis of secondary metabolites	1489	2.7e-76	0.43	0.65	0.97
PGSC0003DMG200020418	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMG200020418	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMG200020419	K04424	ko04010	MAPK signaling pathway	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMG200020419	K04424	ko04530	Tight junction	1088	3.6e-54	0.31	0.50	0.90
PGSC0003DMG200020419	K04424	ko04010	MAPK signaling pathway	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMG200020419	K04424	ko04530	Tight junction	641	1.6e-29	0.27	0.47	0.85
PGSC0003DMG200020419	K04424	ko04010	MAPK signaling pathway	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMG200020419	K04424	ko04530	Tight junction	1193	5.8e-60	0.31	0.50	0.90
PGSC0003DMG200020421	K05741	ko04810	Regulation of actin cytoskeleton	280	3.4e-07	0.32	0.45	0.63
PGSC0003DMG200020422	K01595	ko00620	Pyruvate metabolism	7500	0.	0.91	0.97	1.00
PGSC0003DMG200020422	K01595	ko00710	Carbon fixation in photosynthetic organisms	7500	0.	0.91	0.97	1.00
PGSC0003DMG200020422	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7500	0.	0.91	0.97	1.00
PGSC0003DMG200020422	K01595	ko01100	Metabolic pathways	7500	0.	0.91	0.97	1.00
PGSC0003DMG200020422	K01595	ko00620	Pyruvate metabolism	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMG200020422	K01595	ko00710	Carbon fixation in photosynthetic organisms	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMG200020422	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMG200020422	K01595	ko01100	Metabolic pathways	729	2.3e-34	0.87	0.92	0.99
PGSC0003DMG200020422	K01595	ko00620	Pyruvate metabolism	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMG200020422	K01595	ko00710	Carbon fixation in photosynthetic organisms	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMG200020422	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMG200020422	K01595	ko01100	Metabolic pathways	1027	8.3e-51	0.86	0.93	0.74
PGSC0003DMG200020425	K06630	ko04110	Cell cycle	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMG200020425	K06630	ko04114	Oocyte meiosis	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMG200020425	K06630	ko04722	Neurotrophin signaling pathway	1886	3.5e-98	0.86	0.93	1.00
PGSC0003DMG200020426	K00861	ko00740	Riboflavin metabolism	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMG200020426	K00861	ko01100	Metabolic pathways	905	4.4e-44	0.49	0.60	0.71
PGSC0003DMG200020426	K00861	ko00740	Riboflavin metabolism	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMG200020426	K00861	ko01100	Metabolic pathways	1129	2.0e-56	0.45	0.61	0.91
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	0.99
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1464	6.5e-75	0.67	0.76	1.00
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1481	7.5e-76	0.68	0.76	1.00
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1137	7.1e-57	0.65	0.74	0.90
PGSC0003DMG200027577	K04564	ko04146	Peroxisome	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMG200027577	K04564	ko05016	Huntington's disease	1369	1.1e-69	0.72	0.82	0.96
PGSC0003DMG200027578	K03348	ko04110	Cell cycle	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04111	Cell cycle - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04113	Meiosis - yeast	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04114	Oocyte meiosis	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04120	Ubiquitin mediated proteolysis	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04914	Progesterone-mediated oocyte maturation	8324	0.	0.69	0.80	0.99
PGSC0003DMG200027578	K03348	ko04110	Cell cycle	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04111	Cell cycle - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04113	Meiosis - yeast	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04114	Oocyte meiosis	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04120	Ubiquitin mediated proteolysis	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04914	Progesterone-mediated oocyte maturation	10013	0.	0.66	0.78	1.00
PGSC0003DMG200027578	K03348	ko04110	Cell cycle	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200027578	K03348	ko04111	Cell cycle - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200027578	K03348	ko04113	Meiosis - yeast	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200027578	K03348	ko04114	Oocyte meiosis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200027578	K03348	ko04120	Ubiquitin mediated proteolysis	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200027578	K03348	ko04914	Progesterone-mediated oocyte maturation	4499	2.6e-242	0.69	0.81	0.99
PGSC0003DMG200038099	K05282	ko00904	Diterpenoid biosynthesis	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMG200038099	K05282	ko01100	Metabolic pathways	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMG200038099	K05282	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.67	0.78	0.99
PGSC0003DMG200038101	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.9e-10	0.34	0.51	0.82
PGSC0003DMG200007293	K00901	ko00561	Glycerolipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMG200007293	K00901	ko00564	Glycerophospholipid metabolism	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMG200007293	K00901	ko01100	Metabolic pathways	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMG200007293	K00901	ko04070	Phosphatidylinositol signaling system	1528	1.9e-78	0.43	0.62	0.95
PGSC0003DMG200007293	K00901	ko00561	Glycerolipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMG200007293	K00901	ko00564	Glycerophospholipid metabolism	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMG200007293	K00901	ko01100	Metabolic pathways	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMG200007293	K00901	ko04070	Phosphatidylinositol signaling system	770	1.2e-36	0.46	0.67	0.98
PGSC0003DMG200007294	K05658	ko02010	ABC transporters	7400	0.	0.62	0.76	0.98
PGSC0003DMG200007295	K05658	ko02010	ABC transporters	8550	0.	0.79	0.89	1.00
PGSC0003DMG200007299	K04733	ko04210	Apoptosis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMG200007299	K04733	ko04620	Toll-like receptor signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMG200007299	K04733	ko04722	Neurotrophin signaling pathway	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMG200007299	K04733	ko05140	Leishmaniasis	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMG200007299	K04733	ko05142	Chagas disease	2156	4.4e-113	0.41	0.55	0.99
PGSC0003DMG200007301	K04371	ko04010	MAPK signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04012	ErbB signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04013	MAPK signaling pathway - fly	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04062	Chemokine signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04114	Oocyte meiosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04150	mTOR signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04270	Vascular smooth muscle contraction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04320	Dorso-ventral axis formation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04350	TGF-beta signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04360	Axon guidance	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04370	VEGF signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04510	Focal adhesion	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04520	Adherens junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04540	Gap junction	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04620	Toll-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04621	NOD-like receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04650	Natural killer cell mediated cytotoxicity	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04660	T cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04662	B cell receptor signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04664	Fc epsilon RI signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04666	Fc gamma R-mediated phagocytosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04720	Long-term potentiation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04722	Neurotrophin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04730	Long-term depression	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04810	Regulation of actin cytoskeleton	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04910	Insulin signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04912	GnRH signaling pathway	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04914	Progesterone-mediated oocyte maturation	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04916	Melanogenesis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04930	Type II diabetes mellitus	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko04960	Aldosterone-regulated sodium reabsorption	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05010	Alzheimer's disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05020	Prion diseases	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05131	Shigellosis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05140	Leishmaniasis	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05142	Chagas disease	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05200	Pathways in cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05210	Colorectal cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05211	Renal cell carcinoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05212	Pancreatic cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05213	Endometrial cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05214	Glioma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05215	Prostate cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05216	Thyroid cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05218	Melanoma	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05219	Bladder cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05220	Chronic myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05221	Acute myeloid leukemia	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200007301	K04371	ko05223	Non-small cell lung cancer	401	2.8e-16	0.41	0.61	0.98
PGSC0003DMG200003612	K00754	ko00051	Fructose and mannose metabolism	281	3.2e-08	0.30	0.48	0.55
PGSC0003DMG200003613	K10688	ko04120	Ubiquitin mediated proteolysis	1349	1.4e-68	0.93	0.97	0.99
PGSC0003DMG200003619	K00128	ko00010	Glycolysis / Gluconeogenesis	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00053	Ascorbate and aldarate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00071	Fatty acid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00280	Valine, leucine and isoleucine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00310	Lysine degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00330	Arginine and proline metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00340	Histidine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00380	Tryptophan metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00410	beta-Alanine metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00561	Glycerolipid metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00620	Pyruvate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00631	1,2-Dichloroethane degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00640	Propanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00641	3-Chloroacrylic acid degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00650	Butanoate metabolism	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko01100	Metabolic pathways	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.49	0.67	0.99
PGSC0003DMG200003619	K00128	ko00010	Glycolysis / Gluconeogenesis	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00053	Ascorbate and aldarate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00071	Fatty acid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00280	Valine, leucine and isoleucine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00310	Lysine degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00330	Arginine and proline metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00340	Histidine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00380	Tryptophan metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00410	beta-Alanine metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00561	Glycerolipid metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00620	Pyruvate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00631	1,2-Dichloroethane degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00640	Propanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00641	3-Chloroacrylic acid degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00650	Butanoate metabolism	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00903	Limonene and pinene degradation	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko01100	Metabolic pathways	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko01110	Biosynthesis of secondary metabolites	709	2.9e-33	0.58	0.74	0.97
PGSC0003DMG200003619	K00128	ko00010	Glycolysis / Gluconeogenesis	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00053	Ascorbate and aldarate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00071	Fatty acid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00280	Valine, leucine and isoleucine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00310	Lysine degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00330	Arginine and proline metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00340	Histidine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00380	Tryptophan metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00410	beta-Alanine metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00561	Glycerolipid metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00620	Pyruvate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00631	1,2-Dichloroethane degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00640	Propanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00641	3-Chloroacrylic acid degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00650	Butanoate metabolism	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00903	Limonene and pinene degradation	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko01100	Metabolic pathways	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko01110	Biosynthesis of secondary metabolites	1091	2.4e-54	0.55	0.74	0.99
PGSC0003DMG200003619	K00128	ko00010	Glycolysis / Gluconeogenesis	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00053	Ascorbate and aldarate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00071	Fatty acid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00280	Valine, leucine and isoleucine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00310	Lysine degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00330	Arginine and proline metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00340	Histidine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00380	Tryptophan metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00410	beta-Alanine metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00561	Glycerolipid metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00620	Pyruvate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00631	1,2-Dichloroethane degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00640	Propanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00641	3-Chloroacrylic acid degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00650	Butanoate metabolism	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko00903	Limonene and pinene degradation	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko01100	Metabolic pathways	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003619	K00128	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.52	0.70	0.99
PGSC0003DMG200003623	K01051	ko00040	Pentose and glucuronate interconversions	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMG200003623	K01051	ko00500	Starch and sucrose metabolism	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMG200003623	K01051	ko01100	Metabolic pathways	1884	4.5e-98	0.63	0.79	0.95
PGSC0003DMG200017096	K00001	ko00010	Glycolysis / Gluconeogenesis	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00071	Fatty acid metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00350	Tyrosine metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00641	3-Chloroacrylic acid degradation	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00830	Retinol metabolism	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko00982	Drug metabolism - cytochrome P450	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko01100	Metabolic pathways	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017096	K00001	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.59	0.73	0.98
PGSC0003DMG200017097	K00001	ko00010	Glycolysis / Gluconeogenesis	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00071	Fatty acid metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00350	Tyrosine metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00641	3-Chloroacrylic acid degradation	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00830	Retinol metabolism	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko00982	Drug metabolism - cytochrome P450	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko01100	Metabolic pathways	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017097	K00001	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.56	0.72	0.98
PGSC0003DMG200017100	K00826	ko00280	Valine, leucine and isoleucine degradation	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko00770	Pantothenate and CoA biosynthesis	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko01100	Metabolic pathways	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko01110	Biosynthesis of secondary metabolites	2494	1.0e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko00280	Valine, leucine and isoleucine degradation	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko00770	Pantothenate and CoA biosynthesis	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko01100	Metabolic pathways	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMG200017100	K00826	ko01110	Biosynthesis of secondary metabolites	2490	1.7e-131	0.72	0.82	1.00
PGSC0003DMG200017101	K10606	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.49	0.64	0.99
PGSC0003DMG200017101	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMG200017101	K10606	ko04120	Ubiquitin mediated proteolysis	337	9.4e-13	0.55	0.67	0.84
PGSC0003DMG200017101	K10606	ko04120	Ubiquitin mediated proteolysis	219	3.0e-06	0.55	0.67	0.94
PGSC0003DMG200017111	K12606	ko03018	RNA degradation	676	1.9e-31	0.44	0.61	0.86
PGSC0003DMG200020999	K00454	ko00591	Linoleic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMG200020999	K00454	ko00592	alpha-Linolenic acid metabolism	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMG200020999	K00454	ko01100	Metabolic pathways	4948	4.5e-267	0.67	0.81	1.00
PGSC0003DMG200021002	K12877	ko03040	Spliceosome	1044	9.5e-52	0.90	0.96	0.58
PGSC0003DMG200021002	K12877	ko03040	Spliceosome	1194	5.1e-60	0.92	0.97	0.97
PGSC0003DMG200021004	K11420	ko00310	Lysine degradation	698	4.1e-32	0.38	0.52	0.34
PGSC0003DMG200021005	K11420	ko00310	Lysine degradation	710	8.5e-33	0.38	0.52	0.34
PGSC0003DMG200021006	K11421	ko00310	Lysine degradation	485	1.1e-34	0.34	0.50	0.68
PGSC0003DMG200021009	K00020	ko00280	Valine, leucine and isoleucine degradation	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMG200021009	K00020	ko01100	Metabolic pathways	1780	2.4e-92	0.71	0.85	0.99
PGSC0003DMG200021009	K00020	ko00280	Valine, leucine and isoleucine degradation	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMG200021009	K00020	ko01100	Metabolic pathways	1860	9.4e-97	0.67	0.81	0.96
PGSC0003DMG200021019	K01583	ko00330	Arginine and proline metabolism	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMG200021019	K01583	ko01100	Metabolic pathways	257	3.0e-15	0.53	0.68	0.98
PGSC0003DMG200021019	K01583	ko00330	Arginine and proline metabolism	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMG200021019	K01583	ko01100	Metabolic pathways	924	4.0e-45	0.46	0.66	0.93
PGSC0003DMG200021019	K01583	ko00330	Arginine and proline metabolism	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMG200021019	K01583	ko01100	Metabolic pathways	1169	1.2e-58	0.46	0.66	0.96
PGSC0003DMG200024759	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMG200024767	K01051	ko00040	Pentose and glucuronate interconversions	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMG200024767	K01051	ko00500	Starch and sucrose metabolism	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMG200024767	K01051	ko01100	Metabolic pathways	2151	8.4e-113	0.47	0.65	0.82
PGSC0003DMG200024767	K01051	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMG200024767	K01051	ko00500	Starch and sucrose metabolism	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMG200024767	K01051	ko01100	Metabolic pathways	1728	1.8e-89	0.44	0.63	0.74
PGSC0003DMG200024767	K01051	ko00040	Pentose and glucuronate interconversions	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMG200024767	K01051	ko00500	Starch and sucrose metabolism	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMG200024767	K01051	ko01100	Metabolic pathways	1994	3.8e-104	0.50	0.68	0.90
PGSC0003DMG200037791	K03094	ko04110	Cell cycle	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04111	Cell cycle - yeast	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04114	Oocyte meiosis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04120	Ubiquitin mediated proteolysis	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04310	Wnt signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04350	TGF-beta signaling pathway	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200037791	K03094	ko04710	Circadian rhythm - mammal	693	2.2e-32	0.61	0.72	0.99
PGSC0003DMG200004301	K08913	ko00196	Photosynthesis - antenna proteins	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMG200004301	K08913	ko01100	Metabolic pathways	2044	6.7e-107	0.89	0.94	0.99
PGSC0003DMG200004305	K09828	ko00100	Steroid biosynthesis	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMG200004305	K09828	ko01100	Metabolic pathways	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMG200004305	K09828	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.69	0.78	0.93
PGSC0003DMG200004306	K12478	ko04144	Endocytosis	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMG200004306	K12478	ko04145	Phagosome	580	3.5e-24	0.25	0.47	0.88
PGSC0003DMG200004310	K12590	ko03018	RNA degradation	935	9.8e-46	0.59	0.67	0.85
PGSC0003DMG200004310	K12590	ko03018	RNA degradation	1612	4.5e-83	0.78	0.91	1.00
PGSC0003DMG200004310	K12590	ko03018	RNA degradation	844	1.0e-40	0.83	0.93	0.86
PGSC0003DMG200004310	K12590	ko03018	RNA degradation	799	3.1e-38	0.84	0.93	0.87
PGSC0003DMG200008018	K09756	ko00940	Phenylpropanoid biosynthesis	1781	2.1e-92	0.47	0.67	0.99
PGSC0003DMG200008026	K03030	ko03050	Proteasome	2584	1.1e-136	0.97	0.99	1.00
PGSC0003DMG200003039	K05592	ko03018	RNA degradation	786	1.6e-37	0.31	0.52	0.78
PGSC0003DMG200003051	K10755	ko03030	DNA replication	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMG200003051	K10755	ko03420	Nucleotide excision repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMG200003051	K10755	ko03430	Mismatch repair	690	3.2e-32	0.92	0.98	0.98
PGSC0003DMG200003051	K10755	ko03030	DNA replication	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMG200003051	K10755	ko03420	Nucleotide excision repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMG200003051	K10755	ko03430	Mismatch repair	2537	4.3e-134	0.91	0.96	1.00
PGSC0003DMG200003051	K10755	ko03030	DNA replication	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMG200003051	K10755	ko03420	Nucleotide excision repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMG200003051	K10755	ko03430	Mismatch repair	1533	1.0e-78	0.91	0.96	0.99
PGSC0003DMG200003054	K01784	ko00052	Galactose metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMG200003054	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMG200003054	K01784	ko01100	Metabolic pathways	1803	1.3e-93	0.79	0.89	0.99
PGSC0003DMG200003054	K01784	ko00052	Galactose metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMG200003054	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMG200003054	K01784	ko01100	Metabolic pathways	2465	4.0e-130	0.81	0.91	0.99
PGSC0003DMG200010140	K00020	ko00280	Valine, leucine and isoleucine degradation	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMG200010140	K00020	ko01100	Metabolic pathways	267	6.8e-09	0.71	0.86	0.32
PGSC0003DMG200010152	K07151	ko00510	N-Glycan biosynthesis	5704	0.	0.92	0.95	1.00
PGSC0003DMG200010152	K07151	ko01100	Metabolic pathways	5704	0.	0.92	0.95	1.00
PGSC0003DMG200010152	K07151	ko00510	N-Glycan biosynthesis	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMG200010152	K07151	ko01100	Metabolic pathways	639	2.1e-29	1.00	1.00	0.99
PGSC0003DMG200010153	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMG200010153	K12486	ko04144	Endocytosis	870	3.8e-42	0.50	0.63	0.94
PGSC0003DMG200010156	K11097	ko03040	Spliceosome	687	4.7e-32	0.98	0.98	0.91
PGSC0003DMG200039296	K01213	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMG200039296	K01213	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMG200039296	K01213	ko01100	Metabolic pathways	1004	1.5e-49	0.42	0.59	0.99
PGSC0003DMG200039299	K12126	ko04712	Circadian rhythm - plant	322	7.2e-12	0.29	0.47	0.82
PGSC0003DMG200029225	K12872	ko03040	Spliceosome	422	1.9e-17	0.83	0.88	0.55
PGSC0003DMG200029226	K12356	ko00940	Phenylpropanoid biosynthesis	404	1.9e-16	0.59	0.65	0.90
PGSC0003DMG200029231	K08241	ko00592	alpha-Linolenic acid metabolism	609	9.4e-28	0.34	0.53	0.92
PGSC0003DMG200029239	K13230	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.42	0.58	0.97
PGSC0003DMG200029240	K13230	ko00402	Benzoxazinoid biosynthesis	362	3.9e-14	0.47	0.66	0.74
PGSC0003DMG200026608	K01392	ko04614	Renin-angiotensin system	3227	3.8e-172	0.55	0.76	0.99
PGSC0003DMG200026608	K01392	ko04614	Renin-angiotensin system	3298	4.6e-176	0.57	0.79	0.99
PGSC0003DMG200026613	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMG200026613	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMG200026613	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMG200026613	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMG200026613	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.44	0.63	0.97
PGSC0003DMG200026617	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMG200026617	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMG200026617	K08233	ko00901	Indole alkaloid biosynthesis	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMG200026617	K08233	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.50	0.70	0.81
PGSC0003DMG200026617	K08233	ko00901	Indole alkaloid biosynthesis	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMG200026617	K08233	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.43	0.63	0.88
PGSC0003DMG200023657	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMG200023657	K00517	ko00626	Naphthalene and anthracene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMG200023657	K00517	ko00903	Limonene and pinene degradation	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMG200023657	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMG200023657	K00517	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.43	0.63	0.99
PGSC0003DMG200023657	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMG200023657	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMG200023657	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMG200023657	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMG200023657	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.43	0.62	0.99
PGSC0003DMG200023658	K00889	ko00562	Inositol phosphate metabolism	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023658	K00889	ko01100	Metabolic pathways	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023658	K00889	ko04070	Phosphatidylinositol signaling system	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023658	K00889	ko04144	Endocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023658	K00889	ko04666	Fc gamma R-mediated phagocytosis	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023658	K00889	ko04810	Regulation of actin cytoskeleton	1648	4.6e-85	0.70	0.84	0.99
PGSC0003DMG200023661	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3596	1.7e-192	0.74	0.84	0.99
PGSC0003DMG200023663	K00860	ko00230	Purine metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMG200023663	K00860	ko00450	Selenoamino acid metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMG200023663	K00860	ko00920	Sulfur metabolism	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMG200023663	K00860	ko01100	Metabolic pathways	1288	3.3e-65	0.73	0.85	0.99
PGSC0003DMG200023663	K00860	ko00230	Purine metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMG200023663	K00860	ko00450	Selenoamino acid metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMG200023663	K00860	ko00920	Sulfur metabolism	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMG200023663	K00860	ko01100	Metabolic pathways	497	1.4e-21	0.77	0.90	0.97
PGSC0003DMG200023664	K03259	ko04150	mTOR signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMG200023664	K03259	ko04910	Insulin signaling pathway	1660	1.0e-85	0.86	0.92	0.99
PGSC0003DMG200023665	K12830	ko03040	Spliceosome	733	1.6e-31	0.25	0.41	0.95
PGSC0003DMG200023665	K12830	ko03040	Spliceosome	627	2.1e-25	0.24	0.40	0.94
PGSC0003DMG200023667	K02889	ko03010	Ribosome	1211	5.9e-61	0.84	0.92	0.99
PGSC0003DMG200020015	K04733	ko04210	Apoptosis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMG200020015	K04733	ko04620	Toll-like receptor signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMG200020015	K04733	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMG200020015	K04733	ko05140	Leishmaniasis	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMG200020015	K04733	ko05142	Chagas disease	698	1.2e-32	0.37	0.57	0.60
PGSC0003DMG200020017	K01199	ko00500	Starch and sucrose metabolism	1076	1.6e-53	0.41	0.57	0.94
PGSC0003DMG200020017	K01199	ko00500	Starch and sucrose metabolism	634	3.9e-29	0.45	0.69	0.91
PGSC0003DMG200020017	K01199	ko00500	Starch and sucrose metabolism	531	1.9e-23	0.45	0.67	0.93
PGSC0003DMG200020019	K04733	ko04210	Apoptosis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMG200020019	K04733	ko04620	Toll-like receptor signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMG200020019	K04733	ko04722	Neurotrophin signaling pathway	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMG200020019	K04733	ko05140	Leishmaniasis	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMG200020019	K04733	ko05142	Chagas disease	215	9.2e-06	0.47	0.57	0.39
PGSC0003DMG200020023	K04733	ko04210	Apoptosis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMG200020023	K04733	ko04620	Toll-like receptor signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMG200020023	K04733	ko04722	Neurotrophin signaling pathway	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMG200020023	K04733	ko05140	Leishmaniasis	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMG200020023	K04733	ko05142	Chagas disease	579	2.8e-32	0.41	0.60	0.36
PGSC0003DMG200020027	K02738	ko03050	Proteasome	468	5.6e-20	0.72	0.82	0.61
PGSC0003DMG200020034	K01853	ko00100	Steroid biosynthesis	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMG200020034	K01853	ko01100	Metabolic pathways	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMG200020034	K01853	ko01110	Biosynthesis of secondary metabolites	3762	1.2e-201	0.69	0.83	0.91
PGSC0003DMG200020034	K01853	ko00100	Steroid biosynthesis	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMG200020034	K01853	ko01100	Metabolic pathways	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMG200020034	K01853	ko01110	Biosynthesis of secondary metabolites	4668	1.2e-251	0.69	0.83	0.98
PGSC0003DMG200008562	K01069	ko00620	Pyruvate metabolism	657	2.1e-30	0.55	0.67	0.94
PGSC0003DMG200008562	K01069	ko00620	Pyruvate metabolism	861	1.2e-41	0.56	0.69	0.95
PGSC0003DMG200008562	K01069	ko00620	Pyruvate metabolism	987	1.3e-48	0.53	0.68	0.98
PGSC0003DMG200008564	K08914	ko00196	Photosynthesis - antenna proteins	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMG200008564	K08914	ko01100	Metabolic pathways	2012	3.9e-105	0.88	0.93	0.98
PGSC0003DMG200008565	K11252	ko05322	Systemic lupus erythematosus	892	2.3e-43	0.84	0.88	0.40
PGSC0003DMG200008565	K11252	ko05322	Systemic lupus erythematosus	1043	1.1e-51	0.89	0.93	0.99
PGSC0003DMG200008568	K01082	ko00920	Sulfur metabolism	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMG200008568	K01082	ko01100	Metabolic pathways	2231	3.2e-117	0.68	0.85	0.99
PGSC0003DMG200008571	K12484	ko04144	Endocytosis	280	2.2e-07	0.26	0.42	0.98
PGSC0003DMG200008571	K12484	ko04144	Endocytosis	272	1.7e-06	0.25	0.42	0.69
PGSC0003DMG200008571	K12484	ko04144	Endocytosis	272	1.3e-06	0.25	0.42	0.78
PGSC0003DMG200008572	K11252	ko05322	Systemic lupus erythematosus	1062	9.7e-53	0.89	0.91	0.99
PGSC0003DMG200005516	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMG200005516	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMG200005516	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMG200005516	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMG200005516	K03142	ko03022	Basal transcription factors	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMG200005516	K03142	ko03420	Nucleotide excision repair	2820	1.1e-149	0.79	0.88	1.00
PGSC0003DMG200005516	K03142	ko03022	Basal transcription factors	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMG200005516	K03142	ko03420	Nucleotide excision repair	1593	5.0e-82	0.77	0.89	0.98
PGSC0003DMG200005522	K01728	ko00040	Pentose and glucuronate interconversions	1570	9.3e-81	0.55	0.68	0.92
PGSC0003DMG200005523	K01728	ko00040	Pentose and glucuronate interconversions	1831	3.7e-95	0.59	0.71	0.84
PGSC0003DMG200005526	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMG200005526	K00517	ko00626	Naphthalene and anthracene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMG200005526	K00517	ko00903	Limonene and pinene degradation	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMG200005526	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMG200005526	K00517	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.70	0.85	0.96
PGSC0003DMG200001959	K12741	ko03040	Spliceosome	312	4.5e-11	0.36	0.45	0.32
PGSC0003DMG200001960	K09843	ko00906	Carotenoid biosynthesis	3082	3.7e-164	0.78	0.88	0.99
PGSC0003DMG200001960	K09843	ko00906	Carotenoid biosynthesis	1301	6.4e-66	0.75	0.86	0.99
PGSC0003DMG200001960	K09843	ko00906	Carotenoid biosynthesis	1713	1.2e-88	0.81	0.91	0.94
PGSC0003DMG200001966	K02886	ko03010	Ribosome	681	1.0e-31	0.48	0.64	0.96
PGSC0003DMG200001966	K06066	ko04330	Notch signaling pathway	697	1.3e-32	0.29	0.44	0.85
PGSC0003DMG200001967	K05681	ko02010	ABC transporters	1011	6.3e-50	0.41	0.59	0.91
PGSC0003DMG200001967	K05681	ko02010	ABC transporters	1391	6.9e-71	0.38	0.57	0.96
PGSC0003DMG200001968	K09840	ko00906	Carotenoid biosynthesis	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMG200001968	K09840	ko01100	Metabolic pathways	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMG200001968	K09840	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.36	0.51	0.91
PGSC0003DMG200001968	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001968	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001968	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001968	K09840	ko00906	Carotenoid biosynthesis	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMG200001968	K09840	ko01100	Metabolic pathways	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMG200001968	K09840	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.35	0.59	0.99
PGSC0003DMG200001968	K09840	ko00906	Carotenoid biosynthesis	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMG200001968	K09840	ko01100	Metabolic pathways	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMG200001968	K09840	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.38	0.57	0.95
PGSC0003DMG200001968	K09840	ko00906	Carotenoid biosynthesis	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001968	K09840	ko01100	Metabolic pathways	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001968	K09840	ko01110	Biosynthesis of secondary metabolites	328	4.8e-12	0.42	0.55	0.61
PGSC0003DMG200001969	K09840	ko00906	Carotenoid biosynthesis	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMG200001969	K09840	ko01100	Metabolic pathways	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMG200001969	K09840	ko01110	Biosynthesis of secondary metabolites	374	9.4e-15	0.47	0.65	0.96
PGSC0003DMG200001969	K09840	ko00906	Carotenoid biosynthesis	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMG200001969	K09840	ko01100	Metabolic pathways	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMG200001969	K09840	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.38	0.56	0.98
PGSC0003DMG200047162	K12194	ko04144	Endocytosis	331	2.0e-12	0.50	0.71	0.33
PGSC0003DMG200000364	K06063	ko03040	Spliceosome	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMG200000364	K06063	ko04330	Notch signaling pathway	4052	1.2e-217	0.80	0.87	1.00
PGSC0003DMG200000366	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMG200000366	K02367	ko01100	Metabolic pathways	283	1.5e-07	0.26	0.45	0.88
PGSC0003DMG200000366	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMG200000366	K02367	ko01100	Metabolic pathways	283	1.0e-06	0.26	0.45	0.54
PGSC0003DMG200000367	K08139	ko04113	Meiosis - yeast	846	7.9e-41	0.35	0.56	0.87
PGSC0003DMG200000376	K10527	ko00592	alpha-Linolenic acid metabolism	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMG200000376	K10527	ko01100	Metabolic pathways	719	8.0e-34	0.75	0.86	0.99
PGSC0003DMG200000376	K10527	ko00592	alpha-Linolenic acid metabolism	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMG200000376	K10527	ko01100	Metabolic pathways	4418	7.7e-238	0.73	0.87	1.00
PGSC0003DMG200047231	K10591	ko04120	Ubiquitin mediated proteolysis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMG200047231	K10591	ko04144	Endocytosis	307	2.2e-10	0.31	0.48	0.78
PGSC0003DMG200047233	K02183	ko04020	Calcium signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04070	Phosphatidylinositol signaling system	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04114	Oocyte meiosis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04270	Vascular smooth muscle contraction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04626	Plant-pathogen interaction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04720	Long-term potentiation	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04722	Neurotrophin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04740	Olfactory transduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04744	Phototransduction	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04745	Phototransduction - fly	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04910	Insulin signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04912	GnRH signaling pathway	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04916	Melanogenesis	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04970	Salivary secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko04971	Gastric acid secretion	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko05010	Alzheimer's disease	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047233	K02183	ko05214	Glioma	1011	6.3e-50	0.77	0.87	0.71
PGSC0003DMG200047254	K12132	ko04712	Circadian rhythm - plant	1051	3.9e-52	0.51	0.67	0.77
PGSC0003DMG200008852	K00620	ko00330	Arginine and proline metabolism	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMG200008852	K00620	ko01100	Metabolic pathways	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMG200008852	K00620	ko01110	Biosynthesis of secondary metabolites	3043	5.3e-162	0.80	0.88	1.00
PGSC0003DMG200008857	K12611	ko03018	RNA degradation	452	4.3e-19	0.34	0.55	0.90
PGSC0003DMG200008857	K12611	ko03018	RNA degradation	543	4.1e-24	0.29	0.49	0.94
PGSC0003DMG200008857	K12611	ko03018	RNA degradation	526	3.5e-23	0.30	0.49	0.87
PGSC0003DMG200008857	K12611	ko03018	RNA degradation	281	1.2e-09	0.28	0.45	0.90
PGSC0003DMG200008857	K05746	ko04810	Regulation of actin cytoskeleton	237	1.7e-06	0.36	0.45	0.63
PGSC0003DMG200008860	K12733	ko03040	Spliceosome	1300	7.2e-66	0.90	0.96	0.99
PGSC0003DMG200016408	K00558	ko00270	Cysteine and methionine metabolism	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMG200016408	K00558	ko01100	Metabolic pathways	353	1.8e-12	0.48	0.66	0.24
PGSC0003DMG200016411	K01252	ko01053	Biosynthesis of siderophore group nonribosomal peptides	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMG200016411	K01252	ko01110	Biosynthesis of secondary metabolites	387	1.6e-15	0.39	0.55	0.79
PGSC0003DMG200001702	K10742	ko03030	DNA replication	4201	7.1e-226	0.70	0.82	0.98
PGSC0003DMG200001702	K10742	ko03030	DNA replication	3430	2.4e-183	0.68	0.81	1.00
PGSC0003DMG200001708	K10601	ko04120	Ubiquitin mediated proteolysis	233	1.4e-06	0.38	0.59	0.46
PGSC0003DMG200001709	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMG200001709	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMG200001709	K00945	ko00240	Pyrimidine metabolism	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMG200001709	K00945	ko01100	Metabolic pathways	1399	2.5e-71	0.84	0.91	0.94
PGSC0003DMG200001711	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMG200001711	K03861	ko01100	Metabolic pathways	706	4.2e-33	0.53	0.66	0.94
PGSC0003DMG200001714	K01528	ko04144	Endocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMG200001714	K01528	ko04666	Fc gamma R-mediated phagocytosis	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMG200001714	K01528	ko05100	Bacterial invasion of epithelial cells	1416	1.5e-78	0.37	0.56	0.98
PGSC0003DMG200001720	K03849	ko00510	N-Glycan biosynthesis	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMG200001720	K03849	ko01100	Metabolic pathways	2699	5.0e-143	0.69	0.81	0.51
PGSC0003DMG200012259	K03031	ko03050	Proteasome	1854	2.0e-96	0.82	0.90	1.00
PGSC0003DMG200012259	K03031	ko03050	Proteasome	1867	3.9e-97	0.83	0.91	1.00
PGSC0003DMG200012262	K09458	ko00061	Fatty acid biosynthesis	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMG200012262	K09458	ko01100	Metabolic pathways	2754	4.6e-146	0.76	0.88	0.99
PGSC0003DMG200012262	K09458	ko00061	Fatty acid biosynthesis	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMG200012262	K09458	ko01100	Metabolic pathways	2785	9.0e-148	0.72	0.84	0.95
PGSC0003DMG200035390	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMG200035390	K00517	ko00626	Naphthalene and anthracene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMG200035390	K00517	ko00903	Limonene and pinene degradation	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMG200035390	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMG200035390	K00517	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.61	0.95
PGSC0003DMG200026936	K08488	ko04130	SNARE interactions in vesicular transport	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMG200026936	K08488	ko04145	Phagosome	759	1.5e-38	0.54	0.76	0.73
PGSC0003DMG200026937	K13056	ko04114	Oocyte meiosis	259	1.9e-08	0.29	0.43	0.60
PGSC0003DMG200026937	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMG200026937	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.29	0.42	0.69
PGSC0003DMG200026939	K00071	ko00140	Steroid hormone biosynthesis	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMG200026939	K00071	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMG200026939	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1042	1.2e-51	0.49	0.67	0.81
PGSC0003DMG200026940	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	411	3.2e-16	0.30	0.44	0.98
PGSC0003DMG200026943	K00162	ko00010	Glycolysis / Gluconeogenesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko00020	Citrate cycle (TCA cycle)	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko00620	Pyruvate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko00650	Butanoate metabolism	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko01100	Metabolic pathways	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200026943	K00162	ko01110	Biosynthesis of secondary metabolites	2561	2.0e-135	0.84	0.87	0.97
PGSC0003DMG200019718	K00308	ko04146	Peroxisome	288	1.2e-09	0.45	0.66	0.66
PGSC0003DMG200019720	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMG200019720	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMG200019720	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMG200019720	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMG200019720	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.60	0.84
PGSC0003DMG200019721	K04733	ko04210	Apoptosis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMG200019721	K04733	ko04620	Toll-like receptor signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMG200019721	K04733	ko04722	Neurotrophin signaling pathway	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMG200019721	K04733	ko05140	Leishmaniasis	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMG200019721	K04733	ko05142	Chagas disease	641	1.6e-29	0.35	0.56	0.83
PGSC0003DMG200019724	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200019724	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200019724	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200019724	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200019725	K04733	ko04210	Apoptosis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMG200019725	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMG200019725	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMG200019725	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMG200019725	K04733	ko05142	Chagas disease	539	1.3e-23	0.40	0.61	0.40
PGSC0003DMG200019726	K04733	ko04210	Apoptosis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMG200019726	K04733	ko04620	Toll-like receptor signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMG200019726	K04733	ko04722	Neurotrophin signaling pathway	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMG200019726	K04733	ko05140	Leishmaniasis	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMG200019726	K04733	ko05142	Chagas disease	656	2.4e-30	0.35	0.58	0.51
PGSC0003DMG200019728	K00799	ko00480	Glutathione metabolism	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMG200019728	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMG200019728	K00799	ko00982	Drug metabolism - cytochrome P450	846	7.9e-41	0.68	0.82	0.99
PGSC0003DMG200019729	K12864	ko03040	Spliceosome	3476	6.9e-186	0.78	0.88	1.00
PGSC0003DMG200019729	K12864	ko03040	Spliceosome	2287	2.6e-120	0.72	0.80	0.99
PGSC0003DMG200030386	K02866	ko03010	Ribosome	1779	2.8e-92	0.93	0.97	0.99
PGSC0003DMG200030390	K08008	ko04145	Phagosome	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMG200030390	K08008	ko04670	Leukocyte transendothelial migration	1132	1.3e-56	0.33	0.50	0.68
PGSC0003DMG200030394	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.48	0.65	0.99
PGSC0003DMG200030395	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.98	0.99
PGSC0003DMG200030398	K03946	ko00190	Oxidative phosphorylation	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMG200030398	K03946	ko01100	Metabolic pathways	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMG200030398	K03946	ko05010	Alzheimer's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMG200030398	K03946	ko05012	Parkinson's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMG200030398	K03946	ko05016	Huntington's disease	624	1.4e-28	0.78	0.87	0.98
PGSC0003DMG200030399	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200030400	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200030401	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200030402	K11254	ko05322	Systemic lupus erythematosus	513	1.8e-22	1.00	1.00	0.94
PGSC0003DMG200030405	K03283	ko03040	Spliceosome	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMG200030405	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMG200030405	K03283	ko04144	Endocytosis	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMG200030405	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.95	0.97	1.00
PGSC0003DMG200030407	K08332	ko04140	Regulation of autophagy	310	5.5e-11	0.30	0.52	0.77
PGSC0003DMG200030407	K08332	ko04140	Regulation of autophagy	310	1.4e-08	0.30	0.52	0.39
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1780	2.4e-92	0.78	0.88	0.97
PGSC0003DMG200022413	K02183	ko04020	Calcium signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04070	Phosphatidylinositol signaling system	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04114	Oocyte meiosis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04270	Vascular smooth muscle contraction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04626	Plant-pathogen interaction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04720	Long-term potentiation	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04740	Olfactory transduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04744	Phototransduction	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04745	Phototransduction - fly	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04910	Insulin signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04912	GnRH signaling pathway	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04916	Melanogenesis	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04970	Salivary secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04971	Gastric acid secretion	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko05010	Alzheimer's disease	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko05214	Glioma	664	8.7e-31	0.52	0.66	0.99
PGSC0003DMG200022413	K02183	ko04020	Calcium signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04070	Phosphatidylinositol signaling system	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04114	Oocyte meiosis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04270	Vascular smooth muscle contraction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04626	Plant-pathogen interaction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04720	Long-term potentiation	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04722	Neurotrophin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04740	Olfactory transduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04744	Phototransduction	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04745	Phototransduction - fly	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04910	Insulin signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04912	GnRH signaling pathway	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04916	Melanogenesis	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04970	Salivary secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04971	Gastric acid secretion	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko05010	Alzheimer's disease	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko05214	Glioma	3500	3.3e-187	0.69	0.79	1.00
PGSC0003DMG200022413	K02183	ko04020	Calcium signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04070	Phosphatidylinositol signaling system	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04114	Oocyte meiosis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04270	Vascular smooth muscle contraction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04626	Plant-pathogen interaction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04720	Long-term potentiation	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04722	Neurotrophin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04740	Olfactory transduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04744	Phototransduction	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04745	Phototransduction - fly	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04910	Insulin signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04912	GnRH signaling pathway	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04916	Melanogenesis	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04970	Salivary secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko04971	Gastric acid secretion	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko05010	Alzheimer's disease	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200022413	K02183	ko05214	Glioma	914	1.4e-44	0.51	0.65	0.98
PGSC0003DMG200045707	K02893	ko03010	Ribosome	483	8.3e-21	0.84	0.87	0.92
PGSC0003DMG200014029	K10702	ko00642	Ethylbenzene degradation	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMG200014029	K10702	ko01100	Metabolic pathways	237	3.1e-07	0.30	0.47	0.95
PGSC0003DMG200014030	K00951	ko00230	Purine metabolism	1234	3.2e-62	0.40	0.57	0.67
PGSC0003DMG200014030	K00951	ko00230	Purine metabolism	940	5.2e-46	0.43	0.65	0.59
PGSC0003DMG200014030	K00951	ko00230	Purine metabolism	1219	2.1e-61	0.45	0.64	0.61
PGSC0003DMG200014031	K00430	ko00360	Phenylalanine metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMG200014031	K00430	ko00680	Methane metabolism	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMG200014031	K00430	ko00940	Phenylpropanoid biosynthesis	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMG200014031	K00430	ko01100	Metabolic pathways	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMG200014031	K00430	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.67	0.80	0.97
PGSC0003DMG200014031	K00430	ko00360	Phenylalanine metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00680	Methane metabolism	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00940	Phenylpropanoid biosynthesis	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01100	Metabolic pathways	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01110	Biosynthesis of secondary metabolites	1690	2.2e-87	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00360	Phenylalanine metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00680	Methane metabolism	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01100	Metabolic pathways	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00360	Phenylalanine metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00680	Methane metabolism	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko00940	Phenylpropanoid biosynthesis	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMG200014031	K00430	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.66	0.80	0.97
PGSC0003DMG200014032	K03217	ko03060	Protein export	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMG200014032	K03217	ko03070	Bacterial secretion system	374	8.6e-15	0.28	0.45	0.53
PGSC0003DMG200014038	K05849	ko04020	Calcium signaling pathway	323	2.2e-11	0.34	0.52	0.65
PGSC0003DMG200003300	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMG200003300	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMG200003300	K12366	ko05131	Shigellosis	247	2.9e-07	0.27	0.51	0.88
PGSC0003DMG200003302	K12885	ko03040	Spliceosome	434	4.2e-18	0.33	0.42	0.87
PGSC0003DMG200003304	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMG200003304	K00517	ko00626	Naphthalene and anthracene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMG200003304	K00517	ko00903	Limonene and pinene degradation	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMG200003304	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMG200003304	K00517	ko01110	Biosynthesis of secondary metabolites	1249	4.7e-63	0.42	0.62	0.99
PGSC0003DMG200003305	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMG200003305	K00517	ko00626	Naphthalene and anthracene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMG200003305	K00517	ko00903	Limonene and pinene degradation	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMG200003305	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMG200003305	K00517	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.45	0.62	0.96
PGSC0003DMG200003305	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMG200003305	K00517	ko00626	Naphthalene and anthracene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMG200003305	K00517	ko00903	Limonene and pinene degradation	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMG200003305	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMG200003305	K00517	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.41	0.58	0.98
PGSC0003DMG200003306	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMG200003306	K00517	ko00626	Naphthalene and anthracene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMG200003306	K00517	ko00903	Limonene and pinene degradation	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMG200003306	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMG200003306	K00517	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.40	0.60	0.88
PGSC0003DMG200003307	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMG200003307	K00517	ko00626	Naphthalene and anthracene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMG200003307	K00517	ko00903	Limonene and pinene degradation	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMG200003307	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMG200003307	K00517	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.47	0.67	0.89
PGSC0003DMG200003308	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMG200003308	K00517	ko00626	Naphthalene and anthracene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMG200003308	K00517	ko00903	Limonene and pinene degradation	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMG200003308	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMG200003308	K00517	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.42	0.62	0.98
PGSC0003DMG200003308	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMG200003308	K00517	ko00626	Naphthalene and anthracene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMG200003308	K00517	ko00903	Limonene and pinene degradation	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMG200003308	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMG200003308	K00517	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.51	0.75	0.97
PGSC0003DMG200009887	K01115	ko00564	Glycerophospholipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko00565	Ether lipid metabolism	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko01100	Metabolic pathways	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko04144	Endocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko04666	Fc gamma R-mediated phagocytosis	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko04912	GnRH signaling pathway	971	1.0e-47	0.46	0.66	0.99
PGSC0003DMG200009887	K01115	ko00564	Glycerophospholipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko00565	Ether lipid metabolism	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko01100	Metabolic pathways	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko04144	Endocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko04666	Fc gamma R-mediated phagocytosis	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko04912	GnRH signaling pathway	3735	3.6e-200	0.58	0.72	0.96
PGSC0003DMG200009887	K01115	ko00564	Glycerophospholipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009887	K01115	ko00565	Ether lipid metabolism	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009887	K01115	ko01100	Metabolic pathways	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009887	K01115	ko04144	Endocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009887	K01115	ko04666	Fc gamma R-mediated phagocytosis	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009887	K01115	ko04912	GnRH signaling pathway	431	3.5e-17	0.56	0.70	0.98
PGSC0003DMG200009891	K01176	ko00500	Starch and sucrose metabolism	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMG200009891	K01176	ko01100	Metabolic pathways	1471	2.7e-75	0.48	0.63	0.97
PGSC0003DMG200009891	K01176	ko00500	Starch and sucrose metabolism	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMG200009891	K01176	ko01100	Metabolic pathways	1482	6.6e-76	0.48	0.63	0.95
PGSC0003DMG200009891	K01176	ko00500	Starch and sucrose metabolism	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMG200009891	K01176	ko01100	Metabolic pathways	1106	3.6e-55	0.48	0.63	0.92
PGSC0003DMG200009893	K07466	ko03030	DNA replication	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMG200009893	K07466	ko03420	Nucleotide excision repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMG200009893	K07466	ko03430	Mismatch repair	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMG200009893	K07466	ko03440	Homologous recombination	300	3.0e-10	0.26	0.42	0.95
PGSC0003DMG200009895	K00121	ko00010	Glycolysis / Gluconeogenesis	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00071	Fatty acid metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00350	Tyrosine metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00641	3-Chloroacrylic acid degradation	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00680	Methane metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00830	Retinol metabolism	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko00982	Drug metabolism - cytochrome P450	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko01100	Metabolic pathways	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200009895	K00121	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.76	0.90	0.97
PGSC0003DMG200011150	K06268	ko04010	MAPK signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04020	Calcium signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04114	Oocyte meiosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04210	Apoptosis	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04310	Wnt signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04360	Axon guidance	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04370	VEGF signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04650	Natural killer cell mediated cytotoxicity	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04660	T cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04662	B cell receptor signaling pathway	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko04720	Long-term potentiation	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko05010	Alzheimer's disease	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011150	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	989	1.0e-48	0.84	0.94	0.84
PGSC0003DMG200011156	K07297	ko04920	Adipocytokine signaling pathway	1710	1.8e-88	0.56	0.73	0.99
PGSC0003DMG200011156	K07297	ko04920	Adipocytokine signaling pathway	1087	4.1e-54	0.68	0.81	0.95
PGSC0003DMG200011157	K11424	ko00310	Lysine degradation	1074	2.1e-53	0.38	0.52	0.39
PGSC0003DMG200011157	K04514	ko04062	Chemokine signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04270	Vascular smooth muscle contraction	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04310	Wnt signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04350	TGF-beta signaling pathway	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04360	Axon guidance	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04510	Focal adhesion	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04670	Leukocyte transendothelial migration	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04810	Regulation of actin cytoskeleton	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko05131	Shigellosis	278	7.1e-06	0.26	0.46	0.67
PGSC0003DMG200011157	K04514	ko04062	Chemokine signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04270	Vascular smooth muscle contraction	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04310	Wnt signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04350	TGF-beta signaling pathway	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04360	Axon guidance	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04510	Focal adhesion	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04670	Leukocyte transendothelial migration	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko04810	Regulation of actin cytoskeleton	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko05130	Pathogenic Escherichia coli infection	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K04514	ko05131	Shigellosis	278	7.3e-06	0.26	0.46	0.66
PGSC0003DMG200011157	K11424	ko00310	Lysine degradation	859	1.5e-41	0.51	0.68	0.83
PGSC0003DMG200011157	K11424	ko00310	Lysine degradation	602	2.3e-27	0.52	0.67	0.77
PGSC0003DMG200033116	K10760	ko00908	Zeatin biosynthesis	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMG200033116	K10760	ko01100	Metabolic pathways	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMG200033116	K10760	ko01110	Biosynthesis of secondary metabolites	1253	2.8e-63	0.51	0.69	0.94
PGSC0003DMG200033126	K12524	ko00260	Glycine, serine and threonine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMG200033126	K12524	ko00270	Cysteine and methionine metabolism	5788	0.	0.75	0.86	1.00
PGSC0003DMG200033126	K12524	ko00300	Lysine biosynthesis	5788	0.	0.75	0.86	1.00
PGSC0003DMG200033126	K12524	ko01100	Metabolic pathways	5788	0.	0.75	0.86	1.00
PGSC0003DMG200033126	K12524	ko01110	Biosynthesis of secondary metabolites	5788	0.	0.75	0.86	1.00
PGSC0003DMG200033131	K02084	ko04115	p53 signaling pathway	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko04210	Apoptosis	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko05010	Alzheimer's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko05012	Parkinson's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko05016	Huntington's disease	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033131	K02084	ko05222	Small cell lung cancer	299	4.2e-07	0.28	0.46	0.46
PGSC0003DMG200033133	K03544	ko04112	Cell cycle - Caulobacter	3973	2.7e-213	0.74	0.81	0.98
PGSC0003DMG200033133	K03544	ko04112	Cell cycle - Caulobacter	3866	2.1e-207	0.75	0.82	0.97
PGSC0003DMG200033137	K02936	ko03010	Ribosome	1691	2.0e-87	0.86	0.94	0.92
PGSC0003DMG200033137	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMG200033137	K02936	ko03010	Ribosome	1686	3.7e-87	0.86	0.94	0.92
PGSC0003DMG200033137	K02936	ko03010	Ribosome	405	1.7e-16	0.87	0.98	0.98
PGSC0003DMG200033138	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMG200033138	K02367	ko01100	Metabolic pathways	276	9.6e-09	0.29	0.50	0.80
PGSC0003DMG200027888	K01366	ko04142	Lysosome	581	3.3e-26	0.57	0.69	0.90
PGSC0003DMG200027888	K01366	ko04142	Lysosome	2092	1.5e-109	0.71	0.82	0.99
PGSC0003DMG200027894	K05849	ko04020	Calcium signaling pathway	436	3.1e-15	0.34	0.55	0.18
PGSC0003DMG200014695	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMG200014700	K02875	ko03010	Ribosome	1015	3.8e-50	0.90	0.96	0.99
PGSC0003DMG200014701	K12192	ko04144	Endocytosis	1153	9.3e-58	0.77	0.91	0.95
PGSC0003DMG200014705	K12126	ko04712	Circadian rhythm - plant	745	3.0e-35	0.37	0.49	0.77
PGSC0003DMG200014705	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.72
PGSC0003DMG200014705	K12126	ko04712	Circadian rhythm - plant	759	5.0e-36	0.37	0.49	0.73
PGSC0003DMG200014707	K11816	ko00380	Tryptophan metabolism	2517	5.4e-133	0.72	0.86	0.97
PGSC0003DMG200014708	K03869	ko04120	Ubiquitin mediated proteolysis	437	6.3e-18	0.33	0.54	0.95
PGSC0003DMG200010460	K04733	ko04210	Apoptosis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMG200010460	K04733	ko04620	Toll-like receptor signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMG200010460	K04733	ko04722	Neurotrophin signaling pathway	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMG200010460	K04733	ko05140	Leishmaniasis	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMG200010460	K04733	ko05142	Chagas disease	580	5.0e-26	0.44	0.64	0.83
PGSC0003DMG200010465	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMG200010465	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMG200010465	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMG200010465	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMG200010465	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.94
PGSC0003DMG200010465	K00430	ko00360	Phenylalanine metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMG200010465	K00430	ko00680	Methane metabolism	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMG200010465	K00430	ko00940	Phenylpropanoid biosynthesis	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMG200010465	K00430	ko01100	Metabolic pathways	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMG200010465	K00430	ko01110	Biosynthesis of secondary metabolites	1823	1.0e-94	0.69	0.86	0.89
PGSC0003DMG200044500	K01213	ko00040	Pentose and glucuronate interconversions	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMG200044500	K01213	ko00500	Starch and sucrose metabolism	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMG200044500	K01213	ko01100	Metabolic pathways	874	2.3e-42	0.37	0.53	0.99
PGSC0003DMG200044519	K02893	ko03010	Ribosome	1066	5.8e-53	0.85	0.90	0.99
PGSC0003DMG200031399	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMG200031399	K12448	ko01100	Metabolic pathways	873	2.6e-42	0.89	0.96	0.95
PGSC0003DMG200031404	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMG200031404	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.31	0.49	0.79
PGSC0003DMG200031405	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko04210	Apoptosis	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko05016	Huntington's disease	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.26	0.44	0.46
PGSC0003DMG200031405	K02084	ko04115	p53 signaling pathway	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko04210	Apoptosis	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko05010	Alzheimer's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko05012	Parkinson's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko05016	Huntington's disease	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031405	K02084	ko05222	Small cell lung cancer	302	3.6e-07	0.27	0.44	0.48
PGSC0003DMG200031420	K00279	ko00908	Zeatin biosynthesis	453	3.8e-19	0.58	0.74	0.96
PGSC0003DMG200031420	K00279	ko00908	Zeatin biosynthesis	1140	4.8e-57	0.61	0.72	0.95
PGSC0003DMG200031420	K00279	ko00908	Zeatin biosynthesis	2560	2.3e-135	0.60	0.74	0.99
PGSC0003DMG200031421	K00279	ko00908	Zeatin biosynthesis	2652	1.9e-140	0.62	0.77	0.92
PGSC0003DMG200031423	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMG200031423	K00517	ko00626	Naphthalene and anthracene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMG200031423	K00517	ko00903	Limonene and pinene degradation	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMG200031423	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMG200031423	K00517	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.49	0.67	0.99
PGSC0003DMG200031423	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMG200031423	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMG200031423	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMG200031423	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMG200031423	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.47	0.64	0.97
PGSC0003DMG200027269	K00889	ko00562	Inositol phosphate metabolism	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027269	K00889	ko01100	Metabolic pathways	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027269	K00889	ko04070	Phosphatidylinositol signaling system	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027269	K00889	ko04144	Endocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027269	K00889	ko04666	Fc gamma R-mediated phagocytosis	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027269	K00889	ko04810	Regulation of actin cytoskeleton	3737	2.8e-200	0.62	0.72	0.97
PGSC0003DMG200027271	K05279	ko00944	Flavone and flavonol biosynthesis	1066	5.8e-53	0.51	0.70	0.99
PGSC0003DMG200027271	K13066	ko00940	Phenylpropanoid biosynthesis	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMG200027271	K13066	ko01110	Biosynthesis of secondary metabolites	1471	2.7e-75	0.53	0.69	0.99
PGSC0003DMG200027276	K03403	ko00860	Porphyrin and chlorophyll metabolism	9108	0.	0.85	0.93	0.91
PGSC0003DMG200027276	K03403	ko01100	Metabolic pathways	9108	0.	0.85	0.93	0.91
PGSC0003DMG200027276	K03403	ko01110	Biosynthesis of secondary metabolites	9108	0.	0.85	0.93	0.91
PGSC0003DMG200027279	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMG200027279	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMG200027279	K09756	ko00940	Phenylpropanoid biosynthesis	1094	1.7e-54	0.45	0.69	0.89
PGSC0003DMG200027279	K09756	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.52	0.73	0.87
PGSC0003DMG200027279	K13289	ko04142	Lysosome	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMG200027279	K13289	ko04614	Renin-angiotensin system	429	7.9e-18	0.44	0.69	0.88
PGSC0003DMG200018413	K01510	ko00230	Purine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMG200018413	K01510	ko00240	Pyrimidine metabolism	647	7.5e-30	0.33	0.51	0.87
PGSC0003DMG200018413	K01510	ko00230	Purine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMG200018413	K01510	ko00240	Pyrimidine metabolism	818	2.8e-39	0.32	0.49	0.92
PGSC0003DMG200018416	K13030	ko00460	Cyanoamino acid metabolism	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMG200018416	K13030	ko01110	Biosynthesis of secondary metabolites	293	3.0e-10	0.34	0.51	0.97
PGSC0003DMG200018417	K13030	ko00460	Cyanoamino acid metabolism	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMG200018417	K13030	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.38	0.60	0.98
PGSC0003DMG200018424	K08243	ko00941	Flavonoid biosynthesis	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMG200018424	K08243	ko01110	Biosynthesis of secondary metabolites	224	1.6e-06	0.47	0.67	0.92
PGSC0003DMG200018424	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.98
PGSC0003DMG200018424	K08243	ko00941	Flavonoid biosynthesis	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMG200018424	K08243	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.50	0.68	0.98
PGSC0003DMG200018425	K02881	ko03010	Ribosome	289	4.2e-10	0.43	0.61	0.60
PGSC0003DMG200018425	K02881	ko03010	Ribosome	352	1.4e-13	0.39	0.54	0.85
PGSC0003DMG200028528	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.57
PGSC0003DMG200028529	K01507	ko00190	Oxidative phosphorylation	2272	1.8e-119	0.96	0.99	1.00
PGSC0003DMG200028529	K01507	ko00190	Oxidative phosphorylation	228	5.0e-06	0.64	0.87	0.68
PGSC0003DMG200028531	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMG200028531	K01563	ko00626	Naphthalene and anthracene degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMG200028531	K01563	ko00631	1,2-Dichloroethane degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMG200028531	K01563	ko00641	3-Chloroacrylic acid degradation	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMG200028531	K01563	ko01100	Metabolic pathways	754	9.4e-36	0.40	0.55	0.71
PGSC0003DMG200028533	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	271	2.3e-08	0.34	0.45	0.97
PGSC0003DMG200028533	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	340	4.4e-12	0.29	0.45	0.91
PGSC0003DMG200028539	K01115	ko00564	Glycerophospholipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko00565	Ether lipid metabolism	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko01100	Metabolic pathways	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko04144	Endocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko04666	Fc gamma R-mediated phagocytosis	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko04912	GnRH signaling pathway	938	6.7e-46	0.83	0.90	0.99
PGSC0003DMG200028539	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMG200000093	K04427	ko04010	MAPK signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04310	Wnt signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04520	Adherens junction	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04620	Toll-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04621	NOD-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04622	RIG-I-like receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko04660	T cell receptor signaling pathway	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000093	K04427	ko05140	Leishmaniasis	492	2.7e-21	0.28	0.46	0.66
PGSC0003DMG200000103	K12356	ko00940	Phenylpropanoid biosynthesis	690	3.2e-32	0.31	0.50	0.94
PGSC0003DMG200009472	K01834	ko00010	Glycolysis / Gluconeogenesis	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMG200009472	K01834	ko01100	Metabolic pathways	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMG200009472	K01834	ko01110	Biosynthesis of secondary metabolites	2130	1.2e-111	0.76	0.86	0.99
PGSC0003DMG200009472	K01834	ko00010	Glycolysis / Gluconeogenesis	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMG200009472	K01834	ko01100	Metabolic pathways	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMG200009472	K01834	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.77	0.87	0.99
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1032	1.5e-56	0.69	0.83	0.91
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1317	8.4e-67	0.75	0.85	0.95
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1541	3.7e-79	0.71	0.81	0.96
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	1893	1.4e-98	0.68	0.80	0.99
PGSC0003DMG200009473	K06634	ko03420	Nucleotide excision repair	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMG200009473	K06634	ko04110	Cell cycle	312	2.3e-11	0.63	0.75	0.92
PGSC0003DMG200009477	K01087	ko00500	Starch and sucrose metabolism	1865	5.0e-97	0.73	0.84	0.82
PGSC0003DMG200015681	K01768	ko00230	Purine metabolism	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMG200015681	K01768	ko04113	Meiosis - yeast	311	2.1e-07	0.27	0.45	0.33
PGSC0003DMG200015684	K12881	ko03040	Spliceosome	1485	4.5e-76	0.68	0.79	1.00
PGSC0003DMG200015684	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMG200015684	K12881	ko03040	Spliceosome	355	9.6e-14	0.65	0.75	0.93
PGSC0003DMG200015684	K12881	ko03040	Spliceosome	814	4.6e-39	0.65	0.78	0.99
PGSC0003DMG200015684	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMG200012934	K01213	ko00040	Pentose and glucuronate interconversions	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMG200012934	K01213	ko00500	Starch and sucrose metabolism	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMG200012934	K01213	ko01100	Metabolic pathways	443	1.3e-18	0.28	0.45	0.69
PGSC0003DMG200012939	K12815	ko03040	Spliceosome	415	4.4e-16	0.27	0.45	0.93
PGSC0003DMG200012940	K01199	ko00500	Starch and sucrose metabolism	769	1.4e-36	0.35	0.55	0.70
PGSC0003DMG200012940	K01199	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.38	0.58	0.53
PGSC0003DMG200012941	K00889	ko00562	Inositol phosphate metabolism	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200012941	K00889	ko01100	Metabolic pathways	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200012941	K00889	ko04070	Phosphatidylinositol signaling system	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200012941	K00889	ko04144	Endocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200012941	K00889	ko04666	Fc gamma R-mediated phagocytosis	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200012941	K00889	ko04810	Regulation of actin cytoskeleton	4596	1.2e-247	0.69	0.80	1.00
PGSC0003DMG200002397	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMG200002398	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko01100	Metabolic pathways	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko01110	Biosynthesis of secondary metabolites	1804	1.2e-93	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko01100	Metabolic pathways	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.68	0.81	0.99
PGSC0003DMG200002398	K05928	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMG200002398	K05928	ko01100	Metabolic pathways	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMG200002398	K05928	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.77	0.86	0.99
PGSC0003DMG200002401	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMG200002401	K00517	ko00626	Naphthalene and anthracene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMG200002401	K00517	ko00903	Limonene and pinene degradation	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMG200002401	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMG200002401	K00517	ko01110	Biosynthesis of secondary metabolites	1103	5.3e-55	0.36	0.54	1.00
PGSC0003DMG200002405	K02866	ko03010	Ribosome	1450	3.9e-74	0.92	0.95	0.99
PGSC0003DMG200002408	K03063	ko03050	Proteasome	2698	5.7e-143	0.98	0.99	1.00
PGSC0003DMG200002409	K03063	ko03050	Proteasome	366	2.4e-14	0.67	0.79	0.99
PGSC0003DMG200004975	K01598	ko00770	Pantothenate and CoA biosynthesis	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMG200004975	K01598	ko01100	Metabolic pathways	1261	1.0e-63	0.73	0.86	0.95
PGSC0003DMG200004977	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMG200004977	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMG200004977	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.98
PGSC0003DMG200004977	K00799	ko00480	Glutathione metabolism	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMG200004977	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMG200004977	K00799	ko00982	Drug metabolism - cytochrome P450	535	1.1e-23	0.44	0.63	0.75
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	1164	2.3e-58	0.78	0.90	0.99
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	1187	1.2e-59	0.80	0.89	0.99
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	1209	7.6e-61	0.83	0.90	0.99
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	1271	2.9e-64	0.86	0.94	0.99
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	989	1.0e-48	0.90	0.97	0.98
PGSC0003DMG200004978	K00432	ko00480	Glutathione metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMG200004978	K00432	ko00590	Arachidonic acid metabolism	1169	1.2e-58	0.79	0.90	0.99
PGSC0003DMG200040479	K10760	ko00908	Zeatin biosynthesis	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMG200040479	K10760	ko01100	Metabolic pathways	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMG200040479	K10760	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.48	0.67	0.97
PGSC0003DMG200001014	K02112	ko00190	Oxidative phosphorylation	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMG200001014	K02112	ko00195	Photosynthesis	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMG200001014	K02112	ko01100	Metabolic pathways	2527	1.5e-133	0.80	0.84	0.97
PGSC0003DMG200001015	K01112	ko00051	Fructose and mannose metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMG200001015	K01112	ko00730	Thiamine metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMG200001015	K01112	ko00740	Riboflavin metabolism	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMG200001015	K01112	ko01100	Metabolic pathways	328	3.0e-12	0.32	0.45	0.93
PGSC0003DMG200001015	K01112	ko00051	Fructose and mannose metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMG200001015	K01112	ko00730	Thiamine metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMG200001015	K01112	ko00740	Riboflavin metabolism	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMG200001015	K01112	ko01100	Metabolic pathways	308	3.7e-11	0.37	0.53	0.89
PGSC0003DMG200001028	K05746	ko04810	Regulation of actin cytoskeleton	371	4.1e-14	0.36	0.42	0.55
PGSC0003DMG200001035	K00600	ko00260	Glycine, serine and threonine metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200001035	K00600	ko00460	Cyanoamino acid metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200001035	K00600	ko00670	One carbon pool by folate	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200001035	K00600	ko00680	Methane metabolism	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200001035	K00600	ko01100	Metabolic pathways	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200001035	K00600	ko01110	Biosynthesis of secondary metabolites	1280	9.2e-65	0.77	0.86	0.95
PGSC0003DMG200036579	K03122	ko03022	Basal transcription factors	321	7.2e-12	0.31	0.55	0.84
PGSC0003DMG200026246	K00030	ko00020	Citrate cycle (TCA cycle)	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMG200026246	K00030	ko01100	Metabolic pathways	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMG200026246	K00030	ko01110	Biosynthesis of secondary metabolites	2576	3.0e-136	0.83	0.89	1.00
PGSC0003DMG200026247	K11419	ko00310	Lysine degradation	655	6.0e-30	0.39	0.54	0.25
PGSC0003DMG200026251	K02214	ko04110	Cell cycle	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMG200026251	K02214	ko04111	Cell cycle - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMG200026251	K02214	ko04113	Meiosis - yeast	445	1.0e-18	0.54	0.70	0.95
PGSC0003DMG200026251	K02214	ko04110	Cell cycle	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMG200026251	K02214	ko04111	Cell cycle - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMG200026251	K02214	ko04113	Meiosis - yeast	1972	6.2e-103	0.38	0.56	0.90
PGSC0003DMG200026251	K02214	ko04110	Cell cycle	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMG200026251	K02214	ko04111	Cell cycle - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMG200026251	K02214	ko04113	Meiosis - yeast	2958	2.6e-157	0.43	0.60	0.96
PGSC0003DMG200026252	K06096	ko04530	Tight junction	297	1.5e-10	0.34	0.51	0.81
PGSC0003DMG200026253	K02884	ko03010	Ribosome	380	4.0e-15	0.43	0.68	0.50
PGSC0003DMG200029675	K03364	ko04110	Cell cycle	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMG200029675	K03364	ko04111	Cell cycle - yeast	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMG200029675	K03364	ko04120	Ubiquitin mediated proteolysis	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMG200029675	K03364	ko04914	Progesterone-mediated oocyte maturation	2886	2.4e-153	0.69	0.80	0.98
PGSC0003DMG200029675	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04110	Cell cycle	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04111	Cell cycle - yeast	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04120	Ubiquitin mediated proteolysis	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029675	K03364	ko04914	Progesterone-mediated oocyte maturation	2643	6.1e-140	0.69	0.80	0.97
PGSC0003DMG200029676	K05350	ko00460	Cyanoamino acid metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMG200029676	K05350	ko00500	Starch and sucrose metabolism	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMG200029676	K05350	ko00940	Phenylpropanoid biosynthesis	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMG200029676	K05350	ko01110	Biosynthesis of secondary metabolites	2218	1.7e-116	0.64	0.77	0.99
PGSC0003DMG200029676	K05350	ko00460	Cyanoamino acid metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMG200029676	K05350	ko00500	Starch and sucrose metabolism	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMG200029676	K05350	ko00940	Phenylpropanoid biosynthesis	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMG200029676	K05350	ko01110	Biosynthesis of secondary metabolites	2678	7.2e-142	0.63	0.76	0.98
PGSC0003DMG200029680	K10591	ko04120	Ubiquitin mediated proteolysis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMG200029680	K10591	ko04144	Endocytosis	1006	1.2e-49	0.58	0.74	0.99
PGSC0003DMG200029682	K12397	ko04142	Lysosome	3043	5.3e-162	0.60	0.75	1.00
PGSC0003DMG200029682	K12397	ko04142	Lysosome	6116	0.	0.67	0.79	1.00
PGSC0003DMG200029682	K12397	ko04142	Lysosome	1204	1.4e-60	0.66	0.77	0.98
PGSC0003DMG200029682	K12397	ko04142	Lysosome	1599	2.3e-82	0.55	0.73	0.91
PGSC0003DMG200029688	K03127	ko03022	Basal transcription factors	929	2.1e-45	0.86	0.97	0.98
PGSC0003DMG200019011	K01915	ko00250	Alanine, aspartate and glutamate metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMG200019011	K01915	ko00330	Arginine and proline metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMG200019011	K01915	ko00910	Nitrogen metabolism	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMG200019011	K01915	ko01100	Metabolic pathways	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMG200019011	K01915	ko02020	Two-component system	244	2.1e-07	0.36	0.56	0.75
PGSC0003DMG200019017	K12126	ko04712	Circadian rhythm - plant	244	2.9e-07	0.37	0.56	0.35
PGSC0003DMG200019019	K02918	ko03010	Ribosome	566	2.2e-25	0.89	0.95	0.80
PGSC0003DMG200019022	K12828	ko03040	Spliceosome	2880	5.2e-153	0.90	0.94	0.99
PGSC0003DMG200019023	K00901	ko00561	Glycerolipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMG200019023	K00901	ko00564	Glycerophospholipid metabolism	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMG200019023	K00901	ko01100	Metabolic pathways	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMG200019023	K00901	ko04070	Phosphatidylinositol signaling system	939	5.9e-46	0.36	0.53	0.76
PGSC0003DMG200019024	K03014	ko00230	Purine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMG200019024	K03014	ko00240	Pyrimidine metabolism	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMG200019024	K03014	ko01100	Metabolic pathways	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMG200019024	K03014	ko03020	RNA polymerase	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMG200019024	K03014	ko05016	Huntington's disease	242	1.6e-07	0.35	0.52	0.56
PGSC0003DMG200019026	K05391	ko04626	Plant-pathogen interaction	3502	2.6e-187	0.65	0.77	0.92
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.70	0.84	0.99
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.67	0.86	1.00
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.58	0.76	0.99
PGSC0003DMG200021858	K03028	ko03050	Proteasome	2079	7.8e-109	0.73	0.84	0.92
PGSC0003DMG200021858	K03028	ko03050	Proteasome	5725	0.	0.78	0.88	0.99
PGSC0003DMG200021858	K03028	ko03050	Proteasome	3223	6.2e-172	0.81	0.90	0.99
PGSC0003DMG200021858	K03028	ko03050	Proteasome	3400	1.1e-181	0.81	0.91	1.00
PGSC0003DMG200021858	K03028	ko03050	Proteasome	1064	7.5e-53	0.79	0.85	0.94
PGSC0003DMG200021860	K05863	ko04020	Calcium signaling pathway	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMG200021860	K05863	ko05012	Parkinson's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMG200021860	K05863	ko05016	Huntington's disease	346	3.0e-13	0.91	0.91	0.90
PGSC0003DMG200021861	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko04115	p53 signaling pathway	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko04210	Apoptosis	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05010	Alzheimer's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05012	Parkinson's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05016	Huntington's disease	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021861	K02084	ko05222	Small cell lung cancer	306	2.0e-07	0.27	0.43	0.50
PGSC0003DMG200021865	K07466	ko03030	DNA replication	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMG200021865	K07466	ko03420	Nucleotide excision repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMG200021865	K07466	ko03430	Mismatch repair	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMG200021865	K07466	ko03440	Homologous recombination	781	3.1e-37	0.69	0.76	0.94
PGSC0003DMG200021866	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00270	Cysteine and methionine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00350	Tyrosine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00360	Phenylalanine metabolism	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00401	Novobiocin biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko01100	Metabolic pathways	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.51	0.66	0.99
PGSC0003DMG200021866	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00270	Cysteine and methionine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00350	Tyrosine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00360	Phenylalanine metabolism	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00401	Novobiocin biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko01100	Metabolic pathways	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021866	K00815	ko01110	Biosynthesis of secondary metabolites	2277	9.4e-120	0.63	0.81	0.99
PGSC0003DMG200021868	K12929	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMG200021868	K12929	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.41	0.63	0.99
PGSC0003DMG200021870	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMG200021870	K00517	ko00626	Naphthalene and anthracene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMG200021870	K00517	ko00903	Limonene and pinene degradation	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMG200021870	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMG200021870	K00517	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.57	0.74	0.94
PGSC0003DMG200021871	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMG200021871	K00517	ko00626	Naphthalene and anthracene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMG200021871	K00517	ko00903	Limonene and pinene degradation	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMG200021871	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMG200021871	K00517	ko01110	Biosynthesis of secondary metabolites	253	7.5e-08	0.50	0.71	0.94
PGSC0003DMG200021872	K11818	ko00380	Tryptophan metabolism	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMG200021872	K11818	ko00966	Glucosinolate biosynthesis	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMG200021872	K11818	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.48	0.68	1.00
PGSC0003DMG200021873	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMG200021873	K00517	ko00626	Naphthalene and anthracene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMG200021873	K00517	ko00903	Limonene and pinene degradation	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMG200021873	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMG200021873	K00517	ko01110	Biosynthesis of secondary metabolites	1746	1.8e-90	0.48	0.62	0.99
PGSC0003DMG200021874	K11818	ko00380	Tryptophan metabolism	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMG200021874	K11818	ko00966	Glucosinolate biosynthesis	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMG200021874	K11818	ko01110	Biosynthesis of secondary metabolites	1131	1.5e-56	0.45	0.67	0.94
PGSC0003DMG200021875	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMG200021875	K00517	ko00626	Naphthalene and anthracene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMG200021875	K00517	ko00903	Limonene and pinene degradation	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMG200021875	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMG200021875	K00517	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.36	0.52	0.97
PGSC0003DMG200021875	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMG200021875	K00517	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMG200021875	K00517	ko00903	Limonene and pinene degradation	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMG200021875	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMG200021875	K00517	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.37	0.57	0.96
PGSC0003DMG200030832	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMG200030834	K00434	ko00053	Ascorbate and aldarate metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMG200030834	K00434	ko00480	Glutathione metabolism	1617	2.4e-83	0.70	0.80	0.96
PGSC0003DMG200030834	K00434	ko00053	Ascorbate and aldarate metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMG200030834	K00434	ko00480	Glutathione metabolism	1855	1.8e-96	0.66	0.79	0.99
PGSC0003DMG200030840	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.30	0.48	0.67
PGSC0003DMG200028893	K05666	ko02010	ABC transporters	3169	5.9e-169	0.36	0.56	0.88
PGSC0003DMG200028895	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMG200028895	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMG200028896	K12134	ko04712	Circadian rhythm - plant	468	5.6e-20	0.54	0.68	0.33
PGSC0003DMG200028897	K02294	ko00906	Carotenoid biosynthesis	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMG200028897	K02294	ko01100	Metabolic pathways	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMG200028897	K02294	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.66	0.75	0.91
PGSC0003DMG200028899	K03127	ko03022	Basal transcription factors	501	8.7e-22	0.52	0.67	0.18
PGSC0003DMG200028899	K03127	ko03022	Basal transcription factors	771	1.1e-36	0.73	0.88	0.96
PGSC0003DMG200028904	K12795	ko04621	NOD-like receptor signaling pathway	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMG200028904	K12795	ko04626	Plant-pathogen interaction	920	6.6e-45	0.73	0.86	0.99
PGSC0003DMG200028904	K12795	ko04621	NOD-like receptor signaling pathway	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMG200028904	K12795	ko04626	Plant-pathogen interaction	2134	7.2e-112	0.69	0.81	1.00
PGSC0003DMG200028904	K12795	ko04621	NOD-like receptor signaling pathway	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMG200028904	K12795	ko04626	Plant-pathogen interaction	332	1.8e-12	0.85	0.91	0.77
PGSC0003DMG200028905	K03949	ko00190	Oxidative phosphorylation	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMG200028905	K03949	ko01100	Metabolic pathways	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMG200028905	K03949	ko05010	Alzheimer's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMG200028905	K03949	ko05012	Parkinson's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMG200028905	K03949	ko05016	Huntington's disease	1119	7.0e-56	0.77	0.85	0.99
PGSC0003DMG200006826	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko00906	Carotenoid biosynthesis	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMG200006826	K09842	ko01100	Metabolic pathways	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMG200006826	K09842	ko01110	Biosynthesis of secondary metabolites	4380	9.6e-236	0.61	0.80	0.99
PGSC0003DMG200006826	K09842	ko00906	Carotenoid biosynthesis	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01100	Metabolic pathways	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K09842	ko01110	Biosynthesis of secondary metabolites	2610	4.0e-138	0.63	0.82	0.98
PGSC0003DMG200006826	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMG200006826	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMG200006826	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMG200006826	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMG200006834	K01759	ko00620	Pyruvate metabolism	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMG200006834	K01759	ko04011	MAPK signaling pathway - yeast	242	1.6e-07	0.31	0.51	0.64
PGSC0003DMG200006835	K00658	ko00020	Citrate cycle (TCA cycle)	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMG200006835	K00658	ko00310	Lysine degradation	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMG200006835	K00658	ko01100	Metabolic pathways	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMG200006835	K00658	ko01110	Biosynthesis of secondary metabolites	237	9.8e-07	0.37	0.45	0.70
PGSC0003DMG200003738	K00088	ko00230	Purine metabolism	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMG200003738	K00088	ko00983	Drug metabolism - other enzymes	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMG200003738	K00088	ko01100	Metabolic pathways	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMG200003738	K00088	ko01110	Biosynthesis of secondary metabolites	503	6.6e-22	0.48	0.69	0.68
PGSC0003DMG200003740	K02725	ko03050	Proteasome	1981	2.0e-103	0.85	0.90	1.00
PGSC0003DMG200003741	K00611	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMG200003741	K00611	ko01100	Metabolic pathways	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMG200003741	K00611	ko01110	Biosynthesis of secondary metabolites	2580	1.8e-136	0.81	0.90	1.00
PGSC0003DMG200003741	K00611	ko00330	Arginine and proline metabolism	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMG200003741	K00611	ko01100	Metabolic pathways	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMG200003741	K00611	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.91	0.97	0.99
PGSC0003DMG200003741	K00611	ko00330	Arginine and proline metabolism	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMG200003741	K00611	ko01100	Metabolic pathways	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMG200003741	K00611	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.70	0.83	0.98
PGSC0003DMG200003743	K08241	ko00592	alpha-Linolenic acid metabolism	1558	4.3e-80	0.52	0.66	0.99
PGSC0003DMG200003744	K10610	ko03420	Nucleotide excision repair	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMG200003744	K10610	ko04120	Ubiquitin mediated proteolysis	831	5.3e-40	0.44	0.58	0.95
PGSC0003DMG200003747	K13065	ko00940	Phenylpropanoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMG200003747	K13065	ko00941	Flavonoid biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMG200003747	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMG200003747	K13065	ko01110	Biosynthesis of secondary metabolites	639	2.1e-29	0.31	0.49	0.91
PGSC0003DMG200010832	K00680	ko00350	Tyrosine metabolism	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMG200010832	K00680	ko00624	1- and 2-Methylnaphthalene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMG200010832	K00680	ko00632	Benzoate degradation via CoA ligation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMG200010832	K00680	ko00642	Ethylbenzene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMG200010832	K00680	ko00903	Limonene and pinene degradation	266	7.8e-09	0.35	0.58	0.39
PGSC0003DMG200010835	K00600	ko00260	Glycine, serine and threonine metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010835	K00600	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010835	K00600	ko00670	One carbon pool by folate	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010835	K00600	ko00680	Methane metabolism	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010835	K00600	ko01100	Metabolic pathways	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010835	K00600	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.41	0.55	0.31
PGSC0003DMG200010836	K11090	ko05322	Systemic lupus erythematosus	2332	8.7e-123	0.62	0.78	0.99
PGSC0003DMG200010839	K01590	ko00340	Histidine metabolism	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMG200010839	K01590	ko01100	Metabolic pathways	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMG200010839	K01590	ko01110	Biosynthesis of secondary metabolites	2052	2.4e-107	0.66	0.83	0.86
PGSC0003DMG200010839	K01590	ko00340	Histidine metabolism	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMG200010839	K01590	ko01100	Metabolic pathways	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMG200010839	K01590	ko01110	Biosynthesis of secondary metabolites	1187	1.2e-59	0.67	0.83	0.62
PGSC0003DMG200010840	K00813	ko00250	Alanine, aspartate and glutamate metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00270	Cysteine and methionine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00330	Arginine and proline metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00350	Tyrosine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00360	Phenylalanine metabolism	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00401	Novobiocin biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00710	Carbon fixation in photosynthetic organisms	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00950	Isoquinoline alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko01100	Metabolic pathways	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.93	0.97	0.98
PGSC0003DMG200010840	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00270	Cysteine and methionine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00330	Arginine and proline metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00350	Tyrosine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00360	Phenylalanine metabolism	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00401	Novobiocin biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00710	Carbon fixation in photosynthetic organisms	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko01100	Metabolic pathways	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200010840	K00813	ko01110	Biosynthesis of secondary metabolites	3187	6.0e-170	0.85	0.91	0.98
PGSC0003DMG200022657	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.30	0.48	0.99
PGSC0003DMG200026524	K12836	ko03040	Spliceosome	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMG200026524	K12836	ko05131	Shigellosis	2079	7.8e-109	0.71	0.78	1.00
PGSC0003DMG200026524	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMG200026524	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMG200026524	K12836	ko03040	Spliceosome	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMG200026524	K12836	ko05131	Shigellosis	2132	9.3e-112	0.76	0.83	1.00
PGSC0003DMG200026526	K08488	ko04130	SNARE interactions in vesicular transport	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMG200026526	K08488	ko04145	Phagosome	1542	3.2e-79	0.75	0.87	0.84
PGSC0003DMG200026529	K06067	ko04110	Cell cycle	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMG200026529	K06067	ko04330	Notch signaling pathway	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMG200026529	K06067	ko05016	Huntington's disease	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMG200026529	K06067	ko05200	Pathways in cancer	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMG200026529	K06067	ko05220	Chronic myeloid leukemia	3118	3.9e-166	0.83	0.90	0.99
PGSC0003DMG200026529	K06067	ko04110	Cell cycle	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMG200026529	K06067	ko04330	Notch signaling pathway	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMG200026529	K06067	ko05016	Huntington's disease	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMG200026529	K06067	ko05200	Pathways in cancer	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMG200026529	K06067	ko05220	Chronic myeloid leukemia	3461	4.7e-185	0.90	0.97	1.00
PGSC0003DMG200026530	K01193	ko00052	Galactose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMG200026530	K01193	ko00500	Starch and sucrose metabolism	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMG200026530	K01193	ko01100	Metabolic pathways	1067	5.1e-53	0.36	0.54	0.71
PGSC0003DMG200026530	K01193	ko00052	Galactose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMG200026530	K01193	ko00500	Starch and sucrose metabolism	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMG200026530	K01193	ko01100	Metabolic pathways	413	6.1e-17	0.37	0.56	0.83
PGSC0003DMG200026536	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMG200026536	K04518	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.81	0.70
PGSC0003DMG200037250	K00789	ko00270	Cysteine and methionine metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMG200037250	K00789	ko00450	Selenoamino acid metabolism	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMG200037250	K00789	ko01100	Metabolic pathways	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMG200037250	K00789	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.95	0.97	1.00
PGSC0003DMG200037265	K03094	ko04110	Cell cycle	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04111	Cell cycle - yeast	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04114	Oocyte meiosis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04310	Wnt signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04350	TGF-beta signaling pathway	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200037265	K03094	ko04710	Circadian rhythm - mammal	680	1.1e-31	0.57	0.72	0.99
PGSC0003DMG200034597	K00128	ko00010	Glycolysis / Gluconeogenesis	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00053	Ascorbate and aldarate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00071	Fatty acid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00280	Valine, leucine and isoleucine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00310	Lysine degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00330	Arginine and proline metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00340	Histidine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00380	Tryptophan metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00410	beta-Alanine metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00561	Glycerolipid metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00620	Pyruvate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00631	1,2-Dichloroethane degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00640	Propanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00641	3-Chloroacrylic acid degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00650	Butanoate metabolism	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko00903	Limonene and pinene degradation	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko01100	Metabolic pathways	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034597	K00128	ko01110	Biosynthesis of secondary metabolites	464	9.3e-20	0.81	0.86	0.33
PGSC0003DMG200034602	K10760	ko00908	Zeatin biosynthesis	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMG200034602	K10760	ko01100	Metabolic pathways	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMG200034602	K10760	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.41	0.53	0.99
PGSC0003DMG200034609	K09866	ko04962	Vasopressin-regulated water reabsorption	298	1.3e-10	0.30	0.45	0.98
PGSC0003DMG200034612	K08059	ko04612	Antigen processing and presentation	457	2.3e-19	0.54	0.69	0.91
PGSC0003DMG200016112	K00002	ko00010	Glycolysis / Gluconeogenesis	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMG200016112	K00002	ko00561	Glycerolipid metabolism	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMG200016112	K00002	ko00930	Caprolactam degradation	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMG200016112	K00002	ko01100	Metabolic pathways	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMG200016112	K00002	ko01110	Biosynthesis of secondary metabolites	378	5.2e-15	0.70	0.87	0.85
PGSC0003DMG200016117	K12857	ko03040	Spliceosome	224	1.6e-06	0.28	0.44	0.92
PGSC0003DMG200016117	K12857	ko03040	Spliceosome	223	1.8e-06	0.29	0.48	0.82
PGSC0003DMG200016119	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMG200016119	K02366	ko01100	Metabolic pathways	400	5.9e-16	0.29	0.47	0.94
PGSC0003DMG200016120	K01662	ko00900	Terpenoid backbone biosynthesis	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMG200016120	K01662	ko01100	Metabolic pathways	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMG200016120	K01662	ko01110	Biosynthesis of secondary metabolites	4966	4.6e-268	0.84	0.90	0.99
PGSC0003DMG200016120	K01662	ko00900	Terpenoid backbone biosynthesis	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMG200016120	K01662	ko01100	Metabolic pathways	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMG200016120	K01662	ko01110	Biosynthesis of secondary metabolites	294	8.1e-10	0.72	0.91	0.90
PGSC0003DMG200016121	K12356	ko00940	Phenylpropanoid biosynthesis	671	3.6e-31	0.32	0.49	0.93
PGSC0003DMG200016122	K12356	ko00940	Phenylpropanoid biosynthesis	654	3.1e-30	0.33	0.47	0.93
PGSC0003DMG200016123	K12356	ko00940	Phenylpropanoid biosynthesis	545	3.2e-24	0.38	0.54	0.84
PGSC0003DMG200016126	K00558	ko00270	Cysteine and methionine metabolism	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMG200016126	K00558	ko01100	Metabolic pathways	358	9.3e-13	0.37	0.57	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1231	4.6e-62	0.91	0.93	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMG200005911	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMG200005911	K02949	ko03010	Ribosome	734	1.2e-34	0.92	0.97	0.88
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMG200005911	K02949	ko03010	Ribosome	1275	1.7e-64	0.92	0.95	0.99
PGSC0003DMG200005912	K06669	ko04110	Cell cycle	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMG200005912	K06669	ko04111	Cell cycle - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMG200005912	K06669	ko04113	Meiosis - yeast	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMG200005912	K06669	ko04114	Oocyte meiosis	1802	1.5e-93	0.88	0.93	1.00
PGSC0003DMG200005912	K06669	ko04110	Cell cycle	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMG200005912	K06669	ko04111	Cell cycle - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMG200005912	K06669	ko04113	Meiosis - yeast	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMG200005912	K06669	ko04114	Oocyte meiosis	4622	4.3e-249	0.79	0.91	0.95
PGSC0003DMG200005912	K06669	ko04110	Cell cycle	7897	0.	0.79	0.90	1.00
PGSC0003DMG200005912	K06669	ko04111	Cell cycle - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMG200005912	K06669	ko04113	Meiosis - yeast	7897	0.	0.79	0.90	1.00
PGSC0003DMG200005912	K06669	ko04114	Oocyte meiosis	7897	0.	0.79	0.90	1.00
PGSC0003DMG200005912	K06669	ko04110	Cell cycle	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMG200005912	K06669	ko04111	Cell cycle - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMG200005912	K06669	ko04113	Meiosis - yeast	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMG200005912	K06669	ko04114	Oocyte meiosis	404	1.4e-15	0.94	1.00	0.93
PGSC0003DMG200005912	K06669	ko04110	Cell cycle	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMG200005912	K06669	ko04111	Cell cycle - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMG200005912	K06669	ko04113	Meiosis - yeast	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMG200005912	K06669	ko04114	Oocyte meiosis	2857	9.6e-152	0.80	0.89	1.00
PGSC0003DMG200005916	K12627	ko03018	RNA degradation	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMG200005916	K12627	ko03040	Spliceosome	710	2.5e-33	0.82	0.88	0.99
PGSC0003DMG200005916	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMG200005916	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMG200005916	K12627	ko03018	RNA degradation	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMG200005916	K12627	ko03040	Spliceosome	741	4.9e-35	0.91	0.98	0.99
PGSC0003DMG200009788	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMG200009788	K00517	ko00626	Naphthalene and anthracene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMG200009788	K00517	ko00903	Limonene and pinene degradation	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMG200009788	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMG200009788	K00517	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.30	0.54	1.00
PGSC0003DMG200009789	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMG200009789	K00517	ko00626	Naphthalene and anthracene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMG200009789	K00517	ko00903	Limonene and pinene degradation	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMG200009789	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMG200009789	K00517	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.52	0.69	0.99
PGSC0003DMG200009790	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMG200009790	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMG200009790	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMG200009790	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMG200009790	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.62	0.97
PGSC0003DMG200009791	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMG200009791	K00517	ko00626	Naphthalene and anthracene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMG200009791	K00517	ko00903	Limonene and pinene degradation	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMG200009791	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMG200009791	K00517	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.47	0.67	0.92
PGSC0003DMG200009791	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMG200009791	K00517	ko00626	Naphthalene and anthracene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMG200009791	K00517	ko00903	Limonene and pinene degradation	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMG200009791	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMG200009791	K00517	ko01110	Biosynthesis of secondary metabolites	1221	1.6e-61	0.39	0.56	0.97
PGSC0003DMG200009792	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMG200009792	K00517	ko00626	Naphthalene and anthracene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMG200009792	K00517	ko00903	Limonene and pinene degradation	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMG200009792	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMG200009792	K00517	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.56	0.68	0.95
PGSC0003DMG200009797	K06674	ko04111	Cell cycle - yeast	271	4.9e-06	0.29	0.47	0.78
PGSC0003DMG200009799	K05663	ko02010	ABC transporters	1305	3.8e-66	0.82	0.92	0.88
PGSC0003DMG200046710	K10760	ko00908	Zeatin biosynthesis	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMG200046710	K10760	ko01100	Metabolic pathways	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMG200046710	K10760	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.54	0.72	0.94
PGSC0003DMG200042103	K03094	ko04110	Cell cycle	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04111	Cell cycle - yeast	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04114	Oocyte meiosis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04120	Ubiquitin mediated proteolysis	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04310	Wnt signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04350	TGF-beta signaling pathway	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042103	K03094	ko04710	Circadian rhythm - mammal	608	1.1e-27	0.52	0.69	0.99
PGSC0003DMG200042122	K03403	ko00860	Porphyrin and chlorophyll metabolism	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMG200042122	K03403	ko01100	Metabolic pathways	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMG200042122	K03403	ko01110	Biosynthesis of secondary metabolites	260	1.7e-07	0.76	0.89	0.43
PGSC0003DMG200018660	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMG200018660	K00485	ko00982	Drug metabolism - cytochrome P450	442	1.5e-18	0.31	0.47	0.96
PGSC0003DMG200018660	K00485	ko00982	Drug metabolism - cytochrome P450	362	3.9e-14	0.39	0.55	0.84
PGSC0003DMG200018665	K00384	ko00240	Pyrimidine metabolism	2354	5.3e-124	0.83	0.93	1.00
PGSC0003DMG200018666	K08139	ko04113	Meiosis - yeast	578	3.1e-51	0.36	0.59	0.62
PGSC0003DMG200018674	K05868	ko04110	Cell cycle	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMG200018674	K05868	ko04115	p53 signaling pathway	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMG200018674	K05868	ko04914	Progesterone-mediated oocyte maturation	2181	1.9e-114	0.69	0.83	1.00
PGSC0003DMG200018674	K05868	ko04110	Cell cycle	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMG200018674	K05868	ko04115	p53 signaling pathway	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMG200018674	K05868	ko04914	Progesterone-mediated oocyte maturation	2511	1.2e-132	0.71	0.84	0.99
PGSC0003DMG200027206	K04125	ko00904	Diterpenoid biosynthesis	1058	1.6e-52	0.45	0.61	0.93
PGSC0003DMG200027210	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMG200027210	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.61	0.92
PGSC0003DMG200027211	K12121	ko04712	Circadian rhythm - plant	2256	1.4e-118	0.72	0.85	0.98
PGSC0003DMG200027211	K12121	ko04712	Circadian rhythm - plant	7381	0.	0.78	0.87	0.99
PGSC0003DMG200027212	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko00020	Citrate cycle (TCA cycle)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMG200027212	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMG200027212	K01648	ko01100	Metabolic pathways	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMG200027212	K01648	ko01110	Biosynthesis of secondary metabolites	2361	2.2e-124	0.84	0.92	1.00
PGSC0003DMG200027212	K01648	ko00020	Citrate cycle (TCA cycle)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko01100	Metabolic pathways	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027212	K01648	ko01110	Biosynthesis of secondary metabolites	1759	3.5e-91	0.91	0.94	0.98
PGSC0003DMG200027213	K03017	ko00230	Purine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMG200027213	K03017	ko00240	Pyrimidine metabolism	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMG200027213	K03017	ko01100	Metabolic pathways	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMG200027213	K03017	ko03020	RNA polymerase	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMG200027213	K03017	ko05016	Huntington's disease	976	5.4e-48	0.94	0.96	0.99
PGSC0003DMG200027215	K00382	ko00010	Glycolysis / Gluconeogenesis	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko00020	Citrate cycle (TCA cycle)	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko00260	Glycine, serine and threonine metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko00620	Pyruvate metabolism	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko01100	Metabolic pathways	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027215	K00382	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.85	0.91	0.95
PGSC0003DMG200027217	K00878	ko00730	Thiamine metabolism	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMG200027217	K00878	ko01100	Metabolic pathways	1371	8.8e-70	0.70	0.84	1.00
PGSC0003DMG200027218	K03013	ko00230	Purine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMG200027218	K03013	ko00240	Pyrimidine metabolism	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMG200027218	K03013	ko01100	Metabolic pathways	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMG200027218	K03013	ko03020	RNA polymerase	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMG200027218	K03013	ko05016	Huntington's disease	1167	1.6e-58	0.67	0.83	0.99
PGSC0003DMG200023403	K06269	ko04113	Meiosis - yeast	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04114	Oocyte meiosis	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04270	Vascular smooth muscle contraction	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04510	Focal adhesion	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04720	Long-term potentiation	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04810	Regulation of actin cytoskeleton	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04910	Insulin signaling pathway	2471	1.1e-134	0.78	0.82	0.90
PGSC0003DMG200023403	K06269	ko04113	Meiosis - yeast	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04114	Oocyte meiosis	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04270	Vascular smooth muscle contraction	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04510	Focal adhesion	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04720	Long-term potentiation	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04810	Regulation of actin cytoskeleton	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023403	K06269	ko04910	Insulin signaling pathway	2595	1.6e-141	0.90	0.95	0.98
PGSC0003DMG200023408	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMG200023408	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMG200023408	K02990	ko03010	Ribosome	848	6.2e-41	0.69	0.85	0.90
PGSC0003DMG200023415	K03075	ko03060	Protein export	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMG200023415	K03075	ko03070	Bacterial secretion system	265	8.8e-09	0.40	0.50	0.28
PGSC0003DMG200036052	K02183	ko04020	Calcium signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04070	Phosphatidylinositol signaling system	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04114	Oocyte meiosis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04270	Vascular smooth muscle contraction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04626	Plant-pathogen interaction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04720	Long-term potentiation	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04722	Neurotrophin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04740	Olfactory transduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04744	Phototransduction	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04745	Phototransduction - fly	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04910	Insulin signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04912	GnRH signaling pathway	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04916	Melanogenesis	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04970	Salivary secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko04971	Gastric acid secretion	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko05010	Alzheimer's disease	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036052	K02183	ko05214	Glioma	216	4.4e-06	0.38	0.59	0.90
PGSC0003DMG200036058	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMG200036058	K00517	ko00626	Naphthalene and anthracene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMG200036058	K00517	ko00903	Limonene and pinene degradation	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMG200036058	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMG200036058	K00517	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.37	0.62	0.99
PGSC0003DMG200040911	K11093	ko03040	Spliceosome	248	7.6e-08	0.29	0.49	0.83
PGSC0003DMG200040913	K03006	ko00230	Purine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMG200040913	K03006	ko00240	Pyrimidine metabolism	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMG200040913	K03006	ko01100	Metabolic pathways	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMG200040913	K03006	ko03020	RNA polymerase	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMG200040913	K03006	ko05016	Huntington's disease	954	7.7e-46	0.35	0.54	0.60
PGSC0003DMG200016796	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00340	Histidine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00350	Tyrosine metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00450	Selenoamino acid metabolism	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00626	Naphthalene and anthracene degradation	1591	6.4e-82	0.39	0.55	0.95
PGSC0003DMG200016796	K00599	ko00340	Histidine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMG200016796	K00599	ko00350	Tyrosine metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMG200016796	K00599	ko00450	Selenoamino acid metabolism	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMG200016796	K00599	ko00626	Naphthalene and anthracene degradation	2066	4.1e-108	0.40	0.57	0.94
PGSC0003DMG200016796	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00340	Histidine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00350	Tyrosine metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00450	Selenoamino acid metabolism	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016796	K00599	ko00626	Naphthalene and anthracene degradation	1237	2.2e-62	0.36	0.53	0.94
PGSC0003DMG200016797	K05681	ko02010	ABC transporters	1091	2.4e-54	0.35	0.53	0.80
PGSC0003DMG200016804	K05681	ko02010	ABC transporters	1154	8.2e-58	0.34	0.54	0.78
PGSC0003DMG200016804	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMG200016804	K05681	ko02010	ABC transporters	1152	1.1e-57	0.34	0.52	0.85
PGSC0003DMG200016808	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMG200016808	K12796	ko04621	NOD-like receptor signaling pathway	438	1.1e-14	0.31	0.46	0.46
PGSC0003DMG200016808	K12796	ko04621	NOD-like receptor signaling pathway	434	3.7e-15	0.32	0.47	0.63
PGSC0003DMG200009147	K00889	ko00562	Inositol phosphate metabolism	8174	0.	0.63	0.74	1.00
PGSC0003DMG200009147	K00889	ko01100	Metabolic pathways	8174	0.	0.63	0.74	1.00
PGSC0003DMG200009147	K00889	ko04070	Phosphatidylinositol signaling system	8174	0.	0.63	0.74	1.00
PGSC0003DMG200009147	K00889	ko04144	Endocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMG200009147	K00889	ko04666	Fc gamma R-mediated phagocytosis	8174	0.	0.63	0.74	1.00
PGSC0003DMG200009147	K00889	ko04810	Regulation of actin cytoskeleton	8174	0.	0.63	0.74	1.00
PGSC0003DMG200005217	K02874	ko03010	Ribosome	993	6.2e-49	0.74	0.86	0.98
PGSC0003DMG200005217	K02874	ko03010	Ribosome	847	7.0e-41	0.86	0.94	0.99
PGSC0003DMG200005223	K03921	ko00061	Fatty acid biosynthesis	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMG200005223	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1473	2.1e-75	0.62	0.78	1.00
PGSC0003DMG200005223	K03921	ko00061	Fatty acid biosynthesis	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMG200005223	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1050	4.4e-52	0.71	0.84	0.96
PGSC0003DMG200005225	K03921	ko00061	Fatty acid biosynthesis	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMG200005225	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1821	1.3e-94	0.61	0.77	0.99
PGSC0003DMG200005225	K03921	ko00061	Fatty acid biosynthesis	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMG200005225	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1043	1.1e-51	0.72	0.88	0.97
PGSC0003DMG200005225	K03921	ko00061	Fatty acid biosynthesis	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMG200005225	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1909	1.9e-99	0.63	0.79	0.97
PGSC0003DMG200005231	K00599	ko00340	Histidine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMG200005231	K00599	ko00350	Tyrosine metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMG200005231	K00599	ko00450	Selenoamino acid metabolism	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMG200005231	K00599	ko00626	Naphthalene and anthracene degradation	255	1.7e-07	0.34	0.49	0.82
PGSC0003DMG200005235	K01564	ko00791	Atrazine degradation	1060	1.2e-52	0.38	0.57	0.96
PGSC0003DMG200005235	K01564	ko00791	Atrazine degradation	927	2.7e-45	0.38	0.56	0.92
PGSC0003DMG200015221	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMG200015221	K00517	ko00626	Naphthalene and anthracene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMG200015221	K00517	ko00903	Limonene and pinene degradation	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMG200015221	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMG200015221	K00517	ko01110	Biosynthesis of secondary metabolites	1840	1.2e-95	0.47	0.68	0.99
PGSC0003DMG200015229	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMG200015229	K00517	ko00626	Naphthalene and anthracene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMG200015229	K00517	ko00903	Limonene and pinene degradation	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMG200015229	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMG200015229	K00517	ko01110	Biosynthesis of secondary metabolites	1648	4.6e-85	0.60	0.78	0.92
PGSC0003DMG200015230	K01728	ko00040	Pentose and glucuronate interconversions	2622	8.8e-139	0.74	0.85	0.98
PGSC0003DMG200015239	K02495	ko00860	Porphyrin and chlorophyll metabolism	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMG200015239	K02495	ko01100	Metabolic pathways	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMG200015239	K02495	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.69	0.81	1.00
PGSC0003DMG200021147	K08507	ko04130	SNARE interactions in vesicular transport	216	4.4e-06	0.29	0.49	0.90
PGSC0003DMG200021156	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	609	9.4e-28	0.34	0.50	0.45
PGSC0003DMG200021156	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	606	1.4e-27	0.34	0.50	0.84
PGSC0003DMG200021157	K09832	ko00100	Steroid biosynthesis	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMG200021157	K09832	ko01110	Biosynthesis of secondary metabolites	2527	1.5e-133	0.63	0.78	1.00
PGSC0003DMG200021158	K02955	ko03010	Ribosome	1205	1.3e-60	0.95	0.98	0.99
PGSC0003DMG200021159	K01000	ko00550	Peptidoglycan biosynthesis	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMG200021159	K01000	ko01100	Metabolic pathways	1090	2.8e-54	0.80	0.88	0.99
PGSC0003DMG200021159	K01000	ko00550	Peptidoglycan biosynthesis	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMG200021159	K01000	ko01100	Metabolic pathways	634	3.9e-29	0.60	0.75	0.70
PGSC0003DMG200021160	K11090	ko05322	Systemic lupus erythematosus	400	3.2e-16	0.31	0.52	0.70
PGSC0003DMG200021160	K11090	ko05322	Systemic lupus erythematosus	439	2.2e-18	0.33	0.54	0.68
PGSC0003DMG200024329	K00430	ko00360	Phenylalanine metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMG200024329	K00430	ko00680	Methane metabolism	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMG200024329	K00430	ko00940	Phenylpropanoid biosynthesis	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMG200024329	K00430	ko01100	Metabolic pathways	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMG200024329	K00430	ko01110	Biosynthesis of secondary metabolites	1663	6.9e-86	0.62	0.77	0.98
PGSC0003DMG200024330	K00430	ko00360	Phenylalanine metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMG200024330	K00430	ko00680	Methane metabolism	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMG200024330	K00430	ko00940	Phenylpropanoid biosynthesis	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMG200024330	K00430	ko01100	Metabolic pathways	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMG200024330	K00430	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.64	0.77	0.96
PGSC0003DMG200024330	K00430	ko00360	Phenylalanine metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMG200024330	K00430	ko00680	Methane metabolism	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMG200024330	K00430	ko00940	Phenylpropanoid biosynthesis	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMG200024330	K00430	ko01100	Metabolic pathways	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMG200024330	K00430	ko01110	Biosynthesis of secondary metabolites	1617	2.4e-83	0.63	0.76	0.98
PGSC0003DMG200024332	K00430	ko00360	Phenylalanine metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMG200024332	K00430	ko00680	Methane metabolism	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMG200024332	K00430	ko00940	Phenylpropanoid biosynthesis	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMG200024332	K00430	ko01100	Metabolic pathways	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMG200024332	K00430	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.63	0.75	0.98
PGSC0003DMG200024332	K00430	ko00360	Phenylalanine metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMG200024332	K00430	ko00680	Methane metabolism	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMG200024332	K00430	ko00940	Phenylpropanoid biosynthesis	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMG200024332	K00430	ko01100	Metabolic pathways	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMG200024332	K00430	ko01110	Biosynthesis of secondary metabolites	1376	4.7e-70	0.59	0.73	0.84
PGSC0003DMG200024340	K08266	ko04150	mTOR signaling pathway	2614	2.4e-138	0.94	0.98	0.99
PGSC0003DMG200028268	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMG200028268	K00517	ko00626	Naphthalene and anthracene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMG200028268	K00517	ko00903	Limonene and pinene degradation	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMG200028268	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMG200028268	K00517	ko01110	Biosynthesis of secondary metabolites	1579	3.0e-81	0.43	0.65	0.99
PGSC0003DMG200028269	K05280	ko00941	Flavonoid biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMG200028269	K05280	ko00944	Flavone and flavonol biosynthesis	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMG200028269	K05280	ko01100	Metabolic pathways	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMG200028269	K05280	ko01110	Biosynthesis of secondary metabolites	880	1.1e-42	0.51	0.71	0.98
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	900	8.3e-44	0.40	0.61	0.97
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	1623	1.1e-83	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	1756	5.1e-91	0.45	0.65	0.97
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	1638	1.6e-84	0.45	0.65	0.99
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.45	0.65	0.96
PGSC0003DMG200028269	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMG200028269	K00517	ko00626	Naphthalene and anthracene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMG200028269	K00517	ko00903	Limonene and pinene degradation	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMG200028269	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMG200028269	K00517	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.44	0.64	0.98
PGSC0003DMG200028270	K12869	ko03040	Spliceosome	4679	3.1e-252	0.80	0.88	1.00
PGSC0003DMG200028271	K02896	ko03010	Ribosome	1255	2.2e-63	0.91	0.94	0.99
PGSC0003DMG200028272	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMG200028272	K02366	ko01100	Metabolic pathways	364	9.1e-14	0.27	0.43	0.68
PGSC0003DMG200028273	K01754	ko00260	Glycine, serine and threonine metabolism	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMG200028273	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMG200028273	K01754	ko01100	Metabolic pathways	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMG200028273	K01754	ko01110	Biosynthesis of secondary metabolites	3471	1.3e-185	0.72	0.82	0.96
PGSC0003DMG200028273	K01754	ko00260	Glycine, serine and threonine metabolism	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMG200028273	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMG200028273	K01754	ko01100	Metabolic pathways	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMG200028273	K01754	ko01110	Biosynthesis of secondary metabolites	3517	3.8e-188	0.72	0.83	0.96
PGSC0003DMG200028276	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMG200028276	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMG200028276	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMG200028276	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMG200028276	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.71
PGSC0003DMG200028276	K01915	ko00250	Alanine, aspartate and glutamate metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMG200028276	K01915	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMG200028276	K01915	ko00910	Nitrogen metabolism	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMG200028276	K01915	ko01100	Metabolic pathways	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMG200028276	K01915	ko02020	Two-component system	1074	2.1e-53	0.38	0.56	0.52
PGSC0003DMG200028276	K01915	ko00250	Alanine, aspartate and glutamate metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMG200028276	K01915	ko00330	Arginine and proline metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMG200028276	K01915	ko00910	Nitrogen metabolism	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMG200028276	K01915	ko01100	Metabolic pathways	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMG200028276	K01915	ko02020	Two-component system	954	8.8e-47	0.40	0.59	0.94
PGSC0003DMG200028277	K01915	ko00250	Alanine, aspartate and glutamate metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMG200028277	K01915	ko00330	Arginine and proline metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMG200028277	K01915	ko00910	Nitrogen metabolism	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMG200028277	K01915	ko01100	Metabolic pathways	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMG200028277	K01915	ko02020	Two-component system	854	2.9e-41	0.33	0.52	0.50
PGSC0003DMG200028281	K01674	ko00910	Nitrogen metabolism	1406	1.0e-71	0.66	0.78	0.93
PGSC0003DMG200028281	K01674	ko00910	Nitrogen metabolism	1307	3.0e-66	0.69	0.82	0.96
PGSC0003DMG200028281	K01674	ko00910	Nitrogen metabolism	1501	5.9e-77	0.66	0.79	0.97
PGSC0003DMG200028281	K01674	ko00910	Nitrogen metabolism	1487	3.5e-76	0.66	0.79	0.97
PGSC0003DMG200001495	K11294	ko05130	Pathogenic Escherichia coli infection	420	2.5e-17	0.32	0.51	0.54
PGSC0003DMG200001496	K11294	ko05130	Pathogenic Escherichia coli infection	244	4.6e-07	0.36	0.48	0.87
PGSC0003DMG200001496	K12890	ko03040	Spliceosome	232	1.1e-06	0.37	0.51	0.28
PGSC0003DMG200001500	K08737	ko03430	Mismatch repair	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMG200001500	K08737	ko05200	Pathways in cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMG200001500	K08737	ko05210	Colorectal cancer	505	1.3e-21	0.34	0.52	0.32
PGSC0003DMG200001500	K08737	ko03430	Mismatch repair	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMG200001500	K08737	ko05200	Pathways in cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMG200001500	K08737	ko05210	Colorectal cancer	505	5.1e-22	0.34	0.52	0.51
PGSC0003DMG200040027	K10760	ko00908	Zeatin biosynthesis	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMG200040027	K10760	ko01100	Metabolic pathways	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMG200040027	K10760	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.59	0.75	0.89
PGSC0003DMG200040031	K03094	ko04110	Cell cycle	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04111	Cell cycle - yeast	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04114	Oocyte meiosis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04310	Wnt signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04350	TGF-beta signaling pathway	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040031	K03094	ko04710	Circadian rhythm - mammal	326	3.8e-12	0.50	0.62	0.89
PGSC0003DMG200040053	K11228	ko04011	MAPK signaling pathway - yeast	328	1.6e-11	0.37	0.49	0.93
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004426	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004427	K00754	ko00051	Fructose and mannose metabolism	1355	6.7e-69	0.42	0.60	0.98
PGSC0003DMG200004431	K01159	ko03440	Homologous recombination	238	2.7e-07	0.30	0.48	0.53
PGSC0003DMG200004436	K01803	ko00010	Glycolysis / Gluconeogenesis	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004436	K01803	ko00051	Fructose and mannose metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004436	K01803	ko00562	Inositol phosphate metabolism	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004436	K01803	ko00710	Carbon fixation in photosynthetic organisms	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004436	K01803	ko01100	Metabolic pathways	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004436	K01803	ko01110	Biosynthesis of secondary metabolites	2140	3.4e-112	0.81	0.90	0.99
PGSC0003DMG200004437	K10949	ko05110	Vibrio cholerae infection	535	1.1e-23	0.36	0.58	0.82
PGSC0003DMG200007507	K12586	ko03018	RNA degradation	1996	3.0e-104	0.81	0.90	1.00
PGSC0003DMG200007507	K12586	ko03018	RNA degradation	1942	2.8e-101	0.82	0.91	1.00
PGSC0003DMG200007514	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMG200007514	K11517	ko01100	Metabolic pathways	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMG200007514	K11517	ko04146	Peroxisome	2697	6.4e-143	0.85	0.95	1.00
PGSC0003DMG200007514	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMG200007514	K11517	ko01100	Metabolic pathways	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMG200007514	K11517	ko04146	Peroxisome	1328	2.1e-67	0.89	0.95	0.96
PGSC0003DMG200007514	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko01100	Metabolic pathways	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko04146	Peroxisome	727	2.9e-34	0.84	0.93	0.99
PGSC0003DMG200007514	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMG200007514	K11517	ko01100	Metabolic pathways	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMG200007514	K11517	ko04146	Peroxisome	1679	9.0e-87	0.86	0.95	0.99
PGSC0003DMG200007515	K00993	ko00440	Phosphonate and phosphinate metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMG200007515	K00993	ko00564	Glycerophospholipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMG200007515	K00993	ko00565	Ether lipid metabolism	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMG200007515	K00993	ko01100	Metabolic pathways	2423	8.3e-128	0.78	0.87	0.94
PGSC0003DMG200007518	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200007518	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200007518	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200007518	K01611	ko00270	Cysteine and methionine metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200007518	K01611	ko00330	Arginine and proline metabolism	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200007518	K01611	ko01100	Metabolic pathways	2225	6.9e-117	0.76	0.85	0.98
PGSC0003DMG200013396	K07192	ko04910	Insulin signaling pathway	1311	1.8e-66	0.39	0.60	0.97
PGSC0003DMG200013396	K07192	ko04910	Insulin signaling pathway	990	9.1e-49	0.44	0.66	0.93
PGSC0003DMG200011496	K10581	ko04120	Ubiquitin mediated proteolysis	534	5.7e-23	0.29	0.42	0.72
PGSC0003DMG200011499	K01620	ko00260	Glycine, serine and threonine metabolism	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMG200011499	K01620	ko01100	Metabolic pathways	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMG200011499	K01620	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.83	0.92	0.99
PGSC0003DMG200011499	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011499	K01620	ko01110	Biosynthesis of secondary metabolites	2337	4.6e-123	0.77	0.90	0.99
PGSC0003DMG200011500	K12860	ko03040	Spliceosome	651	8.0e-30	0.45	0.60	0.78
PGSC0003DMG200011500	K12860	ko03040	Spliceosome	5879	0.	0.73	0.84	1.00
PGSC0003DMG200013748	K08486	ko04130	SNARE interactions in vesicular transport	1883	5.1e-98	0.77	0.87	0.96
PGSC0003DMG200013751	K02636	ko00195	Photosynthesis	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMG200013751	K02636	ko01100	Metabolic pathways	1496	1.1e-76	0.77	0.85	1.00
PGSC0003DMG200013755	K03006	ko00230	Purine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMG200013755	K03006	ko00240	Pyrimidine metabolism	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMG200013755	K03006	ko01100	Metabolic pathways	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMG200013755	K03006	ko03020	RNA polymerase	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMG200013755	K03006	ko05016	Huntington's disease	309	5.6e-10	0.44	0.57	0.40
PGSC0003DMG200004694	K10581	ko04120	Ubiquitin mediated proteolysis	980	3.2e-48	0.48	0.65	0.82
PGSC0003DMG200004695	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMG200004695	K04424	ko04530	Tight junction	1439	1.6e-73	0.56	0.71	0.41
PGSC0003DMG200004695	K04424	ko04010	MAPK signaling pathway	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMG200004695	K04424	ko04530	Tight junction	875	2.0e-42	0.52	0.67	0.58
PGSC0003DMG200004696	K01648	ko00020	Citrate cycle (TCA cycle)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMG200004696	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMG200004696	K01648	ko01100	Metabolic pathways	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMG200004696	K01648	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.97	0.97	0.99
PGSC0003DMG200004696	K01648	ko00020	Citrate cycle (TCA cycle)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMG200004696	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMG200004696	K01648	ko01100	Metabolic pathways	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMG200004696	K01648	ko01110	Biosynthesis of secondary metabolites	4824	3.1e-260	0.94	0.97	1.00
PGSC0003DMG200004698	K00128	ko00010	Glycolysis / Gluconeogenesis	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00053	Ascorbate and aldarate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00071	Fatty acid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00280	Valine, leucine and isoleucine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00310	Lysine degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00330	Arginine and proline metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00340	Histidine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00380	Tryptophan metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00410	beta-Alanine metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00561	Glycerolipid metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00620	Pyruvate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00631	1,2-Dichloroethane degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00640	Propanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00641	3-Chloroacrylic acid degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00650	Butanoate metabolism	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00903	Limonene and pinene degradation	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko01100	Metabolic pathways	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko01110	Biosynthesis of secondary metabolites	1564	2.0e-80	0.42	0.58	0.88
PGSC0003DMG200004698	K00128	ko00010	Glycolysis / Gluconeogenesis	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00053	Ascorbate and aldarate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00071	Fatty acid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00280	Valine, leucine and isoleucine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00310	Lysine degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00330	Arginine and proline metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00340	Histidine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00380	Tryptophan metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00410	beta-Alanine metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00561	Glycerolipid metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00620	Pyruvate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00631	1,2-Dichloroethane degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00640	Propanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00641	3-Chloroacrylic acid degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00650	Butanoate metabolism	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko01100	Metabolic pathways	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.98
PGSC0003DMG200004698	K00128	ko00010	Glycolysis / Gluconeogenesis	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00053	Ascorbate and aldarate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00071	Fatty acid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00280	Valine, leucine and isoleucine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00310	Lysine degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00330	Arginine and proline metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00340	Histidine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00380	Tryptophan metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00410	beta-Alanine metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00561	Glycerolipid metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00620	Pyruvate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00631	1,2-Dichloroethane degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00640	Propanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00641	3-Chloroacrylic acid degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00650	Butanoate metabolism	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko00903	Limonene and pinene degradation	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko01100	Metabolic pathways	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004698	K00128	ko01110	Biosynthesis of secondary metabolites	1984	1.4e-103	0.48	0.66	0.89
PGSC0003DMG200004699	K10578	ko04120	Ubiquitin mediated proteolysis	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMG200004699	K10578	ko05012	Parkinson's disease	1883	5.1e-98	0.74	0.84	1.00
PGSC0003DMG200004700	K02905	ko03010	Ribosome	461	1.4e-19	0.91	0.96	0.95
PGSC0003DMG200006613	K02206	ko04110	Cell cycle	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko04114	Oocyte meiosis	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko04115	p53 signaling pathway	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko04914	Progesterone-mediated oocyte maturation	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko05200	Pathways in cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko05215	Prostate cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko05222	Small cell lung cancer	314	1.7e-11	0.34	0.50	0.55
PGSC0003DMG200006613	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04110	Cell cycle	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04114	Oocyte meiosis	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04115	p53 signaling pathway	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko04914	Progesterone-mediated oocyte maturation	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05200	Pathways in cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05215	Prostate cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006613	K02206	ko05222	Small cell lung cancer	330	2.3e-12	0.31	0.46	0.64
PGSC0003DMG200006614	K12857	ko03040	Spliceosome	238	1.4e-06	0.34	0.50	0.53
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011206	K02144	ko04142	Lysosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011206	K02144	ko04145	Phagosome	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2626	5.3e-139	0.83	0.92	1.00
PGSC0003DMG200011211	K02916	ko03010	Ribosome	272	3.6e-09	0.53	0.69	0.41
PGSC0003DMG200011217	K07424	ko00140	Steroid hormone biosynthesis	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00591	Linoleic acid metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00830	Retinol metabolism	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00982	Drug metabolism - cytochrome P450	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko00983	Drug metabolism - other enzymes	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011217	K07424	ko01100	Metabolic pathways	1972	6.2e-103	0.49	0.72	0.99
PGSC0003DMG200011222	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMG200011222	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMG200011222	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.86	0.94	1.00
PGSC0003DMG200011224	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMG200011224	K05286	ko01100	Metabolic pathways	3176	2.4e-169	0.67	0.80	1.00
PGSC0003DMG200039944	K01184	ko00040	Pentose and glucuronate interconversions	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMG200039944	K01184	ko00500	Starch and sucrose metabolism	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMG200039944	K01184	ko01100	Metabolic pathways	1295	1.4e-65	0.46	0.61	0.97
PGSC0003DMG200039958	K01051	ko00040	Pentose and glucuronate interconversions	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMG200039958	K01051	ko00500	Starch and sucrose metabolism	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMG200039958	K01051	ko01100	Metabolic pathways	1922	3.6e-100	0.46	0.62	0.98
PGSC0003DMG200043318	K01516	ko00230	Purine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMG200043318	K01516	ko00730	Thiamine metabolism	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMG200043318	K01516	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.59	0.78
PGSC0003DMG200045494	K05279	ko00944	Flavone and flavonol biosynthesis	738	7.2e-35	0.36	0.55	0.78
PGSC0003DMG200021414	K00619	ko00330	Arginine and proline metabolism	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMG200021414	K00619	ko01100	Metabolic pathways	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMG200021414	K00619	ko01110	Biosynthesis of secondary metabolites	2252	2.2e-118	0.78	0.88	0.98
PGSC0003DMG200021414	K00619	ko00330	Arginine and proline metabolism	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMG200021414	K00619	ko01100	Metabolic pathways	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMG200021414	K00619	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.73	0.83	0.99
PGSC0003DMG200021420	K02898	ko03010	Ribosome	1123	4.2e-56	0.89	0.99	0.99
PGSC0003DMG200021422	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00626	Naphthalene and anthracene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00903	Limonene and pinene degradation	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.44	0.61	0.80
PGSC0003DMG200021422	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMG200021422	K00517	ko00626	Naphthalene and anthracene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMG200021422	K00517	ko00903	Limonene and pinene degradation	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMG200021422	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMG200021422	K00517	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.46	0.63	0.84
PGSC0003DMG200021425	K00826	ko00280	Valine, leucine and isoleucine degradation	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMG200021425	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMG200021425	K00826	ko00770	Pantothenate and CoA biosynthesis	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMG200021425	K00826	ko01100	Metabolic pathways	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMG200021425	K00826	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.74	0.84	1.00
PGSC0003DMG200021426	K01762	ko00270	Cysteine and methionine metabolism	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMG200021426	K01762	ko01110	Biosynthesis of secondary metabolites	2982	1.2e-158	0.75	0.85	1.00
PGSC0003DMG200032468	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMG200032468	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMG200032468	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMG200032468	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMG200032468	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.50	0.69	0.96
PGSC0003DMG200032482	K09754	ko00360	Phenylalanine metabolism	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032482	K09754	ko00940	Phenylpropanoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032482	K09754	ko00941	Flavonoid biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032482	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032482	K09754	ko01100	Metabolic pathways	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032482	K09754	ko01110	Biosynthesis of secondary metabolites	1386	1.3e-70	0.75	0.87	0.97
PGSC0003DMG200032492	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMG200032492	K09880	ko00270	Cysteine and methionine metabolism	416	1.3e-13	0.29	0.43	0.47
PGSC0003DMG200032494	K03108	ko03060	Protein export	2925	1.7e-155	0.75	0.87	0.99
PGSC0003DMG200027984	K03139	ko03022	Basal transcription factors	1519	6.0e-78	0.62	0.70	1.00
PGSC0003DMG200027984	K03139	ko03022	Basal transcription factors	1813	3.7e-94	0.80	0.89	1.00
PGSC0003DMG200027984	K03139	ko03022	Basal transcription factors	1447	5.6e-74	0.86	0.91	0.99
PGSC0003DMG200027985	K11594	ko04622	RIG-I-like receptor signaling pathway	1440	1.4e-73	0.42	0.55	0.92
PGSC0003DMG200017237	K13229	ko00402	Benzoxazinoid biosynthesis	1084	5.9e-54	0.43	0.58	0.93
PGSC0003DMG200017237	K13229	ko00402	Benzoxazinoid biosynthesis	1077	1.4e-53	0.43	0.58	0.98
PGSC0003DMG200017238	K13229	ko00402	Benzoxazinoid biosynthesis	281	1.2e-09	0.43	0.62	0.84
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	880	1.1e-42	0.39	0.54	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	426	1.2e-17	0.38	0.56	0.96
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	1047	6.5e-52	0.41	0.59	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	1020	2.0e-50	0.40	0.58	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	1038	2.0e-51	0.41	0.58	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	1036	2.6e-51	0.41	0.58	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	985	1.7e-48	0.41	0.57	0.98
PGSC0003DMG200017239	K13229	ko00402	Benzoxazinoid biosynthesis	868	4.9e-42	0.42	0.58	0.89
PGSC0003DMG200017240	K13229	ko00402	Benzoxazinoid biosynthesis	1111	1.9e-55	0.44	0.59	0.96
PGSC0003DMG200017241	K13229	ko00402	Benzoxazinoid biosynthesis	288	4.8e-10	0.33	0.52	0.97
PGSC0003DMG200017241	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.37	0.53	0.77
PGSC0003DMG200017241	K13229	ko00402	Benzoxazinoid biosynthesis	1094	1.7e-54	0.44	0.58	0.98
PGSC0003DMG200017241	K13229	ko00402	Benzoxazinoid biosynthesis	1200	2.4e-60	0.45	0.63	0.96
PGSC0003DMG200017242	K13229	ko00402	Benzoxazinoid biosynthesis	340	6.4e-13	0.41	0.57	0.88
PGSC0003DMG200017243	K13229	ko00402	Benzoxazinoid biosynthesis	833	4.1e-40	0.33	0.48	0.97
PGSC0003DMG200017243	K13229	ko00402	Benzoxazinoid biosynthesis	540	6.0e-24	0.29	0.42	0.96
PGSC0003DMG200017244	K13229	ko00402	Benzoxazinoid biosynthesis	995	4.8e-49	0.40	0.54	0.97
PGSC0003DMG200017244	K13229	ko00402	Benzoxazinoid biosynthesis	400	3.2e-16	0.55	0.69	0.68
PGSC0003DMG200017245	K13229	ko00402	Benzoxazinoid biosynthesis	1223	1.3e-61	0.45	0.63	0.93
PGSC0003DMG200017245	K13229	ko00402	Benzoxazinoid biosynthesis	1209	7.6e-61	0.44	0.63	0.92
PGSC0003DMG200017246	K13229	ko00402	Benzoxazinoid biosynthesis	1219	2.1e-61	0.46	0.62	0.94
PGSC0003DMG200017246	K13229	ko00402	Benzoxazinoid biosynthesis	963	2.8e-47	0.46	0.63	0.87
PGSC0003DMG200017247	K13229	ko00402	Benzoxazinoid biosynthesis	989	1.0e-48	0.46	0.64	0.92
PGSC0003DMG200017247	K13229	ko00402	Benzoxazinoid biosynthesis	1128	2.2e-56	0.43	0.60	0.99
PGSC0003DMG200017247	K13229	ko00402	Benzoxazinoid biosynthesis	1216	3.1e-61	0.45	0.62	0.99
PGSC0003DMG200017248	K13229	ko00402	Benzoxazinoid biosynthesis	1161	3.4e-58	0.43	0.61	0.97
PGSC0003DMG200016494	K02866	ko03010	Ribosome	642	1.4e-29	0.41	0.59	0.96
PGSC0003DMG200016495	K02866	ko03010	Ribosome	685	6.0e-32	0.41	0.55	0.95
PGSC0003DMG200016495	K02866	ko03010	Ribosome	687	4.7e-32	0.40	0.56	0.95
PGSC0003DMG200016495	K02866	ko03010	Ribosome	674	2.4e-31	0.40	0.54	0.95
PGSC0003DMG200016496	K05759	ko04810	Regulation of actin cytoskeleton	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMG200016496	K05759	ko05131	Shigellosis	909	2.7e-44	0.78	0.89	0.98
PGSC0003DMG200016501	K06664	ko04146	Peroxisome	1976	3.8e-103	0.85	0.92	0.99
PGSC0003DMG200016501	K06664	ko04146	Peroxisome	2401	1.4e-126	0.79	0.89	1.00
PGSC0003DMG200002274	K02912	ko03010	Ribosome	1028	7.3e-51	0.89	0.95	0.99
PGSC0003DMG200002278	K06685	ko04111	Cell cycle - yeast	400	6.5e-13	0.25	0.42	0.89
PGSC0003DMG200002284	K03115	ko04310	Wnt signaling pathway	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMG200002284	K03115	ko04520	Adherens junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMG200002284	K03115	ko04530	Tight junction	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMG200002284	K03115	ko04712	Circadian rhythm - plant	1006	1.2e-49	0.73	0.82	0.84
PGSC0003DMG200002284	K03115	ko04310	Wnt signaling pathway	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMG200002284	K03115	ko04520	Adherens junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMG200002284	K03115	ko04530	Tight junction	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMG200002284	K03115	ko04712	Circadian rhythm - plant	2142	2.6e-112	0.83	0.89	0.99
PGSC0003DMG200002284	K03115	ko04310	Wnt signaling pathway	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMG200002284	K03115	ko04520	Adherens junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMG200002284	K03115	ko04530	Tight junction	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMG200002284	K03115	ko04712	Circadian rhythm - plant	1804	1.2e-93	0.82	0.88	0.89
PGSC0003DMG200012046	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	578	4.8e-26	0.75	0.82	0.95
PGSC0003DMG200012053	K00273	ko00260	Glycine, serine and threonine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012053	K00273	ko00311	Penicillin and cephalosporin biosynthesis	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012053	K00273	ko00330	Arginine and proline metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012053	K00273	ko00472	D-Arginine and D-ornithine metabolism	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012053	K00273	ko01100	Metabolic pathways	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012053	K00273	ko04146	Peroxisome	415	4.7e-17	0.41	0.59	0.79
PGSC0003DMG200012062	K12796	ko04621	NOD-like receptor signaling pathway	261	3.9e-08	0.31	0.46	0.96
PGSC0003DMG200000128	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMG200000133	K01115	ko00564	Glycerophospholipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko00565	Ether lipid metabolism	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko01100	Metabolic pathways	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko04144	Endocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko04666	Fc gamma R-mediated phagocytosis	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko04912	GnRH signaling pathway	1840	1.2e-95	0.79	0.90	1.00
PGSC0003DMG200000133	K01115	ko00564	Glycerophospholipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000133	K01115	ko00565	Ether lipid metabolism	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000133	K01115	ko01100	Metabolic pathways	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000133	K01115	ko04144	Endocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000133	K01115	ko04666	Fc gamma R-mediated phagocytosis	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000133	K01115	ko04912	GnRH signaling pathway	6363	0.	0.67	0.78	1.00
PGSC0003DMG200000137	K00100	ko00051	Fructose and mannose metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko00363	Bisphenol A degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko00591	Linoleic acid metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko00625	Tetrachloroethene degradation	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko00650	Butanoate metabolism	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko01100	Metabolic pathways	836	2.8e-40	0.41	0.60	0.95
PGSC0003DMG200000137	K00100	ko00051	Fructose and mannose metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko00363	Bisphenol A degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko00591	Linoleic acid metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko00625	Tetrachloroethene degradation	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko00650	Butanoate metabolism	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko01100	Metabolic pathways	843	1.2e-40	0.42	0.60	0.95
PGSC0003DMG200000137	K00100	ko00051	Fructose and mannose metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200000137	K00100	ko00363	Bisphenol A degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200000137	K00100	ko00591	Linoleic acid metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200000137	K00100	ko00625	Tetrachloroethene degradation	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200000137	K00100	ko00650	Butanoate metabolism	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200000137	K00100	ko01100	Metabolic pathways	822	1.7e-39	0.42	0.61	0.94
PGSC0003DMG200035530	K10760	ko00908	Zeatin biosynthesis	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMG200035530	K10760	ko01100	Metabolic pathways	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMG200035530	K10760	ko01110	Biosynthesis of secondary metabolites	306	4.8e-11	0.51	0.73	0.99
PGSC0003DMG200035555	K03980	ko00550	Peptidoglycan biosynthesis	336	5.6e-12	0.39	0.43	0.92
PGSC0003DMG200020296	K03046	ko00230	Purine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMG200020296	K03046	ko00240	Pyrimidine metabolism	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMG200020296	K03046	ko01100	Metabolic pathways	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMG200020296	K03046	ko03020	RNA polymerase	3739	2.2e-200	0.91	0.94	1.00
PGSC0003DMG200020296	K03046	ko00230	Purine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMG200020296	K03046	ko00240	Pyrimidine metabolism	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMG200020296	K03046	ko01100	Metabolic pathways	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMG200020296	K03046	ko03020	RNA polymerase	2793	3.3e-148	0.91	0.94	0.99
PGSC0003DMG200020297	K03046	ko00230	Purine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMG200020297	K03046	ko00240	Pyrimidine metabolism	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMG200020297	K03046	ko01100	Metabolic pathways	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMG200020297	K03046	ko03020	RNA polymerase	726	1.6e-33	0.88	0.92	0.84
PGSC0003DMG200020298	K00088	ko00230	Purine metabolism	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMG200020298	K00088	ko00983	Drug metabolism - other enzymes	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMG200020298	K00088	ko01100	Metabolic pathways	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMG200020298	K00088	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.48	0.71	0.60
PGSC0003DMG200020299	K00042	ko00630	Glyoxylate and dicarboxylate metabolism	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMG200020299	K00042	ko01100	Metabolic pathways	1447	5.6e-74	0.62	0.78	0.99
PGSC0003DMG200020301	K09526	ko04144	Endocytosis	329	1.4e-11	0.46	0.65	0.94
PGSC0003DMG200020305	K02932	ko03010	Ribosome	1688	2.9e-87	0.85	0.95	1.00
PGSC0003DMG200020305	K02932	ko03010	Ribosome	2239	1.2e-117	0.86	0.94	1.00
PGSC0003DMG200020306	K02956	ko03010	Ribosome	508	3.5e-22	0.73	0.84	0.99
PGSC0003DMG200020312	K01142	ko03410	Base excision repair	297	1.5e-10	0.32	0.44	0.71
PGSC0003DMG200020317	K06119	ko00561	Glycerolipid metabolism	2888	1.9e-153	0.77	0.90	0.99
PGSC0003DMG200030153	K02882	ko03010	Ribosome	1444	8.3e-74	0.92	0.98	0.99
PGSC0003DMG200030158	K09458	ko00061	Fatty acid biosynthesis	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMG200030158	K09458	ko01100	Metabolic pathways	3458	6.8e-185	0.87	0.92	1.00
PGSC0003DMG200025685	K02915	ko03010	Ribosome	651	4.5e-30	0.90	0.93	0.99
PGSC0003DMG200025686	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMG200025686	K00517	ko00626	Naphthalene and anthracene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMG200025686	K00517	ko00903	Limonene and pinene degradation	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMG200025686	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMG200025686	K00517	ko01110	Biosynthesis of secondary metabolites	749	1.8e-35	0.37	0.62	0.95
PGSC0003DMG200025686	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMG200025686	K00517	ko00626	Naphthalene and anthracene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMG200025686	K00517	ko00903	Limonene and pinene degradation	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMG200025686	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMG200025686	K00517	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.39	0.64	0.98
PGSC0003DMG200025687	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMG200025687	K00517	ko00626	Naphthalene and anthracene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMG200025687	K00517	ko00903	Limonene and pinene degradation	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMG200025687	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMG200025687	K00517	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.39	0.62	0.96
PGSC0003DMG200025689	K13230	ko00402	Benzoxazinoid biosynthesis	636	3.0e-29	0.38	0.54	0.96
PGSC0003DMG200025689	K13230	ko00402	Benzoxazinoid biosynthesis	1046	7.4e-52	0.41	0.58	0.98
PGSC0003DMG200025689	K13230	ko00402	Benzoxazinoid biosynthesis	1053	3.0e-52	0.42	0.58	0.97
PGSC0003DMG200025689	K13230	ko00402	Benzoxazinoid biosynthesis	1028	7.3e-51	0.41	0.58	0.97
PGSC0003DMG200025696	K00852	ko00030	Pentose phosphate pathway	292	2.9e-10	0.28	0.45	0.95
PGSC0003DMG200025696	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMG200025696	K00852	ko00030	Pentose phosphate pathway	221	2.4e-06	0.39	0.60	0.58
PGSC0003DMG200000761	K00423	ko00053	Ascorbate and aldarate metabolism	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMG200000761	K00423	ko01100	Metabolic pathways	1338	5.8e-68	0.53	0.70	0.97
PGSC0003DMG200000761	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMG200000761	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMG200000761	K00423	ko00053	Ascorbate and aldarate metabolism	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMG200000761	K00423	ko01100	Metabolic pathways	2464	4.6e-130	0.55	0.71	0.95
PGSC0003DMG200000764	K01955	ko00240	Pyrimidine metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMG200000764	K01955	ko00250	Alanine, aspartate and glutamate metabolism	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMG200000764	K01955	ko01100	Metabolic pathways	492	2.1e-20	0.47	0.63	0.47
PGSC0003DMG200000764	K01955	ko00240	Pyrimidine metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMG200000764	K01955	ko00250	Alanine, aspartate and glutamate metabolism	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMG200000764	K01955	ko01100	Metabolic pathways	520	5.6e-22	0.49	0.65	0.47
PGSC0003DMG200000767	K00100	ko00051	Fructose and mannose metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000767	K00100	ko00363	Bisphenol A degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000767	K00100	ko00591	Linoleic acid metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000767	K00100	ko00625	Tetrachloroethene degradation	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000767	K00100	ko00650	Butanoate metabolism	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000767	K00100	ko01100	Metabolic pathways	422	1.9e-17	0.32	0.51	0.95
PGSC0003DMG200000772	K01853	ko00100	Steroid biosynthesis	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMG200000772	K01853	ko01100	Metabolic pathways	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMG200000772	K01853	ko01110	Biosynthesis of secondary metabolites	4807	2.7e-259	0.73	0.82	1.00
PGSC0003DMG200000772	K01853	ko00100	Steroid biosynthesis	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMG200000772	K01853	ko01100	Metabolic pathways	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMG200000772	K01853	ko01110	Biosynthesis of secondary metabolites	5520	1.3e-298	0.81	0.91	1.00
PGSC0003DMG200000774	K11091	ko03040	Spliceosome	215	5.0e-06	0.31	0.51	0.51
PGSC0003DMG200000781	K05753	ko04520	Adherens junction	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMG200000781	K05753	ko04666	Fc gamma R-mediated phagocytosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMG200000781	K05753	ko04810	Regulation of actin cytoskeleton	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMG200000781	K05753	ko05100	Bacterial invasion of epithelial cells	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMG200000781	K05753	ko05131	Shigellosis	319	1.5e-11	0.34	0.44	0.71
PGSC0003DMG200000782	K10955	ko05110	Vibrio cholerae infection	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMG200000782	K10955	ko05146	Amoebiasis	1019	9.7e-49	0.36	0.45	0.93
PGSC0003DMG200000785	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMG200000785	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMG200000785	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.97
PGSC0003DMG200000785	K01590	ko00340	Histidine metabolism	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMG200000785	K01590	ko01100	Metabolic pathways	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMG200000785	K01590	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.81	0.89	0.99
PGSC0003DMG200015753	K10866	ko03440	Homologous recombination	6622	0.	0.75	0.86	1.00
PGSC0003DMG200015753	K10866	ko03450	Non-homologous end-joining	6622	0.	0.75	0.86	1.00
PGSC0003DMG200015753	K10866	ko03440	Homologous recombination	8512	0.	0.78	0.88	1.00
PGSC0003DMG200015753	K10866	ko03450	Non-homologous end-joining	8512	0.	0.78	0.88	1.00
PGSC0003DMG200015759	K02872	ko03010	Ribosome	1610	5.8e-83	0.91	0.97	1.00
PGSC0003DMG200015761	K03032	ko03050	Proteasome	7019	0.	0.85	0.92	1.00
PGSC0003DMG200015761	K03032	ko03050	Proteasome	6080	0.	0.85	0.92	1.00
PGSC0003DMG200015766	K12120	ko04712	Circadian rhythm - plant	7050	0.	0.76	0.84	1.00
PGSC0003DMG200015766	K12120	ko04712	Circadian rhythm - plant	7809	0.	0.82	0.91	1.00
PGSC0003DMG200012700	K02913	ko03010	Ribosome	334	1.4e-12	0.70	0.77	0.98
PGSC0003DMG200012702	K01199	ko00500	Starch and sucrose metabolism	1464	6.5e-75	0.56	0.72	0.95
PGSC0003DMG200012703	K12662	ko03040	Spliceosome	3811	2.3e-204	0.78	0.87	0.99
PGSC0003DMG200012707	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.48	0.59	0.94
PGSC0003DMG200012708	K12356	ko00940	Phenylpropanoid biosynthesis	801	2.4e-38	0.36	0.50	0.98
PGSC0003DMG200012712	K00057	ko00564	Glycerophospholipid metabolism	362	3.9e-14	0.27	0.46	0.77
PGSC0003DMG200002918	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMG200002918	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMG200002918	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMG200002918	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.41
PGSC0003DMG200002918	K00599	ko00340	Histidine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMG200002918	K00599	ko00350	Tyrosine metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMG200002918	K00599	ko00450	Selenoamino acid metabolism	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMG200002918	K00599	ko00626	Naphthalene and anthracene degradation	291	3.2e-10	0.34	0.54	0.56
PGSC0003DMG200002921	K00161	ko00010	Glycolysis / Gluconeogenesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko00020	Citrate cycle (TCA cycle)	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko00620	Pyruvate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko00650	Butanoate metabolism	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko01100	Metabolic pathways	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002921	K00161	ko01110	Biosynthesis of secondary metabolites	3030	2.8e-161	0.82	0.89	0.99
PGSC0003DMG200002922	K02961	ko03010	Ribosome	332	1.8e-12	0.70	0.75	0.98
PGSC0003DMG200002922	K02961	ko03010	Ribosome	660	1.4e-30	0.68	0.80	0.99
PGSC0003DMG200002924	K02961	ko03010	Ribosome	264	1.0e-08	0.50	0.56	0.91
PGSC0003DMG200002925	K04424	ko04010	MAPK signaling pathway	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMG200002925	K04424	ko04530	Tight junction	786	4.6e-37	0.39	0.59	0.76
PGSC0003DMG200002927	K09458	ko00061	Fatty acid biosynthesis	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMG200002927	K09458	ko01100	Metabolic pathways	2580	1.8e-136	0.86	0.95	1.00
PGSC0003DMG200002927	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMG200002927	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMG200002927	K09458	ko00061	Fatty acid biosynthesis	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMG200002927	K09458	ko01100	Metabolic pathways	3121	2.6e-166	0.71	0.80	0.99
PGSC0003DMG200008262	K00366	ko00910	Nitrogen metabolism	4175	1.9e-224	0.82	0.91	1.00
PGSC0003DMG200008267	K07424	ko00140	Steroid hormone biosynthesis	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00591	Linoleic acid metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00830	Retinol metabolism	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00982	Drug metabolism - cytochrome P450	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko00983	Drug metabolism - other enzymes	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008267	K07424	ko01100	Metabolic pathways	2046	5.2e-107	0.49	0.70	0.98
PGSC0003DMG200008269	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	367	1.9e-11	0.27	0.41	0.60
PGSC0003DMG200008269	K12580	ko03018	RNA degradation	312	4.6e-09	0.29	0.39	0.47
PGSC0003DMG200008269	K12580	ko03018	RNA degradation	306	1.1e-08	0.30	0.40	0.45
PGSC0003DMG200008269	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	374	7.4e-12	0.27	0.41	0.61
PGSC0003DMG200008269	K12580	ko03018	RNA degradation	306	1.5e-08	0.28	0.38	0.50
PGSC0003DMG200036740	K08243	ko00941	Flavonoid biosynthesis	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMG200036740	K08243	ko01110	Biosynthesis of secondary metabolites	701	7.9e-33	0.49	0.66	0.83
PGSC0003DMG200029449	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMG200029449	K01078	ko00740	Riboflavin metabolism	1807	7.9e-94	0.67	0.84	0.96
PGSC0003DMG200029450	K01184	ko00040	Pentose and glucuronate interconversions	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMG200029450	K01184	ko00500	Starch and sucrose metabolism	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMG200029450	K01184	ko01100	Metabolic pathways	1457	1.6e-74	0.47	0.63	0.81
PGSC0003DMG200029450	K01184	ko00040	Pentose and glucuronate interconversions	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMG200029450	K01184	ko00500	Starch and sucrose metabolism	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMG200029450	K01184	ko01100	Metabolic pathways	269	5.3e-09	0.46	0.68	0.95
PGSC0003DMG200029450	K01184	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMG200029450	K01184	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMG200029450	K01184	ko01100	Metabolic pathways	459	1.8e-19	0.51	0.67	0.96
PGSC0003DMG200019605	K00873	ko00010	Glycolysis / Gluconeogenesis	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko00230	Purine metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko00620	Pyruvate metabolism	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko00710	Carbon fixation in photosynthetic organisms	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko01100	Metabolic pathways	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko01110	Biosynthesis of secondary metabolites	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko04930	Type II diabetes mellitus	3513	6.3e-188	0.60	0.76	0.96
PGSC0003DMG200019605	K00873	ko00010	Glycolysis / Gluconeogenesis	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko00230	Purine metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko00620	Pyruvate metabolism	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko00710	Carbon fixation in photosynthetic organisms	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko01100	Metabolic pathways	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko01110	Biosynthesis of secondary metabolites	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019605	K00873	ko04930	Type II diabetes mellitus	2714	7.4e-144	0.68	0.83	0.95
PGSC0003DMG200019606	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.80
PGSC0003DMG200019606	K11091	ko03040	Spliceosome	216	4.4e-06	0.36	0.51	0.61
PGSC0003DMG200019606	K11091	ko03040	Spliceosome	240	2.1e-07	0.33	0.52	0.61
PGSC0003DMG200019608	K09490	ko03060	Protein export	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMG200019608	K09490	ko05020	Prion diseases	2171	6.6e-114	0.86	0.89	0.59
PGSC0003DMG200019611	K01051	ko00040	Pentose and glucuronate interconversions	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMG200019611	K01051	ko00500	Starch and sucrose metabolism	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMG200019611	K01051	ko01100	Metabolic pathways	777	5.1e-37	0.64	0.79	0.96
PGSC0003DMG200019611	K01051	ko00040	Pentose and glucuronate interconversions	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMG200019611	K01051	ko00500	Starch and sucrose metabolism	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMG200019611	K01051	ko01100	Metabolic pathways	1873	1.8e-97	0.44	0.61	0.96
PGSC0003DMG200019612	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMG200019612	K05391	ko04626	Plant-pathogen interaction	4562	8.8e-246	0.75	0.85	1.00
PGSC0003DMG200038762	K10601	ko04120	Ubiquitin mediated proteolysis	225	4.7e-06	0.31	0.51	0.67
PGSC0003DMG200044295	K05747	ko04062	Chemokine signaling pathway	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko04520	Adherens junction	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko04666	Fc gamma R-mediated phagocytosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko04810	Regulation of actin cytoskeleton	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko05100	Bacterial invasion of epithelial cells	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko05130	Pathogenic Escherichia coli infection	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044295	K05747	ko05131	Shigellosis	286	6.7e-07	0.34	0.41	0.28
PGSC0003DMG200044316	K03094	ko04110	Cell cycle	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04111	Cell cycle - yeast	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04114	Oocyte meiosis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04120	Ubiquitin mediated proteolysis	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04310	Wnt signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04350	TGF-beta signaling pathway	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200044316	K03094	ko04710	Circadian rhythm - mammal	472	3.4e-20	0.61	0.78	0.93
PGSC0003DMG200014483	K12486	ko04144	Endocytosis	386	7.1e-14	0.26	0.42	0.98
PGSC0003DMG200014483	K12486	ko04144	Endocytosis	387	9.0e-14	0.26	0.41	0.93
PGSC0003DMG200014483	K12486	ko04144	Endocytosis	404	9.0e-15	0.25	0.40	0.94
PGSC0003DMG200014486	K02879	ko03010	Ribosome	1254	2.5e-63	0.91	0.96	0.98
PGSC0003DMG200014487	K10144	ko04115	p53 signaling pathway	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMG200014487	K10144	ko04120	Ubiquitin mediated proteolysis	1372	7.7e-70	0.61	0.80	0.82
PGSC0003DMG200014487	K10144	ko04115	p53 signaling pathway	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMG200014487	K10144	ko04120	Ubiquitin mediated proteolysis	426	1.2e-17	0.55	0.79	0.61
PGSC0003DMG200003990	K08300	ko03018	RNA degradation	369	1.1e-13	0.35	0.48	0.94
PGSC0003DMG200003998	K08269	ko04140	Regulation of autophagy	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMG200003998	K08269	ko04150	mTOR signaling pathway	233	2.4e-06	0.33	0.56	0.84
PGSC0003DMG200003998	K08269	ko04140	Regulation of autophagy	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMG200003998	K08269	ko04150	mTOR signaling pathway	565	2.5e-25	0.52	0.74	0.88
PGSC0003DMG200003998	K08269	ko04140	Regulation of autophagy	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMG200003998	K08269	ko04150	mTOR signaling pathway	671	3.6e-31	0.37	0.53	0.94
PGSC0003DMG200003998	K08269	ko04140	Regulation of autophagy	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMG200003998	K08269	ko04150	mTOR signaling pathway	721	6.2e-34	0.54	0.73	0.93
PGSC0003DMG200003998	K08269	ko04140	Regulation of autophagy	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMG200003998	K08269	ko04150	mTOR signaling pathway	1140	4.8e-57	0.52	0.71	0.94
PGSC0003DMG200010537	K07424	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00591	Linoleic acid metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00830	Retinol metabolism	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00982	Drug metabolism - cytochrome P450	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko00983	Drug metabolism - other enzymes	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010537	K07424	ko01100	Metabolic pathways	1928	1.7e-100	0.47	0.70	0.96
PGSC0003DMG200010538	K07424	ko00140	Steroid hormone biosynthesis	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00591	Linoleic acid metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00830	Retinol metabolism	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00982	Drug metabolism - cytochrome P450	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00983	Drug metabolism - other enzymes	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko01100	Metabolic pathways	1175	5.7e-59	0.47	0.67	0.98
PGSC0003DMG200010538	K07424	ko00140	Steroid hormone biosynthesis	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00591	Linoleic acid metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00830	Retinol metabolism	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00982	Drug metabolism - cytochrome P450	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko00983	Drug metabolism - other enzymes	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010538	K07424	ko01100	Metabolic pathways	657	2.1e-30	0.56	0.73	0.98
PGSC0003DMG200010539	K07424	ko00140	Steroid hormone biosynthesis	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00591	Linoleic acid metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00830	Retinol metabolism	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00982	Drug metabolism - cytochrome P450	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko00983	Drug metabolism - other enzymes	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010539	K07424	ko01100	Metabolic pathways	989	1.0e-48	0.52	0.72	0.96
PGSC0003DMG200010541	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMG200010541	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMG200010541	K10712	ko00430	Taurine and hypotaurine metabolism	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMG200010541	K10712	ko01100	Metabolic pathways	455	2.9e-19	0.36	0.51	0.93
PGSC0003DMG200010543	K02726	ko03050	Proteasome	1643	8.7e-85	0.87	0.89	1.00
PGSC0003DMG200010543	K02726	ko03050	Proteasome	1856	1.6e-96	0.96	0.97	1.00
PGSC0003DMG200010544	K00599	ko00340	Histidine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMG200010544	K00599	ko00350	Tyrosine metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMG200010544	K00599	ko00450	Selenoamino acid metabolism	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMG200010544	K00599	ko00626	Naphthalene and anthracene degradation	690	1.8e-36	0.41	0.57	0.68
PGSC0003DMG200010544	K00599	ko00340	Histidine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMG200010544	K00599	ko00350	Tyrosine metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMG200010544	K00599	ko00450	Selenoamino acid metabolism	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMG200010544	K00599	ko00626	Naphthalene and anthracene degradation	845	9.0e-41	0.39	0.57	0.81
PGSC0003DMG200010547	K12669	ko00510	N-Glycan biosynthesis	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMG200010547	K12669	ko01100	Metabolic pathways	1413	4.2e-72	0.56	0.77	0.77
PGSC0003DMG200010548	K00232	ko00071	Fatty acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko00592	alpha-Linolenic acid metabolism	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko01100	Metabolic pathways	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko03320	PPAR signaling pathway	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko04146	Peroxisome	4497	3.4e-242	0.77	0.89	1.00
PGSC0003DMG200010548	K00232	ko00071	Fatty acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010548	K00232	ko00592	alpha-Linolenic acid metabolism	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010548	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010548	K00232	ko01100	Metabolic pathways	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010548	K00232	ko03320	PPAR signaling pathway	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010548	K00232	ko04146	Peroxisome	4454	7.9e-240	0.76	0.89	1.00
PGSC0003DMG200010549	K05279	ko00944	Flavone and flavonol biosynthesis	465	8.2e-20	0.36	0.54	0.96
PGSC0003DMG200022159	K04079	ko04612	Antigen processing and presentation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022159	K04079	ko04621	NOD-like receptor signaling pathway	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022159	K04079	ko04626	Plant-pathogen interaction	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022159	K04079	ko04914	Progesterone-mediated oocyte maturation	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022159	K04079	ko05200	Pathways in cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022159	K04079	ko05215	Prostate cancer	5505	8.5e-298	0.94	0.98	1.00
PGSC0003DMG200022160	K12863	ko03040	Spliceosome	1614	3.5e-83	0.80	0.89	1.00
PGSC0003DMG200022160	K12863	ko03040	Spliceosome	1637	1.9e-84	0.83	0.92	1.00
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	1243	6.1e-69	0.48	0.63	0.62
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	2970	5.6e-158	0.72	0.86	0.95
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	1710	1.8e-88	0.67	0.81	0.97
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	748	2.0e-35	0.65	0.80	0.97
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	2087	2.8e-109	0.75	0.88	0.98
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	2339	3.6e-123	0.75	0.88	0.96
PGSC0003DMG200031172	K03847	ko00510	N-Glycan biosynthesis	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMG200031172	K03847	ko01100	Metabolic pathways	2239	1.2e-117	0.76	0.89	0.98
PGSC0003DMG200031173	K07192	ko04910	Insulin signaling pathway	1265	6.2e-64	0.38	0.55	0.97
PGSC0003DMG200031176	K12366	ko04062	Chemokine signaling pathway	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMG200031176	K12366	ko05100	Bacterial invasion of epithelial cells	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMG200031176	K12366	ko05131	Shigellosis	247	2.9e-07	0.28	0.50	0.99
PGSC0003DMG200017965	K02183	ko04020	Calcium signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04070	Phosphatidylinositol signaling system	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04114	Oocyte meiosis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04270	Vascular smooth muscle contraction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04626	Plant-pathogen interaction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04720	Long-term potentiation	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04722	Neurotrophin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04740	Olfactory transduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04744	Phototransduction	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04745	Phototransduction - fly	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04910	Insulin signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04912	GnRH signaling pathway	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04916	Melanogenesis	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04970	Salivary secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko04971	Gastric acid secretion	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko05010	Alzheimer's disease	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017965	K02183	ko05214	Glioma	637	2.7e-29	0.72	0.82	0.99
PGSC0003DMG200017970	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMG200017970	K08332	ko04140	Regulation of autophagy	392	1.9e-13	0.31	0.53	0.36
PGSC0003DMG200017970	K08332	ko04140	Regulation of autophagy	392	1.8e-13	0.31	0.53	0.38
PGSC0003DMG200017978	K10352	ko04530	Tight junction	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMG200017978	K10352	ko05416	Viral myocarditis	480	1.4e-16	0.26	0.45	0.57
PGSC0003DMG200028606	K01423	ko00310	Lysine degradation	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMG200028606	K01423	ko00780	Biotin metabolism	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMG200028606	K01423	ko01100	Metabolic pathways	1170	1.1e-58	0.78	0.92	0.99
PGSC0003DMG200024423	K00167	ko00280	Valine, leucine and isoleucine degradation	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMG200024423	K00167	ko01100	Metabolic pathways	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMG200024423	K00167	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.84	0.91	1.00
PGSC0003DMG200024424	K03120	ko03022	Basal transcription factors	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMG200024424	K03120	ko05016	Huntington's disease	894	1.8e-43	0.97	0.99	0.76
PGSC0003DMG200024424	K03120	ko03022	Basal transcription factors	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMG200024424	K03120	ko05016	Huntington's disease	1627	6.7e-84	0.96	0.99	1.00
PGSC0003DMG200024426	K00558	ko00270	Cysteine and methionine metabolism	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMG200024426	K00558	ko01100	Metabolic pathways	2012	3.9e-105	0.55	0.67	0.98
PGSC0003DMG200024426	K00558	ko00270	Cysteine and methionine metabolism	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMG200024426	K00558	ko01100	Metabolic pathways	2184	1.3e-114	0.49	0.61	0.80
PGSC0003DMG200024429	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04115	p53 signaling pathway	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko04210	Apoptosis	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05010	Alzheimer's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05012	Parkinson's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05016	Huntington's disease	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024429	K02084	ko05222	Small cell lung cancer	288	8.2e-08	0.28	0.47	0.85
PGSC0003DMG200024430	K02084	ko04115	p53 signaling pathway	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko04210	Apoptosis	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko05010	Alzheimer's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko05012	Parkinson's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko05016	Huntington's disease	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024430	K02084	ko05222	Small cell lung cancer	274	5.0e-06	0.31	0.51	0.34
PGSC0003DMG200024432	K07195	ko04910	Insulin signaling pathway	422	1.9e-17	0.83	0.93	0.86
PGSC0003DMG200024434	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200024434	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200024434	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200024440	K12929	ko00904	Diterpenoid biosynthesis	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMG200024440	K12929	ko01110	Biosynthesis of secondary metabolites	386	2.2e-15	0.38	0.63	0.92
PGSC0003DMG200024441	K12929	ko00904	Diterpenoid biosynthesis	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMG200024441	K12929	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.38	0.60	0.99
PGSC0003DMG200024441	K12929	ko00904	Diterpenoid biosynthesis	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMG200024441	K12929	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.37	0.60	0.95
PGSC0003DMG200024441	K12467	ko00902	Monoterpenoid biosynthesis	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMG200024441	K12467	ko01110	Biosynthesis of secondary metabolites	316	2.8e-11	0.44	0.63	0.91
PGSC0003DMG200024442	K12929	ko00904	Diterpenoid biosynthesis	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMG200024442	K12929	ko01110	Biosynthesis of secondary metabolites	508	3.5e-22	0.43	0.70	0.99
PGSC0003DMG200032190	K02942	ko03010	Ribosome	714	1.5e-33	0.80	0.85	0.99
PGSC0003DMG200032194	K04506	ko04115	p53 signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMG200032194	K04506	ko04120	Ubiquitin mediated proteolysis	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMG200032194	K04506	ko04310	Wnt signaling pathway	584	2.2e-26	0.84	0.91	0.96
PGSC0003DMG200032194	K04506	ko04115	p53 signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMG200032194	K04506	ko04120	Ubiquitin mediated proteolysis	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMG200032194	K04506	ko04310	Wnt signaling pathway	362	3.9e-14	0.58	0.75	0.91
PGSC0003DMG200032194	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032194	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032194	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032194	K04506	ko04115	p53 signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMG200032194	K04506	ko04120	Ubiquitin mediated proteolysis	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMG200032194	K04506	ko04310	Wnt signaling pathway	1029	6.4e-51	0.86	0.96	0.98
PGSC0003DMG200032194	K04506	ko04115	p53 signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032194	K04506	ko04120	Ubiquitin mediated proteolysis	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032194	K04506	ko04310	Wnt signaling pathway	2129	1.4e-111	0.77	0.89	0.99
PGSC0003DMG200032199	K00430	ko00360	Phenylalanine metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMG200032199	K00430	ko00680	Methane metabolism	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMG200032199	K00430	ko00940	Phenylpropanoid biosynthesis	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMG200032199	K00430	ko01100	Metabolic pathways	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMG200032199	K00430	ko01110	Biosynthesis of secondary metabolites	1670	2.8e-86	0.62	0.77	0.98
PGSC0003DMG200028190	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMG200028190	K00517	ko00626	Naphthalene and anthracene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMG200028190	K00517	ko00903	Limonene and pinene degradation	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMG200028190	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMG200028190	K00517	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.43	0.63	0.99
PGSC0003DMG200028190	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMG200028190	K00517	ko00626	Naphthalene and anthracene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMG200028190	K00517	ko00903	Limonene and pinene degradation	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMG200028190	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMG200028190	K00517	ko01110	Biosynthesis of secondary metabolites	1641	1.1e-84	0.43	0.62	0.98
PGSC0003DMG200028193	K07375	ko04145	Phagosome	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMG200028193	K07375	ko04540	Gap junction	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMG200028193	K07375	ko05130	Pathogenic Escherichia coli infection	1816	2.5e-94	0.98	0.99	0.99
PGSC0003DMG200028193	K07375	ko04145	Phagosome	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMG200028193	K07375	ko04540	Gap junction	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMG200028193	K07375	ko05130	Pathogenic Escherichia coli infection	3827	3.0e-205	0.99	1.00	1.00
PGSC0003DMG200028201	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1351	1.1e-68	0.35	0.52	0.90
PGSC0003DMG200028203	K02183	ko04020	Calcium signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04070	Phosphatidylinositol signaling system	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04114	Oocyte meiosis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04270	Vascular smooth muscle contraction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04626	Plant-pathogen interaction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04720	Long-term potentiation	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04722	Neurotrophin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04740	Olfactory transduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04744	Phototransduction	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04745	Phototransduction - fly	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04910	Insulin signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04912	GnRH signaling pathway	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04916	Melanogenesis	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04970	Salivary secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04971	Gastric acid secretion	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko05010	Alzheimer's disease	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko05214	Glioma	1121	5.4e-56	0.76	0.84	0.99
PGSC0003DMG200028203	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200017385	K01178	ko00500	Starch and sucrose metabolism	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMG200017385	K01178	ko01100	Metabolic pathways	420	7.4e-14	0.25	0.39	0.74
PGSC0003DMG200017385	K01178	ko00500	Starch and sucrose metabolism	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMG200017385	K01178	ko01100	Metabolic pathways	418	9.5e-14	0.25	0.39	0.74
PGSC0003DMG200017385	K01178	ko00500	Starch and sucrose metabolism	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMG200017385	K01178	ko01100	Metabolic pathways	415	1.4e-13	0.25	0.39	0.74
PGSC0003DMG200017389	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMG200017389	K02366	ko01100	Metabolic pathways	364	3.1e-14	0.28	0.44	0.62
PGSC0003DMG200017394	K00036	ko00030	Pentose phosphate pathway	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMG200017394	K00036	ko00480	Glutathione metabolism	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMG200017394	K00036	ko01100	Metabolic pathways	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMG200017394	K00036	ko01110	Biosynthesis of secondary metabolites	3907	1.2e-209	0.80	0.88	0.98
PGSC0003DMG200017394	K00036	ko00030	Pentose phosphate pathway	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMG200017394	K00036	ko00480	Glutathione metabolism	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMG200017394	K00036	ko01100	Metabolic pathways	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMG200017394	K00036	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.92	0.97	1.00
PGSC0003DMG200017396	K12121	ko04712	Circadian rhythm - plant	5599	0.	0.60	0.78	0.99
PGSC0003DMG200017397	K00736	ko00510	N-Glycan biosynthesis	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMG200017397	K00736	ko01100	Metabolic pathways	2201	1.5e-115	0.71	0.82	0.82
PGSC0003DMG200017398	K07199	ko04910	Insulin signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMG200017398	K07199	ko04920	Adipocytokine signaling pathway	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMG200017398	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	407	1.3e-16	0.51	0.65	0.96
PGSC0003DMG200017398	K07199	ko04910	Insulin signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMG200017398	K07199	ko04920	Adipocytokine signaling pathway	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMG200017398	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	966	1.9e-47	0.60	0.74	0.97
PGSC0003DMG200017398	K07199	ko04910	Insulin signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMG200017398	K07199	ko04920	Adipocytokine signaling pathway	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMG200017398	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1202	1.8e-60	0.58	0.73	0.90
PGSC0003DMG200017398	K07199	ko04910	Insulin signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMG200017398	K07199	ko04920	Adipocytokine signaling pathway	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMG200017398	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	807	1.1e-38	0.63	0.78	0.82
PGSC0003DMG200013669	K12585	ko03018	RNA degradation	6422	0.	0.81	0.90	1.00
PGSC0003DMG200013674	K10840	ko03420	Nucleotide excision repair	716	1.2e-33	0.57	0.82	0.89
PGSC0003DMG200013674	K10840	ko03420	Nucleotide excision repair	798	3.5e-38	0.58	0.81	0.91
PGSC0003DMG200013675	K00948	ko00030	Pentose phosphate pathway	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMG200013675	K00948	ko00230	Purine metabolism	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMG200013675	K00948	ko01100	Metabolic pathways	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMG200013675	K00948	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.36	0.55	0.89
PGSC0003DMG200013675	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko00030	Pentose phosphate pathway	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko00230	Purine metabolism	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko01100	Metabolic pathways	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013675	K00948	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.30	0.50	0.76
PGSC0003DMG200013680	K01051	ko00040	Pentose and glucuronate interconversions	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMG200013680	K01051	ko00500	Starch and sucrose metabolism	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMG200013680	K01051	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.52	0.98
PGSC0003DMG200013680	K01051	ko00040	Pentose and glucuronate interconversions	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMG200013680	K01051	ko00500	Starch and sucrose metabolism	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMG200013680	K01051	ko01100	Metabolic pathways	1542	3.2e-79	0.58	0.72	0.97
PGSC0003DMG200013681	K01853	ko00100	Steroid biosynthesis	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMG200013681	K01853	ko01100	Metabolic pathways	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMG200013681	K01853	ko01110	Biosynthesis of secondary metabolites	2288	2.3e-120	0.45	0.54	0.97
PGSC0003DMG200013684	K00487	ko00360	Phenylalanine metabolism	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013684	K00487	ko00940	Phenylpropanoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013684	K00487	ko00941	Flavonoid biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013684	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013684	K00487	ko01100	Metabolic pathways	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013684	K00487	ko01110	Biosynthesis of secondary metabolites	2579	2.1e-136	0.68	0.81	0.99
PGSC0003DMG200013685	K02738	ko03050	Proteasome	1682	6.2e-87	0.86	0.94	0.97
PGSC0003DMG200013690	K12667	ko00510	N-Glycan biosynthesis	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMG200013690	K12667	ko01100	Metabolic pathways	963	2.8e-47	0.53	0.67	0.37
PGSC0003DMG200007599	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMG200007599	K02962	ko03010	Ribosome	1004	1.5e-49	0.85	0.92	0.99
PGSC0003DMG200007612	K03025	ko00230	Purine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMG200007612	K03025	ko00240	Pyrimidine metabolism	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMG200007612	K03025	ko01100	Metabolic pathways	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMG200007612	K03025	ko03020	RNA polymerase	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMG200007612	K03025	ko04623	Cytosolic DNA-sensing pathway	1087	4.1e-54	0.56	0.76	0.98
PGSC0003DMG200006531	K02084	ko04115	p53 signaling pathway	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko04210	Apoptosis	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko05010	Alzheimer's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko05012	Parkinson's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko05016	Huntington's disease	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006531	K02084	ko05222	Small cell lung cancer	295	8.4e-07	0.27	0.44	0.58
PGSC0003DMG200006541	K05282	ko00904	Diterpenoid biosynthesis	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMG200006541	K05282	ko01100	Metabolic pathways	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMG200006541	K05282	ko01110	Biosynthesis of secondary metabolites	1023	1.4e-50	0.49	0.65	0.57
PGSC0003DMG200006542	K01875	ko00970	Aminoacyl-tRNA biosynthesis	875	2.0e-42	0.82	0.92	0.96
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.47	0.62	0.98
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	2280	6.4e-120	0.54	0.71	0.97
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.56	0.66	0.79
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.57	0.65	0.79
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.48	0.67	0.98
PGSC0003DMG200011400	K01188	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMG200011400	K01188	ko00500	Starch and sucrose metabolism	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMG200011400	K01188	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMG200011400	K01188	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.54	0.71	0.90
PGSC0003DMG200011400	K05350	ko00460	Cyanoamino acid metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMG200011400	K05350	ko00500	Starch and sucrose metabolism	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMG200011400	K05350	ko00940	Phenylpropanoid biosynthesis	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMG200011400	K05350	ko01110	Biosynthesis of secondary metabolites	342	1.6e-27	0.44	0.58	0.74
PGSC0003DMG200011402	K12890	ko03040	Spliceosome	1966	1.3e-102	0.78	0.85	0.97
PGSC0003DMG200011402	K12890	ko03040	Spliceosome	783	2.4e-37	0.73	0.80	0.95
PGSC0003DMG200011402	K12890	ko03040	Spliceosome	1111	1.9e-55	0.85	0.91	0.96
PGSC0003DMG200011403	K11096	ko03040	Spliceosome	838	2.2e-40	0.94	0.96	0.99
PGSC0003DMG200045154	K03412	ko02020	Two-component system	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMG200045154	K03412	ko02030	Bacterial chemotaxis	229	8.5e-07	0.30	0.50	0.85
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.65	0.83	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4172	2.8e-224	0.64	0.83	0.99
PGSC0003DMG200018708	K11817	ko00380	Tryptophan metabolism	6653	0.	0.60	0.77	1.00
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4140	1.7e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4155	2.5e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4147	6.8e-223	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4132	4.6e-222	0.64	0.82	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	4137	2.4e-222	0.64	0.83	0.99
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	3222	7.1e-172	0.63	0.82	0.94
PGSC0003DMG200018708	K09842	ko00906	Carotenoid biosynthesis	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMG200018708	K09842	ko01100	Metabolic pathways	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMG200018708	K09842	ko01110	Biosynthesis of secondary metabolites	3165	9.9e-169	0.63	0.82	0.93
PGSC0003DMG200018708	K11817	ko00380	Tryptophan metabolism	588	8.9e-26	0.64	0.78	0.99
PGSC0003DMG200018709	K11817	ko00380	Tryptophan metabolism	6084	0.	0.56	0.73	0.99
PGSC0003DMG200018709	K11817	ko00380	Tryptophan metabolism	6464	0.	0.58	0.76	0.99
PGSC0003DMG200018712	K00079	ko00590	Arachidonic acid metabolism	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMG200018712	K00079	ko01100	Metabolic pathways	678	1.5e-31	0.37	0.57	0.97
PGSC0003DMG200018713	K00079	ko00590	Arachidonic acid metabolism	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMG200018713	K00079	ko01100	Metabolic pathways	656	2.4e-30	0.37	0.56	0.97
PGSC0003DMG200018715	K02935	ko03010	Ribosome	367	2.1e-14	0.43	0.63	0.65
PGSC0003DMG200018716	K00606	ko00770	Pantothenate and CoA biosynthesis	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMG200018716	K00606	ko01100	Metabolic pathways	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMG200018716	K00606	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.87	0.93	0.99
PGSC0003DMG200035893	K12800	ko04621	NOD-like receptor signaling pathway	321	5.4e-09	0.30	0.50	0.50
PGSC0003DMG200035905	K02183	ko04020	Calcium signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04070	Phosphatidylinositol signaling system	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04114	Oocyte meiosis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04270	Vascular smooth muscle contraction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04626	Plant-pathogen interaction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04720	Long-term potentiation	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04722	Neurotrophin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04740	Olfactory transduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04744	Phototransduction	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04745	Phototransduction - fly	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04910	Insulin signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04912	GnRH signaling pathway	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04916	Melanogenesis	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04970	Salivary secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko04971	Gastric acid secretion	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko05010	Alzheimer's disease	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035905	K02183	ko05214	Glioma	407	1.3e-16	0.39	0.57	0.95
PGSC0003DMG200035908	K10760	ko00908	Zeatin biosynthesis	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMG200035908	K10760	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMG200035908	K10760	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.70	0.59
PGSC0003DMG200020063	K00551	ko00564	Glycerophospholipid metabolism	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMG200020063	K00551	ko01100	Metabolic pathways	455	2.9e-19	0.40	0.53	0.78
PGSC0003DMG200020063	K00551	ko00564	Glycerophospholipid metabolism	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMG200020063	K00551	ko01100	Metabolic pathways	463	1.1e-19	0.38	0.52	0.85
PGSC0003DMG200020067	K10352	ko04530	Tight junction	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMG200020067	K10352	ko05416	Viral myocarditis	2633	2.2e-139	0.45	0.66	0.89
PGSC0003DMG200020069	K01955	ko00240	Pyrimidine metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMG200020069	K01955	ko00250	Alanine, aspartate and glutamate metabolism	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMG200020069	K01955	ko01100	Metabolic pathways	485	5.1e-20	0.46	0.60	0.81
PGSC0003DMG200020070	K05278	ko00941	Flavonoid biosynthesis	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMG200020070	K05278	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMG200020070	K05278	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.55	0.94
PGSC0003DMG200020072	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMG200020072	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.50	0.64	0.90
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.68	0.82	0.98
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko00230	Purine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko00240	Pyrimidine metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko00760	Nicotinate and nicotinamide metabolism	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko01100	Metabolic pathways	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030079	K03787	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.64	0.78	1.00
PGSC0003DMG200030082	K00276	ko00260	Glycine, serine and threonine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00350	Tyrosine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00410	beta-Alanine metabolism	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko01100	Metabolic pathways	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.35	0.52	0.99
PGSC0003DMG200030082	K00276	ko00260	Glycine, serine and threonine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko00350	Tyrosine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko00360	Phenylalanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko00410	beta-Alanine metabolism	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko01100	Metabolic pathways	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030082	K00276	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.34	0.53	0.98
PGSC0003DMG200030085	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030085	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030085	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030085	K01693	ko00340	Histidine metabolism	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030085	K01693	ko01100	Metabolic pathways	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030085	K01693	ko01110	Biosynthesis of secondary metabolites	1541	3.7e-79	0.84	0.91	0.96
PGSC0003DMG200030087	K12132	ko04712	Circadian rhythm - plant	1254	2.5e-63	0.48	0.63	0.99
PGSC0003DMG200030087	K12132	ko04712	Circadian rhythm - plant	2032	3.1e-106	0.53	0.65	1.00
PGSC0003DMG200030087	K12132	ko04712	Circadian rhythm - plant	2679	6.3e-142	0.57	0.69	0.99
PGSC0003DMG200030087	K12132	ko04712	Circadian rhythm - plant	3548	7.4e-190	0.62	0.73	1.00
PGSC0003DMG200030087	K12132	ko04712	Circadian rhythm - plant	3126	1.4e-166	0.60	0.71	1.00
PGSC0003DMG200030089	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko03040	Spliceosome	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04010	MAPK signaling pathway	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04144	Endocytosis	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200030089	K03283	ko04612	Antigen processing and presentation	1249	4.7e-63	0.39	0.58	0.86
PGSC0003DMG200025806	K05864	ko04020	Calcium signaling pathway	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMG200025806	K05864	ko05012	Parkinson's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMG200025806	K05864	ko05016	Huntington's disease	2679	6.3e-142	0.85	0.93	0.99
PGSC0003DMG200025813	K01046	ko00561	Glycerolipid metabolism	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMG200025813	K01046	ko01100	Metabolic pathways	358	6.5e-14	0.31	0.48	0.70
PGSC0003DMG200025814	K01066	ko00623	2,4-Dichlorobenzoate degradation	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMG200025814	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	325	4.3e-12	0.35	0.49	0.97
PGSC0003DMG200025815	K01046	ko00561	Glycerolipid metabolism	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMG200025815	K01046	ko01100	Metabolic pathways	417	3.6e-17	0.34	0.48	0.76
PGSC0003DMG200025819	K01046	ko00561	Glycerolipid metabolism	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMG200025819	K01046	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.51	0.78
PGSC0003DMG200016691	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00360	Phenylalanine metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00910	Nitrogen metabolism	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00940	Phenylpropanoid biosynthesis	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko01100	Metabolic pathways	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko01110	Biosynthesis of secondary metabolites	4988	2.8e-269	0.86	0.94	1.00
PGSC0003DMG200016691	K10775	ko00360	Phenylalanine metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMG200016691	K10775	ko00910	Nitrogen metabolism	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMG200016691	K10775	ko00940	Phenylpropanoid biosynthesis	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMG200016691	K10775	ko01100	Metabolic pathways	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMG200016691	K10775	ko01110	Biosynthesis of secondary metabolites	5063	2.0e-273	0.84	0.92	0.98
PGSC0003DMG200016691	K10775	ko00360	Phenylalanine metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMG200016691	K10775	ko00910	Nitrogen metabolism	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMG200016691	K10775	ko00940	Phenylpropanoid biosynthesis	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMG200016691	K10775	ko01100	Metabolic pathways	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMG200016691	K10775	ko01110	Biosynthesis of secondary metabolites	4894	4.3e-264	0.84	0.92	0.97
PGSC0003DMG200016693	K04506	ko04115	p53 signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMG200016693	K04506	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMG200016693	K04506	ko04310	Wnt signaling pathway	294	2.2e-10	0.29	0.44	0.45
PGSC0003DMG200016693	K04506	ko04115	p53 signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMG200016693	K04506	ko04120	Ubiquitin mediated proteolysis	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMG200016693	K04506	ko04310	Wnt signaling pathway	369	1.6e-14	0.31	0.45	0.64
PGSC0003DMG200016693	K04506	ko04115	p53 signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMG200016693	K04506	ko04120	Ubiquitin mediated proteolysis	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMG200016693	K04506	ko04310	Wnt signaling pathway	391	9.9e-16	0.32	0.50	0.47
PGSC0003DMG200016695	K08912	ko00196	Photosynthesis - antenna proteins	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMG200016695	K08912	ko01100	Metabolic pathways	2051	2.7e-107	0.89	0.94	1.00
PGSC0003DMG200016708	K13229	ko00402	Benzoxazinoid biosynthesis	298	1.3e-10	0.49	0.65	0.90
PGSC0003DMG200001988	K01081	ko00230	Purine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMG200001988	K01081	ko00240	Pyrimidine metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMG200001988	K01081	ko00760	Nicotinate and nicotinamide metabolism	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMG200001988	K01081	ko01100	Metabolic pathways	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMG200001988	K01081	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.41	0.62	0.93
PGSC0003DMG200001988	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko00230	Purine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMG200001988	K01081	ko00240	Pyrimidine metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMG200001988	K01081	ko00760	Nicotinate and nicotinamide metabolism	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMG200001988	K01081	ko01100	Metabolic pathways	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMG200001988	K01081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.44	0.65	0.92
PGSC0003DMG200001991	K02084	ko04115	p53 signaling pathway	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko04210	Apoptosis	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko05010	Alzheimer's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko05012	Parkinson's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko05016	Huntington's disease	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001991	K02084	ko05222	Small cell lung cancer	307	1.6e-07	0.27	0.45	0.43
PGSC0003DMG200001995	K07195	ko04910	Insulin signaling pathway	3859	5.2e-207	0.72	0.86	0.97
PGSC0003DMG200001997	K11818	ko00380	Tryptophan metabolism	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMG200001997	K11818	ko00966	Glucosinolate biosynthesis	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMG200001997	K11818	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.47	0.71	1.00
PGSC0003DMG200001997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.55	0.72	0.98
PGSC0003DMG200001997	K11818	ko00380	Tryptophan metabolism	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMG200001997	K11818	ko00966	Glucosinolate biosynthesis	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMG200001997	K11818	ko01110	Biosynthesis of secondary metabolites	1063	8.5e-53	0.45	0.71	0.99
PGSC0003DMG200002008	K02703	ko00195	Photosynthesis	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMG200002008	K02703	ko01100	Metabolic pathways	485	6.5e-21	0.92	0.97	0.98
PGSC0003DMG200011964	K08139	ko04113	Meiosis - yeast	915	1.2e-44	0.34	0.55	0.92
PGSC0003DMG200011964	K08139	ko04113	Meiosis - yeast	694	1.9e-32	0.36	0.59	0.94
PGSC0003DMG200011964	K08139	ko04113	Meiosis - yeast	1048	5.7e-52	0.36	0.58	0.89
PGSC0003DMG200011972	K12356	ko00940	Phenylpropanoid biosynthesis	780	3.5e-37	0.43	0.59	0.90
PGSC0003DMG200011979	K06627	ko04110	Cell cycle	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMG200011979	K06627	ko04914	Progesterone-mediated oocyte maturation	345	2.8e-18	0.44	0.54	0.77
PGSC0003DMG200011980	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMG200011980	K12128	ko04712	Circadian rhythm - plant	386	1.9e-15	0.28	0.47	0.68
PGSC0003DMG200037106	K10760	ko00908	Zeatin biosynthesis	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMG200037106	K10760	ko01100	Metabolic pathways	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMG200037106	K10760	ko01110	Biosynthesis of secondary metabolites	1054	2.7e-52	0.53	0.71	0.98
PGSC0003DMG200029389	K00600	ko00260	Glycine, serine and threonine metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029389	K00600	ko00460	Cyanoamino acid metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029389	K00600	ko00670	One carbon pool by folate	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029389	K00600	ko00680	Methane metabolism	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029389	K00600	ko01100	Metabolic pathways	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029389	K00600	ko01110	Biosynthesis of secondary metabolites	3789	3.8e-203	0.85	0.92	1.00
PGSC0003DMG200029390	K01369	ko04142	Lysosome	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMG200029390	K01369	ko04612	Antigen processing and presentation	3239	8.2e-173	0.76	0.87	0.99
PGSC0003DMG200029391	K00970	ko03018	RNA degradation	1893	1.4e-98	0.64	0.80	0.82
PGSC0003DMG200029391	K00970	ko03018	RNA degradation	3077	7.1e-164	0.67	0.82	0.87
PGSC0003DMG200029392	K11481	ko04114	Oocyte meiosis	431	6.2e-18	0.79	0.93	0.97
PGSC0003DMG200029392	K11481	ko04114	Oocyte meiosis	2309	1.6e-121	0.89	0.97	1.00
PGSC0003DMG200029393	K01867	ko00380	Tryptophan metabolism	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMG200029393	K01867	ko00970	Aminoacyl-tRNA biosynthesis	1652	2.8e-85	0.77	0.85	0.99
PGSC0003DMG200029393	K01867	ko00380	Tryptophan metabolism	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMG200029393	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2771	5.3e-147	0.80	0.88	1.00
PGSC0003DMG200029393	K01867	ko00380	Tryptophan metabolism	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMG200029393	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2782	1.3e-147	0.80	0.88	1.00
PGSC0003DMG200019333	K03111	ko03030	DNA replication	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMG200019333	K03111	ko03430	Mismatch repair	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMG200019333	K03111	ko03440	Homologous recombination	233	5.1e-07	0.32	0.48	0.45
PGSC0003DMG200019334	K12126	ko04712	Circadian rhythm - plant	294	3.4e-10	0.47	0.81	0.24
PGSC0003DMG200019336	K12183	ko04144	Endocytosis	725	3.7e-34	0.35	0.53	0.92
PGSC0003DMG200046838	K01955	ko00240	Pyrimidine metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMG200046838	K01955	ko00250	Alanine, aspartate and glutamate metabolism	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMG200046838	K01955	ko01100	Metabolic pathways	246	1.1e-06	0.46	0.65	0.42
PGSC0003DMG200046851	K01066	ko00623	2,4-Dichlorobenzoate degradation	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMG200046851	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	338	8.3e-13	0.41	0.56	0.91
PGSC0003DMG200000689	K01199	ko00500	Starch and sucrose metabolism	872	2.9e-42	0.38	0.58	0.72
PGSC0003DMG200000692	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMG200000692	K08139	ko04113	Meiosis - yeast	446	9.2e-19	0.37	0.55	0.89
PGSC0003DMG200000692	K08139	ko04113	Meiosis - yeast	303	7.1e-11	0.38	0.56	0.96
PGSC0003DMG200000692	K08139	ko04113	Meiosis - yeast	491	3.0e-21	0.39	0.62	0.97
PGSC0003DMG200000692	K08139	ko04113	Meiosis - yeast	530	2.1e-23	0.42	0.64	0.65
PGSC0003DMG200000693	K00430	ko00360	Phenylalanine metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMG200000693	K00430	ko00680	Methane metabolism	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMG200000693	K00430	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMG200000693	K00430	ko01100	Metabolic pathways	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMG200000693	K00430	ko01110	Biosynthesis of secondary metabolites	1850	3.3e-96	0.68	0.83	0.95
PGSC0003DMG200000694	K00430	ko00360	Phenylalanine metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMG200000694	K00430	ko00680	Methane metabolism	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMG200000694	K00430	ko00940	Phenylpropanoid biosynthesis	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMG200000694	K00430	ko01100	Metabolic pathways	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMG200000694	K00430	ko01110	Biosynthesis of secondary metabolites	1807	7.9e-94	0.69	0.84	0.97
PGSC0003DMG200000695	K11584	ko04113	Meiosis - yeast	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMG200000695	K11584	ko04114	Oocyte meiosis	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMG200000695	K11584	ko04310	Wnt signaling pathway	3528	9.4e-189	0.79	0.86	1.00
PGSC0003DMG200000703	K00558	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMG200000703	K00558	ko01100	Metabolic pathways	1941	3.2e-101	0.56	0.67	0.98
PGSC0003DMG200000703	K00558	ko00270	Cysteine and methionine metabolism	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMG200000703	K00558	ko01100	Metabolic pathways	2114	9.2e-111	0.48	0.60	0.86
PGSC0003DMG200015992	K02966	ko03010	Ribosome	1079	1.1e-53	0.87	0.93	0.99
PGSC0003DMG200015998	K02942	ko03010	Ribosome	685	6.0e-32	0.75	0.83	0.99
PGSC0003DMG200016001	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016001	K00261	ko00330	Arginine and proline metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016001	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016001	K00261	ko00910	Nitrogen metabolism	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016001	K00261	ko01100	Metabolic pathways	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016001	K00261	ko04964	Proximal tubule bicarbonate reclamation	3094	8.1e-165	0.88	0.95	1.00
PGSC0003DMG200016009	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016009	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016009	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016009	K01611	ko00270	Cysteine and methionine metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016009	K01611	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016009	K01611	ko01100	Metabolic pathways	2177	3.1e-114	0.75	0.84	0.98
PGSC0003DMG200016011	K02183	ko04020	Calcium signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04070	Phosphatidylinositol signaling system	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04114	Oocyte meiosis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04270	Vascular smooth muscle contraction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04626	Plant-pathogen interaction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04720	Long-term potentiation	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04722	Neurotrophin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04740	Olfactory transduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04744	Phototransduction	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04745	Phototransduction - fly	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04910	Insulin signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04912	GnRH signaling pathway	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04916	Melanogenesis	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04970	Salivary secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko04971	Gastric acid secretion	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko05010	Alzheimer's disease	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016011	K02183	ko05214	Glioma	483	8.3e-21	0.39	0.66	0.92
PGSC0003DMG200016012	K00558	ko00270	Cysteine and methionine metabolism	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMG200016012	K00558	ko01100	Metabolic pathways	1706	2.9e-88	0.44	0.58	0.76
PGSC0003DMG200016013	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMG200016013	K00517	ko00626	Naphthalene and anthracene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMG200016013	K00517	ko00903	Limonene and pinene degradation	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMG200016013	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMG200016013	K00517	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.43	0.63	0.98
PGSC0003DMG200016014	K01597	ko00900	Terpenoid backbone biosynthesis	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMG200016014	K01597	ko01100	Metabolic pathways	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMG200016014	K01597	ko01110	Biosynthesis of secondary metabolites	2896	6.8e-154	0.80	0.89	1.00
PGSC0003DMG200012634	K03980	ko00550	Peptidoglycan biosynthesis	492	1.6e-25	0.34	0.49	0.62
PGSC0003DMG200012634	K03980	ko00550	Peptidoglycan biosynthesis	534	1.3e-23	0.41	0.62	0.92
PGSC0003DMG200012635	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMG200012635	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMG200012635	K00737	ko00510	N-Glycan biosynthesis	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMG200012635	K00737	ko01100	Metabolic pathways	371	1.3e-14	0.29	0.45	0.72
PGSC0003DMG200012640	K01728	ko00040	Pentose and glucuronate interconversions	2728	1.3e-144	0.76	0.87	0.99
PGSC0003DMG200012642	K00100	ko00051	Fructose and mannose metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K00100	ko00363	Bisphenol A degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K00100	ko00591	Linoleic acid metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K00100	ko00625	Tetrachloroethene degradation	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K00100	ko00650	Butanoate metabolism	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K00100	ko01100	Metabolic pathways	637	2.7e-29	0.43	0.64	0.95
PGSC0003DMG200012642	K10251	ko01040	Biosynthesis of unsaturated fatty acids	856	2.2e-41	0.41	0.61	0.93
PGSC0003DMG200012647	K01814	ko00340	Histidine metabolism	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMG200012647	K01814	ko01100	Metabolic pathways	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMG200012647	K01814	ko01110	Biosynthesis of secondary metabolites	299	1.2e-10	0.41	0.62	0.67
PGSC0003DMG200012647	K01814	ko00340	Histidine metabolism	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMG200012647	K01814	ko01100	Metabolic pathways	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMG200012647	K01814	ko01110	Biosynthesis of secondary metabolites	227	1.1e-06	0.49	0.68	0.87
PGSC0003DMG200002665	K10865	ko03440	Homologous recombination	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMG200002665	K10865	ko03450	Non-homologous end-joining	4957	1.4e-267	0.80	0.90	1.00
PGSC0003DMG200002665	K10865	ko03440	Homologous recombination	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMG200002665	K10865	ko03450	Non-homologous end-joining	2080	6.9e-109	0.71	0.85	0.99
PGSC0003DMG200002669	K10865	ko03440	Homologous recombination	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMG200002669	K10865	ko03450	Non-homologous end-joining	1396	3.7e-71	0.91	0.97	0.58
PGSC0003DMG200002671	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMG200002671	K12873	ko03040	Spliceosome	1278	1.2e-64	0.96	0.98	0.99
PGSC0003DMG200002673	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMG200002673	K12183	ko04144	Endocytosis	2319	4.5e-122	0.66	0.81	0.99
PGSC0003DMG200002675	K01623	ko00010	Glycolysis / Gluconeogenesis	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko00030	Pentose phosphate pathway	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko00710	Carbon fixation in photosynthetic organisms	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko01100	Metabolic pathways	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.87	0.93	1.00
PGSC0003DMG200002675	K01623	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002675	K01623	ko00030	Pentose phosphate pathway	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002675	K01623	ko00051	Fructose and mannose metabolism	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002675	K01623	ko00710	Carbon fixation in photosynthetic organisms	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002675	K01623	ko01100	Metabolic pathways	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002675	K01623	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.86	0.93	1.00
PGSC0003DMG200002680	K09540	ko03060	Protein export	4426	2.8e-238	0.76	0.87	1.00
PGSC0003DMG200002680	K09540	ko03060	Protein export	1560	3.3e-80	0.70	0.83	0.97
PGSC0003DMG200008396	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMG200008396	K02366	ko01100	Metabolic pathways	337	5.1e-11	0.29	0.43	0.62
PGSC0003DMG200008403	K04733	ko04210	Apoptosis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMG200008403	K04733	ko04620	Toll-like receptor signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMG200008403	K04733	ko04722	Neurotrophin signaling pathway	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMG200008403	K04733	ko05140	Leishmaniasis	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMG200008403	K04733	ko05142	Chagas disease	1016	3.3e-50	0.44	0.63	0.83
PGSC0003DMG200008403	K04733	ko04210	Apoptosis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMG200008403	K04733	ko04620	Toll-like receptor signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMG200008403	K04733	ko04722	Neurotrophin signaling pathway	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMG200008403	K04733	ko05140	Leishmaniasis	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMG200008403	K04733	ko05142	Chagas disease	1047	6.5e-52	0.42	0.62	0.71
PGSC0003DMG200008403	K04733	ko04210	Apoptosis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMG200008403	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMG200008403	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMG200008403	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMG200008403	K04733	ko05142	Chagas disease	1058	1.6e-52	0.38	0.55	0.64
PGSC0003DMG200008404	K02087	ko04110	Cell cycle	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMG200008404	K02087	ko04114	Oocyte meiosis	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMG200008404	K02087	ko04115	p53 signaling pathway	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMG200008404	K02087	ko04540	Gap junction	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMG200008404	K02087	ko04914	Progesterone-mediated oocyte maturation	242	3.3e-07	0.26	0.42	0.67
PGSC0003DMG200025035	K00979	ko00540	Lipopolysaccharide biosynthesis	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMG200025035	K00979	ko01100	Metabolic pathways	2247	4.2e-118	0.89	0.96	1.00
PGSC0003DMG200025036	K03514	ko03018	RNA degradation	454	3.3e-19	0.66	0.78	0.62
PGSC0003DMG200025036	K03514	ko03018	RNA degradation	998	3.3e-49	0.69	0.81	0.76
PGSC0003DMG200025036	K03514	ko03018	RNA degradation	2644	5.4e-140	0.69	0.80	0.90
PGSC0003DMG200025037	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.49
PGSC0003DMG200025037	K10581	ko04120	Ubiquitin mediated proteolysis	1218	2.4e-61	0.47	0.61	0.53
PGSC0003DMG200025038	K02260	ko00190	Oxidative phosphorylation	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMG200025038	K02260	ko01100	Metabolic pathways	493	2.3e-21	0.69	0.88	0.99
PGSC0003DMG200025040	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMG200025040	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMG200025040	K00771	ko01100	Metabolic pathways	461	5.3e-19	0.31	0.49	0.81
PGSC0003DMG200025041	K09880	ko00270	Cysteine and methionine metabolism	2120	4.3e-111	0.56	0.62	0.99
PGSC0003DMG200025042	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMG200025042	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.66
PGSC0003DMG200025042	K10955	ko05110	Vibrio cholerae infection	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMG200025042	K10955	ko05146	Amoebiasis	365	1.4e-12	0.30	0.51	0.52
PGSC0003DMG200025055	K00760	ko00230	Purine metabolism	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMG200025055	K00760	ko00983	Drug metabolism - other enzymes	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMG200025055	K00760	ko01100	Metabolic pathways	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMG200025055	K00760	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.70	0.84	0.99
PGSC0003DMG200031113	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMG200031113	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMG200031113	K00020	ko00280	Valine, leucine and isoleucine degradation	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMG200031113	K00020	ko01100	Metabolic pathways	1077	1.4e-53	0.49	0.70	0.99
PGSC0003DMG200031122	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMG200031122	K06127	ko01100	Metabolic pathways	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMG200031122	K06127	ko01110	Biosynthesis of secondary metabolites	1835	2.2e-95	0.76	0.86	0.99
PGSC0003DMG200024032	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	216	8.7e-06	0.40	0.54	0.82
PGSC0003DMG200024037	K02885	ko03010	Ribosome	764	2.6e-36	0.99	0.99	0.57
PGSC0003DMG200024037	K02885	ko03010	Ribosome	1005	1.3e-49	0.98	0.99	0.99
PGSC0003DMG200024038	K10532	ko00531	Glycosaminoglycan degradation	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMG200024038	K10532	ko01100	Metabolic pathways	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMG200024038	K10532	ko04142	Lysosome	2607	5.9e-138	0.65	0.76	1.00
PGSC0003DMG200024038	K10532	ko00531	Glycosaminoglycan degradation	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMG200024038	K10532	ko01100	Metabolic pathways	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMG200024038	K10532	ko04142	Lysosome	2437	1.4e-128	0.66	0.77	0.95
PGSC0003DMG200024038	K10532	ko00531	Glycosaminoglycan degradation	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMG200024038	K10532	ko01100	Metabolic pathways	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMG200024038	K10532	ko04142	Lysosome	2692	1.2e-142	0.66	0.78	1.00
PGSC0003DMG200024038	K10532	ko00531	Glycosaminoglycan degradation	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMG200024038	K10532	ko01100	Metabolic pathways	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMG200024038	K10532	ko04142	Lysosome	1604	1.2e-82	0.67	0.78	0.93
PGSC0003DMG200024038	K10532	ko00531	Glycosaminoglycan degradation	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMG200024038	K10532	ko01100	Metabolic pathways	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMG200024038	K10532	ko04142	Lysosome	1409	7.0e-72	0.70	0.80	0.82
PGSC0003DMG200024039	K02986	ko03010	Ribosome	1292	2.0e-65	0.87	0.92	0.99
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	1406	1.0e-71	0.43	0.60	0.92
PGSC0003DMG200018126	K12467	ko00902	Monoterpenoid biosynthesis	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMG200018126	K12467	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.41	0.63	0.86
PGSC0003DMG200018126	K12467	ko00902	Monoterpenoid biosynthesis	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMG200018126	K12467	ko01110	Biosynthesis of secondary metabolites	820	2.2e-39	0.41	0.62	0.92
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	400	3.2e-16	0.45	0.67	0.86
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	854	2.9e-41	0.58	0.75	0.88
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	692	2.5e-32	0.56	0.74	0.98
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	689	3.6e-32	0.56	0.74	0.98
PGSC0003DMG200018126	K07385	ko00902	Monoterpenoid biosynthesis	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMG200018126	K07385	ko01100	Metabolic pathways	289	7.8e-10	0.61	0.79	0.90
PGSC0003DMG200028818	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMG200028818	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMG200028818	K12135	ko04712	Circadian rhythm - plant	278	1.7e-09	0.42	0.56	0.21
PGSC0003DMG200028820	K12741	ko03040	Spliceosome	358	6.5e-14	0.39	0.54	0.72
PGSC0003DMG200028822	K00857	ko00240	Pyrimidine metabolism	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMG200028822	K00857	ko00983	Drug metabolism - other enzymes	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMG200028822	K00857	ko01100	Metabolic pathways	1337	6.6e-68	0.70	0.85	0.93
PGSC0003DMG200014413	K03131	ko03022	Basal transcription factors	1421	1.5e-72	0.64	0.75	1.00
PGSC0003DMG200014413	K03131	ko03022	Basal transcription factors	3169	5.9e-169	0.70	0.82	1.00
PGSC0003DMG200014414	K12476	ko04144	Endocytosis	1873	1.8e-97	0.53	0.68	0.84
PGSC0003DMG200014414	K12476	ko04144	Endocytosis	1872	2.0e-97	0.53	0.68	0.84
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	1109	2.5e-55	0.83	0.88	0.82
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	2230	3.7e-117	0.86	0.89	1.00
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	1102	6.0e-55	0.83	0.88	0.98
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014418	K12606	ko03018	RNA degradation	818	2.8e-39	0.77	0.84	0.99
PGSC0003DMG200014419	K12606	ko03018	RNA degradation	1353	8.6e-69	0.58	0.64	0.99
PGSC0003DMG200014419	K12606	ko03018	RNA degradation	897	1.2e-43	0.84	0.90	0.98
PGSC0003DMG200006924	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMG200006924	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMG200006924	K01046	ko00561	Glycerolipid metabolism	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMG200006924	K01046	ko01100	Metabolic pathways	967	1.7e-47	0.39	0.57	0.85
PGSC0003DMG200006924	K01052	ko00100	Steroid biosynthesis	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMG200006924	K01052	ko04142	Lysosome	634	3.9e-29	0.40	0.55	0.94
PGSC0003DMG200010739	K10594	ko04120	Ubiquitin mediated proteolysis	544	1.6e-22	0.32	0.49	0.89
PGSC0003DMG200010739	K10595	ko04120	Ubiquitin mediated proteolysis	606	6.1e-26	0.32	0.48	0.96
PGSC0003DMG200010739	K10615	ko04120	Ubiquitin mediated proteolysis	535	4.3e-23	0.32	0.51	0.85
PGSC0003DMG200010740	K03217	ko03060	Protein export	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMG200010740	K03217	ko03070	Bacterial secretion system	2245	5.5e-118	0.70	0.82	0.98
PGSC0003DMG200010740	K03217	ko03060	Protein export	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMG200010740	K03217	ko03070	Bacterial secretion system	811	6.8e-39	0.49	0.63	1.00
PGSC0003DMG200010740	K03217	ko03060	Protein export	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMG200010740	K03217	ko03070	Bacterial secretion system	2499	5.3e-132	0.61	0.72	1.00
PGSC0003DMG200010742	K10251	ko01040	Biosynthesis of unsaturated fatty acids	831	5.3e-40	0.39	0.62	0.95
PGSC0003DMG200006965	K00006	ko00564	Glycerophospholipid metabolism	2140	3.4e-112	0.84	0.92	0.99
PGSC0003DMG200006965	K00006	ko00564	Glycerophospholipid metabolism	2621	1.0e-138	0.84	0.92	1.00
PGSC0003DMG200006969	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.56
PGSC0003DMG200006969	K10652	ko04622	RIG-I-like receptor signaling pathway	287	2.2e-09	0.35	0.46	0.57
PGSC0003DMG200006969	K10652	ko04622	RIG-I-like receptor signaling pathway	265	3.9e-08	0.35	0.47	0.56
PGSC0003DMG200006969	K10652	ko04622	RIG-I-like receptor signaling pathway	260	4.1e-06	0.32	0.44	0.57
PGSC0003DMG200006970	K11584	ko04113	Meiosis - yeast	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMG200006970	K11584	ko04114	Oocyte meiosis	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMG200006970	K11584	ko04310	Wnt signaling pathway	3622	6.1e-194	0.81	0.89	1.00
PGSC0003DMG200003947	K10352	ko04530	Tight junction	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMG200003947	K10352	ko05416	Viral myocarditis	303	1.3e-07	0.28	0.44	0.85
PGSC0003DMG200003952	K01358	ko04112	Cell cycle - Caulobacter	1751	9.6e-91	0.70	0.86	1.00
PGSC0003DMG200003953	K10845	ko03420	Nucleotide excision repair	457	2.3e-19	0.75	0.90	0.97
PGSC0003DMG200003959	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko00362	Benzoate degradation via hydroxylation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko00632	Benzoate degradation via CoA ligation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko00903	Limonene and pinene degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko00930	Caprolactam degradation	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko01100	Metabolic pathways	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003959	K01559	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.27	0.46	0.65
PGSC0003DMG200003960	K08679	ko00500	Starch and sucrose metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMG200003960	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMG200003960	K08679	ko01100	Metabolic pathways	2742	2.1e-145	0.74	0.83	0.98
PGSC0003DMG200003960	K08679	ko00500	Starch and sucrose metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMG200003960	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMG200003960	K08679	ko01100	Metabolic pathways	1419	2.0e-72	0.48	0.55	0.97
PGSC0003DMG200003961	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMG200003961	K00517	ko00626	Naphthalene and anthracene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMG200003961	K00517	ko00903	Limonene and pinene degradation	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMG200003961	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMG200003961	K00517	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.39	0.59	0.96
PGSC0003DMG200038590	K03094	ko04110	Cell cycle	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04111	Cell cycle - yeast	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04114	Oocyte meiosis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04120	Ubiquitin mediated proteolysis	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04310	Wnt signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04350	TGF-beta signaling pathway	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200038590	K03094	ko04710	Circadian rhythm - mammal	397	4.6e-16	0.55	0.70	0.98
PGSC0003DMG200044451	K09490	ko03060	Protein export	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMG200044451	K09490	ko05020	Prion diseases	725	3.7e-34	0.86	0.92	0.96
PGSC0003DMG200044453	K10760	ko00908	Zeatin biosynthesis	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMG200044453	K10760	ko01100	Metabolic pathways	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMG200044453	K10760	ko01110	Biosynthesis of secondary metabolites	581	3.3e-26	0.41	0.63	0.96
PGSC0003DMG200025089	K05280	ko00941	Flavonoid biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMG200025089	K05280	ko00944	Flavone and flavonol biosynthesis	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMG200025089	K05280	ko01100	Metabolic pathways	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMG200025089	K05280	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.39	0.58	0.80
PGSC0003DMG200025089	K05280	ko00941	Flavonoid biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMG200025089	K05280	ko00944	Flavone and flavonol biosynthesis	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMG200025089	K05280	ko01100	Metabolic pathways	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMG200025089	K05280	ko01110	Biosynthesis of secondary metabolites	1225	9.9e-62	0.38	0.57	1.00
PGSC0003DMG200025098	K09835	ko00906	Carotenoid biosynthesis	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMG200025098	K09835	ko01100	Metabolic pathways	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMG200025098	K09835	ko01110	Biosynthesis of secondary metabolites	650	5.1e-30	0.42	0.62	0.91
PGSC0003DMG200025098	K09835	ko00906	Carotenoid biosynthesis	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMG200025098	K09835	ko01100	Metabolic pathways	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMG200025098	K09835	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.42	0.61	0.96
PGSC0003DMG200025098	K09835	ko00906	Carotenoid biosynthesis	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMG200025098	K09835	ko01100	Metabolic pathways	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMG200025098	K09835	ko01110	Biosynthesis of secondary metabolites	1104	4.7e-55	0.38	0.54	0.92
PGSC0003DMG200025098	K09835	ko00906	Carotenoid biosynthesis	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMG200025098	K09835	ko01100	Metabolic pathways	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMG200025098	K09835	ko01110	Biosynthesis of secondary metabolites	867	5.5e-42	0.40	0.57	0.91
PGSC0003DMG200025102	K00558	ko00270	Cysteine and methionine metabolism	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMG200025102	K00558	ko01100	Metabolic pathways	1458	1.4e-74	0.45	0.55	0.73
PGSC0003DMG200025102	K00558	ko00270	Cysteine and methionine metabolism	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMG200025102	K00558	ko01100	Metabolic pathways	1784	1.5e-92	0.44	0.56	0.77
PGSC0003DMG200025103	K01500	ko00791	Atrazine degradation	596	4.9e-27	0.49	0.64	0.83
PGSC0003DMG200025103	K01500	ko00791	Atrazine degradation	610	4.4e-27	0.49	0.63	0.13
PGSC0003DMG200025105	K01423	ko00310	Lysine degradation	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMG200025105	K01423	ko00780	Biotin metabolism	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMG200025105	K01423	ko01100	Metabolic pathways	318	1.1e-11	0.31	0.46	0.58
PGSC0003DMG200025105	K01423	ko00310	Lysine degradation	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMG200025105	K01423	ko00780	Biotin metabolism	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMG200025105	K01423	ko01100	Metabolic pathways	308	3.7e-11	0.32	0.47	0.46
PGSC0003DMG200025105	K01066	ko00623	2,4-Dichlorobenzoate degradation	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMG200025105	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.29	0.48	0.54
PGSC0003DMG200025105	K01432	ko00380	Tryptophan metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMG200025105	K01432	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMG200025105	K01432	ko01100	Metabolic pathways	303	7.1e-11	0.35	0.51	0.45
PGSC0003DMG200022117	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMG200022117	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMG200022117	K04424	ko04010	MAPK signaling pathway	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMG200022117	K04424	ko04530	Tight junction	695	3.9e-32	0.39	0.59	0.24
PGSC0003DMG200022117	K13237	ko04146	Peroxisome	1261	1.0e-63	0.86	0.92	0.99
PGSC0003DMG200022118	K00927	ko00010	Glycolysis / Gluconeogenesis	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMG200022118	K00927	ko00710	Carbon fixation in photosynthetic organisms	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMG200022118	K00927	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMG200022118	K00927	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.72	0.80	0.92
PGSC0003DMG200022118	K00927	ko00010	Glycolysis / Gluconeogenesis	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMG200022118	K00927	ko00710	Carbon fixation in photosynthetic organisms	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMG200022118	K00927	ko01100	Metabolic pathways	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMG200022118	K00927	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.86	0.91	1.00
PGSC0003DMG200022119	K00927	ko00010	Glycolysis / Gluconeogenesis	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMG200022119	K00927	ko00710	Carbon fixation in photosynthetic organisms	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMG200022119	K00927	ko01100	Metabolic pathways	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMG200022119	K00927	ko01110	Biosynthesis of secondary metabolites	2991	3.9e-159	0.90	0.96	1.00
PGSC0003DMG200022122	K09561	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.30	0.52	0.71
PGSC0003DMG200022126	K01749	ko00860	Porphyrin and chlorophyll metabolism	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMG200022126	K01749	ko01100	Metabolic pathways	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMG200022126	K01749	ko01110	Biosynthesis of secondary metabolites	2356	4.1e-124	0.82	0.91	0.95
PGSC0003DMG200030769	K06061	ko04330	Notch signaling pathway	299	6.5e-13	0.28	0.39	0.60
PGSC0003DMG200030769	K04498	ko04110	Cell cycle	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04310	Wnt signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04330	Notch signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04350	TGF-beta signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04520	Adherens junction	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04630	Jak-STAT signaling pathway	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04720	Long-term potentiation	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko04916	Melanogenesis	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko05016	Huntington's disease	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko05200	Pathways in cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko05211	Renal cell carcinoma	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030769	K04498	ko05215	Prostate cancer	358	1.7e-10	0.30	0.44	0.66
PGSC0003DMG200030771	K00001	ko00010	Glycolysis / Gluconeogenesis	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00071	Fatty acid metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00350	Tyrosine metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00624	1- and 2-Methylnaphthalene degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00641	3-Chloroacrylic acid degradation	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00830	Retinol metabolism	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00982	Drug metabolism - cytochrome P450	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko01100	Metabolic pathways	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.81	0.88	0.97
PGSC0003DMG200030771	K00001	ko00010	Glycolysis / Gluconeogenesis	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00071	Fatty acid metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00350	Tyrosine metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00641	3-Chloroacrylic acid degradation	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00830	Retinol metabolism	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko00982	Drug metabolism - cytochrome P450	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko01100	Metabolic pathways	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030771	K00001	ko01110	Biosynthesis of secondary metabolites	2837	1.2e-150	0.86	0.94	1.00
PGSC0003DMG200030772	K03921	ko00061	Fatty acid biosynthesis	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMG200030772	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1166	1.8e-58	0.66	0.83	1.00
PGSC0003DMG200030772	K03921	ko00061	Fatty acid biosynthesis	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMG200030772	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1015	3.8e-50	0.66	0.82	0.99
PGSC0003DMG200030773	K03921	ko00061	Fatty acid biosynthesis	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMG200030773	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2020	1.4e-105	0.64	0.79	0.95
PGSC0003DMG200030774	K03921	ko00061	Fatty acid biosynthesis	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMG200030774	K03921	ko01040	Biosynthesis of unsaturated fatty acids	752	1.2e-35	0.68	0.83	0.98
PGSC0003DMG200030775	K03921	ko00061	Fatty acid biosynthesis	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMG200030775	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1546	2.0e-79	0.68	0.83	0.99
PGSC0003DMG200030775	K03921	ko00061	Fatty acid biosynthesis	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMG200030775	K03921	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.55	0.72	0.82
PGSC0003DMG200030776	K03921	ko00061	Fatty acid biosynthesis	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMG200030776	K03921	ko01040	Biosynthesis of unsaturated fatty acids	1986	1.1e-103	0.63	0.78	0.95
PGSC0003DMG200018013	K13065	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMG200018013	K13065	ko00941	Flavonoid biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMG200018013	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMG200018013	K13065	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.28	0.45	0.80
PGSC0003DMG200018031	K00430	ko00360	Phenylalanine metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMG200018031	K00430	ko00680	Methane metabolism	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMG200018031	K00430	ko00940	Phenylpropanoid biosynthesis	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMG200018031	K00430	ko01100	Metabolic pathways	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMG200018031	K00430	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.67	0.81	0.95
PGSC0003DMG200005838	K01897	ko00071	Fatty acid metabolism	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMG200005838	K01897	ko01100	Metabolic pathways	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMG200005838	K01897	ko03320	PPAR signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMG200005838	K01897	ko04146	Peroxisome	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMG200005838	K01897	ko04920	Adipocytokine signaling pathway	669	4.6e-31	0.72	0.88	0.87
PGSC0003DMG200005839	K03217	ko03060	Protein export	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMG200005839	K03217	ko03070	Bacterial secretion system	1609	6.6e-83	0.56	0.71	0.99
PGSC0003DMG200005839	K03217	ko03060	Protein export	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMG200005839	K03217	ko03070	Bacterial secretion system	310	2.9e-11	0.44	0.58	0.96
PGSC0003DMG200005839	K03217	ko03060	Protein export	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMG200005839	K03217	ko03070	Bacterial secretion system	1841	1.0e-95	0.52	0.66	1.00
PGSC0003DMG200005840	K06268	ko04010	MAPK signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04020	Calcium signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04114	Oocyte meiosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04210	Apoptosis	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04310	Wnt signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04360	Axon guidance	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04370	VEGF signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04660	T cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko04720	Long-term potentiation	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko05010	Alzheimer's disease	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005840	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.58	0.81	0.98
PGSC0003DMG200005841	K06268	ko04010	MAPK signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04020	Calcium signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04114	Oocyte meiosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04210	Apoptosis	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04310	Wnt signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04360	Axon guidance	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04370	VEGF signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04650	Natural killer cell mediated cytotoxicity	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04660	T cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04662	B cell receptor signaling pathway	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko04720	Long-term potentiation	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko05010	Alzheimer's disease	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005841	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	364	3.1e-14	0.51	0.76	0.84
PGSC0003DMG200005846	K00059	ko00061	Fatty acid biosynthesis	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMG200005846	K00059	ko01040	Biosynthesis of unsaturated fatty acids	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMG200005846	K00059	ko01100	Metabolic pathways	576	6.2e-26	0.78	0.92	0.99
PGSC0003DMG200005851	K12660	ko00051	Fructose and mannose metabolism	570	1.3e-25	0.36	0.57	0.71
PGSC0003DMG200009501	K02294	ko00906	Carotenoid biosynthesis	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMG200009501	K02294	ko01100	Metabolic pathways	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMG200009501	K02294	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.51	0.62	0.91
PGSC0003DMG200009506	K12869	ko03040	Spliceosome	4223	4.4e-227	0.74	0.82	0.99
PGSC0003DMG200009509	K04079	ko04612	Antigen processing and presentation	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009509	K04079	ko04621	NOD-like receptor signaling pathway	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009509	K04079	ko04626	Plant-pathogen interaction	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009509	K04079	ko04914	Progesterone-mediated oocyte maturation	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009509	K04079	ko05200	Pathways in cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009509	K04079	ko05215	Prostate cancer	5613	0.	0.96	0.99	1.00
PGSC0003DMG200009510	K01213	ko00040	Pentose and glucuronate interconversions	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMG200009510	K01213	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMG200009510	K01213	ko01100	Metabolic pathways	797	4.0e-38	0.33	0.52	0.76
PGSC0003DMG200008349	K02084	ko04115	p53 signaling pathway	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko04210	Apoptosis	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko05010	Alzheimer's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko05012	Parkinson's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko05016	Huntington's disease	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008349	K02084	ko05222	Small cell lung cancer	340	2.1e-09	0.32	0.48	0.34
PGSC0003DMG200008350	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMG200008350	K02979	ko03010	Ribosome	507	4.0e-22	0.94	0.97	0.98
PGSC0003DMG200008351	K02989	ko03010	Ribosome	1260	1.2e-63	0.97	0.99	0.99
PGSC0003DMG200008356	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00330	Arginine and proline metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko00910	Nitrogen metabolism	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko01100	Metabolic pathways	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200008356	K00261	ko04964	Proximal tubule bicarbonate reclamation	3265	3.0e-174	0.93	0.96	1.00
PGSC0003DMG200046343	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200046343	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200046343	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200046345	K02872	ko03010	Ribosome	1509	2.1e-77	0.89	0.95	0.98
PGSC0003DMG200046352	K00791	ko00908	Zeatin biosynthesis	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMG200046352	K00791	ko01100	Metabolic pathways	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMG200046352	K00791	ko01110	Biosynthesis of secondary metabolites	283	3.3e-19	0.56	0.78	0.96
PGSC0003DMG200042593	K02707	ko00195	Photosynthesis	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMG200042593	K02707	ko01100	Metabolic pathways	716	1.2e-33	1.00	1.00	0.99
PGSC0003DMG200042597	K04508	ko04310	Wnt signaling pathway	2837	1.2e-150	0.66	0.80	0.99
PGSC0003DMG200022597	K00117	ko00030	Pentose phosphate pathway	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMG200022597	K00117	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMG200022597	K00117	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.35	0.48	0.56
PGSC0003DMG200022597	K00117	ko00030	Pentose phosphate pathway	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMG200022597	K00117	ko01100	Metabolic pathways	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMG200022597	K00117	ko01110	Biosynthesis of secondary metabolites	855	2.5e-41	0.34	0.50	0.62
PGSC0003DMG200022597	K00100	ko00051	Fructose and mannose metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022597	K00100	ko00363	Bisphenol A degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022597	K00100	ko00591	Linoleic acid metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022597	K00100	ko00625	Tetrachloroethene degradation	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022597	K00100	ko00650	Butanoate metabolism	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022597	K00100	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.61	0.93
PGSC0003DMG200022600	K12126	ko04712	Circadian rhythm - plant	337	9.4e-13	0.40	0.60	0.58
PGSC0003DMG200022600	K12126	ko04712	Circadian rhythm - plant	363	3.5e-14	0.37	0.53	0.70
PGSC0003DMG200022604	K04382	ko04111	Cell cycle - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04113	Meiosis - yeast	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04114	Oocyte meiosis	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04310	Wnt signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04350	TGF-beta signaling pathway	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04530	Tight junction	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko04730	Long-term depression	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022604	K04382	ko05142	Chagas disease	2598	1.9e-137	0.95	0.98	1.00
PGSC0003DMG200022606	K11644	ko05016	Huntington's disease	4257	5.8e-229	0.60	0.72	1.00
PGSC0003DMG200022606	K11644	ko05016	Huntington's disease	6612	0.	0.59	0.72	0.99
PGSC0003DMG200022606	K11644	ko05016	Huntington's disease	6616	0.	0.59	0.72	0.99
PGSC0003DMG200022607	K00161	ko00010	Glycolysis / Gluconeogenesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko00020	Citrate cycle (TCA cycle)	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko00620	Pyruvate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko00650	Butanoate metabolism	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko01100	Metabolic pathways	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022607	K00161	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200022608	K00754	ko00051	Fructose and mannose metabolism	366	2.4e-14	0.27	0.47	0.81
PGSC0003DMG200026272	K00588	ko00360	Phenylalanine metabolism	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko01100	Metabolic pathways	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.51	0.76	0.86
PGSC0003DMG200026272	K00588	ko00360	Phenylalanine metabolism	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko00940	Phenylpropanoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko00941	Flavonoid biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko01100	Metabolic pathways	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko01110	Biosynthesis of secondary metabolites	450	2.4e-22	0.49	0.73	0.98
PGSC0003DMG200026272	K00588	ko00360	Phenylalanine metabolism	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko00941	Flavonoid biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko01100	Metabolic pathways	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.52	0.75	0.76
PGSC0003DMG200026272	K00588	ko00360	Phenylalanine metabolism	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026272	K00588	ko00940	Phenylpropanoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026272	K00588	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026272	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026272	K00588	ko01100	Metabolic pathways	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026272	K00588	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.51	0.73	0.99
PGSC0003DMG200026275	K13230	ko00402	Benzoxazinoid biosynthesis	851	4.2e-41	0.36	0.53	0.99
PGSC0003DMG200026275	K13230	ko00402	Benzoxazinoid biosynthesis	332	1.8e-12	0.40	0.59	0.99
PGSC0003DMG200026276	K05277	ko00941	Flavonoid biosynthesis	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMG200026276	K05277	ko01100	Metabolic pathways	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMG200026276	K05277	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.43	0.61	0.59
PGSC0003DMG200026276	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMG200026276	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMG200026276	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.62
PGSC0003DMG200026276	K05277	ko00941	Flavonoid biosynthesis	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMG200026276	K05277	ko01100	Metabolic pathways	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMG200026276	K05277	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.43	0.61	0.94
PGSC0003DMG200026277	K05277	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMG200026277	K05277	ko01100	Metabolic pathways	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMG200026277	K05277	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.34	0.53	0.97
PGSC0003DMG200026277	K05277	ko00941	Flavonoid biosynthesis	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMG200026277	K05277	ko01100	Metabolic pathways	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMG200026277	K05277	ko01110	Biosynthesis of secondary metabolites	266	7.8e-09	0.28	0.45	0.87
PGSC0003DMG200026279	K07385	ko00902	Monoterpenoid biosynthesis	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMG200026279	K07385	ko01100	Metabolic pathways	1169	1.2e-58	0.54	0.70	0.98
PGSC0003DMG200026280	K01590	ko00340	Histidine metabolism	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMG200026280	K01590	ko01100	Metabolic pathways	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMG200026280	K01590	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.46	0.63	0.95
PGSC0003DMG200026280	K01590	ko00340	Histidine metabolism	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMG200026280	K01590	ko01100	Metabolic pathways	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMG200026280	K01590	ko01110	Biosynthesis of secondary metabolites	2212	3.6e-116	0.58	0.74	0.97
PGSC0003DMG200026281	K00432	ko00480	Glutathione metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMG200026281	K00432	ko00590	Arachidonic acid metabolism	1357	5.2e-69	0.70	0.79	1.00
PGSC0003DMG200026285	K01613	ko00564	Glycerophospholipid metabolism	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMG200026285	K01613	ko01100	Metabolic pathways	428	9.0e-18	0.34	0.58	0.92
PGSC0003DMG200034479	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMG200034479	K00517	ko00626	Naphthalene and anthracene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMG200034479	K00517	ko00903	Limonene and pinene degradation	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMG200034479	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMG200034479	K00517	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.55	0.71	0.56
PGSC0003DMG200034487	K12818	ko03040	Spliceosome	6479	0.	0.94	0.98	1.00
PGSC0003DMG200034489	K01507	ko00190	Oxidative phosphorylation	456	2.6e-19	0.90	0.94	0.95
PGSC0003DMG200041388	K10760	ko00908	Zeatin biosynthesis	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMG200041388	K10760	ko01100	Metabolic pathways	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMG200041388	K10760	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.43	0.66	0.86
PGSC0003DMG200041395	K00791	ko00908	Zeatin biosynthesis	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMG200041395	K00791	ko01100	Metabolic pathways	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMG200041395	K00791	ko01110	Biosynthesis of secondary metabolites	321	6.0e-26	0.42	0.62	0.99
PGSC0003DMG200041401	K10760	ko00908	Zeatin biosynthesis	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMG200041401	K10760	ko01100	Metabolic pathways	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMG200041401	K10760	ko01110	Biosynthesis of secondary metabolites	256	1.6e-15	0.64	0.81	0.95
PGSC0003DMG200008884	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMG200008884	K00517	ko00626	Naphthalene and anthracene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMG200008884	K00517	ko00903	Limonene and pinene degradation	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMG200008884	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMG200008884	K00517	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.44	0.64	0.98
PGSC0003DMG200008887	K08269	ko04140	Regulation of autophagy	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMG200008887	K08269	ko04150	mTOR signaling pathway	2297	7.4e-121	0.76	0.84	0.83
PGSC0003DMG200008887	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMG200008887	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMG200008887	K08269	ko04140	Regulation of autophagy	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMG200008887	K08269	ko04150	mTOR signaling pathway	2507	1.9e-132	0.61	0.72	1.00
PGSC0003DMG200008887	K08269	ko04140	Regulation of autophagy	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMG200008887	K08269	ko04150	mTOR signaling pathway	1363	2.4e-69	0.63	0.74	0.99
PGSC0003DMG200008887	K08269	ko04140	Regulation of autophagy	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMG200008887	K08269	ko04150	mTOR signaling pathway	3801	8.2e-204	0.67	0.77	1.00
PGSC0003DMG200008888	K00761	ko00240	Pyrimidine metabolism	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMG200008888	K00761	ko01100	Metabolic pathways	1031	5.0e-51	0.89	0.98	0.99
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.66	0.78	0.99
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.69	0.82	0.92
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200005155	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.34	0.52	0.84
PGSC0003DMG200005155	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	416	7.0e-17	0.37	0.54	0.89
PGSC0003DMG200005159	K01520	ko00240	Pyrimidine metabolism	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMG200005159	K01520	ko01100	Metabolic pathways	633	4.4e-29	0.65	0.75	0.80
PGSC0003DMG200005159	K01520	ko00240	Pyrimidine metabolism	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMG200005159	K01520	ko01100	Metabolic pathways	495	1.8e-21	0.69	0.78	0.96
PGSC0003DMG200005170	K02084	ko04115	p53 signaling pathway	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko04210	Apoptosis	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko05010	Alzheimer's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko05012	Parkinson's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko05016	Huntington's disease	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005170	K02084	ko05222	Small cell lung cancer	304	8.9e-08	0.26	0.43	0.84
PGSC0003DMG200005173	K02084	ko04115	p53 signaling pathway	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko04210	Apoptosis	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko05010	Alzheimer's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko05012	Parkinson's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko05016	Huntington's disease	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200005173	K02084	ko05222	Small cell lung cancer	300	3.6e-07	0.27	0.44	0.46
PGSC0003DMG200015153	K01609	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMG200015153	K01609	ko01100	Metabolic pathways	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMG200015153	K01609	ko01110	Biosynthesis of secondary metabolites	2350	8.8e-124	0.73	0.84	0.92
PGSC0003DMG200015154	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMG200015154	K06611	ko00052	Galactose metabolism	877	1.5e-42	0.41	0.61	0.89
PGSC0003DMG200015154	K06611	ko00052	Galactose metabolism	404	5.3e-16	0.37	0.56	0.89
PGSC0003DMG200015154	K06611	ko00052	Galactose metabolism	756	7.3e-36	0.40	0.58	0.98
PGSC0003DMG200015154	K06611	ko00052	Galactose metabolism	2107	2.2e-110	0.40	0.58	0.97
PGSC0003DMG200015155	K11294	ko05130	Pathogenic Escherichia coli infection	492	2.7e-21	0.36	0.56	0.77
PGSC0003DMG200015161	K02343	ko00230	Purine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015161	K02343	ko00240	Pyrimidine metabolism	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015161	K02343	ko01100	Metabolic pathways	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015161	K02343	ko03030	DNA replication	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015161	K02343	ko03430	Mismatch repair	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015161	K02343	ko03440	Homologous recombination	866	6.3e-42	0.36	0.57	0.35
PGSC0003DMG200015165	K01838	ko00500	Starch and sucrose metabolism	538	7.7e-24	0.39	0.56	0.69
PGSC0003DMG200018801	K09841	ko00906	Carotenoid biosynthesis	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMG200018801	K09841	ko01100	Metabolic pathways	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMG200018801	K09841	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.49	0.66	0.91
PGSC0003DMG200018801	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018801	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018801	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018801	K09841	ko00906	Carotenoid biosynthesis	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018801	K09841	ko01100	Metabolic pathways	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018801	K09841	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.51	0.68	0.94
PGSC0003DMG200018802	K09841	ko00906	Carotenoid biosynthesis	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMG200018802	K09841	ko01100	Metabolic pathways	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMG200018802	K09841	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.50	0.70	0.97
PGSC0003DMG200018802	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMG200018802	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMG200018802	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.51	0.71	0.89
PGSC0003DMG200018802	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko00906	Carotenoid biosynthesis	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko01100	Metabolic pathways	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.51	0.71	0.98
PGSC0003DMG200018802	K09841	ko00906	Carotenoid biosynthesis	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMG200018802	K09841	ko01100	Metabolic pathways	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMG200018802	K09841	ko01110	Biosynthesis of secondary metabolites	1053	3.0e-52	0.51	0.71	0.91
PGSC0003DMG200026970	K02998	ko03010	Ribosome	1911	1.4e-99	0.77	0.80	1.00
PGSC0003DMG200026970	K02998	ko03010	Ribosome	1912	1.3e-99	0.76	0.80	1.00
PGSC0003DMG200026970	K02998	ko03010	Ribosome	610	8.3e-28	0.97	1.00	0.85
PGSC0003DMG200026971	K05681	ko02010	ABC transporters	1018	2.6e-50	0.33	0.49	0.90
PGSC0003DMG200026972	K05680	ko02010	ABC transporters	311	6.6e-11	0.27	0.50	0.89
PGSC0003DMG200026973	K10684	ko04120	Ubiquitin mediated proteolysis	2010	5.0e-105	0.75	0.87	0.98
PGSC0003DMG200026976	K00940	ko00230	Purine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMG200026976	K00940	ko00240	Pyrimidine metabolism	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMG200026976	K00940	ko01100	Metabolic pathways	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMG200026976	K00940	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.72	0.78	1.00
PGSC0003DMG200026977	K13065	ko00940	Phenylpropanoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMG200026977	K13065	ko00941	Flavonoid biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMG200026977	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMG200026977	K13065	ko01110	Biosynthesis of secondary metabolites	318	1.1e-11	0.33	0.49	0.63
PGSC0003DMG200026978	K00134	ko00010	Glycolysis / Gluconeogenesis	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMG200026978	K00134	ko01100	Metabolic pathways	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMG200026978	K00134	ko01110	Biosynthesis of secondary metabolites	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMG200026978	K00134	ko05010	Alzheimer's disease	2612	3.1e-138	0.92	0.97	1.00
PGSC0003DMG200023342	K12613	ko03018	RNA degradation	2239	1.2e-117	0.80	0.90	1.00
PGSC0003DMG200023344	K08907	ko00196	Photosynthesis - antenna proteins	1801	1.7e-93	0.84	0.91	0.99
PGSC0003DMG200023356	K13228	ko00402	Benzoxazinoid biosynthesis	601	2.6e-27	0.38	0.61	0.82
PGSC0003DMG200023356	K13068	ko00940	Phenylpropanoid biosynthesis	811	6.8e-39	0.30	0.51	0.99
PGSC0003DMG200025767	K00083	ko00940	Phenylpropanoid biosynthesis	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMG200025767	K00083	ko01100	Metabolic pathways	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMG200025767	K00083	ko01110	Biosynthesis of secondary metabolites	977	4.7e-48	0.66	0.78	0.96
PGSC0003DMG200025772	K03544	ko04112	Cell cycle - Caulobacter	413	8.3e-17	0.49	0.57	0.41
PGSC0003DMG200025784	K04733	ko04210	Apoptosis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMG200025784	K04733	ko04620	Toll-like receptor signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMG200025784	K04733	ko04722	Neurotrophin signaling pathway	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMG200025784	K04733	ko05140	Leishmaniasis	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMG200025784	K04733	ko05142	Chagas disease	464	2.8e-19	0.40	0.56	0.48
PGSC0003DMG200025784	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko04210	Apoptosis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMG200025784	K04733	ko04620	Toll-like receptor signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMG200025784	K04733	ko04722	Neurotrophin signaling pathway	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMG200025784	K04733	ko05140	Leishmaniasis	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMG200025784	K04733	ko05142	Chagas disease	946	2.4e-46	0.40	0.55	0.61
PGSC0003DMG200025784	K04733	ko04210	Apoptosis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko04620	Toll-like receptor signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko04722	Neurotrophin signaling pathway	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko05140	Leishmaniasis	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200025784	K04733	ko05142	Chagas disease	373	4.2e-14	0.39	0.53	0.45
PGSC0003DMG200001419	K05658	ko02010	ABC transporters	1964	1.7e-102	0.60	0.80	0.99
PGSC0003DMG200001419	K05658	ko02010	ABC transporters	3845	3.1e-206	0.48	0.68	1.00
PGSC0003DMG200001419	K05658	ko02010	ABC transporters	4788	3.0e-258	0.48	0.68	1.00
PGSC0003DMG200001421	K02915	ko03010	Ribosome	967	1.7e-47	0.96	0.98	0.99
PGSC0003DMG200001425	K01535	ko00190	Oxidative phosphorylation	3351	5.4e-179	0.51	0.64	0.98
PGSC0003DMG200039791	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMG200039791	K00517	ko00626	Naphthalene and anthracene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMG200039791	K00517	ko00903	Limonene and pinene degradation	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMG200039791	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMG200039791	K00517	ko01110	Biosynthesis of secondary metabolites	1715	9.3e-89	0.47	0.65	0.94
PGSC0003DMG200045643	K11644	ko05016	Huntington's disease	270	5.4e-08	0.29	0.48	0.76
PGSC0003DMG200045645	K03094	ko04110	Cell cycle	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04111	Cell cycle - yeast	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04114	Oocyte meiosis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04120	Ubiquitin mediated proteolysis	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04310	Wnt signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04350	TGF-beta signaling pathway	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200045645	K03094	ko04710	Circadian rhythm - mammal	488	4.4e-21	0.53	0.67	0.72
PGSC0003DMG200004647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMG200004647	K00517	ko00626	Naphthalene and anthracene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMG200004647	K00517	ko00903	Limonene and pinene degradation	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMG200004647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMG200004647	K00517	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.45	0.65	0.99
PGSC0003DMG200004647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMG200004647	K00517	ko00626	Naphthalene and anthracene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMG200004647	K00517	ko00903	Limonene and pinene degradation	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMG200004647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMG200004647	K00517	ko01110	Biosynthesis of secondary metabolites	481	1.1e-20	0.52	0.70	0.96
PGSC0003DMG200004647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMG200004647	K00517	ko00626	Naphthalene and anthracene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMG200004647	K00517	ko00903	Limonene and pinene degradation	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMG200004647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMG200004647	K00517	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.55	0.74	0.98
PGSC0003DMG200004652	K13290	ko00250	Alanine, aspartate and glutamate metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMG200004652	K13290	ko00260	Glycine, serine and threonine metabolism	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMG200004652	K13290	ko01100	Metabolic pathways	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMG200004652	K13290	ko01110	Biosynthesis of secondary metabolites	2801	1.2e-148	0.91	0.96	0.99
PGSC0003DMG200004652	K13290	ko00250	Alanine, aspartate and glutamate metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMG200004652	K13290	ko00260	Glycine, serine and threonine metabolism	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMG200004652	K13290	ko01100	Metabolic pathways	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMG200004652	K13290	ko01110	Biosynthesis of secondary metabolites	3122	2.3e-166	0.91	0.96	1.00
PGSC0003DMG200004655	K07199	ko04910	Insulin signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMG200004655	K07199	ko04920	Adipocytokine signaling pathway	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMG200004655	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1668	3.6e-86	0.71	0.80	1.00
PGSC0003DMG200004659	K08679	ko00500	Starch and sucrose metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMG200004659	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMG200004659	K08679	ko01100	Metabolic pathways	3086	2.2e-164	0.81	0.90	0.97
PGSC0003DMG200004660	K00600	ko00260	Glycine, serine and threonine metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200004660	K00600	ko00460	Cyanoamino acid metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200004660	K00600	ko00670	One carbon pool by folate	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200004660	K00600	ko00680	Methane metabolism	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200004660	K00600	ko01100	Metabolic pathways	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200004660	K00600	ko01110	Biosynthesis of secondary metabolites	3722	1.9e-199	0.91	0.96	1.00
PGSC0003DMG200007654	K08233	ko00901	Indole alkaloid biosynthesis	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMG200007654	K08233	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.52	0.69	0.97
PGSC0003DMG200007656	K01516	ko00230	Purine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMG200007656	K01516	ko00730	Thiamine metabolism	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMG200007656	K01516	ko01100	Metabolic pathways	2533	7.1e-134	0.66	0.79	0.98
PGSC0003DMG200007656	K01516	ko00230	Purine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMG200007656	K01516	ko00730	Thiamine metabolism	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMG200007656	K01516	ko01100	Metabolic pathways	1959	3.3e-102	0.70	0.82	0.99
PGSC0003DMG200007659	K01874	ko00450	Selenoamino acid metabolism	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMG200007659	K01874	ko00970	Aminoacyl-tRNA biosynthesis	511	3.6e-22	0.50	0.63	0.59
PGSC0003DMG200007659	K01874	ko00450	Selenoamino acid metabolism	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMG200007659	K01874	ko00970	Aminoacyl-tRNA biosynthesis	586	1.7e-26	0.48	0.62	0.60
PGSC0003DMG200007665	K09753	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMG200007665	K09753	ko01100	Metabolic pathways	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMG200007665	K09753	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.57	0.90
PGSC0003DMG200007665	K09753	ko00940	Phenylpropanoid biosynthesis	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMG200007665	K09753	ko01100	Metabolic pathways	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMG200007665	K09753	ko01110	Biosynthesis of secondary metabolites	573	9.1e-26	0.33	0.57	0.90
PGSC0003DMG200013331	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013331	K01580	ko00410	beta-Alanine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013331	K01580	ko00430	Taurine and hypotaurine metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013331	K01580	ko00650	Butanoate metabolism	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013331	K01580	ko01100	Metabolic pathways	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013331	K01580	ko04940	Type I diabetes mellitus	3637	9.1e-195	0.85	0.92	1.00
PGSC0003DMG200013332	K00031	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko00480	Glutathione metabolism	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko01100	Metabolic pathways	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko04146	Peroxisome	2593	3.5e-137	0.73	0.81	0.99
PGSC0003DMG200013332	K00031	ko00020	Citrate cycle (TCA cycle)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko00480	Glutathione metabolism	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko01100	Metabolic pathways	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko01110	Biosynthesis of secondary metabolites	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko04146	Peroxisome	1219	2.1e-61	0.94	0.99	0.99
PGSC0003DMG200013332	K00031	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko00480	Glutathione metabolism	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko01100	Metabolic pathways	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko04146	Peroxisome	3219	1.0e-171	0.90	0.96	0.99
PGSC0003DMG200013332	K00031	ko00020	Citrate cycle (TCA cycle)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013332	K00031	ko00480	Glutathione metabolism	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013332	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013332	K00031	ko01100	Metabolic pathways	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013332	K00031	ko01110	Biosynthesis of secondary metabolites	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013332	K00031	ko04146	Peroxisome	1659	1.1e-85	0.90	0.98	0.98
PGSC0003DMG200013333	K00963	ko00040	Pentose and glucuronate interconversions	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013333	K00963	ko00052	Galactose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013333	K00963	ko00500	Starch and sucrose metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013333	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013333	K00963	ko01100	Metabolic pathways	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013333	K00963	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.87	0.91	1.00
PGSC0003DMG200013334	K10143	ko04115	p53 signaling pathway	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMG200013334	K10143	ko04120	Ubiquitin mediated proteolysis	2779	1.9e-147	0.86	0.93	0.98
PGSC0003DMG200013334	K10143	ko04115	p53 signaling pathway	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMG200013334	K10143	ko04120	Ubiquitin mediated proteolysis	4296	4.1e-231	0.75	0.84	0.99
PGSC0003DMG200013334	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMG200013334	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMG200013334	K10143	ko04115	p53 signaling pathway	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMG200013334	K10143	ko04120	Ubiquitin mediated proteolysis	4305	1.3e-231	0.75	0.84	0.99
PGSC0003DMG200013335	K10143	ko04115	p53 signaling pathway	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMG200013335	K10143	ko04120	Ubiquitin mediated proteolysis	350	6.1e-13	0.58	0.74	0.20
PGSC0003DMG200021362	K00645	ko00061	Fatty acid biosynthesis	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMG200021362	K00645	ko01100	Metabolic pathways	2489	1.9e-131	0.83	0.90	0.99
PGSC0003DMG200021364	K11294	ko05130	Pathogenic Escherichia coli infection	432	5.4e-18	0.30	0.50	0.71
PGSC0003DMG200021365	K08064	ko04612	Antigen processing and presentation	422	1.9e-17	0.37	0.49	0.75
PGSC0003DMG200021370	K11422	ko00310	Lysine degradation	2670	2.0e-141	0.35	0.48	0.99
PGSC0003DMG200021370	K11422	ko00310	Lysine degradation	2340	3.1e-123	0.35	0.48	0.99
PGSC0003DMG200021370	K11422	ko00310	Lysine degradation	1812	4.2e-94	0.35	0.51	0.98
PGSC0003DMG200021370	K11422	ko00310	Lysine degradation	3215	1.7e-171	0.38	0.52	0.99
PGSC0003DMG200021370	K11422	ko00310	Lysine degradation	3093	9.2e-165	0.36	0.50	1.00
PGSC0003DMG200024478	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04020	Calcium signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04070	Phosphatidylinositol signaling system	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04114	Oocyte meiosis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04270	Vascular smooth muscle contraction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04626	Plant-pathogen interaction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04720	Long-term potentiation	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04722	Neurotrophin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04740	Olfactory transduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04744	Phototransduction	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04745	Phototransduction - fly	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04910	Insulin signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04912	GnRH signaling pathway	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04916	Melanogenesis	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04970	Salivary secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04971	Gastric acid secretion	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko05010	Alzheimer's disease	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko05214	Glioma	394	9.8e-16	0.37	0.52	0.93
PGSC0003DMG200024478	K02183	ko04020	Calcium signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04070	Phosphatidylinositol signaling system	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04114	Oocyte meiosis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04270	Vascular smooth muscle contraction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04626	Plant-pathogen interaction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04720	Long-term potentiation	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04722	Neurotrophin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04740	Olfactory transduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04744	Phototransduction	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04745	Phototransduction - fly	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04910	Insulin signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04912	GnRH signaling pathway	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04916	Melanogenesis	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04970	Salivary secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko04971	Gastric acid secretion	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko05010	Alzheimer's disease	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024478	K02183	ko05214	Glioma	272	1.2e-08	0.36	0.53	0.89
PGSC0003DMG200024479	K02183	ko04020	Calcium signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04070	Phosphatidylinositol signaling system	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04114	Oocyte meiosis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04270	Vascular smooth muscle contraction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04626	Plant-pathogen interaction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04720	Long-term potentiation	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04722	Neurotrophin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04740	Olfactory transduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04744	Phototransduction	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04745	Phototransduction - fly	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04910	Insulin signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04912	GnRH signaling pathway	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04916	Melanogenesis	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04970	Salivary secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko04971	Gastric acid secretion	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko05010	Alzheimer's disease	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024479	K02183	ko05214	Glioma	527	3.1e-23	0.35	0.52	0.75
PGSC0003DMG200024480	K02183	ko04020	Calcium signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04070	Phosphatidylinositol signaling system	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04114	Oocyte meiosis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04270	Vascular smooth muscle contraction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04626	Plant-pathogen interaction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04720	Long-term potentiation	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04722	Neurotrophin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04740	Olfactory transduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04744	Phototransduction	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04745	Phototransduction - fly	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04910	Insulin signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04912	GnRH signaling pathway	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04916	Melanogenesis	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04970	Salivary secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko04971	Gastric acid secretion	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko05010	Alzheimer's disease	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024480	K02183	ko05214	Glioma	727	2.9e-34	0.33	0.49	0.82
PGSC0003DMG200024490	K00128	ko00010	Glycolysis / Gluconeogenesis	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00053	Ascorbate and aldarate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00071	Fatty acid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00280	Valine, leucine and isoleucine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00310	Lysine degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00330	Arginine and proline metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00340	Histidine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00380	Tryptophan metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00410	beta-Alanine metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00561	Glycerolipid metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00620	Pyruvate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00631	1,2-Dichloroethane degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00640	Propanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00641	3-Chloroacrylic acid degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00650	Butanoate metabolism	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko00903	Limonene and pinene degradation	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko01100	Metabolic pathways	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024490	K00128	ko01110	Biosynthesis of secondary metabolites	3660	4.9e-196	0.79	0.89	1.00
PGSC0003DMG200024492	K10881	ko03050	Proteasome	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMG200024492	K10881	ko03440	Homologous recombination	467	6.4e-20	0.75	0.79	0.97
PGSC0003DMG200017293	K04424	ko04010	MAPK signaling pathway	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMG200017293	K04424	ko04530	Tight junction	551	2.6e-24	0.37	0.55	0.83
PGSC0003DMG200017293	K04424	ko04010	MAPK signaling pathway	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMG200017293	K04424	ko04530	Tight junction	555	5.5e-24	0.42	0.56	0.62
PGSC0003DMG200017293	K04424	ko04010	MAPK signaling pathway	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMG200017293	K04424	ko04530	Tight junction	623	8.2e-28	0.41	0.55	0.60
PGSC0003DMG200017293	K04424	ko04010	MAPK signaling pathway	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMG200017293	K04424	ko04530	Tight junction	628	4.3e-28	0.39	0.53	0.84
PGSC0003DMG200017297	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.38	0.59	0.97
PGSC0003DMG200017302	K04042	ko00520	Amino sugar and nucleotide sugar metabolism	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMG200017302	K04042	ko01100	Metabolic pathways	235	1.4e-06	0.30	0.48	0.77
PGSC0003DMG200028958	K00423	ko00053	Ascorbate and aldarate metabolism	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMG200028958	K00423	ko01100	Metabolic pathways	1968	1.0e-102	0.48	0.61	0.99
PGSC0003DMG200028958	K00423	ko00053	Ascorbate and aldarate metabolism	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMG200028958	K00423	ko01100	Metabolic pathways	1661	8.9e-86	0.55	0.70	0.96
PGSC0003DMG200028958	K00423	ko00053	Ascorbate and aldarate metabolism	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMG200028958	K00423	ko01100	Metabolic pathways	570	1.3e-25	0.54	0.68	0.99
PGSC0003DMG200028959	K00423	ko00053	Ascorbate and aldarate metabolism	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMG200028959	K00423	ko01100	Metabolic pathways	1502	5.2e-77	0.57	0.72	0.89
PGSC0003DMG200028959	K00423	ko00053	Ascorbate and aldarate metabolism	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMG200028959	K00423	ko01100	Metabolic pathways	2379	2.2e-125	0.54	0.69	0.96
PGSC0003DMG200028959	K00423	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMG200028959	K00423	ko01100	Metabolic pathways	1972	6.2e-103	0.55	0.70	0.95
PGSC0003DMG200028960	K00071	ko00140	Steroid hormone biosynthesis	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMG200028960	K00071	ko01100	Metabolic pathways	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMG200028960	K00071	ko04960	Aldosterone-regulated sodium reabsorption	1009	8.1e-50	0.48	0.67	0.80
PGSC0003DMG200028960	K00071	ko00140	Steroid hormone biosynthesis	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMG200028960	K00071	ko01100	Metabolic pathways	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMG200028960	K00071	ko04960	Aldosterone-regulated sodium reabsorption	245	1.1e-07	0.47	0.64	0.86
PGSC0003DMG200028961	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMG200028961	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMG200028961	K00734	ko01100	Metabolic pathways	365	2.7e-14	0.33	0.49	0.63
PGSC0003DMG200028961	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMG200028961	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMG200028961	K00734	ko01100	Metabolic pathways	378	5.2e-15	0.32	0.49	0.61
PGSC0003DMG200023754	K01046	ko00561	Glycerolipid metabolism	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMG200023754	K01046	ko01100	Metabolic pathways	343	4.4e-13	0.36	0.54	0.51
PGSC0003DMG200023754	K11157	ko00830	Retinol metabolism	383	2.7e-15	0.33	0.49	0.56
PGSC0003DMG200026869	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMG200026869	K01657	ko01100	Metabolic pathways	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMG200026869	K01657	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.71	0.81	0.76
PGSC0003DMG200026870	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMG200026870	K01657	ko01100	Metabolic pathways	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMG200026870	K01657	ko01110	Biosynthesis of secondary metabolites	328	3.3e-12	0.61	0.75	0.90
PGSC0003DMG200026871	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMG200026871	K00517	ko00626	Naphthalene and anthracene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMG200026871	K00517	ko00903	Limonene and pinene degradation	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMG200026871	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMG200026871	K00517	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.54	0.69	0.95
PGSC0003DMG200026871	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMG200026871	K00517	ko00626	Naphthalene and anthracene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMG200026871	K00517	ko00903	Limonene and pinene degradation	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMG200026871	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMG200026871	K00517	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.44	0.62	0.97
PGSC0003DMG200026872	K12832	ko03040	Spliceosome	739	6.3e-35	0.97	0.98	0.99
PGSC0003DMG200026880	K03821	ko00650	Butanoate metabolism	279	3.5e-09	0.31	0.48	0.43
PGSC0003DMG200026882	K04123	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMG200026882	K04123	ko01100	Metabolic pathways	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMG200026882	K04123	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.28	0.43	0.98
PGSC0003DMG200026882	K04123	ko00904	Diterpenoid biosynthesis	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMG200026882	K04123	ko01100	Metabolic pathways	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMG200026882	K04123	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.38	0.59	0.97
PGSC0003DMG200022473	K00514	ko00906	Carotenoid biosynthesis	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMG200022473	K00514	ko01100	Metabolic pathways	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMG200022473	K00514	ko01110	Biosynthesis of secondary metabolites	3899	3.2e-209	0.80	0.88	0.96
PGSC0003DMG200005633	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.31
PGSC0003DMG200005633	K12135	ko04712	Circadian rhythm - plant	250	5.9e-08	0.40	0.55	0.35
PGSC0003DMG200005640	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMG200005640	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMG200008796	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1868	3.4e-97	0.67	0.76	1.00
PGSC0003DMG200008797	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1425	9.2e-73	0.60	0.71	1.00
PGSC0003DMG200008804	K08912	ko00196	Photosynthesis - antenna proteins	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMG200008804	K08912	ko01100	Metabolic pathways	1959	3.3e-102	0.78	0.82	1.00
PGSC0003DMG200008804	K08912	ko00196	Photosynthesis - antenna proteins	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMG200008804	K08912	ko01100	Metabolic pathways	2037	1.6e-106	0.89	0.94	1.00
PGSC0003DMG200008804	K08912	ko00196	Photosynthesis - antenna proteins	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMG200008804	K08912	ko01100	Metabolic pathways	1967	1.2e-102	0.78	0.82	1.00
PGSC0003DMG200008805	K12126	ko04712	Circadian rhythm - plant	305	1.0e-08	0.30	0.46	0.60
PGSC0003DMG200008806	K04410	ko04010	MAPK signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko04012	ErbB signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko04360	Axon guidance	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko04510	Focal adhesion	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko04660	T cell receptor signaling pathway	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko04810	Regulation of actin cytoskeleton	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008806	K04410	ko05211	Renal cell carcinoma	354	1.1e-13	0.41	0.59	0.54
PGSC0003DMG200008810	K01581	ko00330	Arginine and proline metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMG200008810	K01581	ko00480	Glutathione metabolism	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMG200008810	K01581	ko01100	Metabolic pathways	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMG200008810	K01581	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.59	0.75	0.75
PGSC0003DMG200016412	K01899	ko00020	Citrate cycle (TCA cycle)	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMG200016412	K01899	ko00640	Propanoate metabolism	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMG200016412	K01899	ko01100	Metabolic pathways	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMG200016412	K01899	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.88	0.93	0.99
PGSC0003DMG200016413	K08139	ko04113	Meiosis - yeast	467	6.4e-20	0.40	0.64	0.75
PGSC0003DMG200016418	K06620	ko04110	Cell cycle	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05200	Pathways in cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05212	Pancreatic cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05214	Glioma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05215	Prostate cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05218	Melanoma	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05219	Bladder cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05220	Chronic myeloid leukemia	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05222	Small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko05223	Non-small cell lung cancer	332	1.8e-12	0.33	0.54	0.79
PGSC0003DMG200016418	K06620	ko04110	Cell cycle	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05200	Pathways in cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05212	Pancreatic cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05214	Glioma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05215	Prostate cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05218	Melanoma	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05219	Bladder cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05220	Chronic myeloid leukemia	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05222	Small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05223	Non-small cell lung cancer	772	9.6e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko04110	Cell cycle	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05200	Pathways in cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05212	Pancreatic cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05214	Glioma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05215	Prostate cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05218	Melanoma	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05219	Bladder cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05220	Chronic myeloid leukemia	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05222	Small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko05223	Non-small cell lung cancer	806	1.3e-38	0.35	0.51	0.93
PGSC0003DMG200016418	K06620	ko04110	Cell cycle	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05200	Pathways in cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05212	Pancreatic cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05214	Glioma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05215	Prostate cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05218	Melanoma	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05219	Bladder cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05220	Chronic myeloid leukemia	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05222	Small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200016418	K06620	ko05223	Non-small cell lung cancer	779	3.9e-37	0.35	0.50	0.93
PGSC0003DMG200041492	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMG200041492	K00517	ko00626	Naphthalene and anthracene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMG200041492	K00517	ko00903	Limonene and pinene degradation	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMG200041492	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMG200041492	K00517	ko01110	Biosynthesis of secondary metabolites	406	1.5e-16	0.40	0.62	0.94
PGSC0003DMG200024689	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMG200024689	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMG200024689	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.62	0.76	1.00
PGSC0003DMG200024690	K00454	ko00591	Linoleic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMG200024690	K00454	ko00592	alpha-Linolenic acid metabolism	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMG200024690	K00454	ko01100	Metabolic pathways	4164	7.8e-224	0.59	0.73	1.00
PGSC0003DMG200024691	K00454	ko00591	Linoleic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMG200024691	K00454	ko00592	alpha-Linolenic acid metabolism	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMG200024691	K00454	ko01100	Metabolic pathways	3731	6.0e-200	0.66	0.80	0.95
PGSC0003DMG200024691	K00454	ko00591	Linoleic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMG200024691	K00454	ko00592	alpha-Linolenic acid metabolism	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMG200024691	K00454	ko01100	Metabolic pathways	651	4.5e-30	0.62	0.76	0.98
PGSC0003DMG200024691	K00454	ko00591	Linoleic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMG200024691	K00454	ko00592	alpha-Linolenic acid metabolism	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMG200024691	K00454	ko01100	Metabolic pathways	1078	1.3e-53	0.67	0.82	0.97
PGSC0003DMG200024692	K00454	ko00591	Linoleic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMG200024692	K00454	ko00592	alpha-Linolenic acid metabolism	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMG200024692	K00454	ko01100	Metabolic pathways	4475	5.5e-241	0.63	0.78	0.99
PGSC0003DMG200024692	K00454	ko00591	Linoleic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMG200024692	K00454	ko00592	alpha-Linolenic acid metabolism	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMG200024692	K00454	ko01100	Metabolic pathways	500	2.5e-21	0.60	0.75	0.93
PGSC0003DMG200024693	K00454	ko00591	Linoleic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMG200024693	K00454	ko00592	alpha-Linolenic acid metabolism	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMG200024693	K00454	ko01100	Metabolic pathways	4571	2.8e-246	0.64	0.80	0.98
PGSC0003DMG200024693	K00454	ko00591	Linoleic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMG200024693	K00454	ko00592	alpha-Linolenic acid metabolism	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMG200024693	K00454	ko01100	Metabolic pathways	462	3.7e-19	0.64	0.77	0.99
PGSC0003DMG200024694	K02350	ko01100	Metabolic pathways	7592	0.	0.55	0.67	1.00
PGSC0003DMG200024695	K12893	ko03040	Spliceosome	254	1.7e-06	0.30	0.43	0.34
PGSC0003DMG200024696	K00020	ko00280	Valine, leucine and isoleucine degradation	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMG200024696	K00020	ko01100	Metabolic pathways	1603	1.4e-82	0.67	0.76	0.96
PGSC0003DMG200024696	K00020	ko00280	Valine, leucine and isoleucine degradation	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMG200024696	K00020	ko01100	Metabolic pathways	1911	1.4e-99	0.76	0.87	0.97
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	1490	2.4e-76	0.57	0.68	0.98
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	1512	1.5e-77	0.69	0.80	0.98
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	1529	1.7e-78	0.66	0.77	0.98
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	1590	7.3e-82	0.66	0.77	0.98
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	1627	6.7e-84	0.69	0.81	0.98
PGSC0003DMG200024698	K06634	ko03420	Nucleotide excision repair	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMG200024698	K06634	ko04110	Cell cycle	323	5.6e-12	0.67	0.77	0.92
PGSC0003DMG200020720	K08247	ko00450	Selenoamino acid metabolism	6265	0.	0.70	0.84	0.99
PGSC0003DMG200020732	K02084	ko04115	p53 signaling pathway	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko04210	Apoptosis	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko05010	Alzheimer's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko05012	Parkinson's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko05016	Huntington's disease	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020732	K02084	ko05222	Small cell lung cancer	357	5.0e-10	0.28	0.44	0.36
PGSC0003DMG200020736	K02084	ko04115	p53 signaling pathway	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko04210	Apoptosis	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko05010	Alzheimer's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko05012	Parkinson's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko05016	Huntington's disease	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200020736	K02084	ko05222	Small cell lung cancer	368	5.6e-11	0.29	0.47	0.44
PGSC0003DMG200027898	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMG200027898	K00517	ko00626	Naphthalene and anthracene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMG200027898	K00517	ko00903	Limonene and pinene degradation	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMG200027898	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMG200027898	K00517	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.51	0.66	0.97
PGSC0003DMG200027900	K10878	ko04113	Meiosis - yeast	2979	1.8e-158	0.85	0.91	1.00
PGSC0003DMG200027903	K02930	ko03010	Ribosome	2898	5.3e-154	0.84	0.91	1.00
PGSC0003DMG200027906	K00939	ko00230	Purine metabolism	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMG200027906	K00939	ko01100	Metabolic pathways	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMG200027906	K00939	ko01110	Biosynthesis of secondary metabolites	1248	5.3e-63	0.60	0.75	0.87
PGSC0003DMG200027913	K03142	ko03022	Basal transcription factors	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMG200027913	K03142	ko03420	Nucleotide excision repair	1561	2.9e-80	0.76	0.87	0.98
PGSC0003DMG200027914	K00423	ko00053	Ascorbate and aldarate metabolism	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMG200027914	K00423	ko01100	Metabolic pathways	2070	2.5e-108	0.49	0.65	0.93
PGSC0003DMG200007901	K02184	ko04320	Dorso-ventral axis formation	710	2.3e-32	0.34	0.39	0.82
PGSC0003DMG200007901	K02184	ko04320	Dorso-ventral axis formation	901	5.4e-43	0.29	0.42	0.77
PGSC0003DMG200007901	K04512	ko04310	Wnt signaling pathway	230	4.1e-06	0.29	0.52	0.98
PGSC0003DMG200007901	K05740	ko04510	Focal adhesion	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMG200007901	K05740	ko04810	Regulation of actin cytoskeleton	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMG200007901	K05740	ko05131	Shigellosis	1177	4.4e-59	0.32	0.47	0.51
PGSC0003DMG200007902	K01246	ko03410	Base excision repair	296	1.7e-10	0.62	0.76	0.98
PGSC0003DMG200007902	K01246	ko03410	Base excision repair	2155	5.0e-113	0.72	0.80	1.00
PGSC0003DMG200007903	K05391	ko04626	Plant-pathogen interaction	4312	5.4e-232	0.76	0.85	0.99
PGSC0003DMG200007903	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMG200007903	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMG200007903	K05391	ko04626	Plant-pathogen interaction	4500	2.3e-242	0.78	0.87	0.99
PGSC0003DMG200007905	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMG200007905	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMG200007905	K03110	ko03060	Protein export	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMG200007905	K03110	ko03070	Bacterial secretion system	4201	7.1e-226	0.83	0.90	1.00
PGSC0003DMG200007907	K03260	ko05416	Viral myocarditis	2329	1.3e-122	0.47	0.63	0.89
PGSC0003DMG200007907	K03260	ko05416	Viral myocarditis	1019	2.3e-50	0.44	0.58	0.93
PGSC0003DMG200007908	K12356	ko00940	Phenylpropanoid biosynthesis	243	2.6e-07	0.50	0.65	0.22
PGSC0003DMG200007908	K12356	ko00940	Phenylpropanoid biosynthesis	379	4.5e-15	0.41	0.63	0.92
PGSC0003DMG200004052	K03456	ko04111	Cell cycle - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04113	Meiosis - yeast	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04114	Oocyte meiosis	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04310	Wnt signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04350	TGF-beta signaling pathway	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04530	Tight junction	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko04730	Long-term depression	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004052	K03456	ko05142	Chagas disease	4469	1.2e-240	0.92	0.97	1.00
PGSC0003DMG200004065	K05863	ko04020	Calcium signaling pathway	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMG200004065	K05863	ko05012	Parkinson's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMG200004065	K05863	ko05016	Huntington's disease	2013	3.4e-105	0.76	0.89	0.97
PGSC0003DMG200004065	K05863	ko04020	Calcium signaling pathway	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMG200004065	K05863	ko05012	Parkinson's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMG200004065	K05863	ko05016	Huntington's disease	567	1.9e-25	0.65	0.80	0.85
PGSC0003DMG200004066	K05748	ko04520	Adherens junction	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMG200004066	K05748	ko04666	Fc gamma R-mediated phagocytosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMG200004066	K05748	ko04810	Regulation of actin cytoskeleton	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMG200004066	K05748	ko05100	Bacterial invasion of epithelial cells	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMG200004066	K05748	ko05131	Shigellosis	439	1.9e-17	0.30	0.41	0.25
PGSC0003DMG200004067	K01126	ko00564	Glycerophospholipid metabolism	2616	1.9e-138	0.76	0.87	0.99
PGSC0003DMG200003282	K10591	ko04120	Ubiquitin mediated proteolysis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMG200003282	K10591	ko04144	Endocytosis	518	2.3e-22	0.72	0.84	0.96
PGSC0003DMG200003283	K10591	ko04120	Ubiquitin mediated proteolysis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMG200003283	K10591	ko04144	Endocytosis	763	3.0e-36	0.63	0.83	0.77
PGSC0003DMG200003284	K10591	ko04120	Ubiquitin mediated proteolysis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMG200003284	K10591	ko04144	Endocytosis	1576	4.3e-81	0.37	0.52	1.00
PGSC0003DMG200003289	K09754	ko00360	Phenylalanine metabolism	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003289	K09754	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003289	K09754	ko00941	Flavonoid biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003289	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003289	K09754	ko01100	Metabolic pathways	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003289	K09754	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.88	0.92	1.00
PGSC0003DMG200003291	K02969	ko03010	Ribosome	985	1.7e-48	0.97	0.98	0.98
PGSC0003DMG200003292	K12878	ko03040	Spliceosome	3260	5.7e-174	0.66	0.75	1.00
PGSC0003DMG200003292	K12878	ko03040	Spliceosome	4122	1.6e-221	0.79	0.89	1.00
PGSC0003DMG200011158	K02377	ko00051	Fructose and mannose metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMG200011158	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMG200011158	K02377	ko01100	Metabolic pathways	2229	4.2e-117	0.85	0.92	0.99
PGSC0003DMG200011159	K01951	ko00230	Purine metabolism	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMG200011159	K01951	ko00983	Drug metabolism - other enzymes	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMG200011159	K01951	ko01100	Metabolic pathways	477	1.8e-20	0.35	0.55	0.87
PGSC0003DMG200011164	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMG200011164	K02367	ko01100	Metabolic pathways	243	3.9e-07	0.37	0.63	0.42
PGSC0003DMG200011166	K03022	ko00230	Purine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMG200011166	K03022	ko00240	Pyrimidine metabolism	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMG200011166	K03022	ko01100	Metabolic pathways	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMG200011166	K03022	ko03020	RNA polymerase	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMG200011166	K03022	ko04623	Cytosolic DNA-sensing pathway	1124	3.7e-56	0.72	0.83	0.90
PGSC0003DMG200011166	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko00230	Purine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko00240	Pyrimidine metabolism	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko01100	Metabolic pathways	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko03020	RNA polymerase	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011166	K03022	ko04623	Cytosolic DNA-sensing pathway	1261	1.0e-63	0.75	0.86	0.99
PGSC0003DMG200011168	K02267	ko00190	Oxidative phosphorylation	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko01100	Metabolic pathways	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko04260	Cardiac muscle contraction	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko05010	Alzheimer's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko05012	Parkinson's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko05016	Huntington's disease	636	3.0e-29	0.89	0.96	0.79
PGSC0003DMG200011168	K02267	ko00190	Oxidative phosphorylation	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200011168	K02267	ko01100	Metabolic pathways	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200011168	K02267	ko04260	Cardiac muscle contraction	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200011168	K02267	ko05010	Alzheimer's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200011168	K02267	ko05012	Parkinson's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200011168	K02267	ko05016	Huntington's disease	647	7.5e-30	0.88	0.97	0.99
PGSC0003DMG200039457	K10760	ko00908	Zeatin biosynthesis	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMG200039457	K10760	ko01100	Metabolic pathways	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMG200039457	K10760	ko01110	Biosynthesis of secondary metabolites	365	2.7e-14	0.40	0.61	0.58
PGSC0003DMG200021475	K08339	ko04140	Regulation of autophagy	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMG200021475	K08339	ko04622	RIG-I-like receptor signaling pathway	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMG200021475	K08339	ko05131	Shigellosis	1165	2.0e-58	0.59	0.75	0.16
PGSC0003DMG200021475	K08339	ko04140	Regulation of autophagy	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMG200021475	K08339	ko04622	RIG-I-like receptor signaling pathway	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMG200021475	K08339	ko05131	Shigellosis	406	1.5e-16	0.57	0.75	0.68
PGSC0003DMG200021475	K08339	ko04140	Regulation of autophagy	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMG200021475	K08339	ko04622	RIG-I-like receptor signaling pathway	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMG200021475	K08339	ko05131	Shigellosis	1089	3.1e-54	0.57	0.74	0.87
PGSC0003DMG200021476	K05933	ko00270	Cysteine and methionine metabolism	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMG200021476	K05933	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.87	0.93	0.92
PGSC0003DMG200021476	K05933	ko00270	Cysteine and methionine metabolism	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMG200021476	K05933	ko01110	Biosynthesis of secondary metabolites	2297	7.4e-121	0.83	0.92	0.99
PGSC0003DMG200021494	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMG200021494	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMG200021494	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMG200021494	K02367	ko01100	Metabolic pathways	282	3.9e-09	0.28	0.45	0.86
PGSC0003DMG200025319	K05584	ko00190	Oxidative phosphorylation	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMG200025319	K05584	ko01100	Metabolic pathways	465	8.2e-20	0.54	0.67	0.56
PGSC0003DMG200025321	K00799	ko00480	Glutathione metabolism	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMG200025321	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMG200025321	K00799	ko00982	Drug metabolism - cytochrome P450	293	2.5e-10	0.30	0.52	0.88
PGSC0003DMG200025322	K00368	ko00910	Nitrogen metabolism	514	1.6e-22	0.39	0.56	0.74
PGSC0003DMG200025324	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMG200025324	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMG200025325	K02957	ko03010	Ribosome	453	3.8e-19	0.95	0.96	0.89
PGSC0003DMG200025328	K01535	ko00190	Oxidative phosphorylation	7328	0.	0.88	0.93	1.00
PGSC0003DMG200025328	K01535	ko00190	Oxidative phosphorylation	2737	4.0e-145	0.92	0.97	0.92
PGSC0003DMG200025328	K01535	ko00190	Oxidative phosphorylation	7398	0.	0.91	0.97	1.00
PGSC0003DMG200025331	K09841	ko00906	Carotenoid biosynthesis	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMG200025331	K09841	ko01100	Metabolic pathways	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMG200025331	K09841	ko01110	Biosynthesis of secondary metabolites	462	1.2e-19	0.42	0.59	0.98
PGSC0003DMG200020657	K02932	ko03010	Ribosome	2184	1.3e-114	0.84	0.93	0.99
PGSC0003DMG200028539	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko00564	Glycerophospholipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko00565	Ether lipid metabolism	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko01100	Metabolic pathways	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04144	Endocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04666	Fc gamma R-mediated phagocytosis	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028539	K01115	ko04912	GnRH signaling pathway	5836	0.	0.81	0.91	1.00
PGSC0003DMG200028541	K01184	ko00040	Pentose and glucuronate interconversions	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMG200028541	K01184	ko00500	Starch and sucrose metabolism	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMG200028541	K01184	ko01100	Metabolic pathways	351	1.6e-13	0.48	0.59	0.80
PGSC0003DMG200028542	K02160	ko00061	Fatty acid biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028542	K02160	ko00253	Tetracycline biosynthesis	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028542	K02160	ko00620	Pyruvate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028542	K02160	ko00640	Propanoate metabolism	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028542	K02160	ko01100	Metabolic pathways	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028542	K02160	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.36	0.51	0.63
PGSC0003DMG200028544	K06130	ko00564	Glycerophospholipid metabolism	623	1.6e-28	0.37	0.56	0.88
PGSC0003DMG200028545	K02265	ko00190	Oxidative phosphorylation	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028545	K02265	ko01100	Metabolic pathways	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028545	K02265	ko04260	Cardiac muscle contraction	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028545	K02265	ko05010	Alzheimer's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028545	K02265	ko05012	Parkinson's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028545	K02265	ko05016	Huntington's disease	962	3.2e-47	0.66	0.80	0.99
PGSC0003DMG200028549	K03661	ko00190	Oxidative phosphorylation	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028549	K03661	ko01100	Metabolic pathways	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028549	K03661	ko04142	Lysosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028549	K03661	ko04145	Phagosome	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028549	K03661	ko05110	Vibrio cholerae infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028549	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1372	7.7e-70	0.95	0.98	0.99
PGSC0003DMG200028559	K01044	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMG200028559	K01044	ko00983	Drug metabolism - other enzymes	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMG200028559	K01044	ko01100	Metabolic pathways	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMG200028559	K01044	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.33	0.50	0.69
PGSC0003DMG200038258	K04428	ko04010	MAPK signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMG200038258	K04428	ko04912	GnRH signaling pathway	386	1.9e-15	0.43	0.60	0.60
PGSC0003DMG200038280	K12604	ko03018	RNA degradation	316	3.5e-10	0.26	0.47	0.99
PGSC0003DMG200003383	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMG200003383	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMG200003383	K04713	ko00600	Sphingolipid metabolism	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMG200003383	K04713	ko01100	Metabolic pathways	887	4.4e-43	0.42	0.58	0.90
PGSC0003DMG200003384	K02608	ko04110	Cell cycle	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMG200003384	K02608	ko04111	Cell cycle - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMG200003384	K02608	ko04113	Meiosis - yeast	1586	1.2e-81	0.69	0.83	0.98
PGSC0003DMG200007178	K09754	ko00360	Phenylalanine metabolism	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007178	K09754	ko00940	Phenylpropanoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007178	K09754	ko00941	Flavonoid biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007178	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007178	K09754	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007178	K09754	ko01110	Biosynthesis of secondary metabolites	3410	3.0e-182	0.75	0.88	1.00
PGSC0003DMG200007179	K09754	ko00360	Phenylalanine metabolism	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007179	K09754	ko00940	Phenylpropanoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007179	K09754	ko00941	Flavonoid biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007179	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007179	K09754	ko01100	Metabolic pathways	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007179	K09754	ko01110	Biosynthesis of secondary metabolites	2925	1.7e-155	0.66	0.80	0.99
PGSC0003DMG200007180	K09754	ko00360	Phenylalanine metabolism	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007180	K09754	ko00940	Phenylpropanoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007180	K09754	ko00941	Flavonoid biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007180	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007180	K09754	ko01100	Metabolic pathways	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007180	K09754	ko01110	Biosynthesis of secondary metabolites	2413	3.0e-127	0.63	0.80	0.97
PGSC0003DMG200007181	K09754	ko00360	Phenylalanine metabolism	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007181	K09754	ko00940	Phenylpropanoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007181	K09754	ko00941	Flavonoid biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007181	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007181	K09754	ko01100	Metabolic pathways	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007181	K09754	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.59	0.78	0.94
PGSC0003DMG200007182	K00558	ko00270	Cysteine and methionine metabolism	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMG200007182	K00558	ko01100	Metabolic pathways	261	8.6e-06	0.34	0.54	0.34
PGSC0003DMG200007182	K00558	ko00270	Cysteine and methionine metabolism	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMG200007182	K00558	ko01100	Metabolic pathways	261	5.6e-06	0.34	0.54	0.37
PGSC0003DMG200007185	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMG200007185	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMG200007185	K11419	ko00310	Lysine degradation	642	1.4e-29	0.37	0.52	0.37
PGSC0003DMG200007188	K04035	ko00860	Porphyrin and chlorophyll metabolism	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMG200007188	K04035	ko01100	Metabolic pathways	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMG200007188	K04035	ko01110	Biosynthesis of secondary metabolites	2945	1.3e-156	0.85	0.91	1.00
PGSC0003DMG200007189	K02727	ko03050	Proteasome	626	1.1e-28	0.97	0.99	0.67
PGSC0003DMG200007189	K02727	ko03050	Proteasome	2017	2.1e-105	0.94	0.99	1.00
PGSC0003DMG200007189	K02727	ko03050	Proteasome	529	2.4e-23	0.92	1.00	0.99
PGSC0003DMG200010469	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMG200010474	K10604	ko04120	Ubiquitin mediated proteolysis	615	4.4e-28	0.37	0.53	0.91
PGSC0003DMG200010476	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMG200010476	K08770	ko03320	PPAR signaling pathway	3125	1.6e-166	1.00	1.00	1.00
PGSC0003DMG200010479	K00430	ko00360	Phenylalanine metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMG200010479	K00430	ko00680	Methane metabolism	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMG200010479	K00430	ko00940	Phenylpropanoid biosynthesis	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMG200010479	K00430	ko01100	Metabolic pathways	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMG200010479	K00430	ko01110	Biosynthesis of secondary metabolites	1336	7.5e-68	0.55	0.71	0.80
PGSC0003DMG200010480	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMG200010480	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMG200010480	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMG200010480	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMG200010480	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.55	0.72	0.94
PGSC0003DMG200010480	K08506	ko04130	SNARE interactions in vesicular transport	1750	1.1e-90	0.78	0.90	0.99
PGSC0003DMG200010483	K01199	ko00500	Starch and sucrose metabolism	1216	3.1e-61	0.49	0.69	0.88
PGSC0003DMG200010483	K01199	ko00500	Starch and sucrose metabolism	1087	4.1e-54	0.49	0.69	0.98
PGSC0003DMG200010484	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200016867	K00660	ko00941	Flavonoid biosynthesis	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko01100	Metabolic pathways	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko04712	Circadian rhythm - plant	2423	8.3e-128	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko00941	Flavonoid biosynthesis	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko01100	Metabolic pathways	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko01110	Biosynthesis of secondary metabolites	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMG200016867	K00660	ko04712	Circadian rhythm - plant	1800	1.9e-93	0.74	0.86	0.99
PGSC0003DMG200016869	K08515	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.87	0.96	0.29
PGSC0003DMG200016873	K00660	ko00941	Flavonoid biosynthesis	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMG200016873	K00660	ko01100	Metabolic pathways	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMG200016873	K00660	ko01110	Biosynthesis of secondary metabolites	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMG200016873	K00660	ko04712	Circadian rhythm - plant	2347	1.3e-123	0.71	0.86	0.96
PGSC0003DMG200016876	K00469	ko00053	Ascorbate and aldarate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMG200016876	K00469	ko00562	Inositol phosphate metabolism	2007	7.3e-105	0.80	0.90	0.96
PGSC0003DMG200016879	K01404	ko05140	Leishmaniasis	5188	2.6e-280	0.72	0.82	0.95
PGSC0003DMG200026194	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMG200026194	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMG200026194	K12866	ko03040	Spliceosome	247	3.0e-07	0.44	0.51	0.71
PGSC0003DMG200026194	K12866	ko03040	Spliceosome	247	3.0e-07	0.40	0.48	0.85
PGSC0003DMG200026194	K12866	ko03040	Spliceosome	240	7.6e-07	0.38	0.46	0.72
PGSC0003DMG200026195	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	282	1.8e-07	0.29	0.43	0.94
PGSC0003DMG200026197	K05740	ko04510	Focal adhesion	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMG200026197	K05740	ko04810	Regulation of actin cytoskeleton	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMG200026197	K05740	ko05131	Shigellosis	313	1.8e-10	0.30	0.46	0.74
PGSC0003DMG200026199	K01177	ko00500	Starch and sucrose metabolism	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMG200026199	K01177	ko01100	Metabolic pathways	1745	2.1e-90	0.49	0.63	0.75
PGSC0003DMG200026199	K01177	ko00500	Starch and sucrose metabolism	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMG200026199	K01177	ko01100	Metabolic pathways	319	1.3e-11	0.50	0.58	0.84
PGSC0003DMG200026199	K01177	ko00500	Starch and sucrose metabolism	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMG200026199	K01177	ko01100	Metabolic pathways	1794	4.1e-93	0.51	0.65	0.75
PGSC0003DMG200026199	K01177	ko00500	Starch and sucrose metabolism	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMG200026199	K01177	ko01100	Metabolic pathways	1129	2.0e-56	0.52	0.65	0.79
PGSC0003DMG200023019	K01509	ko00230	Purine metabolism	1521	4.7e-78	0.42	0.57	0.58
PGSC0003DMG200023020	K02957	ko03010	Ribosome	712	2.0e-33	0.87	0.90	0.64
PGSC0003DMG200023022	K02957	ko03010	Ribosome	366	2.4e-14	0.85	0.91	0.42
PGSC0003DMG200023023	K00368	ko00910	Nitrogen metabolism	437	2.9e-18	0.35	0.55	0.76
PGSC0003DMG200023024	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMG200023024	K12447	ko01100	Metabolic pathways	4287	1.3e-230	0.80	0.89	1.00
PGSC0003DMG200023024	K12447	ko00520	Amino sugar and nucleotide sugar metabolism	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMG200023024	K12447	ko01100	Metabolic pathways	4091	8.3e-220	0.82	0.91	1.00
PGSC0003DMG200023027	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04020	Calcium signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04070	Phosphatidylinositol signaling system	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04114	Oocyte meiosis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04270	Vascular smooth muscle contraction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04626	Plant-pathogen interaction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04720	Long-term potentiation	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04722	Neurotrophin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04740	Olfactory transduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04744	Phototransduction	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04745	Phototransduction - fly	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04910	Insulin signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04912	GnRH signaling pathway	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04916	Melanogenesis	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04970	Salivary secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko04971	Gastric acid secretion	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko05010	Alzheimer's disease	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023027	K02183	ko05214	Glioma	299	1.2e-10	0.35	0.56	0.96
PGSC0003DMG200023028	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04744	Phototransduction	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04916	Melanogenesis	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04970	Salivary secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023028	K02183	ko05214	Glioma	297	1.5e-10	0.36	0.56	0.88
PGSC0003DMG200023032	K01933	ko00230	Purine metabolism	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMG200023032	K01933	ko01100	Metabolic pathways	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMG200023032	K01933	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.76	0.84	1.00
PGSC0003DMG200042679	K01593	ko00340	Histidine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00350	Tyrosine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00360	Phenylalanine metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00380	Tryptophan metabolism	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00901	Indole alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00950	Isoquinoline alkaloid biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko00965	Betalain biosynthesis	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko01100	Metabolic pathways	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042679	K01593	ko01110	Biosynthesis of secondary metabolites	409	1.0e-16	0.47	0.71	0.99
PGSC0003DMG200042692	K12493	ko04144	Endocytosis	924	4.0e-45	0.54	0.72	0.72
PGSC0003DMG200040535	K09481	ko03060	Protein export	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMG200040535	K09481	ko04145	Phagosome	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMG200040535	K09481	ko05110	Vibrio cholerae infection	636	3.0e-29	0.79	0.85	0.91
PGSC0003DMG200000078	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1648	4.6e-85	0.66	0.78	0.95
PGSC0003DMG200000079	K03260	ko05416	Viral myocarditis	293	7.6e-07	0.26	0.38	0.80
PGSC0003DMG200000090	K06689	ko04120	Ubiquitin mediated proteolysis	1103	5.3e-55	0.95	0.96	0.86
PGSC0003DMG200000090	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMG200000090	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMG200011537	K07374	ko04145	Phagosome	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMG200011537	K07374	ko04540	Gap junction	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMG200011537	K07374	ko05130	Pathogenic Escherichia coli infection	3759	1.7e-201	0.97	0.98	1.00
PGSC0003DMG200011540	K00826	ko00280	Valine, leucine and isoleucine degradation	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMG200011540	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMG200011540	K00826	ko00770	Pantothenate and CoA biosynthesis	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMG200011540	K00826	ko01100	Metabolic pathways	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMG200011540	K00826	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.58	0.69	0.95
PGSC0003DMG200011540	K00826	ko00280	Valine, leucine and isoleucine degradation	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMG200011540	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMG200011540	K00826	ko00770	Pantothenate and CoA biosynthesis	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMG200011540	K00826	ko01100	Metabolic pathways	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMG200011540	K00826	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.62	0.78	0.84
PGSC0003DMG200011540	K00826	ko00280	Valine, leucine and isoleucine degradation	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMG200011540	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMG200011540	K00826	ko00770	Pantothenate and CoA biosynthesis	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMG200011540	K00826	ko01100	Metabolic pathways	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMG200011540	K00826	ko01110	Biosynthesis of secondary metabolites	2010	5.0e-105	0.61	0.78	0.99
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	1104	4.7e-55	0.58	0.73	0.50
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	1475	3.1e-80	0.45	0.61	0.94
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMG200011542	K09757	ko00940	Phenylpropanoid biosynthesis	851	4.2e-41	0.48	0.64	1.00
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	1868	3.4e-97	0.52	0.67	1.00
PGSC0003DMG200011542	K09756	ko00940	Phenylpropanoid biosynthesis	669	4.6e-31	0.53	0.72	0.84
PGSC0003DMG200009421	K02151	ko00190	Oxidative phosphorylation	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko01100	Metabolic pathways	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko04145	Phagosome	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko04966	Collecting duct acid secretion	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko05110	Vibrio cholerae infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.70	0.79	0.99
PGSC0003DMG200009421	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko00190	Oxidative phosphorylation	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko01100	Metabolic pathways	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04145	Phagosome	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko04966	Collecting duct acid secretion	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05110	Vibrio cholerae infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009421	K02151	ko05120	Epithelial cell signaling in Helicobacter pylori infection	994	5.5e-49	0.90	0.97	0.99
PGSC0003DMG200009423	K11160	ko00561	Glycerolipid metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMG200009423	K11160	ko00830	Retinol metabolism	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMG200009423	K11160	ko01100	Metabolic pathways	463	1.1e-19	0.35	0.52	0.93
PGSC0003DMG200009423	K11160	ko00561	Glycerolipid metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMG200009423	K11160	ko00830	Retinol metabolism	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMG200009423	K11160	ko01100	Metabolic pathways	325	4.3e-12	0.36	0.57	0.85
PGSC0003DMG200009423	K11160	ko00561	Glycerolipid metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMG200009423	K11160	ko00830	Retinol metabolism	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMG200009423	K11160	ko01100	Metabolic pathways	519	8.6e-23	0.34	0.49	0.84
PGSC0003DMG200009429	K01719	ko00860	Porphyrin and chlorophyll metabolism	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMG200009429	K01719	ko01100	Metabolic pathways	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMG200009429	K01719	ko01110	Biosynthesis of secondary metabolites	502	7.5e-22	0.36	0.51	0.89
PGSC0003DMG200006270	K04103	ko00380	Tryptophan metabolism	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMG200006270	K04103	ko01100	Metabolic pathways	4505	1.2e-242	0.86	0.93	1.00
PGSC0003DMG200015684	K02892	ko03010	Ribosome	211	8.4e-06	0.38	0.59	0.44
PGSC0003DMG200005019	K12667	ko00510	N-Glycan biosynthesis	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMG200005019	K12667	ko01100	Metabolic pathways	405	6.1e-16	0.38	0.59	0.87
PGSC0003DMG200005021	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.78
PGSC0003DMG200005021	K01199	ko00500	Starch and sucrose metabolism	770	1.2e-36	0.37	0.54	0.82
PGSC0003DMG200005023	K10717	ko00908	Zeatin biosynthesis	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMG200005023	K10717	ko01100	Metabolic pathways	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMG200005023	K10717	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.43	0.64	0.77
PGSC0003DMG200005030	K04121	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMG200005030	K04121	ko01100	Metabolic pathways	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMG200005030	K04121	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.32	0.51	0.88
PGSC0003DMG200005031	K01054	ko00561	Glycerolipid metabolism	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMG200005031	K01054	ko01100	Metabolic pathways	557	6.9e-25	0.35	0.55	0.89
PGSC0003DMG200011801	K09828	ko00100	Steroid biosynthesis	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMG200011801	K09828	ko01100	Metabolic pathways	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMG200011801	K09828	ko01110	Biosynthesis of secondary metabolites	3894	6.1e-209	0.78	0.89	0.99
PGSC0003DMG200011806	K08064	ko04612	Antigen processing and presentation	305	5.5e-11	0.49	0.64	0.50
PGSC0003DMG200011806	K08064	ko04612	Antigen processing and presentation	504	5.8e-22	0.53	0.69	0.59
PGSC0003DMG200011807	K12486	ko04144	Endocytosis	527	3.1e-23	0.37	0.55	0.64
PGSC0003DMG200015448	K04420	ko04010	MAPK signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMG200015448	K04420	ko04540	Gap junction	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMG200015448	K04420	ko04912	GnRH signaling pathway	823	1.5e-39	0.33	0.50	0.81
PGSC0003DMG200015448	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.78
PGSC0003DMG200015448	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.77
PGSC0003DMG200015448	K11228	ko04011	MAPK signaling pathway - yeast	921	5.8e-45	0.34	0.49	0.84
PGSC0003DMG200015451	K10260	ko04120	Ubiquitin mediated proteolysis	394	6.8e-16	0.31	0.45	0.78
PGSC0003DMG200015457	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMG200015457	K08498	ko04130	SNARE interactions in vesicular transport	1563	2.3e-80	0.75	0.89	1.00
PGSC0003DMG200002619	K01179	ko00500	Starch and sucrose metabolism	320	8.2e-12	0.67	0.78	0.58
PGSC0003DMG200002625	K00058	ko00260	Glycine, serine and threonine metabolism	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMG200002625	K00058	ko01100	Metabolic pathways	1042	1.2e-51	0.49	0.63	0.93
PGSC0003DMG200002625	K00100	ko00051	Fructose and mannose metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00100	ko00363	Bisphenol A degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00100	ko00591	Linoleic acid metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00100	ko00625	Tetrachloroethene degradation	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00100	ko00650	Butanoate metabolism	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00100	ko01100	Metabolic pathways	933	1.3e-45	0.45	0.59	0.98
PGSC0003DMG200002625	K00058	ko00260	Glycine, serine and threonine metabolism	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMG200002625	K00058	ko01100	Metabolic pathways	1076	1.6e-53	0.50	0.64	0.94
PGSC0003DMG200002625	K00058	ko00260	Glycine, serine and threonine metabolism	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMG200002625	K00058	ko01100	Metabolic pathways	424	1.5e-17	0.43	0.61	0.90
PGSC0003DMG200002626	K02695	ko00195	Photosynthesis	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMG200002626	K02695	ko01100	Metabolic pathways	960	4.1e-47	0.78	0.88	0.99
PGSC0003DMG200013018	K01066	ko00623	2,4-Dichlorobenzoate degradation	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMG200013018	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	674	2.4e-31	0.35	0.58	0.92
PGSC0003DMG200013019	K00472	ko00330	Arginine and proline metabolism	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMG200013019	K00472	ko01100	Metabolic pathways	737	8.2e-35	0.43	0.58	0.90
PGSC0003DMG200013019	K00472	ko00330	Arginine and proline metabolism	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMG200013019	K00472	ko01100	Metabolic pathways	283	9.0e-10	0.60	0.75	0.78
PGSC0003DMG200013027	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013027	K01652	ko00650	Butanoate metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013027	K01652	ko00660	C5-Branched dibasic acid metabolism	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013027	K01652	ko00770	Pantothenate and CoA biosynthesis	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013027	K01652	ko01100	Metabolic pathways	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013027	K01652	ko01110	Biosynthesis of secondary metabolites	4167	5.4e-224	0.75	0.85	1.00
PGSC0003DMG200013028	K00166	ko00280	Valine, leucine and isoleucine degradation	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMG200013028	K00166	ko01100	Metabolic pathways	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMG200013028	K00166	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.61	0.82	0.98
PGSC0003DMG200013029	K00166	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMG200013029	K00166	ko01100	Metabolic pathways	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMG200013029	K00166	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.66	0.79	0.99
PGSC0003DMG200013029	K00166	ko00280	Valine, leucine and isoleucine degradation	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMG200013029	K00166	ko01100	Metabolic pathways	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMG200013029	K00166	ko01110	Biosynthesis of secondary metabolites	2349	1.0e-123	0.68	0.84	0.85
PGSC0003DMG200013029	K00166	ko00280	Valine, leucine and isoleucine degradation	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMG200013029	K00166	ko01100	Metabolic pathways	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMG200013029	K00166	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.82	0.88	0.79
PGSC0003DMG200013029	K00166	ko00280	Valine, leucine and isoleucine degradation	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMG200013029	K00166	ko01100	Metabolic pathways	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMG200013029	K00166	ko01110	Biosynthesis of secondary metabolites	297	1.6e-10	0.58	0.76	0.98
PGSC0003DMG200013033	K12929	ko00904	Diterpenoid biosynthesis	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMG200013033	K12929	ko01110	Biosynthesis of secondary metabolites	427	1.0e-17	0.37	0.60	0.83
PGSC0003DMG200013034	K12929	ko00904	Diterpenoid biosynthesis	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMG200013034	K12929	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.44	0.63	0.99
PGSC0003DMG200013035	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMG200013035	K02957	ko03010	Ribosome	1082	7.6e-54	0.98	1.00	0.99
PGSC0003DMG200004756	K02084	ko04115	p53 signaling pathway	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko04210	Apoptosis	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko05010	Alzheimer's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko05012	Parkinson's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko05016	Huntington's disease	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004756	K02084	ko05222	Small cell lung cancer	288	7.7e-07	0.26	0.44	0.71
PGSC0003DMG200004759	K01051	ko00040	Pentose and glucuronate interconversions	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMG200004759	K01051	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMG200004759	K01051	ko01100	Metabolic pathways	1261	1.0e-63	0.51	0.71	0.82
PGSC0003DMG200004759	K01051	ko00040	Pentose and glucuronate interconversions	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMG200004759	K01051	ko00500	Starch and sucrose metabolism	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMG200004759	K01051	ko01100	Metabolic pathways	859	1.5e-41	0.54	0.74	0.96
PGSC0003DMG200001136	K12393	ko04142	Lysosome	1644	7.7e-85	0.94	0.98	0.79
PGSC0003DMG200001136	K12393	ko04142	Lysosome	1749	1.2e-90	0.92	0.97	0.99
PGSC0003DMG200001136	K12393	ko04142	Lysosome	3398	1.4e-181	0.93	0.97	1.00
PGSC0003DMG200001144	K05280	ko00941	Flavonoid biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMG200001144	K05280	ko00944	Flavone and flavonol biosynthesis	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMG200001144	K05280	ko01100	Metabolic pathways	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMG200001144	K05280	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.37	0.56	0.93
PGSC0003DMG200001144	K05280	ko00941	Flavonoid biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMG200001144	K05280	ko00944	Flavone and flavonol biosynthesis	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMG200001144	K05280	ko01100	Metabolic pathways	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMG200001144	K05280	ko01110	Biosynthesis of secondary metabolites	1481	7.5e-76	0.40	0.60	0.93
PGSC0003DMG200001146	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko04910	Insulin signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko04920	Adipocytokine signaling pathway	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001146	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	459	1.8e-19	0.58	0.73	0.78
PGSC0003DMG200001148	K04077	ko03018	RNA degradation	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMG200001148	K04077	ko04940	Type I diabetes mellitus	2649	2.8e-140	0.60	0.81	0.91
PGSC0003DMG200001149	K01723	ko00592	alpha-Linolenic acid metabolism	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMG200001149	K01723	ko01100	Metabolic pathways	3080	4.8e-164	0.69	0.82	1.00
PGSC0003DMG200001150	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMG200001150	K12655	ko04622	RIG-I-like receptor signaling pathway	243	3.0e-07	0.32	0.50	0.42
PGSC0003DMG200001151	K09590	ko00905	Brassinosteroid biosynthesis	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMG200001151	K09590	ko01100	Metabolic pathways	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMG200001151	K09590	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.44	0.68	0.98
PGSC0003DMG200036170	K02639	ko00195	Photosynthesis	650	5.1e-30	0.78	0.87	0.99
PGSC0003DMG200036174	K08243	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMG200036174	K08243	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.38	0.52	0.90
PGSC0003DMG200036177	K12132	ko04712	Circadian rhythm - plant	1043	1.1e-51	0.49	0.67	0.89
PGSC0003DMG200019271	K11294	ko05130	Pathogenic Escherichia coli infection	300	1.0e-10	0.33	0.53	0.80
PGSC0003DMG200019272	K02938	ko03010	Ribosome	2216	2.2e-116	0.97	0.99	1.00
PGSC0003DMG200019286	K12486	ko04144	Endocytosis	2659	8.0e-141	0.67	0.79	1.00
PGSC0003DMG200029785	K02377	ko00051	Fructose and mannose metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMG200029785	K02377	ko00520	Amino sugar and nucleotide sugar metabolism	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMG200029785	K02377	ko01100	Metabolic pathways	396	5.2e-16	0.75	0.86	0.76
PGSC0003DMG200029787	K04079	ko04612	Antigen processing and presentation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029787	K04079	ko04621	NOD-like receptor signaling pathway	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029787	K04079	ko04626	Plant-pathogen interaction	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029787	K04079	ko04914	Progesterone-mediated oocyte maturation	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029787	K04079	ko05200	Pathways in cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029787	K04079	ko05215	Prostate cancer	5475	3.9e-296	0.93	0.97	1.00
PGSC0003DMG200029788	K00795	ko00900	Terpenoid backbone biosynthesis	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMG200029788	K00795	ko01100	Metabolic pathways	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMG200029788	K00795	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.78	0.87	1.00
PGSC0003DMG200029791	K03027	ko00230	Purine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMG200029791	K03027	ko00240	Pyrimidine metabolism	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMG200029791	K03027	ko01100	Metabolic pathways	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMG200029791	K03027	ko03020	RNA polymerase	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMG200029791	K03027	ko04623	Cytosolic DNA-sensing pathway	2516	6.2e-133	0.80	0.90	0.93
PGSC0003DMG200003662	K00472	ko00330	Arginine and proline metabolism	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMG200003662	K00472	ko01100	Metabolic pathways	948	1.9e-46	0.52	0.74	0.73
PGSC0003DMG200003681	K01081	ko00230	Purine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMG200003681	K01081	ko00240	Pyrimidine metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMG200003681	K01081	ko00760	Nicotinate and nicotinamide metabolism	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMG200003681	K01081	ko01100	Metabolic pathways	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMG200003681	K01081	ko01110	Biosynthesis of secondary metabolites	1010	7.2e-50	0.36	0.54	0.91
PGSC0003DMG200003684	K01247	ko03410	Base excision repair	1046	7.4e-52	0.60	0.72	0.95
PGSC0003DMG200003684	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMG200003684	K01247	ko03410	Base excision repair	1793	4.7e-93	0.62	0.74	1.00
PGSC0003DMG200014814	K03094	ko04110	Cell cycle	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04111	Cell cycle - yeast	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04114	Oocyte meiosis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04120	Ubiquitin mediated proteolysis	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04310	Wnt signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04350	TGF-beta signaling pathway	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014814	K03094	ko04710	Circadian rhythm - mammal	748	2.0e-35	0.61	0.73	0.99
PGSC0003DMG200014821	K06674	ko04111	Cell cycle - yeast	7527	0.	0.77	0.86	1.00
PGSC0003DMG200014821	K06674	ko04111	Cell cycle - yeast	7634	0.	0.80	0.90	1.00
PGSC0003DMG200014822	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMG200014822	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMG200014822	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMG200014822	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMG200014822	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.45	0.64	0.98
PGSC0003DMG200010218	K01046	ko00561	Glycerolipid metabolism	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMG200010218	K01046	ko01100	Metabolic pathways	264	1.0e-08	0.34	0.46	0.47
PGSC0003DMG200010218	K01066	ko00623	2,4-Dichlorobenzoate degradation	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMG200010218	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	287	8.3e-10	0.29	0.45	0.54
PGSC0003DMG200010219	K01046	ko00561	Glycerolipid metabolism	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMG200010219	K01046	ko01100	Metabolic pathways	284	7.9e-10	0.32	0.46	0.62
PGSC0003DMG200010220	K01046	ko00561	Glycerolipid metabolism	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMG200010220	K01046	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.52
PGSC0003DMG200010221	K01046	ko00561	Glycerolipid metabolism	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMG200010221	K01046	ko01100	Metabolic pathways	287	5.4e-10	0.30	0.44	0.52
PGSC0003DMG200010222	K01046	ko00561	Glycerolipid metabolism	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMG200010222	K01046	ko01100	Metabolic pathways	272	3.6e-09	0.30	0.44	0.52
PGSC0003DMG200010228	K01046	ko00561	Glycerolipid metabolism	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMG200010228	K01046	ko01100	Metabolic pathways	312	2.3e-11	0.31	0.46	0.57
PGSC0003DMG200017123	K05280	ko00941	Flavonoid biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMG200017123	K05280	ko00944	Flavone and flavonol biosynthesis	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMG200017123	K05280	ko01100	Metabolic pathways	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMG200017123	K05280	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.44	0.64	0.99
PGSC0003DMG200017123	K05280	ko00941	Flavonoid biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMG200017123	K05280	ko00944	Flavone and flavonol biosynthesis	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMG200017123	K05280	ko01100	Metabolic pathways	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMG200017123	K05280	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.46	0.67	0.99
PGSC0003DMG200017124	K05280	ko00941	Flavonoid biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMG200017124	K05280	ko00944	Flavone and flavonol biosynthesis	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMG200017124	K05280	ko01100	Metabolic pathways	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMG200017124	K05280	ko01110	Biosynthesis of secondary metabolites	1316	9.5e-67	0.39	0.59	1.00
PGSC0003DMG200017125	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMG200017125	K00517	ko00626	Naphthalene and anthracene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMG200017125	K00517	ko00903	Limonene and pinene degradation	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMG200017125	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMG200017125	K00517	ko01110	Biosynthesis of secondary metabolites	330	2.3e-12	0.31	0.55	0.87
PGSC0003DMG200017131	K10589	ko04120	Ubiquitin mediated proteolysis	4751	3.3e-256	0.79	0.88	0.97
PGSC0003DMG200017131	K10589	ko04120	Ubiquitin mediated proteolysis	5308	6.3e-287	0.76	0.86	0.96
PGSC0003DMG200017135	K12153	ko00966	Glucosinolate biosynthesis	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMG200017135	K12153	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.46	0.65	0.97
PGSC0003DMG200017135	K11812	ko00380	Tryptophan metabolism	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMG200017135	K11812	ko00966	Glucosinolate biosynthesis	969	1.3e-47	0.58	0.74	0.99
PGSC0003DMG200017139	K02084	ko04115	p53 signaling pathway	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko04210	Apoptosis	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko05010	Alzheimer's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko05012	Parkinson's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko05016	Huntington's disease	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko05222	Small cell lung cancer	275	1.6e-06	0.32	0.51	0.43
PGSC0003DMG200017139	K02084	ko04115	p53 signaling pathway	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko04210	Apoptosis	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko05010	Alzheimer's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko05012	Parkinson's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko05016	Huntington's disease	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017139	K02084	ko05222	Small cell lung cancer	321	5.9e-11	0.32	0.49	0.75
PGSC0003DMG200017140	K04124	ko00904	Diterpenoid biosynthesis	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMG200017140	K04124	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.45	0.62	0.77
PGSC0003DMG200038123	K10760	ko00908	Zeatin biosynthesis	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMG200038123	K10760	ko01100	Metabolic pathways	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMG200038123	K10760	ko01110	Biosynthesis of secondary metabolites	477	1.8e-20	0.44	0.60	0.77
PGSC0003DMG200038129	K11818	ko00380	Tryptophan metabolism	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMG200038129	K11818	ko00966	Glucosinolate biosynthesis	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMG200038129	K11818	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.58	0.72	0.96
PGSC0003DMG200038135	K01528	ko04144	Endocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMG200038135	K01528	ko04666	Fc gamma R-mediated phagocytosis	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMG200038135	K01528	ko05100	Bacterial invasion of epithelial cells	279	5.5e-09	0.39	0.59	0.84
PGSC0003DMG200031553	K00599	ko00340	Histidine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMG200031553	K00599	ko00350	Tyrosine metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMG200031553	K00599	ko00450	Selenoamino acid metabolism	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMG200031553	K00599	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.33	0.51	0.99
PGSC0003DMG200031553	K00599	ko00340	Histidine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMG200031553	K00599	ko00350	Tyrosine metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMG200031553	K00599	ko00450	Selenoamino acid metabolism	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMG200031553	K00599	ko00626	Naphthalene and anthracene degradation	1944	2.2e-101	0.39	0.57	1.00
PGSC0003DMG200031553	K00599	ko00340	Histidine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMG200031553	K00599	ko00350	Tyrosine metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMG200031553	K00599	ko00450	Selenoamino acid metabolism	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMG200031553	K00599	ko00626	Naphthalene and anthracene degradation	688	4.1e-32	0.35	0.52	0.97
PGSC0003DMG200021784	K13030	ko00460	Cyanoamino acid metabolism	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMG200021784	K13030	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.65	0.94
PGSC0003DMG200021785	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMG200021785	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.43	0.66	0.98
PGSC0003DMG200021787	K13030	ko00460	Cyanoamino acid metabolism	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMG200021787	K13030	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.43	0.66	0.98
PGSC0003DMG200021788	K13030	ko00460	Cyanoamino acid metabolism	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMG200021788	K13030	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.42	0.63	1.00
PGSC0003DMG200021790	K08139	ko04113	Meiosis - yeast	324	7.2e-12	0.41	0.60	0.62
PGSC0003DMG200021791	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.44	0.58	0.88
PGSC0003DMG200021791	K08770	ko03320	PPAR signaling pathway	449	6.3e-19	0.45	0.59	0.77
PGSC0003DMG200021801	K00430	ko00360	Phenylalanine metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMG200021801	K00430	ko00680	Methane metabolism	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMG200021801	K00430	ko00940	Phenylpropanoid biosynthesis	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMG200021801	K00430	ko01100	Metabolic pathways	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMG200021801	K00430	ko01110	Biosynthesis of secondary metabolites	1654	2.2e-85	0.63	0.75	0.98
PGSC0003DMG200027526	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3901	2.5e-209	0.82	0.90	1.00
PGSC0003DMG200027528	K08387	ko04080	Neuroactive ligand-receptor interaction	842	1.3e-40	0.48	0.69	0.78
PGSC0003DMG200027528	K08387	ko04080	Neuroactive ligand-receptor interaction	568	1.7e-25	0.43	0.66	0.83
PGSC0003DMG200027528	K08387	ko04080	Neuroactive ligand-receptor interaction	1101	6.8e-55	0.44	0.66	0.89
PGSC0003DMG200027531	K12875	ko03040	Spliceosome	633	4.4e-29	0.26	0.44	0.94
PGSC0003DMG200027531	K12875	ko03040	Spliceosome	670	4.0e-31	0.27	0.45	0.93
PGSC0003DMG200027531	K12875	ko03040	Spliceosome	650	5.1e-30	0.27	0.44	0.94
PGSC0003DMG200027531	K12875	ko03040	Spliceosome	679	1.3e-31	0.29	0.44	0.77
PGSC0003DMG200027531	K12875	ko03040	Spliceosome	395	6.0e-16	0.35	0.49	0.99
PGSC0003DMG200027532	K02908	ko03010	Ribosome	867	5.5e-42	0.91	0.97	0.99
PGSC0003DMG200028331	K12356	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.32	0.48	0.93
PGSC0003DMG200028334	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMG200028334	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMG200028334	K02180	ko04110	Cell cycle	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMG200028334	K02180	ko04111	Cell cycle - yeast	1519	6.0e-78	0.59	0.74	0.97
PGSC0003DMG200028334	K02180	ko04110	Cell cycle	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMG200028334	K02180	ko04111	Cell cycle - yeast	270	4.7e-09	0.67	0.79	0.82
PGSC0003DMG200028339	K02084	ko04115	p53 signaling pathway	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko04210	Apoptosis	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko05010	Alzheimer's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko05012	Parkinson's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko05016	Huntington's disease	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028339	K02084	ko05222	Small cell lung cancer	313	1.9e-07	0.25	0.43	0.40
PGSC0003DMG200028340	K10744	ko03030	DNA replication	1148	1.8e-57	0.58	0.74	0.42
PGSC0003DMG200028340	K10744	ko03030	DNA replication	1270	3.3e-64	0.57	0.72	0.83
PGSC0003DMG200028340	K10744	ko03030	DNA replication	1272	2.5e-64	0.58	0.73	0.83
PGSC0003DMG200028340	K11821	ko00380	Tryptophan metabolism	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMG200028340	K11821	ko00966	Glucosinolate biosynthesis	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMG200028340	K11821	ko01110	Biosynthesis of secondary metabolites	705	4.8e-33	0.40	0.63	0.99
PGSC0003DMG200028341	K11821	ko00380	Tryptophan metabolism	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMG200028341	K11821	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMG200028341	K11821	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.42	0.63	0.99
PGSC0003DMG200028342	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMG200028342	K03036	ko03050	Proteasome	3050	2.2e-162	0.87	0.96	1.00
PGSC0003DMG200018293	K01648	ko00020	Citrate cycle (TCA cycle)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMG200018293	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMG200018293	K01648	ko01100	Metabolic pathways	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMG200018293	K01648	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.94	0.98	0.99
PGSC0003DMG200018293	K01648	ko00020	Citrate cycle (TCA cycle)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMG200018293	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMG200018293	K01648	ko01100	Metabolic pathways	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMG200018293	K01648	ko01110	Biosynthesis of secondary metabolites	3396	1.8e-181	0.94	0.98	1.00
PGSC0003DMG200018305	K10581	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.45	0.61	0.85
PGSC0003DMG200018311	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMG200018311	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMG200018311	K03144	ko03022	Basal transcription factors	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMG200018311	K03144	ko03420	Nucleotide excision repair	399	3.6e-16	0.41	0.55	0.62
PGSC0003DMG200018313	K12855	ko03040	Spliceosome	7156	0.	0.83	0.91	1.00
PGSC0003DMG200039318	K01369	ko04142	Lysosome	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMG200039318	K01369	ko04612	Antigen processing and presentation	1672	2.2e-86	0.50	0.62	0.89
PGSC0003DMG200039325	K10577	ko04120	Ubiquitin mediated proteolysis	325	4.3e-12	0.50	0.53	0.94
PGSC0003DMG200046146	K05282	ko00904	Diterpenoid biosynthesis	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMG200046146	K05282	ko01100	Metabolic pathways	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMG200046146	K05282	ko01110	Biosynthesis of secondary metabolites	370	1.4e-14	0.36	0.54	0.88
PGSC0003DMG200004353	K02008	ko02010	ABC transporters	458	2.0e-19	0.41	0.62	0.82
PGSC0003DMG200004353	K02008	ko02010	ABC transporters	681	1.0e-31	0.38	0.60	0.65
PGSC0003DMG200004355	K01915	ko00250	Alanine, aspartate and glutamate metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMG200004355	K01915	ko00330	Arginine and proline metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMG200004355	K01915	ko00910	Nitrogen metabolism	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMG200004355	K01915	ko01100	Metabolic pathways	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMG200004355	K01915	ko02020	Two-component system	3346	1.0e-178	0.87	0.95	1.00
PGSC0003DMG200004358	K01066	ko00623	2,4-Dichlorobenzoate degradation	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMG200004358	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	391	9.9e-16	0.31	0.48	0.96
PGSC0003DMG200004358	K01066	ko00623	2,4-Dichlorobenzoate degradation	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMG200004358	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	366	2.4e-14	0.30	0.49	0.96
PGSC0003DMG200004358	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMG200004358	K01061	ko00364	Fluorobenzoate degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMG200004358	K01061	ko00627	1,4-Dichlorobenzene degradation	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMG200004358	K01061	ko01100	Metabolic pathways	429	7.9e-18	0.34	0.52	0.92
PGSC0003DMG200004358	K01066	ko00623	2,4-Dichlorobenzoate degradation	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMG200004358	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	213	6.5e-06	0.32	0.54	0.98
PGSC0003DMG200004364	K00940	ko00230	Purine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMG200004364	K00940	ko00240	Pyrimidine metabolism	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMG200004364	K00940	ko01100	Metabolic pathways	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMG200004364	K00940	ko01110	Biosynthesis of secondary metabolites	861	1.2e-41	0.63	0.76	0.97
PGSC0003DMG200004365	K12620	ko03018	RNA degradation	247	8.7e-08	0.83	0.92	0.09
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	2119	4.9e-111	0.41	0.56	0.99
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	1962	2.2e-102	0.41	0.55	0.99
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	3478	5.4e-186	0.36	0.53	1.00
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	2702	3.4e-143	0.41	0.56	0.99
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMG200014149	K05674	ko02010	ABC transporters	660	7.7e-30	0.46	0.69	0.98
PGSC0003DMG200014152	K13065	ko00940	Phenylpropanoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMG200014152	K13065	ko00941	Flavonoid biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMG200014152	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMG200014152	K13065	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.81	0.88	1.00
PGSC0003DMG200014153	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMG200014153	K05287	ko01100	Metabolic pathways	403	2.2e-16	0.34	0.55	0.85
PGSC0003DMG200014153	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMG200014153	K05287	ko01100	Metabolic pathways	242	1.6e-07	0.43	0.58	0.97
PGSC0003DMG200014155	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.56
PGSC0003DMG200014155	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.48
PGSC0003DMG200014155	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.57
PGSC0003DMG200014155	K00889	ko00562	Inositol phosphate metabolism	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200014155	K00889	ko01100	Metabolic pathways	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200014155	K00889	ko04070	Phosphatidylinositol signaling system	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200014155	K00889	ko04144	Endocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200014155	K00889	ko04666	Fc gamma R-mediated phagocytosis	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200014155	K00889	ko04810	Regulation of actin cytoskeleton	317	3.0e-11	0.42	0.58	0.47
PGSC0003DMG200010077	K01354	ko05142	Chagas disease	710	2.5e-33	0.42	0.60	0.96
PGSC0003DMG200010077	K01354	ko05142	Chagas disease	1278	1.2e-64	0.32	0.50	0.94
PGSC0003DMG200010080	K04631	ko04744	Phototransduction	668	5.9e-31	0.35	0.52	0.39
PGSC0003DMG200010081	K00908	ko01100	Metabolic pathways	420	3.5e-17	0.27	0.45	0.77
PGSC0003DMG200010900	K00626	ko00071	Fatty acid metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00072	Synthesis and degradation of ketone bodies	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00280	Valine, leucine and isoleucine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00310	Lysine degradation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00380	Tryptophan metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00620	Pyruvate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00632	Benzoate degradation via CoA ligation	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00640	Propanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00650	Butanoate metabolism	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00900	Terpenoid backbone biosynthesis	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko01100	Metabolic pathways	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko02020	Two-component system	1640	1.3e-84	0.79	0.86	0.98
PGSC0003DMG200010900	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00071	Fatty acid metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00072	Synthesis and degradation of ketone bodies	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00280	Valine, leucine and isoleucine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00310	Lysine degradation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00380	Tryptophan metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00620	Pyruvate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00632	Benzoate degradation via CoA ligation	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00640	Propanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00650	Butanoate metabolism	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko00900	Terpenoid backbone biosynthesis	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko01100	Metabolic pathways	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko01110	Biosynthesis of secondary metabolites	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010900	K00626	ko02020	Two-component system	2872	1.4e-152	0.85	0.94	1.00
PGSC0003DMG200010913	K00873	ko00010	Glycolysis / Gluconeogenesis	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko00230	Purine metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko00620	Pyruvate metabolism	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko00710	Carbon fixation in photosynthetic organisms	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko01100	Metabolic pathways	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko01110	Biosynthesis of secondary metabolites	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010913	K00873	ko04930	Type II diabetes mellitus	3715	4.6e-199	0.90	0.96	0.98
PGSC0003DMG200010924	K12488	ko04144	Endocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMG200010924	K12488	ko04666	Fc gamma R-mediated phagocytosis	238	2.0e-06	0.31	0.43	0.89
PGSC0003DMG200033584	K03841	ko00010	Glycolysis / Gluconeogenesis	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko00030	Pentose phosphate pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko00051	Fructose and mannose metabolism	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko00710	Carbon fixation in photosynthetic organisms	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko01100	Metabolic pathways	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033584	K03841	ko04910	Insulin signaling pathway	1108	2.8e-55	0.46	0.65	0.88
PGSC0003DMG200033588	K03110	ko03060	Protein export	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMG200033588	K03110	ko03070	Bacterial secretion system	304	7.0e-11	0.43	0.54	0.73
PGSC0003DMG200033589	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMG200033589	K12567	ko05414	Dilated cardiomyopathy	847	2.5e-38	0.37	0.50	0.90
PGSC0003DMG200033590	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMG200033590	K12567	ko05414	Dilated cardiomyopathy	1089	1.1e-51	0.38	0.51	0.93
PGSC0003DMG200033591	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMG200033591	K12567	ko05414	Dilated cardiomyopathy	1151	4.2e-55	0.37	0.52	0.92
PGSC0003DMG200033617	K13027	ko00460	Cyanoamino acid metabolism	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMG200033617	K13027	ko00966	Glucosinolate biosynthesis	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMG200033617	K13027	ko01100	Metabolic pathways	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMG200033617	K13027	ko01110	Biosynthesis of secondary metabolites	1193	5.8e-60	0.60	0.75	0.99
PGSC0003DMG200021087	K10676	ko00627	1,4-Dichlorobenzene degradation	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMG200021087	K10676	ko01100	Metabolic pathways	640	1.8e-29	0.39	0.59	0.71
PGSC0003DMG200021087	K10676	ko00627	1,4-Dichlorobenzene degradation	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMG200021087	K10676	ko01100	Metabolic pathways	606	1.4e-27	0.44	0.65	0.67
PGSC0003DMG200021095	K04125	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.58	0.74	0.89
PGSC0003DMG200021097	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMG200021097	K07819	ko01100	Metabolic pathways	471	3.8e-20	0.32	0.51	0.38
PGSC0003DMG200021098	K02084	ko04115	p53 signaling pathway	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko04210	Apoptosis	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko05010	Alzheimer's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko05012	Parkinson's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko05016	Huntington's disease	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021098	K02084	ko05222	Small cell lung cancer	294	1.1e-06	0.28	0.44	0.52
PGSC0003DMG200021100	K02912	ko03010	Ribosome	545	3.2e-24	0.83	0.93	0.96
PGSC0003DMG200017568	K00128	ko00010	Glycolysis / Gluconeogenesis	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00053	Ascorbate and aldarate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00071	Fatty acid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00280	Valine, leucine and isoleucine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00310	Lysine degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00330	Arginine and proline metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00340	Histidine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00380	Tryptophan metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00410	beta-Alanine metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00561	Glycerolipid metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00620	Pyruvate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00631	1,2-Dichloroethane degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00640	Propanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00641	3-Chloroacrylic acid degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00650	Butanoate metabolism	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko00903	Limonene and pinene degradation	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko01100	Metabolic pathways	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017568	K00128	ko01110	Biosynthesis of secondary metabolites	2713	8.4e-144	0.67	0.84	0.99
PGSC0003DMG200017570	K03862	ko00623	2,4-Dichlorobenzoate degradation	243	1.4e-07	0.44	0.61	0.24
PGSC0003DMG200017570	K03862	ko00623	2,4-Dichlorobenzoate degradation	450	5.5e-19	0.32	0.46	0.53
PGSC0003DMG200017573	K02877	ko03010	Ribosome	1697	9.2e-88	0.94	0.97	1.00
PGSC0003DMG200017574	K01881	ko00970	Aminoacyl-tRNA biosynthesis	363	8.2e-14	0.35	0.57	0.51
PGSC0003DMG200017584	K11294	ko05130	Pathogenic Escherichia coli infection	471	3.8e-20	0.37	0.56	0.71
PGSC0003DMG200017589	K10604	ko04120	Ubiquitin mediated proteolysis	586	1.7e-26	0.36	0.56	0.72
PGSC0003DMG200027644	K04734	ko04062	Chemokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04210	Apoptosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04620	Toll-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04621	NOD-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04622	RIG-I-like receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04623	Cytosolic DNA-sensing pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04660	T cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04662	B cell receptor signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko04920	Adipocytokine signaling pathway	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05120	Epithelial cell signaling in Helicobacter pylori infection	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05131	Shigellosis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05140	Leishmaniasis	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05142	Chagas disease	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05200	Pathways in cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05215	Prostate cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05220	Chronic myeloid leukemia	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K04734	ko05222	Small cell lung cancer	238	2.7e-07	0.36	0.52	0.75
PGSC0003DMG200027644	K08803	ko05200	Pathways in cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMG200027644	K08803	ko05219	Bladder cancer	347	5.1e-11	0.31	0.50	0.58
PGSC0003DMG200027645	K04125	ko00904	Diterpenoid biosynthesis	435	3.7e-18	0.67	0.81	0.94
PGSC0003DMG200027645	K04125	ko00904	Diterpenoid biosynthesis	1469	3.5e-75	0.52	0.67	0.99
PGSC0003DMG200027647	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200027647	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200027647	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200027647	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200027647	K10352	ko04530	Tight junction	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200027647	K10352	ko05416	Viral myocarditis	285	1.2e-08	0.29	0.49	0.79
PGSC0003DMG200037819	K10591	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMG200037819	K10591	ko04144	Endocytosis	1072	2.7e-53	0.60	0.76	0.99
PGSC0003DMG200000456	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMG200000458	K02219	ko04111	Cell cycle - yeast	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMG200000458	K02219	ko05200	Pathways in cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMG200000458	K02219	ko05222	Small cell lung cancer	742	4.3e-35	0.94	0.98	0.99
PGSC0003DMG200000459	K10603	ko04120	Ubiquitin mediated proteolysis	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMG200000459	K10603	ko05340	Primary immunodeficiency	331	1.1e-09	0.29	0.44	0.32
PGSC0003DMG200000466	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.36	0.54	0.87
PGSC0003DMG200000466	K00679	ko00561	Glycerolipid metabolism	1328	2.1e-67	0.37	0.52	0.86
PGSC0003DMG200000466	K00679	ko00561	Glycerolipid metabolism	966	1.9e-47	0.41	0.59	0.65
PGSC0003DMG200000477	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMG200000477	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.76
PGSC0003DMG200000477	K03795	ko00860	Porphyrin and chlorophyll metabolism	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMG200000477	K03795	ko01100	Metabolic pathways	309	3.3e-11	0.37	0.54	0.58
PGSC0003DMG200016174	K06670	ko04110	Cell cycle	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMG200016174	K06670	ko04111	Cell cycle - yeast	2805	7.1e-149	0.40	0.51	1.00
PGSC0003DMG200016177	K03921	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMG200016177	K03921	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.80	0.89	0.69
PGSC0003DMG200016181	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	2331	9.9e-123	0.79	0.86	0.99
PGSC0003DMG200016190	K12356	ko00940	Phenylpropanoid biosynthesis	625	1.6e-30	0.31	0.48	0.94
PGSC0003DMG200016193	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.32	0.48	0.93
PGSC0003DMG200012376	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMG200012376	K06672	ko04111	Cell cycle - yeast	5979	0.	0.66	0.79	0.95
PGSC0003DMG200012376	K06672	ko04111	Cell cycle - yeast	2528	1.3e-133	0.66	0.78	1.00
PGSC0003DMG200012376	K06672	ko04111	Cell cycle - yeast	9601	0.	0.61	0.73	1.00
PGSC0003DMG200012380	K07195	ko04910	Insulin signaling pathway	2269	2.6e-119	0.47	0.66	0.98
PGSC0003DMG200012385	K07424	ko00140	Steroid hormone biosynthesis	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00591	Linoleic acid metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00830	Retinol metabolism	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00982	Drug metabolism - cytochrome P450	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko00983	Drug metabolism - other enzymes	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012385	K07424	ko01100	Metabolic pathways	376	6.7e-15	0.52	0.71	0.45
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1589	8.3e-82	0.53	0.75	1.00
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	2121	3.8e-111	0.51	0.70	0.97
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	735	1.1e-34	0.59	0.80	0.99
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1240	1.5e-62	0.55	0.78	0.99
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1853	2.3e-96	0.54	0.75	1.00
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1201	2.1e-60	0.53	0.77	0.99
PGSC0003DMG200012386	K07424	ko00140	Steroid hormone biosynthesis	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00591	Linoleic acid metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00830	Retinol metabolism	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00982	Drug metabolism - cytochrome P450	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko00983	Drug metabolism - other enzymes	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012386	K07424	ko01100	Metabolic pathways	1597	3.0e-82	0.57	0.78	0.96
PGSC0003DMG200012387	K01595	ko00620	Pyruvate metabolism	7238	0.	0.87	0.95	1.00
PGSC0003DMG200012387	K01595	ko00710	Carbon fixation in photosynthetic organisms	7238	0.	0.87	0.95	1.00
PGSC0003DMG200012387	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7238	0.	0.87	0.95	1.00
PGSC0003DMG200012387	K01595	ko01100	Metabolic pathways	7238	0.	0.87	0.95	1.00
PGSC0003DMG200012388	K03846	ko00510	N-Glycan biosynthesis	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMG200012388	K03846	ko01100	Metabolic pathways	3735	3.6e-200	0.75	0.87	1.00
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.57	0.77	0.85
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.53	0.71	0.88
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2689	1.8e-142	0.49	0.67	0.92
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.48	0.67	0.95
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	662	1.1e-30	0.28	0.48	0.73
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.81
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.65
PGSC0003DMG200001951	K00108	ko00260	Glycine, serine and threonine metabolism	682	8.8e-32	0.28	0.49	0.87
PGSC0003DMG200001953	K12400	ko04142	Lysosome	4000	8.7e-215	0.87	0.95	0.97
PGSC0003DMG200001953	K12400	ko04142	Lysosome	6108	0.	0.77	0.86	1.00
PGSC0003DMG200001953	K12400	ko04142	Lysosome	1944	2.2e-101	0.61	0.73	1.00
PGSC0003DMG200001953	K12400	ko04142	Lysosome	1552	9.1e-80	0.58	0.70	1.00
PGSC0003DMG200029243	K09754	ko00360	Phenylalanine metabolism	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029243	K09754	ko00940	Phenylpropanoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029243	K09754	ko00941	Flavonoid biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029243	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029243	K09754	ko01100	Metabolic pathways	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029243	K09754	ko01110	Biosynthesis of secondary metabolites	2619	1.3e-138	0.67	0.80	1.00
PGSC0003DMG200029250	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.69
PGSC0003DMG200029250	K06685	ko04111	Cell cycle - yeast	401	1.5e-12	0.27	0.44	0.68
PGSC0003DMG200029253	K12127	ko04712	Circadian rhythm - plant	282	1.1e-07	0.33	0.52	0.34
PGSC0003DMG200029255	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMG200029255	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMG200029255	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMG200029255	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.45	0.96
PGSC0003DMG200029257	K07512	ko00062	Fatty acid elongation in mitochondria	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMG200029257	K07512	ko01100	Metabolic pathways	219	3.8e-13	0.68	0.88	0.58
PGSC0003DMG200029257	K07512	ko00062	Fatty acid elongation in mitochondria	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMG200029257	K07512	ko01100	Metabolic pathways	1030	5.6e-51	0.63	0.84	0.94
PGSC0003DMG200029259	K13065	ko00940	Phenylpropanoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMG200029259	K13065	ko00941	Flavonoid biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMG200029259	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMG200029259	K13065	ko01110	Biosynthesis of secondary metabolites	387	1.9e-15	0.27	0.47	0.61
PGSC0003DMG200029260	K07512	ko00062	Fatty acid elongation in mitochondria	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMG200029260	K07512	ko01100	Metabolic pathways	391	9.9e-16	0.78	0.96	0.98
PGSC0003DMG200030507	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.84
PGSC0003DMG200030507	K05681	ko02010	ABC transporters	1237	2.2e-62	0.35	0.53	0.82
PGSC0003DMG200030509	K01807	ko00030	Pentose phosphate pathway	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMG200030509	K01807	ko00710	Carbon fixation in photosynthetic organisms	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMG200030509	K01807	ko01100	Metabolic pathways	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMG200030509	K01807	ko01110	Biosynthesis of secondary metabolites	1651	3.2e-85	0.75	0.87	0.99
PGSC0003DMG200030517	K02606	ko04110	Cell cycle	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMG200030517	K02606	ko04111	Cell cycle - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMG200030517	K02606	ko04113	Meiosis - yeast	2294	1.1e-120	0.66	0.83	0.99
PGSC0003DMG200019984	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko00230	Purine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko00240	Pyrimidine metabolism	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko01100	Metabolic pathways	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko03020	RNA polymerase	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019984	K03013	ko05016	Huntington's disease	1475	1.6e-75	0.83	0.94	1.00
PGSC0003DMG200019991	K00128	ko00010	Glycolysis / Gluconeogenesis	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00053	Ascorbate and aldarate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00071	Fatty acid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00310	Lysine degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00330	Arginine and proline metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00340	Histidine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00380	Tryptophan metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00410	beta-Alanine metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00561	Glycerolipid metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00620	Pyruvate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00631	1,2-Dichloroethane degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00640	Propanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00641	3-Chloroacrylic acid degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00650	Butanoate metabolism	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00903	Limonene and pinene degradation	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko01100	Metabolic pathways	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.60	0.67	0.62
PGSC0003DMG200019991	K00128	ko00010	Glycolysis / Gluconeogenesis	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00053	Ascorbate and aldarate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00071	Fatty acid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00280	Valine, leucine and isoleucine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00310	Lysine degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00330	Arginine and proline metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00340	Histidine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00380	Tryptophan metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00410	beta-Alanine metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00561	Glycerolipid metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00620	Pyruvate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00631	1,2-Dichloroethane degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00640	Propanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00641	3-Chloroacrylic acid degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00650	Butanoate metabolism	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00903	Limonene and pinene degradation	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.69	0.98
PGSC0003DMG200019991	K00128	ko00010	Glycolysis / Gluconeogenesis	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00053	Ascorbate and aldarate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00071	Fatty acid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00280	Valine, leucine and isoleucine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00310	Lysine degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00330	Arginine and proline metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00340	Histidine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00380	Tryptophan metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00410	beta-Alanine metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00561	Glycerolipid metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00620	Pyruvate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00631	1,2-Dichloroethane degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00640	Propanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00641	3-Chloroacrylic acid degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00650	Butanoate metabolism	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko00903	Limonene and pinene degradation	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko01100	Metabolic pathways	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200019991	K00128	ko01110	Biosynthesis of secondary metabolites	1112	1.7e-55	0.49	0.67	0.99
PGSC0003DMG200022200	K03531	ko04112	Cell cycle - Caulobacter	2809	4.3e-149	0.83	0.91	1.00
PGSC0003DMG200022202	K05399	ko04620	Toll-like receptor signaling pathway	985	1.7e-48	0.50	0.69	0.69
PGSC0003DMG200022202	K05399	ko04620	Toll-like receptor signaling pathway	1269	3.7e-64	0.47	0.66	0.78
PGSC0003DMG200022202	K05399	ko04620	Toll-like receptor signaling pathway	233	5.1e-07	0.61	0.75	0.31
PGSC0003DMG200022202	K05399	ko04620	Toll-like receptor signaling pathway	756	7.3e-36	0.47	0.67	0.97
PGSC0003DMG200022203	K08241	ko00592	alpha-Linolenic acid metabolism	820	2.2e-39	0.38	0.52	0.88
PGSC0003DMG200022205	K00981	ko00564	Glycerophospholipid metabolism	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMG200022205	K00981	ko01100	Metabolic pathways	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMG200022205	K00981	ko04070	Phosphatidylinositol signaling system	2411	3.8e-127	0.80	0.89	0.99
PGSC0003DMG200022208	K01179	ko00500	Starch and sucrose metabolism	1376	4.7e-70	0.43	0.62	0.98
PGSC0003DMG200022210	K04426	ko04010	MAPK signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMG200022210	K04426	ko04722	Neurotrophin signaling pathway	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMG200022210	K04426	ko05014	Amyotrophic lateral sclerosis (ALS)	698	1.2e-32	0.42	0.59	0.53
PGSC0003DMG200022211	K02501	ko00340	Histidine metabolism	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMG200022211	K02501	ko01100	Metabolic pathways	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMG200022211	K02501	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.86	0.92	0.69
PGSC0003DMG200022211	K02501	ko00340	Histidine metabolism	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMG200022211	K02501	ko01100	Metabolic pathways	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMG200022211	K02501	ko01110	Biosynthesis of secondary metabolites	4039	6.1e-217	0.82	0.89	1.00
PGSC0003DMG200022211	K02501	ko00340	Histidine metabolism	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMG200022211	K02501	ko01100	Metabolic pathways	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMG200022211	K02501	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.93	0.98	0.74
PGSC0003DMG200022214	K00795	ko00900	Terpenoid backbone biosynthesis	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMG200022214	K00795	ko01100	Metabolic pathways	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMG200022214	K00795	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.29	0.50	0.87
PGSC0003DMG200036530	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMG200036530	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMG200036530	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.47	0.73	0.96
PGSC0003DMG200036536	K10717	ko00908	Zeatin biosynthesis	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMG200036536	K10717	ko01100	Metabolic pathways	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMG200036536	K10717	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.39	0.59	1.00
PGSC0003DMG200036538	K12831	ko03040	Spliceosome	326	3.8e-12	0.51	0.61	0.72
PGSC0003DMG200018961	K01853	ko00100	Steroid biosynthesis	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMG200018961	K01853	ko01100	Metabolic pathways	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMG200018961	K01853	ko01110	Biosynthesis of secondary metabolites	2783	1.2e-147	0.48	0.58	0.98
PGSC0003DMG200018961	K01853	ko00100	Steroid biosynthesis	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMG200018961	K01853	ko01100	Metabolic pathways	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMG200018961	K01853	ko01110	Biosynthesis of secondary metabolites	286	2.6e-09	0.78	0.82	0.68
PGSC0003DMG200018962	K01853	ko00100	Steroid biosynthesis	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMG200018962	K01853	ko01100	Metabolic pathways	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMG200018962	K01853	ko01110	Biosynthesis of secondary metabolites	4443	3.2e-239	0.68	0.82	0.98
PGSC0003DMG200018962	K01853	ko00100	Steroid biosynthesis	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMG200018962	K01853	ko01100	Metabolic pathways	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMG200018962	K01853	ko01110	Biosynthesis of secondary metabolites	4831	1.3e-260	0.71	0.84	0.99
PGSC0003DMG200018963	K13280	ko03060	Protein export	1250	4.1e-63	0.96	0.99	0.36
PGSC0003DMG200018963	K13280	ko03060	Protein export	1275	1.7e-64	0.90	0.93	0.80
PGSC0003DMG200018963	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMG200018963	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMG200018963	K13280	ko03060	Protein export	1439	1.6e-73	0.94	0.98	0.99
PGSC0003DMG200018966	K12929	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMG200018966	K12929	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.41	0.61	0.86
PGSC0003DMG200029721	K03010	ko00230	Purine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMG200029721	K03010	ko00240	Pyrimidine metabolism	9859	0.	0.96	0.98	1.00
PGSC0003DMG200029721	K03010	ko01100	Metabolic pathways	9859	0.	0.96	0.98	1.00
PGSC0003DMG200029721	K03010	ko03020	RNA polymerase	9859	0.	0.96	0.98	1.00
PGSC0003DMG200029721	K03010	ko05016	Huntington's disease	9859	0.	0.96	0.98	1.00
PGSC0003DMG200029721	K03010	ko00230	Purine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMG200029721	K03010	ko00240	Pyrimidine metabolism	6353	0.	0.69	0.70	1.00
PGSC0003DMG200029721	K03010	ko01100	Metabolic pathways	6353	0.	0.69	0.70	1.00
PGSC0003DMG200029721	K03010	ko03020	RNA polymerase	6353	0.	0.69	0.70	1.00
PGSC0003DMG200029721	K03010	ko05016	Huntington's disease	6353	0.	0.69	0.70	1.00
PGSC0003DMG200029722	K01834	ko00010	Glycolysis / Gluconeogenesis	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMG200029722	K01834	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMG200029722	K01834	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.35	0.53	0.83
PGSC0003DMG200029722	K01834	ko00010	Glycolysis / Gluconeogenesis	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMG200029722	K01834	ko01100	Metabolic pathways	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMG200029722	K01834	ko01110	Biosynthesis of secondary metabolites	284	7.9e-10	0.40	0.61	0.53
PGSC0003DMG200029724	K10581	ko04120	Ubiquitin mediated proteolysis	2564	1.4e-135	0.40	0.57	0.95
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	1221	1.6e-61	0.66	0.82	0.91
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	2184	1.3e-114	0.56	0.73	0.96
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	1625	8.6e-84	0.53	0.70	0.99
PGSC0003DMG200002359	K07195	ko04910	Insulin signaling pathway	2209	5.3e-116	0.48	0.67	0.97
PGSC0003DMG200012961	K12819	ko03040	Spliceosome	268	5.4e-06	0.30	0.49	0.34
PGSC0003DMG200012961	K12819	ko03040	Spliceosome	268	3.5e-08	0.30	0.49	0.72
PGSC0003DMG200012964	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMG200012964	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.31	0.46	0.84
PGSC0003DMG200012966	K00627	ko00010	Glycolysis / Gluconeogenesis	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMG200012966	K00627	ko00020	Citrate cycle (TCA cycle)	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMG200012966	K00627	ko00620	Pyruvate metabolism	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMG200012966	K00627	ko01100	Metabolic pathways	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMG200012966	K00627	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.64	0.74	1.00
PGSC0003DMG200012971	K03456	ko04111	Cell cycle - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04113	Meiosis - yeast	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04114	Oocyte meiosis	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04310	Wnt signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04350	TGF-beta signaling pathway	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04530	Tight junction	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko04730	Long-term depression	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200012971	K03456	ko05142	Chagas disease	4673	6.6e-252	0.95	0.98	1.00
PGSC0003DMG200004939	K09756	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.61	0.78	0.86
PGSC0003DMG200001065	K11251	ko05322	Systemic lupus erythematosus	1000	2.5e-49	0.93	0.95	0.99
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2125	2.3e-111	0.63	0.77	0.96
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04113	Meiosis - yeast	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04114	Oocyte meiosis	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001069	K11584	ko04310	Wnt signaling pathway	2602	1.1e-137	0.62	0.78	1.00
PGSC0003DMG200001070	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMG200001070	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMG200001070	K10781	ko00061	Fatty acid biosynthesis	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMG200001070	K10781	ko01100	Metabolic pathways	2612	3.1e-138	0.75	0.84	0.99
PGSC0003DMG200001072	K02184	ko04320	Dorso-ventral axis formation	1292	2.0e-65	0.42	0.47	0.44
PGSC0003DMG200001075	K13065	ko00940	Phenylpropanoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMG200001075	K13065	ko00941	Flavonoid biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMG200001075	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMG200001075	K13065	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.32	0.52	0.90
PGSC0003DMG200001076	K13065	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMG200001076	K13065	ko00941	Flavonoid biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMG200001076	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMG200001076	K13065	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.34	0.51	0.91
PGSC0003DMG200001077	K06676	ko04111	Cell cycle - yeast	3594	2.2e-192	0.67	0.78	0.99
PGSC0003DMG200001078	K10528	ko00592	alpha-Linolenic acid metabolism	1870	2.6e-97	0.49	0.69	0.96
PGSC0003DMG200001079	K00748	ko00540	Lipopolysaccharide biosynthesis	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMG200001079	K00748	ko01100	Metabolic pathways	1193	5.8e-60	0.68	0.79	0.93
PGSC0003DMG200001079	K00748	ko00540	Lipopolysaccharide biosynthesis	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMG200001079	K00748	ko01100	Metabolic pathways	1570	9.3e-81	0.64	0.75	0.97
PGSC0003DMG200031454	K12356	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.30	0.45	0.85
PGSC0003DMG200031457	K10775	ko00360	Phenylalanine metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMG200031457	K10775	ko00910	Nitrogen metabolism	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMG200031457	K10775	ko00940	Phenylpropanoid biosynthesis	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMG200031457	K10775	ko01100	Metabolic pathways	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMG200031457	K10775	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.87	0.95	1.00
PGSC0003DMG200031459	K10571	ko04120	Ubiquitin mediated proteolysis	1876	1.2e-97	0.82	0.90	0.89
PGSC0003DMG200031459	K10571	ko04120	Ubiquitin mediated proteolysis	3824	4.4e-205	0.84	0.92	1.00
PGSC0003DMG200031459	K10571	ko04120	Ubiquitin mediated proteolysis	1303	4.9e-66	0.85	0.94	0.99
PGSC0003DMG200031460	K02894	ko03010	Ribosome	792	7.6e-38	0.92	0.95	0.42
PGSC0003DMG200025373	K09753	ko00940	Phenylpropanoid biosynthesis	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMG200025373	K09753	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMG200025373	K09753	ko01110	Biosynthesis of secondary metabolites	1071	3.1e-53	0.45	0.64	0.98
PGSC0003DMG200025373	K09753	ko00940	Phenylpropanoid biosynthesis	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMG200025373	K09753	ko01100	Metabolic pathways	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMG200025373	K09753	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.47	0.67	0.98
PGSC0003DMG200025374	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMG200025374	K04518	ko01100	Metabolic pathways	1852	2.6e-96	0.62	0.73	0.96
PGSC0003DMG200025374	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMG200025374	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMG200025374	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMG200025374	K04518	ko01100	Metabolic pathways	1912	1.3e-99	0.63	0.74	0.96
PGSC0003DMG200025375	K02154	ko00190	Oxidative phosphorylation	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko01100	Metabolic pathways	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko04142	Lysosome	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko04145	Phagosome	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko04966	Collecting duct acid secretion	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko05110	Vibrio cholerae infection	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025375	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	6059	0.	0.86	0.93	1.00
PGSC0003DMG200025377	K05915	ko00363	Bisphenol A degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMG200025377	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMG200025377	K05915	ko01100	Metabolic pathways	1027	8.3e-51	0.51	0.64	0.95
PGSC0003DMG200025378	K10643	ko03018	RNA degradation	4110	7.5e-221	0.51	0.64	1.00
PGSC0003DMG200025378	K10643	ko03018	RNA degradation	4123	1.4e-221	0.52	0.64	1.00
PGSC0003DMG200025378	K10643	ko03018	RNA degradation	4121	1.8e-221	0.51	0.64	1.00
PGSC0003DMG200025384	K01955	ko00240	Pyrimidine metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMG200025384	K01955	ko00250	Alanine, aspartate and glutamate metabolism	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMG200025384	K01955	ko01100	Metabolic pathways	930	2.7e-45	0.66	0.77	0.78
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	1180	3.0e-59	0.67	0.84	0.97
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	787	1.4e-37	0.64	0.79	0.77
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	1154	8.2e-58	0.69	0.79	0.89
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	1773	5.9e-92	0.60	0.80	0.98
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	407	6.0e-16	0.57	0.80	0.81
PGSC0003DMG200027251	K05768	ko04666	Fc gamma R-mediated phagocytosis	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMG200027251	K05768	ko04810	Regulation of actin cytoskeleton	3306	1.7e-176	0.48	0.67	0.97
PGSC0003DMG200027251	K05768	ko04666	Fc gamma R-mediated phagocytosis	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMG200027251	K05768	ko04810	Regulation of actin cytoskeleton	3559	1.8e-190	0.47	0.65	1.00
PGSC0003DMG200027254	K05643	ko02010	ABC transporters	2969	6.4e-158	0.33	0.48	0.99
PGSC0003DMG200027254	K05643	ko02010	ABC transporters	3229	1.1e-178	0.34	0.51	0.97
PGSC0003DMG200027256	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMG200027256	K00384	ko00240	Pyrimidine metabolism	941	4.6e-46	0.64	0.75	0.87
PGSC0003DMG200027256	K00384	ko00240	Pyrimidine metabolism	3414	1.8e-182	0.76	0.87	0.97
PGSC0003DMG200027256	K00384	ko00240	Pyrimidine metabolism	1648	4.6e-85	0.83	0.92	1.00
PGSC0003DMG200028505	K05277	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMG200028505	K05277	ko01100	Metabolic pathways	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMG200028505	K05277	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.33	0.55	0.70
PGSC0003DMG200028505	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028505	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028505	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028516	K00413	ko00190	Oxidative phosphorylation	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200028516	K00413	ko01100	Metabolic pathways	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200028516	K00413	ko04260	Cardiac muscle contraction	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200028516	K00413	ko05010	Alzheimer's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200028516	K00413	ko05012	Parkinson's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200028516	K00413	ko05016	Huntington's disease	2293	1.2e-120	0.84	0.90	1.00
PGSC0003DMG200018452	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko04210	Apoptosis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko04620	Toll-like receptor signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko04722	Neurotrophin signaling pathway	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko05140	Leishmaniasis	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018452	K04733	ko05142	Chagas disease	829	6.9e-40	0.30	0.44	0.89
PGSC0003DMG200018458	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.74
PGSC0003DMG200018458	K00108	ko00260	Glycine, serine and threonine metabolism	669	4.6e-31	0.28	0.49	0.65
PGSC0003DMG200018461	K06685	ko04111	Cell cycle - yeast	368	1.0e-10	0.26	0.42	0.75
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	9.7e-07	0.27	0.46	0.34
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200007229	K04124	ko00904	Diterpenoid biosynthesis	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMG200007229	K04124	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.37	0.57	0.86
PGSC0003DMG200007229	K04124	ko00904	Diterpenoid biosynthesis	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMG200007229	K04124	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.41	0.63	0.90
PGSC0003DMG200007229	K04124	ko00904	Diterpenoid biosynthesis	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMG200007229	K04124	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.41	0.63	0.82
PGSC0003DMG200007229	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007229	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007229	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007229	K05278	ko00941	Flavonoid biosynthesis	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007229	K05278	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007229	K05278	ko01110	Biosynthesis of secondary metabolites	237	3.1e-07	0.32	0.50	0.98
PGSC0003DMG200007232	K05278	ko00941	Flavonoid biosynthesis	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMG200007232	K05278	ko01100	Metabolic pathways	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMG200007232	K05278	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.35	0.51	0.93
PGSC0003DMG200007233	K01046	ko00561	Glycerolipid metabolism	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMG200007233	K01046	ko01100	Metabolic pathways	396	5.2e-16	0.35	0.48	0.74
PGSC0003DMG200007235	K06316	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.90	0.95	0.98
PGSC0003DMG200007235	K06316	ko00510	N-Glycan biosynthesis	568	1.7e-25	0.68	0.82	0.99
PGSC0003DMG200007235	K06316	ko00510	N-Glycan biosynthesis	1872	2.0e-97	0.79	0.88	1.00
PGSC0003DMG200007236	K03026	ko00230	Purine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMG200007236	K03026	ko00240	Pyrimidine metabolism	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMG200007236	K03026	ko01100	Metabolic pathways	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMG200007236	K03026	ko03020	RNA polymerase	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMG200007236	K03026	ko04623	Cytosolic DNA-sensing pathway	892	2.3e-43	0.53	0.68	0.99
PGSC0003DMG200007236	K03026	ko00230	Purine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMG200007236	K03026	ko00240	Pyrimidine metabolism	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMG200007236	K03026	ko01100	Metabolic pathways	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMG200007236	K03026	ko03020	RNA polymerase	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMG200007236	K03026	ko04623	Cytosolic DNA-sensing pathway	1267	4.8e-64	0.49	0.65	0.98
PGSC0003DMG200014733	K09561	ko04120	Ubiquitin mediated proteolysis	239	3.7e-07	0.49	0.67	0.15
PGSC0003DMG200014734	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00360	Phenylalanine metabolism	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00940	Phenylpropanoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00941	Flavonoid biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01100	Metabolic pathways	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01110	Biosynthesis of secondary metabolites	2894	8.7e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00360	Phenylalanine metabolism	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00941	Flavonoid biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01100	Metabolic pathways	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014734	K09754	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.66	0.81	0.98
PGSC0003DMG200014735	K12611	ko03018	RNA degradation	555	8.9e-25	0.31	0.49	0.95
PGSC0003DMG200014755	K09843	ko00906	Carotenoid biosynthesis	730	2.0e-34	0.39	0.58	0.96
PGSC0003DMG200014755	K09843	ko00906	Carotenoid biosynthesis	1015	3.8e-50	0.36	0.54	0.93
PGSC0003DMG200014756	K00615	ko00030	Pentose phosphate pathway	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMG200014756	K00615	ko00710	Carbon fixation in photosynthetic organisms	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMG200014756	K00615	ko01051	Biosynthesis of ansamycins	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMG200014756	K00615	ko01100	Metabolic pathways	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMG200014756	K00615	ko01110	Biosynthesis of secondary metabolites	2843	5.7e-151	0.55	0.70	0.99
PGSC0003DMG200014757	K01955	ko00240	Pyrimidine metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMG200014757	K01955	ko00250	Alanine, aspartate and glutamate metabolism	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMG200014757	K01955	ko01100	Metabolic pathways	486	4.5e-20	0.50	0.64	0.98
PGSC0003DMG200014760	K09843	ko00906	Carotenoid biosynthesis	438	2.5e-18	0.39	0.60	0.84
PGSC0003DMG200010424	K04077	ko03018	RNA degradation	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMG200010424	K04077	ko04940	Type I diabetes mellitus	1493	1.6e-76	0.56	0.76	0.99
PGSC0003DMG200010424	K04077	ko03018	RNA degradation	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMG200010424	K04077	ko04940	Type I diabetes mellitus	1945	1.9e-101	0.55	0.76	0.89
PGSC0003DMG200010424	K04077	ko03018	RNA degradation	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMG200010424	K04077	ko04940	Type I diabetes mellitus	2162	2.1e-113	0.55	0.75	0.94
PGSC0003DMG200010425	K05750	ko04810	Regulation of actin cytoskeleton	6846	0.	0.87	0.94	0.99
PGSC0003DMG200010425	K05750	ko04810	Regulation of actin cytoskeleton	4758	1.4e-256	0.77	0.89	1.00
PGSC0003DMG200010425	K05750	ko04810	Regulation of actin cytoskeleton	8187	0.	0.83	0.92	1.00
PGSC0003DMG200010425	K05750	ko04810	Regulation of actin cytoskeleton	4147	6.8e-223	0.75	0.88	0.99
PGSC0003DMG200044557	K00368	ko00910	Nitrogen metabolism	633	4.4e-29	0.32	0.48	0.83
PGSC0003DMG200044568	K12412	ko04111	Cell cycle - yeast	247	8.7e-08	0.34	0.50	0.89
PGSC0003DMG200044580	K08065	ko04612	Antigen processing and presentation	611	7.3e-28	0.65	0.80	0.61
PGSC0003DMG200033171	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMG200033171	K00517	ko00626	Naphthalene and anthracene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMG200033171	K00517	ko00903	Limonene and pinene degradation	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMG200033171	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMG200033171	K00517	ko01110	Biosynthesis of secondary metabolites	910	2.3e-44	0.45	0.64	0.97
PGSC0003DMG200033184	K05745	ko04810	Regulation of actin cytoskeleton	310	2.5e-10	0.44	0.57	0.63
PGSC0003DMG200033320	K03350	ko04110	Cell cycle	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033320	K03350	ko04111	Cell cycle - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033320	K03350	ko04113	Meiosis - yeast	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033320	K03350	ko04114	Oocyte meiosis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033320	K03350	ko04120	Ubiquitin mediated proteolysis	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033320	K03350	ko04914	Progesterone-mediated oocyte maturation	694	1.9e-32	0.83	0.92	0.91
PGSC0003DMG200033334	K06685	ko04111	Cell cycle - yeast	308	5.6e-09	0.34	0.52	0.56
PGSC0003DMG200033334	K06685	ko04111	Cell cycle - yeast	367	1.1e-11	0.33	0.50	0.55
PGSC0003DMG200033334	K06685	ko04111	Cell cycle - yeast	377	1.7e-11	0.27	0.42	0.78
PGSC0003DMG200033334	K06685	ko04111	Cell cycle - yeast	377	2.2e-11	0.27	0.42	0.70
PGSC0003DMG200024723	K02883	ko03010	Ribosome	1389	8.9e-71	0.87	0.95	0.99
PGSC0003DMG200024724	K01115	ko00564	Glycerophospholipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko00565	Ether lipid metabolism	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko01100	Metabolic pathways	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko04144	Endocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko04666	Fc gamma R-mediated phagocytosis	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko04912	GnRH signaling pathway	5784	0.	0.64	0.76	0.99
PGSC0003DMG200024724	K01115	ko00564	Glycerophospholipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko00565	Ether lipid metabolism	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko01100	Metabolic pathways	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko04144	Endocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko04666	Fc gamma R-mediated phagocytosis	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko04912	GnRH signaling pathway	6322	0.	0.68	0.82	0.99
PGSC0003DMG200024724	K01115	ko00564	Glycerophospholipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko00565	Ether lipid metabolism	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko01100	Metabolic pathways	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko04144	Endocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko04666	Fc gamma R-mediated phagocytosis	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko04912	GnRH signaling pathway	5482	1.6e-296	0.69	0.81	1.00
PGSC0003DMG200024724	K01115	ko00564	Glycerophospholipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024724	K01115	ko00565	Ether lipid metabolism	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024724	K01115	ko01100	Metabolic pathways	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024724	K01115	ko04144	Endocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024724	K01115	ko04666	Fc gamma R-mediated phagocytosis	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024724	K01115	ko04912	GnRH signaling pathway	766	2.2e-36	0.68	0.76	0.85
PGSC0003DMG200024725	K01520	ko00240	Pyrimidine metabolism	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMG200024725	K01520	ko01100	Metabolic pathways	1089	3.1e-54	0.77	0.88	0.97
PGSC0003DMG200024727	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMG200024727	K08266	ko04150	mTOR signaling pathway	245	1.2e-10	0.27	0.45	0.26
PGSC0003DMG200024728	K12849	ko03040	Spliceosome	2653	1.7e-140	0.80	0.87	1.00
PGSC0003DMG200024729	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMG200024729	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMG200024729	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.84
PGSC0003DMG200024729	K03111	ko03030	DNA replication	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMG200024729	K03111	ko03430	Mismatch repair	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMG200024729	K03111	ko03440	Homologous recombination	468	5.6e-20	0.38	0.62	0.92
PGSC0003DMG200024731	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.7e-20	0.30	0.45	0.56
PGSC0003DMG200024731	K11294	ko05130	Pathogenic Escherichia coli infection	521	2.6e-20	0.30	0.45	0.57
PGSC0003DMG200024732	K08489	ko04130	SNARE interactions in vesicular transport	445	1.0e-18	0.77	0.84	0.93
PGSC0003DMG200024732	K08489	ko04130	SNARE interactions in vesicular transport	1075	1.9e-53	0.80	0.90	0.90
PGSC0003DMG200024732	K08489	ko04130	SNARE interactions in vesicular transport	2110	1.5e-110	0.74	0.81	0.99
PGSC0003DMG200024732	K08489	ko04130	SNARE interactions in vesicular transport	2205	8.8e-116	0.84	0.92	0.99
PGSC0003DMG200024732	K08489	ko04130	SNARE interactions in vesicular transport	798	3.5e-38	0.92	0.99	0.93
PGSC0003DMG200024735	K01514	ko00230	Purine metabolism	829	6.9e-40	0.35	0.54	0.94
PGSC0003DMG200024735	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMG200017702	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMG200017702	K01491	ko00670	One carbon pool by folate	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMG200017702	K01491	ko01100	Metabolic pathways	1623	1.1e-83	0.65	0.79	0.88
PGSC0003DMG200017702	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMG200017702	K01491	ko00670	One carbon pool by folate	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMG200017702	K01491	ko01100	Metabolic pathways	1601	1.8e-82	0.64	0.82	0.92
PGSC0003DMG200017703	K01915	ko00250	Alanine, aspartate and glutamate metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMG200017703	K01915	ko00330	Arginine and proline metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMG200017703	K01915	ko00910	Nitrogen metabolism	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMG200017703	K01915	ko01100	Metabolic pathways	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMG200017703	K01915	ko02020	Two-component system	417	3.6e-17	0.92	0.96	0.25
PGSC0003DMG200017704	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMG200017704	K02366	ko01100	Metabolic pathways	411	1.3e-16	0.29	0.45	0.98
PGSC0003DMG200017705	K12617	ko03018	RNA degradation	4657	5.0e-251	0.69	0.81	1.00
PGSC0003DMG200017707	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMG200017707	K00457	ko00350	Tyrosine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMG200017707	K00457	ko00360	Phenylalanine metabolism	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMG200017707	K00457	ko01100	Metabolic pathways	2795	2.5e-148	0.75	0.84	0.99
PGSC0003DMG200017711	K02969	ko03010	Ribosome	360	5.1e-14	0.48	0.56	0.99
PGSC0003DMG200017716	K03660	ko03410	Base excision repair	1107	3.2e-55	0.40	0.56	0.86
PGSC0003DMG200017717	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMG200017717	K03660	ko03410	Base excision repair	224	1.0e-05	0.36	0.54	0.86
PGSC0003DMG200017717	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMG200017717	K03660	ko03410	Base excision repair	404	6.9e-16	0.38	0.52	0.92
PGSC0003DMG200017718	K03660	ko03410	Base excision repair	798	3.5e-38	0.48	0.67	0.92
PGSC0003DMG200017718	K03660	ko03410	Base excision repair	962	3.2e-47	0.44	0.60	0.96
PGSC0003DMG200017719	K12891	ko03040	Spliceosome	1785	1.3e-92	0.80	0.88	1.00
PGSC0003DMG200027848	K10579	ko04120	Ubiquitin mediated proteolysis	1215	3.5e-61	0.92	0.97	0.66
PGSC0003DMG200027848	K10579	ko04120	Ubiquitin mediated proteolysis	1477	1.3e-75	0.91	0.96	0.99
PGSC0003DMG200027849	K03006	ko00230	Purine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMG200027849	K03006	ko00240	Pyrimidine metabolism	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMG200027849	K03006	ko01100	Metabolic pathways	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMG200027849	K03006	ko03020	RNA polymerase	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMG200027849	K03006	ko05016	Huntington's disease	243	2.4e-06	0.34	0.48	0.64
PGSC0003DMG200027852	K12356	ko00940	Phenylpropanoid biosynthesis	1696	1.0e-87	0.48	0.66	0.97
PGSC0003DMG200027853	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMG200027853	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMG200027853	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.79
PGSC0003DMG200027853	K00655	ko00561	Glycerolipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMG200027853	K00655	ko00564	Glycerophospholipid metabolism	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMG200027853	K00655	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.51	0.78
PGSC0003DMG200027856	K00795	ko00900	Terpenoid backbone biosynthesis	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMG200027856	K00795	ko01100	Metabolic pathways	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMG200027856	K00795	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.64	0.79	0.99
PGSC0003DMG200027857	K01246	ko03410	Base excision repair	1537	6.1e-79	0.57	0.72	0.98
PGSC0003DMG200045761	K02960	ko03010	Ribosome	648	6.6e-30	0.95	0.99	0.99
PGSC0003DMG200007965	K01046	ko00561	Glycerolipid metabolism	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMG200007965	K01046	ko01100	Metabolic pathways	323	5.6e-12	0.35	0.50	0.68
PGSC0003DMG200007972	K09843	ko00906	Carotenoid biosynthesis	2668	2.6e-141	0.71	0.83	0.93
PGSC0003DMG200007973	K08764	ko00120	Primary bile acid biosynthesis	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMG200007973	K08764	ko01100	Metabolic pathways	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMG200007973	K08764	ko03320	PPAR signaling pathway	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMG200007973	K08764	ko04146	Peroxisome	773	8.4e-37	0.73	0.90	0.95
PGSC0003DMG200007974	K01176	ko00500	Starch and sucrose metabolism	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMG200007974	K01176	ko01100	Metabolic pathways	2352	6.9e-124	0.64	0.77	0.98
PGSC0003DMG200007974	K01176	ko00500	Starch and sucrose metabolism	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMG200007974	K01176	ko01100	Metabolic pathways	251	5.5e-08	0.58	0.83	0.94
PGSC0003DMG200007977	K11820	ko00380	Tryptophan metabolism	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMG200007977	K11820	ko00966	Glucosinolate biosynthesis	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMG200007977	K11820	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.58	0.70
PGSC0003DMG200007980	K12356	ko00940	Phenylpropanoid biosynthesis	394	6.8e-16	0.29	0.44	0.88
PGSC0003DMG200007981	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.30	0.46	0.91
PGSC0003DMG200007982	K12356	ko00940	Phenylpropanoid biosynthesis	349	2.1e-13	0.29	0.43	0.98
PGSC0003DMG200014062	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMG200014062	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMG200014062	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMG200014062	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.28	0.47	0.97
PGSC0003DMG200014067	K02537	ko04110	Cell cycle	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMG200014067	K02537	ko04111	Cell cycle - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMG200014067	K02537	ko04113	Meiosis - yeast	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMG200014067	K02537	ko04114	Oocyte meiosis	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMG200014067	K02537	ko04914	Progesterone-mediated oocyte maturation	1090	2.8e-54	0.76	0.90	0.36
PGSC0003DMG200014067	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04110	Cell cycle	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04111	Cell cycle - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04113	Meiosis - yeast	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04114	Oocyte meiosis	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014067	K02537	ko04914	Progesterone-mediated oocyte maturation	1322	4.4e-67	0.75	0.89	1.00
PGSC0003DMG200014069	K10884	ko03450	Non-homologous end-joining	1956	4.8e-102	0.80	0.89	0.99
PGSC0003DMG200014069	K10884	ko03450	Non-homologous end-joining	3237	1.1e-172	0.75	0.90	0.97
PGSC0003DMG200014069	K10884	ko03450	Non-homologous end-joining	4063	2.9e-218	0.76	0.89	1.00
PGSC0003DMG200014071	K05282	ko00904	Diterpenoid biosynthesis	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMG200014071	K05282	ko01100	Metabolic pathways	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMG200014071	K05282	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.63	0.78	0.99
PGSC0003DMG200014073	K12811	ko03040	Spliceosome	431	3.4e-17	0.30	0.61	0.90
PGSC0003DMG200014075	K02948	ko03010	Ribosome	806	1.3e-38	0.92	0.93	0.99
PGSC0003DMG200014075	K03040	ko00230	Purine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMG200014075	K03040	ko00240	Pyrimidine metabolism	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMG200014075	K03040	ko01100	Metabolic pathways	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMG200014075	K03040	ko03020	RNA polymerase	2357	3.6e-124	0.83	0.90	1.00
PGSC0003DMG200014076	K02874	ko03010	Ribosome	779	3.9e-37	0.93	0.96	0.92
PGSC0003DMG200009861	K00844	ko00010	Glycolysis / Gluconeogenesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00051	Fructose and mannose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00052	Galactose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00500	Starch and sucrose metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00521	Streptomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00524	Butirosin and neomycin biosynthesis	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko01100	Metabolic pathways	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko01110	Biosynthesis of secondary metabolites	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko04910	Insulin signaling pathway	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko04930	Type II diabetes mellitus	3214	2.0e-171	0.77	0.83	0.99
PGSC0003DMG200009861	K00844	ko00010	Glycolysis / Gluconeogenesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00051	Fructose and mannose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00052	Galactose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00500	Starch and sucrose metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00521	Streptomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00524	Butirosin and neomycin biosynthesis	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko01100	Metabolic pathways	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko01110	Biosynthesis of secondary metabolites	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko04910	Insulin signaling pathway	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko04930	Type II diabetes mellitus	1671	2.5e-86	0.83	0.90	0.98
PGSC0003DMG200009861	K00844	ko00010	Glycolysis / Gluconeogenesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00051	Fructose and mannose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00052	Galactose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00500	Starch and sucrose metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00521	Streptomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko00524	Butirosin and neomycin biosynthesis	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko01100	Metabolic pathways	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko01110	Biosynthesis of secondary metabolites	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko04910	Insulin signaling pathway	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009861	K00844	ko04930	Type II diabetes mellitus	3291	1.1e-175	0.82	0.88	0.99
PGSC0003DMG200009862	K11827	ko04144	Endocytosis	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMG200009862	K11827	ko05016	Huntington's disease	1169	1.2e-58	0.97	1.00	0.99
PGSC0003DMG200009868	K00423	ko00053	Ascorbate and aldarate metabolism	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMG200009868	K00423	ko01100	Metabolic pathways	1503	4.6e-77	0.44	0.64	0.99
PGSC0003DMG200011110	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMG200011110	K06685	ko04111	Cell cycle - yeast	442	2.7e-17	0.27	0.43	0.85
PGSC0003DMG200035331	K11816	ko00380	Tryptophan metabolism	636	3.0e-29	0.38	0.60	0.90
PGSC0003DMG200035337	K02898	ko03010	Ribosome	1122	4.8e-56	0.90	0.98	0.99
PGSC0003DMG200030430	K00430	ko00360	Phenylalanine metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMG200030430	K00430	ko00680	Methane metabolism	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMG200030430	K00430	ko00940	Phenylpropanoid biosynthesis	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMG200030430	K00430	ko01100	Metabolic pathways	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMG200030430	K00430	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.72	0.82	0.97
PGSC0003DMG200030431	K07375	ko04145	Phagosome	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMG200030431	K07375	ko04540	Gap junction	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMG200030431	K07375	ko05130	Pathogenic Escherichia coli infection	3740	1.9e-200	0.97	0.99	0.99
PGSC0003DMG200030432	K04802	ko03030	DNA replication	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMG200030432	K04802	ko03410	Base excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMG200030432	K04802	ko03420	Nucleotide excision repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMG200030432	K04802	ko03430	Mismatch repair	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMG200030432	K04802	ko04110	Cell cycle	2131	1.1e-111	0.96	0.99	1.00
PGSC0003DMG200030439	K01188	ko00460	Cyanoamino acid metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMG200030439	K01188	ko00500	Starch and sucrose metabolism	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMG200030439	K01188	ko00940	Phenylpropanoid biosynthesis	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMG200030439	K01188	ko01110	Biosynthesis of secondary metabolites	3621	7.0e-194	0.69	0.85	0.99
PGSC0003DMG200030442	K02941	ko03010	Ribosome	2057	1.3e-107	0.78	0.89	1.00
PGSC0003DMG200030443	K11778	ko00900	Terpenoid backbone biosynthesis	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMG200030443	K11778	ko01110	Biosynthesis of secondary metabolites	1133	1.2e-56	0.59	0.78	0.81
PGSC0003DMG200030444	K11778	ko00900	Terpenoid backbone biosynthesis	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMG200030444	K11778	ko01110	Biosynthesis of secondary metabolites	1090	2.8e-54	0.55	0.72	0.78
PGSC0003DMG200030444	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMG200030444	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMG200019692	K10807	ko00230	Purine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMG200019692	K10807	ko00240	Pyrimidine metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMG200019692	K10807	ko00480	Glutathione metabolism	6338	0.	0.91	0.97	1.00
PGSC0003DMG200019692	K10807	ko01100	Metabolic pathways	6338	0.	0.91	0.97	1.00
PGSC0003DMG200022386	K01466	ko00230	Purine metabolism	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMG200022386	K01466	ko01100	Metabolic pathways	2979	1.8e-158	0.73	0.88	0.95
PGSC0003DMG200022386	K01466	ko00230	Purine metabolism	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMG200022386	K01466	ko01100	Metabolic pathways	3009	4.0e-160	0.71	0.86	0.97
PGSC0003DMG200022387	K07456	ko03430	Mismatch repair	2409	4.9e-127	0.69	0.82	0.92
PGSC0003DMG200022387	K07456	ko03430	Mismatch repair	3429	2.7e-183	0.62	0.79	1.00
PGSC0003DMG200022397	K10145	ko04115	p53 signaling pathway	281	1.2e-09	0.32	0.48	0.66
PGSC0003DMG200047169	K03876	ko04120	Ubiquitin mediated proteolysis	251	5.2e-08	0.31	0.52	0.79
PGSC0003DMG200000398	K03283	ko03040	Spliceosome	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMG200000398	K03283	ko04010	MAPK signaling pathway	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMG200000398	K03283	ko04144	Endocytosis	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMG200000398	K03283	ko04612	Antigen processing and presentation	5173	1.7e-279	0.94	0.98	1.00
PGSC0003DMG200000401	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMG200000401	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMG200000401	K03217	ko03060	Protein export	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMG200000401	K03217	ko03070	Bacterial secretion system	2991	3.9e-159	0.79	0.89	1.00
PGSC0003DMG200000404	K01710	ko00521	Streptomycin biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMG200000404	K01710	ko00523	Polyketide sugar unit biosynthesis	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMG200000404	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMG200000404	K01710	ko01100	Metabolic pathways	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMG200000404	K01710	ko01110	Biosynthesis of secondary metabolites	2757	3.1e-146	0.93	0.96	0.99
PGSC0003DMG200000405	K11254	ko05322	Systemic lupus erythematosus	856	2.2e-41	1.00	1.00	0.99
PGSC0003DMG200000411	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMG200000411	K02366	ko01100	Metabolic pathways	260	7.3e-06	0.28	0.41	0.75
PGSC0003DMG200016383	K12581	ko03018	RNA degradation	1047	6.5e-52	0.51	0.67	0.98
PGSC0003DMG200016390	K08488	ko04130	SNARE interactions in vesicular transport	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMG200016390	K08488	ko04145	Phagosome	389	1.3e-15	0.43	0.58	0.60
PGSC0003DMG200016393	K12833	ko03040	Spliceosome	977	4.7e-48	0.92	0.96	0.99
PGSC0003DMG200016394	K02884	ko03010	Ribosome	245	1.1e-07	0.37	0.53	0.33
PGSC0003DMG200016394	K02884	ko03010	Ribosome	326	3.8e-12	0.53	0.74	0.91
PGSC0003DMG200016394	K02884	ko03010	Ribosome	370	1.4e-14	0.44	0.71	0.41
PGSC0003DMG200016395	K01961	ko00061	Fatty acid biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01961	ko00253	Tetracycline biosynthesis	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01961	ko00620	Pyruvate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01961	ko00640	Propanoate metabolism	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01961	ko01100	Metabolic pathways	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01961	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.67	0.82	0.82
PGSC0003DMG200016395	K01066	ko00623	2,4-Dichlorobenzoate degradation	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMG200016395	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	788	1.3e-37	0.27	0.41	0.78
PGSC0003DMG200016395	K01066	ko00623	2,4-Dichlorobenzoate degradation	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMG200016395	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	691	2.8e-32	0.32	0.50	0.58
PGSC0003DMG200016396	K00254	ko00240	Pyrimidine metabolism	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMG200016396	K00254	ko01100	Metabolic pathways	3195	2.2e-170	0.83	0.90	1.00
PGSC0003DMG200012290	K02684	ko00230	Purine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMG200012290	K02684	ko00240	Pyrimidine metabolism	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMG200012290	K02684	ko01100	Metabolic pathways	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMG200012290	K02684	ko03030	DNA replication	680	1.1e-31	0.42	0.50	0.70
PGSC0003DMG200012304	K04424	ko04010	MAPK signaling pathway	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMG200012304	K04424	ko04530	Tight junction	458	5.6e-16	0.33	0.47	0.31
PGSC0003DMG200012306	K06689	ko04120	Ubiquitin mediated proteolysis	1285	4.9e-65	0.97	0.98	0.99
PGSC0003DMG200012308	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMG200012308	K01687	ko00770	Pantothenate and CoA biosynthesis	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMG200012308	K01687	ko01100	Metabolic pathways	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMG200012308	K01687	ko01110	Biosynthesis of secondary metabolites	560	1.0e-24	0.34	0.50	0.88
PGSC0003DMG200001676	K07750	ko00100	Steroid biosynthesis	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMG200001676	K07750	ko01100	Metabolic pathways	241	5.5e-07	0.34	0.48	0.31
PGSC0003DMG200001676	K07750	ko00100	Steroid biosynthesis	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMG200001676	K07750	ko01100	Metabolic pathways	239	8.2e-07	0.34	0.47	0.27
PGSC0003DMG200001676	K07750	ko00100	Steroid biosynthesis	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMG200001676	K07750	ko01100	Metabolic pathways	239	6.7e-07	0.34	0.47	0.30
PGSC0003DMG200001677	K03358	ko04110	Cell cycle	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001677	K03358	ko04111	Cell cycle - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001677	K03358	ko04113	Meiosis - yeast	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001677	K03358	ko04114	Oocyte meiosis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001677	K03358	ko04120	Ubiquitin mediated proteolysis	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001677	K03358	ko04914	Progesterone-mediated oocyte maturation	211	8.4e-06	0.43	0.63	0.38
PGSC0003DMG200001678	K12823	ko03040	Spliceosome	242	4.7e-07	0.56	0.75	0.51
PGSC0003DMG200001678	K12823	ko03040	Spliceosome	250	1.6e-07	0.75	0.88	0.54
PGSC0003DMG200001680	K02881	ko03010	Ribosome	229	8.5e-07	0.34	0.56	0.64
PGSC0003DMG200001681	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMG200001681	K03861	ko01100	Metabolic pathways	326	3.8e-12	0.51	0.62	0.93
PGSC0003DMG200001682	K01528	ko04144	Endocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMG200001682	K01528	ko04666	Fc gamma R-mediated phagocytosis	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMG200001682	K01528	ko05100	Bacterial invasion of epithelial cells	228	4.9e-06	0.27	0.44	0.88
PGSC0003DMG200001683	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMG200001683	K03861	ko01100	Metabolic pathways	230	7.5e-07	0.32	0.41	0.92
PGSC0003DMG200001683	K03861	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMG200001683	K03861	ko01100	Metabolic pathways	288	4.8e-10	0.55	0.68	0.90
PGSC0003DMG200001685	K03955	ko00190	Oxidative phosphorylation	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMG200001685	K03955	ko01100	Metabolic pathways	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMG200001685	K03955	ko05010	Alzheimer's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMG200001685	K03955	ko05012	Parkinson's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMG200001685	K03955	ko05016	Huntington's disease	728	2.6e-34	0.71	0.87	0.97
PGSC0003DMG200005557	K01178	ko00500	Starch and sucrose metabolism	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMG200005557	K01178	ko01100	Metabolic pathways	375	2.8e-11	0.25	0.39	0.86
PGSC0003DMG200005563	K00660	ko00941	Flavonoid biosynthesis	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMG200005563	K00660	ko01100	Metabolic pathways	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMG200005563	K00660	ko01110	Biosynthesis of secondary metabolites	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMG200005563	K00660	ko04712	Circadian rhythm - plant	242	1.6e-07	0.29	0.45	0.91
PGSC0003DMG200008533	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMG200008533	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.36	0.56	0.85
PGSC0003DMG200041976	K01142	ko03410	Base excision repair	245	1.8e-07	0.45	0.56	0.64
PGSC0003DMG200029181	K10755	ko03030	DNA replication	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMG200029181	K10755	ko03420	Nucleotide excision repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMG200029181	K10755	ko03430	Mismatch repair	773	8.4e-37	0.96	0.98	0.99
PGSC0003DMG200029195	K00522	ko00860	Porphyrin and chlorophyll metabolism	827	8.9e-40	0.59	0.76	0.71
PGSC0003DMG200029198	K12929	ko00904	Diterpenoid biosynthesis	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMG200029198	K12929	ko01110	Biosynthesis of secondary metabolites	348	4.1e-13	0.39	0.57	0.95
PGSC0003DMG200029198	K12929	ko00904	Diterpenoid biosynthesis	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMG200029198	K12929	ko01110	Biosynthesis of secondary metabolites	361	7.0e-14	0.31	0.47	0.96
PGSC0003DMG200029200	K12929	ko00904	Diterpenoid biosynthesis	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMG200029200	K12929	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.41	0.61	0.92
PGSC0003DMG200029201	K12929	ko00904	Diterpenoid biosynthesis	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMG200029201	K12929	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.43	0.65	0.95
PGSC0003DMG200029201	K12929	ko00904	Diterpenoid biosynthesis	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMG200029201	K12929	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.44	0.65	0.97
PGSC0003DMG200029201	K12929	ko00904	Diterpenoid biosynthesis	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMG200029201	K12929	ko01110	Biosynthesis of secondary metabolites	1857	1.4e-96	0.43	0.64	1.00
PGSC0003DMG200029202	K12929	ko00904	Diterpenoid biosynthesis	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMG200029202	K12929	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.50	0.71	0.95
PGSC0003DMG200029202	K12929	ko00904	Diterpenoid biosynthesis	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMG200029202	K12929	ko01110	Biosynthesis of secondary metabolites	873	2.6e-42	0.49	0.71	0.80
PGSC0003DMG200023689	K05768	ko04666	Fc gamma R-mediated phagocytosis	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMG200023689	K05768	ko04810	Regulation of actin cytoskeleton	3292	9.8e-176	0.46	0.64	1.00
PGSC0003DMG200023689	K05768	ko04666	Fc gamma R-mediated phagocytosis	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMG200023689	K05768	ko04810	Regulation of actin cytoskeleton	2174	4.5e-114	0.45	0.63	0.97
PGSC0003DMG200023689	K05768	ko04666	Fc gamma R-mediated phagocytosis	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMG200023689	K05768	ko04810	Regulation of actin cytoskeleton	2740	2.7e-145	0.45	0.64	0.99
PGSC0003DMG200023691	K00384	ko00240	Pyrimidine metabolism	3477	6.1e-186	0.77	0.88	0.98
PGSC0003DMG200023691	K00384	ko00240	Pyrimidine metabolism	1613	3.9e-83	0.66	0.79	0.93
PGSC0003DMG200023693	K03124	ko03022	Basal transcription factors	771	1.1e-36	0.76	0.87	0.99
PGSC0003DMG200023693	K03124	ko03022	Basal transcription factors	2044	6.7e-107	0.76	0.89	0.99
PGSC0003DMG200023693	K03124	ko03022	Basal transcription factors	1760	3.1e-91	0.75	0.89	0.98
PGSC0003DMG200023693	K03124	ko03022	Basal transcription factors	471	3.8e-20	0.75	0.90	0.74
PGSC0003DMG200023693	K03124	ko03022	Basal transcription factors	950	1.5e-46	0.74	0.91	0.84
PGSC0003DMG200023694	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMG200023694	K00517	ko00626	Naphthalene and anthracene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMG200023694	K00517	ko00903	Limonene and pinene degradation	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMG200023694	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMG200023694	K00517	ko01110	Biosynthesis of secondary metabolites	1704	3.8e-88	0.47	0.65	0.92
PGSC0003DMG200026572	K12382	ko04142	Lysosome	337	9.4e-13	0.31	0.50	0.77
PGSC0003DMG200026575	K00430	ko00360	Phenylalanine metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMG200026575	K00430	ko00680	Methane metabolism	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMG200026575	K00430	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMG200026575	K00430	ko01100	Metabolic pathways	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMG200026575	K00430	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.67	0.84	0.99
PGSC0003DMG200026575	K00430	ko00360	Phenylalanine metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMG200026575	K00430	ko00680	Methane metabolism	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMG200026575	K00430	ko00940	Phenylpropanoid biosynthesis	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMG200026575	K00430	ko01100	Metabolic pathways	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMG200026575	K00430	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.66	0.82	1.00
PGSC0003DMG200026579	K11420	ko00310	Lysine degradation	681	4.7e-34	0.31	0.42	0.87
PGSC0003DMG200026579	K11420	ko00310	Lysine degradation	681	1.3e-29	0.31	0.42	0.60
PGSC0003DMG200026580	K06268	ko04010	MAPK signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04020	Calcium signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04114	Oocyte meiosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04210	Apoptosis	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04310	Wnt signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04360	Axon guidance	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04370	VEGF signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04650	Natural killer cell mediated cytotoxicity	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04660	T cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04662	B cell receptor signaling pathway	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko04720	Long-term potentiation	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko05010	Alzheimer's disease	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026580	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1545	2.2e-79	0.86	0.95	0.99
PGSC0003DMG200026581	K00430	ko00360	Phenylalanine metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMG200026581	K00430	ko00680	Methane metabolism	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMG200026581	K00430	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMG200026581	K00430	ko01100	Metabolic pathways	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMG200026581	K00430	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.60	0.71	0.91
PGSC0003DMG200026584	K03115	ko04310	Wnt signaling pathway	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04520	Adherens junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04530	Tight junction	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04712	Circadian rhythm - plant	1912	1.3e-99	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04310	Wnt signaling pathway	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04520	Adherens junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04530	Tight junction	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04712	Circadian rhythm - plant	1921	4.1e-100	0.77	0.85	1.00
PGSC0003DMG200026584	K03115	ko04310	Wnt signaling pathway	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04520	Adherens junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04530	Tight junction	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04712	Circadian rhythm - plant	1847	4.9e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04310	Wnt signaling pathway	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04520	Adherens junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04530	Tight junction	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMG200026584	K03115	ko04712	Circadian rhythm - plant	1856	1.6e-96	0.75	0.83	1.00
PGSC0003DMG200008050	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008050	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008050	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008050	K03526	ko00900	Terpenoid backbone biosynthesis	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008050	K03526	ko01100	Metabolic pathways	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008050	K03526	ko01110	Biosynthesis of secondary metabolites	5494	3.4e-297	0.88	0.94	1.00
PGSC0003DMG200008060	K08681	ko00750	Vitamin B6 metabolism	1492	1.9e-76	0.72	0.83	1.00
PGSC0003DMG200008060	K08681	ko00750	Vitamin B6 metabolism	1156	6.3e-58	0.77	0.90	0.95
PGSC0003DMG200008062	K02006	ko02010	ABC transporters	910	2.3e-44	0.55	0.69	0.95
PGSC0003DMG200008062	K02006	ko02010	ABC transporters	566	2.2e-25	0.54	0.70	0.91
PGSC0003DMG200004271	K00423	ko00053	Ascorbate and aldarate metabolism	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMG200004271	K00423	ko01100	Metabolic pathways	3169	5.9e-169	0.65	0.78	0.98
PGSC0003DMG200004272	K07374	ko04145	Phagosome	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMG200004272	K07374	ko04540	Gap junction	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMG200004272	K07374	ko05130	Pathogenic Escherichia coli infection	3772	3.3e-202	0.97	0.99	1.00
PGSC0003DMG200004272	K07374	ko04145	Phagosome	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMG200004272	K07374	ko04540	Gap junction	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMG200004272	K07374	ko05130	Pathogenic Escherichia coli infection	1231	4.6e-62	0.99	1.00	0.99
PGSC0003DMG200004273	K12900	ko03040	Spliceosome	622	1.8e-28	0.40	0.54	0.86
PGSC0003DMG200004273	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMG200004273	K12896	ko03040	Spliceosome	427	1.0e-17	0.43	0.51	0.99
PGSC0003DMG200004274	K01895	ko00010	Glycolysis / Gluconeogenesis	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko00620	Pyruvate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko00640	Propanoate metabolism	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko01100	Metabolic pathways	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko01110	Biosynthesis of secondary metabolites	3360	1.7e-179	0.77	0.88	1.00
PGSC0003DMG200004274	K01895	ko00010	Glycolysis / Gluconeogenesis	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko00620	Pyruvate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko00640	Propanoate metabolism	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko01100	Metabolic pathways	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.81	0.89	0.89
PGSC0003DMG200004274	K01895	ko00010	Glycolysis / Gluconeogenesis	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004274	K01895	ko00620	Pyruvate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004274	K01895	ko00640	Propanoate metabolism	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004274	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004274	K01895	ko01100	Metabolic pathways	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004274	K01895	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.85	0.94	0.98
PGSC0003DMG200004275	K05277	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMG200004275	K05277	ko01100	Metabolic pathways	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMG200004275	K05277	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.34	0.55	0.91
PGSC0003DMG200004276	K03950	ko00190	Oxidative phosphorylation	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMG200004276	K03950	ko01100	Metabolic pathways	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMG200004276	K03950	ko05010	Alzheimer's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMG200004276	K03950	ko05012	Parkinson's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMG200004276	K03950	ko05016	Huntington's disease	407	1.3e-16	0.67	0.78	0.86
PGSC0003DMG200004276	K03950	ko00190	Oxidative phosphorylation	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMG200004276	K03950	ko01100	Metabolic pathways	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMG200004276	K03950	ko05010	Alzheimer's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMG200004276	K03950	ko05012	Parkinson's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMG200004276	K03950	ko05016	Huntington's disease	405	1.7e-16	0.68	0.78	0.87
PGSC0003DMG200004276	K03950	ko00190	Oxidative phosphorylation	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMG200004276	K03950	ko01100	Metabolic pathways	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMG200004276	K03950	ko05010	Alzheimer's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMG200004276	K03950	ko05012	Parkinson's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMG200004276	K03950	ko05016	Huntington's disease	799	3.1e-38	0.70	0.83	0.97
PGSC0003DMG200004277	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMG200004277	K11594	ko04622	RIG-I-like receptor signaling pathway	4272	8.7e-230	0.81	0.87	1.00
PGSC0003DMG200004277	K11594	ko04622	RIG-I-like receptor signaling pathway	546	2.8e-24	0.77	0.83	0.99
PGSC0003DMG200003003	K10576	ko04120	Ubiquitin mediated proteolysis	1299	8.2e-66	0.84	0.92	0.99
PGSC0003DMG200003003	K10576	ko04120	Ubiquitin mediated proteolysis	585	2.0e-26	0.75	0.88	0.99
PGSC0003DMG200003003	K10576	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.83	0.92	0.99
PGSC0003DMG200003003	K10576	ko04120	Ubiquitin mediated proteolysis	733	1.4e-34	0.93	0.97	0.81
PGSC0003DMG200003009	K01046	ko00561	Glycerolipid metabolism	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMG200003009	K01046	ko01100	Metabolic pathways	455	2.9e-19	0.35	0.51	0.75
PGSC0003DMG200003012	K01188	ko00460	Cyanoamino acid metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMG200003012	K01188	ko00500	Starch and sucrose metabolism	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMG200003012	K01188	ko00940	Phenylpropanoid biosynthesis	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMG200003012	K01188	ko01110	Biosynthesis of secondary metabolites	2486	2.8e-131	0.52	0.69	0.94
PGSC0003DMG200003013	K01188	ko00460	Cyanoamino acid metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMG200003013	K01188	ko00500	Starch and sucrose metabolism	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMG200003013	K01188	ko00940	Phenylpropanoid biosynthesis	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMG200003013	K01188	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.55	0.70	0.94
PGSC0003DMG200003013	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko00460	Cyanoamino acid metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko00500	Starch and sucrose metabolism	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko00940	Phenylpropanoid biosynthesis	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003013	K01188	ko01110	Biosynthesis of secondary metabolites	2898	5.3e-154	0.57	0.74	0.96
PGSC0003DMG200003022	K12929	ko00904	Diterpenoid biosynthesis	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMG200003022	K12929	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.40	0.62	1.00
PGSC0003DMG200003023	K08008	ko04145	Phagosome	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMG200003023	K08008	ko04670	Leukocyte transendothelial migration	593	1.0e-38	0.40	0.57	0.35
PGSC0003DMG200039221	K13229	ko00402	Benzoxazinoid biosynthesis	403	2.2e-16	0.52	0.68	0.82
PGSC0003DMG200024785	K02183	ko04020	Calcium signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04070	Phosphatidylinositol signaling system	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04114	Oocyte meiosis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04270	Vascular smooth muscle contraction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04626	Plant-pathogen interaction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04720	Long-term potentiation	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04722	Neurotrophin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04740	Olfactory transduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04744	Phototransduction	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04745	Phototransduction - fly	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04910	Insulin signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04912	GnRH signaling pathway	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04916	Melanogenesis	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04970	Salivary secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04971	Gastric acid secretion	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko05010	Alzheimer's disease	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko05214	Glioma	1191	7.4e-60	0.35	0.51	0.99
PGSC0003DMG200024785	K02183	ko04020	Calcium signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04070	Phosphatidylinositol signaling system	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04114	Oocyte meiosis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04270	Vascular smooth muscle contraction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04626	Plant-pathogen interaction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04720	Long-term potentiation	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04722	Neurotrophin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04740	Olfactory transduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04744	Phototransduction	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04745	Phototransduction - fly	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04910	Insulin signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04912	GnRH signaling pathway	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04916	Melanogenesis	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04970	Salivary secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko04971	Gastric acid secretion	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko05010	Alzheimer's disease	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024785	K02183	ko05214	Glioma	1133	1.2e-56	0.46	0.61	0.97
PGSC0003DMG200024802	K13289	ko04142	Lysosome	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMG200024802	K13289	ko04614	Renin-angiotensin system	1630	4.6e-84	0.46	0.64	0.94
PGSC0003DMG200024802	K13289	ko04142	Lysosome	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMG200024802	K13289	ko04614	Renin-angiotensin system	1660	1.0e-85	0.47	0.66	0.94
PGSC0003DMG200024804	K13289	ko04142	Lysosome	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMG200024804	K13289	ko04614	Renin-angiotensin system	579	4.2e-26	0.50	0.61	0.61
PGSC0003DMG200020965	K12929	ko00904	Diterpenoid biosynthesis	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMG200020965	K12929	ko01110	Biosynthesis of secondary metabolites	1314	1.2e-66	0.41	0.64	0.86
PGSC0003DMG200020972	K00599	ko00340	Histidine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMG200020972	K00599	ko00350	Tyrosine metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMG200020972	K00599	ko00450	Selenoamino acid metabolism	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMG200020972	K00599	ko00626	Naphthalene and anthracene degradation	870	3.8e-42	0.33	0.52	0.99
PGSC0003DMG200020972	K00599	ko00340	Histidine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMG200020972	K00599	ko00350	Tyrosine metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMG200020972	K00599	ko00450	Selenoamino acid metabolism	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMG200020972	K00599	ko00626	Naphthalene and anthracene degradation	1896	9.7e-99	0.38	0.58	1.00
PGSC0003DMG200020975	K00430	ko00360	Phenylalanine metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMG200020975	K00430	ko00680	Methane metabolism	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMG200020975	K00430	ko00940	Phenylpropanoid biosynthesis	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMG200020975	K00430	ko01100	Metabolic pathways	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMG200020975	K00430	ko01110	Biosynthesis of secondary metabolites	942	4.0e-46	0.44	0.55	0.97
PGSC0003DMG200017656	K04733	ko04210	Apoptosis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMG200017656	K04733	ko04620	Toll-like receptor signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMG200017656	K04733	ko04722	Neurotrophin signaling pathway	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMG200017656	K04733	ko05140	Leishmaniasis	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMG200017656	K04733	ko05142	Chagas disease	1068	4.5e-53	0.33	0.49	0.77
PGSC0003DMG200017663	K03043	ko00230	Purine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMG200017663	K03043	ko00240	Pyrimidine metabolism	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMG200017663	K03043	ko01100	Metabolic pathways	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMG200017663	K03043	ko03020	RNA polymerase	3390	3.8e-181	0.96	0.99	1.00
PGSC0003DMG200017663	K03046	ko00230	Purine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMG200017663	K03046	ko00240	Pyrimidine metabolism	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMG200017663	K03046	ko01100	Metabolic pathways	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMG200017663	K03046	ko03020	RNA polymerase	1343	3.1e-68	0.85	0.91	0.99
PGSC0003DMG200017663	K02967	ko03010	Ribosome	798	3.5e-38	0.93	0.95	0.56
PGSC0003DMG200017663	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko00230	Purine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko00240	Pyrimidine metabolism	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko01100	Metabolic pathways	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017663	K03043	ko03020	RNA polymerase	4773	2.0e-257	0.95	0.98	1.00
PGSC0003DMG200017664	K03046	ko00230	Purine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMG200017664	K03046	ko00240	Pyrimidine metabolism	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMG200017664	K03046	ko01100	Metabolic pathways	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMG200017664	K03046	ko03020	RNA polymerase	3206	5.4e-171	0.88	0.91	1.00
PGSC0003DMG200037729	K00059	ko00061	Fatty acid biosynthesis	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMG200037729	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMG200037729	K00059	ko01100	Metabolic pathways	1312	1.6e-66	0.63	0.78	1.00
PGSC0003DMG200037737	K04371	ko04010	MAPK signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04012	ErbB signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04013	MAPK signaling pathway - fly	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04062	Chemokine signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04114	Oocyte meiosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04150	mTOR signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04320	Dorso-ventral axis formation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04350	TGF-beta signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04360	Axon guidance	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04370	VEGF signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04510	Focal adhesion	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04520	Adherens junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04540	Gap junction	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04620	Toll-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04621	NOD-like receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04650	Natural killer cell mediated cytotoxicity	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04660	T cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04662	B cell receptor signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04664	Fc epsilon RI signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04666	Fc gamma R-mediated phagocytosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04720	Long-term potentiation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04730	Long-term depression	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04810	Regulation of actin cytoskeleton	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04910	Insulin signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04912	GnRH signaling pathway	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04914	Progesterone-mediated oocyte maturation	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04916	Melanogenesis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04930	Type II diabetes mellitus	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko04960	Aldosterone-regulated sodium reabsorption	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05010	Alzheimer's disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05020	Prion diseases	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05131	Shigellosis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05140	Leishmaniasis	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05142	Chagas disease	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05200	Pathways in cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05210	Colorectal cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05211	Renal cell carcinoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05212	Pancreatic cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05213	Endometrial cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05214	Glioma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05215	Prostate cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05216	Thyroid cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05218	Melanoma	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05219	Bladder cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05220	Chronic myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05221	Acute myeloid leukemia	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200037737	K04371	ko05223	Non-small cell lung cancer	423	1.7e-17	0.43	0.61	0.98
PGSC0003DMG200038027	K06261	ko04512	ECM-receptor interaction	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMG200038027	K06261	ko04640	Hematopoietic cell lineage	229	3.3e-06	0.32	0.48	0.98
PGSC0003DMG200038034	K13229	ko00402	Benzoxazinoid biosynthesis	937	7.6e-46	0.45	0.62	0.91
PGSC0003DMG200003582	K01735	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMG200003582	K01735	ko01100	Metabolic pathways	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMG200003582	K01735	ko01110	Biosynthesis of secondary metabolites	2799	1.5e-148	0.75	0.85	1.00
PGSC0003DMG200003584	K06689	ko04120	Ubiquitin mediated proteolysis	841	1.5e-40	0.69	0.73	0.98
PGSC0003DMG200003584	K06689	ko04120	Ubiquitin mediated proteolysis	1195	4.5e-60	0.90	0.97	0.99
PGSC0003DMG200003585	K00889	ko00562	Inositol phosphate metabolism	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003585	K00889	ko01100	Metabolic pathways	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003585	K00889	ko04070	Phosphatidylinositol signaling system	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003585	K00889	ko04144	Endocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003585	K00889	ko04666	Fc gamma R-mediated phagocytosis	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003585	K00889	ko04810	Regulation of actin cytoskeleton	301	4.0e-08	0.33	0.46	0.45
PGSC0003DMG200003590	K03006	ko00230	Purine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMG200003590	K03006	ko00240	Pyrimidine metabolism	14720	0.	0.91	0.96	1.00
PGSC0003DMG200003590	K03006	ko01100	Metabolic pathways	14720	0.	0.91	0.96	1.00
PGSC0003DMG200003590	K03006	ko03020	RNA polymerase	14720	0.	0.91	0.96	1.00
PGSC0003DMG200003590	K03006	ko05016	Huntington's disease	14720	0.	0.91	0.96	1.00
PGSC0003DMG200003591	K01115	ko00564	Glycerophospholipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003591	K01115	ko00565	Ether lipid metabolism	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003591	K01115	ko01100	Metabolic pathways	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003591	K01115	ko04144	Endocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003591	K01115	ko04666	Fc gamma R-mediated phagocytosis	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003591	K01115	ko04912	GnRH signaling pathway	2043	7.6e-107	0.50	0.64	0.95
PGSC0003DMG200003592	K01115	ko00564	Glycerophospholipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko00565	Ether lipid metabolism	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko01100	Metabolic pathways	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko04144	Endocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko04666	Fc gamma R-mediated phagocytosis	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko04912	GnRH signaling pathway	821	1.9e-39	0.55	0.74	0.99
PGSC0003DMG200003592	K01115	ko00564	Glycerophospholipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K01115	ko00565	Ether lipid metabolism	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K01115	ko01100	Metabolic pathways	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K01115	ko04144	Endocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K01115	ko04666	Fc gamma R-mediated phagocytosis	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K01115	ko04912	GnRH signaling pathway	1256	1.9e-63	0.55	0.75	0.95
PGSC0003DMG200003592	K12897	ko03040	Spliceosome	336	1.1e-12	0.43	0.49	0.97
PGSC0003DMG200007322	K12825	ko03040	Spliceosome	1405	1.2e-71	0.75	0.86	1.00
PGSC0003DMG200007322	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMG200007322	K12825	ko03040	Spliceosome	5563	5.4e-301	0.79	0.88	1.00
PGSC0003DMG200007331	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMG200007331	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMG200007331	K00771	ko01100	Metabolic pathways	237	1.9e-06	0.36	0.51	0.54
PGSC0003DMG200007331	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMG200007331	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMG200007331	K00771	ko01100	Metabolic pathways	430	3.2e-17	0.33	0.52	0.57
PGSC0003DMG200007335	K01516	ko00230	Purine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMG200007335	K01516	ko00730	Thiamine metabolism	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMG200007335	K01516	ko01100	Metabolic pathways	1155	7.2e-58	0.51	0.71	0.94
PGSC0003DMG200017069	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko00100	Steroid biosynthesis	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01100	Metabolic pathways	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200017069	K01853	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.69	0.82	1.00
PGSC0003DMG200021687	K13030	ko00460	Cyanoamino acid metabolism	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMG200021687	K13030	ko01110	Biosynthesis of secondary metabolites	813	5.2e-39	0.35	0.54	0.88
PGSC0003DMG200021689	K13228	ko00402	Benzoxazinoid biosynthesis	760	4.4e-36	0.32	0.48	0.85
PGSC0003DMG200021690	K13228	ko00402	Benzoxazinoid biosynthesis	624	1.4e-28	0.43	0.60	0.96
PGSC0003DMG200021694	K13228	ko00402	Benzoxazinoid biosynthesis	1123	4.2e-56	0.39	0.59	0.98
PGSC0003DMG200021695	K13228	ko00402	Benzoxazinoid biosynthesis	506	4.5e-22	0.52	0.72	0.87
PGSC0003DMG200025470	K01379	ko04142	Lysosome	290	1.7e-09	0.27	0.43	0.83
PGSC0003DMG200025472	K11229	ko04011	MAPK signaling pathway - yeast	611	5.0e-27	0.37	0.56	0.73
PGSC0003DMG200025478	K00430	ko00360	Phenylalanine metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMG200025478	K00430	ko00680	Methane metabolism	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMG200025478	K00430	ko00940	Phenylpropanoid biosynthesis	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMG200025478	K00430	ko01100	Metabolic pathways	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMG200025478	K00430	ko01110	Biosynthesis of secondary metabolites	1812	4.2e-94	0.69	0.80	0.97
PGSC0003DMG200020377	K07466	ko03030	DNA replication	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMG200020377	K07466	ko03420	Nucleotide excision repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMG200020377	K07466	ko03430	Mismatch repair	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMG200020377	K07466	ko03440	Homologous recombination	229	2.8e-06	0.25	0.43	0.98
PGSC0003DMG200020380	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMG200020380	K06127	ko01100	Metabolic pathways	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMG200020380	K06127	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.75	0.85	0.89
PGSC0003DMG200020380	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMG200020380	K06127	ko01100	Metabolic pathways	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMG200020380	K06127	ko01110	Biosynthesis of secondary metabolites	682	8.8e-32	0.85	0.90	0.77
PGSC0003DMG200020380	K06127	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMG200020380	K06127	ko01100	Metabolic pathways	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMG200020380	K06127	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.75	0.84	0.98
PGSC0003DMG200020381	K11090	ko05322	Systemic lupus erythematosus	328	3.0e-12	0.34	0.55	0.56
PGSC0003DMG200020381	K11090	ko05322	Systemic lupus erythematosus	359	5.8e-14	0.30	0.46	0.59
PGSC0003DMG200020388	K00430	ko00360	Phenylalanine metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMG200020388	K00430	ko00680	Methane metabolism	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMG200020388	K00430	ko00940	Phenylpropanoid biosynthesis	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMG200020388	K00430	ko01100	Metabolic pathways	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMG200020388	K00430	ko01110	Biosynthesis of secondary metabolites	1066	5.8e-53	0.48	0.64	0.84
PGSC0003DMG200020389	K12598	ko03018	RNA degradation	4700	2.1e-253	0.82	0.90	0.97
PGSC0003DMG200020389	K12598	ko03018	RNA degradation	3393	2.6e-181	0.78	0.86	0.98
PGSC0003DMG200020389	K12598	ko03018	RNA degradation	6837	0.	0.82	0.91	1.00
PGSC0003DMG200020389	K12598	ko03018	RNA degradation	5237	5.2e-283	0.82	0.90	1.00
PGSC0003DMG200020389	K12598	ko03018	RNA degradation	1602	1.6e-82	0.82	0.94	0.92
PGSC0003DMG200020393	K01184	ko00040	Pentose and glucuronate interconversions	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMG200020393	K01184	ko00500	Starch and sucrose metabolism	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMG200020393	K01184	ko01100	Metabolic pathways	2065	4.6e-108	0.63	0.77	0.96
PGSC0003DMG200018402	K00876	ko00240	Pyrimidine metabolism	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMG200018402	K00876	ko00983	Drug metabolism - other enzymes	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMG200018402	K00876	ko01100	Metabolic pathways	324	2.4e-10	0.29	0.48	0.46
PGSC0003DMG200018402	K00876	ko00240	Pyrimidine metabolism	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMG200018402	K00876	ko00983	Drug metabolism - other enzymes	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMG200018402	K00876	ko01100	Metabolic pathways	333	5.9e-12	0.32	0.49	0.49
PGSC0003DMG200018402	K00876	ko00240	Pyrimidine metabolism	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMG200018402	K00876	ko00983	Drug metabolism - other enzymes	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMG200018402	K00876	ko01100	Metabolic pathways	333	9.0e-12	0.32	0.49	0.40
PGSC0003DMG200018405	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200018405	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200018405	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200018405	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200018405	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200018405	K03877	ko01100	Metabolic pathways	500	9.6e-22	0.35	0.50	0.41
PGSC0003DMG200043162	K12493	ko04144	Endocytosis	581	1.4e-25	0.46	0.60	0.74
PGSC0003DMG200011746	K01051	ko00040	Pentose and glucuronate interconversions	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMG200011746	K01051	ko00500	Starch and sucrose metabolism	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMG200011746	K01051	ko01100	Metabolic pathways	919	7.5e-45	0.53	0.72	0.98
PGSC0003DMG200011746	K01051	ko00040	Pentose and glucuronate interconversions	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMG200011746	K01051	ko00500	Starch and sucrose metabolism	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMG200011746	K01051	ko01100	Metabolic pathways	268	6.0e-09	0.43	0.66	0.93
PGSC0003DMG200011749	K13228	ko00402	Benzoxazinoid biosynthesis	679	1.3e-31	0.31	0.48	0.97
PGSC0003DMG200011750	K07424	ko00140	Steroid hormone biosynthesis	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00591	Linoleic acid metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00830	Retinol metabolism	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00982	Drug metabolism - cytochrome P450	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00983	Drug metabolism - other enzymes	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko01100	Metabolic pathways	575	7.0e-26	0.52	0.69	0.99
PGSC0003DMG200011750	K07424	ko00140	Steroid hormone biosynthesis	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00591	Linoleic acid metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00830	Retinol metabolism	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00982	Drug metabolism - cytochrome P450	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00983	Drug metabolism - other enzymes	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko01100	Metabolic pathways	1065	6.6e-53	0.49	0.68	0.94
PGSC0003DMG200011750	K07424	ko00140	Steroid hormone biosynthesis	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00591	Linoleic acid metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00830	Retinol metabolism	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00982	Drug metabolism - cytochrome P450	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00983	Drug metabolism - other enzymes	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko01100	Metabolic pathways	1291	2.3e-65	0.47	0.67	1.00
PGSC0003DMG200011750	K07424	ko00140	Steroid hormone biosynthesis	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00591	Linoleic acid metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00830	Retinol metabolism	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00982	Drug metabolism - cytochrome P450	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko00983	Drug metabolism - other enzymes	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011750	K07424	ko01100	Metabolic pathways	1867	3.9e-97	0.46	0.65	0.98
PGSC0003DMG200011751	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011751	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011751	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011751	K05278	ko00941	Flavonoid biosynthesis	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011751	K05278	ko01100	Metabolic pathways	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011751	K05278	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.37	0.55	0.89
PGSC0003DMG200011753	K10352	ko04530	Tight junction	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMG200011753	K10352	ko05416	Viral myocarditis	930	1.9e-44	0.27	0.46	0.98
PGSC0003DMG200011755	K01962	ko00061	Fatty acid biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200011755	K01962	ko00253	Tetracycline biosynthesis	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200011755	K01962	ko00620	Pyruvate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200011755	K01962	ko00640	Propanoate metabolism	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200011755	K01962	ko01100	Metabolic pathways	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200011755	K01962	ko01110	Biosynthesis of secondary metabolites	201	6.9e-11	0.74	0.84	0.54
PGSC0003DMG200009172	K10773	ko03410	Base excision repair	1556	5.5e-80	0.36	0.49	0.46
PGSC0003DMG200009176	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMG200009176	K00814	ko00710	Carbon fixation in photosynthetic organisms	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMG200009176	K00814	ko01100	Metabolic pathways	3614	1.7e-193	0.89	0.93	0.88
PGSC0003DMG200009176	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMG200009176	K00814	ko00710	Carbon fixation in photosynthetic organisms	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMG200009176	K00814	ko01100	Metabolic pathways	3482	3.2e-186	0.86	0.91	0.88
PGSC0003DMG200009176	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMG200009176	K00814	ko00710	Carbon fixation in photosynthetic organisms	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMG200009176	K00814	ko01100	Metabolic pathways	3625	4.2e-194	0.89	0.94	0.88
PGSC0003DMG200009177	K01051	ko00040	Pentose and glucuronate interconversions	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMG200009177	K01051	ko00500	Starch and sucrose metabolism	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMG200009177	K01051	ko01100	Metabolic pathways	893	2.0e-43	0.51	0.73	0.99
PGSC0003DMG200009177	K01051	ko00040	Pentose and glucuronate interconversions	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMG200009177	K01051	ko00500	Starch and sucrose metabolism	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMG200009177	K01051	ko01100	Metabolic pathways	1638	1.6e-84	0.43	0.59	0.95
PGSC0003DMG200009178	K01051	ko00040	Pentose and glucuronate interconversions	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMG200009178	K01051	ko00500	Starch and sucrose metabolism	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMG200009178	K01051	ko01100	Metabolic pathways	903	5.7e-44	0.76	0.85	0.99
PGSC0003DMG200009178	K01051	ko00040	Pentose and glucuronate interconversions	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMG200009178	K01051	ko00500	Starch and sucrose metabolism	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMG200009178	K01051	ko01100	Metabolic pathways	3396	1.8e-181	0.70	0.81	1.00
PGSC0003DMG200009183	K04368	ko04010	MAPK signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04012	ErbB signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04013	MAPK signaling pathway - fly	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04062	Chemokine signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04114	Oocyte meiosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04270	Vascular smooth muscle contraction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04320	Dorso-ventral axis formation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04370	VEGF signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04510	Focal adhesion	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04540	Gap junction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04620	Toll-like receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04626	Plant-pathogen interaction	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04650	Natural killer cell mediated cytotoxicity	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04660	T cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04662	B cell receptor signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04664	Fc epsilon RI signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04666	Fc gamma R-mediated phagocytosis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04720	Long-term potentiation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04730	Long-term depression	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04810	Regulation of actin cytoskeleton	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04910	Insulin signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04912	GnRH signaling pathway	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04914	Progesterone-mediated oocyte maturation	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko04916	Melanogenesis	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05020	Prion diseases	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05200	Pathways in cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05210	Colorectal cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05211	Renal cell carcinoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05212	Pancreatic cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05213	Endometrial cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05214	Glioma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05215	Prostate cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05216	Thyroid cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05218	Melanoma	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05219	Bladder cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05220	Chronic myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05221	Acute myeloid leukemia	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200009183	K04368	ko05223	Non-small cell lung cancer	872	2.9e-42	0.44	0.60	0.81
PGSC0003DMG200006192	K10590	ko04120	Ubiquitin mediated proteolysis	12254	0.	0.79	0.88	0.99
PGSC0003DMG200006192	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMG200006192	K10590	ko04120	Ubiquitin mediated proteolysis	12573	0.	0.80	0.89	1.00
PGSC0003DMG200006193	K02731	ko03050	Proteasome	1990	6.3e-104	0.96	0.99	1.00
PGSC0003DMG200006199	K05765	ko04360	Axon guidance	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMG200006199	K05765	ko04666	Fc gamma R-mediated phagocytosis	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMG200006199	K05765	ko04810	Regulation of actin cytoskeleton	782	2.7e-37	0.63	0.81	0.97
PGSC0003DMG200006207	K02936	ko03010	Ribosome	880	1.1e-42	0.77	0.82	0.99
PGSC0003DMG200025920	K08233	ko00901	Indole alkaloid biosynthesis	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMG200025920	K08233	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.44	0.61	0.89
PGSC0003DMG200025920	K08233	ko00901	Indole alkaloid biosynthesis	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMG200025920	K08233	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.39	0.58	0.99
PGSC0003DMG200025926	K02184	ko04320	Dorso-ventral axis formation	1074	7.4e-53	0.38	0.46	0.43
PGSC0003DMG200025931	K04631	ko04744	Phototransduction	534	1.3e-23	0.33	0.53	0.80
PGSC0003DMG200025932	K10260	ko04120	Ubiquitin mediated proteolysis	297	1.5e-10	0.34	0.49	0.47
PGSC0003DMG200025932	K10260	ko04120	Ubiquitin mediated proteolysis	354	1.5e-16	0.31	0.47	0.64
PGSC0003DMG200022940	K13229	ko00402	Benzoxazinoid biosynthesis	289	4.2e-10	0.39	0.52	0.94
PGSC0003DMG200022945	K02878	ko03010	Ribosome	246	9.8e-08	0.61	0.73	0.94
PGSC0003DMG200022953	K04103	ko00380	Tryptophan metabolism	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMG200022953	K04103	ko01100	Metabolic pathways	4329	6.2e-233	0.87	0.93	0.98
PGSC0003DMG200022953	K04103	ko00380	Tryptophan metabolism	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMG200022953	K04103	ko01100	Metabolic pathways	1107	3.2e-55	0.83	0.90	0.82
PGSC0003DMG200022955	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200022955	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200022955	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200022955	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200022955	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200040249	K05278	ko00941	Flavonoid biosynthesis	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMG200040249	K05278	ko01100	Metabolic pathways	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMG200040249	K05278	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.43	0.58	0.97
PGSC0003DMG200040260	K01199	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.54	0.71	0.92
PGSC0003DMG200040261	K10760	ko00908	Zeatin biosynthesis	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMG200040261	K10760	ko01100	Metabolic pathways	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMG200040261	K10760	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.43	0.61	0.94
PGSC0003DMG200045199	K10760	ko00908	Zeatin biosynthesis	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMG200045199	K10760	ko01100	Metabolic pathways	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMG200045199	K10760	ko01110	Biosynthesis of secondary metabolites	363	3.5e-14	0.62	0.78	0.87
PGSC0003DMG200043616	K01051	ko00040	Pentose and glucuronate interconversions	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMG200043616	K01051	ko00500	Starch and sucrose metabolism	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMG200043616	K01051	ko01100	Metabolic pathways	1719	5.6e-89	0.44	0.60	0.98
PGSC0003DMG200013563	K04424	ko04010	MAPK signaling pathway	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMG200013563	K04424	ko04530	Tight junction	331	2.0e-12	0.45	0.64	0.77
PGSC0003DMG200013568	K09843	ko00906	Carotenoid biosynthesis	1009	8.1e-50	0.36	0.53	0.96
PGSC0003DMG200004541	K00430	ko00360	Phenylalanine metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMG200004541	K00430	ko00680	Methane metabolism	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMG200004541	K00430	ko00940	Phenylpropanoid biosynthesis	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMG200004541	K00430	ko01100	Metabolic pathways	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMG200004541	K00430	ko01110	Biosynthesis of secondary metabolites	236	3.5e-07	0.39	0.51	0.46
PGSC0003DMG200004553	K04733	ko04210	Apoptosis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMG200004553	K04733	ko04620	Toll-like receptor signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMG200004553	K04733	ko04722	Neurotrophin signaling pathway	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMG200004553	K04733	ko05140	Leishmaniasis	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMG200004553	K04733	ko05142	Chagas disease	597	4.7e-27	0.44	0.64	0.99
PGSC0003DMG200004553	K04733	ko04210	Apoptosis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMG200004553	K04733	ko04620	Toll-like receptor signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMG200004553	K04733	ko04722	Neurotrophin signaling pathway	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMG200004553	K04733	ko05140	Leishmaniasis	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMG200004553	K04733	ko05142	Chagas disease	615	4.4e-28	0.43	0.63	0.83
PGSC0003DMG200004554	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04010	MAPK signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04020	Calcium signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04114	Oocyte meiosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04210	Apoptosis	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04310	Wnt signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04360	Axon guidance	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04370	VEGF signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04650	Natural killer cell mediated cytotoxicity	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04660	T cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04662	B cell receptor signaling pathway	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko04720	Long-term potentiation	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko05010	Alzheimer's disease	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200004554	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1585	1.4e-81	0.88	0.95	1.00
PGSC0003DMG200011372	K00949	ko00730	Thiamine metabolism	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMG200011372	K00949	ko01100	Metabolic pathways	1365	1.9e-69	0.63	0.77	0.97
PGSC0003DMG200011372	K00949	ko00730	Thiamine metabolism	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMG200011372	K00949	ko01100	Metabolic pathways	1071	3.1e-53	0.65	0.80	0.98
PGSC0003DMG200011372	K00949	ko00730	Thiamine metabolism	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMG200011372	K00949	ko01100	Metabolic pathways	648	6.6e-30	0.54	0.71	0.97
PGSC0003DMG200011373	K10858	ko03430	Mismatch repair	3978	1.4e-213	0.56	0.71	0.99
PGSC0003DMG200011374	K05666	ko02010	ABC transporters	3402	8.4e-182	0.35	0.55	0.94
PGSC0003DMG200011374	K05666	ko02010	ABC transporters	3424	5.1e-183	0.35	0.55	0.97
PGSC0003DMG200011377	K01710	ko00521	Streptomycin biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMG200011377	K01710	ko00523	Polyketide sugar unit biosynthesis	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMG200011377	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMG200011377	K01710	ko01100	Metabolic pathways	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMG200011377	K01710	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.56	0.66	0.97
PGSC0003DMG200011377	K01710	ko00521	Streptomycin biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMG200011377	K01710	ko00523	Polyketide sugar unit biosynthesis	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMG200011377	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMG200011377	K01710	ko01100	Metabolic pathways	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMG200011377	K01710	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.86	0.93	0.99
PGSC0003DMG200011377	K01710	ko00521	Streptomycin biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMG200011377	K01710	ko00523	Polyketide sugar unit biosynthesis	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMG200011377	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMG200011377	K01710	ko01100	Metabolic pathways	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMG200011377	K01710	ko01110	Biosynthesis of secondary metabolites	2506	2.2e-132	0.81	0.90	0.81
PGSC0003DMG200011378	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.29
PGSC0003DMG200011378	K12135	ko04712	Circadian rhythm - plant	314	1.7e-11	0.40	0.58	0.40
PGSC0003DMG200011383	K08852	ko05010	Alzheimer's disease	246	1.5e-07	0.45	0.57	0.31
PGSC0003DMG200006410	K01046	ko00561	Glycerolipid metabolism	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMG200006410	K01046	ko01100	Metabolic pathways	296	1.7e-10	0.29	0.47	0.86
PGSC0003DMG200006410	K01046	ko00561	Glycerolipid metabolism	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMG200006410	K01046	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.48	0.77
PGSC0003DMG200006415	K06630	ko04110	Cell cycle	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMG200006415	K06630	ko04114	Oocyte meiosis	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMG200006415	K06630	ko04722	Neurotrophin signaling pathway	1899	6.6e-99	0.90	0.96	1.00
PGSC0003DMG200006425	K05933	ko00270	Cysteine and methionine metabolism	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMG200006425	K05933	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.83	0.92	0.94
PGSC0003DMG200006425	K05933	ko00270	Cysteine and methionine metabolism	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko00270	Cysteine and methionine metabolism	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko01110	Biosynthesis of secondary metabolites	2272	1.8e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko00270	Cysteine and methionine metabolism	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko01110	Biosynthesis of secondary metabolites	2263	5.6e-119	0.83	0.91	1.00
PGSC0003DMG200006425	K05933	ko00270	Cysteine and methionine metabolism	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMG200006425	K05933	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.82	0.91	1.00
PGSC0003DMG200006426	K09458	ko00061	Fatty acid biosynthesis	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMG200006426	K09458	ko01100	Metabolic pathways	3035	1.5e-161	0.76	0.88	0.98
PGSC0003DMG200006426	K09458	ko00061	Fatty acid biosynthesis	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMG200006426	K09458	ko01100	Metabolic pathways	2946	1.2e-156	0.80	0.92	1.00
PGSC0003DMG200006426	K09458	ko00061	Fatty acid biosynthesis	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMG200006426	K09458	ko01100	Metabolic pathways	1461	9.5e-75	0.79	0.91	1.00
PGSC0003DMG200006426	K09458	ko00061	Fatty acid biosynthesis	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMG200006426	K09458	ko01100	Metabolic pathways	3064	3.7e-163	0.78	0.90	0.98
PGSC0003DMG200006426	K09458	ko00061	Fatty acid biosynthesis	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMG200006426	K09458	ko01100	Metabolic pathways	920	6.6e-45	0.81	0.93	0.99
PGSC0003DMG200021248	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021248	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021248	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021248	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021248	K11517	ko01100	Metabolic pathways	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021248	K11517	ko04146	Peroxisome	2708	1.6e-143	0.87	0.94	0.99
PGSC0003DMG200021254	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMG200021254	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMG200021254	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5081	2.1e-274	0.87	0.93	1.00
PGSC0003DMG200021256	K01307	ko00790	Folate biosynthesis	1944	2.2e-101	0.73	0.84	0.95
PGSC0003DMG200021257	K03504	ko00230	Purine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko00240	Pyrimidine metabolism	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko01100	Metabolic pathways	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko03030	DNA replication	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko03410	Base excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko03420	Nucleotide excision repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko03430	Mismatch repair	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko03440	Homologous recombination	1485	1.3e-80	0.43	0.56	0.92
PGSC0003DMG200021257	K03504	ko00230	Purine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko00240	Pyrimidine metabolism	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko01100	Metabolic pathways	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03030	DNA replication	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03410	Base excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03420	Nucleotide excision repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03430	Mismatch repair	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03440	Homologous recombination	1642	9.9e-85	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko00230	Purine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko00240	Pyrimidine metabolism	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko01100	Metabolic pathways	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03030	DNA replication	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03410	Base excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03420	Nucleotide excision repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03430	Mismatch repair	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021257	K03504	ko03440	Homologous recombination	1661	8.9e-86	0.45	0.60	0.99
PGSC0003DMG200021258	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200021258	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200021258	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200021258	K10956	ko03060	Protein export	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200021258	K10956	ko04145	Phagosome	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200021258	K10956	ko05110	Vibrio cholerae infection	3712	6.7e-199	0.95	0.97	1.00
PGSC0003DMG200032102	K00472	ko00330	Arginine and proline metabolism	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMG200032102	K00472	ko01100	Metabolic pathways	1482	6.6e-76	0.62	0.76	0.95
PGSC0003DMG200032107	K01006	ko00620	Pyruvate metabolism	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMG200032107	K01006	ko00710	Carbon fixation in photosynthetic organisms	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMG200032107	K01006	ko01100	Metabolic pathways	5348	3.9e-289	0.86	0.94	0.97
PGSC0003DMG200032107	K01006	ko00620	Pyruvate metabolism	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMG200032107	K01006	ko00710	Carbon fixation in photosynthetic organisms	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMG200032107	K01006	ko01100	Metabolic pathways	2273	1.6e-119	0.83	0.93	0.94
PGSC0003DMG200032107	K01006	ko00620	Pyruvate metabolism	6272	0.	0.87	0.95	1.00
PGSC0003DMG200032107	K01006	ko00710	Carbon fixation in photosynthetic organisms	6272	0.	0.87	0.95	1.00
PGSC0003DMG200032107	K01006	ko01100	Metabolic pathways	6272	0.	0.87	0.95	1.00
PGSC0003DMG200032112	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200032117	K01611	ko00270	Cysteine and methionine metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMG200032117	K01611	ko00330	Arginine and proline metabolism	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMG200032117	K01611	ko01100	Metabolic pathways	2153	6.5e-113	0.73	0.86	1.00
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	953	1.0e-46	0.52	0.65	1.00
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	755	8.3e-36	0.63	0.88	0.76
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMG200017410	K10601	ko04120	Ubiquitin mediated proteolysis	214	5.7e-06	0.32	0.52	0.74
PGSC0003DMG200017411	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMG200017411	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.20
PGSC0003DMG200017411	K12135	ko04712	Circadian rhythm - plant	300	1.0e-10	0.43	0.57	0.30
PGSC0003DMG200017413	K00850	ko00010	Glycolysis / Gluconeogenesis	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017413	K00850	ko00030	Pentose phosphate pathway	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017413	K00850	ko00051	Fructose and mannose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017413	K00850	ko00052	Galactose metabolism	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017413	K00850	ko01100	Metabolic pathways	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017413	K00850	ko01110	Biosynthesis of secondary metabolites	3290	1.3e-175	0.81	0.89	0.94
PGSC0003DMG200017416	K02084	ko04115	p53 signaling pathway	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko04210	Apoptosis	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko05010	Alzheimer's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko05012	Parkinson's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko05016	Huntington's disease	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko05222	Small cell lung cancer	284	4.0e-06	0.31	0.46	0.28
PGSC0003DMG200017416	K02084	ko04115	p53 signaling pathway	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko04210	Apoptosis	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko05010	Alzheimer's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko05012	Parkinson's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko05016	Huntington's disease	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200017416	K02084	ko05222	Small cell lung cancer	284	5.2e-06	0.31	0.46	0.24
PGSC0003DMG200028168	K03531	ko04112	Cell cycle - Caulobacter	3206	5.4e-171	0.81	0.89	1.00
PGSC0003DMG200028171	K01915	ko00250	Alanine, aspartate and glutamate metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMG200028171	K01915	ko00330	Arginine and proline metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMG200028171	K01915	ko00910	Nitrogen metabolism	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMG200028171	K01915	ko01100	Metabolic pathways	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMG200028171	K01915	ko02020	Two-component system	932	1.4e-45	0.35	0.53	0.92
PGSC0003DMG200028175	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMG200028175	K00517	ko00626	Naphthalene and anthracene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMG200028175	K00517	ko00903	Limonene and pinene degradation	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMG200028175	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMG200028175	K00517	ko01110	Biosynthesis of secondary metabolites	1748	1.4e-90	0.43	0.64	0.98
PGSC0003DMG200028176	K02527	ko00540	Lipopolysaccharide biosynthesis	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMG200028176	K02527	ko01100	Metabolic pathways	2477	8.7e-131	0.68	0.82	0.98
PGSC0003DMG200028176	K02527	ko00540	Lipopolysaccharide biosynthesis	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMG200028176	K02527	ko01100	Metabolic pathways	384	2.4e-15	0.68	0.87	0.98
PGSC0003DMG200016669	K01426	ko00330	Arginine and proline metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00360	Phenylalanine metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00380	Tryptophan metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00460	Cyanoamino acid metabolism	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00632	Benzoate degradation via CoA ligation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00643	Styrene degradation	717	1.0e-33	0.51	0.65	0.54
PGSC0003DMG200016669	K01426	ko00330	Arginine and proline metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016669	K01426	ko00360	Phenylalanine metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016669	K01426	ko00380	Tryptophan metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016669	K01426	ko00460	Cyanoamino acid metabolism	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016669	K01426	ko00632	Benzoate degradation via CoA ligation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016669	K01426	ko00643	Styrene degradation	905	4.4e-44	0.37	0.54	0.64
PGSC0003DMG200016674	K01692	ko00071	Fatty acid metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00280	Valine, leucine and isoleucine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00281	Geraniol degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00310	Lysine degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00380	Tryptophan metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00410	beta-Alanine metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00632	Benzoate degradation via CoA ligation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00640	Propanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00650	Butanoate metabolism	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00903	Limonene and pinene degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko00930	Caprolactam degradation	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko01100	Metabolic pathways	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200016674	K01692	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.45	0.69	0.93
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMG200011840	K02924	ko03010	Ribosome	310	2.9e-11	0.92	0.97	0.63
PGSC0003DMG200011840	K02924	ko03010	Ribosome	439	2.2e-18	0.94	0.98	0.98
PGSC0003DMG200011841	K06237	ko04510	Focal adhesion	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMG200011841	K06237	ko04512	ECM-receptor interaction	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMG200011841	K06237	ko05146	Amoebiasis	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMG200011841	K06237	ko05200	Pathways in cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMG200011841	K06237	ko05222	Small cell lung cancer	543	4.3e-23	0.39	0.49	0.97
PGSC0003DMG200011842	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	773	8.4e-37	0.36	0.52	0.92
PGSC0003DMG200011843	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	462	1.2e-19	0.31	0.49	0.65
PGSC0003DMG200011845	K01053	ko00030	Pentose phosphate pathway	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMG200011845	K01053	ko00053	Ascorbate and aldarate metabolism	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMG200011845	K01053	ko00930	Caprolactam degradation	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMG200011845	K01053	ko01100	Metabolic pathways	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMG200011845	K01053	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.35	0.52	0.99
PGSC0003DMG200002095	K11826	ko04144	Endocytosis	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMG200002095	K11826	ko05016	Huntington's disease	3576	2.1e-191	0.96	0.98	1.00
PGSC0003DMG200002095	K11826	ko04144	Endocytosis	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMG200002095	K11826	ko05016	Huntington's disease	3587	5.2e-192	0.96	0.98	1.00
PGSC0003DMG200035835	K10760	ko00908	Zeatin biosynthesis	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMG200035835	K10760	ko01100	Metabolic pathways	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMG200035835	K10760	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.50	0.68	0.95
PGSC0003DMG200029958	K12667	ko00510	N-Glycan biosynthesis	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMG200029958	K12667	ko01100	Metabolic pathways	1005	1.3e-49	0.52	0.66	0.38
PGSC0003DMG200029964	K01047	ko00564	Glycerophospholipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko00565	Ether lipid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko00590	Arachidonic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko00591	Linoleic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko00592	alpha-Linolenic acid metabolism	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko01100	Metabolic pathways	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04010	MAPK signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04270	Vascular smooth muscle contraction	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04370	VEGF signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04664	Fc epsilon RI signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04730	Long-term depression	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029964	K01047	ko04912	GnRH signaling pathway	638	2.4e-29	0.51	0.64	0.99
PGSC0003DMG200029967	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMG200029967	K00517	ko00626	Naphthalene and anthracene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMG200029967	K00517	ko00903	Limonene and pinene degradation	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMG200029967	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMG200029967	K00517	ko01110	Biosynthesis of secondary metabolites	915	1.2e-44	0.55	0.76	0.90
PGSC0003DMG200029967	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMG200029967	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMG200029967	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMG200029967	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMG200029967	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.63	0.98
PGSC0003DMG200029973	K01834	ko00010	Glycolysis / Gluconeogenesis	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMG200029973	K01834	ko01100	Metabolic pathways	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMG200029973	K01834	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.36	0.53	0.84
PGSC0003DMG200029974	K05350	ko00460	Cyanoamino acid metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMG200029974	K05350	ko00500	Starch and sucrose metabolism	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMG200029974	K05350	ko00940	Phenylpropanoid biosynthesis	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMG200029974	K05350	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.52	0.65	0.91
PGSC0003DMG200029974	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMG200029974	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMG200029974	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMG200029974	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.93
PGSC0003DMG200029980	K01354	ko05142	Chagas disease	416	8.0e-17	0.57	0.72	0.65
PGSC0003DMG200029980	K01354	ko05142	Chagas disease	2254	1.7e-118	0.74	0.86	0.99
PGSC0003DMG200020141	K02721	ko00195	Photosynthesis	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMG200020141	K02721	ko01100	Metabolic pathways	602	2.3e-27	0.58	0.75	0.99
PGSC0003DMG200020144	K10955	ko05110	Vibrio cholerae infection	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMG200020144	K10955	ko05146	Amoebiasis	424	7.6e-16	0.29	0.37	0.94
PGSC0003DMG200020146	K06636	ko04110	Cell cycle	7300	0.	0.69	0.81	1.00
PGSC0003DMG200020146	K06636	ko04111	Cell cycle - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMG200020146	K06636	ko04113	Meiosis - yeast	7300	0.	0.69	0.81	1.00
PGSC0003DMG200020146	K06636	ko04114	Oocyte meiosis	7300	0.	0.69	0.81	1.00
PGSC0003DMG200020146	K06636	ko04110	Cell cycle	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMG200020146	K06636	ko04111	Cell cycle - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMG200020146	K06636	ko04113	Meiosis - yeast	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMG200020146	K06636	ko04114	Oocyte meiosis	1776	4.0e-92	0.79	0.89	1.00
PGSC0003DMG200020148	K02875	ko03010	Ribosome	1011	6.3e-50	0.90	0.95	0.99
PGSC0003DMG200020149	K01900	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMG200020149	K01900	ko00640	Propanoate metabolism	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMG200020149	K01900	ko01100	Metabolic pathways	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMG200020149	K01900	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.88	0.96	1.00
PGSC0003DMG200020150	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMG200020151	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.62
PGSC0003DMG200020151	K11420	ko00310	Lysine degradation	671	3.6e-31	0.36	0.51	0.48
PGSC0003DMG200020152	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMG200020152	K12896	ko03040	Spliceosome	228	1.8e-06	0.39	0.50	0.27
PGSC0003DMG200020154	K02693	ko00195	Photosynthesis	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMG200020154	K02693	ko01100	Metabolic pathways	573	9.1e-26	0.74	0.78	0.84
PGSC0003DMG200020156	K01728	ko00040	Pentose and glucuronate interconversions	2857	9.6e-152	0.80	0.89	0.87
PGSC0003DMG200015950	K10572	ko00562	Inositol phosphate metabolism	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMG200015950	K10572	ko01100	Metabolic pathways	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMG200015950	K10572	ko04070	Phosphatidylinositol signaling system	256	5.6e-13	0.33	0.50	0.75
PGSC0003DMG200015952	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko00500	Starch and sucrose metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko01100	Metabolic pathways	2015	2.7e-105	0.84	0.93	1.00
PGSC0003DMG200015952	K00975	ko00500	Starch and sucrose metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMG200015952	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMG200015952	K00975	ko01100	Metabolic pathways	3452	1.5e-184	0.77	0.87	1.00
PGSC0003DMG200015960	K02689	ko00195	Photosynthesis	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMG200015960	K02689	ko01100	Metabolic pathways	1472	2.4e-75	0.95	0.97	0.98
PGSC0003DMG200015961	K04618	ko00052	Galactose metabolism	341	3.2e-10	0.27	0.41	0.78
PGSC0003DMG200015963	K12821	ko03040	Spliceosome	3869	1.5e-207	0.62	0.72	0.99
PGSC0003DMG200015963	K12821	ko03040	Spliceosome	3769	4.8e-202	0.69	0.82	1.00
PGSC0003DMG200015963	K12821	ko03040	Spliceosome	5200	5.7e-281	0.61	0.72	1.00
PGSC0003DMG200008440	K07199	ko04910	Insulin signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMG200008440	K07199	ko04920	Adipocytokine signaling pathway	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMG200008440	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1675	1.5e-86	0.66	0.78	1.00
PGSC0003DMG200008440	K07199	ko04910	Insulin signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMG200008440	K07199	ko04920	Adipocytokine signaling pathway	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMG200008440	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1521	4.7e-78	0.77	0.91	1.00
PGSC0003DMG200008440	K07199	ko04910	Insulin signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMG200008440	K07199	ko04920	Adipocytokine signaling pathway	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMG200008440	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1137	7.1e-57	0.79	0.93	0.99
PGSC0003DMG200008444	K08300	ko03018	RNA degradation	238	2.4e-06	0.40	0.47	0.86
PGSC0003DMG200008444	K08300	ko03018	RNA degradation	241	1.6e-06	0.41	0.47	0.90
PGSC0003DMG200002768	K01358	ko04112	Cell cycle - Caulobacter	1882	5.7e-98	0.90	0.94	0.44
PGSC0003DMG200002768	K01358	ko04112	Cell cycle - Caulobacter	1964	1.7e-102	0.80	0.87	0.98
PGSC0003DMG200002771	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200002771	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	1047	6.5e-52	0.32	0.52	0.88
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	450	5.5e-19	0.48	0.69	0.74
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	367	4.6e-14	0.29	0.49	0.83
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	1132	1.3e-56	0.33	0.54	0.89
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	834	3.6e-40	0.31	0.53	0.92
PGSC0003DMG200012548	K05681	ko02010	ABC transporters	1123	4.2e-56	0.34	0.55	0.87
PGSC0003DMG200012549	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMG200012549	K01626	ko01100	Metabolic pathways	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMG200012549	K01626	ko01110	Biosynthesis of secondary metabolites	3527	1.1e-188	0.80	0.87	0.96
PGSC0003DMG200012550	K02371	ko00061	Fatty acid biosynthesis	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMG200012550	K02371	ko01100	Metabolic pathways	909	2.7e-44	0.71	0.87	0.98
PGSC0003DMG200012550	K02371	ko00061	Fatty acid biosynthesis	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMG200012550	K02371	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.84	0.80
PGSC0003DMG200012551	K13030	ko00460	Cyanoamino acid metabolism	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMG200012551	K13030	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.45	0.63	0.97
PGSC0003DMG200012551	K13030	ko00460	Cyanoamino acid metabolism	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMG200012551	K13030	ko01110	Biosynthesis of secondary metabolites	615	4.4e-28	0.47	0.62	0.93
PGSC0003DMG200012560	K12891	ko03040	Spliceosome	1647	5.3e-85	0.76	0.84	0.99
PGSC0003DMG200000582	K00475	ko00941	Flavonoid biosynthesis	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMG200000582	K00475	ko01100	Metabolic pathways	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMG200000582	K00475	ko01110	Biosynthesis of secondary metabolites	859	1.5e-41	0.38	0.60	0.93
PGSC0003DMG200000584	K12130	ko04712	Circadian rhythm - plant	1781	2.1e-92	0.42	0.54	1.00
PGSC0003DMG200000584	K12130	ko04712	Circadian rhythm - plant	1585	1.4e-81	0.40	0.52	0.95
PGSC0003DMG200000593	K05933	ko00270	Cysteine and methionine metabolism	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMG200000593	K05933	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.37	0.61	0.84
PGSC0003DMG200000594	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMG200000594	K13229	ko00402	Benzoxazinoid biosynthesis	259	1.9e-08	0.42	0.58	0.80
PGSC0003DMG200000594	K05278	ko00941	Flavonoid biosynthesis	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMG200000594	K05278	ko01100	Metabolic pathways	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMG200000594	K05278	ko01110	Biosynthesis of secondary metabolites	403	2.2e-16	0.35	0.50	0.89
PGSC0003DMG200000594	K05282	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMG200000594	K05282	ko01100	Metabolic pathways	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMG200000594	K05282	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.39	0.56	0.81
PGSC0003DMG200000594	K05933	ko00270	Cysteine and methionine metabolism	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMG200000594	K05933	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.35	0.49	0.96
PGSC0003DMG200000594	K05933	ko00270	Cysteine and methionine metabolism	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMG200000594	K05933	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.34	0.49	0.95
PGSC0003DMG200000594	K05933	ko00270	Cysteine and methionine metabolism	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMG200000594	K05933	ko01110	Biosynthesis of secondary metabolites	396	5.2e-16	0.34	0.49	0.92
PGSC0003DMG200000594	K05933	ko00270	Cysteine and methionine metabolism	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMG200000594	K05933	ko01110	Biosynthesis of secondary metabolites	574	8.0e-26	0.35	0.49	0.96
PGSC0003DMG200000595	K05933	ko00270	Cysteine and methionine metabolism	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMG200000595	K05933	ko01110	Biosynthesis of secondary metabolites	582	2.9e-26	0.35	0.48	0.94
PGSC0003DMG200037043	K03007	ko00230	Purine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMG200037043	K03007	ko00240	Pyrimidine metabolism	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMG200037043	K03007	ko01100	Metabolic pathways	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMG200037043	K03007	ko03020	RNA polymerase	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMG200037043	K03007	ko05016	Huntington's disease	479	1.4e-20	0.86	0.89	0.82
PGSC0003DMG200037044	K00059	ko00061	Fatty acid biosynthesis	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMG200037044	K00059	ko01040	Biosynthesis of unsaturated fatty acids	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMG200037044	K00059	ko01100	Metabolic pathways	283	9.0e-10	0.49	0.67	0.83
PGSC0003DMG200019430	K12843	ko03040	Spliceosome	1782	1.9e-92	0.37	0.52	0.94
PGSC0003DMG200019435	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.31
PGSC0003DMG200019435	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.57	0.74	0.33
PGSC0003DMG200019435	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	326	3.8e-12	0.61	0.70	0.32
PGSC0003DMG200019439	K03006	ko00230	Purine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMG200019439	K03006	ko00240	Pyrimidine metabolism	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMG200019439	K03006	ko01100	Metabolic pathways	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMG200019439	K03006	ko03020	RNA polymerase	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMG200019439	K03006	ko05016	Huntington's disease	785	1.8e-36	0.38	0.46	0.92
PGSC0003DMG200029294	K06685	ko04111	Cell cycle - yeast	1669	3.0e-88	0.82	0.85	0.87
PGSC0003DMG200029294	K06685	ko04111	Cell cycle - yeast	1795	3.6e-93	0.95	0.99	1.00
PGSC0003DMG200029294	K06685	ko04111	Cell cycle - yeast	1739	4.4e-90	0.95	0.99	0.96
PGSC0003DMG200029303	K12125	ko04712	Circadian rhythm - plant	1607	8.4e-83	0.40	0.53	0.99
PGSC0003DMG200029303	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.40	0.51	0.84
PGSC0003DMG200029303	K12125	ko04712	Circadian rhythm - plant	819	2.5e-39	0.40	0.50	0.93
PGSC0003DMG200029304	K00850	ko00010	Glycolysis / Gluconeogenesis	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029304	K00850	ko00030	Pentose phosphate pathway	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029304	K00850	ko00051	Fructose and mannose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029304	K00850	ko00052	Galactose metabolism	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029304	K00850	ko01100	Metabolic pathways	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029304	K00850	ko01110	Biosynthesis of secondary metabolites	3345	1.2e-178	0.84	0.90	0.98
PGSC0003DMG200029305	K02087	ko04110	Cell cycle	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMG200029305	K02087	ko04114	Oocyte meiosis	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMG200029305	K02087	ko04115	p53 signaling pathway	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMG200029305	K02087	ko04540	Gap junction	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMG200029305	K02087	ko04914	Progesterone-mediated oocyte maturation	2184	1.3e-114	0.86	0.93	1.00
PGSC0003DMG200014306	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMG200014306	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMG200014306	K05657	ko02010	ABC transporters	1070	3.5e-53	0.46	0.61	0.98
PGSC0003DMG200014306	K05658	ko02010	ABC transporters	1051	1.1e-55	0.43	0.61	0.94
PGSC0003DMG200014325	K08094	ko00040	Pentose and glucuronate interconversions	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMG200014325	K08094	ko00680	Methane metabolism	681	1.0e-31	0.53	0.65	0.91
PGSC0003DMG200003826	K02894	ko03010	Ribosome	1192	6.5e-60	1.00	1.00	0.99
PGSC0003DMG200003827	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.40
PGSC0003DMG200003827	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.37
PGSC0003DMG200003827	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMG200003827	K11420	ko00310	Lysine degradation	638	2.4e-29	0.35	0.52	0.36
PGSC0003DMG200003830	K02922	ko03010	Ribosome	465	8.2e-20	0.64	0.69	0.97
PGSC0003DMG200003832	K10143	ko04115	p53 signaling pathway	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMG200003832	K10143	ko04120	Ubiquitin mediated proteolysis	283	5.1e-09	0.47	0.61	0.91
PGSC0003DMG200003836	K12621	ko03018	RNA degradation	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMG200003836	K12621	ko03040	Spliceosome	765	2.3e-36	0.97	0.99	0.99
PGSC0003DMG200003838	K02358	ko04626	Plant-pathogen interaction	3395	2.0e-181	0.90	0.93	1.00
PGSC0003DMG200003843	K00754	ko00051	Fructose and mannose metabolism	335	1.6e-12	0.30	0.50	0.53
PGSC0003DMG200003846	K03025	ko00230	Purine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMG200003846	K03025	ko00240	Pyrimidine metabolism	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMG200003846	K03025	ko01100	Metabolic pathways	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMG200003846	K03025	ko03020	RNA polymerase	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMG200003846	K03025	ko04623	Cytosolic DNA-sensing pathway	1068	4.5e-53	0.55	0.75	0.99
PGSC0003DMG200010703	K12275	ko03060	Protein export	2026	6.6e-106	0.79	0.87	0.92
PGSC0003DMG200010703	K12275	ko03060	Protein export	2034	2.4e-106	0.79	0.87	0.92
PGSC0003DMG200010703	K12275	ko03060	Protein export	2163	1.8e-113	0.72	0.83	0.99
PGSC0003DMG200010710	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMG200010710	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMG200010710	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMG200010710	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMG200010710	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.43
PGSC0003DMG200010710	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMG200010710	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMG200010710	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMG200010710	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMG200010710	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.38
PGSC0003DMG200010710	K04733	ko04210	Apoptosis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010710	K04733	ko05142	Chagas disease	694	1.9e-32	0.37	0.57	0.53
PGSC0003DMG200010715	K00430	ko00360	Phenylalanine metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200010715	K00430	ko00680	Methane metabolism	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200010715	K00430	ko00940	Phenylpropanoid biosynthesis	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200010715	K00430	ko01100	Metabolic pathways	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200010715	K00430	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.66	0.83	0.89
PGSC0003DMG200010716	K00430	ko00360	Phenylalanine metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMG200010716	K00430	ko00680	Methane metabolism	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMG200010716	K00430	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMG200010716	K00430	ko01100	Metabolic pathways	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMG200010716	K00430	ko01110	Biosynthesis of secondary metabolites	524	4.6e-23	0.64	0.77	0.94
PGSC0003DMG200039051	K11251	ko05322	Systemic lupus erythematosus	763	3.0e-36	0.73	0.84	0.94
PGSC0003DMG200039054	K03094	ko04110	Cell cycle	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04111	Cell cycle - yeast	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04114	Oocyte meiosis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04120	Ubiquitin mediated proteolysis	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04310	Wnt signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04350	TGF-beta signaling pathway	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200039054	K03094	ko04710	Circadian rhythm - mammal	580	3.7e-26	0.51	0.68	0.99
PGSC0003DMG200043989	K11644	ko05016	Huntington's disease	286	2.8e-06	0.24	0.42	0.53
PGSC0003DMG200043992	K11251	ko05322	Systemic lupus erythematosus	536	1.0e-23	0.71	0.85	0.72
PGSC0003DMG200043994	K03133	ko03022	Basal transcription factors	231	6.6e-07	0.55	0.70	0.33
PGSC0003DMG200044009	K01955	ko00240	Pyrimidine metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMG200044009	K01955	ko00250	Alanine, aspartate and glutamate metabolism	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMG200044009	K01955	ko01100	Metabolic pathways	350	1.8e-12	0.41	0.62	0.38
PGSC0003DMG200021956	K02894	ko03010	Ribosome	179	2.6e-06	0.91	0.97	0.19
PGSC0003DMG200021965	K06110	ko04530	Tight junction	765	2.3e-36	0.28	0.44	0.83
PGSC0003DMG200021965	K06110	ko04530	Tight junction	788	1.3e-37	0.28	0.44	0.84
PGSC0003DMG200021966	K00368	ko00910	Nitrogen metabolism	878	1.4e-42	0.40	0.57	0.86
PGSC0003DMG200021966	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.88
PGSC0003DMG200021966	K00368	ko00910	Nitrogen metabolism	1650	3.6e-85	0.43	0.59	0.95
PGSC0003DMG200021981	K13229	ko00402	Benzoxazinoid biosynthesis	343	4.4e-13	0.42	0.57	0.91
PGSC0003DMG200021981	K13229	ko00402	Benzoxazinoid biosynthesis	649	5.8e-30	0.42	0.58	0.99
PGSC0003DMG200031019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMG200031019	K00517	ko00626	Naphthalene and anthracene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMG200031019	K00517	ko00903	Limonene and pinene degradation	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMG200031019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMG200031019	K00517	ko01110	Biosynthesis of secondary metabolites	719	8.0e-34	0.45	0.65	0.97
PGSC0003DMG200031019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMG200031019	K00517	ko00626	Naphthalene and anthracene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMG200031019	K00517	ko00903	Limonene and pinene degradation	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMG200031019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMG200031019	K00517	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.48	0.67	0.96
PGSC0003DMG200031019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMG200031019	K00517	ko00626	Naphthalene and anthracene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMG200031019	K00517	ko00903	Limonene and pinene degradation	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMG200031019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMG200031019	K00517	ko01110	Biosynthesis of secondary metabolites	1222	1.5e-61	0.43	0.61	0.95
PGSC0003DMG200031019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMG200031019	K00517	ko00626	Naphthalene and anthracene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMG200031019	K00517	ko00903	Limonene and pinene degradation	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMG200031019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMG200031019	K00517	ko01110	Biosynthesis of secondary metabolites	1347	1.8e-68	0.40	0.58	0.94
PGSC0003DMG200031019	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMG200031019	K00517	ko00626	Naphthalene and anthracene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMG200031019	K00517	ko00903	Limonene and pinene degradation	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMG200031019	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMG200031019	K00517	ko01110	Biosynthesis of secondary metabolites	287	1.1e-09	0.52	0.66	0.85
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMG200028784	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMG200028784	K04424	ko04530	Tight junction	2814	2.3e-149	0.43	0.58	1.00
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMG200028784	K04424	ko04530	Tight junction	2004	1.1e-104	0.46	0.58	0.96
PGSC0003DMG200028787	K13289	ko04142	Lysosome	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMG200028787	K13289	ko04614	Renin-angiotensin system	3084	2.9e-164	0.79	0.90	0.98
PGSC0003DMG200028787	K13289	ko04142	Lysosome	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMG200028787	K13289	ko04614	Renin-angiotensin system	2450	2.7e-129	0.79	0.89	0.97
PGSC0003DMG200018148	K09680	ko00770	Pantothenate and CoA biosynthesis	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMG200018148	K09680	ko01100	Metabolic pathways	5206	2.6e-281	0.89	0.94	0.95
PGSC0003DMG200018148	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMG200018148	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMG200018148	K09680	ko00770	Pantothenate and CoA biosynthesis	6692	0.	0.89	0.94	0.98
PGSC0003DMG200018148	K09680	ko01100	Metabolic pathways	6692	0.	0.89	0.94	0.98
PGSC0003DMG200018159	K10573	ko04120	Ubiquitin mediated proteolysis	1333	1.1e-67	0.98	1.00	0.99
PGSC0003DMG200023939	K01955	ko00240	Pyrimidine metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMG200023939	K01955	ko00250	Alanine, aspartate and glutamate metabolism	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMG200023939	K01955	ko01100	Metabolic pathways	641	9.1e-29	0.52	0.67	0.85
PGSC0003DMG200023947	K01227	ko00511	Other glycan degradation	434	6.6e-18	0.29	0.46	0.96
PGSC0003DMG200023947	K01227	ko00511	Other glycan degradation	1350	1.3e-68	0.36	0.52	0.97
PGSC0003DMG200023947	K01227	ko00511	Other glycan degradation	897	1.2e-43	0.31	0.45	0.96
PGSC0003DMG200030656	K01613	ko00564	Glycerophospholipid metabolism	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMG200030656	K01613	ko01100	Metabolic pathways	227	8.9e-06	0.41	0.61	0.51
PGSC0003DMG200030658	K04733	ko04210	Apoptosis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMG200030658	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMG200030658	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMG200030658	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMG200030658	K04733	ko05142	Chagas disease	834	3.6e-40	0.30	0.45	0.94
PGSC0003DMG200030662	K05349	ko00460	Cyanoamino acid metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMG200030662	K05349	ko00500	Starch and sucrose metabolism	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMG200030662	K05349	ko00940	Phenylpropanoid biosynthesis	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMG200030662	K05349	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.47	0.63	0.99
PGSC0003DMG200030662	K05349	ko00460	Cyanoamino acid metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMG200030662	K05349	ko00500	Starch and sucrose metabolism	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMG200030662	K05349	ko00940	Phenylpropanoid biosynthesis	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMG200030662	K05349	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.49	0.65	0.99
PGSC0003DMG200030665	K09880	ko00270	Cysteine and methionine metabolism	742	6.5e-35	0.27	0.44	0.93
PGSC0003DMG200022075	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMG200022075	K00517	ko00626	Naphthalene and anthracene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMG200022075	K00517	ko00903	Limonene and pinene degradation	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMG200022075	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMG200022075	K00517	ko01110	Biosynthesis of secondary metabolites	2056	1.5e-107	0.48	0.69	0.99
PGSC0003DMG200022075	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMG200022075	K00517	ko00626	Naphthalene and anthracene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMG200022075	K00517	ko00903	Limonene and pinene degradation	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMG200022075	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMG200022075	K00517	ko01110	Biosynthesis of secondary metabolites	1087	4.1e-54	0.43	0.63	0.95
PGSC0003DMG200022078	K10140	ko03420	Nucleotide excision repair	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMG200022078	K10140	ko04115	p53 signaling pathway	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMG200022078	K10140	ko04120	Ubiquitin mediated proteolysis	680	1.1e-31	0.60	0.81	0.94
PGSC0003DMG200022078	K10140	ko03420	Nucleotide excision repair	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMG200022078	K10140	ko04115	p53 signaling pathway	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMG200022078	K10140	ko04120	Ubiquitin mediated proteolysis	2530	1.0e-133	0.68	0.83	0.99
PGSC0003DMG200022081	K01582	ko00310	Lysine degradation	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMG200022081	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMG200022081	K01582	ko01100	Metabolic pathways	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMG200022081	K01582	ko01110	Biosynthesis of secondary metabolites	1166	1.8e-58	0.40	0.56	0.99
PGSC0003DMG200022082	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00230	Purine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko00232	Caffeine metabolism	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko00983	Drug metabolism - other enzymes	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko01100	Metabolic pathways	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko01110	Biosynthesis of secondary metabolites	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko04146	Peroxisome	2159	3.0e-113	0.76	0.87	0.99
PGSC0003DMG200022082	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00230	Purine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00232	Caffeine metabolism	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00983	Drug metabolism - other enzymes	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01100	Metabolic pathways	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko01110	Biosynthesis of secondary metabolites	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko04146	Peroxisome	5976	0.	0.73	0.85	1.00
PGSC0003DMG200022082	K00106	ko00230	Purine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022082	K00106	ko00232	Caffeine metabolism	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022082	K00106	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022082	K00106	ko01100	Metabolic pathways	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022082	K00106	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022082	K00106	ko04146	Peroxisome	1394	4.7e-71	0.75	0.86	0.99
PGSC0003DMG200022088	K00615	ko00030	Pentose phosphate pathway	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMG200022088	K00615	ko00710	Carbon fixation in photosynthetic organisms	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMG200022088	K00615	ko01051	Biosynthesis of ansamycins	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMG200022088	K00615	ko01100	Metabolic pathways	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMG200022088	K00615	ko01110	Biosynthesis of secondary metabolites	5385	3.5e-291	0.85	0.91	1.00
PGSC0003DMG200025118	K03011	ko00230	Purine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMG200025118	K03011	ko00240	Pyrimidine metabolism	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMG200025118	K03011	ko01100	Metabolic pathways	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMG200025118	K03011	ko03020	RNA polymerase	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMG200025118	K03011	ko05016	Huntington's disease	1424	1.0e-72	0.81	0.92	0.99
PGSC0003DMG200025118	K03011	ko00230	Purine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMG200025118	K03011	ko00240	Pyrimidine metabolism	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMG200025118	K03011	ko01100	Metabolic pathways	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMG200025118	K03011	ko03020	RNA polymerase	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMG200025118	K03011	ko05016	Huntington's disease	2361	2.2e-124	0.87	0.96	1.00
PGSC0003DMG200025121	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko00030	Pentose phosphate pathway	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko00480	Glutathione metabolism	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko01100	Metabolic pathways	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025121	K00033	ko01110	Biosynthesis of secondary metabolites	3687	1.6e-197	0.90	0.95	1.00
PGSC0003DMG200025122	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMG200025122	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMG200025122	K04077	ko03018	RNA degradation	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMG200025122	K04077	ko04940	Type I diabetes mellitus	2365	1.3e-124	0.67	0.87	0.93
PGSC0003DMG200025122	K04077	ko03018	RNA degradation	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMG200025122	K04077	ko04940	Type I diabetes mellitus	2068	3.2e-108	0.63	0.81	0.99
PGSC0003DMG200025122	K04077	ko03018	RNA degradation	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMG200025122	K04077	ko04940	Type I diabetes mellitus	1264	7.0e-64	0.64	0.78	0.98
PGSC0003DMG200025122	K04077	ko03018	RNA degradation	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMG200025122	K04077	ko04940	Type I diabetes mellitus	2164	1.6e-113	0.66	0.86	0.99
PGSC0003DMG200025131	K02183	ko04020	Calcium signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04070	Phosphatidylinositol signaling system	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04114	Oocyte meiosis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04270	Vascular smooth muscle contraction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04626	Plant-pathogen interaction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04720	Long-term potentiation	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04722	Neurotrophin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04740	Olfactory transduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04744	Phototransduction	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04745	Phototransduction - fly	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04910	Insulin signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04912	GnRH signaling pathway	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04916	Melanogenesis	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04970	Salivary secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko04971	Gastric acid secretion	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko05010	Alzheimer's disease	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025131	K02183	ko05214	Glioma	239	2.4e-07	0.37	0.55	0.62
PGSC0003DMG200025134	K01739	ko00270	Cysteine and methionine metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMG200025134	K01739	ko00450	Selenoamino acid metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMG200025134	K01739	ko00920	Sulfur metabolism	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMG200025134	K01739	ko01100	Metabolic pathways	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMG200025134	K01739	ko01110	Biosynthesis of secondary metabolites	3040	7.7e-162	0.72	0.80	1.00
PGSC0003DMG200025135	K06653	ko04111	Cell cycle - yeast	309	2.1e-10	0.30	0.46	0.98
PGSC0003DMG200028736	K12856	ko03040	Spliceosome	19338	0.	0.94	0.96	0.99
PGSC0003DMG200028736	K12856	ko03040	Spliceosome	19795	0.	0.95	0.97	1.00
PGSC0003DMG200003914	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	664	8.7e-31	0.45	0.56	0.68
PGSC0003DMG200003914	K04569	ko05014	Amyotrophic lateral sclerosis (ALS)	628	8.4e-29	0.44	0.55	0.98
PGSC0003DMG200003918	K01762	ko00270	Cysteine and methionine metabolism	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMG200003918	K01762	ko01110	Biosynthesis of secondary metabolites	1640	1.3e-84	0.47	0.68	0.78
PGSC0003DMG200003929	K07750	ko00100	Steroid biosynthesis	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMG200003929	K07750	ko01100	Metabolic pathways	858	1.7e-41	0.51	0.68	0.92
PGSC0003DMG200006993	K00430	ko00360	Phenylalanine metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMG200006993	K00430	ko00680	Methane metabolism	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMG200006993	K00430	ko00940	Phenylpropanoid biosynthesis	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMG200006993	K00430	ko01100	Metabolic pathways	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMG200006993	K00430	ko01110	Biosynthesis of secondary metabolites	1411	5.5e-72	0.64	0.80	0.96
PGSC0003DMG200006993	K00430	ko00360	Phenylalanine metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMG200006993	K00430	ko00680	Methane metabolism	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMG200006993	K00430	ko00940	Phenylpropanoid biosynthesis	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMG200006993	K00430	ko01100	Metabolic pathways	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMG200006993	K00430	ko01110	Biosynthesis of secondary metabolites	729	2.3e-34	0.62	0.81	0.99
PGSC0003DMG200006994	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko03060	Protein export	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko04145	Phagosome	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006994	K09481	ko05110	Vibrio cholerae infection	531	1.9e-23	0.78	0.90	0.98
PGSC0003DMG200006997	K13065	ko00940	Phenylpropanoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMG200006997	K13065	ko00941	Flavonoid biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMG200006997	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMG200006997	K13065	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.28	0.44	0.90
PGSC0003DMG200006998	K02183	ko04020	Calcium signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04070	Phosphatidylinositol signaling system	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04114	Oocyte meiosis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04270	Vascular smooth muscle contraction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04626	Plant-pathogen interaction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04720	Long-term potentiation	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04722	Neurotrophin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04740	Olfactory transduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04744	Phototransduction	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04745	Phototransduction - fly	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04910	Insulin signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04912	GnRH signaling pathway	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04916	Melanogenesis	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04970	Salivary secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko04971	Gastric acid secretion	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko05010	Alzheimer's disease	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200006998	K02183	ko05214	Glioma	487	5.0e-21	0.46	0.66	0.92
PGSC0003DMG200007000	K06129	ko00564	Glycerophospholipid metabolism	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMG200007000	K06129	ko04142	Lysosome	1022	1.6e-50	0.39	0.56	0.94
PGSC0003DMG200007001	K03115	ko04310	Wnt signaling pathway	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMG200007001	K03115	ko04520	Adherens junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMG200007001	K03115	ko04530	Tight junction	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMG200007001	K03115	ko04712	Circadian rhythm - plant	1837	1.7e-95	0.84	0.90	0.80
PGSC0003DMG200007001	K03115	ko04310	Wnt signaling pathway	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMG200007001	K03115	ko04520	Adherens junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMG200007001	K03115	ko04530	Tight junction	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMG200007001	K03115	ko04712	Circadian rhythm - plant	2184	1.3e-114	0.85	0.91	0.99
PGSC0003DMG200007007	K02113	ko00190	Oxidative phosphorylation	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMG200007007	K02113	ko00195	Photosynthesis	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMG200007007	K02113	ko01100	Metabolic pathways	401	2.8e-16	0.42	0.63	0.59
PGSC0003DMG200007008	K00275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMG200007008	K00275	ko01100	Metabolic pathways	279	1.5e-09	0.36	0.50	0.88
PGSC0003DMG200010659	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMG200010659	K03785	ko01100	Metabolic pathways	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMG200010659	K03785	ko01110	Biosynthesis of secondary metabolites	2919	3.7e-155	0.70	0.83	1.00
PGSC0003DMG200010660	K04565	ko04146	Peroxisome	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMG200010660	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMG200010660	K04565	ko05016	Huntington's disease	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMG200010660	K04565	ko05020	Prion diseases	1156	6.3e-58	0.88	0.94	0.99
PGSC0003DMG200010664	K01177	ko00500	Starch and sucrose metabolism	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMG200010664	K01177	ko01100	Metabolic pathways	1346	2.1e-68	0.41	0.59	0.80
PGSC0003DMG200010664	K01177	ko00500	Starch and sucrose metabolism	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMG200010664	K01177	ko01100	Metabolic pathways	1343	3.1e-68	0.41	0.59	0.92
PGSC0003DMG200010673	K00140	ko00280	Valine, leucine and isoleucine degradation	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMG200010673	K00140	ko00562	Inositol phosphate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMG200010673	K00140	ko00640	Propanoate metabolism	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMG200010673	K00140	ko01100	Metabolic pathways	3621	7.0e-194	0.74	0.85	0.98
PGSC0003DMG200010673	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00280	Valine, leucine and isoleucine degradation	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00562	Inositol phosphate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00640	Propanoate metabolism	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko01100	Metabolic pathways	306	5.2e-11	0.44	0.57	0.87
PGSC0003DMG200010673	K00140	ko00280	Valine, leucine and isoleucine degradation	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMG200010673	K00140	ko00562	Inositol phosphate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMG200010673	K00140	ko00640	Propanoate metabolism	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMG200010673	K00140	ko01100	Metabolic pathways	3910	8.0e-210	0.83	0.95	1.00
PGSC0003DMG200010674	K01951	ko00230	Purine metabolism	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMG200010674	K01951	ko00983	Drug metabolism - other enzymes	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMG200010674	K01951	ko01100	Metabolic pathways	457	2.3e-19	0.36	0.54	0.87
PGSC0003DMG200026384	K04733	ko04210	Apoptosis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMG200026384	K04733	ko04620	Toll-like receptor signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMG200026384	K04733	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMG200026384	K04733	ko05140	Leishmaniasis	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMG200026384	K04733	ko05142	Chagas disease	916	1.1e-44	0.39	0.57	0.61
PGSC0003DMG200026384	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMG200026384	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMG200026384	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMG200026384	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMG200026384	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.97
PGSC0003DMG200026384	K04733	ko04210	Apoptosis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMG200026384	K04733	ko04620	Toll-like receptor signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMG200026384	K04733	ko04722	Neurotrophin signaling pathway	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMG200026384	K04733	ko05140	Leishmaniasis	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMG200026384	K04733	ko05142	Chagas disease	912	1.8e-44	0.39	0.57	0.58
PGSC0003DMG200022480	K03013	ko00230	Purine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMG200022480	K03013	ko00240	Pyrimidine metabolism	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMG200022480	K03013	ko01100	Metabolic pathways	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMG200022480	K03013	ko03020	RNA polymerase	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMG200022480	K03013	ko05016	Huntington's disease	615	4.4e-28	0.74	0.88	0.99
PGSC0003DMG200022480	K03013	ko00230	Purine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMG200022480	K03013	ko00240	Pyrimidine metabolism	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMG200022480	K03013	ko01100	Metabolic pathways	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMG200022480	K03013	ko03020	RNA polymerase	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMG200022480	K03013	ko05016	Huntington's disease	400	3.2e-16	0.56	0.75	0.90
PGSC0003DMG200022492	K01066	ko00623	2,4-Dichlorobenzoate degradation	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMG200022492	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	359	5.8e-14	0.33	0.46	0.79
PGSC0003DMG200022493	K01066	ko00623	2,4-Dichlorobenzoate degradation	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMG200022493	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	330	2.3e-12	0.33	0.46	0.79
PGSC0003DMG200022494	K03006	ko00230	Purine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMG200022494	K03006	ko00240	Pyrimidine metabolism	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMG200022494	K03006	ko01100	Metabolic pathways	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMG200022494	K03006	ko03020	RNA polymerase	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMG200022494	K03006	ko05016	Huntington's disease	719	9.7e-33	0.32	0.43	0.86
PGSC0003DMG200036946	K10760	ko00908	Zeatin biosynthesis	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMG200036946	K10760	ko01100	Metabolic pathways	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMG200036946	K10760	ko01110	Biosynthesis of secondary metabolites	382	3.1e-15	0.60	0.78	0.93
PGSC0003DMG200036951	K10760	ko00908	Zeatin biosynthesis	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMG200036951	K10760	ko01100	Metabolic pathways	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMG200036951	K10760	ko01110	Biosynthesis of secondary metabolites	329	2.6e-12	0.75	0.85	0.33
PGSC0003DMG200036966	K00012	ko00040	Pentose and glucuronate interconversions	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200036966	K00012	ko00053	Ascorbate and aldarate metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200036966	K00012	ko00500	Starch and sucrose metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200036966	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200036966	K00012	ko01100	Metabolic pathways	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200036966	K00012	ko01110	Biosynthesis of secondary metabolites	3763	1.0e-201	0.91	0.97	1.00
PGSC0003DMG200034306	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMG200034306	K08065	ko04612	Antigen processing and presentation	440	2.0e-18	0.53	0.76	0.47
PGSC0003DMG200042401	K10760	ko00908	Zeatin biosynthesis	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMG200042401	K10760	ko01100	Metabolic pathways	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMG200042401	K10760	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.45	0.61	0.97
PGSC0003DMG200042425	K09880	ko00270	Cysteine and methionine metabolism	244	6.4e-07	0.28	0.50	0.78
PGSC0003DMG200046401	K12581	ko03018	RNA degradation	927	2.7e-45	0.51	0.67	0.94
PGSC0003DMG200015887	K07253	ko00350	Tyrosine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMG200015887	K07253	ko00360	Phenylalanine metabolism	302	8.0e-11	0.40	0.55	0.98
PGSC0003DMG200015895	K12869	ko03040	Spliceosome	828	7.8e-40	0.57	0.71	0.83
PGSC0003DMG200015900	K05583	ko00190	Oxidative phosphorylation	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMG200015900	K05583	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.59	0.41
PGSC0003DMG200015901	K06671	ko04110	Cell cycle	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMG200015901	K06671	ko04111	Cell cycle - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMG200015901	K06671	ko04113	Meiosis - yeast	5296	2.9e-286	0.70	0.84	0.97
PGSC0003DMG200015901	K06671	ko04110	Cell cycle	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMG200015901	K06671	ko04111	Cell cycle - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMG200015901	K06671	ko04113	Meiosis - yeast	1080	9.9e-54	0.64	0.80	0.95
PGSC0003DMG200015901	K06671	ko04110	Cell cycle	6343	0.	0.68	0.84	1.00
PGSC0003DMG200015901	K06671	ko04111	Cell cycle - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMG200015901	K06671	ko04113	Meiosis - yeast	6343	0.	0.68	0.84	1.00
PGSC0003DMG200015902	K01840	ko00051	Fructose and mannose metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMG200015902	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMG200015902	K01840	ko01100	Metabolic pathways	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMG200015902	K01840	ko01110	Biosynthesis of secondary metabolites	3206	5.4e-171	0.68	0.80	0.92
PGSC0003DMG200015906	K00908	ko01100	Metabolic pathways	268	2.2e-08	0.33	0.49	0.98
PGSC0003DMG200009619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMG200009619	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMG200009619	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMG200009619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMG200009619	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.43	0.62	0.98
PGSC0003DMG200009619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMG200009619	K00517	ko00626	Naphthalene and anthracene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMG200009619	K00517	ko00903	Limonene and pinene degradation	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMG200009619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMG200009619	K00517	ko01110	Biosynthesis of secondary metabolites	1559	3.8e-80	0.45	0.62	0.99
PGSC0003DMG200009619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMG200009619	K00517	ko00626	Naphthalene and anthracene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMG200009619	K00517	ko00903	Limonene and pinene degradation	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMG200009619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMG200009619	K00517	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.44	0.62	0.98
PGSC0003DMG200009620	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMG200009620	K00517	ko00626	Naphthalene and anthracene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMG200009620	K00517	ko00903	Limonene and pinene degradation	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMG200009620	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMG200009620	K00517	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.54	0.69	0.97
PGSC0003DMG200009621	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMG200009621	K00517	ko00626	Naphthalene and anthracene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMG200009621	K00517	ko00903	Limonene and pinene degradation	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMG200009621	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMG200009621	K00517	ko01110	Biosynthesis of secondary metabolites	1614	3.5e-83	0.44	0.64	0.92
PGSC0003DMG200009622	K09755	ko00940	Phenylpropanoid biosynthesis	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMG200009622	K09755	ko01100	Metabolic pathways	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMG200009622	K09755	ko01110	Biosynthesis of secondary metabolites	936	8.6e-46	0.44	0.65	1.00
PGSC0003DMG200009622	K09755	ko00940	Phenylpropanoid biosynthesis	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMG200009622	K09755	ko01100	Metabolic pathways	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMG200009622	K09755	ko01110	Biosynthesis of secondary metabolites	1425	9.2e-73	0.39	0.58	0.99
PGSC0003DMG200009623	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMG200009623	K00517	ko00626	Naphthalene and anthracene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMG200009623	K00517	ko00903	Limonene and pinene degradation	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMG200009623	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMG200009623	K00517	ko01110	Biosynthesis of secondary metabolites	1329	1.8e-67	0.40	0.59	0.99
PGSC0003DMG200005732	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMG200005732	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.76
PGSC0003DMG200005732	K01781	ko00362	Benzoate degradation via hydroxylation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMG200005732	K01781	ko00622	Toluene and xylene degradation	698	1.2e-32	0.34	0.54	0.79
PGSC0003DMG200005734	K04424	ko04010	MAPK signaling pathway	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMG200005734	K04424	ko04530	Tight junction	2766	1.0e-146	0.42	0.57	0.98
PGSC0003DMG200005734	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMG200005734	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMG200005734	K04424	ko04010	MAPK signaling pathway	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMG200005734	K04424	ko04530	Tight junction	2131	1.1e-111	0.39	0.54	0.99
PGSC0003DMG200005737	K10746	ko03430	Mismatch repair	2459	8.6e-130	0.59	0.74	0.87
PGSC0003DMG200005737	K10746	ko03430	Mismatch repair	1046	7.4e-52	0.62	0.79	0.86
PGSC0003DMG200005738	K10529	ko00592	alpha-Linolenic acid metabolism	2785	9.0e-148	0.62	0.80	0.99
PGSC0003DMG200005738	K10529	ko00592	alpha-Linolenic acid metabolism	3217	1.3e-171	0.60	0.77	0.99
PGSC0003DMG200005738	K10529	ko00592	alpha-Linolenic acid metabolism	2288	2.3e-120	0.57	0.74	0.96
PGSC0003DMG200005738	K10529	ko00592	alpha-Linolenic acid metabolism	1982	1.8e-103	0.58	0.74	0.96
PGSC0003DMG200023211	K01771	ko00562	Inositol phosphate metabolism	271	4.1e-09	0.35	0.57	0.35
PGSC0003DMG200023229	K01590	ko00340	Histidine metabolism	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMG200023229	K01590	ko01100	Metabolic pathways	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMG200023229	K01590	ko01110	Biosynthesis of secondary metabolites	1498	8.7e-77	0.65	0.81	0.97
PGSC0003DMG200023230	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMG200023230	K01649	ko00620	Pyruvate metabolism	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMG200023230	K01649	ko01100	Metabolic pathways	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMG200023230	K01649	ko01110	Biosynthesis of secondary metabolites	2033	2.7e-106	0.68	0.83	0.91
PGSC0003DMG200027059	K12871	ko03040	Spliceosome	840	1.7e-40	0.64	0.81	0.99
PGSC0003DMG200027060	K00001	ko00010	Glycolysis / Gluconeogenesis	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00071	Fatty acid metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00350	Tyrosine metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00641	3-Chloroacrylic acid degradation	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00830	Retinol metabolism	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00982	Drug metabolism - cytochrome P450	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko01100	Metabolic pathways	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko01110	Biosynthesis of secondary metabolites	1380	2.8e-70	0.53	0.72	0.94
PGSC0003DMG200027060	K00001	ko00010	Glycolysis / Gluconeogenesis	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00071	Fatty acid metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00350	Tyrosine metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00641	3-Chloroacrylic acid degradation	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00830	Retinol metabolism	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko00982	Drug metabolism - cytochrome P450	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko01100	Metabolic pathways	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00001	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.54	0.74	0.94
PGSC0003DMG200027060	K00121	ko00010	Glycolysis / Gluconeogenesis	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00071	Fatty acid metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00350	Tyrosine metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00624	1- and 2-Methylnaphthalene degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00641	3-Chloroacrylic acid degradation	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00680	Methane metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00830	Retinol metabolism	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko00982	Drug metabolism - cytochrome P450	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko01100	Metabolic pathways	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027060	K00121	ko01110	Biosynthesis of secondary metabolites	668	5.2e-31	0.53	0.70	0.92
PGSC0003DMG200027063	K07342	ko03060	Protein export	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMG200027063	K07342	ko04145	Phagosome	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMG200027063	K07342	ko05110	Vibrio cholerae infection	552	1.3e-24	0.96	0.97	0.97
PGSC0003DMG200035738	K00942	ko00230	Purine metabolism	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMG200035738	K00942	ko01100	Metabolic pathways	1543	2.9e-79	0.66	0.78	0.86
PGSC0003DMG200018832	K08496	ko04130	SNARE interactions in vesicular transport	1230	5.3e-62	0.63	0.81	0.96
PGSC0003DMG200018839	K02866	ko03010	Ribosome	727	2.9e-34	0.44	0.60	0.80
PGSC0003DMG200018842	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMG200016614	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMG200016614	K00517	ko00626	Naphthalene and anthracene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMG200016614	K00517	ko00903	Limonene and pinene degradation	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMG200016614	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMG200016614	K00517	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.45	0.66	0.98
PGSC0003DMG200016615	K11818	ko00380	Tryptophan metabolism	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMG200016615	K11818	ko00966	Glucosinolate biosynthesis	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMG200016615	K11818	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.65	0.87
PGSC0003DMG200016616	K11818	ko00380	Tryptophan metabolism	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMG200016616	K11818	ko00966	Glucosinolate biosynthesis	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMG200016616	K11818	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.49	0.70	0.97
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.41	0.58	0.98
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.56	0.78	0.96
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.57	0.75	0.98
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.45	0.63	0.97
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.47	0.65	0.91
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.52	0.68	0.99
PGSC0003DMG200016617	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMG200016617	K00517	ko00626	Naphthalene and anthracene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMG200016617	K00517	ko00903	Limonene and pinene degradation	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMG200016617	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMG200016617	K00517	ko01110	Biosynthesis of secondary metabolites	1797	2.8e-93	0.50	0.68	0.94
PGSC0003DMG200016618	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMG200016618	K00517	ko00626	Naphthalene and anthracene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMG200016618	K00517	ko00903	Limonene and pinene degradation	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMG200016618	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMG200016618	K00517	ko01110	Biosynthesis of secondary metabolites	1524	3.2e-78	0.43	0.63	0.99
PGSC0003DMG200016619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMG200016619	K00517	ko00626	Naphthalene and anthracene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMG200016619	K00517	ko00903	Limonene and pinene degradation	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMG200016619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMG200016619	K00517	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.36	0.52	0.99
PGSC0003DMG200016619	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMG200016619	K00517	ko00626	Naphthalene and anthracene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMG200016619	K00517	ko00903	Limonene and pinene degradation	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMG200016619	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMG200016619	K00517	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.44	0.64	1.00
PGSC0003DMG200016620	K00100	ko00051	Fructose and mannose metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko00363	Bisphenol A degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko00591	Linoleic acid metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko00625	Tetrachloroethene degradation	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko00650	Butanoate metabolism	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko01100	Metabolic pathways	754	9.4e-36	0.38	0.53	0.55
PGSC0003DMG200016620	K00100	ko00051	Fructose and mannose metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016620	K00100	ko00363	Bisphenol A degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016620	K00100	ko00591	Linoleic acid metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016620	K00100	ko00625	Tetrachloroethene degradation	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016620	K00100	ko00650	Butanoate metabolism	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016620	K00100	ko01100	Metabolic pathways	1091	2.4e-54	0.46	0.65	0.90
PGSC0003DMG200016621	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMG200016621	K00517	ko00626	Naphthalene and anthracene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMG200016621	K00517	ko00903	Limonene and pinene degradation	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMG200016621	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMG200016621	K00517	ko01110	Biosynthesis of secondary metabolites	1446	6.4e-74	0.45	0.64	1.00
PGSC0003DMG200016622	K00100	ko00051	Fructose and mannose metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko00363	Bisphenol A degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko00591	Linoleic acid metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko00625	Tetrachloroethene degradation	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko00650	Butanoate metabolism	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko01100	Metabolic pathways	294	2.2e-10	0.46	0.69	0.91
PGSC0003DMG200016622	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00051	Fructose and mannose metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00363	Bisphenol A degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00591	Linoleic acid metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00625	Tetrachloroethene degradation	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00650	Butanoate metabolism	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko01100	Metabolic pathways	1087	4.1e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00051	Fructose and mannose metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00363	Bisphenol A degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00591	Linoleic acid metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00625	Tetrachloroethene degradation	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00650	Butanoate metabolism	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko01100	Metabolic pathways	369	1.6e-14	0.44	0.66	0.93
PGSC0003DMG200016622	K00100	ko00051	Fructose and mannose metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00363	Bisphenol A degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00591	Linoleic acid metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00625	Tetrachloroethene degradation	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko00650	Butanoate metabolism	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016622	K00100	ko01100	Metabolic pathways	1095	1.5e-54	0.44	0.64	0.95
PGSC0003DMG200016623	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMG200016623	K00517	ko00626	Naphthalene and anthracene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMG200016623	K00517	ko00903	Limonene and pinene degradation	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMG200016623	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMG200016623	K00517	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.47	0.65	0.98
PGSC0003DMG200016624	K05275	ko00750	Vitamin B6 metabolism	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMG200016624	K05275	ko01100	Metabolic pathways	248	7.6e-08	0.52	0.67	0.67
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	238	2.7e-07	0.52	0.63	0.81
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	303	7.1e-11	0.47	0.68	0.92
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	1131	1.5e-56	0.47	0.65	0.92
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	1093	1.9e-54	0.47	0.64	0.98
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	1113	1.5e-55	0.47	0.65	0.90
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	1121	5.4e-56	0.47	0.66	0.92
PGSC0003DMG200005035	K12486	ko04144	Endocytosis	469	4.9e-20	0.30	0.45	0.98
PGSC0003DMG200005035	K12486	ko04144	Endocytosis	1334	9.6e-68	0.42	0.56	1.00
PGSC0003DMG200005035	K12486	ko04144	Endocytosis	1324	3.4e-67	0.42	0.56	1.00
PGSC0003DMG200005035	K12486	ko04144	Endocytosis	1324	3.4e-67	0.43	0.57	1.00
PGSC0003DMG200005035	K12486	ko04144	Endocytosis	229	1.6e-06	0.36	0.50	0.93
PGSC0003DMG200005039	K08139	ko04113	Meiosis - yeast	910	2.3e-44	0.36	0.56	0.85
PGSC0003DMG200005041	K06627	ko04110	Cell cycle	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMG200005041	K06627	ko04914	Progesterone-mediated oocyte maturation	250	5.9e-08	0.34	0.53	0.54
PGSC0003DMG200005049	K02536	ko00540	Lipopolysaccharide biosynthesis	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMG200005049	K02536	ko01100	Metabolic pathways	743	3.8e-35	0.49	0.64	0.26
PGSC0003DMG200005049	K02536	ko00540	Lipopolysaccharide biosynthesis	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMG200005049	K02536	ko01100	Metabolic pathways	577	5.5e-26	0.56	0.68	0.96
PGSC0003DMG200005049	K02536	ko00540	Lipopolysaccharide biosynthesis	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMG200005049	K02536	ko01100	Metabolic pathways	809	8.7e-39	0.48	0.63	0.75
PGSC0003DMG200005050	K09755	ko00940	Phenylpropanoid biosynthesis	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMG200005050	K09755	ko01100	Metabolic pathways	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMG200005050	K09755	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.38	0.62	0.73
PGSC0003DMG200005052	K02084	ko04115	p53 signaling pathway	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko04210	Apoptosis	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko05010	Alzheimer's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko05012	Parkinson's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko05016	Huntington's disease	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200005052	K02084	ko05222	Small cell lung cancer	281	8.5e-06	0.27	0.46	0.43
PGSC0003DMG200008974	K01193	ko00052	Galactose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMG200008974	K01193	ko00500	Starch and sucrose metabolism	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMG200008974	K01193	ko01100	Metabolic pathways	241	5.4e-07	0.60	0.70	0.62
PGSC0003DMG200008977	K00680	ko00350	Tyrosine metabolism	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMG200008977	K00680	ko00624	1- and 2-Methylnaphthalene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMG200008977	K00680	ko00632	Benzoate degradation via CoA ligation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMG200008977	K00680	ko00642	Ethylbenzene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMG200008977	K00680	ko00903	Limonene and pinene degradation	379	4.5e-15	0.60	0.71	0.88
PGSC0003DMG200008988	K01953	ko00250	Alanine, aspartate and glutamate metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMG200008988	K01953	ko00910	Nitrogen metabolism	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMG200008988	K01953	ko01100	Metabolic pathways	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMG200008988	K01953	ko01110	Biosynthesis of secondary metabolites	258	5.3e-08	0.36	0.50	0.54
PGSC0003DMG200008989	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMG200008989	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.76
PGSC0003DMG200008989	K08066	ko04612	Antigen processing and presentation	684	6.8e-32	0.52	0.67	0.68
PGSC0003DMG200015019	K04428	ko04010	MAPK signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMG200015019	K04428	ko04912	GnRH signaling pathway	675	1.6e-30	0.38	0.55	0.67
PGSC0003DMG200015020	K11230	ko04011	MAPK signaling pathway - yeast	698	5.8e-32	0.39	0.58	0.76
PGSC0003DMG200015021	K04428	ko04010	MAPK signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMG200015021	K04428	ko04912	GnRH signaling pathway	693	2.2e-32	0.40	0.57	0.76
PGSC0003DMG200015022	K12929	ko00904	Diterpenoid biosynthesis	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMG200015022	K12929	ko01110	Biosynthesis of secondary metabolites	283	2.4e-09	0.39	0.63	0.87
PGSC0003DMG200015022	K12929	ko00904	Diterpenoid biosynthesis	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMG200015022	K12929	ko01110	Biosynthesis of secondary metabolites	224	5.4e-06	0.39	0.59	0.80
PGSC0003DMG200015022	K12929	ko00904	Diterpenoid biosynthesis	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMG200015022	K12929	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.64	1.00
PGSC0003DMG200015035	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMG200015035	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMG200015035	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMG200015035	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMG200015035	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.70	0.84	0.94
PGSC0003DMG200041203	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.32	0.48	0.96
PGSC0003DMG200041210	K13030	ko00460	Cyanoamino acid metabolism	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMG200041210	K13030	ko01110	Biosynthesis of secondary metabolites	288	6.0e-10	0.43	0.66	0.94
PGSC0003DMG200024509	K01895	ko00010	Glycolysis / Gluconeogenesis	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko00620	Pyruvate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko00640	Propanoate metabolism	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko01100	Metabolic pathways	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.40	0.61	0.90
PGSC0003DMG200024509	K01895	ko00010	Glycolysis / Gluconeogenesis	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko00620	Pyruvate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko00640	Propanoate metabolism	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko01100	Metabolic pathways	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko01110	Biosynthesis of secondary metabolites	2926	1.5e-155	0.53	0.68	0.97
PGSC0003DMG200024509	K01895	ko00010	Glycolysis / Gluconeogenesis	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024509	K01895	ko00620	Pyruvate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024509	K01895	ko00640	Propanoate metabolism	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024509	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024509	K01895	ko01100	Metabolic pathways	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024509	K01895	ko01110	Biosynthesis of secondary metabolites	1891	1.8e-98	0.57	0.71	0.98
PGSC0003DMG200024510	K01689	ko00010	Glycolysis / Gluconeogenesis	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMG200024510	K01689	ko01100	Metabolic pathways	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMG200024510	K01689	ko01110	Biosynthesis of secondary metabolites	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMG200024510	K01689	ko03018	RNA degradation	3487	1.7e-186	0.87	0.92	1.00
PGSC0003DMG200024510	K01689	ko00010	Glycolysis / Gluconeogenesis	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMG200024510	K01689	ko01100	Metabolic pathways	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMG200024510	K01689	ko01110	Biosynthesis of secondary metabolites	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMG200024510	K01689	ko03018	RNA degradation	834	3.6e-40	0.95	0.97	0.95
PGSC0003DMG200021331	K08486	ko04130	SNARE interactions in vesicular transport	1108	2.8e-55	0.73	0.84	0.92
PGSC0003DMG200021331	K08486	ko04130	SNARE interactions in vesicular transport	1887	3.0e-98	0.75	0.88	1.00
PGSC0003DMG200021339	K12811	ko03040	Spliceosome	318	5.6e-09	0.25	0.43	0.92
PGSC0003DMG200021343	K05681	ko02010	ABC transporters	1249	4.7e-63	0.36	0.54	0.81
PGSC0003DMG200028116	K02327	ko00230	Purine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko00240	Pyrimidine metabolism	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko01100	Metabolic pathways	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko03030	DNA replication	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko03410	Base excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko03420	Nucleotide excision repair	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko03430	Mismatch repair	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko03440	Homologous recombination	7941	0.	0.85	0.92	1.00
PGSC0003DMG200028116	K02327	ko00230	Purine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko00240	Pyrimidine metabolism	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko01100	Metabolic pathways	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko03030	DNA replication	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko03410	Base excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko03420	Nucleotide excision repair	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko03430	Mismatch repair	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028116	K02327	ko03440	Homologous recombination	8040	0.	0.86	0.93	1.00
PGSC0003DMG200028118	K01625	ko00030	Pentose phosphate pathway	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMG200028118	K01625	ko00040	Pentose and glucuronate interconversions	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMG200028118	K01625	ko00330	Arginine and proline metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMG200028118	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMG200028118	K01625	ko01100	Metabolic pathways	422	1.9e-17	0.38	0.67	0.87
PGSC0003DMG200028118	K01625	ko00030	Pentose phosphate pathway	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMG200028118	K01625	ko00040	Pentose and glucuronate interconversions	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMG200028118	K01625	ko00330	Arginine and proline metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMG200028118	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMG200028118	K01625	ko01100	Metabolic pathways	263	1.1e-08	0.49	0.74	0.84
PGSC0003DMG200028118	K01625	ko00030	Pentose phosphate pathway	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMG200028118	K01625	ko00040	Pentose and glucuronate interconversions	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMG200028118	K01625	ko00330	Arginine and proline metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMG200028118	K01625	ko00630	Glyoxylate and dicarboxylate metabolism	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMG200028118	K01625	ko01100	Metabolic pathways	487	5.0e-21	0.38	0.62	0.68
PGSC0003DMG200028121	K09054	ko05010	Alzheimer's disease	253	1.5e-06	0.28	0.46	0.66
PGSC0003DMG200028122	K11098	ko03040	Spliceosome	644	1.1e-29	0.85	0.95	0.99
PGSC0003DMG200028124	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMG200028124	K01563	ko00626	Naphthalene and anthracene degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMG200028124	K01563	ko00631	1,2-Dichloroethane degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMG200028124	K01563	ko00641	3-Chloroacrylic acid degradation	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMG200028124	K01563	ko01100	Metabolic pathways	268	6.0e-09	0.28	0.43	0.61
PGSC0003DMG200028127	K00549	ko00270	Cysteine and methionine metabolism	5729	0.	0.88	0.94	1.00
PGSC0003DMG200028127	K00549	ko01100	Metabolic pathways	5729	0.	0.88	0.94	1.00
PGSC0003DMG200028127	K00549	ko01110	Biosynthesis of secondary metabolites	5729	0.	0.88	0.94	1.00
PGSC0003DMG200028128	K08486	ko04130	SNARE interactions in vesicular transport	2080	6.9e-109	0.82	0.90	1.00
PGSC0003DMG200007692	K13065	ko00940	Phenylpropanoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMG200007692	K13065	ko00941	Flavonoid biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMG200007692	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMG200007692	K13065	ko01110	Biosynthesis of secondary metabolites	339	1.0e-12	0.25	0.44	0.91
PGSC0003DMG200007704	K10589	ko04120	Ubiquitin mediated proteolysis	674	3.4e-34	0.35	0.52	0.86
PGSC0003DMG200007704	K10589	ko04120	Ubiquitin mediated proteolysis	589	1.8e-29	0.36	0.55	0.79
PGSC0003DMG200007707	K02872	ko03010	Ribosome	1619	1.8e-83	0.92	0.97	1.00
PGSC0003DMG200007714	K00799	ko00480	Glutathione metabolism	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMG200007714	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMG200007714	K00799	ko00982	Drug metabolism - cytochrome P450	789	1.1e-37	0.46	0.67	0.96
PGSC0003DMG200004613	K13289	ko04142	Lysosome	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMG200004613	K13289	ko04614	Renin-angiotensin system	232	7.0e-07	0.60	0.73	0.94
PGSC0003DMG200004615	K00970	ko03018	RNA degradation	1185	1.6e-59	0.37	0.56	0.86
PGSC0003DMG200004615	K00970	ko03018	RNA degradation	257	5.8e-08	0.29	0.49	0.93
PGSC0003DMG200004619	K01051	ko00040	Pentose and glucuronate interconversions	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMG200004619	K01051	ko00500	Starch and sucrose metabolism	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMG200004619	K01051	ko01100	Metabolic pathways	901	7.4e-44	0.43	0.62	0.85
PGSC0003DMG200004619	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMG200004619	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMG200004619	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.41	0.60	0.93
PGSC0003DMG200004627	K01051	ko00040	Pentose and glucuronate interconversions	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMG200004627	K01051	ko00500	Starch and sucrose metabolism	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMG200004627	K01051	ko01100	Metabolic pathways	1914	9.9e-100	0.45	0.64	0.98
PGSC0003DMG200011325	K11818	ko00380	Tryptophan metabolism	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMG200011325	K11818	ko00966	Glucosinolate biosynthesis	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMG200011325	K11818	ko01110	Biosynthesis of secondary metabolites	1845	6.3e-96	0.49	0.68	0.98
PGSC0003DMG200011327	K01557	ko00350	Tyrosine metabolism	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMG200011327	K01557	ko01100	Metabolic pathways	820	2.2e-39	0.49	0.68	0.80
PGSC0003DMG200011330	K09699	ko00280	Valine, leucine and isoleucine degradation	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMG200011330	K09699	ko01100	Metabolic pathways	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMG200011330	K09699	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.75	0.93	0.98
PGSC0003DMG200011330	K09699	ko00280	Valine, leucine and isoleucine degradation	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMG200011330	K09699	ko01100	Metabolic pathways	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMG200011330	K09699	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.64	0.82	0.83
PGSC0003DMG200011330	K09699	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMG200011330	K09699	ko01100	Metabolic pathways	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMG200011330	K09699	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.59	0.77	1.00
PGSC0003DMG200011331	K10418	ko04962	Vasopressin-regulated water reabsorption	706	4.2e-33	0.74	0.82	0.98
PGSC0003DMG200011335	K01710	ko00521	Streptomycin biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMG200011335	K01710	ko00523	Polyketide sugar unit biosynthesis	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMG200011335	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMG200011335	K01710	ko01100	Metabolic pathways	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMG200011335	K01710	ko01110	Biosynthesis of secondary metabolites	1726	2.3e-89	0.89	0.96	0.96
PGSC0003DMG200011335	K01710	ko00521	Streptomycin biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMG200011335	K01710	ko00523	Polyketide sugar unit biosynthesis	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMG200011335	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMG200011335	K01710	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMG200011335	K01710	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.56	0.71	0.90
PGSC0003DMG200011337	K10599	ko03040	Spliceosome	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMG200011337	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.6e-06	0.29	0.46	0.24
PGSC0003DMG200039730	K11644	ko05016	Huntington's disease	687	1.9e-31	0.59	0.71	0.55
PGSC0003DMG200039752	K07195	ko04910	Insulin signaling pathway	3008	4.5e-160	0.59	0.72	0.99
PGSC0003DMG200039755	K11816	ko00380	Tryptophan metabolism	803	1.9e-38	0.46	0.65	0.95
PGSC0003DMG200001321	K03869	ko04120	Ubiquitin mediated proteolysis	5513	3.1e-298	0.88	0.95	1.00
PGSC0003DMG200001321	K03869	ko04120	Ubiquitin mediated proteolysis	4903	1.4e-264	0.88	0.95	1.00
PGSC0003DMG200001326	K06675	ko04111	Cell cycle - yeast	5148	4.2e-278	0.77	0.89	0.98
PGSC0003DMG200001326	K06675	ko04111	Cell cycle - yeast	7990	0.	0.78	0.89	0.99
PGSC0003DMG200001328	K00703	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMG200001328	K00703	ko01100	Metabolic pathways	809	8.7e-39	0.43	0.54	0.92
PGSC0003DMG200001328	K00703	ko00500	Starch and sucrose metabolism	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMG200001328	K00703	ko01100	Metabolic pathways	4372	2.6e-235	0.69	0.78	0.99
PGSC0003DMG200001333	K02183	ko04020	Calcium signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04070	Phosphatidylinositol signaling system	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04114	Oocyte meiosis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04270	Vascular smooth muscle contraction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04626	Plant-pathogen interaction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04720	Long-term potentiation	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04722	Neurotrophin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04740	Olfactory transduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04744	Phototransduction	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04745	Phototransduction - fly	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04910	Insulin signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04912	GnRH signaling pathway	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04916	Melanogenesis	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04970	Salivary secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko04971	Gastric acid secretion	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko05010	Alzheimer's disease	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001333	K02183	ko05214	Glioma	295	2.0e-10	0.36	0.57	0.72
PGSC0003DMG200001340	K06653	ko04111	Cell cycle - yeast	296	1.1e-09	0.31	0.49	0.77
PGSC0003DMG200038897	K00368	ko00910	Nitrogen metabolism	712	2.0e-33	0.37	0.52	0.89
PGSC0003DMG200038901	K10760	ko00908	Zeatin biosynthesis	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMG200038901	K10760	ko01100	Metabolic pathways	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMG200038901	K10760	ko01110	Biosynthesis of secondary metabolites	579	4.2e-26	0.40	0.53	0.99
PGSC0003DMG200044152	K12356	ko00940	Phenylpropanoid biosynthesis	764	2.6e-36	0.35	0.50	0.92
PGSC0003DMG200044156	K00799	ko00480	Glutathione metabolism	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMG200044156	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMG200044156	K00799	ko00982	Drug metabolism - cytochrome P450	897	1.2e-43	0.48	0.70	1.00
PGSC0003DMG200003766	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003766	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003768	K04618	ko00052	Galactose metabolism	482	9.5e-21	0.29	0.45	0.87
PGSC0003DMG200003769	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMG200003772	K12383	ko04142	Lysosome	219	3.0e-06	0.35	0.45	0.43
PGSC0003DMG200003774	K01179	ko00500	Starch and sucrose metabolism	372	1.1e-14	0.50	0.72	0.86
PGSC0003DMG200003774	K01179	ko00500	Starch and sucrose metabolism	1583	1.8e-81	0.43	0.63	0.91
PGSC0003DMG200003774	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.42	0.61	0.92
PGSC0003DMG200003778	K09389	ko04110	Cell cycle	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05200	Pathways in cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05212	Pancreatic cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05214	Glioma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05215	Prostate cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05218	Melanoma	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05219	Bladder cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05220	Chronic myeloid leukemia	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05222	Small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K09389	ko05223	Non-small cell lung cancer	405	1.7e-16	0.31	0.44	0.70
PGSC0003DMG200003778	K06620	ko04110	Cell cycle	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05200	Pathways in cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05212	Pancreatic cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05214	Glioma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05215	Prostate cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05218	Melanoma	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05219	Bladder cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05220	Chronic myeloid leukemia	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05222	Small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko05223	Non-small cell lung cancer	523	5.2e-23	0.39	0.54	0.73
PGSC0003DMG200003778	K06620	ko04110	Cell cycle	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05200	Pathways in cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05212	Pancreatic cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05214	Glioma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05215	Prostate cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05218	Melanoma	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05219	Bladder cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05220	Chronic myeloid leukemia	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05222	Small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200003778	K06620	ko05223	Non-small cell lung cancer	697	1.3e-32	0.37	0.52	0.83
PGSC0003DMG200006806	K05863	ko04020	Calcium signaling pathway	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMG200006806	K05863	ko05012	Parkinson's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMG200006806	K05863	ko05016	Huntington's disease	2558	3.0e-135	0.78	0.88	0.98
PGSC0003DMG200030936	K02878	ko03010	Ribosome	525	4.0e-23	0.52	0.65	0.95
PGSC0003DMG200030941	K00558	ko00270	Cysteine and methionine metabolism	9011	0.	0.73	0.84	1.00
PGSC0003DMG200030941	K00558	ko01100	Metabolic pathways	9011	0.	0.73	0.84	1.00
PGSC0003DMG200030943	K03935	ko00190	Oxidative phosphorylation	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMG200030943	K03935	ko01100	Metabolic pathways	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMG200030943	K03935	ko05010	Alzheimer's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMG200030943	K03935	ko05012	Parkinson's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMG200030943	K03935	ko05016	Huntington's disease	1695	1.2e-87	0.89	0.92	0.86
PGSC0003DMG200030946	K04371	ko04010	MAPK signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04012	ErbB signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04013	MAPK signaling pathway - fly	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04062	Chemokine signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04114	Oocyte meiosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04150	mTOR signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04270	Vascular smooth muscle contraction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04320	Dorso-ventral axis formation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04350	TGF-beta signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04360	Axon guidance	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04370	VEGF signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04510	Focal adhesion	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04520	Adherens junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04540	Gap junction	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04621	NOD-like receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04650	Natural killer cell mediated cytotoxicity	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04660	T cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04662	B cell receptor signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04664	Fc epsilon RI signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04666	Fc gamma R-mediated phagocytosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04720	Long-term potentiation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04730	Long-term depression	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04810	Regulation of actin cytoskeleton	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04910	Insulin signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04912	GnRH signaling pathway	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04916	Melanogenesis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04930	Type II diabetes mellitus	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko04960	Aldosterone-regulated sodium reabsorption	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05010	Alzheimer's disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05020	Prion diseases	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05131	Shigellosis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05140	Leishmaniasis	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05142	Chagas disease	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05200	Pathways in cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05210	Colorectal cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05211	Renal cell carcinoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05212	Pancreatic cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05213	Endometrial cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05214	Glioma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05215	Prostate cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05216	Thyroid cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05218	Melanoma	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05219	Bladder cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05220	Chronic myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05221	Acute myeloid leukemia	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030946	K04371	ko05223	Non-small cell lung cancer	753	1.1e-35	0.62	0.74	0.98
PGSC0003DMG200030950	K01092	ko00521	Streptomycin biosynthesis	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMG200030950	K01092	ko00562	Inositol phosphate metabolism	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMG200030950	K01092	ko01100	Metabolic pathways	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMG200030950	K01092	ko01110	Biosynthesis of secondary metabolites	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMG200030950	K01092	ko04070	Phosphatidylinositol signaling system	979	3.7e-48	0.48	0.66	0.75
PGSC0003DMG200030951	K10685	ko04120	Ubiquitin mediated proteolysis	4207	3.3e-226	0.78	0.86	1.00
PGSC0003DMG200030952	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMG200030952	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.61
PGSC0003DMG200030952	K10875	ko03440	Homologous recombination	643	1.2e-29	0.28	0.46	0.68
PGSC0003DMG200030953	K11294	ko05130	Pathogenic Escherichia coli infection	254	4.3e-08	0.33	0.56	0.62
PGSC0003DMG200030954	K01190	ko00052	Galactose metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMG200030954	K01190	ko00511	Other glycan degradation	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMG200030954	K01190	ko00600	Sphingolipid metabolism	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMG200030954	K01190	ko01100	Metabolic pathways	2995	2.3e-159	0.60	0.76	0.99
PGSC0003DMG200030954	K01190	ko00052	Galactose metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMG200030954	K01190	ko00511	Other glycan degradation	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMG200030954	K01190	ko00600	Sphingolipid metabolism	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMG200030954	K01190	ko01100	Metabolic pathways	1239	1.7e-62	0.68	0.83	0.95
PGSC0003DMG200021908	K01076	ko00632	Benzoate degradation via CoA ligation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMG200021908	K01076	ko00903	Limonene and pinene degradation	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMG200021908	K01076	ko01040	Biosynthesis of unsaturated fatty acids	633	4.4e-29	0.35	0.53	0.76
PGSC0003DMG200021908	K01076	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMG200021908	K01076	ko00903	Limonene and pinene degradation	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMG200021908	K01076	ko01040	Biosynthesis of unsaturated fatty acids	543	4.1e-24	0.35	0.54	0.79
PGSC0003DMG200021912	K05740	ko04510	Focal adhesion	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMG200021912	K05740	ko04810	Regulation of actin cytoskeleton	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMG200021912	K05740	ko05131	Shigellosis	541	3.2e-23	0.29	0.49	0.84
PGSC0003DMG200024926	K00765	ko00340	Histidine metabolism	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMG200024926	K00765	ko01100	Metabolic pathways	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMG200024926	K00765	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.82	0.92	0.98
PGSC0003DMG200024929	K02951	ko03010	Ribosome	1014	4.3e-50	0.84	0.92	0.99
PGSC0003DMG200018196	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMG200018196	K00517	ko00626	Naphthalene and anthracene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMG200018196	K00517	ko00903	Limonene and pinene degradation	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMG200018196	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMG200018196	K00517	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.48	0.67	0.99
PGSC0003DMG200018197	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMG200018197	K00517	ko00626	Naphthalene and anthracene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMG200018197	K00517	ko00903	Limonene and pinene degradation	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMG200018197	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMG200018197	K00517	ko01110	Biosynthesis of secondary metabolites	470	4.3e-20	0.59	0.82	0.83
PGSC0003DMG200018198	K07466	ko03030	DNA replication	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMG200018198	K07466	ko03420	Nucleotide excision repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMG200018198	K07466	ko03430	Mismatch repair	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMG200018198	K07466	ko03440	Homologous recombination	350	1.8e-13	0.31	0.49	0.93
PGSC0003DMG200018199	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMG200018199	K00517	ko00626	Naphthalene and anthracene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMG200018199	K00517	ko00903	Limonene and pinene degradation	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMG200018199	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMG200018199	K00517	ko01110	Biosynthesis of secondary metabolites	1667	4.1e-86	0.48	0.67	0.96
PGSC0003DMG200018218	K00991	ko00900	Terpenoid backbone biosynthesis	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMG200018218	K00991	ko01100	Metabolic pathways	1528	1.9e-78	0.89	0.95	0.98
PGSC0003DMG200018218	K00991	ko00900	Terpenoid backbone biosynthesis	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMG200018218	K00991	ko01100	Metabolic pathways	1004	1.5e-49	0.65	0.77	0.99
PGSC0003DMG200018218	K00991	ko00900	Terpenoid backbone biosynthesis	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMG200018218	K00991	ko01100	Metabolic pathways	1807	7.9e-94	0.74	0.83	0.99
PGSC0003DMG200018218	K00991	ko00900	Terpenoid backbone biosynthesis	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMG200018218	K00991	ko01100	Metabolic pathways	1596	3.4e-82	0.68	0.77	0.99
PGSC0003DMG200018219	K09753	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMG200018219	K09753	ko01100	Metabolic pathways	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMG200018219	K09753	ko01110	Biosynthesis of secondary metabolites	544	3.6e-24	0.52	0.66	0.46
PGSC0003DMG200018219	K09753	ko00940	Phenylpropanoid biosynthesis	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMG200018219	K09753	ko01100	Metabolic pathways	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMG200018219	K09753	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.41	0.59	0.77
PGSC0003DMG200018219	K09753	ko00940	Phenylpropanoid biosynthesis	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMG200018219	K09753	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMG200018219	K09753	ko01110	Biosynthesis of secondary metabolites	978	4.2e-48	0.46	0.62	0.97
PGSC0003DMG200042285	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200042285	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200042285	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200042294	K01762	ko00270	Cysteine and methionine metabolism	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMG200042294	K01762	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.53	0.70	0.98
PGSC0003DMG200042297	K05278	ko00941	Flavonoid biosynthesis	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMG200042297	K05278	ko01100	Metabolic pathways	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMG200042297	K05278	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.36	0.53	0.80
PGSC0003DMG200046627	K10760	ko00908	Zeatin biosynthesis	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMG200046627	K10760	ko01100	Metabolic pathways	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMG200046627	K10760	ko01110	Biosynthesis of secondary metabolites	513	1.8e-22	0.56	0.74	0.99
PGSC0003DMG200046641	K01051	ko00040	Pentose and glucuronate interconversions	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMG200046641	K01051	ko00500	Starch and sucrose metabolism	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMG200046641	K01051	ko01100	Metabolic pathways	895	1.6e-43	0.50	0.65	0.99
PGSC0003DMG200009689	K04733	ko04210	Apoptosis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMG200009689	K04733	ko04620	Toll-like receptor signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMG200009689	K04733	ko04722	Neurotrophin signaling pathway	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMG200009689	K04733	ko05140	Leishmaniasis	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMG200009689	K04733	ko05142	Chagas disease	2204	1.0e-115	0.42	0.58	0.98
PGSC0003DMG200009698	K00284	ko00910	Nitrogen metabolism	11627	0.	0.85	0.91	1.00
PGSC0003DMG200009698	K00284	ko00910	Nitrogen metabolism	11939	0.	0.86	0.93	1.00
PGSC0003DMG200009699	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMG200009699	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.42
PGSC0003DMG200009699	K00942	ko00230	Purine metabolism	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMG200009699	K00942	ko01100	Metabolic pathways	1023	1.4e-50	0.71	0.81	0.44
PGSC0003DMG200005998	K12126	ko04712	Circadian rhythm - plant	319	1.1e-11	0.47	0.71	0.43
PGSC0003DMG200006003	K06685	ko04111	Cell cycle - yeast	411	2.7e-13	0.28	0.44	0.43
PGSC0003DMG200006003	K06685	ko04111	Cell cycle - yeast	425	6.4e-14	0.27	0.43	0.44
PGSC0003DMG200008518	K01426	ko00330	Arginine and proline metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008518	K01426	ko00360	Phenylalanine metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008518	K01426	ko00380	Tryptophan metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008518	K01426	ko00460	Cyanoamino acid metabolism	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008518	K01426	ko00632	Benzoate degradation via CoA ligation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008518	K01426	ko00643	Styrene degradation	500	9.6e-22	0.64	0.81	0.82
PGSC0003DMG200008523	K00558	ko00270	Cysteine and methionine metabolism	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMG200008523	K00558	ko01100	Metabolic pathways	407	1.4e-13	0.51	0.75	0.16
PGSC0003DMG200022764	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022764	K01580	ko00410	beta-Alanine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022764	K01580	ko00430	Taurine and hypotaurine metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022764	K01580	ko00650	Butanoate metabolism	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022764	K01580	ko01100	Metabolic pathways	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022764	K01580	ko04940	Type I diabetes mellitus	3591	3.2e-192	0.85	0.91	1.00
PGSC0003DMG200022770	K09659	ko00510	N-Glycan biosynthesis	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMG200022770	K09659	ko01100	Metabolic pathways	493	2.3e-21	0.53	0.64	0.98
PGSC0003DMG200022770	K09659	ko00510	N-Glycan biosynthesis	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMG200022770	K09659	ko01100	Metabolic pathways	570	1.3e-25	0.74	0.89	0.97
PGSC0003DMG200034788	K03094	ko04110	Cell cycle	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04111	Cell cycle - yeast	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04114	Oocyte meiosis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04120	Ubiquitin mediated proteolysis	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04310	Wnt signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04350	TGF-beta signaling pathway	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200034788	K03094	ko04710	Circadian rhythm - mammal	575	7.0e-26	0.58	0.71	0.99
PGSC0003DMG200005347	K01509	ko00230	Purine metabolism	824	1.4e-39	0.49	0.67	0.96
PGSC0003DMG200005347	K01509	ko00230	Purine metabolism	1483	5.8e-76	0.47	0.66	0.84
PGSC0003DMG200005347	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMG200005347	K01509	ko00230	Purine metabolism	1564	2.0e-80	0.34	0.53	0.84
PGSC0003DMG200005347	K01509	ko00230	Purine metabolism	1462	8.4e-75	0.55	0.73	0.84
PGSC0003DMG200009040	K02210	ko03030	DNA replication	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMG200009040	K02210	ko04110	Cell cycle	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMG200009040	K02210	ko04111	Cell cycle - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMG200009040	K02210	ko04113	Meiosis - yeast	5491	5.0e-297	0.90	0.96	1.00
PGSC0003DMG200009052	K01897	ko00071	Fatty acid metabolism	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMG200009052	K01897	ko01100	Metabolic pathways	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMG200009052	K01897	ko03320	PPAR signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMG200009052	K01897	ko04146	Peroxisome	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMG200009052	K01897	ko04920	Adipocytokine signaling pathway	2308	1.8e-121	0.45	0.63	1.00
PGSC0003DMG200009052	K01897	ko00071	Fatty acid metabolism	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMG200009052	K01897	ko01100	Metabolic pathways	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMG200009052	K01897	ko03320	PPAR signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMG200009052	K01897	ko04146	Peroxisome	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMG200009052	K01897	ko04920	Adipocytokine signaling pathway	2444	5.8e-129	0.49	0.68	0.97
PGSC0003DMG200015339	K06636	ko04110	Cell cycle	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMG200015339	K06636	ko04111	Cell cycle - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMG200015339	K06636	ko04113	Meiosis - yeast	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMG200015339	K06636	ko04114	Oocyte meiosis	358	5.0e-13	0.32	0.52	0.89
PGSC0003DMG200015341	K01810	ko00010	Glycolysis / Gluconeogenesis	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015341	K01810	ko00030	Pentose phosphate pathway	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015341	K01810	ko00500	Starch and sucrose metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015341	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015341	K01810	ko01100	Metabolic pathways	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015341	K01810	ko01110	Biosynthesis of secondary metabolites	4165	6.9e-224	0.85	0.93	1.00
PGSC0003DMG200015343	K05681	ko02010	ABC transporters	1201	2.1e-60	0.36	0.55	0.99
PGSC0003DMG200015344	K05681	ko02010	ABC transporters	1307	3.0e-66	0.36	0.55	0.96
PGSC0003DMG200015346	K00492	ko00340	Histidine metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00363	Bisphenol A degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00622	Toluene and xylene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00624	1- and 2-Methylnaphthalene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00626	Naphthalene and anthracene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00627	1,4-Dichlorobenzene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00680	Methane metabolism	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00903	Limonene and pinene degradation	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko01100	Metabolic pathways	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.31	0.46	0.65
PGSC0003DMG200015346	K00492	ko00340	Histidine metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00363	Bisphenol A degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00622	Toluene and xylene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00624	1- and 2-Methylnaphthalene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00626	Naphthalene and anthracene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00627	1,4-Dichlorobenzene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00680	Methane metabolism	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko00903	Limonene and pinene degradation	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko01100	Metabolic pathways	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200015346	K00492	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.32	0.45	0.65
PGSC0003DMG200041097	K05282	ko00904	Diterpenoid biosynthesis	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMG200041097	K05282	ko01100	Metabolic pathways	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMG200041097	K05282	ko01110	Biosynthesis of secondary metabolites	853	3.3e-41	0.43	0.54	0.85
PGSC0003DMG200041100	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMG200041100	K00517	ko00626	Naphthalene and anthracene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMG200041100	K00517	ko00903	Limonene and pinene degradation	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMG200041100	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMG200041100	K00517	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.44	0.64	0.96
PGSC0003DMG200041104	K03133	ko03022	Basal transcription factors	315	1.5e-11	0.58	0.73	0.90
PGSC0003DMG200023491	K00430	ko00360	Phenylalanine metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMG200023491	K00430	ko00680	Methane metabolism	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMG200023491	K00430	ko00940	Phenylpropanoid biosynthesis	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMG200023491	K00430	ko01100	Metabolic pathways	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMG200023491	K00430	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.46	0.64	0.88
PGSC0003DMG200023501	K11717	ko00450	Selenoamino acid metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMG200023501	K11717	ko00730	Thiamine metabolism	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMG200023501	K11717	ko01100	Metabolic pathways	2100	5.4e-110	0.73	0.86	0.34
PGSC0003DMG200023501	K11717	ko00450	Selenoamino acid metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMG200023501	K11717	ko00730	Thiamine metabolism	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMG200023501	K11717	ko01100	Metabolic pathways	2972	4.4e-158	0.76	0.87	0.99
PGSC0003DMG200027119	K00522	ko00860	Porphyrin and chlorophyll metabolism	538	7.7e-24	0.67	0.78	0.51
PGSC0003DMG200027119	K00522	ko00860	Porphyrin and chlorophyll metabolism	823	1.5e-39	0.60	0.75	0.66
PGSC0003DMG200027120	K03103	ko00562	Inositol phosphate metabolism	401	2.8e-16	0.29	0.45	0.93
PGSC0003DMG200027120	K03103	ko00562	Inositol phosphate metabolism	566	2.2e-25	0.28	0.49	0.81
PGSC0003DMG200027120	K03103	ko00562	Inositol phosphate metabolism	562	3.7e-25	0.28	0.49	0.81
PGSC0003DMG200027120	K03103	ko00562	Inositol phosphate metabolism	530	2.1e-23	0.27	0.46	0.82
PGSC0003DMG200027125	K01100	ko00710	Carbon fixation in photosynthetic organisms	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMG200027125	K01100	ko01100	Metabolic pathways	2645	4.7e-140	0.81	0.89	0.99
PGSC0003DMG200027125	K01100	ko00710	Carbon fixation in photosynthetic organisms	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMG200027125	K01100	ko01100	Metabolic pathways	2026	6.6e-106	0.80	0.88	0.98
PGSC0003DMG200027127	K13065	ko00940	Phenylpropanoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMG200027127	K13065	ko00941	Flavonoid biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMG200027127	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMG200027127	K13065	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.30	0.45	0.96
PGSC0003DMG200027130	K05857	ko00562	Inositol phosphate metabolism	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMG200027130	K05857	ko01100	Metabolic pathways	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMG200027130	K05857	ko04020	Calcium signaling pathway	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMG200027130	K05857	ko04070	Phosphatidylinositol signaling system	3957	2.0e-212	0.77	0.88	1.00
PGSC0003DMG200027130	K05857	ko00562	Inositol phosphate metabolism	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMG200027130	K05857	ko01100	Metabolic pathways	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMG200027130	K05857	ko04020	Calcium signaling pathway	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMG200027130	K05857	ko04070	Phosphatidylinositol signaling system	3244	4.3e-173	0.75	0.87	0.99
PGSC0003DMG200018633	K04733	ko04210	Apoptosis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMG200018633	K04733	ko04620	Toll-like receptor signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMG200018633	K04733	ko04722	Neurotrophin signaling pathway	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMG200018633	K04733	ko05140	Leishmaniasis	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMG200018633	K04733	ko05142	Chagas disease	649	5.8e-30	0.34	0.53	0.61
PGSC0003DMG200018633	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMG200018633	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMG200018633	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMG200018633	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMG200018633	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.62
PGSC0003DMG200018634	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6180	0.	0.75	0.84	0.81
PGSC0003DMG200018634	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6350	0.	0.77	0.86	0.99
PGSC0003DMG200018636	K00655	ko00561	Glycerolipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMG200018636	K00655	ko00564	Glycerophospholipid metabolism	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMG200018636	K00655	ko01100	Metabolic pathways	447	5.0e-22	0.46	0.60	0.84
PGSC0003DMG200018636	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018636	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018636	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018636	K00655	ko00561	Glycerolipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018636	K00655	ko00564	Glycerophospholipid metabolism	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018636	K00655	ko01100	Metabolic pathways	477	1.8e-20	0.50	0.68	0.89
PGSC0003DMG200018641	K08242	ko00100	Steroid biosynthesis	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMG200018641	K08242	ko01110	Biosynthesis of secondary metabolites	2562	1.8e-135	0.82	0.90	0.99
PGSC0003DMG200018643	K06640	ko04110	Cell cycle	11655	0.	0.68	0.82	1.00
PGSC0003DMG200018643	K06640	ko04115	p53 signaling pathway	11655	0.	0.68	0.82	1.00
PGSC0003DMG200018643	K06640	ko04110	Cell cycle	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMG200018643	K06640	ko04115	p53 signaling pathway	713	3.3e-32	0.64	0.76	0.96
PGSC0003DMG200018644	K04424	ko04010	MAPK signaling pathway	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMG200018644	K04424	ko04530	Tight junction	887	4.4e-43	0.34	0.55	0.66
PGSC0003DMG200018644	K04424	ko04010	MAPK signaling pathway	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMG200018644	K04424	ko04530	Tight junction	873	2.6e-42	0.42	0.66	0.67
PGSC0003DMG200025903	K00145	ko00330	Arginine and proline metabolism	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMG200025903	K00145	ko01100	Metabolic pathways	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMG200025903	K00145	ko01110	Biosynthesis of secondary metabolites	2380	2.0e-125	0.74	0.83	1.00
PGSC0003DMG200025903	K00145	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMG200025903	K00145	ko01100	Metabolic pathways	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMG200025903	K00145	ko01110	Biosynthesis of secondary metabolites	2525	2.0e-133	0.77	0.87	1.00
PGSC0003DMG200025905	K08233	ko00901	Indole alkaloid biosynthesis	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMG200025905	K08233	ko01110	Biosynthesis of secondary metabolites	908	3.0e-44	0.48	0.64	0.89
PGSC0003DMG200025906	K08233	ko00901	Indole alkaloid biosynthesis	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMG200025906	K08233	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.44	0.60	0.92
PGSC0003DMG200025906	K08233	ko00901	Indole alkaloid biosynthesis	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMG200025906	K08233	ko01110	Biosynthesis of secondary metabolites	833	4.1e-40	0.44	0.61	0.92
PGSC0003DMG200025906	K08233	ko00901	Indole alkaloid biosynthesis	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMG200025906	K08233	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.44	0.60	1.00
PGSC0003DMG200025906	K08233	ko00901	Indole alkaloid biosynthesis	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMG200025906	K08233	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.55	0.70	0.72
PGSC0003DMG200025906	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMG200025906	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.45	0.61	0.92
PGSC0003DMG200025907	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMG200025907	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.45	0.62	0.88
PGSC0003DMG200025908	K08233	ko00901	Indole alkaloid biosynthesis	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMG200025908	K08233	ko01110	Biosynthesis of secondary metabolites	868	4.9e-42	0.48	0.62	0.89
PGSC0003DMG200025908	K08233	ko00901	Indole alkaloid biosynthesis	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMG200025908	K08233	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.47	0.62	0.89
PGSC0003DMG200025908	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMG200025908	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.46	0.60	0.89
PGSC0003DMG200025908	K08233	ko00901	Indole alkaloid biosynthesis	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMG200025908	K08233	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.47	0.62	0.90
PGSC0003DMG200025909	K08233	ko00901	Indole alkaloid biosynthesis	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMG200025909	K08233	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.43	0.60	0.89
PGSC0003DMG200025910	K08233	ko00901	Indole alkaloid biosynthesis	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMG200025910	K08233	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.47	0.64	0.86
PGSC0003DMG200025911	K08233	ko00901	Indole alkaloid biosynthesis	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMG200025911	K08233	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.46	0.61	0.91
PGSC0003DMG200025912	K08233	ko00901	Indole alkaloid biosynthesis	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMG200025912	K08233	ko01110	Biosynthesis of secondary metabolites	826	1.0e-39	0.44	0.62	0.93
PGSC0003DMG200025914	K08233	ko00901	Indole alkaloid biosynthesis	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMG200025914	K08233	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.58	0.90
PGSC0003DMG200025915	K08233	ko00901	Indole alkaloid biosynthesis	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMG200025915	K08233	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.37	0.55	0.91
PGSC0003DMG200025916	K08233	ko00901	Indole alkaloid biosynthesis	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMG200025916	K08233	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.45	0.64	0.98
PGSC0003DMG200025917	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMG200025917	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMG200025918	K08233	ko00901	Indole alkaloid biosynthesis	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMG200025918	K08233	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.48	0.63	0.91
PGSC0003DMG200025919	K08233	ko00901	Indole alkaloid biosynthesis	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMG200025919	K08233	ko01110	Biosynthesis of secondary metabolites	286	2.3e-15	0.42	0.61	0.86
PGSC0003DMG200013505	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMG200013505	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMG200013505	K08065	ko04612	Antigen processing and presentation	389	1.3e-15	0.39	0.54	0.70
PGSC0003DMG200013511	K09680	ko00770	Pantothenate and CoA biosynthesis	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMG200013511	K09680	ko01100	Metabolic pathways	1321	5.0e-67	0.63	0.79	0.98
PGSC0003DMG200013511	K09680	ko00770	Pantothenate and CoA biosynthesis	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMG200013511	K09680	ko01100	Metabolic pathways	1318	7.4e-67	0.62	0.78	0.97
PGSC0003DMG200013511	K09680	ko00770	Pantothenate and CoA biosynthesis	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMG200013511	K09680	ko01100	Metabolic pathways	2092	1.5e-109	0.68	0.81	0.88
PGSC0003DMG200013515	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMG200013515	K01661	ko01100	Metabolic pathways	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMG200013515	K01661	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.68	0.80	0.92
PGSC0003DMG200013515	K01661	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMG200013515	K01661	ko01100	Metabolic pathways	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMG200013515	K01661	ko01110	Biosynthesis of secondary metabolites	2233	2.5e-117	0.77	0.86	1.00
PGSC0003DMG200013516	K01184	ko00040	Pentose and glucuronate interconversions	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMG200013516	K01184	ko00500	Starch and sucrose metabolism	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMG200013516	K01184	ko01100	Metabolic pathways	1896	9.7e-99	0.58	0.72	1.00
PGSC0003DMG200013516	K01184	ko00040	Pentose and glucuronate interconversions	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMG200013516	K01184	ko00500	Starch and sucrose metabolism	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMG200013516	K01184	ko01100	Metabolic pathways	2070	2.5e-108	0.51	0.65	1.00
PGSC0003DMG200013516	K01184	ko00040	Pentose and glucuronate interconversions	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMG200013516	K01184	ko00500	Starch and sucrose metabolism	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMG200013516	K01184	ko01100	Metabolic pathways	677	1.7e-31	0.54	0.72	0.99
PGSC0003DMG200013516	K01184	ko00040	Pentose and glucuronate interconversions	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMG200013516	K01184	ko00500	Starch and sucrose metabolism	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMG200013516	K01184	ko01100	Metabolic pathways	1318	7.4e-67	0.58	0.70	0.99
PGSC0003DMG200007465	K05681	ko02010	ABC transporters	898	1.1e-43	0.42	0.68	0.70
PGSC0003DMG200007465	K05681	ko02010	ABC transporters	931	1.6e-45	0.36	0.59	0.80
PGSC0003DMG200007466	K01595	ko00620	Pyruvate metabolism	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMG200007466	K01595	ko00710	Carbon fixation in photosynthetic organisms	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMG200007466	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMG200007466	K01595	ko01100	Metabolic pathways	4221	5.6e-227	0.89	0.97	1.00
PGSC0003DMG200007466	K01595	ko00620	Pyruvate metabolism	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMG200007466	K01595	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMG200007466	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMG200007466	K01595	ko01100	Metabolic pathways	2627	4.7e-139	0.89	0.96	1.00
PGSC0003DMG200007466	K01595	ko00620	Pyruvate metabolism	7179	0.	0.80	0.89	1.00
PGSC0003DMG200007466	K01595	ko00710	Carbon fixation in photosynthetic organisms	7179	0.	0.80	0.89	1.00
PGSC0003DMG200007466	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7179	0.	0.80	0.89	1.00
PGSC0003DMG200007466	K01595	ko01100	Metabolic pathways	7179	0.	0.80	0.89	1.00
PGSC0003DMG200007466	K01595	ko00620	Pyruvate metabolism	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMG200007466	K01595	ko00710	Carbon fixation in photosynthetic organisms	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMG200007466	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMG200007466	K01595	ko01100	Metabolic pathways	4036	9.0e-217	0.75	0.85	1.00
PGSC0003DMG200007488	K00162	ko00010	Glycolysis / Gluconeogenesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko00020	Citrate cycle (TCA cycle)	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko00620	Pyruvate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko00650	Butanoate metabolism	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko01100	Metabolic pathways	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200007488	K00162	ko01110	Biosynthesis of secondary metabolites	3008	4.5e-160	0.87	0.91	1.00
PGSC0003DMG200004463	K01193	ko00052	Galactose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMG200004463	K01193	ko00500	Starch and sucrose metabolism	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMG200004463	K01193	ko01100	Metabolic pathways	839	1.9e-40	0.55	0.71	0.91
PGSC0003DMG200004463	K01193	ko00052	Galactose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMG200004463	K01193	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMG200004463	K01193	ko01100	Metabolic pathways	651	4.5e-30	0.54	0.62	0.89
PGSC0003DMG200004471	K13065	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMG200004471	K13065	ko00941	Flavonoid biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMG200004471	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMG200004471	K13065	ko01110	Biosynthesis of secondary metabolites	447	8.1e-19	0.28	0.46	0.91
PGSC0003DMG200004471	K13065	ko00940	Phenylpropanoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMG200004471	K13065	ko00941	Flavonoid biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMG200004471	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMG200004471	K13065	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.29	0.46	0.93
PGSC0003DMG200040089	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200040089	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200040089	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200040094	K12929	ko00904	Diterpenoid biosynthesis	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMG200040094	K12929	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.34	0.53	0.99
PGSC0003DMG200040099	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMG200040099	K00517	ko00626	Naphthalene and anthracene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMG200040099	K00517	ko00903	Limonene and pinene degradation	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMG200040099	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMG200040099	K00517	ko01110	Biosynthesis of secondary metabolites	517	5.8e-37	0.47	0.63	0.98
PGSC0003DMG200045346	K00799	ko00480	Glutathione metabolism	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMG200045346	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMG200045346	K00799	ko00982	Drug metabolism - cytochrome P450	650	5.1e-30	0.46	0.63	0.92
PGSC0003DMG200001573	K00640	ko00270	Cysteine and methionine metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMG200001573	K00640	ko00920	Sulfur metabolism	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMG200001573	K00640	ko01100	Metabolic pathways	1964	1.7e-102	0.68	0.82	0.97
PGSC0003DMG200001573	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMG200001573	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMG200001573	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.89
PGSC0003DMG200001574	K01053	ko00030	Pentose phosphate pathway	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMG200001574	K01053	ko00053	Ascorbate and aldarate metabolism	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMG200001574	K01053	ko00930	Caprolactam degradation	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMG200001574	K01053	ko01100	Metabolic pathways	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMG200001574	K01053	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.33	0.53	0.88
PGSC0003DMG200001576	K06636	ko04110	Cell cycle	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMG200001576	K06636	ko04111	Cell cycle - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMG200001576	K06636	ko04113	Meiosis - yeast	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMG200001576	K06636	ko04114	Oocyte meiosis	533	7.5e-23	0.31	0.49	0.79
PGSC0003DMG200001580	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMG200001580	K05284	ko01100	Metabolic pathways	646	8.5e-30	0.71	0.85	0.98
PGSC0003DMG200001580	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMG200001580	K05284	ko01100	Metabolic pathways	2006	8.3e-105	0.72	0.84	0.99
PGSC0003DMG200001580	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMG200001580	K05284	ko01100	Metabolic pathways	2776	2.8e-147	0.74	0.86	0.99
PGSC0003DMG200001580	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMG200001580	K05284	ko01100	Metabolic pathways	1603	1.4e-82	0.70	0.82	0.99
PGSC0003DMG200001580	K05284	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMG200001580	K05284	ko01100	Metabolic pathways	1075	1.9e-53	0.81	0.93	0.94
PGSC0003DMG200024304	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMG200024304	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.76
PGSC0003DMG200024304	K04424	ko04010	MAPK signaling pathway	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMG200024304	K04424	ko04530	Tight junction	686	2.3e-31	0.38	0.54	0.74
PGSC0003DMG200024304	K04424	ko04010	MAPK signaling pathway	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMG200024304	K04424	ko04530	Tight junction	677	7.4e-31	0.38	0.54	0.67
PGSC0003DMG200021180	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMG200021180	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMG200021180	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.57	0.92
PGSC0003DMG200021181	K12182	ko04144	Endocytosis	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMG200021181	K12182	ko04145	Phagosome	263	6.1e-07	0.34	0.45	0.45
PGSC0003DMG200021186	K04733	ko04210	Apoptosis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMG200021186	K04733	ko04620	Toll-like receptor signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMG200021186	K04733	ko04722	Neurotrophin signaling pathway	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMG200021186	K04733	ko05140	Leishmaniasis	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMG200021186	K04733	ko05142	Chagas disease	2373	4.8e-125	0.42	0.58	0.97
PGSC0003DMG200021188	K01897	ko00071	Fatty acid metabolism	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMG200021188	K01897	ko01100	Metabolic pathways	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMG200021188	K01897	ko03320	PPAR signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMG200021188	K01897	ko04146	Peroxisome	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMG200021188	K01897	ko04920	Adipocytokine signaling pathway	818	2.8e-39	0.33	0.51	0.86
PGSC0003DMG200021188	K01897	ko00071	Fatty acid metabolism	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMG200021188	K01897	ko01100	Metabolic pathways	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMG200021188	K01897	ko03320	PPAR signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMG200021188	K01897	ko04146	Peroxisome	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMG200021188	K01897	ko04920	Adipocytokine signaling pathway	716	1.2e-33	0.32	0.53	0.98
PGSC0003DMG200021188	K01897	ko00071	Fatty acid metabolism	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMG200021188	K01897	ko01100	Metabolic pathways	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMG200021188	K01897	ko03320	PPAR signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMG200021188	K01897	ko04146	Peroxisome	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMG200021188	K01897	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.31	0.52	0.98
PGSC0003DMG200021189	K02975	ko03010	Ribosome	850	4.8e-41	0.93	0.98	0.99
PGSC0003DMG200021190	K02887	ko03010	Ribosome	931	1.6e-45	0.83	0.97	0.99
PGSC0003DMG200021191	K12840	ko03040	Spliceosome	2254	1.7e-118	0.70	0.79	1.00
PGSC0003DMG200021197	K12192	ko04144	Endocytosis	1090	2.8e-54	0.64	0.81	0.95
PGSC0003DMG200017464	K03165	ko03440	Homologous recombination	2868	2.4e-152	0.75	0.82	0.94
PGSC0003DMG200017464	K03165	ko03440	Homologous recombination	2314	8.5e-122	0.72	0.84	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	3113	7.3e-166	0.57	0.74	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	2075	1.3e-108	0.74	0.87	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	4650	1.2e-250	0.61	0.76	1.00
PGSC0003DMG200017465	K00454	ko00591	Linoleic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017465	K00454	ko00592	alpha-Linolenic acid metabolism	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017465	K00454	ko01100	Metabolic pathways	2846	3.9e-151	0.72	0.87	1.00
PGSC0003DMG200017466	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200017466	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200017466	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200017467	K00454	ko00591	Linoleic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200017467	K00454	ko00592	alpha-Linolenic acid metabolism	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200017467	K00454	ko01100	Metabolic pathways	761	3.9e-36	0.54	0.70	0.99
PGSC0003DMG200024580	K00275	ko00750	Vitamin B6 metabolism	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMG200024580	K00275	ko01100	Metabolic pathways	697	1.3e-32	0.49	0.65	0.57
PGSC0003DMG200024580	K00275	ko00750	Vitamin B6 metabolism	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMG200024580	K00275	ko01100	Metabolic pathways	722	5.5e-34	0.49	0.63	0.55
PGSC0003DMG200024581	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMG200024581	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.46
PGSC0003DMG200024581	K00275	ko00750	Vitamin B6 metabolism	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMG200024581	K00275	ko01100	Metabolic pathways	994	5.5e-49	0.56	0.71	0.41
PGSC0003DMG200024581	K00971	ko00051	Fructose and mannose metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMG200024581	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMG200024581	K00971	ko01100	Metabolic pathways	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMG200024581	K00971	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.44	0.62	0.98
PGSC0003DMG200024581	K00966	ko00051	Fructose and mannose metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMG200024581	K00966	ko00520	Amino sugar and nucleotide sugar metabolism	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMG200024581	K00966	ko01100	Metabolic pathways	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMG200024581	K00966	ko01110	Biosynthesis of secondary metabolites	1278	1.2e-64	0.44	0.65	0.97
PGSC0003DMG200024582	K00130	ko00260	Glycine, serine and threonine metabolism	3144	1.4e-167	0.72	0.85	0.99
PGSC0003DMG200024584	K01205	ko00531	Glycosaminoglycan degradation	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMG200024584	K01205	ko01100	Metabolic pathways	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMG200024584	K01205	ko04142	Lysosome	2096	9.0e-110	0.73	0.84	1.00
PGSC0003DMG200024590	K04392	ko04010	MAPK signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04062	Chemokine signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04145	Phagosome	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04310	Wnt signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04360	Axon guidance	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04370	VEGF signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04510	Focal adhesion	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04520	Adherens junction	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04650	Natural killer cell mediated cytotoxicity	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04662	B cell receptor signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04664	Fc epsilon RI signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04666	Fc gamma R-mediated phagocytosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04670	Leukocyte transendothelial migration	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04810	Regulation of actin cytoskeleton	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05100	Bacterial invasion of epithelial cells	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05131	Shigellosis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05200	Pathways in cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05210	Colorectal cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05211	Renal cell carcinoma	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05212	Pancreatic cancer	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko05416	Viral myocarditis	1027	8.3e-51	0.75	0.81	0.97
PGSC0003DMG200024590	K04392	ko04010	MAPK signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04062	Chemokine signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04145	Phagosome	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04310	Wnt signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04360	Axon guidance	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04370	VEGF signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04510	Focal adhesion	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04520	Adherens junction	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04620	Toll-like receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04650	Natural killer cell mediated cytotoxicity	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04662	B cell receptor signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04664	Fc epsilon RI signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04666	Fc gamma R-mediated phagocytosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04670	Leukocyte transendothelial migration	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04722	Neurotrophin signaling pathway	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04810	Regulation of actin cytoskeleton	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05100	Bacterial invasion of epithelial cells	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05131	Shigellosis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05200	Pathways in cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05210	Colorectal cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05211	Renal cell carcinoma	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05212	Pancreatic cancer	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko05416	Viral myocarditis	587	1.5e-26	0.80	0.91	0.74
PGSC0003DMG200024590	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04010	MAPK signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04062	Chemokine signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04145	Phagosome	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04310	Wnt signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04360	Axon guidance	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04370	VEGF signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04510	Focal adhesion	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04520	Adherens junction	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04620	Toll-like receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04650	Natural killer cell mediated cytotoxicity	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04662	B cell receptor signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04664	Fc epsilon RI signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04666	Fc gamma R-mediated phagocytosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04670	Leukocyte transendothelial migration	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04722	Neurotrophin signaling pathway	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko04810	Regulation of actin cytoskeleton	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05100	Bacterial invasion of epithelial cells	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05131	Shigellosis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05200	Pathways in cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05210	Colorectal cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05211	Renal cell carcinoma	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05212	Pancreatic cancer	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024590	K04392	ko05416	Viral myocarditis	1696	1.0e-87	0.93	0.97	1.00
PGSC0003DMG200024591	K05391	ko04626	Plant-pathogen interaction	1374	6.0e-70	0.69	0.79	0.97
PGSC0003DMG200024591	K05391	ko04626	Plant-pathogen interaction	3594	2.2e-192	0.62	0.75	0.99
PGSC0003DMG200024593	K12356	ko00940	Phenylpropanoid biosynthesis	797	4.0e-38	0.34	0.51	0.97
PGSC0003DMG200024594	K12356	ko00940	Phenylpropanoid biosynthesis	785	1.8e-37	0.34	0.50	0.99
PGSC0003DMG200032788	K00635	ko00561	Glycerolipid metabolism	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMG200032788	K00635	ko01100	Metabolic pathways	1151	1.2e-57	0.66	0.82	0.61
PGSC0003DMG200032789	K00635	ko00561	Glycerolipid metabolism	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMG200032789	K00635	ko01100	Metabolic pathways	441	1.7e-18	0.60	0.78	0.67
PGSC0003DMG200032791	K02218	ko04340	Hedgehog signaling pathway	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMG200032791	K02218	ko04711	Circadian rhythm - fly	2996	2.1e-159	0.76	0.85	0.99
PGSC0003DMG200032800	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMG200032800	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMG200032800	K00734	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.58
PGSC0003DMG200017211	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMG200017211	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMG200017211	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMG200017211	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.97
PGSC0003DMG200017211	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko00362	Benzoate degradation via hydroxylation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko00440	Phosphonate and phosphinate metabolism	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko00903	Limonene and pinene degradation	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017211	K00119	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.28	0.47	0.68
PGSC0003DMG200017218	K02218	ko04340	Hedgehog signaling pathway	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMG200017218	K02218	ko04711	Circadian rhythm - fly	1985	1.2e-103	0.81	0.90	0.85
PGSC0003DMG200028020	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028020	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028020	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028020	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMG200028020	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMG200028020	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.95
PGSC0003DMG200028020	K09841	ko00906	Carotenoid biosynthesis	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMG200028020	K09841	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMG200028020	K09841	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.51	0.70	0.97
PGSC0003DMG200028020	K09841	ko00906	Carotenoid biosynthesis	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMG200028020	K09841	ko01100	Metabolic pathways	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMG200028020	K09841	ko01110	Biosynthesis of secondary metabolites	671	3.6e-31	0.50	0.68	0.99
PGSC0003DMG200028020	K09841	ko00906	Carotenoid biosynthesis	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028020	K09841	ko01100	Metabolic pathways	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028020	K09841	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.50	0.69	0.99
PGSC0003DMG200028021	K09841	ko00906	Carotenoid biosynthesis	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMG200028021	K09841	ko01100	Metabolic pathways	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMG200028021	K09841	ko01110	Biosynthesis of secondary metabolites	1032	4.4e-51	0.51	0.69	0.97
PGSC0003DMG200028021	K09841	ko00906	Carotenoid biosynthesis	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMG200028021	K09841	ko01100	Metabolic pathways	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMG200028021	K09841	ko01110	Biosynthesis of secondary metabolites	653	3.5e-30	0.50	0.67	0.98
PGSC0003DMG200028027	K00616	ko00030	Pentose phosphate pathway	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMG200028027	K00616	ko01100	Metabolic pathways	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMG200028027	K00616	ko01110	Biosynthesis of secondary metabolites	567	1.9e-25	0.87	0.97	0.99
PGSC0003DMG200028027	K00616	ko00030	Pentose phosphate pathway	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMG200028027	K00616	ko01100	Metabolic pathways	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMG200028027	K00616	ko01110	Biosynthesis of secondary metabolites	3012	2.7e-160	0.84	0.91	1.00
PGSC0003DMG200028032	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMG200028032	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMG200028032	K12478	ko04144	Endocytosis	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMG200028032	K12478	ko04145	Phagosome	367	9.8e-11	0.25	0.46	0.99
PGSC0003DMG200028033	K00218	ko00860	Porphyrin and chlorophyll metabolism	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMG200028033	K00218	ko01100	Metabolic pathways	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMG200028033	K00218	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.34	0.60	0.77
PGSC0003DMG200045451	K10760	ko00908	Zeatin biosynthesis	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMG200045451	K10760	ko01100	Metabolic pathways	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMG200045451	K10760	ko01110	Biosynthesis of secondary metabolites	367	2.1e-14	0.43	0.58	0.99
PGSC0003DMG200045454	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMG200013884	K04733	ko04210	Apoptosis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMG200013884	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMG200013884	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMG200013884	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMG200013884	K04733	ko05142	Chagas disease	716	1.2e-33	0.38	0.59	0.84
PGSC0003DMG200013886	K04733	ko04210	Apoptosis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMG200013886	K04733	ko04620	Toll-like receptor signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMG200013886	K04733	ko04722	Neurotrophin signaling pathway	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMG200013886	K04733	ko05140	Leishmaniasis	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMG200013886	K04733	ko05142	Chagas disease	865	7.1e-42	0.39	0.55	0.43
PGSC0003DMG200013888	K10840	ko03420	Nucleotide excision repair	212	7.4e-06	0.34	0.61	0.76
PGSC0003DMG200013893	K10143	ko04115	p53 signaling pathway	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMG200013893	K10143	ko04120	Ubiquitin mediated proteolysis	4281	2.8e-230	0.75	0.85	1.00
PGSC0003DMG200013893	K10143	ko04115	p53 signaling pathway	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMG200013893	K10143	ko04120	Ubiquitin mediated proteolysis	3971	3.5e-213	0.81	0.92	1.00
PGSC0003DMG200013893	K10143	ko04115	p53 signaling pathway	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMG200013893	K10143	ko04120	Ubiquitin mediated proteolysis	3721	2.1e-199	0.82	0.92	1.00
PGSC0003DMG200013894	K05933	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMG200013894	K05933	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.81	0.89	1.00
PGSC0003DMG200007800	K13065	ko00940	Phenylpropanoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMG200007800	K13065	ko00941	Flavonoid biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMG200007800	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMG200007800	K13065	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.27	0.44	0.88
PGSC0003DMG200007801	K13065	ko00940	Phenylpropanoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMG200007801	K13065	ko00941	Flavonoid biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMG200007801	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMG200007801	K13065	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.27	0.45	0.89
PGSC0003DMG200007807	K06630	ko04110	Cell cycle	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMG200007807	K06630	ko04114	Oocyte meiosis	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMG200007807	K06630	ko04722	Neurotrophin signaling pathway	1794	4.1e-93	0.83	0.92	1.00
PGSC0003DMG200007807	K06630	ko04110	Cell cycle	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMG200007807	K06630	ko04114	Oocyte meiosis	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMG200007807	K06630	ko04722	Neurotrophin signaling pathway	1790	6.8e-93	0.82	0.92	1.00
PGSC0003DMG200011242	K08770	ko03320	PPAR signaling pathway	1014	4.3e-50	0.81	0.89	0.99
PGSC0003DMG200011244	K12882	ko03040	Spliceosome	3663	3.4e-196	0.77	0.88	0.96
PGSC0003DMG200011244	K12882	ko03040	Spliceosome	2196	2.8e-115	0.78	0.89	0.96
PGSC0003DMG200011244	K12882	ko03040	Spliceosome	5680	0.	0.77	0.88	1.00
PGSC0003DMG200011246	K00134	ko00010	Glycolysis / Gluconeogenesis	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMG200011246	K00134	ko01100	Metabolic pathways	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMG200011246	K00134	ko01110	Biosynthesis of secondary metabolites	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMG200011246	K00134	ko05010	Alzheimer's disease	2851	2.1e-151	0.82	0.90	1.00
PGSC0003DMG200011251	K04733	ko04210	Apoptosis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMG200011251	K04733	ko04620	Toll-like receptor signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMG200011251	K04733	ko04722	Neurotrophin signaling pathway	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMG200011251	K04733	ko05140	Leishmaniasis	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMG200011251	K04733	ko05142	Chagas disease	849	5.4e-41	0.36	0.56	0.49
PGSC0003DMG200011252	K07385	ko00902	Monoterpenoid biosynthesis	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMG200011252	K07385	ko01100	Metabolic pathways	1258	1.5e-63	0.38	0.58	0.94
PGSC0003DMG200011252	K07385	ko00902	Monoterpenoid biosynthesis	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMG200011252	K07385	ko01100	Metabolic pathways	873	2.6e-42	0.34	0.49	0.93
PGSC0003DMG200011252	K12742	ko00900	Terpenoid backbone biosynthesis	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMG200011252	K12742	ko01110	Biosynthesis of secondary metabolites	681	1.0e-31	0.41	0.58	0.94
PGSC0003DMG200011254	K05282	ko00904	Diterpenoid biosynthesis	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMG200011254	K05282	ko01100	Metabolic pathways	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMG200011254	K05282	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.32	0.48	0.94
PGSC0003DMG200006708	K01066	ko00623	2,4-Dichlorobenzoate degradation	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMG200006708	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	383	2.7e-15	0.32	0.49	0.85
PGSC0003DMG200006709	K01066	ko00623	2,4-Dichlorobenzoate degradation	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMG200006709	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	367	2.1e-14	0.30	0.44	0.84
PGSC0003DMG200006710	K12598	ko03018	RNA degradation	600	9.2e-27	0.75	0.80	0.93
PGSC0003DMG200006711	K12598	ko03018	RNA degradation	823	1.5e-39	0.83	0.93	0.81
PGSC0003DMG200006712	K11778	ko00900	Terpenoid backbone biosynthesis	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMG200006712	K11778	ko01110	Biosynthesis of secondary metabolites	940	5.2e-46	0.50	0.66	0.88
PGSC0003DMG200006713	K12929	ko00904	Diterpenoid biosynthesis	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMG200006713	K12929	ko01110	Biosynthesis of secondary metabolites	1738	5.0e-90	0.42	0.62	0.99
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.34	0.56	0.83
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	287	6.8e-10	0.32	0.50	0.96
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	1375	5.3e-70	0.39	0.58	0.99
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	1098	1.0e-54	0.38	0.58	1.00
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.47	0.66	0.98
PGSC0003DMG200006718	K04123	ko00904	Diterpenoid biosynthesis	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMG200006718	K04123	ko01100	Metabolic pathways	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMG200006718	K04123	ko01110	Biosynthesis of secondary metabolites	747	2.3e-35	0.35	0.56	0.94
PGSC0003DMG200035602	K03413	ko02020	Two-component system	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMG200035602	K03413	ko02030	Bacterial chemotaxis	245	1.1e-07	0.38	0.54	0.85
PGSC0003DMG200018890	K02894	ko03010	Ribosome	346	3.0e-13	0.93	1.00	0.50
PGSC0003DMG200018893	K01757	ko00901	Indole alkaloid biosynthesis	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMG200018893	K01757	ko01100	Metabolic pathways	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMG200018893	K01757	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.37	0.53	0.79
PGSC0003DMG200018893	K01757	ko00901	Indole alkaloid biosynthesis	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMG200018893	K01757	ko01100	Metabolic pathways	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMG200018893	K01757	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.39	0.55	0.84
PGSC0003DMG200018903	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko04115	p53 signaling pathway	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko04210	Apoptosis	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05010	Alzheimer's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05012	Parkinson's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05016	Huntington's disease	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018903	K02084	ko05222	Small cell lung cancer	298	3.4e-07	0.28	0.42	0.56
PGSC0003DMG200018907	K02084	ko04115	p53 signaling pathway	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko04210	Apoptosis	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko05010	Alzheimer's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko05012	Parkinson's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko05016	Huntington's disease	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200018907	K02084	ko05222	Small cell lung cancer	240	2.2e-06	0.32	0.51	0.85
PGSC0003DMG200025643	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMG200025643	K03785	ko01100	Metabolic pathways	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMG200025643	K03785	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.49	0.64	0.83
PGSC0003DMG200025647	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMG200025647	K01061	ko00364	Fluorobenzoate degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMG200025647	K01061	ko00627	1,4-Dichlorobenzene degradation	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMG200025647	K01061	ko01100	Metabolic pathways	1461	9.5e-75	0.62	0.77	0.90
PGSC0003DMG200025647	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00364	Fluorobenzoate degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko00627	1,4-Dichlorobenzene degradation	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025647	K01061	ko01100	Metabolic pathways	953	1.0e-46	0.64	0.81	0.99
PGSC0003DMG200025661	K12600	ko03018	RNA degradation	2894	8.7e-154	0.51	0.68	0.96
PGSC0003DMG200025661	K12600	ko03018	RNA degradation	2646	4.2e-140	0.55	0.74	0.97
PGSC0003DMG200030265	K12356	ko00940	Phenylpropanoid biosynthesis	703	6.1e-33	0.36	0.56	0.94
PGSC0003DMG200030274	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMG200030274	K12132	ko04712	Circadian rhythm - plant	1366	1.7e-69	0.59	0.73	0.97
PGSC0003DMG200030278	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1846	5.6e-96	0.67	0.81	1.00
PGSC0003DMG200020212	K00387	ko00920	Sulfur metabolism	2676	9.2e-142	0.76	0.87	1.00
PGSC0003DMG200020213	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMG200020213	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMG200020213	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMG200020213	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMG200020213	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.62	0.96
PGSC0003DMG200000213	K11253	ko05322	Systemic lupus erythematosus	660	1.4e-30	0.69	0.81	0.60
PGSC0003DMG200000213	K11253	ko05322	Systemic lupus erythematosus	863	9.2e-42	0.68	0.80	0.99
PGSC0003DMG200000216	K01897	ko00071	Fatty acid metabolism	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMG200000216	K01897	ko01100	Metabolic pathways	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMG200000216	K01897	ko03320	PPAR signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMG200000216	K01897	ko04146	Peroxisome	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMG200000216	K01897	ko04920	Adipocytokine signaling pathway	3782	9.2e-203	0.67	0.82	0.99
PGSC0003DMG200000217	K05391	ko04626	Plant-pathogen interaction	1959	3.3e-102	0.76	0.88	1.00
PGSC0003DMG200000223	K11422	ko00310	Lysine degradation	644	2.3e-29	0.39	0.54	0.26
PGSC0003DMG200000223	K11422	ko00310	Lysine degradation	644	2.6e-29	0.39	0.54	0.26
PGSC0003DMG200000227	K01528	ko04144	Endocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMG200000227	K01528	ko04666	Fc gamma R-mediated phagocytosis	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMG200000227	K01528	ko05100	Bacterial invasion of epithelial cells	1435	2.6e-73	0.47	0.64	0.93
PGSC0003DMG200016521	K00844	ko00010	Glycolysis / Gluconeogenesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00051	Fructose and mannose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00052	Galactose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00500	Starch and sucrose metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00521	Streptomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00524	Butirosin and neomycin biosynthesis	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko01100	Metabolic pathways	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko01110	Biosynthesis of secondary metabolites	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko04910	Insulin signaling pathway	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko04930	Type II diabetes mellitus	3256	9.5e-174	0.79	0.89	0.99
PGSC0003DMG200016521	K00844	ko00010	Glycolysis / Gluconeogenesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00051	Fructose and mannose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00052	Galactose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00500	Starch and sucrose metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00521	Streptomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00524	Butirosin and neomycin biosynthesis	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko01100	Metabolic pathways	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko04910	Insulin signaling pathway	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko04930	Type II diabetes mellitus	1403	1.5e-71	0.80	0.91	0.98
PGSC0003DMG200016521	K00844	ko00010	Glycolysis / Gluconeogenesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00051	Fructose and mannose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00052	Galactose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00521	Streptomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00524	Butirosin and neomycin biosynthesis	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko01100	Metabolic pathways	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko01110	Biosynthesis of secondary metabolites	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko04910	Insulin signaling pathway	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko04930	Type II diabetes mellitus	866	6.3e-42	0.79	0.92	0.97
PGSC0003DMG200016521	K00844	ko00010	Glycolysis / Gluconeogenesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00051	Fructose and mannose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00052	Galactose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00500	Starch and sucrose metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00521	Streptomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko00524	Butirosin and neomycin biosynthesis	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko01100	Metabolic pathways	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko01110	Biosynthesis of secondary metabolites	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko04910	Insulin signaling pathway	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016521	K00844	ko04930	Type II diabetes mellitus	1450	3.9e-74	0.75	0.87	0.97
PGSC0003DMG200016522	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMG200016522	K00970	ko03018	RNA degradation	336	2.0e-12	0.39	0.61	0.44
PGSC0003DMG200016522	K00970	ko03018	RNA degradation	1990	6.3e-104	0.73	0.84	0.93
PGSC0003DMG200016530	K08139	ko04113	Meiosis - yeast	359	5.8e-14	0.37	0.61	0.68
PGSC0003DMG200012156	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200012156	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200012156	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200012163	K10143	ko04115	p53 signaling pathway	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMG200012163	K10143	ko04120	Ubiquitin mediated proteolysis	1155	7.2e-58	0.34	0.50	0.75
PGSC0003DMG200012163	K10143	ko04115	p53 signaling pathway	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMG200012163	K10143	ko04120	Ubiquitin mediated proteolysis	1387	1.2e-70	0.35	0.52	0.75
PGSC0003DMG200012163	K10143	ko04115	p53 signaling pathway	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMG200012163	K10143	ko04120	Ubiquitin mediated proteolysis	2266	3.8e-119	0.40	0.56	0.81
PGSC0003DMG200012163	K10143	ko04115	p53 signaling pathway	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMG200012163	K10143	ko04120	Ubiquitin mediated proteolysis	1946	1.7e-101	0.38	0.54	0.77
PGSC0003DMG200012163	K10143	ko04115	p53 signaling pathway	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMG200012163	K10143	ko04120	Ubiquitin mediated proteolysis	1953	7.0e-102	0.38	0.54	0.78
PGSC0003DMG200012166	K02150	ko00190	Oxidative phosphorylation	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko01100	Metabolic pathways	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko04145	Phagosome	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko04966	Collecting duct acid secretion	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko05110	Vibrio cholerae infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1583	1.8e-81	0.86	0.95	0.93
PGSC0003DMG200012166	K02150	ko00190	Oxidative phosphorylation	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012166	K02150	ko01100	Metabolic pathways	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012166	K02150	ko04145	Phagosome	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012166	K02150	ko04966	Collecting duct acid secretion	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012166	K02150	ko05110	Vibrio cholerae infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012166	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1650	3.6e-85	0.87	0.95	0.99
PGSC0003DMG200012167	K05666	ko02010	ABC transporters	1596	3.4e-82	0.29	0.49	0.96
PGSC0003DMG200012167	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMG200012167	K05666	ko02010	ABC transporters	1686	3.7e-87	0.29	0.49	0.95
PGSC0003DMG200002167	K00799	ko00480	Glutathione metabolism	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMG200002167	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMG200002167	K00799	ko00982	Drug metabolism - cytochrome P450	671	3.6e-31	0.48	0.64	0.84
PGSC0003DMG200002168	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMG200002168	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMG200002168	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.45	0.65	0.97
PGSC0003DMG200002169	K00799	ko00480	Glutathione metabolism	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMG200002169	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMG200002169	K00799	ko00982	Drug metabolism - cytochrome P450	698	1.2e-32	0.47	0.63	0.91
PGSC0003DMG200002170	K00799	ko00480	Glutathione metabolism	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMG200002170	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMG200002170	K00799	ko00982	Drug metabolism - cytochrome P450	713	1.7e-33	0.47	0.67	0.86
PGSC0003DMG200002171	K00799	ko00480	Glutathione metabolism	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMG200002171	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMG200002171	K00799	ko00982	Drug metabolism - cytochrome P450	708	3.2e-33	0.47	0.65	0.91
PGSC0003DMG200002172	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMG200002172	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMG200002172	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.47	0.66	0.92
PGSC0003DMG200002174	K00799	ko00480	Glutathione metabolism	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMG200002174	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMG200002174	K00799	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.65	0.84	0.94
PGSC0003DMG200002174	K00799	ko00480	Glutathione metabolism	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMG200002174	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMG200002174	K00799	ko00982	Drug metabolism - cytochrome P450	702	7.0e-33	0.47	0.65	0.90
PGSC0003DMG200002175	K00799	ko00480	Glutathione metabolism	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMG200002175	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMG200002175	K00799	ko00982	Drug metabolism - cytochrome P450	677	1.7e-31	0.44	0.61	0.91
PGSC0003DMG200002176	K00799	ko00480	Glutathione metabolism	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMG200002176	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMG200002176	K00799	ko00982	Drug metabolism - cytochrome P450	542	4.6e-24	0.40	0.58	0.88
PGSC0003DMG200002177	K00799	ko00480	Glutathione metabolism	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMG200002177	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMG200002177	K00799	ko00982	Drug metabolism - cytochrome P450	630	6.5e-29	0.53	0.70	0.86
PGSC0003DMG200002178	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002178	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002178	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002178	K00799	ko00480	Glutathione metabolism	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMG200002178	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMG200002178	K00799	ko00982	Drug metabolism - cytochrome P450	681	1.0e-31	0.46	0.63	0.89
PGSC0003DMG200002178	K00799	ko00480	Glutathione metabolism	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002178	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002178	K00799	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.47	0.64	0.89
PGSC0003DMG200002179	K00799	ko00480	Glutathione metabolism	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMG200002179	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMG200002179	K00799	ko00982	Drug metabolism - cytochrome P450	673	2.8e-31	0.48	0.63	0.81
PGSC0003DMG200002180	K00799	ko00480	Glutathione metabolism	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMG200002180	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMG200002180	K00799	ko00982	Drug metabolism - cytochrome P450	707	3.7e-33	0.47	0.62	0.89
PGSC0003DMG200002182	K11808	ko00230	Purine metabolism	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMG200002182	K11808	ko01100	Metabolic pathways	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMG200002182	K11808	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.87	0.99	0.24
PGSC0003DMG200002183	K10532	ko00531	Glycosaminoglycan degradation	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMG200002183	K10532	ko01100	Metabolic pathways	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMG200002183	K10532	ko04142	Lysosome	1845	6.3e-96	0.56	0.72	0.81
PGSC0003DMG200019485	K12356	ko00940	Phenylpropanoid biosynthesis	620	2.3e-28	0.34	0.46	0.89
PGSC0003DMG200019489	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMG200019489	K12196	ko04144	Endocytosis	3228	3.3e-172	0.88	0.94	1.00
PGSC0003DMG200019490	K00430	ko00360	Phenylalanine metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMG200019490	K00430	ko00680	Methane metabolism	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMG200019490	K00430	ko00940	Phenylpropanoid biosynthesis	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMG200019490	K00430	ko01100	Metabolic pathways	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMG200019490	K00430	ko01110	Biosynthesis of secondary metabolites	1007	1.0e-49	0.43	0.61	0.99
PGSC0003DMG200019491	K00430	ko00360	Phenylalanine metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMG200019491	K00430	ko00680	Methane metabolism	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMG200019491	K00430	ko00940	Phenylpropanoid biosynthesis	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMG200019491	K00430	ko01100	Metabolic pathways	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMG200019491	K00430	ko01110	Biosynthesis of secondary metabolites	1030	5.6e-51	0.43	0.61	0.97
PGSC0003DMG200019492	K00430	ko00360	Phenylalanine metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMG200019492	K00430	ko00680	Methane metabolism	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMG200019492	K00430	ko00940	Phenylpropanoid biosynthesis	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMG200019492	K00430	ko01100	Metabolic pathways	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMG200019492	K00430	ko01110	Biosynthesis of secondary metabolites	1022	1.6e-50	0.44	0.60	0.97
PGSC0003DMG200019494	K01193	ko00052	Galactose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMG200019494	K01193	ko00500	Starch and sucrose metabolism	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMG200019494	K01193	ko01100	Metabolic pathways	679	1.3e-31	0.40	0.57	0.80
PGSC0003DMG200019494	K01193	ko00052	Galactose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMG200019494	K01193	ko00500	Starch and sucrose metabolism	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMG200019494	K01193	ko01100	Metabolic pathways	1070	3.5e-53	0.36	0.53	0.72
PGSC0003DMG200019494	K01193	ko00052	Galactose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMG200019494	K01193	ko00500	Starch and sucrose metabolism	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMG200019494	K01193	ko01100	Metabolic pathways	948	1.9e-46	0.37	0.55	0.73
PGSC0003DMG200019497	K12356	ko00940	Phenylpropanoid biosynthesis	258	9.1e-11	0.29	0.46	0.94
PGSC0003DMG200019502	K08493	ko04130	SNARE interactions in vesicular transport	1175	5.7e-59	0.78	0.89	0.99
PGSC0003DMG200019502	K08493	ko04130	SNARE interactions in vesicular transport	1512	1.5e-77	0.82	0.93	1.00
PGSC0003DMG200029565	K01867	ko00380	Tryptophan metabolism	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMG200029565	K01867	ko00970	Aminoacyl-tRNA biosynthesis	2159	3.0e-113	0.89	0.94	0.81
PGSC0003DMG200029565	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMG200029565	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMG200029565	K01867	ko00380	Tryptophan metabolism	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMG200029565	K01867	ko00970	Aminoacyl-tRNA biosynthesis	3112	8.3e-166	0.88	0.95	1.00
PGSC0003DMG200029571	K01868	ko00970	Aminoacyl-tRNA biosynthesis	1271	2.9e-64	0.74	0.87	0.98
PGSC0003DMG200029571	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4821	4.5e-260	0.82	0.91	0.99
PGSC0003DMG200029575	K00422	ko00350	Tyrosine metabolism	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMG200029575	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMG200029575	K00422	ko01100	Metabolic pathways	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMG200029575	K00422	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.45	0.60	0.99
PGSC0003DMG200029576	K00422	ko00350	Tyrosine metabolism	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMG200029576	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMG200029576	K00422	ko01100	Metabolic pathways	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMG200029576	K00422	ko01110	Biosynthesis of secondary metabolites	1936	6.0e-101	0.45	0.60	0.99
PGSC0003DMG200029579	K08300	ko03018	RNA degradation	346	2.0e-12	0.25	0.45	0.96
PGSC0003DMG200015788	K00472	ko00330	Arginine and proline metabolism	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMG200015788	K00472	ko01100	Metabolic pathways	616	3.9e-28	0.39	0.62	0.96
PGSC0003DMG200015788	K00472	ko00330	Arginine and proline metabolism	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMG200015788	K00472	ko01100	Metabolic pathways	836	2.8e-40	0.39	0.58	0.97
PGSC0003DMG200015788	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMG200015788	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMG200015788	K00472	ko00330	Arginine and proline metabolism	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMG200015788	K00472	ko01100	Metabolic pathways	499	1.1e-21	0.43	0.64	0.99
PGSC0003DMG200015793	K00100	ko00051	Fructose and mannose metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015793	K00100	ko00363	Bisphenol A degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015793	K00100	ko00591	Linoleic acid metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015793	K00100	ko00625	Tetrachloroethene degradation	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015793	K00100	ko00650	Butanoate metabolism	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015793	K00100	ko01100	Metabolic pathways	827	8.9e-40	0.45	0.59	0.92
PGSC0003DMG200015794	K11778	ko00900	Terpenoid backbone biosynthesis	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMG200015794	K11778	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.58	0.78	0.98
PGSC0003DMG200015795	K02920	ko03010	Ribosome	828	7.8e-40	0.92	0.96	0.99
PGSC0003DMG200015798	K10352	ko04530	Tight junction	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMG200015798	K10352	ko05416	Viral myocarditis	364	1.0e-11	0.26	0.49	0.91
PGSC0003DMG200015800	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200008208	K00599	ko00340	Histidine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMG200008208	K00599	ko00350	Tyrosine metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMG200008208	K00599	ko00450	Selenoamino acid metabolism	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMG200008208	K00599	ko00626	Naphthalene and anthracene degradation	660	1.4e-30	0.33	0.48	0.84
PGSC0003DMG200008208	K00599	ko00340	Histidine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMG200008208	K00599	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMG200008208	K00599	ko00450	Selenoamino acid metabolism	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMG200008208	K00599	ko00626	Naphthalene and anthracene degradation	721	6.2e-34	0.33	0.49	0.81
PGSC0003DMG200008208	K00599	ko00340	Histidine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMG200008208	K00599	ko00350	Tyrosine metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMG200008208	K00599	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMG200008208	K00599	ko00626	Naphthalene and anthracene degradation	383	2.7e-15	0.32	0.48	0.73
PGSC0003DMG200008222	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMG200008222	K00517	ko00626	Naphthalene and anthracene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMG200008222	K00517	ko00903	Limonene and pinene degradation	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMG200008222	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMG200008222	K00517	ko01110	Biosynthesis of secondary metabolites	2671	1.7e-141	0.59	0.79	0.99
PGSC0003DMG200002806	K12848	ko03040	Spliceosome	1422	1.4e-72	0.84	0.93	0.97
PGSC0003DMG200002808	K10901	ko03440	Homologous recombination	2561	2.0e-135	0.77	0.85	0.86
PGSC0003DMG200002808	K10901	ko03440	Homologous recombination	2035	2.1e-106	0.82	0.91	0.99
PGSC0003DMG200002808	K10901	ko03440	Homologous recombination	800	2.7e-38	0.74	0.88	0.87
PGSC0003DMG200002809	K10901	ko03440	Homologous recombination	632	5.0e-29	0.51	0.67	0.80
PGSC0003DMG200012812	K02603	ko04110	Cell cycle	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMG200012812	K02603	ko04111	Cell cycle - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMG200012812	K02603	ko04113	Meiosis - yeast	4374	2.0e-235	0.65	0.76	0.94
PGSC0003DMG200012812	K02603	ko04110	Cell cycle	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMG200012812	K02603	ko04111	Cell cycle - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMG200012812	K02603	ko04113	Meiosis - yeast	4255	7.5e-229	0.71	0.83	0.96
PGSC0003DMG200012812	K02603	ko04110	Cell cycle	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMG200012812	K02603	ko04111	Cell cycle - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMG200012812	K02603	ko04113	Meiosis - yeast	4994	1.3e-269	0.72	0.84	0.99
PGSC0003DMG200012812	K02603	ko04110	Cell cycle	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMG200012812	K02603	ko04111	Cell cycle - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMG200012812	K02603	ko04113	Meiosis - yeast	648	6.6e-30	0.80	0.92	0.99
PGSC0003DMG200012813	K04424	ko04010	MAPK signaling pathway	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMG200012813	K04424	ko04530	Tight junction	754	3.1e-35	0.31	0.53	0.86
PGSC0003DMG200000867	K05280	ko00941	Flavonoid biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMG200000867	K05280	ko00944	Flavone and flavonol biosynthesis	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMG200000867	K05280	ko01100	Metabolic pathways	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMG200000867	K05280	ko01110	Biosynthesis of secondary metabolites	583	2.5e-26	0.47	0.63	0.99
PGSC0003DMG200000878	K02911	ko03010	Ribosome	367	2.1e-14	0.85	0.88	0.93
PGSC0003DMG200000882	K09841	ko00906	Carotenoid biosynthesis	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMG200000882	K09841	ko01100	Metabolic pathways	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMG200000882	K09841	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.44	0.63	0.90
PGSC0003DMG200000885	K03876	ko04120	Ubiquitin mediated proteolysis	292	2.9e-10	0.31	0.49	0.67
PGSC0003DMG200046561	K03094	ko04110	Cell cycle	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04111	Cell cycle - yeast	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04114	Oocyte meiosis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04120	Ubiquitin mediated proteolysis	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04310	Wnt signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04350	TGF-beta signaling pathway	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200046561	K03094	ko04710	Circadian rhythm - mammal	274	2.8e-09	0.47	0.73	0.53
PGSC0003DMG200025206	K13065	ko00940	Phenylpropanoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMG200025206	K13065	ko00941	Flavonoid biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMG200025206	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMG200025206	K13065	ko01110	Biosynthesis of secondary metabolites	431	6.2e-18	0.29	0.47	0.82
PGSC0003DMG200025207	K04371	ko04010	MAPK signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04012	ErbB signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04013	MAPK signaling pathway - fly	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04062	Chemokine signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04114	Oocyte meiosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04150	mTOR signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04270	Vascular smooth muscle contraction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04320	Dorso-ventral axis formation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04350	TGF-beta signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04360	Axon guidance	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04370	VEGF signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04510	Focal adhesion	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04520	Adherens junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04540	Gap junction	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04620	Toll-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04621	NOD-like receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04650	Natural killer cell mediated cytotoxicity	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04660	T cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04662	B cell receptor signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04664	Fc epsilon RI signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04666	Fc gamma R-mediated phagocytosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04720	Long-term potentiation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04722	Neurotrophin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04730	Long-term depression	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04810	Regulation of actin cytoskeleton	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04910	Insulin signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04912	GnRH signaling pathway	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04914	Progesterone-mediated oocyte maturation	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04916	Melanogenesis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04930	Type II diabetes mellitus	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05010	Alzheimer's disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05020	Prion diseases	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05131	Shigellosis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05140	Leishmaniasis	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05142	Chagas disease	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05200	Pathways in cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05210	Colorectal cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05211	Renal cell carcinoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05212	Pancreatic cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05213	Endometrial cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05214	Glioma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05215	Prostate cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05216	Thyroid cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05218	Melanoma	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05219	Bladder cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05220	Chronic myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05221	Acute myeloid leukemia	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025207	K04371	ko05223	Non-small cell lung cancer	2980	1.6e-158	0.95	0.98	0.98
PGSC0003DMG200025208	K05740	ko04510	Focal adhesion	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMG200025208	K05740	ko04810	Regulation of actin cytoskeleton	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMG200025208	K05740	ko05131	Shigellosis	560	6.6e-23	0.30	0.48	0.55
PGSC0003DMG200025208	K04512	ko04310	Wnt signaling pathway	304	7.6e-08	0.32	0.52	0.35
PGSC0003DMG200025209	K05849	ko04020	Calcium signaling pathway	297	6.5e-10	0.37	0.56	0.33
PGSC0003DMG200025212	K02940	ko03010	Ribosome	1466	5.1e-75	0.91	0.96	0.99
PGSC0003DMG200025213	K01184	ko00040	Pentose and glucuronate interconversions	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMG200025213	K01184	ko00500	Starch and sucrose metabolism	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMG200025213	K01184	ko01100	Metabolic pathways	1643	8.7e-85	0.51	0.69	0.96
PGSC0003DMG200025213	K01184	ko00040	Pentose and glucuronate interconversions	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMG200025213	K01184	ko00500	Starch and sucrose metabolism	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMG200025213	K01184	ko01100	Metabolic pathways	1007	1.0e-49	0.53	0.72	0.99
PGSC0003DMG200025214	K08803	ko05200	Pathways in cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMG200025214	K08803	ko05219	Bladder cancer	497	1.2e-20	0.33	0.52	0.57
PGSC0003DMG200031273	K05277	ko00941	Flavonoid biosynthesis	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200031273	K05277	ko01100	Metabolic pathways	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200031273	K05277	ko01110	Biosynthesis of secondary metabolites	296	1.7e-10	0.34	0.52	0.77
PGSC0003DMG200031286	K02183	ko04020	Calcium signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04070	Phosphatidylinositol signaling system	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04114	Oocyte meiosis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04270	Vascular smooth muscle contraction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04626	Plant-pathogen interaction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04720	Long-term potentiation	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04722	Neurotrophin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04740	Olfactory transduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04744	Phototransduction	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04745	Phototransduction - fly	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04910	Insulin signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04912	GnRH signaling pathway	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04916	Melanogenesis	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04970	Salivary secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko04971	Gastric acid secretion	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko05010	Alzheimer's disease	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200031286	K02183	ko05214	Glioma	251	5.2e-08	0.33	0.49	0.66
PGSC0003DMG200028636	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMG200028636	K01687	ko00770	Pantothenate and CoA biosynthesis	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMG200028636	K01687	ko01100	Metabolic pathways	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMG200028636	K01687	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.82	0.94	0.99
PGSC0003DMG200028636	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMG200028636	K01687	ko00770	Pantothenate and CoA biosynthesis	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMG200028636	K01687	ko01100	Metabolic pathways	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMG200028636	K01687	ko01110	Biosynthesis of secondary metabolites	4329	6.2e-233	0.82	0.91	1.00
PGSC0003DMG200028642	K00413	ko00190	Oxidative phosphorylation	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko01100	Metabolic pathways	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko04260	Cardiac muscle contraction	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko05010	Alzheimer's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko05012	Parkinson's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko05016	Huntington's disease	1304	4.4e-66	0.70	0.79	0.97
PGSC0003DMG200028642	K00413	ko00190	Oxidative phosphorylation	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028642	K00413	ko01100	Metabolic pathways	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028642	K00413	ko04260	Cardiac muscle contraction	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028642	K00413	ko05010	Alzheimer's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028642	K00413	ko05012	Parkinson's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028642	K00413	ko05016	Huntington's disease	2290	1.8e-120	0.83	0.90	1.00
PGSC0003DMG200028647	K11152	ko00830	Retinol metabolism	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMG200028647	K11152	ko01100	Metabolic pathways	220	2.7e-06	0.28	0.52	0.87
PGSC0003DMG200028650	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2360	2.5e-124	0.69	0.83	0.99
PGSC0003DMG200028651	K10256	ko01040	Biosynthesis of unsaturated fatty acids	833	4.1e-40	0.78	0.90	0.98
PGSC0003DMG200028652	K13083	ko00941	Flavonoid biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMG200028652	K13083	ko00944	Flavone and flavonol biosynthesis	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMG200028652	K13083	ko01110	Biosynthesis of secondary metabolites	732	1.5e-34	0.49	0.67	0.94
PGSC0003DMG200017923	K12929	ko00904	Diterpenoid biosynthesis	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMG200017923	K12929	ko01110	Biosynthesis of secondary metabolites	941	4.6e-46	0.36	0.55	0.98
PGSC0003DMG200017924	K12929	ko00904	Diterpenoid biosynthesis	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMG200017924	K12929	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.33	0.53	0.98
PGSC0003DMG200017924	K12929	ko00904	Diterpenoid biosynthesis	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMG200017924	K12929	ko01110	Biosynthesis of secondary metabolites	372	1.5e-14	0.32	0.54	0.96
PGSC0003DMG200017929	K01051	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMG200017929	K01051	ko00500	Starch and sucrose metabolism	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMG200017929	K01051	ko01100	Metabolic pathways	1447	5.6e-74	0.58	0.70	0.85
PGSC0003DMG200017929	K01051	ko00040	Pentose and glucuronate interconversions	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMG200017929	K01051	ko00500	Starch and sucrose metabolism	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMG200017929	K01051	ko01100	Metabolic pathways	1276	1.5e-64	0.64	0.76	0.92
PGSC0003DMG200017930	K10527	ko00592	alpha-Linolenic acid metabolism	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMG200017930	K10527	ko01100	Metabolic pathways	3175	2.8e-169	0.58	0.77	0.92
PGSC0003DMG200017930	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMG200017930	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMG200017930	K10527	ko00592	alpha-Linolenic acid metabolism	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMG200017930	K10527	ko01100	Metabolic pathways	3419	9.7e-183	0.58	0.77	0.97
PGSC0003DMG200017930	K10527	ko00592	alpha-Linolenic acid metabolism	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMG200017930	K10527	ko01100	Metabolic pathways	1305	3.8e-66	0.56	0.76	0.99
PGSC0003DMG200017933	K02885	ko03010	Ribosome	1654	2.2e-85	0.93	0.96	1.00
PGSC0003DMG200017934	K01213	ko00040	Pentose and glucuronate interconversions	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMG200017934	K01213	ko00500	Starch and sucrose metabolism	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMG200017934	K01213	ko01100	Metabolic pathways	1354	7.6e-69	0.43	0.63	0.97
PGSC0003DMG200017934	K01051	ko00040	Pentose and glucuronate interconversions	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMG200017934	K01051	ko00500	Starch and sucrose metabolism	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMG200017934	K01051	ko01100	Metabolic pathways	1526	2.5e-78	0.69	0.81	0.98
PGSC0003DMG200017934	K01051	ko00040	Pentose and glucuronate interconversions	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMG200017934	K01051	ko00500	Starch and sucrose metabolism	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMG200017934	K01051	ko01100	Metabolic pathways	2090	1.9e-109	0.50	0.64	0.98
PGSC0003DMG200017937	K05849	ko04020	Calcium signaling pathway	1488	3.1e-76	0.81	0.92	0.99
PGSC0003DMG200017937	K05849	ko04020	Calcium signaling pathway	2887	2.1e-153	0.53	0.60	0.97
PGSC0003DMG200024210	K03037	ko03050	Proteasome	459	1.8e-19	0.61	0.81	0.61
PGSC0003DMG200024210	K03037	ko03050	Proteasome	2100	5.4e-110	0.93	0.97	0.99
PGSC0003DMG200024210	K03037	ko03050	Proteasome	2784	1.0e-147	0.87	0.94	1.00
PGSC0003DMG200024212	K00945	ko00240	Pyrimidine metabolism	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMG200024212	K00945	ko01100	Metabolic pathways	1115	1.2e-55	0.70	0.87	0.85
PGSC0003DMG200024212	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200024212	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200024212	K00945	ko00240	Pyrimidine metabolism	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMG200024212	K00945	ko01100	Metabolic pathways	1050	4.4e-52	0.69	0.87	0.90
PGSC0003DMG200024212	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200024212	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200024212	K00945	ko00240	Pyrimidine metabolism	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200024212	K00945	ko01100	Metabolic pathways	1163	2.6e-58	0.68	0.85	0.90
PGSC0003DMG200014582	K00287	ko00670	One carbon pool by folate	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMG200014582	K00287	ko00790	Folate biosynthesis	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMG200014582	K00287	ko01100	Metabolic pathways	230	1.3e-06	0.31	0.44	0.91
PGSC0003DMG200014584	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMG200014584	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMG200014584	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.45	0.93
PGSC0003DMG200014589	K02183	ko04020	Calcium signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04070	Phosphatidylinositol signaling system	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04114	Oocyte meiosis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04270	Vascular smooth muscle contraction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04626	Plant-pathogen interaction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04720	Long-term potentiation	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04722	Neurotrophin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04740	Olfactory transduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04744	Phototransduction	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04745	Phototransduction - fly	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04910	Insulin signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04912	GnRH signaling pathway	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04916	Melanogenesis	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04970	Salivary secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko04971	Gastric acid secretion	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko05010	Alzheimer's disease	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014589	K02183	ko05214	Glioma	508	3.5e-22	0.36	0.62	0.57
PGSC0003DMG200014592	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMG200014592	K01915	ko00330	Arginine and proline metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMG200014592	K01915	ko00910	Nitrogen metabolism	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMG200014592	K01915	ko01100	Metabolic pathways	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMG200014592	K01915	ko02020	Two-component system	2820	1.1e-149	0.87	0.96	1.00
PGSC0003DMG200014595	K04503	ko04110	Cell cycle	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko04115	p53 signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko04310	Wnt signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko04510	Focal adhesion	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko04630	Jak-STAT signaling pathway	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05200	Pathways in cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05210	Colorectal cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05212	Pancreatic cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05213	Endometrial cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05214	Glioma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05215	Prostate cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05216	Thyroid cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05218	Melanoma	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05219	Bladder cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05220	Chronic myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05221	Acute myeloid leukemia	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05222	Small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05223	Non-small cell lung cancer	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200014595	K04503	ko05416	Viral myocarditis	327	3.4e-12	0.32	0.52	0.69
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	2150	9.5e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	1265	6.2e-64	0.55	0.76	0.80
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	2152	7.4e-113	0.51	0.73	0.96
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	393	7.7e-16	0.56	0.78	0.99
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	1200	2.4e-60	0.54	0.75	0.99
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	710	2.5e-33	0.58	0.76	0.99
PGSC0003DMG200007074	K07424	ko00140	Steroid hormone biosynthesis	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00591	Linoleic acid metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00830	Retinol metabolism	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00982	Drug metabolism - cytochrome P450	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko00983	Drug metabolism - other enzymes	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007074	K07424	ko01100	Metabolic pathways	1879	8.4e-98	0.55	0.75	1.00
PGSC0003DMG200007075	K07424	ko00140	Steroid hormone biosynthesis	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00591	Linoleic acid metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00830	Retinol metabolism	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00982	Drug metabolism - cytochrome P450	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00983	Drug metabolism - other enzymes	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko01100	Metabolic pathways	497	1.4e-21	0.53	0.76	0.97
PGSC0003DMG200007075	K07424	ko00140	Steroid hormone biosynthesis	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00591	Linoleic acid metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00830	Retinol metabolism	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00982	Drug metabolism - cytochrome P450	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko00983	Drug metabolism - other enzymes	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007075	K07424	ko01100	Metabolic pathways	531	1.9e-23	0.58	0.79	0.99
PGSC0003DMG200007076	K07424	ko00140	Steroid hormone biosynthesis	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00591	Linoleic acid metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00830	Retinol metabolism	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00982	Drug metabolism - cytochrome P450	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko00983	Drug metabolism - other enzymes	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007076	K07424	ko01100	Metabolic pathways	283	1.5e-09	0.48	0.61	0.42
PGSC0003DMG200007078	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko00650	Butanoate metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko00660	C5-Branched dibasic acid metabolism	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko00770	Pantothenate and CoA biosynthesis	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko01100	Metabolic pathways	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko01110	Biosynthesis of secondary metabolites	3844	3.5e-206	0.72	0.79	1.00
PGSC0003DMG200007078	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007078	K01652	ko00650	Butanoate metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007078	K01652	ko00660	C5-Branched dibasic acid metabolism	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007078	K01652	ko00770	Pantothenate and CoA biosynthesis	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007078	K01652	ko01100	Metabolic pathways	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007078	K01652	ko01110	Biosynthesis of secondary metabolites	4552	3.1e-245	0.82	0.89	1.00
PGSC0003DMG200007080	K09647	ko03060	Protein export	757	6.4e-36	0.72	0.84	0.99
PGSC0003DMG200007081	K02523	ko00900	Terpenoid backbone biosynthesis	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMG200007081	K02523	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.85	1.00
PGSC0003DMG200007081	K02523	ko00900	Terpenoid backbone biosynthesis	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMG200007081	K02523	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.83	0.94	1.00
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	541	1.3e-23	0.64	0.77	0.96
PGSC0003DMG200010570	K08332	ko04140	Regulation of autophagy	235	1.2e-06	0.29	0.51	0.64
PGSC0003DMG200010574	K08065	ko04612	Antigen processing and presentation	614	5.0e-28	0.54	0.71	0.92
PGSC0003DMG200010574	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMG200010574	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMG200010574	K08065	ko04612	Antigen processing and presentation	596	4.9e-27	0.67	0.85	0.77
PGSC0003DMG200010576	K12831	ko03040	Spliceosome	368	1.9e-13	0.38	0.44	0.12
PGSC0003DMG200010577	K04733	ko04210	Apoptosis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMG200010577	K04733	ko04620	Toll-like receptor signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMG200010577	K04733	ko04722	Neurotrophin signaling pathway	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMG200010577	K04733	ko05140	Leishmaniasis	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMG200010577	K04733	ko05142	Chagas disease	2185	1.1e-114	0.42	0.59	0.90
PGSC0003DMG200010578	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMG200010578	K00517	ko00626	Naphthalene and anthracene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMG200010578	K00517	ko00903	Limonene and pinene degradation	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMG200010578	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMG200010578	K00517	ko01110	Biosynthesis of secondary metabolites	3205	6.1e-171	0.73	0.85	1.00
PGSC0003DMG200010580	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMG200010580	K01358	ko04112	Cell cycle - Caulobacter	1645	6.8e-85	0.88	0.96	0.90
PGSC0003DMG200010585	K12929	ko00904	Diterpenoid biosynthesis	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMG200010585	K12929	ko01110	Biosynthesis of secondary metabolites	1252	3.2e-63	0.39	0.64	0.97
PGSC0003DMG200010587	K12929	ko00904	Diterpenoid biosynthesis	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMG200010587	K12929	ko01110	Biosynthesis of secondary metabolites	1558	4.3e-80	0.39	0.61	0.97
PGSC0003DMG200010588	K12868	ko03040	Spliceosome	1866	4.4e-97	0.73	0.82	1.00
PGSC0003DMG200010589	K12868	ko03040	Spliceosome	742	4.3e-35	0.44	0.51	0.99
PGSC0003DMG200040358	K03715	ko00561	Glycerolipid metabolism	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMG200040358	K03715	ko01100	Metabolic pathways	689	3.6e-32	0.65	0.71	0.41
PGSC0003DMG200000946	K00967	ko00440	Phosphonate and phosphinate metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMG200000946	K00967	ko00564	Glycerophospholipid metabolism	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMG200000946	K00967	ko01100	Metabolic pathways	233	5.4e-07	0.74	0.86	0.50
PGSC0003DMG200000948	K00432	ko00480	Glutathione metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMG200000948	K00432	ko00590	Arachidonic acid metabolism	1074	2.1e-53	0.75	0.86	0.89
PGSC0003DMG200000948	K00432	ko00480	Glutathione metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMG200000948	K00432	ko00590	Arachidonic acid metabolism	1136	8.0e-57	0.78	0.89	0.99
PGSC0003DMG200000957	K10760	ko00908	Zeatin biosynthesis	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMG200000957	K10760	ko01100	Metabolic pathways	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMG200000957	K10760	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.50	0.68	0.98
PGSC0003DMG200015620	K11422	ko00310	Lysine degradation	384	1.2e-16	0.46	0.59	0.15
PGSC0003DMG200011614	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	407	5.1e-16	0.30	0.43	0.93
PGSC0003DMG200011615	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMG200011615	K12567	ko05414	Dilated cardiomyopathy	354	9.4e-11	0.35	0.45	0.77
PGSC0003DMG200011619	K00002	ko00010	Glycolysis / Gluconeogenesis	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMG200011619	K00002	ko00561	Glycerolipid metabolism	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMG200011619	K00002	ko00930	Caprolactam degradation	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMG200011619	K00002	ko01100	Metabolic pathways	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMG200011619	K00002	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.47	0.62	0.95
PGSC0003DMG200011640	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMG200011640	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMG200011640	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMG200011640	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMG200011640	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.75	0.85	1.00
PGSC0003DMG200004916	K04371	ko04010	MAPK signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04012	ErbB signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04013	MAPK signaling pathway - fly	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04062	Chemokine signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04114	Oocyte meiosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04150	mTOR signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04270	Vascular smooth muscle contraction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04320	Dorso-ventral axis formation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04350	TGF-beta signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04360	Axon guidance	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04370	VEGF signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04510	Focal adhesion	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04520	Adherens junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04540	Gap junction	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04620	Toll-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04621	NOD-like receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04650	Natural killer cell mediated cytotoxicity	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04660	T cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04662	B cell receptor signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04664	Fc epsilon RI signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04666	Fc gamma R-mediated phagocytosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04720	Long-term potentiation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04722	Neurotrophin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04730	Long-term depression	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04810	Regulation of actin cytoskeleton	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04910	Insulin signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04912	GnRH signaling pathway	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04914	Progesterone-mediated oocyte maturation	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04916	Melanogenesis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04930	Type II diabetes mellitus	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko04960	Aldosterone-regulated sodium reabsorption	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05010	Alzheimer's disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05020	Prion diseases	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05131	Shigellosis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05140	Leishmaniasis	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05142	Chagas disease	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05200	Pathways in cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05210	Colorectal cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05211	Renal cell carcinoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05212	Pancreatic cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05213	Endometrial cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05214	Glioma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05215	Prostate cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05216	Thyroid cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05218	Melanoma	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05219	Bladder cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05220	Chronic myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05221	Acute myeloid leukemia	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004916	K04371	ko05223	Non-small cell lung cancer	245	3.1e-07	0.36	0.64	0.74
PGSC0003DMG200004919	K12741	ko03040	Spliceosome	1048	5.7e-52	0.44	0.58	0.96
PGSC0003DMG200004922	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.85
PGSC0003DMG200004922	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMG200004922	K12126	ko04712	Circadian rhythm - plant	383	2.7e-15	0.29	0.48	0.78
PGSC0003DMG200004923	K00511	ko00100	Steroid biosynthesis	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMG200004923	K00511	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMG200004923	K00511	ko01110	Biosynthesis of secondary metabolites	3635	1.2e-194	0.82	0.90	1.00
PGSC0003DMG200004923	K00511	ko00100	Steroid biosynthesis	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMG200004923	K00511	ko01100	Metabolic pathways	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMG200004923	K00511	ko01110	Biosynthesis of secondary metabolites	246	2.2e-07	0.48	0.64	0.92
PGSC0003DMG200004923	K00511	ko00100	Steroid biosynthesis	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMG200004923	K00511	ko01100	Metabolic pathways	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMG200004923	K00511	ko01110	Biosynthesis of secondary metabolites	736	9.3e-35	0.90	0.97	0.89
PGSC0003DMG200004925	K01762	ko00270	Cysteine and methionine metabolism	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMG200004925	K01762	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.66	0.80	0.99
PGSC0003DMG200012859	K12476	ko04144	Endocytosis	1866	4.4e-97	0.54	0.72	0.77
PGSC0003DMG200012862	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.73
PGSC0003DMG200012862	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMG200012862	K01199	ko00500	Starch and sucrose metabolism	902	6.5e-44	0.38	0.58	0.72
PGSC0003DMG200012862	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMG200012862	K01199	ko00500	Starch and sucrose metabolism	892	2.3e-43	0.38	0.58	0.85
PGSC0003DMG200012863	K08770	ko03320	PPAR signaling pathway	376	6.7e-15	0.36	0.55	0.93
PGSC0003DMG200012865	K12606	ko03018	RNA degradation	1090	2.8e-54	0.57	0.60	0.99
PGSC0003DMG200012865	K12606	ko03018	RNA degradation	2198	2.1e-115	0.94	0.97	1.00
PGSC0003DMG200012868	K00995	ko00564	Glycerophospholipid metabolism	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMG200012868	K00995	ko01100	Metabolic pathways	482	9.5e-21	0.52	0.60	0.82
PGSC0003DMG200002483	K00679	ko00561	Glycerolipid metabolism	1312	1.6e-66	0.36	0.51	0.90
PGSC0003DMG200002483	K00679	ko00561	Glycerolipid metabolism	226	3.0e-06	0.53	0.71	0.31
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	495	1.8e-21	0.61	0.78	0.54
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	440	2.0e-18	0.40	0.61	0.91
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	643	1.2e-29	0.44	0.63	0.68
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	582	2.9e-26	0.58	0.76	0.57
PGSC0003DMG200002484	K08064	ko04612	Antigen processing and presentation	483	8.3e-21	0.65	0.78	0.52
PGSC0003DMG200002486	K01733	ko00260	Glycine, serine and threonine metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMG200002486	K01733	ko00750	Vitamin B6 metabolism	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMG200002486	K01733	ko01100	Metabolic pathways	3703	2.1e-198	0.84	0.90	1.00
PGSC0003DMG200029613	K03046	ko00230	Purine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMG200029613	K03046	ko00240	Pyrimidine metabolism	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMG200029613	K03046	ko01100	Metabolic pathways	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMG200029613	K03046	ko03020	RNA polymerase	3242	5.6e-173	0.92	0.96	1.00
PGSC0003DMG200029615	K01519	ko00230	Purine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMG200029615	K01519	ko00240	Pyrimidine metabolism	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMG200029615	K01519	ko00983	Drug metabolism - other enzymes	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMG200029615	K01519	ko01100	Metabolic pathways	1447	5.6e-74	0.83	0.90	0.98
PGSC0003DMG200029615	K01519	ko00230	Purine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMG200029615	K01519	ko00240	Pyrimidine metabolism	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMG200029615	K01519	ko00983	Drug metabolism - other enzymes	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMG200029615	K01519	ko01100	Metabolic pathways	802	2.1e-38	0.74	0.82	0.93
PGSC0003DMG200029616	K03505	ko00230	Purine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko00240	Pyrimidine metabolism	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko01100	Metabolic pathways	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko03030	DNA replication	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko03410	Base excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko03420	Nucleotide excision repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko03430	Mismatch repair	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029616	K03505	ko03440	Homologous recombination	675	2.1e-31	0.63	0.81	0.99
PGSC0003DMG200029617	K04424	ko04010	MAPK signaling pathway	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMG200029617	K04424	ko04530	Tight junction	716	3.8e-33	0.32	0.48	0.36
PGSC0003DMG200029617	K04424	ko04010	MAPK signaling pathway	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMG200029617	K04424	ko04530	Tight junction	702	2.4e-32	0.32	0.48	0.36
PGSC0003DMG200029617	K04423	ko04010	MAPK signaling pathway	492	6.2e-21	0.42	0.57	0.88
PGSC0003DMG200029618	K00632	ko00071	Fatty acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko00280	Valine, leucine and isoleucine degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko00281	Geraniol degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko00362	Benzoate degradation via hydroxylation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko00592	alpha-Linolenic acid metabolism	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko00642	Ethylbenzene degradation	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko01100	Metabolic pathways	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029618	K00632	ko01110	Biosynthesis of secondary metabolites	3420	8.5e-183	0.87	0.95	1.00
PGSC0003DMG200029620	K00660	ko00941	Flavonoid biosynthesis	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMG200029620	K00660	ko01100	Metabolic pathways	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMG200029620	K00660	ko01110	Biosynthesis of secondary metabolites	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMG200029620	K00660	ko04712	Circadian rhythm - plant	2969	6.4e-158	0.90	0.96	1.00
PGSC0003DMG200029621	K00660	ko00941	Flavonoid biosynthesis	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMG200029621	K00660	ko01100	Metabolic pathways	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMG200029621	K00660	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMG200029621	K00660	ko04712	Circadian rhythm - plant	2691	1.4e-142	0.83	0.93	1.00
PGSC0003DMG200029622	K02941	ko03010	Ribosome	1877	1.1e-97	0.81	0.90	0.99
PGSC0003DMG200029623	K08241	ko00592	alpha-Linolenic acid metabolism	655	1.0e-34	0.45	0.63	0.98
PGSC0003DMG200029623	K08241	ko00592	alpha-Linolenic acid metabolism	1168	1.4e-58	0.44	0.59	0.99
PGSC0003DMG200029624	K08241	ko00592	alpha-Linolenic acid metabolism	547	2.5e-24	0.49	0.60	0.99
PGSC0003DMG200029624	K08241	ko00592	alpha-Linolenic acid metabolism	471	3.8e-20	0.45	0.65	0.86
PGSC0003DMG200029626	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMG200029626	K06126	ko01100	Metabolic pathways	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMG200029626	K06126	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.71	0.86	1.00
PGSC0003DMG200029626	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029626	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029626	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029626	K06126	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029626	K06126	ko01100	Metabolic pathways	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029626	K06126	ko01110	Biosynthesis of secondary metabolites	2665	3.7e-141	0.71	0.85	1.00
PGSC0003DMG200029627	K12741	ko03040	Spliceosome	463	1.1e-19	0.43	0.53	0.51
PGSC0003DMG200019087	K10845	ko03420	Nucleotide excision repair	449	6.3e-19	0.74	0.88	0.97
PGSC0003DMG200019091	K05350	ko00460	Cyanoamino acid metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko00500	Starch and sucrose metabolism	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko00940	Phenylpropanoid biosynthesis	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko01110	Biosynthesis of secondary metabolites	3320	2.8e-177	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko00460	Cyanoamino acid metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko00500	Starch and sucrose metabolism	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko00940	Phenylpropanoid biosynthesis	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMG200019091	K05350	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.75	0.88	0.99
PGSC0003DMG200019097	K10879	ko03440	Homologous recombination	603	2.0e-27	0.64	0.79	0.84
PGSC0003DMG200019109	K03505	ko00230	Purine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko00240	Pyrimidine metabolism	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko01100	Metabolic pathways	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko03030	DNA replication	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko03410	Base excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko03420	Nucleotide excision repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko03430	Mismatch repair	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019109	K03505	ko03440	Homologous recombination	603	2.0e-27	0.55	0.75	0.99
PGSC0003DMG200019110	K00660	ko00941	Flavonoid biosynthesis	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMG200019110	K00660	ko01100	Metabolic pathways	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMG200019110	K00660	ko01110	Biosynthesis of secondary metabolites	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMG200019110	K00660	ko04712	Circadian rhythm - plant	2961	1.8e-157	0.89	0.96	0.99
PGSC0003DMG200019111	K08241	ko00592	alpha-Linolenic acid metabolism	1074	2.1e-53	0.42	0.60	0.99
PGSC0003DMG200019113	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200019113	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200019113	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200019113	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200019113	K01874	ko00450	Selenoamino acid metabolism	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200019113	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1548	1.5e-79	0.77	0.86	1.00
PGSC0003DMG200038420	K11816	ko00380	Tryptophan metabolism	304	4.6e-18	0.46	0.63	0.94
PGSC0003DMG200038422	K10760	ko00908	Zeatin biosynthesis	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMG200038422	K10760	ko01100	Metabolic pathways	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMG200038422	K10760	ko01110	Biosynthesis of secondary metabolites	838	2.2e-40	0.49	0.67	0.97
PGSC0003DMG200038434	K05282	ko00904	Diterpenoid biosynthesis	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMG200038434	K05282	ko01100	Metabolic pathways	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMG200038434	K05282	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.64	0.76	0.91
PGSC0003DMG200003507	K01103	ko00051	Fructose and mannose metabolism	393	8.9e-13	0.31	0.51	0.52
PGSC0003DMG200003507	K01103	ko00051	Fructose and mannose metabolism	385	4.5e-14	0.31	0.51	0.58
PGSC0003DMG200003507	K01103	ko00051	Fructose and mannose metabolism	393	1.5e-12	0.31	0.51	0.49
PGSC0003DMG200003507	K01103	ko00051	Fructose and mannose metabolism	393	5.8e-13	0.25	0.43	0.84
PGSC0003DMG200003509	K10702	ko00642	Ethylbenzene degradation	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMG200003509	K10702	ko01100	Metabolic pathways	301	9.1e-11	0.26	0.45	0.81
PGSC0003DMG200003512	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMG200003512	K00368	ko00910	Nitrogen metabolism	1761	2.7e-91	0.45	0.61	0.92
PGSC0003DMG200003512	K00368	ko00910	Nitrogen metabolism	1775	4.6e-92	0.46	0.61	0.92
PGSC0003DMG200003512	K00368	ko00910	Nitrogen metabolism	1747	1.6e-90	0.46	0.62	0.88
PGSC0003DMG200003514	K01507	ko00190	Oxidative phosphorylation	1637	1.9e-84	0.90	0.94	0.99
PGSC0003DMG200003514	K01507	ko00190	Oxidative phosphorylation	1341	4.0e-68	0.90	0.94	0.88
PGSC0003DMG200003515	K00680	ko00350	Tyrosine metabolism	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMG200003515	K00680	ko00624	1- and 2-Methylnaphthalene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMG200003515	K00680	ko00632	Benzoate degradation via CoA ligation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMG200003515	K00680	ko00642	Ethylbenzene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMG200003515	K00680	ko00903	Limonene and pinene degradation	533	1.5e-23	0.44	0.61	0.65
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	1584	1.6e-81	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	1588	9.4e-82	0.71	0.84	0.94
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	620	2.3e-28	0.71	0.85	0.99
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	5006	2.8e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	3270	1.6e-174	0.65	0.79	0.97
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	5008	2.2e-270	0.67	0.82	1.00
PGSC0003DMG200014631	K00454	ko00591	Linoleic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMG200014631	K00454	ko00592	alpha-Linolenic acid metabolism	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMG200014631	K00454	ko01100	Metabolic pathways	4975	1.5e-268	0.67	0.81	1.00
PGSC0003DMG200014637	K00754	ko00051	Fructose and mannose metabolism	342	6.3e-13	0.27	0.44	0.89
PGSC0003DMG200014640	K10844	ko03420	Nucleotide excision repair	557	6.9e-25	0.86	0.93	0.90
PGSC0003DMG200014640	K10844	ko03420	Nucleotide excision repair	4707	8.8e-254	0.81	0.91	0.99
PGSC0003DMG200014640	K10844	ko03420	Nucleotide excision repair	4507	9.5e-243	0.81	0.91	0.99
PGSC0003DMG200014643	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.48	0.63	0.92
PGSC0003DMG200014645	K12890	ko03040	Spliceosome	1669	3.2e-86	0.81	0.87	0.83
PGSC0003DMG200016953	K00368	ko00910	Nitrogen metabolism	1047	6.5e-52	0.35	0.47	0.90
PGSC0003DMG200016958	K01922	ko00770	Pantothenate and CoA biosynthesis	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMG200016958	K01922	ko01100	Metabolic pathways	865	7.1e-42	0.44	0.62	0.84
PGSC0003DMG200016958	K01922	ko00770	Pantothenate and CoA biosynthesis	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMG200016958	K01922	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.68	0.89
PGSC0003DMG200016958	K01922	ko00770	Pantothenate and CoA biosynthesis	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMG200016958	K01922	ko01100	Metabolic pathways	978	4.2e-48	0.46	0.63	0.93
PGSC0003DMG200016958	K01922	ko00770	Pantothenate and CoA biosynthesis	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMG200016958	K01922	ko01100	Metabolic pathways	634	3.9e-29	0.42	0.61	0.94
PGSC0003DMG200016959	K02113	ko00190	Oxidative phosphorylation	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMG200016959	K02113	ko00195	Photosynthesis	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMG200016959	K02113	ko01100	Metabolic pathways	1265	6.2e-64	0.65	0.78	0.99
PGSC0003DMG200016960	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMG200016960	K00517	ko00626	Naphthalene and anthracene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMG200016960	K00517	ko00903	Limonene and pinene degradation	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMG200016960	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMG200016960	K00517	ko01110	Biosynthesis of secondary metabolites	2754	4.6e-146	0.62	0.77	0.98
PGSC0003DMG200016961	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	444	1.2e-18	0.38	0.51	0.65
PGSC0003DMG200016965	K01179	ko00500	Starch and sucrose metabolism	291	1.6e-07	0.26	0.41	0.67
PGSC0003DMG200010386	K00026	ko00020	Citrate cycle (TCA cycle)	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00620	Pyruvate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00710	Carbon fixation in photosynthetic organisms	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko01100	Metabolic pathways	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko01110	Biosynthesis of secondary metabolites	2593	3.5e-137	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00020	Citrate cycle (TCA cycle)	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00620	Pyruvate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00710	Carbon fixation in photosynthetic organisms	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko01100	Metabolic pathways	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.89	0.93	0.98
PGSC0003DMG200010386	K00026	ko00020	Citrate cycle (TCA cycle)	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010386	K00026	ko00620	Pyruvate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010386	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010386	K00026	ko00710	Carbon fixation in photosynthetic organisms	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010386	K00026	ko01100	Metabolic pathways	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010386	K00026	ko01110	Biosynthesis of secondary metabolites	2129	1.4e-111	0.93	0.96	0.88
PGSC0003DMG200010391	K10591	ko04120	Ubiquitin mediated proteolysis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMG200010391	K10591	ko04144	Endocytosis	237	1.6e-06	0.31	0.55	0.80
PGSC0003DMG200010391	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMG200010391	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.45	0.56	0.55
PGSC0003DMG200010391	K01613	ko00564	Glycerophospholipid metabolism	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMG200010391	K01613	ko01100	Metabolic pathways	228	8.9e-06	0.44	0.58	0.55
PGSC0003DMG200010391	K10591	ko04120	Ubiquitin mediated proteolysis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMG200010391	K10591	ko04144	Endocytosis	234	3.0e-06	0.34	0.58	0.63
PGSC0003DMG200010392	K02183	ko04020	Calcium signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04070	Phosphatidylinositol signaling system	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04114	Oocyte meiosis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04270	Vascular smooth muscle contraction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04626	Plant-pathogen interaction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04720	Long-term potentiation	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04722	Neurotrophin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04740	Olfactory transduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04744	Phototransduction	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04745	Phototransduction - fly	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04910	Insulin signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04912	GnRH signaling pathway	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04916	Melanogenesis	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04970	Salivary secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko04971	Gastric acid secretion	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko05010	Alzheimer's disease	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010392	K02183	ko05214	Glioma	269	5.3e-09	0.45	0.65	0.87
PGSC0003DMG200010399	K01809	ko00051	Fructose and mannose metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMG200010399	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMG200010399	K01809	ko01100	Metabolic pathways	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMG200010399	K01809	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.66	0.81	1.00
PGSC0003DMG200031334	K10609	ko03420	Nucleotide excision repair	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMG200031334	K10609	ko04120	Ubiquitin mediated proteolysis	331	8.2e-12	0.57	0.65	0.62
PGSC0003DMG200031334	K10609	ko03420	Nucleotide excision repair	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMG200031334	K10609	ko04120	Ubiquitin mediated proteolysis	2694	9.4e-143	0.87	0.92	0.79
PGSC0003DMG200031334	K10609	ko03420	Nucleotide excision repair	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMG200031334	K10609	ko04120	Ubiquitin mediated proteolysis	2893	9.9e-154	0.92	0.96	0.98
PGSC0003DMG200031334	K10609	ko03420	Nucleotide excision repair	5917	0.	0.89	0.93	0.95
PGSC0003DMG200031334	K10609	ko04120	Ubiquitin mediated proteolysis	5917	0.	0.89	0.93	0.95
PGSC0003DMG200031340	K13034	ko00270	Cysteine and methionine metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMG200031340	K13034	ko00450	Selenoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMG200031340	K13034	ko00460	Cyanoamino acid metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMG200031340	K13034	ko00920	Sulfur metabolism	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMG200031340	K13034	ko01100	Metabolic pathways	353	1.2e-13	0.54	0.60	0.47
PGSC0003DMG200031344	K01051	ko00040	Pentose and glucuronate interconversions	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMG200031344	K01051	ko00500	Starch and sucrose metabolism	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMG200031344	K01051	ko01100	Metabolic pathways	1284	5.5e-65	0.38	0.53	1.00
PGSC0003DMG200031344	K01051	ko00040	Pentose and glucuronate interconversions	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMG200031344	K01051	ko00500	Starch and sucrose metabolism	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMG200031344	K01051	ko01100	Metabolic pathways	908	3.0e-44	0.50	0.66	0.99
PGSC0003DMG200031345	K02964	ko03010	Ribosome	1229	6.0e-62	0.94	0.98	0.99
PGSC0003DMG200021596	K02866	ko03010	Ribosome	710	2.5e-33	0.43	0.60	0.84
PGSC0003DMG200021602	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	754	9.4e-36	0.39	0.57	0.76
PGSC0003DMG200021607	K04536	ko04062	Chemokine signaling pathway	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMG200021607	K04536	ko04742	Taste transduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMG200021607	K04536	ko04744	Phototransduction	298	1.3e-10	0.30	0.44	0.61
PGSC0003DMG200021607	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMG200021607	K12662	ko03040	Spliceosome	260	3.1e-08	0.30	0.52	0.88
PGSC0003DMG200018479	K05681	ko02010	ABC transporters	995	4.8e-49	0.36	0.56	0.99
PGSC0003DMG200018479	K05681	ko02010	ABC transporters	1415	3.3e-72	0.37	0.57	0.94
PGSC0003DMG200018479	K05681	ko02010	ABC transporters	1409	7.0e-72	0.37	0.57	0.94
PGSC0003DMG200018480	K09840	ko00906	Carotenoid biosynthesis	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMG200018480	K09840	ko01100	Metabolic pathways	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMG200018480	K09840	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.39	0.60	0.97
PGSC0003DMG200018481	K09840	ko00906	Carotenoid biosynthesis	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMG200018481	K09840	ko01100	Metabolic pathways	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMG200018481	K09840	ko01110	Biosynthesis of secondary metabolites	1451	3.4e-74	0.36	0.57	0.95
PGSC0003DMG200018489	K11984	ko03040	Spliceosome	370	9.6e-14	0.30	0.46	0.68
PGSC0003DMG200018490	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko04115	p53 signaling pathway	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko04210	Apoptosis	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05010	Alzheimer's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05012	Parkinson's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05016	Huntington's disease	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200018490	K02084	ko05222	Small cell lung cancer	291	1.7e-06	0.27	0.45	0.44
PGSC0003DMG200028487	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMG200028487	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.68
PGSC0003DMG200028487	K11229	ko04011	MAPK signaling pathway - yeast	601	1.9e-26	0.36	0.52	0.70
PGSC0003DMG200027353	K00627	ko00010	Glycolysis / Gluconeogenesis	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMG200027353	K00627	ko00020	Citrate cycle (TCA cycle)	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMG200027353	K00627	ko00620	Pyruvate metabolism	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMG200027353	K00627	ko01100	Metabolic pathways	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMG200027353	K00627	ko01110	Biosynthesis of secondary metabolites	3461	4.7e-185	0.74	0.85	0.99
PGSC0003DMG200027353	K00627	ko00010	Glycolysis / Gluconeogenesis	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMG200027353	K00627	ko00020	Citrate cycle (TCA cycle)	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMG200027353	K00627	ko00620	Pyruvate metabolism	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMG200027353	K00627	ko01100	Metabolic pathways	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMG200027353	K00627	ko01110	Biosynthesis of secondary metabolites	3470	1.5e-185	0.74	0.84	0.90
PGSC0003DMG200027353	K00627	ko00010	Glycolysis / Gluconeogenesis	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMG200027353	K00627	ko00020	Citrate cycle (TCA cycle)	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMG200027353	K00627	ko00620	Pyruvate metabolism	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMG200027353	K00627	ko01100	Metabolic pathways	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMG200027353	K00627	ko01110	Biosynthesis of secondary metabolites	2642	6.9e-140	0.68	0.82	0.89
PGSC0003DMG200027354	K01243	ko00270	Cysteine and methionine metabolism	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMG200027354	K01243	ko01100	Metabolic pathways	214	5.7e-06	0.53	0.64	0.88
PGSC0003DMG200027354	K01243	ko00270	Cysteine and methionine metabolism	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMG200027354	K01243	ko01100	Metabolic pathways	596	4.9e-27	0.35	0.50	0.94
PGSC0003DMG200027355	K06276	ko03320	PPAR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko04150	mTOR signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko04510	Focal adhesion	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko04910	Insulin signaling pathway	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko04960	Aldosterone-regulated sodium reabsorption	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko05213	Endometrial cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko05215	Prostate cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko05223	Non-small cell lung cancer	1250	4.1e-63	0.87	0.91	0.79
PGSC0003DMG200027355	K06276	ko03320	PPAR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko04150	mTOR signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko04510	Focal adhesion	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko04910	Insulin signaling pathway	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko05213	Endometrial cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko05215	Prostate cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027355	K06276	ko05223	Non-small cell lung cancer	3554	3.5e-190	0.84	0.90	1.00
PGSC0003DMG200027356	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMG200027356	K02367	ko01100	Metabolic pathways	574	8.0e-26	0.37	0.57	0.32
PGSC0003DMG200027358	K01099	ko00562	Inositol phosphate metabolism	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMG200027358	K01099	ko01100	Metabolic pathways	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMG200027358	K01099	ko04070	Phosphatidylinositol signaling system	382	3.4e-15	0.29	0.46	0.98
PGSC0003DMG200004162	K01188	ko00460	Cyanoamino acid metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMG200004162	K01188	ko00500	Starch and sucrose metabolism	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMG200004162	K01188	ko00940	Phenylpropanoid biosynthesis	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMG200004162	K01188	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.68	0.83	0.99
PGSC0003DMG200004162	K01188	ko00460	Cyanoamino acid metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMG200004162	K01188	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMG200004162	K01188	ko00940	Phenylpropanoid biosynthesis	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMG200004162	K01188	ko01110	Biosynthesis of secondary metabolites	3299	4.0e-176	0.65	0.79	0.99
PGSC0003DMG200004162	K01188	ko00460	Cyanoamino acid metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMG200004162	K01188	ko00500	Starch and sucrose metabolism	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMG200004162	K01188	ko00940	Phenylpropanoid biosynthesis	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMG200004162	K01188	ko01110	Biosynthesis of secondary metabolites	3557	2.4e-190	0.69	0.83	0.99
PGSC0003DMG200004162	K01188	ko00460	Cyanoamino acid metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMG200004162	K01188	ko00500	Starch and sucrose metabolism	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMG200004162	K01188	ko00940	Phenylpropanoid biosynthesis	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMG200004162	K01188	ko01110	Biosynthesis of secondary metabolites	879	1.2e-42	0.61	0.81	0.97
PGSC0003DMG200004166	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMG200004166	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMG200004166	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2402	1.2e-126	0.72	0.85	0.96
PGSC0003DMG200004166	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2431	3.0e-128	0.72	0.86	0.97
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	3040	7.7e-162	0.72	0.84	1.00
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	2752	5.9e-146	0.72	0.83	0.92
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.88	0.89
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	1627	6.7e-84	0.69	0.80	0.99
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	1899	6.6e-99	0.81	0.89	0.95
PGSC0003DMG200004168	K03885	ko00190	Oxidative phosphorylation	3095	7.2e-165	0.73	0.85	1.00
PGSC0003DMG200004170	K01953	ko00250	Alanine, aspartate and glutamate metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMG200004170	K01953	ko00910	Nitrogen metabolism	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMG200004170	K01953	ko01100	Metabolic pathways	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMG200004170	K01953	ko01110	Biosynthesis of secondary metabolites	3966	6.5e-213	0.89	0.95	0.97
PGSC0003DMG200004170	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMG200004170	K01953	ko00910	Nitrogen metabolism	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMG200004170	K01953	ko01100	Metabolic pathways	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMG200004170	K01953	ko01110	Biosynthesis of secondary metabolites	4528	6.6e-244	0.89	0.95	0.98
PGSC0003DMG200011072	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200011072	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200011072	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200011074	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.38	0.58	0.88
PGSC0003DMG200011088	K07375	ko04145	Phagosome	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMG200011088	K07375	ko04540	Gap junction	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMG200011088	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.97	0.98	1.00
PGSC0003DMG200011091	K06119	ko00561	Glycerolipid metabolism	1051	3.9e-52	0.80	0.89	0.97
PGSC0003DMG200011091	K06119	ko00561	Glycerolipid metabolism	2951	6.3e-157	0.83	0.92	0.95
PGSC0003DMG200011091	K06119	ko00561	Glycerolipid metabolism	1412	4.8e-72	0.78	0.90	0.98
PGSC0003DMG200009938	K07375	ko04145	Phagosome	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMG200009938	K07375	ko04540	Gap junction	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMG200009938	K07375	ko05130	Pathogenic Escherichia coli infection	3725	1.3e-199	0.95	0.98	1.00
PGSC0003DMG200009940	K09487	ko04621	NOD-like receptor signaling pathway	5765	0.	0.85	0.92	1.00
PGSC0003DMG200009940	K09487	ko04626	Plant-pathogen interaction	5765	0.	0.85	0.92	1.00
PGSC0003DMG200009940	K09487	ko05200	Pathways in cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMG200009940	K09487	ko05215	Prostate cancer	5765	0.	0.85	0.92	1.00
PGSC0003DMG200009940	K09487	ko04621	NOD-like receptor signaling pathway	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMG200009940	K09487	ko04626	Plant-pathogen interaction	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMG200009940	K09487	ko05200	Pathways in cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMG200009940	K09487	ko05215	Prostate cancer	1656	1.7e-85	0.80	0.85	1.00
PGSC0003DMG200009943	K05868	ko04110	Cell cycle	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMG200009943	K05868	ko04115	p53 signaling pathway	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMG200009943	K05868	ko04914	Progesterone-mediated oocyte maturation	386	1.9e-15	0.59	0.68	0.86
PGSC0003DMG200009948	K03260	ko05416	Viral myocarditis	340	1.1e-09	0.28	0.38	0.63
PGSC0003DMG200009948	K03260	ko05416	Viral myocarditis	340	9.2e-12	0.28	0.38	0.79
PGSC0003DMG200009950	K00430	ko00360	Phenylalanine metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMG200009950	K00430	ko00680	Methane metabolism	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMG200009950	K00430	ko00940	Phenylpropanoid biosynthesis	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMG200009950	K00430	ko01100	Metabolic pathways	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMG200009950	K00430	ko01110	Biosynthesis of secondary metabolites	1602	1.6e-82	0.70	0.82	0.99
PGSC0003DMG200009953	K00472	ko00330	Arginine and proline metabolism	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMG200009953	K00472	ko01100	Metabolic pathways	996	4.2e-49	0.49	0.66	0.86
PGSC0003DMG200039636	K08066	ko04612	Antigen processing and presentation	404	1.9e-16	0.45	0.66	0.81
PGSC0003DMG200045839	K09487	ko04621	NOD-like receptor signaling pathway	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMG200045839	K09487	ko04626	Plant-pathogen interaction	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMG200045839	K09487	ko05200	Pathways in cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMG200045839	K09487	ko05215	Prostate cancer	988	1.2e-48	0.42	0.62	0.81
PGSC0003DMG200033034	K01535	ko00190	Oxidative phosphorylation	7433	0.	0.92	0.97	1.00
PGSC0003DMG200033034	K01535	ko00190	Oxidative phosphorylation	286	3.9e-09	0.73	0.86	0.96
PGSC0003DMG200033036	K05748	ko04520	Adherens junction	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMG200033036	K05748	ko04666	Fc gamma R-mediated phagocytosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMG200033036	K05748	ko04810	Regulation of actin cytoskeleton	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMG200033036	K05748	ko05100	Bacterial invasion of epithelial cells	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMG200033036	K05748	ko05131	Shigellosis	259	3.4e-06	0.39	0.43	0.23
PGSC0003DMG200033037	K01601	ko00630	Glyoxylate and dicarboxylate metabolism	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMG200033037	K01601	ko00710	Carbon fixation in photosynthetic organisms	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMG200033037	K01601	ko01100	Metabolic pathways	3002	9.7e-160	0.96	0.98	0.99
PGSC0003DMG200033038	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMG200033038	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMG200033038	K02552	ko01100	Metabolic pathways	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMG200033038	K02552	ko01110	Biosynthesis of secondary metabolites	1159	4.3e-58	0.63	0.76	0.88
PGSC0003DMG200033038	K02552	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMG200033038	K02552	ko01053	Biosynthesis of siderophore group nonribosomal peptides	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMG200033038	K02552	ko01100	Metabolic pathways	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMG200033038	K02552	ko01110	Biosynthesis of secondary metabolites	3182	1.1e-169	0.70	0.81	0.97
PGSC0003DMG200033039	K10573	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.99	1.00	0.99
PGSC0003DMG200033041	K05648	ko02010	ABC transporters	286	8.5e-09	0.33	0.56	0.97
PGSC0003DMG200033042	K05643	ko02010	ABC transporters	1094	4.4e-54	0.34	0.52	0.74
PGSC0003DMG200020854	K05849	ko04020	Calcium signaling pathway	239	1.2e-06	0.41	0.54	0.90
PGSC0003DMG200020858	K06677	ko04111	Cell cycle - yeast	455	2.5e-18	0.56	0.69	0.95
PGSC0003DMG200020860	K07192	ko04910	Insulin signaling pathway	612	6.4e-28	0.49	0.67	0.98
PGSC0003DMG200020860	K07192	ko04910	Insulin signaling pathway	344	3.9e-13	0.39	0.59	0.84
PGSC0003DMG200020862	K06677	ko04111	Cell cycle - yeast	403	1.9e-15	0.62	0.74	0.81
PGSC0003DMG200020871	K12272	ko03060	Protein export	775	6.5e-37	0.49	0.60	0.97
PGSC0003DMG200020872	K02084	ko04115	p53 signaling pathway	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko04210	Apoptosis	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko05010	Alzheimer's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko05012	Parkinson's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko05016	Huntington's disease	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020872	K02084	ko05222	Small cell lung cancer	293	8.4e-07	0.28	0.49	0.37
PGSC0003DMG200020873	K00700	ko00500	Starch and sucrose metabolism	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMG200020873	K00700	ko01100	Metabolic pathways	396	1.8e-15	0.35	0.42	0.58
PGSC0003DMG200020874	K02084	ko04115	p53 signaling pathway	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko04210	Apoptosis	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko05010	Alzheimer's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko05012	Parkinson's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko05016	Huntington's disease	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200020874	K02084	ko05222	Small cell lung cancer	303	1.9e-07	0.26	0.46	0.55
PGSC0003DMG200027811	K04733	ko04210	Apoptosis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMG200027811	K04733	ko04620	Toll-like receptor signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMG200027811	K04733	ko04722	Neurotrophin signaling pathway	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMG200027811	K04733	ko05140	Leishmaniasis	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMG200027811	K04733	ko05142	Chagas disease	508	8.3e-22	0.43	0.65	0.70
PGSC0003DMG200027820	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko00230	Purine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko00240	Pyrimidine metabolism	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko01100	Metabolic pathways	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko03020	RNA polymerase	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200027820	K03006	ko05016	Huntington's disease	303	1.1e-09	0.36	0.48	0.56
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	339	5.2e-10	0.25	0.42	0.86
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017739	K10867	ko03440	Homologous recombination	390	2.0e-13	0.24	0.42	0.96
PGSC0003DMG200017743	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMG200017743	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMG200017743	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMG200017743	K03859	ko01100	Metabolic pathways	1849	3.8e-96	0.72	0.87	1.00
PGSC0003DMG200017748	K13030	ko00460	Cyanoamino acid metabolism	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMG200017748	K13030	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.47	0.66	0.99
PGSC0003DMG200017748	K13030	ko00460	Cyanoamino acid metabolism	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMG200017748	K13030	ko01110	Biosynthesis of secondary metabolites	1774	5.2e-92	0.46	0.64	0.99
PGSC0003DMG200016344	K01069	ko00620	Pyruvate metabolism	992	7.0e-49	0.48	0.64	0.80
PGSC0003DMG200016358	K03038	ko03050	Proteasome	2432	2.7e-128	0.93	0.98	1.00
PGSC0003DMG200016359	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3814	1.6e-204	0.76	0.86	1.00
PGSC0003DMG200016359	K01890	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.77	0.87	1.00
PGSC0003DMG200016360	K13065	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMG200016360	K13065	ko00941	Flavonoid biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMG200016360	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMG200016360	K13065	ko01110	Biosynthesis of secondary metabolites	472	3.4e-20	0.29	0.45	0.92
PGSC0003DMG200016362	K08139	ko04113	Meiosis - yeast	1037	2.3e-51	0.33	0.51	0.90
PGSC0003DMG200001777	K10604	ko04120	Ubiquitin mediated proteolysis	603	2.0e-27	0.35	0.52	0.81
PGSC0003DMG200001788	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko00230	Purine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko00240	Pyrimidine metabolism	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko01100	Metabolic pathways	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko03020	RNA polymerase	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001788	K03016	ko05016	Huntington's disease	557	6.9e-25	0.51	0.71	0.94
PGSC0003DMG200001792	K10756	ko03030	DNA replication	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMG200001792	K10756	ko03420	Nucleotide excision repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMG200001792	K10756	ko03430	Mismatch repair	581	3.3e-26	0.31	0.49	0.51
PGSC0003DMG200012205	K01951	ko00230	Purine metabolism	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMG200012205	K01951	ko00983	Drug metabolism - other enzymes	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMG200012205	K01951	ko01100	Metabolic pathways	1829	4.8e-95	0.80	0.90	0.96
PGSC0003DMG200012205	K01951	ko00230	Purine metabolism	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMG200012205	K01951	ko00983	Drug metabolism - other enzymes	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMG200012205	K01951	ko01100	Metabolic pathways	3851	1.4e-206	0.82	0.93	1.00
PGSC0003DMG200012209	K01838	ko00500	Starch and sucrose metabolism	355	9.6e-14	0.33	0.49	0.54
PGSC0003DMG200012210	K01919	ko00480	Glutathione metabolism	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMG200012210	K01919	ko01100	Metabolic pathways	3431	2.1e-183	0.78	0.85	1.00
PGSC0003DMG200012210	K01919	ko00480	Glutathione metabolism	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMG200012210	K01919	ko01100	Metabolic pathways	3671	1.2e-196	0.82	0.89	1.00
PGSC0003DMG200012213	K12298	ko00100	Steroid biosynthesis	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMG200012213	K12298	ko00561	Glycerolipid metabolism	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMG200012213	K12298	ko01100	Metabolic pathways	349	3.0e-11	0.31	0.41	0.63
PGSC0003DMG200012213	K12298	ko00100	Steroid biosynthesis	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMG200012213	K12298	ko00561	Glycerolipid metabolism	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMG200012213	K12298	ko01100	Metabolic pathways	326	1.2e-11	0.30	0.40	0.66
PGSC0003DMG200012213	K12298	ko00100	Steroid biosynthesis	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMG200012213	K12298	ko00561	Glycerolipid metabolism	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMG200012213	K12298	ko01100	Metabolic pathways	318	3.4e-11	0.34	0.44	0.51
PGSC0003DMG200000302	K01759	ko00620	Pyruvate metabolism	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMG200000302	K01759	ko04011	MAPK signaling pathway - yeast	666	6.7e-31	0.61	0.78	0.68
PGSC0003DMG200000304	K04392	ko04010	MAPK signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04062	Chemokine signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04145	Phagosome	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04310	Wnt signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04360	Axon guidance	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04370	VEGF signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04510	Focal adhesion	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04520	Adherens junction	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04620	Toll-like receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04650	Natural killer cell mediated cytotoxicity	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04662	B cell receptor signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04664	Fc epsilon RI signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04666	Fc gamma R-mediated phagocytosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04670	Leukocyte transendothelial migration	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04722	Neurotrophin signaling pathway	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04810	Regulation of actin cytoskeleton	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05100	Bacterial invasion of epithelial cells	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05131	Shigellosis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05200	Pathways in cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05210	Colorectal cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05211	Renal cell carcinoma	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05212	Pancreatic cancer	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05416	Viral myocarditis	1610	5.8e-83	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04010	MAPK signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04062	Chemokine signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04145	Phagosome	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04310	Wnt signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04360	Axon guidance	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04370	VEGF signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04510	Focal adhesion	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04520	Adherens junction	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04620	Toll-like receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04650	Natural killer cell mediated cytotoxicity	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04662	B cell receptor signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04664	Fc epsilon RI signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04666	Fc gamma R-mediated phagocytosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04670	Leukocyte transendothelial migration	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04722	Neurotrophin signaling pathway	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04810	Regulation of actin cytoskeleton	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05100	Bacterial invasion of epithelial cells	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05131	Shigellosis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05200	Pathways in cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05210	Colorectal cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05211	Renal cell carcinoma	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05212	Pancreatic cancer	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko05416	Viral myocarditis	1599	2.3e-82	0.90	0.95	0.99
PGSC0003DMG200000304	K04392	ko04010	MAPK signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04062	Chemokine signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04145	Phagosome	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04310	Wnt signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04360	Axon guidance	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04370	VEGF signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04510	Focal adhesion	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04520	Adherens junction	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04620	Toll-like receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04650	Natural killer cell mediated cytotoxicity	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04662	B cell receptor signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04664	Fc epsilon RI signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04666	Fc gamma R-mediated phagocytosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04670	Leukocyte transendothelial migration	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04722	Neurotrophin signaling pathway	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04810	Regulation of actin cytoskeleton	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05100	Bacterial invasion of epithelial cells	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05131	Shigellosis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05200	Pathways in cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05210	Colorectal cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05211	Renal cell carcinoma	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05212	Pancreatic cancer	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko05416	Viral myocarditis	820	2.2e-39	0.87	0.93	0.97
PGSC0003DMG200000304	K04392	ko04010	MAPK signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04062	Chemokine signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04145	Phagosome	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04310	Wnt signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04360	Axon guidance	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04370	VEGF signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04510	Focal adhesion	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04520	Adherens junction	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04620	Toll-like receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04650	Natural killer cell mediated cytotoxicity	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04662	B cell receptor signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04664	Fc epsilon RI signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04666	Fc gamma R-mediated phagocytosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04670	Leukocyte transendothelial migration	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04722	Neurotrophin signaling pathway	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko04810	Regulation of actin cytoskeleton	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05100	Bacterial invasion of epithelial cells	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05131	Shigellosis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05200	Pathways in cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05210	Colorectal cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05211	Renal cell carcinoma	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05212	Pancreatic cancer	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000304	K04392	ko05416	Viral myocarditis	499	1.1e-21	0.88	0.91	0.96
PGSC0003DMG200000321	K12355	ko00940	Phenylpropanoid biosynthesis	2055	1.6e-107	0.75	0.86	0.98
PGSC0003DMG200029050	K01590	ko00340	Histidine metabolism	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMG200029050	K01590	ko01100	Metabolic pathways	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMG200029050	K01590	ko01110	Biosynthesis of secondary metabolites	2242	8.0e-118	0.58	0.76	0.97
PGSC0003DMG200029051	K09834	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMG200029051	K09834	ko01100	Metabolic pathways	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMG200029051	K09834	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.68	0.81	0.89
PGSC0003DMG200029052	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMG200029052	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMG200029052	K10157	ko01100	Metabolic pathways	393	7.7e-16	0.33	0.50	0.51
PGSC0003DMG200029059	K00970	ko03018	RNA degradation	1228	6.8e-62	0.41	0.59	0.83
PGSC0003DMG200029059	K00970	ko03018	RNA degradation	1093	1.9e-54	0.41	0.59	0.90
PGSC0003DMG200029063	K04124	ko00904	Diterpenoid biosynthesis	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMG200029063	K04124	ko01110	Biosynthesis of secondary metabolites	1232	4.1e-62	0.47	0.64	0.99
PGSC0003DMG200029068	K12338	ko00942	Anthocyanin biosynthesis	523	5.2e-23	0.53	0.66	0.89
PGSC0003DMG200022352	K06096	ko04530	Tight junction	223	1.8e-06	0.32	0.54	0.55
PGSC0003DMG200022353	K06236	ko04510	Focal adhesion	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMG200022353	K06236	ko04512	ECM-receptor interaction	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMG200022353	K06236	ko05146	Amoebiasis	948	1.9e-46	0.35	0.47	0.99
PGSC0003DMG200022357	K12888	ko03040	Spliceosome	800	2.7e-38	0.31	0.49	0.68
PGSC0003DMG200022357	K12888	ko03040	Spliceosome	841	1.5e-40	0.31	0.49	0.76
PGSC0003DMG200022360	K03351	ko04110	Cell cycle	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022360	K03351	ko04111	Cell cycle - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022360	K03351	ko04113	Meiosis - yeast	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022360	K03351	ko04114	Oocyte meiosis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022360	K03351	ko04120	Ubiquitin mediated proteolysis	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022360	K03351	ko04914	Progesterone-mediated oocyte maturation	801	2.4e-38	0.27	0.47	0.99
PGSC0003DMG200022361	K04718	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMG200022361	K04718	ko01100	Metabolic pathways	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMG200022361	K04718	ko04020	Calcium signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMG200022361	K04718	ko04370	VEGF signaling pathway	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMG200022361	K04718	ko04666	Fc gamma R-mediated phagocytosis	1736	6.5e-90	0.71	0.81	0.99
PGSC0003DMG200022361	K04718	ko00600	Sphingolipid metabolism	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMG200022361	K04718	ko01100	Metabolic pathways	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMG200022361	K04718	ko04020	Calcium signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMG200022361	K04718	ko04370	VEGF signaling pathway	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMG200022361	K04718	ko04666	Fc gamma R-mediated phagocytosis	2687	2.3e-142	0.66	0.80	1.00
PGSC0003DMG200022364	K12816	ko03040	Spliceosome	4257	5.8e-229	0.82	0.90	1.00
PGSC0003DMG200022365	K01190	ko00052	Galactose metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMG200022365	K01190	ko00511	Other glycan degradation	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMG200022365	K01190	ko00600	Sphingolipid metabolism	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMG200022365	K01190	ko01100	Metabolic pathways	2230	3.7e-117	0.49	0.63	0.84
PGSC0003DMG200019790	K04733	ko04210	Apoptosis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMG200019790	K04733	ko04620	Toll-like receptor signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMG200019790	K04733	ko04722	Neurotrophin signaling pathway	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMG200019790	K04733	ko05140	Leishmaniasis	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMG200019790	K04733	ko05142	Chagas disease	545	5.8e-24	0.42	0.60	0.96
PGSC0003DMG200019810	K01634	ko00600	Sphingolipid metabolism	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMG200019810	K01634	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.85	0.97
PGSC0003DMG200019810	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMG200019810	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMG200019810	K01634	ko00600	Sphingolipid metabolism	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMG200019810	K01634	ko01100	Metabolic pathways	3680	3.9e-197	0.81	0.93	0.97
PGSC0003DMG200019810	K01634	ko00600	Sphingolipid metabolism	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMG200019810	K01634	ko01100	Metabolic pathways	2435	1.8e-128	0.81	0.93	0.96
PGSC0003DMG200030334	K03872	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMG200030334	K03872	ko05200	Pathways in cancer	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMG200030334	K03872	ko05211	Renal cell carcinoma	754	9.4e-36	0.90	0.97	0.99
PGSC0003DMG200035116	K10760	ko00908	Zeatin biosynthesis	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMG200035116	K10760	ko01100	Metabolic pathways	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMG200035116	K10760	ko01110	Biosynthesis of secondary metabolites	595	5.5e-27	0.53	0.71	0.88
PGSC0003DMG200035128	K03133	ko03022	Basal transcription factors	348	2.3e-13	0.62	0.75	0.63
PGSC0003DMG200035130	K04371	ko04010	MAPK signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04012	ErbB signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04013	MAPK signaling pathway - fly	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04062	Chemokine signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04114	Oocyte meiosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04150	mTOR signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04270	Vascular smooth muscle contraction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04320	Dorso-ventral axis formation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04350	TGF-beta signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04360	Axon guidance	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04370	VEGF signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04510	Focal adhesion	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04520	Adherens junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04540	Gap junction	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04620	Toll-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04621	NOD-like receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04650	Natural killer cell mediated cytotoxicity	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04660	T cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04662	B cell receptor signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04664	Fc epsilon RI signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04666	Fc gamma R-mediated phagocytosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04720	Long-term potentiation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04722	Neurotrophin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04730	Long-term depression	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04810	Regulation of actin cytoskeleton	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04910	Insulin signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04912	GnRH signaling pathway	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04914	Progesterone-mediated oocyte maturation	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04916	Melanogenesis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04930	Type II diabetes mellitus	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko04960	Aldosterone-regulated sodium reabsorption	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05010	Alzheimer's disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05020	Prion diseases	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05131	Shigellosis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05140	Leishmaniasis	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05142	Chagas disease	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05200	Pathways in cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05210	Colorectal cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05211	Renal cell carcinoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05212	Pancreatic cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05213	Endometrial cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05214	Glioma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05215	Prostate cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05216	Thyroid cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05218	Melanoma	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05219	Bladder cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05220	Chronic myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05221	Acute myeloid leukemia	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200035130	K04371	ko05223	Non-small cell lung cancer	435	3.7e-18	0.45	0.65	0.93
PGSC0003DMG200026670	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMG200026670	K03139	ko03022	Basal transcription factors	1485	4.5e-76	0.68	0.80	0.94
PGSC0003DMG200026671	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMG200026671	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMG200026671	K01583	ko00330	Arginine and proline metabolism	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMG200026671	K01583	ko01100	Metabolic pathways	4300	2.5e-231	0.73	0.85	0.97
PGSC0003DMG200026679	K06668	ko04111	Cell cycle - yeast	297	1.2e-09	0.35	0.52	0.93
PGSC0003DMG200026684	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMG200026684	K00517	ko00626	Naphthalene and anthracene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMG200026684	K00517	ko00903	Limonene and pinene degradation	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMG200026684	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMG200026684	K00517	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.60	0.81	0.96
PGSC0003DMG200026685	K06627	ko04110	Cell cycle	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMG200026685	K06627	ko04914	Progesterone-mediated oocyte maturation	243	1.4e-07	0.36	0.59	0.42
PGSC0003DMG200026686	K06626	ko04110	Cell cycle	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026686	K06626	ko04114	Oocyte meiosis	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026686	K06626	ko04115	p53 signaling pathway	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026686	K06626	ko05200	Pathways in cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026686	K06626	ko05215	Prostate cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026686	K06626	ko05222	Small cell lung cancer	262	1.3e-08	0.34	0.55	0.54
PGSC0003DMG200026690	K12130	ko04712	Circadian rhythm - plant	228	3.5e-06	0.37	0.55	0.38
PGSC0003DMG200023576	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1463	7.4e-75	0.77	0.87	1.00
PGSC0003DMG200023576	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMG200023576	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1516	8.8e-78	0.79	0.90	1.00
PGSC0003DMG200023576	K10703	ko01040	Biosynthesis of unsaturated fatty acids	403	2.2e-16	0.76	0.90	0.90
PGSC0003DMG200023578	K12831	ko03040	Spliceosome	330	2.3e-12	0.51	0.61	0.73
PGSC0003DMG200023579	K12831	ko03040	Spliceosome	287	6.5e-10	0.51	0.60	0.69
PGSC0003DMG200023580	K12831	ko03040	Spliceosome	315	1.5e-11	0.51	0.60	0.70
PGSC0003DMG200023583	K04733	ko04210	Apoptosis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMG200023583	K04733	ko04620	Toll-like receptor signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMG200023583	K04733	ko04722	Neurotrophin signaling pathway	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMG200023583	K04733	ko05140	Leishmaniasis	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMG200023583	K04733	ko05142	Chagas disease	383	1.1e-14	0.42	0.64	0.78
PGSC0003DMG200023586	K04733	ko04210	Apoptosis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMG200023586	K04733	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMG200023586	K04733	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMG200023586	K04733	ko05140	Leishmaniasis	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMG200023586	K04733	ko05142	Chagas disease	654	3.1e-30	0.43	0.65	0.86
PGSC0003DMG200023589	K08333	ko04140	Regulation of autophagy	676	1.3e-30	0.86	0.92	0.97
PGSC0003DMG200023589	K08333	ko04140	Regulation of autophagy	9877	0.	0.75	0.85	1.00
PGSC0003DMG200023589	K08333	ko04140	Regulation of autophagy	9220	0.	0.75	0.85	1.00
PGSC0003DMG200023590	K06630	ko04110	Cell cycle	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMG200023590	K06630	ko04114	Oocyte meiosis	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMG200023590	K06630	ko04722	Neurotrophin signaling pathway	1860	9.4e-97	0.88	0.95	1.00
PGSC0003DMG200023592	K10807	ko00230	Purine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMG200023592	K10807	ko00240	Pyrimidine metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMG200023592	K10807	ko00480	Glutathione metabolism	6309	0.	0.90	0.96	1.00
PGSC0003DMG200023592	K10807	ko01100	Metabolic pathways	6309	0.	0.90	0.96	1.00
PGSC0003DMG200023594	K13065	ko00940	Phenylpropanoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMG200023594	K13065	ko00941	Flavonoid biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMG200023594	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMG200023594	K13065	ko01110	Biosynthesis of secondary metabolites	337	9.4e-13	0.25	0.44	0.90
PGSC0003DMG200023595	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMG200023595	K00517	ko00626	Naphthalene and anthracene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMG200023595	K00517	ko00903	Limonene and pinene degradation	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMG200023595	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMG200023595	K00517	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.49	0.69	0.99
PGSC0003DMG200023595	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMG200023595	K00517	ko00626	Naphthalene and anthracene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMG200023595	K00517	ko00903	Limonene and pinene degradation	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMG200023595	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMG200023595	K00517	ko01110	Biosynthesis of secondary metabolites	1404	1.3e-71	0.48	0.65	0.99
PGSC0003DMG200029157	K05656	ko02010	ABC transporters	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMG200029157	K05656	ko04142	Lysosome	1480	8.5e-76	0.42	0.62	0.79
PGSC0003DMG200029157	K05656	ko02010	ABC transporters	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMG200029157	K05656	ko04142	Lysosome	1386	1.3e-70	0.39	0.60	0.80
PGSC0003DMG200029157	K05656	ko02010	ABC transporters	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMG200029157	K05656	ko04142	Lysosome	1423	1.2e-72	0.39	0.59	0.80
PGSC0003DMG200029157	K05656	ko02010	ABC transporters	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMG200029157	K05656	ko04142	Lysosome	1491	2.1e-76	0.40	0.61	0.78
PGSC0003DMG200029157	K05656	ko02010	ABC transporters	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMG200029157	K05656	ko04142	Lysosome	1555	6.2e-80	0.40	0.61	0.81
PGSC0003DMG200029158	K09756	ko00940	Phenylpropanoid biosynthesis	1721	4.4e-89	0.47	0.66	0.95
PGSC0003DMG200029158	K09756	ko00940	Phenylpropanoid biosynthesis	1227	7.7e-62	0.47	0.65	0.93
PGSC0003DMG200029158	K09756	ko00940	Phenylpropanoid biosynthesis	1706	2.9e-88	0.49	0.68	0.94
PGSC0003DMG200029158	K09756	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.48	0.67	0.95
PGSC0003DMG200029160	K10609	ko03420	Nucleotide excision repair	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMG200029160	K10609	ko04120	Ubiquitin mediated proteolysis	712	2.0e-33	0.39	0.60	0.93
PGSC0003DMG200029166	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMG200029166	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMG200029166	K07359	ko04920	Adipocytokine signaling pathway	522	5.9e-23	0.63	0.81	0.99
PGSC0003DMG200029167	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.92	0.99
PGSC0003DMG200029167	K11252	ko05322	Systemic lupus erythematosus	718	9.1e-34	0.82	0.88	0.79
PGSC0003DMG200022303	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.73
PGSC0003DMG200022303	K12476	ko04144	Endocytosis	1842	9.2e-96	0.56	0.74	0.84
PGSC0003DMG200022307	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMG200022307	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMG200022307	K00700	ko00500	Starch and sucrose metabolism	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMG200022307	K00700	ko01100	Metabolic pathways	755	8.3e-36	0.42	0.61	0.96
PGSC0003DMG200022307	K00700	ko00500	Starch and sucrose metabolism	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMG200022307	K00700	ko01100	Metabolic pathways	1036	9.3e-62	0.46	0.64	0.57
PGSC0003DMG200022308	K00658	ko00020	Citrate cycle (TCA cycle)	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMG200022308	K00658	ko00310	Lysine degradation	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMG200022308	K00658	ko01100	Metabolic pathways	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMG200022308	K00658	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.83	0.88	0.85
PGSC0003DMG200022308	K00658	ko00020	Citrate cycle (TCA cycle)	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMG200022308	K00658	ko00310	Lysine degradation	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMG200022308	K00658	ko01100	Metabolic pathways	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMG200022308	K00658	ko01110	Biosynthesis of secondary metabolites	3006	5.8e-160	0.77	0.86	1.00
PGSC0003DMG200022308	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko00020	Citrate cycle (TCA cycle)	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko00310	Lysine degradation	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko01100	Metabolic pathways	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022308	K00658	ko01110	Biosynthesis of secondary metabolites	2715	6.5e-144	0.88	0.94	1.00
PGSC0003DMG200022310	K12741	ko03040	Spliceosome	258	2.1e-08	0.48	0.52	0.72
PGSC0003DMG200022313	K00912	ko00540	Lipopolysaccharide biosynthesis	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMG200022313	K00912	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.53	0.84
PGSC0003DMG200022313	K00912	ko00540	Lipopolysaccharide biosynthesis	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMG200022313	K00912	ko01100	Metabolic pathways	300	1.0e-10	0.36	0.56	0.64
PGSC0003DMG200022313	K00912	ko00540	Lipopolysaccharide biosynthesis	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMG200022313	K00912	ko01100	Metabolic pathways	368	1.8e-14	0.36	0.54	0.69
PGSC0003DMG200022314	K08341	ko04140	Regulation of autophagy	982	2.5e-48	0.97	1.00	0.99
PGSC0003DMG200041767	K02358	ko04626	Plant-pathogen interaction	3382	1.1e-180	0.84	0.90	0.99
PGSC0003DMG200008627	K12796	ko04621	NOD-like receptor signaling pathway	330	2.6e-09	0.30	0.48	0.33
PGSC0003DMG200008627	K12796	ko04621	NOD-like receptor signaling pathway	330	3.1e-09	0.30	0.48	0.29
PGSC0003DMG200008631	K00799	ko00480	Glutathione metabolism	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMG200008631	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMG200008631	K00799	ko00982	Drug metabolism - cytochrome P450	520	7.6e-23	0.36	0.61	0.96
PGSC0003DMG200008632	K00660	ko00941	Flavonoid biosynthesis	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMG200008632	K00660	ko01100	Metabolic pathways	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMG200008632	K00660	ko01110	Biosynthesis of secondary metabolites	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMG200008632	K00660	ko04712	Circadian rhythm - plant	2435	1.8e-128	0.74	0.85	0.99
PGSC0003DMG200008633	K00660	ko00941	Flavonoid biosynthesis	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMG200008633	K00660	ko01100	Metabolic pathways	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMG200008633	K00660	ko01110	Biosynthesis of secondary metabolites	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMG200008633	K00660	ko04712	Circadian rhythm - plant	1911	1.4e-99	0.70	0.82	0.98
PGSC0003DMG200008634	K00660	ko00941	Flavonoid biosynthesis	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMG200008634	K00660	ko01100	Metabolic pathways	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMG200008634	K00660	ko01110	Biosynthesis of secondary metabolites	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMG200008634	K00660	ko04712	Circadian rhythm - plant	2281	5.6e-120	0.70	0.83	0.99
PGSC0003DMG200008635	K00660	ko00941	Flavonoid biosynthesis	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMG200008635	K00660	ko01100	Metabolic pathways	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMG200008635	K00660	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMG200008635	K00660	ko04712	Circadian rhythm - plant	743	3.8e-35	0.65	0.78	0.97
PGSC0003DMG200005443	K01593	ko00340	Histidine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00350	Tyrosine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00360	Phenylalanine metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00380	Tryptophan metabolism	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00901	Indole alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00950	Isoquinoline alkaloid biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko00965	Betalain biosynthesis	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko01100	Metabolic pathways	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005443	K01593	ko01110	Biosynthesis of secondary metabolites	780	3.5e-37	0.59	0.74	0.88
PGSC0003DMG200005444	K01593	ko00340	Histidine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00350	Tyrosine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00360	Phenylalanine metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00380	Tryptophan metabolism	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00901	Indole alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko00965	Betalain biosynthesis	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko01100	Metabolic pathways	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005444	K01593	ko01110	Biosynthesis of secondary metabolites	1279	1.0e-64	0.57	0.77	0.97
PGSC0003DMG200005445	K05277	ko00941	Flavonoid biosynthesis	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMG200005445	K05277	ko01100	Metabolic pathways	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMG200005445	K05277	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.37	0.56	0.92
PGSC0003DMG200005446	K08233	ko00901	Indole alkaloid biosynthesis	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMG200005446	K08233	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.44	0.61	0.98
PGSC0003DMG200005448	K05277	ko00941	Flavonoid biosynthesis	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMG200005448	K05277	ko01100	Metabolic pathways	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMG200005448	K05277	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.90
PGSC0003DMG200005448	K05277	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMG200005448	K05277	ko01100	Metabolic pathways	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMG200005448	K05277	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.36	0.54	0.86
PGSC0003DMG200005449	K05277	ko00941	Flavonoid biosynthesis	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMG200005449	K05277	ko01100	Metabolic pathways	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMG200005449	K05277	ko01110	Biosynthesis of secondary metabolites	637	2.7e-29	0.37	0.56	0.92
PGSC0003DMG200005450	K08233	ko00901	Indole alkaloid biosynthesis	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMG200005450	K08233	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.44	0.62	0.97
PGSC0003DMG200005451	K05933	ko00270	Cysteine and methionine metabolism	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMG200005451	K05933	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.41	0.59	0.95
PGSC0003DMG200016268	K08099	ko00860	Porphyrin and chlorophyll metabolism	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMG200016268	K08099	ko01100	Metabolic pathways	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMG200016268	K08099	ko01110	Biosynthesis of secondary metabolites	368	1.8e-14	0.50	0.69	0.90
PGSC0003DMG200016268	K08099	ko00860	Porphyrin and chlorophyll metabolism	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMG200016268	K08099	ko01100	Metabolic pathways	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMG200016268	K08099	ko01110	Biosynthesis of secondary metabolites	1583	1.8e-81	0.59	0.76	0.97
PGSC0003DMG200016275	K00648	ko00061	Fatty acid biosynthesis	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMG200016275	K00648	ko01100	Metabolic pathways	258	2.4e-08	0.27	0.45	0.74
PGSC0003DMG200020924	K12591	ko03018	RNA degradation	3520	2.6e-188	0.51	0.64	1.00
PGSC0003DMG200020926	K12126	ko04712	Circadian rhythm - plant	328	1.5e-10	0.28	0.40	0.71
PGSC0003DMG200020938	K12338	ko00942	Anthocyanin biosynthesis	519	8.6e-23	0.49	0.67	0.85
PGSC0003DMG200020939	K12929	ko00904	Diterpenoid biosynthesis	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMG200020939	K12929	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.42	0.63	0.97
PGSC0003DMG200020940	K12929	ko00904	Diterpenoid biosynthesis	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMG200020940	K12929	ko01110	Biosynthesis of secondary metabolites	447	1.2e-24	0.39	0.63	0.93
PGSC0003DMG200020941	K12929	ko00904	Diterpenoid biosynthesis	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMG200020941	K12929	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.41	0.65	1.00
PGSC0003DMG200020942	K12338	ko00942	Anthocyanin biosynthesis	325	4.3e-12	0.48	0.69	0.98
PGSC0003DMG200020942	K12338	ko00942	Anthocyanin biosynthesis	1883	5.1e-98	0.51	0.69	0.98
PGSC0003DMG200020942	K12338	ko00942	Anthocyanin biosynthesis	502	7.5e-22	0.54	0.72	0.97
PGSC0003DMG200020942	K12338	ko00942	Anthocyanin biosynthesis	1177	4.4e-59	0.50	0.69	0.95
PGSC0003DMG200020943	K12338	ko00942	Anthocyanin biosynthesis	264	1.2e-08	0.37	0.54	0.71
PGSC0003DMG200024824	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.76
PGSC0003DMG200024824	K00754	ko00051	Fructose and mannose metabolism	1688	2.9e-87	0.50	0.67	0.87
PGSC0003DMG200024838	K02981	ko03010	Ribosome	2040	1.1e-106	0.88	0.92	1.00
PGSC0003DMG200037657	K05282	ko00904	Diterpenoid biosynthesis	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMG200037657	K05282	ko01100	Metabolic pathways	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMG200037657	K05282	ko01110	Biosynthesis of secondary metabolites	339	7.3e-13	0.38	0.53	0.77
PGSC0003DMG200037669	K05759	ko04810	Regulation of actin cytoskeleton	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMG200037669	K05759	ko05131	Shigellosis	798	3.5e-38	0.71	0.85	0.98
PGSC0003DMG200037678	K02894	ko03010	Ribosome	550	1.7e-24	0.93	0.94	0.99
PGSC0003DMG200027727	K04646	ko04142	Lysosome	10758	0.	0.78	0.82	1.00
PGSC0003DMG200027727	K04646	ko04144	Endocytosis	10758	0.	0.78	0.82	1.00
PGSC0003DMG200027727	K04646	ko05016	Huntington's disease	10758	0.	0.78	0.82	1.00
PGSC0003DMG200027727	K04646	ko05100	Bacterial invasion of epithelial cells	10758	0.	0.78	0.82	1.00
PGSC0003DMG200027727	K04646	ko04142	Lysosome	13479	0.	0.93	0.97	1.00
PGSC0003DMG200027727	K04646	ko04144	Endocytosis	13479	0.	0.93	0.97	1.00
PGSC0003DMG200027727	K04646	ko05016	Huntington's disease	13479	0.	0.93	0.97	1.00
PGSC0003DMG200027727	K04646	ko05100	Bacterial invasion of epithelial cells	13479	0.	0.93	0.97	1.00
PGSC0003DMG200027733	K10575	ko04120	Ubiquitin mediated proteolysis	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMG200027733	K10575	ko05012	Parkinson's disease	1321	5.0e-67	0.90	0.97	0.99
PGSC0003DMG200027735	K01710	ko00521	Streptomycin biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMG200027735	K01710	ko00523	Polyketide sugar unit biosynthesis	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMG200027735	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMG200027735	K01710	ko01100	Metabolic pathways	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMG200027735	K01710	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.91	0.97	0.99
PGSC0003DMG200027736	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200027739	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko00020	Citrate cycle (TCA cycle)	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko00310	Lysine degradation	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko00380	Tryptophan metabolism	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko01100	Metabolic pathways	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027739	K00164	ko01110	Biosynthesis of secondary metabolites	7884	0.	0.88	0.95	1.00
PGSC0003DMG200027741	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMG200027741	K00517	ko00626	Naphthalene and anthracene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMG200027741	K00517	ko00903	Limonene and pinene degradation	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMG200027741	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMG200027741	K00517	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.51	0.67	0.96
PGSC0003DMG200003103	K01507	ko00190	Oxidative phosphorylation	2043	7.6e-107	0.81	0.86	1.00
PGSC0003DMG200003105	K02492	ko00860	Porphyrin and chlorophyll metabolism	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMG200003105	K02492	ko01100	Metabolic pathways	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMG200003105	K02492	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.74	0.88	0.96
PGSC0003DMG200003105	K02492	ko00860	Porphyrin and chlorophyll metabolism	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMG200003105	K02492	ko01100	Metabolic pathways	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMG200003105	K02492	ko01110	Biosynthesis of secondary metabolites	3099	4.3e-165	0.70	0.84	0.99
PGSC0003DMG200003105	K02492	ko00860	Porphyrin and chlorophyll metabolism	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMG200003105	K02492	ko01100	Metabolic pathways	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMG200003105	K02492	ko01110	Biosynthesis of secondary metabolites	2824	6.3e-150	0.75	0.90	0.99
PGSC0003DMG200003109	K12135	ko04712	Circadian rhythm - plant	319	9.3e-12	0.47	0.57	0.64
PGSC0003DMG200003109	K12135	ko04712	Circadian rhythm - plant	340	6.4e-13	0.33	0.46	0.85
PGSC0003DMG200003111	K11247	ko04144	Endocytosis	864	8.1e-42	0.64	0.79	0.95
PGSC0003DMG200003111	K11247	ko04144	Endocytosis	1464	6.5e-75	0.57	0.74	0.99
PGSC0003DMG200003111	K11247	ko04144	Endocytosis	1674	1.7e-86	0.57	0.75	0.99
PGSC0003DMG200008089	K05391	ko04626	Plant-pathogen interaction	2025	7.4e-106	0.78	0.84	0.98
PGSC0003DMG200008089	K05391	ko04626	Plant-pathogen interaction	4387	3.9e-236	0.74	0.83	0.99
PGSC0003DMG200008094	K01674	ko00910	Nitrogen metabolism	1444	8.3e-74	0.62	0.80	0.95
PGSC0003DMG200008095	K03008	ko00230	Purine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMG200008095	K03008	ko00240	Pyrimidine metabolism	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMG200008095	K03008	ko01100	Metabolic pathways	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMG200008095	K03008	ko03020	RNA polymerase	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMG200008095	K03008	ko05016	Huntington's disease	891	2.6e-43	0.88	0.97	0.99
PGSC0003DMG200010991	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMG200010991	K00517	ko00626	Naphthalene and anthracene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMG200010991	K00517	ko00903	Limonene and pinene degradation	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMG200010991	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMG200010991	K00517	ko01110	Biosynthesis of secondary metabolites	1603	1.4e-82	0.45	0.63	0.99
PGSC0003DMG200010991	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMG200010991	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.45	0.64	0.97
PGSC0003DMG200010992	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMG200010992	K00517	ko00626	Naphthalene and anthracene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMG200010992	K00517	ko00903	Limonene and pinene degradation	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMG200010992	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMG200010992	K00517	ko01110	Biosynthesis of secondary metabolites	394	9.1e-24	0.47	0.65	0.77
PGSC0003DMG200010993	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMG200010993	K00517	ko00626	Naphthalene and anthracene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMG200010993	K00517	ko00903	Limonene and pinene degradation	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMG200010993	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMG200010993	K00517	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.53	0.69	0.97
PGSC0003DMG200010994	K09755	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMG200010994	K09755	ko01100	Metabolic pathways	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMG200010994	K09755	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.37	0.62	0.96
PGSC0003DMG200010995	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMG200010995	K00517	ko00626	Naphthalene and anthracene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMG200010995	K00517	ko00903	Limonene and pinene degradation	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMG200010995	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMG200010995	K00517	ko01110	Biosynthesis of secondary metabolites	1420	1.7e-72	0.45	0.63	0.98
PGSC0003DMG200010996	K02308	ko04010	MAPK signaling pathway	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMG200010996	K02308	ko05014	Amyotrophic lateral sclerosis (ALS)	312	9.2e-11	0.38	0.59	0.43
PGSC0003DMG200010997	K00680	ko00350	Tyrosine metabolism	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMG200010997	K00680	ko00624	1- and 2-Methylnaphthalene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMG200010997	K00680	ko00632	Benzoate degradation via CoA ligation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMG200010997	K00680	ko00642	Ethylbenzene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMG200010997	K00680	ko00903	Limonene and pinene degradation	248	7.6e-08	0.65	0.77	0.84
PGSC0003DMG200010998	K05765	ko04360	Axon guidance	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMG200010998	K05765	ko04666	Fc gamma R-mediated phagocytosis	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMG200010998	K05765	ko04810	Regulation of actin cytoskeleton	1088	3.6e-54	0.91	0.96	0.98
PGSC0003DMG200011001	K12492	ko04144	Endocytosis	2717	5.1e-144	0.70	0.81	1.00
PGSC0003DMG200011001	K12492	ko04144	Endocytosis	838	2.2e-40	0.64	0.77	0.99
PGSC0003DMG200011001	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.28
PGSC0003DMG200020489	K13065	ko00940	Phenylpropanoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMG200020489	K13065	ko00941	Flavonoid biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMG200020489	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMG200020489	K13065	ko01110	Biosynthesis of secondary metabolites	279	6.0e-09	0.30	0.44	0.64
PGSC0003DMG200020493	K06268	ko04010	MAPK signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04020	Calcium signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04114	Oocyte meiosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04210	Apoptosis	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04310	Wnt signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04360	Axon guidance	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04370	VEGF signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04650	Natural killer cell mediated cytotoxicity	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04660	T cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04662	B cell receptor signaling pathway	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04720	Long-term potentiation	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko05010	Alzheimer's disease	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1461	9.5e-75	0.80	0.93	1.00
PGSC0003DMG200020493	K06268	ko04010	MAPK signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04020	Calcium signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04114	Oocyte meiosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04210	Apoptosis	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04310	Wnt signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04360	Axon guidance	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04370	VEGF signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04650	Natural killer cell mediated cytotoxicity	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04660	T cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04662	B cell receptor signaling pathway	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04720	Long-term potentiation	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko05010	Alzheimer's disease	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	747	2.3e-35	0.73	0.92	0.81
PGSC0003DMG200020493	K06268	ko04010	MAPK signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04020	Calcium signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04114	Oocyte meiosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04210	Apoptosis	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04310	Wnt signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04360	Axon guidance	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04370	VEGF signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04650	Natural killer cell mediated cytotoxicity	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04660	T cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04662	B cell receptor signaling pathway	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko04720	Long-term potentiation	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko05010	Alzheimer's disease	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020493	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1318	7.4e-67	0.80	0.93	0.74
PGSC0003DMG200020494	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMG200020494	K00430	ko00680	Methane metabolism	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMG200020494	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMG200020494	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMG200020494	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.53	0.72	0.99
PGSC0003DMG200020494	K00430	ko00360	Phenylalanine metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMG200020494	K00430	ko00680	Methane metabolism	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMG200020494	K00430	ko00940	Phenylpropanoid biosynthesis	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMG200020494	K00430	ko01100	Metabolic pathways	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMG200020494	K00430	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.55	0.72	0.98
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	813	5.2e-39	0.38	0.57	0.64
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	213	8.6e-06	0.34	0.54	0.38
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	270	8.6e-14	0.35	0.56	0.44
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	520	2.6e-32	0.36	0.54	0.56
PGSC0003DMG200025507	K03660	ko03410	Base excision repair	279	8.0e-09	0.42	0.56	0.62
PGSC0003DMG200025507	K03660	ko03410	Base excision repair	279	8.0e-09	0.45	0.59	0.53
PGSC0003DMG200021647	K11086	ko03040	Spliceosome	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMG200021647	K11086	ko05322	Systemic lupus erythematosus	1540	4.2e-79	0.69	0.75	1.00
PGSC0003DMG200021647	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMG200021647	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMG200021647	K11086	ko03040	Spliceosome	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMG200021647	K11086	ko05322	Systemic lupus erythematosus	1796	3.2e-93	0.72	0.77	1.00
PGSC0003DMG200021649	K04371	ko04010	MAPK signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04012	ErbB signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04013	MAPK signaling pathway - fly	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04062	Chemokine signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04114	Oocyte meiosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04150	mTOR signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04270	Vascular smooth muscle contraction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04320	Dorso-ventral axis formation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04350	TGF-beta signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04360	Axon guidance	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04370	VEGF signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04510	Focal adhesion	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04520	Adherens junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04540	Gap junction	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04620	Toll-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04621	NOD-like receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04650	Natural killer cell mediated cytotoxicity	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04660	T cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04662	B cell receptor signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04664	Fc epsilon RI signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04666	Fc gamma R-mediated phagocytosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04720	Long-term potentiation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04722	Neurotrophin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04730	Long-term depression	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04810	Regulation of actin cytoskeleton	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04910	Insulin signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04912	GnRH signaling pathway	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04914	Progesterone-mediated oocyte maturation	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04916	Melanogenesis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04930	Type II diabetes mellitus	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05010	Alzheimer's disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05020	Prion diseases	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05131	Shigellosis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05140	Leishmaniasis	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05142	Chagas disease	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05200	Pathways in cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05210	Colorectal cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05211	Renal cell carcinoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05212	Pancreatic cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05213	Endometrial cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05214	Glioma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05215	Prostate cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05216	Thyroid cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05218	Melanoma	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05219	Bladder cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05220	Chronic myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05221	Acute myeloid leukemia	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021649	K04371	ko05223	Non-small cell lung cancer	2766	1.0e-146	0.84	0.92	1.00
PGSC0003DMG200021651	K01762	ko00270	Cysteine and methionine metabolism	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMG200021651	K01762	ko01110	Biosynthesis of secondary metabolites	1569	1.1e-80	0.56	0.74	0.88
PGSC0003DMG200021655	K12614	ko03018	RNA degradation	3586	5.9e-192	0.87	0.92	1.00
PGSC0003DMG200021658	K01213	ko00040	Pentose and glucuronate interconversions	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMG200021658	K01213	ko00500	Starch and sucrose metabolism	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMG200021658	K01213	ko01100	Metabolic pathways	891	2.6e-43	0.35	0.54	0.81
PGSC0003DMG200021658	K01213	ko00040	Pentose and glucuronate interconversions	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMG200021658	K01213	ko00500	Starch and sucrose metabolism	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMG200021658	K01213	ko01100	Metabolic pathways	332	1.8e-12	0.31	0.50	0.82
PGSC0003DMG200021662	K08486	ko04130	SNARE interactions in vesicular transport	1841	1.0e-95	0.76	0.86	0.96
PGSC0003DMG200028409	K00013	ko00340	Histidine metabolism	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMG200028409	K00013	ko01100	Metabolic pathways	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMG200028409	K00013	ko01110	Biosynthesis of secondary metabolites	3283	3.1e-175	0.82	0.91	0.98
PGSC0003DMG200028409	K00013	ko00340	Histidine metabolism	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMG200028409	K00013	ko01100	Metabolic pathways	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMG200028409	K00013	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.92	0.98	0.95
PGSC0003DMG200028412	K11093	ko03040	Spliceosome	225	1.4e-06	0.37	0.46	0.69
PGSC0003DMG200028417	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200028417	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200028417	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200028417	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200007353	K05665	ko02010	ABC transporters	1289	2.9e-65	0.35	0.54	0.91
PGSC0003DMG200007356	K00857	ko00240	Pyrimidine metabolism	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMG200007356	K00857	ko00983	Drug metabolism - other enzymes	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMG200007356	K00857	ko01100	Metabolic pathways	1350	1.3e-68	0.79	0.89	0.83
PGSC0003DMG200007362	K08139	ko04113	Meiosis - yeast	897	1.2e-43	0.33	0.52	0.96
PGSC0003DMG200007363	K00106	ko00230	Purine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko00232	Caffeine metabolism	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko00983	Drug metabolism - other enzymes	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko01100	Metabolic pathways	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko01110	Biosynthesis of secondary metabolites	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko04146	Peroxisome	6366	0.	0.61	0.72	1.00
PGSC0003DMG200007363	K00106	ko00230	Purine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko00232	Caffeine metabolism	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko00983	Drug metabolism - other enzymes	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko01100	Metabolic pathways	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko01110	Biosynthesis of secondary metabolites	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko04146	Peroxisome	8662	0.	0.74	0.86	1.00
PGSC0003DMG200007363	K00106	ko00230	Purine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko00232	Caffeine metabolism	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko00983	Drug metabolism - other enzymes	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko01100	Metabolic pathways	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko01110	Biosynthesis of secondary metabolites	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko04146	Peroxisome	2110	1.5e-110	0.82	0.91	1.00
PGSC0003DMG200007363	K00106	ko00230	Purine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007363	K00106	ko00232	Caffeine metabolism	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007363	K00106	ko00983	Drug metabolism - other enzymes	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007363	K00106	ko01100	Metabolic pathways	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007363	K00106	ko01110	Biosynthesis of secondary metabolites	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007363	K00106	ko04146	Peroxisome	2394	3.3e-126	0.64	0.79	1.00
PGSC0003DMG200007371	K00680	ko00350	Tyrosine metabolism	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMG200007371	K00680	ko00624	1- and 2-Methylnaphthalene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMG200007371	K00680	ko00632	Benzoate degradation via CoA ligation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMG200007371	K00680	ko00642	Ethylbenzene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMG200007371	K00680	ko00903	Limonene and pinene degradation	375	7.6e-15	0.60	0.73	0.91
PGSC0003DMG200007372	K12183	ko04144	Endocytosis	231	2.0e-06	0.32	0.45	0.57
PGSC0003DMG200003548	K01623	ko00010	Glycolysis / Gluconeogenesis	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko00030	Pentose phosphate pathway	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko00051	Fructose and mannose metabolism	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko00710	Carbon fixation in photosynthetic organisms	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko01100	Metabolic pathways	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko01110	Biosynthesis of secondary metabolites	2412	3.4e-127	0.77	0.81	1.00
PGSC0003DMG200003548	K01623	ko00010	Glycolysis / Gluconeogenesis	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003548	K01623	ko00030	Pentose phosphate pathway	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003548	K01623	ko00051	Fructose and mannose metabolism	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003548	K01623	ko00710	Carbon fixation in photosynthetic organisms	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003548	K01623	ko01100	Metabolic pathways	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003548	K01623	ko01110	Biosynthesis of secondary metabolites	3011	3.1e-160	0.90	0.95	1.00
PGSC0003DMG200003559	K11088	ko03040	Spliceosome	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMG200003559	K11088	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.91	0.97	0.99
PGSC0003DMG200003563	K00475	ko00941	Flavonoid biosynthesis	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMG200003563	K00475	ko01100	Metabolic pathways	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMG200003563	K00475	ko01110	Biosynthesis of secondary metabolites	1912	1.3e-99	0.81	0.91	0.96
PGSC0003DMG200003563	K00475	ko00941	Flavonoid biosynthesis	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMG200003563	K00475	ko01100	Metabolic pathways	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMG200003563	K00475	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.81	0.92	1.00
PGSC0003DMG200003563	K00475	ko00941	Flavonoid biosynthesis	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMG200003563	K00475	ko01100	Metabolic pathways	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMG200003563	K00475	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.93	0.98	0.91
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	242	1.1e-06	0.61	0.82	0.78
PGSC0003DMG200017028	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K12879	ko03040	Spliceosome	323	9.0e-11	0.72	0.85	0.61
PGSC0003DMG200017035	K07204	ko04150	mTOR signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMG200017035	K07204	ko04910	Insulin signaling pathway	9072	0.	0.78	0.86	1.00
PGSC0003DMG200017035	K07204	ko04150	mTOR signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMG200017035	K07204	ko04910	Insulin signaling pathway	9314	0.	0.80	0.88	1.00
PGSC0003DMG200017035	K07204	ko04150	mTOR signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMG200017035	K07204	ko04910	Insulin signaling pathway	5820	0.	0.79	0.89	0.99
PGSC0003DMG200017039	K01762	ko00270	Cysteine and methionine metabolism	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMG200017039	K01762	ko01110	Biosynthesis of secondary metabolites	2198	2.1e-115	0.60	0.79	0.95
PGSC0003DMG200010314	K12608	ko03018	RNA degradation	1844	7.2e-96	0.78	0.89	0.98
PGSC0003DMG200010314	K12608	ko03018	RNA degradation	1109	2.5e-55	0.79	0.90	0.89
PGSC0003DMG200010317	K08332	ko04140	Regulation of autophagy	390	1.0e-13	0.31	0.53	0.47
PGSC0003DMG200010317	K08332	ko04140	Regulation of autophagy	390	2.3e-13	0.31	0.53	0.38
PGSC0003DMG200010319	K09647	ko03060	Protein export	230	7.5e-07	0.33	0.49	0.59
PGSC0003DMG200010319	K09647	ko03060	Protein export	232	5.8e-07	0.34	0.50	0.59
PGSC0003DMG200010324	K12819	ko03040	Spliceosome	3985	5.9e-214	0.85	0.93	1.00
PGSC0003DMG200010327	K13065	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMG200010327	K13065	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMG200010327	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMG200010327	K13065	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.29	0.47	0.96
PGSC0003DMG200037969	K10591	ko04120	Ubiquitin mediated proteolysis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMG200037969	K10591	ko04144	Endocytosis	456	8.4e-19	0.70	0.79	0.98
PGSC0003DMG200037976	K08243	ko00941	Flavonoid biosynthesis	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMG200037976	K08243	ko01110	Biosynthesis of secondary metabolites	381	3.5e-15	0.49	0.71	0.89
PGSC0003DMG200036324	K11821	ko00380	Tryptophan metabolism	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMG200036324	K11821	ko00966	Glucosinolate biosynthesis	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMG200036324	K11821	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.45	0.57	0.91
PGSC0003DMG200022848	K00430	ko00360	Phenylalanine metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMG200022848	K00430	ko00680	Methane metabolism	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMG200022848	K00430	ko00940	Phenylpropanoid biosynthesis	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMG200022848	K00430	ko01100	Metabolic pathways	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMG200022848	K00430	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.54	0.70	0.97
PGSC0003DMG200022849	K00430	ko00360	Phenylalanine metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMG200022849	K00430	ko00680	Methane metabolism	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMG200022849	K00430	ko00940	Phenylpropanoid biosynthesis	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMG200022849	K00430	ko01100	Metabolic pathways	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMG200022849	K00430	ko01110	Biosynthesis of secondary metabolites	1326	2.7e-67	0.55	0.70	0.91
PGSC0003DMG200022849	K00430	ko00360	Phenylalanine metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMG200022849	K00430	ko00680	Methane metabolism	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMG200022849	K00430	ko00940	Phenylpropanoid biosynthesis	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMG200022849	K00430	ko01100	Metabolic pathways	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMG200022849	K00430	ko01110	Biosynthesis of secondary metabolites	1357	5.2e-69	0.57	0.71	0.91
PGSC0003DMG200022849	K00430	ko00360	Phenylalanine metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMG200022849	K00430	ko00680	Methane metabolism	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMG200022849	K00430	ko00940	Phenylpropanoid biosynthesis	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMG200022849	K00430	ko01100	Metabolic pathways	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMG200022849	K00430	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.57	0.71	0.76
PGSC0003DMG200022850	K00430	ko00360	Phenylalanine metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMG200022850	K00430	ko00680	Methane metabolism	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMG200022850	K00430	ko00940	Phenylpropanoid biosynthesis	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMG200022850	K00430	ko01100	Metabolic pathways	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMG200022850	K00430	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.56	0.72	0.91
PGSC0003DMG200022854	K11095	ko03040	Spliceosome	932	1.4e-45	0.61	0.68	0.92
PGSC0003DMG200022855	K01662	ko00900	Terpenoid backbone biosynthesis	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMG200022855	K01662	ko01100	Metabolic pathways	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMG200022855	K01662	ko01110	Biosynthesis of secondary metabolites	5177	1.1e-279	0.88	0.93	1.00
PGSC0003DMG200022855	K01662	ko00900	Terpenoid backbone biosynthesis	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMG200022855	K01662	ko01100	Metabolic pathways	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMG200022855	K01662	ko01110	Biosynthesis of secondary metabolites	5294	3.7e-286	0.87	0.93	1.00
PGSC0003DMG200026024	K12604	ko03018	RNA degradation	8425	0.	0.50	0.60	1.00
PGSC0003DMG200026029	K00026	ko00020	Citrate cycle (TCA cycle)	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko00620	Pyruvate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko00710	Carbon fixation in photosynthetic organisms	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko01100	Metabolic pathways	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.89	0.94	0.78
PGSC0003DMG200026029	K00026	ko00020	Citrate cycle (TCA cycle)	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026029	K00026	ko00620	Pyruvate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026029	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026029	K00026	ko00710	Carbon fixation in photosynthetic organisms	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026029	K00026	ko01100	Metabolic pathways	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026029	K00026	ko01110	Biosynthesis of secondary metabolites	2456	1.3e-129	0.87	0.93	1.00
PGSC0003DMG200026042	K05754	ko04666	Fc gamma R-mediated phagocytosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMG200026042	K05754	ko04810	Regulation of actin cytoskeleton	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMG200026042	K05754	ko05100	Bacterial invasion of epithelial cells	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMG200026042	K05754	ko05130	Pathogenic Escherichia coli infection	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMG200026042	K05754	ko05131	Shigellosis	884	6.4e-43	0.63	0.67	0.99
PGSC0003DMG200026042	K05754	ko04666	Fc gamma R-mediated phagocytosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMG200026042	K05754	ko04810	Regulation of actin cytoskeleton	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMG200026042	K05754	ko05100	Bacterial invasion of epithelial cells	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMG200026042	K05754	ko05130	Pathogenic Escherichia coli infection	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMG200026042	K05754	ko05131	Shigellosis	1004	1.5e-49	0.89	0.93	0.99
PGSC0003DMG200026043	K02084	ko04115	p53 signaling pathway	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko04210	Apoptosis	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko05010	Alzheimer's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko05012	Parkinson's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko05016	Huntington's disease	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200026043	K02084	ko05222	Small cell lung cancer	291	1.6e-06	0.26	0.46	0.46
PGSC0003DMG200006089	K12126	ko04712	Circadian rhythm - plant	315	1.9e-11	0.49	0.85	0.24
PGSC0003DMG200006097	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko01100	Metabolic pathways	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006097	K10046	ko01110	Biosynthesis of secondary metabolites	2977	2.3e-158	0.90	0.96	1.00
PGSC0003DMG200006099	K10773	ko03410	Base excision repair	275	2.5e-09	0.64	0.71	0.85
PGSC0003DMG200006099	K10773	ko03410	Base excision repair	312	2.3e-11	0.70	0.94	0.53
PGSC0003DMG200006099	K10773	ko03410	Base excision repair	1564	2.0e-80	0.59	0.71	0.99
PGSC0003DMG200006099	K10773	ko03410	Base excision repair	1153	9.3e-58	0.56	0.71	0.88
PGSC0003DMG200006101	K00660	ko00941	Flavonoid biosynthesis	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMG200006101	K00660	ko01100	Metabolic pathways	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMG200006101	K00660	ko01110	Biosynthesis of secondary metabolites	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMG200006101	K00660	ko04712	Circadian rhythm - plant	235	4.6e-07	0.37	0.50	0.43
PGSC0003DMG200009273	K13065	ko00940	Phenylpropanoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMG200009273	K13065	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMG200009273	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMG200009273	K13065	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.30	0.50	0.93
PGSC0003DMG200009278	K00893	ko00230	Purine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMG200009278	K00893	ko00240	Pyrimidine metabolism	2510	1.3e-132	0.80	0.90	0.62
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2189	6.7e-115	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2185	1.1e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2184	1.3e-114	0.40	0.58	0.98
PGSC0003DMG200009279	K00599	ko00340	Histidine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMG200009279	K00599	ko00350	Tyrosine metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMG200009279	K00599	ko00450	Selenoamino acid metabolism	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMG200009279	K00599	ko00626	Naphthalene and anthracene degradation	2146	1.6e-112	0.40	0.57	1.00
PGSC0003DMG200015527	K12605	ko03018	RNA degradation	746	2.6e-35	0.77	0.92	0.93
PGSC0003DMG200015529	K03946	ko00190	Oxidative phosphorylation	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMG200015529	K03946	ko01100	Metabolic pathways	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMG200015529	K03946	ko05010	Alzheimer's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMG200015529	K03946	ko05012	Parkinson's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMG200015529	K03946	ko05016	Huntington's disease	588	1.3e-26	0.74	0.85	0.98
PGSC0003DMG200015537	K10703	ko01040	Biosynthesis of unsaturated fatty acids	614	5.0e-28	0.66	0.81	0.54
PGSC0003DMG200015537	K10703	ko01040	Biosynthesis of unsaturated fatty acids	421	2.2e-17	0.52	0.64	0.98
PGSC0003DMG200015537	K10703	ko01040	Biosynthesis of unsaturated fatty acids	530	2.1e-23	0.58	0.70	0.98
PGSC0003DMG200015537	K10703	ko01040	Biosynthesis of unsaturated fatty acids	1070	3.5e-53	0.60	0.74	0.99
PGSC0003DMG200015537	K10703	ko01040	Biosynthesis of unsaturated fatty acids	373	9.7e-15	0.61	0.76	0.44
PGSC0003DMG200015538	K02858	ko00740	Riboflavin metabolism	2657	1.0e-140	0.84	0.92	0.94
PGSC0003DMG200015538	K02858	ko00740	Riboflavin metabolism	2618	1.5e-138	0.71	0.80	0.96
PGSC0003DMG200015538	K02858	ko00740	Riboflavin metabolism	3110	1.1e-165	0.73	0.82	0.95
PGSC0003DMG200011712	K02865	ko03010	Ribosome	1259	1.3e-63	0.89	0.92	0.44
PGSC0003DMG200011712	K02865	ko03010	Ribosome	1643	8.7e-85	0.92	0.95	1.00
PGSC0003DMG200011723	K10352	ko04530	Tight junction	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMG200011723	K10352	ko05416	Viral myocarditis	474	2.6e-17	0.26	0.47	0.92
PGSC0003DMG200011728	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMG200011728	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMG200011728	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMG200011728	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.57
PGSC0003DMG200011728	K07407	ko00052	Galactose metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMG200011728	K07407	ko00561	Glycerolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMG200011728	K07407	ko00600	Sphingolipid metabolism	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMG200011728	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	473	3.0e-20	0.30	0.47	0.57
PGSC0003DMG200004867	K04554	ko04120	Ubiquitin mediated proteolysis	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMG200004867	K04554	ko05012	Parkinson's disease	593	7.1e-27	0.93	0.96	0.97
PGSC0003DMG200004870	K03061	ko03050	Proteasome	888	3.8e-43	0.91	0.96	0.94
PGSC0003DMG200004870	K03061	ko03050	Proteasome	3554	3.5e-190	0.97	0.99	1.00
PGSC0003DMG200004870	K03061	ko03050	Proteasome	513	1.8e-22	1.00	1.00	0.82
PGSC0003DMG200004870	K03061	ko03050	Proteasome	837	2.5e-40	0.87	0.91	0.97
PGSC0003DMG200004872	K00469	ko00053	Ascorbate and aldarate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMG200004872	K00469	ko00562	Inositol phosphate metabolism	2092	1.5e-109	0.78	0.90	1.00
PGSC0003DMG200042971	K01051	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMG200042971	K01051	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMG200042971	K01051	ko01100	Metabolic pathways	518	9.8e-23	0.32	0.45	0.93
PGSC0003DMG200042975	K13065	ko00940	Phenylpropanoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMG200042975	K13065	ko00941	Flavonoid biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMG200042975	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMG200042975	K13065	ko01110	Biosynthesis of secondary metabolites	223	3.3e-06	0.30	0.47	0.65
PGSC0003DMG200042987	K00799	ko00480	Glutathione metabolism	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMG200042987	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMG200042987	K00799	ko00982	Drug metabolism - cytochrome P450	294	2.2e-10	0.45	0.71	0.91
PGSC0003DMG200042990	K03094	ko04110	Cell cycle	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04111	Cell cycle - yeast	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04114	Oocyte meiosis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04120	Ubiquitin mediated proteolysis	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04310	Wnt signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04350	TGF-beta signaling pathway	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200042990	K03094	ko04710	Circadian rhythm - mammal	683	7.8e-32	0.58	0.71	0.99
PGSC0003DMG200041652	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2321	3.5e-122	0.66	0.80	0.99
PGSC0003DMG200041656	K12836	ko03040	Spliceosome	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMG200041656	K12836	ko05131	Shigellosis	554	1.0e-24	0.49	0.62	0.99
PGSC0003DMG200008690	K00795	ko00900	Terpenoid backbone biosynthesis	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMG200008690	K00795	ko01100	Metabolic pathways	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMG200008690	K00795	ko01110	Biosynthesis of secondary metabolites	1818	1.9e-94	0.67	0.75	1.00
PGSC0003DMG200008690	K00795	ko00900	Terpenoid backbone biosynthesis	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMG200008690	K00795	ko01100	Metabolic pathways	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMG200008690	K00795	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.78	0.89	1.00
PGSC0003DMG200008690	K00795	ko00900	Terpenoid backbone biosynthesis	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMG200008690	K00795	ko01100	Metabolic pathways	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMG200008690	K00795	ko01110	Biosynthesis of secondary metabolites	2261	7.2e-119	0.78	0.88	1.00
PGSC0003DMG200008692	K12042	ko04020	Calcium signaling pathway	296	1.7e-10	0.37	0.52	0.68
PGSC0003DMG200008696	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200008698	K03283	ko03040	Spliceosome	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMG200008698	K03283	ko04010	MAPK signaling pathway	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMG200008698	K03283	ko04144	Endocytosis	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMG200008698	K03283	ko04612	Antigen processing and presentation	3270	1.6e-174	0.75	0.83	1.00
PGSC0003DMG200005707	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko00270	Cysteine and methionine metabolism	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005707	K08967	ko01100	Metabolic pathways	299	1.2e-10	0.75	0.89	0.66
PGSC0003DMG200005709	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMG200005709	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.58
PGSC0003DMG200005709	K01052	ko00100	Steroid biosynthesis	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMG200005709	K01052	ko04142	Lysosome	527	3.1e-23	0.32	0.45	0.52
PGSC0003DMG200005710	K12603	ko03018	RNA degradation	496	1.6e-21	0.35	0.57	0.56
PGSC0003DMG200005710	K12603	ko03018	RNA degradation	301	1.8e-10	0.31	0.43	0.95
PGSC0003DMG200005710	K12603	ko03018	RNA degradation	346	4.5e-13	0.36	0.50	0.69
PGSC0003DMG200005712	K10260	ko04120	Ubiquitin mediated proteolysis	558	3.3e-24	0.32	0.51	0.24
PGSC0003DMG200005712	K10260	ko04120	Ubiquitin mediated proteolysis	558	6.1e-25	0.32	0.51	0.51
PGSC0003DMG200026761	K12489	ko04144	Endocytosis	3267	2.3e-174	0.70	0.84	0.99
PGSC0003DMG200026761	K12489	ko04144	Endocytosis	634	3.9e-29	0.60	0.75	0.99
PGSC0003DMG200026761	K12489	ko04144	Endocytosis	957	6.0e-47	0.61	0.79	0.88
PGSC0003DMG200026762	K05282	ko00904	Diterpenoid biosynthesis	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMG200026762	K05282	ko01100	Metabolic pathways	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMG200026762	K05282	ko01110	Biosynthesis of secondary metabolites	603	2.0e-27	0.33	0.49	0.86
PGSC0003DMG200023883	K00889	ko00562	Inositol phosphate metabolism	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko01100	Metabolic pathways	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko04070	Phosphatidylinositol signaling system	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko04144	Endocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko04666	Fc gamma R-mediated phagocytosis	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko04810	Regulation of actin cytoskeleton	340	2.6e-10	0.33	0.47	0.33
PGSC0003DMG200023883	K00889	ko00562	Inositol phosphate metabolism	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023883	K00889	ko01100	Metabolic pathways	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023883	K00889	ko04070	Phosphatidylinositol signaling system	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023883	K00889	ko04144	Endocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023883	K00889	ko04666	Fc gamma R-mediated phagocytosis	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023883	K00889	ko04810	Regulation of actin cytoskeleton	328	1.8e-09	0.34	0.49	0.29
PGSC0003DMG200023884	K02901	ko03010	Ribosome	766	2.1e-36	0.71	0.81	0.99
PGSC0003DMG200023893	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMG200023893	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMG200023893	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMG200023893	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMG200023893	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.44	0.62	0.97
PGSC0003DMG200028996	K01423	ko00310	Lysine degradation	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMG200028996	K01423	ko00780	Biotin metabolism	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMG200028996	K01423	ko01100	Metabolic pathways	2298	6.5e-121	0.47	0.64	0.92
PGSC0003DMG200028998	K01254	ko00590	Arachidonic acid metabolism	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMG200028998	K01254	ko01100	Metabolic pathways	4046	2.5e-217	0.77	0.87	1.00
PGSC0003DMG200029005	K02291	ko00906	Carotenoid biosynthesis	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMG200029005	K02291	ko01100	Metabolic pathways	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMG200029005	K02291	ko01110	Biosynthesis of secondary metabolites	920	2.0e-50	0.72	0.82	0.78
PGSC0003DMG200029008	K05577	ko00190	Oxidative phosphorylation	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMG200029008	K05577	ko01100	Metabolic pathways	3832	1.6e-205	0.79	0.85	0.99
PGSC0003DMG200039522	K00002	ko00010	Glycolysis / Gluconeogenesis	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMG200039522	K00002	ko00561	Glycerolipid metabolism	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMG200039522	K00002	ko00930	Caprolactam degradation	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMG200039522	K00002	ko01100	Metabolic pathways	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMG200039522	K00002	ko01110	Biosynthesis of secondary metabolites	1035	3.0e-51	0.45	0.63	0.98
PGSC0003DMG200039532	K02183	ko04020	Calcium signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04070	Phosphatidylinositol signaling system	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04114	Oocyte meiosis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04270	Vascular smooth muscle contraction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04626	Plant-pathogen interaction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04720	Long-term potentiation	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04722	Neurotrophin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04740	Olfactory transduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04744	Phototransduction	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04745	Phototransduction - fly	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04910	Insulin signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04912	GnRH signaling pathway	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04916	Melanogenesis	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04970	Salivary secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko04971	Gastric acid secretion	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko05010	Alzheimer's disease	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039532	K02183	ko05214	Glioma	381	3.5e-15	0.40	0.58	0.80
PGSC0003DMG200039535	K01051	ko00040	Pentose and glucuronate interconversions	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMG200039535	K01051	ko00500	Starch and sucrose metabolism	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMG200039535	K01051	ko01100	Metabolic pathways	1641	1.1e-84	0.44	0.59	0.96
PGSC0003DMG200003155	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMG200003155	K01904	ko00360	Phenylalanine metabolism	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMG200003155	K01904	ko00940	Phenylpropanoid biosynthesis	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMG200003155	K01904	ko01100	Metabolic pathways	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMG200003155	K01904	ko01110	Biosynthesis of secondary metabolites	3600	1.0e-192	0.76	0.86	0.99
PGSC0003DMG200003156	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMG200003156	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.72
PGSC0003DMG200003156	K02368	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMG200003156	K02368	ko01100	Metabolic pathways	224	6.8e-06	0.29	0.49	0.89
PGSC0003DMG200003163	K10352	ko04530	Tight junction	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMG200003163	K10352	ko05416	Viral myocarditis	774	7.6e-36	0.28	0.48	0.89
PGSC0003DMG200003167	K10610	ko03420	Nucleotide excision repair	8587	0.	0.93	0.97	1.00
PGSC0003DMG200003167	K10610	ko04120	Ubiquitin mediated proteolysis	8587	0.	0.93	0.97	1.00
PGSC0003DMG200003167	K10610	ko03420	Nucleotide excision repair	8568	0.	0.92	0.97	1.00
PGSC0003DMG200003167	K10610	ko04120	Ubiquitin mediated proteolysis	8568	0.	0.92	0.97	1.00
PGSC0003DMG200003169	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMG200003169	K12741	ko03040	Spliceosome	682	8.8e-32	0.35	0.45	0.81
PGSC0003DMG200003170	K03259	ko04150	mTOR signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMG200003170	K03259	ko04910	Insulin signaling pathway	1482	6.6e-76	0.82	0.92	0.90
PGSC0003DMG200004088	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMG200004088	K12846	ko03040	Spliceosome	1073	2.4e-53	0.65	0.71	1.00
PGSC0003DMG200004090	K00430	ko00360	Phenylalanine metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMG200004090	K00430	ko00680	Methane metabolism	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMG200004090	K00430	ko00940	Phenylpropanoid biosynthesis	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMG200004090	K00430	ko01100	Metabolic pathways	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMG200004090	K00430	ko01110	Biosynthesis of secondary metabolites	2022	1.1e-105	0.72	0.85	1.00
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	3820	7.4e-205	0.58	0.73	0.99
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	1796	3.2e-93	0.49	0.67	1.00
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	747	2.3e-35	0.82	0.88	0.82
PGSC0003DMG200004094	K10777	ko03450	Non-homologous end-joining	2277	9.4e-120	0.83	0.92	0.94
PGSC0003DMG200007870	K02084	ko04115	p53 signaling pathway	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko04210	Apoptosis	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko05010	Alzheimer's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko05012	Parkinson's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko05016	Huntington's disease	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007870	K02084	ko05222	Small cell lung cancer	346	1.3e-09	0.28	0.45	0.52
PGSC0003DMG200007871	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.40
PGSC0003DMG200007871	K02084	ko04115	p53 signaling pathway	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko04210	Apoptosis	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko05010	Alzheimer's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko05012	Parkinson's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko05016	Huntington's disease	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007871	K02084	ko05222	Small cell lung cancer	301	4.4e-07	0.28	0.44	0.41
PGSC0003DMG200007872	K02084	ko04115	p53 signaling pathway	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko04210	Apoptosis	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko05010	Alzheimer's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko05012	Parkinson's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko05016	Huntington's disease	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko05222	Small cell lung cancer	339	3.0e-09	0.28	0.45	0.55
PGSC0003DMG200007872	K02084	ko04115	p53 signaling pathway	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko04210	Apoptosis	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko05010	Alzheimer's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko05012	Parkinson's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko05016	Huntington's disease	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007872	K02084	ko05222	Small cell lung cancer	339	3.3e-09	0.28	0.45	0.52
PGSC0003DMG200007877	K03010	ko00230	Purine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMG200007877	K03010	ko00240	Pyrimidine metabolism	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMG200007877	K03010	ko01100	Metabolic pathways	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMG200007877	K03010	ko03020	RNA polymerase	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMG200007877	K03010	ko05016	Huntington's disease	1777	3.6e-92	0.88	0.95	1.00
PGSC0003DMG200020773	K04706	ko04120	Ubiquitin mediated proteolysis	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMG200020773	K04706	ko04630	Jak-STAT signaling pathway	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMG200020773	K04706	ko05200	Pathways in cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMG200020773	K04706	ko05222	Small cell lung cancer	256	1.5e-07	0.33	0.50	0.16
PGSC0003DMG200020773	K04706	ko04120	Ubiquitin mediated proteolysis	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMG200020773	K04706	ko04630	Jak-STAT signaling pathway	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMG200020773	K04706	ko05200	Pathways in cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMG200020773	K04706	ko05222	Small cell lung cancer	409	3.1e-14	0.28	0.46	0.55
PGSC0003DMG200020781	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMG200020781	K12812	ko03040	Spliceosome	3465	2.8e-185	0.96	0.98	1.00
PGSC0003DMG200020781	K12812	ko03040	Spliceosome	1363	2.4e-69	0.96	0.99	0.88
PGSC0003DMG200020781	K12812	ko03040	Spliceosome	2834	1.8e-150	0.97	0.99	1.00
PGSC0003DMG200024649	K12813	ko03040	Spliceosome	657	4.6e-30	0.57	0.75	0.99
PGSC0003DMG200024649	K12813	ko03040	Spliceosome	983	2.2e-48	0.86	0.95	0.98
PGSC0003DMG200024649	K12813	ko03040	Spliceosome	2692	1.2e-142	0.92	0.96	0.99
PGSC0003DMG200024649	K12813	ko03040	Spliceosome	6693	0.	0.86	0.94	1.00
PGSC0003DMG200024649	K12813	ko03040	Spliceosome	7348	0.	0.82	0.92	1.00
PGSC0003DMG200024654	K07964	ko00531	Glycosaminoglycan degradation	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMG200024654	K07964	ko01100	Metabolic pathways	314	2.3e-11	0.29	0.50	0.97
PGSC0003DMG200024654	K07964	ko00531	Glycosaminoglycan degradation	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMG200024654	K07964	ko01100	Metabolic pathways	288	7.9e-10	0.29	0.50	0.94
PGSC0003DMG200024654	K07964	ko00531	Glycosaminoglycan degradation	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMG200024654	K07964	ko01100	Metabolic pathways	613	5.6e-28	0.33	0.47	0.75
PGSC0003DMG200024658	K10849	ko03420	Nucleotide excision repair	402	2.4e-16	0.52	0.62	0.91
PGSC0003DMG200024658	K10849	ko03420	Nucleotide excision repair	557	6.9e-25	0.59	0.67	0.94
PGSC0003DMG200024658	K10849	ko03420	Nucleotide excision repair	1204	1.4e-60	0.70	0.80	0.94
PGSC0003DMG200024658	K10849	ko03420	Nucleotide excision repair	2219	1.5e-116	0.70	0.79	0.97
PGSC0003DMG200037424	K01750	ko00330	Arginine and proline metabolism	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMG200037424	K01750	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.67	0.82	0.99
PGSC0003DMG200037444	K01051	ko00040	Pentose and glucuronate interconversions	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMG200037444	K01051	ko00500	Starch and sucrose metabolism	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMG200037444	K01051	ko01100	Metabolic pathways	1178	3.9e-59	0.47	0.63	0.91
PGSC0003DMG200017837	K08488	ko04130	SNARE interactions in vesicular transport	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMG200017837	K08488	ko04145	Phagosome	543	4.1e-24	0.76	0.94	0.64
PGSC0003DMG200017842	K09753	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMG200017842	K09753	ko01100	Metabolic pathways	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMG200017842	K09753	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.33	0.53	0.72
PGSC0003DMG200017842	K13082	ko00941	Flavonoid biosynthesis	254	3.6e-08	0.32	0.55	0.95
PGSC0003DMG200017848	K02703	ko00195	Photosynthesis	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMG200017848	K02703	ko01100	Metabolic pathways	427	1.0e-17	0.86	0.90	0.69
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	636	3.0e-29	0.33	0.49	0.94
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.76
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	247	1.2e-07	0.30	0.47	0.89
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.34	0.50	0.85
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.34	0.52	0.86
PGSC0003DMG200007149	K01834	ko00010	Glycolysis / Gluconeogenesis	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMG200007149	K01834	ko01100	Metabolic pathways	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMG200007149	K01834	ko01110	Biosynthesis of secondary metabolites	585	2.0e-26	0.33	0.48	0.95
PGSC0003DMG200007150	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.52
PGSC0003DMG200007150	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.70
PGSC0003DMG200007150	K00694	ko00500	Starch and sucrose metabolism	278	2.4e-09	0.34	0.51	0.43
PGSC0003DMG200007151	K11824	ko04144	Endocytosis	7439	0.	0.86	0.91	1.00
PGSC0003DMG200007151	K11824	ko05016	Huntington's disease	7439	0.	0.86	0.91	1.00
PGSC0003DMG200007151	K11824	ko04144	Endocytosis	7490	0.	0.88	0.93	1.00
PGSC0003DMG200007151	K11824	ko05016	Huntington's disease	7490	0.	0.88	0.93	1.00
PGSC0003DMG200007152	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMG200007152	K12449	ko01100	Metabolic pathways	3015	1.9e-160	0.90	0.95	0.99
PGSC0003DMG200003412	K10643	ko03018	RNA degradation	2173	5.1e-114	0.38	0.53	1.00
PGSC0003DMG200003416	K11584	ko04113	Meiosis - yeast	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMG200003416	K11584	ko04114	Oocyte meiosis	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMG200003416	K11584	ko04310	Wnt signaling pathway	2466	3.5e-130	0.71	0.86	0.99
PGSC0003DMG200003419	K02147	ko00190	Oxidative phosphorylation	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko01100	Metabolic pathways	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko04145	Phagosome	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko04966	Collecting duct acid secretion	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko05110	Vibrio cholerae infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3874	7.8e-208	0.90	0.92	1.00
PGSC0003DMG200003419	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko00190	Oxidative phosphorylation	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko01100	Metabolic pathways	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko04145	Phagosome	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko04966	Collecting duct acid secretion	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko05110	Vibrio cholerae infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003419	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3980	1.1e-213	0.97	0.99	1.00
PGSC0003DMG200003423	K12741	ko03040	Spliceosome	334	1.4e-12	0.41	0.48	0.62
PGSC0003DMG200003423	K12741	ko03040	Spliceosome	320	8.2e-12	0.34	0.45	0.92
PGSC0003DMG200003423	K12741	ko03040	Spliceosome	318	1.1e-11	0.34	0.45	0.92
PGSC0003DMG200016905	K12929	ko00904	Diterpenoid biosynthesis	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMG200016905	K12929	ko01110	Biosynthesis of secondary metabolites	792	7.6e-38	0.33	0.51	0.99
PGSC0003DMG200016906	K04371	ko04010	MAPK signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04012	ErbB signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04013	MAPK signaling pathway - fly	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04062	Chemokine signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04114	Oocyte meiosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04150	mTOR signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04270	Vascular smooth muscle contraction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04320	Dorso-ventral axis formation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04350	TGF-beta signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04360	Axon guidance	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04370	VEGF signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04510	Focal adhesion	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04520	Adherens junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04540	Gap junction	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04620	Toll-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04621	NOD-like receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04650	Natural killer cell mediated cytotoxicity	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04660	T cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04662	B cell receptor signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04664	Fc epsilon RI signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04666	Fc gamma R-mediated phagocytosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04720	Long-term potentiation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04722	Neurotrophin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04730	Long-term depression	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04810	Regulation of actin cytoskeleton	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04910	Insulin signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04912	GnRH signaling pathway	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04914	Progesterone-mediated oocyte maturation	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04916	Melanogenesis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04930	Type II diabetes mellitus	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko04960	Aldosterone-regulated sodium reabsorption	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05010	Alzheimer's disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05020	Prion diseases	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05131	Shigellosis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05140	Leishmaniasis	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05142	Chagas disease	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05200	Pathways in cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05210	Colorectal cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05211	Renal cell carcinoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05212	Pancreatic cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05213	Endometrial cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05214	Glioma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05215	Prostate cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05216	Thyroid cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05218	Melanoma	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05219	Bladder cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05220	Chronic myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05221	Acute myeloid leukemia	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200016906	K04371	ko05223	Non-small cell lung cancer	654	3.1e-30	0.54	0.71	0.99
PGSC0003DMG200038331	K04508	ko04310	Wnt signaling pathway	2773	4.1e-147	0.64	0.78	1.00
PGSC0003DMG200038336	K10760	ko00908	Zeatin biosynthesis	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMG200038336	K10760	ko01100	Metabolic pathways	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMG200038336	K10760	ko01110	Biosynthesis of secondary metabolites	510	2.3e-30	0.54	0.71	0.92
PGSC0003DMG200038341	K10760	ko00908	Zeatin biosynthesis	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMG200038341	K10760	ko01100	Metabolic pathways	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMG200038341	K10760	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.48	0.68	0.96
PGSC0003DMG200044730	K03921	ko00061	Fatty acid biosynthesis	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMG200044730	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2036	1.8e-106	0.63	0.76	0.99
PGSC0003DMG200020547	K02987	ko03010	Ribosome	1939	4.1e-101	0.92	0.98	0.98
PGSC0003DMG200020547	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMG200020547	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMG200020547	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMG200020547	K02987	ko03010	Ribosome	2104	3.3e-110	0.93	0.98	0.98
PGSC0003DMG200020548	K02987	ko03010	Ribosome	1303	4.9e-66	0.85	0.94	0.96
PGSC0003DMG200020558	K03178	ko04120	Ubiquitin mediated proteolysis	7555	0.	0.81	0.90	1.00
PGSC0003DMG200020558	K03178	ko05012	Parkinson's disease	7555	0.	0.81	0.90	1.00
PGSC0003DMG200020559	K08059	ko04612	Antigen processing and presentation	798	3.5e-38	0.53	0.68	0.89
PGSC0003DMG200020559	K08059	ko04612	Antigen processing and presentation	974	6.9e-48	0.64	0.77	0.69
PGSC0003DMG200025275	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMG200025275	K00517	ko00626	Naphthalene and anthracene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMG200025275	K00517	ko00903	Limonene and pinene degradation	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMG200025275	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMG200025275	K00517	ko01110	Biosynthesis of secondary metabolites	935	9.8e-46	0.42	0.61	0.96
PGSC0003DMG200025280	K08248	ko00460	Cyanoamino acid metabolism	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMG200025280	K08248	ko01100	Metabolic pathways	1966	1.3e-102	0.50	0.65	0.94
PGSC0003DMG200025281	K00008	ko00051	Fructose and mannose metabolism	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMG200025281	K00008	ko01100	Metabolic pathways	2224	7.9e-117	0.71	0.89	0.99
PGSC0003DMG200021512	K13239	ko00071	Fatty acid metabolism	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMG200021512	K13239	ko04146	Peroxisome	254	2.7e-06	0.33	0.53	0.30
PGSC0003DMG200021519	K06627	ko04110	Cell cycle	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMG200021519	K06627	ko04914	Progesterone-mediated oocyte maturation	2090	1.9e-109	0.70	0.79	0.99
PGSC0003DMG200021520	K04503	ko04110	Cell cycle	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko04115	p53 signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko04310	Wnt signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko04510	Focal adhesion	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko04630	Jak-STAT signaling pathway	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05200	Pathways in cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05210	Colorectal cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05212	Pancreatic cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05213	Endometrial cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05214	Glioma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05215	Prostate cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05216	Thyroid cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05218	Melanoma	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05219	Bladder cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05220	Chronic myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05221	Acute myeloid leukemia	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05222	Small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05223	Non-small cell lung cancer	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021520	K04503	ko05416	Viral myocarditis	262	1.3e-08	0.31	0.52	0.71
PGSC0003DMG200021525	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMG200021525	K02184	ko04320	Dorso-ventral axis formation	533	1.2e-19	0.31	0.43	0.31
PGSC0003DMG200021526	K12126	ko04712	Circadian rhythm - plant	289	6.7e-10	0.31	0.46	0.75
PGSC0003DMG200018565	K00001	ko00010	Glycolysis / Gluconeogenesis	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00071	Fatty acid metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00350	Tyrosine metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00641	3-Chloroacrylic acid degradation	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00830	Retinol metabolism	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko00982	Drug metabolism - cytochrome P450	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko01100	Metabolic pathways	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00001	ko01110	Biosynthesis of secondary metabolites	1165	2.0e-58	0.45	0.63	0.94
PGSC0003DMG200018565	K00121	ko00010	Glycolysis / Gluconeogenesis	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00071	Fatty acid metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00350	Tyrosine metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00641	3-Chloroacrylic acid degradation	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00680	Methane metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00830	Retinol metabolism	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00982	Drug metabolism - cytochrome P450	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko01100	Metabolic pathways	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko01110	Biosynthesis of secondary metabolites	1242	1.1e-62	0.44	0.65	0.97
PGSC0003DMG200018565	K00121	ko00010	Glycolysis / Gluconeogenesis	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00071	Fatty acid metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00350	Tyrosine metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00624	1- and 2-Methylnaphthalene degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00641	3-Chloroacrylic acid degradation	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00680	Methane metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00830	Retinol metabolism	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko00982	Drug metabolism - cytochrome P450	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko01100	Metabolic pathways	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018565	K00121	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.45	0.65	0.94
PGSC0003DMG200018566	K02899	ko03010	Ribosome	1023	1.4e-50	0.82	0.90	0.98
PGSC0003DMG200006361	K02872	ko03010	Ribosome	279	1.5e-09	0.79	0.85	0.83
PGSC0003DMG200006367	K05280	ko00941	Flavonoid biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMG200006367	K05280	ko00944	Flavone and flavonol biosynthesis	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMG200006367	K05280	ko01100	Metabolic pathways	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMG200006367	K05280	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.40	0.59	0.98
PGSC0003DMG200006368	K05280	ko00941	Flavonoid biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMG200006368	K05280	ko00944	Flavone and flavonol biosynthesis	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMG200006368	K05280	ko01100	Metabolic pathways	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMG200006368	K05280	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.39	0.58	1.00
PGSC0003DMG200006372	K08492	ko04130	SNARE interactions in vesicular transport	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMG200006372	K08492	ko04145	Phagosome	1320	5.7e-67	0.70	0.83	0.97
PGSC0003DMG200006372	K08492	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMG200006372	K08492	ko04145	Phagosome	1595	3.9e-82	0.78	0.87	1.00
PGSC0003DMG200006372	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMG200006372	K08492	ko04145	Phagosome	2008	6.4e-105	0.77	0.87	1.00
PGSC0003DMG200006373	K01934	ko00670	One carbon pool by folate	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMG200006373	K01934	ko01100	Metabolic pathways	2025	7.4e-106	0.69	0.80	0.99
PGSC0003DMG200006373	K01934	ko00670	One carbon pool by folate	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMG200006373	K01934	ko01100	Metabolic pathways	1690	2.2e-87	0.67	0.78	0.98
PGSC0003DMG200006379	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200006379	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200006379	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200009331	K10592	ko04120	Ubiquitin mediated proteolysis	21015	0.	0.71	0.83	0.98
PGSC0003DMG200009331	K10592	ko04120	Ubiquitin mediated proteolysis	21346	0.	0.72	0.84	0.99
PGSC0003DMG200009337	K04424	ko04010	MAPK signaling pathway	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMG200009337	K04424	ko04530	Tight junction	1710	1.8e-88	0.38	0.51	0.76
PGSC0003DMG200009337	K04424	ko04010	MAPK signaling pathway	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMG200009337	K04424	ko04530	Tight junction	1640	1.3e-84	0.38	0.52	0.76
PGSC0003DMG200009337	K04424	ko04010	MAPK signaling pathway	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMG200009337	K04424	ko04530	Tight junction	1832	3.3e-95	0.39	0.53	0.77
PGSC0003DMG200011560	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMG200011560	K00517	ko00626	Naphthalene and anthracene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMG200011560	K00517	ko00903	Limonene and pinene degradation	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMG200011560	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMG200011560	K00517	ko01110	Biosynthesis of secondary metabolites	1998	2.3e-104	0.51	0.70	0.97
PGSC0003DMG200011561	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMG200011561	K00517	ko00626	Naphthalene and anthracene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMG200011561	K00517	ko00903	Limonene and pinene degradation	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMG200011561	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMG200011561	K00517	ko01110	Biosynthesis of secondary metabolites	1155	7.2e-58	0.56	0.73	0.98
PGSC0003DMG200011563	K06627	ko04110	Cell cycle	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMG200011563	K06627	ko04914	Progesterone-mediated oocyte maturation	2018	1.8e-105	0.70	0.79	1.00
PGSC0003DMG200011570	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00020	Citrate cycle (TCA cycle)	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00620	Pyruvate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko00710	Carbon fixation in photosynthetic organisms	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko01100	Metabolic pathways	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011570	K00026	ko01110	Biosynthesis of secondary metabolites	2805	7.1e-149	0.84	0.91	1.00
PGSC0003DMG200011572	K11816	ko00380	Tryptophan metabolism	2536	4.9e-134	0.71	0.86	0.97
PGSC0003DMG200000002	K10610	ko03420	Nucleotide excision repair	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMG200000002	K10610	ko04120	Ubiquitin mediated proteolysis	675	1.9e-30	0.39	0.64	0.85
PGSC0003DMG200000002	K10610	ko03420	Nucleotide excision repair	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMG200000002	K10610	ko04120	Ubiquitin mediated proteolysis	318	1.5e-10	0.37	0.63	0.74
PGSC0003DMG200000003	K12307	ko04142	Lysosome	263	3.3e-06	0.24	0.43	0.59
PGSC0003DMG200000003	K12307	ko04142	Lysosome	348	2.7e-11	0.24	0.43	0.70
PGSC0003DMG200000003	K12307	ko04142	Lysosome	316	2.7e-09	0.24	0.43	0.68
PGSC0003DMG200000003	K12307	ko04142	Lysosome	344	1.9e-11	0.24	0.43	0.91
PGSC0003DMG200000007	K00680	ko00350	Tyrosine metabolism	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMG200000007	K00680	ko00624	1- and 2-Methylnaphthalene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMG200000007	K00680	ko00632	Benzoate degradation via CoA ligation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMG200000007	K00680	ko00642	Ethylbenzene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMG200000007	K00680	ko00903	Limonene and pinene degradation	344	3.9e-13	0.29	0.47	0.96
PGSC0003DMG200000007	K00680	ko00350	Tyrosine metabolism	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMG200000007	K00680	ko00624	1- and 2-Methylnaphthalene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMG200000007	K00680	ko00632	Benzoate degradation via CoA ligation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMG200000007	K00680	ko00642	Ethylbenzene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMG200000007	K00680	ko00903	Limonene and pinene degradation	804	1.6e-38	0.33	0.51	0.74
PGSC0003DMG200023150	K00558	ko00270	Cysteine and methionine metabolism	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMG200023150	K00558	ko01100	Metabolic pathways	1504	4.1e-77	0.65	0.77	0.84
PGSC0003DMG200023150	K00558	ko00270	Cysteine and methionine metabolism	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMG200023150	K00558	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.77	0.97
PGSC0003DMG200023158	K04124	ko00904	Diterpenoid biosynthesis	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMG200023158	K04124	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.47	0.63	0.98
PGSC0003DMG200026090	K04428	ko04010	MAPK signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMG200026090	K04428	ko04912	GnRH signaling pathway	447	8.1e-19	0.30	0.51	0.85
PGSC0003DMG200026090	K02216	ko04110	Cell cycle	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMG200026090	K02216	ko04111	Cell cycle - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMG200026090	K02216	ko04113	Meiosis - yeast	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMG200026090	K02216	ko04115	p53 signaling pathway	351	1.6e-13	0.36	0.53	0.98
PGSC0003DMG200026091	K06627	ko04110	Cell cycle	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMG200026091	K06627	ko04914	Progesterone-mediated oocyte maturation	2019	1.6e-105	0.57	0.71	0.94
PGSC0003DMG200026091	K06627	ko04110	Cell cycle	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMG200026091	K06627	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.57	0.71	0.99
PGSC0003DMG200026092	K03130	ko03022	Basal transcription factors	4519	2.1e-243	0.79	0.88	1.00
PGSC0003DMG200026095	K08495	ko04130	SNARE interactions in vesicular transport	1456	1.8e-74	0.80	0.90	1.00
PGSC0003DMG200026097	K11228	ko04011	MAPK signaling pathway - yeast	325	2.3e-11	0.36	0.54	0.64
PGSC0003DMG200029882	K11821	ko00380	Tryptophan metabolism	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMG200029882	K11821	ko00966	Glucosinolate biosynthesis	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMG200029882	K11821	ko01110	Biosynthesis of secondary metabolites	229	8.5e-07	0.36	0.56	0.91
PGSC0003DMG200029885	K04733	ko04210	Apoptosis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMG200029885	K04733	ko04620	Toll-like receptor signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMG200029885	K04733	ko04722	Neurotrophin signaling pathway	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMG200029885	K04733	ko05140	Leishmaniasis	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMG200029885	K04733	ko05142	Chagas disease	3142	1.8e-167	0.49	0.63	0.99
PGSC0003DMG200029891	K00696	ko00500	Starch and sucrose metabolism	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMG200029891	K00696	ko01100	Metabolic pathways	1167	1.6e-58	0.79	0.86	0.95
PGSC0003DMG200029892	K00696	ko00500	Starch and sucrose metabolism	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMG200029892	K00696	ko01100	Metabolic pathways	2707	1.8e-143	0.62	0.78	1.00
PGSC0003DMG200029894	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMG200029894	K00517	ko00626	Naphthalene and anthracene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMG200029894	K00517	ko00903	Limonene and pinene degradation	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMG200029894	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMG200029894	K00517	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.41	0.61	0.96
PGSC0003DMG200029894	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200029894	K00517	ko00626	Naphthalene and anthracene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200029894	K00517	ko00903	Limonene and pinene degradation	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200029894	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200029894	K00517	ko01110	Biosynthesis of secondary metabolites	385	2.1e-15	0.53	0.75	0.73
PGSC0003DMG200029896	K12489	ko04144	Endocytosis	578	4.8e-26	0.78	0.92	0.64
PGSC0003DMG200029897	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200019176	K00232	ko00071	Fatty acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K00232	ko00592	alpha-Linolenic acid metabolism	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K00232	ko01100	Metabolic pathways	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K00232	ko03320	PPAR signaling pathway	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K00232	ko04146	Peroxisome	3054	1.3e-162	0.81	0.92	0.99
PGSC0003DMG200019176	K04567	ko00970	Aminoacyl-tRNA biosynthesis	717	1.0e-33	0.78	0.87	0.99
PGSC0003DMG200019176	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3430	2.4e-183	0.66	0.83	1.00
PGSC0003DMG200019179	K05857	ko00562	Inositol phosphate metabolism	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMG200019179	K05857	ko01100	Metabolic pathways	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMG200019179	K05857	ko04020	Calcium signaling pathway	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMG200019179	K05857	ko04070	Phosphatidylinositol signaling system	680	1.1e-31	0.79	0.91	0.97
PGSC0003DMG200019179	K05857	ko00562	Inositol phosphate metabolism	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMG200019179	K05857	ko01100	Metabolic pathways	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMG200019179	K05857	ko04020	Calcium signaling pathway	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMG200019179	K05857	ko04070	Phosphatidylinositol signaling system	1185	1.6e-59	0.71	0.85	0.99
PGSC0003DMG200019179	K05857	ko00562	Inositol phosphate metabolism	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMG200019179	K05857	ko01100	Metabolic pathways	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMG200019179	K05857	ko04020	Calcium signaling pathway	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMG200019179	K05857	ko04070	Phosphatidylinositol signaling system	3590	3.6e-192	0.70	0.83	1.00
PGSC0003DMG200019179	K05857	ko00562	Inositol phosphate metabolism	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMG200019179	K05857	ko01100	Metabolic pathways	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMG200019179	K05857	ko04020	Calcium signaling pathway	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMG200019179	K05857	ko04070	Phosphatidylinositol signaling system	1306	3.4e-66	0.75	0.88	0.99
PGSC0003DMG200019183	K03844	ko00510	N-Glycan biosynthesis	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMG200019183	K03844	ko01100	Metabolic pathways	1056	2.1e-52	0.77	0.89	0.99
PGSC0003DMG200019183	K03844	ko00510	N-Glycan biosynthesis	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMG200019183	K03844	ko01100	Metabolic pathways	1836	2.0e-95	0.79	0.89	0.88
PGSC0003DMG200019183	K03844	ko00510	N-Glycan biosynthesis	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMG200019183	K03844	ko01100	Metabolic pathways	2976	2.6e-158	0.77	0.90	0.94
PGSC0003DMG200040729	K04733	ko04210	Apoptosis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMG200040729	K04733	ko04620	Toll-like receptor signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMG200040729	K04733	ko04722	Neurotrophin signaling pathway	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMG200040729	K04733	ko05140	Leishmaniasis	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMG200040729	K04733	ko05142	Chagas disease	769	1.4e-36	0.43	0.61	0.87
PGSC0003DMG200040732	K07466	ko03030	DNA replication	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMG200040732	K07466	ko03420	Nucleotide excision repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMG200040732	K07466	ko03430	Mismatch repair	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMG200040732	K07466	ko03440	Homologous recombination	327	6.8e-12	0.32	0.47	0.65
PGSC0003DMG200001263	K12135	ko04712	Circadian rhythm - plant	254	3.6e-08	0.45	0.56	0.17
PGSC0003DMG200001282	K05279	ko00944	Flavone and flavonol biosynthesis	411	7.8e-17	0.34	0.47	0.96
PGSC0003DMG200015476	K00558	ko00270	Cysteine and methionine metabolism	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMG200015476	K00558	ko01100	Metabolic pathways	2251	2.6e-118	0.49	0.60	0.94
PGSC0003DMG200015479	K01247	ko03410	Base excision repair	1708	2.3e-88	0.59	0.72	1.00
PGSC0003DMG200015482	K12126	ko04712	Circadian rhythm - plant	306	6.6e-11	0.32	0.47	0.63
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	582	2.9e-26	0.74	0.85	0.99
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	1448	5.0e-74	0.88	0.95	0.99
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	409	1.0e-16	0.82	0.93	0.98
PGSC0003DMG200015483	K03357	ko04110	Cell cycle	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015483	K03357	ko04111	Cell cycle - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015483	K03357	ko04113	Meiosis - yeast	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015483	K03357	ko04114	Oocyte meiosis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015483	K03357	ko04120	Ubiquitin mediated proteolysis	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015483	K03357	ko04914	Progesterone-mediated oocyte maturation	532	1.7e-23	0.88	0.96	0.99
PGSC0003DMG200015484	K00368	ko00910	Nitrogen metabolism	1750	1.1e-90	0.45	0.61	0.91
PGSC0003DMG200015484	K00368	ko00910	Nitrogen metabolism	1132	1.3e-56	0.42	0.56	0.96
PGSC0003DMG200015485	K13034	ko00270	Cysteine and methionine metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMG200015485	K13034	ko00450	Selenoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMG200015485	K13034	ko00460	Cyanoamino acid metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMG200015485	K13034	ko00920	Sulfur metabolism	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMG200015485	K13034	ko01100	Metabolic pathways	568	1.7e-25	0.62	0.70	0.88
PGSC0003DMG200015487	K12883	ko03040	Spliceosome	1881	6.5e-98	0.82	0.92	0.99
PGSC0003DMG200015487	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMG200015487	K12883	ko03040	Spliceosome	1903	4.0e-99	0.83	0.93	0.99
PGSC0003DMG200015489	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00350	Tyrosine metabolism	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00632	Benzoate degradation via CoA ligation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00642	Ethylbenzene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200015489	K00680	ko00903	Limonene and pinene degradation	522	5.9e-23	0.43	0.62	0.65
PGSC0003DMG200004789	K00423	ko00053	Ascorbate and aldarate metabolism	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMG200004789	K00423	ko01100	Metabolic pathways	2040	1.1e-106	0.47	0.66	0.91
PGSC0003DMG200004790	K01193	ko00052	Galactose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMG200004790	K01193	ko00500	Starch and sucrose metabolism	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMG200004790	K01193	ko01100	Metabolic pathways	3527	1.1e-188	0.64	0.76	0.99
PGSC0003DMG200004791	K00616	ko00030	Pentose phosphate pathway	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMG200004791	K00616	ko01100	Metabolic pathways	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMG200004791	K00616	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.77	0.87	1.00
PGSC0003DMG200004792	K01087	ko00500	Starch and sucrose metabolism	1444	8.3e-74	0.58	0.75	0.81
PGSC0003DMG200004800	K00016	ko00010	Glycolysis / Gluconeogenesis	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004800	K00016	ko00270	Cysteine and methionine metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004800	K00016	ko00620	Pyruvate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004800	K00016	ko00640	Propanoate metabolism	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004800	K00016	ko01100	Metabolic pathways	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004800	K00016	ko01110	Biosynthesis of secondary metabolites	2509	1.5e-132	0.86	0.93	1.00
PGSC0003DMG200004802	K08341	ko04140	Regulation of autophagy	937	7.6e-46	0.95	0.97	0.95
PGSC0003DMG200004802	K08341	ko04140	Regulation of autophagy	700	9.0e-33	0.97	0.99	0.91
PGSC0003DMG200013135	K01188	ko00460	Cyanoamino acid metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMG200013135	K01188	ko00500	Starch and sucrose metabolism	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMG200013135	K01188	ko00940	Phenylpropanoid biosynthesis	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMG200013135	K01188	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.53	0.69	0.96
PGSC0003DMG200013135	K01188	ko00460	Cyanoamino acid metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMG200013135	K01188	ko00500	Starch and sucrose metabolism	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMG200013135	K01188	ko00940	Phenylpropanoid biosynthesis	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMG200013135	K01188	ko01110	Biosynthesis of secondary metabolites	2849	2.7e-151	0.56	0.74	0.96
PGSC0003DMG200002540	K00430	ko00360	Phenylalanine metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMG200002540	K00430	ko00680	Methane metabolism	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMG200002540	K00430	ko00940	Phenylpropanoid biosynthesis	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMG200002540	K00430	ko01100	Metabolic pathways	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMG200002540	K00430	ko01110	Biosynthesis of secondary metabolites	951	1.3e-46	0.39	0.57	0.99
PGSC0003DMG200002541	K02922	ko03010	Ribosome	783	2.4e-37	0.93	0.98	0.99
PGSC0003DMG200002542	K00558	ko00270	Cysteine and methionine metabolism	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMG200002542	K00558	ko01100	Metabolic pathways	1948	1.3e-101	0.47	0.59	0.97
PGSC0003DMG200002542	K00558	ko00270	Cysteine and methionine metabolism	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMG200002542	K00558	ko01100	Metabolic pathways	1945	1.9e-101	0.47	0.59	0.97
PGSC0003DMG200002542	K07897	ko04144	Endocytosis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMG200002542	K07897	ko04145	Phagosome	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMG200002542	K07897	ko05146	Amoebiasis	1687	3.3e-87	0.96	0.98	1.00
PGSC0003DMG200002545	K10418	ko04962	Vasopressin-regulated water reabsorption	325	4.3e-12	0.48	0.65	0.94
PGSC0003DMG200002547	K02961	ko03010	Ribosome	895	1.6e-43	0.71	0.84	0.98
PGSC0003DMG200031808	K06061	ko04330	Notch signaling pathway	837	6.5e-37	0.27	0.38	0.49
PGSC0003DMG200031808	K06061	ko04330	Notch signaling pathway	830	1.7e-36	0.26	0.38	0.49
PGSC0003DMG200031808	K06061	ko04330	Notch signaling pathway	830	2.7e-39	0.26	0.38	0.82
PGSC0003DMG200031809	K00454	ko00591	Linoleic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMG200031809	K00454	ko00592	alpha-Linolenic acid metabolism	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMG200031809	K00454	ko01100	Metabolic pathways	5064	1.8e-273	0.68	0.82	0.96
PGSC0003DMG200031809	K00454	ko00591	Linoleic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMG200031809	K00454	ko00592	alpha-Linolenic acid metabolism	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMG200031809	K00454	ko01100	Metabolic pathways	234	2.7e-06	0.64	0.80	0.47
PGSC0003DMG200031811	K01054	ko00561	Glycerolipid metabolism	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMG200031811	K01054	ko01100	Metabolic pathways	253	4.0e-08	0.47	0.63	0.51
PGSC0003DMG200031811	K01054	ko00561	Glycerolipid metabolism	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMG200031811	K01054	ko01100	Metabolic pathways	569	1.5e-25	0.34	0.52	0.79
PGSC0003DMG200031814	K11094	ko03040	Spliceosome	528	2.8e-23	0.60	0.78	0.82
PGSC0003DMG200031814	K11094	ko03040	Spliceosome	1165	2.0e-58	0.60	0.79	0.92
PGSC0003DMG200031816	K01051	ko00040	Pentose and glucuronate interconversions	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMG200031816	K01051	ko00500	Starch and sucrose metabolism	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMG200031816	K01051	ko01100	Metabolic pathways	2066	4.1e-108	0.48	0.65	0.94
PGSC0003DMG200031817	K01139	ko00230	Purine metabolism	820	2.2e-39	0.37	0.54	0.93
PGSC0003DMG200031817	K01139	ko00230	Purine metabolism	1236	2.5e-62	0.37	0.55	0.91
PGSC0003DMG200031817	K01139	ko00230	Purine metabolism	1941	3.2e-101	0.42	0.59	0.80
PGSC0003DMG200031817	K01139	ko00230	Purine metabolism	799	3.1e-38	0.52	0.65	0.58
PGSC0003DMG200025549	K04713	ko00600	Sphingolipid metabolism	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMG200025549	K04713	ko01100	Metabolic pathways	511	2.4e-22	0.39	0.57	0.78
PGSC0003DMG200025549	K04713	ko00600	Sphingolipid metabolism	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMG200025549	K04713	ko01100	Metabolic pathways	802	2.1e-38	0.56	0.72	0.86
PGSC0003DMG200025549	K04713	ko00600	Sphingolipid metabolism	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMG200025549	K04713	ko01100	Metabolic pathways	874	2.3e-42	0.45	0.62	0.85
PGSC0003DMG200025549	K04713	ko00600	Sphingolipid metabolism	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMG200025549	K04713	ko01100	Metabolic pathways	780	3.5e-37	0.56	0.74	0.97
PGSC0003DMG200025550	K04713	ko00600	Sphingolipid metabolism	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMG200025550	K04713	ko01100	Metabolic pathways	545	3.2e-24	0.57	0.74	0.79
PGSC0003DMG200025555	K02964	ko03010	Ribosome	1231	4.6e-62	0.94	0.98	0.99
PGSC0003DMG200025557	K03950	ko00190	Oxidative phosphorylation	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMG200025557	K03950	ko01100	Metabolic pathways	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMG200025557	K03950	ko05010	Alzheimer's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMG200025557	K03950	ko05012	Parkinson's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMG200025557	K03950	ko05016	Huntington's disease	431	6.2e-18	0.69	0.83	0.96
PGSC0003DMG200025570	K01692	ko00071	Fatty acid metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00280	Valine, leucine and isoleucine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00281	Geraniol degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00310	Lysine degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00380	Tryptophan metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00410	beta-Alanine metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00632	Benzoate degradation via CoA ligation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00640	Propanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00650	Butanoate metabolism	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00903	Limonene and pinene degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko00930	Caprolactam degradation	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko01100	Metabolic pathways	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025570	K01692	ko01110	Biosynthesis of secondary metabolites	323	1.3e-23	0.48	0.64	0.66
PGSC0003DMG200025573	K00079	ko00590	Arachidonic acid metabolism	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMG200025573	K00079	ko01100	Metabolic pathways	806	1.3e-38	0.42	0.62	0.98
PGSC0003DMG200018275	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMG200018275	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.88
PGSC0003DMG200018275	K01569	ko00630	Glyoxylate and dicarboxylate metabolism	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMG200018275	K01569	ko01100	Metabolic pathways	236	3.5e-07	0.34	0.51	0.66
PGSC0003DMG200018278	K04799	ko03030	DNA replication	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMG200018278	K04799	ko03410	Base excision repair	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMG200018278	K04799	ko03450	Non-homologous end-joining	1397	3.2e-71	0.80	0.91	0.99
PGSC0003DMG200018280	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMG200018280	K12126	ko04712	Circadian rhythm - plant	1104	4.7e-55	0.37	0.50	0.81
PGSC0003DMG200018281	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200018281	K03358	ko04110	Cell cycle	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04111	Cell cycle - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04113	Meiosis - yeast	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04114	Oocyte meiosis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04120	Ubiquitin mediated proteolysis	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04914	Progesterone-mediated oocyte maturation	686	5.3e-32	0.87	0.95	0.71
PGSC0003DMG200018281	K03358	ko04110	Cell cycle	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018281	K03358	ko04111	Cell cycle - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018281	K03358	ko04113	Meiosis - yeast	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018281	K03358	ko04114	Oocyte meiosis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018281	K03358	ko04120	Ubiquitin mediated proteolysis	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018281	K03358	ko04914	Progesterone-mediated oocyte maturation	376	6.7e-15	0.90	0.97	0.49
PGSC0003DMG200018284	K12929	ko00904	Diterpenoid biosynthesis	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMG200018284	K12929	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.45	0.70	0.94
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.40	0.68	0.93
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200028363	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028363	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028363	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028365	K04406	ko04010	MAPK signaling pathway	516	7.2e-22	0.41	0.57	0.52
PGSC0003DMG200028365	K04411	ko04010	MAPK signaling pathway	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMG200028365	K04411	ko05200	Pathways in cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMG200028365	K04411	ko05223	Non-small cell lung cancer	1255	2.2e-63	0.42	0.61	0.50
PGSC0003DMG200028365	K04406	ko04010	MAPK signaling pathway	369	1.3e-13	0.38	0.53	0.47
PGSC0003DMG200028367	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMG200028367	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.64
PGSC0003DMG200028367	K08233	ko00901	Indole alkaloid biosynthesis	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMG200028367	K08233	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.35	0.54	0.62
PGSC0003DMG200028368	K06027	ko04962	Vasopressin-regulated water reabsorption	2015	2.7e-105	0.47	0.65	0.89
PGSC0003DMG200028368	K06027	ko04962	Vasopressin-regulated water reabsorption	1282	7.1e-65	0.52	0.71	0.80
PGSC0003DMG200027407	K06685	ko04111	Cell cycle - yeast	433	2.4e-14	0.26	0.41	0.76
PGSC0003DMG200027411	K12890	ko03040	Spliceosome	493	2.7e-21	0.35	0.46	0.43
PGSC0003DMG200027411	K12890	ko03040	Spliceosome	407	1.3e-16	0.35	0.44	0.79
PGSC0003DMG200027412	K03364	ko04110	Cell cycle	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMG200027412	K03364	ko04111	Cell cycle - yeast	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMG200027412	K03364	ko04120	Ubiquitin mediated proteolysis	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMG200027412	K03364	ko04914	Progesterone-mediated oocyte maturation	308	3.7e-11	0.26	0.46	0.96
PGSC0003DMG200027413	K12893	ko03040	Spliceosome	445	1.0e-18	0.33	0.47	0.61
PGSC0003DMG200027424	K01768	ko00230	Purine metabolism	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMG200027424	K01768	ko04113	Meiosis - yeast	770	1.2e-36	0.39	0.62	0.93
PGSC0003DMG200027425	K08139	ko04113	Meiosis - yeast	917	9.6e-45	0.34	0.53	0.89
PGSC0003DMG200044859	K01188	ko00460	Cyanoamino acid metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMG200044859	K01188	ko00500	Starch and sucrose metabolism	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMG200044859	K01188	ko00940	Phenylpropanoid biosynthesis	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMG200044859	K01188	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.39	0.48	0.97
PGSC0003DMG200044885	K07466	ko03030	DNA replication	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMG200044885	K07466	ko03420	Nucleotide excision repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMG200044885	K07466	ko03430	Mismatch repair	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMG200044885	K07466	ko03440	Homologous recombination	259	5.7e-08	0.32	0.51	0.73
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	1229	6.0e-62	0.92	0.96	0.90
PGSC0003DMG200007406	K01897	ko00071	Fatty acid metabolism	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMG200007406	K01897	ko01100	Metabolic pathways	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMG200007406	K01897	ko03320	PPAR signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMG200007406	K01897	ko04146	Peroxisome	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMG200007406	K01897	ko04920	Adipocytokine signaling pathway	539	5.7e-23	0.30	0.46	0.99
PGSC0003DMG200007408	K00100	ko00051	Fructose and mannose metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko00363	Bisphenol A degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko00591	Linoleic acid metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko00625	Tetrachloroethene degradation	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko00650	Butanoate metabolism	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko01100	Metabolic pathways	350	1.8e-13	0.29	0.46	0.77
PGSC0003DMG200007408	K00100	ko00051	Fructose and mannose metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007408	K00100	ko00363	Bisphenol A degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007408	K00100	ko00591	Linoleic acid metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007408	K00100	ko00625	Tetrachloroethene degradation	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007408	K00100	ko00650	Butanoate metabolism	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007408	K00100	ko01100	Metabolic pathways	371	1.3e-14	0.30	0.46	0.82
PGSC0003DMG200007410	K02943	ko03010	Ribosome	749	1.8e-35	0.83	0.88	0.99
PGSC0003DMG200007412	K05658	ko02010	ABC transporters	5887	0.	0.51	0.70	0.91
PGSC0003DMG200007412	K05658	ko02010	ABC transporters	1034	3.4e-51	0.70	0.85	0.99
PGSC0003DMG200007417	K02324	ko00230	Purine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMG200007417	K02324	ko00240	Pyrimidine metabolism	14930	0.	0.78	0.88	1.00
PGSC0003DMG200007417	K02324	ko01100	Metabolic pathways	14930	0.	0.78	0.88	1.00
PGSC0003DMG200007417	K02324	ko03030	DNA replication	14930	0.	0.78	0.88	1.00
PGSC0003DMG200007417	K02324	ko03410	Base excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMG200007417	K02324	ko03420	Nucleotide excision repair	14930	0.	0.78	0.88	1.00
PGSC0003DMG200014919	K12818	ko03040	Spliceosome	1489	2.7e-76	0.48	0.66	0.98
PGSC0003DMG200014919	K12818	ko03040	Spliceosome	486	2.0e-20	0.59	0.81	0.87
PGSC0003DMG200014922	K02987	ko03010	Ribosome	448	7.1e-19	0.72	0.83	0.29
PGSC0003DMG200014923	K07375	ko04145	Phagosome	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMG200014923	K07375	ko04540	Gap junction	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMG200014923	K07375	ko05130	Pathogenic Escherichia coli infection	973	7.9e-48	0.71	0.77	0.97
PGSC0003DMG200014931	K02935	ko03010	Ribosome	397	4.6e-16	0.48	0.64	0.62
PGSC0003DMG200014932	K12356	ko00940	Phenylpropanoid biosynthesis	676	1.9e-31	0.30	0.51	0.95
PGSC0003DMG200010257	K01255	ko00480	Glutathione metabolism	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMG200010257	K01255	ko01100	Metabolic pathways	928	2.4e-45	0.72	0.82	0.63
PGSC0003DMG200010261	K08271	ko04150	mTOR signaling pathway	343	4.4e-13	0.29	0.45	0.93
PGSC0003DMG200010264	K00754	ko00051	Fructose and mannose metabolism	1984	1.4e-103	0.49	0.68	0.79
PGSC0003DMG200010264	K00754	ko00051	Fructose and mannose metabolism	403	2.2e-16	0.59	0.74	0.97
PGSC0003DMG200010265	K00079	ko00590	Arachidonic acid metabolism	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMG200010265	K00079	ko01100	Metabolic pathways	721	6.2e-34	0.39	0.56	0.95
PGSC0003DMG200010265	K00079	ko00590	Arachidonic acid metabolism	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMG200010265	K00079	ko01100	Metabolic pathways	339	7.3e-13	0.41	0.62	0.75
PGSC0003DMG200010266	K05765	ko04360	Axon guidance	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMG200010266	K05765	ko04666	Fc gamma R-mediated phagocytosis	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMG200010266	K05765	ko04810	Regulation of actin cytoskeleton	896	1.4e-43	0.77	0.92	0.94
PGSC0003DMG200010268	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMG200010268	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMG200010268	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMG200010268	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMG200010268	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.44	0.64	0.98
PGSC0003DMG200033877	K06689	ko04120	Ubiquitin mediated proteolysis	1277	1.3e-64	0.97	0.98	0.99
PGSC0003DMG200033877	K06689	ko04120	Ubiquitin mediated proteolysis	897	1.2e-43	0.98	0.99	0.75
PGSC0003DMG200033882	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1614	3.5e-83	0.68	0.81	0.92
PGSC0003DMG200033885	K01762	ko00270	Cysteine and methionine metabolism	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMG200033885	K01762	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.60	0.81	0.96
PGSC0003DMG200033890	K05681	ko02010	ABC transporters	883	7.2e-43	0.32	0.54	0.47
PGSC0003DMG200024876	K08738	ko04115	p53 signaling pathway	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko04210	Apoptosis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05010	Alzheimer's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05012	Parkinson's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05016	Huntington's disease	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05200	Pathways in cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05210	Colorectal cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05222	Small cell lung cancer	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024876	K08738	ko05416	Viral myocarditis	912	1.8e-44	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04012	ErbB signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04062	Chemokine signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04110	Cell cycle	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04310	Wnt signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04340	Hedgehog signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04360	Axon guidance	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04510	Focal adhesion	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04660	T cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04662	B cell receptor signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04711	Circadian rhythm - fly	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04722	Neurotrophin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04910	Insulin signaling pathway	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko04916	Melanogenesis	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05010	Alzheimer's disease	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05200	Pathways in cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05210	Colorectal cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05213	Endometrial cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05215	Prostate cancer	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200024885	K03083	ko05217	Basal cell carcinoma	3020	9.8e-161	0.84	0.87	0.99
PGSC0003DMG200027672	K02699	ko00195	Photosynthesis	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMG200027672	K02699	ko01100	Metabolic pathways	1558	4.3e-80	0.83	0.92	1.00
PGSC0003DMG200027674	K02879	ko03010	Ribosome	1260	1.2e-63	0.77	0.87	0.99
PGSC0003DMG200027675	K02879	ko03010	Ribosome	1271	2.9e-64	0.77	0.87	0.99
PGSC0003DMG200027678	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	1558	4.3e-80	0.91	0.96	0.99
PGSC0003DMG200027678	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2325	2.1e-122	0.86	0.93	1.00
PGSC0003DMG200027684	K01824	ko00100	Steroid biosynthesis	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMG200027684	K01824	ko01100	Metabolic pathways	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMG200027684	K01824	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.65	0.78	0.97
PGSC0003DMG200027685	K02183	ko04020	Calcium signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04070	Phosphatidylinositol signaling system	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04114	Oocyte meiosis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04270	Vascular smooth muscle contraction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04626	Plant-pathogen interaction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04720	Long-term potentiation	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04722	Neurotrophin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04740	Olfactory transduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04744	Phototransduction	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04745	Phototransduction - fly	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04910	Insulin signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04912	GnRH signaling pathway	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04916	Melanogenesis	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04970	Salivary secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko04971	Gastric acid secretion	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko05010	Alzheimer's disease	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027685	K02183	ko05214	Glioma	500	9.6e-22	0.48	0.67	0.91
PGSC0003DMG200027687	K13289	ko04142	Lysosome	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	2123	2.9e-111	0.68	0.80	0.96
PGSC0003DMG200027687	K13289	ko04142	Lysosome	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	1868	1.4e-103	0.57	0.70	0.96
PGSC0003DMG200017541	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMG200017541	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMG200017541	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMG200017541	K05283	ko01100	Metabolic pathways	648	6.6e-30	0.38	0.54	1.00
PGSC0003DMG200017541	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMG200017541	K05283	ko01100	Metabolic pathways	259	2.8e-08	0.32	0.48	0.91
PGSC0003DMG200017542	K09753	ko00940	Phenylpropanoid biosynthesis	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMG200017542	K09753	ko01100	Metabolic pathways	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMG200017542	K09753	ko01110	Biosynthesis of secondary metabolites	533	1.5e-23	0.34	0.52	0.49
PGSC0003DMG200017542	K09753	ko00940	Phenylpropanoid biosynthesis	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMG200017542	K09753	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMG200017542	K09753	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.56	0.91
PGSC0003DMG200017542	K09753	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMG200017542	K09753	ko01100	Metabolic pathways	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMG200017542	K09753	ko01110	Biosynthesis of secondary metabolites	526	3.5e-23	0.33	0.53	0.94
PGSC0003DMG200017542	K09753	ko00940	Phenylpropanoid biosynthesis	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMG200017542	K09753	ko01100	Metabolic pathways	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMG200017542	K09753	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.34	0.52	0.91
PGSC0003DMG200017546	K00697	ko00500	Starch and sucrose metabolism	441	4.4e-18	0.65	0.77	0.92
PGSC0003DMG200017546	K00697	ko00500	Starch and sucrose metabolism	435	1.2e-17	0.79	0.88	0.84
PGSC0003DMG200017546	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMG200017546	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMG200017546	K00697	ko00500	Starch and sucrose metabolism	4891	6.3e-264	0.67	0.81	1.00
PGSC0003DMG200017552	K13066	ko00940	Phenylpropanoid biosynthesis	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMG200017552	K13066	ko01110	Biosynthesis of secondary metabolites	1064	7.5e-53	0.52	0.69	0.99
PGSC0003DMG200017552	K13066	ko00940	Phenylpropanoid biosynthesis	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMG200017552	K13066	ko01110	Biosynthesis of secondary metabolites	1197	3.5e-60	0.56	0.73	0.99
PGSC0003DMG200017554	K00434	ko00053	Ascorbate and aldarate metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMG200017554	K00434	ko00480	Glutathione metabolism	2162	2.1e-113	0.75	0.86	0.99
PGSC0003DMG200008136	K03124	ko03022	Basal transcription factors	2346	1.5e-123	0.88	0.95	0.99
PGSC0003DMG200008137	K12356	ko00940	Phenylpropanoid biosynthesis	707	3.7e-33	0.33	0.49	0.96
PGSC0003DMG200008138	K12356	ko00940	Phenylpropanoid biosynthesis	655	2.7e-30	0.45	0.62	0.42
PGSC0003DMG200008140	K12356	ko00940	Phenylpropanoid biosynthesis	749	1.8e-35	0.33	0.49	0.90
PGSC0003DMG200008143	K03553	ko03440	Homologous recombination	1253	2.8e-63	0.48	0.68	0.98
PGSC0003DMG200008145	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMG200008145	K12872	ko03040	Spliceosome	3490	1.2e-186	0.82	0.90	1.00
PGSC0003DMG200008148	K08064	ko04612	Antigen processing and presentation	243	1.4e-07	0.56	0.68	0.63
PGSC0003DMG200008148	K08064	ko04612	Antigen processing and presentation	514	1.6e-22	0.42	0.58	0.82
PGSC0003DMG200008151	K00655	ko00561	Glycerolipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMG200008151	K00655	ko00564	Glycerophospholipid metabolism	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMG200008151	K00655	ko01100	Metabolic pathways	2149	1.1e-112	0.67	0.79	1.00
PGSC0003DMG200008151	K00655	ko00561	Glycerolipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMG200008151	K00655	ko00564	Glycerophospholipid metabolism	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMG200008151	K00655	ko01100	Metabolic pathways	2515	7.0e-133	0.74	0.88	1.00
PGSC0003DMG200014230	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMG200014230	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMG200014230	K02433	ko00970	Aminoacyl-tRNA biosynthesis	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMG200014230	K02433	ko01100	Metabolic pathways	843	1.2e-40	0.34	0.48	0.72
PGSC0003DMG200014232	K08054	ko04145	Phagosome	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMG200014232	K08054	ko04612	Antigen processing and presentation	3557	2.4e-190	0.75	0.86	0.99
PGSC0003DMG200014237	K00079	ko00590	Arachidonic acid metabolism	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMG200014237	K00079	ko01100	Metabolic pathways	795	5.2e-38	0.42	0.61	0.88
PGSC0003DMG200014239	K01880	ko00970	Aminoacyl-tRNA biosynthesis	4676	4.5e-252	0.88	0.94	0.99
PGSC0003DMG200014239	K01880	ko00970	Aminoacyl-tRNA biosynthesis	2858	8.5e-152	0.91	0.96	0.97
PGSC0003DMG200010947	K04733	ko04210	Apoptosis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMG200010947	K04733	ko04620	Toll-like receptor signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMG200010947	K04733	ko04722	Neurotrophin signaling pathway	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMG200010947	K04733	ko05140	Leishmaniasis	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMG200010947	K04733	ko05142	Chagas disease	257	3.3e-08	0.30	0.50	0.82
PGSC0003DMG200010953	K02084	ko04115	p53 signaling pathway	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko04210	Apoptosis	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko05010	Alzheimer's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko05012	Parkinson's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko05016	Huntington's disease	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010953	K02084	ko05222	Small cell lung cancer	289	9.0e-07	0.32	0.49	0.41
PGSC0003DMG200010000	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko00940	Phenylpropanoid biosynthesis	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko01100	Metabolic pathways	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.39	0.61	0.99
PGSC0003DMG200010000	K09753	ko00940	Phenylpropanoid biosynthesis	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMG200010000	K09753	ko01100	Metabolic pathways	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMG200010000	K09753	ko01110	Biosynthesis of secondary metabolites	1127	2.5e-56	0.48	0.65	0.97
PGSC0003DMG200010005	K11820	ko00380	Tryptophan metabolism	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMG200010005	K11820	ko00966	Glucosinolate biosynthesis	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMG200010005	K11820	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.50	0.71	0.91
PGSC0003DMG200010005	K11820	ko00380	Tryptophan metabolism	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMG200010005	K11820	ko00966	Glucosinolate biosynthesis	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMG200010005	K11820	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.36	0.52	0.89
PGSC0003DMG200010005	K11820	ko00380	Tryptophan metabolism	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMG200010005	K11820	ko00966	Glucosinolate biosynthesis	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMG200010005	K11820	ko01110	Biosynthesis of secondary metabolites	1341	4.0e-68	0.42	0.60	0.95
PGSC0003DMG200010007	K00895	ko00051	Fructose and mannose metabolism	2052	2.4e-107	0.85	0.90	0.89
PGSC0003DMG200010007	K00895	ko00051	Fructose and mannose metabolism	2936	4.2e-156	0.85	0.92	0.99
PGSC0003DMG200010007	K00895	ko00051	Fructose and mannose metabolism	4395	1.4e-236	0.84	0.92	0.99
PGSC0003DMG200010009	K02178	ko04110	Cell cycle	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMG200010009	K02178	ko04111	Cell cycle - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMG200010009	K02178	ko04113	Meiosis - yeast	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMG200010009	K02178	ko04114	Oocyte meiosis	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMG200010009	K02178	ko04914	Progesterone-mediated oocyte maturation	2108	2.0e-110	0.66	0.80	1.00
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.45
PGSC0003DMG200022238	K02132	ko00190	Oxidative phosphorylation	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMG200022238	K02132	ko01100	Metabolic pathways	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMG200022238	K02132	ko05010	Alzheimer's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMG200022238	K02132	ko05012	Parkinson's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMG200022238	K02132	ko05016	Huntington's disease	1729	1.6e-89	0.95	0.96	0.82
PGSC0003DMG200022241	K03541	ko00195	Photosynthesis	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMG200022241	K03541	ko01100	Metabolic pathways	905	4.4e-44	0.79	0.89	0.99
PGSC0003DMG200019870	K00430	ko00360	Phenylalanine metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMG200019870	K00430	ko00680	Methane metabolism	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMG200019870	K00430	ko00940	Phenylpropanoid biosynthesis	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMG200019870	K00430	ko01100	Metabolic pathways	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMG200019870	K00430	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.54	0.93
PGSC0003DMG200019873	K01046	ko00561	Glycerolipid metabolism	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMG200019873	K01046	ko01100	Metabolic pathways	232	7.0e-06	0.32	0.45	0.31
PGSC0003DMG200019885	K08695	ko00941	Flavonoid biosynthesis	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMG200019885	K08695	ko01110	Biosynthesis of secondary metabolites	413	6.1e-17	0.28	0.46	0.95
PGSC0003DMG200019885	K08695	ko00941	Flavonoid biosynthesis	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMG200019885	K08695	ko01110	Biosynthesis of secondary metabolites	683	7.8e-32	0.35	0.56	0.96
PGSC0003DMG200019886	K08695	ko00941	Flavonoid biosynthesis	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMG200019886	K08695	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.37	0.57	0.94
PGSC0003DMG200019888	K00499	ko00260	Glycine, serine and threonine metabolism	2264	4.9e-119	0.67	0.79	0.96
PGSC0003DMG200019888	K00499	ko00260	Glycine, serine and threonine metabolism	1396	3.7e-71	0.70	0.81	0.99
PGSC0003DMG200019888	K00499	ko00260	Glycine, serine and threonine metabolism	341	5.7e-13	0.58	0.73	0.97
PGSC0003DMG200019890	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200019890	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200019890	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200030590	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030590	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.68
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	463	1.1e-19	0.30	0.48	0.70
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	427	1.0e-17	0.34	0.48	0.89
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	481	1.1e-20	0.33	0.46	0.71
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	439	2.2e-18	0.37	0.53	0.58
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	465	8.2e-20	0.31	0.48	0.63
PGSC0003DMG200030592	K08066	ko04612	Antigen processing and presentation	293	2.5e-10	0.28	0.43	0.84
PGSC0003DMG200030594	K02133	ko00190	Oxidative phosphorylation	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMG200030594	K02133	ko01100	Metabolic pathways	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMG200030594	K02133	ko05010	Alzheimer's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMG200030594	K02133	ko05012	Parkinson's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMG200030594	K02133	ko05016	Huntington's disease	4109	8.5e-221	0.90	0.93	1.00
PGSC0003DMG200030594	K02133	ko00190	Oxidative phosphorylation	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMG200030594	K02133	ko01100	Metabolic pathways	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMG200030594	K02133	ko05010	Alzheimer's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMG200030594	K02133	ko05012	Parkinson's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMG200030594	K02133	ko05016	Huntington's disease	2112	1.2e-110	0.98	1.00	1.00
PGSC0003DMG200030595	K06272	ko03320	PPAR signaling pathway	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMG200030595	K06272	ko04510	Focal adhesion	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMG200030595	K06272	ko05100	Bacterial invasion of epithelial cells	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMG200030595	K06272	ko05213	Endometrial cancer	393	7.7e-16	0.30	0.48	0.56
PGSC0003DMG200030595	K06272	ko03320	PPAR signaling pathway	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMG200030595	K06272	ko04510	Focal adhesion	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMG200030595	K06272	ko05100	Bacterial invasion of epithelial cells	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMG200030595	K06272	ko05213	Endometrial cancer	420	2.5e-17	0.27	0.47	0.90
PGSC0003DMG200016212	K05933	ko00270	Cysteine and methionine metabolism	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMG200016212	K05933	ko01110	Biosynthesis of secondary metabolites	445	1.0e-18	0.41	0.60	0.91
PGSC0003DMG200016213	K05278	ko00941	Flavonoid biosynthesis	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMG200016213	K05278	ko01100	Metabolic pathways	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMG200016213	K05278	ko01110	Biosynthesis of secondary metabolites	677	1.7e-31	0.33	0.54	0.90
PGSC0003DMG200016216	K01210	ko00500	Starch and sucrose metabolism	2022	1.1e-105	0.52	0.68	0.89
PGSC0003DMG200016218	K12818	ko03040	Spliceosome	1665	5.3e-86	0.38	0.57	0.40
PGSC0003DMG200016219	K02858	ko00740	Riboflavin metabolism	1798	2.5e-93	0.89	0.95	0.93
PGSC0003DMG200016219	K02858	ko00740	Riboflavin metabolism	3265	3.0e-174	0.76	0.84	0.95
PGSC0003DMG200016221	K06630	ko04110	Cell cycle	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMG200016221	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMG200016221	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.89	0.95	1.00
PGSC0003DMG200016223	K00430	ko00360	Phenylalanine metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMG200016223	K00430	ko00680	Methane metabolism	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMG200016223	K00430	ko00940	Phenylpropanoid biosynthesis	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMG200016223	K00430	ko01100	Metabolic pathways	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMG200016223	K00430	ko01110	Biosynthesis of secondary metabolites	2099	6.2e-110	0.76	0.88	0.96
PGSC0003DMG200016225	K05681	ko02010	ABC transporters	1085	5.2e-54	0.32	0.54	0.96
PGSC0003DMG200016226	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMG200016226	K01626	ko01100	Metabolic pathways	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMG200016226	K01626	ko01110	Biosynthesis of secondary metabolites	3350	6.2e-179	0.76	0.84	1.00
PGSC0003DMG200016226	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMG200016226	K01626	ko01100	Metabolic pathways	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMG200016226	K01626	ko01110	Biosynthesis of secondary metabolites	3548	7.4e-190	0.80	0.87	1.00
PGSC0003DMG200016229	K01259	ko00330	Arginine and proline metabolism	312	2.3e-11	0.30	0.48	0.77
PGSC0003DMG200001847	K01528	ko04144	Endocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMG200001847	K01528	ko04666	Fc gamma R-mediated phagocytosis	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMG200001847	K01528	ko05100	Bacterial invasion of epithelial cells	1438	1.6e-79	0.39	0.57	0.97
PGSC0003DMG200001849	K02921	ko03010	Ribosome	776	5.8e-37	0.99	1.00	0.92
PGSC0003DMG200001849	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMG200001850	K03260	ko05416	Viral myocarditis	3612	2.2e-193	0.56	0.69	0.99
PGSC0003DMG200001851	K10875	ko03440	Homologous recombination	472	1.8e-17	0.27	0.45	0.43
PGSC0003DMG200001851	K10875	ko03440	Homologous recombination	770	1.2e-36	0.31	0.51	0.47
PGSC0003DMG200001852	K10875	ko03440	Homologous recombination	596	2.2e-26	0.28	0.46	0.50
PGSC0003DMG200001855	K01177	ko00500	Starch and sucrose metabolism	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMG200001855	K01177	ko01100	Metabolic pathways	3319	3.2e-177	0.69	0.83	1.00
PGSC0003DMG200001856	K08014	ko04670	Leukocyte transendothelial migration	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMG200001856	K08014	ko04720	Long-term potentiation	690	5.5e-32	0.41	0.57	0.61
PGSC0003DMG200012477	K06096	ko04530	Tight junction	364	3.1e-14	0.34	0.53	0.85
PGSC0003DMG200012477	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMG200012477	K08341	ko04140	Regulation of autophagy	941	4.6e-46	0.96	0.98	0.95
PGSC0003DMG200012478	K00016	ko00010	Glycolysis / Gluconeogenesis	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko00270	Cysteine and methionine metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko00620	Pyruvate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko00640	Propanoate metabolism	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko01100	Metabolic pathways	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.82	0.88	0.94
PGSC0003DMG200012478	K00016	ko00010	Glycolysis / Gluconeogenesis	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012478	K00016	ko00270	Cysteine and methionine metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012478	K00016	ko00620	Pyruvate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012478	K00016	ko00640	Propanoate metabolism	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012478	K00016	ko01100	Metabolic pathways	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012478	K00016	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.83	0.91	0.99
PGSC0003DMG200012480	K09553	ko05020	Prion diseases	3725	1.3e-199	0.64	0.78	0.99
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	964	5.8e-55	0.36	0.52	0.78
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	973	1.9e-55	0.35	0.51	0.70
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	629	7.4e-29	0.48	0.65	0.48
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	768	1.6e-36	0.40	0.51	0.65
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	750	1.6e-35	0.38	0.52	0.67
PGSC0003DMG200000538	K06228	ko04340	Hedgehog signaling pathway	5770	0.	0.56	0.72	1.00
PGSC0003DMG200000538	K06228	ko05200	Pathways in cancer	5770	0.	0.56	0.72	1.00
PGSC0003DMG200000538	K06228	ko05217	Basal cell carcinoma	5770	0.	0.56	0.72	1.00
PGSC0003DMG200000538	K06228	ko04340	Hedgehog signaling pathway	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMG200000538	K06228	ko05200	Pathways in cancer	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMG200000538	K06228	ko05217	Basal cell carcinoma	400	2.9e-15	0.63	0.76	0.93
PGSC0003DMG200000540	K03363	ko04110	Cell cycle	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMG200000540	K03363	ko04111	Cell cycle - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMG200000540	K03363	ko04113	Meiosis - yeast	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMG200000540	K03363	ko04114	Oocyte meiosis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMG200000540	K03363	ko04120	Ubiquitin mediated proteolysis	3390	3.8e-181	0.86	0.93	1.00
PGSC0003DMG200000554	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko00230	Purine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko00240	Pyrimidine metabolism	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko01100	Metabolic pathways	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko03020	RNA polymerase	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200000554	K03026	ko04623	Cytosolic DNA-sensing pathway	347	4.3e-13	0.30	0.52	0.50
PGSC0003DMG200046891	K00975	ko00500	Starch and sucrose metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMG200046891	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMG200046891	K00975	ko01100	Metabolic pathways	3626	3.7e-194	0.83	0.90	1.00
PGSC0003DMG200013265	K12483	ko04144	Endocytosis	1298	9.3e-66	0.56	0.74	0.97
PGSC0003DMG200013266	K11147	ko00830	Retinol metabolism	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMG200013266	K11147	ko01100	Metabolic pathways	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMG200013266	K11147	ko04146	Peroxisome	1570	9.3e-81	0.74	0.90	0.99
PGSC0003DMG200013267	K04424	ko04010	MAPK signaling pathway	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMG200013267	K04424	ko04530	Tight junction	810	1.9e-38	0.40	0.60	0.84
PGSC0003DMG200013269	K00601	ko00230	Purine metabolism	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMG200013269	K00601	ko00670	One carbon pool by folate	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMG200013269	K00601	ko01100	Metabolic pathways	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMG200013269	K00601	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.58	0.70	0.99
PGSC0003DMG200013270	K02934	ko03010	Ribosome	1598	2.6e-82	0.81	0.89	1.00
PGSC0003DMG200013273	K01555	ko00350	Tyrosine metabolism	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMG200013273	K01555	ko00643	Styrene degradation	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMG200013273	K01555	ko01100	Metabolic pathways	2873	1.3e-152	0.68	0.75	1.00
PGSC0003DMG200013273	K01555	ko00350	Tyrosine metabolism	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMG200013273	K01555	ko00643	Styrene degradation	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMG200013273	K01555	ko01100	Metabolic pathways	1466	5.1e-75	0.80	0.89	0.90
PGSC0003DMG200013273	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko00350	Tyrosine metabolism	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko00643	Styrene degradation	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013273	K01555	ko01100	Metabolic pathways	3041	6.8e-162	0.82	0.90	1.00
PGSC0003DMG200013281	K02705	ko00195	Photosynthesis	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMG200013281	K02705	ko01100	Metabolic pathways	446	9.2e-19	0.66	0.71	0.49
PGSC0003DMG200013894	K05933	ko00270	Cysteine and methionine metabolism	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMG200013894	K05933	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.75	0.83	0.98
PGSC0003DMG200013901	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMG200013901	K04459	ko04010	MAPK signaling pathway	339	7.3e-13	0.54	0.61	0.99
PGSC0003DMG200013901	K04459	ko04010	MAPK signaling pathway	1699	7.1e-88	0.74	0.84	0.99
PGSC0003DMG200013909	K12356	ko00940	Phenylpropanoid biosynthesis	512	2.1e-22	0.35	0.51	0.89
PGSC0003DMG200013910	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200013910	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200013910	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200013911	K10591	ko04120	Ubiquitin mediated proteolysis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMG200013911	K10591	ko04144	Endocytosis	1312	1.6e-66	0.39	0.53	0.96
PGSC0003DMG200004584	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004584	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004584	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004584	K04536	ko04062	Chemokine signaling pathway	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004584	K04536	ko04742	Taste transduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004584	K04536	ko04744	Phototransduction	247	1.6e-06	0.25	0.45	0.51
PGSC0003DMG200004585	K12811	ko03040	Spliceosome	6963	0.	0.72	0.84	1.00
PGSC0003DMG200004588	K12471	ko04144	Endocytosis	640	2.4e-29	0.29	0.42	0.62
PGSC0003DMG200004588	K12471	ko04144	Endocytosis	810	7.7e-39	0.31	0.45	0.65
PGSC0003DMG200004592	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.84
PGSC0003DMG200004592	K05185	ko04080	Neuroactive ligand-receptor interaction	611	9.4e-28	0.36	0.38	0.47
PGSC0003DMG200004592	K05185	ko04080	Neuroactive ligand-receptor interaction	645	9.7e-30	0.35	0.38	0.50
PGSC0003DMG200004593	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	764	2.6e-36	0.40	0.58	0.75
PGSC0003DMG200004595	K05658	ko02010	ABC transporters	1111	1.9e-55	0.75	0.86	0.98
PGSC0003DMG200004598	K03260	ko05416	Viral myocarditis	358	6.7e-13	0.42	0.55	0.96
PGSC0003DMG200007737	K03110	ko03060	Protein export	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMG200007737	K03110	ko03070	Bacterial secretion system	250	1.1e-07	0.37	0.44	0.44
PGSC0003DMG200007749	K12135	ko04712	Circadian rhythm - plant	308	6.6e-11	0.33	0.47	0.34
PGSC0003DMG200007749	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.33	0.47	0.44
PGSC0003DMG200007756	K01489	ko00240	Pyrimidine metabolism	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMG200007756	K01489	ko00983	Drug metabolism - other enzymes	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMG200007756	K01489	ko01100	Metabolic pathways	1499	7.6e-77	0.61	0.71	0.99
PGSC0003DMG200006758	K01255	ko00480	Glutathione metabolism	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMG200006758	K01255	ko01100	Metabolic pathways	607	1.2e-27	0.62	0.71	0.67
PGSC0003DMG200006764	K00279	ko00908	Zeatin biosynthesis	2766	1.0e-146	0.62	0.78	0.97
PGSC0003DMG200006765	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.77
PGSC0003DMG200006765	K00057	ko00564	Glycerophospholipid metabolism	386	1.9e-15	0.31	0.46	0.74
PGSC0003DMG200006765	K00057	ko00564	Glycerophospholipid metabolism	368	1.8e-14	0.31	0.45	0.88
PGSC0003DMG200006769	K06685	ko04111	Cell cycle - yeast	421	7.0e-14	0.26	0.41	0.83
PGSC0003DMG200006769	K06685	ko04111	Cell cycle - yeast	421	8.8e-14	0.26	0.41	0.75
PGSC0003DMG200001361	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001361	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001361	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001361	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001361	K00558	ko00270	Cysteine and methionine metabolism	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001361	K00558	ko01100	Metabolic pathways	290	5.6e-09	0.48	0.66	0.66
PGSC0003DMG200001363	K08233	ko00901	Indole alkaloid biosynthesis	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMG200001363	K08233	ko01110	Biosynthesis of secondary metabolites	617	3.4e-28	0.38	0.56	0.78
PGSC0003DMG200039667	K01516	ko00230	Purine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMG200039667	K01516	ko00730	Thiamine metabolism	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMG200039667	K01516	ko01100	Metabolic pathways	561	4.2e-25	0.52	0.65	0.81
PGSC0003DMG200039679	K04371	ko04010	MAPK signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04012	ErbB signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04013	MAPK signaling pathway - fly	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04062	Chemokine signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04114	Oocyte meiosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04150	mTOR signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04270	Vascular smooth muscle contraction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04320	Dorso-ventral axis formation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04350	TGF-beta signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04360	Axon guidance	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04370	VEGF signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04510	Focal adhesion	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04520	Adherens junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04540	Gap junction	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04620	Toll-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04621	NOD-like receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04650	Natural killer cell mediated cytotoxicity	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04660	T cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04662	B cell receptor signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04664	Fc epsilon RI signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04666	Fc gamma R-mediated phagocytosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04720	Long-term potentiation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04722	Neurotrophin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04730	Long-term depression	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04810	Regulation of actin cytoskeleton	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04910	Insulin signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04912	GnRH signaling pathway	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04914	Progesterone-mediated oocyte maturation	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04916	Melanogenesis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04930	Type II diabetes mellitus	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko04960	Aldosterone-regulated sodium reabsorption	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05010	Alzheimer's disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05020	Prion diseases	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05131	Shigellosis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05140	Leishmaniasis	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05142	Chagas disease	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05200	Pathways in cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05210	Colorectal cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05211	Renal cell carcinoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05212	Pancreatic cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05213	Endometrial cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05214	Glioma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05215	Prostate cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05216	Thyroid cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05218	Melanoma	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05219	Bladder cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05220	Chronic myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05221	Acute myeloid leukemia	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039679	K04371	ko05223	Non-small cell lung cancer	367	2.1e-14	0.70	0.78	0.62
PGSC0003DMG200039685	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMG200039685	K00517	ko00626	Naphthalene and anthracene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMG200039685	K00517	ko00903	Limonene and pinene degradation	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMG200039685	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMG200039685	K00517	ko01110	Biosynthesis of secondary metabolites	1208	8.6e-61	0.40	0.58	0.98
PGSC0003DMG200043512	K09843	ko00906	Carotenoid biosynthesis	835	3.2e-40	0.39	0.56	0.98
PGSC0003DMG200043528	K00791	ko00908	Zeatin biosynthesis	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMG200043528	K00791	ko01100	Metabolic pathways	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMG200043528	K00791	ko01110	Biosynthesis of secondary metabolites	269	6.7e-16	0.45	0.74	0.94
PGSC0003DMG200021307	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMG200021307	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMG200021307	K00734	ko01100	Metabolic pathways	295	2.0e-10	0.31	0.50	0.61
PGSC0003DMG200024539	K07195	ko04910	Insulin signaling pathway	1887	3.0e-98	0.43	0.63	0.99
PGSC0003DMG200024543	K04458	ko04010	MAPK signaling pathway	359	5.8e-14	0.48	0.64	0.56
PGSC0003DMG200024546	K02966	ko03010	Ribosome	1065	6.6e-53	0.86	0.92	0.99
PGSC0003DMG200024547	K00901	ko00561	Glycerolipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMG200024547	K00901	ko00564	Glycerophospholipid metabolism	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMG200024547	K00901	ko01100	Metabolic pathways	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMG200024547	K00901	ko04070	Phosphatidylinositol signaling system	4843	2.8e-261	0.78	0.86	1.00
PGSC0003DMG200024547	K00901	ko00561	Glycerolipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMG200024547	K00901	ko00564	Glycerophospholipid metabolism	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMG200024547	K00901	ko01100	Metabolic pathways	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMG200024547	K00901	ko04070	Phosphatidylinositol signaling system	3715	4.6e-199	0.75	0.84	0.99
PGSC0003DMG200032813	K05894	ko00592	alpha-Linolenic acid metabolism	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMG200032813	K05894	ko01100	Metabolic pathways	257	2.4e-08	0.64	0.76	0.82
PGSC0003DMG200032815	K10841	ko03420	Nucleotide excision repair	1276	1.5e-64	0.32	0.52	0.85
PGSC0003DMG200032824	K05863	ko04020	Calcium signaling pathway	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMG200032824	K05863	ko05012	Parkinson's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMG200032824	K05863	ko05016	Huntington's disease	2612	3.1e-138	0.81	0.88	1.00
PGSC0003DMG200032825	K02178	ko04110	Cell cycle	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMG200032825	K02178	ko04111	Cell cycle - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMG200032825	K02178	ko04113	Meiosis - yeast	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMG200032825	K02178	ko04114	Oocyte meiosis	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMG200032825	K02178	ko04914	Progesterone-mediated oocyte maturation	1251	3.6e-63	0.67	0.78	0.88
PGSC0003DMG200032825	K02178	ko04110	Cell cycle	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMG200032825	K02178	ko04111	Cell cycle - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMG200032825	K02178	ko04113	Meiosis - yeast	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMG200032825	K02178	ko04114	Oocyte meiosis	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMG200032825	K02178	ko04914	Progesterone-mediated oocyte maturation	1732	1.1e-89	0.65	0.80	0.93
PGSC0003DMG200032825	K02178	ko04110	Cell cycle	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMG200032825	K02178	ko04111	Cell cycle - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMG200032825	K02178	ko04113	Meiosis - yeast	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMG200032825	K02178	ko04114	Oocyte meiosis	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMG200032825	K02178	ko04914	Progesterone-mediated oocyte maturation	2044	6.7e-107	0.65	0.81	0.69
PGSC0003DMG200032825	K02178	ko04110	Cell cycle	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMG200032825	K02178	ko04111	Cell cycle - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMG200032825	K02178	ko04113	Meiosis - yeast	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMG200032825	K02178	ko04114	Oocyte meiosis	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMG200032825	K02178	ko04914	Progesterone-mediated oocyte maturation	1711	1.6e-88	0.64	0.79	0.93
PGSC0003DMG200008938	K01179	ko00500	Starch and sucrose metabolism	2383	1.3e-125	0.60	0.74	0.95
PGSC0003DMG200008942	K01193	ko00052	Galactose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMG200008942	K01193	ko00500	Starch and sucrose metabolism	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMG200008942	K01193	ko01100	Metabolic pathways	3129	9.6e-167	0.71	0.82	0.99
PGSC0003DMG200008943	K01193	ko00052	Galactose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMG200008943	K01193	ko00500	Starch and sucrose metabolism	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMG200008943	K01193	ko01100	Metabolic pathways	3153	4.5e-168	0.70	0.82	1.00
PGSC0003DMG200008943	K01193	ko00052	Galactose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMG200008943	K01193	ko00500	Starch and sucrose metabolism	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMG200008943	K01193	ko01100	Metabolic pathways	552	1.3e-24	0.77	0.90	0.92
PGSC0003DMG200008946	K13229	ko00402	Benzoxazinoid biosynthesis	479	1.4e-20	0.34	0.54	0.96
PGSC0003DMG200008946	K13229	ko00402	Benzoxazinoid biosynthesis	1119	7.0e-56	0.42	0.60	0.95
PGSC0003DMG200008946	K13229	ko00402	Benzoxazinoid biosynthesis	482	9.5e-21	0.40	0.59	0.82
PGSC0003DMG200008946	K13229	ko00402	Benzoxazinoid biosynthesis	912	1.8e-44	0.43	0.62	0.88
PGSC0003DMG200008946	K13229	ko00402	Benzoxazinoid biosynthesis	1192	6.5e-60	0.43	0.62	0.98
PGSC0003DMG200008947	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMG200008947	K13229	ko00402	Benzoxazinoid biosynthesis	561	4.2e-25	0.43	0.61	0.90
PGSC0003DMG200008947	K13229	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.46	0.65	0.98
PGSC0003DMG200008947	K13229	ko00402	Benzoxazinoid biosynthesis	1308	2.6e-66	0.46	0.64	0.99
PGSC0003DMG200008948	K03869	ko04120	Ubiquitin mediated proteolysis	1396	3.7e-71	0.36	0.57	0.99
PGSC0003DMG200008949	K10609	ko03420	Nucleotide excision repair	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMG200008949	K10609	ko04120	Ubiquitin mediated proteolysis	1639	1.5e-84	0.36	0.56	0.98
PGSC0003DMG200005075	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMG200005075	K08341	ko04140	Regulation of autophagy	922	5.1e-45	0.92	0.97	0.94
PGSC0003DMG200005079	K03016	ko00230	Purine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMG200005079	K03016	ko00240	Pyrimidine metabolism	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMG200005079	K03016	ko01100	Metabolic pathways	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMG200005079	K03016	ko03020	RNA polymerase	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMG200005079	K03016	ko05016	Huntington's disease	671	3.6e-31	0.72	0.87	0.99
PGSC0003DMG200005079	K03016	ko00230	Purine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMG200005079	K03016	ko00240	Pyrimidine metabolism	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMG200005079	K03016	ko01100	Metabolic pathways	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMG200005079	K03016	ko03020	RNA polymerase	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMG200005079	K03016	ko05016	Huntington's disease	876	1.8e-42	0.72	0.83	0.99
PGSC0003DMG200005082	K05350	ko00460	Cyanoamino acid metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMG200005082	K05350	ko00500	Starch and sucrose metabolism	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMG200005082	K05350	ko00940	Phenylpropanoid biosynthesis	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMG200005082	K05350	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.65	0.81	0.98
PGSC0003DMG200005091	K02981	ko03010	Ribosome	519	8.6e-23	0.74	0.80	0.79
PGSC0003DMG200012183	K01179	ko00500	Starch and sucrose metabolism	1950	1.0e-101	0.48	0.67	0.95
PGSC0003DMG200012183	K01179	ko00500	Starch and sucrose metabolism	467	6.4e-20	0.53	0.73	0.85
PGSC0003DMG200012184	K10878	ko04113	Meiosis - yeast	279	1.5e-09	0.33	0.53	0.77
PGSC0003DMG200012185	K01770	ko00900	Terpenoid backbone biosynthesis	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMG200012185	K01770	ko01100	Metabolic pathways	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMG200012185	K01770	ko01110	Biosynthesis of secondary metabolites	1394	4.7e-71	0.76	0.86	1.00
PGSC0003DMG200012186	K01762	ko00270	Cysteine and methionine metabolism	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMG200012186	K01762	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.64	0.80	0.98
PGSC0003DMG200041269	K09843	ko00906	Carotenoid biosynthesis	852	3.7e-41	0.32	0.51	0.98
PGSC0003DMG200041277	K04371	ko04010	MAPK signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04012	ErbB signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04013	MAPK signaling pathway - fly	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04062	Chemokine signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04114	Oocyte meiosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04150	mTOR signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04270	Vascular smooth muscle contraction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04320	Dorso-ventral axis formation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04350	TGF-beta signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04360	Axon guidance	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04370	VEGF signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04510	Focal adhesion	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04520	Adherens junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04540	Gap junction	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04620	Toll-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04621	NOD-like receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04650	Natural killer cell mediated cytotoxicity	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04660	T cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04662	B cell receptor signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04664	Fc epsilon RI signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04666	Fc gamma R-mediated phagocytosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04720	Long-term potentiation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04722	Neurotrophin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04730	Long-term depression	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04810	Regulation of actin cytoskeleton	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04910	Insulin signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04912	GnRH signaling pathway	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04914	Progesterone-mediated oocyte maturation	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04916	Melanogenesis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04930	Type II diabetes mellitus	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko04960	Aldosterone-regulated sodium reabsorption	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05010	Alzheimer's disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05020	Prion diseases	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05131	Shigellosis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05140	Leishmaniasis	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05142	Chagas disease	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05200	Pathways in cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05210	Colorectal cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05211	Renal cell carcinoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05212	Pancreatic cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05213	Endometrial cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05214	Glioma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05215	Prostate cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05216	Thyroid cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05218	Melanoma	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05219	Bladder cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05220	Chronic myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05221	Acute myeloid leukemia	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200041277	K04371	ko05223	Non-small cell lung cancer	370	1.4e-14	0.56	0.64	0.86
PGSC0003DMG200000270	K05279	ko00944	Flavone and flavonol biosynthesis	686	5.3e-32	0.41	0.59	0.92
PGSC0003DMG200000272	K08064	ko04612	Antigen processing and presentation	418	3.2e-17	0.40	0.53	0.63
PGSC0003DMG200000272	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMG200000272	K08064	ko04612	Antigen processing and presentation	597	4.3e-27	0.44	0.59	0.83
PGSC0003DMG200000272	K08064	ko04612	Antigen processing and presentation	501	8.5e-22	0.57	0.73	0.75
PGSC0003DMG200000273	K04368	ko04010	MAPK signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04012	ErbB signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04013	MAPK signaling pathway - fly	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04062	Chemokine signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04114	Oocyte meiosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04270	Vascular smooth muscle contraction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04320	Dorso-ventral axis formation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04370	VEGF signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04510	Focal adhesion	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04540	Gap junction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04620	Toll-like receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04626	Plant-pathogen interaction	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04650	Natural killer cell mediated cytotoxicity	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04660	T cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04662	B cell receptor signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04664	Fc epsilon RI signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04666	Fc gamma R-mediated phagocytosis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04720	Long-term potentiation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04722	Neurotrophin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04730	Long-term depression	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04810	Regulation of actin cytoskeleton	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04910	Insulin signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04912	GnRH signaling pathway	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04914	Progesterone-mediated oocyte maturation	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04916	Melanogenesis	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05020	Prion diseases	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05200	Pathways in cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05210	Colorectal cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05211	Renal cell carcinoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05212	Pancreatic cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05213	Endometrial cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05214	Glioma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05215	Prostate cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05216	Thyroid cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05218	Melanoma	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05219	Bladder cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05220	Chronic myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05221	Acute myeloid leukemia	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko05223	Non-small cell lung cancer	2387	8.0e-126	0.78	0.88	0.99
PGSC0003DMG200000273	K04368	ko04010	MAPK signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04012	ErbB signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04013	MAPK signaling pathway - fly	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04062	Chemokine signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04114	Oocyte meiosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04270	Vascular smooth muscle contraction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04320	Dorso-ventral axis formation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04370	VEGF signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04510	Focal adhesion	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04540	Gap junction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04620	Toll-like receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04626	Plant-pathogen interaction	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04650	Natural killer cell mediated cytotoxicity	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04660	T cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04662	B cell receptor signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04664	Fc epsilon RI signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04666	Fc gamma R-mediated phagocytosis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04720	Long-term potentiation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04722	Neurotrophin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04730	Long-term depression	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04810	Regulation of actin cytoskeleton	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04910	Insulin signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04912	GnRH signaling pathway	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04914	Progesterone-mediated oocyte maturation	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko04916	Melanogenesis	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05020	Prion diseases	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05200	Pathways in cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05210	Colorectal cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05211	Renal cell carcinoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05212	Pancreatic cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05213	Endometrial cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05214	Glioma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05215	Prostate cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05216	Thyroid cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05218	Melanoma	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05219	Bladder cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05220	Chronic myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05221	Acute myeloid leukemia	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000273	K04368	ko05223	Non-small cell lung cancer	520	7.6e-23	0.74	0.84	0.77
PGSC0003DMG200000274	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMG200000274	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMG200000274	K00635	ko00561	Glycerolipid metabolism	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMG200000274	K00635	ko01100	Metabolic pathways	2112	1.2e-110	0.62	0.75	0.76
PGSC0003DMG200000277	K00279	ko00908	Zeatin biosynthesis	2211	4.1e-116	0.56	0.75	0.96
PGSC0003DMG200000282	K00640	ko00270	Cysteine and methionine metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMG200000282	K00640	ko00920	Sulfur metabolism	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMG200000282	K00640	ko01100	Metabolic pathways	2126	2.0e-111	0.86	0.91	1.00
PGSC0003DMG200000282	K00640	ko00270	Cysteine and methionine metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMG200000282	K00640	ko00920	Sulfur metabolism	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMG200000282	K00640	ko01100	Metabolic pathways	846	7.9e-41	0.80	0.83	0.96
PGSC0003DMG200000283	K00968	ko00440	Phosphonate and phosphinate metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMG200000283	K00968	ko00564	Glycerophospholipid metabolism	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMG200000283	K00968	ko01100	Metabolic pathways	1369	1.1e-69	0.75	0.88	0.61
PGSC0003DMG200000283	K00968	ko00440	Phosphonate and phosphinate metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMG200000283	K00968	ko00564	Glycerophospholipid metabolism	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMG200000283	K00968	ko01100	Metabolic pathways	373	9.7e-15	0.59	0.72	0.98
PGSC0003DMG200000283	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200000283	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200000283	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200027026	K05658	ko02010	ABC transporters	3425	4.5e-183	0.40	0.60	0.98
PGSC0003DMG200027032	K03363	ko04110	Cell cycle	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMG200027032	K03363	ko04111	Cell cycle - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMG200027032	K03363	ko04113	Meiosis - yeast	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMG200027032	K03363	ko04114	Oocyte meiosis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMG200027032	K03363	ko04120	Ubiquitin mediated proteolysis	1506	3.1e-77	0.89	0.94	0.99
PGSC0003DMG200027032	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04110	Cell cycle	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04111	Cell cycle - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04113	Meiosis - yeast	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04114	Oocyte meiosis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027032	K03363	ko04120	Ubiquitin mediated proteolysis	3368	6.3e-180	0.85	0.93	1.00
PGSC0003DMG200027033	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMG200027033	K10601	ko04120	Ubiquitin mediated proteolysis	2868	2.4e-152	0.67	0.77	0.97
PGSC0003DMG200027033	K10601	ko04120	Ubiquitin mediated proteolysis	1509	2.1e-77	0.58	0.69	0.96
PGSC0003DMG200023264	K00058	ko00260	Glycine, serine and threonine metabolism	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMG200023264	K00058	ko01100	Metabolic pathways	3852	1.3e-206	0.80	0.89	0.99
PGSC0003DMG200023273	K02084	ko04115	p53 signaling pathway	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko04210	Apoptosis	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko05010	Alzheimer's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko05012	Parkinson's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko05016	Huntington's disease	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023273	K02084	ko05222	Small cell lung cancer	272	2.9e-06	0.28	0.47	0.65
PGSC0003DMG200023276	K02901	ko03010	Ribosome	490	3.4e-21	0.82	0.89	0.61
PGSC0003DMG200018875	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMG200018875	K12893	ko03040	Spliceosome	440	2.0e-18	0.35	0.51	0.93
PGSC0003DMG200018875	K12891	ko03040	Spliceosome	261	1.5e-08	0.33	0.43	0.97
PGSC0003DMG200018876	K05280	ko00941	Flavonoid biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMG200018876	K05280	ko00944	Flavone and flavonol biosynthesis	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMG200018876	K05280	ko01100	Metabolic pathways	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMG200018876	K05280	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.38	0.58	0.97
PGSC0003DMG200018878	K04506	ko04115	p53 signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMG200018878	K04506	ko04120	Ubiquitin mediated proteolysis	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMG200018878	K04506	ko04310	Wnt signaling pathway	2488	2.2e-131	0.82	0.88	1.00
PGSC0003DMG200018878	K04506	ko04115	p53 signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMG200018878	K04506	ko04120	Ubiquitin mediated proteolysis	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMG200018878	K04506	ko04310	Wnt signaling pathway	810	7.7e-39	0.97	0.99	0.99
PGSC0003DMG200018882	K02934	ko03010	Ribosome	227	1.1e-06	0.49	0.61	0.52
PGSC0003DMG200018885	K12132	ko04712	Circadian rhythm - plant	645	9.7e-30	0.44	0.60	0.46
PGSC0003DMG200030288	K04733	ko04210	Apoptosis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMG200030288	K04733	ko04620	Toll-like receptor signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMG200030288	K04733	ko04722	Neurotrophin signaling pathway	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMG200030288	K04733	ko05140	Leishmaniasis	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMG200030288	K04733	ko05142	Chagas disease	271	2.4e-08	0.38	0.61	0.75
PGSC0003DMG200030291	K04733	ko04210	Apoptosis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMG200030291	K04733	ko04620	Toll-like receptor signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMG200030291	K04733	ko04722	Neurotrophin signaling pathway	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMG200030291	K04733	ko05140	Leishmaniasis	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMG200030291	K04733	ko05142	Chagas disease	787	1.4e-37	0.34	0.55	0.52
PGSC0003DMG200030292	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko04210	Apoptosis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko04620	Toll-like receptor signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko04722	Neurotrophin signaling pathway	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko05140	Leishmaniasis	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030292	K04733	ko05142	Chagas disease	539	1.3e-23	0.35	0.58	0.92
PGSC0003DMG200030301	K01853	ko00100	Steroid biosynthesis	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMG200030301	K01853	ko01100	Metabolic pathways	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMG200030301	K01853	ko01110	Biosynthesis of secondary metabolites	1598	1.4e-88	0.54	0.63	0.73
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	4162	1.0e-223	0.74	0.82	0.97
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	2793	3.3e-148	0.78	0.88	0.91
PGSC0003DMG200000917	K00889	ko00562	Inositol phosphate metabolism	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko01100	Metabolic pathways	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko04070	Phosphatidylinositol signaling system	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko04144	Endocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko04666	Fc gamma R-mediated phagocytosis	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko04810	Regulation of actin cytoskeleton	323	2.3e-11	0.38	0.53	0.39
PGSC0003DMG200000917	K00889	ko00562	Inositol phosphate metabolism	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000917	K00889	ko01100	Metabolic pathways	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000917	K00889	ko04070	Phosphatidylinositol signaling system	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000917	K00889	ko04144	Endocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000917	K00889	ko04666	Fc gamma R-mediated phagocytosis	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000917	K00889	ko04810	Regulation of actin cytoskeleton	491	5.0e-21	0.34	0.48	0.57
PGSC0003DMG200000926	K02717	ko00195	Photosynthesis	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMG200000926	K02717	ko01100	Metabolic pathways	1531	1.3e-78	0.69	0.80	0.99
PGSC0003DMG200000926	K02717	ko00195	Photosynthesis	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMG200000926	K02717	ko01100	Metabolic pathways	1580	2.6e-81	0.74	0.86	0.99
PGSC0003DMG200000928	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMG200000928	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMG200000928	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.90	0.92	0.99
PGSC0003DMG200042470	K03413	ko02020	Two-component system	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMG200042470	K03413	ko02030	Bacterial chemotaxis	250	5.9e-08	0.36	0.54	0.82
PGSC0003DMG200046476	K10747	ko03030	DNA replication	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMG200046476	K10747	ko03410	Base excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMG200046476	K10747	ko03420	Nucleotide excision repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMG200046476	K10747	ko03430	Mismatch repair	236	1.7e-06	0.37	0.53	0.94
PGSC0003DMG200005773	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMG200005773	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMG200005773	K04424	ko04010	MAPK signaling pathway	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMG200005773	K04424	ko04530	Tight junction	383	3.3e-13	0.45	0.60	0.23
PGSC0003DMG200005773	K04424	ko04010	MAPK signaling pathway	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMG200005773	K04424	ko04530	Tight junction	1119	7.0e-56	0.57	0.71	0.37
PGSC0003DMG200005773	K04424	ko04010	MAPK signaling pathway	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMG200005773	K04424	ko04530	Tight junction	1342	3.5e-68	0.57	0.71	0.40
PGSC0003DMG200005776	K02945	ko03010	Ribosome	315	8.5e-11	0.33	0.56	0.17
PGSC0003DMG200005777	K12478	ko04144	Endocytosis	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMG200005777	K12478	ko04145	Phagosome	727	1.7e-31	0.27	0.47	0.77
PGSC0003DMG200005782	K04079	ko04612	Antigen processing and presentation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005782	K04079	ko04621	NOD-like receptor signaling pathway	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005782	K04079	ko04626	Plant-pathogen interaction	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005782	K04079	ko04914	Progesterone-mediated oocyte maturation	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005782	K04079	ko05200	Pathways in cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005782	K04079	ko05215	Prostate cancer	1179	3.4e-59	0.63	0.69	0.90
PGSC0003DMG200005784	K06689	ko04120	Ubiquitin mediated proteolysis	1284	5.5e-65	0.97	0.99	0.99
PGSC0003DMG200009571	K00558	ko00270	Cysteine and methionine metabolism	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMG200009571	K00558	ko01100	Metabolic pathways	413	8.1e-16	0.42	0.60	0.37
PGSC0003DMG200009577	K00888	ko00562	Inositol phosphate metabolism	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMG200009577	K00888	ko01100	Metabolic pathways	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMG200009577	K00888	ko04070	Phosphatidylinositol signaling system	2078	8.9e-109	0.55	0.71	0.94
PGSC0003DMG200009577	K00888	ko00562	Inositol phosphate metabolism	7866	0.	0.81	0.89	1.00
PGSC0003DMG200009577	K00888	ko01100	Metabolic pathways	7866	0.	0.81	0.89	1.00
PGSC0003DMG200009577	K00888	ko04070	Phosphatidylinositol signaling system	7866	0.	0.81	0.89	1.00
PGSC0003DMG200009577	K00888	ko00562	Inositol phosphate metabolism	12335	0.	0.74	0.84	1.00
PGSC0003DMG200009577	K00888	ko01100	Metabolic pathways	12335	0.	0.74	0.84	1.00
PGSC0003DMG200009577	K00888	ko04070	Phosphatidylinositol signaling system	12335	0.	0.74	0.84	1.00
PGSC0003DMG200009581	K03094	ko04110	Cell cycle	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04111	Cell cycle - yeast	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04120	Ubiquitin mediated proteolysis	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04310	Wnt signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04350	TGF-beta signaling pathway	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009581	K03094	ko04710	Circadian rhythm - mammal	1100	7.8e-55	0.87	0.93	0.99
PGSC0003DMG200009584	K00854	ko00040	Pentose and glucuronate interconversions	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMG200009584	K00854	ko01100	Metabolic pathways	231	8.1e-07	0.40	0.62	0.45
PGSC0003DMG200009584	K00854	ko00040	Pentose and glucuronate interconversions	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMG200009584	K00854	ko01100	Metabolic pathways	647	7.5e-30	0.46	0.61	0.77
PGSC0003DMG200009584	K00854	ko00040	Pentose and glucuronate interconversions	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMG200009584	K00854	ko01100	Metabolic pathways	1713	1.2e-88	0.55	0.69	0.87
PGSC0003DMG200009584	K00854	ko00040	Pentose and glucuronate interconversions	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMG200009584	K00854	ko01100	Metabolic pathways	1614	3.5e-83	0.56	0.69	0.96
PGSC0003DMG200009588	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMG200009591	K08679	ko00500	Starch and sucrose metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMG200009591	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMG200009591	K08679	ko01100	Metabolic pathways	3156	3.1e-168	0.86	0.91	1.00
PGSC0003DMG200012846	K03531	ko04112	Cell cycle - Caulobacter	2289	2.0e-120	0.69	0.77	1.00
PGSC0003DMG200022511	K02936	ko03010	Ribosome	1892	1.6e-98	0.85	0.95	1.00
PGSC0003DMG200022514	K03006	ko00230	Purine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMG200022514	K03006	ko00240	Pyrimidine metabolism	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMG200022514	K03006	ko01100	Metabolic pathways	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMG200022514	K03006	ko03020	RNA polymerase	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMG200022514	K03006	ko05016	Huntington's disease	573	1.2e-24	0.41	0.48	0.90
PGSC0003DMG200022516	K03006	ko00230	Purine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMG200022516	K03006	ko00240	Pyrimidine metabolism	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMG200022516	K03006	ko01100	Metabolic pathways	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMG200022516	K03006	ko03020	RNA polymerase	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMG200022516	K03006	ko05016	Huntington's disease	763	3.1e-35	0.42	0.48	0.92
PGSC0003DMG200022517	K03006	ko00230	Purine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMG200022517	K03006	ko00240	Pyrimidine metabolism	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMG200022517	K03006	ko01100	Metabolic pathways	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMG200022517	K03006	ko03020	RNA polymerase	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMG200022517	K03006	ko05016	Huntington's disease	585	2.4e-25	0.40	0.47	0.92
PGSC0003DMG200022518	K03006	ko00230	Purine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMG200022518	K03006	ko00240	Pyrimidine metabolism	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMG200022518	K03006	ko01100	Metabolic pathways	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMG200022518	K03006	ko03020	RNA polymerase	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMG200022518	K03006	ko05016	Huntington's disease	642	1.7e-28	0.41	0.48	0.90
PGSC0003DMG200022524	K00472	ko00330	Arginine and proline metabolism	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMG200022524	K00472	ko01100	Metabolic pathways	977	4.7e-48	0.47	0.64	0.91
PGSC0003DMG200026342	K00419	ko00190	Oxidative phosphorylation	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko01100	Metabolic pathways	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko04260	Cardiac muscle contraction	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko05010	Alzheimer's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko05012	Parkinson's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko05016	Huntington's disease	353	1.2e-13	0.69	0.77	0.46
PGSC0003DMG200026342	K00419	ko00190	Oxidative phosphorylation	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026342	K00419	ko01100	Metabolic pathways	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026342	K00419	ko04260	Cardiac muscle contraction	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026342	K00419	ko05010	Alzheimer's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026342	K00419	ko05012	Parkinson's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026342	K00419	ko05016	Huntington's disease	472	3.4e-20	0.76	0.85	0.99
PGSC0003DMG200026345	K10352	ko04530	Tight junction	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMG200026345	K10352	ko05416	Viral myocarditis	323	1.4e-08	0.26	0.47	0.84
PGSC0003DMG200026347	K01768	ko00230	Purine metabolism	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMG200026347	K01768	ko04113	Meiosis - yeast	295	2.3e-10	0.30	0.54	0.46
PGSC0003DMG200026348	K12655	ko04622	RIG-I-like receptor signaling pathway	411	7.8e-17	0.38	0.59	0.70
PGSC0003DMG200026348	K12655	ko04622	RIG-I-like receptor signaling pathway	559	2.0e-27	0.33	0.53	0.69
PGSC0003DMG200026348	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMG200026348	K12655	ko04622	RIG-I-like receptor signaling pathway	879	1.2e-42	0.38	0.56	0.61
PGSC0003DMG200026348	K12655	ko04622	RIG-I-like receptor signaling pathway	320	8.2e-12	0.54	0.74	0.85
PGSC0003DMG200026351	K05758	ko04666	Fc gamma R-mediated phagocytosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMG200026351	K05758	ko04810	Regulation of actin cytoskeleton	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMG200026351	K05758	ko05100	Bacterial invasion of epithelial cells	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMG200026351	K05758	ko05130	Pathogenic Escherichia coli infection	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMG200026351	K05758	ko05131	Shigellosis	2143	2.3e-112	0.79	0.87	0.99
PGSC0003DMG200029581	K12832	ko03040	Spliceosome	603	2.0e-27	0.94	1.00	0.31
PGSC0003DMG200029581	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMG200029582	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko04210	Apoptosis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko04620	Toll-like receptor signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko04722	Neurotrophin signaling pathway	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko05140	Leishmaniasis	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029582	K04733	ko05142	Chagas disease	753	1.1e-35	0.40	0.59	0.37
PGSC0003DMG200029587	K12356	ko00940	Phenylpropanoid biosynthesis	327	3.4e-12	0.43	0.56	0.84
PGSC0003DMG200029594	K12886	ko03040	Spliceosome	411	7.8e-17	0.29	0.44	0.81
PGSC0003DMG200029595	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMG200029595	K03434	ko01100	Metabolic pathways	1389	8.9e-71	0.68	0.84	0.84
PGSC0003DMG200038470	K10760	ko00908	Zeatin biosynthesis	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMG200038470	K10760	ko01100	Metabolic pathways	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMG200038470	K10760	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.37	0.53	0.96
PGSC0003DMG200007028	K09756	ko00940	Phenylpropanoid biosynthesis	1003	1.7e-49	0.51	0.70	0.79
PGSC0003DMG200007028	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMG200007028	K09756	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.50	0.73	0.69
PGSC0003DMG200007028	K09756	ko00940	Phenylpropanoid biosynthesis	1632	3.5e-84	0.48	0.67	0.86
PGSC0003DMG200007029	K13289	ko04142	Lysosome	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMG200007029	K13289	ko04614	Renin-angiotensin system	432	1.4e-24	0.50	0.69	0.97
PGSC0003DMG200007030	K02084	ko04115	p53 signaling pathway	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko04210	Apoptosis	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko05010	Alzheimer's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko05012	Parkinson's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko05016	Huntington's disease	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007030	K02084	ko05222	Small cell lung cancer	298	1.3e-06	0.28	0.44	0.22
PGSC0003DMG200007034	K00368	ko00910	Nitrogen metabolism	658	1.9e-30	0.40	0.54	0.86
PGSC0003DMG200007034	K00368	ko00910	Nitrogen metabolism	1486	4.0e-76	0.43	0.58	0.91
PGSC0003DMG200003882	K00927	ko00010	Glycolysis / Gluconeogenesis	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMG200003882	K00927	ko00710	Carbon fixation in photosynthetic organisms	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMG200003882	K00927	ko01100	Metabolic pathways	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMG200003882	K00927	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.34	0.53	0.82
PGSC0003DMG200003882	K00927	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMG200003882	K00927	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMG200003882	K00927	ko01100	Metabolic pathways	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMG200003882	K00927	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.32	0.51	0.60
PGSC0003DMG200003886	K01512	ko00620	Pyruvate metabolism	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMG200003886	K01512	ko00632	Benzoate degradation via CoA ligation	645	9.7e-30	0.78	0.89	0.91
PGSC0003DMG200003886	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMG200003886	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMG200003886	K01512	ko00620	Pyruvate metabolism	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMG200003886	K01512	ko00632	Benzoate degradation via CoA ligation	672	3.1e-31	0.67	0.79	0.56
PGSC0003DMG200003886	K01512	ko00620	Pyruvate metabolism	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMG200003886	K01512	ko00632	Benzoate degradation via CoA ligation	469	4.9e-20	0.61	0.77	0.92
PGSC0003DMG200003889	K05658	ko02010	ABC transporters	4475	5.5e-241	0.47	0.68	0.94
PGSC0003DMG200003892	K00953	ko00740	Riboflavin metabolism	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMG200003892	K00953	ko01100	Metabolic pathways	607	1.2e-27	0.40	0.55	0.88
PGSC0003DMG200003894	K10532	ko00531	Glycosaminoglycan degradation	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMG200003894	K10532	ko01100	Metabolic pathways	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMG200003894	K10532	ko04142	Lysosome	2643	6.1e-140	0.64	0.73	1.00
PGSC0003DMG200003895	K11584	ko04113	Meiosis - yeast	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMG200003895	K11584	ko04114	Oocyte meiosis	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMG200003895	K11584	ko04310	Wnt signaling pathway	3231	2.3e-172	0.77	0.86	1.00
PGSC0003DMG200030697	K04424	ko04010	MAPK signaling pathway	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMG200030697	K04424	ko04530	Tight junction	648	1.3e-27	0.31	0.48	0.34
PGSC0003DMG200030697	K04424	ko04010	MAPK signaling pathway	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMG200030697	K04424	ko04530	Tight junction	755	3.9e-35	0.31	0.48	0.37
PGSC0003DMG200030704	K04733	ko04210	Apoptosis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMG200030704	K04733	ko04620	Toll-like receptor signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMG200030704	K04733	ko04722	Neurotrophin signaling pathway	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMG200030704	K04733	ko05140	Leishmaniasis	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMG200030704	K04733	ko05142	Chagas disease	841	1.5e-40	0.35	0.53	0.51
PGSC0003DMG200025152	K13030	ko00460	Cyanoamino acid metabolism	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMG200025152	K13030	ko01110	Biosynthesis of secondary metabolites	845	9.0e-41	0.32	0.51	0.97
PGSC0003DMG200025153	K01176	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMG200025153	K01176	ko01100	Metabolic pathways	546	2.8e-24	0.44	0.61	0.21
PGSC0003DMG200025153	K01176	ko00500	Starch and sucrose metabolism	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMG200025153	K01176	ko01100	Metabolic pathways	1125	3.2e-56	0.55	0.72	0.77
PGSC0003DMG200025153	K01176	ko00500	Starch and sucrose metabolism	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMG200025153	K01176	ko01100	Metabolic pathways	1651	3.2e-85	0.52	0.69	0.38
PGSC0003DMG200025154	K02965	ko03010	Ribosome	325	4.3e-12	0.45	0.67	0.85
PGSC0003DMG200025158	K01723	ko00592	alpha-Linolenic acid metabolism	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMG200025158	K01723	ko01100	Metabolic pathways	1793	4.7e-93	0.46	0.66	0.98
PGSC0003DMG200025158	K01723	ko00592	alpha-Linolenic acid metabolism	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMG200025158	K01723	ko01100	Metabolic pathways	876	1.8e-42	0.54	0.72	0.99
PGSC0003DMG200025159	K01723	ko00592	alpha-Linolenic acid metabolism	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMG200025159	K01723	ko01100	Metabolic pathways	1540	4.2e-79	0.52	0.71	0.98
PGSC0003DMG200025165	K03527	ko00900	Terpenoid backbone biosynthesis	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMG200025165	K03527	ko01100	Metabolic pathways	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMG200025165	K03527	ko01110	Biosynthesis of secondary metabolites	3260	5.7e-174	0.82	0.91	1.00
PGSC0003DMG200025166	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2697	6.4e-143	0.80	0.90	0.96
PGSC0003DMG200025167	K00680	ko00350	Tyrosine metabolism	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMG200025167	K00680	ko00624	1- and 2-Methylnaphthalene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMG200025167	K00680	ko00632	Benzoate degradation via CoA ligation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMG200025167	K00680	ko00642	Ethylbenzene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMG200025167	K00680	ko00903	Limonene and pinene degradation	630	6.5e-29	0.33	0.50	0.88
PGSC0003DMG200022038	K03000	ko00230	Purine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMG200022038	K03000	ko00240	Pyrimidine metabolism	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMG200022038	K03000	ko01100	Metabolic pathways	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMG200022038	K03000	ko03020	RNA polymerase	241	1.9e-07	0.46	0.64	0.83
PGSC0003DMG200022038	K03000	ko00230	Purine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMG200022038	K03000	ko00240	Pyrimidine metabolism	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMG200022038	K03000	ko01100	Metabolic pathways	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMG200022038	K03000	ko03020	RNA polymerase	480	1.2e-20	0.49	0.67	0.98
PGSC0003DMG200022045	K12818	ko03040	Spliceosome	8022	0.	0.82	0.89	0.99
PGSC0003DMG200031291	K10949	ko05110	Vibrio cholerae infection	1624	9.8e-84	0.85	0.94	1.00
PGSC0003DMG200031302	K02261	ko00190	Oxidative phosphorylation	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031302	K02261	ko01100	Metabolic pathways	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031302	K02261	ko04260	Cardiac muscle contraction	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031302	K02261	ko05010	Alzheimer's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031302	K02261	ko05012	Parkinson's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031302	K02261	ko05016	Huntington's disease	925	3.5e-45	0.91	0.93	0.57
PGSC0003DMG200031304	K11420	ko00310	Lysine degradation	400	2.5e-15	0.39	0.54	0.33
PGSC0003DMG200031305	K11421	ko00310	Lysine degradation	311	2.9e-10	0.43	0.55	0.85
PGSC0003DMG200031306	K11420	ko00310	Lysine degradation	706	1.4e-32	0.38	0.52	0.32
PGSC0003DMG200024246	K00847	ko00051	Fructose and mannose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMG200024246	K00847	ko00500	Starch and sucrose metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMG200024246	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMG200024246	K00847	ko01100	Metabolic pathways	1941	3.2e-101	0.78	0.86	0.98
PGSC0003DMG200024246	K00847	ko00051	Fructose and mannose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMG200024246	K00847	ko00500	Starch and sucrose metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMG200024246	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMG200024246	K00847	ko01100	Metabolic pathways	2148	1.2e-112	0.75	0.85	0.99
PGSC0003DMG200024246	K00847	ko00051	Fructose and mannose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMG200024246	K00847	ko00500	Starch and sucrose metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMG200024246	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMG200024246	K00847	ko01100	Metabolic pathways	1620	1.6e-83	0.82	0.93	0.89
PGSC0003DMG200024246	K00847	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMG200024246	K00847	ko00500	Starch and sucrose metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMG200024246	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMG200024246	K00847	ko01100	Metabolic pathways	435	3.7e-18	0.65	0.79	0.95
PGSC0003DMG200024249	K05282	ko00904	Diterpenoid biosynthesis	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMG200024249	K05282	ko01100	Metabolic pathways	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMG200024249	K05282	ko01110	Biosynthesis of secondary metabolites	2038	1.4e-106	0.67	0.78	0.95
PGSC0003DMG200024250	K01835	ko00010	Glycolysis / Gluconeogenesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00030	Pentose phosphate pathway	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00052	Galactose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00230	Purine metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00521	Streptomycin biosynthesis	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko01100	Metabolic pathways	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko01110	Biosynthesis of secondary metabolites	4353	3.0e-234	0.84	0.91	0.95
PGSC0003DMG200024250	K01835	ko00010	Glycolysis / Gluconeogenesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00030	Pentose phosphate pathway	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00052	Galactose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00230	Purine metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko00521	Streptomycin biosynthesis	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko01100	Metabolic pathways	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024250	K01835	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.88	0.95	1.00
PGSC0003DMG200024253	K00430	ko00360	Phenylalanine metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMG200024253	K00430	ko00680	Methane metabolism	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMG200024253	K00430	ko00940	Phenylpropanoid biosynthesis	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMG200024253	K00430	ko01100	Metabolic pathways	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMG200024253	K00430	ko01110	Biosynthesis of secondary metabolites	1836	2.0e-95	0.68	0.79	1.00
PGSC0003DMG200030954	K01190	ko00052	Galactose metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMG200030954	K01190	ko00511	Other glycan degradation	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMG200030954	K01190	ko00600	Sphingolipid metabolism	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMG200030954	K01190	ko01100	Metabolic pathways	3879	4.1e-208	0.62	0.77	0.99
PGSC0003DMG200030958	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.41
PGSC0003DMG200030958	K12135	ko04712	Circadian rhythm - plant	308	3.7e-11	0.41	0.52	0.49
PGSC0003DMG200030960	K03064	ko03050	Proteasome	506	4.5e-22	0.97	0.98	0.95
PGSC0003DMG200030960	K03064	ko03050	Proteasome	3154	4.0e-168	0.95	0.98	1.00
PGSC0003DMG200030967	K02154	ko00190	Oxidative phosphorylation	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko01100	Metabolic pathways	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko04142	Lysosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko04145	Phagosome	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko04966	Collecting duct acid secretion	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko05110	Vibrio cholerae infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030967	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5518	1.6e-298	0.80	0.89	0.99
PGSC0003DMG200030968	K02212	ko03030	DNA replication	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMG200030968	K02212	ko04110	Cell cycle	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMG200030968	K02212	ko04111	Cell cycle - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMG200030968	K02212	ko04113	Meiosis - yeast	566	2.4e-25	0.86	0.92	0.99
PGSC0003DMG200030968	K02212	ko03030	DNA replication	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMG200030968	K02212	ko04110	Cell cycle	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMG200030968	K02212	ko04111	Cell cycle - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMG200030968	K02212	ko04113	Meiosis - yeast	5216	7.4e-282	0.86	0.92	0.97
PGSC0003DMG200030968	K02212	ko03030	DNA replication	6005	0.	0.86	0.92	1.00
PGSC0003DMG200030968	K02212	ko04110	Cell cycle	6005	0.	0.86	0.92	1.00
PGSC0003DMG200030968	K02212	ko04111	Cell cycle - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMG200030968	K02212	ko04113	Meiosis - yeast	6005	0.	0.86	0.92	1.00
PGSC0003DMG200031041	K01505	ko00640	Propanoate metabolism	1280	9.2e-65	0.44	0.62	0.94
PGSC0003DMG200031041	K01505	ko00640	Propanoate metabolism	1252	3.2e-63	0.43	0.61	0.94
PGSC0003DMG200031041	K01505	ko00640	Propanoate metabolism	1253	2.8e-63	0.43	0.61	0.94
PGSC0003DMG200031042	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko00410	beta-Alanine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko00430	Taurine and hypotaurine metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko00650	Butanoate metabolism	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko01100	Metabolic pathways	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko04940	Type I diabetes mellitus	3298	4.6e-176	0.77	0.88	1.00
PGSC0003DMG200031042	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko00410	beta-Alanine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko00430	Taurine and hypotaurine metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko00650	Butanoate metabolism	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko01100	Metabolic pathways	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko04940	Type I diabetes mellitus	2566	1.1e-135	0.87	0.95	0.92
PGSC0003DMG200031042	K01580	ko00250	Alanine, aspartate and glutamate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031042	K01580	ko00410	beta-Alanine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031042	K01580	ko00430	Taurine and hypotaurine metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031042	K01580	ko00650	Butanoate metabolism	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031042	K01580	ko01100	Metabolic pathways	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031042	K01580	ko04940	Type I diabetes mellitus	657	2.1e-30	0.57	0.77	0.99
PGSC0003DMG200031043	K02325	ko00230	Purine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko00240	Pyrimidine metabolism	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko01100	Metabolic pathways	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko03030	DNA replication	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko03410	Base excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko03420	Nucleotide excision repair	2622	8.8e-139	0.63	0.72	1.00
PGSC0003DMG200031043	K02325	ko00230	Purine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko00240	Pyrimidine metabolism	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko01100	Metabolic pathways	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko03030	DNA replication	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko03410	Base excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko03420	Nucleotide excision repair	1823	1.0e-94	0.74	0.87	0.93
PGSC0003DMG200031043	K02325	ko00230	Purine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko00240	Pyrimidine metabolism	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko01100	Metabolic pathways	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko03030	DNA replication	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko03410	Base excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko03420	Nucleotide excision repair	3572	3.5e-191	0.78	0.89	1.00
PGSC0003DMG200031043	K02325	ko00230	Purine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko00240	Pyrimidine metabolism	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko01100	Metabolic pathways	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko03030	DNA replication	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko03410	Base excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko03420	Nucleotide excision repair	1625	8.6e-84	0.71	0.86	0.93
PGSC0003DMG200031043	K02325	ko00230	Purine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031043	K02325	ko00240	Pyrimidine metabolism	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031043	K02325	ko01100	Metabolic pathways	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031043	K02325	ko03030	DNA replication	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031043	K02325	ko03410	Base excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031043	K02325	ko03420	Nucleotide excision repair	863	9.2e-42	0.89	0.94	0.99
PGSC0003DMG200031046	K00695	ko00500	Starch and sucrose metabolism	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMG200031046	K00695	ko01100	Metabolic pathways	1142	3.7e-57	0.75	0.84	0.99
PGSC0003DMG200031047	K01581	ko00330	Arginine and proline metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMG200031047	K01581	ko00480	Glutathione metabolism	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMG200031047	K01581	ko01100	Metabolic pathways	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMG200031047	K01581	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.47	0.64	0.94
PGSC0003DMG200018178	K06067	ko04110	Cell cycle	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMG200018178	K06067	ko04330	Notch signaling pathway	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMG200018178	K06067	ko05016	Huntington's disease	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMG200018178	K06067	ko05200	Pathways in cancer	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMG200018178	K06067	ko05220	Chronic myeloid leukemia	2803	9.1e-149	0.73	0.85	0.96
PGSC0003DMG200018180	K02900	ko03010	Ribosome	1132	1.3e-56	0.87	0.93	0.99
PGSC0003DMG200018181	K12823	ko03040	Spliceosome	3245	3.8e-173	0.59	0.69	0.99
PGSC0003DMG200018181	K12823	ko03040	Spliceosome	3488	1.5e-186	0.67	0.78	0.99
PGSC0003DMG200018181	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMG200018181	K12823	ko03040	Spliceosome	2766	1.0e-146	0.65	0.75	0.99
PGSC0003DMG200018190	K02358	ko04626	Plant-pathogen interaction	3409	3.4e-182	0.84	0.90	1.00
PGSC0003DMG200018191	K12132	ko04712	Circadian rhythm - plant	2130	1.2e-111	0.47	0.59	0.99
PGSC0003DMG200018191	K12132	ko04712	Circadian rhythm - plant	2133	8.2e-112	0.46	0.59	0.99
PGSC0003DMG200018191	K12132	ko04712	Circadian rhythm - plant	2157	3.9e-113	0.46	0.59	0.95
PGSC0003DMG200018194	K03517	ko00760	Nicotinate and nicotinamide metabolism	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMG200018194	K03517	ko01100	Metabolic pathways	4203	5.5e-226	0.70	0.80	1.00
PGSC0003DMG200028747	K02535	ko00540	Lipopolysaccharide biosynthesis	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMG200028747	K02535	ko01100	Metabolic pathways	1199	2.7e-60	0.61	0.76	1.00
PGSC0003DMG200028747	K02535	ko00540	Lipopolysaccharide biosynthesis	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMG200028747	K02535	ko01100	Metabolic pathways	1650	3.6e-85	0.65	0.78	0.94
PGSC0003DMG200028753	K01874	ko00450	Selenoamino acid metabolism	5739	0.	0.82	0.90	1.00
PGSC0003DMG200028753	K01874	ko00970	Aminoacyl-tRNA biosynthesis	5739	0.	0.82	0.90	1.00
PGSC0003DMG200023974	K00990	ko02020	Two-component system	230	5.3e-06	0.29	0.45	0.73
PGSC0003DMG200023975	K02259	ko00190	Oxidative phosphorylation	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMG200023975	K02259	ko00860	Porphyrin and chlorophyll metabolism	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMG200023975	K02259	ko01100	Metabolic pathways	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMG200023975	K02259	ko01110	Biosynthesis of secondary metabolites	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMG200023975	K02259	ko02020	Two-component system	2867	2.7e-152	0.75	0.82	0.99
PGSC0003DMG200023978	K01597	ko00900	Terpenoid backbone biosynthesis	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMG200023978	K01597	ko01100	Metabolic pathways	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMG200023978	K01597	ko01110	Biosynthesis of secondary metabolites	3037	1.1e-161	0.84	0.93	1.00
PGSC0003DMG200023981	K11099	ko03040	Spliceosome	604	1.8e-27	0.88	0.95	0.99
PGSC0003DMG200023985	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMG200023985	K02639	ko00195	Photosynthesis	837	2.5e-40	0.66	0.82	0.99
PGSC0003DMG200014337	K08736	ko03430	Mismatch repair	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMG200014337	K08736	ko05200	Pathways in cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMG200014337	K08736	ko05210	Colorectal cancer	5525	6.7e-299	0.63	0.75	1.00
PGSC0003DMG200014338	K08517	ko04130	SNARE interactions in vesicular transport	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMG200014338	K08517	ko04145	Phagosome	765	2.3e-36	0.56	0.79	0.74
PGSC0003DMG200014344	K05765	ko04360	Axon guidance	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMG200014344	K05765	ko04666	Fc gamma R-mediated phagocytosis	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMG200014344	K05765	ko04810	Regulation of actin cytoskeleton	900	8.3e-44	0.74	0.90	0.99
PGSC0003DMG200014351	K01199	ko00500	Starch and sucrose metabolism	1126	2.9e-56	0.48	0.65	0.91
PGSC0003DMG200010675	K01528	ko04144	Endocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMG200010675	K01528	ko04666	Fc gamma R-mediated phagocytosis	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMG200010675	K01528	ko05100	Bacterial invasion of epithelial cells	4647	1.8e-250	0.70	0.83	0.98
PGSC0003DMG200010675	K01528	ko04144	Endocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMG200010675	K01528	ko04666	Fc gamma R-mediated phagocytosis	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMG200010675	K01528	ko05100	Bacterial invasion of epithelial cells	302	3.7e-10	0.54	0.70	0.82
PGSC0003DMG200010677	K04043	ko03018	RNA degradation	1298	9.3e-66	0.83	0.93	0.99
PGSC0003DMG200010677	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMG200010677	K04043	ko03018	RNA degradation	5026	2.2e-271	0.89	0.95	1.00
PGSC0003DMG200010677	K04043	ko03018	RNA degradation	4617	8.1e-249	0.91	0.97	1.00
PGSC0003DMG200010682	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMG200010682	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMG200010682	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMG200010682	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.83
PGSC0003DMG200010682	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMG200010682	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.75
PGSC0003DMG200010682	K02717	ko00195	Photosynthesis	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMG200010682	K02717	ko01100	Metabolic pathways	346	3.0e-13	0.34	0.55	0.59
PGSC0003DMG200010684	K12131	ko04712	Circadian rhythm - plant	222	4.7e-06	0.42	0.59	0.38
PGSC0003DMG200044056	K00472	ko00330	Arginine and proline metabolism	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMG200044056	K00472	ko01100	Metabolic pathways	501	8.5e-22	0.52	0.64	0.67
PGSC0003DMG200022806	K05747	ko04062	Chemokine signaling pathway	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko04520	Adherens junction	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko04666	Fc gamma R-mediated phagocytosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko04810	Regulation of actin cytoskeleton	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko05100	Bacterial invasion of epithelial cells	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko05130	Pathogenic Escherichia coli infection	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022806	K05747	ko05131	Shigellosis	397	3.5e-14	0.31	0.40	0.28
PGSC0003DMG200022818	K12356	ko00940	Phenylpropanoid biosynthesis	408	1.1e-16	0.34	0.48	0.80
PGSC0003DMG200022818	K12356	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.29	0.42	0.98
PGSC0003DMG200036990	K03006	ko00230	Purine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMG200036990	K03006	ko00240	Pyrimidine metabolism	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMG200036990	K03006	ko01100	Metabolic pathways	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMG200036990	K03006	ko03020	RNA polymerase	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMG200036990	K03006	ko05016	Huntington's disease	487	7.2e-20	0.39	0.56	0.93
PGSC0003DMG200029326	K12405	ko00120	Primary bile acid biosynthesis	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMG200029326	K12405	ko01100	Metabolic pathways	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMG200029326	K12405	ko04146	Peroxisome	834	3.6e-40	0.39	0.56	0.99
PGSC0003DMG200029326	K12405	ko00120	Primary bile acid biosynthesis	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMG200029326	K12405	ko01100	Metabolic pathways	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMG200029326	K12405	ko04146	Peroxisome	890	3.0e-43	0.42	0.61	0.99
PGSC0003DMG200029330	K00480	ko00624	1- and 2-Methylnaphthalene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMG200029330	K00480	ko00626	Naphthalene and anthracene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMG200029330	K00480	ko00628	Fluorene degradation	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMG200029330	K00480	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.48	0.78
PGSC0003DMG200029330	K00480	ko00624	1- and 2-Methylnaphthalene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMG200029330	K00480	ko00626	Naphthalene and anthracene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMG200029330	K00480	ko00628	Fluorene degradation	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMG200029330	K00480	ko01100	Metabolic pathways	420	2.5e-17	0.29	0.46	0.78
PGSC0003DMG200029332	K00430	ko00360	Phenylalanine metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMG200029332	K00430	ko00680	Methane metabolism	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMG200029332	K00430	ko00940	Phenylpropanoid biosynthesis	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMG200029332	K00430	ko01100	Metabolic pathways	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMG200029332	K00430	ko01110	Biosynthesis of secondary metabolites	1889	2.4e-98	0.72	0.82	0.97
PGSC0003DMG200029332	K00430	ko00360	Phenylalanine metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMG200029332	K00430	ko00680	Methane metabolism	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMG200029332	K00430	ko00940	Phenylpropanoid biosynthesis	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMG200029332	K00430	ko01100	Metabolic pathways	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMG200029332	K00430	ko01110	Biosynthesis of secondary metabolites	911	2.1e-44	0.69	0.83	0.99
PGSC0003DMG200029335	K10591	ko04120	Ubiquitin mediated proteolysis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMG200029335	K10591	ko04144	Endocytosis	305	4.8e-08	0.33	0.47	0.44
PGSC0003DMG200029337	K07375	ko04145	Phagosome	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMG200029337	K07375	ko04540	Gap junction	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMG200029337	K07375	ko05130	Pathogenic Escherichia coli infection	3642	4.8e-195	0.93	0.97	1.00
PGSC0003DMG200029342	K10599	ko03040	Spliceosome	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMG200029342	K10599	ko04120	Ubiquitin mediated proteolysis	2989	5.0e-159	0.74	0.82	0.98
PGSC0003DMG200029342	K10599	ko03040	Spliceosome	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMG200029342	K10599	ko04120	Ubiquitin mediated proteolysis	2613	2.8e-138	0.79	0.88	1.00
PGSC0003DMG200029342	K10599	ko03040	Spliceosome	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMG200029342	K10599	ko04120	Ubiquitin mediated proteolysis	2020	1.4e-105	0.79	0.89	0.99
PGSC0003DMG200019395	K10576	ko04120	Ubiquitin mediated proteolysis	1405	1.2e-71	0.90	0.96	0.99
PGSC0003DMG200019395	K10576	ko04120	Ubiquitin mediated proteolysis	870	3.8e-42	0.88	0.94	0.99
PGSC0003DMG200019398	K06689	ko04120	Ubiquitin mediated proteolysis	1288	3.3e-65	0.98	0.98	0.99
PGSC0003DMG200019398	K06689	ko04120	Ubiquitin mediated proteolysis	972	8.9e-48	0.98	0.98	0.99
PGSC0003DMG200015909	K01880	ko00970	Aminoacyl-tRNA biosynthesis	5018	6.2e-271	0.86	0.93	0.99
PGSC0003DMG200015910	K00411	ko00190	Oxidative phosphorylation	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015910	K00411	ko01100	Metabolic pathways	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015910	K00411	ko04260	Cardiac muscle contraction	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015910	K00411	ko05010	Alzheimer's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015910	K00411	ko05012	Parkinson's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015910	K00411	ko05016	Huntington's disease	1834	2.5e-95	0.80	0.89	1.00
PGSC0003DMG200015914	K01199	ko00500	Starch and sucrose metabolism	391	9.9e-16	0.31	0.51	0.92
PGSC0003DMG200015918	K13065	ko00940	Phenylpropanoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMG200015918	K13065	ko00941	Flavonoid biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMG200015918	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMG200015918	K13065	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.28	0.46	0.94
PGSC0003DMG200015921	K01692	ko00071	Fatty acid metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00280	Valine, leucine and isoleucine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00281	Geraniol degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00310	Lysine degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00380	Tryptophan metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00410	beta-Alanine metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00632	Benzoate degradation via CoA ligation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00640	Propanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00650	Butanoate metabolism	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00903	Limonene and pinene degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko00930	Caprolactam degradation	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko01100	Metabolic pathways	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015921	K01692	ko01110	Biosynthesis of secondary metabolites	965	2.2e-47	0.40	0.56	0.96
PGSC0003DMG200015926	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMG200015926	K12126	ko04712	Circadian rhythm - plant	754	9.4e-36	0.35	0.51	0.77
PGSC0003DMG200015927	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMG200015927	K12448	ko01100	Metabolic pathways	1692	1.7e-87	0.86	0.93	0.99
PGSC0003DMG200015927	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMG200015927	K12448	ko01100	Metabolic pathways	2688	2.0e-142	0.80	0.90	0.99
PGSC0003DMG200006051	K03070	ko03060	Protein export	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	2083	4.7e-109	0.77	0.87	1.00
PGSC0003DMG200006051	K03070	ko03060	Protein export	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	1376	4.7e-70	0.73	0.83	1.00
PGSC0003DMG200006054	K00858	ko00760	Nicotinate and nicotinamide metabolism	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMG200006054	K00858	ko01100	Metabolic pathways	503	6.6e-22	0.60	0.78	0.99
PGSC0003DMG200006054	K00858	ko00760	Nicotinate and nicotinamide metabolism	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMG200006054	K00858	ko01100	Metabolic pathways	975	6.1e-48	0.45	0.61	0.39
PGSC0003DMG200006054	K12865	ko03040	Spliceosome	2263	5.6e-119	0.60	0.74	0.84
PGSC0003DMG200006061	K00472	ko00330	Arginine and proline metabolism	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMG200006061	K00472	ko01100	Metabolic pathways	567	1.9e-25	0.52	0.63	0.95
PGSC0003DMG200006061	K00472	ko00330	Arginine and proline metabolism	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMG200006061	K00472	ko01100	Metabolic pathways	825	1.1e-39	0.46	0.59	0.91
PGSC0003DMG200008472	K10257	ko01040	Biosynthesis of unsaturated fatty acids	2918	4.1e-155	0.76	0.83	0.99
PGSC0003DMG200008474	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMG200008474	K01817	ko01100	Metabolic pathways	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMG200008474	K01817	ko01110	Biosynthesis of secondary metabolites	525	4.0e-23	0.82	0.91	0.90
PGSC0003DMG200008474	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko01100	Metabolic pathways	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.66	0.79	0.98
PGSC0003DMG200008474	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMG200008474	K01817	ko01100	Metabolic pathways	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMG200008474	K01817	ko01110	Biosynthesis of secondary metabolites	986	1.5e-48	0.63	0.71	0.98
PGSC0003DMG200008474	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMG200008474	K01817	ko01100	Metabolic pathways	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMG200008474	K01817	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.57	0.72	0.93
PGSC0003DMG200008476	K02111	ko00190	Oxidative phosphorylation	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMG200008476	K02111	ko00195	Photosynthesis	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMG200008476	K02111	ko01100	Metabolic pathways	576	6.2e-26	0.83	0.87	0.32
PGSC0003DMG200008477	K01739	ko00270	Cysteine and methionine metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMG200008477	K01739	ko00450	Selenoamino acid metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMG200008477	K01739	ko00920	Sulfur metabolism	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMG200008477	K01739	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMG200008477	K01739	ko01110	Biosynthesis of secondary metabolites	3352	4.8e-179	0.75	0.84	1.00
PGSC0003DMG200008479	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMG200008479	K03857	ko01100	Metabolic pathways	580	5.0e-22	0.26	0.43	0.63
PGSC0003DMG200012575	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMG200012575	K02548	ko01100	Metabolic pathways	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMG200012575	K02548	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.76	0.85	0.72
PGSC0003DMG200012575	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMG200012575	K02548	ko01100	Metabolic pathways	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMG200012575	K02548	ko01110	Biosynthesis of secondary metabolites	647	7.5e-30	0.43	0.54	0.86
PGSC0003DMG200012575	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMG200012575	K02548	ko01100	Metabolic pathways	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMG200012575	K02548	ko01110	Biosynthesis of secondary metabolites	1977	3.3e-103	0.76	0.86	0.79
PGSC0003DMG200012575	K02548	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMG200012575	K02548	ko01100	Metabolic pathways	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMG200012575	K02548	ko01110	Biosynthesis of secondary metabolites	435	3.7e-18	0.74	0.84	0.88
PGSC0003DMG200012578	K13030	ko00460	Cyanoamino acid metabolism	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMG200012578	K13030	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.40	0.63	0.96
PGSC0003DMG200012578	K13030	ko00460	Cyanoamino acid metabolism	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMG200012578	K13030	ko01110	Biosynthesis of secondary metabolites	1250	4.1e-63	0.40	0.62	0.97
PGSC0003DMG200002721	K01689	ko00010	Glycolysis / Gluconeogenesis	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMG200002721	K01689	ko01100	Metabolic pathways	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMG200002721	K01689	ko01110	Biosynthesis of secondary metabolites	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMG200002721	K01689	ko03018	RNA degradation	3364	1.0e-179	0.88	0.92	0.85
PGSC0003DMG200002721	K01689	ko00010	Glycolysis / Gluconeogenesis	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMG200002721	K01689	ko01100	Metabolic pathways	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMG200002721	K01689	ko01110	Biosynthesis of secondary metabolites	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMG200002721	K01689	ko03018	RNA degradation	3407	4.4e-182	0.91	0.95	1.00
PGSC0003DMG200002726	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMG200002726	K00517	ko00626	Naphthalene and anthracene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMG200002726	K00517	ko00903	Limonene and pinene degradation	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMG200002726	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMG200002726	K00517	ko01110	Biosynthesis of secondary metabolites	927	2.7e-45	0.41	0.62	0.92
PGSC0003DMG200002726	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMG200002726	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMG200002726	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMG200002726	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMG200002726	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.46	0.66	0.97
PGSC0003DMG200002727	K09903	ko00240	Pyrimidine metabolism	1201	2.1e-60	0.61	0.76	0.46
PGSC0003DMG200002729	K02896	ko03010	Ribosome	1252	3.2e-63	0.91	0.95	0.99
PGSC0003DMG200002741	K05280	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMG200002741	K05280	ko00944	Flavone and flavonol biosynthesis	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMG200002741	K05280	ko01100	Metabolic pathways	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMG200002741	K05280	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.53	0.69	0.94
PGSC0003DMG200000625	K03106	ko03060	Protein export	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMG200000625	K03106	ko03070	Bacterial secretion system	3793	2.3e-203	0.90	0.97	0.99
PGSC0003DMG200000625	K03106	ko03060	Protein export	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMG200000625	K03106	ko03070	Bacterial secretion system	2490	1.7e-131	0.90	0.97	0.98
PGSC0003DMG200000630	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMG200000630	K01779	ko00250	Alanine, aspartate and glutamate metabolism	363	3.5e-14	0.28	0.49	0.76
PGSC0003DMG200023533	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMG200023533	K01199	ko00500	Starch and sucrose metabolism	649	5.8e-30	0.31	0.53	0.67
PGSC0003DMG200023534	K12128	ko04712	Circadian rhythm - plant	409	1.4e-16	0.26	0.45	0.63
PGSC0003DMG200023534	K12129	ko04712	Circadian rhythm - plant	426	2.7e-17	0.36	0.54	0.73
PGSC0003DMG200035768	K01052	ko00100	Steroid biosynthesis	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMG200035768	K01052	ko04142	Lysosome	674	2.4e-31	0.34	0.45	1.00
PGSC0003DMG200035769	K09755	ko00940	Phenylpropanoid biosynthesis	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMG200035769	K09755	ko01100	Metabolic pathways	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMG200035769	K09755	ko01110	Biosynthesis of secondary metabolites	1147	2.0e-57	0.43	0.62	0.96
PGSC0003DMG200035778	K11423	ko00310	Lysine degradation	512	3.6e-21	0.37	0.53	0.83
PGSC0003DMG200035782	K13229	ko00402	Benzoxazinoid biosynthesis	247	8.7e-08	0.27	0.41	0.99
PGSC0003DMG200035792	K03469	ko03030	DNA replication	233	8.0e-07	0.34	0.53	0.27
PGSC0003DMG200025861	K00899	ko00270	Cysteine and methionine metabolism	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMG200025861	K00899	ko01100	Metabolic pathways	1548	1.5e-79	0.47	0.65	0.99
PGSC0003DMG200025862	K13068	ko00940	Phenylpropanoid biosynthesis	1950	1.0e-101	0.51	0.70	0.96
PGSC0003DMG200025868	K10151	ko04110	Cell cycle	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMG200025868	K10151	ko04115	p53 signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMG200025868	K10151	ko04310	Wnt signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMG200025868	K10151	ko04510	Focal adhesion	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMG200025868	K10151	ko04630	Jak-STAT signaling pathway	329	2.6e-12	0.29	0.50	0.75
PGSC0003DMG200025869	K05402	ko04620	Toll-like receptor signaling pathway	296	1.7e-10	0.31	0.39	0.87
PGSC0003DMG200025870	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko00562	Inositol phosphate metabolism	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04070	Phosphatidylinositol signaling system	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04115	p53 signaling pathway	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04510	Focal adhesion	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko04530	Tight junction	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05200	Pathways in cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05213	Endometrial cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05214	Glioma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05215	Prostate cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05218	Melanoma	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko05222	Small cell lung cancer	805	1.4e-38	0.54	0.67	0.99
PGSC0003DMG200025870	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko00562	Inositol phosphate metabolism	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04070	Phosphatidylinositol signaling system	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04115	p53 signaling pathway	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04510	Focal adhesion	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko04530	Tight junction	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05200	Pathways in cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05213	Endometrial cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05214	Glioma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05215	Prostate cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05218	Melanoma	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko05222	Small cell lung cancer	3797	1.4e-203	0.73	0.82	1.00
PGSC0003DMG200025870	K01110	ko00562	Inositol phosphate metabolism	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko04070	Phosphatidylinositol signaling system	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko04115	p53 signaling pathway	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko04510	Focal adhesion	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko04530	Tight junction	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05200	Pathways in cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05213	Endometrial cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05214	Glioma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05215	Prostate cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05218	Melanoma	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025870	K01110	ko05222	Small cell lung cancer	2599	1.6e-137	0.82	0.87	0.96
PGSC0003DMG200025871	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMG200020116	K13289	ko04142	Lysosome	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMG200020116	K13289	ko04614	Renin-angiotensin system	3094	8.1e-165	0.71	0.82	1.00
PGSC0003DMG200029995	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMG200029995	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMG200030001	K12200	ko04144	Endocytosis	259	1.1e-07	0.38	0.43	0.75
PGSC0003DMG200030007	K01107	ko00562	Inositol phosphate metabolism	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMG200030007	K01107	ko01100	Metabolic pathways	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMG200030007	K01107	ko04070	Phosphatidylinositol signaling system	321	7.2e-12	0.54	0.70	0.56
PGSC0003DMG200041121	K03469	ko03030	DNA replication	223	8.1e-06	0.31	0.56	0.53
PGSC0003DMG200041132	K13066	ko00940	Phenylpropanoid biosynthesis	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMG200041132	K13066	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.60	0.82
PGSC0003DMG200016624	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMG200016624	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMG200016624	K05275	ko00750	Vitamin B6 metabolism	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMG200016624	K05275	ko01100	Metabolic pathways	303	7.1e-11	0.51	0.67	0.76
PGSC0003DMG200016624	K05275	ko00750	Vitamin B6 metabolism	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMG200016624	K05275	ko01100	Metabolic pathways	918	8.5e-45	0.46	0.61	0.97
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	847	7.0e-41	0.48	0.65	0.85
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	930	1.8e-45	0.49	0.66	0.84
PGSC0003DMG200016624	K00100	ko00051	Fructose and mannose metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K00100	ko00363	Bisphenol A degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K00100	ko00591	Linoleic acid metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K00100	ko00625	Tetrachloroethene degradation	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K00100	ko00650	Butanoate metabolism	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K00100	ko01100	Metabolic pathways	932	1.4e-45	0.48	0.66	0.84
PGSC0003DMG200016624	K05275	ko00750	Vitamin B6 metabolism	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMG200016624	K05275	ko01100	Metabolic pathways	751	1.4e-35	0.51	0.65	0.96
PGSC0003DMG200016625	K02945	ko03010	Ribosome	381	3.5e-15	0.34	0.56	0.73
PGSC0003DMG200016625	K02945	ko03010	Ribosome	488	4.4e-21	0.34	0.51	0.70
PGSC0003DMG200016626	K03165	ko03440	Homologous recombination	3946	8.3e-212	0.81	0.90	1.00
PGSC0003DMG200016626	K03165	ko03440	Homologous recombination	2161	2.3e-113	0.83	0.91	0.99
PGSC0003DMG200016626	K03165	ko03440	Homologous recombination	5715	0.	0.81	0.89	1.00
PGSC0003DMG200016626	K03165	ko03440	Homologous recombination	6074	0.	0.81	0.89	0.99
PGSC0003DMG200016626	K03165	ko03440	Homologous recombination	2145	1.8e-112	0.77	0.88	0.90
PGSC0003DMG200005395	K01768	ko00230	Purine metabolism	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMG200005395	K01768	ko04113	Meiosis - yeast	230	4.5e-06	0.35	0.60	0.88
PGSC0003DMG200005397	K00901	ko00561	Glycerolipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMG200005397	K00901	ko00564	Glycerophospholipid metabolism	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMG200005397	K00901	ko01100	Metabolic pathways	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMG200005397	K00901	ko04070	Phosphatidylinositol signaling system	4929	5.0e-266	0.78	0.87	1.00
PGSC0003DMG200005402	K04718	ko00600	Sphingolipid metabolism	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMG200005402	K04718	ko01100	Metabolic pathways	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMG200005402	K04718	ko04020	Calcium signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMG200005402	K04718	ko04370	VEGF signaling pathway	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMG200005402	K04718	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.29	0.43	0.81
PGSC0003DMG200005404	K05395	ko00270	Cysteine and methionine metabolism	544	3.6e-24	0.51	0.61	0.86
PGSC0003DMG200005404	K05395	ko00270	Cysteine and methionine metabolism	274	2.8e-09	0.58	0.66	0.94
PGSC0003DMG200005406	K09567	ko03040	Spliceosome	1464	6.5e-75	0.87	0.93	0.99
PGSC0003DMG200002066	K05862	ko04020	Calcium signaling pathway	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMG200002066	K05862	ko05012	Parkinson's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMG200002066	K05862	ko05016	Huntington's disease	1858	1.2e-96	0.79	0.92	1.00
PGSC0003DMG200002072	K12669	ko00510	N-Glycan biosynthesis	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMG200002072	K12669	ko01100	Metabolic pathways	1427	7.2e-73	0.52	0.69	0.99
PGSC0003DMG200002074	K01051	ko00040	Pentose and glucuronate interconversions	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMG200002074	K01051	ko00500	Starch and sucrose metabolism	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMG200002074	K01051	ko01100	Metabolic pathways	1074	2.1e-53	0.46	0.53	0.96
PGSC0003DMG200002074	K01051	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMG200002074	K01051	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMG200002074	K01051	ko01100	Metabolic pathways	563	3.2e-25	0.37	0.60	0.77
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2704	2.6e-143	0.63	0.77	0.97
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2705	2.3e-143	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.54	0.71	0.99
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.63	0.78	0.97
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2749	8.7e-146	0.64	0.78	0.97
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2730	9.7e-145	0.62	0.77	0.99
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	1611	5.1e-83	0.67	0.78	0.96
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2663	4.8e-141	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko00460	Cyanoamino acid metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko00500	Starch and sucrose metabolism	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko00940	Phenylpropanoid biosynthesis	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMG200002077	K05350	ko01110	Biosynthesis of secondary metabolites	2691	1.4e-142	0.62	0.77	0.97
PGSC0003DMG200002078	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMG200002078	K00517	ko00626	Naphthalene and anthracene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMG200002078	K00517	ko00903	Limonene and pinene degradation	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMG200002078	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMG200002078	K00517	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.70	0.84	0.98
PGSC0003DMG200011882	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMG200011882	K01433	ko00670	One carbon pool by folate	1568	1.2e-80	0.80	0.93	1.00
PGSC0003DMG200011882	K01613	ko00564	Glycerophospholipid metabolism	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMG200011882	K01613	ko01100	Metabolic pathways	1124	3.7e-56	0.74	0.85	0.99
PGSC0003DMG200011882	K01613	ko00564	Glycerophospholipid metabolism	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMG200011882	K01613	ko01100	Metabolic pathways	2578	2.3e-136	0.69	0.82	1.00
PGSC0003DMG200011882	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMG200011882	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMG200011882	K01613	ko00564	Glycerophospholipid metabolism	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMG200011882	K01613	ko01100	Metabolic pathways	1095	1.5e-54	0.72	0.84	0.99
PGSC0003DMG200015356	K00218	ko00860	Porphyrin and chlorophyll metabolism	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMG200015356	K00218	ko01100	Metabolic pathways	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMG200015356	K00218	ko01110	Biosynthesis of secondary metabolites	723	4.8e-34	0.91	0.98	0.85
PGSC0003DMG200015356	K00218	ko00860	Porphyrin and chlorophyll metabolism	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMG200015356	K00218	ko01100	Metabolic pathways	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMG200015356	K00218	ko01110	Biosynthesis of secondary metabolites	2463	5.2e-130	0.74	0.84	0.99
PGSC0003DMG200015358	K12822	ko03040	Spliceosome	341	2.2e-12	0.29	0.47	0.88
PGSC0003DMG200015361	K10581	ko04120	Ubiquitin mediated proteolysis	459	3.6e-20	0.52	0.64	0.24
PGSC0003DMG200015361	K10581	ko04120	Ubiquitin mediated proteolysis	990	9.1e-49	0.56	0.71	0.90
PGSC0003DMG200015361	K10581	ko04120	Ubiquitin mediated proteolysis	1188	3.7e-61	0.52	0.67	0.42
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	498	1.2e-21	0.37	0.57	0.96
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	1692	1.7e-87	0.53	0.69	0.96
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	2709	1.4e-143	0.51	0.67	0.99
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	1191	7.4e-60	0.48	0.65	0.99
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	931	1.6e-45	0.43	0.61	0.97
PGSC0003DMG200015362	K02605	ko04110	Cell cycle	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMG200015362	K02605	ko04111	Cell cycle - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMG200015362	K02605	ko04113	Meiosis - yeast	1573	6.3e-81	0.56	0.72	0.98
PGSC0003DMG200032132	K12900	ko03040	Spliceosome	310	2.9e-11	0.44	0.60	0.56
PGSC0003DMG200032132	K12900	ko03040	Spliceosome	637	2.7e-29	0.44	0.56	0.83
PGSC0003DMG200032133	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.74
PGSC0003DMG200032133	K01199	ko00500	Starch and sucrose metabolism	690	3.2e-32	0.35	0.53	0.66
PGSC0003DMG200032133	K01199	ko00500	Starch and sucrose metabolism	687	4.7e-32	0.35	0.52	0.65
PGSC0003DMG200032137	K11594	ko04622	RIG-I-like receptor signaling pathway	2294	1.1e-120	0.76	0.85	0.92
PGSC0003DMG200032137	K11594	ko04622	RIG-I-like receptor signaling pathway	4135	3.1e-222	0.79	0.86	1.00
PGSC0003DMG200032139	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMG200032139	K07542	ko01100	Metabolic pathways	966	1.9e-47	0.64	0.76	0.87
PGSC0003DMG200032139	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMG200032139	K07542	ko01100	Metabolic pathways	2625	6.0e-139	0.63	0.76	0.98
PGSC0003DMG200032139	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMG200032139	K07542	ko01100	Metabolic pathways	1564	2.0e-80	0.63	0.76	0.99
PGSC0003DMG200032139	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMG200032139	K07542	ko01100	Metabolic pathways	1147	2.0e-57	0.62	0.74	1.00
PGSC0003DMG200032139	K07542	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMG200032139	K07542	ko01100	Metabolic pathways	599	3.3e-27	0.57	0.69	0.98
PGSC0003DMG200028138	K03110	ko03060	Protein export	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMG200028138	K03110	ko03070	Bacterial secretion system	380	8.4e-13	0.42	0.58	0.18
PGSC0003DMG200028143	K10739	ko03030	DNA replication	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMG200028143	K10739	ko03420	Nucleotide excision repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMG200028143	K10739	ko03430	Mismatch repair	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMG200028143	K10739	ko03440	Homologous recombination	1547	1.7e-79	0.67	0.80	1.00
PGSC0003DMG200028144	K08064	ko04612	Antigen processing and presentation	365	2.7e-14	0.42	0.58	0.68
PGSC0003DMG200028144	K08064	ko04612	Antigen processing and presentation	363	3.5e-14	0.46	0.62	0.60
PGSC0003DMG200028144	K08064	ko04612	Antigen processing and presentation	356	8.4e-14	0.49	0.64	0.60
PGSC0003DMG200028145	K08486	ko04130	SNARE interactions in vesicular transport	1923	3.1e-100	0.75	0.89	1.00
PGSC0003DMG200017455	K11584	ko04113	Meiosis - yeast	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMG200017455	K11584	ko04114	Oocyte meiosis	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMG200017455	K11584	ko04310	Wnt signaling pathway	3280	4.5e-175	0.76	0.86	1.00
PGSC0003DMG200017456	K05666	ko02010	ABC transporters	2956	3.3e-157	0.36	0.56	0.94
PGSC0003DMG200017457	K02537	ko04110	Cell cycle	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMG200017457	K02537	ko04111	Cell cycle - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMG200017457	K02537	ko04113	Meiosis - yeast	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMG200017457	K02537	ko04114	Oocyte meiosis	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMG200017457	K02537	ko04914	Progesterone-mediated oocyte maturation	1111	1.9e-55	0.89	0.96	0.88
PGSC0003DMG200017457	K02537	ko04110	Cell cycle	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMG200017457	K02537	ko04111	Cell cycle - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMG200017457	K02537	ko04113	Meiosis - yeast	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMG200017457	K02537	ko04114	Oocyte meiosis	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMG200017457	K02537	ko04914	Progesterone-mediated oocyte maturation	1392	6.1e-71	0.88	0.93	0.92
PGSC0003DMG200017457	K02537	ko04110	Cell cycle	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMG200017457	K02537	ko04111	Cell cycle - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMG200017457	K02537	ko04113	Meiosis - yeast	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMG200017457	K02537	ko04114	Oocyte meiosis	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMG200017457	K02537	ko04914	Progesterone-mediated oocyte maturation	1600	2.1e-82	0.92	0.97	0.99
PGSC0003DMG200017459	K00059	ko00061	Fatty acid biosynthesis	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMG200017459	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMG200017459	K00059	ko01100	Metabolic pathways	1857	1.4e-96	0.74	0.83	0.98
PGSC0003DMG200017459	K00059	ko00061	Fatty acid biosynthesis	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMG200017459	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMG200017459	K00059	ko01100	Metabolic pathways	1956	4.8e-102	0.77	0.86	1.00
PGSC0003DMG200017464	K03165	ko03440	Homologous recombination	644	1.1e-29	0.77	0.90	0.71
PGSC0003DMG200017464	K03165	ko03440	Homologous recombination	1490	2.4e-76	0.86	0.93	0.82
PGSC0003DMG200045253	K00021	ko00900	Terpenoid backbone biosynthesis	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMG200045253	K00021	ko01100	Metabolic pathways	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMG200045253	K00021	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.52	0.68	0.89
PGSC0003DMG200045275	K11251	ko05322	Systemic lupus erythematosus	643	1.2e-29	0.66	0.79	0.91
PGSC0003DMG200001622	K01771	ko00562	Inositol phosphate metabolism	246	9.8e-08	0.30	0.43	0.74
PGSC0003DMG200001625	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMG200001625	K02433	ko01100	Metabolic pathways	1293	1.8e-65	0.38	0.55	0.95
PGSC0003DMG200001625	K02433	ko00970	Aminoacyl-tRNA biosynthesis	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMG200001625	K02433	ko01100	Metabolic pathways	1366	1.7e-69	0.41	0.58	0.95
PGSC0003DMG200001635	K00660	ko00941	Flavonoid biosynthesis	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMG200001635	K00660	ko01100	Metabolic pathways	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMG200001635	K00660	ko01110	Biosynthesis of secondary metabolites	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMG200001635	K00660	ko04712	Circadian rhythm - plant	1212	5.2e-61	0.45	0.64	0.97
PGSC0003DMG200001636	K01243	ko00270	Cysteine and methionine metabolism	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMG200001636	K01243	ko01100	Metabolic pathways	1653	2.5e-85	0.75	0.87	1.00
PGSC0003DMG200013523	K01179	ko00500	Starch and sucrose metabolism	4113	5.1e-221	0.75	0.86	1.00
PGSC0003DMG200013525	K04733	ko04210	Apoptosis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMG200013525	K04733	ko04620	Toll-like receptor signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMG200013525	K04733	ko04722	Neurotrophin signaling pathway	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMG200013525	K04733	ko05140	Leishmaniasis	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMG200013525	K04733	ko05142	Chagas disease	834	3.6e-40	0.38	0.54	0.53
PGSC0003DMG200013538	K10447	ko04120	Ubiquitin mediated proteolysis	358	6.5e-14	0.29	0.45	0.65
PGSC0003DMG200013598	K02912	ko03010	Ribosome	980	3.2e-48	0.89	0.96	0.33
PGSC0003DMG200013603	K12356	ko00940	Phenylpropanoid biosynthesis	658	1.9e-30	0.41	0.57	0.73
PGSC0003DMG200013605	K12356	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.39	0.55	0.88
PGSC0003DMG200011337	K10599	ko03040	Spliceosome	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMG200011337	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.7e-09	0.29	0.46	0.94
PGSC0003DMG200011337	K10599	ko03040	Spliceosome	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMG200011337	K10599	ko04120	Ubiquitin mediated proteolysis	281	3.0e-07	0.29	0.46	0.58
PGSC0003DMG200011337	K10599	ko03040	Spliceosome	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMG200011337	K10599	ko04120	Ubiquitin mediated proteolysis	281	1.2e-06	0.29	0.46	0.30
PGSC0003DMG200011339	K05580	ko00190	Oxidative phosphorylation	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMG200011339	K05580	ko01100	Metabolic pathways	1381	2.5e-70	0.93	0.96	0.99
PGSC0003DMG200011339	K05576	ko00190	Oxidative phosphorylation	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMG200011339	K05576	ko01100	Metabolic pathways	728	2.6e-34	0.92	0.95	0.98
PGSC0003DMG200011339	K05575	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMG200011339	K05575	ko01100	Metabolic pathways	2933	6.2e-156	0.91	0.96	1.00
PGSC0003DMG200006448	K13067	ko00940	Phenylpropanoid biosynthesis	1112	1.7e-55	0.62	0.79	0.95
PGSC0003DMG200006449	K08967	ko00270	Cysteine and methionine metabolism	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMG200006449	K08967	ko01100	Metabolic pathways	1498	8.7e-77	0.84	0.93	0.98
PGSC0003DMG200006450	K08967	ko00270	Cysteine and methionine metabolism	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMG200006450	K08967	ko01100	Metabolic pathways	1317	8.4e-67	0.83	0.92	0.99
PGSC0003DMG200006450	K08967	ko00270	Cysteine and methionine metabolism	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMG200006450	K08967	ko01100	Metabolic pathways	1381	2.5e-70	0.84	0.92	0.99
PGSC0003DMG200006452	K08099	ko00860	Porphyrin and chlorophyll metabolism	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMG200006452	K08099	ko01100	Metabolic pathways	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMG200006452	K08099	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.65	0.82	0.98
PGSC0003DMG200006452	K08099	ko00860	Porphyrin and chlorophyll metabolism	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMG200006452	K08099	ko01100	Metabolic pathways	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMG200006452	K08099	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.60	0.76	0.98
PGSC0003DMG200014549	K00660	ko00941	Flavonoid biosynthesis	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMG200014549	K00660	ko01100	Metabolic pathways	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMG200014549	K00660	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMG200014549	K00660	ko04712	Circadian rhythm - plant	305	5.5e-11	0.27	0.46	0.78
PGSC0003DMG200014549	K00660	ko00941	Flavonoid biosynthesis	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMG200014549	K00660	ko01100	Metabolic pathways	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMG200014549	K00660	ko01110	Biosynthesis of secondary metabolites	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMG200014549	K00660	ko04712	Circadian rhythm - plant	282	9.9e-09	0.28	0.44	0.71
PGSC0003DMG200014552	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3172	4.1e-169	0.72	0.84	0.92
PGSC0003DMG200014554	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMG200014554	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMG200014554	K01069	ko00620	Pyruvate metabolism	213	6.5e-06	0.31	0.50	0.33
PGSC0003DMG200014554	K01069	ko00620	Pyruvate metabolism	297	1.6e-10	0.28	0.45	0.56
PGSC0003DMG200010612	K02084	ko04115	p53 signaling pathway	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko04210	Apoptosis	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko05010	Alzheimer's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko05012	Parkinson's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko05016	Huntington's disease	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010612	K02084	ko05222	Small cell lung cancer	331	7.7e-09	0.27	0.48	0.42
PGSC0003DMG200010616	K08332	ko04140	Regulation of autophagy	381	3.5e-15	0.30	0.50	0.84
PGSC0003DMG200010621	K07195	ko04910	Insulin signaling pathway	739	6.3e-35	0.31	0.55	0.98
PGSC0003DMG200010623	K09756	ko00940	Phenylpropanoid biosynthesis	1804	1.2e-93	0.48	0.67	0.96
PGSC0003DMG200010625	K09756	ko00940	Phenylpropanoid biosynthesis	1392	6.1e-71	0.48	0.68	0.93
PGSC0003DMG200010625	K09756	ko00940	Phenylpropanoid biosynthesis	1144	2.9e-57	0.44	0.59	0.99
PGSC0003DMG200010625	K09756	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.48	0.65	1.00
PGSC0003DMG200010625	K09756	ko00940	Phenylpropanoid biosynthesis	1611	5.1e-83	0.49	0.69	1.00
PGSC0003DMG200010625	K09756	ko00940	Phenylpropanoid biosynthesis	1235	2.8e-62	0.49	0.67	0.99
PGSC0003DMG200031228	K04733	ko04210	Apoptosis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMG200031228	K04733	ko04620	Toll-like receptor signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMG200031228	K04733	ko04722	Neurotrophin signaling pathway	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMG200031228	K04733	ko05140	Leishmaniasis	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMG200031228	K04733	ko05142	Chagas disease	722	5.5e-34	0.37	0.55	0.62
PGSC0003DMG200031240	K06688	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.89	0.91	0.97
PGSC0003DMG200031246	K10595	ko04120	Ubiquitin mediated proteolysis	861	4.7e-40	0.34	0.51	0.41
PGSC0003DMG200017886	K06268	ko04010	MAPK signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04020	Calcium signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04114	Oocyte meiosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04210	Apoptosis	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04310	Wnt signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04360	Axon guidance	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04370	VEGF signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04650	Natural killer cell mediated cytotoxicity	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04660	T cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04662	B cell receptor signaling pathway	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko04720	Long-term potentiation	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko05010	Alzheimer's disease	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017886	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1048	5.7e-52	0.64	0.81	0.99
PGSC0003DMG200017891	K08967	ko00270	Cysteine and methionine metabolism	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMG200017891	K08967	ko01100	Metabolic pathways	337	9.4e-13	0.52	0.64	0.99
PGSC0003DMG200028674	K01051	ko00040	Pentose and glucuronate interconversions	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMG200028674	K01051	ko00500	Starch and sucrose metabolism	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMG200028674	K01051	ko01100	Metabolic pathways	1220	1.9e-61	0.36	0.52	0.94
PGSC0003DMG200028675	K01051	ko00040	Pentose and glucuronate interconversions	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMG200028675	K01051	ko00500	Starch and sucrose metabolism	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMG200028675	K01051	ko01100	Metabolic pathways	1242	1.1e-62	0.37	0.53	0.99
PGSC0003DMG200028679	K11717	ko00450	Selenoamino acid metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMG200028679	K11717	ko00730	Thiamine metabolism	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMG200028679	K11717	ko01100	Metabolic pathways	294	2.1e-08	0.26	0.43	0.69
PGSC0003DMG200028681	K03938	ko00190	Oxidative phosphorylation	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMG200028681	K03938	ko01100	Metabolic pathways	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMG200028681	K03938	ko05010	Alzheimer's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMG200028681	K03938	ko05012	Parkinson's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMG200028681	K03938	ko05016	Huntington's disease	622	1.8e-28	0.82	0.87	0.99
PGSC0003DMG200024169	K01115	ko00564	Glycerophospholipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024169	K01115	ko00565	Ether lipid metabolism	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024169	K01115	ko01100	Metabolic pathways	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024169	K01115	ko04144	Endocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024169	K01115	ko04666	Fc gamma R-mediated phagocytosis	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024169	K01115	ko04912	GnRH signaling pathway	3860	4.6e-207	0.57	0.71	0.98
PGSC0003DMG200024170	K04508	ko04310	Wnt signaling pathway	262	6.4e-19	0.44	0.60	0.66
PGSC0003DMG200024172	K05349	ko00460	Cyanoamino acid metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMG200024172	K05349	ko00500	Starch and sucrose metabolism	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMG200024172	K05349	ko00940	Phenylpropanoid biosynthesis	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMG200024172	K05349	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.42	0.65	0.99
PGSC0003DMG200024178	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMG200024178	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMG200024178	K08505	ko04130	SNARE interactions in vesicular transport	773	8.4e-37	0.69	0.82	0.99
PGSC0003DMG200024181	K00660	ko00941	Flavonoid biosynthesis	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMG200024181	K00660	ko01100	Metabolic pathways	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMG200024181	K00660	ko01110	Biosynthesis of secondary metabolites	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMG200024181	K00660	ko04712	Circadian rhythm - plant	259	3.3e-07	0.31	0.49	0.41
PGSC0003DMG200024181	K00660	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMG200024181	K00660	ko01100	Metabolic pathways	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMG200024181	K00660	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMG200024181	K00660	ko04712	Circadian rhythm - plant	295	2.0e-10	0.26	0.47	0.83
PGSC0003DMG200024182	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMG200024182	K01602	ko00710	Carbon fixation in photosynthetic organisms	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMG200024182	K01602	ko01100	Metabolic pathways	1244	8.9e-63	0.79	0.91	0.98
PGSC0003DMG200024183	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200024183	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200024183	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200024183	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200015827	K04733	ko04210	Apoptosis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMG200015827	K04733	ko04620	Toll-like receptor signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMG200015827	K04733	ko04722	Neurotrophin signaling pathway	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMG200015827	K04733	ko05140	Leishmaniasis	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMG200015827	K04733	ko05142	Chagas disease	863	9.2e-42	0.43	0.61	0.76
PGSC0003DMG200015851	K01066	ko00623	2,4-Dichlorobenzoate degradation	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMG200015851	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	377	5.9e-15	0.34	0.47	0.80
PGSC0003DMG200009633	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMG200009633	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMG200009633	K12796	ko04621	NOD-like receptor signaling pathway	457	5.0e-17	0.31	0.46	0.57
PGSC0003DMG200009633	K12796	ko04621	NOD-like receptor signaling pathway	450	1.5e-16	0.31	0.47	0.57
PGSC0003DMG200008176	K00942	ko00230	Purine metabolism	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMG200008176	K00942	ko01100	Metabolic pathways	826	1.0e-39	0.72	0.82	0.47
PGSC0003DMG200008176	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMG200008176	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.44
PGSC0003DMG200008176	K00942	ko00230	Purine metabolism	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMG200008176	K00942	ko01100	Metabolic pathways	1045	8.4e-52	0.72	0.83	0.53
PGSC0003DMG200008183	K12126	ko04712	Circadian rhythm - plant	287	8.8e-10	0.31	0.50	0.52
PGSC0003DMG200008184	K00801	ko00100	Steroid biosynthesis	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMG200008184	K00801	ko01100	Metabolic pathways	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMG200008184	K00801	ko01110	Biosynthesis of secondary metabolites	327	3.4e-12	0.68	0.91	0.98
PGSC0003DMG200012770	K02183	ko04020	Calcium signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04070	Phosphatidylinositol signaling system	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04114	Oocyte meiosis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04270	Vascular smooth muscle contraction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04626	Plant-pathogen interaction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04720	Long-term potentiation	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04722	Neurotrophin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04740	Olfactory transduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04744	Phototransduction	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04745	Phototransduction - fly	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04910	Insulin signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04912	GnRH signaling pathway	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04916	Melanogenesis	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04970	Salivary secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04971	Gastric acid secretion	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko05010	Alzheimer's disease	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko05214	Glioma	421	2.2e-17	0.46	0.61	0.93
PGSC0003DMG200012770	K02183	ko04020	Calcium signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04070	Phosphatidylinositol signaling system	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04114	Oocyte meiosis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04270	Vascular smooth muscle contraction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04626	Plant-pathogen interaction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04720	Long-term potentiation	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04722	Neurotrophin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04740	Olfactory transduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04744	Phototransduction	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04745	Phototransduction - fly	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04910	Insulin signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04912	GnRH signaling pathway	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04916	Melanogenesis	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04970	Salivary secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko04971	Gastric acid secretion	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko05010	Alzheimer's disease	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012770	K02183	ko05214	Glioma	433	4.8e-18	0.43	0.57	0.85
PGSC0003DMG200012772	K01955	ko00240	Pyrimidine metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMG200012772	K01955	ko00250	Alanine, aspartate and glutamate metabolism	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMG200012772	K01955	ko01100	Metabolic pathways	418	2.8e-16	0.55	0.67	0.64
PGSC0003DMG200012776	K00908	ko01100	Metabolic pathways	338	1.2e-12	0.30	0.48	0.88
PGSC0003DMG200000839	K13230	ko00402	Benzoxazinoid biosynthesis	629	7.4e-29	0.33	0.49	0.46
PGSC0003DMG200000849	K02184	ko04320	Dorso-ventral axis formation	699	3.0e-32	0.33	0.51	0.88
PGSC0003DMG200000850	K13230	ko00402	Benzoxazinoid biosynthesis	892	2.3e-43	0.37	0.56	0.97
PGSC0003DMG200000851	K13230	ko00402	Benzoxazinoid biosynthesis	419	2.8e-17	0.41	0.68	0.99
PGSC0003DMG200026392	K01809	ko00051	Fructose and mannose metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMG200026392	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMG200026392	K01809	ko01100	Metabolic pathways	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMG200026392	K01809	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.65	0.80	1.00
PGSC0003DMG200026397	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMG200026397	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMG200026397	K12478	ko04144	Endocytosis	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMG200026397	K12478	ko04145	Phagosome	414	2.4e-14	0.25	0.47	0.91
PGSC0003DMG200026398	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMG200026400	K00227	ko00100	Steroid biosynthesis	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMG200026400	K00227	ko01100	Metabolic pathways	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMG200026400	K00227	ko01110	Biosynthesis of secondary metabolites	994	5.5e-49	0.66	0.80	0.22
PGSC0003DMG200026400	K00227	ko00100	Steroid biosynthesis	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMG200026400	K00227	ko01100	Metabolic pathways	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMG200026400	K00227	ko01110	Biosynthesis of secondary metabolites	1714	1.1e-88	0.70	0.84	0.98
PGSC0003DMG200026401	K00227	ko00100	Steroid biosynthesis	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMG200026401	K00227	ko01100	Metabolic pathways	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMG200026401	K00227	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.78	0.87	0.98
PGSC0003DMG200026402	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMG200026402	K08139	ko04113	Meiosis - yeast	1030	5.6e-51	0.38	0.61	0.78
PGSC0003DMG200036851	K05765	ko04360	Axon guidance	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMG200036851	K05765	ko04666	Fc gamma R-mediated phagocytosis	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMG200036851	K05765	ko04810	Regulation of actin cytoskeleton	1048	5.7e-52	0.92	0.97	0.96
PGSC0003DMG200036874	K04728	ko04110	Cell cycle	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMG200036874	K04728	ko04115	p53 signaling pathway	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMG200036874	K04728	ko04210	Apoptosis	362	4.4e-10	0.26	0.40	0.89
PGSC0003DMG200029521	K12478	ko04144	Endocytosis	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMG200029521	K12478	ko04145	Phagosome	334	6.8e-09	0.25	0.45	0.81
PGSC0003DMG200029542	K02489	ko02020	Two-component system	966	1.9e-47	0.31	0.46	0.67
PGSC0003DMG200029545	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029545	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029545	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029545	K01698	ko00860	Porphyrin and chlorophyll metabolism	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029545	K01698	ko01100	Metabolic pathways	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029545	K01698	ko01110	Biosynthesis of secondary metabolites	3104	2.3e-165	0.85	0.90	1.00
PGSC0003DMG200029546	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMG200029546	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMG200029546	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMG200029546	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMG200029546	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.58	0.76	1.00
PGSC0003DMG200029547	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko01100	Metabolic pathways	392	8.7e-16	0.32	0.51	0.57
PGSC0003DMG200029547	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMG200029547	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMG200029547	K00734	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.46	0.77
PGSC0003DMG200029548	K04420	ko04010	MAPK signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMG200029548	K04420	ko04540	Gap junction	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMG200029548	K04420	ko04912	GnRH signaling pathway	549	1.9e-24	0.39	0.56	0.85
PGSC0003DMG200029549	K07195	ko04910	Insulin signaling pathway	3835	1.1e-205	0.69	0.83	1.00
PGSC0003DMG200029550	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4432	1.3e-238	0.78	0.87	0.99
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200019527	K12042	ko04020	Calcium signaling pathway	227	1.1e-06	0.46	0.67	0.32
PGSC0003DMG200019537	K00799	ko00480	Glutathione metabolism	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMG200019537	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMG200019537	K00799	ko00982	Drug metabolism - cytochrome P450	647	7.5e-30	0.41	0.63	0.95
PGSC0003DMG200019538	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	287	5.4e-10	0.64	0.72	0.27
PGSC0003DMG200019539	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	227	1.1e-06	0.50	0.56	0.53
PGSC0003DMG200019542	K04422	ko04010	MAPK signaling pathway	292	2.9e-10	0.38	0.65	0.80
PGSC0003DMG200019546	K04043	ko03018	RNA degradation	703	6.1e-33	0.81	0.91	0.88
PGSC0003DMG200000183	K08008	ko04145	Phagosome	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	454	3.3e-19	0.30	0.48	0.45
PGSC0003DMG200000183	K08008	ko04145	Phagosome	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	463	1.3e-19	0.28	0.43	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	467	7.2e-20	0.28	0.43	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	464	1.1e-19	0.27	0.44	0.51
PGSC0003DMG200000183	K08008	ko04145	Phagosome	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000183	K08008	ko04670	Leukocyte transendothelial migration	477	1.8e-20	0.29	0.43	0.51
PGSC0003DMG200000184	K08008	ko04145	Phagosome	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMG200000184	K08008	ko04670	Leukocyte transendothelial migration	466	3.2e-23	0.31	0.49	0.43
PGSC0003DMG200000184	K08008	ko04145	Phagosome	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMG200000184	K08008	ko04670	Leukocyte transendothelial migration	466	7.2e-20	0.32	0.50	0.32
PGSC0003DMG200000184	K08008	ko04145	Phagosome	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMG200000184	K08008	ko04670	Leukocyte transendothelial migration	466	4.9e-23	0.31	0.49	0.39
PGSC0003DMG200000185	K04733	ko04210	Apoptosis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMG200000185	K04733	ko04620	Toll-like receptor signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMG200000185	K04733	ko04722	Neurotrophin signaling pathway	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMG200000185	K04733	ko05140	Leishmaniasis	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMG200000185	K04733	ko05142	Chagas disease	759	5.0e-36	0.32	0.51	0.92
PGSC0003DMG200000186	K01213	ko00040	Pentose and glucuronate interconversions	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMG200000186	K01213	ko00500	Starch and sucrose metabolism	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMG200000186	K01213	ko01100	Metabolic pathways	868	4.9e-42	0.35	0.54	0.78
PGSC0003DMG200000189	K12134	ko04712	Circadian rhythm - plant	474	2.6e-20	0.53	0.70	0.30
PGSC0003DMG200000190	K04496	ko04310	Wnt signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMG200000190	K04496	ko04330	Notch signaling pathway	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMG200000190	K04496	ko05200	Pathways in cancer	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMG200000190	K04496	ko05220	Chronic myeloid leukemia	522	5.9e-23	0.34	0.53	0.48
PGSC0003DMG200000193	K01762	ko00270	Cysteine and methionine metabolism	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMG200000193	K01762	ko01110	Biosynthesis of secondary metabolites	2729	1.1e-144	0.67	0.81	0.98
PGSC0003DMG200016553	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMG200016553	K00891	ko01100	Metabolic pathways	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMG200016553	K00891	ko01110	Biosynthesis of secondary metabolites	1361	3.1e-69	0.59	0.76	0.95
PGSC0003DMG200016553	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko01100	Metabolic pathways	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko01110	Biosynthesis of secondary metabolites	1403	1.5e-71	0.60	0.77	0.97
PGSC0003DMG200016553	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMG200016553	K00891	ko01100	Metabolic pathways	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMG200016553	K00891	ko01110	Biosynthesis of secondary metabolites	1152	1.1e-57	0.60	0.76	0.89
PGSC0003DMG200016571	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMG200016571	K00517	ko00626	Naphthalene and anthracene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMG200016571	K00517	ko00903	Limonene and pinene degradation	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMG200016571	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMG200016571	K00517	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.63	0.75	0.99
PGSC0003DMG200008991	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMG200008991	K10686	ko04120	Ubiquitin mediated proteolysis	3287	1.8e-175	0.85	0.92	1.00
PGSC0003DMG200008991	K10686	ko04120	Ubiquitin mediated proteolysis	659	1.6e-30	0.80	0.89	0.89
PGSC0003DMG200008995	K05592	ko03018	RNA degradation	440	2.0e-18	0.31	0.50	0.94
PGSC0003DMG200008995	K05592	ko03018	RNA degradation	448	7.1e-19	0.36	0.55	0.76
PGSC0003DMG200002205	K01369	ko04142	Lysosome	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMG200002205	K01369	ko04612	Antigen processing and presentation	1623	1.1e-83	0.51	0.64	0.88
PGSC0003DMG200002206	K01369	ko04142	Lysosome	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMG200002206	K01369	ko04612	Antigen processing and presentation	2087	2.8e-109	0.61	0.75	0.96
PGSC0003DMG200002207	K01369	ko04142	Lysosome	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMG200002207	K01369	ko04612	Antigen processing and presentation	2187	8.6e-115	0.63	0.78	0.70
PGSC0003DMG200002209	K02140	ko00190	Oxidative phosphorylation	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMG200002209	K02140	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.98
PGSC0003DMG200002212	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1890	2.1e-98	0.44	0.63	0.82
PGSC0003DMG200002213	K00128	ko00010	Glycolysis / Gluconeogenesis	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00053	Ascorbate and aldarate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00071	Fatty acid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00280	Valine, leucine and isoleucine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00310	Lysine degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00330	Arginine and proline metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00340	Histidine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00380	Tryptophan metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00410	beta-Alanine metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00561	Glycerolipid metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00620	Pyruvate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00631	1,2-Dichloroethane degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00640	Propanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00641	3-Chloroacrylic acid degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00650	Butanoate metabolism	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko00903	Limonene and pinene degradation	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko01100	Metabolic pathways	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002213	K00128	ko01110	Biosynthesis of secondary metabolites	284	1.4e-09	0.55	0.73	0.47
PGSC0003DMG200002217	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko04115	p53 signaling pathway	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko04210	Apoptosis	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05010	Alzheimer's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05012	Parkinson's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05016	Huntington's disease	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002217	K02084	ko05222	Small cell lung cancer	307	3.4e-07	0.27	0.45	0.42
PGSC0003DMG200002219	K01184	ko00040	Pentose and glucuronate interconversions	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMG200002219	K01184	ko00500	Starch and sucrose metabolism	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMG200002219	K01184	ko01100	Metabolic pathways	670	4.0e-31	0.56	0.73	0.99
PGSC0003DMG200002221	K11294	ko05130	Pathogenic Escherichia coli infection	242	5.2e-07	0.30	0.50	0.55
PGSC0003DMG200002225	K04416	ko04010	MAPK signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMG200002225	K04416	ko04120	Ubiquitin mediated proteolysis	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMG200002225	K04416	ko04622	RIG-I-like receptor signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMG200002225	K04416	ko04722	Neurotrophin signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMG200002225	K04416	ko04912	GnRH signaling pathway	276	1.9e-08	0.28	0.44	0.89
PGSC0003DMG200002226	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMG200012123	K01509	ko00230	Purine metabolism	1073	2.4e-53	0.45	0.61	0.91
PGSC0003DMG200012124	K12667	ko00510	N-Glycan biosynthesis	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMG200012124	K12667	ko01100	Metabolic pathways	312	1.1e-10	0.41	0.57	0.86
PGSC0003DMG200012124	K12667	ko00510	N-Glycan biosynthesis	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMG200012124	K12667	ko01100	Metabolic pathways	394	2.6e-15	0.40	0.57	0.85
PGSC0003DMG200012127	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMG200012127	K03857	ko01100	Metabolic pathways	2601	1.3e-137	0.75	0.82	0.81
PGSC0003DMG200012127	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMG200012127	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMG200012127	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMG200012127	K03857	ko01100	Metabolic pathways	2449	3.1e-129	0.91	0.97	1.00
PGSC0003DMG200012127	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMG200012127	K03857	ko01100	Metabolic pathways	716	1.2e-33	0.67	0.80	0.99
PGSC0003DMG200012128	K01950	ko00760	Nicotinate and nicotinamide metabolism	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMG200012128	K01950	ko01100	Metabolic pathways	488	4.5e-21	0.86	0.95	0.97
PGSC0003DMG200012128	K01950	ko00760	Nicotinate and nicotinamide metabolism	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMG200012128	K01950	ko01100	Metabolic pathways	5472	5.6e-296	0.86	0.93	1.00
PGSC0003DMG200012128	K01950	ko00760	Nicotinate and nicotinamide metabolism	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMG200012128	K01950	ko01100	Metabolic pathways	5030	1.3e-271	0.88	0.94	0.98
PGSC0003DMG200012128	K01950	ko00760	Nicotinate and nicotinamide metabolism	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMG200012128	K01950	ko01100	Metabolic pathways	3975	2.1e-213	0.87	0.93	0.99
PGSC0003DMG200012128	K01950	ko00760	Nicotinate and nicotinamide metabolism	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMG200012128	K01950	ko01100	Metabolic pathways	460	1.5e-19	0.74	0.89	0.91
PGSC0003DMG200012129	K01177	ko00500	Starch and sucrose metabolism	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMG200012129	K01177	ko01100	Metabolic pathways	1000	2.5e-49	0.49	0.63	0.89
PGSC0003DMG200012129	K01177	ko00500	Starch and sucrose metabolism	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMG200012129	K01177	ko01100	Metabolic pathways	1788	8.8e-93	0.47	0.62	0.92
PGSC0003DMG200012133	K03105	ko03060	Protein export	927	2.7e-45	0.80	0.89	0.99
PGSC0003DMG200027069	K02350	ko01100	Metabolic pathways	359	2.2e-10	0.26	0.44	0.65
PGSC0003DMG200027070	K01728	ko00040	Pentose and glucuronate interconversions	2578	2.3e-136	0.74	0.85	0.98
PGSC0003DMG200027078	K01955	ko00240	Pyrimidine metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMG200027078	K01955	ko00250	Alanine, aspartate and glutamate metabolism	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMG200027078	K01955	ko01100	Metabolic pathways	522	4.3e-22	0.56	0.75	0.59
PGSC0003DMG200035665	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMG200035665	K00517	ko00626	Naphthalene and anthracene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMG200035665	K00517	ko00903	Limonene and pinene degradation	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMG200035665	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMG200035665	K00517	ko01110	Biosynthesis of secondary metabolites	1178	3.9e-59	0.48	0.70	0.98
PGSC0003DMG200020229	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMG200020229	K05294	ko01100	Metabolic pathways	724	7.5e-34	0.35	0.54	0.29
PGSC0003DMG200020229	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMG200020229	K05294	ko01100	Metabolic pathways	724	7.9e-34	0.35	0.54	0.29
PGSC0003DMG200020229	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMG200020229	K05294	ko01100	Metabolic pathways	430	7.6e-17	0.37	0.56	0.18
PGSC0003DMG200020230	K10652	ko04622	RIG-I-like receptor signaling pathway	280	1.0e-07	0.39	0.53	0.31
PGSC0003DMG200020231	K01895	ko00010	Glycolysis / Gluconeogenesis	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko00620	Pyruvate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko00640	Propanoate metabolism	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko01100	Metabolic pathways	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko01110	Biosynthesis of secondary metabolites	3632	1.7e-194	0.64	0.70	0.87
PGSC0003DMG200020231	K01895	ko00010	Glycolysis / Gluconeogenesis	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020231	K01895	ko00620	Pyruvate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020231	K01895	ko00640	Propanoate metabolism	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020231	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020231	K01895	ko01100	Metabolic pathways	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020231	K01895	ko01110	Biosynthesis of secondary metabolites	5356	1.4e-289	0.85	0.93	0.90
PGSC0003DMG200020233	K03723	ko03420	Nucleotide excision repair	1273	2.2e-64	0.42	0.60	0.97
PGSC0003DMG200020233	K03723	ko03420	Nucleotide excision repair	2362	1.9e-124	0.45	0.66	0.85
PGSC0003DMG200030239	K06685	ko04111	Cell cycle - yeast	342	1.0e-09	0.27	0.43	0.93
PGSC0003DMG200045371	K04508	ko04310	Wnt signaling pathway	298	4.4e-08	0.53	0.64	0.14
PGSC0003DMG200045386	K00850	ko00010	Glycolysis / Gluconeogenesis	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200045386	K00850	ko00030	Pentose phosphate pathway	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200045386	K00850	ko00051	Fructose and mannose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200045386	K00850	ko00052	Galactose metabolism	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200045386	K00850	ko01100	Metabolic pathways	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200045386	K00850	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.66	0.75	0.96
PGSC0003DMG200013831	K01369	ko04142	Lysosome	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMG200013831	K01369	ko04612	Antigen processing and presentation	1924	2.8e-100	0.55	0.69	0.91
PGSC0003DMG200013835	K12471	ko04144	Endocytosis	627	9.5e-29	0.31	0.47	0.81
PGSC0003DMG200013845	K05853	ko04020	Calcium signaling pathway	6444	0.	0.81	0.88	0.92
PGSC0003DMG200013845	K05853	ko05010	Alzheimer's disease	6444	0.	0.81	0.88	0.92
PGSC0003DMG200013849	K02132	ko00190	Oxidative phosphorylation	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMG200013849	K02132	ko01100	Metabolic pathways	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMG200013849	K02132	ko05010	Alzheimer's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMG200013849	K02132	ko05012	Parkinson's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMG200013849	K02132	ko05016	Huntington's disease	699	1.0e-32	1.00	1.00	0.97
PGSC0003DMG200013855	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMG200013855	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.92
PGSC0003DMG200013855	K00423	ko00053	Ascorbate and aldarate metabolism	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMG200013855	K00423	ko01100	Metabolic pathways	509	3.1e-22	0.46	0.70	0.73
PGSC0003DMG200013855	K00423	ko00053	Ascorbate and aldarate metabolism	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMG200013855	K00423	ko01100	Metabolic pathways	2057	1.3e-107	0.48	0.66	0.89
PGSC0003DMG200011264	K00228	ko00860	Porphyrin and chlorophyll metabolism	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMG200011264	K00228	ko01100	Metabolic pathways	2648	3.2e-140	0.86	0.91	0.99
PGSC0003DMG200011266	K13066	ko00940	Phenylpropanoid biosynthesis	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMG200011266	K13066	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.59	0.73	1.00
PGSC0003DMG200011279	K12742	ko00900	Terpenoid backbone biosynthesis	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMG200011279	K12742	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.36	0.54	0.94
PGSC0003DMG200006672	K00695	ko00500	Starch and sucrose metabolism	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMG200006672	K00695	ko01100	Metabolic pathways	5561	7.0e-301	0.78	0.90	1.00
PGSC0003DMG200006672	K00695	ko00500	Starch and sucrose metabolism	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMG200006672	K00695	ko01100	Metabolic pathways	2581	1.6e-136	0.75	0.89	0.90
PGSC0003DMG200006672	K00695	ko00500	Starch and sucrose metabolism	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMG200006672	K00695	ko01100	Metabolic pathways	537	1.0e-23	0.86	0.94	0.88
PGSC0003DMG200006672	K00695	ko00500	Starch and sucrose metabolism	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMG200006672	K00695	ko01100	Metabolic pathways	245	6.0e-07	0.85	0.94	0.61
PGSC0003DMG200006672	K00695	ko00500	Starch and sucrose metabolism	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMG200006672	K00695	ko01100	Metabolic pathways	565	2.5e-25	0.85	0.93	0.80
PGSC0003DMG200006677	K01066	ko00623	2,4-Dichlorobenzoate degradation	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMG200006677	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	282	1.0e-09	0.26	0.47	0.85
PGSC0003DMG200006678	K00813	ko00250	Alanine, aspartate and glutamate metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00270	Cysteine and methionine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00330	Arginine and proline metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00350	Tyrosine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00360	Phenylalanine metabolism	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00401	Novobiocin biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00710	Carbon fixation in photosynthetic organisms	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00950	Isoquinoline alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko01100	Metabolic pathways	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko01110	Biosynthesis of secondary metabolites	673	2.8e-31	0.55	0.73	0.87
PGSC0003DMG200006678	K00813	ko00250	Alanine, aspartate and glutamate metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00270	Cysteine and methionine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00330	Arginine and proline metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00350	Tyrosine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00360	Phenylalanine metabolism	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00401	Novobiocin biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00710	Carbon fixation in photosynthetic organisms	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00950	Isoquinoline alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko01100	Metabolic pathways	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.66	0.84	0.85
PGSC0003DMG200006678	K00813	ko00250	Alanine, aspartate and glutamate metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00270	Cysteine and methionine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00330	Arginine and proline metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00350	Tyrosine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00360	Phenylalanine metabolism	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00401	Novobiocin biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00710	Carbon fixation in photosynthetic organisms	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00950	Isoquinoline alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko01100	Metabolic pathways	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko01110	Biosynthesis of secondary metabolites	2255	1.5e-118	0.64	0.81	0.95
PGSC0003DMG200006678	K00813	ko00250	Alanine, aspartate and glutamate metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00270	Cysteine and methionine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00330	Arginine and proline metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00350	Tyrosine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00360	Phenylalanine metabolism	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00401	Novobiocin biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00710	Carbon fixation in photosynthetic organisms	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00950	Isoquinoline alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko01100	Metabolic pathways	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006678	K00813	ko01110	Biosynthesis of secondary metabolites	352	1.4e-13	0.66	0.80	0.58
PGSC0003DMG200006679	K00430	ko00360	Phenylalanine metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMG200006679	K00430	ko00680	Methane metabolism	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMG200006679	K00430	ko00940	Phenylpropanoid biosynthesis	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMG200006679	K00430	ko01100	Metabolic pathways	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMG200006679	K00430	ko01110	Biosynthesis of secondary metabolites	895	1.6e-43	0.44	0.56	0.95
PGSC0003DMG200006680	K00430	ko00360	Phenylalanine metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMG200006680	K00430	ko00680	Methane metabolism	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMG200006680	K00430	ko00940	Phenylpropanoid biosynthesis	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMG200006680	K00430	ko01100	Metabolic pathways	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMG200006680	K00430	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.61	0.72	0.73
PGSC0003DMG200006681	K00430	ko00360	Phenylalanine metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMG200006681	K00430	ko00680	Methane metabolism	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMG200006681	K00430	ko00940	Phenylpropanoid biosynthesis	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMG200006681	K00430	ko01100	Metabolic pathways	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMG200006681	K00430	ko01110	Biosynthesis of secondary metabolites	679	1.3e-31	0.58	0.74	0.93
PGSC0003DMG200006683	K04567	ko00970	Aminoacyl-tRNA biosynthesis	602	2.3e-27	0.60	0.68	0.48
PGSC0003DMG200032557	K02735	ko03050	Proteasome	1599	2.3e-82	0.92	0.97	1.00
PGSC0003DMG200032562	K01358	ko04112	Cell cycle - Caulobacter	1672	2.2e-86	0.83	0.91	1.00
PGSC0003DMG200032570	K02864	ko03010	Ribosome	1290	2.6e-65	0.68	0.79	0.99
PGSC0003DMG200032584	K02084	ko04115	p53 signaling pathway	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko04210	Apoptosis	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko05010	Alzheimer's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko05012	Parkinson's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko05016	Huntington's disease	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200032584	K02084	ko05222	Small cell lung cancer	281	1.1e-08	0.27	0.48	0.84
PGSC0003DMG200028066	K04427	ko04010	MAPK signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04310	Wnt signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04520	Adherens junction	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04620	Toll-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04621	NOD-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04622	RIG-I-like receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04660	T cell receptor signaling pathway	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko05140	Leishmaniasis	516	1.3e-22	0.40	0.58	0.81
PGSC0003DMG200028066	K04427	ko04010	MAPK signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04310	Wnt signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04520	Adherens junction	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04620	Toll-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04621	NOD-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04622	RIG-I-like receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04660	T cell receptor signaling pathway	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko05140	Leishmaniasis	623	1.6e-28	0.36	0.54	0.80
PGSC0003DMG200028066	K04427	ko04010	MAPK signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04310	Wnt signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04520	Adherens junction	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04620	Toll-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04621	NOD-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04622	RIG-I-like receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko04660	T cell receptor signaling pathway	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028066	K04427	ko05140	Leishmaniasis	452	4.3e-19	0.41	0.56	0.83
PGSC0003DMG200028069	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMG200028069	K12449	ko01100	Metabolic pathways	2997	1.8e-159	0.89	0.95	0.99
PGSC0003DMG200028071	K11254	ko05322	Systemic lupus erythematosus	390	1.1e-15	0.55	0.58	0.99
PGSC0003DMG200028079	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	612	6.4e-28	0.34	0.50	0.95
PGSC0003DMG200028079	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	544	3.6e-24	0.33	0.49	0.94
PGSC0003DMG200028079	K00884	ko00520	Amino sugar and nucleotide sugar metabolism	530	2.1e-23	0.37	0.53	0.85
PGSC0003DMG200017184	K13229	ko00402	Benzoxazinoid biosynthesis	820	2.2e-39	0.46	0.65	0.99
PGSC0003DMG200017184	K13229	ko00402	Benzoxazinoid biosynthesis	576	6.2e-26	0.49	0.66	0.95
PGSC0003DMG200017185	K13229	ko00402	Benzoxazinoid biosynthesis	459	1.8e-19	0.45	0.63	0.99
PGSC0003DMG200017188	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMG200017188	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMG200017188	K13229	ko00402	Benzoxazinoid biosynthesis	997	3.7e-49	0.47	0.67	0.97
PGSC0003DMG200017188	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMG200017188	K13229	ko00402	Benzoxazinoid biosynthesis	497	1.4e-21	0.48	0.65	0.99
PGSC0003DMG200017189	K13229	ko00402	Benzoxazinoid biosynthesis	834	3.6e-40	0.48	0.65	0.85
PGSC0003DMG200017189	K13229	ko00402	Benzoxazinoid biosynthesis	439	2.2e-18	0.51	0.69	0.91
PGSC0003DMG200017189	K13229	ko00402	Benzoxazinoid biosynthesis	876	1.8e-42	0.47	0.64	1.00
PGSC0003DMG200017189	K13229	ko00402	Benzoxazinoid biosynthesis	621	2.0e-28	0.49	0.68	0.94
PGSC0003DMG200017190	K13229	ko00402	Benzoxazinoid biosynthesis	267	6.8e-09	0.35	0.58	0.90
PGSC0003DMG200017191	K12356	ko00940	Phenylpropanoid biosynthesis	640	1.8e-29	0.34	0.51	0.97
PGSC0003DMG200017191	K12356	ko00940	Phenylpropanoid biosynthesis	730	2.0e-34	0.34	0.50	0.98
PGSC0003DMG200021238	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMG200021238	K05290	ko01100	Metabolic pathways	1436	2.3e-73	0.61	0.75	0.89
PGSC0003DMG200021239	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMG200021239	K02433	ko01100	Metabolic pathways	2295	9.5e-121	0.75	0.85	0.70
PGSC0003DMG200021239	K02433	ko00970	Aminoacyl-tRNA biosynthesis	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMG200021239	K02433	ko01100	Metabolic pathways	942	4.0e-46	0.83	0.90	0.40
PGSC0003DMG200021239	K02433	ko00970	Aminoacyl-tRNA biosynthesis	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMG200021239	K02433	ko01100	Metabolic pathways	2280	6.4e-120	0.83	0.90	1.00
PGSC0003DMG200021239	K02433	ko00970	Aminoacyl-tRNA biosynthesis	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMG200021239	K02433	ko01100	Metabolic pathways	3408	3.9e-182	0.77	0.86	1.00
PGSC0003DMG200021245	K10595	ko04120	Ubiquitin mediated proteolysis	472	1.5e-18	0.31	0.47	0.97
PGSC0003DMG200021245	K10615	ko04120	Ubiquitin mediated proteolysis	366	1.5e-13	0.31	0.47	0.98
PGSC0003DMG200021247	K00799	ko00480	Glutathione metabolism	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMG200021247	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMG200021247	K00799	ko00982	Drug metabolism - cytochrome P450	1010	7.2e-50	0.56	0.75	0.96
PGSC0003DMG200024264	K12845	ko03040	Spliceosome	995	4.8e-49	0.94	0.97	0.99
PGSC0003DMG200024265	K06700	ko03050	Proteasome	1359	4.0e-69	0.57	0.65	1.00
PGSC0003DMG200024265	K06700	ko03050	Proteasome	1396	3.7e-71	0.60	0.68	1.00
PGSC0003DMG200024265	K06700	ko03050	Proteasome	1406	1.0e-71	0.60	0.69	1.00
PGSC0003DMG200024266	K05863	ko04020	Calcium signaling pathway	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMG200024266	K05863	ko05012	Parkinson's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMG200024266	K05863	ko05016	Huntington's disease	414	5.3e-17	0.38	0.57	0.69
PGSC0003DMG200024271	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMG200024271	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMG200024271	K00771	ko01100	Metabolic pathways	261	8.5e-08	0.34	0.53	0.76
PGSC0003DMG200024271	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMG200024271	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMG200024271	K00771	ko01100	Metabolic pathways	435	1.2e-17	0.30	0.48	0.84
PGSC0003DMG200024273	K02084	ko04115	p53 signaling pathway	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko04210	Apoptosis	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko05010	Alzheimer's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko05012	Parkinson's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko05016	Huntington's disease	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024273	K02084	ko05222	Small cell lung cancer	265	2.4e-06	0.29	0.46	0.80
PGSC0003DMG200024274	K04123	ko00904	Diterpenoid biosynthesis	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMG200024274	K04123	ko01100	Metabolic pathways	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMG200024274	K04123	ko01110	Biosynthesis of secondary metabolites	1398	2.8e-71	0.40	0.60	0.97
PGSC0003DMG200013468	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMG200013468	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMG200013468	K04424	ko04010	MAPK signaling pathway	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMG200013468	K04424	ko04530	Tight junction	396	2.1e-15	0.39	0.61	0.49
PGSC0003DMG200013468	K04424	ko04010	MAPK signaling pathway	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMG200013468	K04424	ko04530	Tight junction	633	2.3e-28	0.35	0.52	0.71
PGSC0003DMG200013477	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMG200013477	K00517	ko00626	Naphthalene and anthracene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMG200013477	K00517	ko00903	Limonene and pinene degradation	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMG200013477	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMG200013477	K00517	ko01110	Biosynthesis of secondary metabolites	693	2.2e-32	0.50	0.68	0.85
PGSC0003DMG200013479	K01875	ko00970	Aminoacyl-tRNA biosynthesis	509	3.1e-22	0.80	0.93	0.34
PGSC0003DMG200013480	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.82	0.91	1.00
PGSC0003DMG200013483	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.76
PGSC0003DMG200013483	K04725	ko04120	Ubiquitin mediated proteolysis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013483	K04725	ko04210	Apoptosis	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013483	K04725	ko04510	Focal adhesion	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013483	K04725	ko04621	NOD-like receptor signaling pathway	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013483	K04725	ko05200	Pathways in cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013483	K04725	ko05222	Small cell lung cancer	264	3.1e-08	0.29	0.47	0.91
PGSC0003DMG200013485	K01648	ko00020	Citrate cycle (TCA cycle)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMG200013485	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMG200013485	K01648	ko01100	Metabolic pathways	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMG200013485	K01648	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.91	0.96	1.00
PGSC0003DMG200004510	K09561	ko04120	Ubiquitin mediated proteolysis	246	9.8e-08	0.36	0.51	0.37
PGSC0003DMG200004514	K00737	ko00510	N-Glycan biosynthesis	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMG200004514	K00737	ko01100	Metabolic pathways	401	2.8e-16	0.30	0.47	0.95
PGSC0003DMG200004514	K00737	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMG200004514	K00737	ko01100	Metabolic pathways	404	1.9e-16	0.30	0.47	0.75
PGSC0003DMG200004526	K12356	ko00940	Phenylpropanoid biosynthesis	682	8.8e-32	0.32	0.49	0.97
PGSC0003DMG200004527	K11866	ko04144	Endocytosis	544	1.4e-23	0.29	0.45	0.91
PGSC0003DMG200004532	K02639	ko00195	Photosynthesis	802	2.1e-38	0.66	0.83	0.99
PGSC0003DMG200004533	K01115	ko00564	Glycerophospholipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200004533	K01115	ko00565	Ether lipid metabolism	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200004533	K01115	ko01100	Metabolic pathways	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200004533	K01115	ko04144	Endocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200004533	K01115	ko04666	Fc gamma R-mediated phagocytosis	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200004533	K01115	ko04912	GnRH signaling pathway	3874	7.8e-208	0.58	0.72	0.95
PGSC0003DMG200007435	K00111	ko00564	Glycerophospholipid metabolism	4432	1.3e-238	0.86	0.93	0.52
PGSC0003DMG200007435	K08332	ko04140	Regulation of autophagy	328	2.5e-10	0.29	0.50	0.59
PGSC0003DMG200007435	K08332	ko04140	Regulation of autophagy	328	9.4e-10	0.29	0.50	0.46
PGSC0003DMG200007436	K03094	ko04110	Cell cycle	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04111	Cell cycle - yeast	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04114	Oocyte meiosis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04120	Ubiquitin mediated proteolysis	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04310	Wnt signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04350	TGF-beta signaling pathway	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200007436	K03094	ko04710	Circadian rhythm - mammal	529	2.4e-23	0.45	0.65	0.77
PGSC0003DMG200001549	K01177	ko00500	Starch and sucrose metabolism	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMG200001549	K01177	ko01100	Metabolic pathways	2479	6.8e-131	0.65	0.79	0.76
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	351	1.6e-13	0.79	0.90	0.96
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.85	0.94	0.97
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.75	0.81	0.99
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko00660	C5-Branched dibasic acid metabolism	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01100	Metabolic pathways	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001552	K01703	ko01110	Biosynthesis of secondary metabolites	1374	6.0e-70	0.88	0.93	0.95
PGSC0003DMG200001555	K02434	ko00970	Aminoacyl-tRNA biosynthesis	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMG200001555	K02434	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.83	0.93
PGSC0003DMG200001555	K02434	ko00970	Aminoacyl-tRNA biosynthesis	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMG200001555	K02434	ko01100	Metabolic pathways	2318	5.1e-122	0.88	0.93	1.00
PGSC0003DMG200027143	K00382	ko00010	Glycolysis / Gluconeogenesis	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko00020	Citrate cycle (TCA cycle)	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko00260	Glycine, serine and threonine metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko00280	Valine, leucine and isoleucine degradation	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko00620	Pyruvate metabolism	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko01100	Metabolic pathways	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko01110	Biosynthesis of secondary metabolites	1391	6.9e-71	0.73	0.82	0.85
PGSC0003DMG200027143	K00382	ko00010	Glycolysis / Gluconeogenesis	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko00020	Citrate cycle (TCA cycle)	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko00260	Glycine, serine and threonine metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko00280	Valine, leucine and isoleucine degradation	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko00620	Pyruvate metabolism	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko01100	Metabolic pathways	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko01110	Biosynthesis of secondary metabolites	3921	2.0e-210	0.84	0.90	1.00
PGSC0003DMG200027143	K00382	ko00010	Glycolysis / Gluconeogenesis	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko00020	Citrate cycle (TCA cycle)	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko00260	Glycine, serine and threonine metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko00280	Valine, leucine and isoleucine degradation	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko00620	Pyruvate metabolism	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko01100	Metabolic pathways	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko01110	Biosynthesis of secondary metabolites	2800	1.3e-148	0.81	0.88	0.98
PGSC0003DMG200027143	K00382	ko00010	Glycolysis / Gluconeogenesis	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko00020	Citrate cycle (TCA cycle)	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko00260	Glycine, serine and threonine metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko00280	Valine, leucine and isoleucine degradation	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko00620	Pyruvate metabolism	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko01100	Metabolic pathways	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027143	K00382	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.91	0.95	0.95
PGSC0003DMG200027146	K00660	ko00941	Flavonoid biosynthesis	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMG200027146	K00660	ko01100	Metabolic pathways	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMG200027146	K00660	ko01110	Biosynthesis of secondary metabolites	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMG200027146	K00660	ko04712	Circadian rhythm - plant	2302	3.9e-121	0.71	0.86	0.97
PGSC0003DMG200027154	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMG200027154	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMG200027154	K03877	ko01100	Metabolic pathways	307	9.8e-11	0.34	0.51	0.25
PGSC0003DMG200027154	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMG200027154	K07819	ko01100	Metabolic pathways	438	2.5e-18	0.31	0.49	0.43
PGSC0003DMG200023458	K10775	ko00360	Phenylalanine metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMG200023458	K10775	ko00910	Nitrogen metabolism	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMG200023458	K10775	ko00940	Phenylpropanoid biosynthesis	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMG200023458	K10775	ko01100	Metabolic pathways	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMG200023458	K10775	ko01110	Biosynthesis of secondary metabolites	4942	9.6e-267	0.84	0.91	1.00
PGSC0003DMG200023461	K08907	ko00196	Photosynthesis - antenna proteins	1812	4.2e-94	0.84	0.91	0.99
PGSC0003DMG200023464	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko00190	Oxidative phosphorylation	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko01100	Metabolic pathways	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko04145	Phagosome	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko04966	Collecting duct acid secretion	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko05110	Vibrio cholerae infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023464	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	677	1.7e-31	0.78	0.88	0.99
PGSC0003DMG200023465	K01054	ko00561	Glycerolipid metabolism	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMG200023465	K01054	ko01100	Metabolic pathways	268	6.0e-09	0.41	0.67	0.78
PGSC0003DMG200023465	K01054	ko00561	Glycerolipid metabolism	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMG200023465	K01054	ko01100	Metabolic pathways	472	3.4e-20	0.32	0.48	0.87
PGSC0003DMG200023468	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko00230	Purine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko00240	Pyrimidine metabolism	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko01100	Metabolic pathways	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko03020	RNA polymerase	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200023468	K03019	ko04623	Cytosolic DNA-sensing pathway	616	3.9e-28	0.58	0.76	0.99
PGSC0003DMG200018606	K00276	ko00260	Glycine, serine and threonine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko00350	Tyrosine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko00360	Phenylalanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko00410	beta-Alanine metabolism	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko01100	Metabolic pathways	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018606	K00276	ko01110	Biosynthesis of secondary metabolites	5714	0.	0.82	0.90	1.00
PGSC0003DMG200018609	K12393	ko04142	Lysosome	3390	3.8e-181	0.93	0.97	1.00
PGSC0003DMG200018611	K00737	ko00510	N-Glycan biosynthesis	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMG200018611	K00737	ko01100	Metabolic pathways	363	3.5e-14	0.30	0.46	0.70
PGSC0003DMG200020191	K11420	ko00310	Lysine degradation	603	2.0e-27	0.36	0.48	0.50
PGSC0003DMG200020191	K11420	ko00310	Lysine degradation	606	1.4e-27	0.36	0.48	0.43
PGSC0003DMG200020194	K01834	ko00010	Glycolysis / Gluconeogenesis	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMG200020194	K01834	ko01100	Metabolic pathways	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMG200020194	K01834	ko01110	Biosynthesis of secondary metabolites	202	1.1e-08	0.33	0.51	0.45
PGSC0003DMG200020200	K07195	ko04910	Insulin signaling pathway	2422	9.4e-128	0.47	0.64	0.97
PGSC0003DMG200009066	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMG200009066	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMG200009066	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.65
PGSC0003DMG200009066	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMG200009066	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMG200009066	K00734	ko01100	Metabolic pathways	366	2.4e-14	0.32	0.48	0.91
PGSC0003DMG200009066	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMG200009066	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMG200009066	K00734	ko01100	Metabolic pathways	335	1.2e-12	0.33	0.51	0.94
PGSC0003DMG200009069	K06689	ko04120	Ubiquitin mediated proteolysis	1306	3.4e-66	0.99	1.00	0.99
PGSC0003DMG200009076	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMG200009076	K05391	ko04626	Plant-pathogen interaction	4154	2.8e-223	0.83	0.91	1.00
PGSC0003DMG200009077	K00797	ko00270	Cysteine and methionine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMG200009077	K00797	ko00330	Arginine and proline metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMG200009077	K00797	ko00410	beta-Alanine metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMG200009077	K00797	ko00480	Glutathione metabolism	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMG200009077	K00797	ko01100	Metabolic pathways	2396	2.6e-126	0.81	0.90	0.97
PGSC0003DMG200009079	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMG200009079	K12827	ko03040	Spliceosome	3426	4.0e-183	0.78	0.88	1.00
PGSC0003DMG200009079	K12827	ko03040	Spliceosome	1846	5.6e-96	0.85	0.92	1.00
PGSC0003DMG200009081	K01051	ko00040	Pentose and glucuronate interconversions	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMG200009081	K01051	ko00500	Starch and sucrose metabolism	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMG200009081	K01051	ko01100	Metabolic pathways	1834	2.5e-95	0.45	0.61	0.95
PGSC0003DMG200005300	K01358	ko04112	Cell cycle - Caulobacter	689	3.6e-32	0.79	0.94	0.92
PGSC0003DMG200005300	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMG200005301	K04382	ko04111	Cell cycle - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04113	Meiosis - yeast	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04114	Oocyte meiosis	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04310	Wnt signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04350	TGF-beta signaling pathway	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04530	Tight junction	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04730	Long-term depression	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko05142	Chagas disease	2634	1.9e-139	0.96	0.99	1.00
PGSC0003DMG200005301	K04382	ko04111	Cell cycle - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04113	Meiosis - yeast	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04114	Oocyte meiosis	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04310	Wnt signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04350	TGF-beta signaling pathway	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04530	Tight junction	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04730	Long-term depression	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko05142	Chagas disease	707	3.7e-33	0.95	0.99	0.76
PGSC0003DMG200005301	K04382	ko04111	Cell cycle - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04113	Meiosis - yeast	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04114	Oocyte meiosis	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04310	Wnt signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04350	TGF-beta signaling pathway	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04530	Tight junction	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko04730	Long-term depression	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005301	K04382	ko05142	Chagas disease	530	2.1e-23	0.98	1.00	0.67
PGSC0003DMG200005310	K02707	ko00195	Photosynthesis	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMG200005310	K02707	ko01100	Metabolic pathways	708	3.2e-33	0.99	1.00	0.99
PGSC0003DMG200002148	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko01100	Metabolic pathways	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.71	0.81	0.98
PGSC0003DMG200002148	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002148	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002148	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002148	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002148	K08081	ko01100	Metabolic pathways	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002148	K08081	ko01110	Biosynthesis of secondary metabolites	1388	1.0e-70	0.62	0.70	0.97
PGSC0003DMG200002149	K12593	ko03018	RNA degradation	270	4.7e-09	0.42	0.60	0.97
PGSC0003DMG200002149	K12593	ko03018	RNA degradation	726	3.3e-34	0.57	0.67	0.97
PGSC0003DMG200002156	K07750	ko00100	Steroid biosynthesis	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMG200002156	K07750	ko01100	Metabolic pathways	1359	4.0e-69	0.85	0.93	0.99
PGSC0003DMG200002156	K07750	ko00100	Steroid biosynthesis	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMG200002156	K07750	ko01100	Metabolic pathways	1926	2.1e-100	0.79	0.89	1.00
PGSC0003DMG200002163	K00799	ko00480	Glutathione metabolism	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMG200002163	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMG200002163	K00799	ko00982	Drug metabolism - cytochrome P450	655	2.7e-30	0.44	0.64	0.99
PGSC0003DMG200002164	K00799	ko00480	Glutathione metabolism	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMG200002164	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMG200002164	K00799	ko00982	Drug metabolism - cytochrome P450	553	1.1e-24	0.65	0.82	0.95
PGSC0003DMG200002164	K00799	ko00480	Glutathione metabolism	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMG200002164	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMG200002164	K00799	ko00982	Drug metabolism - cytochrome P450	699	1.0e-32	0.47	0.64	0.90
PGSC0003DMG200002165	K00799	ko00480	Glutathione metabolism	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMG200002165	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMG200002165	K00799	ko00982	Drug metabolism - cytochrome P450	669	4.6e-31	0.46	0.62	0.88
PGSC0003DMG200002166	K00799	ko00480	Glutathione metabolism	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMG200002166	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMG200002166	K00799	ko00982	Drug metabolism - cytochrome P450	716	1.2e-33	0.46	0.65	0.92
PGSC0003DMG200015304	K05574	ko00190	Oxidative phosphorylation	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMG200015304	K05574	ko01100	Metabolic pathways	582	2.9e-26	0.96	0.99	0.99
PGSC0003DMG200015319	K10143	ko04115	p53 signaling pathway	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMG200015319	K10143	ko04120	Ubiquitin mediated proteolysis	4440	4.7e-239	0.65	0.75	1.00
PGSC0003DMG200015319	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMG200015319	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.94
PGSC0003DMG200041038	K00558	ko00270	Cysteine and methionine metabolism	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMG200041038	K00558	ko01100	Metabolic pathways	454	1.4e-18	0.39	0.55	0.62
PGSC0003DMG200022717	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04510	Focal adhesion	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04670	Leukocyte transendothelial migration	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04810	Regulation of actin cytoskeleton	310	1.6e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04510	Focal adhesion	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMG200022717	K05732	ko04670	Leukocyte transendothelial migration	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMG200022717	K05732	ko04810	Regulation of actin cytoskeleton	310	1.1e-07	0.28	0.50	0.23
PGSC0003DMG200022717	K05732	ko04510	Focal adhesion	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMG200022717	K05732	ko04670	Leukocyte transendothelial migration	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMG200022717	K05732	ko04810	Regulation of actin cytoskeleton	310	8.7e-08	0.28	0.50	0.26
PGSC0003DMG200022717	K05732	ko04510	Focal adhesion	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04670	Leukocyte transendothelial migration	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMG200022717	K05732	ko04810	Regulation of actin cytoskeleton	310	1.5e-07	0.28	0.50	0.20
PGSC0003DMG200022729	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022729	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022729	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022729	K00050	ko00260	Glycine, serine and threonine metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022729	K00050	ko00630	Glyoxylate and dicarboxylate metabolism	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022729	K00050	ko01100	Metabolic pathways	422	1.9e-17	0.43	0.66	0.94
PGSC0003DMG200022730	K00100	ko00051	Fructose and mannose metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022730	K00100	ko00363	Bisphenol A degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022730	K00100	ko00591	Linoleic acid metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022730	K00100	ko00625	Tetrachloroethene degradation	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022730	K00100	ko00650	Butanoate metabolism	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022730	K00100	ko01100	Metabolic pathways	872	2.9e-42	0.47	0.58	0.89
PGSC0003DMG200022734	K03364	ko04110	Cell cycle	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMG200022734	K03364	ko04111	Cell cycle - yeast	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMG200022734	K03364	ko04120	Ubiquitin mediated proteolysis	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMG200022734	K03364	ko04914	Progesterone-mediated oocyte maturation	3266	2.7e-174	0.81	0.88	0.99
PGSC0003DMG200022737	K01115	ko00564	Glycerophospholipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko00565	Ether lipid metabolism	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko01100	Metabolic pathways	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko04144	Endocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko04666	Fc gamma R-mediated phagocytosis	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko04912	GnRH signaling pathway	5300	1.7e-286	0.72	0.84	0.99
PGSC0003DMG200022737	K01115	ko00564	Glycerophospholipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K01115	ko00565	Ether lipid metabolism	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K01115	ko01100	Metabolic pathways	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K01115	ko04144	Endocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K01115	ko04666	Fc gamma R-mediated phagocytosis	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K01115	ko04912	GnRH signaling pathway	5315	2.6e-287	0.72	0.85	0.99
PGSC0003DMG200022737	K12451	ko00520	Amino sugar and nucleotide sugar metabolism	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMG200022737	K12451	ko00523	Polyketide sugar unit biosynthesis	2269	2.6e-119	0.88	0.95	0.98
PGSC0003DMG200026464	K10260	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.29	0.46	0.68
PGSC0003DMG200026470	K00852	ko00030	Pentose phosphate pathway	803	1.9e-38	0.37	0.55	0.67
PGSC0003DMG200026470	K00852	ko00030	Pentose phosphate pathway	382	3.1e-15	0.39	0.59	0.47
PGSC0003DMG200026471	K13056	ko04114	Oocyte meiosis	311	2.6e-11	0.29	0.44	0.58
PGSC0003DMG200026475	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6057	0.	0.73	0.83	0.98
PGSC0003DMG200026475	K01872	ko00970	Aminoacyl-tRNA biosynthesis	6484	0.	0.77	0.88	0.98
PGSC0003DMG200026475	K01872	ko00970	Aminoacyl-tRNA biosynthesis	382	1.7e-14	0.95	0.95	0.66
PGSC0003DMG200019471	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMG200019471	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMG200019471	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMG200019471	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMG200019471	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.64	0.86
PGSC0003DMG200019473	K00430	ko00360	Phenylalanine metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMG200019473	K00430	ko00680	Methane metabolism	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMG200019473	K00430	ko00940	Phenylpropanoid biosynthesis	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMG200019473	K00430	ko01100	Metabolic pathways	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMG200019473	K00430	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.40	0.56	0.96
PGSC0003DMG200019473	K00430	ko00360	Phenylalanine metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMG200019473	K00430	ko00680	Methane metabolism	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMG200019473	K00430	ko00940	Phenylpropanoid biosynthesis	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMG200019473	K00430	ko01100	Metabolic pathways	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMG200019473	K00430	ko01110	Biosynthesis of secondary metabolites	635	3.4e-29	0.50	0.64	0.90
PGSC0003DMG200019474	K00430	ko00360	Phenylalanine metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMG200019474	K00430	ko00680	Methane metabolism	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMG200019474	K00430	ko00940	Phenylpropanoid biosynthesis	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMG200019474	K00430	ko01100	Metabolic pathways	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMG200019474	K00430	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.52	0.72	0.74
PGSC0003DMG200019476	K05681	ko02010	ABC transporters	269	1.7e-08	0.33	0.51	0.69
PGSC0003DMG200034737	K04123	ko00904	Diterpenoid biosynthesis	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMG200034737	K04123	ko01100	Metabolic pathways	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMG200034737	K04123	ko01110	Biosynthesis of secondary metabolites	265	1.4e-08	0.78	0.80	0.34
PGSC0003DMG200042231	K03937	ko00190	Oxidative phosphorylation	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMG200042231	K03937	ko01100	Metabolic pathways	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMG200042231	K03937	ko05010	Alzheimer's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMG200042231	K03937	ko05012	Parkinson's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMG200042231	K03937	ko05016	Huntington's disease	500	9.6e-22	0.73	0.86	0.99
PGSC0003DMG200046578	K11816	ko00380	Tryptophan metabolism	1375	5.3e-70	0.45	0.67	0.96
PGSC0003DMG200046579	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200005974	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMG200005974	K08081	ko01100	Metabolic pathways	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMG200005974	K08081	ko01110	Biosynthesis of secondary metabolites	1149	1.5e-57	0.56	0.74	0.97
PGSC0003DMG200005974	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMG200005974	K08081	ko01100	Metabolic pathways	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMG200005974	K08081	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.57	0.79	0.95
PGSC0003DMG200005975	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko04210	Apoptosis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko04620	Toll-like receptor signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko04722	Neurotrophin signaling pathway	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko05140	Leishmaniasis	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005975	K04733	ko05142	Chagas disease	694	1.9e-32	0.43	0.60	0.85
PGSC0003DMG200005978	K12778	ko04113	Meiosis - yeast	432	6.2e-16	0.32	0.53	0.30
PGSC0003DMG200009726	K08241	ko00592	alpha-Linolenic acid metabolism	689	3.6e-32	0.34	0.52	0.98
PGSC0003DMG200009730	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.99
PGSC0003DMG200009730	K02183	ko04020	Calcium signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04070	Phosphatidylinositol signaling system	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04114	Oocyte meiosis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04270	Vascular smooth muscle contraction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04626	Plant-pathogen interaction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04720	Long-term potentiation	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04722	Neurotrophin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04740	Olfactory transduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04744	Phototransduction	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04745	Phototransduction - fly	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04910	Insulin signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04912	GnRH signaling pathway	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04916	Melanogenesis	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04970	Salivary secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko04971	Gastric acid secretion	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko05010	Alzheimer's disease	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009730	K02183	ko05214	Glioma	512	2.1e-22	0.48	0.65	0.83
PGSC0003DMG200009731	K08241	ko00592	alpha-Linolenic acid metabolism	673	2.8e-31	0.34	0.51	0.89
PGSC0003DMG200009732	K08241	ko00592	alpha-Linolenic acid metabolism	514	1.6e-22	0.32	0.47	0.89
PGSC0003DMG200009742	K03469	ko03030	DNA replication	255	3.1e-08	0.37	0.57	0.30
PGSC0003DMG200030906	K12338	ko00942	Anthocyanin biosynthesis	245	1.7e-07	0.47	0.68	0.53
PGSC0003DMG200030907	K12607	ko03018	RNA degradation	3943	1.2e-211	0.60	0.75	1.00
PGSC0003DMG200030910	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMG200030910	K06611	ko00052	Galactose metabolism	236	1.8e-06	0.34	0.54	0.94
PGSC0003DMG200024903	K01528	ko04144	Endocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMG200024903	K01528	ko04666	Fc gamma R-mediated phagocytosis	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMG200024903	K01528	ko05100	Bacterial invasion of epithelial cells	593	8.4e-25	0.25	0.42	0.95
PGSC0003DMG200024903	K01528	ko04144	Endocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMG200024903	K01528	ko04666	Fc gamma R-mediated phagocytosis	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMG200024903	K01528	ko05100	Bacterial invasion of epithelial cells	617	2.9e-26	0.26	0.43	0.95
PGSC0003DMG200024907	K13034	ko00270	Cysteine and methionine metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMG200024907	K13034	ko00450	Selenoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMG200024907	K13034	ko00460	Cyanoamino acid metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMG200024907	K13034	ko00920	Sulfur metabolism	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMG200024907	K13034	ko01100	Metabolic pathways	465	8.2e-20	0.78	0.89	0.92
PGSC0003DMG200024908	K03024	ko00230	Purine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMG200024908	K03024	ko00240	Pyrimidine metabolism	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMG200024908	K03024	ko01100	Metabolic pathways	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMG200024908	K03024	ko03020	RNA polymerase	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMG200024908	K03024	ko04623	Cytosolic DNA-sensing pathway	724	4.3e-34	0.46	0.64	1.00
PGSC0003DMG200024909	K07904	ko04144	Endocytosis	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMG200024909	K07904	ko04962	Vasopressin-regulated water reabsorption	1607	8.4e-83	0.92	0.96	1.00
PGSC0003DMG200024910	K05894	ko00592	alpha-Linolenic acid metabolism	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMG200024910	K05894	ko01100	Metabolic pathways	1334	9.6e-68	0.47	0.64	0.99
PGSC0003DMG200021936	K02342	ko00230	Purine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021936	K02342	ko00240	Pyrimidine metabolism	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021936	K02342	ko01100	Metabolic pathways	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021936	K02342	ko03030	DNA replication	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021936	K02342	ko03430	Mismatch repair	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021936	K02342	ko03440	Homologous recombination	257	4.8e-08	0.28	0.47	0.53
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	2410	4.3e-127	0.39	0.55	0.95
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	2903	2.8e-154	0.46	0.63	0.94
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	2867	2.7e-152	0.46	0.63	0.91
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	3193	2.8e-170	0.40	0.59	0.96
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	1598	2.6e-82	0.34	0.53	0.95
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	3622	6.1e-194	0.43	0.62	0.96
PGSC0003DMG200021938	K05666	ko02010	ABC transporters	3509	1.0e-187	0.43	0.63	0.97
PGSC0003DMG200021948	K02084	ko04115	p53 signaling pathway	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko04210	Apoptosis	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko05010	Alzheimer's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko05012	Parkinson's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko05016	Huntington's disease	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021948	K02084	ko05222	Small cell lung cancer	287	3.6e-06	0.29	0.47	0.29
PGSC0003DMG200021952	K03097	ko04310	Wnt signaling pathway	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMG200021952	K03097	ko04520	Adherens junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMG200021952	K03097	ko04530	Tight junction	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMG200021952	K03097	ko04712	Circadian rhythm - plant	344	3.9e-13	0.75	0.89	0.29
PGSC0003DMG200038975	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200038975	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200006777	K00680	ko00350	Tyrosine metabolism	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMG200006777	K00680	ko00624	1- and 2-Methylnaphthalene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMG200006777	K00680	ko00632	Benzoate degradation via CoA ligation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMG200006777	K00680	ko00642	Ethylbenzene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMG200006777	K00680	ko00903	Limonene and pinene degradation	853	3.3e-41	0.70	0.81	0.78
PGSC0003DMG200006778	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMG200006778	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMG200006778	K00820	ko01100	Metabolic pathways	4660	3.4e-251	0.83	0.90	1.00
PGSC0003DMG200006778	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko00250	Alanine, aspartate and glutamate metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko00520	Amino sugar and nucleotide sugar metabolism	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006778	K00820	ko01100	Metabolic pathways	4898	2.6e-264	0.86	0.93	1.00
PGSC0003DMG200006783	K03087	ko05111	Vibrio cholerae pathogenic cycle	571	1.2e-25	0.47	0.69	0.75
PGSC0003DMG200006785	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMG200006785	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMG200006785	K01768	ko00230	Purine metabolism	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMG200006785	K01768	ko04113	Meiosis - yeast	307	5.9e-07	0.28	0.42	0.49
PGSC0003DMG200003807	K03679	ko03018	RNA degradation	1883	5.1e-98	0.70	0.83	1.00
PGSC0003DMG200003816	K11251	ko05322	Systemic lupus erythematosus	933	1.3e-45	0.83	0.88	0.99
PGSC0003DMG200003821	K12741	ko03040	Spliceosome	872	2.9e-42	0.43	0.57	0.98
PGSC0003DMG200003821	K12741	ko03040	Spliceosome	1352	9.8e-69	0.46	0.59	0.99
PGSC0003DMG200009237	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMG200009237	K01850	ko01100	Metabolic pathways	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMG200009237	K01850	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.62	0.75	0.96
PGSC0003DMG200009237	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMG200009237	K01850	ko01100	Metabolic pathways	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMG200009237	K01850	ko01110	Biosynthesis of secondary metabolites	751	1.4e-35	0.57	0.72	0.85
PGSC0003DMG200009246	K03660	ko03410	Base excision repair	2101	4.8e-110	0.70	0.81	0.96
PGSC0003DMG200009248	K06627	ko04110	Cell cycle	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMG200009248	K06627	ko04914	Progesterone-mediated oocyte maturation	555	8.9e-25	0.56	0.61	0.80
PGSC0003DMG200006127	K08496	ko04130	SNARE interactions in vesicular transport	1250	4.1e-63	0.62	0.82	0.94
PGSC0003DMG200006134	K12132	ko04712	Circadian rhythm - plant	1304	4.4e-66	0.59	0.73	0.95
PGSC0003DMG200006136	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMG200006136	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMG200006136	K12741	ko03040	Spliceosome	1449	4.4e-74	0.45	0.58	0.99
PGSC0003DMG200006139	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4416	9.9e-238	0.77	0.85	0.98
PGSC0003DMG200006139	K01868	ko00970	Aminoacyl-tRNA biosynthesis	2681	4.9e-142	0.87	0.95	0.99
PGSC0003DMG200006139	K01868	ko00970	Aminoacyl-tRNA biosynthesis	574	8.0e-26	0.77	0.92	0.91
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.67	0.83	0.97
PGSC0003DMG200011681	K03100	ko03060	Protein export	1916	7.7e-100	0.63	0.76	1.00
PGSC0003DMG200011681	K03100	ko03060	Protein export	1701	5.5e-88	0.63	0.76	1.00
PGSC0003DMG200011682	K12356	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.29	0.46	0.93
PGSC0003DMG200011682	K12356	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.29	0.46	0.93
PGSC0003DMG200011683	K03911	ko04610	Complement and coagulation cascades	635	3.4e-29	0.32	0.50	0.94
PGSC0003DMG200011684	K03911	ko04610	Complement and coagulation cascades	705	4.8e-33	0.33	0.53	0.95
PGSC0003DMG200011685	K03911	ko04610	Complement and coagulation cascades	678	1.5e-31	0.32	0.51	0.92
PGSC0003DMG200011687	K03911	ko04610	Complement and coagulation cascades	698	1.2e-32	0.34	0.53	0.89
PGSC0003DMG200013199	K04733	ko04210	Apoptosis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMG200013199	K04733	ko04620	Toll-like receptor signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMG200013199	K04733	ko04722	Neurotrophin signaling pathway	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMG200013199	K04733	ko05140	Leishmaniasis	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMG200013199	K04733	ko05142	Chagas disease	640	1.8e-29	0.39	0.55	0.88
PGSC0003DMG200013204	K03935	ko00190	Oxidative phosphorylation	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMG200013204	K03935	ko01100	Metabolic pathways	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMG200013204	K03935	ko05010	Alzheimer's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMG200013204	K03935	ko05012	Parkinson's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMG200013204	K03935	ko05016	Huntington's disease	889	3.4e-43	0.87	0.90	0.97
PGSC0003DMG200013210	K02739	ko03050	Proteasome	1315	1.1e-66	0.87	0.95	0.99
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	544	2.0e-38	0.44	0.61	0.97
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	502	4.9e-21	0.60	0.64	0.94
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMG200043052	K10884	ko03450	Non-homologous end-joining	446	1.2e-17	0.47	0.66	0.83
PGSC0003DMG200001287	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00250	Alanine, aspartate and glutamate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00410	beta-Alanine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00430	Taurine and hypotaurine metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko00650	Butanoate metabolism	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko01100	Metabolic pathways	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001287	K01580	ko04940	Type I diabetes mellitus	901	7.4e-44	0.78	0.84	0.94
PGSC0003DMG200001289	K13229	ko00402	Benzoxazinoid biosynthesis	605	1.6e-27	0.41	0.58	0.95
PGSC0003DMG200001290	K05280	ko00941	Flavonoid biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMG200001290	K05280	ko00944	Flavone and flavonol biosynthesis	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMG200001290	K05280	ko01100	Metabolic pathways	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMG200001290	K05280	ko01110	Biosynthesis of secondary metabolites	249	2.0e-09	0.36	0.56	0.96
PGSC0003DMG200001292	K03942	ko00190	Oxidative phosphorylation	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMG200001292	K03942	ko01100	Metabolic pathways	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMG200001292	K03942	ko05010	Alzheimer's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMG200001292	K03942	ko05012	Parkinson's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMG200001292	K03942	ko05016	Huntington's disease	3872	1.0e-207	0.92	0.95	1.00
PGSC0003DMG200025997	K01046	ko00561	Glycerolipid metabolism	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMG200025997	K01046	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.49	0.48
PGSC0003DMG200026005	K08679	ko00500	Starch and sucrose metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMG200026005	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMG200026005	K08679	ko01100	Metabolic pathways	3197	1.7e-170	0.87	0.94	1.00
PGSC0003DMG200026006	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMG200026006	K00800	ko01100	Metabolic pathways	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMG200026006	K00800	ko01110	Biosynthesis of secondary metabolites	3409	3.4e-182	0.79	0.88	1.00
PGSC0003DMG200026007	K01480	ko00330	Arginine and proline metabolism	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMG200026007	K01480	ko01100	Metabolic pathways	1515	1.0e-77	0.82	0.93	0.99
PGSC0003DMG200026007	K01480	ko00330	Arginine and proline metabolism	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMG200026007	K01480	ko01100	Metabolic pathways	2525	2.0e-133	0.88	0.96	0.99
PGSC0003DMG200026007	K01480	ko00330	Arginine and proline metabolism	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMG200026007	K01480	ko01100	Metabolic pathways	2463	5.2e-130	0.86	0.95	0.99
PGSC0003DMG200026007	K01480	ko00330	Arginine and proline metabolism	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMG200026007	K01480	ko01100	Metabolic pathways	2416	2.0e-127	0.83	0.93	1.00
PGSC0003DMG200026007	K01476	ko00330	Arginine and proline metabolism	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMG200026007	K01476	ko01100	Metabolic pathways	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMG200026007	K01476	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMG200026007	K01476	ko05146	Amoebiasis	1057	1.8e-52	0.93	0.98	0.99
PGSC0003DMG200026007	K01480	ko00330	Arginine and proline metabolism	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMG200026007	K01480	ko01100	Metabolic pathways	2580	1.8e-136	0.90	0.97	0.99
PGSC0003DMG200022885	K00128	ko00010	Glycolysis / Gluconeogenesis	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00053	Ascorbate and aldarate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00071	Fatty acid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00280	Valine, leucine and isoleucine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00310	Lysine degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00330	Arginine and proline metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00340	Histidine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00380	Tryptophan metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00410	beta-Alanine metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00561	Glycerolipid metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00620	Pyruvate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00631	1,2-Dichloroethane degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00640	Propanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00641	3-Chloroacrylic acid degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00650	Butanoate metabolism	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00903	Limonene and pinene degradation	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko01100	Metabolic pathways	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko01110	Biosynthesis of secondary metabolites	2495	8.9e-132	0.80	0.91	0.98
PGSC0003DMG200022885	K00128	ko00010	Glycolysis / Gluconeogenesis	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00053	Ascorbate and aldarate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00071	Fatty acid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00280	Valine, leucine and isoleucine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00310	Lysine degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00330	Arginine and proline metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00340	Histidine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00380	Tryptophan metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00410	beta-Alanine metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00561	Glycerolipid metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00620	Pyruvate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00631	1,2-Dichloroethane degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00640	Propanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00641	3-Chloroacrylic acid degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00650	Butanoate metabolism	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00903	Limonene and pinene degradation	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko01100	Metabolic pathways	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko01110	Biosynthesis of secondary metabolites	2197	2.4e-115	0.82	0.92	0.99
PGSC0003DMG200022885	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00010	Glycolysis / Gluconeogenesis	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00053	Ascorbate and aldarate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00071	Fatty acid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00280	Valine, leucine and isoleucine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00310	Lysine degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00330	Arginine and proline metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00340	Histidine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00380	Tryptophan metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00410	beta-Alanine metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00561	Glycerolipid metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00620	Pyruvate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00631	1,2-Dichloroethane degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00640	Propanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00641	3-Chloroacrylic acid degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00650	Butanoate metabolism	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00903	Limonene and pinene degradation	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko01100	Metabolic pathways	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko01110	Biosynthesis of secondary metabolites	3571	4.0e-191	0.83	0.91	1.00
PGSC0003DMG200022885	K00128	ko00010	Glycolysis / Gluconeogenesis	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00053	Ascorbate and aldarate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00071	Fatty acid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00280	Valine, leucine and isoleucine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00310	Lysine degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00330	Arginine and proline metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00340	Histidine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00380	Tryptophan metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00410	beta-Alanine metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00561	Glycerolipid metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00620	Pyruvate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00631	1,2-Dichloroethane degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00640	Propanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00641	3-Chloroacrylic acid degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00650	Butanoate metabolism	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko00903	Limonene and pinene degradation	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko01100	Metabolic pathways	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022885	K00128	ko01110	Biosynthesis of secondary metabolites	2993	3.0e-159	0.88	0.94	1.00
PGSC0003DMG200022886	K12620	ko03018	RNA degradation	833	4.1e-40	0.84	0.93	0.16
PGSC0003DMG200022886	K12620	ko03018	RNA degradation	983	2.2e-48	0.91	0.96	0.99
PGSC0003DMG200022886	K12620	ko03018	RNA degradation	789	1.1e-37	0.92	0.95	0.94
PGSC0003DMG200029932	K11229	ko04011	MAPK signaling pathway - yeast	298	1.6e-09	0.38	0.55	0.99
PGSC0003DMG200029938	K00283	ko00260	Glycine, serine and threonine metabolism	7770	0.	0.86	0.92	1.00
PGSC0003DMG200029938	K00283	ko01100	Metabolic pathways	7770	0.	0.86	0.92	1.00
PGSC0003DMG200029939	K04424	ko04010	MAPK signaling pathway	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMG200029939	K04424	ko04530	Tight junction	495	4.7e-21	0.50	0.60	0.99
PGSC0003DMG200029939	K04424	ko04010	MAPK signaling pathway	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMG200029939	K04424	ko04530	Tight junction	3012	2.7e-160	0.54	0.65	0.98
PGSC0003DMG200029939	K04424	ko04010	MAPK signaling pathway	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMG200029939	K04424	ko04530	Tight junction	2321	3.5e-122	0.49	0.62	0.98
PGSC0003DMG200029939	K04424	ko04010	MAPK signaling pathway	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMG200029939	K04424	ko04530	Tight junction	3536	3.4e-189	0.55	0.67	0.99
PGSC0003DMG200029942	K06268	ko04010	MAPK signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04020	Calcium signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04114	Oocyte meiosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04210	Apoptosis	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04310	Wnt signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04360	Axon guidance	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04370	VEGF signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04650	Natural killer cell mediated cytotoxicity	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04660	T cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04662	B cell receptor signaling pathway	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04720	Long-term potentiation	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko05010	Alzheimer's disease	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	888	3.8e-43	0.56	0.68	0.74
PGSC0003DMG200029942	K06268	ko04010	MAPK signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04020	Calcium signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04114	Oocyte meiosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04210	Apoptosis	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04310	Wnt signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04360	Axon guidance	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04370	VEGF signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04650	Natural killer cell mediated cytotoxicity	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04660	T cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04662	B cell receptor signaling pathway	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04720	Long-term potentiation	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko05010	Alzheimer's disease	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	470	4.3e-20	0.68	0.89	0.91
PGSC0003DMG200029942	K06268	ko04010	MAPK signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04020	Calcium signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04114	Oocyte meiosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04210	Apoptosis	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04310	Wnt signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04360	Axon guidance	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04370	VEGF signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04650	Natural killer cell mediated cytotoxicity	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04660	T cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04662	B cell receptor signaling pathway	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04720	Long-term potentiation	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko05010	Alzheimer's disease	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	634	3.9e-29	0.66	0.86	0.65
PGSC0003DMG200029942	K06268	ko04010	MAPK signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04020	Calcium signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04114	Oocyte meiosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04210	Apoptosis	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04310	Wnt signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04360	Axon guidance	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04370	VEGF signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04650	Natural killer cell mediated cytotoxicity	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04660	T cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04662	B cell receptor signaling pathway	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko04720	Long-term potentiation	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko05010	Alzheimer's disease	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200029942	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1107	3.2e-55	0.69	0.85	0.74
PGSC0003DMG200003524	K02732	ko03050	Proteasome	1781	2.1e-92	0.93	0.97	1.00
PGSC0003DMG200003529	K04371	ko04010	MAPK signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04012	ErbB signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04013	MAPK signaling pathway - fly	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04062	Chemokine signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04114	Oocyte meiosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04150	mTOR signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04270	Vascular smooth muscle contraction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04320	Dorso-ventral axis formation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04350	TGF-beta signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04360	Axon guidance	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04370	VEGF signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04510	Focal adhesion	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04520	Adherens junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04540	Gap junction	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04620	Toll-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04621	NOD-like receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04650	Natural killer cell mediated cytotoxicity	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04660	T cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04662	B cell receptor signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04664	Fc epsilon RI signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04666	Fc gamma R-mediated phagocytosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04720	Long-term potentiation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04722	Neurotrophin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04730	Long-term depression	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04810	Regulation of actin cytoskeleton	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04910	Insulin signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04912	GnRH signaling pathway	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04914	Progesterone-mediated oocyte maturation	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04916	Melanogenesis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04930	Type II diabetes mellitus	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko04960	Aldosterone-regulated sodium reabsorption	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05010	Alzheimer's disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05020	Prion diseases	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05131	Shigellosis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05140	Leishmaniasis	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05142	Chagas disease	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05200	Pathways in cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05210	Colorectal cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05211	Renal cell carcinoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05212	Pancreatic cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05213	Endometrial cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05214	Glioma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05215	Prostate cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05216	Thyroid cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05218	Melanoma	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05219	Bladder cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05220	Chronic myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05221	Acute myeloid leukemia	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003529	K04371	ko05223	Non-small cell lung cancer	721	6.2e-34	0.61	0.78	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.71	0.86	0.98
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	2018	1.8e-105	0.71	0.85	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1986	1.1e-103	0.72	0.82	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	793	6.7e-38	0.68	0.80	0.96
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	2001	1.6e-104	0.73	0.83	0.99
PGSC0003DMG200007396	K01528	ko04144	Endocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMG200007396	K01528	ko04666	Fc gamma R-mediated phagocytosis	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMG200007396	K01528	ko05100	Bacterial invasion of epithelial cells	559	7.8e-23	0.25	0.42	0.84
PGSC0003DMG200007399	K05658	ko02010	ABC transporters	5892	0.	0.50	0.70	0.92
PGSC0003DMG200007400	K13065	ko00940	Phenylpropanoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMG200007400	K13065	ko00941	Flavonoid biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMG200007400	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMG200007400	K13065	ko01110	Biosynthesis of secondary metabolites	359	5.8e-14	0.25	0.43	0.95
PGSC0003DMG200007402	K10798	ko03410	Base excision repair	1485	4.5e-76	0.32	0.52	0.97
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	3384	8.2e-181	0.91	0.96	1.00
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	3374	2.9e-180	0.91	0.96	1.00
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	544	3.6e-24	1.00	1.00	0.59
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	352	1.4e-13	1.00	1.00	0.73
PGSC0003DMG200007403	K12196	ko04144	Endocytosis	1678	1.0e-86	0.89	0.96	1.00
PGSC0003DMG200014984	K03046	ko00230	Purine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMG200014984	K03046	ko00240	Pyrimidine metabolism	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMG200014984	K03046	ko01100	Metabolic pathways	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMG200014984	K03046	ko03020	RNA polymerase	627	6.0e-28	0.93	0.95	0.98
PGSC0003DMG200014992	K10875	ko03440	Homologous recombination	599	2.5e-29	0.29	0.49	0.43
PGSC0003DMG200016993	K04733	ko04210	Apoptosis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMG200016993	K04733	ko04620	Toll-like receptor signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMG200016993	K04733	ko04722	Neurotrophin signaling pathway	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMG200016993	K04733	ko05140	Leishmaniasis	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMG200016993	K04733	ko05142	Chagas disease	1286	4.3e-65	0.56	0.72	0.78
PGSC0003DMG200016994	K04733	ko04210	Apoptosis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMG200016994	K04733	ko04620	Toll-like receptor signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMG200016994	K04733	ko04722	Neurotrophin signaling pathway	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMG200016994	K04733	ko05140	Leishmaniasis	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMG200016994	K04733	ko05142	Chagas disease	1318	7.4e-67	0.56	0.73	0.79
PGSC0003DMG200016994	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko04210	Apoptosis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko04620	Toll-like receptor signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko04722	Neurotrophin signaling pathway	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko05140	Leishmaniasis	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016994	K04733	ko05142	Chagas disease	965	2.2e-47	0.57	0.72	0.89
PGSC0003DMG200016995	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04210	Apoptosis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04620	Toll-like receptor signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko04722	Neurotrophin signaling pathway	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05140	Leishmaniasis	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200016995	K04733	ko05142	Chagas disease	1312	1.6e-66	0.55	0.70	0.96
PGSC0003DMG200017001	K00697	ko00500	Starch and sucrose metabolism	4353	3.0e-234	0.63	0.73	0.93
PGSC0003DMG200017001	K00697	ko00500	Starch and sucrose metabolism	4638	5.6e-250	0.65	0.76	0.98
PGSC0003DMG200017001	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMG200017001	K00697	ko00500	Starch and sucrose metabolism	1900	5.8e-99	0.79	0.92	0.94
PGSC0003DMG200017001	K00697	ko00500	Starch and sucrose metabolism	3181	1.3e-169	0.74	0.86	0.99
PGSC0003DMG200017005	K00128	ko00010	Glycolysis / Gluconeogenesis	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00053	Ascorbate and aldarate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00071	Fatty acid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00280	Valine, leucine and isoleucine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00310	Lysine degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00330	Arginine and proline metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00340	Histidine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00380	Tryptophan metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00410	beta-Alanine metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00561	Glycerolipid metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00620	Pyruvate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00631	1,2-Dichloroethane degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00640	Propanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00641	3-Chloroacrylic acid degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00650	Butanoate metabolism	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko00903	Limonene and pinene degradation	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko01100	Metabolic pathways	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200017005	K00128	ko01110	Biosynthesis of secondary metabolites	561	4.2e-25	0.69	0.84	0.79
PGSC0003DMG200020450	K02261	ko00190	Oxidative phosphorylation	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020450	K02261	ko01100	Metabolic pathways	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020450	K02261	ko04260	Cardiac muscle contraction	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020450	K02261	ko05010	Alzheimer's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020450	K02261	ko05012	Parkinson's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020450	K02261	ko05016	Huntington's disease	312	2.3e-11	0.70	0.77	0.75
PGSC0003DMG200020452	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMG200020452	K00517	ko00626	Naphthalene and anthracene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMG200020452	K00517	ko00903	Limonene and pinene degradation	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMG200020452	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMG200020452	K00517	ko01110	Biosynthesis of secondary metabolites	724	4.3e-34	0.55	0.77	0.87
PGSC0003DMG200020453	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMG200020453	K00517	ko00626	Naphthalene and anthracene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMG200020453	K00517	ko00903	Limonene and pinene degradation	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMG200020453	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMG200020453	K00517	ko01110	Biosynthesis of secondary metabolites	400	5.9e-23	0.33	0.55	0.94
PGSC0003DMG200020453	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMG200020453	K00517	ko00626	Naphthalene and anthracene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMG200020453	K00517	ko00903	Limonene and pinene degradation	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMG200020453	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMG200020453	K00517	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.49	0.63	0.96
PGSC0003DMG200020453	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMG200020453	K00517	ko00626	Naphthalene and anthracene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMG200020453	K00517	ko00903	Limonene and pinene degradation	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMG200020453	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMG200020453	K00517	ko01110	Biosynthesis of secondary metabolites	777	5.1e-37	0.49	0.66	0.97
PGSC0003DMG200020453	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMG200020453	K00517	ko00626	Naphthalene and anthracene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMG200020453	K00517	ko00903	Limonene and pinene degradation	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMG200020453	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMG200020453	K00517	ko01110	Biosynthesis of secondary metabolites	700	9.0e-33	0.34	0.61	0.96
PGSC0003DMG200020454	K11229	ko04011	MAPK signaling pathway - yeast	547	2.0e-23	0.34	0.51	0.88
PGSC0003DMG200020456	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMG200020456	K00224	ko00364	Fluorobenzoate degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMG200020456	K00224	ko00628	Fluorene degradation	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMG200020456	K00224	ko00640	Propanoate metabolism	1358	4.6e-69	0.56	0.73	0.98
PGSC0003DMG200020457	K04420	ko04010	MAPK signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMG200020457	K04420	ko04540	Gap junction	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMG200020457	K04420	ko04912	GnRH signaling pathway	548	2.2e-24	0.36	0.55	0.78
PGSC0003DMG200020459	K06228	ko04340	Hedgehog signaling pathway	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMG200020459	K06228	ko05200	Pathways in cancer	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMG200020459	K06228	ko05217	Basal cell carcinoma	565	9.7e-25	0.36	0.52	0.92
PGSC0003DMG200031866	K03006	ko00230	Purine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMG200031866	K03006	ko00240	Pyrimidine metabolism	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMG200031866	K03006	ko01100	Metabolic pathways	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMG200031866	K03006	ko03020	RNA polymerase	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMG200031866	K03006	ko05016	Huntington's disease	443	2.1e-17	0.30	0.45	0.93
PGSC0003DMG200031866	K03006	ko00230	Purine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMG200031866	K03006	ko00240	Pyrimidine metabolism	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMG200031866	K03006	ko01100	Metabolic pathways	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMG200031866	K03006	ko03020	RNA polymerase	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMG200031866	K03006	ko05016	Huntington's disease	459	2.7e-18	0.31	0.46	0.94
PGSC0003DMG200031867	K05863	ko04020	Calcium signaling pathway	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMG200031867	K05863	ko05012	Parkinson's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMG200031867	K05863	ko05016	Huntington's disease	2909	1.3e-154	0.88	0.93	0.99
PGSC0003DMG200031869	K08332	ko04140	Regulation of autophagy	388	1.7e-13	0.33	0.52	0.38
PGSC0003DMG200031869	K08332	ko04140	Regulation of autophagy	388	3.0e-13	0.33	0.52	0.32
PGSC0003DMG200031878	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04115	p53 signaling pathway	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko04210	Apoptosis	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05010	Alzheimer's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05012	Parkinson's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05016	Huntington's disease	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200031878	K02084	ko05222	Small cell lung cancer	326	2.2e-08	0.27	0.44	0.38
PGSC0003DMG200021616	K12471	ko04144	Endocytosis	751	1.4e-35	0.32	0.45	0.71
PGSC0003DMG200021618	K01046	ko00561	Glycerolipid metabolism	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMG200021618	K01046	ko01100	Metabolic pathways	273	4.1e-09	0.33	0.52	0.37
PGSC0003DMG200021620	K02153	ko00190	Oxidative phosphorylation	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200021620	K02153	ko01100	Metabolic pathways	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200021620	K02153	ko04145	Phagosome	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200021620	K02153	ko04966	Collecting duct acid secretion	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200021620	K02153	ko05110	Vibrio cholerae infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200021620	K02153	ko05120	Epithelial cell signaling in Helicobacter pylori infection	493	2.3e-21	0.81	0.90	0.99
PGSC0003DMG200025532	K12356	ko00940	Phenylpropanoid biosynthesis	541	5.3e-24	0.47	0.59	0.39
PGSC0003DMG200025535	K00480	ko00624	1- and 2-Methylnaphthalene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMG200025535	K00480	ko00626	Naphthalene and anthracene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMG200025535	K00480	ko00628	Fluorene degradation	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMG200025535	K00480	ko01100	Metabolic pathways	525	4.0e-23	0.30	0.48	0.89
PGSC0003DMG200025535	K00480	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMG200025535	K00480	ko00626	Naphthalene and anthracene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMG200025535	K00480	ko00628	Fluorene degradation	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMG200025535	K00480	ko01100	Metabolic pathways	243	1.4e-07	0.34	0.47	0.91
PGSC0003DMG200025540	K11866	ko04144	Endocytosis	364	2.0e-13	0.34	0.53	0.83
PGSC0003DMG200025540	K11866	ko04144	Endocytosis	631	1.5e-28	0.31	0.49	0.93
PGSC0003DMG200025541	K12868	ko03040	Spliceosome	522	5.9e-23	0.95	0.97	0.98
PGSC0003DMG200025542	K03661	ko00190	Oxidative phosphorylation	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025542	K03661	ko01100	Metabolic pathways	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025542	K03661	ko04142	Lysosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025542	K03661	ko04145	Phagosome	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025542	K03661	ko05110	Vibrio cholerae infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025542	K03661	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1358	4.6e-69	0.94	0.98	0.98
PGSC0003DMG200025548	K11097	ko03040	Spliceosome	684	6.8e-32	0.94	0.95	0.99
PGSC0003DMG200039106	K00430	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMG200039106	K00430	ko00680	Methane metabolism	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMG200039106	K00430	ko00940	Phenylpropanoid biosynthesis	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMG200039106	K00430	ko01100	Metabolic pathways	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMG200039106	K00430	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.55	0.71	0.99
PGSC0003DMG200003072	K12121	ko04712	Circadian rhythm - plant	483	4.7e-20	0.48	0.72	0.72
PGSC0003DMG200003076	K11247	ko04144	Endocytosis	1440	1.4e-73	0.52	0.68	0.99
PGSC0003DMG200003076	K11247	ko04144	Endocytosis	706	4.2e-33	0.55	0.72	0.90
PGSC0003DMG200003077	K05658	ko02010	ABC transporters	440	1.5e-17	0.88	0.95	0.92
PGSC0003DMG200003078	K05658	ko02010	ABC transporters	8020	0.	0.77	0.90	0.99
PGSC0003DMG200003079	K05278	ko00941	Flavonoid biosynthesis	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMG200003079	K05278	ko01100	Metabolic pathways	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMG200003079	K05278	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.33	0.53	0.91
PGSC0003DMG200003079	K05278	ko00941	Flavonoid biosynthesis	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMG200003079	K05278	ko01100	Metabolic pathways	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMG200003079	K05278	ko01110	Biosynthesis of secondary metabolites	458	2.0e-19	0.42	0.66	0.73
PGSC0003DMG200003079	K05277	ko00941	Flavonoid biosynthesis	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMG200003079	K05277	ko01100	Metabolic pathways	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMG200003079	K05277	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.34	0.54	0.92
PGSC0003DMG200003079	K05277	ko00941	Flavonoid biosynthesis	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMG200003079	K05277	ko01100	Metabolic pathways	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMG200003079	K05277	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.33	0.50	0.80
PGSC0003DMG200003084	K12130	ko04712	Circadian rhythm - plant	315	2.0e-11	0.35	0.58	0.91
PGSC0003DMG200008122	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMG200008122	K01904	ko00360	Phenylalanine metabolism	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMG200008122	K01904	ko00940	Phenylpropanoid biosynthesis	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMG200008122	K01904	ko01100	Metabolic pathways	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMG200008122	K01904	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.63	0.78	0.91
PGSC0003DMG200008122	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMG200008122	K01904	ko00360	Phenylalanine metabolism	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMG200008122	K01904	ko00940	Phenylpropanoid biosynthesis	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMG200008122	K01904	ko01100	Metabolic pathways	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMG200008122	K01904	ko01110	Biosynthesis of secondary metabolites	3158	2.4e-168	0.69	0.82	1.00
PGSC0003DMG200008129	K13230	ko00402	Benzoxazinoid biosynthesis	878	1.4e-42	0.36	0.53	0.99
PGSC0003DMG200008131	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMG200008131	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMG200008131	K00771	ko01100	Metabolic pathways	484	1.9e-20	0.33	0.52	0.71
PGSC0003DMG200008132	K00225	ko00053	Ascorbate and aldarate metabolism	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMG200008132	K00225	ko01100	Metabolic pathways	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMG200008132	K00225	ko01110	Biosynthesis of secondary metabolites	2996	2.1e-159	0.73	0.84	0.81
PGSC0003DMG200008133	K00273	ko00260	Glycine, serine and threonine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko00311	Penicillin and cephalosporin biosynthesis	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko00330	Arginine and proline metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko00472	D-Arginine and D-ornithine metabolism	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko01100	Metabolic pathways	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko04146	Peroxisome	1372	7.7e-70	0.46	0.64	0.90
PGSC0003DMG200008133	K00273	ko00260	Glycine, serine and threonine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko00311	Penicillin and cephalosporin biosynthesis	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko00330	Arginine and proline metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko00472	D-Arginine and D-ornithine metabolism	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko01100	Metabolic pathways	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko04146	Peroxisome	670	4.0e-31	0.52	0.69	0.93
PGSC0003DMG200008133	K00273	ko00260	Glycine, serine and threonine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008133	K00273	ko00311	Penicillin and cephalosporin biosynthesis	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008133	K00273	ko00330	Arginine and proline metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008133	K00273	ko00472	D-Arginine and D-ornithine metabolism	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008133	K00273	ko01100	Metabolic pathways	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008133	K00273	ko04146	Peroxisome	331	2.0e-12	0.56	0.75	0.84
PGSC0003DMG200008134	K05768	ko04666	Fc gamma R-mediated phagocytosis	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMG200008134	K05768	ko04810	Regulation of actin cytoskeleton	3489	1.3e-186	0.46	0.63	1.00
PGSC0003DMG200008135	K03124	ko03022	Basal transcription factors	2039	1.3e-106	0.77	0.88	0.99
PGSC0003DMG200008135	K03124	ko03022	Basal transcription factors	2028	5.1e-106	0.76	0.88	0.99
PGSC0003DMG200008135	K03124	ko03022	Basal transcription factors	1092	2.1e-54	0.76	0.87	0.93
PGSC0003DMG200008136	K03124	ko03022	Basal transcription factors	877	1.5e-42	0.85	0.93	0.87
PGSC0003DMG200008136	K03124	ko03022	Basal transcription factors	1296	1.2e-65	0.89	0.93	0.98
PGSC0003DMG200004176	K07203	ko04012	ErbB signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko04150	mTOR signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko04910	Insulin signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko04920	Adipocytokine signaling pathway	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko04930	Type II diabetes mellitus	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko05200	Pathways in cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko05214	Glioma	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko05215	Prostate cancer	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004176	K07203	ko05221	Acute myeloid leukemia	640	3.3e-28	0.62	0.71	0.37
PGSC0003DMG200004177	K07203	ko04012	ErbB signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko04150	mTOR signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko04910	Insulin signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko04920	Adipocytokine signaling pathway	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko04930	Type II diabetes mellitus	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko05200	Pathways in cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko05214	Glioma	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko05215	Prostate cancer	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004177	K07203	ko05221	Acute myeloid leukemia	1163	2.7e-57	0.67	0.70	0.79
PGSC0003DMG200004189	K01681	ko00020	Citrate cycle (TCA cycle)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMG200004189	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMG200004189	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMG200004189	K01681	ko01100	Metabolic pathways	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMG200004189	K01681	ko01110	Biosynthesis of secondary metabolites	293	7.7e-07	0.49	0.60	0.11
PGSC0003DMG200004204	K02901	ko03010	Ribosome	640	1.8e-29	0.75	0.84	0.48
PGSC0003DMG200004204	K02901	ko03010	Ribosome	359	5.8e-14	0.81	0.87	0.98
PGSC0003DMG200014268	K00215	ko00300	Lysine biosynthesis	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMG200014268	K00215	ko01100	Metabolic pathways	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMG200014268	K00215	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.73	0.87	0.83
PGSC0003DMG200014268	K00215	ko00300	Lysine biosynthesis	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMG200014268	K00215	ko01100	Metabolic pathways	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMG200014268	K00215	ko01110	Biosynthesis of secondary metabolites	1368	1.3e-69	0.73	0.86	0.97
PGSC0003DMG200014270	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMG200014270	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMG200014270	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMG200014270	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMG200014270	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.39	0.61	0.94
PGSC0003DMG200014270	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMG200014270	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMG200014270	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMG200014270	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMG200014270	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.55	0.72	0.93
PGSC0003DMG200014271	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMG200014271	K00517	ko00626	Naphthalene and anthracene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMG200014271	K00517	ko00903	Limonene and pinene degradation	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMG200014271	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMG200014271	K00517	ko01110	Biosynthesis of secondary metabolites	688	1.1e-42	0.39	0.59	0.99
PGSC0003DMG200014271	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMG200014271	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMG200014271	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMG200014271	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMG200014271	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.32	0.54	0.95
PGSC0003DMG200014272	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMG200014272	K00517	ko00626	Naphthalene and anthracene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMG200014272	K00517	ko00903	Limonene and pinene degradation	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMG200014272	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMG200014272	K00517	ko01110	Biosynthesis of secondary metabolites	962	3.2e-47	0.33	0.54	0.99
PGSC0003DMG200014272	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMG200014272	K00517	ko00626	Naphthalene and anthracene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMG200014272	K00517	ko00903	Limonene and pinene degradation	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMG200014272	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMG200014272	K00517	ko01110	Biosynthesis of secondary metabolites	569	1.5e-25	0.43	0.62	0.95
PGSC0003DMG200014272	K13083	ko00941	Flavonoid biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMG200014272	K13083	ko00944	Flavone and flavonol biosynthesis	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMG200014272	K13083	ko01110	Biosynthesis of secondary metabolites	441	1.7e-18	0.38	0.56	0.86
PGSC0003DMG200014273	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMG200014273	K00517	ko00626	Naphthalene and anthracene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMG200014273	K00517	ko00903	Limonene and pinene degradation	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMG200014273	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMG200014273	K00517	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.52	0.70	0.95
PGSC0003DMG200014274	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMG200014274	K00517	ko00626	Naphthalene and anthracene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMG200014274	K00517	ko00903	Limonene and pinene degradation	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMG200014274	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMG200014274	K00517	ko01110	Biosynthesis of secondary metabolites	856	2.2e-41	0.55	0.73	0.94
PGSC0003DMG200014274	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMG200014274	K00517	ko00626	Naphthalene and anthracene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMG200014274	K00517	ko00903	Limonene and pinene degradation	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMG200014274	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMG200014274	K00517	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.40	0.60	0.94
PGSC0003DMG200034081	K08488	ko04130	SNARE interactions in vesicular transport	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMG200034081	K08488	ko04145	Phagosome	417	3.6e-17	0.83	0.87	0.98
PGSC0003DMG200034097	K00763	ko00760	Nicotinate and nicotinamide metabolism	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMG200034097	K00763	ko01100	Metabolic pathways	3806	4.4e-204	0.79	0.90	0.98
PGSC0003DMG200034098	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMG200034098	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMG200034098	K02890	ko03010	Ribosome	221	2.4e-06	0.33	0.52	0.71
PGSC0003DMG200034099	K12655	ko04622	RIG-I-like receptor signaling pathway	312	3.7e-11	0.31	0.49	0.72
PGSC0003DMG200034099	K12655	ko04622	RIG-I-like receptor signaling pathway	320	1.2e-11	0.26	0.47	0.81
PGSC0003DMG200024857	K03875	ko04110	Cell cycle	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMG200024857	K03875	ko04120	Ubiquitin mediated proteolysis	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMG200024857	K03875	ko05200	Pathways in cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMG200024857	K03875	ko05222	Small cell lung cancer	770	1.2e-36	0.72	0.85	0.97
PGSC0003DMG200024857	K03875	ko04110	Cell cycle	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMG200024857	K03875	ko04120	Ubiquitin mediated proteolysis	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMG200024857	K03875	ko05200	Pathways in cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMG200024857	K03875	ko05222	Small cell lung cancer	2124	2.6e-111	0.72	0.86	0.99
PGSC0003DMG200024860	K00166	ko00280	Valine, leucine and isoleucine degradation	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMG200024860	K00166	ko01100	Metabolic pathways	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMG200024860	K00166	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.67	0.82	0.91
PGSC0003DMG200024863	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMG200024863	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMG200024863	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMG200024863	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMG200024863	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.53	0.71	0.98
PGSC0003DMG200024871	K00059	ko00061	Fatty acid biosynthesis	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMG200024871	K00059	ko01040	Biosynthesis of unsaturated fatty acids	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMG200024871	K00059	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.59	0.75
PGSC0003DMG200020877	K05692	ko04145	Phagosome	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04510	Focal adhesion	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04520	Adherens junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04530	Tight junction	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04670	Leukocyte transendothelial migration	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04745	Phototransduction - fly	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05110	Vibrio cholerae infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05131	Shigellosis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05414	Dilated cardiomyopathy	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020877	K05692	ko05416	Viral myocarditis	524	4.6e-23	0.49	0.61	0.99
PGSC0003DMG200020878	K05692	ko04145	Phagosome	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04510	Focal adhesion	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04520	Adherens junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04530	Tight junction	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04670	Leukocyte transendothelial migration	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04745	Phototransduction - fly	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko04810	Regulation of actin cytoskeleton	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05100	Bacterial invasion of epithelial cells	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05110	Vibrio cholerae infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05130	Pathogenic Escherichia coli infection	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05131	Shigellosis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05414	Dilated cardiomyopathy	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020878	K05692	ko05416	Viral myocarditis	647	7.5e-30	0.75	0.82	0.99
PGSC0003DMG200020882	K03936	ko00190	Oxidative phosphorylation	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMG200020882	K03936	ko01100	Metabolic pathways	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMG200020882	K03936	ko05010	Alzheimer's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMG200020882	K03936	ko05012	Parkinson's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMG200020882	K03936	ko05016	Huntington's disease	466	7.2e-20	0.83	0.88	0.95
PGSC0003DMG200020883	K03949	ko00190	Oxidative phosphorylation	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMG200020883	K03949	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMG200020883	K03949	ko05010	Alzheimer's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMG200020883	K03949	ko05012	Parkinson's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMG200020883	K03949	ko05016	Huntington's disease	1160	3.8e-58	0.79	0.87	0.99
PGSC0003DMG200020884	K12795	ko04621	NOD-like receptor signaling pathway	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMG200020884	K12795	ko04626	Plant-pathogen interaction	2234	2.2e-117	0.74	0.83	0.99
PGSC0003DMG200020888	K12843	ko03040	Spliceosome	1138	6.2e-57	0.33	0.52	0.92
PGSC0003DMG200020896	K12356	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.31	0.48	0.96
PGSC0003DMG200020897	K12356	ko00940	Phenylpropanoid biosynthesis	581	3.3e-26	0.41	0.58	0.84
PGSC0003DMG200020898	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020898	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.59	0.95
PGSC0003DMG200020899	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMG200020899	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMG200020899	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMG200020899	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMG200020899	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.46
PGSC0003DMG200037605	K01674	ko00910	Nitrogen metabolism	1078	1.3e-53	0.57	0.74	0.65
PGSC0003DMG200037610	K10760	ko00908	Zeatin biosynthesis	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMG200037610	K10760	ko01100	Metabolic pathways	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMG200037610	K10760	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.74	0.90
PGSC0003DMG200037617	K10760	ko00908	Zeatin biosynthesis	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMG200037617	K10760	ko01100	Metabolic pathways	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMG200037617	K10760	ko01110	Biosynthesis of secondary metabolites	165	3.1e-09	0.55	0.84	0.91
PGSC0003DMG200037625	K11816	ko00380	Tryptophan metabolism	1063	8.5e-53	0.42	0.66	0.98
PGSC0003DMG200000559	K00430	ko00360	Phenylalanine metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMG200000559	K00430	ko00680	Methane metabolism	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMG200000559	K00430	ko00940	Phenylpropanoid biosynthesis	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMG200000559	K00430	ko01100	Metabolic pathways	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMG200000559	K00430	ko01110	Biosynthesis of secondary metabolites	1108	2.8e-55	0.52	0.66	0.99
PGSC0003DMG200000560	K13066	ko00940	Phenylpropanoid biosynthesis	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMG200000560	K13066	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.75	0.86	0.99
PGSC0003DMG200000560	K13066	ko00940	Phenylpropanoid biosynthesis	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMG200000560	K13066	ko01110	Biosynthesis of secondary metabolites	2449	3.1e-129	0.78	0.88	1.00
PGSC0003DMG200000563	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMG200000563	K00517	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMG200000563	K00517	ko00903	Limonene and pinene degradation	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMG200000563	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMG200000563	K00517	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.64	0.80	0.93
PGSC0003DMG200000564	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMG200000564	K00517	ko00626	Naphthalene and anthracene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMG200000564	K00517	ko00903	Limonene and pinene degradation	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMG200000564	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMG200000564	K00517	ko01110	Biosynthesis of secondary metabolites	1905	3.1e-99	0.47	0.66	0.99
PGSC0003DMG200000565	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMG200000565	K00517	ko00626	Naphthalene and anthracene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMG200000565	K00517	ko00903	Limonene and pinene degradation	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMG200000565	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMG200000565	K00517	ko01110	Biosynthesis of secondary metabolites	1429	5.6e-73	0.56	0.69	0.98
PGSC0003DMG200000567	K00356	ko00190	Oxidative phosphorylation	1068	4.5e-53	0.75	0.84	0.99
PGSC0003DMG200041854	K08243	ko00941	Flavonoid biosynthesis	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMG200041854	K08243	ko01110	Biosynthesis of secondary metabolites	841	1.5e-40	0.48	0.65	0.94
PGSC0003DMG200005483	K05658	ko02010	ABC transporters	3770	4.2e-202	0.43	0.64	0.99
PGSC0003DMG200005490	K12338	ko00942	Anthocyanin biosynthesis	539	6.8e-24	0.42	0.60	0.95
PGSC0003DMG200005492	K10775	ko00360	Phenylalanine metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMG200005492	K10775	ko00910	Nitrogen metabolism	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMG200005492	K10775	ko00940	Phenylpropanoid biosynthesis	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMG200005492	K10775	ko01100	Metabolic pathways	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMG200005492	K10775	ko01110	Biosynthesis of secondary metabolites	3773	2.9e-202	0.68	0.79	0.97
PGSC0003DMG200005494	K00103	ko00053	Ascorbate and aldarate metabolism	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMG200005494	K00103	ko01100	Metabolic pathways	445	1.0e-18	0.27	0.44	0.83
PGSC0003DMG200005498	K10527	ko00592	alpha-Linolenic acid metabolism	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMG200005498	K10527	ko01100	Metabolic pathways	3622	6.1e-194	0.62	0.78	1.00
PGSC0003DMG200008590	K12185	ko04144	Endocytosis	1210	6.7e-61	0.67	0.81	0.97
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	984	1.9e-48	0.40	0.59	0.97
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	997	3.7e-49	0.41	0.60	0.97
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	1006	1.2e-49	0.42	0.60	0.96
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	240	2.1e-07	0.42	0.57	0.98
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	982	2.5e-48	0.41	0.59	0.96
PGSC0003DMG200008591	K05279	ko00944	Flavone and flavonol biosynthesis	264	1.0e-08	0.42	0.62	0.99
PGSC0003DMG200012522	K01641	ko00072	Synthesis and degradation of ketone bodies	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012522	K01641	ko00280	Valine, leucine and isoleucine degradation	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012522	K01641	ko00650	Butanoate metabolism	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012522	K01641	ko00900	Terpenoid backbone biosynthesis	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012522	K01641	ko01100	Metabolic pathways	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012522	K01641	ko01110	Biosynthesis of secondary metabolites	3401	9.5e-182	0.86	0.91	1.00
PGSC0003DMG200012523	K12307	ko04142	Lysosome	406	2.7e-16	0.26	0.46	0.61
PGSC0003DMG200023617	K12850	ko03040	Spliceosome	1538	5.4e-79	0.62	0.79	1.00
PGSC0003DMG200023617	K12850	ko03040	Spliceosome	2600	1.4e-137	0.70	0.84	0.99
PGSC0003DMG200023620	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMG200023620	K01915	ko00330	Arginine and proline metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMG200023620	K01915	ko00910	Nitrogen metabolism	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMG200023620	K01915	ko01100	Metabolic pathways	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMG200023620	K01915	ko02020	Two-component system	2880	5.2e-153	0.89	0.97	1.00
PGSC0003DMG200023623	K12881	ko03040	Spliceosome	1399	2.5e-71	0.65	0.78	0.99
PGSC0003DMG200023623	K12881	ko03040	Spliceosome	790	9.7e-38	0.65	0.77	0.99
PGSC0003DMG200023624	K03946	ko00190	Oxidative phosphorylation	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMG200023624	K03946	ko01100	Metabolic pathways	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMG200023624	K03946	ko05010	Alzheimer's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMG200023624	K03946	ko05012	Parkinson's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMG200023624	K03946	ko05016	Huntington's disease	233	5.1e-07	0.33	0.55	0.89
PGSC0003DMG200023624	K12478	ko04144	Endocytosis	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMG200023624	K12478	ko04145	Phagosome	464	2.4e-16	0.25	0.45	0.97
PGSC0003DMG200023631	K00850	ko00010	Glycolysis / Gluconeogenesis	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023631	K00850	ko00030	Pentose phosphate pathway	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023631	K00850	ko00051	Fructose and mannose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023631	K00850	ko00052	Galactose metabolism	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023631	K00850	ko01100	Metabolic pathways	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023631	K00850	ko01110	Biosynthesis of secondary metabolites	3619	9.0e-194	0.88	0.94	0.88
PGSC0003DMG200023635	K12818	ko03040	Spliceosome	1674	1.7e-86	0.35	0.56	0.44
PGSC0003DMG200026649	K08059	ko04612	Antigen processing and presentation	361	4.5e-14	0.56	0.74	0.65
PGSC0003DMG200026654	K12657	ko00330	Arginine and proline metabolism	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMG200026654	K12657	ko01100	Metabolic pathways	1788	8.8e-93	0.81	0.91	0.95
PGSC0003DMG200026654	K12657	ko00330	Arginine and proline metabolism	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMG200026654	K12657	ko01100	Metabolic pathways	2807	5.5e-149	0.80	0.89	0.94
PGSC0003DMG200026654	K12657	ko00330	Arginine and proline metabolism	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMG200026654	K12657	ko01100	Metabolic pathways	4769	3.4e-257	0.80	0.92	0.99
PGSC0003DMG200026658	K12486	ko04144	Endocytosis	509	3.1e-22	0.52	0.66	0.32
PGSC0003DMG200026658	K12486	ko04144	Endocytosis	511	2.4e-22	0.32	0.51	0.81
PGSC0003DMG200026662	K04733	ko04210	Apoptosis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMG200026662	K04733	ko04620	Toll-like receptor signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMG200026662	K04733	ko04722	Neurotrophin signaling pathway	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMG200026662	K04733	ko05140	Leishmaniasis	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMG200026662	K04733	ko05142	Chagas disease	983	2.2e-48	0.40	0.56	0.55
PGSC0003DMG200026662	K04733	ko04210	Apoptosis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMG200026662	K04733	ko04620	Toll-like receptor signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMG200026662	K04733	ko04722	Neurotrophin signaling pathway	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMG200026662	K04733	ko05140	Leishmaniasis	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMG200026662	K04733	ko05142	Chagas disease	994	5.5e-49	0.40	0.56	0.68
PGSC0003DMG200029115	K02706	ko00195	Photosynthesis	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMG200029115	K02706	ko01100	Metabolic pathways	309	3.3e-11	0.90	0.93	0.28
PGSC0003DMG200029122	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029122	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029122	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029122	K01590	ko00340	Histidine metabolism	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029122	K01590	ko01100	Metabolic pathways	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029122	K01590	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.78	0.85	0.97
PGSC0003DMG200029127	K02894	ko03010	Ribosome	394	6.8e-16	0.72	0.74	0.95
PGSC0003DMG200029128	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko04210	Apoptosis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko04620	Toll-like receptor signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko04722	Neurotrophin signaling pathway	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko05140	Leishmaniasis	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029128	K04733	ko05142	Chagas disease	551	2.6e-24	0.44	0.66	0.94
PGSC0003DMG200029130	K12356	ko00940	Phenylpropanoid biosynthesis	544	3.6e-24	0.32	0.50	0.98
PGSC0003DMG200029131	K12356	ko00940	Phenylpropanoid biosynthesis	588	1.3e-26	0.38	0.54	0.95
PGSC0003DMG200030627	K07374	ko04145	Phagosome	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMG200030627	K07374	ko04540	Gap junction	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMG200030627	K07374	ko05130	Pathogenic Escherichia coli infection	3486	1.9e-186	0.91	0.94	1.00
PGSC0003DMG200030627	K07374	ko04145	Phagosome	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMG200030627	K07374	ko04540	Gap junction	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMG200030627	K07374	ko05130	Pathogenic Escherichia coli infection	3677	5.7e-197	0.94	0.97	1.00
PGSC0003DMG200030628	K02266	ko00190	Oxidative phosphorylation	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko01100	Metabolic pathways	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko04260	Cardiac muscle contraction	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko05010	Alzheimer's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko05012	Parkinson's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko05016	Huntington's disease	418	3.2e-17	0.55	0.62	0.99
PGSC0003DMG200030628	K02266	ko00190	Oxidative phosphorylation	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030628	K02266	ko01100	Metabolic pathways	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030628	K02266	ko04260	Cardiac muscle contraction	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030628	K02266	ko05010	Alzheimer's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030628	K02266	ko05012	Parkinson's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030628	K02266	ko05016	Huntington's disease	588	1.3e-26	0.70	0.79	0.99
PGSC0003DMG200030629	K04487	ko00730	Thiamine metabolism	3187	6.0e-170	0.83	0.91	1.00
PGSC0003DMG200030632	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030632	K01873	ko00970	Aminoacyl-tRNA biosynthesis	545	1.3e-23	0.70	0.79	0.25
PGSC0003DMG200030635	K10747	ko03030	DNA replication	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	2102	4.2e-110	0.42	0.66	0.44
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03030	DNA replication	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	878	1.4e-42	0.52	0.73	0.95
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03030	DNA replication	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	1040	1.6e-51	0.46	0.68	0.96
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03030	DNA replication	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03410	Base excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03420	Nucleotide excision repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200030635	K10747	ko03430	Mismatch repair	881	9.3e-43	0.51	0.72	0.88
PGSC0003DMG200023909	K07195	ko04910	Insulin signaling pathway	2729	1.1e-144	0.55	0.73	0.95
PGSC0003DMG200023910	K07195	ko04910	Insulin signaling pathway	2720	3.5e-144	0.55	0.73	0.95
PGSC0003DMG200022314	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMG200022314	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMG200022314	K00734	ko01100	Metabolic pathways	388	1.4e-15	0.32	0.46	0.62
PGSC0003DMG200022319	K01076	ko00632	Benzoate degradation via CoA ligation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMG200022319	K01076	ko00903	Limonene and pinene degradation	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMG200022319	K01076	ko01040	Biosynthesis of unsaturated fatty acids	806	1.3e-38	0.53	0.65	0.97
PGSC0003DMG200022320	K10374	ko04260	Cardiac muscle contraction	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMG200022320	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMG200022320	K10374	ko05414	Dilated cardiomyopathy	225	5.9e-06	0.32	0.48	0.34
PGSC0003DMG200022320	K10374	ko04260	Cardiac muscle contraction	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMG200022320	K10374	ko05410	Hypertrophic cardiomyopathy (HCM)	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMG200022320	K10374	ko05414	Dilated cardiomyopathy	225	6.2e-06	0.32	0.48	0.33
PGSC0003DMG200030355	K12827	ko03040	Spliceosome	303	2.5e-10	0.52	0.65	0.47
PGSC0003DMG200030356	K00874	ko00030	Pentose phosphate pathway	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMG200030356	K00874	ko00040	Pentose and glucuronate interconversions	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMG200030356	K00874	ko01100	Metabolic pathways	262	1.3e-08	0.30	0.46	0.65
PGSC0003DMG200030359	K06215	ko00750	Vitamin B6 metabolism	2427	5.0e-128	0.93	0.98	1.00
PGSC0003DMG200030360	K05857	ko00562	Inositol phosphate metabolism	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMG200030360	K05857	ko01100	Metabolic pathways	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMG200030360	K05857	ko04020	Calcium signaling pathway	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMG200030360	K05857	ko04070	Phosphatidylinositol signaling system	1852	2.6e-96	0.55	0.62	0.86
PGSC0003DMG200030362	K04124	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMG200030362	K04124	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.30	0.49	0.94
PGSC0003DMG200030366	K12854	ko03040	Spliceosome	16280	0.	0.88	0.95	1.00
PGSC0003DMG200030366	K12854	ko03040	Spliceosome	8666	0.	0.64	0.77	1.00
PGSC0003DMG200030367	K12854	ko03040	Spliceosome	847	8.1e-40	0.67	0.81	0.99
PGSC0003DMG200030369	K04103	ko00380	Tryptophan metabolism	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMG200030369	K04103	ko01100	Metabolic pathways	4178	1.3e-224	0.82	0.91	0.99
PGSC0003DMG200030370	K01103	ko00051	Fructose and mannose metabolism	5363	5.8e-290	0.85	0.91	1.00
PGSC0003DMG200030370	K01103	ko00051	Fructose and mannose metabolism	2762	1.7e-146	0.79	0.86	1.00
PGSC0003DMG200030370	K01103	ko00051	Fructose and mannose metabolism	5349	3.4e-289	0.85	0.90	1.00
PGSC0003DMG200019748	K00626	ko00071	Fatty acid metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00072	Synthesis and degradation of ketone bodies	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00280	Valine, leucine and isoleucine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00310	Lysine degradation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00380	Tryptophan metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00620	Pyruvate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00632	Benzoate degradation via CoA ligation	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00640	Propanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00650	Butanoate metabolism	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00900	Terpenoid backbone biosynthesis	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko01100	Metabolic pathways	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko01110	Biosynthesis of secondary metabolites	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko02020	Two-component system	2841	7.3e-151	0.83	0.93	0.99
PGSC0003DMG200019758	K01714	ko00300	Lysine biosynthesis	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMG200019758	K01714	ko01100	Metabolic pathways	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMG200019758	K01714	ko01110	Biosynthesis of secondary metabolites	2476	9.9e-131	0.84	0.93	0.94
PGSC0003DMG200019762	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	283	1.2e-19	0.35	0.51	0.74
PGSC0003DMG200019762	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMG200019762	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMG200019762	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMG200019762	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	272	2.6e-08	0.51	0.65	0.77
PGSC0003DMG200019764	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.68
PGSC0003DMG200019766	K00430	ko00360	Phenylalanine metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMG200019766	K00430	ko00680	Methane metabolism	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMG200019766	K00430	ko00940	Phenylpropanoid biosynthesis	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMG200019766	K00430	ko01100	Metabolic pathways	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMG200019766	K00430	ko01110	Biosynthesis of secondary metabolites	1345	2.4e-68	0.64	0.79	0.99
PGSC0003DMG200019771	K09755	ko00940	Phenylpropanoid biosynthesis	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMG200019771	K09755	ko01100	Metabolic pathways	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMG200019771	K09755	ko01110	Biosynthesis of secondary metabolites	1114	1.3e-55	0.43	0.61	0.97
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	460	1.5e-19	0.30	0.47	0.77
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	405	1.7e-16	0.30	0.48	0.63
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	356	7.7e-15	0.31	0.51	0.65
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.87
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	343	8.0e-13	0.33	0.49	0.85
PGSC0003DMG200005718	K12603	ko03018	RNA degradation	480	1.2e-20	0.30	0.46	0.72
PGSC0003DMG200005720	K04368	ko04010	MAPK signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04012	ErbB signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04013	MAPK signaling pathway - fly	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04062	Chemokine signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04114	Oocyte meiosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04270	Vascular smooth muscle contraction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04320	Dorso-ventral axis formation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04370	VEGF signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04510	Focal adhesion	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04540	Gap junction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04620	Toll-like receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04626	Plant-pathogen interaction	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04650	Natural killer cell mediated cytotoxicity	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04660	T cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04662	B cell receptor signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04664	Fc epsilon RI signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04666	Fc gamma R-mediated phagocytosis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04720	Long-term potentiation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04722	Neurotrophin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04730	Long-term depression	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04810	Regulation of actin cytoskeleton	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04910	Insulin signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04912	GnRH signaling pathway	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04914	Progesterone-mediated oocyte maturation	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko04916	Melanogenesis	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05020	Prion diseases	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05200	Pathways in cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05210	Colorectal cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05211	Renal cell carcinoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05212	Pancreatic cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05213	Endometrial cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05214	Glioma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05215	Prostate cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05216	Thyroid cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05218	Melanoma	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05219	Bladder cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05220	Chronic myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05221	Acute myeloid leukemia	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005720	K04368	ko05223	Non-small cell lung cancer	2633	2.2e-139	0.87	0.94	1.00
PGSC0003DMG200005722	K03008	ko00230	Purine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMG200005722	K03008	ko00240	Pyrimidine metabolism	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMG200005722	K03008	ko01100	Metabolic pathways	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMG200005722	K03008	ko03020	RNA polymerase	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMG200005722	K03008	ko05016	Huntington's disease	301	1.2e-07	0.28	0.47	0.41
PGSC0003DMG200016311	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMG200016311	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMG200016311	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.62
PGSC0003DMG200016311	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016311	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016311	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016311	K01099	ko00562	Inositol phosphate metabolism	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016311	K01099	ko01100	Metabolic pathways	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016311	K01099	ko04070	Phosphatidylinositol signaling system	642	8.4e-40	0.37	0.54	0.60
PGSC0003DMG200016313	K02183	ko04020	Calcium signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04070	Phosphatidylinositol signaling system	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04114	Oocyte meiosis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04270	Vascular smooth muscle contraction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04626	Plant-pathogen interaction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04720	Long-term potentiation	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04722	Neurotrophin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04740	Olfactory transduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04744	Phototransduction	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04745	Phototransduction - fly	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04910	Insulin signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04912	GnRH signaling pathway	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04916	Melanogenesis	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04970	Salivary secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04971	Gastric acid secretion	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko05010	Alzheimer's disease	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko05214	Glioma	1100	7.8e-55	0.87	0.95	0.99
PGSC0003DMG200016313	K02183	ko04020	Calcium signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04070	Phosphatidylinositol signaling system	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04114	Oocyte meiosis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04270	Vascular smooth muscle contraction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04626	Plant-pathogen interaction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04720	Long-term potentiation	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04740	Olfactory transduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04744	Phototransduction	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04745	Phototransduction - fly	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04910	Insulin signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04912	GnRH signaling pathway	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04916	Melanogenesis	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04970	Salivary secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko04971	Gastric acid secretion	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko05010	Alzheimer's disease	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016313	K02183	ko05214	Glioma	741	4.9e-35	0.84	0.92	0.95
PGSC0003DMG200016315	K00660	ko00941	Flavonoid biosynthesis	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMG200016315	K00660	ko01100	Metabolic pathways	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMG200016315	K00660	ko01110	Biosynthesis of secondary metabolites	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMG200016315	K00660	ko04712	Circadian rhythm - plant	263	1.2e-07	0.25	0.42	0.81
PGSC0003DMG200016318	K02958	ko03010	Ribosome	685	6.0e-32	0.94	0.99	0.96
PGSC0003DMG200016318	K02958	ko03010	Ribosome	1205	1.3e-60	0.92	0.97	0.99
PGSC0003DMG200016318	K02958	ko03010	Ribosome	521	6.7e-23	0.91	0.96	0.84
PGSC0003DMG200012228	K00001	ko00010	Glycolysis / Gluconeogenesis	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00071	Fatty acid metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00350	Tyrosine metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00624	1- and 2-Methylnaphthalene degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00641	3-Chloroacrylic acid degradation	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00830	Retinol metabolism	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00982	Drug metabolism - cytochrome P450	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko01100	Metabolic pathways	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.73	0.86	0.97
PGSC0003DMG200012228	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00010	Glycolysis / Gluconeogenesis	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00071	Fatty acid metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00350	Tyrosine metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00624	1- and 2-Methylnaphthalene degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00641	3-Chloroacrylic acid degradation	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00830	Retinol metabolism	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko01100	Metabolic pathways	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.72	0.84	0.99
PGSC0003DMG200012228	K00001	ko00010	Glycolysis / Gluconeogenesis	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00071	Fatty acid metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00350	Tyrosine metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00641	3-Chloroacrylic acid degradation	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00830	Retinol metabolism	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00982	Drug metabolism - cytochrome P450	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko01100	Metabolic pathways	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.66	0.81	1.00
PGSC0003DMG200012228	K00001	ko00010	Glycolysis / Gluconeogenesis	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00071	Fatty acid metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00350	Tyrosine metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00641	3-Chloroacrylic acid degradation	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00830	Retinol metabolism	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko00982	Drug metabolism - cytochrome P450	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko01100	Metabolic pathways	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012228	K00001	ko01110	Biosynthesis of secondary metabolites	2201	1.5e-115	0.67	0.83	1.00
PGSC0003DMG200012232	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMG200012232	K01078	ko00740	Riboflavin metabolism	326	3.8e-12	0.31	0.46	0.88
PGSC0003DMG200012235	K01179	ko00500	Starch and sucrose metabolism	2068	3.2e-108	0.52	0.66	0.98
PGSC0003DMG200012235	K01179	ko00500	Starch and sucrose metabolism	2367	1.0e-124	0.58	0.73	0.99
PGSC0003DMG200012238	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMG200012239	K01761	ko00270	Cysteine and methionine metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMG200012239	K01761	ko00450	Selenoamino acid metabolism	3035	1.5e-161	0.80	0.90	0.99
PGSC0003DMG200001740	K07252	ko00510	N-Glycan biosynthesis	1344	2.7e-68	0.71	0.84	0.97
PGSC0003DMG200001745	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMG200001745	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6571	0.	0.73	0.84	0.98
PGSC0003DMG200001746	K02706	ko00195	Photosynthesis	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMG200001746	K02706	ko01100	Metabolic pathways	2009	5.7e-105	0.99	1.00	0.98
PGSC0003DMG200001748	K02931	ko03010	Ribosome	1639	1.5e-84	0.74	0.86	1.00
PGSC0003DMG200001759	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMG200001760	K12478	ko04144	Endocytosis	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMG200001760	K12478	ko04145	Phagosome	507	3.2e-21	0.29	0.50	0.80
PGSC0003DMG200041741	K11294	ko05130	Pathogenic Escherichia coli infection	219	3.3e-06	0.40	0.65	0.20
PGSC0003DMG200047298	K03869	ko04120	Ubiquitin mediated proteolysis	466	1.4e-19	0.43	0.62	0.84
PGSC0003DMG200047301	K11251	ko05322	Systemic lupus erythematosus	519	8.6e-23	0.68	0.83	0.72
PGSC0003DMG200000339	K01190	ko00052	Galactose metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMG200000339	K01190	ko00511	Other glycan degradation	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMG200000339	K01190	ko00600	Sphingolipid metabolism	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMG200000339	K01190	ko01100	Metabolic pathways	4206	3.8e-226	0.68	0.84	1.00
PGSC0003DMG200000339	K01190	ko00052	Galactose metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMG200000339	K01190	ko00511	Other glycan degradation	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMG200000339	K01190	ko00600	Sphingolipid metabolism	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMG200000339	K01190	ko01100	Metabolic pathways	3432	1.9e-183	0.66	0.83	0.98
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	1761	2.7e-91	0.65	0.75	0.96
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	2046	5.2e-107	0.73	0.85	0.97
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	2033	2.7e-106	0.73	0.84	0.97
PGSC0003DMG200000341	K00677	ko00540	Lipopolysaccharide biosynthesis	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMG200000341	K00677	ko01100	Metabolic pathways	1355	6.7e-69	0.77	0.87	1.00
PGSC0003DMG200000342	K05863	ko04020	Calcium signaling pathway	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMG200000342	K05863	ko05012	Parkinson's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMG200000342	K05863	ko05016	Huntington's disease	393	7.7e-16	0.40	0.61	0.84
PGSC0003DMG200000344	K12837	ko03040	Spliceosome	2859	7.5e-152	0.84	0.92	1.00
PGSC0003DMG200000344	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMG200000344	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMG200000344	K12837	ko03040	Spliceosome	3379	1.6e-180	0.70	0.79	0.98
PGSC0003DMG200000344	K12837	ko03040	Spliceosome	2672	1.5e-141	0.85	0.94	1.00
PGSC0003DMG200000345	K02910	ko03010	Ribosome	960	4.1e-47	0.95	0.98	0.99
PGSC0003DMG200033065	K00117	ko00030	Pentose phosphate pathway	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMG200033065	K00117	ko01100	Metabolic pathways	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMG200033065	K00117	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.32	0.50	0.66
PGSC0003DMG200033065	K00117	ko00030	Pentose phosphate pathway	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMG200033065	K00117	ko01100	Metabolic pathways	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMG200033065	K00117	ko01110	Biosynthesis of secondary metabolites	754	9.4e-36	0.34	0.51	0.68
PGSC0003DMG200033066	K12866	ko03040	Spliceosome	745	3.0e-35	0.31	0.42	0.98
PGSC0003DMG200033070	K01728	ko00040	Pentose and glucuronate interconversions	1872	2.0e-97	0.58	0.72	0.88
PGSC0003DMG200033072	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMG200033072	K00294	ko00330	Arginine and proline metabolism	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMG200033072	K00294	ko01100	Metabolic pathways	3867	1.9e-207	0.80	0.90	1.00
PGSC0003DMG200033072	K00294	ko00250	Alanine, aspartate and glutamate metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMG200033072	K00294	ko00330	Arginine and proline metabolism	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMG200033072	K00294	ko01100	Metabolic pathways	3223	6.2e-172	0.84	0.93	1.00
PGSC0003DMG200033077	K05648	ko02010	ABC transporters	1174	8.5e-59	0.32	0.49	0.67
PGSC0003DMG200033077	K05648	ko02010	ABC transporters	1250	4.1e-63	0.32	0.51	0.68
PGSC0003DMG200033080	K02915	ko03010	Ribosome	764	2.6e-36	0.95	0.99	0.85
PGSC0003DMG200033084	K08910	ko00196	Photosynthesis - antenna proteins	1854	2.0e-96	0.85	0.93	0.99
PGSC0003DMG200017768	K13030	ko00460	Cyanoamino acid metabolism	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMG200017768	K13030	ko01110	Biosynthesis of secondary metabolites	759	5.0e-36	0.43	0.61	0.99
PGSC0003DMG200017779	K00558	ko00270	Cysteine and methionine metabolism	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMG200017779	K00558	ko01100	Metabolic pathways	1814	3.2e-94	0.44	0.53	0.90
PGSC0003DMG200017779	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMG200017779	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMG200017779	K00558	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMG200017779	K00558	ko01100	Metabolic pathways	2221	1.2e-116	0.49	0.59	0.91
PGSC0003DMG200017782	K02933	ko03010	Ribosome	605	1.6e-27	0.84	0.95	0.92
PGSC0003DMG200017785	K00654	ko00600	Sphingolipid metabolism	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMG200017785	K00654	ko01100	Metabolic pathways	2590	5.1e-137	0.79	0.86	0.98
PGSC0003DMG200027779	K11821	ko00380	Tryptophan metabolism	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMG200027779	K11821	ko00966	Glucosinolate biosynthesis	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMG200027779	K11821	ko01110	Biosynthesis of secondary metabolites	1123	4.2e-56	0.44	0.63	0.96
PGSC0003DMG200027789	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K00859	ko00770	Pantothenate and CoA biosynthesis	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K00859	ko01100	Metabolic pathways	1522	4.1e-78	0.80	0.90	0.99
PGSC0003DMG200027789	K02690	ko00195	Photosynthesis	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMG200027789	K02690	ko01100	Metabolic pathways	223	8.9e-06	0.96	1.00	0.39
PGSC0003DMG200027790	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko00770	Pantothenate and CoA biosynthesis	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko01100	Metabolic pathways	1432	3.8e-73	0.78	0.88	0.97
PGSC0003DMG200027790	K00859	ko00770	Pantothenate and CoA biosynthesis	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMG200027790	K00859	ko01100	Metabolic pathways	772	9.6e-37	0.70	0.85	0.96
PGSC0003DMG200027791	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMG200027791	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMG200027791	K00734	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.49	0.54
PGSC0003DMG200013977	K05741	ko04810	Regulation of actin cytoskeleton	681	7.9e-30	0.29	0.44	0.54
PGSC0003DMG200013992	K01047	ko00564	Glycerophospholipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko00565	Ether lipid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko00590	Arachidonic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko00591	Linoleic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko00592	alpha-Linolenic acid metabolism	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko01100	Metabolic pathways	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04010	MAPK signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04370	VEGF signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04664	Fc epsilon RI signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04730	Long-term depression	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko04912	GnRH signaling pathway	266	7.8e-09	0.53	0.73	0.43
PGSC0003DMG200013992	K01047	ko00564	Glycerophospholipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko00565	Ether lipid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko00590	Arachidonic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko00591	Linoleic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko00592	alpha-Linolenic acid metabolism	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko01100	Metabolic pathways	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04010	MAPK signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04270	Vascular smooth muscle contraction	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04370	VEGF signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04664	Fc epsilon RI signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04730	Long-term depression	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200013992	K01047	ko04912	GnRH signaling pathway	335	1.2e-12	0.40	0.66	0.74
PGSC0003DMG200011040	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMG200011041	K02896	ko03010	Ribosome	1268	4.2e-64	0.91	0.95	0.99
PGSC0003DMG200011042	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMG200011042	K00517	ko00626	Naphthalene and anthracene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMG200011042	K00517	ko00903	Limonene and pinene degradation	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMG200011042	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMG200011042	K00517	ko01110	Biosynthesis of secondary metabolites	1730	1.4e-89	0.46	0.69	0.98
PGSC0003DMG200011042	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMG200011042	K00517	ko00626	Naphthalene and anthracene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMG200011042	K00517	ko00903	Limonene and pinene degradation	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMG200011042	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMG200011042	K00517	ko01110	Biosynthesis of secondary metabolites	748	2.0e-35	0.51	0.73	0.96
PGSC0003DMG200011044	K01689	ko00010	Glycolysis / Gluconeogenesis	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMG200011044	K01689	ko01100	Metabolic pathways	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMG200011044	K01689	ko01110	Biosynthesis of secondary metabolites	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMG200011044	K01689	ko03018	RNA degradation	3280	4.5e-175	0.88	0.93	1.00
PGSC0003DMG200011044	K01689	ko00010	Glycolysis / Gluconeogenesis	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMG200011044	K01689	ko01100	Metabolic pathways	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMG200011044	K01689	ko01110	Biosynthesis of secondary metabolites	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMG200011044	K01689	ko03018	RNA degradation	3376	2.3e-180	0.90	0.95	1.00
PGSC0003DMG200011047	K02930	ko03010	Ribosome	2846	3.9e-151	0.85	0.93	1.00
PGSC0003DMG200011048	K12134	ko04712	Circadian rhythm - plant	493	2.3e-21	0.35	0.51	0.88
PGSC0003DMG200011048	K12134	ko04712	Circadian rhythm - plant	293	6.2e-10	0.56	0.74	0.95
PGSC0003DMG200011049	K00799	ko00480	Glutathione metabolism	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMG200011049	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMG200011049	K00799	ko00982	Drug metabolism - cytochrome P450	1200	2.4e-60	0.61	0.75	0.97
PGSC0003DMG200009917	K12666	ko00510	N-Glycan biosynthesis	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMG200009917	K12666	ko01100	Metabolic pathways	3739	2.2e-200	0.71	0.87	1.00
PGSC0003DMG200009923	K00100	ko00051	Fructose and mannose metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009923	K00100	ko00363	Bisphenol A degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009923	K00100	ko00591	Linoleic acid metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009923	K00100	ko00625	Tetrachloroethene degradation	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009923	K00100	ko00650	Butanoate metabolism	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009923	K00100	ko01100	Metabolic pathways	1164	2.3e-58	0.48	0.65	0.71
PGSC0003DMG200009924	K00021	ko00900	Terpenoid backbone biosynthesis	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMG200009924	K00021	ko01100	Metabolic pathways	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMG200009924	K00021	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.75	0.85	1.00
PGSC0003DMG200045892	K01509	ko00230	Purine metabolism	276	1.1e-08	0.40	0.62	0.87
PGSC0003DMG200045895	K03469	ko03030	DNA replication	219	6.6e-06	0.31	0.48	0.26
PGSC0003DMG200031365	K10775	ko00360	Phenylalanine metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMG200031365	K10775	ko00910	Nitrogen metabolism	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMG200031365	K10775	ko00940	Phenylpropanoid biosynthesis	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMG200031365	K10775	ko01100	Metabolic pathways	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMG200031365	K10775	ko01110	Biosynthesis of secondary metabolites	5183	4.9e-280	0.88	0.95	0.98
PGSC0003DMG200031370	K00162	ko00010	Glycolysis / Gluconeogenesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko00020	Citrate cycle (TCA cycle)	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko00620	Pyruvate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko00650	Butanoate metabolism	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko01100	Metabolic pathways	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko01110	Biosynthesis of secondary metabolites	2880	5.2e-153	0.81	0.86	1.00
PGSC0003DMG200031370	K00162	ko00010	Glycolysis / Gluconeogenesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko00020	Citrate cycle (TCA cycle)	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko00620	Pyruvate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko00650	Butanoate metabolism	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko01100	Metabolic pathways	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031370	K00162	ko01110	Biosynthesis of secondary metabolites	3018	1.3e-160	0.88	0.92	1.00
PGSC0003DMG200031372	K04498	ko04110	Cell cycle	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04310	Wnt signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04330	Notch signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04350	TGF-beta signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04520	Adherens junction	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04630	Jak-STAT signaling pathway	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04720	Long-term potentiation	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04916	Melanogenesis	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko05016	Huntington's disease	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko05200	Pathways in cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko05211	Renal cell carcinoma	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko05215	Prostate cancer	8741	0.	0.62	0.74	1.00
PGSC0003DMG200031372	K04498	ko04110	Cell cycle	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04310	Wnt signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04330	Notch signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04350	TGF-beta signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04520	Adherens junction	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04630	Jak-STAT signaling pathway	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04720	Long-term potentiation	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04916	Melanogenesis	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko05016	Huntington's disease	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko05200	Pathways in cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko05211	Renal cell carcinoma	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko05215	Prostate cancer	9248	0.	0.64	0.76	1.00
PGSC0003DMG200031372	K04498	ko04110	Cell cycle	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04310	Wnt signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04330	Notch signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04350	TGF-beta signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04520	Adherens junction	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04630	Jak-STAT signaling pathway	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04720	Long-term potentiation	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04916	Melanogenesis	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05016	Huntington's disease	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05200	Pathways in cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05211	Renal cell carcinoma	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05215	Prostate cancer	9243	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04110	Cell cycle	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04310	Wnt signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04330	Notch signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04350	TGF-beta signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04520	Adherens junction	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04630	Jak-STAT signaling pathway	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04720	Long-term potentiation	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko04916	Melanogenesis	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05016	Huntington's disease	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05200	Pathways in cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05211	Renal cell carcinoma	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031372	K04498	ko05215	Prostate cancer	9241	0.	0.65	0.76	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5215	8.4e-282	0.72	0.83	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.74	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5268	1.0e-284	0.73	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5326	6.4e-288	0.74	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5273	5.3e-285	0.73	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5316	2.3e-287	0.74	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5279	2.5e-285	0.73	0.85	1.00
PGSC0003DMG200028449	K04733	ko04210	Apoptosis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMG200028449	K04733	ko04620	Toll-like receptor signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMG200028449	K04733	ko04722	Neurotrophin signaling pathway	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMG200028449	K04733	ko05140	Leishmaniasis	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMG200028449	K04733	ko05142	Chagas disease	854	2.9e-41	0.33	0.48	0.94
PGSC0003DMG200028449	K04733	ko04210	Apoptosis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMG200028449	K04733	ko04620	Toll-like receptor signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMG200028449	K04733	ko04722	Neurotrophin signaling pathway	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMG200028449	K04733	ko05140	Leishmaniasis	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMG200028449	K04733	ko05142	Chagas disease	716	1.2e-33	0.32	0.47	0.95
PGSC0003DMG200028450	K00558	ko00270	Cysteine and methionine metabolism	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMG200028450	K00558	ko01100	Metabolic pathways	556	8.9e-24	0.42	0.58	0.95
PGSC0003DMG200028450	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04210	Apoptosis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04620	Toll-like receptor signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko04722	Neurotrophin signaling pathway	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05140	Leishmaniasis	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028450	K04733	ko05142	Chagas disease	427	3.6e-17	0.29	0.45	0.78
PGSC0003DMG200028454	K04733	ko04210	Apoptosis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMG200028454	K04733	ko04620	Toll-like receptor signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMG200028454	K04733	ko04722	Neurotrophin signaling pathway	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMG200028454	K04733	ko05140	Leishmaniasis	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMG200028454	K04733	ko05142	Chagas disease	675	2.1e-31	0.29	0.45	0.96
PGSC0003DMG200018511	K01057	ko00030	Pentose phosphate pathway	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMG200018511	K01057	ko01100	Metabolic pathways	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMG200018511	K01057	ko01110	Biosynthesis of secondary metabolites	1727	2.0e-89	0.66	0.78	0.97
PGSC0003DMG200018513	K01509	ko00230	Purine metabolism	740	5.6e-35	0.48	0.63	0.91
PGSC0003DMG200018513	K01509	ko00230	Purine metabolism	1083	6.7e-54	0.47	0.64	0.90
PGSC0003DMG200018513	K01509	ko00230	Purine metabolism	1097	1.1e-54	0.47	0.62	0.85
PGSC0003DMG200018513	K01509	ko00230	Purine metabolism	1055	2.4e-52	0.51	0.67	0.81
PGSC0003DMG200018523	K01199	ko00500	Starch and sucrose metabolism	747	2.3e-35	0.36	0.55	0.86
PGSC0003DMG200027315	K03707	ko00730	Thiamine metabolism	263	1.1e-08	0.28	0.47	0.91
PGSC0003DMG200027317	K02180	ko04110	Cell cycle	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMG200027317	K02180	ko04111	Cell cycle - yeast	275	2.5e-09	0.40	0.50	0.92
PGSC0003DMG200027320	K01112	ko00051	Fructose and mannose metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMG200027320	K01112	ko00730	Thiamine metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMG200027320	K01112	ko00740	Riboflavin metabolism	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMG200027320	K01112	ko01100	Metabolic pathways	1118	7.9e-56	0.37	0.54	0.74
PGSC0003DMG200027321	K00873	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko00230	Purine metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko00620	Pyruvate metabolism	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko00710	Carbon fixation in photosynthetic organisms	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko01100	Metabolic pathways	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027321	K00873	ko04930	Type II diabetes mellitus	3286	2.1e-175	0.82	0.94	0.90
PGSC0003DMG200027324	K12662	ko03040	Spliceosome	296	2.3e-10	0.31	0.48	0.59
PGSC0003DMG200027325	K06685	ko04111	Cell cycle - yeast	404	4.4e-13	0.25	0.44	0.92
PGSC0003DMG200027327	K07199	ko04910	Insulin signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMG200027327	K07199	ko04920	Adipocytokine signaling pathway	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMG200027327	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	245	1.1e-07	0.32	0.50	0.42
PGSC0003DMG200044693	K10760	ko00908	Zeatin biosynthesis	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMG200044693	K10760	ko01100	Metabolic pathways	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMG200044693	K10760	ko01110	Biosynthesis of secondary metabolites	351	1.4e-22	0.59	0.82	0.91
PGSC0003DMG200044699	K01528	ko04144	Endocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMG200044699	K01528	ko04666	Fc gamma R-mediated phagocytosis	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMG200044699	K01528	ko05100	Bacterial invasion of epithelial cells	461	1.4e-19	0.26	0.46	1.00
PGSC0003DMG200014667	K01885	ko00860	Porphyrin and chlorophyll metabolism	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMG200014667	K01885	ko00970	Aminoacyl-tRNA biosynthesis	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMG200014667	K01885	ko01100	Metabolic pathways	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMG200014667	K01885	ko01110	Biosynthesis of secondary metabolites	3670	1.4e-196	0.77	0.87	0.99
PGSC0003DMG200014672	K00799	ko00480	Glutathione metabolism	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMG200014672	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMG200014672	K00799	ko00982	Drug metabolism - cytochrome P450	576	6.2e-26	0.66	0.82	0.89
PGSC0003DMG200014672	K00799	ko00480	Glutathione metabolism	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMG200014672	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMG200014672	K00799	ko00982	Drug metabolism - cytochrome P450	994	5.5e-49	0.57	0.74	0.95
PGSC0003DMG200014673	K00485	ko00982	Drug metabolism - cytochrome P450	644	1.1e-29	0.31	0.47	0.93
PGSC0003DMG200014673	K00485	ko00982	Drug metabolism - cytochrome P450	687	4.7e-32	0.31	0.47	0.97
PGSC0003DMG200014677	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.66
PGSC0003DMG200014677	K00754	ko00051	Fructose and mannose metabolism	1933	8.8e-101	0.51	0.69	0.67
PGSC0003DMG200010360	K10745	ko03030	DNA replication	676	1.9e-31	0.47	0.60	0.36
PGSC0003DMG200010360	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMG200010360	K10745	ko03030	DNA replication	752	1.2e-35	0.58	0.73	0.90
PGSC0003DMG200010362	K01363	ko04142	Lysosome	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMG200010362	K01363	ko04612	Antigen processing and presentation	1664	6.1e-86	0.75	0.87	0.94
PGSC0003DMG200010362	K01363	ko04142	Lysosome	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMG200010362	K01363	ko04612	Antigen processing and presentation	1641	1.1e-84	0.77	0.89	0.91
PGSC0003DMG200010374	K08139	ko04113	Meiosis - yeast	1002	2.0e-49	0.35	0.52	0.82
PGSC0003DMG200010374	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMG200036399	K10760	ko00908	Zeatin biosynthesis	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMG200036399	K10760	ko01100	Metabolic pathways	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMG200036399	K10760	ko01110	Biosynthesis of secondary metabolites	302	8.0e-11	0.70	0.85	0.63
PGSC0003DMG200023171	K01738	ko00270	Cysteine and methionine metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMG200023171	K01738	ko00450	Selenoamino acid metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMG200023171	K01738	ko00920	Sulfur metabolism	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMG200023171	K01738	ko01100	Metabolic pathways	2505	2.5e-132	0.78	0.88	0.99
PGSC0003DMG200023173	K00276	ko00260	Glycine, serine and threonine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko00350	Tyrosine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko00360	Phenylalanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko00410	beta-Alanine metabolism	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko00950	Isoquinoline alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko01100	Metabolic pathways	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023173	K00276	ko01110	Biosynthesis of secondary metabolites	5560	7.9e-301	0.80	0.89	1.00
PGSC0003DMG200023181	K12662	ko03040	Spliceosome	288	3.2e-08	0.28	0.45	0.63
PGSC0003DMG200023182	K01046	ko00561	Glycerolipid metabolism	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMG200023182	K01046	ko01100	Metabolic pathways	270	3.0e-08	0.31	0.46	0.43
PGSC0003DMG200023184	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.41	0.57	0.89
PGSC0003DMG200023184	K08770	ko03320	PPAR signaling pathway	435	3.7e-18	0.42	0.57	0.95
PGSC0003DMG200023186	K13030	ko00460	Cyanoamino acid metabolism	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMG200023186	K13030	ko01110	Biosynthesis of secondary metabolites	959	4.6e-47	0.33	0.54	0.99
PGSC0003DMG200019060	K00696	ko00500	Starch and sucrose metabolism	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMG200019060	K00696	ko01100	Metabolic pathways	1036	2.6e-51	0.88	0.95	0.95
PGSC0003DMG200019060	K00696	ko00500	Starch and sucrose metabolism	6570	0.	0.75	0.85	1.00
PGSC0003DMG200019060	K00696	ko01100	Metabolic pathways	6570	0.	0.75	0.85	1.00
PGSC0003DMG200019060	K00696	ko00500	Starch and sucrose metabolism	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMG200019060	K00696	ko01100	Metabolic pathways	986	1.5e-48	0.59	0.72	0.96
PGSC0003DMG200019060	K00696	ko00500	Starch and sucrose metabolism	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMG200019060	K00696	ko01100	Metabolic pathways	1699	7.1e-88	0.66	0.78	0.97
PGSC0003DMG200019060	K00696	ko00500	Starch and sucrose metabolism	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMG200019060	K00696	ko01100	Metabolic pathways	3376	2.3e-180	0.72	0.83	0.99
PGSC0003DMG200019063	K06118	ko00520	Amino sugar and nucleotide sugar metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMG200019063	K06118	ko00561	Glycerolipid metabolism	3243	4.9e-173	0.81	0.87	1.00
PGSC0003DMG200029638	K12596	ko03018	RNA degradation	246	3.4e-07	0.31	0.47	0.68
PGSC0003DMG200029645	K01728	ko00040	Pentose and glucuronate interconversions	2903	2.8e-154	0.77	0.86	0.94
PGSC0003DMG200029646	K06067	ko04110	Cell cycle	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMG200029646	K06067	ko04330	Notch signaling pathway	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMG200029646	K06067	ko05016	Huntington's disease	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMG200029646	K06067	ko05200	Pathways in cancer	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMG200029646	K06067	ko05220	Chronic myeloid leukemia	3568	5.8e-191	0.78	0.84	0.99
PGSC0003DMG200029646	K06067	ko04110	Cell cycle	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMG200029646	K06067	ko04330	Notch signaling pathway	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMG200029646	K06067	ko05016	Huntington's disease	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMG200029646	K06067	ko05200	Pathways in cancer	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMG200029646	K06067	ko05220	Chronic myeloid leukemia	3653	1.2e-195	0.84	0.90	0.99
PGSC0003DMG200029651	K12624	ko03018	RNA degradation	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMG200029651	K12624	ko03040	Spliceosome	690	3.2e-32	0.95	0.97	0.98
PGSC0003DMG200000978	K03921	ko00061	Fatty acid biosynthesis	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMG200000978	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2628	4.1e-139	0.77	0.86	0.99
PGSC0003DMG200000980	K00609	ko00240	Pyrimidine metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMG200000980	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMG200000980	K00609	ko01100	Metabolic pathways	2043	7.6e-107	0.67	0.74	0.96
PGSC0003DMG200000980	K00609	ko00240	Pyrimidine metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMG200000980	K00609	ko00250	Alanine, aspartate and glutamate metabolism	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMG200000980	K00609	ko01100	Metabolic pathways	2352	6.9e-124	0.87	0.93	0.86
PGSC0003DMG200000984	K10258	ko01040	Biosynthesis of unsaturated fatty acids	525	4.0e-23	0.33	0.53	0.95
PGSC0003DMG200000984	K10258	ko01040	Biosynthesis of unsaturated fatty acids	351	1.6e-13	0.37	0.56	0.94
PGSC0003DMG200000985	K10258	ko01040	Biosynthesis of unsaturated fatty acids	467	6.4e-20	0.36	0.51	0.91
PGSC0003DMG200000986	K10258	ko01040	Biosynthesis of unsaturated fatty acids	502	7.5e-22	0.35	0.54	0.88
PGSC0003DMG200000995	K11808	ko00230	Purine metabolism	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMG200000995	K11808	ko01100	Metabolic pathways	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMG200000995	K11808	ko01110	Biosynthesis of secondary metabolites	2909	1.3e-154	0.63	0.74	1.00
PGSC0003DMG200000995	K11808	ko00230	Purine metabolism	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMG200000995	K11808	ko01100	Metabolic pathways	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMG200000995	K11808	ko01110	Biosynthesis of secondary metabolites	4034	1.2e-216	0.79	0.89	0.99
PGSC0003DMG200042942	K02925	ko03010	Ribosome	214	6.9e-06	0.80	0.87	0.36
PGSC0003DMG200042943	K02738	ko03050	Proteasome	467	6.4e-20	0.37	0.55	0.80
PGSC0003DMG200042963	K12849	ko03040	Spliceosome	221	2.4e-06	0.30	0.49	0.90
PGSC0003DMG200040303	K00001	ko00010	Glycolysis / Gluconeogenesis	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00071	Fatty acid metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00350	Tyrosine metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00624	1- and 2-Methylnaphthalene degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00641	3-Chloroacrylic acid degradation	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00830	Retinol metabolism	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko00982	Drug metabolism - cytochrome P450	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko01100	Metabolic pathways	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040303	K00001	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.40	0.57	0.79
PGSC0003DMG200040317	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1396	3.7e-71	0.56	0.66	0.99
PGSC0003DMG200006379	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200006379	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200006379	K10157	ko01100	Metabolic pathways	530	2.1e-23	0.36	0.51	0.84
PGSC0003DMG200006379	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMG200006379	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMG200006379	K10158	ko01100	Metabolic pathways	325	4.3e-12	0.44	0.60	0.60
PGSC0003DMG200006381	K02492	ko00860	Porphyrin and chlorophyll metabolism	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMG200006381	K02492	ko01100	Metabolic pathways	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMG200006381	K02492	ko01110	Biosynthesis of secondary metabolites	3790	3.3e-203	0.85	0.92	1.00
PGSC0003DMG200006386	K00430	ko00360	Phenylalanine metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMG200006386	K00430	ko00680	Methane metabolism	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMG200006386	K00430	ko00940	Phenylpropanoid biosynthesis	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMG200006386	K00430	ko01100	Metabolic pathways	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMG200006386	K00430	ko01110	Biosynthesis of secondary metabolites	1926	2.1e-100	0.72	0.85	0.95
PGSC0003DMG200006387	K12129	ko04712	Circadian rhythm - plant	248	3.4e-07	0.28	0.44	0.92
PGSC0003DMG200006390	K06100	ko04530	Tight junction	3487	1.7e-186	0.50	0.67	0.73
PGSC0003DMG200006391	K01610	ko00010	Glycolysis / Gluconeogenesis	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko00020	Citrate cycle (TCA cycle)	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko00620	Pyruvate metabolism	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko00710	Carbon fixation in photosynthetic organisms	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko01100	Metabolic pathways	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.81	0.90	0.97
PGSC0003DMG200006391	K01610	ko00010	Glycolysis / Gluconeogenesis	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko00020	Citrate cycle (TCA cycle)	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko00620	Pyruvate metabolism	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko00710	Carbon fixation in photosynthetic organisms	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko01100	Metabolic pathways	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko01110	Biosynthesis of secondary metabolites	576	6.2e-26	0.99	0.99	0.97
PGSC0003DMG200006391	K01610	ko00010	Glycolysis / Gluconeogenesis	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200006391	K01610	ko00020	Citrate cycle (TCA cycle)	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200006391	K01610	ko00620	Pyruvate metabolism	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200006391	K01610	ko00710	Carbon fixation in photosynthetic organisms	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200006391	K01610	ko01100	Metabolic pathways	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200006391	K01610	ko01110	Biosynthesis of secondary metabolites	4868	1.2e-262	0.85	0.92	1.00
PGSC0003DMG200015579	K11820	ko00380	Tryptophan metabolism	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMG200015579	K11820	ko00966	Glucosinolate biosynthesis	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMG200015579	K11820	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.53	0.72	0.99
PGSC0003DMG200015581	K01199	ko00500	Starch and sucrose metabolism	767	1.8e-36	0.36	0.58	0.69
PGSC0003DMG200015584	K00430	ko00360	Phenylalanine metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMG200015584	K00430	ko00680	Methane metabolism	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMG200015584	K00430	ko00940	Phenylpropanoid biosynthesis	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMG200015584	K00430	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMG200015584	K00430	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.72	0.94
PGSC0003DMG200015584	K00430	ko00360	Phenylalanine metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMG200015584	K00430	ko00680	Methane metabolism	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMG200015584	K00430	ko00940	Phenylpropanoid biosynthesis	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMG200015584	K00430	ko01100	Metabolic pathways	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMG200015584	K00430	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.61	0.74	0.95
PGSC0003DMG200015597	K06627	ko04110	Cell cycle	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMG200015597	K06627	ko04914	Progesterone-mediated oocyte maturation	335	1.2e-12	0.34	0.47	0.72
PGSC0003DMG200015600	K03512	ko03410	Base excision repair	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMG200015600	K03512	ko03450	Non-homologous end-joining	2965	1.1e-157	0.65	0.76	1.00
PGSC0003DMG200004878	K04354	ko04111	Cell cycle - yeast	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMG200004878	K04354	ko04530	Tight junction	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMG200004878	K04354	ko05142	Chagas disease	3548	7.4e-190	0.82	0.87	1.00
PGSC0003DMG200004878	K04354	ko04111	Cell cycle - yeast	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMG200004878	K04354	ko04530	Tight junction	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMG200004878	K04354	ko05142	Chagas disease	3804	5.6e-204	0.87	0.92	1.00
PGSC0003DMG200004880	K01955	ko00240	Pyrimidine metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMG200004880	K01955	ko00250	Alanine, aspartate and glutamate metabolism	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMG200004880	K01955	ko01100	Metabolic pathways	332	1.8e-11	0.41	0.59	0.37
PGSC0003DMG200004881	K12309	ko00052	Galactose metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko00511	Other glycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko00531	Glycosaminoglycan degradation	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko00600	Sphingolipid metabolism	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko01100	Metabolic pathways	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko04142	Lysosome	953	1.0e-46	0.85	0.91	0.91
PGSC0003DMG200004881	K12309	ko00052	Galactose metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko00511	Other glycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko00531	Glycosaminoglycan degradation	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko00600	Sphingolipid metabolism	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko01100	Metabolic pathways	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko04142	Lysosome	3255	1.1e-173	0.71	0.81	0.93
PGSC0003DMG200004881	K12309	ko00052	Galactose metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko00511	Other glycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko00531	Glycosaminoglycan degradation	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko00600	Sphingolipid metabolism	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko01100	Metabolic pathways	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko04142	Lysosome	2822	8.2e-150	0.68	0.81	0.99
PGSC0003DMG200004881	K12309	ko00052	Galactose metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko00511	Other glycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko00531	Glycosaminoglycan degradation	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko00600	Sphingolipid metabolism	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko00604	Glycosphingolipid biosynthesis - ganglio series	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko01100	Metabolic pathways	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004881	K12309	ko04142	Lysosome	1306	3.4e-66	0.61	0.75	0.98
PGSC0003DMG200004885	K04733	ko04210	Apoptosis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMG200004885	K04733	ko04620	Toll-like receptor signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMG200004885	K04733	ko04722	Neurotrophin signaling pathway	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMG200004885	K04733	ko05140	Leishmaniasis	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMG200004885	K04733	ko05142	Chagas disease	745	3.0e-35	0.38	0.57	0.39
PGSC0003DMG200004886	K01733	ko00260	Glycine, serine and threonine metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMG200004886	K01733	ko00750	Vitamin B6 metabolism	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMG200004886	K01733	ko01100	Metabolic pathways	3697	4.5e-198	0.83	0.91	1.00
PGSC0003DMG200002442	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	246	9.8e-08	0.57	0.65	0.41
PGSC0003DMG200002459	K05350	ko00460	Cyanoamino acid metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMG200002459	K05350	ko00500	Starch and sucrose metabolism	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMG200002459	K05350	ko00940	Phenylpropanoid biosynthesis	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMG200002459	K05350	ko01110	Biosynthesis of secondary metabolites	1275	1.7e-64	0.51	0.67	0.94
PGSC0003DMG200002459	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00460	Cyanoamino acid metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00500	Starch and sucrose metabolism	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00940	Phenylpropanoid biosynthesis	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00460	Cyanoamino acid metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00500	Starch and sucrose metabolism	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko00940	Phenylpropanoid biosynthesis	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMG200002459	K05350	ko01110	Biosynthesis of secondary metabolites	1898	7.5e-99	0.54	0.70	0.96
PGSC0003DMG200012899	K06630	ko04110	Cell cycle	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMG200012899	K06630	ko04114	Oocyte meiosis	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMG200012899	K06630	ko04722	Neurotrophin signaling pathway	1555	6.2e-80	0.77	0.90	0.96
PGSC0003DMG200012900	K06627	ko04110	Cell cycle	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMG200012900	K06627	ko04914	Progesterone-mediated oocyte maturation	269	5.3e-09	0.40	0.62	0.50
PGSC0003DMG200012900	K06627	ko04110	Cell cycle	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMG200012900	K06627	ko04914	Progesterone-mediated oocyte maturation	341	5.7e-13	0.31	0.53	0.62
PGSC0003DMG200012905	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMG200012905	K06027	ko04962	Vasopressin-regulated water reabsorption	1034	3.4e-51	0.35	0.53	0.46
PGSC0003DMG200008678	K04424	ko04010	MAPK signaling pathway	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMG200008678	K04424	ko04530	Tight junction	848	6.2e-41	0.41	0.64	0.80
PGSC0003DMG200008678	K04424	ko04010	MAPK signaling pathway	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMG200008678	K04424	ko04530	Tight junction	820	6.7e-42	0.38	0.58	0.64
PGSC0003DMG200008678	K04424	ko04010	MAPK signaling pathway	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMG200008678	K04424	ko04530	Tight junction	353	1.2e-13	0.42	0.65	0.78
PGSC0003DMG200008680	K12897	ko03040	Spliceosome	847	7.0e-41	0.52	0.66	0.98
PGSC0003DMG200008680	K12897	ko03040	Spliceosome	252	4.6e-08	0.47	0.53	0.87
PGSC0003DMG200008680	K12897	ko03040	Spliceosome	638	2.4e-29	0.59	0.75	0.97
PGSC0003DMG200008681	K01115	ko00564	Glycerophospholipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008681	K01115	ko00565	Ether lipid metabolism	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008681	K01115	ko01100	Metabolic pathways	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008681	K01115	ko04144	Endocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008681	K01115	ko04666	Fc gamma R-mediated phagocytosis	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008681	K01115	ko04912	GnRH signaling pathway	3558	2.1e-190	0.52	0.68	0.98
PGSC0003DMG200008684	K12863	ko03040	Spliceosome	1674	1.7e-86	0.84	0.93	1.00
PGSC0003DMG200016246	K02988	ko03010	Ribosome	471	3.8e-20	0.39	0.62	0.31
PGSC0003DMG200016247	K03921	ko00061	Fatty acid biosynthesis	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMG200016247	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2611	3.6e-138	0.79	0.89	0.95
PGSC0003DMG200016249	K13065	ko00940	Phenylpropanoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMG200016249	K13065	ko00941	Flavonoid biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMG200016249	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMG200016249	K13065	ko01110	Biosynthesis of secondary metabolites	731	1.7e-34	0.32	0.50	0.96
PGSC0003DMG200016253	K00650	ko00564	Glycerophospholipid metabolism	423	1.7e-17	0.31	0.44	0.90
PGSC0003DMG200016253	K00650	ko00564	Glycerophospholipid metabolism	361	4.5e-14	0.34	0.48	0.89
PGSC0003DMG200012440	K00826	ko00280	Valine, leucine and isoleucine degradation	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMG200012440	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMG200012440	K00826	ko00770	Pantothenate and CoA biosynthesis	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMG200012440	K00826	ko01100	Metabolic pathways	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMG200012440	K00826	ko01110	Biosynthesis of secondary metabolites	2368	9.0e-125	0.81	0.92	0.97
PGSC0003DMG200012440	K00826	ko00280	Valine, leucine and isoleucine degradation	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMG200012440	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMG200012440	K00826	ko00770	Pantothenate and CoA biosynthesis	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMG200012440	K00826	ko01100	Metabolic pathways	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMG200012440	K00826	ko01110	Biosynthesis of secondary metabolites	2363	1.7e-124	0.79	0.91	0.99
PGSC0003DMG200012444	K01528	ko04144	Endocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMG200012444	K01528	ko04666	Fc gamma R-mediated phagocytosis	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMG200012444	K01528	ko05100	Bacterial invasion of epithelial cells	397	1.2e-13	0.34	0.53	0.24
PGSC0003DMG200012445	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMG200012445	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	345	4.2e-10	0.27	0.42	0.94
PGSC0003DMG200012446	K10143	ko04115	p53 signaling pathway	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMG200012446	K10143	ko04120	Ubiquitin mediated proteolysis	4709	6.8e-254	0.65	0.78	1.00
PGSC0003DMG200012446	K10143	ko04115	p53 signaling pathway	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMG200012446	K10143	ko04120	Ubiquitin mediated proteolysis	4736	2.2e-255	0.66	0.78	1.00
PGSC0003DMG200012446	K10143	ko04115	p53 signaling pathway	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMG200012446	K10143	ko04120	Ubiquitin mediated proteolysis	3355	3.3e-179	0.60	0.74	0.98
PGSC0003DMG200001884	K01760	ko00270	Cysteine and methionine metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001884	K01760	ko00450	Selenoamino acid metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001884	K01760	ko00910	Nitrogen metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001884	K01760	ko00920	Sulfur metabolism	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001884	K01760	ko01100	Metabolic pathways	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001884	K01760	ko01110	Biosynthesis of secondary metabolites	305	5.5e-11	0.70	0.85	0.37
PGSC0003DMG200001886	K00680	ko00350	Tyrosine metabolism	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMG200001886	K00680	ko00624	1- and 2-Methylnaphthalene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMG200001886	K00680	ko00632	Benzoate degradation via CoA ligation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMG200001886	K00680	ko00642	Ethylbenzene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMG200001886	K00680	ko00903	Limonene and pinene degradation	223	3.6e-06	0.33	0.49	0.41
PGSC0003DMG200001893	K05677	ko02010	ABC transporters	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMG200001893	K05677	ko04146	Peroxisome	1411	5.5e-72	0.36	0.53	0.88
PGSC0003DMG200046928	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMG200046928	K00517	ko00626	Naphthalene and anthracene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMG200046928	K00517	ko00903	Limonene and pinene degradation	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMG200046928	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMG200046928	K00517	ko01110	Biosynthesis of secondary metabolites	2584	1.1e-136	0.68	0.83	0.99
PGSC0003DMG200046949	K10592	ko04120	Ubiquitin mediated proteolysis	467	1.0e-15	0.29	0.48	0.64
PGSC0003DMG200000516	K00962	ko00230	Purine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMG200000516	K00962	ko00240	Pyrimidine metabolism	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMG200000516	K00962	ko03018	RNA degradation	3251	1.8e-173	0.69	0.81	0.99
PGSC0003DMG200000516	K00962	ko00230	Purine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMG200000516	K00962	ko00240	Pyrimidine metabolism	6035	0.	0.74	0.85	1.00
PGSC0003DMG200000516	K00962	ko03018	RNA degradation	6035	0.	0.74	0.85	1.00
PGSC0003DMG200000517	K12823	ko03040	Spliceosome	1968	1.0e-102	0.53	0.67	0.66
PGSC0003DMG200000517	K03083	ko04012	ErbB signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04062	Chemokine signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04110	Cell cycle	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04310	Wnt signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04340	Hedgehog signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04360	Axon guidance	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04510	Focal adhesion	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04660	T cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04662	B cell receptor signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04711	Circadian rhythm - fly	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04722	Neurotrophin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04910	Insulin signaling pathway	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko04916	Melanogenesis	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05010	Alzheimer's disease	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05200	Pathways in cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05210	Colorectal cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05213	Endometrial cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05215	Prostate cancer	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000517	K03083	ko05217	Basal cell carcinoma	3133	5.7e-167	0.89	0.93	1.00
PGSC0003DMG200000519	K01199	ko00500	Starch and sucrose metabolism	1122	4.8e-56	0.47	0.66	1.00
PGSC0003DMG200000519	K01199	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.46	0.64	0.96
PGSC0003DMG200000521	K09753	ko00940	Phenylpropanoid biosynthesis	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMG200000521	K09753	ko01100	Metabolic pathways	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMG200000521	K09753	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.36	0.51	0.82
PGSC0003DMG200000521	K09753	ko00940	Phenylpropanoid biosynthesis	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMG200000521	K09753	ko01100	Metabolic pathways	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMG200000521	K09753	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.36	0.49	0.73
PGSC0003DMG200026725	K03094	ko04110	Cell cycle	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04111	Cell cycle - yeast	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04114	Oocyte meiosis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04120	Ubiquitin mediated proteolysis	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04310	Wnt signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04350	TGF-beta signaling pathway	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026725	K03094	ko04710	Circadian rhythm - mammal	281	1.2e-09	0.63	0.84	0.94
PGSC0003DMG200026727	K05849	ko04020	Calcium signaling pathway	322	2.5e-11	0.33	0.52	0.92
PGSC0003DMG200026735	K13082	ko00941	Flavonoid biosynthesis	707	3.7e-33	0.39	0.61	0.85
PGSC0003DMG200026744	K03083	ko04012	ErbB signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04062	Chemokine signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04110	Cell cycle	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04310	Wnt signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04340	Hedgehog signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04360	Axon guidance	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04510	Focal adhesion	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04660	T cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04662	B cell receptor signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04711	Circadian rhythm - fly	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04722	Neurotrophin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04910	Insulin signaling pathway	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04916	Melanogenesis	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05010	Alzheimer's disease	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05200	Pathways in cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05210	Colorectal cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05213	Endometrial cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05215	Prostate cancer	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko05217	Basal cell carcinoma	2727	1.4e-144	0.85	0.90	0.97
PGSC0003DMG200026744	K03083	ko04012	ErbB signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04062	Chemokine signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04110	Cell cycle	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04310	Wnt signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04340	Hedgehog signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04360	Axon guidance	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04510	Focal adhesion	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04660	T cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04662	B cell receptor signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04711	Circadian rhythm - fly	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04722	Neurotrophin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04910	Insulin signaling pathway	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04916	Melanogenesis	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05010	Alzheimer's disease	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05200	Pathways in cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05210	Colorectal cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05213	Endometrial cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05215	Prostate cancer	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko05217	Basal cell carcinoma	2932	7.0e-156	0.90	0.96	0.97
PGSC0003DMG200026744	K03083	ko04012	ErbB signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04062	Chemokine signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04110	Cell cycle	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04310	Wnt signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04340	Hedgehog signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04360	Axon guidance	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04510	Focal adhesion	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04660	T cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04662	B cell receptor signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04711	Circadian rhythm - fly	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04722	Neurotrophin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04910	Insulin signaling pathway	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko04916	Melanogenesis	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05010	Alzheimer's disease	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05200	Pathways in cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05210	Colorectal cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05213	Endometrial cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05215	Prostate cancer	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200026744	K03083	ko05217	Basal cell carcinoma	2880	5.2e-153	0.89	0.96	0.97
PGSC0003DMG200022258	K06611	ko00052	Galactose metabolism	228	5.2e-06	0.44	0.57	0.80
PGSC0003DMG200022258	K06611	ko00052	Galactose metabolism	505	6.9e-22	0.53	0.69	0.82
PGSC0003DMG200022258	K06611	ko00052	Galactose metabolism	2251	2.6e-118	0.42	0.60	0.96
PGSC0003DMG200022259	K12616	ko03018	RNA degradation	7528	0.	0.66	0.77	1.00
PGSC0003DMG200022260	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMG200022260	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMG200022260	K03876	ko04120	Ubiquitin mediated proteolysis	309	3.3e-11	0.38	0.55	0.78
PGSC0003DMG200022260	K03876	ko04120	Ubiquitin mediated proteolysis	326	3.8e-12	0.28	0.48	0.78
PGSC0003DMG200022263	K01623	ko00010	Glycolysis / Gluconeogenesis	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko00030	Pentose phosphate pathway	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko00051	Fructose and mannose metabolism	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko00710	Carbon fixation in photosynthetic organisms	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko01100	Metabolic pathways	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.87	0.92	0.99
PGSC0003DMG200022263	K01623	ko00010	Glycolysis / Gluconeogenesis	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00030	Pentose phosphate pathway	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00051	Fructose and mannose metabolism	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00710	Carbon fixation in photosynthetic organisms	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko01100	Metabolic pathways	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko01110	Biosynthesis of secondary metabolites	2594	3.1e-137	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00010	Glycolysis / Gluconeogenesis	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00030	Pentose phosphate pathway	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00051	Fructose and mannose metabolism	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko00710	Carbon fixation in photosynthetic organisms	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko01100	Metabolic pathways	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022263	K01623	ko01110	Biosynthesis of secondary metabolites	2685	2.9e-142	0.91	0.95	1.00
PGSC0003DMG200022267	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04010	MAPK signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04020	Calcium signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04114	Oocyte meiosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04210	Apoptosis	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04310	Wnt signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04360	Axon guidance	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04370	VEGF signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04650	Natural killer cell mediated cytotoxicity	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04660	T cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04662	B cell receptor signaling pathway	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04720	Long-term potentiation	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko05010	Alzheimer's disease	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	649	5.8e-30	0.96	1.00	0.99
PGSC0003DMG200022267	K06268	ko04010	MAPK signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04020	Calcium signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04114	Oocyte meiosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04210	Apoptosis	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04310	Wnt signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04360	Axon guidance	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04370	VEGF signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04650	Natural killer cell mediated cytotoxicity	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04660	T cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04662	B cell receptor signaling pathway	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04720	Long-term potentiation	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko05010	Alzheimer's disease	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1664	6.1e-86	0.95	0.98	0.96
PGSC0003DMG200022267	K06268	ko04010	MAPK signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04020	Calcium signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04114	Oocyte meiosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04210	Apoptosis	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04310	Wnt signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04360	Axon guidance	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04370	VEGF signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04650	Natural killer cell mediated cytotoxicity	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04660	T cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04662	B cell receptor signaling pathway	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko04720	Long-term potentiation	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko05010	Alzheimer's disease	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200022267	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	541	5.3e-24	0.91	0.95	0.86
PGSC0003DMG200030558	K12200	ko04144	Endocytosis	993	6.2e-49	0.64	0.75	0.99
PGSC0003DMG200030558	K12200	ko04144	Endocytosis	5898	0.	0.79	0.88	1.00
PGSC0003DMG200030558	K12200	ko04144	Endocytosis	4586	4.2e-247	0.83	0.92	0.96
PGSC0003DMG200030558	K12200	ko04144	Endocytosis	3967	5.8e-213	0.84	0.91	0.99
PGSC0003DMG200030559	K00523	ko00520	Amino sugar and nucleotide sugar metabolism	354	1.1e-13	0.31	0.49	0.74
PGSC0003DMG200030560	K02133	ko00190	Oxidative phosphorylation	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMG200030560	K02133	ko01100	Metabolic pathways	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMG200030560	K02133	ko05010	Alzheimer's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMG200030560	K02133	ko05012	Parkinson's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMG200030560	K02133	ko05016	Huntington's disease	4184	6.2e-225	0.91	0.95	1.00
PGSC0003DMG200030563	K03118	ko03060	Protein export	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMG200030563	K03118	ko03070	Bacterial secretion system	414	5.3e-17	0.98	1.00	0.98
PGSC0003DMG200030563	K03118	ko03060	Protein export	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMG200030563	K03118	ko03070	Bacterial secretion system	2061	7.7e-108	0.73	0.83	1.00
PGSC0003DMG200030564	K08730	ko00564	Glycerophospholipid metabolism	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMG200030564	K08730	ko01100	Metabolic pathways	1699	7.1e-88	0.80	0.89	0.99
PGSC0003DMG200030564	K08730	ko00564	Glycerophospholipid metabolism	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMG200030564	K08730	ko01100	Metabolic pathways	1088	3.6e-54	0.75	0.86	0.93
PGSC0003DMG200030564	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMG200030564	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMG200030564	K08730	ko00564	Glycerophospholipid metabolism	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMG200030564	K08730	ko01100	Metabolic pathways	2879	5.9e-153	0.82	0.90	0.91
PGSC0003DMG200030565	K01623	ko00010	Glycolysis / Gluconeogenesis	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko00030	Pentose phosphate pathway	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko00051	Fructose and mannose metabolism	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko00710	Carbon fixation in photosynthetic organisms	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko01100	Metabolic pathways	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.93	1.00	0.99
PGSC0003DMG200030565	K01623	ko00010	Glycolysis / Gluconeogenesis	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030565	K01623	ko00030	Pentose phosphate pathway	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030565	K01623	ko00051	Fructose and mannose metabolism	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030565	K01623	ko00710	Carbon fixation in photosynthetic organisms	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030565	K01623	ko01100	Metabolic pathways	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030565	K01623	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.88	0.95	1.00
PGSC0003DMG200030569	K10352	ko04530	Tight junction	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMG200030569	K10352	ko05416	Viral myocarditis	633	4.3e-25	0.24	0.44	0.91
PGSC0003DMG200030569	K10352	ko04530	Tight junction	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMG200030569	K10352	ko05416	Viral myocarditis	550	1.8e-20	0.24	0.44	0.85
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200019907	K00852	ko00030	Pentose phosphate pathway	315	1.5e-11	0.36	0.51	0.51
PGSC0003DMG200019909	K12886	ko03040	Spliceosome	276	2.2e-09	0.33	0.45	0.68
PGSC0003DMG200019914	K00799	ko00480	Glutathione metabolism	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMG200019914	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMG200019914	K00799	ko00982	Drug metabolism - cytochrome P450	726	3.3e-34	0.43	0.61	0.98
PGSC0003DMG200019920	K04424	ko04010	MAPK signaling pathway	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMG200019920	K04424	ko04530	Tight junction	613	5.6e-28	0.33	0.49	0.92
PGSC0003DMG200003118	K02433	ko00970	Aminoacyl-tRNA biosynthesis	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMG200003118	K02433	ko01100	Metabolic pathways	330	1.3e-18	0.39	0.53	0.64
PGSC0003DMG200003118	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMG200003118	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMG200003118	K02433	ko00970	Aminoacyl-tRNA biosynthesis	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMG200003118	K02433	ko01100	Metabolic pathways	911	2.1e-44	0.36	0.53	0.76
PGSC0003DMG200003118	K02433	ko00970	Aminoacyl-tRNA biosynthesis	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMG200003118	K02433	ko01100	Metabolic pathways	789	1.1e-37	0.38	0.55	0.97
PGSC0003DMG200003118	K02433	ko00970	Aminoacyl-tRNA biosynthesis	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMG200003118	K02433	ko01100	Metabolic pathways	861	1.2e-41	0.38	0.55	0.98
PGSC0003DMG200003119	K01426	ko00330	Arginine and proline metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003119	K01426	ko00360	Phenylalanine metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003119	K01426	ko00380	Tryptophan metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003119	K01426	ko00460	Cyanoamino acid metabolism	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003119	K01426	ko00632	Benzoate degradation via CoA ligation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003119	K01426	ko00643	Styrene degradation	303	1.8e-10	0.33	0.45	0.62
PGSC0003DMG200003120	K02433	ko00970	Aminoacyl-tRNA biosynthesis	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMG200003120	K02433	ko01100	Metabolic pathways	792	7.6e-38	0.37	0.52	0.64
PGSC0003DMG200003120	K01426	ko00330	Arginine and proline metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003120	K01426	ko00360	Phenylalanine metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003120	K01426	ko00380	Tryptophan metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003120	K01426	ko00460	Cyanoamino acid metabolism	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003120	K01426	ko00632	Benzoate degradation via CoA ligation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003120	K01426	ko00643	Styrene degradation	883	7.2e-43	0.34	0.49	0.86
PGSC0003DMG200003122	K04043	ko03018	RNA degradation	1261	1.0e-63	0.81	0.92	0.99
PGSC0003DMG200003122	K04043	ko03018	RNA degradation	4523	1.2e-243	0.89	0.96	1.00
PGSC0003DMG200003122	K04043	ko03018	RNA degradation	2075	1.3e-108	0.86	0.94	1.00
PGSC0003DMG200003122	K04043	ko03018	RNA degradation	4816	8.6e-260	0.86	0.93	1.00
PGSC0003DMG200003123	K01623	ko00010	Glycolysis / Gluconeogenesis	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko00030	Pentose phosphate pathway	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko00051	Fructose and mannose metabolism	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko00710	Carbon fixation in photosynthetic organisms	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko01100	Metabolic pathways	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko01110	Biosynthesis of secondary metabolites	2887	2.1e-153	0.88	0.92	1.00
PGSC0003DMG200003123	K01623	ko00010	Glycolysis / Gluconeogenesis	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200003123	K01623	ko00030	Pentose phosphate pathway	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200003123	K01623	ko00051	Fructose and mannose metabolism	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200003123	K01623	ko00710	Carbon fixation in photosynthetic organisms	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200003123	K01623	ko01100	Metabolic pathways	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200003123	K01623	ko01110	Biosynthesis of secondary metabolites	3087	2.0e-164	0.92	0.96	1.00
PGSC0003DMG200014207	K06268	ko04010	MAPK signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04020	Calcium signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04114	Oocyte meiosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04210	Apoptosis	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04310	Wnt signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04360	Axon guidance	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04370	VEGF signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04650	Natural killer cell mediated cytotoxicity	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04660	T cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04662	B cell receptor signaling pathway	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04720	Long-term potentiation	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko05010	Alzheimer's disease	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1016	3.3e-50	0.69	0.78	0.99
PGSC0003DMG200014207	K06268	ko04010	MAPK signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04020	Calcium signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04114	Oocyte meiosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04210	Apoptosis	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04310	Wnt signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04360	Axon guidance	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04370	VEGF signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04650	Natural killer cell mediated cytotoxicity	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04660	T cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04662	B cell receptor signaling pathway	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko04720	Long-term potentiation	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko05010	Alzheimer's disease	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014207	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1240	1.5e-62	0.83	0.95	0.99
PGSC0003DMG200014208	K01507	ko00190	Oxidative phosphorylation	5947	0.	0.93	0.97	1.00
PGSC0003DMG200014212	K03283	ko03040	Spliceosome	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMG200014212	K03283	ko04010	MAPK signaling pathway	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMG200014212	K03283	ko04144	Endocytosis	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMG200014212	K03283	ko04612	Antigen processing and presentation	4227	2.6e-227	0.80	0.83	1.00
PGSC0003DMG200014212	K03283	ko03040	Spliceosome	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMG200014212	K03283	ko04010	MAPK signaling pathway	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMG200014212	K03283	ko04144	Endocytosis	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMG200014212	K03283	ko04612	Antigen processing and presentation	5063	2.0e-273	0.91	0.96	1.00
PGSC0003DMG200014213	K11229	ko04011	MAPK signaling pathway - yeast	583	1.9e-25	0.37	0.52	0.70
PGSC0003DMG200014216	K01213	ko00040	Pentose and glucuronate interconversions	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMG200014216	K01213	ko00500	Starch and sucrose metabolism	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMG200014216	K01213	ko01100	Metabolic pathways	650	5.1e-30	0.35	0.55	0.78
PGSC0003DMG200014216	K01213	ko00040	Pentose and glucuronate interconversions	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMG200014216	K01213	ko00500	Starch and sucrose metabolism	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMG200014216	K01213	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.58	0.69
PGSC0003DMG200014216	K01213	ko00040	Pentose and glucuronate interconversions	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMG200014216	K01213	ko00500	Starch and sucrose metabolism	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMG200014216	K01213	ko01100	Metabolic pathways	838	2.2e-40	0.35	0.56	0.74
PGSC0003DMG200014218	K10839	ko03420	Nucleotide excision repair	1111	1.9e-55	0.73	0.80	0.88
PGSC0003DMG200014218	K10839	ko03420	Nucleotide excision repair	2279	7.3e-120	0.70	0.79	1.00
PGSC0003DMG200010964	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMG200010972	K11423	ko00310	Lysine degradation	780	3.5e-37	0.41	0.55	0.64
PGSC0003DMG200010972	K11424	ko00310	Lysine degradation	685	6.0e-32	0.48	0.64	0.44
PGSC0003DMG200010973	K07253	ko00350	Tyrosine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMG200010973	K07253	ko00360	Phenylalanine metabolism	315	1.5e-11	0.38	0.59	0.99
PGSC0003DMG200010974	K02634	ko00195	Photosynthesis	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMG200010974	K02634	ko01100	Metabolic pathways	829	6.9e-40	0.89	0.96	0.92
PGSC0003DMG200010980	K11424	ko00310	Lysine degradation	475	2.3e-20	0.49	0.65	0.56
PGSC0003DMG200010983	K11812	ko00380	Tryptophan metabolism	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMG200010983	K11812	ko00966	Glucosinolate biosynthesis	915	1.2e-44	0.64	0.81	0.96
PGSC0003DMG200010035	K02716	ko00195	Photosynthesis	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMG200010035	K02716	ko01100	Metabolic pathways	2507	1.9e-132	0.89	0.96	0.99
PGSC0003DMG200010039	K11419	ko00310	Lysine degradation	671	2.5e-30	0.35	0.50	0.17
PGSC0003DMG200010039	K11419	ko00310	Lysine degradation	242	1.9e-06	0.30	0.47	0.13
PGSC0003DMG200010042	K01784	ko00052	Galactose metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMG200010042	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMG200010042	K01784	ko01100	Metabolic pathways	215	5.0e-06	0.29	0.45	0.75
PGSC0003DMG200045997	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200045997	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200045997	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200045997	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200045997	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200046024	K10747	ko03030	DNA replication	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMG200046024	K10747	ko03410	Base excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMG200046024	K10747	ko03420	Nucleotide excision repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMG200046024	K10747	ko03430	Mismatch repair	344	3.2e-12	0.27	0.51	0.87
PGSC0003DMG200033683	K00207	ko00240	Pyrimidine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMG200033683	K00207	ko00410	beta-Alanine metabolism	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMG200033683	K00207	ko00770	Pantothenate and CoA biosynthesis	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMG200033683	K00207	ko00983	Drug metabolism - other enzymes	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMG200033683	K00207	ko01100	Metabolic pathways	1773	5.9e-92	0.85	0.89	0.86
PGSC0003DMG200033683	K00207	ko00240	Pyrimidine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMG200033683	K00207	ko00410	beta-Alanine metabolism	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMG200033683	K00207	ko00770	Pantothenate and CoA biosynthesis	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMG200033683	K00207	ko00983	Drug metabolism - other enzymes	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMG200033683	K00207	ko01100	Metabolic pathways	2860	6.6e-152	0.85	0.90	0.92
PGSC0003DMG200033683	K00207	ko00240	Pyrimidine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMG200033683	K00207	ko00410	beta-Alanine metabolism	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMG200033683	K00207	ko00770	Pantothenate and CoA biosynthesis	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMG200033683	K00207	ko00983	Drug metabolism - other enzymes	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMG200033683	K00207	ko01100	Metabolic pathways	371	1.3e-14	0.81	0.91	0.96
PGSC0003DMG200033684	K02984	ko03010	Ribosome	1960	2.9e-102	0.89	0.95	1.00
PGSC0003DMG200033685	K02183	ko04020	Calcium signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04070	Phosphatidylinositol signaling system	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04114	Oocyte meiosis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04270	Vascular smooth muscle contraction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04626	Plant-pathogen interaction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04720	Long-term potentiation	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04722	Neurotrophin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04740	Olfactory transduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04744	Phototransduction	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04745	Phototransduction - fly	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04910	Insulin signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04912	GnRH signaling pathway	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04916	Melanogenesis	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04970	Salivary secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko04971	Gastric acid secretion	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko05010	Alzheimer's disease	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033685	K02183	ko05214	Glioma	1196	3.9e-60	0.96	0.99	0.99
PGSC0003DMG200033687	K01054	ko00561	Glycerolipid metabolism	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMG200033687	K01054	ko01100	Metabolic pathways	621	2.0e-28	0.37	0.53	0.67
PGSC0003DMG200033688	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMG200033688	K01078	ko00740	Riboflavin metabolism	1656	1.7e-85	0.61	0.78	0.96
PGSC0003DMG200033691	K02904	ko03010	Ribosome	754	9.4e-36	0.78	0.88	0.72
PGSC0003DMG200033692	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMG200033692	K04951	ko04740	Olfactory transduction	463	2.7e-19	0.26	0.47	0.59
PGSC0003DMG200033696	K04368	ko04010	MAPK signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04012	ErbB signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04013	MAPK signaling pathway - fly	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04062	Chemokine signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04114	Oocyte meiosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04270	Vascular smooth muscle contraction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04320	Dorso-ventral axis formation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04370	VEGF signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04510	Focal adhesion	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04540	Gap junction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04620	Toll-like receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04626	Plant-pathogen interaction	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04650	Natural killer cell mediated cytotoxicity	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04660	T cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04662	B cell receptor signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04664	Fc epsilon RI signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04666	Fc gamma R-mediated phagocytosis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04720	Long-term potentiation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04722	Neurotrophin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04730	Long-term depression	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04810	Regulation of actin cytoskeleton	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04910	Insulin signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04912	GnRH signaling pathway	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04914	Progesterone-mediated oocyte maturation	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko04916	Melanogenesis	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05020	Prion diseases	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05200	Pathways in cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05210	Colorectal cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05211	Renal cell carcinoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05212	Pancreatic cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05213	Endometrial cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05214	Glioma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05215	Prostate cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05216	Thyroid cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05218	Melanoma	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05219	Bladder cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05220	Chronic myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05221	Acute myeloid leukemia	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200033696	K04368	ko05223	Non-small cell lung cancer	920	6.6e-45	0.44	0.62	0.85
PGSC0003DMG200017507	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMG200017507	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMG200017507	K05283	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMG200017507	K05283	ko01100	Metabolic pathways	257	3.8e-08	0.31	0.48	0.91
PGSC0003DMG200017508	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.29	0.48	0.93
PGSC0003DMG200017512	K01438	ko00330	Arginine and proline metabolism	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMG200017512	K01438	ko01100	Metabolic pathways	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMG200017512	K01438	ko01110	Biosynthesis of secondary metabolites	3200	1.2e-170	0.85	0.93	0.98
PGSC0003DMG200017512	K01438	ko00330	Arginine and proline metabolism	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMG200017512	K01438	ko01100	Metabolic pathways	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMG200017512	K01438	ko01110	Biosynthesis of secondary metabolites	3113	7.3e-166	0.83	0.92	0.98
PGSC0003DMG200017512	K01438	ko00330	Arginine and proline metabolism	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMG200017512	K01438	ko01100	Metabolic pathways	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMG200017512	K01438	ko01110	Biosynthesis of secondary metabolites	2915	6.1e-155	0.77	0.89	0.99
PGSC0003DMG200017513	K01438	ko00330	Arginine and proline metabolism	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMG200017513	K01438	ko01100	Metabolic pathways	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMG200017513	K01438	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.75	0.87	0.99
PGSC0003DMG200017515	K12493	ko04144	Endocytosis	2138	4.4e-112	0.66	0.76	1.00
PGSC0003DMG200017515	K12493	ko04144	Endocytosis	1297	1.1e-65	0.73	0.83	0.85
PGSC0003DMG200017515	K12493	ko04144	Endocytosis	2444	5.8e-129	0.72	0.84	1.00
PGSC0003DMG200017516	K12493	ko04144	Endocytosis	2439	1.1e-128	0.49	0.63	0.97
PGSC0003DMG200017519	K11294	ko05130	Pathogenic Escherichia coli infection	374	1.9e-14	0.31	0.51	0.76
PGSC0003DMG200027701	K03945	ko00190	Oxidative phosphorylation	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMG200027701	K03945	ko01100	Metabolic pathways	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMG200027701	K03945	ko05010	Alzheimer's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMG200027701	K03945	ko05012	Parkinson's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMG200027701	K03945	ko05016	Huntington's disease	443	1.3e-18	0.77	0.89	0.94
PGSC0003DMG200027706	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMG200027706	K00517	ko00626	Naphthalene and anthracene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMG200027706	K00517	ko00903	Limonene and pinene degradation	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMG200027706	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMG200027706	K00517	ko01110	Biosynthesis of secondary metabolites	1595	3.9e-82	0.45	0.63	0.97
PGSC0003DMG200027710	K04733	ko04210	Apoptosis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMG200027710	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMG200027710	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMG200027710	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMG200027710	K04733	ko05142	Chagas disease	1027	8.3e-51	0.34	0.49	0.74
PGSC0003DMG200027716	K13229	ko00402	Benzoxazinoid biosynthesis	986	1.5e-48	0.38	0.58	0.97
PGSC0003DMG200027718	K01955	ko00240	Pyrimidine metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMG200027718	K01955	ko00250	Alanine, aspartate and glutamate metabolism	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMG200027718	K01955	ko01100	Metabolic pathways	518	7.2e-22	0.44	0.60	0.90
PGSC0003DMG200027720	K11188	ko00360	Phenylalanine metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMG200027720	K11188	ko00680	Methane metabolism	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMG200027720	K11188	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMG200027720	K11188	ko01100	Metabolic pathways	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMG200027720	K11188	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.80	0.88	1.00
PGSC0003DMG200044817	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMG200014888	K03469	ko03030	DNA replication	291	3.2e-10	0.37	0.54	0.82
PGSC0003DMG200014892	K00558	ko00270	Cysteine and methionine metabolism	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMG200014892	K00558	ko01100	Metabolic pathways	1753	7.5e-91	0.49	0.60	0.96
PGSC0003DMG200014892	K00558	ko00270	Cysteine and methionine metabolism	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMG200014892	K00558	ko01100	Metabolic pathways	1760	3.1e-91	0.50	0.60	0.96
PGSC0003DMG200014893	K11093	ko03040	Spliceosome	1256	1.9e-63	0.83	0.93	0.92
PGSC0003DMG200014893	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMG200014893	K11093	ko03040	Spliceosome	2893	9.9e-154	0.67	0.80	1.00
PGSC0003DMG200014893	K11093	ko03040	Spliceosome	2894	8.7e-154	0.67	0.80	1.00
PGSC0003DMG200014893	K11093	ko03040	Spliceosome	1624	9.8e-84	0.59	0.74	0.99
PGSC0003DMG200014899	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	393	1.5e-15	0.39	0.57	0.73
PGSC0003DMG200014899	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	473	3.0e-20	0.35	0.56	0.79
PGSC0003DMG200014901	K00234	ko00020	Citrate cycle (TCA cycle)	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko00190	Oxidative phosphorylation	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko01100	Metabolic pathways	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko01110	Biosynthesis of secondary metabolites	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko05010	Alzheimer's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko05012	Parkinson's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014901	K00234	ko05016	Huntington's disease	5014	1.0e-270	0.92	0.96	1.00
PGSC0003DMG200014902	K09587	ko00905	Brassinosteroid biosynthesis	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMG200014902	K09587	ko01100	Metabolic pathways	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMG200014902	K09587	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.64	0.77	0.83
PGSC0003DMG200010292	K10841	ko03420	Nucleotide excision repair	6820	0.	0.69	0.80	1.00
PGSC0003DMG200010300	K05765	ko04360	Axon guidance	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMG200010300	K05765	ko04666	Fc gamma R-mediated phagocytosis	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMG200010300	K05765	ko04810	Regulation of actin cytoskeleton	1038	2.0e-51	0.86	0.95	0.76
PGSC0003DMG200010300	K05765	ko04360	Axon guidance	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMG200010300	K05765	ko04666	Fc gamma R-mediated phagocytosis	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMG200010300	K05765	ko04810	Regulation of actin cytoskeleton	1058	1.6e-52	0.86	0.92	0.99
PGSC0003DMG200010304	K00392	ko00450	Selenoamino acid metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMG200010304	K00392	ko00920	Sulfur metabolism	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMG200010304	K00392	ko01100	Metabolic pathways	4273	7.6e-230	0.77	0.89	0.92
PGSC0003DMG200010310	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMG200010310	K00517	ko00626	Naphthalene and anthracene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMG200010310	K00517	ko00903	Limonene and pinene degradation	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMG200010310	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMG200010310	K00517	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.59	0.99
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020498	K01099	ko00562	Inositol phosphate metabolism	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020498	K01099	ko01100	Metabolic pathways	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020498	K01099	ko04070	Phosphatidylinositol signaling system	735	1.1e-42	0.39	0.56	0.56
PGSC0003DMG200020499	K04123	ko00904	Diterpenoid biosynthesis	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMG200020499	K04123	ko01100	Metabolic pathways	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMG200020499	K04123	ko01110	Biosynthesis of secondary metabolites	1734	8.4e-90	0.51	0.71	0.98
PGSC0003DMG200020502	K11826	ko04144	Endocytosis	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMG200020502	K11826	ko05016	Huntington's disease	3557	2.4e-190	0.96	0.98	1.00
PGSC0003DMG200020505	K02698	ko00195	Photosynthesis	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMG200020505	K02698	ko01100	Metabolic pathways	938	6.7e-46	0.87	0.92	0.99
PGSC0003DMG200020509	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMG200020509	K01177	ko00500	Starch and sucrose metabolism	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMG200020509	K01177	ko01100	Metabolic pathways	3380	1.4e-180	0.71	0.84	1.00
PGSC0003DMG200031765	K00688	ko00500	Starch and sucrose metabolism	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMG200031765	K00688	ko04910	Insulin signaling pathway	1846	5.6e-96	0.63	0.74	0.97
PGSC0003DMG200031765	K00688	ko00500	Starch and sucrose metabolism	5956	0.	0.83	0.92	0.81
PGSC0003DMG200031765	K00688	ko04910	Insulin signaling pathway	5956	0.	0.83	0.92	0.81
PGSC0003DMG200031771	K13230	ko00402	Benzoxazinoid biosynthesis	942	4.0e-46	0.38	0.55	0.98
PGSC0003DMG200031771	K13230	ko00402	Benzoxazinoid biosynthesis	924	4.0e-45	0.37	0.55	0.99
PGSC0003DMG200031776	K11821	ko00380	Tryptophan metabolism	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMG200031776	K11821	ko00966	Glucosinolate biosynthesis	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMG200031776	K11821	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.43	0.63	0.95
PGSC0003DMG200031778	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200031780	K03801	ko00785	Lipoic acid metabolism	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMG200031780	K03801	ko01100	Metabolic pathways	609	9.4e-28	0.79	0.88	0.98
PGSC0003DMG200031786	K02891	ko03010	Ribosome	869	4.3e-42	0.83	0.91	0.99
PGSC0003DMG200031786	K02891	ko03010	Ribosome	514	1.6e-22	0.78	0.90	0.99
PGSC0003DMG200031787	K02891	ko03010	Ribosome	871	3.3e-42	0.83	0.93	0.99
PGSC0003DMG200031789	K02883	ko03010	Ribosome	1426	8.1e-73	0.90	0.95	0.99
PGSC0003DMG200028389	K01925	ko00471	D-Glutamine and D-glutamate metabolism	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMG200028389	K01925	ko00550	Peptidoglycan biosynthesis	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMG200028389	K01925	ko01100	Metabolic pathways	926	3.1e-45	0.36	0.53	0.94
PGSC0003DMG200018236	K11866	ko04144	Endocytosis	626	3.0e-28	0.32	0.46	0.88
PGSC0003DMG200018238	K01136	ko00531	Glycosaminoglycan degradation	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMG200018238	K01136	ko01100	Metabolic pathways	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMG200018238	K01136	ko04142	Lysosome	303	2.7e-10	0.30	0.47	0.94
PGSC0003DMG200018245	K12929	ko00904	Diterpenoid biosynthesis	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMG200018245	K12929	ko01110	Biosynthesis of secondary metabolites	1951	9.0e-102	0.43	0.68	0.99
PGSC0003DMG200018245	K12929	ko00904	Diterpenoid biosynthesis	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMG200018245	K12929	ko01110	Biosynthesis of secondary metabolites	571	1.2e-25	0.41	0.65	0.98
PGSC0003DMG200018247	K10352	ko04530	Tight junction	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMG200018247	K10352	ko05416	Viral myocarditis	313	3.4e-10	0.28	0.48	0.86
PGSC0003DMG200018248	K00558	ko00270	Cysteine and methionine metabolism	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMG200018248	K00558	ko01100	Metabolic pathways	446	1.2e-17	0.49	0.64	0.44
PGSC0003DMG200027449	K00697	ko00500	Starch and sucrose metabolism	4624	3.3e-249	0.63	0.79	0.98
PGSC0003DMG200027449	K00697	ko00500	Starch and sucrose metabolism	4132	4.6e-222	0.64	0.79	0.96
PGSC0003DMG200027449	K00697	ko00500	Starch and sucrose metabolism	515	1.7e-22	0.64	0.73	0.83
PGSC0003DMG200027450	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMG200027450	K05391	ko04626	Plant-pathogen interaction	4270	1.1e-229	0.70	0.81	1.00
PGSC0003DMG200027451	K01756	ko00230	Purine metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMG200027451	K01756	ko00250	Alanine, aspartate and glutamate metabolism	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMG200027451	K01756	ko01100	Metabolic pathways	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMG200027451	K01756	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.71	0.83	0.99
PGSC0003DMG200027456	K00901	ko00561	Glycerolipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMG200027456	K00901	ko00564	Glycerophospholipid metabolism	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMG200027456	K00901	ko01100	Metabolic pathways	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMG200027456	K00901	ko04070	Phosphatidylinositol signaling system	1487	3.5e-76	0.43	0.61	0.92
PGSC0003DMG200027456	K00901	ko00561	Glycerolipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMG200027456	K00901	ko00564	Glycerophospholipid metabolism	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMG200027456	K00901	ko01100	Metabolic pathways	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMG200027456	K00901	ko04070	Phosphatidylinositol signaling system	1327	2.3e-67	0.43	0.61	0.91
PGSC0003DMG200027458	K00558	ko00270	Cysteine and methionine metabolism	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMG200027458	K00558	ko01100	Metabolic pathways	948	1.1e-45	0.38	0.58	0.85
PGSC0003DMG200001225	K04498	ko04110	Cell cycle	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04310	Wnt signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04330	Notch signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04350	TGF-beta signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04520	Adherens junction	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04630	Jak-STAT signaling pathway	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04720	Long-term potentiation	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko04916	Melanogenesis	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko05016	Huntington's disease	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko05200	Pathways in cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko05211	Renal cell carcinoma	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001225	K04498	ko05215	Prostate cancer	528	7.6e-20	0.30	0.42	0.68
PGSC0003DMG200001233	K02945	ko03010	Ribosome	2917	4.7e-155	0.84	0.93	1.00
PGSC0003DMG200009321	K00938	ko00900	Terpenoid backbone biosynthesis	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMG200009321	K00938	ko01100	Metabolic pathways	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMG200009321	K00938	ko01110	Biosynthesis of secondary metabolites	3080	4.8e-164	0.75	0.86	1.00
PGSC0003DMG200009321	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009321	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009321	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009321	K00938	ko00900	Terpenoid backbone biosynthesis	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009321	K00938	ko01100	Metabolic pathways	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009321	K00938	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.77	0.88	1.00
PGSC0003DMG200009323	K04733	ko04210	Apoptosis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMG200009323	K04733	ko04620	Toll-like receptor signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMG200009323	K04733	ko04722	Neurotrophin signaling pathway	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMG200009323	K04733	ko05140	Leishmaniasis	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMG200009323	K04733	ko05142	Chagas disease	286	6.1e-10	0.45	0.64	0.99
PGSC0003DMG200009324	K02084	ko04115	p53 signaling pathway	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko04210	Apoptosis	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko05010	Alzheimer's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko05012	Parkinson's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko05016	Huntington's disease	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200009324	K02084	ko05222	Small cell lung cancer	279	8.9e-06	0.26	0.42	0.43
PGSC0003DMG200015508	K02201	ko00770	Pantothenate and CoA biosynthesis	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMG200015508	K02201	ko01100	Metabolic pathways	255	7.8e-08	0.49	0.69	0.97
PGSC0003DMG200015508	K02201	ko00770	Pantothenate and CoA biosynthesis	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMG200015508	K02201	ko01100	Metabolic pathways	500	9.6e-22	0.42	0.63	0.90
PGSC0003DMG200015511	K07252	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.37	0.57	0.67
PGSC0003DMG200015511	K07252	ko00510	N-Glycan biosynthesis	367	2.1e-14	0.38	0.56	0.67
PGSC0003DMG200015511	K07252	ko00510	N-Glycan biosynthesis	368	1.8e-14	0.35	0.53	0.70
PGSC0003DMG200015511	K07252	ko00510	N-Glycan biosynthesis	353	1.2e-13	0.37	0.56	0.68
PGSC0003DMG200015514	K00100	ko00051	Fructose and mannose metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00100	ko00363	Bisphenol A degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00100	ko00591	Linoleic acid metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00100	ko00625	Tetrachloroethene degradation	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00100	ko00650	Butanoate metabolism	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00100	ko01100	Metabolic pathways	2216	2.2e-116	0.58	0.76	0.83
PGSC0003DMG200015514	K00102	ko00620	Pyruvate metabolism	838	2.2e-40	0.51	0.69	0.95
PGSC0003DMG200015514	K00102	ko00620	Pyruvate metabolism	836	2.8e-40	0.52	0.70	0.89
PGSC0003DMG200015524	K12127	ko04712	Circadian rhythm - plant	224	5.8e-06	0.32	0.50	0.93
PGSC0003DMG200015525	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200015525	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200015527	K12605	ko03018	RNA degradation	3598	1.3e-192	0.78	0.89	0.96
PGSC0003DMG200015527	K12605	ko03018	RNA degradation	4388	3.5e-236	0.77	0.88	1.00
PGSC0003DMG200015527	K12605	ko03018	RNA degradation	4152	3.6e-223	0.79	0.90	1.00
PGSC0003DMG200004822	K00010	ko00521	Streptomycin biosynthesis	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMG200004822	K00010	ko00562	Inositol phosphate metabolism	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMG200004822	K00010	ko01100	Metabolic pathways	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMG200004822	K00010	ko01110	Biosynthesis of secondary metabolites	430	7.0e-18	0.29	0.50	0.96
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	2295	9.5e-121	0.43	0.61	0.97
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	2249	3.3e-118	0.42	0.60	0.97
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	1131	1.5e-56	0.46	0.67	0.95
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	747	2.3e-35	0.44	0.64	0.90
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	821	1.9e-39	0.46	0.66	0.93
PGSC0003DMG200004823	K12353	ko00600	Sphingolipid metabolism	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMG200004823	K12353	ko01100	Metabolic pathways	348	7.3e-13	0.44	0.65	0.96
PGSC0003DMG200004824	K05280	ko00941	Flavonoid biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMG200004824	K05280	ko00944	Flavone and flavonol biosynthesis	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMG200004824	K05280	ko01100	Metabolic pathways	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMG200004824	K05280	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.41	0.61	0.99
PGSC0003DMG200004824	K05280	ko00941	Flavonoid biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMG200004824	K05280	ko00944	Flavone and flavonol biosynthesis	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMG200004824	K05280	ko01100	Metabolic pathways	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMG200004824	K05280	ko01110	Biosynthesis of secondary metabolites	946	2.4e-46	0.40	0.60	0.99
PGSC0003DMG200004827	K00232	ko00071	Fatty acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004827	K00232	ko00592	alpha-Linolenic acid metabolism	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004827	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004827	K00232	ko01100	Metabolic pathways	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004827	K00232	ko03320	PPAR signaling pathway	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004827	K00232	ko04146	Peroxisome	4463	2.5e-240	0.78	0.89	1.00
PGSC0003DMG200004828	K00232	ko00071	Fatty acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004828	K00232	ko00592	alpha-Linolenic acid metabolism	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004828	K00232	ko01040	Biosynthesis of unsaturated fatty acids	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004828	K00232	ko01100	Metabolic pathways	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004828	K00232	ko03320	PPAR signaling pathway	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004828	K00232	ko04146	Peroxisome	4748	4.8e-256	0.83	0.93	1.00
PGSC0003DMG200004837	K12125	ko04712	Circadian rhythm - plant	817	3.2e-39	0.31	0.45	0.96
PGSC0003DMG200004838	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMG200004838	K02903	ko03010	Ribosome	999	2.9e-49	0.85	0.92	0.99
PGSC0003DMG200004839	K12197	ko04144	Endocytosis	817	3.2e-39	0.87	0.94	0.99
PGSC0003DMG200004839	K12197	ko04144	Endocytosis	1478	1.1e-75	0.89	0.96	1.00
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	500	9.6e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	499	1.1e-21	0.36	0.54	0.86
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.53	0.85
PGSC0003DMG200002557	K00812	ko00250	Alanine, aspartate and glutamate metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00270	Cysteine and methionine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00330	Arginine and proline metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00350	Tyrosine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00360	Phenylalanine metabolism	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00401	Novobiocin biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00710	Carbon fixation in photosynthetic organisms	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00950	Isoquinoline alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko01100	Metabolic pathways	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002557	K00812	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.30	0.51	0.97
PGSC0003DMG200002558	K06627	ko04110	Cell cycle	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMG200002558	K06627	ko04914	Progesterone-mediated oocyte maturation	2010	5.0e-105	0.55	0.67	0.99
PGSC0003DMG200002559	K00865	ko00260	Glycine, serine and threonine metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMG200002559	K00865	ko00561	Glycerolipid metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMG200002559	K00865	ko00630	Glyoxylate and dicarboxylate metabolism	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMG200002559	K00865	ko01100	Metabolic pathways	319	9.3e-12	0.38	0.59	0.38
PGSC0003DMG200002563	K03350	ko04110	Cell cycle	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04111	Cell cycle - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04113	Meiosis - yeast	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04114	Oocyte meiosis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04120	Ubiquitin mediated proteolysis	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04914	Progesterone-mediated oocyte maturation	4641	3.8e-250	0.73	0.83	1.00
PGSC0003DMG200002563	K03350	ko04110	Cell cycle	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04111	Cell cycle - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04113	Meiosis - yeast	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04114	Oocyte meiosis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04120	Ubiquitin mediated proteolysis	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04914	Progesterone-mediated oocyte maturation	4682	2.1e-252	0.74	0.84	1.00
PGSC0003DMG200002563	K03350	ko04110	Cell cycle	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04111	Cell cycle - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04113	Meiosis - yeast	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04114	Oocyte meiosis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04120	Ubiquitin mediated proteolysis	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04914	Progesterone-mediated oocyte maturation	4579	1.0e-246	0.74	0.84	0.99
PGSC0003DMG200002563	K03350	ko04110	Cell cycle	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002563	K03350	ko04111	Cell cycle - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002563	K03350	ko04113	Meiosis - yeast	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002563	K03350	ko04114	Oocyte meiosis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002563	K03350	ko04120	Ubiquitin mediated proteolysis	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002563	K03350	ko04914	Progesterone-mediated oocyte maturation	1984	1.4e-103	0.86	0.93	0.97
PGSC0003DMG200002568	K03126	ko03022	Basal transcription factors	870	3.8e-42	0.35	0.50	0.97
PGSC0003DMG200002568	K03126	ko03022	Basal transcription factors	940	5.2e-46	0.32	0.47	0.97
PGSC0003DMG200002574	K00599	ko00340	Histidine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMG200002574	K00599	ko00350	Tyrosine metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMG200002574	K00599	ko00450	Selenoamino acid metabolism	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMG200002574	K00599	ko00626	Naphthalene and anthracene degradation	718	9.1e-34	0.55	0.73	0.69
PGSC0003DMG200013101	K08233	ko00901	Indole alkaloid biosynthesis	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMG200013101	K08233	ko01110	Biosynthesis of secondary metabolites	461	9.3e-30	0.59	0.73	0.84
PGSC0003DMG200013102	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMG200013102	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7318	0.	0.77	0.89	1.00
PGSC0003DMG200013103	K10802	ko03410	Base excision repair	459	1.8e-19	0.47	0.62	0.70
PGSC0003DMG200013104	K10802	ko03410	Base excision repair	398	4.1e-16	0.46	0.61	0.41
PGSC0003DMG200036280	K10760	ko00908	Zeatin biosynthesis	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMG200036280	K10760	ko01100	Metabolic pathways	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMG200036280	K10760	ko01110	Biosynthesis of secondary metabolites	609	9.4e-28	0.54	0.71	0.96
PGSC0003DMG200026078	K02888	ko03010	Ribosome	1021	1.8e-50	0.66	0.75	0.96
PGSC0003DMG200026078	K02888	ko03010	Ribosome	266	7.8e-09	0.48	0.59	0.83
PGSC0003DMG200026080	K09843	ko00906	Carotenoid biosynthesis	800	2.7e-38	0.40	0.62	0.97
PGSC0003DMG200026087	K11816	ko00380	Tryptophan metabolism	2048	4.0e-107	0.71	0.85	0.99
PGSC0003DMG200026087	K11816	ko00380	Tryptophan metabolism	1082	7.6e-54	0.71	0.86	0.94
PGSC0003DMG200026088	K06666	ko04111	Cell cycle - yeast	649	5.8e-30	0.26	0.41	0.92
PGSC0003DMG200026088	K06666	ko04111	Cell cycle - yeast	653	3.5e-30	0.26	0.41	0.92
PGSC0003DMG200019204	K05692	ko04145	Phagosome	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04510	Focal adhesion	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04520	Adherens junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04530	Tight junction	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04670	Leukocyte transendothelial migration	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04745	Phototransduction - fly	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04810	Regulation of actin cytoskeleton	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05100	Bacterial invasion of epithelial cells	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05110	Vibrio cholerae infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05130	Pathogenic Escherichia coli infection	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05131	Shigellosis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05414	Dilated cardiomyopathy	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko05416	Viral myocarditis	1793	4.7e-93	0.94	0.98	0.97
PGSC0003DMG200019204	K05692	ko04145	Phagosome	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04510	Focal adhesion	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04520	Adherens junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04530	Tight junction	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04670	Leukocyte transendothelial migration	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04745	Phototransduction - fly	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko04810	Regulation of actin cytoskeleton	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05100	Bacterial invasion of epithelial cells	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05110	Vibrio cholerae infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05130	Pathogenic Escherichia coli infection	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05131	Shigellosis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05414	Dilated cardiomyopathy	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019204	K05692	ko05416	Viral myocarditis	3065	3.2e-163	0.95	0.98	1.00
PGSC0003DMG200019208	K03283	ko03040	Spliceosome	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMG200019208	K03283	ko04010	MAPK signaling pathway	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMG200019208	K03283	ko04144	Endocytosis	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMG200019208	K03283	ko04612	Antigen processing and presentation	5161	8.0e-279	0.94	0.97	1.00
PGSC0003DMG200019209	K12881	ko03040	Spliceosome	1021	1.8e-50	0.62	0.70	0.93
PGSC0003DMG200019209	K12881	ko03040	Spliceosome	304	6.2e-11	0.49	0.65	0.93
PGSC0003DMG200019209	K12881	ko03040	Spliceosome	1284	5.5e-65	0.66	0.74	1.00
PGSC0003DMG200019215	K02893	ko03010	Ribosome	1141	4.3e-57	0.89	0.93	0.99
PGSC0003DMG200029839	K12129	ko04712	Circadian rhythm - plant	283	3.9e-09	0.32	0.53	0.70
PGSC0003DMG200029839	K03415	ko02020	Two-component system	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMG200029839	K03415	ko02030	Bacterial chemotaxis	230	7.5e-07	0.39	0.55	0.83
PGSC0003DMG200029843	K13228	ko00402	Benzoxazinoid biosynthesis	314	1.7e-11	0.29	0.44	0.88
PGSC0003DMG200029845	K00279	ko00908	Zeatin biosynthesis	1646	6.0e-85	0.67	0.84	0.90
PGSC0003DMG200029847	K01633	ko00790	Folate biosynthesis	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMG200029847	K01633	ko01100	Metabolic pathways	396	5.2e-16	0.77	0.92	0.97
PGSC0003DMG200029847	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMG200029847	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMG200029847	K01633	ko00790	Folate biosynthesis	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMG200029847	K01633	ko01100	Metabolic pathways	888	3.8e-43	0.82	0.94	0.95
PGSC0003DMG200029852	K12129	ko04712	Circadian rhythm - plant	274	1.3e-08	0.32	0.53	0.70
PGSC0003DMG200026123	K04428	ko04010	MAPK signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMG200026123	K04428	ko04912	GnRH signaling pathway	558	5.7e-24	0.34	0.55	0.86
PGSC0003DMG200026126	K00889	ko00562	Inositol phosphate metabolism	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko01100	Metabolic pathways	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko04070	Phosphatidylinositol signaling system	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko04144	Endocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko04666	Fc gamma R-mediated phagocytosis	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko04810	Regulation of actin cytoskeleton	3542	1.6e-189	0.39	0.56	0.95
PGSC0003DMG200026126	K00889	ko00562	Inositol phosphate metabolism	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026126	K00889	ko01100	Metabolic pathways	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026126	K00889	ko04070	Phosphatidylinositol signaling system	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026126	K00889	ko04144	Endocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026126	K00889	ko04666	Fc gamma R-mediated phagocytosis	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026126	K00889	ko04810	Regulation of actin cytoskeleton	3040	7.7e-162	0.38	0.55	0.95
PGSC0003DMG200026128	K00680	ko00350	Tyrosine metabolism	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMG200026128	K00680	ko00624	1- and 2-Methylnaphthalene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMG200026128	K00680	ko00632	Benzoate degradation via CoA ligation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMG200026128	K00680	ko00642	Ethylbenzene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMG200026128	K00680	ko00903	Limonene and pinene degradation	643	1.2e-29	0.52	0.68	0.92
PGSC0003DMG200026129	K00876	ko00240	Pyrimidine metabolism	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMG200026129	K00876	ko00983	Drug metabolism - other enzymes	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMG200026129	K00876	ko01100	Metabolic pathways	3685	2.1e-197	0.90	0.95	0.99
PGSC0003DMG200026130	K02882	ko03010	Ribosome	1451	3.4e-74	0.93	0.98	0.99
PGSC0003DMG200026132	K11584	ko04113	Meiosis - yeast	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMG200026132	K11584	ko04114	Oocyte meiosis	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMG200026132	K11584	ko04310	Wnt signaling pathway	3208	4.2e-171	0.75	0.87	1.00
PGSC0003DMG200026139	K07192	ko04910	Insulin signaling pathway	1420	1.7e-72	0.42	0.62	1.00
PGSC0003DMG200026142	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMG200026142	K08515	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.81	0.93	0.99
PGSC0003DMG200026149	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMG200023110	K03966	ko00190	Oxidative phosphorylation	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMG200023110	K03966	ko01100	Metabolic pathways	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMG200023110	K03966	ko05010	Alzheimer's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMG200023110	K03966	ko05012	Parkinson's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMG200023110	K03966	ko05016	Huntington's disease	745	3.0e-35	0.78	0.89	0.99
PGSC0003DMG200023114	K02976	ko03010	Ribosome	716	1.2e-33	0.78	0.87	0.99
PGSC0003DMG200023118	K09837	ko00906	Carotenoid biosynthesis	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMG200023118	K09837	ko01100	Metabolic pathways	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMG200023118	K09837	ko01110	Biosynthesis of secondary metabolites	1900	5.8e-99	0.49	0.70	0.77
PGSC0003DMG200023118	K09837	ko00906	Carotenoid biosynthesis	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMG200023118	K09837	ko01100	Metabolic pathways	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMG200023118	K09837	ko01110	Biosynthesis of secondary metabolites	1793	4.7e-93	0.49	0.72	0.78
PGSC0003DMG200019119	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMG200019119	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMG200019119	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.40	0.58	0.96
PGSC0003DMG200019120	K05933	ko00270	Cysteine and methionine metabolism	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMG200019120	K05933	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.40	0.59	0.97
PGSC0003DMG200019123	K01051	ko00040	Pentose and glucuronate interconversions	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMG200019123	K01051	ko00500	Starch and sucrose metabolism	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMG200019123	K01051	ko01100	Metabolic pathways	254	1.0e-07	0.30	0.51	0.82
PGSC0003DMG200019126	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMG200019126	K01988	ko01100	Metabolic pathways	545	3.2e-24	0.34	0.56	0.61
PGSC0003DMG200019131	K07375	ko04145	Phagosome	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMG200019131	K07375	ko04540	Gap junction	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMG200019131	K07375	ko05130	Pathogenic Escherichia coli infection	3777	1.7e-202	0.97	0.99	1.00
PGSC0003DMG200019131	K07375	ko04145	Phagosome	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMG200019131	K07375	ko04540	Gap junction	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMG200019131	K07375	ko05130	Pathogenic Escherichia coli infection	1810	5.4e-94	0.97	0.99	0.99
PGSC0003DMG200000020	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000020	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000020	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000020	K00028	ko00620	Pyruvate metabolism	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMG200000020	K00028	ko00710	Carbon fixation in photosynthetic organisms	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMG200000020	K00028	ko01100	Metabolic pathways	3352	4.8e-179	0.78	0.89	1.00
PGSC0003DMG200000020	K00028	ko00620	Pyruvate metabolism	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000020	K00028	ko00710	Carbon fixation in photosynthetic organisms	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000020	K00028	ko01100	Metabolic pathways	4004	5.2e-215	0.77	0.89	1.00
PGSC0003DMG200000021	K00079	ko00590	Arachidonic acid metabolism	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMG200000021	K00079	ko01100	Metabolic pathways	344	3.9e-13	0.50	0.66	0.79
PGSC0003DMG200000021	K00079	ko00590	Arachidonic acid metabolism	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMG200000021	K00079	ko01100	Metabolic pathways	683	7.8e-32	0.38	0.56	0.98
PGSC0003DMG200000022	K00079	ko00590	Arachidonic acid metabolism	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMG200000022	K00079	ko01100	Metabolic pathways	589	1.2e-26	0.35	0.54	0.98
PGSC0003DMG200000023	K12844	ko03040	Spliceosome	2317	5.8e-122	0.64	0.75	1.00
PGSC0003DMG200000025	K01962	ko00061	Fatty acid biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko00253	Tetracycline biosynthesis	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko00620	Pyruvate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko00640	Propanoate metabolism	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko01100	Metabolic pathways	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko01110	Biosynthesis of secondary metabolites	2951	6.3e-157	0.54	0.71	0.95
PGSC0003DMG200000025	K01962	ko00061	Fatty acid biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko00253	Tetracycline biosynthesis	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko00620	Pyruvate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko00640	Propanoate metabolism	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko01100	Metabolic pathways	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko01110	Biosynthesis of secondary metabolites	2620	1.1e-138	0.55	0.72	0.97
PGSC0003DMG200000025	K01962	ko00061	Fatty acid biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00253	Tetracycline biosynthesis	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00620	Pyruvate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00640	Propanoate metabolism	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko01100	Metabolic pathways	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00061	Fatty acid biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00253	Tetracycline biosynthesis	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00620	Pyruvate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko00640	Propanoate metabolism	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko01100	Metabolic pathways	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000025	K01962	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.36	0.56	0.97
PGSC0003DMG200000026	K12614	ko03018	RNA degradation	3635	1.2e-194	0.88	0.92	0.99
PGSC0003DMG200000029	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMG200000029	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMG200000029	K01613	ko00564	Glycerophospholipid metabolism	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMG200000029	K01613	ko01100	Metabolic pathways	280	6.2e-06	0.25	0.43	0.32
PGSC0003DMG200009358	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2806	6.2e-149	0.81	0.91	0.99
PGSC0003DMG200009358	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3490	1.2e-186	0.82	0.91	0.89
PGSC0003DMG200009358	K01883	ko00970	Aminoacyl-tRNA biosynthesis	2684	3.3e-142	0.81	0.91	0.90
PGSC0003DMG200009358	K01883	ko00970	Aminoacyl-tRNA biosynthesis	3022	7.6e-161	0.82	0.92	0.81
PGSC0003DMG200006332	K08737	ko03430	Mismatch repair	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMG200006332	K08737	ko05200	Pathways in cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMG200006332	K08737	ko05210	Colorectal cancer	255	3.4e-07	0.31	0.41	0.50
PGSC0003DMG200006333	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200006338	K07466	ko03030	DNA replication	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMG200006338	K07466	ko03420	Nucleotide excision repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMG200006338	K07466	ko03430	Mismatch repair	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMG200006338	K07466	ko03440	Homologous recombination	254	1.4e-06	0.27	0.42	0.73
PGSC0003DMG200011599	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMG200011599	K12567	ko05414	Dilated cardiomyopathy	607	4.3e-25	0.33	0.45	0.91
PGSC0003DMG200011601	K00059	ko00061	Fatty acid biosynthesis	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMG200011601	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMG200011601	K00059	ko01100	Metabolic pathways	1436	2.3e-73	0.64	0.80	1.00
PGSC0003DMG200011602	K00059	ko00061	Fatty acid biosynthesis	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMG200011602	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMG200011602	K00059	ko01100	Metabolic pathways	1402	1.7e-71	0.62	0.80	1.00
PGSC0003DMG200011604	K08336	ko04140	Regulation of autophagy	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMG200011604	K08336	ko04622	RIG-I-like receptor signaling pathway	370	1.4e-14	0.60	0.67	0.71
PGSC0003DMG200011604	K08336	ko04140	Regulation of autophagy	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMG200011604	K08336	ko04622	RIG-I-like receptor signaling pathway	706	4.2e-33	0.89	0.94	0.99
PGSC0003DMG200011612	K05658	ko02010	ABC transporters	2958	2.1e-163	0.42	0.60	0.99
PGSC0003DMG200011613	K05658	ko02010	ABC transporters	3859	5.2e-207	0.43	0.65	0.99
PGSC0003DMG200002501	K09589	ko00905	Brassinosteroid biosynthesis	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMG200002501	K09589	ko01100	Metabolic pathways	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMG200002501	K09589	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.61	0.80	0.95
PGSC0003DMG200002501	K09589	ko00905	Brassinosteroid biosynthesis	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMG200002501	K09589	ko01100	Metabolic pathways	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMG200002501	K09589	ko01110	Biosynthesis of secondary metabolites	840	1.7e-40	0.77	0.89	0.97
PGSC0003DMG200002506	K04354	ko04111	Cell cycle - yeast	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMG200002506	K04354	ko04530	Tight junction	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMG200002506	K04354	ko05142	Chagas disease	3691	9.6e-198	0.91	0.95	0.98
PGSC0003DMG200002509	K02957	ko03010	Ribosome	851	4.2e-41	0.75	0.91	0.69
PGSC0003DMG200020579	K06685	ko04111	Cell cycle - yeast	331	2.8e-10	0.27	0.45	0.63
PGSC0003DMG200020589	K08679	ko00500	Starch and sucrose metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMG200020589	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMG200020589	K08679	ko01100	Metabolic pathways	3210	3.3e-171	0.85	0.91	0.98
PGSC0003DMG200020593	K01897	ko00071	Fatty acid metabolism	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMG200020593	K01897	ko01100	Metabolic pathways	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMG200020593	K01897	ko03320	PPAR signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMG200020593	K01897	ko04146	Peroxisome	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMG200020593	K01897	ko04920	Adipocytokine signaling pathway	3334	4.7e-178	0.65	0.79	1.00
PGSC0003DMG200020593	K01897	ko00071	Fatty acid metabolism	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMG200020593	K01897	ko01100	Metabolic pathways	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMG200020593	K01897	ko03320	PPAR signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMG200020593	K01897	ko04146	Peroxisome	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMG200020593	K01897	ko04920	Adipocytokine signaling pathway	2999	1.4e-159	0.68	0.81	0.99
PGSC0003DMG200021550	K00856	ko00230	Purine metabolism	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMG200021550	K00856	ko01100	Metabolic pathways	2613	2.8e-138	0.89	0.95	0.99
PGSC0003DMG200021554	K13068	ko00940	Phenylpropanoid biosynthesis	883	7.2e-43	0.33	0.51	0.99
PGSC0003DMG200021555	K13068	ko00940	Phenylpropanoid biosynthesis	865	7.1e-42	0.32	0.51	0.96
PGSC0003DMG200021559	K12818	ko03040	Spliceosome	968	1.5e-47	0.52	0.65	0.93
PGSC0003DMG200025239	K05350	ko00460	Cyanoamino acid metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMG200025239	K05350	ko00500	Starch and sucrose metabolism	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMG200025239	K05350	ko00940	Phenylpropanoid biosynthesis	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMG200025239	K05350	ko01110	Biosynthesis of secondary metabolites	1470	3.0e-75	0.46	0.57	0.97
PGSC0003DMG200025239	K05350	ko00460	Cyanoamino acid metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMG200025239	K05350	ko00500	Starch and sucrose metabolism	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMG200025239	K05350	ko00940	Phenylpropanoid biosynthesis	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMG200025239	K05350	ko01110	Biosynthesis of secondary metabolites	1909	1.9e-99	0.62	0.76	0.95
PGSC0003DMG200025239	K05350	ko00460	Cyanoamino acid metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMG200025239	K05350	ko00500	Starch and sucrose metabolism	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMG200025239	K05350	ko00940	Phenylpropanoid biosynthesis	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMG200025239	K05350	ko01110	Biosynthesis of secondary metabolites	2540	2.9e-134	0.61	0.75	0.96
PGSC0003DMG200025242	K00799	ko00480	Glutathione metabolism	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMG200025242	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMG200025242	K00799	ko00982	Drug metabolism - cytochrome P450	753	1.1e-35	0.47	0.67	0.91
PGSC0003DMG200025243	K03002	ko00230	Purine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMG200025243	K03002	ko00240	Pyrimidine metabolism	7162	0.	0.76	0.87	1.00
PGSC0003DMG200025243	K03002	ko01100	Metabolic pathways	7162	0.	0.76	0.87	1.00
PGSC0003DMG200025243	K03002	ko03020	RNA polymerase	7162	0.	0.76	0.87	1.00
PGSC0003DMG200025246	K11253	ko05322	Systemic lupus erythematosus	906	3.9e-44	0.83	0.88	0.89
PGSC0003DMG200025246	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200025248	K00600	ko00260	Glycine, serine and threonine metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200025248	K00600	ko00460	Cyanoamino acid metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200025248	K00600	ko00670	One carbon pool by folate	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200025248	K00600	ko00680	Methane metabolism	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200025248	K00600	ko01100	Metabolic pathways	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200025248	K00600	ko01110	Biosynthesis of secondary metabolites	667	5.9e-31	0.44	0.54	0.90
PGSC0003DMG200027395	K00475	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMG200027395	K00475	ko01100	Metabolic pathways	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMG200027395	K00475	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.37	0.60	0.91
PGSC0003DMG200027396	K00475	ko00941	Flavonoid biosynthesis	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMG200027396	K00475	ko01100	Metabolic pathways	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMG200027396	K00475	ko01110	Biosynthesis of secondary metabolites	505	5.1e-22	0.42	0.63	0.95
PGSC0003DMG200027401	K12524	ko00260	Glycine, serine and threonine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMG200027401	K12524	ko00270	Cysteine and methionine metabolism	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMG200027401	K12524	ko00300	Lysine biosynthesis	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMG200027401	K12524	ko01100	Metabolic pathways	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMG200027401	K12524	ko01110	Biosynthesis of secondary metabolites	756	7.3e-36	0.36	0.50	0.97
PGSC0003DMG200027403	K04532	ko05010	Alzheimer's disease	3133	5.7e-167	0.80	0.88	1.00
PGSC0003DMG200027403	K04532	ko05010	Alzheimer's disease	2944	1.5e-156	0.84	0.92	0.98
PGSC0003DMG200027403	K04532	ko05010	Alzheimer's disease	3680	3.9e-197	0.81	0.90	1.00
PGSC0003DMG200027403	K04532	ko05010	Alzheimer's disease	3711	7.6e-199	0.83	0.92	1.00
PGSC0003DMG200027404	K03133	ko03022	Basal transcription factors	1195	4.5e-60	0.76	0.90	0.99
PGSC0003DMG200027406	K05282	ko00904	Diterpenoid biosynthesis	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMG200027406	K05282	ko01100	Metabolic pathways	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMG200027406	K05282	ko01110	Biosynthesis of secondary metabolites	1503	4.6e-77	0.61	0.76	0.29
PGSC0003DMG200027406	K05282	ko00904	Diterpenoid biosynthesis	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMG200027406	K05282	ko01100	Metabolic pathways	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMG200027406	K05282	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.74	0.82	0.82
PGSC0003DMG200027406	K05282	ko00904	Diterpenoid biosynthesis	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMG200027406	K05282	ko01100	Metabolic pathways	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMG200027406	K05282	ko01110	Biosynthesis of secondary metabolites	1987	9.3e-104	0.63	0.76	1.00
PGSC0003DMG200003450	K01051	ko00040	Pentose and glucuronate interconversions	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMG200003450	K01051	ko00500	Starch and sucrose metabolism	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMG200003450	K01051	ko01100	Metabolic pathways	2570	6.5e-136	0.57	0.74	0.96
PGSC0003DMG200003451	K06654	ko04111	Cell cycle - yeast	284	7.9e-10	0.33	0.55	0.70
PGSC0003DMG200003458	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.50
PGSC0003DMG200003458	K03469	ko03030	DNA replication	213	6.5e-06	0.32	0.53	0.43
PGSC0003DMG200003461	K00021	ko00900	Terpenoid backbone biosynthesis	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMG200003461	K00021	ko01100	Metabolic pathways	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMG200003461	K00021	ko01110	Biosynthesis of secondary metabolites	3493	8.0e-187	0.70	0.83	1.00
PGSC0003DMG200003465	K07407	ko00052	Galactose metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMG200003465	K07407	ko00561	Glycerolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMG200003465	K07407	ko00600	Sphingolipid metabolism	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMG200003465	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2470	2.1e-130	0.64	0.80	0.98
PGSC0003DMG200003465	K07407	ko00052	Galactose metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMG200003465	K07407	ko00561	Glycerolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMG200003465	K07407	ko00600	Sphingolipid metabolism	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMG200003465	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	2619	1.3e-138	0.69	0.85	0.98
PGSC0003DMG200003467	K02936	ko03010	Ribosome	1872	2.0e-97	0.86	0.94	0.99
PGSC0003DMG200003468	K05765	ko04360	Axon guidance	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMG200003468	K05765	ko04666	Fc gamma R-mediated phagocytosis	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMG200003468	K05765	ko04810	Regulation of actin cytoskeleton	1029	6.4e-51	0.86	0.94	0.99
PGSC0003DMG200003469	K01834	ko00010	Glycolysis / Gluconeogenesis	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMG200003469	K01834	ko01100	Metabolic pathways	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMG200003469	K01834	ko01110	Biosynthesis of secondary metabolites	2586	8.5e-137	0.91	0.96	0.96
PGSC0003DMG200003469	K01834	ko00010	Glycolysis / Gluconeogenesis	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMG200003469	K01834	ko01100	Metabolic pathways	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMG200003469	K01834	ko01110	Biosynthesis of secondary metabolites	3561	1.4e-190	0.86	0.92	0.99
PGSC0003DMG200007109	K07424	ko00140	Steroid hormone biosynthesis	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00591	Linoleic acid metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00830	Retinol metabolism	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00982	Drug metabolism - cytochrome P450	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko00983	Drug metabolism - other enzymes	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007109	K07424	ko01100	Metabolic pathways	324	5.4e-12	0.60	0.76	0.66
PGSC0003DMG200007118	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMG200007118	K00517	ko00626	Naphthalene and anthracene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMG200007118	K00517	ko00903	Limonene and pinene degradation	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMG200007118	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMG200007118	K00517	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.45	0.65	0.89
PGSC0003DMG200007119	K02943	ko03010	Ribosome	814	4.6e-39	0.88	0.96	0.99
PGSC0003DMG200007119	K02943	ko03010	Ribosome	632	5.0e-29	0.87	0.96	0.72
PGSC0003DMG200007122	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMG200007122	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.67	0.81	0.71
PGSC0003DMG200007127	K00679	ko00561	Glycerolipid metabolism	1393	5.4e-71	0.37	0.55	0.84
PGSC0003DMG200016931	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.0e-12	0.31	0.47	0.65
PGSC0003DMG200016931	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	383	1.6e-13	0.31	0.47	0.75
PGSC0003DMG200016933	K02084	ko04115	p53 signaling pathway	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko04210	Apoptosis	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko05010	Alzheimer's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko05012	Parkinson's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko05016	Huntington's disease	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko05222	Small cell lung cancer	309	1.5e-07	0.27	0.45	0.49
PGSC0003DMG200016933	K02084	ko04115	p53 signaling pathway	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko04210	Apoptosis	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko05010	Alzheimer's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko05012	Parkinson's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko05016	Huntington's disease	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko05222	Small cell lung cancer	309	2.3e-07	0.27	0.45	0.39
PGSC0003DMG200016933	K02084	ko04115	p53 signaling pathway	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko04210	Apoptosis	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko05010	Alzheimer's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko05012	Parkinson's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko05016	Huntington's disease	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016933	K02084	ko05222	Small cell lung cancer	309	2.8e-07	0.27	0.45	0.34
PGSC0003DMG200016939	K02985	ko03010	Ribosome	293	2.5e-10	0.76	0.82	0.49
PGSC0003DMG200038389	K13065	ko00940	Phenylpropanoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMG200038389	K13065	ko00941	Flavonoid biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMG200038389	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMG200038389	K13065	ko01110	Biosynthesis of secondary metabolites	335	5.6e-12	0.25	0.40	0.91
PGSC0003DMG200038391	K03094	ko04110	Cell cycle	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04111	Cell cycle - yeast	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04114	Oocyte meiosis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04120	Ubiquitin mediated proteolysis	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04310	Wnt signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04350	TGF-beta signaling pathway	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038391	K03094	ko04710	Circadian rhythm - mammal	741	4.9e-35	0.61	0.75	0.99
PGSC0003DMG200038399	K01051	ko00040	Pentose and glucuronate interconversions	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMG200038399	K01051	ko00500	Starch and sucrose metabolism	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMG200038399	K01051	ko01100	Metabolic pathways	853	3.3e-41	0.47	0.62	1.00
PGSC0003DMG200024610	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMG200024610	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMG200024610	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.41	0.59	0.97
PGSC0003DMG200024610	K01757	ko00901	Indole alkaloid biosynthesis	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMG200024610	K01757	ko01100	Metabolic pathways	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMG200024610	K01757	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.41	0.60	0.98
PGSC0003DMG200024610	K01757	ko00901	Indole alkaloid biosynthesis	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMG200024610	K01757	ko01100	Metabolic pathways	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMG200024610	K01757	ko01110	Biosynthesis of secondary metabolites	471	3.8e-20	0.44	0.62	0.92
PGSC0003DMG200024611	K01757	ko00901	Indole alkaloid biosynthesis	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMG200024611	K01757	ko01100	Metabolic pathways	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMG200024611	K01757	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.44	0.62	0.98
PGSC0003DMG200024612	K00876	ko00240	Pyrimidine metabolism	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMG200024612	K00876	ko00983	Drug metabolism - other enzymes	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMG200024612	K00876	ko01100	Metabolic pathways	445	1.0e-18	0.35	0.54	0.45
PGSC0003DMG200024622	K11821	ko00380	Tryptophan metabolism	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMG200024622	K11821	ko00966	Glucosinolate biosynthesis	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMG200024622	K11821	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.43	0.61	0.86
PGSC0003DMG200024623	K00754	ko00051	Fructose and mannose metabolism	1606	9.6e-83	0.40	0.60	0.95
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020798	K00430	ko00360	Phenylalanine metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMG200020798	K00430	ko00680	Methane metabolism	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMG200020798	K00430	ko00940	Phenylpropanoid biosynthesis	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMG200020798	K00430	ko01100	Metabolic pathways	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMG200020798	K00430	ko01110	Biosynthesis of secondary metabolites	684	6.8e-32	0.54	0.66	0.97
PGSC0003DMG200020799	K00430	ko00360	Phenylalanine metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMG200020799	K00430	ko00680	Methane metabolism	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMG200020799	K00430	ko00940	Phenylpropanoid biosynthesis	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMG200020799	K00430	ko01100	Metabolic pathways	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMG200020799	K00430	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.59	0.74	1.00
PGSC0003DMG200020800	K00430	ko00360	Phenylalanine metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMG200020800	K00430	ko00680	Methane metabolism	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMG200020800	K00430	ko00940	Phenylpropanoid biosynthesis	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMG200020800	K00430	ko01100	Metabolic pathways	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMG200020800	K00430	ko01110	Biosynthesis of secondary metabolites	1175	5.7e-59	0.60	0.74	0.99
PGSC0003DMG200020801	K00430	ko00360	Phenylalanine metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMG200020801	K00430	ko00680	Methane metabolism	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMG200020801	K00430	ko00940	Phenylpropanoid biosynthesis	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMG200020801	K00430	ko01100	Metabolic pathways	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMG200020801	K00430	ko01110	Biosynthesis of secondary metabolites	1415	3.3e-72	0.58	0.75	0.98
PGSC0003DMG200020803	K02995	ko03010	Ribosome	1669	3.2e-86	0.90	0.93	0.99
PGSC0003DMG200020807	K12126	ko04712	Circadian rhythm - plant	291	5.7e-08	0.30	0.54	0.38
PGSC0003DMG200020809	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMG200020809	K00517	ko00626	Naphthalene and anthracene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMG200020809	K00517	ko00903	Limonene and pinene degradation	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMG200020809	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMG200020809	K00517	ko01110	Biosynthesis of secondary metabolites	1088	3.6e-54	0.45	0.66	0.97
PGSC0003DMG200020809	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMG200020809	K00517	ko00626	Naphthalene and anthracene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMG200020809	K00517	ko00903	Limonene and pinene degradation	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMG200020809	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMG200020809	K00517	ko01110	Biosynthesis of secondary metabolites	1639	1.5e-84	0.45	0.64	0.98
PGSC0003DMG200020809	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMG200020809	K00517	ko00626	Naphthalene and anthracene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMG200020809	K00517	ko00903	Limonene and pinene degradation	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMG200020809	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMG200020809	K00517	ko01110	Biosynthesis of secondary metabolites	863	9.2e-42	0.52	0.71	0.97
PGSC0003DMG200037480	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	439	2.2e-18	0.29	0.51	0.61
PGSC0003DMG200037491	K03006	ko00230	Purine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMG200037491	K03006	ko00240	Pyrimidine metabolism	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMG200037491	K03006	ko01100	Metabolic pathways	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMG200037491	K03006	ko03020	RNA polymerase	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMG200037491	K03006	ko05016	Huntington's disease	719	8.5e-33	0.40	0.50	0.94
PGSC0003DMG200039594	K08488	ko04130	SNARE interactions in vesicular transport	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMG200039594	K08488	ko04145	Phagosome	330	2.3e-12	0.35	0.52	0.72
PGSC0003DMG200003191	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	568	1.7e-25	0.30	0.50	0.92
PGSC0003DMG200003194	K08516	ko04130	SNARE interactions in vesicular transport	1551	1.0e-79	0.90	0.94	0.99
PGSC0003DMG200003196	K12128	ko04712	Circadian rhythm - plant	405	4.5e-16	0.35	0.54	0.22
PGSC0003DMG200003196	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMG200003196	K12128	ko04712	Circadian rhythm - plant	405	2.6e-16	0.35	0.54	0.25
PGSC0003DMG200003196	K12128	ko04712	Circadian rhythm - plant	405	2.8e-16	0.35	0.54	0.25
PGSC0003DMG200003200	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	689	3.6e-32	0.32	0.54	0.86
PGSC0003DMG200003200	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	502	7.5e-22	0.37	0.57	0.97
PGSC0003DMG200007833	K12356	ko00940	Phenylpropanoid biosynthesis	677	1.7e-31	0.30	0.51	0.95
PGSC0003DMG200007834	K02706	ko00195	Photosynthesis	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMG200007834	K02706	ko01100	Metabolic pathways	1136	8.0e-57	0.94	0.94	0.89
PGSC0003DMG200007838	K03715	ko00561	Glycerolipid metabolism	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMG200007838	K03715	ko01100	Metabolic pathways	3170	5.2e-169	0.80	0.90	1.00
PGSC0003DMG200007838	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMG200007838	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMG200007838	K07432	ko00510	N-Glycan biosynthesis	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMG200007838	K07432	ko01100	Metabolic pathways	1086	4.6e-54	0.74	0.87	0.99
PGSC0003DMG200007838	K07432	ko00510	N-Glycan biosynthesis	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMG200007838	K07432	ko01100	Metabolic pathways	404	1.9e-16	0.77	0.87	0.98
PGSC0003DMG200007844	K00799	ko00480	Glutathione metabolism	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMG200007844	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMG200007844	K00799	ko00982	Drug metabolism - cytochrome P450	867	5.5e-42	0.54	0.74	0.92
PGSC0003DMG200004116	K12391	ko04142	Lysosome	5879	0.	0.81	0.89	1.00
PGSC0003DMG200004117	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4661	3.0e-251	0.74	0.83	0.97
PGSC0003DMG200004117	K01868	ko00970	Aminoacyl-tRNA biosynthesis	4731	4.2e-255	0.80	0.89	1.00
PGSC0003DMG200004122	K02952	ko03010	Ribosome	1117	9.0e-56	0.80	0.90	0.98
PGSC0003DMG200004124	K02960	ko03010	Ribosome	1134	1.0e-56	0.92	0.98	0.97
PGSC0003DMG200004125	K00128	ko00010	Glycolysis / Gluconeogenesis	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00053	Ascorbate and aldarate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00071	Fatty acid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00280	Valine, leucine and isoleucine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00310	Lysine degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00330	Arginine and proline metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00340	Histidine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00380	Tryptophan metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00410	beta-Alanine metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00561	Glycerolipid metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00620	Pyruvate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00631	1,2-Dichloroethane degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00640	Propanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00641	3-Chloroacrylic acid degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00650	Butanoate metabolism	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00903	Limonene and pinene degradation	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko01100	Metabolic pathways	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko01110	Biosynthesis of secondary metabolites	3530	7.3e-189	0.78	0.88	0.99
PGSC0003DMG200004125	K00128	ko00010	Glycolysis / Gluconeogenesis	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00053	Ascorbate and aldarate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00071	Fatty acid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00280	Valine, leucine and isoleucine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00310	Lysine degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00330	Arginine and proline metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00340	Histidine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00380	Tryptophan metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00410	beta-Alanine metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00561	Glycerolipid metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00620	Pyruvate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00631	1,2-Dichloroethane degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00640	Propanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00641	3-Chloroacrylic acid degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00650	Butanoate metabolism	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko00903	Limonene and pinene degradation	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko01100	Metabolic pathways	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200004125	K00128	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.67	0.73	0.82
PGSC0003DMG200009991	K08852	ko05010	Alzheimer's disease	947	2.1e-46	0.74	0.87	0.92
PGSC0003DMG200009991	K08852	ko05010	Alzheimer's disease	3640	6.2e-195	0.53	0.67	1.00
PGSC0003DMG200009991	K08852	ko05010	Alzheimer's disease	3262	4.4e-174	0.56	0.69	0.99
PGSC0003DMG200009991	K08852	ko05010	Alzheimer's disease	1351	1.1e-68	0.43	0.58	0.97
PGSC0003DMG200009992	K05298	ko00710	Carbon fixation in photosynthetic organisms	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMG200009992	K05298	ko01100	Metabolic pathways	3274	9.6e-175	0.86	0.92	1.00
PGSC0003DMG200009999	K12741	ko03040	Spliceosome	341	5.7e-13	0.29	0.40	0.80
PGSC0003DMG200023832	K10256	ko01040	Biosynthesis of unsaturated fatty acids	776	5.8e-37	0.74	0.87	0.98
PGSC0003DMG200023833	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2416	2.0e-127	0.68	0.84	0.99
PGSC0003DMG200023834	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMG200023840	K09755	ko00940	Phenylpropanoid biosynthesis	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMG200023840	K09755	ko01100	Metabolic pathways	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMG200023840	K09755	ko01110	Biosynthesis of secondary metabolites	1520	5.3e-78	0.40	0.60	0.98
PGSC0003DMG200023840	K09755	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMG200023840	K09755	ko01100	Metabolic pathways	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMG200023840	K09755	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.40	0.60	0.98
PGSC0003DMG200023841	K07750	ko00100	Steroid biosynthesis	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMG200023841	K07750	ko01100	Metabolic pathways	291	8.4e-10	0.30	0.44	0.44
PGSC0003DMG200023842	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2314	8.5e-122	0.67	0.80	1.00
PGSC0003DMG200023843	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2482	4.6e-131	0.70	0.84	0.99
PGSC0003DMG200023844	K10256	ko01040	Biosynthesis of unsaturated fatty acids	802	2.1e-38	0.67	0.78	0.99
PGSC0003DMG200023844	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1081	8.7e-54	0.74	0.89	0.99
PGSC0003DMG200023844	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1658	1.3e-85	0.71	0.85	0.97
PGSC0003DMG200023845	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2390	5.5e-126	0.68	0.82	0.99
PGSC0003DMG200023845	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2393	3.8e-126	0.68	0.81	0.99
PGSC0003DMG200023846	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.82	0.98
PGSC0003DMG200023847	K00059	ko00061	Fatty acid biosynthesis	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMG200023847	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMG200023847	K00059	ko01100	Metabolic pathways	1409	7.0e-72	0.62	0.82	1.00
PGSC0003DMG200023848	K10256	ko01040	Biosynthesis of unsaturated fatty acids	1377	4.1e-70	0.71	0.86	0.60
PGSC0003DMG200023850	K05282	ko00904	Diterpenoid biosynthesis	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMG200023850	K05282	ko01100	Metabolic pathways	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMG200023850	K05282	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.30	0.45	0.96
PGSC0003DMG200023851	K02933	ko03010	Ribosome	1507	2.8e-77	0.78	0.90	1.00
PGSC0003DMG200023851	K01955	ko00240	Pyrimidine metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMG200023851	K01955	ko00250	Alanine, aspartate and glutamate metabolism	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMG200023851	K01955	ko01100	Metabolic pathways	660	7.7e-30	0.55	0.68	0.84
PGSC0003DMG200026796	K02084	ko04115	p53 signaling pathway	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko04210	Apoptosis	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko05010	Alzheimer's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko05012	Parkinson's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko05016	Huntington's disease	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026796	K02084	ko05222	Small cell lung cancer	337	4.7e-09	0.27	0.46	0.47
PGSC0003DMG200026801	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMG200026801	K00122	ko00680	Methane metabolism	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMG200026801	K00122	ko01100	Metabolic pathways	609	9.3e-30	0.79	0.86	0.69
PGSC0003DMG200026801	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMG200026801	K00122	ko00680	Methane metabolism	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMG200026801	K00122	ko01100	Metabolic pathways	227	1.1e-06	0.74	0.82	0.56
PGSC0003DMG200026805	K10760	ko00908	Zeatin biosynthesis	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMG200026805	K10760	ko01100	Metabolic pathways	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMG200026805	K10760	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.60	0.79	0.42
PGSC0003DMG200029034	K05749	ko04810	Regulation of actin cytoskeleton	5915	0.	0.83	0.93	1.00
PGSC0003DMG200029035	K05749	ko04810	Regulation of actin cytoskeleton	2319	4.5e-122	0.92	0.98	0.41
PGSC0003DMG200029035	K05749	ko04810	Regulation of actin cytoskeleton	2627	4.7e-139	0.90	0.96	0.98
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	528	2.8e-23	0.45	0.59	0.99
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.57	0.73	0.99
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2234	2.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.68	0.83	0.96
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2146	1.6e-112	0.60	0.77	0.92
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.65	0.81	1.00
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	989	1.0e-48	0.68	0.82	0.99
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2247	4.2e-118	0.61	0.77	0.91
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2231	3.2e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2230	3.7e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko00340	Histidine metabolism	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01100	Metabolic pathways	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMG200029045	K01590	ko01110	Biosynthesis of secondary metabolites	2227	5.4e-117	0.60	0.77	0.91
PGSC0003DMG200029046	K01590	ko00340	Histidine metabolism	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMG200029046	K01590	ko01100	Metabolic pathways	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMG200029046	K01590	ko01110	Biosynthesis of secondary metabolites	2240	1.0e-117	0.60	0.78	0.95
PGSC0003DMG200019819	K01246	ko03410	Base excision repair	1833	2.9e-95	0.60	0.73	1.00
PGSC0003DMG200019819	K01246	ko03410	Base excision repair	605	1.6e-27	0.49	0.61	0.94
PGSC0003DMG200019821	K05391	ko04626	Plant-pathogen interaction	3983	7.5e-214	0.70	0.81	0.97
PGSC0003DMG200019825	K09753	ko00940	Phenylpropanoid biosynthesis	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMG200019825	K09753	ko01100	Metabolic pathways	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMG200019825	K09753	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.76	0.86	0.98
PGSC0003DMG200041592	K06631	ko04110	Cell cycle	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMG200041592	K06631	ko04114	Oocyte meiosis	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMG200041592	K06631	ko04914	Progesterone-mediated oocyte maturation	237	7.3e-07	0.29	0.45	0.90
PGSC0003DMG200005679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMG200005679	K00517	ko00626	Naphthalene and anthracene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMG200005679	K00517	ko00903	Limonene and pinene degradation	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMG200005679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMG200005679	K00517	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.41	0.60	0.97
PGSC0003DMG200005679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMG200005679	K00517	ko00626	Naphthalene and anthracene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMG200005679	K00517	ko00903	Limonene and pinene degradation	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMG200005679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMG200005679	K00517	ko01110	Biosynthesis of secondary metabolites	1284	5.5e-65	0.41	0.61	0.99
PGSC0003DMG200005679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMG200005679	K00517	ko00626	Naphthalene and anthracene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMG200005679	K00517	ko00903	Limonene and pinene degradation	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMG200005679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMG200005679	K00517	ko01110	Biosynthesis of secondary metabolites	1529	1.7e-78	0.43	0.60	0.97
PGSC0003DMG200005679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMG200005679	K00517	ko00626	Naphthalene and anthracene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMG200005679	K00517	ko00903	Limonene and pinene degradation	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMG200005679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMG200005679	K00517	ko01110	Biosynthesis of secondary metabolites	1555	6.2e-80	0.42	0.61	0.98
PGSC0003DMG200005680	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMG200005680	K00517	ko00626	Naphthalene and anthracene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMG200005680	K00517	ko00903	Limonene and pinene degradation	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMG200005680	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMG200005680	K00517	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.53	0.72	0.91
PGSC0003DMG200005690	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMG200008719	K04077	ko03018	RNA degradation	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMG200008719	K04077	ko04940	Type I diabetes mellitus	481	1.1e-20	0.72	0.85	0.71
PGSC0003DMG200008724	K00001	ko00010	Glycolysis / Gluconeogenesis	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00071	Fatty acid metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00350	Tyrosine metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00624	1- and 2-Methylnaphthalene degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00641	3-Chloroacrylic acid degradation	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00830	Retinol metabolism	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00982	Drug metabolism - cytochrome P450	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko01100	Metabolic pathways	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.54	0.74	0.99
PGSC0003DMG200008724	K00001	ko00010	Glycolysis / Gluconeogenesis	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00071	Fatty acid metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00350	Tyrosine metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00641	3-Chloroacrylic acid degradation	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00830	Retinol metabolism	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko00982	Drug metabolism - cytochrome P450	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko01100	Metabolic pathways	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008724	K00001	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.57	0.72	0.98
PGSC0003DMG200008727	K01199	ko00500	Starch and sucrose metabolism	833	4.1e-40	0.34	0.59	0.74
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	1475	1.6e-75	0.91	0.95	0.94
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	1868	3.4e-97	0.76	0.87	1.00
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	1817	2.2e-94	0.88	0.94	0.87
PGSC0003DMG200001797	K01692	ko00071	Fatty acid metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00280	Valine, leucine and isoleucine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00281	Geraniol degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00310	Lysine degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00380	Tryptophan metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00410	beta-Alanine metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00632	Benzoate degradation via CoA ligation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00640	Propanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00650	Butanoate metabolism	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00903	Limonene and pinene degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00930	Caprolactam degradation	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko01100	Metabolic pathways	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko01110	Biosynthesis of secondary metabolites	1338	5.8e-68	0.49	0.65	0.93
PGSC0003DMG200001797	K01692	ko00071	Fatty acid metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00280	Valine, leucine and isoleucine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00281	Geraniol degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00310	Lysine degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00380	Tryptophan metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00410	beta-Alanine metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00632	Benzoate degradation via CoA ligation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00640	Propanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00650	Butanoate metabolism	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00930	Caprolactam degradation	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko01100	Metabolic pathways	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.51	0.68	0.93
PGSC0003DMG200001797	K01692	ko00071	Fatty acid metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00280	Valine, leucine and isoleucine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00281	Geraniol degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00310	Lysine degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00380	Tryptophan metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00410	beta-Alanine metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00632	Benzoate degradation via CoA ligation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00640	Propanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00650	Butanoate metabolism	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00903	Limonene and pinene degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko00930	Caprolactam degradation	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko01100	Metabolic pathways	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001797	K01692	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.44	0.61	0.75
PGSC0003DMG200001800	K08241	ko00592	alpha-Linolenic acid metabolism	302	3.6e-16	0.39	0.53	0.90
PGSC0003DMG200001801	K00799	ko00480	Glutathione metabolism	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMG200001801	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMG200001801	K00799	ko00982	Drug metabolism - cytochrome P450	235	4.0e-07	0.38	0.56	0.75
PGSC0003DMG200001801	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMG200001801	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMG200001801	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.52	0.71	0.92
PGSC0003DMG200001802	K01923	ko00230	Purine metabolism	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMG200001802	K01923	ko01100	Metabolic pathways	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMG200001802	K01923	ko01110	Biosynthesis of secondary metabolites	2539	3.3e-134	0.75	0.86	1.00
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	711	2.2e-33	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	693	2.2e-32	0.44	0.64	0.99
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	734	1.2e-34	0.46	0.67	0.94
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	729	2.3e-34	0.45	0.66	0.94
PGSC0003DMG200001804	K00799	ko00480	Glutathione metabolism	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMG200001804	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMG200001804	K00799	ko00982	Drug metabolism - cytochrome P450	717	1.0e-33	0.43	0.64	0.99
PGSC0003DMG200018540	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.76
PGSC0003DMG200018544	K09490	ko03060	Protein export	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMG200018544	K09490	ko05020	Prion diseases	5170	2.6e-279	0.93	0.96	1.00
PGSC0003DMG200018545	K04461	ko04010	MAPK signaling pathway	474	2.6e-20	0.32	0.47	0.81
PGSC0003DMG200018545	K04461	ko04010	MAPK signaling pathway	548	2.2e-24	0.35	0.52	0.79
PGSC0003DMG200018550	K12478	ko04144	Endocytosis	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMG200018550	K12478	ko04145	Phagosome	397	7.7e-13	0.25	0.45	0.99
PGSC0003DMG200018550	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMG200018550	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMG200018550	K12478	ko04144	Endocytosis	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMG200018550	K12478	ko04145	Phagosome	405	4.8e-13	0.25	0.43	0.90
PGSC0003DMG200018552	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMG200018552	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.97
PGSC0003DMG200018552	K00703	ko00500	Starch and sucrose metabolism	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMG200018552	K00703	ko01100	Metabolic pathways	3098	4.9e-165	0.66	0.81	0.82
PGSC0003DMG200018556	K12194	ko04144	Endocytosis	1608	7.4e-83	0.91	0.94	1.00
PGSC0003DMG200018556	K12194	ko04144	Endocytosis	971	1.0e-47	0.91	0.95	0.99
PGSC0003DMG200018557	K05759	ko04810	Regulation of actin cytoskeleton	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMG200018557	K05759	ko05131	Shigellosis	969	1.3e-47	0.84	0.92	0.98
PGSC0003DMG200018558	K02087	ko04110	Cell cycle	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMG200018558	K02087	ko04114	Oocyte meiosis	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMG200018558	K02087	ko04115	p53 signaling pathway	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMG200018558	K02087	ko04540	Gap junction	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMG200018558	K02087	ko04914	Progesterone-mediated oocyte maturation	1876	1.2e-97	0.83	0.91	0.86
PGSC0003DMG200018558	K02087	ko04110	Cell cycle	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMG200018558	K02087	ko04114	Oocyte meiosis	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMG200018558	K02087	ko04115	p53 signaling pathway	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMG200018558	K02087	ko04540	Gap junction	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMG200018558	K02087	ko04914	Progesterone-mediated oocyte maturation	2073	1.7e-108	0.82	0.89	1.00
PGSC0003DMG200018560	K01051	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMG200018560	K01051	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMG200018560	K01051	ko01100	Metabolic pathways	1105	4.1e-55	0.48	0.62	0.94
PGSC0003DMG200021527	K00759	ko00230	Purine metabolism	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMG200021527	K00759	ko01100	Metabolic pathways	1316	9.5e-67	0.88	0.93	0.99
PGSC0003DMG200021528	K11866	ko04144	Endocytosis	271	7.3e-06	0.27	0.40	0.53
PGSC0003DMG200021533	K00599	ko00340	Histidine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMG200021533	K00599	ko00350	Tyrosine metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMG200021533	K00599	ko00450	Selenoamino acid metabolism	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMG200021533	K00599	ko00626	Naphthalene and anthracene degradation	657	2.1e-30	0.41	0.60	0.83
PGSC0003DMG200021533	K00599	ko00340	Histidine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMG200021533	K00599	ko00350	Tyrosine metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMG200021533	K00599	ko00450	Selenoamino acid metabolism	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMG200021533	K00599	ko00626	Naphthalene and anthracene degradation	851	4.2e-41	0.50	0.68	0.96
PGSC0003DMG200021533	K00599	ko00340	Histidine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMG200021533	K00599	ko00350	Tyrosine metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMG200021533	K00599	ko00450	Selenoamino acid metabolism	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMG200021533	K00599	ko00626	Naphthalene and anthracene degradation	1057	1.8e-52	0.43	0.61	0.97
PGSC0003DMG200021539	K12347	ko04142	Lysosome	240	4.8e-07	0.51	0.63	0.97
PGSC0003DMG200021539	K12347	ko04142	Lysosome	3209	3.7e-171	0.76	0.86	0.94
PGSC0003DMG200021540	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMG200021540	K00517	ko00626	Naphthalene and anthracene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMG200021540	K00517	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMG200021540	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMG200021540	K00517	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.87
PGSC0003DMG200021540	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMG200021540	K00517	ko00626	Naphthalene and anthracene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMG200021540	K00517	ko00903	Limonene and pinene degradation	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMG200021540	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMG200021540	K00517	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.41	0.64	0.76
PGSC0003DMG200021541	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMG200021541	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMG200021541	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMG200021541	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMG200021541	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.48	0.67	1.00
PGSC0003DMG200021542	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMG200021542	K00517	ko00626	Naphthalene and anthracene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMG200021542	K00517	ko00903	Limonene and pinene degradation	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMG200021542	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMG200021542	K00517	ko01110	Biosynthesis of secondary metabolites	1972	6.2e-103	0.49	0.68	0.99
PGSC0003DMG200021543	K04508	ko04310	Wnt signaling pathway	3643	4.3e-195	0.71	0.84	1.00
PGSC0003DMG200021549	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko00360	Phenylalanine metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMG200021549	K10775	ko00910	Nitrogen metabolism	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMG200021549	K10775	ko00940	Phenylpropanoid biosynthesis	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMG200021549	K10775	ko01100	Metabolic pathways	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMG200021549	K10775	ko01110	Biosynthesis of secondary metabolites	5082	1.8e-274	0.84	0.92	1.00
PGSC0003DMG200021549	K10775	ko00360	Phenylalanine metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko00910	Nitrogen metabolism	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko00940	Phenylpropanoid biosynthesis	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko01100	Metabolic pathways	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200021549	K10775	ko01110	Biosynthesis of secondary metabolites	2813	2.6e-149	0.83	0.92	0.99
PGSC0003DMG200025253	K00970	ko03018	RNA degradation	226	6.2e-06	0.30	0.50	0.71
PGSC0003DMG200025254	K02303	ko00860	Porphyrin and chlorophyll metabolism	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMG200025254	K02303	ko01100	Metabolic pathways	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMG200025254	K02303	ko01110	Biosynthesis of secondary metabolites	2217	1.9e-116	0.75	0.84	0.98
PGSC0003DMG200025255	K06670	ko04110	Cell cycle	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMG200025255	K06670	ko04111	Cell cycle - yeast	670	6.9e-31	0.27	0.38	1.00
PGSC0003DMG200025260	K11253	ko05322	Systemic lupus erythematosus	443	1.3e-18	0.82	0.89	0.88
PGSC0003DMG200025261	K11253	ko05322	Systemic lupus erythematosus	449	6.3e-19	0.95	0.95	0.58
PGSC0003DMG200025261	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200025274	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMG200025274	K00517	ko00626	Naphthalene and anthracene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMG200025274	K00517	ko00903	Limonene and pinene degradation	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMG200025274	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMG200025274	K00517	ko01110	Biosynthesis of secondary metabolites	1324	3.4e-67	0.38	0.58	0.98
PGSC0003DMG200025275	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMG200025275	K00517	ko00626	Naphthalene and anthracene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMG200025275	K00517	ko00903	Limonene and pinene degradation	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMG200025275	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMG200025275	K00517	ko01110	Biosynthesis of secondary metabolites	1377	4.1e-70	0.40	0.59	0.98
PGSC0003DMG200020529	K05577	ko00190	Oxidative phosphorylation	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMG200020529	K05577	ko01100	Metabolic pathways	980	3.2e-48	0.54	0.66	0.97
PGSC0003DMG200020539	K05575	ko00190	Oxidative phosphorylation	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMG200020539	K05575	ko01100	Metabolic pathways	1838	1.5e-95	0.89	0.96	1.00
PGSC0003DMG200016879	K01404	ko05140	Leishmaniasis	5417	6.1e-293	0.75	0.85	0.96
PGSC0003DMG200016879	K01404	ko05140	Leishmaniasis	5219	5.1e-282	0.80	0.89	1.00
PGSC0003DMG200016880	K00754	ko00051	Fructose and mannose metabolism	293	4.9e-10	0.29	0.49	0.54
PGSC0003DMG200016883	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMG200016883	K02996	ko03010	Ribosome	1237	2.2e-62	0.76	0.84	1.00
PGSC0003DMG200016886	K03801	ko00785	Lipoic acid metabolism	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMG200016886	K03801	ko01100	Metabolic pathways	534	1.3e-23	0.73	0.86	0.97
PGSC0003DMG200016886	K03801	ko00785	Lipoic acid metabolism	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMG200016886	K03801	ko01100	Metabolic pathways	1470	3.0e-75	0.66	0.83	0.92
PGSC0003DMG200016886	K03801	ko00785	Lipoic acid metabolism	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMG200016886	K03801	ko01100	Metabolic pathways	810	7.7e-39	0.70	0.85	0.98
PGSC0003DMG200016886	K03801	ko00785	Lipoic acid metabolism	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMG200016886	K03801	ko01100	Metabolic pathways	589	1.2e-26	0.54	0.66	0.95
PGSC0003DMG200016887	K01723	ko00592	alpha-Linolenic acid metabolism	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMG200016887	K01723	ko01100	Metabolic pathways	3328	1.0e-177	0.73	0.86	1.00
PGSC0003DMG200016888	K00655	ko00561	Glycerolipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMG200016888	K00655	ko00564	Glycerophospholipid metabolism	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMG200016888	K00655	ko01100	Metabolic pathways	524	4.6e-23	0.40	0.59	0.76
PGSC0003DMG200016891	K01099	ko00562	Inositol phosphate metabolism	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMG200016891	K01099	ko01100	Metabolic pathways	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMG200016891	K01099	ko04070	Phosphatidylinositol signaling system	657	2.1e-30	0.36	0.55	0.86
PGSC0003DMG200003440	K01768	ko00230	Purine metabolism	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMG200003440	K01768	ko04113	Meiosis - yeast	329	4.9e-08	0.29	0.43	0.29
PGSC0003DMG200003446	K11778	ko00900	Terpenoid backbone biosynthesis	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMG200003446	K11778	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.56	0.70	0.75
PGSC0003DMG200003446	K11778	ko00900	Terpenoid backbone biosynthesis	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMG200003446	K11778	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.60	0.77	0.99
PGSC0003DMG200003446	K11778	ko00900	Terpenoid backbone biosynthesis	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMG200003446	K11778	ko01110	Biosynthesis of secondary metabolites	1096	1.3e-54	0.57	0.74	0.76
PGSC0003DMG200007131	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMG200007131	K11252	ko05322	Systemic lupus erythematosus	779	3.9e-37	0.41	0.57	0.96
PGSC0003DMG200007132	K10597	ko04120	Ubiquitin mediated proteolysis	6473	0.	0.77	0.86	1.00
PGSC0003DMG200007136	K12193	ko04144	Endocytosis	1571	8.2e-81	0.86	0.93	1.00
PGSC0003DMG200007143	K03368	ko00512	O-Glycan biosynthesis	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMG200007143	K03368	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMG200007143	K03368	ko00603	Glycosphingolipid biosynthesis - globo series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMG200007143	K03368	ko00604	Glycosphingolipid biosynthesis - ganglio series	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMG200007143	K03368	ko01100	Metabolic pathways	359	5.8e-14	0.29	0.43	0.91
PGSC0003DMG200038289	K06627	ko04110	Cell cycle	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMG200038289	K06627	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.32	0.53	0.61
PGSC0003DMG200026107	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMG200026107	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMG200026107	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.83
PGSC0003DMG200026110	K00939	ko00230	Purine metabolism	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMG200026110	K00939	ko01100	Metabolic pathways	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMG200026110	K00939	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.68	0.79	0.84
PGSC0003DMG200026111	K03800	ko00785	Lipoic acid metabolism	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMG200026111	K03800	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.93
PGSC0003DMG200026115	K09843	ko00906	Carotenoid biosynthesis	1011	6.3e-50	0.34	0.54	0.99
PGSC0003DMG200026119	K12876	ko03040	Spliceosome	1301	6.4e-66	0.77	0.87	0.99
PGSC0003DMG200023119	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMG200023119	K00517	ko00626	Naphthalene and anthracene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMG200023119	K00517	ko00903	Limonene and pinene degradation	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMG200023119	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMG200023119	K00517	ko01110	Biosynthesis of secondary metabolites	560	4.7e-25	0.51	0.69	0.97
PGSC0003DMG200023129	K01259	ko00330	Arginine and proline metabolism	2177	3.1e-114	0.83	0.90	0.81
PGSC0003DMG200023129	K01259	ko00330	Arginine and proline metabolism	2374	4.2e-125	0.82	0.91	0.82
PGSC0003DMG200023132	K12821	ko03040	Spliceosome	665	8.5e-31	0.43	0.66	1.00
PGSC0003DMG200023132	K12821	ko03040	Spliceosome	3260	5.7e-174	0.53	0.68	0.96
PGSC0003DMG200011544	K10570	ko03420	Nucleotide excision repair	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMG200011544	K10570	ko04120	Ubiquitin mediated proteolysis	2827	4.3e-150	0.75	0.83	1.00
PGSC0003DMG200011544	K10570	ko03420	Nucleotide excision repair	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMG200011544	K10570	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.78	0.90	0.86
PGSC0003DMG200011544	K10570	ko03420	Nucleotide excision repair	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMG200011544	K10570	ko04120	Ubiquitin mediated proteolysis	1868	3.4e-97	0.73	0.81	1.00
PGSC0003DMG200011545	K08332	ko04140	Regulation of autophagy	363	3.9e-14	0.28	0.52	0.89
PGSC0003DMG200011551	K06627	ko04110	Cell cycle	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMG200011551	K06627	ko04914	Progesterone-mediated oocyte maturation	1964	1.7e-102	0.68	0.78	0.99
PGSC0003DMG200011555	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.0e-12	0.31	0.49	0.31
PGSC0003DMG200011555	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMG200011555	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	5.9e-12	0.31	0.49	0.29
PGSC0003DMG200009343	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMG200009343	K01755	ko00330	Arginine and proline metabolism	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMG200009343	K01755	ko01100	Metabolic pathways	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMG200009343	K01755	ko01110	Biosynthesis of secondary metabolites	3464	3.2e-185	0.77	0.86	0.99
PGSC0003DMG200009343	K01755	ko00250	Alanine, aspartate and glutamate metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMG200009343	K01755	ko00330	Arginine and proline metabolism	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMG200009343	K01755	ko01100	Metabolic pathways	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMG200009343	K01755	ko01110	Biosynthesis of secondary metabolites	3507	1.4e-187	0.80	0.89	0.99
PGSC0003DMG200009346	K02893	ko03010	Ribosome	225	1.4e-06	0.29	0.45	0.85
PGSC0003DMG200009348	K12402	ko04142	Lysosome	1830	4.2e-95	0.88	0.96	1.00
PGSC0003DMG200009348	K12402	ko04142	Lysosome	2309	1.6e-121	0.86	0.94	1.00
PGSC0003DMG200009348	K12402	ko04142	Lysosome	3386	6.4e-181	0.87	0.95	1.00
PGSC0003DMG200009348	K12402	ko04142	Lysosome	3369	5.5e-180	0.87	0.94	1.00
PGSC0003DMG200009351	K03132	ko03022	Basal transcription factors	1018	2.6e-50	0.66	0.79	0.99
PGSC0003DMG200006346	K09755	ko00940	Phenylpropanoid biosynthesis	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMG200006346	K09755	ko01100	Metabolic pathways	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMG200006346	K09755	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.50	0.72	0.96
PGSC0003DMG200006346	K05280	ko00941	Flavonoid biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMG200006346	K05280	ko00944	Flavone and flavonol biosynthesis	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMG200006346	K05280	ko01100	Metabolic pathways	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMG200006346	K05280	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.40	0.60	0.98
PGSC0003DMG200006347	K11294	ko05130	Pathogenic Escherichia coli infection	244	2.1e-07	0.36	0.50	0.93
PGSC0003DMG200006349	K12741	ko03040	Spliceosome	647	7.5e-30	0.35	0.47	0.71
PGSC0003DMG200006354	K09755	ko00940	Phenylpropanoid biosynthesis	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMG200006354	K09755	ko01100	Metabolic pathways	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMG200006354	K09755	ko01110	Biosynthesis of secondary metabolites	744	3.4e-35	0.49	0.70	0.98
PGSC0003DMG200006354	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMG200006354	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMG200006354	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMG200006354	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.48	0.68	0.96
PGSC0003DMG200006354	K05280	ko00941	Flavonoid biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMG200006354	K05280	ko00944	Flavone and flavonol biosynthesis	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMG200006354	K05280	ko01100	Metabolic pathways	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMG200006354	K05280	ko01110	Biosynthesis of secondary metabolites	1567	1.4e-80	0.41	0.65	0.98
PGSC0003DMG200006356	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMG200006356	K01199	ko00500	Starch and sucrose metabolism	442	1.5e-18	0.26	0.50	0.71
PGSC0003DMG200042880	K01193	ko00052	Galactose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMG200042880	K01193	ko00500	Starch and sucrose metabolism	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMG200042880	K01193	ko01100	Metabolic pathways	470	4.3e-20	0.69	0.84	0.93
PGSC0003DMG200042885	K10760	ko00908	Zeatin biosynthesis	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMG200042885	K10760	ko01100	Metabolic pathways	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMG200042885	K10760	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.45	0.60	0.93
PGSC0003DMG200028976	K02149	ko00190	Oxidative phosphorylation	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028976	K02149	ko01100	Metabolic pathways	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028976	K02149	ko04145	Phagosome	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028976	K02149	ko04966	Collecting duct acid secretion	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028976	K02149	ko05110	Vibrio cholerae infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028976	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1818	1.9e-94	0.85	0.94	1.00
PGSC0003DMG200028982	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko00020	Citrate cycle (TCA cycle)	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko01100	Metabolic pathways	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028982	K01647	ko01110	Biosynthesis of secondary metabolites	3569	5.2e-191	0.88	0.95	1.00
PGSC0003DMG200028992	K00939	ko00230	Purine metabolism	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMG200028992	K00939	ko01100	Metabolic pathways	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMG200028992	K00939	ko01110	Biosynthesis of secondary metabolites	1199	2.7e-60	0.59	0.75	0.92
PGSC0003DMG200028992	K00939	ko00230	Purine metabolism	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMG200028992	K00939	ko01100	Metabolic pathways	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMG200028992	K00939	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.59	0.78	0.80
PGSC0003DMG200028993	K12129	ko04712	Circadian rhythm - plant	3484	2.5e-186	0.58	0.72	0.99
PGSC0003DMG200028996	K01423	ko00310	Lysine degradation	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMG200028996	K01423	ko00780	Biotin metabolism	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMG200028996	K01423	ko01100	Metabolic pathways	1543	2.9e-79	0.44	0.60	0.88
PGSC0003DMG200023855	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMG200023855	K12567	ko05414	Dilated cardiomyopathy	336	3.9e-10	0.37	0.46	0.82
PGSC0003DMG200023856	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMG200023856	K12567	ko05414	Dilated cardiomyopathy	579	1.5e-23	0.34	0.44	0.90
PGSC0003DMG200023857	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMG200023857	K12567	ko05414	Dilated cardiomyopathy	683	2.8e-29	0.30	0.44	0.94
PGSC0003DMG200023858	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMG200023858	K12567	ko05414	Dilated cardiomyopathy	487	1.8e-18	0.32	0.42	0.93
PGSC0003DMG200023859	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMG200023859	K12567	ko05414	Dilated cardiomyopathy	474	9.5e-18	0.31	0.43	0.91
PGSC0003DMG200023860	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	467	2.0e-19	0.31	0.44	0.99
PGSC0003DMG200023861	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMG200023861	K12567	ko05414	Dilated cardiomyopathy	460	5.6e-17	0.32	0.44	0.92
PGSC0003DMG200023862	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	504	1.5e-21	0.31	0.44	0.90
PGSC0003DMG200023877	K01051	ko00040	Pentose and glucuronate interconversions	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMG200023877	K01051	ko00500	Starch and sucrose metabolism	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMG200023877	K01051	ko01100	Metabolic pathways	1138	6.2e-57	0.50	0.62	0.86
PGSC0003DMG200023878	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMG200023878	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMG200023878	K02641	ko00195	Photosynthesis	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMG200023878	K02641	ko01100	Metabolic pathways	2658	9.1e-141	0.85	0.93	1.00
PGSC0003DMG200023878	K08507	ko04130	SNARE interactions in vesicular transport	263	1.1e-08	0.28	0.47	0.99
PGSC0003DMG200026767	K12657	ko00330	Arginine and proline metabolism	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMG200026767	K12657	ko01100	Metabolic pathways	4110	7.5e-221	0.78	0.92	0.98
PGSC0003DMG200026767	K12657	ko00330	Arginine and proline metabolism	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMG200026767	K12657	ko01100	Metabolic pathways	681	1.0e-31	0.83	0.91	0.91
PGSC0003DMG200026767	K12657	ko00330	Arginine and proline metabolism	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMG200026767	K12657	ko01100	Metabolic pathways	4748	4.8e-256	0.80	0.92	0.99
PGSC0003DMG200026767	K12657	ko00330	Arginine and proline metabolism	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMG200026767	K12657	ko01100	Metabolic pathways	1163	2.6e-58	0.80	0.91	0.96
PGSC0003DMG200026772	K10760	ko00908	Zeatin biosynthesis	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMG200026772	K10760	ko01100	Metabolic pathways	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMG200026772	K10760	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.37	0.56	0.86
PGSC0003DMG200026774	K02704	ko00195	Photosynthesis	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMG200026774	K02704	ko01100	Metabolic pathways	1172	1.3e-67	0.92	0.95	0.50
PGSC0003DMG200026778	K11818	ko00380	Tryptophan metabolism	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMG200026778	K11818	ko00966	Glucosinolate biosynthesis	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMG200026778	K11818	ko01110	Biosynthesis of secondary metabolites	851	4.2e-41	0.54	0.69	0.91
PGSC0003DMG200026778	K11818	ko00380	Tryptophan metabolism	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMG200026778	K11818	ko00966	Glucosinolate biosynthesis	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMG200026778	K11818	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.49	0.68	0.93
PGSC0003DMG200026781	K07199	ko04910	Insulin signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMG200026781	K07199	ko04920	Adipocytokine signaling pathway	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMG200026781	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	225	2.8e-06	0.42	0.65	0.15
PGSC0003DMG200026783	K10843	ko03420	Nucleotide excision repair	4741	1.2e-255	0.75	0.84	1.00
PGSC0003DMG200026784	K01507	ko00190	Oxidative phosphorylation	2008	6.4e-105	0.78	0.86	1.00
PGSC0003DMG200005693	K07424	ko00140	Steroid hormone biosynthesis	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00591	Linoleic acid metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00830	Retinol metabolism	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00982	Drug metabolism - cytochrome P450	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00983	Drug metabolism - other enzymes	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko01100	Metabolic pathways	1346	2.1e-68	0.38	0.57	0.95
PGSC0003DMG200005693	K07424	ko00140	Steroid hormone biosynthesis	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00591	Linoleic acid metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00830	Retinol metabolism	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00982	Drug metabolism - cytochrome P450	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko00983	Drug metabolism - other enzymes	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005693	K07424	ko01100	Metabolic pathways	1445	7.3e-74	0.39	0.60	0.95
PGSC0003DMG200005695	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMG200005695	K06573	ko04966	Collecting duct acid secretion	686	5.3e-32	0.28	0.45	0.89
PGSC0003DMG200005698	K04124	ko00904	Diterpenoid biosynthesis	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMG200005698	K04124	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.63	0.80	0.89
PGSC0003DMG200005698	K04124	ko00904	Diterpenoid biosynthesis	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMG200005698	K04124	ko01110	Biosynthesis of secondary metabolites	1608	7.4e-83	0.59	0.76	0.90
PGSC0003DMG200005704	K03136	ko03022	Basal transcription factors	2874	1.1e-152	0.73	0.85	1.00
PGSC0003DMG200005704	K03136	ko03022	Basal transcription factors	736	9.3e-35	0.61	0.75	0.99
PGSC0003DMG200005704	K03136	ko03022	Basal transcription factors	1268	4.2e-64	0.86	0.95	0.96
PGSC0003DMG200008708	K00549	ko00270	Cysteine and methionine metabolism	5723	0.	0.88	0.94	1.00
PGSC0003DMG200008708	K00549	ko01100	Metabolic pathways	5723	0.	0.88	0.94	1.00
PGSC0003DMG200008708	K00549	ko01110	Biosynthesis of secondary metabolites	5723	0.	0.88	0.94	1.00
PGSC0003DMG200008708	K00549	ko00270	Cysteine and methionine metabolism	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMG200008708	K00549	ko01100	Metabolic pathways	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMG200008708	K00549	ko01110	Biosynthesis of secondary metabolites	812	6.0e-39	0.95	0.97	0.99
PGSC0003DMG200008710	K11817	ko00380	Tryptophan metabolism	6807	0.	0.61	0.78	0.99
PGSC0003DMG200008718	K02335	ko00230	Purine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko00240	Pyrimidine metabolism	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko01100	Metabolic pathways	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko03030	DNA replication	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko03410	Base excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko03420	Nucleotide excision repair	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko03440	Homologous recombination	615	5.8e-28	0.48	0.70	0.69
PGSC0003DMG200008718	K02335	ko00230	Purine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko00240	Pyrimidine metabolism	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko01100	Metabolic pathways	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko03030	DNA replication	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko03410	Base excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko03420	Nucleotide excision repair	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko03440	Homologous recombination	676	1.9e-31	0.48	0.70	0.73
PGSC0003DMG200008718	K02335	ko00230	Purine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko00240	Pyrimidine metabolism	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko01100	Metabolic pathways	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko03030	DNA replication	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko03410	Base excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko03420	Nucleotide excision repair	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200008718	K02335	ko03440	Homologous recombination	377	2.4e-14	0.52	0.72	0.61
PGSC0003DMG200017810	K10643	ko03018	RNA degradation	975	6.1e-48	0.65	0.79	0.99
PGSC0003DMG200017812	K02989	ko03010	Ribosome	1444	8.3e-74	0.84	0.90	0.99
PGSC0003DMG200017824	K07904	ko04144	Endocytosis	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMG200017824	K07904	ko04962	Vasopressin-regulated water reabsorption	1520	5.3e-78	0.76	0.80	1.00
PGSC0003DMG200017824	K07904	ko04144	Endocytosis	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMG200017824	K07904	ko04962	Vasopressin-regulated water reabsorption	1609	6.6e-83	0.90	0.94	1.00
PGSC0003DMG200017825	K04460	ko04010	MAPK signaling pathway	369	1.6e-14	0.36	0.54	0.36
PGSC0003DMG200017826	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMG200017826	K00517	ko00626	Naphthalene and anthracene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMG200017826	K00517	ko00903	Limonene and pinene degradation	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMG200017826	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMG200017826	K00517	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.40	0.56	0.97
PGSC0003DMG200037401	K13082	ko00941	Flavonoid biosynthesis	550	1.7e-24	0.39	0.64	0.98
PGSC0003DMG200024630	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMG200024630	K00517	ko00626	Naphthalene and anthracene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMG200024630	K00517	ko00903	Limonene and pinene degradation	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMG200024630	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMG200024630	K00517	ko01110	Biosynthesis of secondary metabolites	2745	1.4e-145	0.66	0.78	0.99
PGSC0003DMG200024634	K07466	ko03030	DNA replication	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMG200024634	K07466	ko03420	Nucleotide excision repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMG200024634	K07466	ko03430	Mismatch repair	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMG200024634	K07466	ko03440	Homologous recombination	2051	2.7e-107	0.54	0.75	0.73
PGSC0003DMG200024636	K06060	ko04330	Notch signaling pathway	827	8.9e-40	0.36	0.57	0.93
PGSC0003DMG200024636	K04505	ko04310	Wnt signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMG200024636	K04505	ko04330	Notch signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMG200024636	K04505	ko04722	Neurotrophin signaling pathway	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMG200024636	K04505	ko05010	Alzheimer's disease	809	8.7e-39	0.36	0.53	0.98
PGSC0003DMG200024638	K02136	ko00190	Oxidative phosphorylation	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMG200024638	K02136	ko01100	Metabolic pathways	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMG200024638	K02136	ko05010	Alzheimer's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMG200024638	K02136	ko05012	Parkinson's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMG200024638	K02136	ko05016	Huntington's disease	2277	9.4e-120	0.86	0.93	1.00
PGSC0003DMG200024643	K05280	ko00941	Flavonoid biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMG200024643	K05280	ko00944	Flavone and flavonol biosynthesis	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMG200024643	K05280	ko01100	Metabolic pathways	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMG200024643	K05280	ko01110	Biosynthesis of secondary metabolites	328	3.0e-12	0.71	0.87	0.96
PGSC0003DMG200024643	K05280	ko00941	Flavonoid biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMG200024643	K05280	ko00944	Flavone and flavonol biosynthesis	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMG200024643	K05280	ko01100	Metabolic pathways	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMG200024643	K05280	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.74	0.88	0.99
PGSC0003DMG200024643	K05280	ko00941	Flavonoid biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMG200024643	K05280	ko00944	Flavone and flavonol biosynthesis	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMG200024643	K05280	ko01100	Metabolic pathways	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMG200024643	K05280	ko01110	Biosynthesis of secondary metabolites	3053	1.5e-162	0.78	0.89	1.00
PGSC0003DMG200020795	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00360	Phenylalanine metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00680	Methane metabolism	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00940	Phenylpropanoid biosynthesis	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko01100	Metabolic pathways	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko01110	Biosynthesis of secondary metabolites	463	1.1e-19	0.63	0.81	0.91
PGSC0003DMG200020795	K00430	ko00360	Phenylalanine metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMG200020795	K00430	ko00680	Methane metabolism	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMG200020795	K00430	ko00940	Phenylpropanoid biosynthesis	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMG200020795	K00430	ko01100	Metabolic pathways	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMG200020795	K00430	ko01110	Biosynthesis of secondary metabolites	452	4.3e-19	0.67	0.75	0.90
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.59	0.70	0.55
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00360	Phenylalanine metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00680	Methane metabolism	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko00940	Phenylpropanoid biosynthesis	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01100	Metabolic pathways	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200020796	K00430	ko01110	Biosynthesis of secondary metabolites	1407	9.1e-72	0.57	0.68	1.00
PGSC0003DMG200039505	K04508	ko04310	Wnt signaling pathway	470	3.8e-27	0.53	0.67	0.97
PGSC0003DMG200039510	K12493	ko04144	Endocytosis	760	7.9e-36	0.35	0.46	0.75
PGSC0003DMG200007848	K01115	ko00564	Glycerophospholipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007848	K01115	ko00565	Ether lipid metabolism	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007848	K01115	ko01100	Metabolic pathways	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007848	K01115	ko04144	Endocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007848	K01115	ko04666	Fc gamma R-mediated phagocytosis	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007848	K01115	ko04912	GnRH signaling pathway	4657	5.0e-251	0.66	0.80	0.99
PGSC0003DMG200007849	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00071	Fatty acid metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00280	Valine, leucine and isoleucine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00281	Geraniol degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00310	Lysine degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00380	Tryptophan metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00410	beta-Alanine metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00632	Benzoate degradation via CoA ligation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00640	Propanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00650	Butanoate metabolism	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00903	Limonene and pinene degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00930	Caprolactam degradation	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko01100	Metabolic pathways	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko01110	Biosynthesis of secondary metabolites	1207	9.7e-61	0.44	0.63	0.95
PGSC0003DMG200007849	K01692	ko00071	Fatty acid metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00280	Valine, leucine and isoleucine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00281	Geraniol degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00310	Lysine degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00380	Tryptophan metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00410	beta-Alanine metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00632	Benzoate degradation via CoA ligation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00640	Propanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00650	Butanoate metabolism	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00903	Limonene and pinene degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko00930	Caprolactam degradation	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko01100	Metabolic pathways	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007849	K01692	ko01110	Biosynthesis of secondary metabolites	1105	4.1e-55	0.45	0.63	0.94
PGSC0003DMG200007855	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMG200007859	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMG200007859	K00053	ko00770	Pantothenate and CoA biosynthesis	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMG200007859	K00053	ko01100	Metabolic pathways	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMG200007859	K00053	ko01110	Biosynthesis of secondary metabolites	4125	1.1e-221	0.84	0.91	1.00
PGSC0003DMG200007863	K13066	ko00940	Phenylpropanoid biosynthesis	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMG200007863	K13066	ko01110	Biosynthesis of secondary metabolites	805	1.4e-38	0.45	0.63	0.93
PGSC0003DMG200007865	K08139	ko04113	Meiosis - yeast	1138	6.2e-57	0.36	0.61	0.86
PGSC0003DMG200004095	K02641	ko00195	Photosynthesis	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMG200004095	K02641	ko01100	Metabolic pathways	2572	5.0e-136	0.79	0.87	1.00
PGSC0003DMG200004095	K02641	ko00195	Photosynthesis	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMG200004095	K02641	ko01100	Metabolic pathways	2711	1.1e-143	0.82	0.91	1.00
PGSC0003DMG200004097	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMG200004097	K01602	ko00710	Carbon fixation in photosynthetic organisms	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMG200004097	K01602	ko01100	Metabolic pathways	1140	4.8e-57	0.74	0.86	0.98
PGSC0003DMG200004100	K01895	ko00010	Glycolysis / Gluconeogenesis	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko00620	Pyruvate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko00640	Propanoate metabolism	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko01100	Metabolic pathways	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko01110	Biosynthesis of secondary metabolites	3934	3.8e-211	0.84	0.94	0.94
PGSC0003DMG200004100	K01895	ko00010	Glycolysis / Gluconeogenesis	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko00620	Pyruvate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko00640	Propanoate metabolism	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko01100	Metabolic pathways	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.91	0.94	1.00
PGSC0003DMG200004100	K01895	ko00010	Glycolysis / Gluconeogenesis	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004100	K01895	ko00620	Pyruvate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004100	K01895	ko00640	Propanoate metabolism	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004100	K01895	ko00720	Reductive carboxylate cycle (CO2 fixation)	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004100	K01895	ko01100	Metabolic pathways	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004100	K01895	ko01110	Biosynthesis of secondary metabolites	4815	9.7e-260	0.85	0.93	1.00
PGSC0003DMG200004101	K01535	ko00190	Oxidative phosphorylation	7118	0.	0.89	0.95	0.99
PGSC0003DMG200004102	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMG200004102	K09833	ko01100	Metabolic pathways	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMG200004102	K09833	ko01110	Biosynthesis of secondary metabolites	1107	3.2e-55	0.45	0.54	0.99
PGSC0003DMG200004102	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMG200004102	K09833	ko01100	Metabolic pathways	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMG200004102	K09833	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.78	0.89	1.00
PGSC0003DMG200004102	K09833	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMG200004102	K09833	ko01100	Metabolic pathways	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMG200004102	K09833	ko01110	Biosynthesis of secondary metabolites	2082	5.3e-109	0.65	0.76	1.00
PGSC0003DMG200004105	K01423	ko00310	Lysine degradation	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMG200004105	K01423	ko00780	Biotin metabolism	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMG200004105	K01423	ko01100	Metabolic pathways	227	3.1e-06	0.33	0.39	0.52
PGSC0003DMG200004106	K12115	ko04712	Circadian rhythm - plant	3939	2.0e-211	0.84	0.93	0.87
PGSC0003DMG200004106	K12115	ko04712	Circadian rhythm - plant	4455	7.0e-240	0.82	0.91	0.99
PGSC0003DMG200004108	K04733	ko04210	Apoptosis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMG200004108	K04733	ko04620	Toll-like receptor signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMG200004108	K04733	ko04722	Neurotrophin signaling pathway	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMG200004108	K04733	ko05140	Leishmaniasis	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMG200004108	K04733	ko05142	Chagas disease	683	7.8e-32	0.37	0.54	0.77
PGSC0003DMG200004111	K00797	ko00270	Cysteine and methionine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMG200004111	K00797	ko00330	Arginine and proline metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMG200004111	K00797	ko00410	beta-Alanine metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMG200004111	K00797	ko00480	Glutathione metabolism	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMG200004111	K00797	ko01100	Metabolic pathways	2397	2.3e-126	0.79	0.89	1.00
PGSC0003DMG200004114	K00697	ko00500	Starch and sucrose metabolism	5607	0.	0.74	0.86	0.95
PGSC0003DMG200004114	K00697	ko00500	Starch and sucrose metabolism	4997	8.9e-270	0.76	0.90	0.95
PGSC0003DMG200004114	K00697	ko00500	Starch and sucrose metabolism	5058	3.8e-273	0.76	0.89	0.95
PGSC0003DMG200003144	K03939	ko00190	Oxidative phosphorylation	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMG200003144	K03939	ko01100	Metabolic pathways	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMG200003144	K03939	ko05010	Alzheimer's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMG200003144	K03939	ko05012	Parkinson's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMG200003144	K03939	ko05016	Huntington's disease	637	2.7e-29	0.73	0.84	0.92
PGSC0003DMG200003146	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04020	Calcium signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04070	Phosphatidylinositol signaling system	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04114	Oocyte meiosis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04270	Vascular smooth muscle contraction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04626	Plant-pathogen interaction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04720	Long-term potentiation	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04722	Neurotrophin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04740	Olfactory transduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04744	Phototransduction	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04745	Phototransduction - fly	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04910	Insulin signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04912	GnRH signaling pathway	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04916	Melanogenesis	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04970	Salivary secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko04971	Gastric acid secretion	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko05010	Alzheimer's disease	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003146	K02183	ko05214	Glioma	585	2.0e-26	0.49	0.72	0.90
PGSC0003DMG200003152	K09753	ko00940	Phenylpropanoid biosynthesis	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMG200003152	K09753	ko01100	Metabolic pathways	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMG200003152	K09753	ko01110	Biosynthesis of secondary metabolites	506	4.5e-22	0.33	0.49	0.92
PGSC0003DMG200003152	K09753	ko00940	Phenylpropanoid biosynthesis	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMG200003152	K09753	ko01100	Metabolic pathways	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMG200003152	K09753	ko01110	Biosynthesis of secondary metabolites	547	2.5e-24	0.34	0.52	0.91
PGSC0003DMG200010021	K00100	ko00051	Fructose and mannose metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko00363	Bisphenol A degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko00591	Linoleic acid metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko00625	Tetrachloroethene degradation	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko00650	Butanoate metabolism	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko01100	Metabolic pathways	435	3.7e-18	0.34	0.49	0.94
PGSC0003DMG200010021	K00100	ko00051	Fructose and mannose metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010021	K00100	ko00363	Bisphenol A degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010021	K00100	ko00591	Linoleic acid metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010021	K00100	ko00625	Tetrachloroethene degradation	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010021	K00100	ko00650	Butanoate metabolism	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010021	K00100	ko01100	Metabolic pathways	440	2.0e-18	0.34	0.51	0.94
PGSC0003DMG200010023	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMG200010023	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMG200010023	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.49	0.66	0.43
PGSC0003DMG200010025	K00423	ko00053	Ascorbate and aldarate metabolism	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMG200010025	K00423	ko01100	Metabolic pathways	2137	4.9e-112	0.55	0.70	0.95
PGSC0003DMG200010025	K00423	ko00053	Ascorbate and aldarate metabolism	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMG200010025	K00423	ko01100	Metabolic pathways	2373	4.8e-125	0.52	0.67	0.96
PGSC0003DMG200010025	K00423	ko00053	Ascorbate and aldarate metabolism	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMG200010025	K00423	ko01100	Metabolic pathways	2421	1.1e-127	0.54	0.70	0.96
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	1431	4.3e-73	0.46	0.66	1.00
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.51	0.73	0.99
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	888	3.8e-43	0.52	0.72	0.93
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.44	0.64	1.00
PGSC0003DMG200010026	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMG200010026	K00517	ko00626	Naphthalene and anthracene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMG200010026	K00517	ko00903	Limonene and pinene degradation	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMG200010026	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMG200010026	K00517	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.44	0.65	1.00
PGSC0003DMG200010931	K03026	ko00230	Purine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMG200010931	K03026	ko00240	Pyrimidine metabolism	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMG200010931	K03026	ko01100	Metabolic pathways	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMG200010931	K03026	ko03020	RNA polymerase	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMG200010931	K03026	ko04623	Cytosolic DNA-sensing pathway	832	4.7e-40	0.63	0.72	0.93
PGSC0003DMG200010931	K03026	ko00230	Purine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMG200010931	K03026	ko00240	Pyrimidine metabolism	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMG200010931	K03026	ko01100	Metabolic pathways	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMG200010931	K03026	ko03020	RNA polymerase	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMG200010931	K03026	ko04623	Cytosolic DNA-sensing pathway	1348	1.6e-68	0.58	0.69	1.00
PGSC0003DMG200010931	K03026	ko00230	Purine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMG200010931	K03026	ko00240	Pyrimidine metabolism	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMG200010931	K03026	ko01100	Metabolic pathways	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMG200010931	K03026	ko03020	RNA polymerase	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMG200010931	K03026	ko04623	Cytosolic DNA-sensing pathway	571	1.2e-25	0.54	0.76	0.99
PGSC0003DMG200008155	K13065	ko00940	Phenylpropanoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMG200008155	K13065	ko00941	Flavonoid biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMG200008155	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMG200008155	K13065	ko01110	Biosynthesis of secondary metabolites	415	4.7e-17	0.26	0.46	0.94
PGSC0003DMG200008158	K00088	ko00230	Purine metabolism	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMG200008158	K00088	ko00983	Drug metabolism - other enzymes	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMG200008158	K00088	ko01100	Metabolic pathways	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMG200008158	K00088	ko01110	Biosynthesis of secondary metabolites	3093	9.2e-165	0.75	0.87	0.99
PGSC0003DMG200008159	K06443	ko00906	Carotenoid biosynthesis	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMG200008159	K06443	ko01100	Metabolic pathways	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMG200008159	K06443	ko01110	Biosynthesis of secondary metabolites	3605	5.3e-193	0.83	0.90	1.00
PGSC0003DMG200008163	K02183	ko04020	Calcium signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04070	Phosphatidylinositol signaling system	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04114	Oocyte meiosis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04270	Vascular smooth muscle contraction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04626	Plant-pathogen interaction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04720	Long-term potentiation	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04722	Neurotrophin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04740	Olfactory transduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04744	Phototransduction	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04745	Phototransduction - fly	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04910	Insulin signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04912	GnRH signaling pathway	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04916	Melanogenesis	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04970	Salivary secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko04971	Gastric acid secretion	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko05010	Alzheimer's disease	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008163	K02183	ko05214	Glioma	387	1.6e-15	0.40	0.56	0.75
PGSC0003DMG200008170	K01674	ko00910	Nitrogen metabolism	1074	2.1e-53	0.49	0.68	0.98
PGSC0003DMG200014243	K03428	ko00860	Porphyrin and chlorophyll metabolism	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMG200014243	K03428	ko01100	Metabolic pathways	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMG200014243	K03428	ko01110	Biosynthesis of secondary metabolites	953	1.0e-46	0.82	0.93	0.89
PGSC0003DMG200014243	K03428	ko00860	Porphyrin and chlorophyll metabolism	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMG200014243	K03428	ko01100	Metabolic pathways	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMG200014243	K03428	ko01110	Biosynthesis of secondary metabolites	1505	3.6e-77	0.62	0.76	0.90
PGSC0003DMG200014249	K05766	ko04810	Regulation of actin cytoskeleton	403	9.3e-16	0.37	0.56	0.19
PGSC0003DMG200014249	K05766	ko04810	Regulation of actin cytoskeleton	403	3.3e-16	0.37	0.56	0.26
PGSC0003DMG200014249	K05766	ko04810	Regulation of actin cytoskeleton	403	2.2e-16	0.37	0.56	0.63
PGSC0003DMG200014250	K13289	ko04142	Lysosome	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMG200014250	K13289	ko04614	Renin-angiotensin system	2464	4.6e-130	0.80	0.93	0.93
PGSC0003DMG200014250	K13289	ko04142	Lysosome	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMG200014250	K13289	ko04614	Renin-angiotensin system	2029	4.5e-106	0.83	0.94	0.88
PGSC0003DMG200014250	K13289	ko04142	Lysosome	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMG200014250	K13289	ko04614	Renin-angiotensin system	1886	3.5e-98	0.80	0.92	0.99
PGSC0003DMG200014250	K13289	ko04142	Lysosome	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMG200014250	K13289	ko04614	Renin-angiotensin system	3087	2.0e-164	0.80	0.92	0.96
PGSC0003DMG200014251	K03015	ko00230	Purine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMG200014251	K03015	ko00240	Pyrimidine metabolism	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMG200014251	K03015	ko01100	Metabolic pathways	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMG200014251	K03015	ko03020	RNA polymerase	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMG200014251	K03015	ko05016	Huntington's disease	1143	3.3e-57	0.75	0.90	0.97
PGSC0003DMG200017556	K03542	ko00195	Photosynthesis	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMG200017556	K03542	ko01100	Metabolic pathways	1596	3.4e-82	0.74	0.83	1.00
PGSC0003DMG200017560	K00889	ko00562	Inositol phosphate metabolism	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko01100	Metabolic pathways	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko04070	Phosphatidylinositol signaling system	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko04144	Endocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko04666	Fc gamma R-mediated phagocytosis	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko04810	Regulation of actin cytoskeleton	505	7.4e-22	0.33	0.47	0.61
PGSC0003DMG200017560	K00889	ko00562	Inositol phosphate metabolism	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017560	K00889	ko01100	Metabolic pathways	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017560	K00889	ko04070	Phosphatidylinositol signaling system	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017560	K00889	ko04144	Endocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017560	K00889	ko04666	Fc gamma R-mediated phagocytosis	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017560	K00889	ko04810	Regulation of actin cytoskeleton	483	1.5e-20	0.36	0.52	0.47
PGSC0003DMG200017568	K00128	ko00010	Glycolysis / Gluconeogenesis	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00053	Ascorbate and aldarate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00071	Fatty acid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00280	Valine, leucine and isoleucine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00310	Lysine degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00330	Arginine and proline metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00340	Histidine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00380	Tryptophan metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00410	beta-Alanine metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00561	Glycerolipid metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00620	Pyruvate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00631	1,2-Dichloroethane degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00640	Propanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00641	3-Chloroacrylic acid degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00650	Butanoate metabolism	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko00903	Limonene and pinene degradation	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko01100	Metabolic pathways	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200017568	K00128	ko01110	Biosynthesis of secondary metabolites	295	2.1e-10	0.60	0.72	0.97
PGSC0003DMG200027654	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMG200027654	K11517	ko01100	Metabolic pathways	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMG200027654	K11517	ko04146	Peroxisome	2822	8.2e-150	0.91	0.96	0.99
PGSC0003DMG200027655	K01179	ko00500	Starch and sucrose metabolism	231	2.3e-06	0.42	0.50	0.70
PGSC0003DMG200027662	K10717	ko00908	Zeatin biosynthesis	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMG200027662	K10717	ko01100	Metabolic pathways	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMG200027662	K10717	ko01110	Biosynthesis of secondary metabolites	1276	1.5e-64	0.36	0.58	0.67
PGSC0003DMG200027662	K10717	ko00908	Zeatin biosynthesis	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMG200027662	K10717	ko01100	Metabolic pathways	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMG200027662	K10717	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.43	0.68	0.99
PGSC0003DMG200027663	K01955	ko00240	Pyrimidine metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMG200027663	K01955	ko00250	Alanine, aspartate and glutamate metabolism	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMG200027663	K01955	ko01100	Metabolic pathways	275	2.7e-08	0.53	0.69	0.50
PGSC0003DMG200027667	K02932	ko03010	Ribosome	2233	2.5e-117	0.86	0.94	1.00
PGSC0003DMG200027669	K05740	ko04510	Focal adhesion	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMG200027669	K05740	ko04810	Regulation of actin cytoskeleton	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMG200027669	K05740	ko05131	Shigellosis	840	3.2e-40	0.31	0.46	0.63
PGSC0003DMG200027669	K11422	ko00310	Lysine degradation	373	7.5e-12	0.27	0.38	0.84
PGSC0003DMG200027671	K02699	ko00195	Photosynthesis	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMG200027671	K02699	ko01100	Metabolic pathways	1563	2.3e-80	0.85	0.91	1.00
PGSC0003DMG200033905	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMG200033905	K00224	ko00364	Fluorobenzoate degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMG200033905	K00224	ko00628	Fluorene degradation	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMG200033905	K00224	ko00640	Propanoate metabolism	1611	5.1e-83	0.65	0.77	0.99
PGSC0003DMG200033906	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMG200033906	K00224	ko00364	Fluorobenzoate degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMG200033906	K00224	ko00628	Fluorene degradation	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMG200033906	K00224	ko00640	Propanoate metabolism	1760	3.1e-91	0.70	0.80	0.99
PGSC0003DMG200033906	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMG200033906	K00224	ko00364	Fluorobenzoate degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMG200033906	K00224	ko00628	Fluorene degradation	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMG200033906	K00224	ko00640	Propanoate metabolism	1749	1.2e-90	0.69	0.80	0.99
PGSC0003DMG200033906	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMG200033906	K00224	ko00364	Fluorobenzoate degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMG200033906	K00224	ko00628	Fluorene degradation	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMG200033906	K00224	ko00640	Propanoate metabolism	1412	4.8e-72	0.69	0.80	1.00
PGSC0003DMG200033907	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMG200033907	K00224	ko00364	Fluorobenzoate degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMG200033907	K00224	ko00628	Fluorene degradation	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMG200033907	K00224	ko00640	Propanoate metabolism	1065	6.6e-53	0.60	0.65	0.97
PGSC0003DMG200024885	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04012	ErbB signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04062	Chemokine signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04110	Cell cycle	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04310	Wnt signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04340	Hedgehog signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04360	Axon guidance	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04510	Focal adhesion	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04660	T cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04662	B cell receptor signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04711	Circadian rhythm - fly	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04722	Neurotrophin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04910	Insulin signaling pathway	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko04916	Melanogenesis	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05010	Alzheimer's disease	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05200	Pathways in cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05210	Colorectal cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05213	Endometrial cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05215	Prostate cancer	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024885	K03083	ko05217	Basal cell carcinoma	3409	3.4e-182	0.93	0.96	0.99
PGSC0003DMG200024886	K01945	ko00230	Purine metabolism	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMG200024886	K01945	ko01100	Metabolic pathways	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMG200024886	K01945	ko01110	Biosynthesis of secondary metabolites	3236	1.2e-172	0.75	0.85	0.99
PGSC0003DMG200024887	K03283	ko03040	Spliceosome	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMG200024887	K03283	ko04010	MAPK signaling pathway	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMG200024887	K03283	ko04144	Endocytosis	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMG200024887	K03283	ko04612	Antigen processing and presentation	4973	1.9e-268	0.85	0.91	1.00
PGSC0003DMG200012485	K09553	ko05020	Prion diseases	3288	1.6e-175	0.69	0.80	0.91
PGSC0003DMG200012485	K09553	ko05020	Prion diseases	2007	7.3e-105	0.74	0.84	0.96
PGSC0003DMG200012496	K03952	ko00190	Oxidative phosphorylation	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMG200012496	K03952	ko01100	Metabolic pathways	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMG200012496	K03952	ko05010	Alzheimer's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMG200012496	K03952	ko05012	Parkinson's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMG200012496	K03952	ko05016	Huntington's disease	428	9.0e-18	0.70	0.82	0.97
PGSC0003DMG200001833	K00889	ko00562	Inositol phosphate metabolism	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001833	K00889	ko01100	Metabolic pathways	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001833	K00889	ko04070	Phosphatidylinositol signaling system	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001833	K00889	ko04144	Endocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001833	K00889	ko04666	Fc gamma R-mediated phagocytosis	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001833	K00889	ko04810	Regulation of actin cytoskeleton	514	2.1e-22	0.34	0.48	0.59
PGSC0003DMG200001835	K10875	ko03440	Homologous recombination	720	7.1e-34	0.30	0.49	0.57
PGSC0003DMG200001842	K01338	ko04112	Cell cycle - Caulobacter	6472	0.	0.87	0.95	1.00
PGSC0003DMG200016205	K00560	ko00240	Pyrimidine metabolism	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMG200016205	K00560	ko00670	One carbon pool by folate	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMG200016205	K00560	ko01100	Metabolic pathways	528	2.8e-23	0.57	0.76	0.67
PGSC0003DMG200016205	K00560	ko00240	Pyrimidine metabolism	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMG200016205	K00560	ko00670	One carbon pool by folate	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMG200016205	K00560	ko01100	Metabolic pathways	533	1.5e-23	0.53	0.70	0.60
PGSC0003DMG200016207	K06670	ko04110	Cell cycle	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMG200016207	K06670	ko04111	Cell cycle - yeast	497	9.8e-19	0.29	0.42	0.66
PGSC0003DMG200016207	K06670	ko04110	Cell cycle	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMG200016207	K06670	ko04111	Cell cycle - yeast	499	6.5e-21	0.29	0.42	0.80
PGSC0003DMG200016208	K00850	ko00010	Glycolysis / Gluconeogenesis	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko00030	Pentose phosphate pathway	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko00051	Fructose and mannose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko00052	Galactose metabolism	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko01100	Metabolic pathways	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko01110	Biosynthesis of secondary metabolites	2063	6.0e-108	0.89	0.95	1.00
PGSC0003DMG200016208	K00850	ko00010	Glycolysis / Gluconeogenesis	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200016208	K00850	ko00030	Pentose phosphate pathway	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200016208	K00850	ko00051	Fructose and mannose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200016208	K00850	ko00052	Galactose metabolism	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200016208	K00850	ko01100	Metabolic pathways	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200016208	K00850	ko01110	Biosynthesis of secondary metabolites	3639	7.1e-195	0.88	0.94	0.89
PGSC0003DMG200046915	K01193	ko00052	Galactose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMG200046915	K01193	ko00500	Starch and sucrose metabolism	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMG200046915	K01193	ko01100	Metabolic pathways	429	7.9e-18	0.61	0.83	0.49
PGSC0003DMG200046917	K10760	ko00908	Zeatin biosynthesis	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMG200046917	K10760	ko01100	Metabolic pathways	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMG200046917	K10760	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.47	0.65	0.97
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	552	1.3e-24	0.75	0.85	0.47
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.57
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.74	0.91	0.91
PGSC0003DMG200000528	K00128	ko00010	Glycolysis / Gluconeogenesis	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00053	Ascorbate and aldarate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00071	Fatty acid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00280	Valine, leucine and isoleucine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00310	Lysine degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00330	Arginine and proline metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00340	Histidine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00380	Tryptophan metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00410	beta-Alanine metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00561	Glycerolipid metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00620	Pyruvate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00631	1,2-Dichloroethane degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00640	Propanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00641	3-Chloroacrylic acid degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00650	Butanoate metabolism	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko00903	Limonene and pinene degradation	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko01100	Metabolic pathways	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000528	K00128	ko01110	Biosynthesis of secondary metabolites	355	9.6e-14	0.80	0.86	0.62
PGSC0003DMG200000529	K05391	ko04626	Plant-pathogen interaction	1341	4.0e-68	0.67	0.77	0.99
PGSC0003DMG200000529	K05391	ko04626	Plant-pathogen interaction	3746	8.9e-201	0.67	0.80	0.95
PGSC0003DMG200000534	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMG200000534	K00517	ko00626	Naphthalene and anthracene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMG200000534	K00517	ko00903	Limonene and pinene degradation	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMG200000534	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMG200000534	K00517	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.47	0.62	0.91
PGSC0003DMG200000535	K10601	ko04120	Ubiquitin mediated proteolysis	3076	8.0e-164	0.72	0.80	0.36
PGSC0003DMG200000535	K10601	ko04120	Ubiquitin mediated proteolysis	2929	1.0e-155	0.72	0.80	0.98
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	990	9.1e-49	0.38	0.53	0.61
PGSC0003DMG200000537	K00951	ko00230	Purine metabolism	800	2.7e-38	0.35	0.51	0.76
PGSC0003DMG200030600	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMG200030600	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMG200030600	K00604	ko00670	One carbon pool by folate	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMG200030600	K00604	ko00970	Aminoacyl-tRNA biosynthesis	2208	6.0e-116	0.75	0.85	1.00
PGSC0003DMG200030600	K00604	ko00670	One carbon pool by folate	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMG200030600	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1731	1.2e-89	0.72	0.82	0.97
PGSC0003DMG200030600	K00604	ko00670	One carbon pool by folate	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMG200030600	K00604	ko00970	Aminoacyl-tRNA biosynthesis	1290	2.6e-65	0.74	0.82	0.96
PGSC0003DMG200030603	K13030	ko00460	Cyanoamino acid metabolism	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMG200030603	K13030	ko01110	Biosynthesis of secondary metabolites	898	1.1e-43	0.33	0.51	0.95
PGSC0003DMG200030603	K13030	ko00460	Cyanoamino acid metabolism	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMG200030603	K13030	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.33	0.52	0.95
PGSC0003DMG200030603	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMG200030603	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.94
PGSC0003DMG200030603	K13030	ko00460	Cyanoamino acid metabolism	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMG200030603	K13030	ko01110	Biosynthesis of secondary metabolites	948	1.9e-46	0.34	0.52	0.94
PGSC0003DMG200030603	K13030	ko00460	Cyanoamino acid metabolism	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMG200030603	K13030	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.54	0.94
PGSC0003DMG200030607	K04733	ko04210	Apoptosis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMG200030607	K04733	ko04620	Toll-like receptor signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMG200030607	K04733	ko04722	Neurotrophin signaling pathway	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMG200030607	K04733	ko05140	Leishmaniasis	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMG200030607	K04733	ko05142	Chagas disease	575	9.9e-26	0.41	0.60	0.92
PGSC0003DMG200030608	K02183	ko04020	Calcium signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04070	Phosphatidylinositol signaling system	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04114	Oocyte meiosis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04270	Vascular smooth muscle contraction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04626	Plant-pathogen interaction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04720	Long-term potentiation	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04722	Neurotrophin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04740	Olfactory transduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04744	Phototransduction	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04745	Phototransduction - fly	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04910	Insulin signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04912	GnRH signaling pathway	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04916	Melanogenesis	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04970	Salivary secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko04971	Gastric acid secretion	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko05010	Alzheimer's disease	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200030608	K02183	ko05214	Glioma	478	1.6e-20	0.45	0.66	0.95
PGSC0003DMG200019860	K00780	ko00512	O-Glycan biosynthesis	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMG200019860	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMG200019860	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMG200019860	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMG200019860	K00780	ko01100	Metabolic pathways	301	9.1e-11	0.34	0.50	0.46
PGSC0003DMG200019860	K00780	ko00512	O-Glycan biosynthesis	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMG200019860	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMG200019860	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMG200019860	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMG200019860	K00780	ko01100	Metabolic pathways	281	1.2e-09	0.34	0.51	0.53
PGSC0003DMG200019860	K00780	ko00512	O-Glycan biosynthesis	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMG200019860	K00780	ko00533	Glycosaminoglycan biosynthesis - keratan sulfate	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMG200019860	K00780	ko00603	Glycosphingolipid biosynthesis - globo series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMG200019860	K00780	ko00604	Glycosphingolipid biosynthesis - ganglio series	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMG200019860	K00780	ko01100	Metabolic pathways	258	2.1e-08	0.39	0.54	0.70
PGSC0003DMG200019861	K12126	ko04712	Circadian rhythm - plant	312	2.9e-11	0.28	0.44	0.98
PGSC0003DMG200019867	K04371	ko04010	MAPK signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04012	ErbB signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04013	MAPK signaling pathway - fly	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04062	Chemokine signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04114	Oocyte meiosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04150	mTOR signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04270	Vascular smooth muscle contraction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04320	Dorso-ventral axis formation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04350	TGF-beta signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04360	Axon guidance	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04370	VEGF signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04510	Focal adhesion	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04520	Adherens junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04540	Gap junction	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04620	Toll-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04621	NOD-like receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04650	Natural killer cell mediated cytotoxicity	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04660	T cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04662	B cell receptor signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04664	Fc epsilon RI signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04666	Fc gamma R-mediated phagocytosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04720	Long-term potentiation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04722	Neurotrophin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04730	Long-term depression	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04810	Regulation of actin cytoskeleton	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04910	Insulin signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04912	GnRH signaling pathway	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04914	Progesterone-mediated oocyte maturation	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04916	Melanogenesis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04930	Type II diabetes mellitus	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko04960	Aldosterone-regulated sodium reabsorption	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05010	Alzheimer's disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05020	Prion diseases	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05131	Shigellosis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05140	Leishmaniasis	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05142	Chagas disease	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05200	Pathways in cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05210	Colorectal cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05211	Renal cell carcinoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05212	Pancreatic cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05213	Endometrial cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05214	Glioma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05215	Prostate cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05216	Thyroid cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05218	Melanoma	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05219	Bladder cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05220	Chronic myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05221	Acute myeloid leukemia	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200019867	K04371	ko05223	Non-small cell lung cancer	280	3.0e-09	0.38	0.63	0.65
PGSC0003DMG200022246	K08770	ko03320	PPAR signaling pathway	887	4.4e-43	0.97	0.97	0.95
PGSC0003DMG200022246	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMG200022246	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMG200022246	K08770	ko03320	PPAR signaling pathway	1243	1.0e-62	0.95	0.97	0.83
PGSC0003DMG200022249	K08905	ko00195	Photosynthesis	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMG200022249	K08905	ko01100	Metabolic pathways	817	3.2e-39	0.68	0.75	0.99
PGSC0003DMG200022250	K03130	ko03022	Basal transcription factors	247	1.1e-07	0.32	0.60	0.23
PGSC0003DMG200022251	K04538	ko04062	Chemokine signaling pathway	282	1.0e-09	0.27	0.42	0.79
PGSC0003DMG200022253	K06689	ko04120	Ubiquitin mediated proteolysis	1271	2.9e-64	0.96	0.99	0.99
PGSC0003DMG200034988	K03094	ko04110	Cell cycle	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04111	Cell cycle - yeast	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04114	Oocyte meiosis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04120	Ubiquitin mediated proteolysis	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04310	Wnt signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04350	TGF-beta signaling pathway	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200034988	K03094	ko04710	Circadian rhythm - mammal	519	8.6e-23	0.55	0.68	0.99
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	592	8.1e-27	0.75	0.87	0.81
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	2247	4.2e-118	0.81	0.89	1.00
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	2121	3.8e-111	0.71	0.82	0.90
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	5255	5.2e-284	0.75	0.85	1.00
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	1162	3.0e-58	0.73	0.84	0.99
PGSC0003DMG200001246	K01427	ko00230	Purine metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMG200001246	K01427	ko00330	Arginine and proline metabolism	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMG200001246	K01427	ko00791	Atrazine degradation	3026	4.6e-161	0.72	0.82	0.97
PGSC0003DMG200001247	K00939	ko00230	Purine metabolism	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMG200001247	K00939	ko01100	Metabolic pathways	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMG200001247	K00939	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.90	0.95	0.99
PGSC0003DMG200001248	K04124	ko00904	Diterpenoid biosynthesis	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMG200001248	K04124	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.30	0.46	0.92
PGSC0003DMG200001248	K04124	ko00904	Diterpenoid biosynthesis	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMG200001248	K04124	ko01110	Biosynthesis of secondary metabolites	410	8.9e-17	0.30	0.46	0.92
PGSC0003DMG200001249	K05282	ko00904	Diterpenoid biosynthesis	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMG200001249	K05282	ko01100	Metabolic pathways	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMG200001249	K05282	ko01110	Biosynthesis of secondary metabolites	326	3.8e-12	0.27	0.47	0.95
PGSC0003DMG200001251	K09843	ko00906	Carotenoid biosynthesis	966	1.9e-47	0.36	0.54	0.98
PGSC0003DMG200002523	K02866	ko03010	Ribosome	271	8.0e-09	0.40	0.53	0.79
PGSC0003DMG200002523	K02866	ko03010	Ribosome	671	3.6e-31	0.43	0.57	0.89
PGSC0003DMG200002525	K00844	ko00010	Glycolysis / Gluconeogenesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00051	Fructose and mannose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00052	Galactose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00500	Starch and sucrose metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00521	Streptomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko00524	Butirosin and neomycin biosynthesis	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko01100	Metabolic pathways	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko01110	Biosynthesis of secondary metabolites	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko04910	Insulin signaling pathway	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002525	K00844	ko04930	Type II diabetes mellitus	3242	5.6e-173	0.79	0.88	0.99
PGSC0003DMG200002537	K04077	ko03018	RNA degradation	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMG200002537	K04077	ko04940	Type I diabetes mellitus	3761	1.3e-201	0.78	0.88	1.00
PGSC0003DMG200013157	K13034	ko00270	Cysteine and methionine metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMG200013157	K13034	ko00450	Selenoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMG200013157	K13034	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMG200013157	K13034	ko00920	Sulfur metabolism	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMG200013157	K13034	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.54	0.92
PGSC0003DMG200013169	K13065	ko00940	Phenylpropanoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMG200013169	K13065	ko00941	Flavonoid biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMG200013169	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMG200013169	K13065	ko01110	Biosynthesis of secondary metabolites	237	2.0e-06	0.25	0.43	0.98
PGSC0003DMG200013173	K07678	ko02020	Two-component system	242	1.3e-06	0.39	0.64	0.80
PGSC0003DMG200004809	K06096	ko04530	Tight junction	337	9.4e-13	0.34	0.54	0.71
PGSC0003DMG200004813	K13034	ko00270	Cysteine and methionine metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMG200004813	K13034	ko00450	Selenoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMG200004813	K13034	ko00460	Cyanoamino acid metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMG200004813	K13034	ko00920	Sulfur metabolism	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMG200004813	K13034	ko01100	Metabolic pathways	570	1.3e-25	0.62	0.72	0.88
PGSC0003DMG200004821	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMG200004821	K01433	ko00670	One carbon pool by folate	1640	1.3e-84	0.77	0.91	0.90
PGSC0003DMG200004821	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMG200004821	K01433	ko00670	One carbon pool by folate	804	1.6e-38	0.81	0.96	0.97
PGSC0003DMG200015462	K02725	ko03050	Proteasome	729	2.3e-34	0.83	0.90	0.84
PGSC0003DMG200015462	K02725	ko03050	Proteasome	1930	1.3e-100	0.82	0.88	1.00
PGSC0003DMG200015463	K00611	ko00330	Arginine and proline metabolism	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMG200015463	K00611	ko01100	Metabolic pathways	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMG200015463	K00611	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.82	0.90	1.00
PGSC0003DMG200015463	K00611	ko00330	Arginine and proline metabolism	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMG200015463	K00611	ko01100	Metabolic pathways	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMG200015463	K00611	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.92	0.98	0.99
PGSC0003DMG200015463	K00611	ko00330	Arginine and proline metabolism	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMG200015463	K00611	ko01100	Metabolic pathways	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMG200015463	K00611	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.71	0.80	0.98
PGSC0003DMG200019158	K11153	ko00830	Retinol metabolism	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMG200019158	K11153	ko01100	Metabolic pathways	919	7.5e-45	0.45	0.61	0.95
PGSC0003DMG200019160	K00889	ko00562	Inositol phosphate metabolism	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko01100	Metabolic pathways	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko04070	Phosphatidylinositol signaling system	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko04144	Endocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko04666	Fc gamma R-mediated phagocytosis	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko04810	Regulation of actin cytoskeleton	3375	2.6e-180	0.47	0.61	0.92
PGSC0003DMG200019160	K00889	ko00562	Inositol phosphate metabolism	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko01100	Metabolic pathways	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko04070	Phosphatidylinositol signaling system	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko04144	Endocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko04666	Fc gamma R-mediated phagocytosis	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko04810	Regulation of actin cytoskeleton	2778	2.2e-147	0.46	0.60	0.90
PGSC0003DMG200019160	K00889	ko00562	Inositol phosphate metabolism	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko01100	Metabolic pathways	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko04070	Phosphatidylinositol signaling system	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko04144	Endocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko04666	Fc gamma R-mediated phagocytosis	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko04810	Regulation of actin cytoskeleton	397	1.3e-15	0.81	0.91	0.98
PGSC0003DMG200019160	K00889	ko00562	Inositol phosphate metabolism	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019160	K00889	ko01100	Metabolic pathways	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019160	K00889	ko04070	Phosphatidylinositol signaling system	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019160	K00889	ko04144	Endocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019160	K00889	ko04666	Fc gamma R-mediated phagocytosis	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019160	K00889	ko04810	Regulation of actin cytoskeleton	465	1.5e-19	0.58	0.80	0.93
PGSC0003DMG200019162	K09840	ko00906	Carotenoid biosynthesis	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMG200019162	K09840	ko01100	Metabolic pathways	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMG200019162	K09840	ko01110	Biosynthesis of secondary metabolites	2781	1.5e-147	0.63	0.80	1.00
PGSC0003DMG200019163	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMG200019163	K01687	ko00770	Pantothenate and CoA biosynthesis	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMG200019163	K01687	ko01100	Metabolic pathways	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMG200019163	K01687	ko01110	Biosynthesis of secondary metabolites	4319	2.2e-232	0.82	0.92	1.00
PGSC0003DMG200019163	K01687	ko00290	Valine, leucine and isoleucine biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMG200019163	K01687	ko00770	Pantothenate and CoA biosynthesis	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMG200019163	K01687	ko01100	Metabolic pathways	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMG200019163	K01687	ko01110	Biosynthesis of secondary metabolites	869	4.3e-42	0.85	0.96	0.99
PGSC0003DMG200029897	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00270	Cysteine and methionine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00330	Arginine and proline metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00350	Tyrosine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00360	Phenylalanine metabolism	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00401	Novobiocin biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00710	Carbon fixation in photosynthetic organisms	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko01100	Metabolic pathways	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029897	K00813	ko01110	Biosynthesis of secondary metabolites	3378	1.8e-180	0.85	0.93	1.00
PGSC0003DMG200029905	K02956	ko03010	Ribosome	590	1.0e-26	0.82	0.91	0.99
PGSC0003DMG200029906	K04733	ko04210	Apoptosis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200029906	K04733	ko04620	Toll-like receptor signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200029906	K04733	ko04722	Neurotrophin signaling pathway	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200029906	K04733	ko05140	Leishmaniasis	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200029906	K04733	ko05142	Chagas disease	806	1.3e-38	0.38	0.59	0.39
PGSC0003DMG200036197	K01199	ko00500	Starch and sucrose metabolism	1243	1.0e-62	0.52	0.67	1.00
PGSC0003DMG200010235	K01952	ko00230	Purine metabolism	9021	0.	0.86	0.94	1.00
PGSC0003DMG200010235	K01952	ko01100	Metabolic pathways	9021	0.	0.86	0.94	1.00
PGSC0003DMG200010235	K01952	ko01110	Biosynthesis of secondary metabolites	9021	0.	0.86	0.94	1.00
PGSC0003DMG200010235	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010235	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010235	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010235	K01952	ko00230	Purine metabolism	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010235	K01952	ko01100	Metabolic pathways	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010235	K01952	ko01110	Biosynthesis of secondary metabolites	9837	0.	0.83	0.92	0.97
PGSC0003DMG200010237	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMG200010237	K01817	ko01100	Metabolic pathways	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMG200010237	K01817	ko01110	Biosynthesis of secondary metabolites	534	1.3e-23	0.65	0.79	0.99
PGSC0003DMG200010237	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200010237	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200010237	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200010237	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMG200010237	K01817	ko01100	Metabolic pathways	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMG200010237	K01817	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.58	0.72	0.88
PGSC0003DMG200010237	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMG200010237	K01817	ko01100	Metabolic pathways	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMG200010237	K01817	ko01110	Biosynthesis of secondary metabolites	1453	2.6e-74	0.68	0.79	0.98
PGSC0003DMG200010237	K01817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200010237	K01817	ko01100	Metabolic pathways	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200010237	K01817	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.78	0.88	0.98
PGSC0003DMG200007421	K06111	ko04530	Tight junction	6165	0.	0.68	0.79	0.93
PGSC0003DMG200007421	K06111	ko04530	Tight junction	6388	0.	0.73	0.84	1.00
PGSC0003DMG200007421	K06111	ko04530	Tight junction	4654	7.4e-251	0.75	0.85	0.99
PGSC0003DMG200007422	K03094	ko04110	Cell cycle	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04111	Cell cycle - yeast	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04114	Oocyte meiosis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04120	Ubiquitin mediated proteolysis	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04310	Wnt signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04350	TGF-beta signaling pathway	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007422	K03094	ko04710	Circadian rhythm - mammal	668	5.2e-31	0.51	0.67	0.94
PGSC0003DMG200007426	K11984	ko03040	Spliceosome	4052	1.2e-217	0.62	0.78	0.95
PGSC0003DMG200007426	K11984	ko03040	Spliceosome	2439	1.1e-128	0.70	0.84	1.00
PGSC0003DMG200007426	K11984	ko03040	Spliceosome	4381	8.4e-236	0.63	0.78	0.98
PGSC0003DMG200007426	K11984	ko03040	Spliceosome	4284	1.9e-230	0.63	0.78	0.98
PGSC0003DMG200007427	K02717	ko00195	Photosynthesis	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMG200007427	K02717	ko01100	Metabolic pathways	287	5.4e-10	0.35	0.49	0.96
PGSC0003DMG200007427	K02717	ko00195	Photosynthesis	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMG200007427	K02717	ko01100	Metabolic pathways	313	2.0e-11	0.35	0.51	0.60
PGSC0003DMG200007427	K02717	ko00195	Photosynthesis	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMG200007427	K02717	ko01100	Metabolic pathways	247	8.7e-08	0.37	0.58	0.86
PGSC0003DMG200007428	K05692	ko04145	Phagosome	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04510	Focal adhesion	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04520	Adherens junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04530	Tight junction	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04670	Leukocyte transendothelial migration	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04745	Phototransduction - fly	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko04810	Regulation of actin cytoskeleton	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05100	Bacterial invasion of epithelial cells	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05110	Vibrio cholerae infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05130	Pathogenic Escherichia coli infection	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05131	Shigellosis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05414	Dilated cardiomyopathy	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007428	K05692	ko05416	Viral myocarditis	949	1.7e-46	0.41	0.55	0.99
PGSC0003DMG200007429	K02923	ko03010	Ribosome	472	3.4e-20	0.92	0.97	0.48
PGSC0003DMG200007429	K02923	ko03010	Ribosome	535	1.1e-23	0.93	0.97	0.99
PGSC0003DMG200014943	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMG200014943	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.74
PGSC0003DMG200014943	K07748	ko00100	Steroid biosynthesis	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMG200014943	K07748	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.59	0.87
PGSC0003DMG200014943	K07748	ko00100	Steroid biosynthesis	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMG200014943	K07748	ko01100	Metabolic pathways	943	3.5e-46	0.39	0.56	0.62
PGSC0003DMG200014952	K12338	ko00942	Anthocyanin biosynthesis	1014	4.3e-50	0.40	0.62	0.99
PGSC0003DMG200014954	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMG200014954	K00517	ko00626	Naphthalene and anthracene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMG200014954	K00517	ko00903	Limonene and pinene degradation	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMG200014954	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMG200014954	K00517	ko01110	Biosynthesis of secondary metabolites	1976	3.8e-103	0.50	0.67	0.98
PGSC0003DMG200014955	K01719	ko00860	Porphyrin and chlorophyll metabolism	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMG200014955	K01719	ko01100	Metabolic pathways	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMG200014955	K01719	ko01110	Biosynthesis of secondary metabolites	966	1.9e-47	0.73	0.84	0.62
PGSC0003DMG200014959	K13065	ko00940	Phenylpropanoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMG200014959	K13065	ko00941	Flavonoid biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMG200014959	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMG200014959	K13065	ko01110	Biosynthesis of secondary metabolites	425	1.3e-17	0.28	0.46	0.97
PGSC0003DMG200027426	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMG200027426	K12885	ko03040	Spliceosome	278	1.7e-09	0.35	0.39	0.94
PGSC0003DMG200027428	K01066	ko00623	2,4-Dichlorobenzoate degradation	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMG200027428	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	609	9.4e-28	0.35	0.56	0.97
PGSC0003DMG200027435	K07376	ko04540	Gap junction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMG200027435	K07376	ko04730	Long-term depression	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMG200027435	K07376	ko04740	Olfactory transduction	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMG200027435	K07376	ko04970	Salivary secretion	979	3.7e-48	0.30	0.50	0.65
PGSC0003DMG200027439	K01692	ko00071	Fatty acid metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00280	Valine, leucine and isoleucine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00281	Geraniol degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00310	Lysine degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00380	Tryptophan metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00410	beta-Alanine metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00632	Benzoate degradation via CoA ligation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00640	Propanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00650	Butanoate metabolism	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00903	Limonene and pinene degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00930	Caprolactam degradation	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko01100	Metabolic pathways	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko01110	Biosynthesis of secondary metabolites	2136	5.6e-112	0.71	0.80	0.91
PGSC0003DMG200027439	K01692	ko00071	Fatty acid metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00280	Valine, leucine and isoleucine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00281	Geraniol degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00310	Lysine degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00380	Tryptophan metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00410	beta-Alanine metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00632	Benzoate degradation via CoA ligation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00640	Propanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00650	Butanoate metabolism	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00903	Limonene and pinene degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko00930	Caprolactam degradation	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko01100	Metabolic pathways	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200027439	K01692	ko01110	Biosynthesis of secondary metabolites	2457	1.1e-129	0.72	0.84	0.97
PGSC0003DMG200028344	K08493	ko04130	SNARE interactions in vesicular transport	1306	3.4e-66	0.72	0.84	1.00
PGSC0003DMG200028344	K08493	ko04130	SNARE interactions in vesicular transport	628	8.4e-29	0.78	0.88	0.99
PGSC0003DMG200028352	K07424	ko00140	Steroid hormone biosynthesis	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00591	Linoleic acid metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00830	Retinol metabolism	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00982	Drug metabolism - cytochrome P450	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko00983	Drug metabolism - other enzymes	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028352	K07424	ko01100	Metabolic pathways	1119	7.0e-56	0.41	0.62	0.97
PGSC0003DMG200028362	K00796	ko00790	Folate biosynthesis	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMG200028362	K00796	ko01100	Metabolic pathways	1116	1.0e-55	0.40	0.57	0.98
PGSC0003DMG200028362	K00796	ko00790	Folate biosynthesis	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMG200028362	K00796	ko01100	Metabolic pathways	1180	3.0e-59	0.40	0.57	0.89
PGSC0003DMG200028363	K01057	ko00030	Pentose phosphate pathway	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028363	K01057	ko01100	Metabolic pathways	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028363	K01057	ko01110	Biosynthesis of secondary metabolites	1922	3.6e-100	0.84	0.93	1.00
PGSC0003DMG200028363	K01057	ko00030	Pentose phosphate pathway	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMG200028363	K01057	ko01100	Metabolic pathways	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMG200028363	K01057	ko01110	Biosynthesis of secondary metabolites	1565	1.8e-80	0.85	0.94	0.98
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.50	0.74	0.82
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	2000	1.8e-104	0.44	0.68	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.43	0.69	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	1953	7.0e-102	0.43	0.67	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	1949	1.2e-101	0.43	0.67	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.42	0.68	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	710	2.5e-33	0.42	0.67	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.43	0.66	0.98
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	991	8.0e-49	0.44	0.69	0.99
PGSC0003DMG200018285	K12929	ko00904	Diterpenoid biosynthesis	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200018285	K12929	ko01110	Biosynthesis of secondary metabolites	761	3.9e-36	0.44	0.67	0.94
PGSC0003DMG200018286	K12929	ko00904	Diterpenoid biosynthesis	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMG200018286	K12929	ko01110	Biosynthesis of secondary metabolites	963	2.8e-47	0.38	0.59	0.94
PGSC0003DMG200018286	K12929	ko00904	Diterpenoid biosynthesis	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMG200018286	K12929	ko01110	Biosynthesis of secondary metabolites	297	3.7e-10	0.47	0.68	0.96
PGSC0003DMG200018286	K12467	ko00902	Monoterpenoid biosynthesis	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMG200018286	K12467	ko01110	Biosynthesis of secondary metabolites	311	5.2e-11	0.38	0.57	0.84
PGSC0003DMG200018286	K12929	ko00904	Diterpenoid biosynthesis	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMG200018286	K12929	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.52	0.78	0.90
PGSC0003DMG200018289	K10955	ko05110	Vibrio cholerae infection	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMG200018289	K10955	ko05146	Amoebiasis	413	8.8e-16	0.31	0.41	0.74
PGSC0003DMG200018292	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko00270	Cysteine and methionine metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko00450	Selenoamino acid metabolism	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko01100	Metabolic pathways	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018292	K00789	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.96	0.98	0.99
PGSC0003DMG200018293	K00430	ko00360	Phenylalanine metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMG200018293	K00430	ko00680	Methane metabolism	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMG200018293	K00430	ko00940	Phenylpropanoid biosynthesis	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMG200018293	K00430	ko01100	Metabolic pathways	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMG200018293	K00430	ko01110	Biosynthesis of secondary metabolites	1085	5.2e-54	0.46	0.61	1.00
PGSC0003DMG200018293	K00430	ko00360	Phenylalanine metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMG200018293	K00430	ko00680	Methane metabolism	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMG200018293	K00430	ko00940	Phenylpropanoid biosynthesis	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMG200018293	K00430	ko01100	Metabolic pathways	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMG200018293	K00430	ko01110	Biosynthesis of secondary metabolites	860	1.3e-41	0.49	0.66	0.88
PGSC0003DMG200031820	K01679	ko00020	Citrate cycle (TCA cycle)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko01100	Metabolic pathways	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko01110	Biosynthesis of secondary metabolites	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko05200	Pathways in cancer	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko05211	Renal cell carcinoma	3574	2.7e-191	0.86	0.92	1.00
PGSC0003DMG200031820	K01679	ko00020	Citrate cycle (TCA cycle)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko01100	Metabolic pathways	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko05200	Pathways in cancer	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko05211	Renal cell carcinoma	903	5.7e-44	0.88	0.94	0.99
PGSC0003DMG200031820	K01679	ko00020	Citrate cycle (TCA cycle)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031820	K01679	ko00720	Reductive carboxylate cycle (CO2 fixation)	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031820	K01679	ko01100	Metabolic pathways	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031820	K01679	ko01110	Biosynthesis of secondary metabolites	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031820	K01679	ko05200	Pathways in cancer	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031820	K01679	ko05211	Renal cell carcinoma	1831	3.7e-95	0.91	0.95	1.00
PGSC0003DMG200031832	K08139	ko04113	Meiosis - yeast	982	2.5e-48	0.34	0.50	0.88
PGSC0003DMG200025587	K01648	ko00020	Citrate cycle (TCA cycle)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMG200025587	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMG200025587	K01648	ko01100	Metabolic pathways	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMG200025587	K01648	ko01110	Biosynthesis of secondary metabolites	3257	8.3e-174	0.90	0.96	1.00
PGSC0003DMG200025595	K04733	ko04210	Apoptosis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMG200025595	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMG200025595	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMG200025595	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMG200025595	K04733	ko05142	Chagas disease	315	7.9e-11	0.43	0.63	0.93
PGSC0003DMG200025597	K04733	ko04210	Apoptosis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMG200025597	K04733	ko04620	Toll-like receptor signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMG200025597	K04733	ko04722	Neurotrophin signaling pathway	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMG200025597	K04733	ko05140	Leishmaniasis	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMG200025597	K04733	ko05142	Chagas disease	370	6.2e-14	0.38	0.59	0.33
PGSC0003DMG200025597	K04733	ko04210	Apoptosis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMG200025597	K04733	ko04620	Toll-like receptor signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMG200025597	K04733	ko04722	Neurotrophin signaling pathway	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMG200025597	K04733	ko05140	Leishmaniasis	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMG200025597	K04733	ko05142	Chagas disease	520	1.7e-22	0.40	0.59	0.40
PGSC0003DMG200025598	K04733	ko04210	Apoptosis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMG200025598	K04733	ko04620	Toll-like receptor signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMG200025598	K04733	ko04722	Neurotrophin signaling pathway	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMG200025598	K04733	ko05140	Leishmaniasis	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMG200025598	K04733	ko05142	Chagas disease	685	6.0e-32	0.38	0.57	0.84
PGSC0003DMG200025600	K04733	ko04210	Apoptosis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMG200025600	K04733	ko04620	Toll-like receptor signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMG200025600	K04733	ko04722	Neurotrophin signaling pathway	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMG200025600	K04733	ko05140	Leishmaniasis	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMG200025600	K04733	ko05142	Chagas disease	600	3.1e-27	0.37	0.59	0.84
PGSC0003DMG200017748	K13030	ko00460	Cyanoamino acid metabolism	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMG200017748	K13030	ko01110	Biosynthesis of secondary metabolites	1073	2.4e-53	0.46	0.65	0.98
PGSC0003DMG200017753	K06630	ko04110	Cell cycle	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMG200017753	K06630	ko04114	Oocyte meiosis	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMG200017753	K06630	ko04722	Neurotrophin signaling pathway	1902	4.5e-99	0.90	0.95	0.99
PGSC0003DMG200017754	K02267	ko00190	Oxidative phosphorylation	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200017754	K02267	ko01100	Metabolic pathways	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200017754	K02267	ko04260	Cardiac muscle contraction	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200017754	K02267	ko05010	Alzheimer's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200017754	K02267	ko05012	Parkinson's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200017754	K02267	ko05016	Huntington's disease	938	6.7e-46	0.62	0.73	0.99
PGSC0003DMG200027797	K12796	ko04621	NOD-like receptor signaling pathway	327	2.3e-08	0.29	0.47	0.42
PGSC0003DMG200027804	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00360	Phenylalanine metabolism	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00940	Phenylpropanoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00941	Flavonoid biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko01100	Metabolic pathways	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200027804	K09754	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.49	0.64	0.97
PGSC0003DMG200037547	K09754	ko00360	Phenylalanine metabolism	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037547	K09754	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037547	K09754	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037547	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037547	K09754	ko01100	Metabolic pathways	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037547	K09754	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.51	0.69	0.99
PGSC0003DMG200037550	K00430	ko00360	Phenylalanine metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMG200037550	K00430	ko00680	Methane metabolism	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMG200037550	K00430	ko00940	Phenylpropanoid biosynthesis	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMG200037550	K00430	ko01100	Metabolic pathways	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMG200037550	K00430	ko01110	Biosynthesis of secondary metabolites	789	1.1e-37	0.49	0.59	0.96
PGSC0003DMG200037553	K10760	ko00908	Zeatin biosynthesis	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMG200037553	K10760	ko01100	Metabolic pathways	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMG200037553	K10760	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.32	0.50	0.64
PGSC0003DMG200033048	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMG200033048	K12127	ko04712	Circadian rhythm - plant	2744	1.6e-145	0.63	0.77	0.98
PGSC0003DMG200033048	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMG200033048	K12127	ko04712	Circadian rhythm - plant	999	2.9e-49	0.58	0.76	0.98
PGSC0003DMG200033053	K07964	ko00531	Glycosaminoglycan degradation	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMG200033053	K07964	ko01100	Metabolic pathways	650	5.1e-30	0.33	0.47	0.75
PGSC0003DMG200033054	K02160	ko00061	Fatty acid biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033054	K02160	ko00253	Tetracycline biosynthesis	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033054	K02160	ko00620	Pyruvate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033054	K02160	ko00640	Propanoate metabolism	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033054	K02160	ko01100	Metabolic pathways	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033054	K02160	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.55	0.67	1.00
PGSC0003DMG200033057	K10643	ko03018	RNA degradation	277	1.9e-09	0.56	0.72	0.14
PGSC0003DMG200033059	K01950	ko00760	Nicotinate and nicotinamide metabolism	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMG200033059	K01950	ko01100	Metabolic pathways	264	4.2e-08	0.55	0.61	0.74
PGSC0003DMG200033059	K01950	ko00760	Nicotinate and nicotinamide metabolism	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMG200033059	K01950	ko01100	Metabolic pathways	256	1.2e-07	0.75	0.85	0.43
PGSC0003DMG200033060	K04688	ko04012	ErbB signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko04150	mTOR signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko04350	TGF-beta signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko04666	Fc gamma R-mediated phagocytosis	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko04910	Insulin signaling pathway	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko05221	Acute myeloid leukemia	302	8.0e-11	0.80	0.91	0.65
PGSC0003DMG200033060	K04688	ko04012	ErbB signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko04150	mTOR signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko04350	TGF-beta signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko04666	Fc gamma R-mediated phagocytosis	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko04910	Insulin signaling pathway	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko05221	Acute myeloid leukemia	684	6.8e-32	0.84	0.94	0.86
PGSC0003DMG200033060	K04688	ko04012	ErbB signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033060	K04688	ko04150	mTOR signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033060	K04688	ko04350	TGF-beta signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033060	K04688	ko04666	Fc gamma R-mediated phagocytosis	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033060	K04688	ko04910	Insulin signaling pathway	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033060	K04688	ko05221	Acute myeloid leukemia	2764	1.3e-146	0.71	0.79	0.99
PGSC0003DMG200033063	K10418	ko04962	Vasopressin-regulated water reabsorption	328	3.0e-12	0.52	0.66	0.31
PGSC0003DMG200020831	K12587	ko03018	RNA degradation	568	1.7e-25	0.38	0.63	0.79
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	2479	6.8e-131	0.80	0.91	0.99
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	2973	3.8e-158	0.77	0.89	0.98
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	2957	2.9e-157	0.77	0.88	0.99
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	3795	1.8e-203	0.80	0.90	1.00
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	483	6.5e-20	0.84	0.88	0.97
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	545	8.0e-24	0.53	0.73	0.94
PGSC0003DMG200020840	K12599	ko03018	RNA degradation	844	2.7e-40	0.88	0.96	0.92
PGSC0003DMG200020850	K07375	ko04145	Phagosome	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMG200020850	K07375	ko04540	Gap junction	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMG200020850	K07375	ko05130	Pathogenic Escherichia coli infection	3736	3.2e-200	0.96	0.98	1.00
PGSC0003DMG200009959	K01581	ko00330	Arginine and proline metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMG200009959	K01581	ko00480	Glutathione metabolism	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMG200009959	K01581	ko01100	Metabolic pathways	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMG200009959	K01581	ko01110	Biosynthesis of secondary metabolites	2311	1.3e-121	0.66	0.80	0.96
PGSC0003DMG200009965	K00423	ko00053	Ascorbate and aldarate metabolism	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMG200009965	K00423	ko01100	Metabolic pathways	2429	3.9e-128	0.55	0.70	0.97
PGSC0003DMG200009965	K00423	ko00053	Ascorbate and aldarate metabolism	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMG200009965	K00423	ko01100	Metabolic pathways	2157	3.9e-113	0.55	0.71	0.97
PGSC0003DMG200009967	K12349	ko00600	Sphingolipid metabolism	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMG200009967	K12349	ko01100	Metabolic pathways	2570	6.5e-136	0.47	0.65	1.00
PGSC0003DMG200011058	K02965	ko03010	Ribosome	286	6.1e-10	0.41	0.62	0.74
PGSC0003DMG200011059	K10603	ko04120	Ubiquitin mediated proteolysis	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMG200011059	K10603	ko05340	Primary immunodeficiency	256	6.8e-06	0.37	0.49	0.20
PGSC0003DMG200011067	K00368	ko00910	Nitrogen metabolism	421	2.2e-17	0.40	0.59	0.80
PGSC0003DMG200011067	K00368	ko00910	Nitrogen metabolism	285	1.4e-09	0.43	0.58	0.94
PGSC0003DMG200011072	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMG200011072	K01602	ko00710	Carbon fixation in photosynthetic organisms	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMG200011072	K01602	ko01100	Metabolic pathways	1174	6.4e-59	0.60	0.77	0.92
PGSC0003DMG200011072	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMG200011072	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMG200011072	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.67
PGSC0003DMG200011072	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200011072	K01602	ko00710	Carbon fixation in photosynthetic organisms	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200011072	K01602	ko01100	Metabolic pathways	1509	2.1e-77	0.61	0.78	0.65
PGSC0003DMG200004151	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMG200004151	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMG200004151	K03147	ko00730	Thiamine metabolism	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMG200004151	K03147	ko01100	Metabolic pathways	4776	1.4e-257	0.84	0.91	1.00
PGSC0003DMG200004153	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMG200004153	K01657	ko01100	Metabolic pathways	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMG200004153	K01657	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.80	0.89	0.99
PGSC0003DMG200004160	K05857	ko00562	Inositol phosphate metabolism	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMG200004160	K05857	ko01100	Metabolic pathways	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMG200004160	K05857	ko04020	Calcium signaling pathway	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMG200004160	K05857	ko04070	Phosphatidylinositol signaling system	3393	2.6e-181	0.79	0.90	1.00
PGSC0003DMG200004160	K05857	ko00562	Inositol phosphate metabolism	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMG200004160	K05857	ko01100	Metabolic pathways	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMG200004160	K05857	ko04020	Calcium signaling pathway	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMG200004160	K05857	ko04070	Phosphatidylinositol signaling system	3967	5.8e-213	0.77	0.88	1.00
PGSC0003DMG200013970	K11646	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	972	8.9e-48	0.41	0.54	0.98
PGSC0003DMG200045798	K10760	ko00908	Zeatin biosynthesis	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMG200045798	K10760	ko01100	Metabolic pathways	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMG200045798	K10760	ko01110	Biosynthesis of secondary metabolites	620	2.3e-28	0.44	0.62	0.91
PGSC0003DMG200045809	K03094	ko04110	Cell cycle	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04111	Cell cycle - yeast	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04114	Oocyte meiosis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04120	Ubiquitin mediated proteolysis	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04310	Wnt signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04350	TGF-beta signaling pathway	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045809	K03094	ko04710	Circadian rhythm - mammal	617	3.4e-28	0.55	0.71	0.97
PGSC0003DMG200045814	K12356	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.32	0.47	0.90
PGSC0003DMG200039643	K03094	ko04110	Cell cycle	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04111	Cell cycle - yeast	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04114	Oocyte meiosis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04120	Ubiquitin mediated proteolysis	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04310	Wnt signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04350	TGF-beta signaling pathway	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039643	K03094	ko04710	Circadian rhythm - mammal	378	5.2e-15	0.51	0.66	0.99
PGSC0003DMG200039644	K10760	ko00908	Zeatin biosynthesis	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMG200039644	K10760	ko01100	Metabolic pathways	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMG200039644	K10760	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.40	0.57	0.93
PGSC0003DMG200030337	K01079	ko00260	Glycine, serine and threonine metabolism	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMG200030337	K01079	ko01100	Metabolic pathways	233	5.1e-07	0.51	0.66	0.76
PGSC0003DMG200030337	K01079	ko00260	Glycine, serine and threonine metabolism	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMG200030337	K01079	ko01100	Metabolic pathways	1718	6.4e-89	0.73	0.84	0.98
PGSC0003DMG200030337	K01079	ko00260	Glycine, serine and threonine metabolism	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMG200030337	K01079	ko01100	Metabolic pathways	1758	4.0e-91	0.72	0.84	0.99
PGSC0003DMG200030338	K13228	ko00402	Benzoxazinoid biosynthesis	680	1.1e-31	0.45	0.64	0.88
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.99
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	1454	2.3e-74	0.66	0.82	0.92
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	2028	5.1e-106	0.62	0.80	0.93
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	1312	1.6e-66	0.66	0.83	0.90
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	2585	9.7e-137	0.65	0.81	1.00
PGSC0003DMG200030344	K01689	ko00010	Glycolysis / Gluconeogenesis	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMG200030344	K01689	ko01100	Metabolic pathways	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMG200030344	K01689	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMG200030344	K01689	ko03018	RNA degradation	467	6.4e-20	0.76	0.87	0.97
PGSC0003DMG200030345	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.37
PGSC0003DMG200030345	K12897	ko03040	Spliceosome	446	9.2e-19	0.49	0.55	0.57
PGSC0003DMG200030345	K12897	ko03040	Spliceosome	871	3.3e-42	0.54	0.61	0.67
PGSC0003DMG200030345	K12891	ko03040	Spliceosome	266	7.8e-09	0.50	0.51	0.39
PGSC0003DMG200030349	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMG200030349	K00517	ko00626	Naphthalene and anthracene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMG200030349	K00517	ko00903	Limonene and pinene degradation	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMG200030349	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMG200030349	K00517	ko01110	Biosynthesis of secondary metabolites	3387	5.6e-181	0.76	0.88	0.97
PGSC0003DMG200030351	K02213	ko04110	Cell cycle	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMG200030351	K02213	ko04111	Cell cycle - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMG200030351	K02213	ko04113	Meiosis - yeast	2663	4.8e-141	0.62	0.79	0.99
PGSC0003DMG200019771	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMG200019771	K00517	ko00626	Naphthalene and anthracene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMG200019771	K00517	ko00903	Limonene and pinene degradation	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMG200019771	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMG200019771	K00517	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.42	0.62	0.98
PGSC0003DMG200019771	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMG200019771	K00517	ko00626	Naphthalene and anthracene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMG200019771	K00517	ko00903	Limonene and pinene degradation	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMG200019771	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMG200019771	K00517	ko01110	Biosynthesis of secondary metabolites	897	1.2e-43	0.36	0.56	0.98
PGSC0003DMG200019771	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMG200019771	K00517	ko00626	Naphthalene and anthracene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMG200019771	K00517	ko00903	Limonene and pinene degradation	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMG200019771	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMG200019771	K00517	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.42	0.63	0.98
PGSC0003DMG200019771	K11818	ko00380	Tryptophan metabolism	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMG200019771	K11818	ko00966	Glucosinolate biosynthesis	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMG200019771	K11818	ko01110	Biosynthesis of secondary metabolites	286	8.4e-10	0.30	0.53	0.86
PGSC0003DMG200019771	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMG200019771	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMG200019771	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMG200019771	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMG200019771	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.36	0.59	0.97
PGSC0003DMG200019772	K11778	ko00900	Terpenoid backbone biosynthesis	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMG200019772	K11778	ko01110	Biosynthesis of secondary metabolites	1047	6.5e-52	0.56	0.70	0.82
PGSC0003DMG200019773	K12929	ko00904	Diterpenoid biosynthesis	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMG200019773	K12929	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.65	1.00
PGSC0003DMG200019773	K12929	ko00904	Diterpenoid biosynthesis	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMG200019773	K12929	ko01110	Biosynthesis of secondary metabolites	1832	3.3e-95	0.44	0.63	0.99
PGSC0003DMG200019773	K12929	ko00904	Diterpenoid biosynthesis	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMG200019773	K12929	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.43	0.62	1.00
PGSC0003DMG200019773	K12929	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMG200019773	K12929	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.49	0.68	0.98
PGSC0003DMG200019774	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMG200019774	K00517	ko00626	Naphthalene and anthracene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMG200019774	K00517	ko00903	Limonene and pinene degradation	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMG200019774	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMG200019774	K00517	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.49	0.66	0.71
PGSC0003DMG200019776	K11778	ko00900	Terpenoid backbone biosynthesis	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMG200019776	K11778	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.62	0.78	0.94
PGSC0003DMG200019777	K11423	ko00310	Lysine degradation	2592	4.0e-137	0.52	0.63	0.46
PGSC0003DMG200019777	K11423	ko00310	Lysine degradation	2652	1.9e-140	0.54	0.66	0.41
PGSC0003DMG200019782	K12929	ko00904	Diterpenoid biosynthesis	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMG200019782	K12929	ko01110	Biosynthesis of secondary metabolites	969	1.3e-47	0.49	0.71	0.95
PGSC0003DMG200019783	K12929	ko00904	Diterpenoid biosynthesis	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMG200019783	K12929	ko01110	Biosynthesis of secondary metabolites	1445	7.3e-74	0.43	0.64	0.99
PGSC0003DMG200019784	K12929	ko00904	Diterpenoid biosynthesis	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMG200019784	K12929	ko01110	Biosynthesis of secondary metabolites	1101	6.8e-55	0.34	0.53	0.70
PGSC0003DMG200022368	K03885	ko00190	Oxidative phosphorylation	3498	4.2e-187	0.75	0.86	1.00
PGSC0003DMG200022370	K01082	ko00920	Sulfur metabolism	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMG200022370	K01082	ko01100	Metabolic pathways	2493	1.1e-131	0.78	0.90	0.96
PGSC0003DMG200022370	K01082	ko00920	Sulfur metabolism	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMG200022370	K01082	ko01100	Metabolic pathways	278	1.7e-09	0.65	0.94	0.33
PGSC0003DMG200022370	K01082	ko00920	Sulfur metabolism	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMG200022370	K01082	ko01100	Metabolic pathways	698	1.2e-32	0.91	0.97	0.99
PGSC0003DMG200022370	K01082	ko00920	Sulfur metabolism	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMG200022370	K01082	ko01100	Metabolic pathways	1424	1.0e-72	0.84	0.93	1.00
PGSC0003DMG200022373	K13289	ko04142	Lysosome	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMG200022373	K13289	ko04614	Renin-angiotensin system	2868	2.4e-152	0.76	0.86	0.80
PGSC0003DMG200022373	K13289	ko04142	Lysosome	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMG200022373	K13289	ko04614	Renin-angiotensin system	2933	6.2e-156	0.70	0.82	0.99
PGSC0003DMG200022374	K05747	ko04062	Chemokine signaling pathway	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko04520	Adherens junction	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko04666	Fc gamma R-mediated phagocytosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko04810	Regulation of actin cytoskeleton	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko05100	Bacterial invasion of epithelial cells	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko05130	Pathogenic Escherichia coli infection	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022374	K05747	ko05131	Shigellosis	538	7.7e-24	0.42	0.49	0.37
PGSC0003DMG200022377	K08139	ko04113	Meiosis - yeast	1108	2.8e-55	0.36	0.61	0.88
PGSC0003DMG200022378	K08726	ko00590	Arachidonic acid metabolism	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMG200022378	K08726	ko00625	Tetrachloroethene degradation	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMG200022378	K08726	ko01100	Metabolic pathways	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMG200022378	K08726	ko04146	Peroxisome	657	2.1e-30	0.34	0.53	0.98
PGSC0003DMG200022378	K08726	ko00590	Arachidonic acid metabolism	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMG200022378	K08726	ko00625	Tetrachloroethene degradation	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMG200022378	K08726	ko01100	Metabolic pathways	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMG200022378	K08726	ko04146	Peroxisome	359	5.8e-14	0.47	0.66	0.71
PGSC0003DMG200029076	K01838	ko00500	Starch and sucrose metabolism	272	3.6e-09	0.34	0.49	0.57
PGSC0003DMG200029076	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMG200029076	K01838	ko00500	Starch and sucrose metabolism	271	4.1e-09	0.34	0.49	0.57
PGSC0003DMG200029076	K01838	ko00500	Starch and sucrose metabolism	292	2.9e-10	0.33	0.48	0.56
PGSC0003DMG200029080	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMG200029080	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMG200029080	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.37
PGSC0003DMG200029080	K01955	ko00240	Pyrimidine metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMG200029080	K01955	ko00250	Alanine, aspartate and glutamate metabolism	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMG200029080	K01955	ko01100	Metabolic pathways	557	4.7e-24	0.60	0.78	0.48
PGSC0003DMG200029085	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko00270	Cysteine and methionine metabolism	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMG200029085	K01243	ko01100	Metabolic pathways	617	3.4e-28	0.37	0.53	0.76
PGSC0003DMG200029085	K01243	ko00270	Cysteine and methionine metabolism	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko01100	Metabolic pathways	625	1.2e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko00270	Cysteine and methionine metabolism	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMG200029085	K01243	ko01100	Metabolic pathways	618	3.0e-28	0.37	0.54	0.76
PGSC0003DMG200029087	K00417	ko00190	Oxidative phosphorylation	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200029087	K00417	ko01100	Metabolic pathways	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200029087	K00417	ko04260	Cardiac muscle contraction	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200029087	K00417	ko05010	Alzheimer's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200029087	K00417	ko05012	Parkinson's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200029087	K00417	ko05016	Huntington's disease	847	7.0e-41	0.83	0.92	0.97
PGSC0003DMG200012216	K00799	ko00480	Glutathione metabolism	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMG200012216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMG200012216	K00799	ko00982	Drug metabolism - cytochrome P450	510	2.7e-22	0.37	0.53	0.98
PGSC0003DMG200012216	K00799	ko00480	Glutathione metabolism	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMG200012216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMG200012216	K00799	ko00982	Drug metabolism - cytochrome P450	503	6.6e-22	0.38	0.52	0.92
PGSC0003DMG200012216	K00799	ko00480	Glutathione metabolism	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMG200012216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMG200012216	K00799	ko00982	Drug metabolism - cytochrome P450	559	5.4e-25	0.39	0.56	0.89
PGSC0003DMG200012216	K00799	ko00480	Glutathione metabolism	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMG200012216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMG200012216	K00799	ko00982	Drug metabolism - cytochrome P450	562	3.7e-25	0.40	0.56	0.89
PGSC0003DMG200012216	K00799	ko00480	Glutathione metabolism	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMG200012216	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMG200012216	K00799	ko00982	Drug metabolism - cytochrome P450	569	1.5e-25	0.40	0.56	0.89
PGSC0003DMG200012223	K01507	ko00190	Oxidative phosphorylation	1349	1.4e-68	0.79	0.86	0.97
PGSC0003DMG200012223	K01507	ko00190	Oxidative phosphorylation	1470	3.0e-75	0.80	0.89	0.97
PGSC0003DMG200012223	K01507	ko00190	Oxidative phosphorylation	1566	1.5e-80	0.89	0.97	0.98
PGSC0003DMG200012225	K02867	ko03010	Ribosome	1346	2.1e-68	0.77	0.86	0.98
PGSC0003DMG200001769	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMG200001769	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMG200001769	K10158	ko01100	Metabolic pathways	392	8.7e-16	0.33	0.50	0.62
PGSC0003DMG200001774	K00430	ko00360	Phenylalanine metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMG200001774	K00430	ko00680	Methane metabolism	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMG200001774	K00430	ko00940	Phenylpropanoid biosynthesis	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMG200001774	K00430	ko01100	Metabolic pathways	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMG200001774	K00430	ko01110	Biosynthesis of secondary metabolites	1604	1.2e-82	0.73	0.86	0.99
PGSC0003DMG200001774	K00430	ko00360	Phenylalanine metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMG200001774	K00430	ko00680	Methane metabolism	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMG200001774	K00430	ko00940	Phenylpropanoid biosynthesis	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMG200001774	K00430	ko01100	Metabolic pathways	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMG200001774	K00430	ko01110	Biosynthesis of secondary metabolites	1897	8.5e-99	0.73	0.87	0.91
PGSC0003DMG200016327	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00061	Fatty acid biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko00253	Tetracycline biosynthesis	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko00620	Pyruvate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko00640	Propanoate metabolism	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko01100	Metabolic pathways	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko01110	Biosynthesis of secondary metabolites	418	7.5e-17	0.66	0.74	0.93
PGSC0003DMG200016327	K01962	ko00061	Fatty acid biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00253	Tetracycline biosynthesis	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00620	Pyruvate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko00640	Propanoate metabolism	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko01100	Metabolic pathways	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016327	K01962	ko01110	Biosynthesis of secondary metabolites	442	3.0e-18	0.66	0.74	0.97
PGSC0003DMG200016328	K09291	ko04011	MAPK signaling pathway - yeast	7204	0.	0.48	0.68	1.00
PGSC0003DMG200016328	K09291	ko05200	Pathways in cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMG200016328	K09291	ko05216	Thyroid cancer	7204	0.	0.48	0.68	1.00
PGSC0003DMG200016329	K00797	ko00270	Cysteine and methionine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMG200016329	K00797	ko00330	Arginine and proline metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMG200016329	K00797	ko00410	beta-Alanine metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMG200016329	K00797	ko00480	Glutathione metabolism	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMG200016329	K00797	ko01100	Metabolic pathways	1305	2.8e-72	0.59	0.78	0.98
PGSC0003DMG200016329	K00797	ko00270	Cysteine and methionine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMG200016329	K00797	ko00330	Arginine and proline metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMG200016329	K00797	ko00410	beta-Alanine metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMG200016329	K00797	ko00480	Glutathione metabolism	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMG200016329	K00797	ko01100	Metabolic pathways	1358	4.6e-69	0.65	0.82	0.96
PGSC0003DMG200016331	K03921	ko00061	Fatty acid biosynthesis	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMG200016331	K03921	ko01040	Biosynthesis of unsaturated fatty acids	2562	1.8e-135	0.78	0.87	0.95
PGSC0003DMG200016333	K00624	ko04146	Peroxisome	533	1.2e-22	0.38	0.58	0.28
PGSC0003DMG200016337	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMG200016337	K01649	ko00620	Pyruvate metabolism	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMG200016337	K01649	ko01100	Metabolic pathways	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMG200016337	K01649	ko01110	Biosynthesis of secondary metabolites	3751	4.7e-201	0.74	0.86	0.98
PGSC0003DMG200000283	K00968	ko00440	Phosphonate and phosphinate metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200000283	K00968	ko00564	Glycerophospholipid metabolism	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200000283	K00968	ko01100	Metabolic pathways	1745	2.1e-90	0.72	0.85	0.90
PGSC0003DMG200000284	K01762	ko00270	Cysteine and methionine metabolism	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMG200000284	K01762	ko01110	Biosynthesis of secondary metabolites	2224	7.9e-117	0.61	0.79	0.98
PGSC0003DMG200000285	K02140	ko00190	Oxidative phosphorylation	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMG200000285	K02140	ko01100	Metabolic pathways	848	6.2e-41	0.82	0.92	0.98
PGSC0003DMG200000286	K02983	ko03010	Ribosome	532	1.7e-23	1.00	1.00	0.98
PGSC0003DMG200000287	K00469	ko00053	Ascorbate and aldarate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMG200000287	K00469	ko00562	Inositol phosphate metabolism	1219	2.1e-61	0.73	0.85	0.98
PGSC0003DMG200000287	K00469	ko00053	Ascorbate and aldarate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMG200000287	K00469	ko00562	Inositol phosphate metabolism	1673	1.9e-86	0.72	0.84	0.98
PGSC0003DMG200000287	K00469	ko00053	Ascorbate and aldarate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMG200000287	K00469	ko00562	Inositol phosphate metabolism	2126	2.0e-111	0.77	0.86	1.00
PGSC0003DMG200000288	K00681	ko00430	Taurine and hypotaurine metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000288	K00681	ko00450	Selenoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000288	K00681	ko00460	Cyanoamino acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000288	K00681	ko00480	Glutathione metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000288	K00681	ko00590	Arachidonic acid metabolism	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000288	K00681	ko01100	Metabolic pathways	3626	3.7e-194	0.68	0.82	1.00
PGSC0003DMG200000291	K05759	ko04810	Regulation of actin cytoskeleton	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMG200000291	K05759	ko05131	Shigellosis	880	1.1e-42	0.75	0.90	0.98
PGSC0003DMG200000293	K01051	ko00040	Pentose and glucuronate interconversions	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMG200000293	K01051	ko00500	Starch and sucrose metabolism	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMG200000293	K01051	ko01100	Metabolic pathways	1931	1.1e-100	0.75	0.87	0.99
PGSC0003DMG200000293	K01051	ko00040	Pentose and glucuronate interconversions	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMG200000293	K01051	ko00500	Starch and sucrose metabolism	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMG200000293	K01051	ko01100	Metabolic pathways	2260	8.1e-119	0.75	0.88	0.99
PGSC0003DMG200000295	K00844	ko00010	Glycolysis / Gluconeogenesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00051	Fructose and mannose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00052	Galactose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00500	Starch and sucrose metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00521	Streptomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00524	Butirosin and neomycin biosynthesis	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko01100	Metabolic pathways	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko01110	Biosynthesis of secondary metabolites	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko04910	Insulin signaling pathway	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko04930	Type II diabetes mellitus	3213	2.2e-171	0.76	0.90	1.00
PGSC0003DMG200000295	K00844	ko00010	Glycolysis / Gluconeogenesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00051	Fructose and mannose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00052	Galactose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00500	Starch and sucrose metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00521	Streptomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko00524	Butirosin and neomycin biosynthesis	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko01100	Metabolic pathways	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko01110	Biosynthesis of secondary metabolites	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko04910	Insulin signaling pathway	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000295	K00844	ko04930	Type II diabetes mellitus	651	4.5e-30	0.71	0.89	0.99
PGSC0003DMG200000300	K07151	ko00510	N-Glycan biosynthesis	5760	0.	0.87	0.93	1.00
PGSC0003DMG200000300	K07151	ko01100	Metabolic pathways	5760	0.	0.87	0.93	1.00
PGSC0003DMG200019077	K00276	ko00260	Glycine, serine and threonine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko00350	Tyrosine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko00360	Phenylalanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko00410	beta-Alanine metabolism	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko01100	Metabolic pathways	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019077	K00276	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.34	0.53	0.89
PGSC0003DMG200019081	K00939	ko00230	Purine metabolism	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMG200019081	K00939	ko01100	Metabolic pathways	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMG200019081	K00939	ko01110	Biosynthesis of secondary metabolites	950	1.5e-46	0.61	0.82	0.56
PGSC0003DMG200019081	K00939	ko00230	Purine metabolism	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMG200019081	K00939	ko01100	Metabolic pathways	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMG200019081	K00939	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.65	0.82	0.62
PGSC0003DMG200019081	K00939	ko00230	Purine metabolism	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMG200019081	K00939	ko01100	Metabolic pathways	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMG200019081	K00939	ko01110	Biosynthesis of secondary metabolites	1001	2.2e-49	0.62	0.82	0.78
PGSC0003DMG200019081	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200019081	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200019081	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200019081	K00939	ko00230	Purine metabolism	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200019081	K00939	ko01100	Metabolic pathways	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200019081	K00939	ko01110	Biosynthesis of secondary metabolites	1012	5.5e-50	0.62	0.83	0.78
PGSC0003DMG200029633	K03032	ko03050	Proteasome	4568	4.1e-246	0.86	0.91	0.97
PGSC0003DMG200029633	K03032	ko03050	Proteasome	5163	6.2e-279	0.87	0.92	0.99
PGSC0003DMG200029633	K03032	ko03050	Proteasome	7089	0.	0.86	0.91	1.00
PGSC0003DMG200036450	K04733	ko04210	Apoptosis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMG200036450	K04733	ko04620	Toll-like receptor signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMG200036450	K04733	ko04722	Neurotrophin signaling pathway	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMG200036450	K04733	ko05140	Leishmaniasis	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMG200036450	K04733	ko05142	Chagas disease	470	1.3e-19	0.31	0.51	0.91
PGSC0003DMG200000933	K01213	ko00040	Pentose and glucuronate interconversions	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMG200000933	K01213	ko00500	Starch and sucrose metabolism	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMG200000933	K01213	ko01100	Metabolic pathways	1369	1.1e-69	0.51	0.66	0.98
PGSC0003DMG200000933	K01213	ko00040	Pentose and glucuronate interconversions	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMG200000933	K01213	ko00500	Starch and sucrose metabolism	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMG200000933	K01213	ko01100	Metabolic pathways	1487	3.5e-76	0.49	0.64	0.94
PGSC0003DMG200000935	K01834	ko00010	Glycolysis / Gluconeogenesis	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMG200000935	K01834	ko01100	Metabolic pathways	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMG200000935	K01834	ko01110	Biosynthesis of secondary metabolites	4112	5.8e-221	0.84	0.93	1.00
PGSC0003DMG200040332	K02893	ko03010	Ribosome	566	2.2e-25	0.97	0.99	0.99
PGSC0003DMG200002462	K05350	ko00460	Cyanoamino acid metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMG200002462	K05350	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMG200002462	K05350	ko00940	Phenylpropanoid biosynthesis	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMG200002462	K05350	ko01110	Biosynthesis of secondary metabolites	1016	3.3e-50	0.49	0.66	0.89
PGSC0003DMG200002462	K05350	ko00460	Cyanoamino acid metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMG200002462	K05350	ko00500	Starch and sucrose metabolism	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMG200002462	K05350	ko00940	Phenylpropanoid biosynthesis	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMG200002462	K05350	ko01110	Biosynthesis of secondary metabolites	819	2.5e-39	0.50	0.67	0.89
PGSC0003DMG200002462	K05350	ko00460	Cyanoamino acid metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMG200002462	K05350	ko00500	Starch and sucrose metabolism	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMG200002462	K05350	ko00940	Phenylpropanoid biosynthesis	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMG200002462	K05350	ko01110	Biosynthesis of secondary metabolites	2342	2.4e-123	0.56	0.73	0.89
PGSC0003DMG200002467	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMG200002467	K00517	ko00626	Naphthalene and anthracene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMG200002467	K00517	ko00903	Limonene and pinene degradation	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMG200002467	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMG200002467	K00517	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.48	0.63	0.95
PGSC0003DMG200002467	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMG200002467	K00517	ko00626	Naphthalene and anthracene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMG200002467	K00517	ko00903	Limonene and pinene degradation	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMG200002467	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMG200002467	K00517	ko01110	Biosynthesis of secondary metabolites	1320	5.7e-67	0.46	0.65	0.96
PGSC0003DMG200002467	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00626	Naphthalene and anthracene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00903	Limonene and pinene degradation	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002467	K00517	ko01110	Biosynthesis of secondary metabolites	893	2.0e-43	0.53	0.73	0.99
PGSC0003DMG200002470	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMG200002470	K00517	ko00626	Naphthalene and anthracene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMG200002470	K00517	ko00903	Limonene and pinene degradation	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMG200002470	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMG200002470	K00517	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.49	0.71	0.92
PGSC0003DMG200002472	K03040	ko00230	Purine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMG200002472	K03040	ko00240	Pyrimidine metabolism	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMG200002472	K03040	ko01100	Metabolic pathways	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMG200002472	K03040	ko03020	RNA polymerase	2027	5.8e-106	0.81	0.89	1.00
PGSC0003DMG200002473	K01580	ko00250	Alanine, aspartate and glutamate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002473	K01580	ko00410	beta-Alanine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002473	K01580	ko00430	Taurine and hypotaurine metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002473	K01580	ko00650	Butanoate metabolism	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002473	K01580	ko01100	Metabolic pathways	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002473	K01580	ko04940	Type I diabetes mellitus	782	2.7e-37	0.94	0.99	0.67
PGSC0003DMG200002479	K00688	ko00500	Starch and sucrose metabolism	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMG200002479	K00688	ko04910	Insulin signaling pathway	1192	6.5e-60	0.77	0.80	0.99
PGSC0003DMG200002479	K00688	ko00500	Starch and sucrose metabolism	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMG200002479	K00688	ko04910	Insulin signaling pathway	1261	1.0e-63	0.91	0.94	0.99
PGSC0003DMG200012879	K04120	ko00904	Diterpenoid biosynthesis	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMG200012879	K04120	ko01100	Metabolic pathways	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMG200012879	K04120	ko01110	Biosynthesis of secondary metabolites	532	1.8e-23	0.46	0.68	0.98
PGSC0003DMG200012880	K08332	ko04140	Regulation of autophagy	449	8.4e-19	0.33	0.53	0.41
PGSC0003DMG200012881	K00788	ko00730	Thiamine metabolism	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMG200012881	K00788	ko01100	Metabolic pathways	288	4.8e-10	0.32	0.50	0.49
PGSC0003DMG200012881	K00788	ko00730	Thiamine metabolism	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMG200012881	K00788	ko01100	Metabolic pathways	288	2.8e-09	0.32	0.50	0.20
PGSC0003DMG200012887	K06654	ko04111	Cell cycle - yeast	311	2.6e-11	0.36	0.55	0.73
PGSC0003DMG200012888	K01784	ko00052	Galactose metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMG200012888	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMG200012888	K01784	ko01100	Metabolic pathways	846	7.9e-41	0.37	0.56	0.79
PGSC0003DMG200004937	K12886	ko03040	Spliceosome	398	6.9e-16	0.28	0.41	0.56
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	3721	2.1e-199	0.78	0.89	1.00
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	3669	1.6e-196	0.77	0.88	1.00
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1219	2.1e-61	0.75	0.83	0.99
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1651	3.2e-85	0.78	0.92	0.99
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1903	4.0e-99	0.78	0.88	0.88
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1728	1.8e-89	0.74	0.85	1.00
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	1447	5.6e-74	0.75	0.90	1.00
PGSC0003DMG200004938	K00854	ko00040	Pentose and glucuronate interconversions	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMG200004938	K00854	ko01100	Metabolic pathways	3633	1.5e-194	0.77	0.88	1.00
PGSC0003DMG200004939	K09756	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.46	0.62	0.85
PGSC0003DMG200004939	K09756	ko00940	Phenylpropanoid biosynthesis	1448	5.0e-74	0.47	0.63	0.84
PGSC0003DMG200004939	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMG200004939	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMG200004939	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMG200004939	K09757	ko00940	Phenylpropanoid biosynthesis	441	1.7e-18	0.65	0.81	0.96
PGSC0003DMG200011647	K02134	ko00190	Oxidative phosphorylation	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMG200011647	K02134	ko01100	Metabolic pathways	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMG200011647	K02134	ko05010	Alzheimer's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMG200011647	K02134	ko05012	Parkinson's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMG200011647	K02134	ko05016	Huntington's disease	481	1.1e-20	0.62	0.77	0.72
PGSC0003DMG200011647	K02134	ko00190	Oxidative phosphorylation	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMG200011647	K02134	ko01100	Metabolic pathways	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMG200011647	K02134	ko05010	Alzheimer's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMG200011647	K02134	ko05012	Parkinson's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMG200011647	K02134	ko05016	Huntington's disease	839	1.9e-40	0.82	0.93	0.37
PGSC0003DMG200011647	K02134	ko00190	Oxidative phosphorylation	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMG200011647	K02134	ko01100	Metabolic pathways	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMG200011647	K02134	ko05010	Alzheimer's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMG200011647	K02134	ko05012	Parkinson's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMG200011647	K02134	ko05016	Huntington's disease	1250	4.1e-63	0.80	0.89	0.97
PGSC0003DMG200011648	K01051	ko00040	Pentose and glucuronate interconversions	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMG200011648	K01051	ko00500	Starch and sucrose metabolism	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMG200011648	K01051	ko01100	Metabolic pathways	1040	1.6e-51	0.45	0.59	0.87
PGSC0003DMG200011652	K03006	ko00230	Purine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMG200011652	K03006	ko00240	Pyrimidine metabolism	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMG200011652	K03006	ko01100	Metabolic pathways	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMG200011652	K03006	ko03020	RNA polymerase	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMG200011652	K03006	ko05016	Huntington's disease	1311	6.5e-66	0.41	0.47	0.85
PGSC0003DMG200011653	K00985	ko00230	Purine metabolism	534	1.3e-23	0.47	0.61	0.88
PGSC0003DMG200011655	K01859	ko00941	Flavonoid biosynthesis	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMG200011655	K01859	ko01100	Metabolic pathways	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMG200011655	K01859	ko01110	Biosynthesis of secondary metabolites	322	6.3e-12	0.36	0.54	0.92
PGSC0003DMG200015600	K03512	ko03410	Base excision repair	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMG200015600	K03512	ko03450	Non-homologous end-joining	3032	2.1e-161	0.69	0.81	1.00
PGSC0003DMG200015600	K03512	ko03410	Base excision repair	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMG200015600	K03512	ko03450	Non-homologous end-joining	1311	1.8e-66	0.82	0.90	0.99
PGSC0003DMG200015601	K11820	ko00380	Tryptophan metabolism	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMG200015601	K11820	ko00966	Glucosinolate biosynthesis	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMG200015601	K11820	ko01110	Biosynthesis of secondary metabolites	1273	2.2e-64	0.58	0.77	0.93
PGSC0003DMG200015601	K11820	ko00380	Tryptophan metabolism	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMG200015601	K11820	ko00966	Glucosinolate biosynthesis	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMG200015601	K11820	ko01110	Biosynthesis of secondary metabolites	1941	3.2e-101	0.53	0.72	0.95
PGSC0003DMG200015603	K08727	ko04621	NOD-like receptor signaling pathway	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMG200015603	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMG200015603	K08727	ko05131	Shigellosis	424	6.6e-17	0.35	0.51	0.98
PGSC0003DMG200015603	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMG200015603	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMG200015603	K08727	ko05131	Shigellosis	425	5.8e-17	0.34	0.50	0.95
PGSC0003DMG200015603	K12800	ko04621	NOD-like receptor signaling pathway	253	3.1e-07	0.31	0.47	0.74
PGSC0003DMG200015603	K08727	ko04621	NOD-like receptor signaling pathway	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMG200015603	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMG200015603	K08727	ko05131	Shigellosis	425	3.1e-15	0.33	0.52	0.71
PGSC0003DMG200015603	K08727	ko04621	NOD-like receptor signaling pathway	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMG200015603	K08727	ko05120	Epithelial cell signaling in Helicobacter pylori infection	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMG200015603	K08727	ko05131	Shigellosis	425	5.8e-17	0.33	0.52	0.97
PGSC0003DMG200015604	K04498	ko04110	Cell cycle	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04310	Wnt signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04330	Notch signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04350	TGF-beta signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04520	Adherens junction	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04630	Jak-STAT signaling pathway	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04720	Long-term potentiation	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko04916	Melanogenesis	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko05016	Huntington's disease	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko05200	Pathways in cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko05211	Renal cell carcinoma	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015604	K04498	ko05215	Prostate cancer	3081	4.2e-164	0.49	0.66	0.96
PGSC0003DMG200015605	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMG200015605	K00517	ko00626	Naphthalene and anthracene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMG200015605	K00517	ko00903	Limonene and pinene degradation	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMG200015605	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMG200015605	K00517	ko01110	Biosynthesis of secondary metabolites	1578	3.4e-81	0.42	0.61	0.98
PGSC0003DMG200015606	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03030	DNA replication	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03420	Nucleotide excision repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03430	Mismatch repair	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015606	K07466	ko03440	Homologous recombination	538	7.7e-24	0.54	0.68	0.98
PGSC0003DMG200015613	K10260	ko04120	Ubiquitin mediated proteolysis	294	2.2e-10	0.33	0.53	0.96
PGSC0003DMG200015613	K10260	ko04120	Ubiquitin mediated proteolysis	485	6.5e-21	0.28	0.47	0.68
PGSC0003DMG200027363	K11252	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.95	0.96	0.99
PGSC0003DMG200027364	K11252	ko05322	Systemic lupus erythematosus	1044	9.5e-52	0.88	0.91	0.99
PGSC0003DMG200027372	K01955	ko00240	Pyrimidine metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMG200027372	K01955	ko00250	Alanine, aspartate and glutamate metabolism	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMG200027372	K01955	ko01100	Metabolic pathways	559	3.6e-24	0.70	0.79	0.99
PGSC0003DMG200027374	K02138	ko00190	Oxidative phosphorylation	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMG200027374	K02138	ko01100	Metabolic pathways	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMG200027374	K02138	ko05010	Alzheimer's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMG200027374	K02138	ko05012	Parkinson's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMG200027374	K02138	ko05016	Huntington's disease	1285	4.9e-65	0.88	0.95	0.99
PGSC0003DMG200027377	K06685	ko04111	Cell cycle - yeast	343	2.0e-09	0.26	0.43	0.89
PGSC0003DMG200028455	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMG200028455	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMG200028455	K00771	ko01100	Metabolic pathways	277	1.1e-08	0.33	0.53	0.77
PGSC0003DMG200028463	K02343	ko00230	Purine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028463	K02343	ko00240	Pyrimidine metabolism	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028463	K02343	ko01100	Metabolic pathways	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028463	K02343	ko03030	DNA replication	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028463	K02343	ko03430	Mismatch repair	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028463	K02343	ko03440	Homologous recombination	876	1.8e-42	0.39	0.60	0.29
PGSC0003DMG200028465	K10949	ko05110	Vibrio cholerae infection	1377	4.1e-70	0.82	0.92	0.76
PGSC0003DMG200028465	K10949	ko05110	Vibrio cholerae infection	1601	1.8e-82	0.86	0.94	1.00
PGSC0003DMG200028467	K01087	ko00500	Starch and sucrose metabolism	428	2.9e-17	0.69	0.80	0.88
PGSC0003DMG200028467	K01087	ko00500	Starch and sucrose metabolism	5572	1.7e-301	0.76	0.89	0.99
PGSC0003DMG200018492	K03363	ko04110	Cell cycle	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMG200018492	K03363	ko04111	Cell cycle - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMG200018492	K03363	ko04113	Meiosis - yeast	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMG200018492	K03363	ko04114	Oocyte meiosis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMG200018492	K03363	ko04120	Ubiquitin mediated proteolysis	2677	8.1e-142	0.70	0.83	1.00
PGSC0003DMG200018493	K00558	ko00270	Cysteine and methionine metabolism	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMG200018493	K00558	ko01100	Metabolic pathways	3452	1.5e-184	0.66	0.80	0.98
PGSC0003DMG200018493	K00558	ko00270	Cysteine and methionine metabolism	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMG200018493	K00558	ko01100	Metabolic pathways	3012	2.7e-160	0.68	0.82	0.97
PGSC0003DMG200018493	K00558	ko00270	Cysteine and methionine metabolism	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMG200018493	K00558	ko01100	Metabolic pathways	4282	2.4e-230	0.52	0.66	0.97
PGSC0003DMG200018502	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.60
PGSC0003DMG200018502	K04631	ko04744	Phototransduction	692	2.5e-32	0.35	0.56	0.84
PGSC0003DMG200018502	K04631	ko04744	Phototransduction	842	1.3e-40	0.35	0.56	0.45
PGSC0003DMG200018505	K12668	ko00510	N-Glycan biosynthesis	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMG200018505	K12668	ko01100	Metabolic pathways	557	6.9e-25	0.97	1.00	0.99
PGSC0003DMG200018505	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMG200018505	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMG200018505	K12668	ko00510	N-Glycan biosynthesis	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMG200018505	K12668	ko01100	Metabolic pathways	835	3.2e-40	0.84	0.97	0.99
PGSC0003DMG200031348	K13065	ko00940	Phenylpropanoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMG200031348	K13065	ko00941	Flavonoid biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMG200031348	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMG200031348	K13065	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.28	0.46	0.86
PGSC0003DMG200031349	K01051	ko00040	Pentose and glucuronate interconversions	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMG200031349	K01051	ko00500	Starch and sucrose metabolism	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMG200031349	K01051	ko01100	Metabolic pathways	1176	5.0e-59	0.47	0.65	0.95
PGSC0003DMG200031350	K09903	ko00240	Pyrimidine metabolism	1915	8.7e-100	0.73	0.81	0.98
PGSC0003DMG200031350	K09903	ko00240	Pyrimidine metabolism	1987	9.3e-104	0.75	0.84	0.98
PGSC0003DMG200031360	K13068	ko00940	Phenylpropanoid biosynthesis	854	2.9e-41	0.32	0.51	0.95
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	2376	3.3e-125	0.73	0.85	0.99
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	1228	6.8e-62	0.73	0.85	0.99
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	2245	5.5e-118	0.73	0.86	0.99
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	737	8.2e-35	0.72	0.82	0.40
PGSC0003DMG200031361	K05894	ko00592	alpha-Linolenic acid metabolism	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031361	K05894	ko01100	Metabolic pathways	1333	1.1e-67	0.77	0.88	0.98
PGSC0003DMG200031362	K05894	ko00592	alpha-Linolenic acid metabolism	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMG200031362	K05894	ko01100	Metabolic pathways	466	7.2e-20	0.51	0.61	0.75
PGSC0003DMG200031362	K05894	ko00592	alpha-Linolenic acid metabolism	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMG200031362	K05894	ko01100	Metabolic pathways	314	1.7e-11	0.77	0.93	0.72
PGSC0003DMG200031364	K00856	ko00230	Purine metabolism	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMG200031364	K00856	ko01100	Metabolic pathways	2588	6.6e-137	0.88	0.95	1.00
PGSC0003DMG200021582	K00652	ko00780	Biotin metabolism	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMG200021582	K00652	ko01100	Metabolic pathways	2513	9.0e-133	0.70	0.81	0.99
PGSC0003DMG200021582	K00652	ko00780	Biotin metabolism	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMG200021582	K00652	ko01100	Metabolic pathways	2172	5.8e-114	0.77	0.87	0.96
PGSC0003DMG200021582	K00652	ko00780	Biotin metabolism	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMG200021582	K00652	ko01100	Metabolic pathways	1832	3.3e-95	0.75	0.86	0.95
PGSC0003DMG200021592	K06096	ko04530	Tight junction	381	3.5e-15	0.34	0.53	0.96
PGSC0003DMG200021592	K06096	ko04530	Tight junction	378	5.2e-15	0.34	0.53	0.96
PGSC0003DMG200021592	K06096	ko04530	Tight junction	359	5.8e-14	0.37	0.53	0.82
PGSC0003DMG200021594	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMG200021594	K08343	ko04140	Regulation of autophagy	2390	5.5e-126	0.87	0.96	1.00
PGSC0003DMG200038438	K12356	ko00940	Phenylpropanoid biosynthesis	599	3.3e-27	0.38	0.57	0.67
PGSC0003DMG200038451	K04103	ko00380	Tryptophan metabolism	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMG200038451	K04103	ko01100	Metabolic pathways	2749	8.7e-146	0.86	0.93	1.00
PGSC0003DMG200038456	K13065	ko00940	Phenylpropanoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMG200038456	K13065	ko00941	Flavonoid biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMG200038456	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMG200038456	K13065	ko01110	Biosynthesis of secondary metabolites	776	5.8e-37	0.34	0.51	0.91
PGSC0003DMG200038458	K11251	ko05322	Systemic lupus erythematosus	503	6.6e-22	0.69	0.84	0.75
PGSC0003DMG200010374	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMG200010374	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMG200010374	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.38	0.56	0.78
PGSC0003DMG200016968	K03110	ko03060	Protein export	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMG200016968	K03110	ko03070	Bacterial secretion system	312	1.2e-08	0.30	0.50	0.38
PGSC0003DMG200016968	K03110	ko03060	Protein export	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMG200016968	K03110	ko03070	Bacterial secretion system	312	5.3e-09	0.30	0.50	0.48
PGSC0003DMG200016968	K03110	ko03060	Protein export	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMG200016968	K03110	ko03070	Bacterial secretion system	284	2.1e-09	0.32	0.50	0.56
PGSC0003DMG200016969	K02739	ko03050	Proteasome	1821	1.3e-94	0.69	0.76	1.00
PGSC0003DMG200016969	K02739	ko03050	Proteasome	1956	4.8e-102	0.85	0.94	1.00
PGSC0003DMG200016973	K10260	ko04120	Ubiquitin mediated proteolysis	436	3.3e-18	0.29	0.48	0.62
PGSC0003DMG200016975	K03469	ko03030	DNA replication	249	6.7e-08	0.39	0.52	0.37
PGSC0003DMG200016979	K12796	ko04621	NOD-like receptor signaling pathway	419	1.2e-13	0.32	0.49	0.39
PGSC0003DMG200016979	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.88
PGSC0003DMG200016979	K12796	ko04621	NOD-like receptor signaling pathway	419	2.7e-16	0.32	0.49	0.70
PGSC0003DMG200003501	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMG200003504	K02933	ko03010	Ribosome	847	7.0e-41	0.96	0.99	0.99
PGSC0003DMG200003505	K02292	ko00906	Carotenoid biosynthesis	1904	3.5e-99	0.51	0.67	0.95
PGSC0003DMG200003505	K02292	ko00906	Carotenoid biosynthesis	1617	2.4e-83	0.50	0.66	0.93
PGSC0003DMG200003505	K02292	ko00906	Carotenoid biosynthesis	260	4.4e-08	0.72	0.78	0.71
PGSC0003DMG200003505	K02292	ko00906	Carotenoid biosynthesis	1185	1.6e-59	0.52	0.67	0.99
PGSC0003DMG200003505	K02292	ko00906	Carotenoid biosynthesis	2151	8.4e-113	0.52	0.67	0.96
PGSC0003DMG200014647	K00454	ko00591	Linoleic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMG200014647	K00454	ko00592	alpha-Linolenic acid metabolism	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMG200014647	K00454	ko01100	Metabolic pathways	350	8.5e-13	0.65	0.72	0.97
PGSC0003DMG200014654	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMG200014654	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMG200014654	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.55	0.76	0.98
PGSC0003DMG200014655	K00799	ko00480	Glutathione metabolism	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMG200014655	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMG200014655	K00799	ko00982	Drug metabolism - cytochrome P450	1067	5.1e-53	0.57	0.78	0.95
PGSC0003DMG200014656	K00799	ko00480	Glutathione metabolism	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMG200014656	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMG200014656	K00799	ko00982	Drug metabolism - cytochrome P450	1040	1.6e-51	0.58	0.75	0.95
PGSC0003DMG200014657	K00799	ko00480	Glutathione metabolism	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMG200014657	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMG200014657	K00799	ko00982	Drug metabolism - cytochrome P450	629	7.4e-29	0.67	0.84	0.97
PGSC0003DMG200014657	K00799	ko00480	Glutathione metabolism	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMG200014657	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMG200014657	K00799	ko00982	Drug metabolism - cytochrome P450	1116	1.0e-55	0.59	0.77	0.98
PGSC0003DMG200014660	K01834	ko00010	Glycolysis / Gluconeogenesis	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMG200014660	K01834	ko01100	Metabolic pathways	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMG200014660	K01834	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.32	0.50	0.75
PGSC0003DMG200014660	K01834	ko00010	Glycolysis / Gluconeogenesis	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMG200014660	K01834	ko01100	Metabolic pathways	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMG200014660	K01834	ko01110	Biosynthesis of secondary metabolites	244	1.3e-07	0.35	0.50	0.76
PGSC0003DMG200014664	K08139	ko04113	Meiosis - yeast	596	4.9e-27	0.40	0.62	0.87
PGSC0003DMG200010337	K01092	ko00521	Streptomycin biosynthesis	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMG200010337	K01092	ko00562	Inositol phosphate metabolism	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMG200010337	K01092	ko01100	Metabolic pathways	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMG200010337	K01092	ko01110	Biosynthesis of secondary metabolites	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMG200010337	K01092	ko04070	Phosphatidylinositol signaling system	1056	2.1e-52	0.69	0.77	0.79
PGSC0003DMG200010337	K01092	ko00521	Streptomycin biosynthesis	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMG200010337	K01092	ko00562	Inositol phosphate metabolism	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMG200010337	K01092	ko01100	Metabolic pathways	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMG200010337	K01092	ko01110	Biosynthesis of secondary metabolites	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMG200010337	K01092	ko04070	Phosphatidylinositol signaling system	2045	5.9e-107	0.88	0.94	0.99
PGSC0003DMG200010337	K01092	ko00521	Streptomycin biosynthesis	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMG200010337	K01092	ko00562	Inositol phosphate metabolism	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMG200010337	K01092	ko01100	Metabolic pathways	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMG200010337	K01092	ko01110	Biosynthesis of secondary metabolites	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMG200010337	K01092	ko04070	Phosphatidylinositol signaling system	1251	3.6e-63	0.87	0.93	0.99
PGSC0003DMG200010338	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMG200010338	K01869	ko00970	Aminoacyl-tRNA biosynthesis	7280	0.	0.76	0.89	1.00
PGSC0003DMG200017014	K00029	ko00620	Pyruvate metabolism	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMG200017014	K00029	ko00710	Carbon fixation in photosynthetic organisms	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMG200017014	K00029	ko01100	Metabolic pathways	1201	2.1e-60	0.65	0.76	0.95
PGSC0003DMG200017025	K10802	ko03410	Base excision repair	362	3.9e-14	0.44	0.62	0.81
PGSC0003DMG200017025	K10802	ko03410	Base excision repair	357	7.4e-14	0.44	0.64	0.81
PGSC0003DMG200017028	K12879	ko03040	Spliceosome	1115	5.4e-55	0.60	0.74	0.84
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	554	4.9e-24	0.44	0.60	0.96
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04110	Cell cycle	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04111	Cell cycle - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200017028	K06671	ko04113	Meiosis - yeast	945	2.8e-46	0.65	0.82	0.99
PGSC0003DMG200003564	K00908	ko01100	Metabolic pathways	3402	8.4e-182	0.80	0.89	0.89
PGSC0003DMG200003564	K00908	ko01100	Metabolic pathways	2377	2.9e-125	0.82	0.89	0.85
PGSC0003DMG200003564	K00908	ko01100	Metabolic pathways	807	1.1e-38	0.74	0.87	0.97
PGSC0003DMG200003567	K02641	ko00195	Photosynthesis	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMG200003567	K02641	ko01100	Metabolic pathways	2736	4.5e-145	0.88	0.95	1.00
PGSC0003DMG200003567	K02641	ko00195	Photosynthesis	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMG200003567	K02641	ko01100	Metabolic pathways	563	3.2e-25	0.85	0.96	0.84
PGSC0003DMG200003575	K03029	ko03050	Proteasome	2477	8.7e-131	0.73	0.81	1.00
PGSC0003DMG200003575	K03029	ko03050	Proteasome	2807	5.5e-149	0.84	0.92	0.99
PGSC0003DMG200003576	K12311	ko00511	Other glycan degradation	6430	0.	0.74	0.85	1.00
PGSC0003DMG200003576	K12311	ko04142	Lysosome	6430	0.	0.74	0.85	1.00
PGSC0003DMG200007335	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007335	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007335	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007335	K01516	ko00230	Purine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007335	K01516	ko00730	Thiamine metabolism	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007335	K01516	ko01100	Metabolic pathways	1751	9.6e-91	0.50	0.70	0.94
PGSC0003DMG200007336	K02958	ko03010	Ribosome	1208	8.6e-61	0.93	0.97	0.99
PGSC0003DMG200007339	K12275	ko03060	Protein export	2116	7.1e-111	0.72	0.80	0.99
PGSC0003DMG200007339	K12275	ko03060	Protein export	2216	2.2e-116	0.75	0.84	0.99
PGSC0003DMG200007340	K05666	ko02010	ABC transporters	2779	1.9e-147	0.35	0.56	0.89
PGSC0003DMG200007343	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMG200007343	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMG200007343	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMG200007343	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMG200007343	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.45	0.65	0.97
PGSC0003DMG200007344	K06685	ko04111	Cell cycle - yeast	490	1.3e-17	0.26	0.41	0.86
PGSC0003DMG200007346	K00655	ko00561	Glycerolipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMG200007346	K00655	ko00564	Glycerophospholipid metabolism	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMG200007346	K00655	ko01100	Metabolic pathways	916	1.1e-44	0.66	0.82	0.99
PGSC0003DMG200007346	K00655	ko00561	Glycerolipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMG200007346	K00655	ko00564	Glycerophospholipid metabolism	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMG200007346	K00655	ko01100	Metabolic pathways	1816	2.5e-94	0.67	0.83	0.92
PGSC0003DMG200007346	K00655	ko00561	Glycerolipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMG200007346	K00655	ko00564	Glycerophospholipid metabolism	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMG200007346	K00655	ko01100	Metabolic pathways	2038	1.4e-106	0.64	0.80	0.97
PGSC0003DMG200007346	K00655	ko00561	Glycerolipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMG200007346	K00655	ko00564	Glycerophospholipid metabolism	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMG200007346	K00655	ko01100	Metabolic pathways	520	7.6e-23	0.54	0.68	0.98
PGSC0003DMG200007346	K00655	ko00561	Glycerolipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMG200007346	K00655	ko00564	Glycerophospholipid metabolism	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMG200007346	K00655	ko01100	Metabolic pathways	249	6.7e-08	0.47	0.61	0.96
PGSC0003DMG200007349	K01582	ko00310	Lysine degradation	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMG200007349	K01582	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMG200007349	K01582	ko01100	Metabolic pathways	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMG200007349	K01582	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.52	0.74	0.97
PGSC0003DMG200007350	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMG200007350	K08064	ko04612	Antigen processing and presentation	520	7.6e-23	0.40	0.60	0.64
PGSC0003DMG200007350	K08064	ko04612	Antigen processing and presentation	375	7.6e-15	0.59	0.75	0.54
PGSC0003DMG200007351	K05666	ko02010	ABC transporters	2307	2.1e-121	0.34	0.55	0.88
PGSC0003DMG200007352	K05666	ko02010	ABC transporters	1627	6.7e-84	0.41	0.66	0.96
PGSC0003DMG200037933	K00657	ko00330	Arginine and proline metabolism	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMG200037933	K00657	ko01100	Metabolic pathways	268	6.0e-09	0.38	0.56	0.33
PGSC0003DMG200028417	K01465	ko00240	Pyrimidine metabolism	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200028417	K01465	ko01100	Metabolic pathways	2504	2.8e-132	0.83	0.93	0.99
PGSC0003DMG200028418	K10956	ko03060	Protein export	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMG200028418	K10956	ko04145	Phagosome	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMG200028418	K10956	ko05110	Vibrio cholerae infection	3624	4.8e-194	0.91	0.97	1.00
PGSC0003DMG200028419	K06636	ko04110	Cell cycle	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMG200028419	K06636	ko04111	Cell cycle - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMG200028419	K06636	ko04113	Meiosis - yeast	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMG200028419	K06636	ko04114	Oocyte meiosis	317	4.3e-09	0.28	0.47	0.61
PGSC0003DMG200028425	K12857	ko03040	Spliceosome	254	6.1e-07	0.29	0.47	0.50
PGSC0003DMG200028428	K03083	ko04012	ErbB signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04062	Chemokine signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04110	Cell cycle	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04310	Wnt signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04340	Hedgehog signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04360	Axon guidance	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04510	Focal adhesion	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04660	T cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04662	B cell receptor signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04711	Circadian rhythm - fly	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04722	Neurotrophin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04910	Insulin signaling pathway	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko04916	Melanogenesis	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05010	Alzheimer's disease	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05200	Pathways in cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05210	Colorectal cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05213	Endometrial cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05215	Prostate cancer	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028428	K03083	ko05217	Basal cell carcinoma	3004	7.5e-160	0.91	0.96	0.98
PGSC0003DMG200028430	K03015	ko00230	Purine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMG200028430	K03015	ko00240	Pyrimidine metabolism	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMG200028430	K03015	ko01100	Metabolic pathways	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMG200028430	K03015	ko03020	RNA polymerase	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMG200028430	K03015	ko05016	Huntington's disease	1107	3.2e-55	0.72	0.89	0.97
PGSC0003DMG200021666	K08726	ko00590	Arachidonic acid metabolism	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMG200021666	K08726	ko00625	Tetrachloroethene degradation	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMG200021666	K08726	ko01100	Metabolic pathways	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMG200021666	K08726	ko04146	Peroxisome	729	2.3e-34	0.36	0.53	0.99
PGSC0003DMG200021666	K08726	ko00590	Arachidonic acid metabolism	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMG200021666	K08726	ko00625	Tetrachloroethene degradation	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMG200021666	K08726	ko01100	Metabolic pathways	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMG200021666	K08726	ko04146	Peroxisome	502	7.5e-22	0.46	0.64	0.84
PGSC0003DMG200021670	K03885	ko00190	Oxidative phosphorylation	2933	6.2e-156	0.71	0.84	0.94
PGSC0003DMG200021670	K03885	ko00190	Oxidative phosphorylation	864	8.1e-42	0.82	0.89	0.98
PGSC0003DMG200021670	K03885	ko00190	Oxidative phosphorylation	3718	3.1e-199	0.75	0.87	0.99
PGSC0003DMG200021670	K03885	ko00190	Oxidative phosphorylation	585	2.0e-26	0.79	0.85	0.86
PGSC0003DMG200025487	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMG200025487	K01637	ko01100	Metabolic pathways	4264	2.4e-229	0.84	0.94	1.00
PGSC0003DMG200025487	K01637	ko00630	Glyoxylate and dicarboxylate metabolism	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMG200025487	K01637	ko01100	Metabolic pathways	4067	1.8e-218	0.86	0.95	0.95
PGSC0003DMG200025490	K00430	ko00360	Phenylalanine metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMG200025490	K00430	ko00680	Methane metabolism	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMG200025490	K00430	ko00940	Phenylpropanoid biosynthesis	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMG200025490	K00430	ko01100	Metabolic pathways	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMG200025490	K00430	ko01110	Biosynthesis of secondary metabolites	1892	1.6e-98	0.69	0.84	0.98
PGSC0003DMG200025491	K00430	ko00360	Phenylalanine metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMG200025491	K00430	ko00680	Methane metabolism	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMG200025491	K00430	ko00940	Phenylpropanoid biosynthesis	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMG200025491	K00430	ko01100	Metabolic pathways	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMG200025491	K00430	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.70	0.85	0.97
PGSC0003DMG200025492	K00430	ko00360	Phenylalanine metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMG200025492	K00430	ko00680	Methane metabolism	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMG200025492	K00430	ko00940	Phenylpropanoid biosynthesis	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMG200025492	K00430	ko01100	Metabolic pathways	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMG200025492	K00430	ko01110	Biosynthesis of secondary metabolites	1809	6.1e-94	0.68	0.81	0.98
PGSC0003DMG200025493	K08486	ko04130	SNARE interactions in vesicular transport	1880	7.4e-98	0.73	0.85	1.00
PGSC0003DMG200025493	K08486	ko04130	SNARE interactions in vesicular transport	1541	3.7e-79	0.81	0.92	0.99
PGSC0003DMG200020466	K02109	ko00190	Oxidative phosphorylation	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMG200020466	K02109	ko00195	Photosynthesis	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMG200020466	K02109	ko01100	Metabolic pathways	1165	2.0e-58	0.68	0.81	0.98
PGSC0003DMG200020467	K09755	ko00940	Phenylpropanoid biosynthesis	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMG200020467	K09755	ko01100	Metabolic pathways	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMG200020467	K09755	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.52	0.72	0.97
PGSC0003DMG200020468	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMG200020468	K00517	ko00626	Naphthalene and anthracene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMG200020468	K00517	ko00903	Limonene and pinene degradation	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMG200020468	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMG200020468	K00517	ko01110	Biosynthesis of secondary metabolites	348	2.3e-13	0.57	0.76	0.67
PGSC0003DMG200020469	K11229	ko04011	MAPK signaling pathway - yeast	556	6.3e-24	0.34	0.51	0.88
PGSC0003DMG200020471	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMG200020471	K00224	ko00364	Fluorobenzoate degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMG200020471	K00224	ko00628	Fluorene degradation	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMG200020471	K00224	ko00640	Propanoate metabolism	1725	2.6e-89	0.66	0.82	0.99
PGSC0003DMG200020473	K01179	ko00500	Starch and sucrose metabolism	2709	1.4e-143	0.69	0.80	0.93
PGSC0003DMG200020476	K12812	ko03040	Spliceosome	3442	5.2e-184	0.94	0.98	1.00
PGSC0003DMG200020476	K12812	ko03040	Spliceosome	2787	7.0e-148	0.96	0.98	1.00
PGSC0003DMG200020484	K02109	ko00190	Oxidative phosphorylation	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMG200020484	K02109	ko00195	Photosynthesis	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMG200020484	K02109	ko01100	Metabolic pathways	1170	1.1e-58	0.68	0.82	0.99
PGSC0003DMG200020487	K01046	ko00561	Glycerolipid metabolism	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMG200020487	K01046	ko01100	Metabolic pathways	268	9.7e-09	0.33	0.49	0.35
PGSC0003DMG200004858	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMG200004858	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMG200004858	K03126	ko03022	Basal transcription factors	545	3.2e-24	0.42	0.64	0.96
PGSC0003DMG200004858	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMG200004858	K03126	ko03022	Basal transcription factors	327	4.4e-12	0.40	0.55	0.92
PGSC0003DMG200004861	K03868	ko03420	Nucleotide excision repair	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04110	Cell cycle	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04111	Cell cycle - yeast	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04114	Oocyte meiosis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04120	Ubiquitin mediated proteolysis	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04310	Wnt signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04350	TGF-beta signaling pathway	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko04710	Circadian rhythm - mammal	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko05200	Pathways in cancer	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004861	K03868	ko05211	Renal cell carcinoma	899	9.5e-44	0.89	0.94	0.91
PGSC0003DMG200004863	K12620	ko03018	RNA degradation	665	7.6e-31	0.80	0.88	0.22
PGSC0003DMG200004863	K12620	ko03018	RNA degradation	969	1.3e-47	0.91	0.96	0.99
PGSC0003DMG200004867	K04554	ko04120	Ubiquitin mediated proteolysis	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMG200004867	K04554	ko05012	Parkinson's disease	624	1.4e-28	0.96	0.99	0.97
PGSC0003DMG200004867	K04554	ko04120	Ubiquitin mediated proteolysis	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMG200004867	K04554	ko05012	Parkinson's disease	1002	2.0e-49	0.96	0.98	0.85
PGSC0003DMG200004867	K04554	ko04120	Ubiquitin mediated proteolysis	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMG200004867	K04554	ko05012	Parkinson's disease	1588	9.4e-82	0.80	0.85	1.00
PGSC0003DMG200011694	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMG200011694	K03911	ko04610	Complement and coagulation cascades	718	9.1e-34	0.35	0.50	0.95
PGSC0003DMG200011702	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMG200011702	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMG200011702	K02943	ko03010	Ribosome	719	8.0e-34	0.82	0.89	0.99
PGSC0003DMG200009291	K10526	ko00592	alpha-Linolenic acid metabolism	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMG200009291	K10526	ko01100	Metabolic pathways	1859	1.1e-96	0.45	0.66	0.93
PGSC0003DMG200009291	K10526	ko00592	alpha-Linolenic acid metabolism	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMG200009291	K10526	ko01100	Metabolic pathways	1572	7.2e-81	0.45	0.65	0.92
PGSC0003DMG200009291	K05339	ko02020	Two-component system	297	1.5e-10	0.34	0.54	0.39
PGSC0003DMG200009293	K04428	ko04010	MAPK signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMG200009293	K04428	ko04912	GnRH signaling pathway	414	6.1e-16	0.31	0.48	0.88
PGSC0003DMG200009294	K08866	ko04110	Cell cycle	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMG200009294	K08866	ko04111	Cell cycle - yeast	279	2.6e-09	0.34	0.55	0.99
PGSC0003DMG200009297	K12189	ko04144	Endocytosis	1374	6.0e-70	0.88	0.96	0.99
PGSC0003DMG200009297	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMG200009297	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMG200009297	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMG200009297	K12189	ko04144	Endocytosis	714	1.5e-33	0.92	0.98	0.99
PGSC0003DMG200009301	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMG200009301	K06666	ko04111	Cell cycle - yeast	359	5.0e-11	0.28	0.42	0.36
PGSC0003DMG200006074	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMG200006074	K00517	ko00626	Naphthalene and anthracene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMG200006074	K00517	ko00903	Limonene and pinene degradation	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMG200006074	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMG200006074	K00517	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.40	0.63	0.97
PGSC0003DMG200006074	K05280	ko00941	Flavonoid biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMG200006074	K05280	ko00944	Flavone and flavonol biosynthesis	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMG200006074	K05280	ko01100	Metabolic pathways	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMG200006074	K05280	ko01110	Biosynthesis of secondary metabolites	604	1.8e-27	0.45	0.62	0.98
PGSC0003DMG200006074	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMG200006074	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMG200006074	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMG200006074	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMG200006074	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.41	0.63	0.95
PGSC0003DMG200006074	K05280	ko00941	Flavonoid biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMG200006074	K05280	ko00944	Flavone and flavonol biosynthesis	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMG200006074	K05280	ko01100	Metabolic pathways	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMG200006074	K05280	ko01110	Biosynthesis of secondary metabolites	621	2.0e-28	0.45	0.62	0.99
PGSC0003DMG200006075	K07424	ko00140	Steroid hormone biosynthesis	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00591	Linoleic acid metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00830	Retinol metabolism	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00982	Drug metabolism - cytochrome P450	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00983	Drug metabolism - other enzymes	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko01100	Metabolic pathways	1401	1.9e-71	0.50	0.72	1.00
PGSC0003DMG200006075	K07424	ko00140	Steroid hormone biosynthesis	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00591	Linoleic acid metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00830	Retinol metabolism	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00982	Drug metabolism - cytochrome P450	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00983	Drug metabolism - other enzymes	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko01100	Metabolic pathways	1908	2.1e-99	0.47	0.68	0.97
PGSC0003DMG200006075	K07424	ko00140	Steroid hormone biosynthesis	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00591	Linoleic acid metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00830	Retinol metabolism	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00982	Drug metabolism - cytochrome P450	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00983	Drug metabolism - other enzymes	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko01100	Metabolic pathways	2016	2.3e-105	0.49	0.69	0.97
PGSC0003DMG200006075	K07424	ko00140	Steroid hormone biosynthesis	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00591	Linoleic acid metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00830	Retinol metabolism	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00982	Drug metabolism - cytochrome P450	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko00983	Drug metabolism - other enzymes	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006075	K07424	ko01100	Metabolic pathways	2031	3.5e-106	0.48	0.70	0.97
PGSC0003DMG200006080	K00873	ko00010	Glycolysis / Gluconeogenesis	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko00230	Purine metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko00620	Pyruvate metabolism	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko00710	Carbon fixation in photosynthetic organisms	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko01100	Metabolic pathways	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko01110	Biosynthesis of secondary metabolites	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006080	K00873	ko04930	Type II diabetes mellitus	1574	5.6e-81	0.44	0.60	0.91
PGSC0003DMG200006084	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMG200006084	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.51
PGSC0003DMG200006084	K05585	ko00190	Oxidative phosphorylation	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMG200006084	K05585	ko01100	Metabolic pathways	526	3.5e-23	0.49	0.65	0.52
PGSC0003DMG200015543	K08008	ko04145	Phagosome	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMG200015543	K08008	ko04670	Leukocyte transendothelial migration	514	1.6e-22	0.28	0.44	0.64
PGSC0003DMG200015543	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMG200015543	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.84
PGSC0003DMG200015543	K08008	ko04145	Phagosome	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMG200015543	K08008	ko04670	Leukocyte transendothelial migration	1136	8.0e-57	0.33	0.52	0.69
PGSC0003DMG200015545	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200015547	K04733	ko04210	Apoptosis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMG200015547	K04733	ko04620	Toll-like receptor signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMG200015547	K04733	ko04722	Neurotrophin signaling pathway	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMG200015547	K04733	ko05140	Leishmaniasis	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMG200015547	K04733	ko05142	Chagas disease	2308	1.8e-121	0.42	0.59	0.99
PGSC0003DMG200015548	K00430	ko00360	Phenylalanine metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMG200015548	K00430	ko00680	Methane metabolism	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMG200015548	K00430	ko00940	Phenylpropanoid biosynthesis	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMG200015548	K00430	ko01100	Metabolic pathways	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMG200015548	K00430	ko01110	Biosynthesis of secondary metabolites	1923	3.1e-100	0.71	0.86	0.99
PGSC0003DMG200015553	K00660	ko00941	Flavonoid biosynthesis	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMG200015553	K00660	ko01100	Metabolic pathways	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMG200015553	K00660	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMG200015553	K00660	ko04712	Circadian rhythm - plant	286	6.1e-10	0.26	0.43	0.74
PGSC0003DMG200015554	K07195	ko04910	Insulin signaling pathway	2046	5.2e-107	0.47	0.64	0.99
PGSC0003DMG200015554	K07195	ko04910	Insulin signaling pathway	1905	3.1e-99	0.51	0.67	0.88
PGSC0003DMG200040839	K01366	ko04142	Lysosome	418	3.2e-17	0.35	0.51	0.80
PGSC0003DMG200040842	K10760	ko00908	Zeatin biosynthesis	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMG200040842	K10760	ko01100	Metabolic pathways	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMG200040842	K10760	ko01110	Biosynthesis of secondary metabolites	434	4.2e-18	0.49	0.67	0.96
PGSC0003DMG200040865	K11433	ko00310	Lysine degradation	227	1.1e-06	0.30	0.44	0.69
PGSC0003DMG200043020	K08506	ko04130	SNARE interactions in vesicular transport	261	1.5e-08	0.38	0.44	0.99
PGSC0003DMG200036341	K03094	ko04110	Cell cycle	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04111	Cell cycle - yeast	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04114	Oocyte meiosis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04120	Ubiquitin mediated proteolysis	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04310	Wnt signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04350	TGF-beta signaling pathway	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036341	K03094	ko04710	Circadian rhythm - mammal	516	1.3e-22	0.56	0.68	0.99
PGSC0003DMG200036363	K06544	ko04514	Cell adhesion molecules (CAMs)	302	8.0e-11	0.27	0.55	0.96
PGSC0003DMG200026043	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko04115	p53 signaling pathway	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko04210	Apoptosis	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05010	Alzheimer's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05012	Parkinson's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05016	Huntington's disease	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026043	K02084	ko05222	Small cell lung cancer	295	8.9e-07	0.26	0.45	0.50
PGSC0003DMG200026044	K01074	ko00062	Fatty acid elongation in mitochondria	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMG200026044	K01074	ko01100	Metabolic pathways	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMG200026044	K01074	ko04142	Lysosome	926	3.1e-45	0.70	0.87	0.97
PGSC0003DMG200026044	K01074	ko00062	Fatty acid elongation in mitochondria	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMG200026044	K01074	ko01100	Metabolic pathways	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMG200026044	K01074	ko04142	Lysosome	1043	1.1e-51	0.71	0.88	0.98
PGSC0003DMG200026044	K01074	ko00062	Fatty acid elongation in mitochondria	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMG200026044	K01074	ko01100	Metabolic pathways	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMG200026044	K01074	ko04142	Lysosome	1715	9.3e-89	0.71	0.82	0.86
PGSC0003DMG200026044	K01074	ko00062	Fatty acid elongation in mitochondria	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMG200026044	K01074	ko01100	Metabolic pathways	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMG200026044	K01074	ko04142	Lysosome	1445	7.3e-74	0.70	0.82	0.98
PGSC0003DMG200026044	K01074	ko00062	Fatty acid elongation in mitochondria	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMG200026044	K01074	ko01100	Metabolic pathways	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMG200026044	K01074	ko04142	Lysosome	282	1.0e-09	0.63	0.78	0.93
PGSC0003DMG200022825	K12132	ko04712	Circadian rhythm - plant	1034	3.4e-51	0.48	0.67	0.85
PGSC0003DMG200022827	K04712	ko00600	Sphingolipid metabolism	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMG200022827	K04712	ko01100	Metabolic pathways	2507	1.9e-132	0.85	0.90	1.00
PGSC0003DMG200022833	K10352	ko04530	Tight junction	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMG200022833	K10352	ko05416	Viral myocarditis	465	2.5e-17	0.28	0.46	0.98
PGSC0003DMG200022836	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200005410	K05395	ko00270	Cysteine and methionine metabolism	491	3.0e-21	0.46	0.59	0.86
PGSC0003DMG200005410	K05395	ko00270	Cysteine and methionine metabolism	486	5.7e-21	0.47	0.61	0.92
PGSC0003DMG200005432	K06671	ko04110	Cell cycle	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMG200005432	K06671	ko04111	Cell cycle - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMG200005432	K06671	ko04113	Meiosis - yeast	263	7.3e-08	0.69	0.83	0.42
PGSC0003DMG200005433	K07203	ko04012	ErbB signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko04150	mTOR signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko04910	Insulin signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko04920	Adipocytokine signaling pathway	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko04930	Type II diabetes mellitus	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko05200	Pathways in cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko05214	Glioma	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko05215	Prostate cancer	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200005433	K07203	ko05221	Acute myeloid leukemia	608	5.7e-32	0.60	0.68	0.86
PGSC0003DMG200008642	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2405	8.2e-127	0.75	0.84	1.00
PGSC0003DMG200008649	K01955	ko00240	Pyrimidine metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMG200008649	K01955	ko00250	Alanine, aspartate and glutamate metabolism	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMG200008649	K01955	ko01100	Metabolic pathways	711	1.0e-32	0.60	0.73	0.81
PGSC0003DMG200008650	K05278	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMG200008650	K05278	ko01100	Metabolic pathways	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMG200008650	K05278	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.43	0.59	0.82
PGSC0003DMG200008659	K04392	ko04010	MAPK signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04062	Chemokine signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04145	Phagosome	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04310	Wnt signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04360	Axon guidance	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04370	VEGF signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04510	Focal adhesion	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04520	Adherens junction	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04620	Toll-like receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04650	Natural killer cell mediated cytotoxicity	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04662	B cell receptor signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04664	Fc epsilon RI signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04666	Fc gamma R-mediated phagocytosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04670	Leukocyte transendothelial migration	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04722	Neurotrophin signaling pathway	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04810	Regulation of actin cytoskeleton	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05100	Bacterial invasion of epithelial cells	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05131	Shigellosis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05200	Pathways in cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05210	Colorectal cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05211	Renal cell carcinoma	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05212	Pancreatic cancer	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko05416	Viral myocarditis	1616	2.7e-83	0.95	0.98	1.00
PGSC0003DMG200008659	K04392	ko04010	MAPK signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04062	Chemokine signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04145	Phagosome	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04310	Wnt signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04360	Axon guidance	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04370	VEGF signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04510	Focal adhesion	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04520	Adherens junction	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04620	Toll-like receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04650	Natural killer cell mediated cytotoxicity	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04662	B cell receptor signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04664	Fc epsilon RI signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04666	Fc gamma R-mediated phagocytosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04670	Leukocyte transendothelial migration	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04722	Neurotrophin signaling pathway	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko04810	Regulation of actin cytoskeleton	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05100	Bacterial invasion of epithelial cells	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05131	Shigellosis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05200	Pathways in cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05210	Colorectal cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05211	Renal cell carcinoma	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05212	Pancreatic cancer	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008659	K04392	ko05416	Viral myocarditis	1668	3.6e-86	0.94	0.97	1.00
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	824	1.3e-39	0.32	0.52	0.95
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	423	1.7e-17	0.30	0.52	0.92
PGSC0003DMG200008660	K07191	ko04910	Insulin signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMG200008660	K07191	ko04920	Adipocytokine signaling pathway	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMG200008660	K07191	ko04930	Type II diabetes mellitus	515	1.4e-22	0.35	0.58	0.98
PGSC0003DMG200016282	K10886	ko03450	Non-homologous end-joining	522	5.9e-23	0.51	0.71	0.98
PGSC0003DMG200016282	K10886	ko03450	Non-homologous end-joining	1258	1.5e-63	0.65	0.77	0.90
PGSC0003DMG200016283	K08486	ko04130	SNARE interactions in vesicular transport	2053	2.1e-107	0.81	0.90	1.00
PGSC0003DMG200016287	K13229	ko00402	Benzoxazinoid biosynthesis	1147	2.0e-57	0.43	0.62	0.99
PGSC0003DMG200016287	K13229	ko00402	Benzoxazinoid biosynthesis	1224	1.1e-61	0.44	0.65	0.99
PGSC0003DMG200016288	K02963	ko03010	Ribosome	238	2.7e-07	0.45	0.65	0.20
PGSC0003DMG200016289	K13229	ko00402	Benzoxazinoid biosynthesis	800	2.7e-38	0.51	0.71	0.85
PGSC0003DMG200016290	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.92
PGSC0003DMG200016290	K06269	ko04113	Meiosis - yeast	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04114	Oocyte meiosis	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04270	Vascular smooth muscle contraction	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04510	Focal adhesion	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04720	Long-term potentiation	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04810	Regulation of actin cytoskeleton	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04910	Insulin signaling pathway	2484	3.6e-131	0.90	0.95	0.98
PGSC0003DMG200016290	K06269	ko04113	Meiosis - yeast	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04114	Oocyte meiosis	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04270	Vascular smooth muscle contraction	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04510	Focal adhesion	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04720	Long-term potentiation	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04810	Regulation of actin cytoskeleton	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200016290	K06269	ko04910	Insulin signaling pathway	1162	3.0e-58	0.89	0.94	0.96
PGSC0003DMG200022287	K01051	ko00040	Pentose and glucuronate interconversions	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMG200022287	K01051	ko00500	Starch and sucrose metabolism	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMG200022287	K01051	ko01100	Metabolic pathways	1084	5.9e-54	0.46	0.64	0.93
PGSC0003DMG200022294	K01126	ko00564	Glycerophospholipid metabolism	455	5.1e-19	0.29	0.51	0.43
PGSC0003DMG200022296	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMG200022296	K03131	ko03022	Basal transcription factors	337	1.1e-12	0.44	0.57	0.99
PGSC0003DMG200022296	K03131	ko03022	Basal transcription factors	3141	2.1e-167	0.68	0.80	1.00
PGSC0003DMG200022297	K08503	ko04130	SNARE interactions in vesicular transport	1360	3.5e-69	0.70	0.85	1.00
PGSC0003DMG200022298	K12199	ko04144	Endocytosis	2502	3.7e-132	0.71	0.80	1.00
PGSC0003DMG200022298	K12199	ko04144	Endocytosis	1213	4.5e-61	0.65	0.76	0.98
PGSC0003DMG200022303	K12477	ko04144	Endocytosis	655	2.7e-30	0.50	0.69	0.95
PGSC0003DMG200029134	K03935	ko00190	Oxidative phosphorylation	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMG200029134	K03935	ko01100	Metabolic pathways	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMG200029134	K03935	ko05010	Alzheimer's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMG200029134	K03935	ko05012	Parkinson's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMG200029134	K03935	ko05016	Huntington's disease	917	9.6e-45	0.87	0.91	0.72
PGSC0003DMG200029135	K03935	ko00190	Oxidative phosphorylation	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMG200029135	K03935	ko01100	Metabolic pathways	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMG200029135	K03935	ko05010	Alzheimer's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMG200029135	K03935	ko05012	Parkinson's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMG200029135	K03935	ko05016	Huntington's disease	296	1.7e-10	0.94	1.00	0.45
PGSC0003DMG200029136	K01696	ko00260	Glycine, serine and threonine metabolism	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMG200029136	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMG200029136	K01696	ko01100	Metabolic pathways	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMG200029136	K01696	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.68	0.87	0.63
PGSC0003DMG200029142	K02866	ko03010	Ribosome	806	1.3e-38	0.47	0.64	0.79
PGSC0003DMG200035146	K12881	ko03040	Spliceosome	1114	1.3e-55	0.72	0.79	0.87
PGSC0003DMG200023557	K12741	ko03040	Spliceosome	1187	1.2e-59	0.40	0.56	0.98
PGSC0003DMG200023558	K12462	ko04722	Neurotrophin signaling pathway	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMG200023558	K12462	ko04962	Vasopressin-regulated water reabsorption	1506	3.1e-77	0.73	0.82	0.99
PGSC0003DMG200023574	K00558	ko00270	Cysteine and methionine metabolism	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMG200023574	K00558	ko01100	Metabolic pathways	596	5.3e-26	0.43	0.63	0.50
PGSC0003DMG200026693	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMG200026693	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMG200026693	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMG200026693	K11294	ko05130	Pathogenic Escherichia coli infection	276	3.5e-09	0.31	0.47	0.97
PGSC0003DMG200026700	K01640	ko00072	Synthesis and degradation of ketone bodies	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko00280	Valine, leucine and isoleucine degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko00281	Geraniol degradation	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko00650	Butanoate metabolism	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko01100	Metabolic pathways	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K01640	ko04146	Peroxisome	518	9.8e-23	0.48	0.63	0.68
PGSC0003DMG200026700	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMG200026700	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMG200026700	K01640	ko00072	Synthesis and degradation of ketone bodies	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko00280	Valine, leucine and isoleucine degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko00281	Geraniol degradation	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko00650	Butanoate metabolism	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko01100	Metabolic pathways	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko04146	Peroxisome	532	1.7e-23	0.81	0.91	0.66
PGSC0003DMG200026700	K01640	ko00072	Synthesis and degradation of ketone bodies	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko00280	Valine, leucine and isoleucine degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko00281	Geraniol degradation	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko00650	Butanoate metabolism	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko01100	Metabolic pathways	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko01110	Biosynthesis of secondary metabolites	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko04146	Peroxisome	555	8.9e-25	0.65	0.75	0.70
PGSC0003DMG200026700	K01640	ko00072	Synthesis and degradation of ketone bodies	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko00280	Valine, leucine and isoleucine degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko00281	Geraniol degradation	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko00650	Butanoate metabolism	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko01100	Metabolic pathways	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko01110	Biosynthesis of secondary metabolites	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K01640	ko04146	Peroxisome	538	7.7e-24	0.65	0.75	0.78
PGSC0003DMG200026700	K03038	ko03050	Proteasome	465	8.2e-20	0.87	0.94	0.59
PGSC0003DMG200026705	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.72
PGSC0003DMG200026705	K09866	ko04962	Vasopressin-regulated water reabsorption	456	2.6e-19	0.35	0.54	0.87
PGSC0003DMG200026705	K09866	ko04962	Vasopressin-regulated water reabsorption	478	1.6e-20	0.35	0.54	0.71
PGSC0003DMG200039134	K03133	ko03022	Basal transcription factors	335	1.2e-12	0.62	0.74	0.72
PGSC0003DMG200011011	K08269	ko04140	Regulation of autophagy	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMG200011011	K08269	ko04150	mTOR signaling pathway	1482	6.6e-76	0.62	0.74	0.99
PGSC0003DMG200011011	K08269	ko04140	Regulation of autophagy	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMG200011011	K08269	ko04150	mTOR signaling pathway	2188	7.6e-115	0.68	0.79	0.90
PGSC0003DMG200011011	K08269	ko04140	Regulation of autophagy	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMG200011011	K08269	ko04150	mTOR signaling pathway	3645	3.3e-195	0.65	0.77	1.00
PGSC0003DMG200011012	K00799	ko00480	Glutathione metabolism	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMG200011012	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMG200011012	K00799	ko00982	Drug metabolism - cytochrome P450	526	3.5e-23	0.60	0.82	0.86
PGSC0003DMG200011012	K00799	ko00480	Glutathione metabolism	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMG200011012	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMG200011012	K00799	ko00982	Drug metabolism - cytochrome P450	685	6.0e-32	0.44	0.65	0.98
PGSC0003DMG200011014	K04714	ko00600	Sphingolipid metabolism	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMG200011014	K04714	ko01100	Metabolic pathways	241	1.9e-07	0.30	0.46	0.67
PGSC0003DMG200011019	K00368	ko00910	Nitrogen metabolism	1703	4.3e-88	0.45	0.60	0.89
PGSC0003DMG200011023	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200011023	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200011023	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200011023	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200011023	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200011023	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	1.00
PGSC0003DMG200008067	K02736	ko03050	Proteasome	1888	2.7e-98	0.89	0.96	1.00
PGSC0003DMG200008067	K02736	ko03050	Proteasome	495	1.8e-21	0.92	1.00	0.77
PGSC0003DMG200008074	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMG200008074	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.99
PGSC0003DMG200008074	K01759	ko00620	Pyruvate metabolism	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMG200008074	K01759	ko04011	MAPK signaling pathway - yeast	1322	4.4e-67	0.82	0.88	0.78
PGSC0003DMG200008079	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMG200004253	K01641	ko00072	Synthesis and degradation of ketone bodies	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004253	K01641	ko00280	Valine, leucine and isoleucine degradation	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004253	K01641	ko00650	Butanoate metabolism	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004253	K01641	ko00900	Terpenoid backbone biosynthesis	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004253	K01641	ko01100	Metabolic pathways	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004253	K01641	ko01110	Biosynthesis of secondary metabolites	3390	3.8e-181	0.86	0.92	1.00
PGSC0003DMG200004254	K12307	ko04142	Lysosome	349	2.3e-11	0.25	0.46	0.60
PGSC0003DMG200004254	K12307	ko04142	Lysosome	351	1.6e-11	0.25	0.46	0.60
PGSC0003DMG200004254	K12307	ko04142	Lysosome	351	2.4e-12	0.25	0.46	0.84
PGSC0003DMG200004254	K12307	ko04142	Lysosome	347	3.1e-11	0.24	0.45	0.60
PGSC0003DMG200004254	K12307	ko04142	Lysosome	349	3.7e-12	0.25	0.46	0.84
PGSC0003DMG200003089	K05933	ko00270	Cysteine and methionine metabolism	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMG200003089	K05933	ko01110	Biosynthesis of secondary metabolites	706	4.2e-33	0.35	0.57	0.80
PGSC0003DMG200003090	K05277	ko00941	Flavonoid biosynthesis	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMG200003090	K05277	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMG200003090	K05277	ko01110	Biosynthesis of secondary metabolites	408	1.1e-16	0.33	0.53	0.94
PGSC0003DMG200003091	K05278	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMG200003091	K05278	ko01100	Metabolic pathways	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMG200003091	K05278	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.35	0.55	0.90
PGSC0003DMG200003091	K05278	ko00941	Flavonoid biosynthesis	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMG200003091	K05278	ko01100	Metabolic pathways	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMG200003091	K05278	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.35	0.56	0.89
PGSC0003DMG200003094	K05278	ko00941	Flavonoid biosynthesis	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMG200003094	K05278	ko01100	Metabolic pathways	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMG200003094	K05278	ko01110	Biosynthesis of secondary metabolites	787	1.4e-37	0.35	0.57	0.90
PGSC0003DMG200003094	K05278	ko00941	Flavonoid biosynthesis	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMG200003094	K05278	ko01100	Metabolic pathways	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMG200003094	K05278	ko01110	Biosynthesis of secondary metabolites	634	3.9e-29	0.35	0.57	0.87
PGSC0003DMG200003095	K05278	ko00941	Flavonoid biosynthesis	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMG200003095	K05278	ko01100	Metabolic pathways	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMG200003095	K05278	ko01110	Biosynthesis of secondary metabolites	768	1.6e-36	0.35	0.55	0.91
PGSC0003DMG200003096	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMG200003096	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMG200003096	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.36	0.55	0.89
PGSC0003DMG200003096	K05277	ko00941	Flavonoid biosynthesis	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMG200003096	K05277	ko01100	Metabolic pathways	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMG200003096	K05277	ko01110	Biosynthesis of secondary metabolites	459	1.6e-24	0.37	0.55	0.84
PGSC0003DMG200003096	K05278	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMG200003096	K05278	ko01100	Metabolic pathways	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMG200003096	K05278	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.41	0.63	0.86
PGSC0003DMG200003096	K05278	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMG200003096	K05278	ko01100	Metabolic pathways	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMG200003096	K05278	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.41	0.61	0.86
PGSC0003DMG200003096	K05278	ko00941	Flavonoid biosynthesis	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMG200003096	K05278	ko01100	Metabolic pathways	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMG200003096	K05278	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.38	0.55	0.89
PGSC0003DMG200003096	K05278	ko00941	Flavonoid biosynthesis	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMG200003096	K05278	ko01100	Metabolic pathways	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMG200003096	K05278	ko01110	Biosynthesis of secondary metabolites	830	6.1e-40	0.36	0.56	0.90
PGSC0003DMG200003096	K04124	ko00904	Diterpenoid biosynthesis	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMG200003096	K04124	ko01110	Biosynthesis of secondary metabolites	562	3.7e-25	0.38	0.59	0.90
PGSC0003DMG200003097	K04124	ko00904	Diterpenoid biosynthesis	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMG200003097	K04124	ko01110	Biosynthesis of secondary metabolites	392	8.7e-16	0.33	0.53	0.69
PGSC0003DMG200003097	K04124	ko00904	Diterpenoid biosynthesis	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMG200003097	K04124	ko01110	Biosynthesis of secondary metabolites	391	9.9e-16	0.35	0.60	0.97
PGSC0003DMG200003102	K00064	ko00053	Ascorbate and aldarate metabolism	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMG200003102	K00064	ko01100	Metabolic pathways	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMG200003102	K00064	ko01110	Biosynthesis of secondary metabolites	2117	6.3e-111	0.81	0.89	0.98
PGSC0003DMG200003102	K00064	ko00053	Ascorbate and aldarate metabolism	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMG200003102	K00064	ko01100	Metabolic pathways	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMG200003102	K00064	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.85	0.91	0.92
PGSC0003DMG200003103	K01507	ko00190	Oxidative phosphorylation	796	4.5e-38	0.69	0.75	0.67
PGSC0003DMG200027745	K01803	ko00010	Glycolysis / Gluconeogenesis	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027745	K01803	ko00051	Fructose and mannose metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027745	K01803	ko00562	Inositol phosphate metabolism	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027745	K01803	ko00710	Carbon fixation in photosynthetic organisms	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027745	K01803	ko01100	Metabolic pathways	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027745	K01803	ko01110	Biosynthesis of secondary metabolites	1887	3.0e-98	0.88	0.94	1.00
PGSC0003DMG200027746	K05692	ko04145	Phagosome	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04510	Focal adhesion	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04520	Adherens junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04530	Tight junction	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04670	Leukocyte transendothelial migration	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04745	Phototransduction - fly	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko04810	Regulation of actin cytoskeleton	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05100	Bacterial invasion of epithelial cells	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05110	Vibrio cholerae infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05130	Pathogenic Escherichia coli infection	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05131	Shigellosis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05414	Dilated cardiomyopathy	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027746	K05692	ko05416	Viral myocarditis	3175	2.8e-169	0.98	1.00	1.00
PGSC0003DMG200027750	K03283	ko03040	Spliceosome	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMG200027750	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMG200027750	K03283	ko04144	Endocytosis	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMG200027750	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.93	0.97	1.00
PGSC0003DMG200027752	K05765	ko04360	Axon guidance	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMG200027752	K05765	ko04666	Fc gamma R-mediated phagocytosis	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMG200027752	K05765	ko04810	Regulation of actin cytoskeleton	1111	1.9e-55	0.93	0.97	0.96
PGSC0003DMG200027756	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMG200027756	K00517	ko00626	Naphthalene and anthracene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMG200027756	K00517	ko00903	Limonene and pinene degradation	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMG200027756	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMG200027756	K00517	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.62	0.74	0.96
PGSC0003DMG200027764	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMG200037634	K07424	ko00140	Steroid hormone biosynthesis	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00591	Linoleic acid metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00830	Retinol metabolism	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00982	Drug metabolism - cytochrome P450	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko00983	Drug metabolism - other enzymes	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037634	K07424	ko01100	Metabolic pathways	1246	6.9e-63	0.43	0.70	0.99
PGSC0003DMG200037650	K03094	ko04110	Cell cycle	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04111	Cell cycle - yeast	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04114	Oocyte meiosis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04120	Ubiquitin mediated proteolysis	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04310	Wnt signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04350	TGF-beta signaling pathway	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037650	K03094	ko04710	Circadian rhythm - mammal	471	3.8e-20	0.54	0.67	0.99
PGSC0003DMG200037655	K12493	ko04144	Endocytosis	658	6.1e-30	0.41	0.59	0.69
PGSC0003DMG200024813	K00430	ko00360	Phenylalanine metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMG200024813	K00430	ko00680	Methane metabolism	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMG200024813	K00430	ko00940	Phenylpropanoid biosynthesis	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMG200024813	K00430	ko01100	Metabolic pathways	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMG200024813	K00430	ko01110	Biosynthesis of secondary metabolites	987	1.3e-48	0.50	0.66	0.97
PGSC0003DMG200024814	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMG200024814	K02367	ko01100	Metabolic pathways	283	3.1e-07	0.29	0.46	0.69
PGSC0003DMG200024820	K04420	ko04010	MAPK signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMG200024820	K04420	ko04540	Gap junction	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMG200024820	K04420	ko04912	GnRH signaling pathway	877	1.5e-42	0.36	0.51	0.96
PGSC0003DMG200024820	K04421	ko04010	MAPK signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMG200024820	K04421	ko04722	Neurotrophin signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMG200024820	K04421	ko04912	GnRH signaling pathway	848	6.2e-41	0.36	0.50	0.98
PGSC0003DMG200020944	K12338	ko00942	Anthocyanin biosynthesis	280	1.3e-09	0.55	0.76	0.91
PGSC0003DMG200020953	K00679	ko00561	Glycerolipid metabolism	1118	7.9e-56	0.35	0.50	0.96
PGSC0003DMG200020953	K00679	ko00561	Glycerolipid metabolism	1285	4.9e-65	0.37	0.52	0.87
PGSC0003DMG200020958	K01199	ko00500	Starch and sucrose metabolism	280	1.3e-09	0.36	0.63	0.44
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	2145	1.8e-112	0.83	0.92	0.99
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	3131	7.4e-167	0.82	0.92	1.00
PGSC0003DMG200025889	K09054	ko05010	Alzheimer's disease	259	4.8e-06	0.34	0.50	0.41
PGSC0003DMG200025892	K02183	ko04020	Calcium signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04070	Phosphatidylinositol signaling system	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04114	Oocyte meiosis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04270	Vascular smooth muscle contraction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04626	Plant-pathogen interaction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04720	Long-term potentiation	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04722	Neurotrophin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04740	Olfactory transduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04744	Phototransduction	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04745	Phototransduction - fly	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04910	Insulin signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04912	GnRH signaling pathway	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04916	Melanogenesis	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04970	Salivary secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko04971	Gastric acid secretion	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko05010	Alzheimer's disease	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025892	K02183	ko05214	Glioma	384	2.4e-15	0.39	0.62	0.75
PGSC0003DMG200025898	K13289	ko04142	Lysosome	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	562	3.7e-25	0.71	0.86	0.75
PGSC0003DMG200025898	K13289	ko04142	Lysosome	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	572	1.0e-25	0.72	0.80	0.96
PGSC0003DMG200025898	K13289	ko04142	Lysosome	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	1483	5.8e-76	0.62	0.77	0.70
PGSC0003DMG200025898	K13289	ko04142	Lysosome	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	1772	6.7e-92	0.64	0.78	0.91
PGSC0003DMG200025898	K13289	ko04142	Lysosome	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	1173	7.3e-59	0.62	0.76	0.97
PGSC0003DMG200025898	K13289	ko04142	Lysosome	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMG200025898	K13289	ko04614	Renin-angiotensin system	1824	9.1e-95	0.62	0.77	0.99
PGSC0003DMG200025899	K13289	ko04142	Lysosome	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMG200025899	K13289	ko04614	Renin-angiotensin system	731	1.7e-34	0.57	0.69	0.94
PGSC0003DMG200025899	K13289	ko04142	Lysosome	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMG200025899	K13289	ko04614	Renin-angiotensin system	2334	6.7e-123	0.55	0.70	0.98
PGSC0003DMG200025899	K13289	ko04142	Lysosome	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMG200025899	K13289	ko04614	Renin-angiotensin system	435	3.7e-18	0.46	0.60	0.74
PGSC0003DMG200025899	K13289	ko04142	Lysosome	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMG200025899	K13289	ko04614	Renin-angiotensin system	1846	5.6e-96	0.49	0.64	0.98
PGSC0003DMG200018622	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMG200018622	K00814	ko00710	Carbon fixation in photosynthetic organisms	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMG200018622	K00814	ko01100	Metabolic pathways	3534	4.4e-189	0.86	0.92	1.00
PGSC0003DMG200018622	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMG200018622	K00814	ko00710	Carbon fixation in photosynthetic organisms	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMG200018622	K00814	ko01100	Metabolic pathways	3699	3.5e-198	0.89	0.95	1.00
PGSC0003DMG200018624	K00430	ko00360	Phenylalanine metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMG200018624	K00430	ko00680	Methane metabolism	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMG200018624	K00430	ko00940	Phenylpropanoid biosynthesis	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMG200018624	K00430	ko01100	Metabolic pathways	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMG200018624	K00430	ko01110	Biosynthesis of secondary metabolites	909	2.7e-44	0.42	0.59	0.61
PGSC0003DMG200018627	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMG200018633	K04733	ko04210	Apoptosis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMG200018633	K04733	ko04620	Toll-like receptor signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMG200018633	K04733	ko04722	Neurotrophin signaling pathway	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMG200018633	K04733	ko05140	Leishmaniasis	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMG200018633	K04733	ko05142	Chagas disease	434	1.4e-17	0.37	0.57	0.69
PGSC0003DMG200027096	K10881	ko03050	Proteasome	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMG200027096	K10881	ko03440	Homologous recombination	450	5.5e-19	0.71	0.84	0.99
PGSC0003DMG200027099	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04110	Cell cycle	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04111	Cell cycle - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04113	Meiosis - yeast	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04114	Oocyte meiosis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04120	Ubiquitin mediated proteolysis	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027099	K03358	ko04914	Progesterone-mediated oocyte maturation	550	1.7e-24	0.96	1.00	0.98
PGSC0003DMG200027116	K00368	ko00910	Nitrogen metabolism	1918	5.9e-100	0.47	0.60	0.89
PGSC0003DMG200027116	K00368	ko00910	Nitrogen metabolism	1945	1.9e-101	0.48	0.60	0.89
PGSC0003DMG200027116	K00368	ko00910	Nitrogen metabolism	1928	1.7e-100	0.47	0.60	0.91
PGSC0003DMG200023504	K12896	ko03040	Spliceosome	1927	1.9e-100	0.75	0.81	0.96
PGSC0003DMG200023504	K12896	ko03040	Spliceosome	1601	1.8e-82	0.72	0.78	0.95
PGSC0003DMG200023506	K12843	ko03040	Spliceosome	4858	4.1e-262	0.80	0.90	1.00
PGSC0003DMG200023507	K12843	ko03040	Spliceosome	3203	7.9e-171	0.72	0.87	0.93
PGSC0003DMG200023507	K12843	ko03040	Spliceosome	3292	9.8e-176	0.53	0.66	1.00
PGSC0003DMG200023508	K04733	ko04210	Apoptosis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMG200023508	K04733	ko04620	Toll-like receptor signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMG200023508	K04733	ko04722	Neurotrophin signaling pathway	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMG200023508	K04733	ko05140	Leishmaniasis	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMG200023508	K04733	ko05142	Chagas disease	1661	8.9e-86	0.43	0.60	0.93
PGSC0003DMG200023508	K04733	ko04210	Apoptosis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMG200023508	K04733	ko04620	Toll-like receptor signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMG200023508	K04733	ko04722	Neurotrophin signaling pathway	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMG200023508	K04733	ko05140	Leishmaniasis	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMG200023508	K04733	ko05142	Chagas disease	2015	2.7e-105	0.40	0.56	0.95
PGSC0003DMG200023510	K12460	ko04722	Neurotrophin signaling pathway	337	1.3e-11	0.40	0.56	0.39
PGSC0003DMG200023510	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.63
PGSC0003DMG200023510	K12460	ko04722	Neurotrophin signaling pathway	472	3.8e-19	0.32	0.50	0.57
PGSC0003DMG200023511	K07195	ko04910	Insulin signaling pathway	2335	5.9e-123	0.49	0.67	0.99
PGSC0003DMG200023512	K02918	ko03010	Ribosome	920	6.6e-45	0.93	0.96	0.99
PGSC0003DMG200015319	K10143	ko04115	p53 signaling pathway	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMG200015319	K10143	ko04120	Ubiquitin mediated proteolysis	3137	3.5e-167	0.60	0.71	0.96
PGSC0003DMG200015323	K00908	ko01100	Metabolic pathways	429	3.0e-17	0.31	0.50	0.46
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMG200015324	K04424	ko04530	Tight junction	445	4.8e-17	0.26	0.45	0.89
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMG200015324	K04424	ko04530	Tight junction	1132	1.3e-56	0.31	0.51	0.91
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMG200015324	K04424	ko04530	Tight junction	1178	3.9e-59	0.31	0.51	0.88
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMG200015324	K04424	ko04530	Tight junction	1232	4.1e-62	0.31	0.52	0.91
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMG200015324	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.67
PGSC0003DMG200015324	K04424	ko04010	MAPK signaling pathway	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMG200015324	K04424	ko04530	Tight junction	1060	1.2e-52	0.47	0.68	0.82
PGSC0003DMG200015325	K02863	ko03010	Ribosome	736	9.3e-35	0.47	0.60	0.58
PGSC0003DMG200015325	K02863	ko03010	Ribosome	745	3.0e-35	0.47	0.62	0.56
PGSC0003DMG200015330	K00451	ko00350	Tyrosine metabolism	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMG200015330	K00451	ko00643	Styrene degradation	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMG200015330	K00451	ko01100	Metabolic pathways	1161	3.4e-58	0.94	0.97	0.91
PGSC0003DMG200015330	K00451	ko00350	Tyrosine metabolism	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMG200015330	K00451	ko00643	Styrene degradation	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMG200015330	K00451	ko01100	Metabolic pathways	2120	4.3e-111	0.86	0.92	0.97
PGSC0003DMG200015330	K00451	ko00350	Tyrosine metabolism	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMG200015330	K00451	ko00643	Styrene degradation	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMG200015330	K00451	ko01100	Metabolic pathways	3419	9.7e-183	0.84	0.92	0.97
PGSC0003DMG200009026	K00975	ko00500	Starch and sucrose metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMG200009026	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMG200009026	K00975	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.90	1.00
PGSC0003DMG200009026	K00975	ko00500	Starch and sucrose metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMG200009026	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMG200009026	K00975	ko01100	Metabolic pathways	1951	9.0e-102	0.86	0.93	1.00
PGSC0003DMG200009031	K01937	ko00240	Pyrimidine metabolism	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMG200009031	K01937	ko01100	Metabolic pathways	1292	2.0e-65	0.82	0.92	0.99
PGSC0003DMG200009031	K01937	ko00240	Pyrimidine metabolism	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMG200009031	K01937	ko01100	Metabolic pathways	4190	2.9e-225	0.88	0.94	1.00
PGSC0003DMG200009036	K05349	ko00460	Cyanoamino acid metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMG200009036	K05349	ko00500	Starch and sucrose metabolism	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMG200009036	K05349	ko00940	Phenylpropanoid biosynthesis	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMG200009036	K05349	ko01110	Biosynthesis of secondary metabolites	5110	5.2e-276	0.76	0.88	0.99
PGSC0003DMG200009039	K08737	ko03430	Mismatch repair	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMG200009039	K08737	ko05200	Pathways in cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMG200009039	K08737	ko05210	Colorectal cancer	3481	3.7e-186	0.64	0.74	1.00
PGSC0003DMG200009039	K08737	ko03430	Mismatch repair	7323	0.	0.69	0.81	1.00
PGSC0003DMG200009039	K08737	ko05200	Pathways in cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMG200009039	K08737	ko05210	Colorectal cancer	7323	0.	0.69	0.81	1.00
PGSC0003DMG200005353	K05546	ko00510	N-Glycan biosynthesis	6249	0.	0.77	0.87	1.00
PGSC0003DMG200005353	K05546	ko01100	Metabolic pathways	6249	0.	0.77	0.87	1.00
PGSC0003DMG200005355	K12619	ko03018	RNA degradation	2575	3.4e-136	0.53	0.60	0.98
PGSC0003DMG200005355	K12619	ko03018	RNA degradation	4234	1.1e-227	0.52	0.62	1.00
PGSC0003DMG200005357	K06065	ko04330	Notch signaling pathway	438	4.9e-14	0.25	0.41	0.71
PGSC0003DMG200005357	K06065	ko04330	Notch signaling pathway	438	5.8e-14	0.25	0.41	0.63
PGSC0003DMG200005361	K08057	ko04145	Phagosome	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMG200005361	K08057	ko04612	Antigen processing and presentation	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMG200005361	K08057	ko05142	Chagas disease	2648	3.2e-140	0.73	0.85	1.00
PGSC0003DMG200005361	K08057	ko04145	Phagosome	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMG200005361	K08057	ko04612	Antigen processing and presentation	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMG200005361	K08057	ko05142	Chagas disease	2627	4.7e-139	0.73	0.86	0.94
PGSC0003DMG200005363	K11866	ko04144	Endocytosis	445	5.6e-18	0.28	0.41	0.92
PGSC0003DMG200005364	K04371	ko04010	MAPK signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04012	ErbB signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04013	MAPK signaling pathway - fly	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04062	Chemokine signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04114	Oocyte meiosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04150	mTOR signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04270	Vascular smooth muscle contraction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04320	Dorso-ventral axis formation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04350	TGF-beta signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04360	Axon guidance	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04370	VEGF signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04510	Focal adhesion	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04520	Adherens junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04540	Gap junction	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04620	Toll-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04621	NOD-like receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04650	Natural killer cell mediated cytotoxicity	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04660	T cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04662	B cell receptor signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04664	Fc epsilon RI signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04666	Fc gamma R-mediated phagocytosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04720	Long-term potentiation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04722	Neurotrophin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04730	Long-term depression	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04810	Regulation of actin cytoskeleton	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04910	Insulin signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04912	GnRH signaling pathway	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04914	Progesterone-mediated oocyte maturation	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04916	Melanogenesis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04930	Type II diabetes mellitus	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko04960	Aldosterone-regulated sodium reabsorption	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05010	Alzheimer's disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05020	Prion diseases	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05131	Shigellosis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05140	Leishmaniasis	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05142	Chagas disease	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05200	Pathways in cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05210	Colorectal cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05211	Renal cell carcinoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05212	Pancreatic cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05213	Endometrial cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05214	Glioma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05215	Prostate cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05216	Thyroid cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05218	Melanoma	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05219	Bladder cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05220	Chronic myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05221	Acute myeloid leukemia	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005364	K04371	ko05223	Non-small cell lung cancer	3055	1.2e-162	0.88	0.93	0.99
PGSC0003DMG200005365	K05740	ko04510	Focal adhesion	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMG200005365	K05740	ko04810	Regulation of actin cytoskeleton	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMG200005365	K05740	ko05131	Shigellosis	679	5.3e-31	0.27	0.41	0.88
PGSC0003DMG200005366	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMG200005366	K00517	ko00626	Naphthalene and anthracene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMG200005366	K00517	ko00903	Limonene and pinene degradation	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMG200005366	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMG200005366	K00517	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.41	0.60	0.69
PGSC0003DMG200005371	K01076	ko00632	Benzoate degradation via CoA ligation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMG200005371	K01076	ko00903	Limonene and pinene degradation	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMG200005371	K01076	ko01040	Biosynthesis of unsaturated fatty acids	710	2.5e-33	0.37	0.54	0.67
PGSC0003DMG200005372	K02689	ko00195	Photosynthesis	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMG200005372	K02689	ko01100	Metabolic pathways	1815	2.8e-94	0.99	0.99	0.90
PGSC0003DMG200041065	K03094	ko04110	Cell cycle	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04111	Cell cycle - yeast	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04114	Oocyte meiosis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04120	Ubiquitin mediated proteolysis	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04310	Wnt signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04350	TGF-beta signaling pathway	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041065	K03094	ko04710	Circadian rhythm - mammal	385	2.1e-15	0.63	0.80	0.95
PGSC0003DMG200041071	K04733	ko04210	Apoptosis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMG200041071	K04733	ko04620	Toll-like receptor signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMG200041071	K04733	ko04722	Neurotrophin signaling pathway	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMG200041071	K04733	ko05140	Leishmaniasis	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMG200041071	K04733	ko05142	Chagas disease	2229	4.2e-117	0.42	0.59	0.93
PGSC0003DMG200041074	K10760	ko00908	Zeatin biosynthesis	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMG200041074	K10760	ko01100	Metabolic pathways	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMG200041074	K10760	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.57	0.74	0.38
PGSC0003DMG200017487	K12472	ko04144	Endocytosis	437	6.5e-15	0.23	0.39	0.91
PGSC0003DMG200017488	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMG200017488	K03858	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.62	0.98
PGSC0003DMG200017488	K03858	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMG200017488	K03858	ko01100	Metabolic pathways	778	4.5e-37	0.55	0.70	0.97
PGSC0003DMG200017493	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMG200017493	K05291	ko01100	Metabolic pathways	410	8.9e-17	0.25	0.42	0.96
PGSC0003DMG200017493	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMG200017493	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.52
PGSC0003DMG200017493	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMG200017493	K05291	ko01100	Metabolic pathways	753	1.1e-35	0.32	0.52	0.69
PGSC0003DMG200017493	K05291	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMG200017493	K05291	ko01100	Metabolic pathways	450	5.5e-19	0.34	0.55	0.50
PGSC0003DMG200021162	K01230	ko00510	N-Glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMG200021162	K01230	ko00513	High-mannose type N-glycan biosynthesis	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMG200021162	K01230	ko01100	Metabolic pathways	3659	5.6e-196	0.70	0.83	0.99
PGSC0003DMG200021163	K02729	ko03050	Proteasome	1922	3.6e-100	0.97	1.00	1.00
PGSC0003DMG200021167	K10609	ko03420	Nucleotide excision repair	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMG200021167	K10609	ko04120	Ubiquitin mediated proteolysis	5570	2.2e-301	0.85	0.90	0.98
PGSC0003DMG200021167	K10609	ko03420	Nucleotide excision repair	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMG200021167	K10609	ko04120	Ubiquitin mediated proteolysis	3500	3.3e-187	0.81	0.86	0.97
PGSC0003DMG200021170	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMG200021170	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMG200021170	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMG200021170	K02987	ko03010	Ribosome	2085	3.7e-109	0.91	0.98	0.98
PGSC0003DMG200021170	K02987	ko03010	Ribosome	2095	1.0e-109	0.92	0.99	0.98
PGSC0003DMG200024315	K01674	ko00910	Nitrogen metabolism	515	1.4e-22	0.53	0.76	0.63
PGSC0003DMG200024321	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko00760	Nicotinate and nicotinamide metabolism	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200024321	K03426	ko04146	Peroxisome	2397	2.3e-126	0.71	0.82	0.98
PGSC0003DMG200004444	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMG200004444	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	266	7.8e-09	0.29	0.46	0.80
PGSC0003DMG200004445	K01052	ko00100	Steroid biosynthesis	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMG200004445	K01052	ko04142	Lysosome	511	2.4e-22	0.31	0.45	0.53
PGSC0003DMG200004446	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMG200004446	K12567	ko05414	Dilated cardiomyopathy	379	1.6e-12	0.32	0.42	0.95
PGSC0003DMG200004447	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMG200004447	K12567	ko05414	Dilated cardiomyopathy	383	9.9e-13	0.33	0.45	1.00
PGSC0003DMG200004448	K13065	ko00940	Phenylpropanoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMG200004448	K13065	ko00941	Flavonoid biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMG200004448	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMG200004448	K13065	ko01110	Biosynthesis of secondary metabolites	269	2.8e-07	0.25	0.42	0.98
PGSC0003DMG200007488	K00162	ko00010	Glycolysis / Gluconeogenesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko00020	Citrate cycle (TCA cycle)	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko00620	Pyruvate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko00650	Butanoate metabolism	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko01100	Metabolic pathways	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007488	K00162	ko01110	Biosynthesis of secondary metabolites	3035	1.5e-161	0.89	0.93	1.00
PGSC0003DMG200007489	K01590	ko00340	Histidine metabolism	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMG200007489	K01590	ko01100	Metabolic pathways	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMG200007489	K01590	ko01110	Biosynthesis of secondary metabolites	2177	3.1e-114	0.63	0.80	0.88
PGSC0003DMG200007496	K03133	ko03022	Basal transcription factors	1023	1.4e-50	0.66	0.80	0.99
PGSC0003DMG200007496	K03133	ko03022	Basal transcription factors	737	8.2e-35	0.72	0.83	0.85
PGSC0003DMG200007496	K03133	ko03022	Basal transcription factors	1044	9.5e-52	0.68	0.82	0.99
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko04142	Lysosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko04145	Phagosome	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1832	3.3e-95	0.78	0.87	0.99
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5263	1.9e-284	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	4607	2.9e-248	0.84	0.92	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5432	9.1e-294	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5946	0.	0.85	0.92	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko04142	Lysosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko04145	Phagosome	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3886	1.7e-208	0.90	0.95	1.00
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko04142	Lysosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko04145	Phagosome	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1140	4.8e-57	0.88	0.93	0.99
PGSC0003DMG200007498	K02154	ko00190	Oxidative phosphorylation	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko01100	Metabolic pathways	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko04142	Lysosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko04145	Phagosome	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko04966	Collecting duct acid secretion	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko05110	Vibrio cholerae infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007498	K02154	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1028	7.3e-51	0.91	0.95	0.96
PGSC0003DMG200007503	K01955	ko00240	Pyrimidine metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMG200007503	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMG200007503	K01955	ko01100	Metabolic pathways	1001	2.2e-49	0.73	0.82	0.83
PGSC0003DMG200007504	K01955	ko00240	Pyrimidine metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMG200007504	K01955	ko00250	Alanine, aspartate and glutamate metabolism	7779	0.	0.73	0.83	1.00
PGSC0003DMG200007504	K01955	ko01100	Metabolic pathways	7779	0.	0.73	0.83	1.00
PGSC0003DMG200007504	K01955	ko00240	Pyrimidine metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMG200007504	K01955	ko00250	Alanine, aspartate and glutamate metabolism	8293	0.	0.83	0.90	1.00
PGSC0003DMG200007504	K01955	ko01100	Metabolic pathways	8293	0.	0.83	0.90	1.00
PGSC0003DMG200013495	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko04210	Apoptosis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko04620	Toll-like receptor signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko05140	Leishmaniasis	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013495	K04733	ko05142	Chagas disease	1307	3.0e-66	0.47	0.65	0.97
PGSC0003DMG200013497	K01184	ko00040	Pentose and glucuronate interconversions	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMG200013497	K01184	ko00500	Starch and sucrose metabolism	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMG200013497	K01184	ko01100	Metabolic pathways	1577	3.8e-81	0.50	0.65	0.82
PGSC0003DMG200013498	K04733	ko04210	Apoptosis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMG200013498	K04733	ko04620	Toll-like receptor signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMG200013498	K04733	ko04722	Neurotrophin signaling pathway	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMG200013498	K04733	ko05140	Leishmaniasis	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMG200013498	K04733	ko05142	Chagas disease	1201	2.1e-60	0.50	0.65	0.91
PGSC0003DMG200013499	K04733	ko04210	Apoptosis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMG200013499	K04733	ko04620	Toll-like receptor signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMG200013499	K04733	ko04722	Neurotrophin signaling pathway	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMG200013499	K04733	ko05140	Leishmaniasis	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMG200013499	K04733	ko05142	Chagas disease	411	2.9e-16	0.57	0.72	0.96
PGSC0003DMG200013500	K03660	ko03410	Base excision repair	593	7.1e-27	0.35	0.52	0.96
PGSC0003DMG200013501	K08065	ko04612	Antigen processing and presentation	512	2.1e-22	0.44	0.60	0.82
PGSC0003DMG200013501	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMG200013501	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMG200013501	K08065	ko04612	Antigen processing and presentation	514	1.6e-22	0.43	0.57	0.73
PGSC0003DMG200013502	K08065	ko04612	Antigen processing and presentation	508	3.5e-22	0.57	0.78	0.59
PGSC0003DMG200013503	K08065	ko04612	Antigen processing and presentation	308	3.7e-11	0.38	0.58	0.70
PGSC0003DMG200013505	K08065	ko04612	Antigen processing and presentation	382	3.1e-15	0.44	0.62	0.56
PGSC0003DMG200001595	K01803	ko00010	Glycolysis / Gluconeogenesis	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko00051	Fructose and mannose metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko00562	Inositol phosphate metabolism	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko00710	Carbon fixation in photosynthetic organisms	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko01100	Metabolic pathways	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko01110	Biosynthesis of secondary metabolites	1925	2.4e-100	0.74	0.82	0.99
PGSC0003DMG200001595	K01803	ko00010	Glycolysis / Gluconeogenesis	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001595	K01803	ko00051	Fructose and mannose metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001595	K01803	ko00562	Inositol phosphate metabolism	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001595	K01803	ko00710	Carbon fixation in photosynthetic organisms	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001595	K01803	ko01100	Metabolic pathways	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001595	K01803	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.82	0.90	0.99
PGSC0003DMG200001596	K01193	ko00052	Galactose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMG200001596	K01193	ko00500	Starch and sucrose metabolism	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMG200001596	K01193	ko01100	Metabolic pathways	1143	3.3e-57	0.35	0.54	0.82
PGSC0003DMG200001597	K10949	ko05110	Vibrio cholerae infection	478	1.6e-20	0.39	0.62	0.79
PGSC0003DMG200001597	K10949	ko05110	Vibrio cholerae infection	550	1.7e-24	0.38	0.59	0.82
PGSC0003DMG200045315	K10760	ko00908	Zeatin biosynthesis	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMG200045315	K10760	ko01100	Metabolic pathways	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMG200045315	K10760	ko01110	Biosynthesis of secondary metabolites	303	1.7e-16	0.40	0.58	0.93
PGSC0003DMG200045327	K12338	ko00942	Anthocyanin biosynthesis	350	1.8e-13	0.39	0.52	0.66
PGSC0003DMG200040134	K12828	ko03040	Spliceosome	630	7.4e-29	0.54	0.70	0.81
PGSC0003DMG200040139	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	275	2.5e-09	0.53	0.72	0.70
PGSC0003DMG200040146	K04428	ko04010	MAPK signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMG200040146	K04428	ko04912	GnRH signaling pathway	646	8.5e-30	0.35	0.57	0.83
PGSC0003DMG200018223	K08008	ko04145	Phagosome	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMG200018223	K08008	ko04670	Leukocyte transendothelial migration	489	4.7e-26	0.29	0.48	0.69
PGSC0003DMG200018223	K08008	ko04145	Phagosome	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMG200018223	K08008	ko04670	Leukocyte transendothelial migration	489	6.0e-26	0.29	0.48	0.53
PGSC0003DMG200018224	K01179	ko00500	Starch and sucrose metabolism	4121	1.8e-221	0.75	0.85	1.00
PGSC0003DMG200018234	K01885	ko00860	Porphyrin and chlorophyll metabolism	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMG200018234	K01885	ko00970	Aminoacyl-tRNA biosynthesis	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMG200018234	K01885	ko01100	Metabolic pathways	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMG200018234	K01885	ko01110	Biosynthesis of secondary metabolites	4811	1.6e-259	0.76	0.87	0.98
PGSC0003DMG200018234	K01885	ko00860	Porphyrin and chlorophyll metabolism	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMG200018234	K01885	ko00970	Aminoacyl-tRNA biosynthesis	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMG200018234	K01885	ko01100	Metabolic pathways	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMG200018234	K01885	ko01110	Biosynthesis of secondary metabolites	325	1.4e-11	0.78	0.91	0.82
PGSC0003DMG200018236	K11866	ko04144	Endocytosis	629	2.0e-28	0.32	0.46	0.88
PGSC0003DMG200018236	K11866	ko04144	Endocytosis	604	5.4e-27	0.33	0.46	0.85
PGSC0003DMG200024939	K03097	ko04310	Wnt signaling pathway	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMG200024939	K03097	ko04520	Adherens junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMG200024939	K03097	ko04530	Tight junction	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMG200024939	K03097	ko04712	Circadian rhythm - plant	2792	3.7e-148	0.95	0.99	1.00
PGSC0003DMG200024941	K00472	ko00330	Arginine and proline metabolism	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMG200024941	K00472	ko01100	Metabolic pathways	685	6.0e-32	0.40	0.56	0.90
PGSC0003DMG200024941	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMG200024941	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMG200024941	K00472	ko00330	Arginine and proline metabolism	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMG200024941	K00472	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.88
PGSC0003DMG200024941	K00472	ko00330	Arginine and proline metabolism	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMG200024941	K00472	ko01100	Metabolic pathways	238	2.7e-07	0.35	0.49	0.85
PGSC0003DMG200024941	K00472	ko00330	Arginine and proline metabolism	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMG200024941	K00472	ko01100	Metabolic pathways	273	3.2e-09	0.48	0.65	0.89
PGSC0003DMG200024945	K01066	ko00623	2,4-Dichlorobenzoate degradation	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMG200024945	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	671	3.6e-31	0.34	0.58	0.97
PGSC0003DMG200024946	K01066	ko00623	2,4-Dichlorobenzoate degradation	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMG200024946	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	680	1.1e-31	0.37	0.58	0.92
PGSC0003DMG200024947	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMG200024947	K00908	ko01100	Metabolic pathways	396	4.1e-13	0.27	0.47	0.40
PGSC0003DMG200024947	K00908	ko01100	Metabolic pathways	396	5.9e-13	0.27	0.47	0.34
PGSC0003DMG200024948	K00658	ko00020	Citrate cycle (TCA cycle)	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMG200024948	K00658	ko00310	Lysine degradation	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMG200024948	K00658	ko01100	Metabolic pathways	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMG200024948	K00658	ko01110	Biosynthesis of secondary metabolites	379	4.5e-15	0.38	0.45	0.91
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	1855	1.8e-96	0.58	0.75	0.99
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	1157	5.6e-58	0.54	0.72	0.94
PGSC0003DMG200024951	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMG200024951	K00517	ko00626	Naphthalene and anthracene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMG200024951	K00517	ko00903	Limonene and pinene degradation	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMG200024951	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMG200024951	K00517	ko01110	Biosynthesis of secondary metabolites	741	4.9e-35	0.51	0.70	0.75
PGSC0003DMG200021876	K11818	ko00380	Tryptophan metabolism	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMG200021876	K11818	ko00966	Glucosinolate biosynthesis	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMG200021876	K11818	ko01110	Biosynthesis of secondary metabolites	248	1.5e-07	0.56	0.69	0.96
PGSC0003DMG200021880	K11818	ko00380	Tryptophan metabolism	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMG200021880	K11818	ko00966	Glucosinolate biosynthesis	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMG200021880	K11818	ko01110	Biosynthesis of secondary metabolites	931	1.6e-45	0.54	0.73	0.99
PGSC0003DMG200021890	K01057	ko00030	Pentose phosphate pathway	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMG200021890	K01057	ko01100	Metabolic pathways	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMG200021890	K01057	ko01110	Biosynthesis of secondary metabolites	801	2.4e-38	0.82	0.93	0.99
PGSC0003DMG200021890	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200021890	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200021890	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200021890	K01057	ko00030	Pentose phosphate pathway	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200021890	K01057	ko01100	Metabolic pathways	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200021890	K01057	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.80	0.91	1.00
PGSC0003DMG200030921	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.88
PGSC0003DMG200030921	K01199	ko00500	Starch and sucrose metabolism	797	4.0e-38	0.35	0.56	0.93
PGSC0003DMG200030923	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.92
PGSC0003DMG200030923	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	338	4.3e-12	0.30	0.43	0.89
PGSC0003DMG200044124	K01952	ko00230	Purine metabolism	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMG200044124	K01952	ko01100	Metabolic pathways	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMG200044124	K01952	ko01110	Biosynthesis of secondary metabolites	433	4.3e-17	0.95	0.95	0.36
PGSC0003DMG200044133	K01213	ko00040	Pentose and glucuronate interconversions	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMG200044133	K01213	ko00500	Starch and sucrose metabolism	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMG200044133	K01213	ko01100	Metabolic pathways	989	1.0e-48	0.44	0.60	0.98
PGSC0003DMG200038943	K00764	ko00230	Purine metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMG200038943	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMG200038943	K00764	ko01100	Metabolic pathways	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMG200038943	K00764	ko01110	Biosynthesis of secondary metabolites	3178	1.9e-169	0.75	0.85	0.93
PGSC0003DMG200006819	K00262	ko00250	Alanine, aspartate and glutamate metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMG200006819	K00262	ko00330	Arginine and proline metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMG200006819	K00262	ko00910	Nitrogen metabolism	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMG200006819	K00262	ko01100	Metabolic pathways	4637	6.4e-250	0.87	0.93	1.00
PGSC0003DMG200006819	K00262	ko00250	Alanine, aspartate and glutamate metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMG200006819	K00262	ko00330	Arginine and proline metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMG200006819	K00262	ko00910	Nitrogen metabolism	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMG200006819	K00262	ko01100	Metabolic pathways	2124	2.6e-111	0.88	0.94	1.00
PGSC0003DMG200006822	K10960	ko00860	Porphyrin and chlorophyll metabolism	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMG200006822	K10960	ko00900	Terpenoid backbone biosynthesis	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMG200006822	K10960	ko01100	Metabolic pathways	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMG200006822	K10960	ko01110	Biosynthesis of secondary metabolites	964	2.5e-47	0.61	0.75	0.82
PGSC0003DMG200006826	K11817	ko00380	Tryptophan metabolism	4064	2.6e-218	0.56	0.75	0.99
PGSC0003DMG200006826	K09842	ko00906	Carotenoid biosynthesis	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMG200006826	K09842	ko01100	Metabolic pathways	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMG200006826	K09842	ko01110	Biosynthesis of secondary metabolites	1749	1.2e-90	0.67	0.82	0.95
PGSC0003DMG200003748	K00430	ko00360	Phenylalanine metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMG200003748	K00430	ko00680	Methane metabolism	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMG200003748	K00430	ko00940	Phenylpropanoid biosynthesis	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMG200003748	K00430	ko01100	Metabolic pathways	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMG200003748	K00430	ko01110	Biosynthesis of secondary metabolites	2004	1.1e-104	0.70	0.82	0.98
PGSC0003DMG200003753	K10688	ko04120	Ubiquitin mediated proteolysis	445	1.0e-18	0.98	1.00	0.98
PGSC0003DMG200003753	K10688	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.94	0.97	0.99
PGSC0003DMG200003754	K00279	ko00908	Zeatin biosynthesis	3146	1.1e-167	0.71	0.82	0.99
PGSC0003DMG200003754	K00279	ko00908	Zeatin biosynthesis	2539	3.3e-134	0.73	0.84	0.99
PGSC0003DMG200003760	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200003760	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200003760	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200003760	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200003760	K03117	ko03060	Protein export	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200003760	K03117	ko03070	Bacterial secretion system	217	3.9e-06	0.31	0.49	0.72
PGSC0003DMG200034769	K02943	ko03010	Ribosome	461	1.4e-19	0.60	0.69	0.99
PGSC0003DMG200022778	K00697	ko00500	Starch and sucrose metabolism	4377	1.4e-235	0.67	0.81	0.99
PGSC0003DMG200022778	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMG200022778	K00697	ko00500	Starch and sucrose metabolism	4862	2.5e-262	0.67	0.81	0.99
PGSC0003DMG200022780	K08241	ko00592	alpha-Linolenic acid metabolism	453	3.8e-19	0.41	0.55	0.74
PGSC0003DMG200022781	K08241	ko00592	alpha-Linolenic acid metabolism	684	6.8e-32	0.34	0.51	0.88
PGSC0003DMG200022782	K00928	ko00260	Glycine, serine and threonine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMG200022782	K00928	ko00270	Cysteine and methionine metabolism	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMG200022782	K00928	ko00300	Lysine biosynthesis	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMG200022782	K00928	ko01100	Metabolic pathways	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMG200022782	K00928	ko01110	Biosynthesis of secondary metabolites	3142	1.8e-167	0.75	0.83	0.88
PGSC0003DMG200022782	K00928	ko00260	Glycine, serine and threonine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMG200022782	K00928	ko00270	Cysteine and methionine metabolism	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMG200022782	K00928	ko00300	Lysine biosynthesis	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMG200022782	K00928	ko01100	Metabolic pathways	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMG200022782	K00928	ko01110	Biosynthesis of secondary metabolites	3429	2.7e-183	0.78	0.85	0.97
PGSC0003DMG200022782	K00928	ko00260	Glycine, serine and threonine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMG200022782	K00928	ko00270	Cysteine and methionine metabolism	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMG200022782	K00928	ko00300	Lysine biosynthesis	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMG200022782	K00928	ko01100	Metabolic pathways	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMG200022782	K00928	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.78	0.86	0.97
PGSC0003DMG200022785	K02084	ko04115	p53 signaling pathway	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko04210	Apoptosis	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko05010	Alzheimer's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko05012	Parkinson's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko05016	Huntington's disease	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200022785	K02084	ko05222	Small cell lung cancer	274	7.1e-06	0.28	0.47	0.53
PGSC0003DMG200026425	K13229	ko00402	Benzoxazinoid biosynthesis	1097	1.1e-54	0.44	0.61	0.98
PGSC0003DMG200026427	K04711	ko00600	Sphingolipid metabolism	983	2.2e-48	0.77	0.85	0.99
PGSC0003DMG200026427	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMG200026427	K04711	ko00600	Sphingolipid metabolism	1758	4.0e-91	0.78	0.87	1.00
PGSC0003DMG200026428	K00696	ko00500	Starch and sucrose metabolism	7278	0.	0.80	0.89	1.00
PGSC0003DMG200026428	K00696	ko01100	Metabolic pathways	7278	0.	0.80	0.89	1.00
PGSC0003DMG200026430	K01190	ko00052	Galactose metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMG200026430	K01190	ko00511	Other glycan degradation	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMG200026430	K01190	ko00600	Sphingolipid metabolism	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMG200026430	K01190	ko01100	Metabolic pathways	2377	2.9e-125	0.48	0.62	0.82
PGSC0003DMG200026430	K01190	ko00052	Galactose metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMG200026430	K01190	ko00511	Other glycan degradation	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMG200026430	K01190	ko00600	Sphingolipid metabolism	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMG200026430	K01190	ko01100	Metabolic pathways	2347	1.3e-123	0.55	0.68	0.93
PGSC0003DMG200026430	K01190	ko00052	Galactose metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMG200026430	K01190	ko00511	Other glycan degradation	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMG200026430	K01190	ko00600	Sphingolipid metabolism	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMG200026430	K01190	ko01100	Metabolic pathways	3013	2.4e-160	0.51	0.65	0.82
PGSC0003DMG200026430	K01190	ko00052	Galactose metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMG200026430	K01190	ko00511	Other glycan degradation	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMG200026430	K01190	ko00600	Sphingolipid metabolism	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMG200026430	K01190	ko01100	Metabolic pathways	1417	2.5e-72	0.43	0.58	0.79
PGSC0003DMG200046664	K11245	ko04011	MAPK signaling pathway - yeast	269	5.3e-09	0.44	0.62	0.44
PGSC0003DMG200046681	K10760	ko00908	Zeatin biosynthesis	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMG200046681	K10760	ko01100	Metabolic pathways	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMG200046681	K10760	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.56	0.75	0.89
PGSC0003DMG200042259	K00071	ko00140	Steroid hormone biosynthesis	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMG200042259	K00071	ko01100	Metabolic pathways	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMG200042259	K00071	ko04960	Aldosterone-regulated sodium reabsorption	984	1.9e-48	0.47	0.65	0.81
PGSC0003DMG200042273	K05915	ko00363	Bisphenol A degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMG200042273	K05915	ko00624	1- and 2-Methylnaphthalene degradation	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMG200042273	K05915	ko01100	Metabolic pathways	1035	3.0e-51	0.51	0.67	0.94
PGSC0003DMG200008496	K01490	ko00230	Purine metabolism	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMG200008496	K01490	ko01100	Metabolic pathways	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMG200008496	K01490	ko01110	Biosynthesis of secondary metabolites	1806	8.9e-94	0.96	0.99	0.93
PGSC0003DMG200008496	K01490	ko00230	Purine metabolism	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMG200008496	K01490	ko01100	Metabolic pathways	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMG200008496	K01490	ko01110	Biosynthesis of secondary metabolites	2274	1.4e-119	0.97	0.98	0.93
PGSC0003DMG200008496	K01490	ko00230	Purine metabolism	5987	0.	0.82	0.89	0.99
PGSC0003DMG200008496	K01490	ko01100	Metabolic pathways	5987	0.	0.82	0.89	0.99
PGSC0003DMG200008496	K01490	ko01110	Biosynthesis of secondary metabolites	5987	0.	0.82	0.89	0.99
PGSC0003DMG200008501	K10802	ko03410	Base excision repair	665	7.6e-31	0.79	0.87	0.85
PGSC0003DMG200008501	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMG200008501	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMG200008501	K10802	ko03410	Base excision repair	1024	1.2e-50	0.71	0.83	0.98
PGSC0003DMG200006008	K10760	ko00908	Zeatin biosynthesis	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMG200006008	K10760	ko01100	Metabolic pathways	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMG200006008	K10760	ko01110	Biosynthesis of secondary metabolites	1120	6.1e-56	0.53	0.68	1.00
PGSC0003DMG200006020	K06627	ko04110	Cell cycle	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMG200006020	K06627	ko04914	Progesterone-mediated oocyte maturation	2563	1.6e-135	0.66	0.79	0.98
PGSC0003DMG200006022	K04733	ko04210	Apoptosis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMG200006022	K04733	ko04620	Toll-like receptor signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMG200006022	K04733	ko04722	Neurotrophin signaling pathway	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMG200006022	K04733	ko05140	Leishmaniasis	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMG200006022	K04733	ko05142	Chagas disease	850	4.8e-41	0.38	0.56	0.58
PGSC0003DMG200006023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMG200006023	K00517	ko00626	Naphthalene and anthracene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMG200006023	K00517	ko00903	Limonene and pinene degradation	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMG200006023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMG200006023	K00517	ko01110	Biosynthesis of secondary metabolites	578	4.8e-26	0.55	0.78	0.94
PGSC0003DMG200006024	K11818	ko00380	Tryptophan metabolism	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMG200006024	K11818	ko00966	Glucosinolate biosynthesis	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMG200006024	K11818	ko01110	Biosynthesis of secondary metabolites	1688	2.9e-87	0.43	0.65	0.99
PGSC0003DMG200006025	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMG200006025	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.68	0.80	1.00
PGSC0003DMG200006033	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMG200006033	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMG200006033	K10143	ko04115	p53 signaling pathway	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMG200006033	K10143	ko04120	Ubiquitin mediated proteolysis	752	1.2e-35	0.34	0.53	0.93
PGSC0003DMG200009667	K12471	ko04144	Endocytosis	270	1.1e-08	0.26	0.43	0.97
PGSC0003DMG200009673	K01803	ko00010	Glycolysis / Gluconeogenesis	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009673	K01803	ko00051	Fructose and mannose metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009673	K01803	ko00562	Inositol phosphate metabolism	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009673	K01803	ko00710	Carbon fixation in photosynthetic organisms	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009673	K01803	ko01100	Metabolic pathways	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009673	K01803	ko01110	Biosynthesis of secondary metabolites	1874	1.6e-97	0.88	0.93	0.98
PGSC0003DMG200009674	K00854	ko00040	Pentose and glucuronate interconversions	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMG200009674	K00854	ko01100	Metabolic pathways	387	1.6e-15	0.60	0.77	0.69
PGSC0003DMG200012789	K09292	ko05200	Pathways in cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMG200012789	K09292	ko05216	Thyroid cancer	252	4.6e-06	0.31	0.41	0.57
PGSC0003DMG200012790	K12929	ko00904	Diterpenoid biosynthesis	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMG200012790	K12929	ko01110	Biosynthesis of secondary metabolites	1883	5.1e-98	0.45	0.68	0.97
PGSC0003DMG200012791	K10601	ko04120	Ubiquitin mediated proteolysis	245	1.7e-07	0.31	0.50	0.81
PGSC0003DMG200012793	K05280	ko00941	Flavonoid biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMG200012793	K05280	ko00944	Flavone and flavonol biosynthesis	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMG200012793	K05280	ko01100	Metabolic pathways	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMG200012793	K05280	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.42	0.58	0.94
PGSC0003DMG200012793	K05280	ko00941	Flavonoid biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMG200012793	K05280	ko00944	Flavone and flavonol biosynthesis	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMG200012793	K05280	ko01100	Metabolic pathways	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMG200012793	K05280	ko01110	Biosynthesis of secondary metabolites	308	5.1e-11	0.54	0.64	0.92
PGSC0003DMG200012794	K09755	ko00940	Phenylpropanoid biosynthesis	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMG200012794	K09755	ko01100	Metabolic pathways	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMG200012794	K09755	ko01110	Biosynthesis of secondary metabolites	1479	9.7e-76	0.39	0.59	0.98
PGSC0003DMG200012795	K09755	ko00940	Phenylpropanoid biosynthesis	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMG200012795	K09755	ko01100	Metabolic pathways	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMG200012795	K09755	ko01110	Biosynthesis of secondary metabolites	1256	1.9e-63	0.36	0.55	0.98
PGSC0003DMG200012795	K09755	ko00940	Phenylpropanoid biosynthesis	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMG200012795	K09755	ko01100	Metabolic pathways	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMG200012795	K09755	ko01110	Biosynthesis of secondary metabolites	1532	1.2e-78	0.40	0.62	0.98
PGSC0003DMG200012795	K09755	ko00940	Phenylpropanoid biosynthesis	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMG200012795	K09755	ko01100	Metabolic pathways	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMG200012795	K09755	ko01110	Biosynthesis of secondary metabolites	924	4.0e-45	0.54	0.75	0.98
PGSC0003DMG200012796	K01509	ko00230	Purine metabolism	343	1.9e-12	0.39	0.61	0.92
PGSC0003DMG200012797	K06123	ko00564	Glycerophospholipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMG200012797	K06123	ko00565	Ether lipid metabolism	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMG200012797	K06123	ko01100	Metabolic pathways	1494	1.4e-76	0.65	0.83	0.94
PGSC0003DMG200012800	K00827	ko00250	Alanine, aspartate and glutamate metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMG200012800	K00827	ko00260	Glycine, serine and threonine metabolism	575	7.0e-26	0.93	0.99	0.91
PGSC0003DMG200012800	K00827	ko00250	Alanine, aspartate and glutamate metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMG200012800	K00827	ko00260	Glycine, serine and threonine metabolism	3353	4.2e-179	0.87	0.96	0.93
PGSC0003DMG200012803	K09755	ko00940	Phenylpropanoid biosynthesis	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMG200012803	K09755	ko01100	Metabolic pathways	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMG200012803	K09755	ko01110	Biosynthesis of secondary metabolites	228	2.4e-06	0.48	0.68	0.93
PGSC0003DMG200012803	K09755	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMG200012803	K09755	ko01100	Metabolic pathways	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMG200012803	K09755	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.39	0.61	0.98
PGSC0003DMG200012803	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMG200012803	K00517	ko00626	Naphthalene and anthracene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMG200012803	K00517	ko00903	Limonene and pinene degradation	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMG200012803	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMG200012803	K00517	ko01110	Biosynthesis of secondary metabolites	758	5.7e-36	0.37	0.58	0.99
PGSC0003DMG200002827	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMG200002827	K12825	ko03040	Spliceosome	5616	0.	0.80	0.88	1.00
PGSC0003DMG200002834	K04618	ko00052	Galactose metabolism	387	2.6e-13	0.28	0.43	0.77
PGSC0003DMG200008225	K05863	ko04020	Calcium signaling pathway	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMG200008225	K05863	ko05012	Parkinson's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMG200008225	K05863	ko05016	Huntington's disease	660	1.4e-30	0.73	0.81	0.87
PGSC0003DMG200008225	K05863	ko04020	Calcium signaling pathway	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMG200008225	K05863	ko05012	Parkinson's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMG200008225	K05863	ko05016	Huntington's disease	2071	2.2e-108	0.74	0.87	1.00
PGSC0003DMG200008244	K01423	ko00310	Lysine degradation	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMG200008244	K01423	ko00780	Biotin metabolism	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMG200008244	K01423	ko01100	Metabolic pathways	1194	5.1e-60	0.43	0.57	0.97
PGSC0003DMG200008244	K01423	ko00310	Lysine degradation	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMG200008244	K01423	ko00780	Biotin metabolism	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMG200008244	K01423	ko01100	Metabolic pathways	1748	1.4e-90	0.47	0.61	0.97
PGSC0003DMG200008244	K01423	ko00310	Lysine degradation	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMG200008244	K01423	ko00780	Biotin metabolism	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMG200008244	K01423	ko01100	Metabolic pathways	2183	1.4e-114	0.46	0.62	0.98
PGSC0003DMG200008244	K01423	ko00310	Lysine degradation	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMG200008244	K01423	ko00780	Biotin metabolism	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMG200008244	K01423	ko01100	Metabolic pathways	1591	6.4e-82	0.44	0.62	0.99
PGSC0003DMG200008244	K01423	ko00310	Lysine degradation	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMG200008244	K01423	ko00780	Biotin metabolism	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMG200008244	K01423	ko01100	Metabolic pathways	999	2.9e-49	0.51	0.70	0.90
PGSC0003DMG200008253	K03133	ko03022	Basal transcription factors	364	3.1e-14	0.62	0.78	0.94
PGSC0003DMG200008256	K02920	ko03010	Ribosome	816	3.6e-39	0.91	0.95	0.99
PGSC0003DMG200008258	K10955	ko05110	Vibrio cholerae infection	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMG200008258	K10955	ko05146	Amoebiasis	343	2.3e-11	0.37	0.44	0.51
PGSC0003DMG200008259	K00964	ko00052	Galactose metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMG200008259	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMG200008259	K00964	ko01100	Metabolic pathways	1358	4.6e-69	0.62	0.79	0.94
PGSC0003DMG200008259	K00964	ko00052	Galactose metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMG200008259	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMG200008259	K00964	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.77	0.87
PGSC0003DMG200008259	K00964	ko00052	Galactose metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMG200008259	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMG200008259	K00964	ko01100	Metabolic pathways	942	4.0e-46	0.64	0.81	0.97
PGSC0003DMG200008259	K00964	ko00052	Galactose metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMG200008259	K00964	ko00520	Amino sugar and nucleotide sugar metabolism	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMG200008259	K00964	ko01100	Metabolic pathways	1854	2.0e-96	0.64	0.80	0.97
PGSC0003DMG200015800	K03094	ko04110	Cell cycle	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04111	Cell cycle - yeast	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04114	Oocyte meiosis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04120	Ubiquitin mediated proteolysis	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04310	Wnt signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04350	TGF-beta signaling pathway	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015800	K03094	ko04710	Circadian rhythm - mammal	876	1.8e-42	0.71	0.86	0.42
PGSC0003DMG200015801	K00430	ko00360	Phenylalanine metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMG200015801	K00430	ko00680	Methane metabolism	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMG200015801	K00430	ko00940	Phenylpropanoid biosynthesis	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMG200015801	K00430	ko01100	Metabolic pathways	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMG200015801	K00430	ko01110	Biosynthesis of secondary metabolites	1722	3.8e-89	0.70	0.82	0.91
PGSC0003DMG200015802	K11229	ko04011	MAPK signaling pathway - yeast	1028	2.2e-50	0.32	0.47	0.71
PGSC0003DMG200015804	K03062	ko03050	Proteasome	3617	1.2e-193	0.97	0.99	1.00
PGSC0003DMG200015807	K04424	ko04010	MAPK signaling pathway	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMG200015807	K04424	ko04530	Tight junction	690	1.3e-31	0.33	0.51	0.30
PGSC0003DMG200015808	K00632	ko00071	Fatty acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko00280	Valine, leucine and isoleucine degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko00281	Geraniol degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko00362	Benzoate degradation via hydroxylation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko00592	alpha-Linolenic acid metabolism	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko00642	Ethylbenzene degradation	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko01100	Metabolic pathways	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015808	K00632	ko01110	Biosynthesis of secondary metabolites	3046	3.6e-162	0.79	0.89	1.00
PGSC0003DMG200015815	K01728	ko00040	Pentose and glucuronate interconversions	2930	9.0e-156	0.76	0.86	1.00
PGSC0003DMG200015825	K04424	ko04010	MAPK signaling pathway	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMG200015825	K04424	ko04530	Tight junction	584	1.3e-25	0.29	0.50	0.94
PGSC0003DMG200015827	K04733	ko04210	Apoptosis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMG200015827	K04733	ko04620	Toll-like receptor signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMG200015827	K04733	ko04722	Neurotrophin signaling pathway	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMG200015827	K04733	ko05140	Leishmaniasis	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMG200015827	K04733	ko05142	Chagas disease	871	3.3e-42	0.40	0.57	0.54
PGSC0003DMG200046515	K05280	ko00941	Flavonoid biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMG200046515	K05280	ko00944	Flavone and flavonol biosynthesis	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMG200046515	K05280	ko01100	Metabolic pathways	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMG200046515	K05280	ko01110	Biosynthesis of secondary metabolites	597	4.3e-27	0.38	0.60	0.97
PGSC0003DMG200000885	K03876	ko04120	Ubiquitin mediated proteolysis	291	3.2e-10	0.37	0.57	0.71
PGSC0003DMG200000888	K12796	ko04621	NOD-like receptor signaling pathway	407	5.4e-13	0.31	0.47	0.30
PGSC0003DMG200000892	K01897	ko00071	Fatty acid metabolism	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMG200000892	K01897	ko01100	Metabolic pathways	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMG200000892	K01897	ko03320	PPAR signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMG200000892	K01897	ko04146	Peroxisome	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMG200000892	K01897	ko04920	Adipocytokine signaling pathway	4243	3.4e-228	0.72	0.84	1.00
PGSC0003DMG200000892	K01897	ko00071	Fatty acid metabolism	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMG200000892	K01897	ko01100	Metabolic pathways	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMG200000892	K01897	ko03320	PPAR signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMG200000892	K01897	ko04146	Peroxisome	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMG200000892	K01897	ko04920	Adipocytokine signaling pathway	4504	1.4e-242	0.75	0.88	1.00
PGSC0003DMG200000893	K02897	ko03010	Ribosome	1380	2.8e-70	0.72	0.84	0.90
PGSC0003DMG200000894	K00434	ko00053	Ascorbate and aldarate metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMG200000894	K00434	ko00480	Glutathione metabolism	2570	6.5e-136	0.74	0.83	0.99
PGSC0003DMG200000895	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.75
PGSC0003DMG200000895	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.68
PGSC0003DMG200000895	K03862	ko00623	2,4-Dichlorobenzoate degradation	447	8.1e-19	0.31	0.45	0.53
PGSC0003DMG200000896	K09291	ko04011	MAPK signaling pathway - yeast	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMG200000896	K09291	ko05200	Pathways in cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMG200000896	K09291	ko05216	Thyroid cancer	386	2.6e-12	0.27	0.46	0.94
PGSC0003DMG200000896	K09291	ko04011	MAPK signaling pathway - yeast	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMG200000896	K09291	ko05200	Pathways in cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMG200000896	K09291	ko05216	Thyroid cancer	419	7.0e-14	0.27	0.46	0.91
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200029551	K12896	ko03040	Spliceosome	1465	5.7e-75	0.91	0.94	0.99
PGSC0003DMG200029552	K05391	ko04626	Plant-pathogen interaction	4363	8.3e-235	0.72	0.82	1.00
PGSC0003DMG200029558	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	7028	0.	0.83	0.92	0.99
PGSC0003DMG200029558	K12446	ko01100	Metabolic pathways	7028	0.	0.83	0.92	0.99
PGSC0003DMG200029558	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMG200029558	K12446	ko01100	Metabolic pathways	566	8.3e-25	0.79	0.90	0.99
PGSC0003DMG200029558	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	5740	0.	0.84	0.92	0.99
PGSC0003DMG200029558	K12446	ko01100	Metabolic pathways	5740	0.	0.84	0.92	0.99
PGSC0003DMG200029558	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMG200029558	K12446	ko01100	Metabolic pathways	301	5.8e-10	0.82	0.91	0.54
PGSC0003DMG200029561	K02991	ko03010	Ribosome	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMG200029561	K02991	ko04150	mTOR signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMG200029561	K02991	ko04910	Insulin signaling pathway	1412	4.8e-72	0.96	0.99	0.74
PGSC0003DMG200029561	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko03010	Ribosome	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04150	mTOR signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029561	K02991	ko04910	Insulin signaling pathway	1994	3.8e-104	0.95	0.98	1.00
PGSC0003DMG200029562	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMG200029562	K00517	ko00626	Naphthalene and anthracene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMG200029562	K00517	ko00903	Limonene and pinene degradation	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMG200029562	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMG200029562	K00517	ko01110	Biosynthesis of secondary metabolites	1444	8.3e-74	0.39	0.59	0.97
PGSC0003DMG200019508	K08910	ko00196	Photosynthesis - antenna proteins	1890	2.1e-98	0.86	0.93	0.99
PGSC0003DMG200019510	K10960	ko00860	Porphyrin and chlorophyll metabolism	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMG200019510	K10960	ko00900	Terpenoid backbone biosynthesis	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMG200019510	K10960	ko01100	Metabolic pathways	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMG200019510	K10960	ko01110	Biosynthesis of secondary metabolites	3428	3.1e-183	0.87	0.92	1.00
PGSC0003DMG200019511	K00026	ko00020	Citrate cycle (TCA cycle)	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019511	K00026	ko00620	Pyruvate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019511	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019511	K00026	ko00710	Carbon fixation in photosynthetic organisms	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019511	K00026	ko01100	Metabolic pathways	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019511	K00026	ko01110	Biosynthesis of secondary metabolites	2802	1.0e-148	0.83	0.92	1.00
PGSC0003DMG200019516	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	195	5.2e-09	0.40	0.49	0.79
PGSC0003DMG200019516	K01452	ko00520	Amino sugar and nucleotide sugar metabolism	197	4.0e-09	0.39	0.48	0.38
PGSC0003DMG200019517	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	218	3.4e-06	0.53	0.64	0.26
PGSC0003DMG200019518	K12127	ko04712	Circadian rhythm - plant	1436	2.3e-73	0.61	0.75	0.98
PGSC0003DMG200019518	K12127	ko04712	Circadian rhythm - plant	2920	3.2e-155	0.67	0.78	0.98
PGSC0003DMG200019519	K02342	ko00230	Purine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019519	K02342	ko00240	Pyrimidine metabolism	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019519	K02342	ko01100	Metabolic pathways	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019519	K02342	ko03030	DNA replication	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019519	K02342	ko03430	Mismatch repair	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019519	K02342	ko03440	Homologous recombination	271	4.1e-09	0.36	0.49	0.42
PGSC0003DMG200019521	K01783	ko00030	Pentose phosphate pathway	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMG200019521	K01783	ko00040	Pentose and glucuronate interconversions	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMG200019521	K01783	ko00710	Carbon fixation in photosynthetic organisms	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMG200019521	K01783	ko01100	Metabolic pathways	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMG200019521	K01783	ko01110	Biosynthesis of secondary metabolites	1924	2.8e-100	0.85	0.91	0.98
PGSC0003DMG200019521	K01783	ko00030	Pentose phosphate pathway	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMG200019521	K01783	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMG200019521	K01783	ko00710	Carbon fixation in photosynthetic organisms	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMG200019521	K01783	ko01100	Metabolic pathways	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMG200019521	K01783	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.86	0.92	1.00
PGSC0003DMG200036827	K00600	ko00260	Glycine, serine and threonine metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200036827	K00600	ko00460	Cyanoamino acid metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200036827	K00600	ko00670	One carbon pool by folate	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200036827	K00600	ko00680	Methane metabolism	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200036827	K00600	ko01100	Metabolic pathways	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200036827	K00600	ko01110	Biosynthesis of secondary metabolites	230	1.4e-06	0.43	0.61	0.86
PGSC0003DMG200010592	K12929	ko00904	Diterpenoid biosynthesis	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMG200010592	K12929	ko01110	Biosynthesis of secondary metabolites	1590	7.3e-82	0.41	0.64	0.99
PGSC0003DMG200010592	K12929	ko00904	Diterpenoid biosynthesis	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMG200010592	K12929	ko01110	Biosynthesis of secondary metabolites	304	1.5e-10	0.43	0.64	0.70
PGSC0003DMG200010598	K07424	ko00140	Steroid hormone biosynthesis	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00591	Linoleic acid metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00830	Retinol metabolism	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00982	Drug metabolism - cytochrome P450	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko00983	Drug metabolism - other enzymes	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010598	K07424	ko01100	Metabolic pathways	573	9.1e-26	0.62	0.81	0.99
PGSC0003DMG200010599	K07424	ko00140	Steroid hormone biosynthesis	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00591	Linoleic acid metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00830	Retinol metabolism	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00982	Drug metabolism - cytochrome P450	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00983	Drug metabolism - other enzymes	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko01100	Metabolic pathways	1253	2.8e-63	0.58	0.75	0.98
PGSC0003DMG200010599	K07424	ko00140	Steroid hormone biosynthesis	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00591	Linoleic acid metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00830	Retinol metabolism	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00982	Drug metabolism - cytochrome P450	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko00983	Drug metabolism - other enzymes	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010599	K07424	ko01100	Metabolic pathways	297	2.2e-10	0.48	0.73	0.99
PGSC0003DMG200010600	K12817	ko03040	Spliceosome	1669	3.2e-86	0.57	0.69	0.98
PGSC0003DMG200010602	K12817	ko03040	Spliceosome	1762	2.4e-91	0.57	0.71	0.98
PGSC0003DMG200010603	K01509	ko00230	Purine metabolism	380	5.5e-39	0.42	0.60	0.63
PGSC0003DMG200014561	K10760	ko00908	Zeatin biosynthesis	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMG200014561	K10760	ko01100	Metabolic pathways	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMG200014561	K10760	ko01110	Biosynthesis of secondary metabolites	324	4.9e-12	0.34	0.49	0.93
PGSC0003DMG200014563	K10760	ko00908	Zeatin biosynthesis	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMG200014563	K10760	ko01100	Metabolic pathways	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMG200014563	K10760	ko01110	Biosynthesis of secondary metabolites	1117	9.0e-56	0.51	0.71	1.00
PGSC0003DMG200014566	K12127	ko04712	Circadian rhythm - plant	225	3.9e-06	0.55	0.76	0.70
PGSC0003DMG200014566	K12135	ko04712	Circadian rhythm - plant	239	3.6e-07	0.38	0.52	0.32
PGSC0003DMG200014570	K11294	ko05130	Pathogenic Escherichia coli infection	283	1.0e-07	0.31	0.42	0.82
PGSC0003DMG200014572	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMG200014572	K01886	ko01100	Metabolic pathways	5003	4.2e-270	0.74	0.83	1.00
PGSC0003DMG200014572	K01886	ko00970	Aminoacyl-tRNA biosynthesis	5679	0.	0.82	0.92	1.00
PGSC0003DMG200014572	K01886	ko01100	Metabolic pathways	5679	0.	0.82	0.92	1.00
PGSC0003DMG200014575	K10144	ko04115	p53 signaling pathway	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMG200014575	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.3e-42	0.41	0.56	0.25
PGSC0003DMG200014575	K10144	ko04115	p53 signaling pathway	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMG200014575	K10144	ko04120	Ubiquitin mediated proteolysis	874	2.4e-42	0.41	0.56	0.22
PGSC0003DMG200007055	K07424	ko00140	Steroid hormone biosynthesis	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00591	Linoleic acid metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00830	Retinol metabolism	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00982	Drug metabolism - cytochrome P450	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko00983	Drug metabolism - other enzymes	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007055	K07424	ko01100	Metabolic pathways	1943	2.5e-101	0.49	0.69	0.99
PGSC0003DMG200007056	K01859	ko00941	Flavonoid biosynthesis	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMG200007056	K01859	ko01100	Metabolic pathways	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMG200007056	K01859	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.27	0.46	0.76
PGSC0003DMG200007057	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMG200007057	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMG200007057	K00852	ko00030	Pentose phosphate pathway	2172	5.8e-114	0.73	0.85	0.92
PGSC0003DMG200007059	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	4771	2.6e-257	0.83	0.89	1.00
PGSC0003DMG200007059	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	5055	5.6e-273	0.86	0.94	1.00
PGSC0003DMG200007059	K12450	ko00520	Amino sugar and nucleotide sugar metabolism	3970	3.9e-213	0.86	0.94	0.99
PGSC0003DMG200007060	K00858	ko00760	Nicotinate and nicotinamide metabolism	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMG200007060	K00858	ko01100	Metabolic pathways	512	2.1e-22	0.37	0.54	0.72
PGSC0003DMG200007061	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.95
PGSC0003DMG200007061	K12135	ko04712	Circadian rhythm - plant	326	3.8e-12	0.31	0.45	0.67
PGSC0003DMG200007062	K02871	ko03010	Ribosome	1545	2.2e-79	0.76	0.86	1.00
PGSC0003DMG200007063	K01710	ko00521	Streptomycin biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMG200007063	K01710	ko00523	Polyketide sugar unit biosynthesis	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMG200007063	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMG200007063	K01710	ko01100	Metabolic pathways	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMG200007063	K01710	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.76	0.85	0.96
PGSC0003DMG200007066	K01307	ko00790	Folate biosynthesis	1771	7.6e-92	0.67	0.80	0.98
PGSC0003DMG200007066	K01307	ko00790	Folate biosynthesis	2051	2.7e-107	0.71	0.83	0.97
PGSC0003DMG200007067	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04110	Cell cycle	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04111	Cell cycle - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04113	Meiosis - yeast	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200007067	K06636	ko04114	Oocyte meiosis	352	1.1e-12	0.29	0.46	0.69
PGSC0003DMG200044260	K10760	ko00908	Zeatin biosynthesis	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMG200044260	K10760	ko01100	Metabolic pathways	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMG200044260	K10760	ko01110	Biosynthesis of secondary metabolites	808	9.9e-39	0.52	0.70	0.94
PGSC0003DMG200024217	K12130	ko04712	Circadian rhythm - plant	278	6.0e-07	0.24	0.50	0.56
PGSC0003DMG200024219	K01099	ko00562	Inositol phosphate metabolism	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMG200024219	K01099	ko01100	Metabolic pathways	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMG200024219	K01099	ko04070	Phosphatidylinositol signaling system	738	3.5e-44	0.38	0.55	0.60
PGSC0003DMG200024220	K00873	ko00010	Glycolysis / Gluconeogenesis	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko00230	Purine metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko00620	Pyruvate metabolism	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko00710	Carbon fixation in photosynthetic organisms	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko01100	Metabolic pathways	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko01110	Biosynthesis of secondary metabolites	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200024220	K00873	ko04930	Type II diabetes mellitus	3480	4.2e-186	0.76	0.86	0.95
PGSC0003DMG200017901	K12823	ko03040	Spliceosome	1880	7.4e-98	0.53	0.66	0.69
PGSC0003DMG200017901	K12823	ko03040	Spliceosome	1986	1.1e-103	0.52	0.65	0.44
PGSC0003DMG200017902	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.85
PGSC0003DMG200017902	K06573	ko04966	Collecting duct acid secretion	708	3.2e-33	0.29	0.44	0.84
PGSC0003DMG200017913	K02266	ko00190	Oxidative phosphorylation	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017913	K02266	ko01100	Metabolic pathways	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017913	K02266	ko04260	Cardiac muscle contraction	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017913	K02266	ko05010	Alzheimer's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017913	K02266	ko05012	Parkinson's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017913	K02266	ko05016	Huntington's disease	508	3.5e-22	0.65	0.76	0.94
PGSC0003DMG200017914	K07374	ko04145	Phagosome	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMG200017914	K07374	ko04540	Gap junction	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMG200017914	K07374	ko05130	Pathogenic Escherichia coli infection	1770	8.6e-92	0.53	0.69	0.97
PGSC0003DMG200017915	K03006	ko00230	Purine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMG200017915	K03006	ko00240	Pyrimidine metabolism	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMG200017915	K03006	ko01100	Metabolic pathways	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMG200017915	K03006	ko03020	RNA polymerase	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMG200017915	K03006	ko05016	Huntington's disease	627	1.2e-27	0.34	0.40	0.89
PGSC0003DMG200017916	K03006	ko00230	Purine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMG200017916	K03006	ko00240	Pyrimidine metabolism	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMG200017916	K03006	ko01100	Metabolic pathways	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMG200017916	K03006	ko03020	RNA polymerase	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMG200017916	K03006	ko05016	Huntington's disease	449	9.0e-18	0.34	0.42	0.96
PGSC0003DMG200028652	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMG200028652	K00517	ko00626	Naphthalene and anthracene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMG200028652	K00517	ko00903	Limonene and pinene degradation	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMG200028652	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMG200028652	K00517	ko01110	Biosynthesis of secondary metabolites	1215	3.5e-61	0.40	0.61	0.97
PGSC0003DMG200028659	K11717	ko00450	Selenoamino acid metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMG200028659	K11717	ko00730	Thiamine metabolism	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMG200028659	K11717	ko01100	Metabolic pathways	351	2.8e-13	0.26	0.42	0.67
PGSC0003DMG200028660	K11717	ko00450	Selenoamino acid metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMG200028660	K11717	ko00730	Thiamine metabolism	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMG200028660	K11717	ko01100	Metabolic pathways	383	2.7e-15	0.29	0.44	0.73
PGSC0003DMG200028660	K11717	ko00450	Selenoamino acid metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMG200028660	K11717	ko00730	Thiamine metabolism	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMG200028660	K11717	ko01100	Metabolic pathways	379	8.2e-15	0.29	0.42	0.69
PGSC0003DMG200028661	K00888	ko00562	Inositol phosphate metabolism	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMG200028661	K00888	ko01100	Metabolic pathways	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMG200028661	K00888	ko04070	Phosphatidylinositol signaling system	2756	3.6e-146	0.66	0.77	0.96
PGSC0003DMG200028661	K00888	ko00562	Inositol phosphate metabolism	6496	0.	0.73	0.83	0.99
PGSC0003DMG200028661	K00888	ko01100	Metabolic pathways	6496	0.	0.73	0.83	0.99
PGSC0003DMG200028661	K00888	ko04070	Phosphatidylinositol signaling system	6496	0.	0.73	0.83	0.99
PGSC0003DMG200028661	K00888	ko00562	Inositol phosphate metabolism	6998	0.	0.74	0.84	1.00
PGSC0003DMG200028661	K00888	ko01100	Metabolic pathways	6998	0.	0.74	0.84	1.00
PGSC0003DMG200028661	K00888	ko04070	Phosphatidylinositol signaling system	6998	0.	0.74	0.84	1.00
PGSC0003DMG200028666	K04420	ko04010	MAPK signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMG200028666	K04420	ko04540	Gap junction	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMG200028666	K04420	ko04912	GnRH signaling pathway	1055	2.4e-52	0.39	0.53	0.70
PGSC0003DMG200028670	K13068	ko00940	Phenylpropanoid biosynthesis	873	2.6e-42	0.33	0.51	0.99
PGSC0003DMG200028671	K13068	ko00940	Phenylpropanoid biosynthesis	891	2.6e-43	0.32	0.52	0.98
PGSC0003DMG200025187	K12670	ko00510	N-Glycan biosynthesis	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMG200025187	K12670	ko01100	Metabolic pathways	3108	1.4e-165	0.83	0.93	1.00
PGSC0003DMG200025187	K12670	ko00510	N-Glycan biosynthesis	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMG200025187	K12670	ko01100	Metabolic pathways	3124	1.8e-166	0.83	0.94	1.00
PGSC0003DMG200031248	K05666	ko02010	ABC transporters	1395	4.2e-71	0.44	0.64	0.98
PGSC0003DMG200031248	K05665	ko02010	ABC transporters	3070	1.7e-163	0.35	0.55	0.97
PGSC0003DMG200031250	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00072	Synthesis and degradation of ketone bodies	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00280	Valine, leucine and isoleucine degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00281	Geraniol degradation	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko00650	Butanoate metabolism	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko01100	Metabolic pathways	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko01110	Biosynthesis of secondary metabolites	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031250	K01640	ko04146	Peroxisome	2555	4.4e-135	0.73	0.82	1.00
PGSC0003DMG200031255	K04127	ko00311	Penicillin and cephalosporin biosynthesis	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMG200031255	K04127	ko01100	Metabolic pathways	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMG200031255	K04127	ko01110	Biosynthesis of secondary metabolites	763	3.0e-36	0.33	0.53	0.89
PGSC0003DMG200031258	K02915	ko03010	Ribosome	972	8.9e-48	0.96	0.98	0.99
PGSC0003DMG200043451	K01426	ko00330	Arginine and proline metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200043451	K01426	ko00360	Phenylalanine metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200043451	K01426	ko00380	Tryptophan metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200043451	K01426	ko00460	Cyanoamino acid metabolism	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200043451	K01426	ko00632	Benzoate degradation via CoA ligation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200043451	K01426	ko00643	Styrene degradation	1159	4.3e-58	0.42	0.59	0.89
PGSC0003DMG200006727	K05391	ko04626	Plant-pathogen interaction	3648	2.3e-195	0.66	0.74	0.99
PGSC0003DMG200006727	K05391	ko04626	Plant-pathogen interaction	4219	7.3e-227	0.72	0.82	0.99
PGSC0003DMG200006730	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMG200006730	K01649	ko00620	Pyruvate metabolism	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMG200006730	K01649	ko01100	Metabolic pathways	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMG200006730	K01649	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.70	0.82	0.99
PGSC0003DMG200006731	K01590	ko00340	Histidine metabolism	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMG200006731	K01590	ko01100	Metabolic pathways	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMG200006731	K01590	ko01110	Biosynthesis of secondary metabolites	2115	8.1e-111	0.63	0.82	0.78
PGSC0003DMG200006733	K12859	ko03040	Spliceosome	1211	5.9e-61	0.97	1.00	0.99
PGSC0003DMG200006733	K12859	ko03040	Spliceosome	858	1.7e-41	0.97	1.00	0.99
PGSC0003DMG200006737	K12338	ko00942	Anthocyanin biosynthesis	1481	7.5e-76	0.36	0.48	0.99
PGSC0003DMG200006739	K06269	ko04113	Meiosis - yeast	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04114	Oocyte meiosis	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04270	Vascular smooth muscle contraction	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04510	Focal adhesion	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04720	Long-term potentiation	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04810	Regulation of actin cytoskeleton	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04910	Insulin signaling pathway	1946	1.7e-101	0.89	0.95	0.95
PGSC0003DMG200006739	K06269	ko04113	Meiosis - yeast	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04114	Oocyte meiosis	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04270	Vascular smooth muscle contraction	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04510	Focal adhesion	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04720	Long-term potentiation	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04810	Regulation of actin cytoskeleton	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200006739	K06269	ko04910	Insulin signaling pathway	2418	1.6e-127	0.91	0.96	1.00
PGSC0003DMG200011254	K05282	ko00904	Diterpenoid biosynthesis	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMG200011254	K05282	ko01100	Metabolic pathways	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMG200011254	K05282	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.44	0.58	0.98
PGSC0003DMG200011257	K01488	ko00230	Purine metabolism	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMG200011257	K01488	ko01100	Metabolic pathways	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMG200011257	K01488	ko05340	Primary immunodeficiency	2225	6.9e-117	0.75	0.86	0.99
PGSC0003DMG200011257	K01488	ko00230	Purine metabolism	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMG200011257	K01488	ko01100	Metabolic pathways	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMG200011257	K01488	ko05340	Primary immunodeficiency	1443	9.4e-74	0.78	0.89	0.94
PGSC0003DMG200011258	K00995	ko00564	Glycerophospholipid metabolism	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMG200011258	K00995	ko01100	Metabolic pathways	325	4.3e-12	0.46	0.66	0.42
PGSC0003DMG200011258	K08744	ko00564	Glycerophospholipid metabolism	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMG200011258	K08744	ko01100	Metabolic pathways	430	7.0e-18	0.36	0.59	0.58
PGSC0003DMG200013856	K01193	ko00052	Galactose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMG200013856	K01193	ko00500	Starch and sucrose metabolism	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMG200013856	K01193	ko01100	Metabolic pathways	3351	5.4e-179	0.65	0.80	0.90
PGSC0003DMG200013857	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMG200013857	K01087	ko00500	Starch and sucrose metabolism	1534	9.0e-79	0.61	0.75	0.83
PGSC0003DMG200013857	K01087	ko00500	Starch and sucrose metabolism	1364	2.1e-69	0.62	0.75	0.80
PGSC0003DMG200013862	K02261	ko00190	Oxidative phosphorylation	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013862	K02261	ko01100	Metabolic pathways	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013862	K02261	ko04260	Cardiac muscle contraction	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013862	K02261	ko05010	Alzheimer's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013862	K02261	ko05012	Parkinson's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013862	K02261	ko05016	Huntington's disease	719	8.0e-34	0.63	0.72	0.35
PGSC0003DMG200013864	K02261	ko00190	Oxidative phosphorylation	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013864	K02261	ko01100	Metabolic pathways	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013864	K02261	ko04260	Cardiac muscle contraction	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013864	K02261	ko05010	Alzheimer's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013864	K02261	ko05012	Parkinson's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013864	K02261	ko05016	Huntington's disease	890	3.0e-43	0.88	0.92	0.55
PGSC0003DMG200013869	K02878	ko03010	Ribosome	253	4.0e-08	0.63	0.75	0.94
PGSC0003DMG200013873	K12124	ko04712	Circadian rhythm - plant	453	2.4e-18	0.59	0.75	0.97
PGSC0003DMG200013874	K08241	ko00592	alpha-Linolenic acid metabolism	381	3.5e-15	0.40	0.61	0.86
PGSC0003DMG200007793	K00454	ko00591	Linoleic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMG200007793	K00454	ko00592	alpha-Linolenic acid metabolism	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMG200007793	K00454	ko01100	Metabolic pathways	3606	4.7e-193	0.61	0.75	0.99
PGSC0003DMG200007796	K03260	ko05416	Viral myocarditis	1183	9.0e-59	0.34	0.49	0.79
PGSC0003DMG200007797	K01647	ko00020	Citrate cycle (TCA cycle)	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMG200007797	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMG200007797	K01647	ko01100	Metabolic pathways	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMG200007797	K01647	ko01110	Biosynthesis of secondary metabolites	3746	8.9e-201	0.86	0.93	1.00
PGSC0003DMG200028034	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMG200028034	K01649	ko00620	Pyruvate metabolism	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMG200028034	K01649	ko01100	Metabolic pathways	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMG200028034	K01649	ko01110	Biosynthesis of secondary metabolites	1538	5.4e-79	0.57	0.70	0.73
PGSC0003DMG200028034	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMG200028034	K01649	ko00620	Pyruvate metabolism	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMG200028034	K01649	ko01100	Metabolic pathways	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMG200028034	K01649	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.67	0.85	0.97
PGSC0003DMG200028034	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMG200028034	K01649	ko00620	Pyruvate metabolism	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMG200028034	K01649	ko01100	Metabolic pathways	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMG200028034	K01649	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.66	0.82	0.95
PGSC0003DMG200028045	K01179	ko00500	Starch and sucrose metabolism	1751	9.6e-91	0.47	0.61	0.97
PGSC0003DMG200028047	K09841	ko00906	Carotenoid biosynthesis	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMG200028047	K09841	ko01100	Metabolic pathways	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMG200028047	K09841	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.34	0.53	0.97
PGSC0003DMG200028052	K05280	ko00941	Flavonoid biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMG200028052	K05280	ko00944	Flavone and flavonol biosynthesis	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMG200028052	K05280	ko01100	Metabolic pathways	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMG200028052	K05280	ko01110	Biosynthesis of secondary metabolites	1515	1.0e-77	0.40	0.60	0.95
PGSC0003DMG200028052	K05280	ko00941	Flavonoid biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMG200028052	K05280	ko00944	Flavone and flavonol biosynthesis	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMG200028052	K05280	ko01100	Metabolic pathways	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMG200028052	K05280	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.40	0.59	0.94
PGSC0003DMG200028052	K05280	ko00941	Flavonoid biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMG200028052	K05280	ko00944	Flavone and flavonol biosynthesis	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMG200028052	K05280	ko01100	Metabolic pathways	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMG200028052	K05280	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.45	0.63	0.97
PGSC0003DMG200028053	K05280	ko00941	Flavonoid biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMG200028053	K05280	ko00944	Flavone and flavonol biosynthesis	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMG200028053	K05280	ko01100	Metabolic pathways	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMG200028053	K05280	ko01110	Biosynthesis of secondary metabolites	1183	2.1e-59	0.41	0.60	0.99
PGSC0003DMG200028053	K05280	ko00941	Flavonoid biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMG200028053	K05280	ko00944	Flavone and flavonol biosynthesis	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMG200028053	K05280	ko01100	Metabolic pathways	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMG200028053	K05280	ko01110	Biosynthesis of secondary metabolites	1496	1.1e-76	0.40	0.60	0.93
PGSC0003DMG200028054	K05280	ko00941	Flavonoid biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMG200028054	K05280	ko00944	Flavone and flavonol biosynthesis	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMG200028054	K05280	ko01100	Metabolic pathways	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMG200028054	K05280	ko01110	Biosynthesis of secondary metabolites	824	1.3e-39	0.48	0.68	0.97
PGSC0003DMG200017196	K10599	ko03040	Spliceosome	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMG200017196	K10599	ko04120	Ubiquitin mediated proteolysis	3798	1.2e-203	0.85	0.93	1.00
PGSC0003DMG200017199	K05758	ko04666	Fc gamma R-mediated phagocytosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMG200017199	K05758	ko04810	Regulation of actin cytoskeleton	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMG200017199	K05758	ko05100	Bacterial invasion of epithelial cells	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMG200017199	K05758	ko05130	Pathogenic Escherichia coli infection	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMG200017199	K05758	ko05131	Shigellosis	1188	1.1e-59	0.71	0.86	0.94
PGSC0003DMG200017199	K05758	ko04666	Fc gamma R-mediated phagocytosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMG200017199	K05758	ko04810	Regulation of actin cytoskeleton	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMG200017199	K05758	ko05100	Bacterial invasion of epithelial cells	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMG200017199	K05758	ko05130	Pathogenic Escherichia coli infection	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMG200017199	K05758	ko05131	Shigellosis	524	4.6e-23	0.79	0.92	0.94
PGSC0003DMG200017199	K05758	ko04666	Fc gamma R-mediated phagocytosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko04810	Regulation of actin cytoskeleton	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05100	Bacterial invasion of epithelial cells	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05130	Pathogenic Escherichia coli infection	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05131	Shigellosis	1978	2.9e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko04666	Fc gamma R-mediated phagocytosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko04810	Regulation of actin cytoskeleton	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05100	Bacterial invasion of epithelial cells	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05130	Pathogenic Escherichia coli infection	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMG200017199	K05758	ko05131	Shigellosis	1980	2.3e-103	0.65	0.80	0.98
PGSC0003DMG200017203	K00276	ko00260	Glycine, serine and threonine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00350	Tyrosine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00360	Phenylalanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00410	beta-Alanine metabolism	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00950	Isoquinoline alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko01100	Metabolic pathways	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko01110	Biosynthesis of secondary metabolites	796	4.5e-38	0.34	0.52	0.95
PGSC0003DMG200017203	K00276	ko00260	Glycine, serine and threonine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00350	Tyrosine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00360	Phenylalanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00410	beta-Alanine metabolism	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko01100	Metabolic pathways	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko01110	Biosynthesis of secondary metabolites	1058	1.6e-52	0.39	0.55	0.99
PGSC0003DMG200017203	K00276	ko00260	Glycine, serine and threonine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko00350	Tyrosine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko00360	Phenylalanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko00410	beta-Alanine metabolism	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko01100	Metabolic pathways	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200017203	K00276	ko01110	Biosynthesis of secondary metabolites	1330	1.6e-67	0.35	0.51	0.96
PGSC0003DMG200024570	K01934	ko00670	One carbon pool by folate	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMG200024570	K01934	ko01100	Metabolic pathways	746	2.6e-35	0.69	0.83	0.96
PGSC0003DMG200024570	K01934	ko00670	One carbon pool by folate	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMG200024570	K01934	ko01100	Metabolic pathways	1179	3.4e-59	0.56	0.71	0.97
PGSC0003DMG200024570	K01934	ko00670	One carbon pool by folate	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMG200024570	K01934	ko01100	Metabolic pathways	1026	9.4e-51	0.66	0.81	0.97
PGSC0003DMG200024577	K05740	ko04510	Focal adhesion	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMG200024577	K05740	ko04810	Regulation of actin cytoskeleton	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMG200024577	K05740	ko05131	Shigellosis	787	2.7e-37	0.29	0.46	0.80
PGSC0003DMG200024578	K03413	ko02020	Two-component system	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMG200024578	K03413	ko02030	Bacterial chemotaxis	277	1.9e-09	0.32	0.59	0.69
PGSC0003DMG200024578	K03415	ko02020	Two-component system	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMG200024578	K03415	ko02030	Bacterial chemotaxis	244	1.3e-07	0.43	0.56	0.84
PGSC0003DMG200024579	K03355	ko04110	Cell cycle	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200024579	K03355	ko04111	Cell cycle - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200024579	K03355	ko04113	Meiosis - yeast	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200024579	K03355	ko04114	Oocyte meiosis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200024579	K03355	ko04120	Ubiquitin mediated proteolysis	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200024579	K03355	ko04914	Progesterone-mediated oocyte maturation	4020	6.9e-216	0.82	0.88	1.00
PGSC0003DMG200032777	K00434	ko00053	Ascorbate and aldarate metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMG200032777	K00434	ko00480	Glutathione metabolism	1461	9.5e-75	0.57	0.72	0.98
PGSC0003DMG200032777	K00434	ko00053	Ascorbate and aldarate metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMG200032777	K00434	ko00480	Glutathione metabolism	800	2.7e-38	0.74	0.88	0.94
PGSC0003DMG200032777	K00434	ko00053	Ascorbate and aldarate metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMG200032777	K00434	ko00480	Glutathione metabolism	248	7.6e-08	0.37	0.50	0.84
PGSC0003DMG200032777	K00434	ko00053	Ascorbate and aldarate metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMG200032777	K00434	ko00480	Glutathione metabolism	620	2.3e-28	0.79	0.91	0.92
PGSC0003DMG200000227	K01528	ko04144	Endocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMG200000227	K01528	ko04666	Fc gamma R-mediated phagocytosis	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMG200000227	K01528	ko05100	Bacterial invasion of epithelial cells	526	3.5e-23	0.31	0.52	0.76
PGSC0003DMG200000227	K01528	ko04144	Endocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMG200000227	K01528	ko04666	Fc gamma R-mediated phagocytosis	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMG200000227	K01528	ko05100	Bacterial invasion of epithelial cells	922	5.1e-45	0.38	0.59	0.75
PGSC0003DMG200000227	K01528	ko04144	Endocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMG200000227	K01528	ko04666	Fc gamma R-mediated phagocytosis	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMG200000227	K01528	ko05100	Bacterial invasion of epithelial cells	1496	1.1e-76	0.43	0.63	0.80
PGSC0003DMG200000229	K04506	ko04115	p53 signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMG200000229	K04506	ko04120	Ubiquitin mediated proteolysis	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMG200000229	K04506	ko04310	Wnt signaling pathway	833	4.1e-40	0.94	0.98	0.99
PGSC0003DMG200000229	K04506	ko04115	p53 signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMG200000229	K04506	ko04120	Ubiquitin mediated proteolysis	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMG200000229	K04506	ko04310	Wnt signaling pathway	2511	1.2e-132	0.82	0.89	1.00
PGSC0003DMG200000236	K12667	ko00510	N-Glycan biosynthesis	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMG200000236	K12667	ko01100	Metabolic pathways	385	8.4e-15	0.38	0.56	0.85
PGSC0003DMG200000238	K05305	ko00051	Fructose and mannose metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMG200000238	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMG200000238	K05305	ko01100	Metabolic pathways	804	1.6e-38	0.29	0.45	0.95
PGSC0003DMG200000238	K05305	ko00051	Fructose and mannose metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMG200000238	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMG200000238	K05305	ko01100	Metabolic pathways	1029	6.4e-51	0.28	0.45	0.95
PGSC0003DMG200000238	K05305	ko00051	Fructose and mannose metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMG200000238	K05305	ko00520	Amino sugar and nucleotide sugar metabolism	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMG200000238	K05305	ko01100	Metabolic pathways	881	9.3e-43	0.28	0.45	0.95
PGSC0003DMG200000239	K12891	ko03040	Spliceosome	226	1.2e-06	0.39	0.50	0.89
PGSC0003DMG200000239	K12890	ko03040	Spliceosome	305	5.5e-11	0.33	0.45	0.91
PGSC0003DMG200000239	K12890	ko03040	Spliceosome	297	2.5e-16	0.43	0.54	0.64
PGSC0003DMG200000241	K09561	ko04120	Ubiquitin mediated proteolysis	254	2.6e-07	0.31	0.48	0.18
PGSC0003DMG200002190	K02540	ko03030	DNA replication	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMG200002190	K02540	ko04110	Cell cycle	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMG200002190	K02540	ko04111	Cell cycle - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMG200002190	K02540	ko04113	Meiosis - yeast	2981	1.4e-158	0.86	0.94	1.00
PGSC0003DMG200002190	K02540	ko03030	DNA replication	6932	0.	0.85	0.93	1.00
PGSC0003DMG200002190	K02540	ko04110	Cell cycle	6932	0.	0.85	0.93	1.00
PGSC0003DMG200002190	K02540	ko04111	Cell cycle - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMG200002190	K02540	ko04113	Meiosis - yeast	6932	0.	0.85	0.93	1.00
PGSC0003DMG200002195	K00705	ko00500	Starch and sucrose metabolism	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMG200002195	K00705	ko01100	Metabolic pathways	3647	2.6e-195	0.73	0.85	0.92
PGSC0003DMG200002195	K00705	ko00500	Starch and sucrose metabolism	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMG200002195	K00705	ko01100	Metabolic pathways	1750	1.1e-90	0.81	0.92	0.79
PGSC0003DMG200002195	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMG200002195	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMG200002195	K00705	ko00500	Starch and sucrose metabolism	6030	0.	0.71	0.82	1.00
PGSC0003DMG200002195	K00705	ko01100	Metabolic pathways	6030	0.	0.71	0.82	1.00
PGSC0003DMG200002197	K00030	ko00020	Citrate cycle (TCA cycle)	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMG200002197	K00030	ko01100	Metabolic pathways	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMG200002197	K00030	ko01110	Biosynthesis of secondary metabolites	2583	1.2e-136	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko00260	Glycine, serine and threonine metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko00460	Cyanoamino acid metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko00670	One carbon pool by folate	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko00680	Methane metabolism	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko01100	Metabolic pathways	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko01110	Biosynthesis of secondary metabolites	2091	1.7e-109	0.80	0.87	1.00
PGSC0003DMG200002200	K00600	ko00260	Glycine, serine and threonine metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko00460	Cyanoamino acid metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko00670	One carbon pool by folate	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko00680	Methane metabolism	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko01100	Metabolic pathways	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002200	K00600	ko01110	Biosynthesis of secondary metabolites	3657	7.2e-196	0.83	0.90	1.00
PGSC0003DMG200002201	K01772	ko00860	Porphyrin and chlorophyll metabolism	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMG200002201	K01772	ko01100	Metabolic pathways	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMG200002201	K01772	ko01110	Biosynthesis of secondary metabolites	2148	1.2e-112	0.68	0.79	0.99
PGSC0003DMG200002201	K01772	ko00860	Porphyrin and chlorophyll metabolism	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMG200002201	K01772	ko01100	Metabolic pathways	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMG200002201	K01772	ko01110	Biosynthesis of secondary metabolites	2784	1.0e-147	0.71	0.83	0.97
PGSC0003DMG200002202	K02128	ko00190	Oxidative phosphorylation	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMG200002202	K02128	ko01100	Metabolic pathways	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMG200002202	K02128	ko05010	Alzheimer's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMG200002202	K02128	ko05012	Parkinson's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMG200002202	K02128	ko05016	Huntington's disease	491	3.0e-21	0.94	0.94	0.94
PGSC0003DMG200012136	K02990	ko03010	Ribosome	221	2.4e-06	0.40	0.55	0.50
PGSC0003DMG200012137	K10601	ko04120	Ubiquitin mediated proteolysis	246	2.1e-07	0.29	0.50	0.80
PGSC0003DMG200012152	K03217	ko03060	Protein export	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMG200012152	K03217	ko03070	Bacterial secretion system	1601	1.8e-82	0.56	0.72	1.00
PGSC0003DMG200012152	K03217	ko03060	Protein export	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMG200012152	K03217	ko03070	Bacterial secretion system	1856	1.6e-96	0.52	0.68	1.00
PGSC0003DMG200012153	K01897	ko00071	Fatty acid metabolism	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMG200012153	K01897	ko01100	Metabolic pathways	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMG200012153	K01897	ko03320	PPAR signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMG200012153	K01897	ko04146	Peroxisome	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMG200012153	K01897	ko04920	Adipocytokine signaling pathway	4305	1.3e-231	0.76	0.88	0.98
PGSC0003DMG200012153	K01897	ko00071	Fatty acid metabolism	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMG200012153	K01897	ko01100	Metabolic pathways	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMG200012153	K01897	ko03320	PPAR signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMG200012153	K01897	ko04146	Peroxisome	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMG200012153	K01897	ko04920	Adipocytokine signaling pathway	4355	2.3e-234	0.76	0.88	0.99
PGSC0003DMG200012156	K01213	ko00040	Pentose and glucuronate interconversions	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200012156	K01213	ko00500	Starch and sucrose metabolism	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200012156	K01213	ko01100	Metabolic pathways	894	1.8e-43	0.37	0.53	0.81
PGSC0003DMG200016534	K02922	ko03010	Ribosome	700	9.0e-33	0.96	0.99	0.75
PGSC0003DMG200016534	K02922	ko03010	Ribosome	775	6.5e-37	0.93	0.98	0.99
PGSC0003DMG200016537	K05282	ko00904	Diterpenoid biosynthesis	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMG200016537	K05282	ko01100	Metabolic pathways	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMG200016537	K05282	ko01110	Biosynthesis of secondary metabolites	1737	5.7e-90	0.61	0.71	0.93
PGSC0003DMG200020221	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMG200020221	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMG200020221	K06670	ko04110	Cell cycle	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMG200020221	K06670	ko04111	Cell cycle - yeast	288	2.5e-07	0.26	0.42	0.89
PGSC0003DMG200020221	K06670	ko04110	Cell cycle	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMG200020221	K06670	ko04111	Cell cycle - yeast	288	1.9e-07	0.26	0.42	0.97
PGSC0003DMG200020224	K00413	ko00190	Oxidative phosphorylation	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020224	K00413	ko01100	Metabolic pathways	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020224	K00413	ko04260	Cardiac muscle contraction	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020224	K00413	ko05010	Alzheimer's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020224	K00413	ko05012	Parkinson's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020224	K00413	ko05016	Huntington's disease	2329	1.3e-122	0.87	0.92	1.00
PGSC0003DMG200020228	K11584	ko04113	Meiosis - yeast	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMG200020228	K11584	ko04114	Oocyte meiosis	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMG200020228	K11584	ko04310	Wnt signaling pathway	2883	3.5e-153	0.84	0.92	0.95
PGSC0003DMG200020228	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020228	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020228	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020228	K11584	ko04113	Meiosis - yeast	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020228	K11584	ko04114	Oocyte meiosis	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020228	K11584	ko04310	Wnt signaling pathway	3706	1.4e-198	0.84	0.91	1.00
PGSC0003DMG200020229	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMG200020229	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.37	0.51	0.54
PGSC0003DMG200020229	K01066	ko00623	2,4-Dichlorobenzoate degradation	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMG200020229	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	423	1.7e-17	0.31	0.44	0.65
PGSC0003DMG200020229	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMG200020229	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.41
PGSC0003DMG200020229	K05294	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMG200020229	K05294	ko01100	Metabolic pathways	724	4.3e-34	0.35	0.54	0.38
PGSC0003DMG200030251	K08241	ko00592	alpha-Linolenic acid metabolism	517	1.1e-22	0.36	0.55	0.93
PGSC0003DMG200030252	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.37	0.53	0.96
PGSC0003DMG200030252	K08241	ko00592	alpha-Linolenic acid metabolism	705	4.8e-33	0.33	0.53	0.98
PGSC0003DMG200030252	K08241	ko00592	alpha-Linolenic acid metabolism	707	3.7e-33	0.33	0.53	0.99
PGSC0003DMG200030252	K08241	ko00592	alpha-Linolenic acid metabolism	711	2.2e-33	0.33	0.53	0.99
PGSC0003DMG200030254	K01719	ko00860	Porphyrin and chlorophyll metabolism	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMG200030254	K01719	ko01100	Metabolic pathways	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMG200030254	K01719	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.82	0.91	0.41
PGSC0003DMG200030257	K07374	ko04145	Phagosome	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMG200030257	K07374	ko04540	Gap junction	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMG200030257	K07374	ko05130	Pathogenic Escherichia coli infection	1659	1.1e-85	0.53	0.66	0.94
PGSC0003DMG200030258	K02266	ko00190	Oxidative phosphorylation	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200030258	K02266	ko01100	Metabolic pathways	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200030258	K02266	ko04260	Cardiac muscle contraction	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200030258	K02266	ko05010	Alzheimer's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200030258	K02266	ko05012	Parkinson's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200030258	K02266	ko05016	Huntington's disease	504	5.8e-22	0.65	0.78	0.94
PGSC0003DMG200025661	K12600	ko03018	RNA degradation	5837	0.	0.61	0.78	0.98
PGSC0003DMG200025661	K12600	ko03018	RNA degradation	4120	2.1e-221	0.58	0.75	0.95
PGSC0003DMG200025662	K03132	ko03022	Basal transcription factors	1058	1.6e-52	0.84	0.97	0.92
PGSC0003DMG200025662	K03132	ko03022	Basal transcription factors	651	4.5e-30	0.70	0.80	0.99
PGSC0003DMG200025662	K03132	ko03022	Basal transcription factors	1236	2.5e-62	0.75	0.88	0.99
PGSC0003DMG200025663	K10352	ko04530	Tight junction	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMG200025663	K10352	ko05416	Viral myocarditis	309	8.3e-08	0.28	0.47	0.74
PGSC0003DMG200025671	K10591	ko04120	Ubiquitin mediated proteolysis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMG200025671	K10591	ko04144	Endocytosis	3495	6.2e-187	0.52	0.69	0.98
PGSC0003DMG200025672	K10591	ko04120	Ubiquitin mediated proteolysis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMG200025672	K10591	ko04144	Endocytosis	3187	6.0e-170	0.51	0.68	0.95
PGSC0003DMG200025682	K09756	ko00940	Phenylpropanoid biosynthesis	1262	9.0e-64	0.41	0.57	0.80
PGSC0003DMG200025682	K09756	ko00940	Phenylpropanoid biosynthesis	1607	8.4e-83	0.45	0.62	0.99
PGSC0003DMG200018908	K10527	ko00592	alpha-Linolenic acid metabolism	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMG200018908	K10527	ko01100	Metabolic pathways	4484	1.8e-241	0.73	0.84	1.00
PGSC0003DMG200018908	K10527	ko00592	alpha-Linolenic acid metabolism	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMG200018908	K10527	ko01100	Metabolic pathways	4541	1.3e-244	0.75	0.86	1.00
PGSC0003DMG200018913	K00422	ko00350	Tyrosine metabolism	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMG200018913	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMG200018913	K00422	ko01100	Metabolic pathways	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMG200018913	K00422	ko01110	Biosynthesis of secondary metabolites	2186	9.8e-115	0.46	0.63	0.99
PGSC0003DMG200018914	K00422	ko00350	Tyrosine metabolism	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMG200018914	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMG200018914	K00422	ko01100	Metabolic pathways	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMG200018914	K00422	ko01110	Biosynthesis of secondary metabolites	1943	2.5e-101	0.46	0.62	0.99
PGSC0003DMG200018916	K00422	ko00350	Tyrosine metabolism	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMG200018916	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMG200018916	K00422	ko01100	Metabolic pathways	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMG200018916	K00422	ko01110	Biosynthesis of secondary metabolites	1932	1.0e-100	0.43	0.60	1.00
PGSC0003DMG200018917	K00422	ko00350	Tyrosine metabolism	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMG200018917	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMG200018917	K00422	ko01100	Metabolic pathways	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMG200018917	K00422	ko01110	Biosynthesis of secondary metabolites	1969	9.1e-103	0.44	0.61	1.00
PGSC0003DMG200018919	K00422	ko00350	Tyrosine metabolism	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMG200018919	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMG200018919	K00422	ko01100	Metabolic pathways	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMG200018919	K00422	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.39	0.51	0.88
PGSC0003DMG200018919	K00422	ko00350	Tyrosine metabolism	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMG200018919	K00422	ko00950	Isoquinoline alkaloid biosynthesis	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMG200018919	K00422	ko01100	Metabolic pathways	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMG200018919	K00422	ko01110	Biosynthesis of secondary metabolites	659	1.6e-30	0.59	0.74	0.92
PGSC0003DMG200018924	K00422	ko00350	Tyrosine metabolism	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMG200018924	K00422	ko00950	Isoquinoline alkaloid biosynthesis	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMG200018924	K00422	ko01100	Metabolic pathways	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMG200018924	K00422	ko01110	Biosynthesis of secondary metabolites	1521	4.7e-78	0.39	0.53	0.99
PGSC0003DMG200018925	K00422	ko00350	Tyrosine metabolism	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMG200018925	K00422	ko00950	Isoquinoline alkaloid biosynthesis	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMG200018925	K00422	ko01100	Metabolic pathways	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMG200018925	K00422	ko01110	Biosynthesis of secondary metabolites	889	3.4e-43	0.46	0.59	0.80
PGSC0003DMG200035631	K11294	ko05130	Pathogenic Escherichia coli infection	315	2.3e-11	0.28	0.49	0.56
PGSC0003DMG200035638	K02951	ko03010	Ribosome	328	3.0e-12	0.49	0.60	0.58
PGSC0003DMG200029281	K07195	ko04910	Insulin signaling pathway	3992	2.4e-214	0.70	0.85	1.00
PGSC0003DMG200029283	K02991	ko03010	Ribosome	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMG200029283	K02991	ko04150	mTOR signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMG200029283	K02991	ko04910	Insulin signaling pathway	1973	5.5e-103	0.94	0.98	1.00
PGSC0003DMG200019448	K01807	ko00030	Pentose phosphate pathway	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMG200019448	K01807	ko00710	Carbon fixation in photosynthetic organisms	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMG200019448	K01807	ko01100	Metabolic pathways	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMG200019448	K01807	ko01110	Biosynthesis of secondary metabolites	1816	2.5e-94	0.79	0.87	1.00
PGSC0003DMG200012537	K13065	ko00940	Phenylpropanoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMG200012537	K13065	ko00941	Flavonoid biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMG200012537	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMG200012537	K13065	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.26	0.43	0.95
PGSC0003DMG200012538	K13065	ko00940	Phenylpropanoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMG200012538	K13065	ko00941	Flavonoid biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMG200012538	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMG200012538	K13065	ko01110	Biosynthesis of secondary metabolites	306	3.0e-10	0.26	0.45	0.98
PGSC0003DMG200012538	K13065	ko00940	Phenylpropanoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMG200012538	K13065	ko00941	Flavonoid biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMG200012538	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMG200012538	K13065	ko01110	Biosynthesis of secondary metabolites	292	2.9e-10	0.26	0.46	0.83
PGSC0003DMG200012539	K13065	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMG200012539	K13065	ko00941	Flavonoid biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMG200012539	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMG200012539	K13065	ko01110	Biosynthesis of secondary metabolites	466	7.2e-20	0.28	0.45	0.95
PGSC0003DMG200012540	K13065	ko00940	Phenylpropanoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMG200012540	K13065	ko00941	Flavonoid biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMG200012540	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMG200012540	K13065	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.29	0.47	0.97
PGSC0003DMG200012542	K13065	ko00940	Phenylpropanoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMG200012542	K13065	ko00941	Flavonoid biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMG200012542	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMG200012542	K13065	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.27	0.45	0.96
PGSC0003DMG200012545	K05849	ko04020	Calcium signaling pathway	240	1.1e-06	0.37	0.54	0.39
PGSC0003DMG200012547	K05681	ko02010	ABC transporters	1176	5.0e-59	0.36	0.53	0.90
PGSC0003DMG200002775	K01507	ko00190	Oxidative phosphorylation	5592	0.	0.89	0.95	1.00
PGSC0003DMG200002776	K08057	ko04145	Phagosome	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMG200002776	K08057	ko04612	Antigen processing and presentation	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMG200002776	K08057	ko05142	Chagas disease	3058	7.9e-163	0.82	0.91	1.00
PGSC0003DMG200002777	K00382	ko00010	Glycolysis / Gluconeogenesis	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko00020	Citrate cycle (TCA cycle)	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko00260	Glycine, serine and threonine metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko00280	Valine, leucine and isoleucine degradation	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko00620	Pyruvate metabolism	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko01100	Metabolic pathways	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002777	K00382	ko01110	Biosynthesis of secondary metabolites	3937	2.6e-211	0.84	0.90	1.00
PGSC0003DMG200002782	K02716	ko00195	Photosynthesis	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMG200002782	K02716	ko01100	Metabolic pathways	2452	2.1e-129	0.88	0.95	1.00
PGSC0003DMG200008445	K00963	ko00040	Pentose and glucuronate interconversions	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K00963	ko00052	Galactose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K00963	ko00500	Starch and sucrose metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K00963	ko00520	Amino sugar and nucleotide sugar metabolism	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K00963	ko01100	Metabolic pathways	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K00963	ko01110	Biosynthesis of secondary metabolites	3267	2.3e-174	0.85	0.91	0.70
PGSC0003DMG200008445	K02934	ko03010	Ribosome	1575	4.9e-81	0.79	0.89	1.00
PGSC0003DMG200008446	K01580	ko00250	Alanine, aspartate and glutamate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko00410	beta-Alanine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko00430	Taurine and hypotaurine metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko00650	Butanoate metabolism	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko01100	Metabolic pathways	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko04940	Type I diabetes mellitus	2820	1.1e-149	0.83	0.90	0.96
PGSC0003DMG200008446	K01580	ko00250	Alanine, aspartate and glutamate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko00410	beta-Alanine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko00430	Taurine and hypotaurine metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko00650	Butanoate metabolism	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko01100	Metabolic pathways	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko04940	Type I diabetes mellitus	1857	1.4e-96	0.92	0.96	1.00
PGSC0003DMG200008446	K01580	ko00250	Alanine, aspartate and glutamate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008446	K01580	ko00410	beta-Alanine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008446	K01580	ko00430	Taurine and hypotaurine metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008446	K01580	ko00650	Butanoate metabolism	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008446	K01580	ko01100	Metabolic pathways	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008446	K01580	ko04940	Type I diabetes mellitus	3592	2.8e-192	0.85	0.91	1.00
PGSC0003DMG200008458	K03004	ko00230	Purine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMG200008458	K03004	ko00240	Pyrimidine metabolism	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMG200008458	K03004	ko01100	Metabolic pathways	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMG200008458	K03004	ko03020	RNA polymerase	747	2.3e-35	0.47	0.65	0.99
PGSC0003DMG200008458	K03004	ko00230	Purine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMG200008458	K03004	ko00240	Pyrimidine metabolism	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMG200008458	K03004	ko01100	Metabolic pathways	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMG200008458	K03004	ko03020	RNA polymerase	713	1.7e-33	0.51	0.70	0.87
PGSC0003DMG200008459	K08272	ko04150	mTOR signaling pathway	2402	1.2e-126	0.85	0.94	0.99
PGSC0003DMG200008461	K12462	ko04722	Neurotrophin signaling pathway	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMG200008461	K12462	ko04962	Vasopressin-regulated water reabsorption	1456	1.8e-74	0.74	0.86	0.97
PGSC0003DMG200008462	K10591	ko04120	Ubiquitin mediated proteolysis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMG200008462	K10591	ko04144	Endocytosis	647	7.5e-30	0.81	0.90	0.72
PGSC0003DMG200008462	K10591	ko04120	Ubiquitin mediated proteolysis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMG200008462	K10591	ko04144	Endocytosis	4635	8.2e-250	0.63	0.79	0.99
PGSC0003DMG200015968	K02990	ko03010	Ribosome	352	1.4e-13	0.34	0.55	0.48
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.40	0.57	0.82
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.32	0.52	0.92
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.31	0.50	0.55
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.32	0.54	0.57
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.55	0.76
PGSC0003DMG200015971	K05350	ko00460	Cyanoamino acid metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMG200015971	K05350	ko00500	Starch and sucrose metabolism	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMG200015971	K05350	ko00940	Phenylpropanoid biosynthesis	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMG200015971	K05350	ko01110	Biosynthesis of secondary metabolites	234	6.9e-07	0.38	0.56	0.88
PGSC0003DMG200015974	K10712	ko00430	Taurine and hypotaurine metabolism	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMG200015974	K10712	ko01100	Metabolic pathways	406	1.5e-16	0.32	0.49	0.83
PGSC0003DMG200000601	K10595	ko04120	Ubiquitin mediated proteolysis	300	4.6e-08	0.43	0.58	0.27
PGSC0003DMG200000608	K01184	ko00040	Pentose and glucuronate interconversions	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMG200000608	K01184	ko00500	Starch and sucrose metabolism	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMG200000608	K01184	ko01100	Metabolic pathways	563	3.2e-25	0.36	0.53	0.90
PGSC0003DMG200000608	K01184	ko00040	Pentose and glucuronate interconversions	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMG200000608	K01184	ko00500	Starch and sucrose metabolism	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMG200000608	K01184	ko01100	Metabolic pathways	1245	7.8e-63	0.41	0.58	0.89
PGSC0003DMG200000614	K01115	ko00564	Glycerophospholipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko00565	Ether lipid metabolism	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko01100	Metabolic pathways	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko04144	Endocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko04666	Fc gamma R-mediated phagocytosis	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko04912	GnRH signaling pathway	5605	0.	0.77	0.90	1.00
PGSC0003DMG200000614	K01115	ko00564	Glycerophospholipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200000614	K01115	ko00565	Ether lipid metabolism	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200000614	K01115	ko01100	Metabolic pathways	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200000614	K01115	ko04144	Endocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200000614	K01115	ko04666	Fc gamma R-mediated phagocytosis	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200000614	K01115	ko04912	GnRH signaling pathway	4460	3.7e-240	0.79	0.91	0.99
PGSC0003DMG200023950	K10875	ko03440	Homologous recombination	630	6.5e-29	0.29	0.48	0.83
PGSC0003DMG200023950	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMG200023950	K10875	ko03440	Homologous recombination	630	3.3e-28	0.29	0.48	0.45
PGSC0003DMG200023951	K00368	ko00910	Nitrogen metabolism	1965	1.5e-102	0.47	0.61	0.92
PGSC0003DMG200023955	K02160	ko00061	Fatty acid biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023955	K02160	ko00253	Tetracycline biosynthesis	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023955	K02160	ko00620	Pyruvate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023955	K02160	ko00640	Propanoate metabolism	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023955	K02160	ko01100	Metabolic pathways	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023955	K02160	ko01110	Biosynthesis of secondary metabolites	251	5.2e-08	0.32	0.50	0.59
PGSC0003DMG200023957	K12586	ko03018	RNA degradation	534	1.1e-22	0.52	0.69	0.95
PGSC0003DMG200023957	K12586	ko03018	RNA degradation	828	3.6e-39	0.43	0.59	0.95
PGSC0003DMG200023970	K10743	ko03030	DNA replication	2030	3.9e-106	0.81	0.90	1.00
PGSC0003DMG200018130	K00058	ko00260	Glycine, serine and threonine metabolism	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMG200018130	K00058	ko01100	Metabolic pathways	3861	4.0e-207	0.80	0.90	1.00
PGSC0003DMG200018131	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMG200018131	K00517	ko00626	Naphthalene and anthracene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMG200018131	K00517	ko00903	Limonene and pinene degradation	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMG200018131	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMG200018131	K00517	ko01110	Biosynthesis of secondary metabolites	1649	4.1e-85	0.49	0.68	0.99
PGSC0003DMG200018132	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMG200018132	K00517	ko00626	Naphthalene and anthracene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMG200018132	K00517	ko00903	Limonene and pinene degradation	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMG200018132	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMG200018132	K00517	ko01110	Biosynthesis of secondary metabolites	456	7.2e-30	0.52	0.75	0.63
PGSC0003DMG200018132	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMG200018132	K00517	ko00626	Naphthalene and anthracene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMG200018132	K00517	ko00903	Limonene and pinene degradation	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMG200018132	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMG200018132	K00517	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.54	0.73	0.90
PGSC0003DMG200018133	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMG200018133	K00517	ko00626	Naphthalene and anthracene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMG200018133	K00517	ko00903	Limonene and pinene degradation	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMG200018133	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMG200018133	K00517	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.52	0.74	0.97
PGSC0003DMG200018134	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMG200018134	K00517	ko00626	Naphthalene and anthracene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMG200018134	K00517	ko00903	Limonene and pinene degradation	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMG200018134	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMG200018134	K00517	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.46	0.63	0.97
PGSC0003DMG200018135	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMG200018135	K00517	ko00626	Naphthalene and anthracene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMG200018135	K00517	ko00903	Limonene and pinene degradation	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMG200018135	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMG200018135	K00517	ko01110	Biosynthesis of secondary metabolites	689	3.6e-32	0.52	0.73	0.96
PGSC0003DMG200018135	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMG200018135	K00517	ko00626	Naphthalene and anthracene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMG200018135	K00517	ko00903	Limonene and pinene degradation	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMG200018135	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMG200018135	K00517	ko01110	Biosynthesis of secondary metabolites	1867	3.9e-97	0.49	0.70	0.95
PGSC0003DMG200018136	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMG200018136	K00517	ko00626	Naphthalene and anthracene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMG200018136	K00517	ko00903	Limonene and pinene degradation	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMG200018136	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMG200018136	K00517	ko01110	Biosynthesis of secondary metabolites	713	1.7e-33	0.50	0.72	0.93
PGSC0003DMG200018137	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMG200018137	K00517	ko00626	Naphthalene and anthracene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMG200018137	K00517	ko00903	Limonene and pinene degradation	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMG200018137	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMG200018137	K00517	ko01110	Biosynthesis of secondary metabolites	1920	4.6e-100	0.49	0.71	0.98
PGSC0003DMG200018137	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMG200018137	K00517	ko00626	Naphthalene and anthracene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMG200018137	K00517	ko00903	Limonene and pinene degradation	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMG200018137	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMG200018137	K00517	ko01110	Biosynthesis of secondary metabolites	1959	3.3e-102	0.50	0.71	0.98
PGSC0003DMG200018137	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMG200018137	K00517	ko00626	Naphthalene and anthracene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMG200018137	K00517	ko00903	Limonene and pinene degradation	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMG200018137	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMG200018137	K00517	ko01110	Biosynthesis of secondary metabolites	1914	9.9e-100	0.48	0.69	0.97
PGSC0003DMG200018137	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMG200018137	K00517	ko00626	Naphthalene and anthracene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMG200018137	K00517	ko00903	Limonene and pinene degradation	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMG200018137	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMG200018137	K00517	ko01110	Biosynthesis of secondary metabolites	795	5.2e-38	0.53	0.74	0.93
PGSC0003DMG200018138	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMG200018138	K00517	ko00626	Naphthalene and anthracene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMG200018138	K00517	ko00903	Limonene and pinene degradation	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMG200018138	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMG200018138	K00517	ko01110	Biosynthesis of secondary metabolites	1769	9.8e-92	0.45	0.66	0.99
PGSC0003DMG200018139	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMG200018139	K00517	ko00626	Naphthalene and anthracene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMG200018139	K00517	ko00903	Limonene and pinene degradation	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMG200018139	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMG200018139	K00517	ko01110	Biosynthesis of secondary metabolites	1596	3.4e-82	0.48	0.69	0.90
PGSC0003DMG200018140	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMG200018140	K00517	ko00626	Naphthalene and anthracene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMG200018140	K00517	ko00903	Limonene and pinene degradation	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMG200018140	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMG200018140	K00517	ko01110	Biosynthesis of secondary metabolites	1775	4.6e-92	0.49	0.66	0.95
PGSC0003DMG200018141	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMG200018141	K00517	ko00626	Naphthalene and anthracene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMG200018141	K00517	ko00903	Limonene and pinene degradation	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMG200018141	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMG200018141	K00517	ko01110	Biosynthesis of secondary metabolites	1844	7.2e-96	0.50	0.68	0.95
PGSC0003DMG200018142	K01728	ko00040	Pentose and glucuronate interconversions	1843	8.1e-96	0.56	0.71	0.90
PGSC0003DMG200018143	K05648	ko02010	ABC transporters	1155	7.9e-58	0.32	0.49	0.63
PGSC0003DMG200018143	K05648	ko02010	ABC transporters	1267	4.8e-64	0.32	0.50	0.73
PGSC0003DMG200018147	K04728	ko04110	Cell cycle	14735	0.	0.61	0.75	0.96
PGSC0003DMG200018147	K04728	ko04115	p53 signaling pathway	14735	0.	0.61	0.75	0.96
PGSC0003DMG200018147	K04728	ko04210	Apoptosis	14735	0.	0.61	0.75	0.96
PGSC0003DMG200018148	K09680	ko00770	Pantothenate and CoA biosynthesis	6275	0.	0.84	0.90	0.98
PGSC0003DMG200018148	K09680	ko01100	Metabolic pathways	6275	0.	0.84	0.90	0.98
PGSC0003DMG200028797	K02183	ko04020	Calcium signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04070	Phosphatidylinositol signaling system	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04114	Oocyte meiosis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04270	Vascular smooth muscle contraction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04626	Plant-pathogen interaction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04720	Long-term potentiation	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04722	Neurotrophin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04740	Olfactory transduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04744	Phototransduction	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04745	Phototransduction - fly	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04910	Insulin signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04912	GnRH signaling pathway	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04916	Melanogenesis	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04970	Salivary secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko04971	Gastric acid secretion	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko05010	Alzheimer's disease	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028797	K02183	ko05214	Glioma	417	3.6e-17	0.40	0.62	0.92
PGSC0003DMG200028798	K05929	ko00564	Glycerophospholipid metabolism	767	1.8e-36	0.41	0.60	0.51
PGSC0003DMG200028799	K01613	ko00564	Glycerophospholipid metabolism	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMG200028799	K01613	ko01100	Metabolic pathways	235	3.6e-06	0.43	0.57	0.54
PGSC0003DMG200028803	K12311	ko00511	Other glycan degradation	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMG200028803	K12311	ko04142	Lysosome	3315	5.3e-177	0.68	0.81	0.96
PGSC0003DMG200028803	K12311	ko00511	Other glycan degradation	6314	0.	0.73	0.84	0.98
PGSC0003DMG200028803	K12311	ko04142	Lysosome	6314	0.	0.73	0.84	0.98
PGSC0003DMG200028806	K10757	ko00944	Flavone and flavonol biosynthesis	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMG200028806	K10757	ko01100	Metabolic pathways	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMG200028806	K10757	ko01110	Biosynthesis of secondary metabolites	607	1.2e-27	0.30	0.49	0.98
PGSC0003DMG200028807	K12617	ko03018	RNA degradation	4534	3.1e-244	0.68	0.79	1.00
PGSC0003DMG200028808	K13229	ko00402	Benzoxazinoid biosynthesis	988	1.2e-48	0.48	0.66	1.00
PGSC0003DMG200028809	K13229	ko00402	Benzoxazinoid biosynthesis	1238	1.9e-62	0.44	0.62	0.99
PGSC0003DMG200028809	K13229	ko00402	Benzoxazinoid biosynthesis	535	1.1e-23	0.41	0.62	0.96
PGSC0003DMG200021981	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMG200021981	K13229	ko00402	Benzoxazinoid biosynthesis	465	8.2e-20	0.47	0.63	0.99
PGSC0003DMG200021986	K02084	ko04115	p53 signaling pathway	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko04210	Apoptosis	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko05010	Alzheimer's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko05012	Parkinson's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko05016	Huntington's disease	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021986	K02084	ko05222	Small cell lung cancer	334	4.3e-09	0.29	0.47	0.41
PGSC0003DMG200021991	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMG200021991	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.77
PGSC0003DMG200021991	K01046	ko00561	Glycerolipid metabolism	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMG200021991	K01046	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.49	0.85
PGSC0003DMG200021997	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMG200021997	K11095	ko03040	Spliceosome	871	3.3e-42	0.57	0.65	0.92
PGSC0003DMG200030988	K04733	ko04210	Apoptosis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMG200030988	K04733	ko04620	Toll-like receptor signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMG200030988	K04733	ko04722	Neurotrophin signaling pathway	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMG200030988	K04733	ko05140	Leishmaniasis	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMG200030988	K04733	ko05142	Chagas disease	664	8.7e-31	0.38	0.55	0.80
PGSC0003DMG200030990	K04424	ko04010	MAPK signaling pathway	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMG200030990	K04424	ko04530	Tight junction	487	3.6e-20	0.39	0.60	0.92
PGSC0003DMG200030997	K07466	ko03030	DNA replication	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMG200030997	K07466	ko03420	Nucleotide excision repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMG200030997	K07466	ko03430	Mismatch repair	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMG200030997	K07466	ko03440	Homologous recombination	741	4.9e-35	0.68	0.80	0.97
PGSC0003DMG200030998	K00001	ko00010	Glycolysis / Gluconeogenesis	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00071	Fatty acid metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00350	Tyrosine metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00624	1- and 2-Methylnaphthalene degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00641	3-Chloroacrylic acid degradation	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00830	Retinol metabolism	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko00982	Drug metabolism - cytochrome P450	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko01100	Metabolic pathways	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200030998	K00001	ko01110	Biosynthesis of secondary metabolites	852	3.7e-41	0.39	0.59	0.78
PGSC0003DMG200031000	K08766	ko00071	Fatty acid metabolism	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMG200031000	K08766	ko03320	PPAR signaling pathway	428	6.4e-16	0.44	0.62	0.41
PGSC0003DMG200010726	K04392	ko04010	MAPK signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04062	Chemokine signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04145	Phagosome	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04310	Wnt signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04360	Axon guidance	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04370	VEGF signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04510	Focal adhesion	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04520	Adherens junction	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04620	Toll-like receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04650	Natural killer cell mediated cytotoxicity	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04662	B cell receptor signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04664	Fc epsilon RI signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04666	Fc gamma R-mediated phagocytosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04670	Leukocyte transendothelial migration	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04722	Neurotrophin signaling pathway	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04810	Regulation of actin cytoskeleton	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05100	Bacterial invasion of epithelial cells	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05131	Shigellosis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05200	Pathways in cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05210	Colorectal cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05211	Renal cell carcinoma	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05212	Pancreatic cancer	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko05416	Viral myocarditis	1108	2.8e-55	0.73	0.75	0.99
PGSC0003DMG200010726	K04392	ko04010	MAPK signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04062	Chemokine signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04145	Phagosome	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04310	Wnt signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04360	Axon guidance	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04370	VEGF signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04510	Focal adhesion	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04520	Adherens junction	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04620	Toll-like receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04650	Natural killer cell mediated cytotoxicity	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04662	B cell receptor signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04664	Fc epsilon RI signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04666	Fc gamma R-mediated phagocytosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04670	Leukocyte transendothelial migration	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04722	Neurotrophin signaling pathway	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko04810	Regulation of actin cytoskeleton	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05100	Bacterial invasion of epithelial cells	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05131	Shigellosis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05200	Pathways in cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05210	Colorectal cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05211	Renal cell carcinoma	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05212	Pancreatic cancer	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010726	K04392	ko05416	Viral myocarditis	1523	3.6e-78	0.91	0.95	0.99
PGSC0003DMG200010729	K08233	ko00901	Indole alkaloid biosynthesis	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMG200010729	K08233	ko01110	Biosynthesis of secondary metabolites	800	2.7e-38	0.43	0.60	0.90
PGSC0003DMG200010730	K08233	ko00901	Indole alkaloid biosynthesis	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMG200010730	K08233	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.62	0.97
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko05214	Glioma	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	514	3.2e-21	0.40	0.55	0.94
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05214	Glioma	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	519	1.7e-21	0.67	0.77	0.79
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko05214	Glioma	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	846	1.2e-39	0.52	0.64	0.87
PGSC0003DMG200010731	K06677	ko04111	Cell cycle - yeast	329	2.6e-11	0.41	0.61	0.84
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05214	Glioma	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	807	1.8e-37	0.64	0.75	0.87
PGSC0003DMG200010731	K07203	ko04012	ErbB signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04150	mTOR signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04910	Insulin signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04920	Adipocytokine signaling pathway	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko04930	Type II diabetes mellitus	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05200	Pathways in cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05214	Glioma	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05215	Prostate cancer	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200010731	K07203	ko05221	Acute myeloid leukemia	437	6.0e-17	0.86	0.92	0.98
PGSC0003DMG200014287	K12614	ko03018	RNA degradation	797	2.2e-37	0.30	0.51	0.92
PGSC0003DMG200014287	K01553	ko00230	Purine metabolism	439	1.2e-17	0.29	0.49	0.90
PGSC0003DMG200014289	K10846	ko03420	Nucleotide excision repair	543	8.7e-32	0.33	0.47	0.76
PGSC0003DMG200014292	K12478	ko04144	Endocytosis	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMG200014292	K12478	ko04145	Phagosome	607	1.5e-24	0.26	0.47	0.86
PGSC0003DMG200014292	K12478	ko04144	Endocytosis	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMG200014292	K12478	ko04145	Phagosome	607	7.9e-25	0.26	0.47	0.95
PGSC0003DMG200014296	K07375	ko04145	Phagosome	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko04540	Gap junction	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko05130	Pathogenic Escherichia coli infection	3768	5.4e-202	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko04145	Phagosome	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko04540	Gap junction	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko05130	Pathogenic Escherichia coli infection	2521	3.3e-133	0.97	0.99	1.00
PGSC0003DMG200014296	K07375	ko04145	Phagosome	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMG200014296	K07375	ko04540	Gap junction	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMG200014296	K07375	ko05130	Pathogenic Escherichia coli infection	1796	3.2e-93	0.95	0.98	1.00
PGSC0003DMG200014299	K02957	ko03010	Ribosome	898	1.1e-43	0.86	0.87	0.99
PGSC0003DMG200014302	K10717	ko00908	Zeatin biosynthesis	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMG200014302	K10717	ko01100	Metabolic pathways	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMG200014302	K10717	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.38	0.59	0.97
PGSC0003DMG200003849	K01046	ko00561	Glycerolipid metabolism	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMG200003849	K01046	ko01100	Metabolic pathways	456	2.6e-19	0.32	0.49	0.77
PGSC0003DMG200003859	K12818	ko03040	Spliceosome	1259	1.3e-63	0.43	0.58	0.99
PGSC0003DMG200003859	K12818	ko03040	Spliceosome	1537	6.1e-79	0.52	0.70	0.99
PGSC0003DMG200044024	K07466	ko03030	DNA replication	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMG200044024	K07466	ko03420	Nucleotide excision repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMG200044024	K07466	ko03430	Mismatch repair	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMG200044024	K07466	ko03440	Homologous recombination	271	1.3e-08	0.31	0.52	0.76
PGSC0003DMG200039032	K03094	ko04110	Cell cycle	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04111	Cell cycle - yeast	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04114	Oocyte meiosis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04120	Ubiquitin mediated proteolysis	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04310	Wnt signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04350	TGF-beta signaling pathway	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200039032	K03094	ko04710	Circadian rhythm - mammal	455	2.9e-19	0.47	0.69	0.92
PGSC0003DMG200028177	K00873	ko00010	Glycolysis / Gluconeogenesis	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko00230	Purine metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko00620	Pyruvate metabolism	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko00710	Carbon fixation in photosynthetic organisms	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko01100	Metabolic pathways	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko01110	Biosynthesis of secondary metabolites	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028177	K00873	ko04930	Type II diabetes mellitus	3541	1.8e-189	0.89	0.96	0.95
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	992	7.0e-49	0.48	0.57	0.99
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	452	4.3e-19	0.55	0.68	0.74
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMG200028179	K12185	ko04144	Endocytosis	1175	5.7e-59	0.66	0.78	0.98
PGSC0003DMG200028180	K09837	ko00906	Carotenoid biosynthesis	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMG200028180	K09837	ko01100	Metabolic pathways	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMG200028180	K09837	ko01110	Biosynthesis of secondary metabolites	3343	1.5e-178	0.75	0.85	0.98
PGSC0003DMG200028180	K09837	ko00906	Carotenoid biosynthesis	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMG200028180	K09837	ko01100	Metabolic pathways	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMG200028180	K09837	ko01110	Biosynthesis of secondary metabolites	3115	5.7e-166	0.78	0.88	0.97
PGSC0003DMG200028180	K09837	ko00906	Carotenoid biosynthesis	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMG200028180	K09837	ko01100	Metabolic pathways	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMG200028180	K09837	ko01110	Biosynthesis of secondary metabolites	3555	3.0e-190	0.78	0.89	0.98
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	297	4.8e-08	0.28	0.48	0.38
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	312	9.2e-09	0.25	0.43	0.45
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	312	1.0e-08	0.25	0.43	0.42
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	290	5.3e-08	0.26	0.44	0.50
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	302	4.9e-08	0.25	0.43	0.39
PGSC0003DMG200028181	K10603	ko04120	Ubiquitin mediated proteolysis	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMG200028181	K10603	ko05340	Primary immunodeficiency	312	1.3e-08	0.25	0.43	0.38
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	517	1.1e-22	0.35	0.51	0.73
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.67
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	651	4.5e-30	0.42	0.57	0.79
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.62	0.45
PGSC0003DMG200028184	K00953	ko00740	Riboflavin metabolism	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMG200028184	K00953	ko01100	Metabolic pathways	290	4.7e-10	0.45	0.59	0.74
PGSC0003DMG200017402	K02881	ko03010	Ribosome	728	2.6e-34	0.73	0.88	0.99
PGSC0003DMG200017408	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko00071	Fatty acid metabolism	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko01100	Metabolic pathways	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko03320	PPAR signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko04146	Peroxisome	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017408	K01897	ko04920	Adipocytokine signaling pathway	4349	4.9e-234	0.70	0.83	1.00
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	618	3.0e-28	0.44	0.51	0.99
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1642	9.9e-85	0.58	0.72	0.97
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1586	1.2e-81	0.54	0.67	0.76
PGSC0003DMG200017409	K12741	ko03040	Spliceosome	1647	5.3e-85	0.59	0.72	0.97
PGSC0003DMG200021263	K01599	ko00860	Porphyrin and chlorophyll metabolism	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMG200021263	K01599	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.77	0.86	0.97
PGSC0003DMG200021263	K01599	ko00860	Porphyrin and chlorophyll metabolism	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMG200021263	K01599	ko01110	Biosynthesis of secondary metabolites	2597	2.1e-137	0.76	0.86	0.98
PGSC0003DMG200021264	K01595	ko00620	Pyruvate metabolism	7497	0.	0.91	0.96	1.00
PGSC0003DMG200021264	K01595	ko00710	Carbon fixation in photosynthetic organisms	7497	0.	0.91	0.96	1.00
PGSC0003DMG200021264	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7497	0.	0.91	0.96	1.00
PGSC0003DMG200021264	K01595	ko01100	Metabolic pathways	7497	0.	0.91	0.96	1.00
PGSC0003DMG200021267	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMG200021272	K06236	ko04510	Focal adhesion	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMG200021272	K06236	ko04512	ECM-receptor interaction	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMG200021272	K06236	ko05146	Amoebiasis	419	1.1e-16	0.28	0.41	1.00
PGSC0003DMG200021275	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMG200021275	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMG200021275	K10955	ko05110	Vibrio cholerae infection	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMG200021275	K10955	ko05146	Amoebiasis	531	9.3e-22	0.32	0.41	0.44
PGSC0003DMG200031910	K12153	ko00966	Glucosinolate biosynthesis	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMG200031910	K12153	ko01110	Biosynthesis of secondary metabolites	284	1.3e-09	0.53	0.68	0.98
PGSC0003DMG200032086	K11778	ko00900	Terpenoid backbone biosynthesis	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMG200032086	K11778	ko01110	Biosynthesis of secondary metabolites	1110	2.2e-55	0.58	0.76	0.74
PGSC0003DMG200032094	K01239	ko00230	Purine metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMG200032094	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMG200032094	K01239	ko01100	Metabolic pathways	288	2.6e-09	0.30	0.46	0.64
PGSC0003DMG200032094	K01239	ko00230	Purine metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMG200032094	K01239	ko00760	Nicotinate and nicotinamide metabolism	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMG200032094	K01239	ko01100	Metabolic pathways	288	7.9e-10	0.28	0.47	0.62
PGSC0003DMG200032094	K01239	ko00230	Purine metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMG200032094	K01239	ko00760	Nicotinate and nicotinamide metabolism	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMG200032094	K01239	ko01100	Metabolic pathways	274	2.8e-09	0.31	0.44	0.74
PGSC0003DMG200043575	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.58	0.66	0.84
PGSC0003DMG200040224	K04428	ko04010	MAPK signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMG200040224	K04428	ko04912	GnRH signaling pathway	492	2.7e-21	0.36	0.55	0.77
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1047	6.5e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1041	1.4e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K05275	ko00750	Vitamin B6 metabolism	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMG200006439	K05275	ko01100	Metabolic pathways	279	1.5e-09	0.57	0.78	0.92
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1050	4.4e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1043	1.1e-51	0.45	0.60	0.94
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.46	0.63	0.91
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1053	3.0e-52	0.45	0.61	0.94
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1037	2.3e-51	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	1048	5.7e-52	0.45	0.60	0.97
PGSC0003DMG200006439	K00100	ko00051	Fructose and mannose metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006439	K00100	ko00363	Bisphenol A degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006439	K00100	ko00591	Linoleic acid metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006439	K00100	ko00625	Tetrachloroethene degradation	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006439	K00100	ko00650	Butanoate metabolism	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006439	K00100	ko01100	Metabolic pathways	283	9.0e-10	0.62	0.71	0.92
PGSC0003DMG200006440	K00100	ko00051	Fructose and mannose metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006440	K00100	ko00363	Bisphenol A degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006440	K00100	ko00591	Linoleic acid metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006440	K00100	ko00625	Tetrachloroethene degradation	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006440	K00100	ko00650	Butanoate metabolism	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006440	K00100	ko01100	Metabolic pathways	645	9.7e-30	0.49	0.65	0.73
PGSC0003DMG200006441	K11251	ko05322	Systemic lupus erythematosus	521	6.7e-23	0.88	0.92	0.96
PGSC0003DMG200006441	K11251	ko05322	Systemic lupus erythematosus	1042	1.2e-51	0.91	0.92	0.99
PGSC0003DMG200011384	K03869	ko04120	Ubiquitin mediated proteolysis	1753	7.5e-91	0.36	0.56	0.98
PGSC0003DMG200011385	K08065	ko04612	Antigen processing and presentation	564	2.8e-25	0.57	0.74	0.85
PGSC0003DMG200011389	K06632	ko04110	Cell cycle	843	5.6e-50	0.76	0.86	0.90
PGSC0003DMG200011389	K06632	ko04110	Cell cycle	2330	1.1e-122	0.79	0.89	0.94
PGSC0003DMG200011389	K06632	ko04110	Cell cycle	2132	9.3e-112	0.79	0.89	0.92
PGSC0003DMG200011391	K00416	ko00190	Oxidative phosphorylation	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko01100	Metabolic pathways	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko04260	Cardiac muscle contraction	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko05010	Alzheimer's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko05016	Huntington's disease	437	2.9e-18	0.67	0.83	0.99
PGSC0003DMG200011391	K00416	ko00190	Oxidative phosphorylation	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011391	K00416	ko01100	Metabolic pathways	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011391	K00416	ko04260	Cardiac muscle contraction	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011391	K00416	ko05010	Alzheimer's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011391	K00416	ko05012	Parkinson's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011391	K00416	ko05016	Huntington's disease	369	1.6e-14	0.67	0.82	0.98
PGSC0003DMG200011392	K00416	ko00190	Oxidative phosphorylation	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko01100	Metabolic pathways	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko04260	Cardiac muscle contraction	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko05010	Alzheimer's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko05012	Parkinson's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko05016	Huntington's disease	325	4.3e-12	0.47	0.63	0.61
PGSC0003DMG200011392	K00416	ko00190	Oxidative phosphorylation	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011392	K00416	ko01100	Metabolic pathways	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011392	K00416	ko04260	Cardiac muscle contraction	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011392	K00416	ko05010	Alzheimer's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011392	K00416	ko05012	Parkinson's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011392	K00416	ko05016	Huntington's disease	436	3.3e-18	0.73	0.83	0.91
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	1934	7.8e-101	0.78	0.91	1.00
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	1169	1.2e-58	0.74	0.89	0.97
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	697	1.3e-32	0.75	0.86	0.93
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	2681	4.9e-142	0.72	0.85	0.99
PGSC0003DMG200011393	K03845	ko00510	N-Glycan biosynthesis	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMG200011393	K03845	ko01100	Metabolic pathways	1445	7.3e-74	0.76	0.91	0.91
PGSC0003DMG200013544	K01853	ko00100	Steroid biosynthesis	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMG200013544	K01853	ko01100	Metabolic pathways	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMG200013544	K01853	ko01110	Biosynthesis of secondary metabolites	3395	2.0e-181	0.53	0.70	0.99
PGSC0003DMG200013546	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMG200013546	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMG200013546	K00695	ko00500	Starch and sucrose metabolism	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMG200013546	K00695	ko01100	Metabolic pathways	5481	1.8e-296	0.80	0.89	1.00
PGSC0003DMG200013546	K00695	ko00500	Starch and sucrose metabolism	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMG200013546	K00695	ko01100	Metabolic pathways	5433	8.0e-294	0.80	0.89	0.98
PGSC0003DMG200013546	K00695	ko00500	Starch and sucrose metabolism	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMG200013546	K00695	ko01100	Metabolic pathways	4499	2.6e-242	0.83	0.91	0.98
PGSC0003DMG200013547	K00695	ko00500	Starch and sucrose metabolism	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMG200013547	K00695	ko01100	Metabolic pathways	4744	8.0e-256	0.70	0.83	0.99
PGSC0003DMG200013550	K08008	ko04145	Phagosome	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMG200013550	K08008	ko04670	Leukocyte transendothelial migration	1200	2.4e-60	0.35	0.51	0.59
PGSC0003DMG200013550	K08008	ko04145	Phagosome	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMG200013550	K08008	ko04670	Leukocyte transendothelial migration	686	5.3e-32	0.31	0.47	0.48
PGSC0003DMG200013550	K08008	ko04145	Phagosome	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMG200013550	K08008	ko04670	Leukocyte transendothelial migration	320	1.3e-11	0.32	0.47	0.91
PGSC0003DMG200013553	K01051	ko00040	Pentose and glucuronate interconversions	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMG200013553	K01051	ko00500	Starch and sucrose metabolism	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMG200013553	K01051	ko01100	Metabolic pathways	319	1.7e-11	0.30	0.59	0.87
PGSC0003DMG200013557	K12356	ko00940	Phenylpropanoid biosynthesis	461	1.4e-19	0.47	0.65	0.93
PGSC0003DMG200013560	K10595	ko04120	Ubiquitin mediated proteolysis	731	1.5e-34	0.35	0.51	0.97
PGSC0003DMG200013561	K00161	ko00010	Glycolysis / Gluconeogenesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko00020	Citrate cycle (TCA cycle)	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko00290	Valine, leucine and isoleucine biosynthesis	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko00620	Pyruvate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko00650	Butanoate metabolism	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko01100	Metabolic pathways	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200013561	K00161	ko01110	Biosynthesis of secondary metabolites	3101	3.3e-165	0.84	0.91	1.00
PGSC0003DMG200004557	K08490	ko04130	SNARE interactions in vesicular transport	1791	6.0e-93	0.75	0.83	0.99
PGSC0003DMG200004557	K08490	ko04130	SNARE interactions in vesicular transport	465	8.2e-20	0.71	0.83	0.67
PGSC0003DMG200004557	K08490	ko04130	SNARE interactions in vesicular transport	2178	2.7e-114	0.76	0.85	1.00
PGSC0003DMG200004560	K02877	ko03010	Ribosome	337	9.4e-13	0.65	0.75	0.83
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.98
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.80	0.89	1.00
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	362	3.9e-14	0.60	0.70	0.87
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	1696	1.0e-87	0.74	0.83	1.00
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.71	0.81	0.87
PGSC0003DMG200004569	K11755	ko00340	Histidine metabolism	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMG200004569	K11755	ko01100	Metabolic pathways	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMG200004569	K11755	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.84	0.93	0.77
PGSC0003DMG200020156	K01728	ko00040	Pentose and glucuronate interconversions	2893	9.9e-154	0.78	0.87	0.97
PGSC0003DMG200020157	K12859	ko03040	Spliceosome	403	2.2e-16	0.41	0.58	0.89
PGSC0003DMG200020163	K10782	ko00061	Fatty acid biosynthesis	2144	2.0e-112	0.76	0.87	0.90
PGSC0003DMG200020165	K03007	ko00230	Purine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMG200020165	K03007	ko00240	Pyrimidine metabolism	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMG200020165	K03007	ko01100	Metabolic pathways	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMG200020165	K03007	ko03020	RNA polymerase	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMG200020165	K03007	ko05016	Huntington's disease	524	4.6e-23	0.94	0.95	0.86
PGSC0003DMG200020165	K03007	ko00230	Purine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMG200020165	K03007	ko00240	Pyrimidine metabolism	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMG200020165	K03007	ko01100	Metabolic pathways	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMG200020165	K03007	ko03020	RNA polymerase	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMG200020165	K03007	ko05016	Huntington's disease	583	2.5e-26	0.96	0.96	0.99
PGSC0003DMG200020168	K10949	ko05110	Vibrio cholerae infection	489	3.9e-21	0.33	0.55	0.82
PGSC0003DMG200020169	K10949	ko05110	Vibrio cholerae infection	512	2.1e-22	0.35	0.57	0.82
PGSC0003DMG200020170	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMG200020170	K00517	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMG200020170	K00517	ko00903	Limonene and pinene degradation	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMG200020170	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMG200020170	K00517	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.58	0.77	0.98
PGSC0003DMG200020170	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMG200020170	K00517	ko00626	Naphthalene and anthracene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMG200020170	K00517	ko00903	Limonene and pinene degradation	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMG200020170	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMG200020170	K00517	ko01110	Biosynthesis of secondary metabolites	1294	1.6e-65	0.49	0.68	0.99
PGSC0003DMG200020170	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMG200020170	K00517	ko00626	Naphthalene and anthracene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMG200020170	K00517	ko00903	Limonene and pinene degradation	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMG200020170	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMG200020170	K00517	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.46	0.66	0.99
PGSC0003DMG200029954	K01184	ko00040	Pentose and glucuronate interconversions	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMG200029954	K01184	ko00500	Starch and sucrose metabolism	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMG200029954	K01184	ko01100	Metabolic pathways	2059	9.9e-108	0.61	0.75	0.86
PGSC0003DMG200029958	K12667	ko00510	N-Glycan biosynthesis	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMG200029958	K12667	ko01100	Metabolic pathways	847	7.0e-41	0.47	0.58	0.34
PGSC0003DMG200029958	K12667	ko00510	N-Glycan biosynthesis	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMG200029958	K12667	ko01100	Metabolic pathways	321	1.6e-09	0.28	0.44	0.90
PGSC0003DMG200025841	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko00940	Phenylpropanoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00941	Flavonoid biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko01110	Biosynthesis of secondary metabolites	310	2.9e-11	0.31	0.49	0.87
PGSC0003DMG200025841	K13065	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko00941	Flavonoid biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025841	K13065	ko01110	Biosynthesis of secondary metabolites	500	9.6e-22	0.29	0.47	0.82
PGSC0003DMG200025842	K13065	ko00940	Phenylpropanoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMG200025842	K13065	ko00941	Flavonoid biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMG200025842	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMG200025842	K13065	ko01110	Biosynthesis of secondary metabolites	467	6.4e-20	0.29	0.45	0.82
PGSC0003DMG200025843	K13065	ko00940	Phenylpropanoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMG200025843	K13065	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMG200025843	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMG200025843	K13065	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.31	0.46	0.82
PGSC0003DMG200025848	K10352	ko04530	Tight junction	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMG200025848	K10352	ko05416	Viral myocarditis	403	1.8e-12	0.25	0.44	0.79
PGSC0003DMG200025849	K01952	ko00230	Purine metabolism	6579	0.	0.84	0.92	1.00
PGSC0003DMG200025849	K01952	ko01100	Metabolic pathways	6579	0.	0.84	0.92	1.00
PGSC0003DMG200025849	K01952	ko01110	Biosynthesis of secondary metabolites	6579	0.	0.84	0.92	1.00
PGSC0003DMG200035878	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2276	1.1e-119	0.64	0.79	1.00
PGSC0003DMG200035881	K10760	ko00908	Zeatin biosynthesis	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMG200035881	K10760	ko01100	Metabolic pathways	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMG200035881	K10760	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.45	0.61	0.90
PGSC0003DMG200002111	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMG200002111	K00517	ko00626	Naphthalene and anthracene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMG200002111	K00517	ko00903	Limonene and pinene degradation	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMG200002111	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMG200002111	K00517	ko01110	Biosynthesis of secondary metabolites	342	5.0e-13	0.53	0.65	0.74
PGSC0003DMG200002119	K08505	ko04130	SNARE interactions in vesicular transport	764	2.6e-36	0.68	0.82	0.99
PGSC0003DMG200002120	K02971	ko03010	Ribosome	658	1.9e-30	0.91	0.98	0.99
PGSC0003DMG200002121	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMG200002121	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMG200002121	K02971	ko03010	Ribosome	594	6.3e-27	0.92	0.97	0.99
PGSC0003DMG200002126	K01507	ko00190	Oxidative phosphorylation	812	6.0e-39	0.86	0.93	0.76
PGSC0003DMG200011829	K12356	ko00940	Phenylpropanoid biosynthesis	221	5.5e-06	0.35	0.47	0.52
PGSC0003DMG200011836	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	785	1.8e-37	0.36	0.53	0.87
PGSC0003DMG200011837	K02209	ko03030	DNA replication	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMG200011837	K02209	ko04110	Cell cycle	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMG200011837	K02209	ko04111	Cell cycle - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMG200011837	K02209	ko04113	Meiosis - yeast	5191	1.8e-280	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6718	0.	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6702	0.	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6708	0.	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6693	0.	0.84	0.92	1.00
PGSC0003DMG200011839	K01535	ko00190	Oxidative phosphorylation	6714	0.	0.84	0.92	1.00
PGSC0003DMG200016682	K10802	ko03410	Base excision repair	533	1.5e-23	0.48	0.64	0.93
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	2389	6.2e-126	0.75	0.86	0.84
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	2660	7.0e-141	0.75	0.86	0.98
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	2915	6.1e-155	0.75	0.87	1.00
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	1087	4.1e-54	0.75	0.87	0.73
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	2984	9.5e-159	0.74	0.86	0.89
PGSC0003DMG200016687	K03885	ko00190	Oxidative phosphorylation	453	3.8e-19	0.77	0.88	0.99
PGSC0003DMG200016688	K05752	ko04810	Regulation of actin cytoskeleton	618	3.0e-28	0.90	0.99	0.97
PGSC0003DMG200015005	K05743	ko04360	Axon guidance	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMG200015005	K05743	ko04666	Fc gamma R-mediated phagocytosis	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMG200015005	K05743	ko04810	Regulation of actin cytoskeleton	293	2.0e-09	0.33	0.50	0.88
PGSC0003DMG200015007	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04010	MAPK signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04011	MAPK signaling pathway - yeast	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04012	ErbB signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04020	Calcium signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04070	Phosphatidylinositol signaling system	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04270	Vascular smooth muscle contraction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04310	Wnt signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04370	VEGF signaling pathway	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04510	Focal adhesion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04530	Tight junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04540	Gap junction	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04650	Natural killer cell mediated cytotoxicity	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04666	Fc gamma R-mediated phagocytosis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04670	Leukocyte transendothelial migration	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04720	Long-term potentiation	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04730	Long-term depression	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04745	Phototransduction - fly	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04916	Melanogenesis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04960	Aldosterone-regulated sodium reabsorption	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04970	Salivary secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko04971	Gastric acid secretion	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05110	Vibrio cholerae infection	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05146	Amoebiasis	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05200	Pathways in cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05214	Glioma	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015007	K02677	ko05223	Non-small cell lung cancer	254	6.8e-08	0.35	0.46	0.86
PGSC0003DMG200015010	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.64
PGSC0003DMG200015010	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	265	7.1e-08	0.35	0.48	0.61
PGSC0003DMG200016601	K02084	ko04115	p53 signaling pathway	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko04210	Apoptosis	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko05010	Alzheimer's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko05012	Parkinson's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko05016	Huntington's disease	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016601	K02084	ko05222	Small cell lung cancer	301	1.8e-06	0.26	0.44	0.13
PGSC0003DMG200016608	K12126	ko04712	Circadian rhythm - plant	322	4.3e-11	0.29	0.47	0.68
PGSC0003DMG200016608	K12126	ko04712	Circadian rhythm - plant	322	1.4e-10	0.29	0.47	0.66
PGSC0003DMG200016609	K05275	ko00750	Vitamin B6 metabolism	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMG200016609	K05275	ko01100	Metabolic pathways	471	3.8e-20	0.49	0.67	0.89
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	1132	1.3e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K05275	ko00750	Vitamin B6 metabolism	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMG200016609	K05275	ko01100	Metabolic pathways	467	6.4e-20	0.50	0.67	0.89
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	527	3.1e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	526	3.5e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	1130	1.7e-56	0.47	0.65	0.92
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.97
PGSC0003DMG200016609	K00100	ko00051	Fructose and mannose metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00363	Bisphenol A degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00591	Linoleic acid metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00625	Tetrachloroethene degradation	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko00650	Butanoate metabolism	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016609	K00100	ko01100	Metabolic pathways	522	5.9e-23	0.44	0.63	0.96
PGSC0003DMG200016610	K12356	ko00940	Phenylpropanoid biosynthesis	642	1.4e-29	0.41	0.59	0.90
PGSC0003DMG200016613	K01007	ko00620	Pyruvate metabolism	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMG200016613	K01007	ko00720	Reductive carboxylate cycle (CO2 fixation)	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMG200016613	K01007	ko01100	Metabolic pathways	474	7.1e-20	0.33	0.51	0.88
PGSC0003DMG200008954	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMG200008954	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMG200008954	K01674	ko00910	Nitrogen metabolism	1174	6.4e-59	0.54	0.74	0.94
PGSC0003DMG200008956	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMG200008956	K00621	ko00520	Amino sugar and nucleotide sugar metabolism	1031	5.0e-51	0.77	0.92	0.94
PGSC0003DMG200008958	K10575	ko04120	Ubiquitin mediated proteolysis	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMG200008958	K10575	ko05012	Parkinson's disease	1245	7.8e-63	0.83	0.94	0.99
PGSC0003DMG200008960	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMG200008960	K00517	ko00626	Naphthalene and anthracene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMG200008960	K00517	ko00903	Limonene and pinene degradation	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMG200008960	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMG200008960	K00517	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.44	0.64	0.98
PGSC0003DMG200008960	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMG200008960	K00517	ko00626	Naphthalene and anthracene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMG200008960	K00517	ko00903	Limonene and pinene degradation	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMG200008960	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMG200008960	K00517	ko01110	Biosynthesis of secondary metabolites	1523	3.6e-78	0.46	0.64	0.88
PGSC0003DMG200008962	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMG200008962	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMG200008962	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.94
PGSC0003DMG200008962	K01239	ko00230	Purine metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMG200008962	K01239	ko00760	Nicotinate and nicotinamide metabolism	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMG200008962	K01239	ko01100	Metabolic pathways	1954	6.1e-102	0.81	0.93	0.84
PGSC0003DMG200008963	K03126	ko03022	Basal transcription factors	2276	1.1e-119	0.55	0.66	1.00
PGSC0003DMG200005054	K01509	ko00230	Purine metabolism	1248	5.3e-63	0.32	0.45	0.62
PGSC0003DMG200005054	K01509	ko00230	Purine metabolism	1292	2.0e-65	0.32	0.46	0.63
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	485	6.5e-21	0.70	0.85	0.94
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	1717	7.2e-89	0.70	0.83	0.98
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	2679	6.3e-142	0.67	0.81	0.96
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko00600	Sphingolipid metabolism	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko01100	Metabolic pathways	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04020	Calcium signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04370	VEGF signaling pathway	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005056	K04718	ko04666	Fc gamma R-mediated phagocytosis	1237	2.2e-62	0.66	0.81	0.79
PGSC0003DMG200005059	K13065	ko00940	Phenylpropanoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMG200005059	K13065	ko00941	Flavonoid biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMG200005059	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMG200005059	K13065	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.29	0.48	0.94
PGSC0003DMG200005061	K13065	ko00940	Phenylpropanoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMG200005061	K13065	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMG200005061	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMG200005061	K13065	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.28	0.46	0.92
PGSC0003DMG200005062	K00430	ko00360	Phenylalanine metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMG200005062	K00430	ko00680	Methane metabolism	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMG200005062	K00430	ko00940	Phenylpropanoid biosynthesis	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMG200005062	K00430	ko01100	Metabolic pathways	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMG200005062	K00430	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.47	0.63	0.87
PGSC0003DMG200005065	K08695	ko00941	Flavonoid biosynthesis	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMG200005065	K08695	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.64	0.78	0.97
PGSC0003DMG200018810	K00558	ko00270	Cysteine and methionine metabolism	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMG200018810	K00558	ko01100	Metabolic pathways	484	7.7e-20	0.35	0.49	0.96
PGSC0003DMG200018822	K02219	ko04111	Cell cycle - yeast	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMG200018822	K02219	ko05200	Pathways in cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMG200018822	K02219	ko05222	Small cell lung cancer	734	1.2e-34	0.95	0.97	0.99
PGSC0003DMG200027037	K10352	ko04530	Tight junction	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMG200027037	K10352	ko05416	Viral myocarditis	626	1.5e-27	0.29	0.48	0.94
PGSC0003DMG200027041	K04649	ko04120	Ubiquitin mediated proteolysis	1368	1.3e-69	0.82	0.92	0.99
PGSC0003DMG200027042	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.62
PGSC0003DMG200027042	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMG200027042	K12126	ko04712	Circadian rhythm - plant	292	4.5e-10	0.38	0.64	0.38
PGSC0003DMG200027044	K00680	ko00350	Tyrosine metabolism	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMG200027044	K00680	ko00624	1- and 2-Methylnaphthalene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMG200027044	K00680	ko00632	Benzoate degradation via CoA ligation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMG200027044	K00680	ko00642	Ethylbenzene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMG200027044	K00680	ko00903	Limonene and pinene degradation	299	1.2e-10	0.36	0.51	0.91
PGSC0003DMG200027045	K02984	ko03010	Ribosome	1973	5.5e-103	0.90	0.95	1.00
PGSC0003DMG200027050	K11097	ko03040	Spliceosome	698	1.2e-32	0.95	0.98	0.99
PGSC0003DMG200027051	K00599	ko00340	Histidine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMG200027051	K00599	ko00350	Tyrosine metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMG200027051	K00599	ko00450	Selenoamino acid metabolism	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMG200027051	K00599	ko00626	Naphthalene and anthracene degradation	351	1.6e-13	0.43	0.64	0.98
PGSC0003DMG200027051	K00599	ko00340	Histidine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMG200027051	K00599	ko00350	Tyrosine metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMG200027051	K00599	ko00450	Selenoamino acid metabolism	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMG200027051	K00599	ko00626	Naphthalene and anthracene degradation	1281	8.1e-65	0.57	0.72	0.99
PGSC0003DMG200023241	K12874	ko03040	Spliceosome	2349	3.1e-125	0.78	0.83	0.90
PGSC0003DMG200023241	K12874	ko03040	Spliceosome	1236	2.5e-62	0.89	0.94	0.84
PGSC0003DMG200023247	K02138	ko00190	Oxidative phosphorylation	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMG200023247	K02138	ko01100	Metabolic pathways	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMG200023247	K02138	ko05010	Alzheimer's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMG200023247	K02138	ko05012	Parkinson's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMG200023247	K02138	ko05016	Huntington's disease	753	1.1e-35	0.97	0.99	0.99
PGSC0003DMG200023247	K02138	ko00190	Oxidative phosphorylation	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMG200023247	K02138	ko01100	Metabolic pathways	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMG200023247	K02138	ko05010	Alzheimer's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMG200023247	K02138	ko05012	Parkinson's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMG200023247	K02138	ko05016	Huntington's disease	1308	2.6e-66	0.90	0.95	0.99
PGSC0003DMG200023247	K02138	ko00190	Oxidative phosphorylation	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMG200023247	K02138	ko01100	Metabolic pathways	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMG200023247	K02138	ko05010	Alzheimer's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMG200023247	K02138	ko05012	Parkinson's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMG200023247	K02138	ko05016	Huntington's disease	1024	1.2e-50	0.82	0.90	0.95
PGSC0003DMG200023249	K02084	ko04115	p53 signaling pathway	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko04210	Apoptosis	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko05010	Alzheimer's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko05012	Parkinson's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko05016	Huntington's disease	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023249	K02084	ko05222	Small cell lung cancer	291	1.0e-06	0.27	0.45	0.56
PGSC0003DMG200023255	K10591	ko04120	Ubiquitin mediated proteolysis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMG200023255	K10591	ko04144	Endocytosis	1201	1.1e-66	0.47	0.60	0.87
PGSC0003DMG200023255	K10591	ko04120	Ubiquitin mediated proteolysis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMG200023255	K10591	ko04144	Endocytosis	265	5.1e-08	0.38	0.54	0.93
PGSC0003DMG200035710	K04124	ko00904	Diterpenoid biosynthesis	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMG200035710	K04124	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.47	0.62	0.98
PGSC0003DMG200035711	K02639	ko00195	Photosynthesis	845	9.0e-41	0.71	0.81	0.99
PGSC0003DMG200011294	K12133	ko04712	Circadian rhythm - plant	2050	3.1e-107	0.44	0.55	1.00
PGSC0003DMG200011297	K12130	ko04712	Circadian rhythm - plant	1396	3.7e-71	0.40	0.53	0.96
PGSC0003DMG200011299	K00558	ko00270	Cysteine and methionine metabolism	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMG200011299	K00558	ko01100	Metabolic pathways	308	4.9e-10	0.33	0.48	0.75
PGSC0003DMG200011314	K10527	ko00592	alpha-Linolenic acid metabolism	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMG200011314	K10527	ko01100	Metabolic pathways	1680	8.0e-87	0.71	0.84	0.96
PGSC0003DMG200011319	K02971	ko03010	Ribosome	645	9.7e-30	0.89	0.95	0.99
PGSC0003DMG200004600	K01275	ko04142	Lysosome	283	9.9e-10	0.34	0.46	0.77
PGSC0003DMG200004600	K01365	ko04142	Lysosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMG200004600	K01365	ko04145	Phagosome	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMG200004600	K01365	ko04612	Antigen processing and presentation	233	5.1e-07	0.30	0.53	0.80
PGSC0003DMG200004605	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMG200004605	K02977	ko03010	Ribosome	1212	5.2e-61	0.99	0.99	0.81
PGSC0003DMG200004608	K00382	ko00010	Glycolysis / Gluconeogenesis	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko00020	Citrate cycle (TCA cycle)	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko00260	Glycine, serine and threonine metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko00280	Valine, leucine and isoleucine degradation	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko00620	Pyruvate metabolism	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko01100	Metabolic pathways	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004608	K00382	ko01110	Biosynthesis of secondary metabolites	3713	5.9e-199	0.87	0.94	1.00
PGSC0003DMG200004609	K02945	ko03010	Ribosome	2753	5.2e-146	0.80	0.90	1.00
PGSC0003DMG200007717	K00121	ko00010	Glycolysis / Gluconeogenesis	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00071	Fatty acid metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00350	Tyrosine metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00624	1- and 2-Methylnaphthalene degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00641	3-Chloroacrylic acid degradation	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00680	Methane metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00830	Retinol metabolism	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko00982	Drug metabolism - cytochrome P450	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko01100	Metabolic pathways	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007717	K00121	ko01110	Biosynthesis of secondary metabolites	3058	7.9e-163	0.94	0.98	0.99
PGSC0003DMG200007719	K09553	ko05020	Prion diseases	286	1.4e-09	0.36	0.51	0.65
PGSC0003DMG200007719	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMG200007719	K09553	ko05020	Prion diseases	286	1.1e-09	0.33	0.48	0.59
PGSC0003DMG200007720	K06061	ko04330	Notch signaling pathway	337	2.0e-09	0.28	0.42	0.49
PGSC0003DMG200007731	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMG200007731	K02975	ko03010	Ribosome	528	2.8e-23	0.91	1.00	0.99
PGSC0003DMG200007732	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMG200007732	K05288	ko01100	Metabolic pathways	327	2.4e-11	0.33	0.50	0.87
PGSC0003DMG200007732	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMG200007732	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMG200007732	K05288	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMG200007732	K05288	ko01100	Metabolic pathways	1136	8.0e-57	0.39	0.56	0.81
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	529	1.5e-22	0.65	0.82	0.98
PGSC0003DMG200013212	K06675	ko04111	Cell cycle - yeast	329	3.3e-11	0.87	0.89	0.81
PGSC0003DMG200013222	K13065	ko00940	Phenylpropanoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMG200013222	K13065	ko00941	Flavonoid biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMG200013222	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMG200013222	K13065	ko01110	Biosynthesis of secondary metabolites	350	1.8e-13	0.38	0.55	0.86
PGSC0003DMG200013223	K13065	ko00940	Phenylpropanoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMG200013223	K13065	ko00941	Flavonoid biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMG200013223	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMG200013223	K13065	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.29	0.44	0.80
PGSC0003DMG200013228	K12929	ko00904	Diterpenoid biosynthesis	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMG200013228	K12929	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.46	0.65	0.92
PGSC0003DMG200013230	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMG200013230	K00517	ko00626	Naphthalene and anthracene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMG200013230	K00517	ko00903	Limonene and pinene degradation	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMG200013230	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMG200013230	K00517	ko01110	Biosynthesis of secondary metabolites	1050	4.4e-52	0.49	0.67	0.94
PGSC0003DMG200013230	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMG200013230	K00517	ko00626	Naphthalene and anthracene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMG200013230	K00517	ko00903	Limonene and pinene degradation	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMG200013230	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMG200013230	K00517	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.44	0.63	0.96
PGSC0003DMG200013235	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMG200013235	K01915	ko00330	Arginine and proline metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMG200013235	K01915	ko00910	Nitrogen metabolism	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMG200013235	K01915	ko01100	Metabolic pathways	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMG200013235	K01915	ko02020	Two-component system	2841	7.3e-151	0.90	0.97	0.99
PGSC0003DMG200039764	K02940	ko03010	Ribosome	293	2.5e-10	0.62	0.72	0.65
PGSC0003DMG200039769	K05282	ko00904	Diterpenoid biosynthesis	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMG200039769	K05282	ko01100	Metabolic pathways	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMG200039769	K05282	ko01110	Biosynthesis of secondary metabolites	416	4.1e-17	0.61	0.77	0.91
PGSC0003DMG200028097	K00059	ko00061	Fatty acid biosynthesis	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMG200028097	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMG200028097	K00059	ko01100	Metabolic pathways	1492	1.9e-76	0.63	0.78	1.00
PGSC0003DMG200028097	K00059	ko00061	Fatty acid biosynthesis	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMG200028097	K00059	ko01040	Biosynthesis of unsaturated fatty acids	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMG200028097	K00059	ko01100	Metabolic pathways	720	7.1e-34	0.64	0.82	0.99
PGSC0003DMG200028097	K00059	ko00061	Fatty acid biosynthesis	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMG200028097	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMG200028097	K00059	ko01100	Metabolic pathways	1481	7.5e-76	0.62	0.81	1.00
PGSC0003DMG200028099	K05868	ko04110	Cell cycle	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMG200028099	K05868	ko04115	p53 signaling pathway	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMG200028099	K05868	ko04914	Progesterone-mediated oocyte maturation	2426	5.7e-128	0.66	0.78	0.99
PGSC0003DMG200028099	K05868	ko04110	Cell cycle	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMG200028099	K05868	ko04115	p53 signaling pathway	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMG200028099	K05868	ko04914	Progesterone-mediated oocyte maturation	753	1.1e-35	0.63	0.76	0.97
PGSC0003DMG200028101	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMG200028101	K01491	ko00670	One carbon pool by folate	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMG200028101	K01491	ko01100	Metabolic pathways	723	4.8e-34	0.88	0.96	0.99
PGSC0003DMG200028101	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMG200028101	K01491	ko00670	One carbon pool by folate	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMG200028101	K01491	ko01100	Metabolic pathways	1499	7.6e-77	0.88	0.96	0.84
PGSC0003DMG200028101	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMG200028101	K01491	ko00670	One carbon pool by folate	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMG200028101	K01491	ko01100	Metabolic pathways	2181	1.9e-114	0.88	0.96	0.98
PGSC0003DMG200028105	K08503	ko04130	SNARE interactions in vesicular transport	1180	3.0e-59	0.62	0.81	1.00
PGSC0003DMG200028106	K12828	ko03040	Spliceosome	7426	0.	0.72	0.80	0.98
PGSC0003DMG200028108	K02727	ko03050	Proteasome	2013	3.4e-105	0.95	0.98	1.00
PGSC0003DMG200028110	K10583	ko04120	Ubiquitin mediated proteolysis	632	5.0e-29	0.85	0.93	0.92
PGSC0003DMG200028110	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMG200028110	K10583	ko04120	Ubiquitin mediated proteolysis	1696	1.0e-87	0.78	0.86	1.00
PGSC0003DMG200028110	K10583	ko04120	Ubiquitin mediated proteolysis	792	7.6e-38	0.67	0.77	0.99
PGSC0003DMG200021319	K10591	ko04120	Ubiquitin mediated proteolysis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMG200021319	K10591	ko04144	Endocytosis	283	2.6e-06	0.31	0.48	0.18
PGSC0003DMG200021322	K09480	ko00561	Glycerolipid metabolism	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMG200021322	K09480	ko01100	Metabolic pathways	4451	1.2e-239	0.67	0.79	0.99
PGSC0003DMG200021322	K09480	ko00561	Glycerolipid metabolism	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMG200021322	K09480	ko01100	Metabolic pathways	3817	1.1e-204	0.77	0.88	0.99
PGSC0003DMG200024531	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMG200024531	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMG200024531	K02717	ko00195	Photosynthesis	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMG200024531	K02717	ko01100	Metabolic pathways	1058	1.6e-52	0.79	0.88	0.71
PGSC0003DMG200024531	K02717	ko00195	Photosynthesis	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMG200024531	K02717	ko01100	Metabolic pathways	1118	7.9e-56	0.60	0.77	0.94
PGSC0003DMG200024532	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMG200024532	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMG200024532	K05657	ko02010	ABC transporters	916	1.1e-44	0.38	0.56	0.95
PGSC0003DMG200024532	K05657	ko02010	ABC transporters	1896	9.7e-99	0.44	0.63	0.98
PGSC0003DMG200038580	K07385	ko00902	Monoterpenoid biosynthesis	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMG200038580	K07385	ko01100	Metabolic pathways	737	8.2e-35	0.59	0.76	0.94
PGSC0003DMG200010653	K06096	ko04530	Tight junction	288	4.8e-10	0.26	0.45	0.80
PGSC0003DMG200010653	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMG200010653	K06096	ko04530	Tight junction	286	6.1e-10	0.27	0.45	0.73
PGSC0003DMG200010657	K07200	ko04910	Insulin signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMG200010657	K07200	ko04920	Adipocytokine signaling pathway	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMG200010657	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	567	1.9e-25	0.44	0.56	0.47
PGSC0003DMG200010657	K07200	ko04910	Insulin signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMG200010657	K07200	ko04920	Adipocytokine signaling pathway	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMG200010657	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	677	1.7e-31	0.35	0.56	0.73
PGSC0003DMG200010657	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010657	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010657	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010657	K07200	ko04910	Insulin signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010657	K07200	ko04920	Adipocytokine signaling pathway	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010657	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1238	1.9e-62	0.39	0.56	0.98
PGSC0003DMG200010659	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMG200010659	K03785	ko01100	Metabolic pathways	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMG200010659	K03785	ko01110	Biosynthesis of secondary metabolites	2935	4.8e-156	0.68	0.81	0.99
PGSC0003DMG200007012	K04506	ko04115	p53 signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMG200007012	K04506	ko04120	Ubiquitin mediated proteolysis	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMG200007012	K04506	ko04310	Wnt signaling pathway	2493	1.1e-131	0.82	0.89	1.00
PGSC0003DMG200007013	K01528	ko04144	Endocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMG200007013	K01528	ko04666	Fc gamma R-mediated phagocytosis	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMG200007013	K01528	ko05100	Bacterial invasion of epithelial cells	1540	4.2e-79	0.44	0.63	0.81
PGSC0003DMG200007013	K01528	ko04144	Endocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMG200007013	K01528	ko04666	Fc gamma R-mediated phagocytosis	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMG200007013	K01528	ko05100	Bacterial invasion of epithelial cells	1558	4.3e-80	0.44	0.63	0.80
PGSC0003DMG200007016	K13082	ko00941	Flavonoid biosynthesis	1058	1.6e-52	0.44	0.63	0.97
PGSC0003DMG200007017	K08679	ko00500	Starch and sucrose metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMG200007017	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMG200007017	K08679	ko01100	Metabolic pathways	3134	5.1e-167	0.84	0.92	1.00
PGSC0003DMG200007018	K00800	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMG200007018	K00800	ko01100	Metabolic pathways	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMG200007018	K00800	ko01110	Biosynthesis of secondary metabolites	3393	2.6e-181	0.78	0.87	1.00
PGSC0003DMG200007019	K00615	ko00030	Pentose phosphate pathway	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMG200007019	K00615	ko00710	Carbon fixation in photosynthetic organisms	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMG200007019	K00615	ko01051	Biosynthesis of ansamycins	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMG200007019	K00615	ko01100	Metabolic pathways	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMG200007019	K00615	ko01110	Biosynthesis of secondary metabolites	5458	3.3e-295	0.86	0.92	1.00
PGSC0003DMG200007020	K10870	ko03440	Homologous recombination	1117	9.0e-56	0.46	0.66	0.91
PGSC0003DMG200007021	K06636	ko04110	Cell cycle	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMG200007021	K06636	ko04111	Cell cycle - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMG200007021	K06636	ko04113	Meiosis - yeast	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMG200007021	K06636	ko04114	Oocyte meiosis	301	5.9e-08	0.27	0.48	0.57
PGSC0003DMG200007024	K01178	ko00500	Starch and sucrose metabolism	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMG200007024	K01178	ko01100	Metabolic pathways	294	2.1e-07	0.28	0.44	0.61
PGSC0003DMG200003897	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003897	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003897	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003897	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003897	K10144	ko04115	p53 signaling pathway	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMG200003897	K10144	ko04120	Ubiquitin mediated proteolysis	1756	5.1e-91	0.65	0.80	0.98
PGSC0003DMG200003897	K10144	ko04115	p53 signaling pathway	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003897	K10144	ko04120	Ubiquitin mediated proteolysis	824	1.3e-39	0.66	0.81	0.90
PGSC0003DMG200003899	K00889	ko00562	Inositol phosphate metabolism	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko01100	Metabolic pathways	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko04070	Phosphatidylinositol signaling system	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko04144	Endocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko04666	Fc gamma R-mediated phagocytosis	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko04810	Regulation of actin cytoskeleton	433	1.1e-17	0.62	0.76	0.92
PGSC0003DMG200003899	K00889	ko00562	Inositol phosphate metabolism	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko01100	Metabolic pathways	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko04070	Phosphatidylinositol signaling system	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko04144	Endocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko04666	Fc gamma R-mediated phagocytosis	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko04810	Regulation of actin cytoskeleton	1292	2.0e-65	0.46	0.61	0.85
PGSC0003DMG200003899	K00889	ko00562	Inositol phosphate metabolism	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko01100	Metabolic pathways	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko04070	Phosphatidylinositol signaling system	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko04144	Endocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko04666	Fc gamma R-mediated phagocytosis	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko04810	Regulation of actin cytoskeleton	1226	8.7e-62	0.61	0.74	0.97
PGSC0003DMG200003899	K00889	ko00562	Inositol phosphate metabolism	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003899	K00889	ko01100	Metabolic pathways	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003899	K00889	ko04070	Phosphatidylinositol signaling system	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003899	K00889	ko04144	Endocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003899	K00889	ko04666	Fc gamma R-mediated phagocytosis	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003899	K00889	ko04810	Regulation of actin cytoskeleton	3506	1.5e-187	0.57	0.70	0.93
PGSC0003DMG200003902	K10603	ko04120	Ubiquitin mediated proteolysis	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMG200003902	K10603	ko05340	Primary immunodeficiency	315	1.3e-09	0.28	0.44	0.57
PGSC0003DMG200003902	K10603	ko04120	Ubiquitin mediated proteolysis	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMG200003902	K10603	ko05340	Primary immunodeficiency	339	2.7e-10	0.27	0.44	0.39
PGSC0003DMG200003902	K10603	ko04120	Ubiquitin mediated proteolysis	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMG200003902	K10603	ko05340	Primary immunodeficiency	325	4.5e-10	0.27	0.44	0.59
PGSC0003DMG200003903	K10352	ko04530	Tight junction	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMG200003903	K10352	ko05416	Viral myocarditis	849	9.7e-38	0.26	0.46	0.87
PGSC0003DMG200003906	K10527	ko00592	alpha-Linolenic acid metabolism	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMG200003906	K10527	ko01100	Metabolic pathways	3382	1.1e-180	0.59	0.76	0.99
PGSC0003DMG200003906	K10527	ko00592	alpha-Linolenic acid metabolism	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMG200003906	K10527	ko01100	Metabolic pathways	3613	1.9e-193	0.62	0.80	0.99
PGSC0003DMG200003906	K10527	ko00592	alpha-Linolenic acid metabolism	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMG200003906	K10527	ko01100	Metabolic pathways	3588	4.6e-192	0.62	0.80	0.99
PGSC0003DMG200028719	K03707	ko00730	Thiamine metabolism	342	5.0e-13	0.40	0.55	0.30
PGSC0003DMG200028719	K03707	ko00730	Thiamine metabolism	473	3.0e-20	0.38	0.52	0.37
PGSC0003DMG200028727	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMG200028727	K12592	ko03018	RNA degradation	228	9.7e-07	0.30	0.60	0.59
PGSC0003DMG200025137	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00040	Pentose and glucuronate interconversions	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00053	Ascorbate and aldarate metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00500	Starch and sucrose metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko01100	Metabolic pathways	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025137	K00012	ko01110	Biosynthesis of secondary metabolites	3631	2.0e-194	0.91	0.96	1.00
PGSC0003DMG200025139	K00754	ko00051	Fructose and mannose metabolism	521	6.7e-23	0.34	0.52	0.81
PGSC0003DMG200025139	K00754	ko00051	Fructose and mannose metabolism	1418	2.2e-72	0.41	0.59	0.88
PGSC0003DMG200025139	K00754	ko00051	Fructose and mannose metabolism	377	5.9e-15	0.48	0.67	0.95
PGSC0003DMG200025140	K07198	ko04140	Regulation of autophagy	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMG200025140	K07198	ko04150	mTOR signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMG200025140	K07198	ko04910	Insulin signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMG200025140	K07198	ko04920	Adipocytokine signaling pathway	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMG200025140	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	3840	5.8e-206	0.87	0.93	1.00
PGSC0003DMG200025145	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMG200025145	K12811	ko03040	Spliceosome	247	6.6e-07	0.35	0.48	0.58
PGSC0003DMG200025147	K12741	ko03040	Spliceosome	336	1.1e-12	0.35	0.41	0.85
PGSC0003DMG200022055	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3012	2.7e-160	0.59	0.79	1.00
PGSC0003DMG200022056	K03660	ko03410	Base excision repair	880	1.1e-42	0.47	0.63	0.76
PGSC0003DMG200022059	K09843	ko00906	Carotenoid biosynthesis	442	1.5e-18	0.33	0.49	0.97
PGSC0003DMG200022066	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko00380	Tryptophan metabolism	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko01100	Metabolic pathways	4498	3.0e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko00380	Tryptophan metabolism	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko01100	Metabolic pathways	4506	1.1e-242	0.86	0.93	1.00
PGSC0003DMG200022066	K04103	ko00380	Tryptophan metabolism	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMG200022066	K04103	ko01100	Metabolic pathways	4453	9.0e-240	0.85	0.92	1.00
PGSC0003DMG200030636	K08241	ko00592	alpha-Linolenic acid metabolism	751	1.4e-35	0.35	0.52	0.89
PGSC0003DMG200030636	K08241	ko00592	alpha-Linolenic acid metabolism	390	1.1e-15	0.35	0.52	0.84
PGSC0003DMG200030641	K01358	ko04112	Cell cycle - Caulobacter	451	4.9e-19	0.63	0.74	0.99
PGSC0003DMG200030641	K01358	ko04112	Cell cycle - Caulobacter	467	6.4e-20	0.91	0.98	0.82
PGSC0003DMG200030641	K01358	ko04112	Cell cycle - Caulobacter	1776	4.0e-92	0.66	0.80	1.00
PGSC0003DMG200030644	K00868	ko00750	Vitamin B6 metabolism	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMG200030644	K00868	ko01100	Metabolic pathways	1244	8.9e-63	0.82	0.92	0.99
PGSC0003DMG200030644	K00868	ko00750	Vitamin B6 metabolism	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMG200030644	K00868	ko01100	Metabolic pathways	2146	1.6e-112	0.80	0.89	1.00
PGSC0003DMG200030649	K08332	ko04140	Regulation of autophagy	322	9.7e-12	0.27	0.47	0.96
PGSC0003DMG200030652	K02183	ko04020	Calcium signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04070	Phosphatidylinositol signaling system	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04114	Oocyte meiosis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04270	Vascular smooth muscle contraction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04626	Plant-pathogen interaction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04720	Long-term potentiation	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04722	Neurotrophin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04740	Olfactory transduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04744	Phototransduction	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04745	Phototransduction - fly	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04910	Insulin signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04912	GnRH signaling pathway	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04916	Melanogenesis	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04970	Salivary secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko04971	Gastric acid secretion	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko05010	Alzheimer's disease	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030652	K02183	ko05214	Glioma	266	7.8e-09	0.45	0.65	0.99
PGSC0003DMG200030653	K00847	ko00051	Fructose and mannose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMG200030653	K00847	ko00500	Starch and sucrose metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMG200030653	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMG200030653	K00847	ko01100	Metabolic pathways	2393	3.8e-126	0.91	0.97	0.99
PGSC0003DMG200030653	K00847	ko00051	Fructose and mannose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMG200030653	K00847	ko00500	Starch and sucrose metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMG200030653	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMG200030653	K00847	ko01100	Metabolic pathways	2595	2.7e-137	0.81	0.89	0.99
PGSC0003DMG200046426	K03469	ko03030	DNA replication	253	4.0e-08	0.39	0.58	0.60
PGSC0003DMG200046434	K03006	ko00230	Purine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMG200046434	K03006	ko00240	Pyrimidine metabolism	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMG200046434	K03006	ko01100	Metabolic pathways	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMG200046434	K03006	ko03020	RNA polymerase	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMG200046434	K03006	ko05016	Huntington's disease	348	3.4e-12	0.38	0.48	0.52
PGSC0003DMG200042385	K06678	ko04111	Cell cycle - yeast	310	1.3e-07	0.26	0.47	0.40
PGSC0003DMG200015875	K10839	ko03420	Nucleotide excision repair	2574	3.9e-136	0.75	0.85	1.00
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04530	Tight junction	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	1747	1.6e-90	0.86	0.94	0.91
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04530	Tight junction	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	3881	3.2e-208	0.64	0.76	0.96
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04530	Tight junction	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	4291	7.8e-231	0.89	0.95	0.99
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04530	Tight junction	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	3306	1.7e-176	0.52	0.66	0.97
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04530	Tight junction	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	3004	7.5e-160	0.54	0.67	0.93
PGSC0003DMG200015876	K03456	ko04111	Cell cycle - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04113	Meiosis - yeast	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04114	Oocyte meiosis	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04310	Wnt signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04350	TGF-beta signaling pathway	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04530	Tight junction	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko04730	Long-term depression	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015876	K03456	ko05142	Chagas disease	2222	1.0e-116	0.92	0.97	0.91
PGSC0003DMG200015881	K01187	ko00052	Galactose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMG200015881	K01187	ko00500	Starch and sucrose metabolism	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMG200015881	K01187	ko01100	Metabolic pathways	4951	3.1e-267	0.65	0.77	0.99
PGSC0003DMG200005745	K02183	ko04020	Calcium signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04070	Phosphatidylinositol signaling system	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04114	Oocyte meiosis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04270	Vascular smooth muscle contraction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04626	Plant-pathogen interaction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04720	Long-term potentiation	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04722	Neurotrophin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04740	Olfactory transduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04744	Phototransduction	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04745	Phototransduction - fly	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04910	Insulin signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04912	GnRH signaling pathway	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04916	Melanogenesis	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04970	Salivary secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko04971	Gastric acid secretion	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko05010	Alzheimer's disease	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005745	K02183	ko05214	Glioma	423	1.7e-17	0.42	0.61	0.88
PGSC0003DMG200005746	K12831	ko03040	Spliceosome	1407	9.1e-72	0.69	0.77	0.99
PGSC0003DMG200005746	K12831	ko03040	Spliceosome	2591	4.5e-137	0.79	0.85	0.99
PGSC0003DMG200005749	K05929	ko00564	Glycerophospholipid metabolism	611	7.3e-28	0.41	0.57	0.99
PGSC0003DMG200005749	K05929	ko00564	Glycerophospholipid metabolism	741	4.9e-35	0.41	0.59	0.51
PGSC0003DMG200005749	K00599	ko00340	Histidine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMG200005749	K00599	ko00350	Tyrosine metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMG200005749	K00599	ko00450	Selenoamino acid metabolism	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMG200005749	K00599	ko00626	Naphthalene and anthracene degradation	216	4.4e-06	0.38	0.52	0.48
PGSC0003DMG200005751	K01613	ko00564	Glycerophospholipid metabolism	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMG200005751	K01613	ko01100	Metabolic pathways	236	2.9e-06	0.41	0.60	0.51
PGSC0003DMG200005752	K01426	ko00330	Arginine and proline metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005752	K01426	ko00360	Phenylalanine metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005752	K01426	ko00380	Tryptophan metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005752	K01426	ko00460	Cyanoamino acid metabolism	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005752	K01426	ko00632	Benzoate degradation via CoA ligation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005752	K01426	ko00643	Styrene degradation	924	4.0e-45	0.37	0.52	0.71
PGSC0003DMG200005754	K01785	ko00010	Glycolysis / Gluconeogenesis	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMG200005754	K01785	ko01110	Biosynthesis of secondary metabolites	2087	2.8e-109	0.79	0.90	0.94
PGSC0003DMG200005754	K01785	ko00010	Glycolysis / Gluconeogenesis	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMG200005754	K01785	ko01110	Biosynthesis of secondary metabolites	2390	5.5e-126	0.79	0.91	1.00
PGSC0003DMG200005755	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko00363	Bisphenol A degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko00624	1- and 2-Methylnaphthalene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko00626	Naphthalene and anthracene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko00632	Benzoate degradation via CoA ligation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko00903	Limonene and pinene degradation	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko01100	Metabolic pathways	7384	0.	0.66	0.78	0.99
PGSC0003DMG200005755	K00120	ko01110	Biosynthesis of secondary metabolites	7384	0.	0.66	0.78	0.99
PGSC0003DMG200009595	K01915	ko00250	Alanine, aspartate and glutamate metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMG200009595	K01915	ko00330	Arginine and proline metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMG200009595	K01915	ko00910	Nitrogen metabolism	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMG200009595	K01915	ko01100	Metabolic pathways	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMG200009595	K01915	ko02020	Two-component system	501	8.5e-22	0.32	0.49	0.91
PGSC0003DMG200009598	K01115	ko00564	Glycerophospholipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009598	K01115	ko00565	Ether lipid metabolism	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009598	K01115	ko01100	Metabolic pathways	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009598	K01115	ko04144	Endocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009598	K01115	ko04666	Fc gamma R-mediated phagocytosis	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009598	K01115	ko04912	GnRH signaling pathway	853	3.3e-41	0.76	0.86	0.99
PGSC0003DMG200009599	K01115	ko00564	Glycerophospholipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko00565	Ether lipid metabolism	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko01100	Metabolic pathways	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04144	Endocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04666	Fc gamma R-mediated phagocytosis	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04912	GnRH signaling pathway	5573	1.5e-301	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko00564	Glycerophospholipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko00565	Ether lipid metabolism	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko01100	Metabolic pathways	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04144	Endocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04666	Fc gamma R-mediated phagocytosis	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko04912	GnRH signaling pathway	5545	5.3e-300	0.76	0.89	1.00
PGSC0003DMG200009599	K01115	ko00564	Glycerophospholipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009599	K01115	ko00565	Ether lipid metabolism	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009599	K01115	ko01100	Metabolic pathways	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009599	K01115	ko04144	Endocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009599	K01115	ko04666	Fc gamma R-mediated phagocytosis	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009599	K01115	ko04912	GnRH signaling pathway	4555	2.1e-245	0.76	0.89	0.97
PGSC0003DMG200009600	K10260	ko04120	Ubiquitin mediated proteolysis	327	3.4e-12	0.28	0.43	0.72
PGSC0003DMG200009601	K01759	ko00620	Pyruvate metabolism	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMG200009601	K01759	ko04011	MAPK signaling pathway - yeast	576	6.2e-26	0.51	0.70	0.66
PGSC0003DMG200009602	K01179	ko00500	Starch and sucrose metabolism	306	3.0e-08	0.25	0.42	0.65
PGSC0003DMG200009603	K00894	ko00564	Glycerophospholipid metabolism	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMG200009603	K00894	ko01100	Metabolic pathways	231	8.8e-07	0.39	0.58	0.60
PGSC0003DMG200009603	K00894	ko00564	Glycerophospholipid metabolism	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMG200009603	K00894	ko01100	Metabolic pathways	723	4.8e-34	0.43	0.61	0.93
PGSC0003DMG200009603	K00894	ko00564	Glycerophospholipid metabolism	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMG200009603	K00894	ko01100	Metabolic pathways	748	2.0e-35	0.37	0.57	0.92
PGSC0003DMG200009603	K00894	ko00564	Glycerophospholipid metabolism	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMG200009603	K00894	ko01100	Metabolic pathways	898	1.1e-43	0.39	0.57	0.91
PGSC0003DMG200034099	K12655	ko04622	RIG-I-like receptor signaling pathway	292	5.5e-10	0.33	0.55	0.49
PGSC0003DMG200034102	K01652	ko00290	Valine, leucine and isoleucine biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034102	K01652	ko00650	Butanoate metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034102	K01652	ko00660	C5-Branched dibasic acid metabolism	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034102	K01652	ko00770	Pantothenate and CoA biosynthesis	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034102	K01652	ko01100	Metabolic pathways	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034102	K01652	ko01110	Biosynthesis of secondary metabolites	4593	1.7e-247	0.82	0.89	1.00
PGSC0003DMG200034115	K12467	ko00902	Monoterpenoid biosynthesis	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMG200034115	K12467	ko01110	Biosynthesis of secondary metabolites	314	3.5e-11	0.38	0.58	0.94
PGSC0003DMG200034116	K12929	ko00904	Diterpenoid biosynthesis	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMG200034116	K12929	ko01110	Biosynthesis of secondary metabolites	549	1.9e-24	0.40	0.64	0.99
PGSC0003DMG200034122	K02112	ko00190	Oxidative phosphorylation	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMG200034122	K02112	ko00195	Photosynthesis	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMG200034122	K02112	ko01100	Metabolic pathways	469	4.9e-20	0.85	0.92	0.98
PGSC0003DMG200034278	K07385	ko00902	Monoterpenoid biosynthesis	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMG200034278	K07385	ko01100	Metabolic pathways	244	3.2e-07	0.48	0.68	0.89
PGSC0003DMG200034287	K03064	ko03050	Proteasome	306	4.8e-11	0.82	0.95	0.60
PGSC0003DMG200034289	K03064	ko03050	Proteasome	324	4.9e-12	0.87	0.91	0.74
PGSC0003DMG200022501	K04424	ko04010	MAPK signaling pathway	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMG200022501	K04424	ko04530	Tight junction	2720	3.5e-144	0.43	0.58	0.98
PGSC0003DMG200022502	K01520	ko00240	Pyrimidine metabolism	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMG200022502	K01520	ko01100	Metabolic pathways	1052	3.5e-52	0.86	0.93	0.97
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	2013	3.4e-105	0.75	0.88	0.99
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	2027	5.8e-106	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	2016	2.3e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	2022	1.1e-105	0.75	0.89	0.99
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	1414	3.7e-72	0.74	0.89	1.00
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	463	1.1e-19	0.81	0.88	0.86
PGSC0003DMG200022503	K01738	ko00270	Cysteine and methionine metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMG200022503	K01738	ko00450	Selenoamino acid metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMG200022503	K01738	ko00920	Sulfur metabolism	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMG200022503	K01738	ko01100	Metabolic pathways	1407	9.1e-72	0.73	0.89	1.00
PGSC0003DMG200022506	K02974	ko03010	Ribosome	883	7.2e-43	0.88	0.90	0.37
PGSC0003DMG200022506	K01487	ko00230	Purine metabolism	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMG200022506	K01487	ko01100	Metabolic pathways	556	7.9e-25	0.47	0.67	0.80
PGSC0003DMG200022507	K12132	ko04712	Circadian rhythm - plant	911	2.1e-44	0.42	0.59	1.00
PGSC0003DMG200022507	K12132	ko04712	Circadian rhythm - plant	3753	3.7e-201	0.63	0.75	1.00
PGSC0003DMG200022507	K12132	ko04712	Circadian rhythm - plant	2200	1.7e-115	0.53	0.68	1.00
PGSC0003DMG200022509	K01808	ko00030	Pentose phosphate pathway	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMG200022509	K01808	ko00710	Carbon fixation in photosynthetic organisms	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMG200022509	K01808	ko01100	Metabolic pathways	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMG200022509	K01808	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.42	0.56	0.51
PGSC0003DMG200022510	K01092	ko00521	Streptomycin biosynthesis	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMG200022510	K01092	ko00562	Inositol phosphate metabolism	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMG200022510	K01092	ko01100	Metabolic pathways	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMG200022510	K01092	ko01110	Biosynthesis of secondary metabolites	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMG200022510	K01092	ko04070	Phosphatidylinositol signaling system	261	1.5e-08	0.39	0.59	0.73
PGSC0003DMG200026357	K02326	ko00230	Purine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026357	K02326	ko00240	Pyrimidine metabolism	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026357	K02326	ko01100	Metabolic pathways	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026357	K02326	ko03030	DNA replication	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026357	K02326	ko03410	Base excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026357	K02326	ko03420	Nucleotide excision repair	639	2.1e-29	0.59	0.73	0.84
PGSC0003DMG200026359	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.34	0.55	0.79
PGSC0003DMG200026359	K01199	ko00500	Starch and sucrose metabolism	803	1.9e-38	0.35	0.55	0.88
PGSC0003DMG200026359	K01199	ko00500	Starch and sucrose metabolism	620	2.3e-28	0.35	0.54	0.87
PGSC0003DMG200026360	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMG200026360	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMG200026360	K02639	ko00195	Photosynthesis	929	2.1e-45	0.73	0.84	0.99
PGSC0003DMG200026361	K02865	ko03010	Ribosome	1581	2.3e-81	0.88	0.94	1.00
PGSC0003DMG200026361	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMG200026361	K02865	ko03010	Ribosome	1639	1.5e-84	0.90	0.96	1.00
PGSC0003DMG200026366	K13065	ko00940	Phenylpropanoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMG200026366	K13065	ko00941	Flavonoid biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMG200026366	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMG200026366	K13065	ko01110	Biosynthesis of secondary metabolites	309	5.8e-10	0.27	0.45	0.83
PGSC0003DMG200026367	K13065	ko00940	Phenylpropanoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMG200026367	K13065	ko00941	Flavonoid biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMG200026367	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMG200026367	K13065	ko01110	Biosynthesis of secondary metabolites	240	6.0e-06	0.28	0.44	0.85
PGSC0003DMG200036912	K10591	ko04120	Ubiquitin mediated proteolysis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMG200036912	K10591	ko04144	Endocytosis	1493	1.6e-76	0.43	0.61	0.92
PGSC0003DMG200036935	K11251	ko05322	Systemic lupus erythematosus	629	7.4e-29	0.63	0.77	0.92
PGSC0003DMG200027462	K13065	ko00940	Phenylpropanoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMG200027462	K13065	ko00941	Flavonoid biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMG200027462	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMG200027462	K13065	ko01110	Biosynthesis of secondary metabolites	433	4.8e-18	0.26	0.44	0.95
PGSC0003DMG200027464	K10757	ko00944	Flavone and flavonol biosynthesis	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMG200027464	K10757	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMG200027464	K10757	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.67	0.99
PGSC0003DMG200027468	K03660	ko03410	Base excision repair	586	1.7e-26	0.34	0.52	0.91
PGSC0003DMG200027469	K04733	ko04210	Apoptosis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMG200027469	K04733	ko04620	Toll-like receptor signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMG200027469	K04733	ko04722	Neurotrophin signaling pathway	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMG200027469	K04733	ko05140	Leishmaniasis	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMG200027469	K04733	ko05142	Chagas disease	518	9.8e-23	0.32	0.51	0.73
PGSC0003DMG200027470	K03660	ko03410	Base excision repair	309	1.6e-10	0.39	0.51	0.58
PGSC0003DMG200027471	K10956	ko03060	Protein export	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMG200027471	K10956	ko04145	Phagosome	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMG200027471	K10956	ko05110	Vibrio cholerae infection	575	7.0e-26	0.93	0.97	0.93
PGSC0003DMG200027471	K10956	ko03060	Protein export	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMG200027471	K10956	ko04145	Phagosome	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMG200027471	K10956	ko05110	Vibrio cholerae infection	3571	4.0e-191	0.79	0.87	1.00
PGSC0003DMG200027475	K12135	ko04712	Circadian rhythm - plant	450	5.5e-19	0.31	0.49	0.59
PGSC0003DMG200027477	K01805	ko00040	Pentose and glucuronate interconversions	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMG200027477	K01805	ko00051	Fructose and mannose metabolism	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMG200027477	K01805	ko01100	Metabolic pathways	3646	2.9e-195	0.88	0.95	0.99
PGSC0003DMG200018259	K02343	ko00230	Purine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018259	K02343	ko00240	Pyrimidine metabolism	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018259	K02343	ko01100	Metabolic pathways	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018259	K02343	ko03030	DNA replication	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018259	K02343	ko03430	Mismatch repair	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018259	K02343	ko03440	Homologous recombination	1005	1.3e-49	0.37	0.54	0.33
PGSC0003DMG200018260	K01892	ko00970	Aminoacyl-tRNA biosynthesis	3949	5.7e-212	0.59	0.74	0.99
PGSC0003DMG200018263	K04733	ko04210	Apoptosis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMG200018263	K04733	ko04620	Toll-like receptor signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMG200018263	K04733	ko04722	Neurotrophin signaling pathway	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMG200018263	K04733	ko05140	Leishmaniasis	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMG200018263	K04733	ko05142	Chagas disease	315	7.9e-11	0.36	0.52	0.87
PGSC0003DMG200018269	K01800	ko00350	Tyrosine metabolism	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMG200018269	K01800	ko00643	Styrene degradation	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMG200018269	K01800	ko01100	Metabolic pathways	1401	1.9e-71	0.76	0.85	0.99
PGSC0003DMG200028377	K06630	ko04110	Cell cycle	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMG200028377	K06630	ko04114	Oocyte meiosis	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMG200028377	K06630	ko04722	Neurotrophin signaling pathway	1307	3.0e-66	0.68	0.72	0.87
PGSC0003DMG200028377	K06630	ko04110	Cell cycle	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMG200028377	K06630	ko04114	Oocyte meiosis	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMG200028377	K06630	ko04722	Neurotrophin signaling pathway	1951	9.0e-102	0.91	0.96	0.90
PGSC0003DMG200028379	K12605	ko03018	RNA degradation	925	3.5e-45	0.40	0.60	0.90
PGSC0003DMG200028379	K12605	ko03018	RNA degradation	683	7.8e-32	0.47	0.66	0.96
PGSC0003DMG200028382	K00688	ko00500	Starch and sucrose metabolism	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMG200028382	K00688	ko04910	Insulin signaling pathway	603	3.8e-27	0.85	0.96	0.99
PGSC0003DMG200028382	K00688	ko00500	Starch and sucrose metabolism	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMG200028382	K00688	ko04910	Insulin signaling pathway	3168	6.7e-169	0.75	0.88	1.00
PGSC0003DMG200028382	K00688	ko00500	Starch and sucrose metabolism	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMG200028382	K00688	ko04910	Insulin signaling pathway	3689	1.2e-197	0.76	0.88	1.00
PGSC0003DMG200028382	K00688	ko00500	Starch and sucrose metabolism	6170	0.	0.75	0.87	0.99
PGSC0003DMG200028382	K00688	ko04910	Insulin signaling pathway	6170	0.	0.75	0.87	0.99
PGSC0003DMG200031791	K01051	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMG200031791	K01051	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMG200031791	K01051	ko01100	Metabolic pathways	2006	8.3e-105	0.48	0.65	0.97
PGSC0003DMG200031792	K01179	ko00500	Starch and sucrose metabolism	2420	1.2e-127	0.60	0.74	0.95
PGSC0003DMG200031796	K02885	ko03010	Ribosome	1619	1.8e-83	0.90	0.93	1.00
PGSC0003DMG200031797	K01213	ko00040	Pentose and glucuronate interconversions	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMG200031797	K01213	ko00500	Starch and sucrose metabolism	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMG200031797	K01213	ko01100	Metabolic pathways	294	2.2e-10	0.32	0.49	0.83
PGSC0003DMG200031797	K01213	ko00040	Pentose and glucuronate interconversions	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMG200031797	K01213	ko00500	Starch and sucrose metabolism	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMG200031797	K01213	ko01100	Metabolic pathways	862	1.0e-41	0.36	0.53	0.82
PGSC0003DMG200031797	K01213	ko00040	Pentose and glucuronate interconversions	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMG200031797	K01213	ko00500	Starch and sucrose metabolism	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMG200031797	K01213	ko01100	Metabolic pathways	321	7.2e-12	0.32	0.49	0.81
PGSC0003DMG200031799	K08489	ko04130	SNARE interactions in vesicular transport	1549	1.3e-79	0.67	0.80	0.88
PGSC0003DMG200031799	K08489	ko04130	SNARE interactions in vesicular transport	1783	1.7e-92	0.69	0.82	1.00
PGSC0003DMG200031806	K01897	ko00071	Fatty acid metabolism	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMG200031806	K01897	ko01100	Metabolic pathways	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMG200031806	K01897	ko03320	PPAR signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMG200031806	K01897	ko04146	Peroxisome	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMG200031806	K01897	ko04920	Adipocytokine signaling pathway	1885	3.9e-98	0.75	0.89	0.99
PGSC0003DMG200031806	K01897	ko00071	Fatty acid metabolism	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMG200031806	K01897	ko01100	Metabolic pathways	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMG200031806	K01897	ko03320	PPAR signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMG200031806	K01897	ko04146	Peroxisome	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMG200031806	K01897	ko04920	Adipocytokine signaling pathway	1639	1.5e-84	0.76	0.89	0.99
PGSC0003DMG200020521	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.97
PGSC0003DMG200020521	K00908	ko01100	Metabolic pathways	479	1.4e-20	0.29	0.46	0.93
PGSC0003DMG200044788	K12338	ko00942	Anthocyanin biosynthesis	641	1.6e-29	0.35	0.51	0.96
PGSC0003DMG200010276	K01115	ko00564	Glycerophospholipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010276	K01115	ko00565	Ether lipid metabolism	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010276	K01115	ko01100	Metabolic pathways	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010276	K01115	ko04144	Endocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010276	K01115	ko04666	Fc gamma R-mediated phagocytosis	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010276	K01115	ko04912	GnRH signaling pathway	2180	2.1e-114	0.80	0.90	1.00
PGSC0003DMG200010277	K00847	ko00051	Fructose and mannose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMG200010277	K00847	ko00500	Starch and sucrose metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMG200010277	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMG200010277	K00847	ko01100	Metabolic pathways	2242	8.0e-118	0.74	0.83	0.99
PGSC0003DMG200010277	K00847	ko00051	Fructose and mannose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMG200010277	K00847	ko00500	Starch and sucrose metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMG200010277	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMG200010277	K00847	ko01100	Metabolic pathways	2263	5.6e-119	0.75	0.85	0.96
PGSC0003DMG200010279	K09480	ko00561	Glycerolipid metabolism	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMG200010279	K09480	ko01100	Metabolic pathways	2618	1.5e-138	0.67	0.82	0.97
PGSC0003DMG200010279	K09480	ko00561	Glycerolipid metabolism	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMG200010279	K09480	ko01100	Metabolic pathways	1271	2.9e-64	0.62	0.78	0.95
PGSC0003DMG200010280	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMG200010280	K12614	ko03018	RNA degradation	3671	1.2e-196	0.91	0.94	0.99
PGSC0003DMG200010281	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04010	MAPK signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04310	Wnt signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04520	Adherens junction	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04620	Toll-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04621	NOD-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04622	RIG-I-like receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko04660	T cell receptor signaling pathway	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04427	ko05140	Leishmaniasis	226	1.2e-06	0.34	0.56	0.83
PGSC0003DMG200010281	K04424	ko04010	MAPK signaling pathway	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMG200010281	K04424	ko04530	Tight junction	603	2.0e-27	0.36	0.56	0.91
PGSC0003DMG200010281	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMG200010281	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMG200010281	K04424	ko04010	MAPK signaling pathway	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMG200010281	K04424	ko04530	Tight junction	448	2.3e-18	0.42	0.60	0.92
PGSC0003DMG200010282	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMG200010282	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMG200010282	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.62	0.77	0.86
PGSC0003DMG200010283	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	315	1.5e-11	0.60	0.73	0.97
PGSC0003DMG200010291	K02875	ko03010	Ribosome	1015	3.8e-50	0.89	0.95	0.99
PGSC0003DMG200014902	K09587	ko00905	Brassinosteroid biosynthesis	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMG200014902	K09587	ko01100	Metabolic pathways	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMG200014902	K09587	ko01110	Biosynthesis of secondary metabolites	1856	1.6e-96	0.69	0.80	0.96
PGSC0003DMG200014902	K09587	ko00905	Brassinosteroid biosynthesis	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMG200014902	K09587	ko01100	Metabolic pathways	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMG200014902	K09587	ko01110	Biosynthesis of secondary metabolites	2954	4.3e-157	0.71	0.82	0.96
PGSC0003DMG200014902	K09587	ko00905	Brassinosteroid biosynthesis	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMG200014902	K09587	ko01100	Metabolic pathways	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMG200014902	K09587	ko01110	Biosynthesis of secondary metabolites	2538	3.8e-134	0.72	0.84	0.97
PGSC0003DMG200014902	K09587	ko00905	Brassinosteroid biosynthesis	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMG200014902	K09587	ko01100	Metabolic pathways	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMG200014902	K09587	ko01110	Biosynthesis of secondary metabolites	2293	1.2e-120	0.72	0.84	0.97
PGSC0003DMG200014907	K03124	ko03022	Basal transcription factors	2146	1.6e-112	0.78	0.87	0.77
PGSC0003DMG200014911	K01228	ko00510	N-Glycan biosynthesis	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMG200014911	K01228	ko01100	Metabolic pathways	359	2.0e-13	0.74	0.87	0.40
PGSC0003DMG200014911	K01228	ko00510	N-Glycan biosynthesis	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMG200014911	K01228	ko01100	Metabolic pathways	2476	9.9e-131	0.59	0.71	0.94
PGSC0003DMG200014911	K01228	ko00510	N-Glycan biosynthesis	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMG200014911	K01228	ko01100	Metabolic pathways	3822	5.7e-205	0.64	0.78	0.91
PGSC0003DMG200014911	K01228	ko00510	N-Glycan biosynthesis	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMG200014911	K01228	ko01100	Metabolic pathways	4208	2.9e-226	0.64	0.78	0.91
PGSC0003DMG200014912	K01199	ko00500	Starch and sucrose metabolism	548	2.2e-24	0.32	0.53	0.98
PGSC0003DMG200014912	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMG200014912	K01199	ko00500	Starch and sucrose metabolism	455	2.9e-19	0.34	0.58	0.58
PGSC0003DMG200014912	K01199	ko00500	Starch and sucrose metabolism	629	7.4e-29	0.32	0.53	0.71
PGSC0003DMG200029857	K01757	ko00901	Indole alkaloid biosynthesis	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMG200029857	K01757	ko01100	Metabolic pathways	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMG200029857	K01757	ko01110	Biosynthesis of secondary metabolites	885	5.6e-43	0.40	0.58	0.96
PGSC0003DMG200029871	K11086	ko03040	Spliceosome	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMG200029871	K11086	ko05322	Systemic lupus erythematosus	219	3.0e-06	0.47	0.64	0.56
PGSC0003DMG200029872	K00819	ko00330	Arginine and proline metabolism	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMG200029872	K00819	ko01100	Metabolic pathways	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMG200029872	K00819	ko01110	Biosynthesis of secondary metabolites	3212	2.5e-171	0.79	0.90	1.00
PGSC0003DMG200029872	K00819	ko00330	Arginine and proline metabolism	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMG200029872	K00819	ko01100	Metabolic pathways	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMG200029872	K00819	ko01110	Biosynthesis of secondary metabolites	1628	5.9e-84	0.79	0.92	0.95
PGSC0003DMG200019185	K00368	ko00910	Nitrogen metabolism	1661	8.9e-86	0.44	0.59	0.89
PGSC0003DMG200019186	K05278	ko00941	Flavonoid biosynthesis	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMG200019186	K05278	ko01100	Metabolic pathways	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMG200019186	K05278	ko01110	Biosynthesis of secondary metabolites	690	3.2e-32	0.35	0.59	0.93
PGSC0003DMG200019187	K02728	ko03050	Proteasome	1859	1.1e-96	0.88	0.96	1.00
PGSC0003DMG200019187	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko00941	Flavonoid biosynthesis	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01100	Metabolic pathways	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019187	K05278	ko01110	Biosynthesis of secondary metabolites	799	3.1e-38	0.34	0.55	0.96
PGSC0003DMG200019188	K03841	ko00010	Glycolysis / Gluconeogenesis	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko00030	Pentose phosphate pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko00051	Fructose and mannose metabolism	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko00710	Carbon fixation in photosynthetic organisms	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko01100	Metabolic pathways	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko01110	Biosynthesis of secondary metabolites	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019188	K03841	ko04910	Insulin signaling pathway	2345	1.7e-123	0.68	0.82	0.97
PGSC0003DMG200019189	K03841	ko00010	Glycolysis / Gluconeogenesis	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko00030	Pentose phosphate pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko00051	Fructose and mannose metabolism	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko00710	Carbon fixation in photosynthetic organisms	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko01100	Metabolic pathways	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko01110	Biosynthesis of secondary metabolites	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019189	K03841	ko04910	Insulin signaling pathway	2651	2.2e-140	0.80	0.88	0.99
PGSC0003DMG200019190	K04714	ko00600	Sphingolipid metabolism	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMG200019190	K04714	ko01100	Metabolic pathways	237	3.1e-07	0.31	0.47	0.70
PGSC0003DMG200019190	K04714	ko00600	Sphingolipid metabolism	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMG200019190	K04714	ko01100	Metabolic pathways	257	2.4e-08	0.30	0.44	0.78
PGSC0003DMG200019196	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMG200019196	K08081	ko01100	Metabolic pathways	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMG200019196	K08081	ko01110	Biosynthesis of secondary metabolites	1195	4.5e-60	0.57	0.76	0.93
PGSC0003DMG200019198	K01051	ko00040	Pentose and glucuronate interconversions	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMG200019198	K01051	ko00500	Starch and sucrose metabolism	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMG200019198	K01051	ko01100	Metabolic pathways	1239	1.7e-62	0.50	0.68	0.90
PGSC0003DMG200019199	K01051	ko00040	Pentose and glucuronate interconversions	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMG200019199	K01051	ko00500	Starch and sucrose metabolism	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMG200019199	K01051	ko01100	Metabolic pathways	1241	1.3e-62	0.50	0.67	0.93
PGSC0003DMG200019202	K12343	ko00140	Steroid hormone biosynthesis	1319	6.5e-67	0.64	0.78	1.00
PGSC0003DMG200019203	K11866	ko04144	Endocytosis	429	4.4e-17	0.37	0.54	0.76
PGSC0003DMG200019203	K11866	ko04144	Endocytosis	653	8.3e-30	0.31	0.47	0.84
PGSC0003DMG200019203	K11866	ko04144	Endocytosis	541	2.1e-23	0.31	0.47	0.94
PGSC0003DMG200036252	K01051	ko00040	Pentose and glucuronate interconversions	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMG200036252	K01051	ko00500	Starch and sucrose metabolism	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMG200036252	K01051	ko01100	Metabolic pathways	900	8.3e-44	0.49	0.64	1.00
PGSC0003DMG200036266	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMG200036266	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMG200036266	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMG200036266	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMG200036266	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.35	0.52	0.96
PGSC0003DMG200026055	K01879	ko00970	Aminoacyl-tRNA biosynthesis	5673	0.	0.71	0.84	0.98
PGSC0003DMG200026055	K01879	ko00970	Aminoacyl-tRNA biosynthesis	4120	2.1e-221	0.67	0.83	1.00
PGSC0003DMG200026055	K01879	ko00970	Aminoacyl-tRNA biosynthesis	6292	0.	0.70	0.83	1.00
PGSC0003DMG200026057	K05278	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMG200026057	K05278	ko01100	Metabolic pathways	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMG200026057	K05278	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.38	0.54	0.84
PGSC0003DMG200026067	K06685	ko04111	Cell cycle - yeast	356	8.6e-11	0.31	0.47	0.52
PGSC0003DMG200026067	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMG200026067	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMG200026067	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMG200026067	K06685	ko04111	Cell cycle - yeast	362	6.2e-11	0.29	0.47	0.54
PGSC0003DMG200026070	K00680	ko00350	Tyrosine metabolism	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMG200026070	K00680	ko00624	1- and 2-Methylnaphthalene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMG200026070	K00680	ko00632	Benzoate degradation via CoA ligation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMG200026070	K00680	ko00642	Ethylbenzene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMG200026070	K00680	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.88	0.95	0.99
PGSC0003DMG200040755	K06627	ko04110	Cell cycle	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMG200040755	K06627	ko04914	Progesterone-mediated oocyte maturation	318	1.1e-11	0.39	0.56	0.98
PGSC0003DMG200040757	K11251	ko05322	Systemic lupus erythematosus	694	1.9e-32	0.69	0.80	0.94
PGSC0003DMG200040760	K05681	ko02010	ABC transporters	301	2.6e-10	0.59	0.73	0.78
PGSC0003DMG200040776	K05282	ko00904	Diterpenoid biosynthesis	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMG200040776	K05282	ko01100	Metabolic pathways	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMG200040776	K05282	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.62	0.80	0.98
PGSC0003DMG200001206	K01692	ko00071	Fatty acid metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00280	Valine, leucine and isoleucine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00281	Geraniol degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00310	Lysine degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00380	Tryptophan metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00410	beta-Alanine metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00632	Benzoate degradation via CoA ligation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00640	Propanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00650	Butanoate metabolism	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00903	Limonene and pinene degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko00930	Caprolactam degradation	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko01100	Metabolic pathways	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001206	K01692	ko01110	Biosynthesis of secondary metabolites	1701	5.5e-88	0.77	0.87	0.98
PGSC0003DMG200001209	K05350	ko00460	Cyanoamino acid metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMG200001209	K05350	ko00500	Starch and sucrose metabolism	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMG200001209	K05350	ko00940	Phenylpropanoid biosynthesis	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMG200001209	K05350	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.80	0.88	0.99
PGSC0003DMG200001210	K05350	ko00460	Cyanoamino acid metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMG200001210	K05350	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMG200001210	K05350	ko00940	Phenylpropanoid biosynthesis	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMG200001210	K05350	ko01110	Biosynthesis of secondary metabolites	388	1.4e-15	0.63	0.75	0.67
PGSC0003DMG200001212	K06630	ko04110	Cell cycle	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMG200001212	K06630	ko04114	Oocyte meiosis	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMG200001212	K06630	ko04722	Neurotrophin signaling pathway	1508	2.4e-77	0.76	0.80	0.36
PGSC0003DMG200013126	K00889	ko00562	Inositol phosphate metabolism	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko01100	Metabolic pathways	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko04070	Phosphatidylinositol signaling system	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko04144	Endocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko04666	Fc gamma R-mediated phagocytosis	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko04810	Regulation of actin cytoskeleton	341	2.0e-12	0.39	0.51	0.36
PGSC0003DMG200013126	K00889	ko00562	Inositol phosphate metabolism	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013126	K00889	ko01100	Metabolic pathways	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013126	K00889	ko04070	Phosphatidylinositol signaling system	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013126	K00889	ko04144	Endocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013126	K00889	ko04666	Fc gamma R-mediated phagocytosis	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013126	K00889	ko04810	Regulation of actin cytoskeleton	520	8.5e-23	0.36	0.48	0.52
PGSC0003DMG200013127	K02921	ko03010	Ribosome	551	1.5e-24	1.00	1.00	0.98
PGSC0003DMG200013127	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMG200002557	K00812	ko00250	Alanine, aspartate and glutamate metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00270	Cysteine and methionine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00330	Arginine and proline metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00350	Tyrosine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00360	Phenylalanine metabolism	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00401	Novobiocin biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00710	Carbon fixation in photosynthetic organisms	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00950	Isoquinoline alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko01100	Metabolic pathways	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200002557	K00812	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.34	0.53	0.70
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	497	1.4e-21	0.35	0.54	0.85
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	508	3.5e-22	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	518	9.8e-23	0.37	0.53	0.83
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	498	1.2e-21	0.37	0.51	0.82
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	507	4.0e-22	0.38	0.53	0.82
PGSC0003DMG200004840	K01112	ko00051	Fructose and mannose metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko00730	Thiamine metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko00740	Riboflavin metabolism	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004840	K01112	ko01100	Metabolic pathways	519	8.6e-23	0.38	0.53	0.83
PGSC0003DMG200004842	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00052	Galactose metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00511	Other glycan degradation	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00600	Sphingolipid metabolism	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko01100	Metabolic pathways	2371	6.1e-125	0.74	0.87	0.94
PGSC0003DMG200004842	K01190	ko00052	Galactose metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMG200004842	K01190	ko00511	Other glycan degradation	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMG200004842	K01190	ko00600	Sphingolipid metabolism	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMG200004842	K01190	ko01100	Metabolic pathways	4316	3.2e-232	0.68	0.82	0.85
PGSC0003DMG200004842	K01190	ko00052	Galactose metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMG200004842	K01190	ko00511	Other glycan degradation	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMG200004842	K01190	ko00600	Sphingolipid metabolism	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMG200004842	K01190	ko01100	Metabolic pathways	1653	2.5e-85	0.62	0.79	0.72
PGSC0003DMG200004844	K08248	ko00460	Cyanoamino acid metabolism	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMG200004844	K08248	ko01100	Metabolic pathways	1754	6.6e-91	0.46	0.61	0.92
PGSC0003DMG200004848	K12741	ko03040	Spliceosome	1268	4.2e-64	0.46	0.61	0.86
PGSC0003DMG200004849	K12741	ko03040	Spliceosome	934	1.1e-45	0.46	0.63	0.99
PGSC0003DMG200004850	K03787	ko00230	Purine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMG200004850	K03787	ko00240	Pyrimidine metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMG200004850	K03787	ko00760	Nicotinate and nicotinamide metabolism	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMG200004850	K03787	ko01100	Metabolic pathways	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMG200004850	K03787	ko01110	Biosynthesis of secondary metabolites	1544	2.5e-79	0.77	0.89	0.96
PGSC0003DMG200004850	K03787	ko00230	Purine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMG200004850	K03787	ko00240	Pyrimidine metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMG200004850	K03787	ko00760	Nicotinate and nicotinamide metabolism	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMG200004850	K03787	ko01100	Metabolic pathways	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMG200004850	K03787	ko01110	Biosynthesis of secondary metabolites	2327	1.6e-122	0.75	0.87	0.98
PGSC0003DMG200004850	K03787	ko00230	Purine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMG200004850	K03787	ko00240	Pyrimidine metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMG200004850	K03787	ko00760	Nicotinate and nicotinamide metabolism	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMG200004850	K03787	ko01100	Metabolic pathways	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMG200004850	K03787	ko01110	Biosynthesis of secondary metabolites	645	9.7e-30	0.74	0.88	0.98
PGSC0003DMG200004851	K02914	ko03010	Ribosome	263	1.1e-08	0.70	0.91	0.29
PGSC0003DMG200004854	K02218	ko04340	Hedgehog signaling pathway	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMG200004854	K02218	ko04711	Circadian rhythm - fly	2921	2.8e-155	0.75	0.85	1.00
PGSC0003DMG200009305	K02084	ko04115	p53 signaling pathway	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko04210	Apoptosis	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko05010	Alzheimer's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko05012	Parkinson's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko05016	Huntington's disease	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009305	K02084	ko05222	Small cell lung cancer	266	5.2e-06	0.25	0.43	0.77
PGSC0003DMG200009310	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMG200009310	K00517	ko00626	Naphthalene and anthracene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMG200009310	K00517	ko00903	Limonene and pinene degradation	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMG200009310	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMG200009310	K00517	ko01110	Biosynthesis of secondary metabolites	461	1.4e-19	0.49	0.73	0.94
PGSC0003DMG200009311	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMG200009311	K00517	ko00626	Naphthalene and anthracene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMG200009311	K00517	ko00903	Limonene and pinene degradation	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMG200009311	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMG200009311	K00517	ko01110	Biosynthesis of secondary metabolites	985	1.7e-48	0.42	0.58	0.91
PGSC0003DMG200009313	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMG200009313	K00517	ko00626	Naphthalene and anthracene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMG200009313	K00517	ko00903	Limonene and pinene degradation	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMG200009313	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMG200009313	K00517	ko01110	Biosynthesis of secondary metabolites	1039	1.8e-51	0.44	0.65	0.99
PGSC0003DMG200009314	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMG200009314	K00517	ko00626	Naphthalene and anthracene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMG200009314	K00517	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMG200009314	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMG200009314	K00517	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.42	0.62	0.99
PGSC0003DMG200009315	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMG200009315	K00517	ko00626	Naphthalene and anthracene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMG200009315	K00517	ko00903	Limonene and pinene degradation	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMG200009315	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMG200009315	K00517	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.42	0.61	1.00
PGSC0003DMG200009315	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMG200009315	K00517	ko00626	Naphthalene and anthracene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMG200009315	K00517	ko00903	Limonene and pinene degradation	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMG200009315	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMG200009315	K00517	ko01110	Biosynthesis of secondary metabolites	1021	1.8e-50	0.44	0.66	0.97
PGSC0003DMG200009316	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMG200009316	K00517	ko00626	Naphthalene and anthracene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMG200009316	K00517	ko00903	Limonene and pinene degradation	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMG200009316	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMG200009316	K00517	ko01110	Biosynthesis of secondary metabolites	1211	5.9e-61	0.38	0.56	1.00
PGSC0003DMG200009317	K00855	ko00710	Carbon fixation in photosynthetic organisms	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMG200009317	K00855	ko01100	Metabolic pathways	3145	1.3e-167	0.90	0.96	1.00
PGSC0003DMG200015494	K04371	ko04010	MAPK signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04012	ErbB signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04013	MAPK signaling pathway - fly	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04062	Chemokine signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04114	Oocyte meiosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04150	mTOR signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04270	Vascular smooth muscle contraction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04320	Dorso-ventral axis formation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04350	TGF-beta signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04360	Axon guidance	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04370	VEGF signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04510	Focal adhesion	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04520	Adherens junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04540	Gap junction	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04620	Toll-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04621	NOD-like receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04650	Natural killer cell mediated cytotoxicity	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04660	T cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04662	B cell receptor signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04664	Fc epsilon RI signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04666	Fc gamma R-mediated phagocytosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04720	Long-term potentiation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04722	Neurotrophin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04730	Long-term depression	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04810	Regulation of actin cytoskeleton	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04910	Insulin signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04912	GnRH signaling pathway	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04914	Progesterone-mediated oocyte maturation	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04916	Melanogenesis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04930	Type II diabetes mellitus	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko04960	Aldosterone-regulated sodium reabsorption	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05010	Alzheimer's disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05020	Prion diseases	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05131	Shigellosis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05140	Leishmaniasis	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05142	Chagas disease	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05200	Pathways in cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05210	Colorectal cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05211	Renal cell carcinoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05212	Pancreatic cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05213	Endometrial cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05214	Glioma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05215	Prostate cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05216	Thyroid cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05218	Melanoma	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05219	Bladder cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05220	Chronic myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05221	Acute myeloid leukemia	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015494	K04371	ko05223	Non-small cell lung cancer	477	1.8e-20	0.52	0.72	0.90
PGSC0003DMG200015497	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMG200015497	K01718	ko00240	Pyrimidine metabolism	827	8.9e-40	0.39	0.54	0.93
PGSC0003DMG200015497	K01718	ko00240	Pyrimidine metabolism	432	5.4e-18	0.42	0.54	0.92
PGSC0003DMG200015497	K00430	ko00360	Phenylalanine metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMG200015497	K00430	ko00680	Methane metabolism	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMG200015497	K00430	ko00940	Phenylpropanoid biosynthesis	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMG200015497	K00430	ko01100	Metabolic pathways	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMG200015497	K00430	ko01110	Biosynthesis of secondary metabolites	2109	1.7e-110	0.74	0.87	1.00
PGSC0003DMG200015500	K12837	ko03040	Spliceosome	3943	1.2e-211	0.81	0.89	1.00
PGSC0003DMG200015500	K12837	ko03040	Spliceosome	2717	5.1e-144	0.88	0.93	1.00
PGSC0003DMG200015500	K12837	ko03040	Spliceosome	2321	3.5e-122	0.88	0.93	1.00
PGSC0003DMG200015501	K03107	ko03060	Protein export	3934	3.8e-211	0.78	0.88	0.98
PGSC0003DMG200015501	K03107	ko03060	Protein export	3338	2.8e-178	0.80	0.91	1.00
PGSC0003DMG200015501	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMG200015501	K03107	ko03060	Protein export	3971	3.5e-213	0.80	0.91	0.98
PGSC0003DMG200015504	K00558	ko00270	Cysteine and methionine metabolism	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMG200015504	K00558	ko01100	Metabolic pathways	265	7.2e-08	0.38	0.54	0.72
PGSC0003DMG200015505	K13065	ko00940	Phenylpropanoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMG200015505	K13065	ko00941	Flavonoid biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMG200015505	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMG200015505	K13065	ko01110	Biosynthesis of secondary metabolites	319	9.3e-12	0.32	0.49	0.76
PGSC0003DMG200019890	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200019890	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200019890	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.51	0.71	1.00
PGSC0003DMG200019891	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMG200019891	K01904	ko00360	Phenylalanine metabolism	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMG200019891	K01904	ko00940	Phenylpropanoid biosynthesis	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMG200019891	K01904	ko01100	Metabolic pathways	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMG200019891	K01904	ko01110	Biosynthesis of secondary metabolites	3484	2.5e-186	0.75	0.87	0.97
PGSC0003DMG200019891	K02937	ko03010	Ribosome	1756	5.1e-91	0.84	0.93	1.00
PGSC0003DMG200019893	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMG200019893	K02919	ko03010	Ribosome	429	7.9e-18	0.55	0.71	0.96
PGSC0003DMG200019898	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.74
PGSC0003DMG200019898	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.73
PGSC0003DMG200019899	K11818	ko00380	Tryptophan metabolism	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMG200019899	K11818	ko00966	Glucosinolate biosynthesis	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMG200019899	K11818	ko01110	Biosynthesis of secondary metabolites	1331	1.4e-67	0.42	0.61	0.96
PGSC0003DMG200019899	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMG200019899	K00517	ko00626	Naphthalene and anthracene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMG200019899	K00517	ko00903	Limonene and pinene degradation	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMG200019899	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMG200019899	K00517	ko01110	Biosynthesis of secondary metabolites	289	5.5e-10	0.59	0.70	0.88
PGSC0003DMG200019907	K00847	ko00051	Fructose and mannose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMG200019907	K00847	ko00500	Starch and sucrose metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMG200019907	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMG200019907	K00847	ko01100	Metabolic pathways	382	3.1e-15	0.32	0.47	0.70
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	681	1.0e-31	0.38	0.54	0.80
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00561	Glycerolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00564	Glycerophospholipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00565	Ether lipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko00600	Sphingolipid metabolism	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko01100	Metabolic pathways	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030570	K01080	ko04666	Fc gamma R-mediated phagocytosis	644	1.1e-29	0.38	0.56	0.73
PGSC0003DMG200030577	K00052	ko00290	Valine, leucine and isoleucine biosynthesis	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMG200030577	K00052	ko01100	Metabolic pathways	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMG200030577	K00052	ko01110	Biosynthesis of secondary metabolites	2775	3.2e-147	0.82	0.90	1.00
PGSC0003DMG200030590	K01080	ko00561	Glycerolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200030590	K01080	ko00564	Glycerophospholipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200030590	K01080	ko00565	Ether lipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200030590	K01080	ko00600	Sphingolipid metabolism	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200030590	K01080	ko01100	Metabolic pathways	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200030590	K01080	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.35	0.52	0.78
PGSC0003DMG200022274	K10592	ko04120	Ubiquitin mediated proteolysis	591	2.9e-25	0.92	0.99	0.75
PGSC0003DMG200022274	K10592	ko04120	Ubiquitin mediated proteolysis	1984	1.6e-102	0.68	0.79	0.97
PGSC0003DMG200022274	K10592	ko04120	Ubiquitin mediated proteolysis	18212	0.	0.62	0.75	1.00
PGSC0003DMG200022277	K08065	ko04612	Antigen processing and presentation	311	2.6e-11	0.49	0.70	0.48
PGSC0003DMG200022282	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	651	8.3e-30	0.32	0.46	0.86
PGSC0003DMG200022282	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	691	3.6e-32	0.31	0.44	0.87
PGSC0003DMG200022283	K01738	ko00270	Cysteine and methionine metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMG200022283	K01738	ko00450	Selenoamino acid metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMG200022283	K01738	ko00920	Sulfur metabolism	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMG200022283	K01738	ko01100	Metabolic pathways	2246	4.8e-118	0.76	0.86	0.98
PGSC0003DMG200022283	K01738	ko00270	Cysteine and methionine metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMG200022283	K01738	ko00450	Selenoamino acid metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMG200022283	K01738	ko00920	Sulfur metabolism	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMG200022283	K01738	ko01100	Metabolic pathways	2768	7.8e-147	0.80	0.89	0.99
PGSC0003DMG200035060	K08066	ko04612	Antigen processing and presentation	313	2.0e-11	0.51	0.77	0.73
PGSC0003DMG200035067	K01593	ko00340	Histidine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00350	Tyrosine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00360	Phenylalanine metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00380	Tryptophan metabolism	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00901	Indole alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00950	Isoquinoline alkaloid biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko00965	Betalain biosynthesis	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko01100	Metabolic pathways	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200035067	K01593	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.53	0.70	0.91
PGSC0003DMG200026707	K01066	ko00623	2,4-Dichlorobenzoate degradation	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMG200026707	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	449	6.3e-19	0.35	0.49	0.74
PGSC0003DMG200026713	K05576	ko00190	Oxidative phosphorylation	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMG200026713	K05576	ko01100	Metabolic pathways	421	2.2e-17	0.76	0.78	0.97
PGSC0003DMG200026715	K12868	ko03040	Spliceosome	1982	1.8e-103	0.74	0.82	1.00
PGSC0003DMG200026716	K02147	ko00190	Oxidative phosphorylation	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026716	K02147	ko01100	Metabolic pathways	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026716	K02147	ko04145	Phagosome	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026716	K02147	ko04966	Collecting duct acid secretion	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026716	K02147	ko05110	Vibrio cholerae infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026716	K02147	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3932	4.9e-211	0.97	0.99	1.00
PGSC0003DMG200026719	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K03094	ko04110	Cell cycle	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04111	Cell cycle - yeast	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04114	Oocyte meiosis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04120	Ubiquitin mediated proteolysis	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04310	Wnt signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04350	TGF-beta signaling pathway	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K03094	ko04710	Circadian rhythm - mammal	564	2.8e-25	0.68	0.85	0.93
PGSC0003DMG200026719	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K10532	ko00531	Glycosaminoglycan degradation	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K10532	ko01100	Metabolic pathways	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K10532	ko04142	Lysosome	656	2.4e-30	0.51	0.74	0.84
PGSC0003DMG200026719	K10532	ko00531	Glycosaminoglycan degradation	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K10532	ko01100	Metabolic pathways	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K10532	ko04142	Lysosome	1621	1.4e-83	0.47	0.65	0.97
PGSC0003DMG200026719	K03094	ko04110	Cell cycle	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04111	Cell cycle - yeast	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04114	Oocyte meiosis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04120	Ubiquitin mediated proteolysis	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04310	Wnt signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04350	TGF-beta signaling pathway	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026719	K03094	ko04710	Circadian rhythm - mammal	1011	6.3e-50	0.81	0.92	0.98
PGSC0003DMG200026722	K03094	ko04110	Cell cycle	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04111	Cell cycle - yeast	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04114	Oocyte meiosis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04120	Ubiquitin mediated proteolysis	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04310	Wnt signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04350	TGF-beta signaling pathway	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026722	K03094	ko04710	Circadian rhythm - mammal	1009	8.1e-50	0.81	0.88	0.99
PGSC0003DMG200026723	K03094	ko04110	Cell cycle	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04111	Cell cycle - yeast	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04114	Oocyte meiosis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04120	Ubiquitin mediated proteolysis	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04310	Wnt signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04350	TGF-beta signaling pathway	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200026723	K03094	ko04710	Circadian rhythm - mammal	1106	3.6e-55	0.87	0.94	0.99
PGSC0003DMG200001865	K01838	ko00500	Starch and sucrose metabolism	546	2.8e-24	0.40	0.60	0.90
PGSC0003DMG200001865	K01838	ko00500	Starch and sucrose metabolism	256	2.8e-08	0.39	0.66	0.76
PGSC0003DMG200001865	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMG200001865	K01838	ko00500	Starch and sucrose metabolism	669	4.6e-31	0.41	0.63	0.85
PGSC0003DMG200001877	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMG200001877	K01953	ko00910	Nitrogen metabolism	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMG200001877	K01953	ko01100	Metabolic pathways	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMG200001877	K01953	ko01110	Biosynthesis of secondary metabolites	4245	2.7e-228	0.90	0.96	0.99
PGSC0003DMG200001877	K01953	ko00250	Alanine, aspartate and glutamate metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMG200001877	K01953	ko00910	Nitrogen metabolism	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMG200001877	K01953	ko01100	Metabolic pathways	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMG200001877	K01953	ko01110	Biosynthesis of secondary metabolites	4430	1.7e-238	0.89	0.96	1.00
PGSC0003DMG200012449	K10418	ko04962	Vasopressin-regulated water reabsorption	314	1.7e-11	0.42	0.61	0.72
PGSC0003DMG200012466	K06685	ko04111	Cell cycle - yeast	295	1.0e-06	0.27	0.45	0.46
PGSC0003DMG200012466	K06685	ko04111	Cell cycle - yeast	295	5.0e-07	0.27	0.45	0.67
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	888	3.8e-43	0.58	0.70	0.98
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	644	1.1e-29	0.89	0.98	0.59
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	416	4.1e-17	0.89	0.94	0.61
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	2749	8.7e-146	0.86	0.94	1.00
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	2544	1.8e-134	0.73	0.83	0.95
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	3605	5.3e-193	0.76	0.85	1.00
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	1364	2.1e-69	0.66	0.76	0.99
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	2204	1.0e-115	0.85	0.93	1.00
PGSC0003DMG200008663	K00004	ko00650	Butanoate metabolism	1688	2.9e-87	0.86	0.94	0.92
PGSC0003DMG200008665	K01046	ko00561	Glycerolipid metabolism	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMG200008665	K01046	ko01100	Metabolic pathways	356	8.4e-14	0.40	0.57	0.64
PGSC0003DMG200008665	K01046	ko00561	Glycerolipid metabolism	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMG200008665	K01046	ko01100	Metabolic pathways	449	6.3e-19	0.35	0.51	0.78
PGSC0003DMG200008673	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1613	3.9e-83	0.72	0.85	0.91
PGSC0003DMG200016237	K00423	ko00053	Ascorbate and aldarate metabolism	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMG200016237	K00423	ko01100	Metabolic pathways	3347	9.0e-179	0.69	0.81	0.98
PGSC0003DMG200016240	K12373	ko00511	Other glycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko00531	Glycosaminoglycan degradation	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko01100	Metabolic pathways	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016240	K12373	ko04142	Lysosome	3210	3.3e-171	0.70	0.83	0.99
PGSC0003DMG200016242	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016242	K01653	ko00650	Butanoate metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016242	K01653	ko00660	C5-Branched dibasic acid metabolism	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016242	K01653	ko00770	Pantothenate and CoA biosynthesis	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016242	K01653	ko01100	Metabolic pathways	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016242	K01653	ko01110	Biosynthesis of secondary metabolites	1910	1.6e-99	0.63	0.79	0.83
PGSC0003DMG200016246	K05350	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMG200016246	K05350	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMG200016246	K05350	ko00940	Phenylpropanoid biosynthesis	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMG200016246	K05350	ko01110	Biosynthesis of secondary metabolites	529	2.4e-23	0.65	0.80	0.90
PGSC0003DMG200016246	K05350	ko00460	Cyanoamino acid metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMG200016246	K05350	ko00500	Starch and sucrose metabolism	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMG200016246	K05350	ko00940	Phenylpropanoid biosynthesis	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMG200016246	K05350	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.61	0.80	0.94
PGSC0003DMG200016246	K05350	ko00460	Cyanoamino acid metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMG200016246	K05350	ko00500	Starch and sucrose metabolism	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMG200016246	K05350	ko00940	Phenylpropanoid biosynthesis	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMG200016246	K05350	ko01110	Biosynthesis of secondary metabolites	2093	1.3e-109	0.60	0.80	0.93
PGSC0003DMG200000505	K10529	ko00592	alpha-Linolenic acid metabolism	4061	3.8e-218	0.74	0.86	0.99
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	3756	2.5e-201	0.70	0.81	0.99
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	3989	3.5e-214	0.73	0.85	0.99
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	3951	4.4e-212	0.72	0.85	0.99
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	410	1.0e-16	0.77	0.89	0.86
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	1884	4.5e-98	0.67	0.81	0.96
PGSC0003DMG200000506	K10529	ko00592	alpha-Linolenic acid metabolism	3810	2.6e-204	0.71	0.83	0.99
PGSC0003DMG200000507	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMG200000507	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMG200000507	K03469	ko03030	DNA replication	365	2.7e-14	0.42	0.61	0.42
PGSC0003DMG200000507	K03469	ko03030	DNA replication	364	3.1e-14	0.43	0.61	0.43
PGSC0003DMG200000507	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.42
PGSC0003DMG200000507	K03469	ko03030	DNA replication	366	2.4e-14	0.43	0.61	0.82
PGSC0003DMG200000507	K03469	ko03030	DNA replication	365	2.7e-14	0.45	0.63	0.42
PGSC0003DMG200000509	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMG200000509	K05285	ko01100	Metabolic pathways	3983	7.5e-214	0.69	0.83	1.00
PGSC0003DMG200000509	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	6030	0.	0.72	0.85	0.99
PGSC0003DMG200000509	K05285	ko01100	Metabolic pathways	6030	0.	0.72	0.85	0.99
PGSC0003DMG200000509	K05285	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMG200000509	K05285	ko01100	Metabolic pathways	1436	2.3e-73	0.66	0.83	0.99
PGSC0003DMG200000511	K00430	ko00360	Phenylalanine metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMG200000511	K00430	ko00680	Methane metabolism	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMG200000511	K00430	ko00940	Phenylpropanoid biosynthesis	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMG200000511	K00430	ko01100	Metabolic pathways	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMG200000511	K00430	ko01110	Biosynthesis of secondary metabolites	1236	2.5e-62	0.68	0.78	0.98
PGSC0003DMG200000511	K00430	ko00360	Phenylalanine metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMG200000511	K00430	ko00680	Methane metabolism	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMG200000511	K00430	ko00940	Phenylpropanoid biosynthesis	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMG200000511	K00430	ko01100	Metabolic pathways	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMG200000511	K00430	ko01110	Biosynthesis of secondary metabolites	1755	5.8e-91	0.66	0.78	0.99
PGSC0003DMG200000513	K06611	ko00052	Galactose metabolism	4630	1.6e-249	0.68	0.81	1.00
PGSC0003DMG200046978	K13065	ko00940	Phenylpropanoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMG200046978	K13065	ko00941	Flavonoid biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMG200046978	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMG200046978	K13065	ko01110	Biosynthesis of secondary metabolites	222	3.8e-06	0.35	0.55	0.82
PGSC0003DMG200046984	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMG200027687	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04142	Lysosome	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	3068	2.2e-163	0.71	0.82	1.00
PGSC0003DMG200027687	K13289	ko04142	Lysosome	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	3059	6.9e-163	0.71	0.82	1.00
PGSC0003DMG200027687	K13289	ko04142	Lysosome	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	2385	1.0e-125	0.63	0.76	0.97
PGSC0003DMG200027687	K13289	ko04142	Lysosome	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMG200027687	K13289	ko04614	Renin-angiotensin system	2377	2.9e-125	0.68	0.80	0.87
PGSC0003DMG200027688	K00967	ko00440	Phosphonate and phosphinate metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMG200027688	K00967	ko00564	Glycerophospholipid metabolism	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMG200027688	K00967	ko01100	Metabolic pathways	2823	7.2e-150	0.76	0.82	0.98
PGSC0003DMG200027688	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027688	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027688	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027688	K00967	ko00440	Phosphonate and phosphinate metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027688	K00967	ko00564	Glycerophospholipid metabolism	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027688	K00967	ko01100	Metabolic pathways	2914	6.9e-155	0.83	0.90	0.98
PGSC0003DMG200027692	K02183	ko04020	Calcium signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04070	Phosphatidylinositol signaling system	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04114	Oocyte meiosis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04270	Vascular smooth muscle contraction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04626	Plant-pathogen interaction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04720	Long-term potentiation	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04722	Neurotrophin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04740	Olfactory transduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04744	Phototransduction	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04745	Phototransduction - fly	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04910	Insulin signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04912	GnRH signaling pathway	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04916	Melanogenesis	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04970	Salivary secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko04971	Gastric acid secretion	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko05010	Alzheimer's disease	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200027692	K02183	ko05214	Glioma	302	8.0e-11	0.39	0.57	0.74
PGSC0003DMG200017524	K05658	ko02010	ABC transporters	262	1.3e-07	0.38	0.55	0.82
PGSC0003DMG200017524	K05658	ko02010	ABC transporters	4433	1.1e-238	0.46	0.66	0.98
PGSC0003DMG200017524	K05658	ko02010	ABC transporters	2008	6.4e-105	0.72	0.89	0.99
PGSC0003DMG200017524	K05658	ko02010	ABC transporters	1260	1.2e-63	0.74	0.87	0.88
PGSC0003DMG200017527	K02882	ko03010	Ribosome	517	1.1e-22	0.84	0.87	0.94
PGSC0003DMG200017532	K02639	ko00195	Photosynthesis	1138	6.2e-57	0.72	0.82	0.99
PGSC0003DMG200017532	K02639	ko00195	Photosynthesis	1319	6.5e-67	0.80	0.90	0.99
PGSC0003DMG200033874	K00029	ko00620	Pyruvate metabolism	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMG200033874	K00029	ko00710	Carbon fixation in photosynthetic organisms	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMG200033874	K00029	ko01100	Metabolic pathways	4133	4.0e-222	0.81	0.93	1.00
PGSC0003DMG200010042	K04072	ko00010	Glycolysis / Gluconeogenesis	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00071	Fatty acid metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00350	Tyrosine metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00620	Pyruvate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00641	3-Chloroacrylic acid degradation	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko00650	Butanoate metabolism	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko01100	Metabolic pathways	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010042	K04072	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.26	0.43	0.82
PGSC0003DMG200010046	K11599	ko03050	Proteasome	946	2.4e-46	0.77	0.90	0.99
PGSC0003DMG200010051	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010051	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010051	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010051	K01611	ko00270	Cysteine and methionine metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010051	K01611	ko00330	Arginine and proline metabolism	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010051	K01611	ko01100	Metabolic pathways	2049	3.5e-107	0.71	0.80	0.99
PGSC0003DMG200010958	K05577	ko00190	Oxidative phosphorylation	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMG200010958	K05577	ko01100	Metabolic pathways	804	1.6e-38	0.76	0.80	0.94
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	338	1.2e-09	0.26	0.42	0.43
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	305	1.9e-07	0.26	0.41	0.46
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	326	1.3e-08	0.26	0.41	0.48
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMG200010959	K06666	ko04111	Cell cycle - yeast	312	7.8e-08	0.26	0.41	0.48
PGSC0003DMG200010963	K04733	ko04210	Apoptosis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMG200010963	K04733	ko04620	Toll-like receptor signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMG200010963	K04733	ko04722	Neurotrophin signaling pathway	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMG200010963	K04733	ko05140	Leishmaniasis	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMG200010963	K04733	ko05142	Chagas disease	491	7.9e-21	0.38	0.57	0.91
PGSC0003DMG200010964	K06685	ko04111	Cell cycle - yeast	358	7.5e-11	0.29	0.48	0.48
PGSC0003DMG200014221	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMG200014221	K01602	ko00710	Carbon fixation in photosynthetic organisms	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMG200014221	K01602	ko01100	Metabolic pathways	1069	4.0e-53	0.50	0.68	0.95
PGSC0003DMG200014221	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko00710	Carbon fixation in photosynthetic organisms	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014221	K01602	ko01100	Metabolic pathways	726	3.3e-34	0.49	0.66	0.96
PGSC0003DMG200014223	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMG200014223	K01904	ko00360	Phenylalanine metabolism	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMG200014223	K01904	ko00940	Phenylpropanoid biosynthesis	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMG200014223	K01904	ko01100	Metabolic pathways	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMG200014223	K01904	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.79	0.90	0.99
PGSC0003DMG200014223	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMG200014223	K01904	ko00360	Phenylalanine metabolism	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMG200014223	K01904	ko00940	Phenylpropanoid biosynthesis	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMG200014223	K01904	ko01100	Metabolic pathways	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMG200014223	K01904	ko01110	Biosynthesis of secondary metabolites	3403	7.4e-182	0.78	0.90	0.97
PGSC0003DMG200014228	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMG200014228	K00328	ko00562	Inositol phosphate metabolism	416	4.1e-17	0.33	0.49	0.90
PGSC0003DMG200003124	K01179	ko00500	Starch and sucrose metabolism	1271	2.9e-64	0.69	0.87	0.98
PGSC0003DMG200003124	K01179	ko00500	Starch and sucrose metabolism	3084	2.9e-164	0.73	0.88	0.94
PGSC0003DMG200003124	K01179	ko00500	Starch and sucrose metabolism	1165	2.0e-58	0.71	0.87	0.98
PGSC0003DMG200003127	K00801	ko00100	Steroid biosynthesis	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMG200003127	K00801	ko01100	Metabolic pathways	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMG200003127	K00801	ko01110	Biosynthesis of secondary metabolites	2920	3.2e-155	0.82	0.92	1.00
PGSC0003DMG200003134	K12489	ko04144	Endocytosis	684	6.8e-32	0.69	0.82	0.53
PGSC0003DMG200003135	K08737	ko03430	Mismatch repair	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMG200003135	K08737	ko05200	Pathways in cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMG200003135	K08737	ko05210	Colorectal cancer	392	3.7e-15	0.71	0.84	0.21
PGSC0003DMG200003137	K08737	ko03430	Mismatch repair	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMG200003137	K08737	ko05200	Pathways in cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMG200003137	K08737	ko05210	Colorectal cancer	1847	4.9e-96	0.47	0.63	0.99
PGSC0003DMG200003140	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMG200003140	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMG200003140	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMG200003140	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMG200003140	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.56	0.71	0.52
PGSC0003DMG200003141	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMG200003141	K00517	ko00626	Naphthalene and anthracene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMG200003141	K00517	ko00903	Limonene and pinene degradation	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMG200003141	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMG200003141	K00517	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.54	0.65	0.89
PGSC0003DMG200003142	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00626	Naphthalene and anthracene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00903	Limonene and pinene degradation	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200003142	K00517	ko01110	Biosynthesis of secondary metabolites	2035	2.1e-106	0.50	0.67	0.99
PGSC0003DMG200045967	K11252	ko05322	Systemic lupus erythematosus	414	5.3e-17	0.43	0.67	0.95
PGSC0003DMG200045976	K10760	ko00908	Zeatin biosynthesis	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMG200045976	K10760	ko01100	Metabolic pathways	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMG200045976	K10760	ko01110	Biosynthesis of secondary metabolites	550	1.7e-24	0.48	0.64	0.92
PGSC0003DMG200045991	K12493	ko04144	Endocytosis	300	8.7e-10	0.49	0.70	0.49
PGSC0003DMG200039559	K12581	ko03018	RNA degradation	904	5.0e-44	0.50	0.65	0.94
PGSC0003DMG200009978	K00162	ko00010	Glycolysis / Gluconeogenesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko00020	Citrate cycle (TCA cycle)	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko00620	Pyruvate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko00650	Butanoate metabolism	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko01100	Metabolic pathways	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009978	K00162	ko01110	Biosynthesis of secondary metabolites	309	2.9e-10	0.52	0.78	0.86
PGSC0003DMG200009979	K01300	ko04610	Complement and coagulation cascades	259	1.9e-08	0.35	0.50	0.47
PGSC0003DMG200009980	K00721	ko00510	N-Glycan biosynthesis	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMG200009980	K00721	ko01100	Metabolic pathways	1801	1.7e-93	0.90	0.95	0.99
PGSC0003DMG200009980	K00721	ko00510	N-Glycan biosynthesis	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMG200009980	K00721	ko01100	Metabolic pathways	951	1.3e-46	0.90	0.97	0.99
PGSC0003DMG200009981	K00700	ko00500	Starch and sucrose metabolism	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMG200009981	K00700	ko01100	Metabolic pathways	5424	2.5e-293	0.84	0.92	0.83
PGSC0003DMG200009981	K00700	ko00500	Starch and sucrose metabolism	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMG200009981	K00700	ko01100	Metabolic pathways	5428	1.5e-293	0.82	0.91	0.81
PGSC0003DMG200009983	K05868	ko04110	Cell cycle	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMG200009983	K05868	ko04115	p53 signaling pathway	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMG200009983	K05868	ko04914	Progesterone-mediated oocyte maturation	1905	3.1e-99	0.77	0.89	0.99
PGSC0003DMG200009983	K05868	ko04110	Cell cycle	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMG200009983	K05868	ko04115	p53 signaling pathway	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMG200009983	K05868	ko04914	Progesterone-mediated oocyte maturation	2529	1.2e-133	0.71	0.83	0.99
PGSC0003DMG200009984	K12385	ko04142	Lysosome	8598	0.	0.82	0.90	0.95
PGSC0003DMG200009984	K12385	ko04142	Lysosome	2386	9.1e-126	0.82	0.91	0.99
PGSC0003DMG200009984	K12385	ko04142	Lysosome	4213	1.6e-226	0.85	0.93	1.00
PGSC0003DMG200009984	K12385	ko04142	Lysosome	963	2.8e-47	0.91	0.95	0.98
PGSC0003DMG200009984	K12385	ko04142	Lysosome	694	6.9e-32	0.88	0.95	0.96
PGSC0003DMG200004130	K00134	ko00010	Glycolysis / Gluconeogenesis	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMG200004130	K00134	ko01100	Metabolic pathways	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMG200004130	K00134	ko01110	Biosynthesis of secondary metabolites	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMG200004130	K00134	ko05010	Alzheimer's disease	2546	1.4e-134	0.89	0.95	0.99
PGSC0003DMG200004138	K01955	ko00240	Pyrimidine metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMG200004138	K01955	ko00250	Alanine, aspartate and glutamate metabolism	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMG200004138	K01955	ko01100	Metabolic pathways	870	8.8e-42	0.65	0.76	0.93
PGSC0003DMG200007816	K08679	ko00500	Starch and sucrose metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMG200007816	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMG200007816	K08679	ko01100	Metabolic pathways	3196	1.9e-170	0.86	0.95	1.00
PGSC0003DMG200007818	K07297	ko04920	Adipocytokine signaling pathway	1700	6.3e-88	0.54	0.70	0.95
PGSC0003DMG200007818	K07297	ko04920	Adipocytokine signaling pathway	1744	2.3e-90	0.58	0.74	0.95
PGSC0003DMG200007822	K00939	ko00230	Purine metabolism	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMG200007822	K00939	ko01100	Metabolic pathways	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMG200007822	K00939	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.67	0.82	0.77
PGSC0003DMG200007823	K12128	ko04712	Circadian rhythm - plant	413	9.8e-17	0.34	0.51	0.29
PGSC0003DMG200007823	K12128	ko04712	Circadian rhythm - plant	413	1.1e-16	0.34	0.51	0.28
PGSC0003DMG200007826	K01658	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMG200007826	K01658	ko01100	Metabolic pathways	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMG200007826	K01658	ko01110	Biosynthesis of secondary metabolites	1369	1.1e-69	0.52	0.60	0.97
PGSC0003DMG200007827	K12126	ko04712	Circadian rhythm - plant	326	4.1e-12	0.51	0.81	0.19
PGSC0003DMG200007831	K01255	ko00480	Glutathione metabolism	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMG200007831	K01255	ko01100	Metabolic pathways	3644	3.8e-195	0.82	0.91	1.00
PGSC0003DMG200003179	K00754	ko00051	Fructose and mannose metabolism	1312	1.6e-66	0.37	0.53	0.84
PGSC0003DMG200003179	K00754	ko00051	Fructose and mannose metabolism	1283	6.3e-65	0.44	0.61	0.97
PGSC0003DMG200003181	K01199	ko00500	Starch and sucrose metabolism	668	5.2e-31	0.35	0.52	0.71
PGSC0003DMG200037454	K12478	ko04144	Endocytosis	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMG200037454	K12478	ko04145	Phagosome	702	3.8e-32	0.26	0.48	0.98
PGSC0003DMG200037460	K04733	ko04210	Apoptosis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMG200037460	K04733	ko04620	Toll-like receptor signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMG200037460	K04733	ko04722	Neurotrophin signaling pathway	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMG200037460	K04733	ko05140	Leishmaniasis	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMG200037460	K04733	ko05142	Chagas disease	1149	1.5e-57	0.45	0.62	0.97
PGSC0003DMG200020813	K02937	ko03010	Ribosome	1768	1.1e-91	0.86	0.94	0.99
PGSC0003DMG200020817	K00602	ko00230	Purine metabolism	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMG200020817	K00602	ko00670	One carbon pool by folate	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMG200020817	K00602	ko01100	Metabolic pathways	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMG200020817	K00602	ko01110	Biosynthesis of secondary metabolites	4085	1.8e-219	0.80	0.87	1.00
PGSC0003DMG200020820	K11866	ko04144	Endocytosis	301	6.8e-10	0.45	0.60	0.94
PGSC0003DMG200020825	K03020	ko00230	Purine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMG200020825	K03020	ko00240	Pyrimidine metabolism	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMG200020825	K03020	ko01100	Metabolic pathways	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMG200020825	K03020	ko03020	RNA polymerase	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMG200020825	K03020	ko04623	Cytosolic DNA-sensing pathway	707	3.7e-33	0.75	0.89	0.99
PGSC0003DMG200020826	K03015	ko00230	Purine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMG200020826	K03015	ko00240	Pyrimidine metabolism	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMG200020826	K03015	ko01100	Metabolic pathways	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMG200020826	K03015	ko03020	RNA polymerase	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMG200020826	K03015	ko05016	Huntington's disease	1351	1.1e-68	0.95	0.99	0.98
PGSC0003DMG200020827	K06269	ko04113	Meiosis - yeast	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04114	Oocyte meiosis	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04270	Vascular smooth muscle contraction	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04510	Focal adhesion	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04720	Long-term potentiation	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04810	Regulation of actin cytoskeleton	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04910	Insulin signaling pathway	1726	2.3e-89	0.69	0.75	0.96
PGSC0003DMG200020827	K06269	ko04113	Meiosis - yeast	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04114	Oocyte meiosis	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04270	Vascular smooth muscle contraction	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04510	Focal adhesion	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04720	Long-term potentiation	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04810	Regulation of actin cytoskeleton	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200020827	K06269	ko04910	Insulin signaling pathway	2322	3.1e-122	0.86	0.93	0.97
PGSC0003DMG200024596	K04424	ko04010	MAPK signaling pathway	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMG200024596	K04424	ko04530	Tight junction	674	1.1e-30	0.36	0.55	0.74
PGSC0003DMG200024604	K02183	ko04020	Calcium signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04070	Phosphatidylinositol signaling system	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04114	Oocyte meiosis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04270	Vascular smooth muscle contraction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04626	Plant-pathogen interaction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04720	Long-term potentiation	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04722	Neurotrophin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04740	Olfactory transduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04744	Phototransduction	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04745	Phototransduction - fly	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04910	Insulin signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04912	GnRH signaling pathway	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04916	Melanogenesis	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04970	Salivary secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko04971	Gastric acid secretion	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko05010	Alzheimer's disease	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024604	K02183	ko05214	Glioma	451	4.9e-19	0.38	0.66	0.88
PGSC0003DMG200024609	K10712	ko00430	Taurine and hypotaurine metabolism	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMG200024609	K10712	ko01100	Metabolic pathways	340	6.4e-13	0.34	0.49	0.70
PGSC0003DMG200024610	K01757	ko00901	Indole alkaloid biosynthesis	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMG200024610	K01757	ko01100	Metabolic pathways	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMG200024610	K01757	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.44	0.62	0.90
PGSC0003DMG200024610	K01757	ko00901	Indole alkaloid biosynthesis	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMG200024610	K01757	ko01100	Metabolic pathways	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMG200024610	K01757	ko01110	Biosynthesis of secondary metabolites	316	1.4e-11	0.42	0.59	0.95
PGSC0003DMG200041620	K02638	ko00195	Photosynthesis	945	2.8e-46	0.69	0.82	0.99
PGSC0003DMG200041631	K13065	ko00940	Phenylpropanoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMG200041631	K13065	ko00941	Flavonoid biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMG200041631	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMG200041631	K13065	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.26	0.44	0.93
PGSC0003DMG200001811	K00142	ko00300	Lysine biosynthesis	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMG200001811	K00142	ko00310	Lysine degradation	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMG200001811	K00142	ko01100	Metabolic pathways	778	4.5e-37	0.36	0.53	0.61
PGSC0003DMG200001811	K04780	ko01053	Biosynthesis of siderophore group nonribosomal peptides	849	7.6e-40	0.30	0.48	0.83
PGSC0003DMG200001812	K10601	ko04120	Ubiquitin mediated proteolysis	249	6.7e-08	0.40	0.58	0.24
PGSC0003DMG200001813	K08241	ko00592	alpha-Linolenic acid metabolism	535	2.4e-28	0.38	0.63	0.97
PGSC0003DMG200001814	K01692	ko00071	Fatty acid metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00280	Valine, leucine and isoleucine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00281	Geraniol degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00310	Lysine degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00380	Tryptophan metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00410	beta-Alanine metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00632	Benzoate degradation via CoA ligation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00640	Propanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00650	Butanoate metabolism	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00903	Limonene and pinene degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko00930	Caprolactam degradation	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko01100	Metabolic pathways	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001814	K01692	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.53	0.69	0.99
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	605	1.6e-27	0.49	0.65	0.69
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	683	7.8e-32	0.32	0.47	0.88
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	1012	5.5e-50	0.42	0.62	0.99
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	1018	2.6e-50	0.39	0.60	0.97
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	612	6.4e-28	0.49	0.65	0.82
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	326	3.8e-12	0.30	0.59	0.97
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	841	1.5e-40	0.45	0.61	0.90
PGSC0003DMG200001815	K08241	ko00592	alpha-Linolenic acid metabolism	989	1.0e-48	0.44	0.62	0.93
PGSC0003DMG200001816	K08241	ko00592	alpha-Linolenic acid metabolism	1142	3.7e-57	0.44	0.63	0.92
PGSC0003DMG200001817	K01692	ko00071	Fatty acid metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00280	Valine, leucine and isoleucine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00281	Geraniol degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00310	Lysine degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00380	Tryptophan metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00410	beta-Alanine metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00632	Benzoate degradation via CoA ligation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00640	Propanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00650	Butanoate metabolism	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00903	Limonene and pinene degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko00930	Caprolactam degradation	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko01100	Metabolic pathways	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001817	K01692	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.49	0.65	0.76
PGSC0003DMG200001820	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMG200001820	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.65
PGSC0003DMG200001820	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMG200001820	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMG200001820	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMG200001820	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.36
PGSC0003DMG200001820	K07127	ko00230	Purine metabolism	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMG200001820	K07127	ko01100	Metabolic pathways	415	4.7e-17	0.45	0.64	0.64
PGSC0003DMG200001823	K04123	ko00904	Diterpenoid biosynthesis	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMG200001823	K04123	ko01100	Metabolic pathways	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMG200001823	K04123	ko01110	Biosynthesis of secondary metabolites	2676	9.2e-142	0.68	0.82	0.99
PGSC0003DMG200001823	K04123	ko00904	Diterpenoid biosynthesis	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMG200001823	K04123	ko01100	Metabolic pathways	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMG200001823	K04123	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.68	0.82	0.97
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	3743	1.3e-200	0.83	0.93	1.00
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	1487	3.5e-76	0.91	0.96	0.91
PGSC0003DMG200008735	K04532	ko05010	Alzheimer's disease	2949	8.1e-157	0.81	0.92	1.00
PGSC0003DMG200008736	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008736	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008736	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008736	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008736	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008736	K00734	ko01100	Metabolic pathways	420	2.5e-17	0.34	0.51	0.59
PGSC0003DMG200008740	K01681	ko00020	Citrate cycle (TCA cycle)	7220	0.	0.87	0.93	1.00
PGSC0003DMG200008740	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7220	0.	0.87	0.93	1.00
PGSC0003DMG200008740	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7220	0.	0.87	0.93	1.00
PGSC0003DMG200008740	K01681	ko01100	Metabolic pathways	7220	0.	0.87	0.93	1.00
PGSC0003DMG200008740	K01681	ko01110	Biosynthesis of secondary metabolites	7220	0.	0.87	0.93	1.00
PGSC0003DMG200008740	K01681	ko00020	Citrate cycle (TCA cycle)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMG200008740	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMG200008740	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMG200008740	K01681	ko01100	Metabolic pathways	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMG200008740	K01681	ko01110	Biosynthesis of secondary metabolites	5304	1.0e-286	0.91	0.95	1.00
PGSC0003DMG200008741	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMG200008741	K00517	ko00626	Naphthalene and anthracene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMG200008741	K00517	ko00903	Limonene and pinene degradation	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMG200008741	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMG200008741	K00517	ko01110	Biosynthesis of secondary metabolites	535	1.1e-23	0.50	0.67	0.99
PGSC0003DMG200008744	K00122	ko00630	Glyoxylate and dicarboxylate metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMG200008744	K00122	ko00680	Methane metabolism	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMG200008744	K00122	ko01100	Metabolic pathways	276	2.2e-09	0.63	0.81	0.63
PGSC0003DMG200008748	K07466	ko03030	DNA replication	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMG200008748	K07466	ko03420	Nucleotide excision repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMG200008748	K07466	ko03430	Mismatch repair	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMG200008748	K07466	ko03440	Homologous recombination	222	8.2e-06	0.30	0.55	0.73
PGSC0003DMG200008750	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMG200008750	K00517	ko00626	Naphthalene and anthracene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMG200008750	K00517	ko00903	Limonene and pinene degradation	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMG200008750	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMG200008750	K00517	ko01110	Biosynthesis of secondary metabolites	1036	2.6e-51	0.39	0.60	0.55
PGSC0003DMG200008752	K07374	ko04145	Phagosome	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMG200008752	K07374	ko04540	Gap junction	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMG200008752	K07374	ko05130	Pathogenic Escherichia coli infection	3756	2.5e-201	0.97	0.99	1.00
PGSC0003DMG200008753	K05666	ko02010	ABC transporters	3353	2.3e-184	0.35	0.55	0.76
PGSC0003DMG200008753	K05666	ko02010	ABC transporters	3778	1.5e-202	0.34	0.54	0.85
PGSC0003DMG200008753	K05667	ko02010	ABC transporters	2276	1.1e-119	0.35	0.54	0.94
PGSC0003DMG200008754	K02912	ko03010	Ribosome	1051	3.9e-52	0.91	0.96	0.99
PGSC0003DMG200005671	K07375	ko04145	Phagosome	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMG200005671	K07375	ko04540	Gap junction	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMG200005671	K07375	ko05130	Pathogenic Escherichia coli infection	2337	4.6e-123	0.97	1.00	0.98
PGSC0003DMG200005676	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMG200005676	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMG200005676	K10411	ko05016	Huntington's disease	226	7.7e-06	0.32	0.53	0.16
PGSC0003DMG200005679	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMG200005679	K00517	ko00626	Naphthalene and anthracene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMG200005679	K00517	ko00903	Limonene and pinene degradation	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMG200005679	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMG200005679	K00517	ko01110	Biosynthesis of secondary metabolites	1272	2.5e-64	0.42	0.61	0.96
PGSC0003DMG200019832	K09481	ko03060	Protein export	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMG200019832	K09481	ko04145	Phagosome	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMG200019832	K09481	ko05110	Vibrio cholerae infection	460	1.5e-19	0.76	0.84	0.92
PGSC0003DMG200019834	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMG200019834	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMG200019834	K03648	ko03410	Base excision repair	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMG200019834	K03648	ko05340	Primary immunodeficiency	1879	8.4e-98	0.68	0.82	1.00
PGSC0003DMG200019834	K03648	ko03410	Base excision repair	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMG200019834	K03648	ko05340	Primary immunodeficiency	1085	5.2e-54	0.82	0.95	0.99
PGSC0003DMG200019844	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04110	Cell cycle	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019844	K06627	ko04914	Progesterone-mediated oocyte maturation	246	1.9e-07	0.51	0.74	0.33
PGSC0003DMG200019845	K08139	ko04113	Meiosis - yeast	389	1.3e-15	0.36	0.53	0.86
PGSC0003DMG200019854	K02148	ko00190	Oxidative phosphorylation	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200019854	K02148	ko01100	Metabolic pathways	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200019854	K02148	ko04145	Phagosome	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200019854	K02148	ko04966	Collecting duct acid secretion	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200019854	K02148	ko05110	Vibrio cholerae infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200019854	K02148	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2671	1.7e-141	0.83	0.93	0.99
PGSC0003DMG200029017	K12128	ko04712	Circadian rhythm - plant	270	5.9e-09	0.38	0.56	0.38
PGSC0003DMG200029018	K00927	ko00010	Glycolysis / Gluconeogenesis	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMG200029018	K00927	ko00710	Carbon fixation in photosynthetic organisms	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMG200029018	K00927	ko01100	Metabolic pathways	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMG200029018	K00927	ko01110	Biosynthesis of secondary metabolites	1269	3.7e-64	0.77	0.84	0.45
PGSC0003DMG200029019	K01431	ko00240	Pyrimidine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMG200029019	K01431	ko00410	beta-Alanine metabolism	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMG200029019	K01431	ko00770	Pantothenate and CoA biosynthesis	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMG200029019	K01431	ko00983	Drug metabolism - other enzymes	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMG200029019	K01431	ko01100	Metabolic pathways	1478	1.1e-75	0.91	0.97	0.99
PGSC0003DMG200029019	K01431	ko00240	Pyrimidine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMG200029019	K01431	ko00410	beta-Alanine metabolism	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMG200029019	K01431	ko00770	Pantothenate and CoA biosynthesis	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMG200029019	K01431	ko00983	Drug metabolism - other enzymes	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMG200029019	K01431	ko01100	Metabolic pathways	2967	8.2e-158	0.83	0.92	0.98
PGSC0003DMG200029019	K01431	ko00240	Pyrimidine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMG200029019	K01431	ko00410	beta-Alanine metabolism	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMG200029019	K01431	ko00770	Pantothenate and CoA biosynthesis	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMG200029019	K01431	ko00983	Drug metabolism - other enzymes	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMG200029019	K01431	ko01100	Metabolic pathways	2611	3.6e-138	0.87	0.95	1.00
PGSC0003DMG200029023	K03883	ko00190	Oxidative phosphorylation	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMG200029023	K03883	ko01100	Metabolic pathways	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMG200029023	K03883	ko05012	Parkinson's disease	1150	1.4e-57	0.86	0.88	0.99
PGSC0003DMG200029028	K05278	ko00941	Flavonoid biosynthesis	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMG200029028	K05278	ko01100	Metabolic pathways	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMG200029028	K05278	ko01110	Biosynthesis of secondary metabolites	298	1.3e-10	0.30	0.47	0.87
PGSC0003DMG200029028	K05282	ko00904	Diterpenoid biosynthesis	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMG200029028	K05282	ko01100	Metabolic pathways	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMG200029028	K05282	ko01110	Biosynthesis of secondary metabolites	291	3.2e-10	0.34	0.56	0.72
PGSC0003DMG200029029	K00889	ko00562	Inositol phosphate metabolism	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029029	K00889	ko01100	Metabolic pathways	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029029	K00889	ko04070	Phosphatidylinositol signaling system	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029029	K00889	ko04144	Endocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029029	K00889	ko04666	Fc gamma R-mediated phagocytosis	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029029	K00889	ko04810	Regulation of actin cytoskeleton	5298	2.2e-286	0.77	0.84	1.00
PGSC0003DMG200029031	K01942	ko00780	Biotin metabolism	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMG200029031	K01942	ko01100	Metabolic pathways	720	7.1e-34	0.57	0.76	0.96
PGSC0003DMG200029031	K01942	ko00780	Biotin metabolism	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMG200029031	K01942	ko01100	Metabolic pathways	1778	3.1e-92	0.65	0.80	0.99
PGSC0003DMG200029032	K08866	ko04110	Cell cycle	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMG200029032	K08866	ko04111	Cell cycle - yeast	1119	7.0e-56	0.71	0.81	0.98
PGSC0003DMG200029032	K08866	ko04110	Cell cycle	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMG200029032	K08866	ko04111	Cell cycle - yeast	3459	6.0e-185	0.68	0.79	0.99
PGSC0003DMG200029032	K08866	ko04110	Cell cycle	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMG200029032	K08866	ko04111	Cell cycle - yeast	2961	1.8e-157	0.58	0.73	0.99
PGSC0003DMG200029032	K08866	ko04110	Cell cycle	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMG200029032	K08866	ko04111	Cell cycle - yeast	4117	3.1e-221	0.61	0.75	0.99
PGSC0003DMG200029032	K08866	ko04110	Cell cycle	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMG200029032	K08866	ko04111	Cell cycle - yeast	546	4.7e-24	0.43	0.59	0.95
PGSC0003DMG200026819	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00270	Cysteine and methionine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00350	Tyrosine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00360	Phenylalanine metabolism	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00401	Novobiocin biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko01100	Metabolic pathways	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko01110	Biosynthesis of secondary metabolites	1399	2.5e-71	0.62	0.73	0.97
PGSC0003DMG200026819	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00270	Cysteine and methionine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00350	Tyrosine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00360	Phenylalanine metabolism	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00401	Novobiocin biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00950	Isoquinoline alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko01100	Metabolic pathways	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026819	K00815	ko01110	Biosynthesis of secondary metabolites	779	3.9e-37	0.65	0.77	0.99
PGSC0003DMG200026820	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00270	Cysteine and methionine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00350	Tyrosine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00360	Phenylalanine metabolism	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00401	Novobiocin biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00950	Isoquinoline alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01100	Metabolic pathways	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko01110	Biosynthesis of secondary metabolites	1360	3.5e-69	0.69	0.83	0.99
PGSC0003DMG200026820	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00350	Tyrosine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00360	Phenylalanine metabolism	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00401	Novobiocin biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko01100	Metabolic pathways	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200026820	K00815	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.69	0.85	1.00
PGSC0003DMG200023810	K10246	ko01040	Biosynthesis of unsaturated fatty acids	397	4.6e-16	0.38	0.52	0.95
PGSC0003DMG200023819	K09588	ko01100	Metabolic pathways	1826	7.0e-95	0.72	0.82	0.98
PGSC0003DMG200023819	K09588	ko01100	Metabolic pathways	2484	3.6e-131	0.74	0.83	0.82
PGSC0003DMG200023823	K00970	ko03018	RNA degradation	339	7.4e-12	0.37	0.54	0.58
PGSC0003DMG200002513	K00599	ko00340	Histidine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMG200002513	K00599	ko00350	Tyrosine metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMG200002513	K00599	ko00450	Selenoamino acid metabolism	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMG200002513	K00599	ko00626	Naphthalene and anthracene degradation	2652	1.9e-140	0.58	0.70	0.88
PGSC0003DMG200002513	K00599	ko00340	Histidine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMG200002513	K00599	ko00350	Tyrosine metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMG200002513	K00599	ko00450	Selenoamino acid metabolism	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMG200002513	K00599	ko00626	Naphthalene and anthracene degradation	2150	9.5e-113	0.71	0.84	0.99
PGSC0003DMG200002513	K00599	ko00340	Histidine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMG200002513	K00599	ko00350	Tyrosine metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMG200002513	K00599	ko00450	Selenoamino acid metabolism	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMG200002513	K00599	ko00626	Naphthalene and anthracene degradation	2810	3.8e-149	0.66	0.80	0.86
PGSC0003DMG200011575	K04077	ko03018	RNA degradation	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMG200011575	K04077	ko04940	Type I diabetes mellitus	4154	2.8e-223	0.89	0.96	1.00
PGSC0003DMG200011578	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMG200011578	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMG200011578	K00771	ko01100	Metabolic pathways	402	1.1e-15	0.31	0.50	0.69
PGSC0003DMG200011581	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMG200011581	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.90
PGSC0003DMG200011581	K04681	ko04110	Cell cycle	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMG200011581	K04681	ko04350	TGF-beta signaling pathway	1135	9.1e-57	0.28	0.48	0.89
PGSC0003DMG200011586	K00441	ko00790	Folate biosynthesis	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMG200011586	K00441	ko01100	Metabolic pathways	1044	9.5e-52	0.80	0.93	0.99
PGSC0003DMG200011586	K00441	ko00790	Folate biosynthesis	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMG200011586	K00441	ko01100	Metabolic pathways	3280	4.5e-175	0.82	0.92	0.99
PGSC0003DMG200011587	K00356	ko00190	Oxidative phosphorylation	1097	1.1e-54	0.87	0.92	0.99
PGSC0003DMG200006315	K11253	ko05322	Systemic lupus erythematosus	1122	4.8e-56	1.00	1.00	0.99
PGSC0003DMG200006319	K05350	ko00460	Cyanoamino acid metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMG200006319	K05350	ko00500	Starch and sucrose metabolism	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMG200006319	K05350	ko00940	Phenylpropanoid biosynthesis	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMG200006319	K05350	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.58	0.71	1.00
PGSC0003DMG200006319	K05350	ko00460	Cyanoamino acid metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMG200006319	K05350	ko00500	Starch and sucrose metabolism	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMG200006319	K05350	ko00940	Phenylpropanoid biosynthesis	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMG200006319	K05350	ko01110	Biosynthesis of secondary metabolites	2508	1.7e-132	0.59	0.74	0.98
PGSC0003DMG200009374	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00270	Cysteine and methionine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00350	Tyrosine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00360	Phenylalanine metabolism	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00401	Novobiocin biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko01100	Metabolic pathways	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009374	K00815	ko01110	Biosynthesis of secondary metabolites	2047	4.6e-107	0.57	0.77	0.99
PGSC0003DMG200009376	K07466	ko03030	DNA replication	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMG200009376	K07466	ko03420	Nucleotide excision repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMG200009376	K07466	ko03430	Mismatch repair	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMG200009376	K07466	ko03440	Homologous recombination	785	1.8e-37	0.70	0.78	0.92
PGSC0003DMG200009378	K12826	ko03040	Spliceosome	346	3.0e-13	0.29	0.41	0.78
PGSC0003DMG200009378	K12826	ko03040	Spliceosome	342	5.0e-13	0.33	0.44	0.85
PGSC0003DMG200009386	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMG200009386	K00517	ko00626	Naphthalene and anthracene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMG200009386	K00517	ko00903	Limonene and pinene degradation	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMG200009386	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMG200009386	K00517	ko01110	Biosynthesis of secondary metabolites	694	1.9e-32	0.56	0.70	0.97
PGSC0003DMG200000010	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.67
PGSC0003DMG200000010	K00754	ko00051	Fructose and mannose metabolism	1950	1.0e-101	0.51	0.70	0.65
PGSC0003DMG200000011	K05282	ko00904	Diterpenoid biosynthesis	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMG200000011	K05282	ko01100	Metabolic pathways	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMG200000011	K05282	ko01110	Biosynthesis of secondary metabolites	1352	9.8e-69	0.59	0.73	0.98
PGSC0003DMG200000011	K05282	ko00904	Diterpenoid biosynthesis	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMG200000011	K05282	ko01100	Metabolic pathways	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMG200000011	K05282	ko01110	Biosynthesis of secondary metabolites	1839	1.4e-95	0.60	0.74	0.99
PGSC0003DMG200000014	K01692	ko00071	Fatty acid metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00280	Valine, leucine and isoleucine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00281	Geraniol degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00310	Lysine degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00380	Tryptophan metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00410	beta-Alanine metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00632	Benzoate degradation via CoA ligation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00640	Propanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00650	Butanoate metabolism	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00903	Limonene and pinene degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00930	Caprolactam degradation	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.59	0.93
PGSC0003DMG200000014	K01692	ko00071	Fatty acid metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00280	Valine, leucine and isoleucine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00281	Geraniol degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00310	Lysine degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00380	Tryptophan metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00410	beta-Alanine metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00632	Benzoate degradation via CoA ligation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00640	Propanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00650	Butanoate metabolism	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00903	Limonene and pinene degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00930	Caprolactam degradation	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko01100	Metabolic pathways	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko01110	Biosynthesis of secondary metabolites	343	4.4e-13	0.75	0.87	0.87
PGSC0003DMG200000014	K01692	ko00071	Fatty acid metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00280	Valine, leucine and isoleucine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00281	Geraniol degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00310	Lysine degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00380	Tryptophan metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00410	beta-Alanine metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00632	Benzoate degradation via CoA ligation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00640	Propanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00650	Butanoate metabolism	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00903	Limonene and pinene degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko00930	Caprolactam degradation	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko01100	Metabolic pathways	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000014	K01692	ko01110	Biosynthesis of secondary metabolites	320	8.2e-12	0.39	0.62	0.97
PGSC0003DMG200000017	K01692	ko00071	Fatty acid metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00280	Valine, leucine and isoleucine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00281	Geraniol degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00310	Lysine degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00410	beta-Alanine metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00632	Benzoate degradation via CoA ligation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00640	Propanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00650	Butanoate metabolism	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00903	Limonene and pinene degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00930	Caprolactam degradation	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko01100	Metabolic pathways	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko01110	Biosynthesis of secondary metabolites	1300	7.2e-66	0.47	0.66	0.94
PGSC0003DMG200000017	K01692	ko00071	Fatty acid metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00280	Valine, leucine and isoleucine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00281	Geraniol degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00310	Lysine degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00380	Tryptophan metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00410	beta-Alanine metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00632	Benzoate degradation via CoA ligation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00640	Propanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00650	Butanoate metabolism	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00903	Limonene and pinene degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00930	Caprolactam degradation	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko01100	Metabolic pathways	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.57	0.77	0.91
PGSC0003DMG200000017	K01692	ko00071	Fatty acid metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00280	Valine, leucine and isoleucine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00281	Geraniol degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00310	Lysine degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00380	Tryptophan metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00410	beta-Alanine metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00632	Benzoate degradation via CoA ligation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00640	Propanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00650	Butanoate metabolism	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00903	Limonene and pinene degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko00930	Caprolactam degradation	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko01100	Metabolic pathways	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000017	K01692	ko01110	Biosynthesis of secondary metabolites	371	1.3e-14	0.38	0.60	0.89
PGSC0003DMG200000019	K00067	ko00521	Streptomycin biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMG200000019	K00067	ko00523	Polyketide sugar unit biosynthesis	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMG200000019	K00067	ko01100	Metabolic pathways	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMG200000019	K00067	ko01110	Biosynthesis of secondary metabolites	1423	1.2e-72	0.54	0.72	0.97
PGSC0003DMG200000019	K00067	ko00521	Streptomycin biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMG200000019	K00067	ko00523	Polyketide sugar unit biosynthesis	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMG200000019	K00067	ko01100	Metabolic pathways	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMG200000019	K00067	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.54	0.71	0.99
PGSC0003DMG200000020	K00028	ko00620	Pyruvate metabolism	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMG200000020	K00028	ko00710	Carbon fixation in photosynthetic organisms	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMG200000020	K00028	ko01100	Metabolic pathways	3943	1.2e-211	0.74	0.85	1.00
PGSC0003DMG200000020	K00079	ko00590	Arachidonic acid metabolism	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMG200000020	K00079	ko01100	Metabolic pathways	668	5.2e-31	0.41	0.56	0.97
PGSC0003DMG200000020	K00079	ko00590	Arachidonic acid metabolism	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMG200000020	K00079	ko01100	Metabolic pathways	477	1.8e-20	0.34	0.49	0.94
PGSC0003DMG200042829	K12356	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.30	0.44	0.88
PGSC0003DMG200019141	K04618	ko00052	Galactose metabolism	526	1.0e-22	0.29	0.41	0.95
PGSC0003DMG200019149	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMG200019149	K01602	ko00710	Carbon fixation in photosynthetic organisms	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMG200019149	K01602	ko01100	Metabolic pathways	1462	8.4e-75	0.60	0.77	0.65
PGSC0003DMG200023086	K04565	ko04146	Peroxisome	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMG200023086	K04565	ko05014	Amyotrophic lateral sclerosis (ALS)	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMG200023086	K04565	ko05016	Huntington's disease	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMG200023086	K04565	ko05020	Prion diseases	1112	1.7e-55	0.84	0.90	0.93
PGSC0003DMG200023087	K01515	ko00230	Purine metabolism	243	1.4e-07	0.35	0.57	0.81
PGSC0003DMG200023092	K01110	ko00562	Inositol phosphate metabolism	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko04070	Phosphatidylinositol signaling system	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko04115	p53 signaling pathway	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko04510	Focal adhesion	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko04530	Tight junction	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05200	Pathways in cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05213	Endometrial cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05214	Glioma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05215	Prostate cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05218	Melanoma	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023092	K01110	ko05222	Small cell lung cancer	2298	6.5e-121	0.67	0.78	0.99
PGSC0003DMG200023096	K07466	ko03030	DNA replication	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMG200023096	K07466	ko03420	Nucleotide excision repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMG200023096	K07466	ko03430	Mismatch repair	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMG200023096	K07466	ko03440	Homologous recombination	224	5.6e-06	0.23	0.50	0.93
PGSC0003DMG200023098	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMG200023098	K05292	ko01100	Metabolic pathways	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMG200023098	K05292	ko01110	Biosynthesis of secondary metabolites	3666	2.3e-196	0.67	0.80	0.99
PGSC0003DMG200023098	K05292	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMG200023098	K05292	ko01100	Metabolic pathways	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMG200023098	K05292	ko01110	Biosynthesis of secondary metabolites	245	4.2e-07	0.62	0.73	0.95
PGSC0003DMG200026149	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K11228	ko04011	MAPK signaling pathway - yeast	805	1.4e-38	0.39	0.58	0.51
PGSC0003DMG200026149	K04428	ko04010	MAPK signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMG200026149	K04428	ko04912	GnRH signaling pathway	425	1.5e-16	0.51	0.73	0.82
PGSC0003DMG200026149	K04420	ko04010	MAPK signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04540	Gap junction	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026149	K04420	ko04912	GnRH signaling pathway	792	7.6e-38	0.43	0.60	0.90
PGSC0003DMG200026150	K01057	ko00030	Pentose phosphate pathway	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMG200026150	K01057	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMG200026150	K01057	ko01110	Biosynthesis of secondary metabolites	1692	1.7e-87	0.66	0.79	0.92
PGSC0003DMG200026150	K01057	ko00030	Pentose phosphate pathway	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMG200026150	K01057	ko01100	Metabolic pathways	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMG200026150	K01057	ko01110	Biosynthesis of secondary metabolites	398	4.1e-16	0.51	0.69	0.80
PGSC0003DMG200026150	K01057	ko00030	Pentose phosphate pathway	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMG200026150	K01057	ko01100	Metabolic pathways	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMG200026150	K01057	ko01110	Biosynthesis of secondary metabolites	1689	2.5e-87	0.67	0.78	0.92
PGSC0003DMG200026150	K01057	ko00030	Pentose phosphate pathway	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMG200026150	K01057	ko01100	Metabolic pathways	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMG200026150	K01057	ko01110	Biosynthesis of secondary metabolites	1700	6.3e-88	0.67	0.79	0.92
PGSC0003DMG200026157	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMG200026157	K01078	ko00740	Riboflavin metabolism	442	1.5e-18	0.28	0.43	0.85
PGSC0003DMG200016913	K06276	ko03320	PPAR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko04150	mTOR signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko04510	Focal adhesion	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko04910	Insulin signaling pathway	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko04960	Aldosterone-regulated sodium reabsorption	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko05213	Endometrial cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko05215	Prostate cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko05223	Non-small cell lung cancer	2743	1.9e-145	0.83	0.87	1.00
PGSC0003DMG200016913	K06276	ko03320	PPAR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko04150	mTOR signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko04510	Focal adhesion	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko04910	Insulin signaling pathway	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko04960	Aldosterone-regulated sodium reabsorption	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko05213	Endometrial cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko05215	Prostate cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016913	K06276	ko05223	Non-small cell lung cancer	3433	1.6e-183	0.82	0.88	1.00
PGSC0003DMG200016916	K01728	ko00040	Pentose and glucuronate interconversions	2088	2.5e-109	0.63	0.77	0.76
PGSC0003DMG200016921	K11252	ko05322	Systemic lupus erythematosus	1101	6.8e-55	0.93	0.94	0.99
PGSC0003DMG200016922	K12897	ko03040	Spliceosome	376	6.7e-15	0.37	0.46	0.93
PGSC0003DMG200016922	K12885	ko03040	Spliceosome	469	4.9e-20	0.34	0.45	0.97
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	6438	0.	0.83	0.90	0.99
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	1792	5.3e-93	0.79	0.86	0.99
PGSC0003DMG200007089	K00697	ko00500	Starch and sucrose metabolism	1202	1.8e-60	0.76	0.84	0.99
PGSC0003DMG200007095	K03006	ko00230	Purine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMG200007095	K03006	ko00240	Pyrimidine metabolism	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMG200007095	K03006	ko01100	Metabolic pathways	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMG200007095	K03006	ko03020	RNA polymerase	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMG200007095	K03006	ko05016	Huntington's disease	240	7.1e-06	0.36	0.48	0.45
PGSC0003DMG200003484	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.92
PGSC0003DMG200003484	K12741	ko03040	Spliceosome	334	1.4e-12	0.33	0.47	0.93
PGSC0003DMG200003487	K09658	ko00510	N-Glycan biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMG200003487	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMG200003487	K09658	ko01100	Metabolic pathways	513	1.8e-22	0.77	0.90	0.99
PGSC0003DMG200003490	K01184	ko00040	Pentose and glucuronate interconversions	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMG200003490	K01184	ko00500	Starch and sucrose metabolism	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMG200003490	K01184	ko01100	Metabolic pathways	1032	4.4e-51	0.42	0.56	0.92
PGSC0003DMG200003490	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003490	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003490	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003490	K01184	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003490	K01184	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003490	K01184	ko01100	Metabolic pathways	580	3.7e-26	0.38	0.55	0.96
PGSC0003DMG200003492	K12885	ko03040	Spliceosome	424	1.5e-17	0.30	0.39	0.90
PGSC0003DMG200003495	K00688	ko00500	Starch and sucrose metabolism	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMG200003495	K00688	ko04910	Insulin signaling pathway	1498	8.7e-77	0.85	0.93	1.00
PGSC0003DMG200003497	K02982	ko03010	Ribosome	576	6.2e-26	0.91	0.97	0.99
PGSC0003DMG200003499	K02982	ko03010	Ribosome	487	5.0e-21	0.90	0.98	0.91
PGSC0003DMG200003501	K12189	ko04144	Endocytosis	701	7.9e-33	0.91	0.97	0.99
PGSC0003DMG200003501	K12189	ko04144	Endocytosis	1357	5.2e-69	0.87	0.96	0.99
PGSC0003DMG200027382	K02183	ko04020	Calcium signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04070	Phosphatidylinositol signaling system	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04114	Oocyte meiosis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04270	Vascular smooth muscle contraction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04626	Plant-pathogen interaction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04720	Long-term potentiation	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04722	Neurotrophin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04740	Olfactory transduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04744	Phototransduction	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04745	Phototransduction - fly	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04910	Insulin signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04912	GnRH signaling pathway	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04916	Melanogenesis	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04970	Salivary secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko04971	Gastric acid secretion	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko05010	Alzheimer's disease	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027382	K02183	ko05214	Glioma	1076	1.6e-53	0.85	0.94	0.99
PGSC0003DMG200027383	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMG200027384	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200027384	K02183	ko04020	Calcium signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04070	Phosphatidylinositol signaling system	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04114	Oocyte meiosis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04270	Vascular smooth muscle contraction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04626	Plant-pathogen interaction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04720	Long-term potentiation	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04722	Neurotrophin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04740	Olfactory transduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04744	Phototransduction	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04745	Phototransduction - fly	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04910	Insulin signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04912	GnRH signaling pathway	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04916	Melanogenesis	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04970	Salivary secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04971	Gastric acid secretion	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko05010	Alzheimer's disease	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko05214	Glioma	222	2.1e-06	1.00	1.00	0.48
PGSC0003DMG200027384	K02183	ko04020	Calcium signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04070	Phosphatidylinositol signaling system	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04114	Oocyte meiosis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04270	Vascular smooth muscle contraction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04626	Plant-pathogen interaction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04720	Long-term potentiation	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04722	Neurotrophin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04740	Olfactory transduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04744	Phototransduction	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04745	Phototransduction - fly	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04910	Insulin signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04912	GnRH signaling pathway	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04916	Melanogenesis	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04970	Salivary secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko04971	Gastric acid secretion	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko05010	Alzheimer's disease	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027384	K02183	ko05214	Glioma	1034	3.4e-51	0.79	0.87	0.95
PGSC0003DMG200027385	K01199	ko00500	Starch and sucrose metabolism	621	2.0e-28	0.32	0.51	0.92
PGSC0003DMG200027392	K00475	ko00941	Flavonoid biosynthesis	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMG200027392	K00475	ko01100	Metabolic pathways	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMG200027392	K00475	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.36	0.57	0.98
PGSC0003DMG200027392	K00475	ko00941	Flavonoid biosynthesis	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMG200027392	K00475	ko01100	Metabolic pathways	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMG200027392	K00475	ko01110	Biosynthesis of secondary metabolites	510	2.7e-22	0.36	0.58	0.98
PGSC0003DMG200027392	K05278	ko00941	Flavonoid biosynthesis	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMG200027392	K05278	ko01100	Metabolic pathways	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMG200027392	K05278	ko01110	Biosynthesis of secondary metabolites	714	1.5e-33	0.36	0.53	0.90
PGSC0003DMG200027392	K05277	ko00941	Flavonoid biosynthesis	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMG200027392	K05277	ko01100	Metabolic pathways	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMG200027392	K05277	ko01110	Biosynthesis of secondary metabolites	309	3.3e-11	0.32	0.54	0.84
PGSC0003DMG200027394	K05277	ko00941	Flavonoid biosynthesis	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMG200027394	K05277	ko01100	Metabolic pathways	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMG200027394	K05277	ko01110	Biosynthesis of secondary metabolites	303	7.1e-11	0.34	0.53	0.84
PGSC0003DMG200027394	K00475	ko00941	Flavonoid biosynthesis	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMG200027394	K00475	ko01100	Metabolic pathways	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMG200027394	K00475	ko01110	Biosynthesis of secondary metabolites	483	8.3e-21	0.36	0.55	0.97
PGSC0003DMG200025216	K11090	ko05322	Systemic lupus erythematosus	318	1.1e-11	0.36	0.55	0.50
PGSC0003DMG200025216	K11090	ko05322	Systemic lupus erythematosus	331	2.0e-12	0.29	0.45	0.59
PGSC0003DMG200025217	K00794	ko00740	Riboflavin metabolism	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMG200025217	K00794	ko01100	Metabolic pathways	784	2.1e-37	0.54	0.62	0.86
PGSC0003DMG200025217	K00794	ko00740	Riboflavin metabolism	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMG200025217	K00794	ko01100	Metabolic pathways	1181	2.6e-59	0.70	0.80	0.88
PGSC0003DMG200025218	K00975	ko00500	Starch and sucrose metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMG200025218	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMG200025218	K00975	ko01100	Metabolic pathways	899	9.5e-44	0.66	0.81	0.99
PGSC0003DMG200025219	K13065	ko00940	Phenylpropanoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMG200025219	K13065	ko00941	Flavonoid biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMG200025219	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMG200025219	K13065	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.33	0.50	0.94
PGSC0003DMG200025221	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMG200025221	K00517	ko00626	Naphthalene and anthracene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMG200025221	K00517	ko00903	Limonene and pinene degradation	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMG200025221	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMG200025221	K00517	ko01110	Biosynthesis of secondary metabolites	1062	9.7e-53	0.44	0.66	0.77
PGSC0003DMG200025221	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMG200025221	K00517	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMG200025221	K00517	ko00903	Limonene and pinene degradation	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMG200025221	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMG200025221	K00517	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.44	0.65	0.62
PGSC0003DMG200025222	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMG200025222	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.61
PGSC0003DMG200025222	K04424	ko04010	MAPK signaling pathway	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMG200025222	K04424	ko04530	Tight junction	399	1.4e-15	0.39	0.56	0.57
PGSC0003DMG200025222	K04424	ko04010	MAPK signaling pathway	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMG200025222	K04424	ko04530	Tight junction	601	2.7e-27	0.33	0.54	0.71
PGSC0003DMG200025224	K01190	ko00052	Galactose metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMG200025224	K01190	ko00511	Other glycan degradation	6612	0.	0.67	0.80	1.00
PGSC0003DMG200025224	K01190	ko00600	Sphingolipid metabolism	6612	0.	0.67	0.80	1.00
PGSC0003DMG200025224	K01190	ko01100	Metabolic pathways	6612	0.	0.67	0.80	1.00
PGSC0003DMG200025224	K01190	ko00052	Galactose metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMG200025224	K01190	ko00511	Other glycan degradation	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMG200025224	K01190	ko00600	Sphingolipid metabolism	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMG200025224	K01190	ko01100	Metabolic pathways	1565	1.8e-80	0.65	0.77	0.98
PGSC0003DMG200025224	K01190	ko00052	Galactose metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMG200025224	K01190	ko00511	Other glycan degradation	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMG200025224	K01190	ko00600	Sphingolipid metabolism	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMG200025224	K01190	ko01100	Metabolic pathways	2471	1.9e-130	0.70	0.83	0.99
PGSC0003DMG200025226	K01099	ko00562	Inositol phosphate metabolism	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMG200025226	K01099	ko01100	Metabolic pathways	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMG200025226	K01099	ko04070	Phosphatidylinositol signaling system	751	2.8e-35	0.30	0.47	0.43
PGSC0003DMG200025227	K00599	ko00340	Histidine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMG200025227	K00599	ko00350	Tyrosine metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMG200025227	K00599	ko00450	Selenoamino acid metabolism	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMG200025227	K00599	ko00626	Naphthalene and anthracene degradation	335	1.2e-12	0.31	0.49	0.82
PGSC0003DMG200025227	K00599	ko00340	Histidine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMG200025227	K00599	ko00350	Tyrosine metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMG200025227	K00599	ko00450	Selenoamino acid metabolism	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMG200025227	K00599	ko00626	Naphthalene and anthracene degradation	211	8.4e-06	0.42	0.58	0.64
PGSC0003DMG200021562	K11294	ko05130	Pathogenic Escherichia coli infection	478	1.6e-20	0.35	0.52	0.84
PGSC0003DMG200021564	K10775	ko00360	Phenylalanine metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMG200021564	K10775	ko00910	Nitrogen metabolism	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMG200021564	K10775	ko00940	Phenylpropanoid biosynthesis	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMG200021564	K10775	ko01100	Metabolic pathways	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMG200021564	K10775	ko01110	Biosynthesis of secondary metabolites	1160	3.8e-58	0.79	0.93	0.99
PGSC0003DMG200021564	K10775	ko00360	Phenylalanine metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMG200021564	K10775	ko00910	Nitrogen metabolism	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMG200021564	K10775	ko00940	Phenylpropanoid biosynthesis	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMG200021564	K10775	ko01100	Metabolic pathways	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMG200021564	K10775	ko01110	Biosynthesis of secondary metabolites	5060	3.0e-273	0.83	0.92	1.00
PGSC0003DMG200021566	K05681	ko02010	ABC transporters	905	8.0e-44	0.30	0.49	0.44
PGSC0003DMG200021566	K05681	ko02010	ABC transporters	921	5.8e-45	0.30	0.49	0.56
PGSC0003DMG200021567	K12356	ko00940	Phenylpropanoid biosynthesis	447	8.1e-19	0.28	0.46	0.92
PGSC0003DMG200021569	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMG200021569	K12356	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.36	0.57	0.87
PGSC0003DMG200021571	K01358	ko04112	Cell cycle - Caulobacter	489	3.9e-21	0.80	0.94	0.94
PGSC0003DMG200021574	K01051	ko00040	Pentose and glucuronate interconversions	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMG200021574	K01051	ko00500	Starch and sucrose metabolism	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMG200021574	K01051	ko01100	Metabolic pathways	359	7.4e-14	0.33	0.58	0.95
PGSC0003DMG200021575	K01051	ko00040	Pentose and glucuronate interconversions	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMG200021575	K01051	ko00500	Starch and sucrose metabolism	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMG200021575	K01051	ko01100	Metabolic pathways	1977	3.3e-103	0.54	0.70	1.00
PGSC0003DMG200021579	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMG200021579	K00517	ko00626	Naphthalene and anthracene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMG200021579	K00517	ko00903	Limonene and pinene degradation	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMG200021579	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMG200021579	K00517	ko01110	Biosynthesis of secondary metabolites	1121	5.4e-56	0.42	0.62	0.99
PGSC0003DMG200020562	K01955	ko00240	Pyrimidine metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMG200020562	K01955	ko00250	Alanine, aspartate and glutamate metabolism	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMG200020562	K01955	ko01100	Metabolic pathways	566	1.5e-24	0.45	0.59	0.87
PGSC0003DMG200020566	K02976	ko03010	Ribosome	981	2.8e-48	0.88	0.91	0.99
PGSC0003DMG200020568	K10579	ko04120	Ubiquitin mediated proteolysis	1061	1.1e-52	0.71	0.81	0.97
PGSC0003DMG200020569	K06689	ko04120	Ubiquitin mediated proteolysis	1231	4.6e-62	0.83	0.83	0.99
PGSC0003DMG200020569	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMG200020570	K03063	ko03050	Proteasome	3209	3.7e-171	0.93	0.96	1.00
PGSC0003DMG200020571	K03063	ko03050	Proteasome	573	9.1e-26	0.95	0.97	0.94
PGSC0003DMG200020577	K01251	ko00270	Cysteine and methionine metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMG200020577	K01251	ko00450	Selenoamino acid metabolism	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMG200020577	K01251	ko01100	Metabolic pathways	3892	7.9e-209	0.94	0.97	1.00
PGSC0003DMG200020577	K01251	ko00270	Cysteine and methionine metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMG200020577	K01251	ko00450	Selenoamino acid metabolism	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMG200020577	K01251	ko01100	Metabolic pathways	3890	1.0e-208	0.94	0.96	1.00
PGSC0003DMG200020577	K01251	ko00270	Cysteine and methionine metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMG200020577	K01251	ko00450	Selenoamino acid metabolism	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMG200020577	K01251	ko01100	Metabolic pathways	2370	7.0e-125	0.96	0.98	1.00
PGSC0003DMG200020578	K01516	ko00230	Purine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMG200020578	K01516	ko00730	Thiamine metabolism	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMG200020578	K01516	ko01100	Metabolic pathways	648	6.6e-30	0.32	0.43	0.94
PGSC0003DMG200020579	K06685	ko04111	Cell cycle - yeast	331	2.1e-10	0.27	0.45	0.69
PGSC0003DMG200037578	K09590	ko00905	Brassinosteroid biosynthesis	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMG200037578	K09590	ko01100	Metabolic pathways	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMG200037578	K09590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.66	0.82	1.00
PGSC0003DMG200037587	K05933	ko00270	Cysteine and methionine metabolism	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMG200037587	K05933	ko01110	Biosynthesis of secondary metabolites	488	4.4e-21	0.30	0.52	0.76
PGSC0003DMG200037588	K01199	ko00500	Starch and sucrose metabolism	480	1.2e-20	0.56	0.81	0.99
PGSC0003DMG200033910	K01358	ko04112	Cell cycle - Caulobacter	1652	2.8e-85	0.73	0.82	1.00
PGSC0003DMG200033912	K03941	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMG200033912	K03941	ko01100	Metabolic pathways	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMG200033912	K03941	ko05010	Alzheimer's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMG200033912	K03941	ko05012	Parkinson's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMG200033912	K03941	ko05016	Huntington's disease	1655	1.9e-85	0.86	0.92	1.00
PGSC0003DMG200033924	K12879	ko03040	Spliceosome	11430	0.	0.74	0.83	1.00
PGSC0003DMG200033924	K12879	ko03040	Spliceosome	6858	0.	0.71	0.80	1.00
PGSC0003DMG200033924	K12879	ko03040	Spliceosome	3449	2.1e-184	0.61	0.73	1.00
PGSC0003DMG200033924	K12879	ko03040	Spliceosome	5317	2.0e-287	0.69	0.78	1.00
PGSC0003DMG200033932	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMG200033932	K00517	ko00626	Naphthalene and anthracene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMG200033932	K00517	ko00903	Limonene and pinene degradation	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMG200033932	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMG200033932	K00517	ko01110	Biosynthesis of secondary metabolites	1111	1.9e-55	0.42	0.65	0.98
PGSC0003DMG200020899	K04733	ko04210	Apoptosis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMG200020899	K04733	ko04620	Toll-like receptor signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMG200020899	K04733	ko04722	Neurotrophin signaling pathway	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMG200020899	K04733	ko05140	Leishmaniasis	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMG200020899	K04733	ko05142	Chagas disease	742	4.3e-35	0.38	0.59	0.72
PGSC0003DMG200020899	K04733	ko04210	Apoptosis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMG200020899	K04733	ko04620	Toll-like receptor signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMG200020899	K04733	ko04722	Neurotrophin signaling pathway	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMG200020899	K04733	ko05140	Leishmaniasis	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMG200020899	K04733	ko05142	Chagas disease	724	4.3e-34	0.38	0.60	0.85
PGSC0003DMG200020900	K12356	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.32	0.50	0.89
PGSC0003DMG200020901	K12356	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.48	0.97
PGSC0003DMG200020903	K12356	ko00940	Phenylpropanoid biosynthesis	672	3.1e-31	0.32	0.49	0.92
PGSC0003DMG200024847	K12479	ko04144	Endocytosis	1614	3.5e-83	0.49	0.72	0.96
PGSC0003DMG200024847	K12479	ko04144	Endocytosis	2125	2.3e-111	0.47	0.71	1.00
PGSC0003DMG200024849	K00001	ko00010	Glycolysis / Gluconeogenesis	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00071	Fatty acid metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00350	Tyrosine metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00641	3-Chloroacrylic acid degradation	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00830	Retinol metabolism	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00982	Drug metabolism - cytochrome P450	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko01100	Metabolic pathways	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.83	0.92	0.99
PGSC0003DMG200024849	K00001	ko00010	Glycolysis / Gluconeogenesis	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00071	Fatty acid metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00350	Tyrosine metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00624	1- and 2-Methylnaphthalene degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00641	3-Chloroacrylic acid degradation	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00830	Retinol metabolism	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko00982	Drug metabolism - cytochrome P450	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko01100	Metabolic pathways	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200024849	K00001	ko01110	Biosynthesis of secondary metabolites	2817	1.5e-149	0.85	0.93	0.99
PGSC0003DMG200004211	K02703	ko00195	Photosynthesis	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMG200004211	K02703	ko01100	Metabolic pathways	2740	2.7e-145	0.98	0.98	0.41
PGSC0003DMG200004218	K01046	ko00561	Glycerolipid metabolism	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMG200004218	K01046	ko01100	Metabolic pathways	238	2.7e-07	0.31	0.49	0.49
PGSC0003DMG200004220	K04708	ko00600	Sphingolipid metabolism	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMG200004220	K04708	ko01100	Metabolic pathways	812	6.0e-39	0.39	0.61	0.93
PGSC0003DMG200004220	K04708	ko00600	Sphingolipid metabolism	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMG200004220	K04708	ko01100	Metabolic pathways	401	2.8e-16	0.38	0.55	0.92
PGSC0003DMG200008103	K04499	ko04310	Wnt signaling pathway	3459	6.0e-185	0.92	0.96	1.00
PGSC0003DMG200008103	K04499	ko04310	Wnt signaling pathway	2089	2.2e-109	0.91	0.97	1.00
PGSC0003DMG200008108	K07359	ko04920	Adipocytokine signaling pathway	2192	4.6e-115	0.65	0.78	1.00
PGSC0003DMG200008108	K07359	ko04920	Adipocytokine signaling pathway	2505	2.5e-132	0.74	0.85	0.98
PGSC0003DMG200008109	K01190	ko00052	Galactose metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMG200008109	K01190	ko00511	Other glycan degradation	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMG200008109	K01190	ko00600	Sphingolipid metabolism	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMG200008109	K01190	ko01100	Metabolic pathways	3410	3.0e-182	0.57	0.71	0.83
PGSC0003DMG200008109	K01190	ko00052	Galactose metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMG200008109	K01190	ko00511	Other glycan degradation	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMG200008109	K01190	ko00600	Sphingolipid metabolism	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMG200008109	K01190	ko01100	Metabolic pathways	594	6.3e-27	0.55	0.68	0.52
PGSC0003DMG200008109	K01190	ko00052	Galactose metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMG200008109	K01190	ko00511	Other glycan degradation	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMG200008109	K01190	ko00600	Sphingolipid metabolism	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMG200008109	K01190	ko01100	Metabolic pathways	2593	3.5e-137	0.54	0.68	0.84
PGSC0003DMG200008109	K01190	ko00052	Galactose metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMG200008109	K01190	ko00511	Other glycan degradation	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMG200008109	K01190	ko00600	Sphingolipid metabolism	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMG200008109	K01190	ko01100	Metabolic pathways	2591	4.5e-137	0.60	0.74	0.94
PGSC0003DMG200008111	K08506	ko04130	SNARE interactions in vesicular transport	460	1.5e-19	0.78	0.94	0.99
PGSC0003DMG200008111	K08506	ko04130	SNARE interactions in vesicular transport	828	7.8e-40	0.59	0.77	0.99
PGSC0003DMG200008111	K08506	ko04130	SNARE interactions in vesicular transport	1385	1.5e-70	0.64	0.81	1.00
PGSC0003DMG200008113	K00253	ko00280	Valine, leucine and isoleucine degradation	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMG200008113	K00253	ko01100	Metabolic pathways	654	3.1e-30	0.84	0.96	0.99
PGSC0003DMG200008113	K00253	ko00280	Valine, leucine and isoleucine degradation	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMG200008113	K00253	ko01100	Metabolic pathways	2894	8.7e-154	0.82	0.92	1.00
PGSC0003DMG200008113	K00253	ko00280	Valine, leucine and isoleucine degradation	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMG200008113	K00253	ko01100	Metabolic pathways	1795	3.6e-93	0.75	0.87	0.96
PGSC0003DMG200008114	K04706	ko04120	Ubiquitin mediated proteolysis	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMG200008114	K04706	ko04630	Jak-STAT signaling pathway	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMG200008114	K04706	ko05200	Pathways in cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMG200008114	K04706	ko05222	Small cell lung cancer	452	6.6e-17	0.27	0.42	0.62
PGSC0003DMG200008114	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko04120	Ubiquitin mediated proteolysis	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko04630	Jak-STAT signaling pathway	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05200	Pathways in cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05222	Small cell lung cancer	336	3.0e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko04120	Ubiquitin mediated proteolysis	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko04630	Jak-STAT signaling pathway	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05200	Pathways in cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMG200008114	K04706	ko05222	Small cell lung cancer	336	2.8e-10	0.31	0.44	0.38
PGSC0003DMG200014257	K08967	ko00270	Cysteine and methionine metabolism	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMG200014257	K08967	ko01100	Metabolic pathways	236	3.5e-07	0.68	0.89	0.55
PGSC0003DMG200014265	K11329	ko02020	Two-component system	300	2.7e-10	0.32	0.51	0.35
PGSC0003DMG200014266	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMG200014266	K12893	ko03040	Spliceosome	492	2.7e-21	0.30	0.45	1.00
PGSC0003DMG200014266	K12891	ko03040	Spliceosome	457	2.3e-19	0.35	0.45	0.83
PGSC0003DMG200014266	K12896	ko03040	Spliceosome	443	1.3e-18	0.36	0.49	0.77
PGSC0003DMG200014268	K00215	ko00300	Lysine biosynthesis	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMG200014268	K00215	ko01100	Metabolic pathways	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMG200014268	K00215	ko01110	Biosynthesis of secondary metabolites	1884	4.5e-98	0.76	0.89	1.00
PGSC0003DMG200014268	K00215	ko00300	Lysine biosynthesis	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMG200014268	K00215	ko01100	Metabolic pathways	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMG200014268	K00215	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.66	0.84	0.83
PGSC0003DMG200003072	K12123	ko04712	Circadian rhythm - plant	3877	4.5e-210	0.68	0.80	0.94
PGSC0003DMG200003072	K12123	ko04712	Circadian rhythm - plant	5792	0.	0.63	0.78	0.96
PGSC0003DMG200003072	K12123	ko04712	Circadian rhythm - plant	5781	0.	0.63	0.78	0.96
PGSC0003DMG200030612	K00600	ko00260	Glycine, serine and threonine metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030612	K00600	ko00460	Cyanoamino acid metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030612	K00600	ko00670	One carbon pool by folate	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030612	K00600	ko00680	Methane metabolism	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030612	K00600	ko01100	Metabolic pathways	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030612	K00600	ko01110	Biosynthesis of secondary metabolites	3936	2.9e-211	0.90	0.95	1.00
PGSC0003DMG200030619	K00703	ko00500	Starch and sucrose metabolism	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMG200030619	K00703	ko01100	Metabolic pathways	932	1.4e-45	0.33	0.53	0.73
PGSC0003DMG200030619	K00703	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMG200030619	K00703	ko01100	Metabolic pathways	761	3.9e-36	0.36	0.57	0.79
PGSC0003DMG200030621	K12126	ko04712	Circadian rhythm - plant	255	9.2e-07	0.28	0.49	0.65
PGSC0003DMG200030622	K12126	ko04712	Circadian rhythm - plant	218	9.1e-06	0.40	0.68	0.48
PGSC0003DMG200030622	K12126	ko04712	Circadian rhythm - plant	220	6.9e-06	0.29	0.46	0.88
PGSC0003DMG200030624	K00844	ko00010	Glycolysis / Gluconeogenesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00051	Fructose and mannose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00052	Galactose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00500	Starch and sucrose metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00521	Streptomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00524	Butirosin and neomycin biosynthesis	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko01100	Metabolic pathways	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko01110	Biosynthesis of secondary metabolites	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko04910	Insulin signaling pathway	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko04930	Type II diabetes mellitus	2459	8.6e-130	0.61	0.75	1.00
PGSC0003DMG200030624	K00844	ko00010	Glycolysis / Gluconeogenesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00051	Fructose and mannose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00052	Galactose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00500	Starch and sucrose metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00521	Streptomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00524	Butirosin and neomycin biosynthesis	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko01100	Metabolic pathways	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko01110	Biosynthesis of secondary metabolites	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko04910	Insulin signaling pathway	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko04930	Type II diabetes mellitus	1961	2.5e-102	0.62	0.76	0.99
PGSC0003DMG200030624	K00844	ko00010	Glycolysis / Gluconeogenesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00051	Fructose and mannose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00052	Galactose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00500	Starch and sucrose metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00521	Streptomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko00524	Butirosin and neomycin biosynthesis	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko01100	Metabolic pathways	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko01110	Biosynthesis of secondary metabolites	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko04910	Insulin signaling pathway	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200030624	K00844	ko04930	Type II diabetes mellitus	980	3.2e-48	0.76	0.89	0.98
PGSC0003DMG200029090	K06573	ko04966	Collecting duct acid secretion	323	3.1e-11	0.33	0.49	0.47
PGSC0003DMG200029090	K06573	ko04966	Collecting duct acid secretion	636	3.3e-29	0.26	0.43	0.92
PGSC0003DMG200029091	K01662	ko00900	Terpenoid backbone biosynthesis	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMG200029091	K01662	ko01100	Metabolic pathways	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMG200029091	K01662	ko01110	Biosynthesis of secondary metabolites	1261	1.0e-63	0.78	0.91	0.99
PGSC0003DMG200029091	K01662	ko00900	Terpenoid backbone biosynthesis	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMG200029091	K01662	ko01100	Metabolic pathways	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMG200029091	K01662	ko01110	Biosynthesis of secondary metabolites	4049	1.7e-217	0.69	0.81	1.00
PGSC0003DMG200029106	K08066	ko04612	Antigen processing and presentation	234	4.5e-07	0.33	0.61	0.75
PGSC0003DMG200029108	K12778	ko04113	Meiosis - yeast	343	8.2e-11	0.34	0.56	0.32
PGSC0003DMG200029108	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMG200029108	K12778	ko04113	Meiosis - yeast	329	5.0e-12	0.34	0.57	0.40
PGSC0003DMG200029109	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMG200029109	K00517	ko00626	Naphthalene and anthracene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMG200029109	K00517	ko00903	Limonene and pinene degradation	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMG200029109	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMG200029109	K00517	ko01110	Biosynthesis of secondary metabolites	2012	3.9e-105	0.56	0.74	0.99
PGSC0003DMG200026665	K01623	ko00010	Glycolysis / Gluconeogenesis	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026665	K01623	ko00030	Pentose phosphate pathway	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026665	K01623	ko00051	Fructose and mannose metabolism	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026665	K01623	ko00710	Carbon fixation in photosynthetic organisms	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026665	K01623	ko01100	Metabolic pathways	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026665	K01623	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.88	0.88	0.15
PGSC0003DMG200026666	K01623	ko00010	Glycolysis / Gluconeogenesis	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko00030	Pentose phosphate pathway	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko00051	Fructose and mannose metabolism	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko00710	Carbon fixation in photosynthetic organisms	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko01100	Metabolic pathways	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko01110	Biosynthesis of secondary metabolites	922	8.8e-45	0.83	0.88	0.10
PGSC0003DMG200026666	K01623	ko00010	Glycolysis / Gluconeogenesis	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko00030	Pentose phosphate pathway	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko00051	Fructose and mannose metabolism	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko00710	Carbon fixation in photosynthetic organisms	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko01100	Metabolic pathways	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko01110	Biosynthesis of secondary metabolites	1473	2.1e-75	0.90	0.93	0.92
PGSC0003DMG200026666	K01623	ko00010	Glycolysis / Gluconeogenesis	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko00030	Pentose phosphate pathway	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko00051	Fructose and mannose metabolism	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko00710	Carbon fixation in photosynthetic organisms	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko01100	Metabolic pathways	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko01110	Biosynthesis of secondary metabolites	1457	1.6e-74	0.91	0.94	0.86
PGSC0003DMG200026666	K01623	ko00010	Glycolysis / Gluconeogenesis	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026666	K01623	ko00030	Pentose phosphate pathway	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026666	K01623	ko00051	Fructose and mannose metabolism	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026666	K01623	ko00710	Carbon fixation in photosynthetic organisms	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026666	K01623	ko01100	Metabolic pathways	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026666	K01623	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.87	0.93	0.82
PGSC0003DMG200026667	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMG200026667	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMG200026667	K02717	ko00195	Photosynthesis	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMG200026667	K02717	ko01100	Metabolic pathways	604	1.8e-27	0.44	0.61	0.78
PGSC0003DMG200026667	K02717	ko00195	Photosynthesis	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMG200026667	K02717	ko01100	Metabolic pathways	380	4.0e-15	0.35	0.48	0.99
PGSC0003DMG200023596	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMG200023596	K00517	ko00626	Naphthalene and anthracene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMG200023596	K00517	ko00903	Limonene and pinene degradation	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMG200023596	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMG200023596	K00517	ko01110	Biosynthesis of secondary metabolites	1061	1.1e-52	0.44	0.64	0.99
PGSC0003DMG200023597	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMG200023597	K00517	ko00626	Naphthalene and anthracene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMG200023597	K00517	ko00903	Limonene and pinene degradation	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMG200023597	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMG200023597	K00517	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.52	0.75	0.96
PGSC0003DMG200023603	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko00521	Streptomycin biosynthesis	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMG200023603	K01092	ko00562	Inositol phosphate metabolism	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMG200023603	K01092	ko01100	Metabolic pathways	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMG200023603	K01092	ko01110	Biosynthesis of secondary metabolites	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMG200023603	K01092	ko04070	Phosphatidylinositol signaling system	1819	1.7e-94	0.80	0.88	1.00
PGSC0003DMG200023603	K01092	ko00521	Streptomycin biosynthesis	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko00562	Inositol phosphate metabolism	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01100	Metabolic pathways	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko01110	Biosynthesis of secondary metabolites	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023603	K01092	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.78	0.87	0.99
PGSC0003DMG200023608	K01555	ko00350	Tyrosine metabolism	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMG200023608	K01555	ko00643	Styrene degradation	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMG200023608	K01555	ko01100	Metabolic pathways	2830	3.0e-150	0.77	0.86	1.00
PGSC0003DMG200023609	K02934	ko03010	Ribosome	1580	2.6e-81	0.81	0.89	1.00
PGSC0003DMG200023610	K04424	ko04010	MAPK signaling pathway	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMG200023610	K04424	ko04530	Tight junction	821	4.5e-39	0.41	0.60	0.81
PGSC0003DMG200023611	K11147	ko00830	Retinol metabolism	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMG200023611	K11147	ko01100	Metabolic pathways	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMG200023611	K11147	ko04146	Peroxisome	694	1.9e-32	0.84	0.91	0.99
PGSC0003DMG200023611	K11147	ko00830	Retinol metabolism	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMG200023611	K11147	ko01100	Metabolic pathways	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMG200023611	K11147	ko04146	Peroxisome	701	7.9e-33	0.85	0.92	0.99
PGSC0003DMG200023617	K12850	ko03040	Spliceosome	1292	2.0e-65	0.60	0.78	1.00
PGSC0003DMG200041859	K10760	ko00908	Zeatin biosynthesis	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMG200041859	K10760	ko01100	Metabolic pathways	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMG200041859	K10760	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.59	0.72	0.83
PGSC0003DMG200041870	K03094	ko04110	Cell cycle	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04111	Cell cycle - yeast	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04114	Oocyte meiosis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04120	Ubiquitin mediated proteolysis	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04310	Wnt signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04350	TGF-beta signaling pathway	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200041870	K03094	ko04710	Circadian rhythm - mammal	551	1.5e-24	0.47	0.66	0.99
PGSC0003DMG200000570	K05743	ko04360	Axon guidance	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMG200000570	K05743	ko04666	Fc gamma R-mediated phagocytosis	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMG200000570	K05743	ko04810	Regulation of actin cytoskeleton	339	4.2e-09	0.34	0.47	0.25
PGSC0003DMG200000570	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMG200000570	K09880	ko00270	Cysteine and methionine metabolism	340	3.4e-09	0.24	0.41	0.78
PGSC0003DMG200000571	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMG200000571	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMG200000571	K08331	ko04140	Regulation of autophagy	389	3.6e-13	0.27	0.42	0.88
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1498	8.7e-77	0.34	0.52	0.93
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1016	1.8e-53	0.54	0.72	0.73
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	262	6.4e-08	0.29	0.50	0.73
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.97
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1101	6.8e-55	0.35	0.54	0.88
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1219	2.1e-61	0.40	0.56	0.99
PGSC0003DMG200000575	K07456	ko03430	Mismatch repair	1562	2.6e-80	0.35	0.54	0.93
PGSC0003DMG200000576	K09880	ko00270	Cysteine and methionine metabolism	266	3.2e-08	0.42	0.52	0.97
PGSC0003DMG200012499	K06685	ko04111	Cell cycle - yeast	439	2.7e-14	0.25	0.41	0.40
PGSC0003DMG200012499	K06685	ko04111	Cell cycle - yeast	344	7.5e-10	0.25	0.41	0.93
PGSC0003DMG200012499	K06685	ko04111	Cell cycle - yeast	444	2.6e-15	0.25	0.42	0.89
PGSC0003DMG200012501	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMG200012501	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.61
PGSC0003DMG200012501	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMG200012501	K02366	ko01100	Metabolic pathways	346	3.0e-13	0.28	0.45	0.95
PGSC0003DMG200012507	K02291	ko00906	Carotenoid biosynthesis	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMG200012507	K02291	ko01100	Metabolic pathways	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMG200012507	K02291	ko01110	Biosynthesis of secondary metabolites	743	3.8e-35	0.38	0.57	0.98
PGSC0003DMG200012510	K12589	ko03018	RNA degradation	1840	1.2e-95	0.78	0.90	0.99
PGSC0003DMG200008606	K01136	ko00531	Glycosaminoglycan degradation	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMG200008606	K01136	ko01100	Metabolic pathways	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMG200008606	K01136	ko04142	Lysosome	228	4.8e-06	0.30	0.46	0.79
PGSC0003DMG200008610	K11253	ko05322	Systemic lupus erythematosus	920	6.6e-45	0.96	0.99	0.98
PGSC0003DMG200008614	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.31
PGSC0003DMG200008614	K12194	ko04144	Endocytosis	462	1.2e-19	0.49	0.68	0.27
PGSC0003DMG200005456	K10147	ko04115	p53 signaling pathway	271	9.6e-09	0.37	0.51	0.59
PGSC0003DMG200005458	K01358	ko04112	Cell cycle - Caulobacter	702	7.0e-33	0.47	0.63	0.53
PGSC0003DMG200005466	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMG200005469	K01509	ko00230	Purine metabolism	1106	3.6e-55	0.46	0.62	0.85
PGSC0003DMG200005471	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005471	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005471	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005471	K01057	ko00030	Pentose phosphate pathway	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005471	K01057	ko01100	Metabolic pathways	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005471	K01057	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.64	0.72	0.95
PGSC0003DMG200005476	K04371	ko04010	MAPK signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04012	ErbB signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04013	MAPK signaling pathway - fly	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04062	Chemokine signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04114	Oocyte meiosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04150	mTOR signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04270	Vascular smooth muscle contraction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04320	Dorso-ventral axis formation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04350	TGF-beta signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04360	Axon guidance	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04370	VEGF signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04510	Focal adhesion	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04520	Adherens junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04540	Gap junction	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04620	Toll-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04621	NOD-like receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04650	Natural killer cell mediated cytotoxicity	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04660	T cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04662	B cell receptor signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04664	Fc epsilon RI signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04666	Fc gamma R-mediated phagocytosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04720	Long-term potentiation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04722	Neurotrophin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04730	Long-term depression	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04810	Regulation of actin cytoskeleton	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04910	Insulin signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04912	GnRH signaling pathway	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04914	Progesterone-mediated oocyte maturation	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04916	Melanogenesis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04930	Type II diabetes mellitus	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko04960	Aldosterone-regulated sodium reabsorption	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05010	Alzheimer's disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05020	Prion diseases	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05131	Shigellosis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05140	Leishmaniasis	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05142	Chagas disease	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05200	Pathways in cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05210	Colorectal cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05211	Renal cell carcinoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05212	Pancreatic cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05213	Endometrial cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05214	Glioma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05215	Prostate cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05216	Thyroid cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05218	Melanoma	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05219	Bladder cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05220	Chronic myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05221	Acute myeloid leukemia	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005476	K04371	ko05223	Non-small cell lung cancer	338	1.2e-12	0.36	0.56	0.72
PGSC0003DMG200005479	K01762	ko00270	Cysteine and methionine metabolism	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMG200005479	K01762	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.73	0.85	1.00
PGSC0003DMG200029916	K05765	ko04360	Axon guidance	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMG200029916	K05765	ko04666	Fc gamma R-mediated phagocytosis	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMG200029916	K05765	ko04810	Regulation of actin cytoskeleton	965	2.2e-47	0.80	0.93	0.97
PGSC0003DMG200029917	K03023	ko00230	Purine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMG200029917	K03023	ko00240	Pyrimidine metabolism	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMG200029917	K03023	ko01100	Metabolic pathways	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMG200029917	K03023	ko03020	RNA polymerase	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMG200029917	K03023	ko04623	Cytosolic DNA-sensing pathway	2528	1.3e-133	0.59	0.77	1.00
PGSC0003DMG200029917	K03023	ko00230	Purine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMG200029917	K03023	ko00240	Pyrimidine metabolism	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMG200029917	K03023	ko01100	Metabolic pathways	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMG200029917	K03023	ko03020	RNA polymerase	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMG200029917	K03023	ko04623	Cytosolic DNA-sensing pathway	2565	1.2e-135	0.60	0.79	1.00
PGSC0003DMG200029924	K00287	ko00670	One carbon pool by folate	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMG200029924	K00287	ko00790	Folate biosynthesis	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMG200029924	K00287	ko01100	Metabolic pathways	312	2.9e-11	0.39	0.54	0.79
PGSC0003DMG200029926	K07375	ko04145	Phagosome	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMG200029926	K07375	ko04540	Gap junction	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMG200029926	K07375	ko05130	Pathogenic Escherichia coli infection	3774	2.5e-202	0.98	0.99	0.99
PGSC0003DMG200029927	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMG200029928	K03094	ko04110	Cell cycle	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04111	Cell cycle - yeast	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04114	Oocyte meiosis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04120	Ubiquitin mediated proteolysis	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04310	Wnt signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04350	TGF-beta signaling pathway	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04710	Circadian rhythm - mammal	927	2.7e-45	0.73	0.89	0.42
PGSC0003DMG200029928	K03094	ko04110	Cell cycle	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04111	Cell cycle - yeast	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04114	Oocyte meiosis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04120	Ubiquitin mediated proteolysis	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04310	Wnt signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04350	TGF-beta signaling pathway	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029928	K03094	ko04710	Circadian rhythm - mammal	842	1.3e-40	0.78	0.93	0.55
PGSC0003DMG200029929	K11229	ko04011	MAPK signaling pathway - yeast	1058	4.1e-52	0.31	0.47	0.75
PGSC0003DMG200029929	K11229	ko04011	MAPK signaling pathway - yeast	897	5.9e-43	0.30	0.46	0.97
PGSC0003DMG200022860	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMG200022860	K12581	ko03018	RNA degradation	1948	1.3e-101	0.83	0.93	0.99
PGSC0003DMG200022868	K00475	ko00941	Flavonoid biosynthesis	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMG200022868	K00475	ko01100	Metabolic pathways	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMG200022868	K00475	ko01110	Biosynthesis of secondary metabolites	451	4.9e-19	0.35	0.56	0.87
PGSC0003DMG200022872	K11927	ko03018	RNA degradation	757	6.4e-36	0.34	0.54	0.61
PGSC0003DMG200026014	K00981	ko00564	Glycerophospholipid metabolism	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMG200026014	K00981	ko01100	Metabolic pathways	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMG200026014	K00981	ko04070	Phosphatidylinositol signaling system	1475	1.6e-75	0.62	0.77	0.70
PGSC0003DMG200026014	K00981	ko00564	Glycerophospholipid metabolism	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMG200026014	K00981	ko01100	Metabolic pathways	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMG200026014	K00981	ko04070	Phosphatidylinositol signaling system	1663	6.9e-86	0.63	0.78	0.74
PGSC0003DMG200026015	K06096	ko04530	Tight junction	342	5.0e-13	0.35	0.54	0.69
PGSC0003DMG200026015	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMG200026015	K06096	ko04530	Tight junction	354	1.1e-13	0.32	0.48	0.91
PGSC0003DMG200026017	K06653	ko04111	Cell cycle - yeast	330	1.4e-11	0.30	0.55	0.70
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	567	1.5e-24	0.31	0.49	0.26
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMG200026018	K03514	ko03018	RNA degradation	566	2.0e-24	0.31	0.49	0.24
PGSC0003DMG200026023	K06654	ko04111	Cell cycle - yeast	290	3.7e-10	0.38	0.57	0.61
PGSC0003DMG200026024	K12604	ko03018	RNA degradation	5926	0.	0.64	0.79	0.99
PGSC0003DMG200026024	K12604	ko03018	RNA degradation	12708	0.	0.66	0.79	1.00
PGSC0003DMG200013182	K01955	ko00240	Pyrimidine metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMG200013182	K01955	ko00250	Alanine, aspartate and glutamate metabolism	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMG200013182	K01955	ko01100	Metabolic pathways	389	1.2e-14	0.40	0.53	0.47
PGSC0003DMG200013184	K10144	ko04115	p53 signaling pathway	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMG200013184	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.3e-43	0.42	0.57	0.24
PGSC0003DMG200013184	K10144	ko04115	p53 signaling pathway	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMG200013184	K10144	ko04120	Ubiquitin mediated proteolysis	881	9.8e-43	0.42	0.57	0.21
PGSC0003DMG200013187	K00844	ko00010	Glycolysis / Gluconeogenesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00051	Fructose and mannose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00052	Galactose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00500	Starch and sucrose metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00520	Amino sugar and nucleotide sugar metabolism	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00521	Streptomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko00524	Butirosin and neomycin biosynthesis	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko01100	Metabolic pathways	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko01110	Biosynthesis of secondary metabolites	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko04910	Insulin signaling pathway	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013187	K00844	ko04930	Type II diabetes mellitus	3105	2.0e-165	0.75	0.87	1.00
PGSC0003DMG200013188	K10756	ko03030	DNA replication	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMG200013188	K10756	ko03420	Nucleotide excision repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMG200013188	K10756	ko03430	Mismatch repair	2680	5.6e-142	0.88	0.95	1.00
PGSC0003DMG200013192	K01952	ko00230	Purine metabolism	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMG200013192	K01952	ko01100	Metabolic pathways	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMG200013192	K01952	ko01110	Biosynthesis of secondary metabolites	657	1.3e-29	0.86	0.92	0.89
PGSC0003DMG200011660	K01051	ko00040	Pentose and glucuronate interconversions	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMG200011660	K01051	ko00500	Starch and sucrose metabolism	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMG200011660	K01051	ko01100	Metabolic pathways	1004	1.5e-49	0.43	0.58	0.88
PGSC0003DMG200011665	K11294	ko05130	Pathogenic Escherichia coli infection	331	2.9e-09	0.28	0.45	0.38
PGSC0003DMG200011665	K11294	ko05130	Pathogenic Escherichia coli infection	296	6.0e-10	0.27	0.44	0.89
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	2557	3.4e-135	0.65	0.80	0.90
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	255	5.9e-08	0.63	0.88	0.75
PGSC0003DMG200011679	K04122	ko00904	Diterpenoid biosynthesis	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMG200011679	K04122	ko01100	Metabolic pathways	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMG200011679	K04122	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.65	0.83	0.97
PGSC0003DMG200006101	K00660	ko00941	Flavonoid biosynthesis	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMG200006101	K00660	ko01100	Metabolic pathways	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMG200006101	K00660	ko01110	Biosynthesis of secondary metabolites	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMG200006101	K00660	ko04712	Circadian rhythm - plant	345	3.4e-13	0.29	0.47	0.57
PGSC0003DMG200006111	K00981	ko00564	Glycerophospholipid metabolism	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMG200006111	K00981	ko01100	Metabolic pathways	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMG200006111	K00981	ko04070	Phosphatidylinositol signaling system	2019	1.6e-105	0.85	0.94	1.00
PGSC0003DMG200006113	K07424	ko00140	Steroid hormone biosynthesis	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00591	Linoleic acid metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00830	Retinol metabolism	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00982	Drug metabolism - cytochrome P450	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko00983	Drug metabolism - other enzymes	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200006113	K07424	ko01100	Metabolic pathways	661	1.3e-30	0.56	0.75	0.99
PGSC0003DMG200009257	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko00052	Galactose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko00500	Starch and sucrose metabolism	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009257	K01193	ko01100	Metabolic pathways	1154	8.2e-58	0.35	0.56	0.86
PGSC0003DMG200009264	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMG200001311	K01728	ko00040	Pentose and glucuronate interconversions	1763	2.1e-91	0.53	0.69	0.89
PGSC0003DMG200001312	K10570	ko03420	Nucleotide excision repair	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMG200001312	K10570	ko04120	Ubiquitin mediated proteolysis	248	7.6e-08	0.30	0.47	0.68
PGSC0003DMG200001313	K10712	ko00430	Taurine and hypotaurine metabolism	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMG200001313	K10712	ko01100	Metabolic pathways	447	8.1e-19	0.34	0.48	0.89
PGSC0003DMG200001313	K10712	ko00430	Taurine and hypotaurine metabolism	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMG200001313	K10712	ko01100	Metabolic pathways	409	1.0e-16	0.35	0.50	0.79
PGSC0003DMG200001314	K10573	ko04120	Ubiquitin mediated proteolysis	1335	8.5e-68	0.98	1.00	0.76
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1950	1.0e-101	0.66	0.78	0.98
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1968	1.0e-102	0.66	0.80	0.97
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1942	2.8e-101	0.67	0.79	0.98
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.65	0.80	0.97
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1956	4.8e-102	0.67	0.78	0.98
PGSC0003DMG200001316	K01785	ko00010	Glycolysis / Gluconeogenesis	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMG200001316	K01785	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.64	0.78	0.99
PGSC0003DMG200001317	K01785	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMG200001317	K01785	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.61	0.77	0.98
PGSC0003DMG200001318	K01785	ko00010	Glycolysis / Gluconeogenesis	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMG200001318	K01785	ko01110	Biosynthesis of secondary metabolites	1637	1.9e-84	0.59	0.70	0.97
PGSC0003DMG200001320	K07374	ko04145	Phagosome	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMG200001320	K07374	ko04540	Gap junction	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMG200001320	K07374	ko05130	Pathogenic Escherichia coli infection	3749	6.1e-201	0.96	0.99	1.00
PGSC0003DMG200001321	K03869	ko04120	Ubiquitin mediated proteolysis	450	8.8e-19	0.86	0.89	0.85
PGSC0003DMG200043062	K10760	ko00908	Zeatin biosynthesis	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMG200043062	K10760	ko01100	Metabolic pathways	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMG200043062	K10760	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.44	0.62	0.92
PGSC0003DMG200031835	K00797	ko00270	Cysteine and methionine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMG200031835	K00797	ko00330	Arginine and proline metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMG200031835	K00797	ko00410	beta-Alanine metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMG200031835	K00797	ko00480	Glutathione metabolism	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMG200031835	K00797	ko01100	Metabolic pathways	2294	1.1e-120	0.80	0.88	1.00
PGSC0003DMG200031836	K00276	ko00260	Glycine, serine and threonine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00350	Tyrosine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00360	Phenylalanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00410	beta-Alanine metabolism	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00950	Isoquinoline alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko01100	Metabolic pathways	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko01110	Biosynthesis of secondary metabolites	854	2.9e-41	0.34	0.56	0.92
PGSC0003DMG200031836	K00276	ko00260	Glycine, serine and threonine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00350	Tyrosine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00360	Phenylalanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00410	beta-Alanine metabolism	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00950	Isoquinoline alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko01100	Metabolic pathways	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.33	0.54	0.91
PGSC0003DMG200031836	K00276	ko00260	Glycine, serine and threonine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko00350	Tyrosine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko00360	Phenylalanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko00410	beta-Alanine metabolism	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko01100	Metabolic pathways	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031836	K00276	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.35	0.54	0.96
PGSC0003DMG200031840	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.27	0.43	0.78
PGSC0003DMG200031845	K01066	ko00623	2,4-Dichlorobenzoate degradation	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMG200031845	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	299	1.2e-10	0.36	0.51	0.46
PGSC0003DMG200031846	K01046	ko00561	Glycerolipid metabolism	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMG200031846	K01046	ko01100	Metabolic pathways	228	9.7e-07	0.32	0.47	0.81
PGSC0003DMG200031856	K00454	ko00591	Linoleic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMG200031856	K00454	ko00592	alpha-Linolenic acid metabolism	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMG200031856	K00454	ko01100	Metabolic pathways	253	2.4e-07	0.50	0.70	0.76
PGSC0003DMG200025511	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko04115	p53 signaling pathway	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko04210	Apoptosis	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05010	Alzheimer's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05012	Parkinson's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05016	Huntington's disease	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025511	K02084	ko05222	Small cell lung cancer	336	4.1e-09	0.29	0.46	0.42
PGSC0003DMG200025512	K02084	ko04115	p53 signaling pathway	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko04210	Apoptosis	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko05010	Alzheimer's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko05012	Parkinson's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko05016	Huntington's disease	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025512	K02084	ko05222	Small cell lung cancer	328	2.2e-08	0.29	0.45	0.40
PGSC0003DMG200025519	K12125	ko04712	Circadian rhythm - plant	1390	7.9e-71	0.38	0.50	1.00
PGSC0003DMG200025519	K12125	ko04712	Circadian rhythm - plant	539	6.8e-24	0.34	0.50	0.98
PGSC0003DMG200025519	K12125	ko04712	Circadian rhythm - plant	1316	9.5e-67	0.37	0.51	0.99
PGSC0003DMG200025521	K03940	ko00190	Oxidative phosphorylation	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMG200025521	K03940	ko01100	Metabolic pathways	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMG200025521	K03940	ko05010	Alzheimer's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMG200025521	K03940	ko05012	Parkinson's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMG200025521	K03940	ko05016	Huntington's disease	1535	7.9e-79	0.83	0.89	1.00
PGSC0003DMG200025522	K01528	ko04144	Endocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMG200025522	K01528	ko04666	Fc gamma R-mediated phagocytosis	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMG200025522	K01528	ko05100	Bacterial invasion of epithelial cells	379	1.8e-14	0.43	0.57	0.71
PGSC0003DMG200025526	K00558	ko00270	Cysteine and methionine metabolism	9363	0.	0.72	0.83	0.99
PGSC0003DMG200025526	K00558	ko01100	Metabolic pathways	9363	0.	0.72	0.83	0.99
PGSC0003DMG200021627	K05894	ko00592	alpha-Linolenic acid metabolism	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMG200021627	K05894	ko01100	Metabolic pathways	1455	2.0e-74	0.50	0.62	0.98
PGSC0003DMG200021627	K05894	ko00592	alpha-Linolenic acid metabolism	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMG200021627	K05894	ko01100	Metabolic pathways	1273	2.2e-64	0.56	0.69	0.97
PGSC0003DMG200021630	K01184	ko00040	Pentose and glucuronate interconversions	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMG200021630	K01184	ko00500	Starch and sucrose metabolism	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMG200021630	K01184	ko01100	Metabolic pathways	1292	2.0e-65	0.43	0.59	0.86
PGSC0003DMG200021634	K08770	ko03320	PPAR signaling pathway	418	3.2e-17	0.71	0.85	0.94
PGSC0003DMG200021636	K01840	ko00051	Fructose and mannose metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMG200021636	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMG200021636	K01840	ko01100	Metabolic pathways	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMG200021636	K01840	ko01110	Biosynthesis of secondary metabolites	1577	3.8e-81	0.87	0.94	0.96
PGSC0003DMG200021636	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko00051	Fructose and mannose metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko01100	Metabolic pathways	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200021636	K01840	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.84	0.93	0.98
PGSC0003DMG200020434	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMG200020437	K00430	ko00360	Phenylalanine metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMG200020437	K00430	ko00680	Methane metabolism	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMG200020437	K00430	ko00940	Phenylpropanoid biosynthesis	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMG200020437	K00430	ko01100	Metabolic pathways	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMG200020437	K00430	ko01110	Biosynthesis of secondary metabolites	973	7.9e-48	0.62	0.79	0.98
PGSC0003DMG200020437	K00430	ko00360	Phenylalanine metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMG200020437	K00430	ko00680	Methane metabolism	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMG200020437	K00430	ko00940	Phenylpropanoid biosynthesis	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMG200020437	K00430	ko01100	Metabolic pathways	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMG200020437	K00430	ko01110	Biosynthesis of secondary metabolites	1182	2.3e-59	0.63	0.79	0.99
PGSC0003DMG200020439	K10880	ko03440	Homologous recombination	1172	8.3e-59	0.51	0.71	0.98
PGSC0003DMG200020441	K02726	ko03050	Proteasome	1634	2.7e-84	0.86	0.89	1.00
PGSC0003DMG200020441	K02726	ko03050	Proteasome	1851	2.9e-96	0.95	0.97	1.00
PGSC0003DMG200020446	K00053	ko00290	Valine, leucine and isoleucine biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMG200020446	K00053	ko00770	Pantothenate and CoA biosynthesis	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMG200020446	K00053	ko01100	Metabolic pathways	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMG200020446	K00053	ko01110	Biosynthesis of secondary metabolites	4186	4.8e-225	0.85	0.91	0.99
PGSC0003DMG200020447	K12843	ko03040	Spliceosome	1344	2.7e-68	0.35	0.55	0.94
PGSC0003DMG200016981	K06685	ko04111	Cell cycle - yeast	330	1.3e-08	0.32	0.45	0.29
PGSC0003DMG200016989	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04210	Apoptosis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04620	Toll-like receptor signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko04722	Neurotrophin signaling pathway	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05140	Leishmaniasis	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016989	K04733	ko05142	Chagas disease	887	4.4e-43	0.55	0.72	0.95
PGSC0003DMG200016990	K07195	ko04910	Insulin signaling pathway	3587	5.2e-192	0.82	0.89	0.93
PGSC0003DMG200016991	K04733	ko04210	Apoptosis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMG200016991	K04733	ko04620	Toll-like receptor signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMG200016991	K04733	ko04722	Neurotrophin signaling pathway	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMG200016991	K04733	ko05140	Leishmaniasis	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMG200016991	K04733	ko05142	Chagas disease	1174	6.4e-59	0.50	0.68	0.95
PGSC0003DMG200016991	K04733	ko04210	Apoptosis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMG200016991	K04733	ko04620	Toll-like receptor signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMG200016991	K04733	ko04722	Neurotrophin signaling pathway	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMG200016991	K04733	ko05140	Leishmaniasis	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMG200016991	K04733	ko05142	Chagas disease	824	1.3e-39	0.53	0.68	0.96
PGSC0003DMG200016992	K04733	ko04210	Apoptosis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMG200016992	K04733	ko04620	Toll-like receptor signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMG200016992	K04733	ko04722	Neurotrophin signaling pathway	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMG200016992	K04733	ko05140	Leishmaniasis	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMG200016992	K04733	ko05142	Chagas disease	372	4.8e-14	0.48	0.68	0.86
PGSC0003DMG200007372	K12603	ko03018	RNA degradation	345	6.8e-13	0.31	0.44	0.31
PGSC0003DMG200007373	K00660	ko00941	Flavonoid biosynthesis	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMG200007373	K00660	ko01100	Metabolic pathways	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMG200007373	K00660	ko01110	Biosynthesis of secondary metabolites	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMG200007373	K00660	ko04712	Circadian rhythm - plant	248	8.1e-07	0.29	0.43	0.88
PGSC0003DMG200007375	K08912	ko00196	Photosynthesis - antenna proteins	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMG200007375	K08912	ko01100	Metabolic pathways	1903	4.0e-99	0.72	0.76	1.00
PGSC0003DMG200007380	K03352	ko04110	Cell cycle	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04111	Cell cycle - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04113	Meiosis - yeast	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04114	Oocyte meiosis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04120	Ubiquitin mediated proteolysis	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04914	Progesterone-mediated oocyte maturation	284	2.1e-07	0.27	0.42	0.90
PGSC0003DMG200007380	K03352	ko04110	Cell cycle	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007380	K03352	ko04111	Cell cycle - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007380	K03352	ko04113	Meiosis - yeast	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007380	K03352	ko04114	Oocyte meiosis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007380	K03352	ko04120	Ubiquitin mediated proteolysis	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007380	K03352	ko04914	Progesterone-mediated oocyte maturation	320	2.0e-09	0.28	0.46	0.67
PGSC0003DMG200007385	K02084	ko04115	p53 signaling pathway	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko04210	Apoptosis	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko05010	Alzheimer's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko05012	Parkinson's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko05016	Huntington's disease	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200007385	K02084	ko05222	Small cell lung cancer	343	2.2e-09	0.29	0.45	0.36
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1999	2.0e-104	0.71	0.84	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1829	4.8e-95	0.74	0.85	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1846	5.6e-96	0.75	0.86	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1838	1.5e-95	0.74	0.86	0.99
PGSC0003DMG200003533	K00430	ko00360	Phenylalanine metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMG200003533	K00430	ko00680	Methane metabolism	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMG200003533	K00430	ko00940	Phenylpropanoid biosynthesis	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMG200003533	K00430	ko01100	Metabolic pathways	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMG200003533	K00430	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.70	0.85	0.99
PGSC0003DMG200003536	K12637	ko00905	Brassinosteroid biosynthesis	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMG200003536	K12637	ko01100	Metabolic pathways	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMG200003536	K12637	ko01110	Biosynthesis of secondary metabolites	2543	2.0e-134	0.64	0.80	0.95
PGSC0003DMG200003536	K12637	ko00905	Brassinosteroid biosynthesis	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMG200003536	K12637	ko01100	Metabolic pathways	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMG200003536	K12637	ko01110	Biosynthesis of secondary metabolites	1526	2.5e-78	0.63	0.80	0.99
PGSC0003DMG200003537	K01190	ko00052	Galactose metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMG200003537	K01190	ko00511	Other glycan degradation	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMG200003537	K01190	ko00600	Sphingolipid metabolism	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMG200003537	K01190	ko01100	Metabolic pathways	3938	2.3e-211	0.61	0.78	0.85
PGSC0003DMG200003546	K09755	ko00940	Phenylpropanoid biosynthesis	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMG200003546	K09755	ko01100	Metabolic pathways	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMG200003546	K09755	ko01110	Biosynthesis of secondary metabolites	3176	2.4e-169	0.71	0.85	0.99
PGSC0003DMG200003546	K09755	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMG200003546	K09755	ko01100	Metabolic pathways	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMG200003546	K09755	ko01110	Biosynthesis of secondary metabolites	1419	2.0e-72	0.78	0.92	0.99
PGSC0003DMG200014960	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	260	9.3e-08	0.42	0.58	0.97
PGSC0003DMG200014964	K03066	ko03050	Proteasome	2770	6.0e-147	0.81	0.86	1.00
PGSC0003DMG200014964	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMG200014964	K03066	ko03050	Proteasome	1292	2.0e-65	0.98	0.99	0.99
PGSC0003DMG200014968	K10615	ko04120	Ubiquitin mediated proteolysis	814	4.6e-39	0.35	0.53	0.89
PGSC0003DMG200014971	K00655	ko00561	Glycerolipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMG200014971	K00655	ko00564	Glycerophospholipid metabolism	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMG200014971	K00655	ko01100	Metabolic pathways	2466	3.5e-130	0.74	0.85	1.00
PGSC0003DMG200014971	K00655	ko00561	Glycerolipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMG200014971	K00655	ko00564	Glycerophospholipid metabolism	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMG200014971	K00655	ko01100	Metabolic pathways	2609	4.6e-138	0.78	0.89	1.00
PGSC0003DMG200014972	K02737	ko03050	Proteasome	827	8.9e-40	0.82	0.89	0.98
PGSC0003DMG200014972	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMG200014972	K02737	ko03050	Proteasome	2018	1.8e-105	0.88	0.92	1.00
PGSC0003DMG200014974	K02328	ko00230	Purine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko00240	Pyrimidine metabolism	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko01100	Metabolic pathways	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko03030	DNA replication	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko03410	Base excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko03420	Nucleotide excision repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko03430	Mismatch repair	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko03440	Homologous recombination	3088	1.7e-164	0.83	0.91	1.00
PGSC0003DMG200014974	K02328	ko00230	Purine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko00240	Pyrimidine metabolism	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko01100	Metabolic pathways	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko03030	DNA replication	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko03410	Base excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko03420	Nucleotide excision repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko03430	Mismatch repair	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200014974	K02328	ko03440	Homologous recombination	2541	2.6e-134	0.82	0.90	0.98
PGSC0003DMG200037891	K10760	ko00908	Zeatin biosynthesis	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMG200037891	K10760	ko01100	Metabolic pathways	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMG200037891	K10760	ko01110	Biosynthesis of secondary metabolites	476	2.0e-20	0.47	0.67	0.99
PGSC0003DMG200044665	K13229	ko00402	Benzoxazinoid biosynthesis	228	9.7e-07	0.40	0.57	0.52
PGSC0003DMG200010352	K00650	ko00564	Glycerophospholipid metabolism	358	6.5e-14	0.29	0.43	0.68
PGSC0003DMG200010352	K00650	ko00564	Glycerophospholipid metabolism	353	1.2e-13	0.31	0.47	0.74
PGSC0003DMG200010353	K08906	ko00195	Photosynthesis	901	7.4e-44	0.72	0.81	0.81
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	405	1.7e-16	0.75	0.88	0.85
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	1512	1.5e-77	0.78	0.90	0.97
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	559	5.4e-25	0.61	0.77	0.79
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	2534	6.3e-134	0.78	0.87	1.00
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	2364	1.5e-124	0.79	0.91	0.99
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	1351	1.1e-68	0.82	0.93	0.97
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	1736	6.5e-90	0.86	0.92	0.98
PGSC0003DMG200014680	K00726	ko00510	N-Glycan biosynthesis	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMG200014680	K00726	ko01100	Metabolic pathways	2120	4.3e-111	0.81	0.90	0.98
PGSC0003DMG200014681	K09680	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMG200014681	K09680	ko01100	Metabolic pathways	887	4.4e-43	0.39	0.58	0.88
PGSC0003DMG200014681	K09680	ko00770	Pantothenate and CoA biosynthesis	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMG200014681	K09680	ko01100	Metabolic pathways	824	1.3e-39	0.40	0.58	0.87
PGSC0003DMG200014682	K01436	ko00330	Arginine and proline metabolism	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMG200014682	K01436	ko01100	Metabolic pathways	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMG200014682	K01436	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.56	0.78	0.88
PGSC0003DMG200014682	K01436	ko00330	Arginine and proline metabolism	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMG200014682	K01436	ko01100	Metabolic pathways	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMG200014682	K01436	ko01110	Biosynthesis of secondary metabolites	2050	3.1e-107	0.55	0.76	0.94
PGSC0003DMG200014688	K05279	ko00944	Flavone and flavonol biosynthesis	1346	2.1e-68	0.49	0.67	0.99
PGSC0003DMG200014690	K06236	ko04510	Focal adhesion	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMG200014690	K06236	ko04512	ECM-receptor interaction	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMG200014690	K06236	ko05146	Amoebiasis	361	5.6e-13	0.39	0.44	0.89
PGSC0003DMG200027333	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMG200027333	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMG200027333	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.55	0.90
PGSC0003DMG200027337	K12929	ko00904	Diterpenoid biosynthesis	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMG200027337	K12929	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.41	0.66	0.99
PGSC0003DMG200027337	K12929	ko00904	Diterpenoid biosynthesis	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMG200027337	K12929	ko01110	Biosynthesis of secondary metabolites	1186	1.4e-59	0.43	0.70	1.00
PGSC0003DMG200027338	K12356	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.36	0.53	0.71
PGSC0003DMG200027340	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMG200027340	K00517	ko00626	Naphthalene and anthracene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMG200027340	K00517	ko00903	Limonene and pinene degradation	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMG200027340	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMG200027340	K00517	ko01110	Biosynthesis of secondary metabolites	1078	1.3e-53	0.71	0.84	0.99
PGSC0003DMG200027340	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMG200027340	K00517	ko00626	Naphthalene and anthracene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMG200027340	K00517	ko00903	Limonene and pinene degradation	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMG200027340	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMG200027340	K00517	ko01110	Biosynthesis of secondary metabolites	2931	8.0e-156	0.69	0.82	0.99
PGSC0003DMG200027342	K10773	ko03410	Base excision repair	2638	1.5e-148	0.38	0.51	0.69
PGSC0003DMG200027344	K05592	ko03018	RNA degradation	245	4.1e-06	0.31	0.53	0.45
PGSC0003DMG200027346	K00873	ko00010	Glycolysis / Gluconeogenesis	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko00230	Purine metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko00620	Pyruvate metabolism	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko00710	Carbon fixation in photosynthetic organisms	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko01100	Metabolic pathways	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko01110	Biosynthesis of secondary metabolites	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027346	K00873	ko04930	Type II diabetes mellitus	401	2.8e-16	0.54	0.67	0.97
PGSC0003DMG200027347	K00873	ko00010	Glycolysis / Gluconeogenesis	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko00230	Purine metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko00620	Pyruvate metabolism	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko00710	Carbon fixation in photosynthetic organisms	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko01100	Metabolic pathways	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200027347	K00873	ko04930	Type II diabetes mellitus	613	5.6e-28	0.71	0.87	0.54
PGSC0003DMG200018533	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMG200018540	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.58
PGSC0003DMG200018540	K11094	ko03040	Spliceosome	212	7.4e-06	0.33	0.50	0.49
PGSC0003DMG200028443	K04424	ko04010	MAPK signaling pathway	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMG200028443	K04424	ko04530	Tight junction	460	4.7e-19	0.40	0.62	0.49
PGSC0003DMG200028443	K04424	ko04010	MAPK signaling pathway	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMG200028443	K04424	ko04530	Tight junction	673	1.2e-30	0.35	0.54	0.71
PGSC0003DMG200031379	K09489	ko04612	Antigen processing and presentation	5305	9.2e-287	0.74	0.85	1.00
PGSC0003DMG200031384	K02690	ko00195	Photosynthesis	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMG200031384	K02690	ko01100	Metabolic pathways	523	5.2e-23	0.89	0.92	0.78
PGSC0003DMG200031385	K11866	ko04144	Endocytosis	594	2.0e-26	0.33	0.43	0.69
PGSC0003DMG200031385	K11866	ko04144	Endocytosis	361	2.9e-13	0.33	0.43	0.96
PGSC0003DMG200031385	K11866	ko04144	Endocytosis	645	2.4e-29	0.34	0.46	0.86
PGSC0003DMG200031389	K03083	ko04012	ErbB signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04062	Chemokine signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04110	Cell cycle	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04310	Wnt signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04340	Hedgehog signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04360	Axon guidance	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04510	Focal adhesion	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04660	T cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04662	B cell receptor signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04711	Circadian rhythm - fly	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04722	Neurotrophin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04910	Insulin signaling pathway	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko04916	Melanogenesis	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05010	Alzheimer's disease	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05200	Pathways in cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05210	Colorectal cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05213	Endometrial cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05215	Prostate cancer	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031389	K03083	ko05217	Basal cell carcinoma	3140	2.4e-167	0.90	0.93	1.00
PGSC0003DMG200031391	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMG200031391	K12823	ko03040	Spliceosome	1948	1.3e-101	0.53	0.71	0.75
PGSC0003DMG200031392	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMG200031392	K00766	ko01100	Metabolic pathways	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMG200031392	K00766	ko01110	Biosynthesis of secondary metabolites	2154	5.7e-113	0.81	0.89	0.98
PGSC0003DMG200031392	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMG200031392	K00766	ko01100	Metabolic pathways	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMG200031392	K00766	ko01110	Biosynthesis of secondary metabolites	2239	1.2e-117	0.75	0.84	0.96
PGSC0003DMG200031392	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMG200031392	K00766	ko01100	Metabolic pathways	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMG200031392	K00766	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.71	0.95	0.81
PGSC0003DMG200031395	K02717	ko00195	Photosynthesis	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMG200031395	K02717	ko01100	Metabolic pathways	776	5.8e-37	0.62	0.70	0.78
PGSC0003DMG200031396	K02149	ko00190	Oxidative phosphorylation	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031396	K02149	ko01100	Metabolic pathways	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031396	K02149	ko04145	Phagosome	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031396	K02149	ko04966	Collecting duct acid secretion	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031396	K02149	ko05110	Vibrio cholerae infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031396	K02149	ko05120	Epithelial cell signaling in Helicobacter pylori infection	576	6.2e-26	0.74	0.87	0.83
PGSC0003DMG200031399	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMG200031399	K12448	ko01100	Metabolic pathways	543	4.1e-24	0.78	0.89	0.69
PGSC0003DMG200031399	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMG200031399	K12448	ko01100	Metabolic pathways	2876	8.6e-153	0.85	0.93	0.98
PGSC0003DMG200031399	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMG200031399	K12448	ko01100	Metabolic pathways	2883	3.5e-153	0.85	0.93	0.98
PGSC0003DMG200040284	K03094	ko04110	Cell cycle	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04111	Cell cycle - yeast	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04114	Oocyte meiosis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04120	Ubiquitin mediated proteolysis	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04310	Wnt signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04350	TGF-beta signaling pathway	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200040284	K03094	ko04710	Circadian rhythm - mammal	576	6.2e-26	0.49	0.66	0.99
PGSC0003DMG200042909	K03094	ko04110	Cell cycle	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04111	Cell cycle - yeast	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04114	Oocyte meiosis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04310	Wnt signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04350	TGF-beta signaling pathway	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042909	K03094	ko04710	Circadian rhythm - mammal	633	4.4e-29	0.54	0.71	0.88
PGSC0003DMG200042913	K13065	ko00940	Phenylpropanoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMG200042913	K13065	ko00941	Flavonoid biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMG200042913	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMG200042913	K13065	ko01110	Biosynthesis of secondary metabolites	341	5.7e-13	0.25	0.44	0.94
PGSC0003DMG200042932	K10760	ko00908	Zeatin biosynthesis	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMG200042932	K10760	ko01100	Metabolic pathways	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMG200042932	K10760	ko01110	Biosynthesis of secondary metabolites	809	8.7e-39	0.53	0.70	0.95
PGSC0003DMG200000965	K02969	ko03010	Ribosome	999	2.9e-49	0.97	0.99	0.99
PGSC0003DMG200000974	K01955	ko00240	Pyrimidine metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMG200000974	K01955	ko00250	Alanine, aspartate and glutamate metabolism	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMG200000974	K01955	ko01100	Metabolic pathways	536	7.1e-23	0.57	0.71	0.57
PGSC0003DMG200000977	K00423	ko00053	Ascorbate and aldarate metabolism	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMG200000977	K00423	ko01100	Metabolic pathways	3351	5.4e-179	0.68	0.82	0.98
PGSC0003DMG200012908	K09756	ko00940	Phenylpropanoid biosynthesis	1534	9.0e-79	0.45	0.59	0.88
PGSC0003DMG200012908	K09756	ko00940	Phenylpropanoid biosynthesis	1685	4.2e-87	0.49	0.62	0.99
PGSC0003DMG200012910	K01810	ko00010	Glycolysis / Gluconeogenesis	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko00030	Pentose phosphate pathway	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko00500	Starch and sucrose metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko01100	Metabolic pathways	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko01110	Biosynthesis of secondary metabolites	2377	2.9e-125	0.92	0.98	1.00
PGSC0003DMG200012910	K01810	ko00010	Glycolysis / Gluconeogenesis	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200012910	K01810	ko00030	Pentose phosphate pathway	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200012910	K01810	ko00500	Starch and sucrose metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200012910	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200012910	K01810	ko01100	Metabolic pathways	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200012910	K01810	ko01110	Biosynthesis of secondary metabolites	4325	1.0e-232	0.83	0.91	1.00
PGSC0003DMG200002420	K10246	ko01040	Biosynthesis of unsaturated fatty acids	450	5.5e-19	0.32	0.52	0.97
PGSC0003DMG200002424	K00002	ko00010	Glycolysis / Gluconeogenesis	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMG200002424	K00002	ko00561	Glycerolipid metabolism	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMG200002424	K00002	ko00930	Caprolactam degradation	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMG200002424	K00002	ko01100	Metabolic pathways	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMG200002424	K00002	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.66	0.84	0.91
PGSC0003DMG200002436	K03005	ko00230	Purine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMG200002436	K03005	ko00240	Pyrimidine metabolism	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMG200002436	K03005	ko01100	Metabolic pathways	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMG200002436	K03005	ko03020	RNA polymerase	484	7.3e-21	0.37	0.48	0.83
PGSC0003DMG200004889	K00679	ko00561	Glycerolipid metabolism	376	1.0e-14	0.41	0.59	0.97
PGSC0003DMG200004893	K07195	ko04910	Insulin signaling pathway	3473	1.0e-185	0.69	0.80	1.00
PGSC0003DMG200004894	K08517	ko04130	SNARE interactions in vesicular transport	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMG200004894	K08517	ko04145	Phagosome	944	3.1e-46	0.92	0.97	0.97
PGSC0003DMG200004894	K08517	ko04130	SNARE interactions in vesicular transport	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMG200004894	K08517	ko04145	Phagosome	1683	5.4e-87	0.89	0.96	1.00
PGSC0003DMG200004894	K08517	ko04130	SNARE interactions in vesicular transport	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMG200004894	K08517	ko04145	Phagosome	1139	5.5e-57	0.93	0.96	0.99
PGSC0003DMG200004899	K00814	ko00250	Alanine, aspartate and glutamate metabolism	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMG200004899	K00814	ko00710	Carbon fixation in photosynthetic organisms	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMG200004899	K00814	ko01100	Metabolic pathways	3567	6.6e-191	0.86	0.93	0.98
PGSC0003DMG200004902	K03061	ko03050	Proteasome	518	9.8e-23	0.92	0.97	0.94
PGSC0003DMG200006396	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00260	Glycine, serine and threonine metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00460	Cyanoamino acid metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00670	One carbon pool by folate	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko00680	Methane metabolism	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko01100	Metabolic pathways	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006396	K00600	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.89	0.94	0.99
PGSC0003DMG200006401	K08139	ko04113	Meiosis - yeast	853	3.3e-41	0.33	0.51	0.99
PGSC0003DMG200006401	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.55	0.89
PGSC0003DMG200006409	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMG200006409	K12118	ko04712	Circadian rhythm - plant	4969	3.1e-268	0.83	0.92	1.00
PGSC0003DMG200015565	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMG200015565	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMG200015565	K11251	ko05322	Systemic lupus erythematosus	1125	3.2e-56	0.91	0.96	0.99
PGSC0003DMG200015576	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMG200015576	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMG200015576	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMG200015576	K03469	ko03030	DNA replication	372	1.1e-14	0.44	0.64	0.42
PGSC0003DMG200029658	K01051	ko00040	Pentose and glucuronate interconversions	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMG200029658	K01051	ko00500	Starch and sucrose metabolism	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMG200029658	K01051	ko01100	Metabolic pathways	554	1.0e-24	0.42	0.58	0.33
PGSC0003DMG200029659	K02872	ko03010	Ribosome	1598	2.6e-82	0.90	0.97	1.00
PGSC0003DMG200029663	K00383	ko00480	Glutathione metabolism	2512	3.6e-142	0.83	0.90	1.00
PGSC0003DMG200029663	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMG200029663	K00383	ko00480	Glutathione metabolism	3524	1.6e-188	0.84	0.92	1.00
PGSC0003DMG200019033	K01366	ko04142	Lysosome	2191	5.2e-115	0.73	0.84	1.00
PGSC0003DMG200019035	K00866	ko00564	Glycerophospholipid metabolism	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMG200019035	K00866	ko01100	Metabolic pathways	352	1.4e-13	0.54	0.73	0.96
PGSC0003DMG200019037	K04125	ko00904	Diterpenoid biosynthesis	1465	5.7e-75	0.56	0.72	0.89
PGSC0003DMG200019052	K03004	ko00230	Purine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMG200019052	K03004	ko00240	Pyrimidine metabolism	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMG200019052	K03004	ko01100	Metabolic pathways	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMG200019052	K03004	ko03020	RNA polymerase	305	5.5e-11	0.43	0.57	0.98
PGSC0003DMG200036392	K02942	ko03010	Ribosome	532	1.7e-23	0.60	0.77	0.99
PGSC0003DMG200023186	K13030	ko00460	Cyanoamino acid metabolism	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMG200023186	K13030	ko01110	Biosynthesis of secondary metabolites	955	7.7e-47	0.34	0.54	0.99
PGSC0003DMG200023186	K13030	ko00460	Cyanoamino acid metabolism	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMG200023186	K13030	ko01110	Biosynthesis of secondary metabolites	976	5.4e-48	0.34	0.54	0.99
PGSC0003DMG200023193	K09841	ko00906	Carotenoid biosynthesis	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMG200023193	K09841	ko01100	Metabolic pathways	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMG200023193	K09841	ko01110	Biosynthesis of secondary metabolites	999	2.9e-49	0.52	0.67	0.88
PGSC0003DMG200023195	K11927	ko03018	RNA degradation	921	5.8e-45	0.36	0.55	0.71
PGSC0003DMG200023195	K11927	ko03018	RNA degradation	428	9.0e-18	0.34	0.52	0.86
PGSC0003DMG200001720	K03849	ko00510	N-Glycan biosynthesis	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMG200001720	K03849	ko01100	Metabolic pathways	441	1.7e-18	0.49	0.66	0.97
PGSC0003DMG200001720	K03849	ko00510	N-Glycan biosynthesis	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMG200001720	K03849	ko01100	Metabolic pathways	3188	5.3e-170	0.70	0.83	0.92
PGSC0003DMG200001722	K03260	ko05416	Viral myocarditis	6741	0.	0.53	0.65	1.00
PGSC0003DMG200001722	K03260	ko05416	Viral myocarditis	7201	0.	0.52	0.64	1.00
PGSC0003DMG200001724	K03115	ko04310	Wnt signaling pathway	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMG200001724	K03115	ko04520	Adherens junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMG200001724	K03115	ko04530	Tight junction	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMG200001724	K03115	ko04712	Circadian rhythm - plant	2277	9.4e-120	0.87	0.92	0.99
PGSC0003DMG200001733	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMG200001733	K08065	ko04612	Antigen processing and presentation	618	3.0e-28	0.64	0.80	0.82
PGSC0003DMG200001734	K10590	ko04120	Ubiquitin mediated proteolysis	6966	0.	0.57	0.73	1.00
PGSC0003DMG200001734	K10590	ko04120	Ubiquitin mediated proteolysis	6297	0.	0.55	0.72	1.00
PGSC0003DMG200012244	K12132	ko04712	Circadian rhythm - plant	1614	3.5e-83	0.54	0.69	0.66
PGSC0003DMG200012244	K12132	ko04712	Circadian rhythm - plant	1738	5.0e-90	0.54	0.68	0.68
PGSC0003DMG200012250	K00599	ko00340	Histidine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMG200012250	K00599	ko00350	Tyrosine metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMG200012250	K00599	ko00450	Selenoamino acid metabolism	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMG200012250	K00599	ko00626	Naphthalene and anthracene degradation	443	3.6e-23	0.33	0.49	0.64
PGSC0003DMG200012250	K00599	ko00340	Histidine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMG200012250	K00599	ko00350	Tyrosine metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMG200012250	K00599	ko00450	Selenoamino acid metabolism	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMG200012250	K00599	ko00626	Naphthalene and anthracene degradation	230	7.5e-07	0.42	0.55	0.36
PGSC0003DMG200012250	K00599	ko00340	Histidine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMG200012250	K00599	ko00350	Tyrosine metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMG200012250	K00599	ko00450	Selenoamino acid metabolism	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMG200012250	K00599	ko00626	Naphthalene and anthracene degradation	499	3.2e-26	0.35	0.50	0.67
PGSC0003DMG200012252	K01194	ko00500	Starch and sucrose metabolism	2228	4.7e-117	0.67	0.82	1.00
PGSC0003DMG200012254	K09490	ko03060	Protein export	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMG200012254	K09490	ko05020	Prion diseases	5192	1.6e-280	0.94	0.97	1.00
PGSC0003DMG200005725	K12126	ko04712	Circadian rhythm - plant	300	1.5e-10	0.34	0.54	0.59
PGSC0003DMG200005727	K10144	ko04115	p53 signaling pathway	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMG200005727	K10144	ko04120	Ubiquitin mediated proteolysis	349	1.6e-12	0.42	0.66	0.08
PGSC0003DMG200005727	K10144	ko04115	p53 signaling pathway	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMG200005727	K10144	ko04120	Ubiquitin mediated proteolysis	877	1.6e-42	0.41	0.58	0.21
PGSC0003DMG200005729	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04210	Apoptosis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04620	Toll-like receptor signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04722	Neurotrophin signaling pathway	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko05140	Leishmaniasis	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko05142	Chagas disease	843	1.2e-40	0.41	0.59	0.86
PGSC0003DMG200005729	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko04210	Apoptosis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko04620	Toll-like receptor signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko04722	Neurotrophin signaling pathway	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko05140	Leishmaniasis	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200005729	K04733	ko05142	Chagas disease	869	4.3e-42	0.38	0.56	0.55
PGSC0003DMG200016301	K03104	ko03060	Protein export	689	3.6e-32	0.70	0.83	0.94
PGSC0003DMG200016302	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1331	1.4e-67	0.58	0.69	0.91
PGSC0003DMG200016302	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	799	3.1e-38	0.63	0.79	0.99
PGSC0003DMG200016304	K03005	ko00230	Purine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMG200016304	K03005	ko00240	Pyrimidine metabolism	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMG200016304	K03005	ko01100	Metabolic pathways	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMG200016304	K03005	ko03020	RNA polymerase	1961	2.5e-102	0.58	0.76	0.98
PGSC0003DMG200000321	K12355	ko00940	Phenylpropanoid biosynthesis	3144	1.4e-167	0.75	0.86	0.99
PGSC0003DMG200000322	K12486	ko04144	Endocytosis	488	4.4e-21	0.26	0.40	0.94
PGSC0003DMG200000328	K12191	ko04144	Endocytosis	1731	1.2e-89	0.95	0.98	1.00
PGSC0003DMG200000329	K01897	ko00071	Fatty acid metabolism	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMG200000329	K01897	ko01100	Metabolic pathways	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMG200000329	K01897	ko03320	PPAR signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMG200000329	K01897	ko04146	Peroxisome	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMG200000329	K01897	ko04920	Adipocytokine signaling pathway	4354	2.6e-234	0.69	0.84	0.99
PGSC0003DMG200000330	K12602	ko03018	RNA degradation	1970	8.0e-103	0.71	0.84	1.00
PGSC0003DMG200000333	K06444	ko00906	Carotenoid biosynthesis	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMG200000333	K06444	ko01100	Metabolic pathways	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMG200000333	K06444	ko01110	Biosynthesis of secondary metabolites	1327	2.3e-67	0.69	0.79	0.99
PGSC0003DMG200000333	K06444	ko00906	Carotenoid biosynthesis	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMG200000333	K06444	ko01100	Metabolic pathways	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMG200000333	K06444	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.76	0.88	0.99
PGSC0003DMG200000333	K06444	ko00906	Carotenoid biosynthesis	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMG200000333	K06444	ko01100	Metabolic pathways	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMG200000333	K06444	ko01110	Biosynthesis of secondary metabolites	3211	2.9e-171	0.73	0.84	0.99
PGSC0003DMG200000335	K00279	ko00908	Zeatin biosynthesis	1858	1.2e-96	0.56	0.76	0.57
PGSC0003DMG200000337	K01956	ko00240	Pyrimidine metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMG200000337	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMG200000337	K01956	ko01100	Metabolic pathways	2838	1.1e-150	0.83	0.89	0.90
PGSC0003DMG200000337	K01956	ko00240	Pyrimidine metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMG200000337	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMG200000337	K01956	ko01100	Metabolic pathways	2940	2.5e-156	0.84	0.91	0.94
PGSC0003DMG200000339	K01190	ko00052	Galactose metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMG200000339	K01190	ko00511	Other glycan degradation	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMG200000339	K01190	ko00600	Sphingolipid metabolism	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMG200000339	K01190	ko01100	Metabolic pathways	263	4.8e-08	0.82	0.97	0.61
PGSC0003DMG200000339	K01190	ko00052	Galactose metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMG200000339	K01190	ko00511	Other glycan degradation	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMG200000339	K01190	ko00600	Sphingolipid metabolism	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMG200000339	K01190	ko01100	Metabolic pathways	1736	6.5e-90	0.62	0.82	0.99
PGSC0003DMG200000339	K01190	ko00052	Galactose metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMG200000339	K01190	ko00511	Other glycan degradation	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMG200000339	K01190	ko00600	Sphingolipid metabolism	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMG200000339	K01190	ko01100	Metabolic pathways	3695	5.8e-198	0.67	0.83	0.98
PGSC0003DMG200047328	K01199	ko00500	Starch and sucrose metabolism	873	2.6e-42	0.37	0.58	0.99
PGSC0003DMG200041730	K07466	ko03030	DNA replication	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMG200041730	K07466	ko03420	Nucleotide excision repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMG200041730	K07466	ko03430	Mismatch repair	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMG200041730	K07466	ko03440	Homologous recombination	540	6.0e-24	0.30	0.50	0.65
PGSC0003DMG200019734	K00850	ko00010	Glycolysis / Gluconeogenesis	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019734	K00850	ko00030	Pentose phosphate pathway	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019734	K00850	ko00051	Fructose and mannose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019734	K00850	ko00052	Galactose metabolism	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019734	K00850	ko01100	Metabolic pathways	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019734	K00850	ko01110	Biosynthesis of secondary metabolites	2065	4.6e-108	0.57	0.73	0.96
PGSC0003DMG200019735	K01199	ko00500	Starch and sucrose metabolism	809	8.7e-39	0.38	0.56	0.65
PGSC0003DMG200019735	K01199	ko00500	Starch and sucrose metabolism	543	4.1e-24	0.38	0.56	0.60
PGSC0003DMG200019736	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	1951	9.0e-102	0.75	0.89	0.99
PGSC0003DMG200019740	K02084	ko04115	p53 signaling pathway	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko04210	Apoptosis	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko05010	Alzheimer's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko05012	Parkinson's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko05016	Huntington's disease	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019740	K02084	ko05222	Small cell lung cancer	330	9.1e-09	0.28	0.46	0.50
PGSC0003DMG200019742	K03012	ko00230	Purine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMG200019742	K03012	ko00240	Pyrimidine metabolism	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMG200019742	K03012	ko01100	Metabolic pathways	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMG200019742	K03012	ko03020	RNA polymerase	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMG200019742	K03012	ko05016	Huntington's disease	284	7.9e-10	0.38	0.60	0.41
PGSC0003DMG200019742	K03012	ko00230	Purine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMG200019742	K03012	ko00240	Pyrimidine metabolism	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMG200019742	K03012	ko01100	Metabolic pathways	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMG200019742	K03012	ko03020	RNA polymerase	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMG200019742	K03012	ko05016	Huntington's disease	314	1.7e-11	0.36	0.59	0.63
PGSC0003DMG200019747	K10352	ko04530	Tight junction	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMG200019747	K10352	ko05416	Viral myocarditis	475	3.8e-19	0.27	0.47	0.89
PGSC0003DMG200019748	K00626	ko00071	Fatty acid metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00072	Synthesis and degradation of ketone bodies	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00280	Valine, leucine and isoleucine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00310	Lysine degradation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00380	Tryptophan metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00620	Pyruvate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00632	Benzoate degradation via CoA ligation	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00640	Propanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00650	Butanoate metabolism	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko00900	Terpenoid backbone biosynthesis	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko01100	Metabolic pathways	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko01110	Biosynthesis of secondary metabolites	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200019748	K00626	ko02020	Two-component system	2814	2.3e-149	0.83	0.93	0.99
PGSC0003DMG200030374	K12741	ko03040	Spliceosome	358	6.5e-14	0.41	0.44	0.63
PGSC0003DMG200030376	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMG200030376	K00368	ko00910	Nitrogen metabolism	1841	1.0e-95	0.45	0.62	0.91
PGSC0003DMG200030382	K00430	ko00360	Phenylalanine metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMG200030382	K00430	ko00680	Methane metabolism	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMG200030382	K00430	ko00940	Phenylpropanoid biosynthesis	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMG200030382	K00430	ko01100	Metabolic pathways	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMG200030382	K00430	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.56	0.77	0.97
PGSC0003DMG200022341	K00430	ko00360	Phenylalanine metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMG200022341	K00430	ko00680	Methane metabolism	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMG200022341	K00430	ko00940	Phenylpropanoid biosynthesis	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMG200022341	K00430	ko01100	Metabolic pathways	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMG200022341	K00430	ko01110	Biosynthesis of secondary metabolites	1019	2.3e-50	0.46	0.61	0.84
PGSC0003DMG200022342	K00430	ko00360	Phenylalanine metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMG200022342	K00430	ko00680	Methane metabolism	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMG200022342	K00430	ko00940	Phenylpropanoid biosynthesis	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMG200022342	K00430	ko01100	Metabolic pathways	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMG200022342	K00430	ko01110	Biosynthesis of secondary metabolites	1057	1.8e-52	0.49	0.64	0.79
PGSC0003DMG200035181	K02966	ko03010	Ribosome	341	5.7e-13	0.66	0.75	0.71
PGSC0003DMG200035185	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200035185	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200035185	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200023918	K12843	ko03040	Spliceosome	4209	2.6e-226	0.70	0.83	0.97
PGSC0003DMG200023919	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMG200023919	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMG200023919	K12896	ko03040	Spliceosome	219	3.0e-06	0.47	0.58	0.78
PGSC0003DMG200023919	K12896	ko03040	Spliceosome	1447	5.6e-74	0.68	0.77	0.94
PGSC0003DMG200023919	K12896	ko03040	Spliceosome	1740	3.9e-90	0.71	0.78	0.95
PGSC0003DMG200023923	K01099	ko00562	Inositol phosphate metabolism	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMG200023923	K01099	ko01100	Metabolic pathways	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMG200023923	K01099	ko04070	Phosphatidylinositol signaling system	371	5.2e-14	0.31	0.43	0.73
PGSC0003DMG200023923	K01099	ko00562	Inositol phosphate metabolism	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMG200023923	K01099	ko01100	Metabolic pathways	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMG200023923	K01099	ko04070	Phosphatidylinositol signaling system	786	1.6e-37	0.34	0.49	0.83
PGSC0003DMG200023924	K01778	ko00300	Lysine biosynthesis	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMG200023924	K01778	ko01100	Metabolic pathways	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMG200023924	K01778	ko01110	Biosynthesis of secondary metabolites	2429	3.9e-128	0.77	0.87	1.00
PGSC0003DMG200023925	K02893	ko03010	Ribosome	1134	1.0e-56	0.88	0.95	0.99
PGSC0003DMG200023926	K13229	ko00402	Benzoxazinoid biosynthesis	312	2.3e-11	0.43	0.61	0.97
PGSC0003DMG200023927	K13229	ko00402	Benzoxazinoid biosynthesis	370	1.4e-14	0.36	0.53	0.86
PGSC0003DMG200023929	K01710	ko00521	Streptomycin biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMG200023929	K01710	ko00523	Polyketide sugar unit biosynthesis	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMG200023929	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMG200023929	K01710	ko01100	Metabolic pathways	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMG200023929	K01710	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.89	0.95	0.94
PGSC0003DMG200023929	K01710	ko00521	Streptomycin biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMG200023929	K01710	ko00523	Polyketide sugar unit biosynthesis	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMG200023929	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMG200023929	K01710	ko01100	Metabolic pathways	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMG200023929	K01710	ko01110	Biosynthesis of secondary metabolites	1626	7.6e-84	0.84	0.93	0.98
PGSC0003DMG200023929	K01710	ko00521	Streptomycin biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMG200023929	K01710	ko00523	Polyketide sugar unit biosynthesis	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMG200023929	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMG200023929	K01710	ko01100	Metabolic pathways	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMG200023929	K01710	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.75	0.86	0.87
PGSC0003DMG200023930	K07195	ko04910	Insulin signaling pathway	2668	2.6e-141	0.54	0.72	0.97
PGSC0003DMG200023931	K01728	ko00040	Pentose and glucuronate interconversions	2056	1.5e-107	0.73	0.86	0.90
PGSC0003DMG200009929	K08913	ko00196	Photosynthesis - antenna proteins	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMG200009929	K08913	ko01100	Metabolic pathways	848	6.2e-41	0.53	0.66	0.94
PGSC0003DMG200009929	K08913	ko00196	Photosynthesis - antenna proteins	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMG200009929	K08913	ko01100	Metabolic pathways	550	1.7e-24	0.52	0.66	0.95
PGSC0003DMG200009929	K08913	ko00196	Photosynthesis - antenna proteins	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMG200009929	K08913	ko01100	Metabolic pathways	869	4.3e-42	0.48	0.62	0.81
PGSC0003DMG200009936	K01193	ko00052	Galactose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMG200009936	K01193	ko00500	Starch and sucrose metabolism	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMG200009936	K01193	ko01100	Metabolic pathways	1131	1.5e-56	0.36	0.55	0.79
PGSC0003DMG200011023	K00232	ko00071	Fatty acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011023	K00232	ko00592	alpha-Linolenic acid metabolism	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011023	K00232	ko01040	Biosynthesis of unsaturated fatty acids	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011023	K00232	ko01100	Metabolic pathways	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011023	K00232	ko03320	PPAR signaling pathway	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011023	K00232	ko04146	Peroxisome	3063	4.2e-163	0.83	0.92	0.97
PGSC0003DMG200011026	K07964	ko00531	Glycosaminoglycan degradation	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMG200011026	K07964	ko01100	Metabolic pathways	618	3.0e-28	0.31	0.47	0.84
PGSC0003DMG200011026	K07964	ko00531	Glycosaminoglycan degradation	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMG200011026	K07964	ko01100	Metabolic pathways	340	6.4e-13	0.35	0.52	0.95
PGSC0003DMG200011027	K13228	ko00402	Benzoxazinoid biosynthesis	1003	1.7e-49	0.39	0.59	0.88
PGSC0003DMG200011027	K13228	ko00402	Benzoxazinoid biosynthesis	783	2.4e-37	0.46	0.65	0.88
PGSC0003DMG200011028	K13228	ko00402	Benzoxazinoid biosynthesis	804	1.6e-38	0.34	0.55	0.93
PGSC0003DMG200011028	K13228	ko00402	Benzoxazinoid biosynthesis	613	5.6e-28	0.41	0.59	0.87
PGSC0003DMG200011029	K13228	ko00402	Benzoxazinoid biosynthesis	1039	1.8e-51	0.34	0.55	0.91
PGSC0003DMG200011030	K13228	ko00402	Benzoxazinoid biosynthesis	805	1.4e-38	0.46	0.67	0.88
PGSC0003DMG200011031	K13228	ko00402	Benzoxazinoid biosynthesis	1033	3.9e-51	0.39	0.58	0.88
PGSC0003DMG200011032	K02184	ko04320	Dorso-ventral axis formation	502	4.3e-21	0.41	0.46	0.44
PGSC0003DMG200011037	K01193	ko00052	Galactose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMG200011037	K01193	ko00500	Starch and sucrose metabolism	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMG200011037	K01193	ko01100	Metabolic pathways	3373	3.3e-180	0.68	0.80	0.97
PGSC0003DMG200011038	K09841	ko00906	Carotenoid biosynthesis	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMG200011038	K09841	ko01100	Metabolic pathways	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMG200011038	K09841	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.51	0.67	0.89
PGSC0003DMG200011040	K12382	ko04142	Lysosome	267	8.7e-09	0.28	0.49	0.71
PGSC0003DMG200011040	K12382	ko04142	Lysosome	270	5.8e-09	0.29	0.50	0.76
PGSC0003DMG200011040	K12382	ko04142	Lysosome	279	1.6e-09	0.28	0.47	0.76
PGSC0003DMG200013997	K13065	ko00940	Phenylpropanoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMG200013997	K13065	ko00941	Flavonoid biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMG200013997	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMG200013997	K13065	ko01110	Biosynthesis of secondary metabolites	236	5.1e-06	0.30	0.48	0.54
PGSC0003DMG200013999	K13065	ko00940	Phenylpropanoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMG200013999	K13065	ko00941	Flavonoid biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMG200013999	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMG200013999	K13065	ko01110	Biosynthesis of secondary metabolites	356	8.4e-14	0.26	0.43	0.89
PGSC0003DMG200014002	K03469	ko03030	DNA replication	239	1.6e-06	0.38	0.54	0.13
PGSC0003DMG200014003	K13065	ko00940	Phenylpropanoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMG200014003	K13065	ko00941	Flavonoid biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMG200014003	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMG200014003	K13065	ko01110	Biosynthesis of secondary metabolites	353	1.2e-13	0.25	0.45	0.89
PGSC0003DMG200014008	K01772	ko00860	Porphyrin and chlorophyll metabolism	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMG200014008	K01772	ko01100	Metabolic pathways	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMG200014008	K01772	ko01110	Biosynthesis of secondary metabolites	3370	4.9e-180	0.86	0.93	0.92
PGSC0003DMG200014009	K05280	ko00941	Flavonoid biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMG200014009	K05280	ko00944	Flavone and flavonol biosynthesis	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMG200014009	K05280	ko01100	Metabolic pathways	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMG200014009	K05280	ko01110	Biosynthesis of secondary metabolites	588	1.3e-26	0.39	0.60	0.96
PGSC0003DMG200014010	K05280	ko00941	Flavonoid biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMG200014010	K05280	ko00944	Flavone and flavonol biosynthesis	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMG200014010	K05280	ko01100	Metabolic pathways	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMG200014010	K05280	ko01110	Biosynthesis of secondary metabolites	1491	2.1e-76	0.40	0.62	0.99
PGSC0003DMG200014010	K05280	ko00941	Flavonoid biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMG200014010	K05280	ko00944	Flavone and flavonol biosynthesis	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMG200014010	K05280	ko01100	Metabolic pathways	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMG200014010	K05280	ko01110	Biosynthesis of secondary metabolites	712	2.0e-33	0.36	0.58	0.95
PGSC0003DMG200014011	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00626	Naphthalene and anthracene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00903	Limonene and pinene degradation	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.36	0.62	0.88
PGSC0003DMG200014011	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMG200014011	K00517	ko00626	Naphthalene and anthracene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMG200014011	K00517	ko00903	Limonene and pinene degradation	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMG200014011	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMG200014011	K00517	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.36	0.61	0.96
PGSC0003DMG200014011	K11868	ko00380	Tryptophan metabolism	512	2.1e-22	0.34	0.59	0.99
PGSC0003DMG200014012	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMG200014012	K00517	ko00626	Naphthalene and anthracene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMG200014012	K00517	ko00903	Limonene and pinene degradation	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMG200014012	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMG200014012	K00517	ko01110	Biosynthesis of secondary metabolites	762	3.4e-36	0.37	0.61	0.94
PGSC0003DMG200014013	K09755	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMG200014013	K09755	ko01100	Metabolic pathways	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMG200014013	K09755	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.40	0.60	0.99
PGSC0003DMG200014013	K05280	ko00941	Flavonoid biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMG200014013	K05280	ko00944	Flavone and flavonol biosynthesis	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMG200014013	K05280	ko01100	Metabolic pathways	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMG200014013	K05280	ko01110	Biosynthesis of secondary metabolites	1466	5.1e-75	0.38	0.62	0.99
PGSC0003DMG200014013	K05280	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMG200014013	K05280	ko00944	Flavone and flavonol biosynthesis	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMG200014013	K05280	ko01100	Metabolic pathways	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMG200014013	K05280	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.34	0.58	0.87
PGSC0003DMG200045868	K01051	ko00040	Pentose and glucuronate interconversions	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMG200045868	K01051	ko00500	Starch and sucrose metabolism	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMG200045868	K01051	ko01100	Metabolic pathways	704	5.4e-33	0.49	0.66	0.97
PGSC0003DMG200027764	K08332	ko04140	Regulation of autophagy	279	6.6e-07	0.26	0.48	0.62
PGSC0003DMG200027773	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.97
PGSC0003DMG200027773	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03060	Protein export	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	1410	6.2e-72	0.77	0.85	0.99
PGSC0003DMG200027773	K03110	ko03060	Protein export	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	2399	1.8e-126	0.81	0.88	0.98
PGSC0003DMG200027773	K03110	ko03060	Protein export	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMG200027773	K03110	ko03070	Bacterial secretion system	522	5.9e-23	0.69	0.77	0.98
PGSC0003DMG200017796	K01509	ko00230	Purine metabolism	1249	4.7e-63	0.32	0.47	0.76
PGSC0003DMG200017796	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.79
PGSC0003DMG200017796	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMG200017796	K01509	ko00230	Purine metabolism	1337	6.6e-68	0.33	0.47	0.76
PGSC0003DMG200033087	K12126	ko04712	Circadian rhythm - plant	395	6.0e-16	0.47	0.64	0.29
PGSC0003DMG200033088	K08509	ko04130	SNARE interactions in vesicular transport	581	3.3e-26	0.67	0.80	0.95
PGSC0003DMG200033088	K08509	ko04130	SNARE interactions in vesicular transport	1521	4.7e-78	0.62	0.75	1.00
PGSC0003DMG200033099	K00059	ko00061	Fatty acid biosynthesis	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMG200033099	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMG200033099	K00059	ko01100	Metabolic pathways	1533	1.0e-78	0.72	0.80	1.00
PGSC0003DMG200033100	K00059	ko00061	Fatty acid biosynthesis	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMG200033100	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMG200033100	K00059	ko01100	Metabolic pathways	1499	7.6e-77	0.69	0.81	1.00
PGSC0003DMG200033107	K00012	ko00040	Pentose and glucuronate interconversions	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033107	K00012	ko00053	Ascorbate and aldarate metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033107	K00012	ko00500	Starch and sucrose metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033107	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033107	K00012	ko01100	Metabolic pathways	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033107	K00012	ko01110	Biosynthesis of secondary metabolites	3697	4.5e-198	0.89	0.95	1.00
PGSC0003DMG200033111	K10604	ko04120	Ubiquitin mediated proteolysis	633	4.4e-29	0.40	0.57	0.69
PGSC0003DMG200033114	K01640	ko00072	Synthesis and degradation of ketone bodies	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko00280	Valine, leucine and isoleucine degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko00281	Geraniol degradation	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko00650	Butanoate metabolism	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko01100	Metabolic pathways	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko01110	Biosynthesis of secondary metabolites	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko04146	Peroxisome	802	2.1e-38	0.83	0.93	0.99
PGSC0003DMG200033114	K01640	ko00072	Synthesis and degradation of ketone bodies	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko00280	Valine, leucine and isoleucine degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko00281	Geraniol degradation	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko00650	Butanoate metabolism	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko01100	Metabolic pathways	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko01110	Biosynthesis of secondary metabolites	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko04146	Peroxisome	967	1.7e-47	0.85	0.91	0.99
PGSC0003DMG200033114	K01640	ko00072	Synthesis and degradation of ketone bodies	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko00280	Valine, leucine and isoleucine degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko00281	Geraniol degradation	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko00650	Butanoate metabolism	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko01100	Metabolic pathways	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko01110	Biosynthesis of secondary metabolites	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200033114	K01640	ko04146	Peroxisome	2168	9.7e-114	0.72	0.82	0.88
PGSC0003DMG200030212	K00360	ko00910	Nitrogen metabolism	2956	3.3e-157	0.78	0.89	1.00
PGSC0003DMG200030212	K00360	ko00910	Nitrogen metabolism	3072	1.3e-163	0.78	0.90	1.00
PGSC0003DMG200030212	K00360	ko00910	Nitrogen metabolism	6070	0.	0.76	0.86	1.00
PGSC0003DMG200030219	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMG200030219	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMG200030219	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.51
PGSC0003DMG200030219	K00059	ko00061	Fatty acid biosynthesis	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMG200030219	K00059	ko01040	Biosynthesis of unsaturated fatty acids	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMG200030219	K00059	ko01100	Metabolic pathways	384	2.4e-15	0.33	0.52	0.45
PGSC0003DMG200030225	K01179	ko00500	Starch and sucrose metabolism	567	1.9e-25	0.37	0.60	0.53
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.39	0.60	0.80
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	222	2.1e-06	0.31	0.61	0.84
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	247	8.7e-08	0.44	0.62	0.69
PGSC0003DMG200020240	K00891	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMG200020240	K00891	ko01100	Metabolic pathways	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMG200020240	K00891	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.48	0.64	0.70
PGSC0003DMG200025624	K12128	ko04712	Circadian rhythm - plant	428	1.2e-17	0.29	0.46	0.60
PGSC0003DMG200025628	K01581	ko00330	Arginine and proline metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMG200025628	K01581	ko00480	Glutathione metabolism	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMG200025628	K01581	ko01100	Metabolic pathways	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMG200025628	K01581	ko01110	Biosynthesis of secondary metabolites	1070	3.5e-53	0.56	0.74	0.97
PGSC0003DMG200025632	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.83
PGSC0003DMG200025632	K12133	ko04712	Circadian rhythm - plant	631	5.7e-29	0.32	0.49	0.85
PGSC0003DMG200025638	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMG200025638	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMG200025638	K00866	ko00564	Glycerophospholipid metabolism	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMG200025638	K00866	ko01100	Metabolic pathways	507	4.0e-22	0.49	0.68	0.97
PGSC0003DMG200027084	K04354	ko04111	Cell cycle - yeast	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMG200027084	K04354	ko04530	Tight junction	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMG200027084	K04354	ko05142	Chagas disease	1148	1.8e-57	0.52	0.72	0.86
PGSC0003DMG200027084	K04354	ko04111	Cell cycle - yeast	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMG200027084	K04354	ko04530	Tight junction	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMG200027084	K04354	ko05142	Chagas disease	1423	1.2e-72	0.56	0.74	0.98
PGSC0003DMG200027084	K04354	ko04111	Cell cycle - yeast	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMG200027084	K04354	ko04530	Tight junction	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMG200027084	K04354	ko05142	Chagas disease	594	6.3e-27	0.52	0.68	0.99
PGSC0003DMG200027084	K04354	ko04111	Cell cycle - yeast	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMG200027084	K04354	ko04530	Tight junction	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMG200027084	K04354	ko05142	Chagas disease	1139	5.5e-57	0.52	0.72	0.93
PGSC0003DMG200027084	K04354	ko04111	Cell cycle - yeast	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMG200027084	K04354	ko04530	Tight junction	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMG200027084	K04354	ko05142	Chagas disease	2270	2.3e-119	0.56	0.74	0.99
PGSC0003DMG200027084	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMG200027084	K00766	ko01100	Metabolic pathways	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMG200027084	K00766	ko01110	Biosynthesis of secondary metabolites	2340	3.1e-123	0.80	0.89	0.91
PGSC0003DMG200027086	K02929	ko03010	Ribosome	917	9.6e-45	0.99	1.00	0.99
PGSC0003DMG200027088	K06573	ko04966	Collecting duct acid secretion	491	9.7e-21	0.29	0.48	0.72
PGSC0003DMG200027088	K06573	ko04966	Collecting duct acid secretion	307	2.5e-10	0.38	0.57	0.80
PGSC0003DMG200027088	K06573	ko04966	Collecting duct acid secretion	752	1.2e-35	0.29	0.46	0.84
PGSC0003DMG200027088	K06573	ko04966	Collecting duct acid secretion	228	6.7e-06	0.26	0.47	0.88
PGSC0003DMG200027091	K03681	ko03018	RNA degradation	1546	2.0e-79	0.81	0.90	0.97
PGSC0003DMG200035685	K08271	ko04150	mTOR signaling pathway	346	3.0e-13	0.30	0.45	0.63
PGSC0003DMG200035702	K12581	ko03018	RNA degradation	982	2.5e-48	0.52	0.68	0.94
PGSC0003DMG200000200	K01068	ko01040	Biosynthesis of unsaturated fatty acids	792	7.6e-38	0.57	0.66	0.99
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2187	8.6e-115	0.59	0.77	0.97
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	571	1.6e-24	0.45	0.63	0.83
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2739	3.1e-145	0.57	0.75	0.99
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	555	1.6e-23	0.48	0.65	0.95
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	760	6.5e-35	0.50	0.65	0.95
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2478	7.7e-131	0.58	0.75	0.99
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2099	6.2e-110	0.59	0.77	0.97
PGSC0003DMG200000201	K12604	ko03018	RNA degradation	2339	3.6e-123	0.58	0.76	0.99
PGSC0003DMG200000206	K11600	ko03018	RNA degradation	1787	1.0e-92	0.90	0.95	0.98
PGSC0003DMG200012111	K00703	ko00500	Starch and sucrose metabolism	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMG200012111	K00703	ko01100	Metabolic pathways	1493	1.6e-76	0.43	0.59	0.82
PGSC0003DMG200012111	K00703	ko00500	Starch and sucrose metabolism	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMG200012111	K00703	ko01100	Metabolic pathways	1266	5.4e-64	0.41	0.57	0.94
PGSC0003DMG200012112	K01199	ko00500	Starch and sucrose metabolism	744	3.4e-35	0.35	0.54	0.80
PGSC0003DMG200002226	K10615	ko04120	Ubiquitin mediated proteolysis	380	2.5e-14	0.33	0.49	0.57
PGSC0003DMG200002229	K00975	ko00500	Starch and sucrose metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMG200002229	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMG200002229	K00975	ko01100	Metabolic pathways	395	6.0e-16	0.36	0.54	0.65
PGSC0003DMG200002229	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko00500	Starch and sucrose metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko01100	Metabolic pathways	441	1.7e-18	0.33	0.51	0.72
PGSC0003DMG200002229	K00975	ko00500	Starch and sucrose metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMG200002229	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMG200002229	K00975	ko01100	Metabolic pathways	349	2.1e-13	0.32	0.48	0.96
PGSC0003DMG200002230	K12842	ko03040	Spliceosome	4915	3.0e-265	0.71	0.79	0.97
PGSC0003DMG200002230	K12842	ko03040	Spliceosome	1543	2.9e-79	0.84	0.93	0.96
PGSC0003DMG200002230	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMG200002230	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMG200002230	K12842	ko03040	Spliceosome	1605	1.1e-82	0.80	0.93	0.88
PGSC0003DMG200002236	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMG200002236	K02367	ko01100	Metabolic pathways	252	2.0e-07	0.33	0.58	0.50
PGSC0003DMG200002236	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMG200002236	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMG200002236	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMG200002236	K02367	ko01100	Metabolic pathways	311	1.8e-08	0.30	0.43	0.55
PGSC0003DMG200002236	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMG200002236	K02367	ko01100	Metabolic pathways	310	9.9e-11	0.30	0.44	0.98
PGSC0003DMG200016589	K00705	ko00500	Starch and sucrose metabolism	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMG200016589	K00705	ko01100	Metabolic pathways	3690	1.1e-197	0.71	0.82	1.00
PGSC0003DMG200016589	K00705	ko00500	Starch and sucrose metabolism	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMG200016589	K00705	ko01100	Metabolic pathways	717	1.0e-33	0.79	0.90	0.77
PGSC0003DMG200016589	K00705	ko00500	Starch and sucrose metabolism	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMG200016589	K00705	ko01100	Metabolic pathways	3739	2.2e-200	0.74	0.85	1.00
PGSC0003DMG200009015	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMG200009015	K12835	ko03040	Spliceosome	5354	1.8e-289	0.81	0.90	1.00
PGSC0003DMG200009017	K06611	ko00052	Galactose metabolism	2939	2.9e-156	0.44	0.60	1.00
PGSC0003DMG200009018	K10581	ko04120	Ubiquitin mediated proteolysis	591	1.8e-26	0.36	0.54	0.82
PGSC0003DMG200009019	K12820	ko03040	Spliceosome	3968	5.1e-213	0.89	0.95	0.99
PGSC0003DMG200009019	K12820	ko03040	Spliceosome	5626	0.	0.90	0.94	1.00
PGSC0003DMG200009019	K12820	ko03040	Spliceosome	3975	2.1e-213	0.89	0.95	0.93
PGSC0003DMG200009021	K04125	ko00904	Diterpenoid biosynthesis	869	4.3e-42	0.47	0.63	0.89
PGSC0003DMG200009021	K04125	ko00904	Diterpenoid biosynthesis	1117	9.0e-56	0.47	0.63	0.93
PGSC0003DMG200017160	K12837	ko03040	Spliceosome	780	1.0e-41	0.35	0.51	0.45
PGSC0003DMG200017161	K02902	ko03010	Ribosome	431	6.2e-18	0.68	0.85	0.50
PGSC0003DMG200017170	K00026	ko00020	Citrate cycle (TCA cycle)	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017170	K00026	ko00620	Pyruvate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017170	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017170	K00026	ko00710	Carbon fixation in photosynthetic organisms	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017170	K00026	ko01100	Metabolic pathways	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017170	K00026	ko01110	Biosynthesis of secondary metabolites	2627	4.7e-139	0.94	0.97	1.00
PGSC0003DMG200017171	K05765	ko04360	Axon guidance	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMG200017171	K05765	ko04666	Fc gamma R-mediated phagocytosis	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMG200017171	K05765	ko04810	Regulation of actin cytoskeleton	1087	4.1e-54	0.88	0.95	0.99
PGSC0003DMG200017172	K12119	ko04712	Circadian rhythm - plant	3751	4.7e-201	0.69	0.82	0.98
PGSC0003DMG200017172	K12119	ko04712	Circadian rhythm - plant	2548	1.1e-134	0.66	0.79	0.99
PGSC0003DMG200017183	K13229	ko00402	Benzoxazinoid biosynthesis	1093	1.9e-54	0.45	0.59	0.98
PGSC0003DMG200017184	K13229	ko00402	Benzoxazinoid biosynthesis	413	6.1e-17	0.50	0.68	0.95
PGSC0003DMG200028081	K02084	ko04115	p53 signaling pathway	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko04210	Apoptosis	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko05010	Alzheimer's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko05012	Parkinson's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko05016	Huntington's disease	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028081	K02084	ko05222	Small cell lung cancer	313	8.2e-10	0.31	0.48	0.58
PGSC0003DMG200028095	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMG200028095	K00517	ko00626	Naphthalene and anthracene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMG200028095	K00517	ko00903	Limonene and pinene degradation	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMG200028095	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMG200028095	K00517	ko01110	Biosynthesis of secondary metabolites	1356	5.9e-69	0.43	0.64	0.90
PGSC0003DMG200028096	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMG200028096	K00517	ko00626	Naphthalene and anthracene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMG200028096	K00517	ko00903	Limonene and pinene degradation	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMG200028096	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMG200028096	K00517	ko01110	Biosynthesis of secondary metabolites	1645	6.8e-85	0.45	0.64	0.94
PGSC0003DMG200028097	K00059	ko00061	Fatty acid biosynthesis	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMG200028097	K00059	ko01040	Biosynthesis of unsaturated fatty acids	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMG200028097	K00059	ko01100	Metabolic pathways	973	7.9e-48	0.61	0.76	0.91
PGSC0003DMG200032544	K12859	ko03040	Spliceosome	861	1.2e-41	0.97	1.00	0.99
PGSC0003DMG200032546	K01845	ko00860	Porphyrin and chlorophyll metabolism	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMG200032546	K01845	ko01100	Metabolic pathways	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMG200032546	K01845	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.73	0.80	0.99
PGSC0003DMG200032546	K01845	ko00860	Porphyrin and chlorophyll metabolism	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMG200032546	K01845	ko01100	Metabolic pathways	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMG200032546	K01845	ko01110	Biosynthesis of secondary metabolites	3327	1.1e-177	0.82	0.90	1.00
PGSC0003DMG200032546	K01845	ko00860	Porphyrin and chlorophyll metabolism	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMG200032546	K01845	ko01100	Metabolic pathways	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMG200032546	K01845	ko01110	Biosynthesis of secondary metabolites	2599	1.6e-137	0.88	0.94	1.00
PGSC0003DMG200032547	K02084	ko04115	p53 signaling pathway	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko04210	Apoptosis	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko05010	Alzheimer's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko05012	Parkinson's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko05016	Huntington's disease	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032547	K02084	ko05222	Small cell lung cancer	312	2.0e-08	0.28	0.46	0.67
PGSC0003DMG200032550	K00995	ko00564	Glycerophospholipid metabolism	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMG200032550	K00995	ko01100	Metabolic pathways	620	2.3e-28	0.52	0.62	0.74
PGSC0003DMG200032550	K00995	ko00564	Glycerophospholipid metabolism	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMG200032550	K00995	ko01100	Metabolic pathways	1367	1.5e-69	0.63	0.72	0.93
PGSC0003DMG200032552	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMG200032552	K08065	ko04612	Antigen processing and presentation	570	1.3e-25	0.64	0.89	0.74
PGSC0003DMG200032553	K10643	ko03018	RNA degradation	941	4.6e-46	0.32	0.49	0.92
PGSC0003DMG200032553	K10643	ko03018	RNA degradation	2311	1.3e-121	0.37	0.52	1.00
PGSC0003DMG200043400	K02084	ko04115	p53 signaling pathway	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko04210	Apoptosis	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko05010	Alzheimer's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko05012	Parkinson's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko05016	Huntington's disease	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043400	K02084	ko05222	Small cell lung cancer	346	2.1e-09	0.28	0.49	0.25
PGSC0003DMG200043416	K12833	ko03040	Spliceosome	421	2.2e-17	0.75	0.81	0.99
PGSC0003DMG200006690	K02685	ko00230	Purine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMG200006690	K02685	ko00240	Pyrimidine metabolism	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMG200006690	K02685	ko01100	Metabolic pathways	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMG200006690	K02685	ko03030	DNA replication	3222	7.1e-172	0.84	0.92	0.97
PGSC0003DMG200006692	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMG200006692	K00517	ko00626	Naphthalene and anthracene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMG200006692	K00517	ko00903	Limonene and pinene degradation	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMG200006692	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMG200006692	K00517	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.52	0.71	0.90
PGSC0003DMG200006694	K12467	ko00902	Monoterpenoid biosynthesis	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMG200006694	K12467	ko01110	Biosynthesis of secondary metabolites	287	1.3e-09	0.36	0.56	0.79
PGSC0003DMG200006696	K13066	ko00940	Phenylpropanoid biosynthesis	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMG200006696	K13066	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.33	0.43	0.98
PGSC0003DMG200006699	K12182	ko04144	Endocytosis	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMG200006699	K12182	ko04145	Phagosome	254	1.7e-07	0.32	0.41	0.70
PGSC0003DMG200006702	K08905	ko00195	Photosynthesis	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMG200006702	K08905	ko01100	Metabolic pathways	382	3.1e-15	0.50	0.60	0.86
PGSC0003DMG200011282	K01696	ko00260	Glycine, serine and threonine metabolism	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMG200011282	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMG200011282	K01696	ko01100	Metabolic pathways	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMG200011282	K01696	ko01110	Biosynthesis of secondary metabolites	2551	7.2e-135	0.77	0.87	0.86
PGSC0003DMG200011283	K12184	ko04144	Endocytosis	748	2.0e-35	0.58	0.70	0.75
PGSC0003DMG200011287	K01246	ko03410	Base excision repair	865	7.1e-42	0.53	0.66	1.00
PGSC0003DMG200011287	K01246	ko03410	Base excision repair	578	4.8e-26	0.69	0.92	0.96
PGSC0003DMG200011287	K01246	ko03410	Base excision repair	1680	8.0e-87	0.59	0.73	0.99
PGSC0003DMG200011292	K05277	ko00941	Flavonoid biosynthesis	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMG200011292	K05277	ko01100	Metabolic pathways	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMG200011292	K05277	ko01110	Biosynthesis of secondary metabolites	721	6.2e-34	0.34	0.57	0.80
PGSC0003DMG200011292	K05277	ko00941	Flavonoid biosynthesis	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMG200011292	K05277	ko01100	Metabolic pathways	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMG200011292	K05277	ko01110	Biosynthesis of secondary metabolites	848	6.2e-41	0.37	0.58	0.90
PGSC0003DMG200011294	K12134	ko04712	Circadian rhythm - plant	480	1.2e-20	0.90	0.98	0.86
PGSC0003DMG200011294	K12133	ko04712	Circadian rhythm - plant	1266	5.4e-64	0.43	0.56	0.85
PGSC0003DMG200011294	K12133	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.44	0.55	0.98
PGSC0003DMG200013822	K06063	ko03040	Spliceosome	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMG200013822	K06063	ko04330	Notch signaling pathway	421	3.8e-17	0.26	0.44	0.92
PGSC0003DMG200013824	K01369	ko04142	Lysosome	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMG200013824	K01369	ko04612	Antigen processing and presentation	1743	2.7e-90	0.55	0.68	1.00
PGSC0003DMG200013824	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMG200013824	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMG200013824	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMG200013824	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMG200013824	K01369	ko04142	Lysosome	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMG200013824	K01369	ko04612	Antigen processing and presentation	580	3.7e-26	0.72	0.83	0.98
PGSC0003DMG200013824	K01369	ko04142	Lysosome	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMG200013824	K01369	ko04612	Antigen processing and presentation	806	1.3e-38	0.47	0.66	0.94
PGSC0003DMG200013826	K12125	ko04712	Circadian rhythm - plant	664	8.7e-31	0.41	0.51	0.98
PGSC0003DMG200013826	K12125	ko04712	Circadian rhythm - plant	700	9.0e-33	0.37	0.53	0.99
PGSC0003DMG200013826	K12125	ko04712	Circadian rhythm - plant	859	1.5e-41	0.40	0.56	0.98
PGSC0003DMG200013826	K12125	ko04712	Circadian rhythm - plant	1636	2.1e-84	0.40	0.54	0.99
PGSC0003DMG200013827	K12194	ko04144	Endocytosis	1410	6.2e-72	0.84	0.87	0.56
PGSC0003DMG200013827	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMG200013827	K12194	ko04144	Endocytosis	1614	3.5e-83	0.92	0.94	1.00
PGSC0003DMG200013828	K01369	ko04142	Lysosome	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMG200013828	K01369	ko04612	Antigen processing and presentation	1284	5.5e-65	0.75	0.86	0.99
PGSC0003DMG200013828	K01369	ko04142	Lysosome	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMG200013828	K01369	ko04612	Antigen processing and presentation	3234	1.5e-172	0.76	0.88	0.99
PGSC0003DMG200013828	K01369	ko04142	Lysosome	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMG200013828	K01369	ko04612	Antigen processing and presentation	2844	5.0e-151	0.74	0.86	0.99
PGSC0003DMG200024183	K01054	ko00561	Glycerolipid metabolism	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200024183	K01054	ko01100	Metabolic pathways	407	1.3e-16	0.32	0.54	0.98
PGSC0003DMG200024187	K06630	ko04110	Cell cycle	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMG200024187	K06630	ko04114	Oocyte meiosis	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMG200024187	K06630	ko04722	Neurotrophin signaling pathway	1895	1.1e-98	0.90	0.96	0.98
PGSC0003DMG200024189	K03715	ko00561	Glycerolipid metabolism	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMG200024189	K03715	ko01100	Metabolic pathways	1631	4.0e-84	0.57	0.64	0.99
PGSC0003DMG200024190	K10839	ko03420	Nucleotide excision repair	2475	1.1e-130	0.76	0.84	1.00
PGSC0003DMG200024192	K00075	ko00520	Amino sugar and nucleotide sugar metabolism	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMG200024192	K00075	ko00550	Peptidoglycan biosynthesis	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMG200024192	K00075	ko01100	Metabolic pathways	1029	6.4e-51	0.49	0.67	0.84
PGSC0003DMG200024198	K01915	ko00250	Alanine, aspartate and glutamate metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMG200024198	K01915	ko00330	Arginine and proline metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMG200024198	K01915	ko00910	Nitrogen metabolism	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMG200024198	K01915	ko01100	Metabolic pathways	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMG200024198	K01915	ko02020	Two-component system	771	1.1e-36	0.31	0.50	0.60
PGSC0003DMG200024202	K02084	ko04115	p53 signaling pathway	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko04210	Apoptosis	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko05010	Alzheimer's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko05012	Parkinson's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko05016	Huntington's disease	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024202	K02084	ko05222	Small cell lung cancer	291	1.4e-06	0.27	0.43	0.38
PGSC0003DMG200024204	K00949	ko00730	Thiamine metabolism	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMG200024204	K00949	ko01100	Metabolic pathways	583	2.5e-26	0.49	0.62	0.45
PGSC0003DMG200028691	K00599	ko00340	Histidine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMG200028691	K00599	ko00350	Tyrosine metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMG200028691	K00599	ko00450	Selenoamino acid metabolism	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMG200028691	K00599	ko00626	Naphthalene and anthracene degradation	603	2.0e-27	0.35	0.53	0.75
PGSC0003DMG200028702	K01853	ko00100	Steroid biosynthesis	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMG200028702	K01853	ko01100	Metabolic pathways	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMG200028702	K01853	ko01110	Biosynthesis of secondary metabolites	4627	2.3e-249	0.70	0.80	0.99
PGSC0003DMG200028702	K01853	ko00100	Steroid biosynthesis	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMG200028702	K01853	ko01100	Metabolic pathways	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMG200028702	K01853	ko01110	Biosynthesis of secondary metabolites	3573	3.1e-191	0.80	0.92	0.99
PGSC0003DMG200028708	K07573	ko03018	RNA degradation	1318	7.4e-67	0.84	0.90	0.96
PGSC0003DMG200017850	K12493	ko04144	Endocytosis	1499	7.6e-77	0.41	0.57	0.93
PGSC0003DMG200017850	K12493	ko04144	Endocytosis	412	4.7e-16	0.32	0.51	0.99
PGSC0003DMG200017854	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMG200017854	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMG200017854	K00771	ko01100	Metabolic pathways	472	1.3e-19	0.30	0.50	0.76
PGSC0003DMG200017861	K04424	ko04010	MAPK signaling pathway	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMG200017861	K04424	ko04530	Tight junction	725	1.5e-33	0.35	0.55	0.27
PGSC0003DMG200031215	K05863	ko04020	Calcium signaling pathway	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMG200031215	K05863	ko05012	Parkinson's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMG200031215	K05863	ko05016	Huntington's disease	259	1.9e-08	0.42	0.59	0.63
PGSC0003DMG200010631	K02183	ko04020	Calcium signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04070	Phosphatidylinositol signaling system	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04114	Oocyte meiosis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04270	Vascular smooth muscle contraction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04626	Plant-pathogen interaction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04720	Long-term potentiation	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04722	Neurotrophin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04740	Olfactory transduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04744	Phototransduction	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04745	Phototransduction - fly	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04910	Insulin signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04912	GnRH signaling pathway	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04916	Melanogenesis	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04970	Salivary secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko04971	Gastric acid secretion	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko05010	Alzheimer's disease	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010631	K02183	ko05214	Glioma	309	3.3e-11	0.36	0.55	0.71
PGSC0003DMG200010637	K06443	ko00906	Carotenoid biosynthesis	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMG200010637	K06443	ko01100	Metabolic pathways	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMG200010637	K06443	ko01110	Biosynthesis of secondary metabolites	3669	1.6e-196	0.86	0.92	1.00
PGSC0003DMG200010638	K00599	ko00340	Histidine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMG200010638	K00599	ko00350	Tyrosine metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMG200010638	K00599	ko00450	Selenoamino acid metabolism	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMG200010638	K00599	ko00626	Naphthalene and anthracene degradation	249	6.7e-08	0.33	0.51	0.50
PGSC0003DMG200010646	K03013	ko00230	Purine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMG200010646	K03013	ko00240	Pyrimidine metabolism	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMG200010646	K03013	ko01100	Metabolic pathways	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMG200010646	K03013	ko03020	RNA polymerase	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMG200010646	K03013	ko05016	Huntington's disease	1286	4.3e-65	0.68	0.84	1.00
PGSC0003DMG200014540	K01187	ko00052	Galactose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMG200014540	K01187	ko00500	Starch and sucrose metabolism	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMG200014540	K01187	ko01100	Metabolic pathways	4980	7.7e-269	0.64	0.78	0.98
PGSC0003DMG200014543	K01054	ko00561	Glycerolipid metabolism	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMG200014543	K01054	ko01100	Metabolic pathways	529	2.4e-23	0.31	0.53	0.75
PGSC0003DMG200014544	K02876	ko03010	Ribosome	1568	1.2e-80	0.77	0.85	0.92
PGSC0003DMG200019558	K06671	ko04110	Cell cycle	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMG200019558	K06671	ko04111	Cell cycle - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMG200019558	K06671	ko04113	Meiosis - yeast	480	7.1e-20	0.59	0.73	0.83
PGSC0003DMG200019559	K06671	ko04110	Cell cycle	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMG200019559	K06671	ko04111	Cell cycle - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMG200019559	K06671	ko04113	Meiosis - yeast	750	2.2e-35	0.59	0.72	0.99
PGSC0003DMG200019559	K06671	ko04110	Cell cycle	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMG200019559	K06671	ko04111	Cell cycle - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMG200019559	K06671	ko04113	Meiosis - yeast	799	3.1e-38	0.66	0.81	0.99
PGSC0003DMG200019560	K12356	ko00940	Phenylpropanoid biosynthesis	536	1.0e-23	0.39	0.53	0.69
PGSC0003DMG200019561	K10352	ko04530	Tight junction	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMG200019561	K10352	ko05416	Viral myocarditis	475	2.8e-16	0.26	0.46	0.48
PGSC0003DMG200019561	K10352	ko04530	Tight junction	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMG200019561	K10352	ko05416	Viral myocarditis	460	2.5e-18	0.27	0.47	0.85
PGSC0003DMG200019563	K02985	ko03010	Ribosome	1782	1.9e-92	0.93	0.96	0.95
PGSC0003DMG200019564	K00797	ko00270	Cysteine and methionine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMG200019564	K00797	ko00330	Arginine and proline metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMG200019564	K00797	ko00410	beta-Alanine metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMG200019564	K00797	ko00480	Glutathione metabolism	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMG200019564	K00797	ko01100	Metabolic pathways	1079	1.1e-53	0.47	0.61	0.96
PGSC0003DMG200019566	K04733	ko04210	Apoptosis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMG200019566	K04733	ko04620	Toll-like receptor signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMG200019566	K04733	ko04722	Neurotrophin signaling pathway	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMG200019566	K04733	ko05140	Leishmaniasis	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMG200019566	K04733	ko05142	Chagas disease	610	8.3e-28	0.37	0.60	0.80
PGSC0003DMG200019567	K07424	ko00140	Steroid hormone biosynthesis	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00591	Linoleic acid metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00830	Retinol metabolism	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00982	Drug metabolism - cytochrome P450	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko00983	Drug metabolism - other enzymes	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019567	K07424	ko01100	Metabolic pathways	2007	7.3e-105	0.48	0.69	0.98
PGSC0003DMG200019574	K01501	ko00380	Tryptophan metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko00460	Cyanoamino acid metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko00632	Benzoate degradation via CoA ligation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko00643	Styrene degradation	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko00910	Nitrogen metabolism	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko01100	Metabolic pathways	1038	2.0e-51	0.50	0.68	0.73
PGSC0003DMG200019574	K01501	ko00380	Tryptophan metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200019574	K01501	ko00460	Cyanoamino acid metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200019574	K01501	ko00632	Benzoate degradation via CoA ligation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200019574	K01501	ko00643	Styrene degradation	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200019574	K01501	ko00910	Nitrogen metabolism	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200019574	K01501	ko01100	Metabolic pathways	1084	5.9e-54	0.49	0.67	0.89
PGSC0003DMG200029513	K05868	ko04110	Cell cycle	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMG200029513	K05868	ko04115	p53 signaling pathway	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMG200029513	K05868	ko04914	Progesterone-mediated oocyte maturation	385	4.8e-15	0.32	0.51	0.35
PGSC0003DMG200029514	K12128	ko04712	Circadian rhythm - plant	406	1.5e-16	0.35	0.55	0.67
PGSC0003DMG200029514	K12128	ko04712	Circadian rhythm - plant	406	2.0e-16	0.35	0.55	0.27
PGSC0003DMG200029514	K12128	ko04712	Circadian rhythm - plant	406	1.9e-16	0.35	0.55	0.27
PGSC0003DMG200029515	K10352	ko04530	Tight junction	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMG200029515	K10352	ko05416	Viral myocarditis	325	1.2e-08	0.27	0.47	0.84
PGSC0003DMG200029515	K10866	ko03440	Homologous recombination	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMG200029515	K10866	ko03450	Non-homologous end-joining	267	7.3e-08	0.30	0.50	0.87
PGSC0003DMG200029515	K10352	ko04530	Tight junction	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMG200029515	K10352	ko05416	Viral myocarditis	366	6.1e-11	0.26	0.46	0.87
PGSC0003DMG200029517	K13229	ko00402	Benzoxazinoid biosynthesis	1103	5.3e-55	0.41	0.60	0.95
PGSC0003DMG200029521	K12478	ko04144	Endocytosis	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMG200029521	K12478	ko04145	Phagosome	334	5.1e-09	0.25	0.45	0.93
PGSC0003DMG200026407	K01054	ko00561	Glycerolipid metabolism	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMG200026407	K01054	ko01100	Metabolic pathways	541	5.3e-24	0.34	0.52	0.84
PGSC0003DMG200026409	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMG200026409	K01602	ko00710	Carbon fixation in photosynthetic organisms	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMG200026409	K01602	ko01100	Metabolic pathways	849	5.4e-41	0.83	0.94	0.96
PGSC0003DMG200026409	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko00630	Glyoxylate and dicarboxylate metabolism	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko00710	Carbon fixation in photosynthetic organisms	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026409	K01602	ko01100	Metabolic pathways	1161	3.4e-58	0.82	0.92	0.97
PGSC0003DMG200026414	K12845	ko03040	Spliceosome	989	1.0e-48	0.93	0.97	0.99
PGSC0003DMG200026415	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.63
PGSC0003DMG200026415	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMG200026415	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMG200026415	K02871	ko03010	Ribosome	517	1.1e-22	0.51	0.71	0.60
PGSC0003DMG200026419	K12831	ko03040	Spliceosome	231	7.1e-07	0.37	0.43	0.57
PGSC0003DMG200002860	K02997	ko03010	Ribosome	1585	1.4e-81	0.94	0.99	0.99
PGSC0003DMG200002879	K07297	ko04920	Adipocytokine signaling pathway	534	1.3e-23	0.59	0.77	0.63
PGSC0003DMG200012752	K10352	ko04530	Tight junction	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMG200012752	K10352	ko05416	Viral myocarditis	393	5.0e-12	0.26	0.48	0.55
PGSC0003DMG200012756	K01046	ko00561	Glycerolipid metabolism	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMG200012756	K01046	ko01100	Metabolic pathways	308	3.7e-11	0.31	0.46	0.92
PGSC0003DMG200012757	K01955	ko00240	Pyrimidine metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMG200012757	K01955	ko00250	Alanine, aspartate and glutamate metabolism	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMG200012757	K01955	ko01100	Metabolic pathways	308	3.9e-10	0.49	0.64	0.60
PGSC0003DMG200012761	K10885	ko03450	Non-homologous end-joining	4138	2.1e-222	0.70	0.85	0.97
PGSC0003DMG200012762	K01800	ko00350	Tyrosine metabolism	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMG200012762	K01800	ko00643	Styrene degradation	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMG200012762	K01800	ko01100	Metabolic pathways	432	5.4e-18	0.75	0.87	0.47
PGSC0003DMG200012762	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMG200012762	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMG200012762	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.74
PGSC0003DMG200012762	K01800	ko00350	Tyrosine metabolism	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMG200012762	K01800	ko00643	Styrene degradation	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMG200012762	K01800	ko01100	Metabolic pathways	1116	1.0e-55	0.63	0.81	0.75
PGSC0003DMG200012762	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012762	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012762	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012762	K01800	ko00350	Tyrosine metabolism	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012762	K01800	ko00643	Styrene degradation	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012762	K01800	ko01100	Metabolic pathways	478	1.6e-20	0.59	0.75	0.99
PGSC0003DMG200012763	K07750	ko00100	Steroid biosynthesis	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMG200012763	K07750	ko01100	Metabolic pathways	866	6.3e-42	0.44	0.61	0.86
PGSC0003DMG200012764	K08272	ko04150	mTOR signaling pathway	1897	8.5e-99	0.80	0.88	0.98
PGSC0003DMG200012764	K08272	ko04150	mTOR signaling pathway	2273	1.6e-119	0.80	0.89	0.99
PGSC0003DMG200012764	K08272	ko04150	mTOR signaling pathway	1998	2.3e-104	0.80	0.89	0.99
PGSC0003DMG200012764	K08272	ko04150	mTOR signaling pathway	1279	1.0e-64	0.79	0.88	0.94
PGSC0003DMG200008194	K00599	ko00340	Histidine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMG200008194	K00599	ko00350	Tyrosine metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMG200008194	K00599	ko00450	Selenoamino acid metabolism	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMG200008194	K00599	ko00626	Naphthalene and anthracene degradation	375	7.6e-15	0.49	0.64	0.25
PGSC0003DMG200008194	K00599	ko00340	Histidine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMG200008194	K00599	ko00350	Tyrosine metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMG200008194	K00599	ko00450	Selenoamino acid metabolism	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMG200008194	K00599	ko00626	Naphthalene and anthracene degradation	998	3.3e-49	0.73	0.85	0.29
PGSC0003DMG200015852	K12194	ko04144	Endocytosis	424	7.9e-17	0.46	0.66	0.13
PGSC0003DMG200015852	K12194	ko04144	Endocytosis	424	3.7e-17	0.46	0.66	0.17
PGSC0003DMG200015855	K00655	ko00561	Glycerolipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMG200015855	K00655	ko00564	Glycerophospholipid metabolism	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMG200015855	K00655	ko01100	Metabolic pathways	341	5.7e-13	0.39	0.51	0.61
PGSC0003DMG200015861	K02703	ko00195	Photosynthesis	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMG200015861	K02703	ko01100	Metabolic pathways	1290	2.6e-65	0.70	0.70	0.98
PGSC0003DMG200015870	K01179	ko00500	Starch and sucrose metabolism	224	3.4e-06	0.53	0.69	0.57
PGSC0003DMG200009650	K02729	ko03050	Proteasome	1652	2.8e-85	0.96	1.00	0.95
PGSC0003DMG200009650	K02729	ko03050	Proteasome	1923	3.1e-100	0.97	1.00	1.00
PGSC0003DMG200009655	K12812	ko03040	Spliceosome	541	5.3e-24	0.73	0.88	0.56
PGSC0003DMG200009655	K12812	ko03040	Spliceosome	2689	1.8e-142	0.89	0.92	0.59
PGSC0003DMG200009655	K12812	ko03040	Spliceosome	2806	6.2e-149	0.96	0.99	1.00
PGSC0003DMG200009655	K12812	ko03040	Spliceosome	3452	1.5e-184	0.94	0.99	1.00
PGSC0003DMG200009660	K11821	ko00380	Tryptophan metabolism	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMG200009660	K11821	ko00966	Glucosinolate biosynthesis	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMG200009660	K11821	ko01110	Biosynthesis of secondary metabolites	373	9.7e-15	0.44	0.65	0.96
PGSC0003DMG200009662	K02471	ko02010	ABC transporters	766	2.1e-36	0.43	0.64	0.74
PGSC0003DMG200009662	K02471	ko02010	ABC transporters	1473	2.1e-75	0.41	0.58	0.98
PGSC0003DMG200009662	K02471	ko02010	ABC transporters	309	7.7e-11	0.43	0.66	0.97
PGSC0003DMG200009662	K02471	ko02010	ABC transporters	338	1.0e-12	0.60	0.73	0.86
PGSC0003DMG200000858	K03129	ko03022	Basal transcription factors	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMG200000858	K03129	ko05016	Huntington's disease	246	6.5e-07	0.34	0.60	0.50
PGSC0003DMG200000859	K01728	ko00040	Pentose and glucuronate interconversions	1820	1.5e-94	0.53	0.69	0.92
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1259	1.3e-63	0.43	0.63	0.93
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.44	0.64	0.90
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1505	3.6e-77	0.45	0.65	0.90
PGSC0003DMG200000860	K13289	ko04142	Lysosome	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	584	2.2e-26	0.39	0.60	0.88
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1170	1.1e-58	0.42	0.62	0.97
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1563	2.3e-80	0.44	0.67	0.90
PGSC0003DMG200000860	K13289	ko04142	Lysosome	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	730	2.0e-34	0.37	0.60	0.96
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1495	1.3e-76	0.45	0.64	0.90
PGSC0003DMG200000860	K13289	ko04142	Lysosome	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMG200000860	K13289	ko04614	Renin-angiotensin system	1501	5.9e-77	0.45	0.64	0.90
PGSC0003DMG200000864	K05862	ko04020	Calcium signaling pathway	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMG200000864	K05862	ko05012	Parkinson's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMG200000864	K05862	ko05016	Huntington's disease	1982	1.8e-103	0.85	0.95	1.00
PGSC0003DMG200046602	K08241	ko00592	alpha-Linolenic acid metabolism	625	1.2e-28	0.33	0.53	0.88
PGSC0003DMG200046623	K10352	ko04530	Tight junction	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMG200046623	K10352	ko05416	Viral myocarditis	394	1.6e-12	0.23	0.45	1.00
PGSC0003DMG200042188	K11816	ko00380	Tryptophan metabolism	497	1.4e-21	0.47	0.66	0.98
PGSC0003DMG200042196	K12586	ko03018	RNA degradation	244	4.5e-11	0.53	0.72	0.48
PGSC0003DMG200002789	K12608	ko03018	RNA degradation	551	1.5e-24	0.80	0.84	0.78
PGSC0003DMG200002789	K12608	ko03018	RNA degradation	631	5.7e-29	0.80	0.86	0.99
PGSC0003DMG200002789	K12608	ko03018	RNA degradation	2391	4.8e-126	0.87	0.92	1.00
PGSC0003DMG200009711	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMG200009711	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMG200009711	K00688	ko00500	Starch and sucrose metabolism	6209	0.	0.85	0.93	0.99
PGSC0003DMG200009711	K00688	ko04910	Insulin signaling pathway	6209	0.	0.85	0.93	0.99
PGSC0003DMG200009712	K01114	ko00562	Inositol phosphate metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMG200009712	K01114	ko00564	Glycerophospholipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMG200009712	K01114	ko00565	Ether lipid metabolism	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMG200009712	K01114	ko01100	Metabolic pathways	3592	2.8e-192	0.79	0.87	0.97
PGSC0003DMG200009713	K01955	ko00240	Pyrimidine metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMG200009713	K01955	ko00250	Alanine, aspartate and glutamate metabolism	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMG200009713	K01955	ko01100	Metabolic pathways	494	1.6e-20	0.47	0.60	0.67
PGSC0003DMG200009715	K05278	ko00941	Flavonoid biosynthesis	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMG200009715	K05278	ko01100	Metabolic pathways	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMG200009715	K05278	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.33	0.55	0.83
PGSC0003DMG200009716	K01955	ko00240	Pyrimidine metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMG200009716	K01955	ko00250	Alanine, aspartate and glutamate metabolism	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMG200009716	K01955	ko01100	Metabolic pathways	451	4.1e-18	0.47	0.60	0.52
PGSC0003DMG200009719	K05278	ko00941	Flavonoid biosynthesis	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMG200009719	K05278	ko01100	Metabolic pathways	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMG200009719	K05278	ko01110	Biosynthesis of secondary metabolites	486	5.7e-21	0.34	0.50	0.85
PGSC0003DMG200009720	K05278	ko00941	Flavonoid biosynthesis	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMG200009720	K05278	ko01100	Metabolic pathways	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMG200009720	K05278	ko01110	Biosynthesis of secondary metabolites	678	1.5e-31	0.34	0.53	0.91
PGSC0003DMG200005987	K08332	ko04140	Regulation of autophagy	388	1.6e-13	0.30	0.51	0.49
PGSC0003DMG200005993	K12200	ko04144	Endocytosis	5739	0.	0.75	0.86	1.00
PGSC0003DMG200005993	K12200	ko04144	Endocytosis	5413	1.0e-292	0.75	0.85	1.00
PGSC0003DMG200005994	K02133	ko00190	Oxidative phosphorylation	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMG200005994	K02133	ko01100	Metabolic pathways	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMG200005994	K02133	ko05010	Alzheimer's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMG200005994	K02133	ko05012	Parkinson's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMG200005994	K02133	ko05016	Huntington's disease	4158	1.7e-223	0.91	0.94	1.00
PGSC0003DMG200005995	K08730	ko00564	Glycerophospholipid metabolism	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMG200005995	K08730	ko01100	Metabolic pathways	2913	7.8e-155	0.79	0.87	0.93
PGSC0003DMG200005997	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.21
PGSC0003DMG200005997	K12135	ko04712	Circadian rhythm - plant	296	1.9e-10	0.45	0.62	0.17
PGSC0003DMG200005997	K12135	ko04712	Circadian rhythm - plant	296	1.7e-10	0.45	0.62	0.27
PGSC0003DMG200034688	K07374	ko04145	Phagosome	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMG200034688	K07374	ko04540	Gap junction	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMG200034688	K07374	ko05130	Pathogenic Escherichia coli infection	1848	4.3e-96	0.60	0.62	0.98
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	941	4.6e-46	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	1019	2.3e-50	0.49	0.69	0.94
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	985	1.7e-48	0.46	0.66	0.95
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	489	3.9e-21	0.44	0.66	0.97
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	1149	1.5e-57	0.47	0.68	0.90
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	293	2.5e-10	0.44	0.69	0.95
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	1066	5.8e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	1071	3.1e-53	0.45	0.65	0.91
PGSC0003DMG200019452	K00100	ko00051	Fructose and mannose metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019452	K00100	ko00363	Bisphenol A degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019452	K00100	ko00591	Linoleic acid metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019452	K00100	ko00625	Tetrachloroethene degradation	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019452	K00100	ko00650	Butanoate metabolism	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019452	K00100	ko01100	Metabolic pathways	1101	6.8e-55	0.45	0.65	0.93
PGSC0003DMG200019454	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko00053	Ascorbate and aldarate metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko00520	Amino sugar and nucleotide sugar metabolism	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko01100	Metabolic pathways	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019454	K10046	ko01110	Biosynthesis of secondary metabolites	3001	1.1e-159	0.91	0.95	1.00
PGSC0003DMG200019455	K04371	ko04010	MAPK signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04012	ErbB signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04013	MAPK signaling pathway - fly	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04062	Chemokine signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04114	Oocyte meiosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04150	mTOR signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04270	Vascular smooth muscle contraction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04320	Dorso-ventral axis formation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04350	TGF-beta signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04360	Axon guidance	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04370	VEGF signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04510	Focal adhesion	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04520	Adherens junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04540	Gap junction	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04620	Toll-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04621	NOD-like receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04650	Natural killer cell mediated cytotoxicity	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04660	T cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04662	B cell receptor signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04664	Fc epsilon RI signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04666	Fc gamma R-mediated phagocytosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04720	Long-term potentiation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04722	Neurotrophin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04730	Long-term depression	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04810	Regulation of actin cytoskeleton	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04910	Insulin signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04912	GnRH signaling pathway	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04914	Progesterone-mediated oocyte maturation	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04916	Melanogenesis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04930	Type II diabetes mellitus	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko04960	Aldosterone-regulated sodium reabsorption	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05010	Alzheimer's disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05020	Prion diseases	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05131	Shigellosis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05140	Leishmaniasis	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05142	Chagas disease	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05200	Pathways in cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05210	Colorectal cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05211	Renal cell carcinoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05212	Pancreatic cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05213	Endometrial cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05214	Glioma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05215	Prostate cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05216	Thyroid cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05218	Melanoma	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05219	Bladder cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05220	Chronic myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05221	Acute myeloid leukemia	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019455	K04371	ko05223	Non-small cell lung cancer	286	1.0e-07	0.34	0.50	0.40
PGSC0003DMG200019456	K03116	ko03060	Protein export	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMG200019456	K03116	ko03070	Bacterial secretion system	529	2.4e-23	0.44	0.58	0.94
PGSC0003DMG200019456	K03116	ko03060	Protein export	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMG200019456	K03116	ko03070	Bacterial secretion system	614	5.0e-28	0.55	0.72	0.93
PGSC0003DMG200019459	K08803	ko05200	Pathways in cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMG200019459	K08803	ko05219	Bladder cancer	433	4.5e-17	0.38	0.54	0.49
PGSC0003DMG200019460	K09553	ko05020	Prion diseases	313	3.4e-11	0.40	0.52	0.39
PGSC0003DMG200019462	K08769	ko03320	PPAR signaling pathway	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMG200019462	K08769	ko05016	Huntington's disease	235	4.0e-07	0.33	0.51	0.35
PGSC0003DMG200026451	K01889	ko00970	Aminoacyl-tRNA biosynthesis	425	3.7e-26	0.85	0.95	0.83
PGSC0003DMG200026456	K00029	ko00620	Pyruvate metabolism	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMG200026456	K00029	ko00710	Carbon fixation in photosynthetic organisms	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMG200026456	K00029	ko01100	Metabolic pathways	4369	3.9e-235	0.80	0.91	1.00
PGSC0003DMG200022739	K03952	ko00190	Oxidative phosphorylation	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMG200022739	K03952	ko01100	Metabolic pathways	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMG200022739	K03952	ko05010	Alzheimer's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMG200022739	K03952	ko05012	Parkinson's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMG200022739	K03952	ko05016	Huntington's disease	435	3.7e-18	0.81	0.86	0.98
PGSC0003DMG200022739	K03952	ko00190	Oxidative phosphorylation	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMG200022739	K03952	ko01100	Metabolic pathways	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMG200022739	K03952	ko05010	Alzheimer's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMG200022739	K03952	ko05012	Parkinson's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMG200022739	K03952	ko05016	Huntington's disease	743	3.8e-35	0.81	0.87	0.98
PGSC0003DMG200022742	K00818	ko00330	Arginine and proline metabolism	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMG200022742	K00818	ko01100	Metabolic pathways	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMG200022742	K00818	ko01110	Biosynthesis of secondary metabolites	2731	8.6e-145	0.81	0.91	0.87
PGSC0003DMG200022743	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMG200022743	K00517	ko00626	Naphthalene and anthracene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMG200022743	K00517	ko00903	Limonene and pinene degradation	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMG200022743	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMG200022743	K00517	ko01110	Biosynthesis of secondary metabolites	661	1.3e-30	0.36	0.54	0.96
PGSC0003DMG200022743	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMG200022743	K00517	ko00626	Naphthalene and anthracene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMG200022743	K00517	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMG200022743	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMG200022743	K00517	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.43	0.60	0.96
PGSC0003DMG200022744	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMG200022744	K00517	ko00626	Naphthalene and anthracene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMG200022744	K00517	ko00903	Limonene and pinene degradation	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMG200022744	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMG200022744	K00517	ko01110	Biosynthesis of secondary metabolites	1393	5.4e-71	0.43	0.61	0.97
PGSC0003DMG200022746	K05277	ko00941	Flavonoid biosynthesis	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMG200022746	K05277	ko01100	Metabolic pathways	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMG200022746	K05277	ko01110	Biosynthesis of secondary metabolites	2308	1.8e-121	0.75	0.88	0.78
PGSC0003DMG200022749	K01641	ko00072	Synthesis and degradation of ketone bodies	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022749	K01641	ko00280	Valine, leucine and isoleucine degradation	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022749	K01641	ko00650	Butanoate metabolism	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022749	K01641	ko00900	Terpenoid backbone biosynthesis	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022749	K01641	ko01100	Metabolic pathways	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022749	K01641	ko01110	Biosynthesis of secondary metabolites	2404	9.3e-127	0.66	0.76	0.97
PGSC0003DMG200022750	K01641	ko00072	Synthesis and degradation of ketone bodies	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022750	K01641	ko00280	Valine, leucine and isoleucine degradation	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022750	K01641	ko00650	Butanoate metabolism	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022750	K01641	ko00900	Terpenoid backbone biosynthesis	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022750	K01641	ko01100	Metabolic pathways	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022750	K01641	ko01110	Biosynthesis of secondary metabolites	3399	1.2e-181	0.85	0.93	1.00
PGSC0003DMG200022752	K08248	ko00460	Cyanoamino acid metabolism	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMG200022752	K08248	ko01100	Metabolic pathways	1965	1.5e-102	0.47	0.62	0.98
PGSC0003DMG200022752	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMG200022752	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMG200022752	K12307	ko04142	Lysosome	360	3.4e-12	0.24	0.45	0.61
PGSC0003DMG200022752	K12307	ko04142	Lysosome	358	4.9e-12	0.24	0.45	0.61
PGSC0003DMG200022752	K06653	ko04111	Cell cycle - yeast	320	5.1e-11	0.33	0.50	0.58
PGSC0003DMG200022753	K03006	ko00230	Purine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMG200022753	K03006	ko00240	Pyrimidine metabolism	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMG200022753	K03006	ko01100	Metabolic pathways	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMG200022753	K03006	ko03020	RNA polymerase	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMG200022753	K03006	ko05016	Huntington's disease	768	2.6e-41	0.26	0.45	0.86
PGSC0003DMG200038978	K05280	ko00941	Flavonoid biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMG200038978	K05280	ko00944	Flavone and flavonol biosynthesis	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMG200038978	K05280	ko01100	Metabolic pathways	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMG200038978	K05280	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.51	0.68	0.97
PGSC0003DMG200038989	K12356	ko00940	Phenylpropanoid biosynthesis	637	2.7e-29	0.29	0.48	0.94
PGSC0003DMG200039005	K00801	ko00100	Steroid biosynthesis	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMG200039005	K00801	ko01100	Metabolic pathways	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMG200039005	K00801	ko01110	Biosynthesis of secondary metabolites	2253	2.0e-118	0.69	0.84	0.99
PGSC0003DMG200003793	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMG200003793	K01061	ko00364	Fluorobenzoate degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMG200003793	K01061	ko00627	1,4-Dichlorobenzene degradation	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMG200003793	K01061	ko01100	Metabolic pathways	432	5.4e-18	0.31	0.50	0.97
PGSC0003DMG200006786	K09753	ko00940	Phenylpropanoid biosynthesis	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMG200006786	K09753	ko01100	Metabolic pathways	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMG200006786	K09753	ko01110	Biosynthesis of secondary metabolites	998	3.3e-49	0.49	0.68	0.97
PGSC0003DMG200006786	K09753	ko00940	Phenylpropanoid biosynthesis	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMG200006786	K09753	ko01100	Metabolic pathways	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMG200006786	K09753	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.45	0.66	0.93
PGSC0003DMG200006786	K09753	ko00940	Phenylpropanoid biosynthesis	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMG200006786	K09753	ko01100	Metabolic pathways	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMG200006786	K09753	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.47	0.65	0.94
PGSC0003DMG200006786	K09753	ko00940	Phenylpropanoid biosynthesis	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMG200006786	K09753	ko01100	Metabolic pathways	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMG200006786	K09753	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.44	0.66	0.93
PGSC0003DMG200006786	K09753	ko00940	Phenylpropanoid biosynthesis	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMG200006786	K09753	ko01100	Metabolic pathways	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMG200006786	K09753	ko01110	Biosynthesis of secondary metabolites	548	2.2e-24	0.40	0.64	0.89
PGSC0003DMG200006787	K01205	ko00531	Glycosaminoglycan degradation	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMG200006787	K01205	ko01100	Metabolic pathways	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMG200006787	K01205	ko04142	Lysosome	2720	3.5e-144	0.76	0.87	0.65
PGSC0003DMG200006787	K01205	ko00531	Glycosaminoglycan degradation	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMG200006787	K01205	ko01100	Metabolic pathways	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMG200006787	K01205	ko04142	Lysosome	2579	2.1e-136	0.73	0.84	0.99
PGSC0003DMG200006787	K01205	ko00531	Glycosaminoglycan degradation	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMG200006787	K01205	ko01100	Metabolic pathways	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMG200006787	K01205	ko04142	Lysosome	5295	3.3e-286	0.75	0.85	1.00
PGSC0003DMG200006787	K01205	ko00531	Glycosaminoglycan degradation	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMG200006787	K01205	ko01100	Metabolic pathways	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMG200006787	K01205	ko04142	Lysosome	262	6.7e-08	0.88	0.97	0.64
PGSC0003DMG200006791	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	301	1.3e-10	0.40	0.63	0.34
PGSC0003DMG200006791	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	437	2.9e-18	0.45	0.69	0.52
PGSC0003DMG200021921	K00948	ko00030	Pentose phosphate pathway	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMG200021921	K00948	ko00230	Purine metabolism	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMG200021921	K00948	ko01100	Metabolic pathways	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMG200021921	K00948	ko01110	Biosynthesis of secondary metabolites	2592	4.0e-137	0.84	0.89	0.80
PGSC0003DMG200021921	K00948	ko00030	Pentose phosphate pathway	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMG200021921	K00948	ko00230	Purine metabolism	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMG200021921	K00948	ko01100	Metabolic pathways	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMG200021921	K00948	ko01110	Biosynthesis of secondary metabolites	2690	1.6e-142	0.86	0.91	0.95
PGSC0003DMG200021921	K00948	ko00030	Pentose phosphate pathway	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMG200021921	K00948	ko00230	Purine metabolism	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMG200021921	K00948	ko01100	Metabolic pathways	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMG200021921	K00948	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.89	0.93	0.98
PGSC0003DMG200021922	K05665	ko02010	ABC transporters	2752	5.9e-146	0.31	0.50	0.93
PGSC0003DMG200021926	K02291	ko00906	Carotenoid biosynthesis	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMG200021926	K02291	ko01100	Metabolic pathways	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMG200021926	K02291	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.60	0.69	0.66
PGSC0003DMG200021927	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.98
PGSC0003DMG200021927	K02979	ko03010	Ribosome	504	5.8e-22	0.92	0.97	0.83
PGSC0003DMG200021930	K05768	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMG200021930	K05768	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.63	0.79	0.99
PGSC0003DMG200021930	K05768	ko04666	Fc gamma R-mediated phagocytosis	5694	0.	0.67	0.83	1.00
PGSC0003DMG200021930	K05768	ko04810	Regulation of actin cytoskeleton	5694	0.	0.67	0.83	1.00
PGSC0003DMG200024915	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMG200024915	K02925	ko03010	Ribosome	2597	2.1e-137	0.91	0.98	0.94
PGSC0003DMG200024915	K02925	ko03010	Ribosome	3151	5.8e-168	0.92	0.98	1.00
PGSC0003DMG200030890	K05894	ko00592	alpha-Linolenic acid metabolism	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMG200030890	K05894	ko01100	Metabolic pathways	2509	1.5e-132	0.74	0.85	0.98
PGSC0003DMG200030891	K06611	ko00052	Galactose metabolism	2157	3.9e-113	0.39	0.57	0.86
PGSC0003DMG200030891	K06611	ko00052	Galactose metabolism	273	1.5e-08	0.30	0.47	0.87
PGSC0003DMG200030892	K02183	ko04020	Calcium signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04070	Phosphatidylinositol signaling system	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04114	Oocyte meiosis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04270	Vascular smooth muscle contraction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04626	Plant-pathogen interaction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04720	Long-term potentiation	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04722	Neurotrophin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04740	Olfactory transduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04744	Phototransduction	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04745	Phototransduction - fly	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04910	Insulin signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04912	GnRH signaling pathway	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04916	Melanogenesis	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04970	Salivary secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko04971	Gastric acid secretion	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko05010	Alzheimer's disease	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030892	K02183	ko05214	Glioma	398	4.1e-16	0.40	0.61	0.65
PGSC0003DMG200030897	K00737	ko00510	N-Glycan biosynthesis	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMG200030897	K00737	ko01100	Metabolic pathways	357	7.4e-14	0.30	0.42	0.76
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko05214	Glioma	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	427	2.1e-16	0.55	0.63	0.75
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05214	Glioma	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1152	1.1e-56	0.68	0.77	0.88
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04012	ErbB signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04150	mTOR signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04910	Insulin signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04920	Adipocytokine signaling pathway	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko04930	Type II diabetes mellitus	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05200	Pathways in cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05214	Glioma	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05215	Prostate cancer	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007451	K07203	ko05221	Acute myeloid leukemia	1003	2.2e-48	0.66	0.75	0.87
PGSC0003DMG200007452	K07203	ko04012	ErbB signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko04150	mTOR signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko04910	Insulin signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko04920	Adipocytokine signaling pathway	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko04930	Type II diabetes mellitus	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko05200	Pathways in cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko05214	Glioma	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko05215	Prostate cancer	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007452	K07203	ko05221	Acute myeloid leukemia	284	1.8e-08	0.80	0.83	0.79
PGSC0003DMG200007453	K07203	ko04012	ErbB signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko04150	mTOR signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko04910	Insulin signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko04920	Adipocytokine signaling pathway	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko04930	Type II diabetes mellitus	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko05200	Pathways in cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko05214	Glioma	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko05215	Prostate cancer	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007453	K07203	ko05221	Acute myeloid leukemia	810	1.2e-37	0.46	0.54	0.88
PGSC0003DMG200007455	K00558	ko00270	Cysteine and methionine metabolism	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMG200007455	K00558	ko01100	Metabolic pathways	1692	1.7e-87	0.41	0.54	0.95
PGSC0003DMG200007456	K02183	ko04020	Calcium signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04070	Phosphatidylinositol signaling system	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04114	Oocyte meiosis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04270	Vascular smooth muscle contraction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04626	Plant-pathogen interaction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04720	Long-term potentiation	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04722	Neurotrophin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04740	Olfactory transduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04744	Phototransduction	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04745	Phototransduction - fly	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04910	Insulin signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04912	GnRH signaling pathway	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04916	Melanogenesis	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04970	Salivary secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko04971	Gastric acid secretion	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko05010	Alzheimer's disease	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200007456	K02183	ko05214	Glioma	254	3.6e-08	0.38	0.60	0.85
PGSC0003DMG200004483	K01054	ko00561	Glycerolipid metabolism	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMG200004483	K01054	ko01100	Metabolic pathways	341	5.7e-13	0.37	0.57	0.91
PGSC0003DMG200004483	K01054	ko00561	Glycerolipid metabolism	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMG200004483	K01054	ko01100	Metabolic pathways	583	2.5e-26	0.35	0.54	0.71
PGSC0003DMG200004491	K05768	ko04666	Fc gamma R-mediated phagocytosis	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMG200004491	K05768	ko04810	Regulation of actin cytoskeleton	476	8.8e-20	0.77	0.88	0.48
PGSC0003DMG200004496	K01190	ko00052	Galactose metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMG200004496	K01190	ko00511	Other glycan degradation	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMG200004496	K01190	ko00600	Sphingolipid metabolism	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMG200004496	K01190	ko01100	Metabolic pathways	3943	1.2e-211	0.65	0.79	0.96
PGSC0003DMG200004496	K01190	ko00052	Galactose metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMG200004496	K01190	ko00511	Other glycan degradation	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMG200004496	K01190	ko00600	Sphingolipid metabolism	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMG200004496	K01190	ko01100	Metabolic pathways	1919	5.2e-100	0.63	0.80	0.74
PGSC0003DMG200004500	K12356	ko00940	Phenylpropanoid biosynthesis	2032	3.1e-106	0.54	0.72	0.99
PGSC0003DMG200004500	K12356	ko00940	Phenylpropanoid biosynthesis	2029	4.5e-106	0.53	0.73	0.99
PGSC0003DMG200004500	K12356	ko00940	Phenylpropanoid biosynthesis	1927	1.9e-100	0.53	0.73	0.97
PGSC0003DMG200004501	K03006	ko00230	Purine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMG200004501	K03006	ko00240	Pyrimidine metabolism	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMG200004501	K03006	ko01100	Metabolic pathways	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMG200004501	K03006	ko03020	RNA polymerase	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMG200004501	K03006	ko05016	Huntington's disease	247	1.4e-06	0.36	0.48	0.54
PGSC0003DMG200004508	K07203	ko04012	ErbB signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko04150	mTOR signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko04910	Insulin signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko04920	Adipocytokine signaling pathway	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko04930	Type II diabetes mellitus	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko05200	Pathways in cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko05214	Glioma	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko05215	Prostate cancer	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200004508	K07203	ko05221	Acute myeloid leukemia	750	7.9e-35	0.83	0.87	0.98
PGSC0003DMG200013446	K00981	ko00564	Glycerophospholipid metabolism	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMG200013446	K00981	ko01100	Metabolic pathways	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMG200013446	K00981	ko04070	Phosphatidylinositol signaling system	3058	7.9e-163	0.82	0.90	1.00
PGSC0003DMG200013453	K10594	ko04120	Ubiquitin mediated proteolysis	793	2.8e-36	0.31	0.49	0.62
PGSC0003DMG200013456	K12741	ko03040	Spliceosome	2738	3.5e-145	0.69	0.79	1.00
PGSC0003DMG200013459	K01703	ko00290	Valine, leucine and isoleucine biosynthesis	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMG200013459	K01703	ko00660	C5-Branched dibasic acid metabolism	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMG200013459	K01703	ko01100	Metabolic pathways	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMG200013459	K01703	ko01110	Biosynthesis of secondary metabolites	3951	4.4e-212	0.90	0.95	0.99
PGSC0003DMG200013460	K08912	ko00196	Photosynthesis - antenna proteins	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMG200013460	K08912	ko01100	Metabolic pathways	567	1.9e-25	0.80	0.90	0.91
PGSC0003DMG200013460	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200013460	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200013461	K08912	ko00196	Photosynthesis - antenna proteins	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200013461	K08912	ko01100	Metabolic pathways	1277	1.3e-64	0.94	0.96	0.99
PGSC0003DMG200040180	K03094	ko04110	Cell cycle	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04111	Cell cycle - yeast	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04114	Oocyte meiosis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04120	Ubiquitin mediated proteolysis	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04310	Wnt signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04350	TGF-beta signaling pathway	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200040180	K03094	ko04710	Circadian rhythm - mammal	754	9.4e-36	0.63	0.75	0.99
PGSC0003DMG200001557	K11420	ko00310	Lysine degradation	490	3.4e-21	0.32	0.47	0.38
PGSC0003DMG200001560	K01091	ko00630	Glyoxylate and dicarboxylate metabolism	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMG200001560	K01091	ko01100	Metabolic pathways	303	7.1e-11	0.33	0.54	0.71
PGSC0003DMG200001567	K10802	ko03410	Base excision repair	837	2.5e-40	0.69	0.79	0.99
PGSC0003DMG200001570	K03781	ko00380	Tryptophan metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMG200001570	K03781	ko00680	Methane metabolism	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMG200001570	K03781	ko01100	Metabolic pathways	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMG200001570	K03781	ko04146	Peroxisome	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMG200001570	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4024	4.1e-216	0.90	0.97	1.00
PGSC0003DMG200001572	K06267	ko04512	ECM-receptor interaction	594	5.6e-25	0.26	0.49	0.88
PGSC0003DMG200001573	K00640	ko00270	Cysteine and methionine metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMG200001573	K00640	ko00920	Sulfur metabolism	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMG200001573	K00640	ko01100	Metabolic pathways	1947	1.5e-101	0.74	0.88	0.88
PGSC0003DMG200001573	K00640	ko00270	Cysteine and methionine metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMG200001573	K00640	ko00920	Sulfur metabolism	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMG200001573	K00640	ko01100	Metabolic pathways	677	1.7e-31	0.76	0.89	0.78
PGSC0003DMG200024276	K01852	ko00100	Steroid biosynthesis	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMG200024276	K01852	ko01100	Metabolic pathways	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMG200024276	K01852	ko01110	Biosynthesis of secondary metabolites	568	1.7e-25	0.42	0.58	0.92
PGSC0003DMG200024278	K01593	ko00340	Histidine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00350	Tyrosine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00360	Phenylalanine metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00380	Tryptophan metabolism	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00901	Indole alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko00965	Betalain biosynthesis	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko01100	Metabolic pathways	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024278	K01593	ko01110	Biosynthesis of secondary metabolites	2408	5.6e-127	0.57	0.76	0.96
PGSC0003DMG200024284	K00679	ko00561	Glycerolipid metabolism	413	6.1e-17	0.34	0.48	0.48
PGSC0003DMG200024284	K00679	ko00561	Glycerolipid metabolism	293	6.6e-10	0.36	0.52	0.79
PGSC0003DMG200024284	K00679	ko00561	Glycerolipid metabolism	531	1.9e-23	0.29	0.43	0.75
PGSC0003DMG200024284	K00679	ko00561	Glycerolipid metabolism	516	1.3e-22	0.30	0.46	0.88
PGSC0003DMG200024285	K00430	ko00360	Phenylalanine metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMG200024285	K00430	ko00680	Methane metabolism	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMG200024285	K00430	ko00940	Phenylpropanoid biosynthesis	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMG200024285	K00430	ko01100	Metabolic pathways	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMG200024285	K00430	ko01110	Biosynthesis of secondary metabolites	1405	1.2e-71	0.55	0.72	0.96
PGSC0003DMG200024285	K00430	ko00360	Phenylalanine metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMG200024285	K00430	ko00680	Methane metabolism	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMG200024285	K00430	ko00940	Phenylpropanoid biosynthesis	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMG200024285	K00430	ko01100	Metabolic pathways	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMG200024285	K00430	ko01110	Biosynthesis of secondary metabolites	558	6.1e-25	0.51	0.72	0.93
PGSC0003DMG200024290	K13065	ko00940	Phenylpropanoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMG200024290	K13065	ko00941	Flavonoid biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMG200024290	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMG200024290	K13065	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.27	0.45	0.96
PGSC0003DMG200024292	K12462	ko04722	Neurotrophin signaling pathway	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMG200024292	K12462	ko04962	Vasopressin-regulated water reabsorption	872	2.9e-42	0.55	0.75	0.88
PGSC0003DMG200024294	K00119	ko00362	Benzoate degradation via hydroxylation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMG200024294	K00119	ko00440	Phosphonate and phosphinate metabolism	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMG200024294	K00119	ko00903	Limonene and pinene degradation	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMG200024294	K00119	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.31	0.47	0.86
PGSC0003DMG200021204	K01955	ko00240	Pyrimidine metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMG200021204	K01955	ko00250	Alanine, aspartate and glutamate metabolism	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMG200021204	K01955	ko01100	Metabolic pathways	681	5.1e-31	0.52	0.65	0.98
PGSC0003DMG200015278	K09587	ko00905	Brassinosteroid biosynthesis	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMG200015278	K09587	ko01100	Metabolic pathways	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMG200015278	K09587	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.36	0.57	0.98
PGSC0003DMG200015285	K03126	ko03022	Basal transcription factors	395	1.1e-14	0.30	0.41	0.16
PGSC0003DMG200015298	K05573	ko00190	Oxidative phosphorylation	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMG200015298	K05573	ko01100	Metabolic pathways	1045	8.4e-52	0.64	0.68	0.95
PGSC0003DMG200002130	K00287	ko00670	One carbon pool by folate	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMG200002130	K00287	ko00790	Folate biosynthesis	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMG200002130	K00287	ko01100	Metabolic pathways	221	2.4e-06	0.36	0.47	0.85
PGSC0003DMG200002130	K00287	ko00670	One carbon pool by folate	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMG200002130	K00287	ko00790	Folate biosynthesis	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMG200002130	K00287	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.49	0.83
PGSC0003DMG200002130	K00287	ko00670	One carbon pool by folate	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMG200002130	K00287	ko00790	Folate biosynthesis	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMG200002130	K00287	ko01100	Metabolic pathways	291	5.2e-10	0.31	0.48	0.83
PGSC0003DMG200002130	K00287	ko00670	One carbon pool by folate	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMG200002130	K00287	ko00790	Folate biosynthesis	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMG200002130	K00287	ko01100	Metabolic pathways	294	2.2e-10	0.30	0.48	0.84
PGSC0003DMG200005317	K05746	ko04810	Regulation of actin cytoskeleton	224	9.0e-06	0.40	0.55	0.34
PGSC0003DMG200005320	K01509	ko00230	Purine metabolism	724	1.6e-61	0.41	0.61	0.82
PGSC0003DMG200005324	K02939	ko03010	Ribosome	716	1.2e-33	0.51	0.64	0.96
PGSC0003DMG200005324	K02939	ko03010	Ribosome	1023	1.4e-50	0.58	0.72	1.00
PGSC0003DMG200005325	K12135	ko04712	Circadian rhythm - plant	263	1.1e-08	0.37	0.52	0.24
PGSC0003DMG200005332	K10609	ko03420	Nucleotide excision repair	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMG200005332	K10609	ko04120	Ubiquitin mediated proteolysis	317	5.3e-11	0.56	0.68	0.96
PGSC0003DMG200005333	K08852	ko05010	Alzheimer's disease	244	3.7e-06	0.40	0.55	0.24
PGSC0003DMG200009052	K01897	ko00071	Fatty acid metabolism	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMG200009052	K01897	ko01100	Metabolic pathways	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMG200009052	K01897	ko03320	PPAR signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMG200009052	K01897	ko04146	Peroxisome	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMG200009052	K01897	ko04920	Adipocytokine signaling pathway	2256	1.4e-118	0.51	0.69	0.99
PGSC0003DMG200009052	K01897	ko00071	Fatty acid metabolism	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMG200009052	K01897	ko01100	Metabolic pathways	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMG200009052	K01897	ko03320	PPAR signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMG200009052	K01897	ko04146	Peroxisome	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMG200009052	K01897	ko04920	Adipocytokine signaling pathway	1436	2.3e-73	0.51	0.70	0.97
PGSC0003DMG200009052	K01897	ko00071	Fatty acid metabolism	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMG200009052	K01897	ko01100	Metabolic pathways	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMG200009052	K01897	ko03320	PPAR signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMG200009052	K01897	ko04146	Peroxisome	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMG200009052	K01897	ko04920	Adipocytokine signaling pathway	2641	7.9e-140	0.49	0.69	1.00
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.70	0.79	0.73
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	1235	2.8e-62	0.69	0.78	0.74
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	839	1.9e-40	0.71	0.82	0.84
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	1333	1.1e-67	0.66	0.78	0.89
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	2855	1.2e-151	0.77	0.88	1.00
PGSC0003DMG200009061	K00619	ko00330	Arginine and proline metabolism	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMG200009061	K00619	ko01100	Metabolic pathways	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMG200009061	K00619	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.73	0.85	0.96
PGSC0003DMG200009063	K02898	ko03010	Ribosome	1137	7.1e-57	0.90	0.99	0.99
PGSC0003DMG200009064	K12867	ko03040	Spliceosome	532	4.0e-23	0.64	0.75	0.96
PGSC0003DMG200009066	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMG200009066	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMG200009066	K00734	ko01100	Metabolic pathways	232	5.8e-07	0.32	0.47	0.61
PGSC0003DMG200040993	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.45	0.63	0.89
PGSC0003DMG200041007	K01148	ko03018	RNA degradation	378	5.2e-15	0.50	0.66	0.59
PGSC0003DMG200020174	K12126	ko04712	Circadian rhythm - plant	308	3.2e-09	0.28	0.50	0.51
PGSC0003DMG200020175	K09561	ko04120	Ubiquitin mediated proteolysis	388	1.4e-15	0.77	0.89	0.67
PGSC0003DMG200020175	K09561	ko04120	Ubiquitin mediated proteolysis	1780	2.4e-92	0.77	0.86	0.98
PGSC0003DMG200020176	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMG200020176	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	487	5.0e-21	0.88	0.90	0.99
PGSC0003DMG200020176	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	458	2.0e-19	0.77	0.81	0.97
PGSC0003DMG200018584	K10158	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMG200018584	K10158	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMG200018584	K10158	ko01100	Metabolic pathways	290	3.7e-10	0.41	0.58	0.36
PGSC0003DMG200018584	K10157	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMG200018584	K10157	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMG200018584	K10157	ko01100	Metabolic pathways	419	2.8e-17	0.34	0.50	0.51
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.80	0.91	0.99
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	2137	4.9e-112	0.80	0.91	1.00
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	2235	1.9e-117	0.72	0.83	0.98
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	2162	2.1e-113	0.80	0.91	0.98
PGSC0003DMG200018587	K00826	ko00280	Valine, leucine and isoleucine degradation	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMG200018587	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMG200018587	K00826	ko00770	Pantothenate and CoA biosynthesis	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMG200018587	K00826	ko01100	Metabolic pathways	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMG200018587	K00826	ko01110	Biosynthesis of secondary metabolites	1948	1.3e-101	0.80	0.91	0.85
PGSC0003DMG200018591	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200018591	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200018591	K00079	ko00590	Arachidonic acid metabolism	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMG200018591	K00079	ko01100	Metabolic pathways	446	9.2e-19	0.44	0.57	0.98
PGSC0003DMG200018591	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200018591	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200018591	K00079	ko00590	Arachidonic acid metabolism	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200018591	K00079	ko01100	Metabolic pathways	672	3.1e-31	0.41	0.55	0.95
PGSC0003DMG200023476	K00423	ko00053	Ascorbate and aldarate metabolism	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMG200023476	K00423	ko01100	Metabolic pathways	3165	9.9e-169	0.66	0.81	0.97
PGSC0003DMG200023477	K02923	ko03010	Ribosome	524	4.6e-23	0.90	0.97	0.22
PGSC0003DMG200023477	K02923	ko03010	Ribosome	491	3.0e-21	0.91	0.97	0.84
PGSC0003DMG200023480	K13065	ko00940	Phenylpropanoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMG200023480	K13065	ko00941	Flavonoid biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMG200023480	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMG200023480	K13065	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.30	0.47	0.89
PGSC0003DMG200023481	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.63	0.80	0.46
PGSC0003DMG200023481	K01728	ko00040	Pentose and glucuronate interconversions	1752	8.5e-91	0.64	0.80	0.93
PGSC0003DMG200023481	K01728	ko00040	Pentose and glucuronate interconversions	1274	2.0e-64	0.60	0.78	0.88
PGSC0003DMG200023481	K01728	ko00040	Pentose and glucuronate interconversions	2009	5.7e-105	0.60	0.76	0.81
PGSC0003DMG200027133	K13030	ko00460	Cyanoamino acid metabolism	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMG200027133	K13030	ko01110	Biosynthesis of secondary metabolites	1008	9.2e-50	0.35	0.53	0.97
PGSC0003DMG200027133	K13030	ko00460	Cyanoamino acid metabolism	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMG200027133	K13030	ko01110	Biosynthesis of secondary metabolites	1009	8.1e-50	0.35	0.53	0.97
PGSC0003DMG200027133	K12356	ko00940	Phenylpropanoid biosynthesis	466	7.2e-20	0.38	0.57	0.94
PGSC0003DMG200027133	K13030	ko00460	Cyanoamino acid metabolism	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMG200027133	K13030	ko01110	Biosynthesis of secondary metabolites	1004	1.5e-49	0.35	0.53	0.97
PGSC0003DMG200027133	K12356	ko00940	Phenylpropanoid biosynthesis	464	9.3e-20	0.39	0.55	0.97
PGSC0003DMG200034328	K01834	ko00010	Glycolysis / Gluconeogenesis	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMG200034328	K01834	ko01100	Metabolic pathways	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMG200034328	K01834	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.34	0.51	0.76
PGSC0003DMG200029595	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMG200029595	K03434	ko01100	Metabolic pathways	1539	4.8e-79	0.70	0.85	1.00
PGSC0003DMG200029596	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.36	0.56	0.67
PGSC0003DMG200029599	K01509	ko00230	Purine metabolism	3627	3.3e-194	0.38	0.56	1.00
PGSC0003DMG200029600	K01509	ko00230	Purine metabolism	300	1.7e-09	0.52	0.68	0.57
PGSC0003DMG200026322	K11820	ko00380	Tryptophan metabolism	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMG200026322	K11820	ko00966	Glucosinolate biosynthesis	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMG200026322	K11820	ko01110	Biosynthesis of secondary metabolites	1351	1.1e-68	0.43	0.59	0.97
PGSC0003DMG200026322	K11820	ko00380	Tryptophan metabolism	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMG200026322	K11820	ko00966	Glucosinolate biosynthesis	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMG200026322	K11820	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.44	0.61	0.99
PGSC0003DMG200026323	K11820	ko00380	Tryptophan metabolism	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMG200026323	K11820	ko00966	Glucosinolate biosynthesis	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMG200026323	K11820	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.46	0.65	0.98
PGSC0003DMG200026325	K04733	ko04210	Apoptosis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMG200026325	K04733	ko04620	Toll-like receptor signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMG200026325	K04733	ko04722	Neurotrophin signaling pathway	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMG200026325	K04733	ko05140	Leishmaniasis	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMG200026325	K04733	ko05142	Chagas disease	1834	2.5e-95	0.42	0.57	0.99
PGSC0003DMG200026325	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko04210	Apoptosis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko04620	Toll-like receptor signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko04722	Neurotrophin signaling pathway	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko05140	Leishmaniasis	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026325	K04733	ko05142	Chagas disease	2068	3.2e-108	0.40	0.56	1.00
PGSC0003DMG200026328	K12857	ko03040	Spliceosome	2641	7.9e-140	0.88	0.94	1.00
PGSC0003DMG200026329	K13035	ko00460	Cyanoamino acid metabolism	2637	1.3e-139	0.87	0.93	1.00
PGSC0003DMG200026336	K12251	ko00330	Arginine and proline metabolism	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMG200026336	K12251	ko01100	Metabolic pathways	1686	3.7e-87	0.69	0.79	0.96
PGSC0003DMG200022537	K11424	ko00310	Lysine degradation	328	1.3e-08	0.44	0.53	0.12
PGSC0003DMG200022541	K00430	ko00360	Phenylalanine metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMG200022541	K00430	ko00680	Methane metabolism	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMG200022541	K00430	ko00940	Phenylpropanoid biosynthesis	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMG200022541	K00430	ko01100	Metabolic pathways	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMG200022541	K00430	ko01110	Biosynthesis of secondary metabolites	2030	3.9e-106	0.73	0.84	1.00
PGSC0003DMG200022548	K08492	ko04130	SNARE interactions in vesicular transport	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMG200022548	K08492	ko04145	Phagosome	2008	6.4e-105	0.76	0.89	1.00
PGSC0003DMG200046494	K12356	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.31	0.45	0.97
PGSC0003DMG200046498	K05282	ko00904	Diterpenoid biosynthesis	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMG200046498	K05282	ko01100	Metabolic pathways	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMG200046498	K05282	ko01110	Biosynthesis of secondary metabolites	257	2.4e-08	0.43	0.64	0.60
PGSC0003DMG200042431	K05282	ko00904	Diterpenoid biosynthesis	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMG200042431	K05282	ko01100	Metabolic pathways	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMG200042431	K05282	ko01110	Biosynthesis of secondary metabolites	383	2.7e-15	0.52	0.70	0.95
PGSC0003DMG200000905	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.81
PGSC0003DMG200000905	K12585	ko03018	RNA degradation	1536	4.6e-81	0.36	0.52	0.79
PGSC0003DMG200000905	K12585	ko03018	RNA degradation	1536	1.9e-81	0.35	0.51	0.75
PGSC0003DMG200000909	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000909	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000909	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000909	K01436	ko00330	Arginine and proline metabolism	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000909	K01436	ko01100	Metabolic pathways	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000909	K01436	ko01110	Biosynthesis of secondary metabolites	2564	1.4e-135	0.69	0.82	0.97
PGSC0003DMG200000914	K05366	ko00550	Peptidoglycan biosynthesis	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMG200000914	K05366	ko01100	Metabolic pathways	247	5.2e-07	0.42	0.60	0.54
PGSC0003DMG200000914	K05366	ko00550	Peptidoglycan biosynthesis	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMG200000914	K05366	ko01100	Metabolic pathways	342	1.2e-12	0.44	0.57	0.60
PGSC0003DMG200000914	K05366	ko00550	Peptidoglycan biosynthesis	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMG200000914	K05366	ko01100	Metabolic pathways	537	8.8e-24	0.39	0.55	0.92
PGSC0003DMG200000916	K03217	ko03060	Protein export	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMG200000916	K03217	ko03070	Bacterial secretion system	370	1.4e-14	0.28	0.45	0.52
PGSC0003DMG200000916	K03217	ko03060	Protein export	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMG200000916	K03217	ko03070	Bacterial secretion system	313	2.1e-11	0.28	0.45	0.70
PGSC0003DMG200012846	K03531	ko04112	Cell cycle - Caulobacter	1193	5.8e-60	0.75	0.83	0.92
PGSC0003DMG200012846	K03531	ko04112	Cell cycle - Caulobacter	2656	1.2e-140	0.79	0.86	1.00
PGSC0003DMG200012848	K00278	ko00250	Alanine, aspartate and glutamate metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMG200012848	K00278	ko00760	Nicotinate and nicotinamide metabolism	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMG200012848	K00278	ko01100	Metabolic pathways	2512	1.0e-132	0.85	0.91	0.99
PGSC0003DMG200012848	K00278	ko00250	Alanine, aspartate and glutamate metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMG200012848	K00278	ko00760	Nicotinate and nicotinamide metabolism	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMG200012848	K00278	ko01100	Metabolic pathways	1792	5.3e-93	0.74	0.84	0.96
PGSC0003DMG200012848	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko00250	Alanine, aspartate and glutamate metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko00760	Nicotinate and nicotinamide metabolism	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012848	K00278	ko01100	Metabolic pathways	4347	6.3e-234	0.80	0.88	1.00
PGSC0003DMG200012849	K08241	ko00592	alpha-Linolenic acid metabolism	799	3.1e-38	0.36	0.52	0.96
PGSC0003DMG200012854	K01126	ko00564	Glycerophospholipid metabolism	224	1.6e-06	0.38	0.50	0.42
PGSC0003DMG200012855	K01126	ko00564	Glycerophospholipid metabolism	448	1.3e-18	0.31	0.47	0.79
PGSC0003DMG200012856	K08503	ko04130	SNARE interactions in vesicular transport	943	3.5e-46	0.62	0.76	0.72
PGSC0003DMG200012856	K08503	ko04130	SNARE interactions in vesicular transport	1190	8.4e-60	0.63	0.82	1.00
PGSC0003DMG200005792	K00940	ko00230	Purine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMG200005792	K00940	ko00240	Pyrimidine metabolism	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMG200005792	K00940	ko01100	Metabolic pathways	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMG200005792	K00940	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.82	0.88	1.00
PGSC0003DMG200005792	K00940	ko00230	Purine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMG200005792	K00940	ko00240	Pyrimidine metabolism	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMG200005792	K00940	ko01100	Metabolic pathways	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMG200005792	K00940	ko01110	Biosynthesis of secondary metabolites	1243	1.0e-62	0.95	0.97	0.99
PGSC0003DMG200024222	K00558	ko00270	Cysteine and methionine metabolism	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMG200024222	K00558	ko01100	Metabolic pathways	412	9.2e-16	0.48	0.63	0.52
PGSC0003DMG200024224	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	1739	4.4e-90	0.76	0.87	0.95
PGSC0003DMG200024224	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	2578	2.3e-136	0.76	0.87	0.98
PGSC0003DMG200024224	K01836	ko00520	Amino sugar and nucleotide sugar metabolism	3071	1.5e-163	0.76	0.87	1.00
PGSC0003DMG200024226	K00948	ko00030	Pentose phosphate pathway	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMG200024226	K00948	ko00230	Purine metabolism	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMG200024226	K00948	ko01100	Metabolic pathways	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMG200024226	K00948	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.74	0.80	0.96
PGSC0003DMG200024226	K00948	ko00030	Pentose phosphate pathway	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMG200024226	K00948	ko00230	Purine metabolism	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMG200024226	K00948	ko01100	Metabolic pathways	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMG200024226	K00948	ko01110	Biosynthesis of secondary metabolites	2662	5.5e-141	0.81	0.87	0.99
PGSC0003DMG200024231	K02084	ko04115	p53 signaling pathway	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko04210	Apoptosis	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko05010	Alzheimer's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko05012	Parkinson's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko05016	Huntington's disease	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024231	K02084	ko05222	Small cell lung cancer	327	2.4e-09	0.27	0.46	0.67
PGSC0003DMG200024232	K00797	ko00270	Cysteine and methionine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMG200024232	K00797	ko00330	Arginine and proline metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMG200024232	K00797	ko00410	beta-Alanine metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMG200024232	K00797	ko00480	Glutathione metabolism	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMG200024232	K00797	ko01100	Metabolic pathways	2357	3.6e-124	0.87	0.95	1.00
PGSC0003DMG200024242	K13065	ko00940	Phenylpropanoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMG200024242	K13065	ko00941	Flavonoid biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMG200024242	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMG200024242	K13065	ko01110	Biosynthesis of secondary metabolites	422	1.9e-17	0.27	0.45	0.95
PGSC0003DMG200022017	K06627	ko04110	Cell cycle	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMG200022017	K06627	ko04914	Progesterone-mediated oocyte maturation	1588	9.4e-82	0.56	0.69	0.99
PGSC0003DMG200022022	K02693	ko00195	Photosynthesis	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMG200022022	K02693	ko01100	Metabolic pathways	708	3.2e-33	0.62	0.74	0.96
PGSC0003DMG200022023	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMG200022023	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMG200022023	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.96
PGSC0003DMG200022023	K00799	ko00480	Glutathione metabolism	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMG200022023	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMG200022023	K00799	ko00982	Drug metabolism - cytochrome P450	436	3.3e-18	0.55	0.71	0.80
PGSC0003DMG200022025	K11816	ko00380	Tryptophan metabolism	2608	5.2e-138	0.72	0.86	0.99
PGSC0003DMG200022026	K11816	ko00380	Tryptophan metabolism	999	2.9e-49	0.41	0.51	0.94
PGSC0003DMG200025167	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00350	Tyrosine metabolism	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00624	1- and 2-Methylnaphthalene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00632	Benzoate degradation via CoA ligation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00642	Ethylbenzene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025167	K00680	ko00903	Limonene and pinene degradation	654	3.1e-30	0.34	0.51	0.88
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	3974	2.4e-213	0.70	0.84	0.99
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	3297	5.2e-176	0.70	0.85	0.99
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	2782	1.3e-147	0.70	0.83	1.00
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	2097	8.0e-110	0.73	0.84	1.00
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	1801	1.7e-93	0.76	0.86	1.00
PGSC0003DMG200025174	K01897	ko00071	Fatty acid metabolism	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMG200025174	K01897	ko01100	Metabolic pathways	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMG200025174	K01897	ko03320	PPAR signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMG200025174	K01897	ko04146	Peroxisome	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMG200025174	K01897	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.74	0.86	0.91
PGSC0003DMG200031307	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMG200031307	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMG200031307	K11420	ko00310	Lysine degradation	697	4.7e-32	0.38	0.50	0.48
PGSC0003DMG200031310	K06654	ko04111	Cell cycle - yeast	332	1.8e-12	0.35	0.53	0.74
PGSC0003DMG200031320	K06685	ko04111	Cell cycle - yeast	312	4.7e-09	0.31	0.49	0.65
PGSC0003DMG200030679	K01613	ko00564	Glycerophospholipid metabolism	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMG200030679	K01613	ko01100	Metabolic pathways	290	2.6e-09	0.36	0.53	0.46
PGSC0003DMG200030682	K01507	ko00190	Oxidative phosphorylation	5771	0.	0.91	0.95	1.00
PGSC0003DMG200030683	K12586	ko03018	RNA degradation	923	1.4e-44	0.42	0.57	0.86
PGSC0003DMG200038504	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMG200038504	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.39	0.49	0.60
PGSC0003DMG200038521	K10760	ko00908	Zeatin biosynthesis	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMG200038521	K10760	ko01100	Metabolic pathways	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMG200038521	K10760	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.53	0.72	1.00
PGSC0003DMG200014617	K13068	ko00940	Phenylpropanoid biosynthesis	1919	5.2e-100	0.51	0.69	0.94
PGSC0003DMG200014619	K12235	ko00260	Glycine, serine and threonine metabolism	1973	5.5e-103	0.72	0.84	0.99
PGSC0003DMG200014619	K12235	ko00260	Glycine, serine and threonine metabolism	340	6.4e-13	0.67	0.80	0.95
PGSC0003DMG200014622	K01649	ko00290	Valine, leucine and isoleucine biosynthesis	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMG200014622	K01649	ko00620	Pyruvate metabolism	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMG200014622	K01649	ko01100	Metabolic pathways	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMG200014622	K01649	ko01110	Biosynthesis of secondary metabolites	3373	3.3e-180	0.78	0.90	0.99
PGSC0003DMG200014624	K02358	ko04626	Plant-pathogen interaction	2244	6.2e-118	0.88	0.92	0.94
PGSC0003DMG200014624	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMG200014624	K02358	ko04626	Plant-pathogen interaction	3334	4.7e-178	0.89	0.93	1.00
PGSC0003DMG200014627	K00799	ko00480	Glutathione metabolism	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMG200014627	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMG200014627	K00799	ko00982	Drug metabolism - cytochrome P450	1071	3.1e-53	0.61	0.76	0.99
PGSC0003DMG200003871	K01728	ko00040	Pentose and glucuronate interconversions	2029	4.5e-106	0.65	0.77	0.83
PGSC0003DMG200003874	K12826	ko03040	Spliceosome	2641	7.9e-140	0.84	0.89	1.00
PGSC0003DMG200007037	K08770	ko03320	PPAR signaling pathway	289	8.8e-10	0.30	0.51	0.37
PGSC0003DMG200007051	K02926	ko03010	Ribosome	1383	1.9e-70	0.73	0.84	0.66
PGSC0003DMG200007054	K12831	ko03040	Spliceosome	247	9.6e-08	0.43	0.54	0.39
PGSC0003DMG200024552	K08509	ko04130	SNARE interactions in vesicular transport	1532	1.2e-78	0.63	0.77	1.00
PGSC0003DMG200024554	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.65
PGSC0003DMG200024554	K12126	ko04712	Circadian rhythm - plant	531	1.9e-23	0.37	0.51	0.61
PGSC0003DMG200024556	K00485	ko00982	Drug metabolism - cytochrome P450	1382	2.2e-70	0.53	0.70	0.97
PGSC0003DMG200024556	K00485	ko00982	Drug metabolism - cytochrome P450	1611	5.1e-83	0.52	0.69	0.96
PGSC0003DMG200024556	K00485	ko00982	Drug metabolism - cytochrome P450	1737	5.7e-90	0.50	0.67	0.95
PGSC0003DMG200024556	K00485	ko00982	Drug metabolism - cytochrome P450	688	4.1e-32	0.50	0.65	0.92
PGSC0003DMG200024557	K01956	ko00240	Pyrimidine metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMG200024557	K01956	ko00250	Alanine, aspartate and glutamate metabolism	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMG200024557	K01956	ko01100	Metabolic pathways	2948	9.2e-157	0.83	0.91	0.95
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1938	4.7e-101	0.31	0.44	0.76
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMG200024560	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1912	1.3e-99	0.31	0.44	0.76
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1928	1.7e-100	0.31	0.44	0.76
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1923	3.1e-100	0.31	0.44	0.76
PGSC0003DMG200024560	K02184	ko04320	Dorso-ventral axis formation	1922	3.6e-100	0.31	0.44	0.76
PGSC0003DMG200024560	K04512	ko04310	Wnt signaling pathway	651	4.5e-30	0.35	0.58	0.98
PGSC0003DMG200024561	K07198	ko04140	Regulation of autophagy	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMG200024561	K07198	ko04150	mTOR signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMG200024561	K07198	ko04910	Insulin signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMG200024561	K07198	ko04920	Adipocytokine signaling pathway	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMG200024561	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2425	6.5e-128	0.81	0.90	0.96
PGSC0003DMG200024561	K07198	ko04140	Regulation of autophagy	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMG200024561	K07198	ko04150	mTOR signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMG200024561	K07198	ko04910	Insulin signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMG200024561	K07198	ko04920	Adipocytokine signaling pathway	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMG200024561	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2719	3.9e-144	0.67	0.74	0.99
PGSC0003DMG200024561	K07198	ko04140	Regulation of autophagy	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMG200024561	K07198	ko04150	mTOR signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMG200024561	K07198	ko04910	Insulin signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMG200024561	K07198	ko04920	Adipocytokine signaling pathway	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMG200024561	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2929	1.0e-155	0.70	0.79	0.99
PGSC0003DMG200024561	K07198	ko04140	Regulation of autophagy	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMG200024561	K07198	ko04150	mTOR signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMG200024561	K07198	ko04910	Insulin signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMG200024561	K07198	ko04920	Adipocytokine signaling pathway	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMG200024561	K07198	ko05410	Hypertrophic cardiomyopathy (HCM)	2461	6.7e-130	0.70	0.80	0.95
PGSC0003DMG200021276	K00815	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00270	Cysteine and methionine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00350	Tyrosine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00360	Phenylalanine metabolism	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00401	Novobiocin biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00950	Isoquinoline alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko01100	Metabolic pathways	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021276	K00815	ko01110	Biosynthesis of secondary metabolites	2668	2.6e-141	0.74	0.90	0.97
PGSC0003DMG200021277	K07466	ko03030	DNA replication	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMG200021277	K07466	ko03420	Nucleotide excision repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMG200021277	K07466	ko03430	Mismatch repair	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMG200021277	K07466	ko03440	Homologous recombination	739	6.3e-35	0.65	0.78	0.99
PGSC0003DMG200021281	K10955	ko05110	Vibrio cholerae infection	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMG200021281	K10955	ko05146	Amoebiasis	620	1.1e-26	0.36	0.45	0.72
PGSC0003DMG200021283	K00948	ko00030	Pentose phosphate pathway	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMG200021283	K00948	ko00230	Purine metabolism	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMG200021283	K00948	ko01100	Metabolic pathways	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMG200021283	K00948	ko01110	Biosynthesis of secondary metabolites	333	1.6e-12	0.35	0.52	0.99
PGSC0003DMG200021283	K00948	ko00030	Pentose phosphate pathway	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMG200021283	K00948	ko00230	Purine metabolism	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMG200021283	K00948	ko01100	Metabolic pathways	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMG200021283	K00948	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.30	0.48	1.00
PGSC0003DMG200021287	K08909	ko00196	Photosynthesis - antenna proteins	2026	6.6e-106	0.86	0.94	1.00
PGSC0003DMG200021289	K03009	ko00230	Purine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMG200021289	K03009	ko00240	Pyrimidine metabolism	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMG200021289	K03009	ko01100	Metabolic pathways	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMG200021289	K03009	ko03020	RNA polymerase	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMG200021289	K03009	ko05016	Huntington's disease	386	1.9e-15	0.88	0.92	0.82
PGSC0003DMG200021289	K03009	ko00230	Purine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMG200021289	K03009	ko00240	Pyrimidine metabolism	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMG200021289	K03009	ko01100	Metabolic pathways	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMG200021289	K03009	ko03020	RNA polymerase	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMG200021289	K03009	ko05016	Huntington's disease	440	2.0e-18	0.96	0.96	0.98
PGSC0003DMG200021292	K04125	ko00904	Diterpenoid biosynthesis	1547	1.7e-79	0.59	0.74	0.99
PGSC0003DMG200033018	K12741	ko03040	Spliceosome	322	6.3e-12	0.52	0.87	0.60
PGSC0003DMG200033028	K00130	ko00260	Glycine, serine and threonine metabolism	3163	1.3e-168	0.72	0.87	0.99
PGSC0003DMG200033031	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMG200033031	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMG200033031	K03877	ko01100	Metabolic pathways	243	4.1e-07	0.29	0.48	0.29
PGSC0003DMG200033031	K03877	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMG200033031	K03877	ko00603	Glycosphingolipid biosynthesis - globo series	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMG200033031	K03877	ko01100	Metabolic pathways	418	4.2e-17	0.30	0.50	0.39
PGSC0003DMG200006741	K04354	ko04111	Cell cycle - yeast	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMG200006741	K04354	ko04530	Tight junction	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMG200006741	K04354	ko05142	Chagas disease	3847	2.4e-206	0.85	0.90	0.99
PGSC0003DMG200006741	K04354	ko04111	Cell cycle - yeast	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMG200006741	K04354	ko04530	Tight junction	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMG200006741	K04354	ko05142	Chagas disease	3901	2.5e-209	0.90	0.94	0.99
PGSC0003DMG200006745	K10875	ko03440	Homologous recombination	610	8.3e-28	0.29	0.47	0.75
PGSC0003DMG200006747	K10875	ko03440	Homologous recombination	678	1.1e-36	0.31	0.51	0.42
PGSC0003DMG200006749	K10841	ko03420	Nucleotide excision repair	1469	3.5e-75	0.31	0.47	0.85
PGSC0003DMG200006751	K10260	ko04120	Ubiquitin mediated proteolysis	335	1.2e-12	0.29	0.46	0.80
PGSC0003DMG200013919	K02335	ko00230	Purine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko00240	Pyrimidine metabolism	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko01100	Metabolic pathways	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko03030	DNA replication	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko03410	Base excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko03420	Nucleotide excision repair	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko03440	Homologous recombination	3906	1.3e-209	0.66	0.76	0.75
PGSC0003DMG200013919	K02335	ko00230	Purine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko00240	Pyrimidine metabolism	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko01100	Metabolic pathways	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko03030	DNA replication	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko03410	Base excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko03420	Nucleotide excision repair	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013919	K02335	ko03440	Homologous recombination	4898	2.6e-264	0.71	0.82	0.73
PGSC0003DMG200013927	K08769	ko03320	PPAR signaling pathway	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMG200013927	K08769	ko05016	Huntington's disease	774	7.4e-37	0.43	0.60	0.92
PGSC0003DMG200013927	K08769	ko03320	PPAR signaling pathway	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMG200013927	K08769	ko05016	Huntington's disease	976	5.4e-48	0.47	0.64	0.85
PGSC0003DMG200013927	K08769	ko03320	PPAR signaling pathway	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMG200013927	K08769	ko05016	Huntington's disease	994	5.5e-49	0.48	0.64	0.95
PGSC0003DMG200013929	K05280	ko00941	Flavonoid biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMG200013929	K05280	ko00944	Flavone and flavonol biosynthesis	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMG200013929	K05280	ko01100	Metabolic pathways	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMG200013929	K05280	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.41	0.62	0.92
PGSC0003DMG200013933	K00939	ko00230	Purine metabolism	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMG200013933	K00939	ko01100	Metabolic pathways	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMG200013933	K00939	ko01110	Biosynthesis of secondary metabolites	1371	8.8e-70	0.66	0.77	0.89
PGSC0003DMG200013933	K00939	ko00230	Purine metabolism	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMG200013933	K00939	ko01100	Metabolic pathways	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMG200013933	K00939	ko01110	Biosynthesis of secondary metabolites	1461	9.5e-75	0.67	0.81	0.90
PGSC0003DMG200013935	K01239	ko00230	Purine metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMG200013935	K01239	ko00760	Nicotinate and nicotinamide metabolism	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMG200013935	K01239	ko01100	Metabolic pathways	762	3.4e-36	0.50	0.59	0.70
PGSC0003DMG200007769	K12197	ko04144	Endocytosis	1314	1.2e-66	0.79	0.90	1.00
PGSC0003DMG200007782	K00688	ko00500	Starch and sucrose metabolism	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMG200007782	K00688	ko04910	Insulin signaling pathway	2588	6.6e-137	0.75	0.83	1.00
PGSC0003DMG200007786	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMG200007786	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMG200007786	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.81
PGSC0003DMG200007786	K00799	ko00480	Glutathione metabolism	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMG200007786	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMG200007786	K00799	ko00982	Drug metabolism - cytochrome P450	794	5.9e-38	0.47	0.66	0.92
PGSC0003DMG200007787	K08909	ko00196	Photosynthesis - antenna proteins	2011	4.4e-105	0.84	0.91	1.00
PGSC0003DMG200004570	K05755	ko04666	Fc gamma R-mediated phagocytosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMG200004570	K05755	ko04810	Regulation of actin cytoskeleton	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMG200004570	K05755	ko05100	Bacterial invasion of epithelial cells	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMG200004570	K05755	ko05130	Pathogenic Escherichia coli infection	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMG200004570	K05755	ko05131	Shigellosis	1005	1.3e-49	0.94	0.98	0.93
PGSC0003DMG200004570	K05755	ko04666	Fc gamma R-mediated phagocytosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMG200004570	K05755	ko04810	Regulation of actin cytoskeleton	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMG200004570	K05755	ko05100	Bacterial invasion of epithelial cells	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMG200004570	K05755	ko05130	Pathogenic Escherichia coli infection	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMG200004570	K05755	ko05131	Shigellosis	603	2.0e-27	0.97	1.00	0.99
PGSC0003DMG200004572	K01251	ko00270	Cysteine and methionine metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMG200004572	K01251	ko00450	Selenoamino acid metabolism	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMG200004572	K01251	ko01100	Metabolic pathways	1899	6.6e-99	0.95	0.97	0.84
PGSC0003DMG200004572	K01251	ko00270	Cysteine and methionine metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMG200004572	K01251	ko00450	Selenoamino acid metabolism	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMG200004572	K01251	ko01100	Metabolic pathways	3899	3.2e-209	0.94	0.97	1.00
PGSC0003DMG200004572	K01251	ko00270	Cysteine and methionine metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMG200004572	K01251	ko00450	Selenoamino acid metabolism	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMG200004572	K01251	ko01100	Metabolic pathways	1873	1.8e-97	0.94	0.97	1.00
PGSC0003DMG200004573	K12338	ko00942	Anthocyanin biosynthesis	451	4.9e-19	0.46	0.66	0.85
PGSC0003DMG200004573	K12338	ko00942	Anthocyanin biosynthesis	1669	3.2e-86	0.47	0.65	0.98
PGSC0003DMG200004573	K12338	ko00942	Anthocyanin biosynthesis	1225	9.9e-62	0.48	0.64	0.97
PGSC0003DMG200004574	K12338	ko00942	Anthocyanin biosynthesis	937	7.6e-46	0.46	0.65	0.98
PGSC0003DMG200004574	K12338	ko00942	Anthocyanin biosynthesis	1408	8.0e-72	0.41	0.62	0.97
PGSC0003DMG200004580	K12126	ko04712	Circadian rhythm - plant	314	2.2e-11	0.29	0.47	0.72
PGSC0003DMG200004580	K12126	ko04712	Circadian rhythm - plant	314	6.5e-11	0.29	0.47	0.66
PGSC0003DMG200004581	K12462	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMG200004581	K12462	ko04962	Vasopressin-regulated water reabsorption	799	3.1e-38	0.56	0.74	0.86
PGSC0003DMG200013248	K00454	ko00591	Linoleic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMG200013248	K00454	ko00592	alpha-Linolenic acid metabolism	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMG200013248	K00454	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.64	0.99
PGSC0003DMG200013248	K00454	ko00591	Linoleic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMG200013248	K00454	ko00592	alpha-Linolenic acid metabolism	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMG200013248	K00454	ko01100	Metabolic pathways	2849	2.7e-151	0.72	0.86	1.00
PGSC0003DMG200013248	K00454	ko00591	Linoleic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMG200013248	K00454	ko00592	alpha-Linolenic acid metabolism	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMG200013248	K00454	ko01100	Metabolic pathways	626	1.2e-28	0.64	0.83	0.98
PGSC0003DMG200013248	K00454	ko00591	Linoleic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMG200013248	K00454	ko00592	alpha-Linolenic acid metabolism	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMG200013248	K00454	ko01100	Metabolic pathways	2088	2.5e-109	0.74	0.87	1.00
PGSC0003DMG200043537	K00021	ko00900	Terpenoid backbone biosynthesis	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200043537	K00021	ko01100	Metabolic pathways	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200043537	K00021	ko01110	Biosynthesis of secondary metabolites	892	2.3e-43	0.82	0.95	0.89
PGSC0003DMG200043544	K05868	ko04110	Cell cycle	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMG200043544	K05868	ko04115	p53 signaling pathway	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMG200043544	K05868	ko04914	Progesterone-mediated oocyte maturation	1674	1.7e-86	0.62	0.79	0.98
PGSC0003DMG200039702	K03006	ko00230	Purine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMG200039702	K03006	ko00240	Pyrimidine metabolism	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMG200039702	K03006	ko01100	Metabolic pathways	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMG200039702	K03006	ko03020	RNA polymerase	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMG200039702	K03006	ko05016	Huntington's disease	645	1.2e-28	0.32	0.43	0.89
PGSC0003DMG200001368	K04733	ko04210	Apoptosis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMG200001368	K04733	ko04620	Toll-like receptor signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMG200001368	K04733	ko04722	Neurotrophin signaling pathway	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMG200001368	K04733	ko05140	Leishmaniasis	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMG200001368	K04733	ko05142	Chagas disease	3135	4.5e-167	0.49	0.64	0.99
PGSC0003DMG200001368	K04733	ko04210	Apoptosis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMG200001368	K04733	ko04620	Toll-like receptor signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMG200001368	K04733	ko04722	Neurotrophin signaling pathway	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMG200001368	K04733	ko05140	Leishmaniasis	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMG200001368	K04733	ko05142	Chagas disease	2273	1.6e-119	0.50	0.64	0.97
PGSC0003DMG200001369	K04733	ko04210	Apoptosis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMG200001369	K04733	ko04620	Toll-like receptor signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMG200001369	K04733	ko04722	Neurotrophin signaling pathway	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMG200001369	K04733	ko05140	Leishmaniasis	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMG200001369	K04733	ko05142	Chagas disease	422	7.0e-17	0.45	0.64	0.67
PGSC0003DMG200001369	K04733	ko04210	Apoptosis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMG200001369	K04733	ko04620	Toll-like receptor signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMG200001369	K04733	ko04722	Neurotrophin signaling pathway	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMG200001369	K04733	ko05140	Leishmaniasis	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMG200001369	K04733	ko05142	Chagas disease	2919	3.7e-155	0.46	0.62	0.99
PGSC0003DMG200001369	K04733	ko04210	Apoptosis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMG200001369	K04733	ko04620	Toll-like receptor signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMG200001369	K04733	ko04722	Neurotrophin signaling pathway	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMG200001369	K04733	ko05140	Leishmaniasis	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMG200001369	K04733	ko05142	Chagas disease	762	3.4e-36	0.46	0.63	0.99
PGSC0003DMG200001374	K12640	ko00905	Brassinosteroid biosynthesis	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMG200001374	K12640	ko01100	Metabolic pathways	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMG200001374	K12640	ko01110	Biosynthesis of secondary metabolites	2717	5.1e-144	0.70	0.84	0.97
PGSC0003DMG200001380	K05746	ko04810	Regulation of actin cytoskeleton	461	2.7e-19	0.38	0.44	0.59
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	2418	1.6e-127	0.79	0.90	0.98
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	4346	7.2e-234	0.78	0.86	1.00
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	4598	9.1e-248	0.80	0.88	1.00
PGSC0003DMG200030306	K12605	ko03018	RNA degradation	482	9.5e-21	0.81	0.91	0.72
PGSC0003DMG200030312	K11252	ko05322	Systemic lupus erythematosus	1138	6.2e-57	0.95	0.97	0.99
PGSC0003DMG200030313	K01227	ko00511	Other glycan degradation	414	5.0e-16	0.29	0.47	0.73
PGSC0003DMG200030319	K05692	ko04145	Phagosome	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04510	Focal adhesion	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04520	Adherens junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04530	Tight junction	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04670	Leukocyte transendothelial migration	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04745	Phototransduction - fly	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04810	Regulation of actin cytoskeleton	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05100	Bacterial invasion of epithelial cells	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05110	Vibrio cholerae infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05130	Pathogenic Escherichia coli infection	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05131	Shigellosis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05414	Dilated cardiomyopathy	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05416	Viral myocarditis	3161	1.6e-168	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04145	Phagosome	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04510	Focal adhesion	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04520	Adherens junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04530	Tight junction	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04670	Leukocyte transendothelial migration	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04745	Phototransduction - fly	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko04810	Regulation of actin cytoskeleton	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05100	Bacterial invasion of epithelial cells	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05110	Vibrio cholerae infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05130	Pathogenic Escherichia coli infection	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05131	Shigellosis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05414	Dilated cardiomyopathy	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200030319	K05692	ko05416	Viral myocarditis	2763	1.5e-146	0.98	0.99	1.00
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMG200018851	K01444	ko04142	Lysosome	472	3.4e-20	0.80	0.91	0.97
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMG200018851	K01444	ko04142	Lysosome	575	7.0e-26	0.81	0.91	0.98
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMG200018851	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMG200018851	K01444	ko04142	Lysosome	2225	6.9e-117	0.75	0.87	0.98
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMG200018851	K01444	ko04142	Lysosome	1650	3.6e-85	0.75	0.88	0.99
PGSC0003DMG200018851	K01444	ko00511	Other glycan degradation	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMG200018851	K01444	ko04142	Lysosome	852	3.7e-41	0.68	0.85	0.99
PGSC0003DMG200018852	K05732	ko04510	Focal adhesion	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMG200018852	K05732	ko04670	Leukocyte transendothelial migration	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMG200018852	K05732	ko04810	Regulation of actin cytoskeleton	320	9.7e-11	0.31	0.49	0.59
PGSC0003DMG200018854	K08139	ko04113	Meiosis - yeast	223	4.8e-06	0.35	0.52	0.80
PGSC0003DMG200018859	K01066	ko00623	2,4-Dichlorobenzoate degradation	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMG200018859	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	210	9.5e-06	0.33	0.48	0.62
PGSC0003DMG200023293	K01190	ko00052	Galactose metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMG200023293	K01190	ko00511	Other glycan degradation	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMG200023293	K01190	ko00600	Sphingolipid metabolism	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMG200023293	K01190	ko01100	Metabolic pathways	2624	6.8e-139	0.49	0.64	0.87
PGSC0003DMG200023297	K06611	ko00052	Galactose metabolism	426	2.9e-17	0.37	0.55	0.91
PGSC0003DMG200023299	K12796	ko04621	NOD-like receptor signaling pathway	396	5.0e-15	0.31	0.47	0.95
PGSC0003DMG200027007	K02980	ko03010	Ribosome	512	2.1e-22	0.96	0.98	0.98
PGSC0003DMG200027008	K06172	ko04330	Notch signaling pathway	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMG200027008	K06172	ko05010	Alzheimer's disease	415	4.7e-17	0.32	0.50	0.93
PGSC0003DMG200027008	K06172	ko04330	Notch signaling pathway	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMG200027008	K06172	ko05010	Alzheimer's disease	228	9.7e-07	0.35	0.50	0.87
PGSC0003DMG200027010	K02964	ko03010	Ribosome	1223	1.3e-61	0.93	0.98	0.66
PGSC0003DMG200027014	K10206	ko00300	Lysine biosynthesis	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMG200027014	K10206	ko01110	Biosynthesis of secondary metabolites	2804	8.0e-149	0.85	0.94	1.00
PGSC0003DMG200027014	K10206	ko00300	Lysine biosynthesis	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMG200027014	K10206	ko01110	Biosynthesis of secondary metabolites	3120	3.0e-166	0.77	0.89	1.00
PGSC0003DMG200027017	K12135	ko04712	Circadian rhythm - plant	318	1.1e-11	0.31	0.49	0.83
PGSC0003DMG200015043	K08734	ko03430	Mismatch repair	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMG200015043	K08734	ko05200	Pathways in cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMG200015043	K08734	ko05210	Colorectal cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMG200015043	K08734	ko05213	Endometrial cancer	1257	1.7e-63	0.75	0.83	1.00
PGSC0003DMG200015043	K08734	ko03430	Mismatch repair	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMG200015043	K08734	ko05200	Pathways in cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMG200015043	K08734	ko05210	Colorectal cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMG200015043	K08734	ko05213	Endometrial cancer	4625	2.9e-249	0.76	0.86	0.99
PGSC0003DMG200015043	K08734	ko03430	Mismatch repair	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMG200015043	K08734	ko05200	Pathways in cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMG200015043	K08734	ko05210	Colorectal cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMG200015043	K08734	ko05213	Endometrial cancer	2079	7.8e-109	0.74	0.85	1.00
PGSC0003DMG200015043	K08734	ko03430	Mismatch repair	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMG200015043	K08734	ko05200	Pathways in cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMG200015043	K08734	ko05210	Colorectal cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMG200015043	K08734	ko05213	Endometrial cancer	464	9.3e-20	0.83	0.94	0.98
PGSC0003DMG200015043	K08734	ko03430	Mismatch repair	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMG200015043	K08734	ko05200	Pathways in cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMG200015043	K08734	ko05210	Colorectal cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMG200015043	K08734	ko05213	Endometrial cancer	830	6.1e-40	0.74	0.88	0.91
PGSC0003DMG200015051	K11821	ko00380	Tryptophan metabolism	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMG200015051	K11821	ko00966	Glucosinolate biosynthesis	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMG200015051	K11821	ko01110	Biosynthesis of secondary metabolites	532	1.7e-23	0.42	0.65	0.97
PGSC0003DMG200015051	K11821	ko00380	Tryptophan metabolism	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMG200015051	K11821	ko00966	Glucosinolate biosynthesis	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMG200015051	K11821	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.41	0.61	0.99
PGSC0003DMG200015059	K02948	ko03010	Ribosome	569	1.5e-25	0.87	0.90	0.57
PGSC0003DMG200015061	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMG200015061	K00517	ko00626	Naphthalene and anthracene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMG200015061	K00517	ko00903	Limonene and pinene degradation	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMG200015061	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMG200015061	K00517	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.43	0.61	0.98
PGSC0003DMG200015062	K02704	ko00195	Photosynthesis	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMG200015062	K02704	ko01100	Metabolic pathways	628	8.4e-29	0.75	0.78	0.37
PGSC0003DMG200012188	K04371	ko04010	MAPK signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04012	ErbB signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04013	MAPK signaling pathway - fly	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04062	Chemokine signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04114	Oocyte meiosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04150	mTOR signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04270	Vascular smooth muscle contraction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04320	Dorso-ventral axis formation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04350	TGF-beta signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04360	Axon guidance	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04370	VEGF signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04510	Focal adhesion	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04520	Adherens junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04540	Gap junction	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04620	Toll-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04621	NOD-like receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04650	Natural killer cell mediated cytotoxicity	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04660	T cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04662	B cell receptor signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04664	Fc epsilon RI signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04666	Fc gamma R-mediated phagocytosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04720	Long-term potentiation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04722	Neurotrophin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04730	Long-term depression	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04810	Regulation of actin cytoskeleton	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04910	Insulin signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04912	GnRH signaling pathway	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04914	Progesterone-mediated oocyte maturation	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04916	Melanogenesis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04930	Type II diabetes mellitus	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05010	Alzheimer's disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05020	Prion diseases	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05131	Shigellosis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05140	Leishmaniasis	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05142	Chagas disease	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05200	Pathways in cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05210	Colorectal cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05211	Renal cell carcinoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05212	Pancreatic cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05213	Endometrial cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05214	Glioma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05215	Prostate cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05216	Thyroid cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05218	Melanoma	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05219	Bladder cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05220	Chronic myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05221	Acute myeloid leukemia	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012188	K04371	ko05223	Non-small cell lung cancer	2787	7.0e-148	0.87	0.94	0.96
PGSC0003DMG200012191	K01834	ko00010	Glycolysis / Gluconeogenesis	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMG200012191	K01834	ko01100	Metabolic pathways	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMG200012191	K01834	ko01110	Biosynthesis of secondary metabolites	380	4.0e-15	0.33	0.48	0.68
PGSC0003DMG200012191	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMG200012191	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMG200012191	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.37	0.52	0.54
PGSC0003DMG200012191	K01834	ko00010	Glycolysis / Gluconeogenesis	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMG200012191	K01834	ko01100	Metabolic pathways	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMG200012191	K01834	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.37	0.54	0.56
PGSC0003DMG200012194	K12392	ko04142	Lysosome	6726	0.	0.90	0.94	1.00
PGSC0003DMG200012198	K10576	ko04120	Ubiquitin mediated proteolysis	1429	5.6e-73	0.89	0.94	0.99
PGSC0003DMG200012199	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMG200012199	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.98
PGSC0003DMG200012199	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMG200012199	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.80
PGSC0003DMG200012199	K01256	ko00480	Glutathione metabolism	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMG200012199	K01256	ko01100	Metabolic pathways	2792	3.7e-148	0.82	0.90	0.79
PGSC0003DMG200012199	K01256	ko00480	Glutathione metabolism	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMG200012199	K01256	ko01100	Metabolic pathways	2781	1.5e-147	0.82	0.90	0.98
PGSC0003DMG200012200	K03006	ko00230	Purine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMG200012200	K03006	ko00240	Pyrimidine metabolism	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMG200012200	K03006	ko01100	Metabolic pathways	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMG200012200	K03006	ko03020	RNA polymerase	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMG200012200	K03006	ko05016	Huntington's disease	289	4.8e-07	0.33	0.48	0.45
PGSC0003DMG200012200	K03006	ko00230	Purine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMG200012200	K03006	ko00240	Pyrimidine metabolism	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMG200012200	K03006	ko01100	Metabolic pathways	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMG200012200	K03006	ko03020	RNA polymerase	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMG200012200	K03006	ko05016	Huntington's disease	289	1.4e-07	0.33	0.48	0.51
PGSC0003DMG200012202	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMG200012202	K00517	ko00626	Naphthalene and anthracene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMG200012202	K00517	ko00903	Limonene and pinene degradation	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMG200012202	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMG200012202	K00517	ko01110	Biosynthesis of secondary metabolites	3337	3.2e-178	0.71	0.84	1.00
PGSC0003DMG200012203	K04421	ko04010	MAPK signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMG200012203	K04421	ko04722	Neurotrophin signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMG200012203	K04421	ko04912	GnRH signaling pathway	1007	1.0e-49	0.36	0.50	0.59
PGSC0003DMG200005099	K08775	ko03440	Homologous recombination	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMG200005099	K08775	ko05200	Pathways in cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMG200005099	K08775	ko05212	Pancreatic cancer	2303	3.5e-121	0.44	0.59	1.00
PGSC0003DMG200005105	K00511	ko00100	Steroid biosynthesis	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMG200005105	K00511	ko01100	Metabolic pathways	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMG200005105	K00511	ko01110	Biosynthesis of secondary metabolites	1853	2.3e-96	0.53	0.65	0.99
PGSC0003DMG200005105	K00511	ko00100	Steroid biosynthesis	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMG200005105	K00511	ko01100	Metabolic pathways	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMG200005105	K00511	ko01110	Biosynthesis of secondary metabolites	266	1.6e-08	0.58	0.85	0.83
PGSC0003DMG200008915	K04683	ko04110	Cell cycle	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMG200008915	K04683	ko04350	TGF-beta signaling pathway	597	4.3e-27	0.42	0.63	0.85
PGSC0003DMG200008915	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMG200008915	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMG200008915	K00771	ko01100	Metabolic pathways	480	2.9e-20	0.31	0.50	0.77
PGSC0003DMG200008917	K03283	ko03040	Spliceosome	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMG200008917	K03283	ko04010	MAPK signaling pathway	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMG200008917	K03283	ko04144	Endocytosis	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMG200008917	K03283	ko04612	Antigen processing and presentation	5197	8.3e-281	0.95	0.98	1.00
PGSC0003DMG200008918	K12862	ko03040	Spliceosome	2006	8.3e-105	0.76	0.85	0.98
PGSC0003DMG200008921	K12492	ko04144	Endocytosis	2778	2.2e-147	0.71	0.80	1.00
PGSC0003DMG200008922	K03014	ko00230	Purine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMG200008922	K03014	ko00240	Pyrimidine metabolism	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMG200008922	K03014	ko01100	Metabolic pathways	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMG200008922	K03014	ko03020	RNA polymerase	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMG200008922	K03014	ko05016	Huntington's disease	793	6.7e-38	0.80	0.86	0.94
PGSC0003DMG200008922	K03014	ko00230	Purine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMG200008922	K03014	ko00240	Pyrimidine metabolism	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMG200008922	K03014	ko01100	Metabolic pathways	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMG200008922	K03014	ko03020	RNA polymerase	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMG200008922	K03014	ko05016	Huntington's disease	991	8.0e-49	0.83	0.88	0.99
PGSC0003DMG200008928	K05765	ko04360	Axon guidance	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMG200008928	K05765	ko04666	Fc gamma R-mediated phagocytosis	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMG200008928	K05765	ko04810	Regulation of actin cytoskeleton	1049	5.1e-52	0.91	0.98	0.99
PGSC0003DMG200008928	K05765	ko04360	Axon guidance	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMG200008928	K05765	ko04666	Fc gamma R-mediated phagocytosis	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMG200008928	K05765	ko04810	Regulation of actin cytoskeleton	1104	4.7e-55	0.91	0.98	0.99
PGSC0003DMG200008930	K11251	ko05322	Systemic lupus erythematosus	1112	1.7e-55	0.95	0.97	0.97
PGSC0003DMG200008932	K01507	ko00190	Oxidative phosphorylation	288	4.8e-10	0.85	0.93	0.78
PGSC0003DMG200008932	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMG200008932	K01507	ko00190	Oxidative phosphorylation	1642	9.9e-85	0.88	0.93	1.00
PGSC0003DMG200008934	K12831	ko03040	Spliceosome	2631	2.8e-139	0.80	0.87	1.00
PGSC0003DMG200000241	K09561	ko04120	Ubiquitin mediated proteolysis	254	1.3e-07	0.31	0.48	0.26
PGSC0003DMG200000244	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMG200000244	K00517	ko00626	Naphthalene and anthracene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMG200000244	K00517	ko00903	Limonene and pinene degradation	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMG200000244	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMG200000244	K00517	ko01110	Biosynthesis of secondary metabolites	2382	1.5e-125	0.68	0.79	0.99
PGSC0003DMG200000246	K00697	ko00500	Starch and sucrose metabolism	1672	2.2e-86	0.65	0.81	0.46
PGSC0003DMG200000249	K02942	ko03010	Ribosome	400	3.2e-16	0.74	0.84	0.97
PGSC0003DMG200000268	K05279	ko00944	Flavone and flavonol biosynthesis	505	5.1e-22	0.36	0.54	0.84
PGSC0003DMG200000268	K05279	ko00944	Flavone and flavonol biosynthesis	764	2.6e-36	0.37	0.56	0.84
PGSC0003DMG200000268	K05279	ko00944	Flavone and flavonol biosynthesis	699	1.0e-32	0.41	0.59	0.92
PGSC0003DMG200000269	K05279	ko00944	Flavone and flavonol biosynthesis	687	4.7e-32	0.38	0.56	0.75
PGSC0003DMG200041228	K03094	ko04110	Cell cycle	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04111	Cell cycle - yeast	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04114	Oocyte meiosis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04120	Ubiquitin mediated proteolysis	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04310	Wnt signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04350	TGF-beta signaling pathway	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041228	K03094	ko04710	Circadian rhythm - mammal	599	3.3e-27	0.50	0.71	0.94
PGSC0003DMG200041235	K13229	ko00402	Benzoxazinoid biosynthesis	521	6.7e-23	0.49	0.67	0.84
PGSC0003DMG200041161	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	343	3.1e-12	0.33	0.44	0.78
PGSC0003DMG200015379	K00026	ko00020	Citrate cycle (TCA cycle)	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015379	K00026	ko00620	Pyruvate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015379	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015379	K00026	ko00710	Carbon fixation in photosynthetic organisms	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015379	K00026	ko01100	Metabolic pathways	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015379	K00026	ko01110	Biosynthesis of secondary metabolites	2400	1.5e-126	0.86	0.92	0.99
PGSC0003DMG200015380	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMG200015380	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMG200015380	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.53
PGSC0003DMG200015380	K00791	ko00908	Zeatin biosynthesis	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMG200015380	K00791	ko01100	Metabolic pathways	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMG200015380	K00791	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.41	0.56	0.61
PGSC0003DMG200015380	K00791	ko00908	Zeatin biosynthesis	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMG200015380	K00791	ko01100	Metabolic pathways	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMG200015380	K00791	ko01110	Biosynthesis of secondary metabolites	811	6.8e-39	0.38	0.53	0.75
PGSC0003DMG200015380	K00791	ko00908	Zeatin biosynthesis	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMG200015380	K00791	ko01100	Metabolic pathways	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMG200015380	K00791	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.41	0.55	0.62
PGSC0003DMG200015380	K00791	ko00908	Zeatin biosynthesis	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMG200015380	K00791	ko01100	Metabolic pathways	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMG200015380	K00791	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.38	0.53	0.78
PGSC0003DMG200011866	K07204	ko04150	mTOR signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMG200011866	K07204	ko04910	Insulin signaling pathway	5952	0.	0.76	0.85	1.00
PGSC0003DMG200011866	K07204	ko04150	mTOR signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMG200011866	K07204	ko04910	Insulin signaling pathway	4281	2.8e-230	0.81	0.90	0.94
PGSC0003DMG200011866	K07204	ko04150	mTOR signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMG200011866	K07204	ko04910	Insulin signaling pathway	6004	0.	0.76	0.86	1.00
PGSC0003DMG200011866	K07204	ko04150	mTOR signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMG200011866	K07204	ko04910	Insulin signaling pathway	5961	0.	0.76	0.86	1.00
PGSC0003DMG200011867	K07204	ko04150	mTOR signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMG200011867	K07204	ko04910	Insulin signaling pathway	314	1.8e-10	0.49	0.61	0.47
PGSC0003DMG200011868	K00827	ko00250	Alanine, aspartate and glutamate metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMG200011868	K00827	ko00260	Glycine, serine and threonine metabolism	2557	3.4e-135	0.63	0.79	1.00
PGSC0003DMG200011882	K01433	ko00630	Glyoxylate and dicarboxylate metabolism	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMG200011882	K01433	ko00670	One carbon pool by folate	2059	9.9e-108	0.75	0.87	1.00
PGSC0003DMG200002078	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMG200002078	K00517	ko00626	Naphthalene and anthracene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMG200002078	K00517	ko00903	Limonene and pinene degradation	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMG200002078	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMG200002078	K00517	ko01110	Biosynthesis of secondary metabolites	3098	4.9e-165	0.70	0.82	1.00
PGSC0003DMG200002078	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMG200002078	K00517	ko00626	Naphthalene and anthracene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMG200002078	K00517	ko00903	Limonene and pinene degradation	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMG200002078	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMG200002078	K00517	ko01110	Biosynthesis of secondary metabolites	1536	7.0e-79	0.70	0.81	0.98
PGSC0003DMG200002080	K00558	ko00270	Cysteine and methionine metabolism	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMG200002080	K00558	ko01100	Metabolic pathways	440	7.3e-15	0.55	0.76	0.12
PGSC0003DMG200002085	K01051	ko00040	Pentose and glucuronate interconversions	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMG200002085	K01051	ko00500	Starch and sucrose metabolism	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMG200002085	K01051	ko01100	Metabolic pathways	1778	3.1e-92	0.52	0.65	0.89
PGSC0003DMG200002086	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMG200002086	K12184	ko04144	Endocytosis	1582	2.0e-81	0.90	0.96	1.00
PGSC0003DMG200016643	K03413	ko02020	Two-component system	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMG200016643	K03413	ko02030	Bacterial chemotaxis	218	3.4e-06	0.37	0.58	0.77
PGSC0003DMG200016643	K03413	ko02020	Two-component system	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMG200016643	K03413	ko02030	Bacterial chemotaxis	305	5.5e-11	0.39	0.59	0.77
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	405	1.7e-16	0.41	0.57	0.59
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	677	1.7e-31	0.43	0.67	0.62
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	854	2.9e-41	0.43	0.66	0.74
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.68
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	920	6.6e-45	0.45	0.62	0.96
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	1002	2.0e-49	0.45	0.62	0.78
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	470	4.3e-20	0.40	0.63	0.67
PGSC0003DMG200016644	K00057	ko00564	Glycerophospholipid metabolism	421	2.2e-17	0.47	0.70	0.93
PGSC0003DMG200016647	K04564	ko04146	Peroxisome	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMG200016647	K04564	ko05016	Huntington's disease	1664	6.1e-86	0.82	0.93	1.00
PGSC0003DMG200005385	K02993	ko03010	Ribosome	696	1.5e-32	0.89	0.99	0.91
PGSC0003DMG200005385	K02993	ko03010	Ribosome	1111	1.9e-55	0.84	0.96	0.91
PGSC0003DMG200005385	K02993	ko03010	Ribosome	1419	2.0e-72	0.87	0.97	0.99
PGSC0003DMG200005388	K12126	ko04712	Circadian rhythm - plant	267	1.3e-08	0.30	0.47	0.96
PGSC0003DMG200005388	K12126	ko04712	Circadian rhythm - plant	297	2.2e-10	0.31	0.47	0.77
PGSC0003DMG200005390	K02183	ko04020	Calcium signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04070	Phosphatidylinositol signaling system	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04114	Oocyte meiosis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04270	Vascular smooth muscle contraction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04626	Plant-pathogen interaction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04720	Long-term potentiation	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04722	Neurotrophin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04740	Olfactory transduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04744	Phototransduction	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04745	Phototransduction - fly	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04910	Insulin signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04912	GnRH signaling pathway	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04916	Melanogenesis	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04970	Salivary secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko04971	Gastric acid secretion	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko05010	Alzheimer's disease	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005390	K02183	ko05214	Glioma	1379	3.2e-70	0.51	0.67	0.82
PGSC0003DMG200005394	K13056	ko04114	Oocyte meiosis	288	4.8e-10	0.28	0.41	0.75
PGSC0003DMG200029980	K01354	ko05142	Chagas disease	1919	5.2e-100	0.87	0.94	0.70
PGSC0003DMG200029980	K01354	ko05142	Chagas disease	2818	1.4e-149	0.74	0.86	0.99
PGSC0003DMG200029980	K01354	ko05142	Chagas disease	4837	6.0e-261	0.78	0.88	1.00
PGSC0003DMG200029988	K01199	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.46	0.62	0.96
PGSC0003DMG200029989	K05681	ko02010	ABC transporters	978	4.2e-48	0.38	0.60	0.88
PGSC0003DMG200029989	K05681	ko02010	ABC transporters	1116	1.0e-55	0.36	0.58	0.89
PGSC0003DMG200029989	K05681	ko02010	ABC transporters	1163	2.6e-58	0.36	0.56	0.86
PGSC0003DMG200029990	K05681	ko02010	ABC transporters	1147	2.0e-57	0.34	0.52	0.89
PGSC0003DMG200029995	K01768	ko00230	Purine metabolism	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMG200029995	K01768	ko04113	Meiosis - yeast	275	1.9e-06	0.29	0.49	0.65
PGSC0003DMG200020126	K08332	ko04140	Regulation of autophagy	465	9.2e-20	0.34	0.53	0.41
PGSC0003DMG200020126	K08332	ko04140	Regulation of autophagy	465	8.2e-20	0.34	0.53	0.51
PGSC0003DMG200020126	K08332	ko04140	Regulation of autophagy	390	1.1e-15	0.34	0.55	0.60
PGSC0003DMG200020134	K11087	ko03040	Spliceosome	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMG200020134	K11087	ko05322	Systemic lupus erythematosus	932	1.4e-45	0.96	0.99	0.99
PGSC0003DMG200020138	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMG200020138	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMG200020138	K11251	ko05322	Systemic lupus erythematosus	1035	3.0e-51	0.92	0.97	0.99
PGSC0003DMG200020138	K00648	ko00061	Fatty acid biosynthesis	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMG200020138	K00648	ko01100	Metabolic pathways	293	2.5e-10	0.27	0.46	0.72
PGSC0003DMG200025872	K12356	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.36	0.51	0.65
PGSC0003DMG200025873	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.33	0.49	0.98
PGSC0003DMG200025874	K12356	ko00940	Phenylpropanoid biosynthesis	765	2.3e-36	0.33	0.48	0.98
PGSC0003DMG200025876	K12356	ko00940	Phenylpropanoid biosynthesis	799	3.1e-38	0.33	0.51	0.97
PGSC0003DMG200025877	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.45	0.59	0.90
PGSC0003DMG200025878	K12356	ko00940	Phenylpropanoid biosynthesis	783	2.4e-37	0.32	0.51	0.99
PGSC0003DMG200025881	K00635	ko00561	Glycerolipid metabolism	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMG200025881	K00635	ko01100	Metabolic pathways	316	4.4e-10	0.29	0.42	0.96
PGSC0003DMG200025882	K00588	ko00360	Phenylalanine metabolism	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko00940	Phenylpropanoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko00941	Flavonoid biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko01100	Metabolic pathways	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko01110	Biosynthesis of secondary metabolites	288	4.8e-10	0.81	0.93	0.81
PGSC0003DMG200025882	K00588	ko00360	Phenylalanine metabolism	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025882	K00588	ko00940	Phenylpropanoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025882	K00588	ko00941	Flavonoid biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025882	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025882	K00588	ko01100	Metabolic pathways	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025882	K00588	ko01110	Biosynthesis of secondary metabolites	1841	1.0e-95	0.88	0.96	0.97
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	440	2.0e-18	0.87	0.95	0.95
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	552	1.3e-24	0.85	0.94	0.95
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	1649	4.1e-85	0.86	0.93	0.86
PGSC0003DMG200025888	K01966	ko00280	Valine, leucine and isoleucine degradation	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMG200025888	K01966	ko00640	Propanoate metabolism	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMG200025888	K01966	ko01100	Metabolic pathways	3635	1.2e-194	0.82	0.92	1.00
PGSC0003DMG200023518	K03128	ko03022	Basal transcription factors	660	3.4e-29	0.52	0.68	0.59
PGSC0003DMG200023519	K00164	ko00020	Citrate cycle (TCA cycle)	7847	0.	0.88	0.95	1.00
PGSC0003DMG200023519	K00164	ko00310	Lysine degradation	7847	0.	0.88	0.95	1.00
PGSC0003DMG200023519	K00164	ko00380	Tryptophan metabolism	7847	0.	0.88	0.95	1.00
PGSC0003DMG200023519	K00164	ko01100	Metabolic pathways	7847	0.	0.88	0.95	1.00
PGSC0003DMG200023519	K00164	ko01110	Biosynthesis of secondary metabolites	7847	0.	0.88	0.95	1.00
PGSC0003DMG200023522	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200023523	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200023524	K01710	ko00521	Streptomycin biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMG200023524	K01710	ko00523	Polyketide sugar unit biosynthesis	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMG200023524	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMG200023524	K01710	ko01100	Metabolic pathways	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMG200023524	K01710	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.91	0.97	0.99
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	1358	4.6e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	685	6.0e-32	0.92	0.96	0.97
PGSC0003DMG200023527	K10575	ko04120	Ubiquitin mediated proteolysis	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023527	K10575	ko05012	Parkinson's disease	1360	3.5e-69	0.91	0.96	0.99
PGSC0003DMG200023531	K00729	ko00510	N-Glycan biosynthesis	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMG200023531	K00729	ko01100	Metabolic pathways	880	1.1e-42	0.69	0.82	0.82
PGSC0003DMG200023531	K00729	ko00510	N-Glycan biosynthesis	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMG200023531	K00729	ko01100	Metabolic pathways	1280	9.2e-65	0.82	0.91	0.98
PGSC0003DMG200023531	K00729	ko00510	N-Glycan biosynthesis	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMG200023531	K00729	ko01100	Metabolic pathways	2148	1.2e-112	0.76	0.87	0.98
PGSC0003DMG200035800	K03094	ko04110	Cell cycle	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04111	Cell cycle - yeast	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04114	Oocyte meiosis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04120	Ubiquitin mediated proteolysis	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04310	Wnt signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04350	TGF-beta signaling pathway	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035800	K03094	ko04710	Circadian rhythm - mammal	522	5.9e-23	0.46	0.65	0.99
PGSC0003DMG200035816	K04733	ko04210	Apoptosis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMG200035816	K04733	ko04620	Toll-like receptor signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMG200035816	K04733	ko04722	Neurotrophin signaling pathway	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMG200035816	K04733	ko05140	Leishmaniasis	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMG200035816	K04733	ko05142	Chagas disease	1172	8.3e-59	0.37	0.53	0.96
PGSC0003DMG200001610	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMG200001610	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMG200001610	K01937	ko00240	Pyrimidine metabolism	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMG200001610	K01937	ko01100	Metabolic pathways	283	2.3e-09	0.70	0.84	0.54
PGSC0003DMG200001617	K09578	ko04622	RIG-I-like receptor signaling pathway	839	1.9e-40	0.80	0.92	0.99
PGSC0003DMG200001618	K00764	ko00230	Purine metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMG200001618	K00764	ko00250	Alanine, aspartate and glutamate metabolism	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMG200001618	K00764	ko01100	Metabolic pathways	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMG200001618	K00764	ko01110	Biosynthesis of secondary metabolites	3803	6.4e-204	0.80	0.88	0.98
PGSC0003DMG200001619	K12345	ko00140	Steroid hormone biosynthesis	1455	2.0e-74	0.55	0.66	1.00
PGSC0003DMG200001619	K12345	ko00140	Steroid hormone biosynthesis	1692	1.7e-87	0.63	0.75	0.96
PGSC0003DMG200001619	K12345	ko00140	Steroid hormone biosynthesis	1554	7.1e-80	0.65	0.77	0.80
PGSC0003DMG200001619	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMG200001619	K12345	ko00140	Steroid hormone biosynthesis	1928	1.7e-100	0.66	0.78	1.00
PGSC0003DMG200001621	K01771	ko00562	Inositol phosphate metabolism	232	2.4e-06	0.29	0.44	0.70
PGSC0003DMG200043641	K12828	ko03040	Spliceosome	1823	1.0e-94	0.92	0.95	0.82
PGSC0003DMG200043651	K10591	ko04120	Ubiquitin mediated proteolysis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMG200043651	K10591	ko04144	Endocytosis	962	3.2e-47	0.56	0.75	0.99
PGSC0003DMG200045287	K01051	ko00040	Pentose and glucuronate interconversions	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMG200045287	K01051	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMG200045287	K01051	ko01100	Metabolic pathways	956	6.8e-47	0.42	0.61	0.91
PGSC0003DMG200045296	K00660	ko00941	Flavonoid biosynthesis	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMG200045296	K00660	ko01100	Metabolic pathways	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMG200045296	K00660	ko01110	Biosynthesis of secondary metabolites	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMG200045296	K00660	ko04712	Circadian rhythm - plant	1229	6.0e-62	0.44	0.64	0.93
PGSC0003DMG200006464	K12194	ko04144	Endocytosis	415	4.7e-17	0.48	0.68	0.24
PGSC0003DMG200006472	K02704	ko00195	Photosynthesis	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMG200006472	K02704	ko01100	Metabolic pathways	925	3.5e-45	0.61	0.64	0.92
PGSC0003DMG200006481	K10577	ko04120	Ubiquitin mediated proteolysis	1204	1.4e-60	0.93	0.98	0.83
PGSC0003DMG200011367	K00799	ko00480	Glutathione metabolism	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMG200011367	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMG200011367	K00799	ko00982	Drug metabolism - cytochrome P450	347	2.6e-13	0.68	0.77	0.93
PGSC0003DMG200011367	K00799	ko00480	Glutathione metabolism	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMG200011367	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMG200011367	K00799	ko00982	Drug metabolism - cytochrome P450	1000	2.5e-49	0.58	0.74	1.00
PGSC0003DMG200011367	K00799	ko00480	Glutathione metabolism	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMG200011367	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMG200011367	K00799	ko00982	Drug metabolism - cytochrome P450	541	5.3e-24	0.55	0.74	0.98
PGSC0003DMG200013577	K00485	ko00982	Drug metabolism - cytochrome P450	652	4.0e-30	0.29	0.47	0.99
PGSC0003DMG200013579	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMG200013579	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMG200013579	K09458	ko00061	Fatty acid biosynthesis	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMG200013579	K09458	ko01100	Metabolic pathways	3385	7.3e-181	0.74	0.83	1.00
PGSC0003DMG200013596	K05863	ko04020	Calcium signaling pathway	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMG200013596	K05863	ko05012	Parkinson's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMG200013596	K05863	ko05016	Huntington's disease	2855	1.2e-151	0.87	0.92	1.00
PGSC0003DMG200013540	K00703	ko00500	Starch and sucrose metabolism	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMG200013540	K00703	ko01100	Metabolic pathways	1449	4.4e-74	0.76	0.86	0.65
PGSC0003DMG200013540	K00703	ko00500	Starch and sucrose metabolism	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMG200013540	K00703	ko01100	Metabolic pathways	2197	2.4e-115	0.68	0.79	0.90
PGSC0003DMG200013540	K00703	ko00500	Starch and sucrose metabolism	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMG200013540	K00703	ko01100	Metabolic pathways	3652	1.4e-195	0.71	0.83	0.95
PGSC0003DMG200013540	K00703	ko00500	Starch and sucrose metabolism	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMG200013540	K00703	ko01100	Metabolic pathways	640	1.8e-29	0.84	0.89	0.74
PGSC0003DMG200017420	K00457	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMG200017420	K00457	ko00350	Tyrosine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMG200017420	K00457	ko00360	Phenylalanine metabolism	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMG200017420	K00457	ko01100	Metabolic pathways	2752	5.9e-146	0.72	0.83	1.00
PGSC0003DMG200017421	K05278	ko00941	Flavonoid biosynthesis	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMG200017421	K05278	ko01100	Metabolic pathways	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMG200017421	K05278	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.33	0.50	0.91
PGSC0003DMG200017431	K13065	ko00940	Phenylpropanoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMG200017431	K13065	ko00941	Flavonoid biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMG200017431	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMG200017431	K13065	ko01110	Biosynthesis of secondary metabolites	587	1.5e-26	0.30	0.47	0.97
PGSC0003DMG200017432	K05666	ko02010	ABC transporters	2942	2.0e-156	0.33	0.53	0.94
PGSC0003DMG200017433	K00134	ko00010	Glycolysis / Gluconeogenesis	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMG200017433	K00134	ko01100	Metabolic pathways	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMG200017433	K00134	ko01110	Biosynthesis of secondary metabolites	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMG200017433	K00134	ko05010	Alzheimer's disease	2617	1.7e-138	0.91	0.97	1.00
PGSC0003DMG200017434	K00134	ko00010	Glycolysis / Gluconeogenesis	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMG200017434	K00134	ko01100	Metabolic pathways	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMG200017434	K00134	ko01110	Biosynthesis of secondary metabolites	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMG200017434	K00134	ko05010	Alzheimer's disease	831	5.3e-40	0.46	0.50	0.91
PGSC0003DMG200017436	K05665	ko02010	ABC transporters	322	5.8e-11	0.62	0.73	0.70
PGSC0003DMG200017439	K02321	ko00230	Purine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMG200017439	K02321	ko00240	Pyrimidine metabolism	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMG200017439	K02321	ko01100	Metabolic pathways	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMG200017439	K02321	ko03030	DNA replication	3389	4.4e-181	0.66	0.81	1.00
PGSC0003DMG200017439	K02321	ko00230	Purine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMG200017439	K02321	ko00240	Pyrimidine metabolism	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMG200017439	K02321	ko01100	Metabolic pathways	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMG200017439	K02321	ko03030	DNA replication	3521	2.3e-188	0.68	0.83	1.00
PGSC0003DMG200017441	K06688	ko04120	Ubiquitin mediated proteolysis	279	1.5e-09	0.94	0.97	0.18
PGSC0003DMG200028149	K07195	ko04910	Insulin signaling pathway	3637	9.1e-195	0.68	0.83	0.99
PGSC0003DMG200028152	K08488	ko04130	SNARE interactions in vesicular transport	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMG200028152	K08488	ko04145	Phagosome	432	5.4e-18	0.40	0.59	0.66
PGSC0003DMG200028153	K08488	ko04130	SNARE interactions in vesicular transport	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMG200028153	K08488	ko04145	Phagosome	442	1.5e-18	0.42	0.61	0.65
PGSC0003DMG200028162	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMG200032124	K00031	ko00020	Citrate cycle (TCA cycle)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200032124	K00031	ko00480	Glutathione metabolism	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200032124	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200032124	K00031	ko01100	Metabolic pathways	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200032124	K00031	ko01110	Biosynthesis of secondary metabolites	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200032124	K00031	ko04146	Peroxisome	3279	5.1e-175	0.92	0.96	0.99
PGSC0003DMG200010688	K09839	ko00906	Carotenoid biosynthesis	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMG200010688	K09839	ko01100	Metabolic pathways	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMG200010688	K09839	ko01110	Biosynthesis of secondary metabolites	2558	3.0e-135	0.82	0.90	0.95
PGSC0003DMG200010688	K09839	ko00906	Carotenoid biosynthesis	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMG200010688	K09839	ko01100	Metabolic pathways	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMG200010688	K09839	ko01110	Biosynthesis of secondary metabolites	2570	6.5e-136	0.67	0.76	1.00
PGSC0003DMG200010690	K09839	ko00906	Carotenoid biosynthesis	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMG200010690	K09839	ko01100	Metabolic pathways	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMG200010690	K09839	ko01110	Biosynthesis of secondary metabolites	1271	2.9e-64	0.61	0.74	0.72
PGSC0003DMG200010690	K09839	ko00906	Carotenoid biosynthesis	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMG200010690	K09839	ko01100	Metabolic pathways	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMG200010690	K09839	ko01110	Biosynthesis of secondary metabolites	217	7.9e-06	0.62	0.73	0.47
PGSC0003DMG200010691	K04733	ko04210	Apoptosis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMG200010691	K04733	ko04620	Toll-like receptor signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMG200010691	K04733	ko04722	Neurotrophin signaling pathway	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMG200010691	K04733	ko05140	Leishmaniasis	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMG200010691	K04733	ko05142	Chagas disease	713	1.7e-33	0.36	0.53	0.60
PGSC0003DMG200010697	K08064	ko04612	Antigen processing and presentation	519	8.6e-23	0.40	0.54	0.73
PGSC0003DMG200010701	K04733	ko04210	Apoptosis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMG200010701	K04733	ko04620	Toll-like receptor signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMG200010701	K04733	ko04722	Neurotrophin signaling pathway	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMG200010701	K04733	ko05140	Leishmaniasis	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMG200010701	K04733	ko05142	Chagas disease	783	2.4e-37	0.35	0.55	0.56
PGSC0003DMG200010703	K12275	ko03060	Protein export	2035	2.1e-106	0.79	0.88	0.92
PGSC0003DMG200014334	K05747	ko04062	Chemokine signaling pathway	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko04520	Adherens junction	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko04666	Fc gamma R-mediated phagocytosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko04810	Regulation of actin cytoskeleton	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko05100	Bacterial invasion of epithelial cells	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko05130	Pathogenic Escherichia coli infection	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200014334	K05747	ko05131	Shigellosis	244	2.0e-07	0.38	0.46	0.53
PGSC0003DMG200023987	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMG200023987	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMG200023987	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.62
PGSC0003DMG200023987	K00142	ko00300	Lysine biosynthesis	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMG200023987	K00142	ko00310	Lysine degradation	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMG200023987	K00142	ko01100	Metabolic pathways	237	3.1e-07	0.32	0.55	0.50
PGSC0003DMG200023995	K00697	ko00500	Starch and sucrose metabolism	5633	0.	0.76	0.88	0.99
PGSC0003DMG200023996	K12391	ko04142	Lysosome	2536	4.9e-134	0.71	0.82	0.97
PGSC0003DMG200023996	K12391	ko04142	Lysosome	4771	2.6e-257	0.85	0.93	0.95
PGSC0003DMG200023996	K12391	ko04142	Lysosome	5866	0.	0.80	0.90	1.00
PGSC0003DMG200023999	K00480	ko00624	1- and 2-Methylnaphthalene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMG200023999	K00480	ko00626	Naphthalene and anthracene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMG200023999	K00480	ko00628	Fluorene degradation	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMG200023999	K00480	ko01100	Metabolic pathways	277	1.9e-09	0.34	0.55	0.58
PGSC0003DMG200023999	K00480	ko00624	1- and 2-Methylnaphthalene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMG200023999	K00480	ko00626	Naphthalene and anthracene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMG200023999	K00480	ko00628	Fluorene degradation	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMG200023999	K00480	ko01100	Metabolic pathways	244	1.3e-07	0.42	0.62	0.87
PGSC0003DMG200028770	K11252	ko05322	Systemic lupus erythematosus	714	1.5e-33	0.61	0.72	0.42
PGSC0003DMG200028771	K11252	ko05322	Systemic lupus erythematosus	830	6.1e-40	0.80	0.87	0.96
PGSC0003DMG200028773	K05350	ko00460	Cyanoamino acid metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMG200028773	K05350	ko00500	Starch and sucrose metabolism	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMG200028773	K05350	ko00940	Phenylpropanoid biosynthesis	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMG200028773	K05350	ko01110	Biosynthesis of secondary metabolites	2630	3.2e-139	0.63	0.78	0.92
PGSC0003DMG200028777	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMG200028777	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMG200028781	K02993	ko03010	Ribosome	1454	2.3e-74	0.88	0.97	0.99
PGSC0003DMG200028783	K00799	ko00480	Glutathione metabolism	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMG200028783	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMG200028783	K00799	ko00982	Drug metabolism - cytochrome P450	764	2.6e-36	0.47	0.69	0.89
PGSC0003DMG200028783	K00799	ko00480	Glutathione metabolism	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMG200028783	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMG200028783	K00799	ko00982	Drug metabolism - cytochrome P450	547	2.5e-24	0.63	0.83	0.91
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMG200028784	K04424	ko04530	Tight junction	872	2.9e-42	0.40	0.57	0.83
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMG200028784	K04424	ko04530	Tight junction	2273	1.6e-119	0.41	0.55	0.99
PGSC0003DMG200028784	K04424	ko04010	MAPK signaling pathway	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMG200028784	K04424	ko04530	Tight junction	2052	2.4e-107	0.46	0.59	0.96
PGSC0003DMG200018161	K10577	ko04120	Ubiquitin mediated proteolysis	1072	2.7e-53	0.75	0.86	0.99
PGSC0003DMG200018162	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.44
PGSC0003DMG200018162	K11422	ko00310	Lysine degradation	639	4.2e-29	0.38	0.57	0.39
PGSC0003DMG200018164	K12609	ko03018	RNA degradation	414	4.4e-13	0.26	0.40	0.47
PGSC0003DMG200018164	K12831	ko03040	Spliceosome	324	4.8e-11	0.37	0.42	0.12
PGSC0003DMG200018174	K11152	ko00830	Retinol metabolism	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMG200018174	K11152	ko01100	Metabolic pathways	790	9.7e-38	0.43	0.62	0.85
PGSC0003DMG200031027	K01762	ko00270	Cysteine and methionine metabolism	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMG200031027	K01762	ko01110	Biosynthesis of secondary metabolites	1657	1.5e-85	0.46	0.71	0.84
PGSC0003DMG200031031	K01206	ko00511	Other glycan degradation	657	2.1e-30	0.68	0.84	0.99
PGSC0003DMG200031031	K01206	ko00511	Other glycan degradation	3091	1.2e-164	0.74	0.86	0.98
PGSC0003DMG200031035	K08243	ko00941	Flavonoid biosynthesis	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMG200031035	K08243	ko01110	Biosynthesis of secondary metabolites	518	9.8e-23	0.47	0.66	0.99
PGSC0003DMG200031036	K00100	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko00363	Bisphenol A degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko00591	Linoleic acid metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko00625	Tetrachloroethene degradation	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko00650	Butanoate metabolism	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko01100	Metabolic pathways	414	5.3e-17	0.52	0.69	0.92
PGSC0003DMG200031036	K00100	ko00051	Fructose and mannose metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko00363	Bisphenol A degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko00591	Linoleic acid metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko00625	Tetrachloroethene degradation	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko00650	Butanoate metabolism	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko01100	Metabolic pathways	910	2.3e-44	0.59	0.71	0.99
PGSC0003DMG200031036	K00100	ko00051	Fructose and mannose metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031036	K00100	ko00363	Bisphenol A degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031036	K00100	ko00591	Linoleic acid metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031036	K00100	ko00625	Tetrachloroethene degradation	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031036	K00100	ko00650	Butanoate metabolism	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031036	K00100	ko01100	Metabolic pathways	1420	1.7e-72	0.57	0.71	0.98
PGSC0003DMG200031040	K01199	ko00500	Starch and sucrose metabolism	501	8.5e-22	0.33	0.50	0.95
PGSC0003DMG200031041	K01505	ko00640	Propanoate metabolism	1109	2.5e-55	0.41	0.57	0.89
PGSC0003DMG200031041	K01505	ko00640	Propanoate metabolism	1278	1.2e-64	0.44	0.62	0.94
PGSC0003DMG200030976	K07432	ko00510	N-Glycan biosynthesis	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMG200030976	K07432	ko01100	Metabolic pathways	1117	9.0e-56	0.75	0.88	0.99
PGSC0003DMG200030976	K07432	ko00510	N-Glycan biosynthesis	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMG200030976	K07432	ko01100	Metabolic pathways	783	2.4e-37	0.76	0.88	0.84
PGSC0003DMG200030976	K07432	ko00510	N-Glycan biosynthesis	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMG200030976	K07432	ko01100	Metabolic pathways	416	4.1e-17	0.79	0.89	0.98
PGSC0003DMG200030977	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMG200030977	K12822	ko03040	Spliceosome	4410	2.1e-237	0.58	0.73	0.99
PGSC0003DMG200030977	K12822	ko03040	Spliceosome	4433	1.1e-238	0.59	0.73	0.99
PGSC0003DMG200030977	K12822	ko03040	Spliceosome	476	7.5e-20	0.41	0.50	0.91
PGSC0003DMG200030977	K12822	ko03040	Spliceosome	3895	5.4e-209	0.62	0.77	1.00
PGSC0003DMG200030979	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMG200030979	K12619	ko03018	RNA degradation	280	3.2e-06	0.24	0.40	0.60
PGSC0003DMG200030979	K12619	ko03018	RNA degradation	280	2.9e-06	0.24	0.40	0.62
PGSC0003DMG200030984	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMG200030984	K01673	ko00910	Nitrogen metabolism	1674	1.7e-86	0.76	0.88	1.00
PGSC0003DMG200030986	K08065	ko04612	Antigen processing and presentation	314	1.7e-11	0.49	0.66	0.60
PGSC0003DMG200002749	K01184	ko00040	Pentose and glucuronate interconversions	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMG200002749	K01184	ko00500	Starch and sucrose metabolism	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMG200002749	K01184	ko01100	Metabolic pathways	1509	2.1e-77	0.46	0.66	0.92
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.68	0.81	0.99
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.70	0.82	1.00
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	2803	9.1e-149	0.66	0.79	0.88
PGSC0003DMG200002750	K00036	ko00030	Pentose phosphate pathway	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko00480	Glutathione metabolism	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01100	Metabolic pathways	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002750	K00036	ko01110	Biosynthesis of secondary metabolites	1289	2.9e-65	0.69	0.81	0.99
PGSC0003DMG200002755	K12398	ko04142	Lysosome	2911	1.0e-154	0.83	0.94	1.00
PGSC0003DMG200002755	K12398	ko04142	Lysosome	2169	8.5e-114	0.83	0.94	1.00
PGSC0003DMG200002755	K12398	ko04142	Lysosome	1612	4.5e-83	0.83	0.95	0.90
PGSC0003DMG200002756	K01193	ko00052	Galactose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMG200002756	K01193	ko00500	Starch and sucrose metabolism	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMG200002756	K01193	ko01100	Metabolic pathways	1123	4.2e-56	0.37	0.55	0.76
PGSC0003DMG200012564	K02372	ko00061	Fatty acid biosynthesis	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMG200012564	K02372	ko01100	Metabolic pathways	1383	1.9e-70	0.74	0.82	1.00
PGSC0003DMG200012571	K02858	ko00740	Riboflavin metabolism	2143	2.3e-112	0.68	0.79	0.93
PGSC0003DMG200012571	K02858	ko00740	Riboflavin metabolism	2374	4.2e-125	0.82	0.90	0.97
PGSC0003DMG200012571	K02858	ko00740	Riboflavin metabolism	3357	2.5e-179	0.74	0.84	0.99
PGSC0003DMG200008479	K03857	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMG200008479	K03857	ko01100	Metabolic pathways	700	2.2e-28	0.25	0.43	0.50
PGSC0003DMG200008481	K04040	ko00860	Porphyrin and chlorophyll metabolism	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMG200008481	K04040	ko01100	Metabolic pathways	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMG200008481	K04040	ko01110	Biosynthesis of secondary metabolites	2682	4.3e-142	0.85	0.92	1.00
PGSC0003DMG200008488	K08915	ko00196	Photosynthesis - antenna proteins	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMG200008488	K08915	ko01100	Metabolic pathways	2092	1.5e-109	0.87	0.92	0.98
PGSC0003DMG200008489	K09648	ko03060	Protein export	498	1.2e-21	0.75	0.83	0.82
PGSC0003DMG200008489	K09648	ko03060	Protein export	434	4.2e-18	0.65	0.79	0.99
PGSC0003DMG200008489	K09648	ko03060	Protein export	965	2.2e-47	0.68	0.80	0.96
PGSC0003DMG200008489	K09648	ko03060	Protein export	799	3.1e-38	0.69	0.80	0.89
PGSC0003DMG200008491	K02085	ko04310	Wnt signaling pathway	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko04810	Regulation of actin cytoskeleton	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko05200	Pathways in cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko05210	Colorectal cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko05213	Endometrial cancer	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko05217	Basal cell carcinoma	504	1.6e-20	0.27	0.43	0.97
PGSC0003DMG200008491	K02085	ko04310	Wnt signaling pathway	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200008491	K02085	ko04810	Regulation of actin cytoskeleton	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200008491	K02085	ko05200	Pathways in cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200008491	K02085	ko05210	Colorectal cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200008491	K02085	ko05213	Endometrial cancer	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200008491	K02085	ko05217	Basal cell carcinoma	467	1.8e-18	0.28	0.44	0.96
PGSC0003DMG200015928	K12617	ko03018	RNA degradation	470	9.4e-20	0.50	0.59	0.79
PGSC0003DMG200015928	K12617	ko03018	RNA degradation	847	7.0e-41	0.73	0.84	0.99
PGSC0003DMG200015928	K12617	ko03018	RNA degradation	247	4.4e-07	0.51	0.63	0.81
PGSC0003DMG200015932	K00889	ko00562	Inositol phosphate metabolism	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko01100	Metabolic pathways	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko04070	Phosphatidylinositol signaling system	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko04144	Endocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko04666	Fc gamma R-mediated phagocytosis	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko04810	Regulation of actin cytoskeleton	7079	0.	0.53	0.64	1.00
PGSC0003DMG200015932	K00889	ko00562	Inositol phosphate metabolism	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko01100	Metabolic pathways	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko04070	Phosphatidylinositol signaling system	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko04144	Endocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko04666	Fc gamma R-mediated phagocytosis	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko04810	Regulation of actin cytoskeleton	5098	2.4e-275	0.61	0.74	0.98
PGSC0003DMG200015932	K00889	ko00562	Inositol phosphate metabolism	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015932	K00889	ko01100	Metabolic pathways	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015932	K00889	ko04070	Phosphatidylinositol signaling system	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015932	K00889	ko04144	Endocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015932	K00889	ko04666	Fc gamma R-mediated phagocytosis	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015932	K00889	ko04810	Regulation of actin cytoskeleton	8889	0.	0.61	0.74	1.00
PGSC0003DMG200015933	K01051	ko00040	Pentose and glucuronate interconversions	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMG200015933	K01051	ko00500	Starch and sucrose metabolism	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMG200015933	K01051	ko01100	Metabolic pathways	2657	1.0e-140	0.60	0.75	0.99
PGSC0003DMG200015935	K00290	ko00300	Lysine biosynthesis	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMG200015935	K00290	ko00310	Lysine degradation	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMG200015935	K00290	ko01100	Metabolic pathways	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMG200015935	K00290	ko01110	Biosynthesis of secondary metabolites	1348	1.6e-68	0.41	0.58	0.92
PGSC0003DMG200015935	K00292	ko00310	Lysine degradation	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMG200015935	K00292	ko01100	Metabolic pathways	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMG200015935	K00292	ko01110	Biosynthesis of secondary metabolites	2450	2.7e-129	0.64	0.77	0.46
PGSC0003DMG200015935	K00292	ko00310	Lysine degradation	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMG200015935	K00292	ko01100	Metabolic pathways	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMG200015935	K00292	ko01110	Biosynthesis of secondary metabolites	2355	4.7e-124	0.63	0.77	0.44
PGSC0003DMG200015935	K00292	ko00310	Lysine degradation	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMG200015935	K00292	ko01100	Metabolic pathways	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMG200015935	K00292	ko01110	Biosynthesis of secondary metabolites	2081	6.1e-109	0.63	0.77	0.91
PGSC0003DMG200015942	K01051	ko00040	Pentose and glucuronate interconversions	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMG200015942	K01051	ko00500	Starch and sucrose metabolism	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMG200015942	K01051	ko01100	Metabolic pathways	1530	1.5e-78	0.43	0.60	0.75
PGSC0003DMG200015944	K10134	ko04115	p53 signaling pathway	242	1.6e-07	0.32	0.44	0.69
PGSC0003DMG200006034	K01509	ko00230	Purine metabolism	2089	2.2e-109	0.41	0.57	0.98
PGSC0003DMG200006035	K12394	ko04142	Lysosome	723	4.8e-34	0.66	0.82	0.86
PGSC0003DMG200006035	K12394	ko04142	Lysosome	219	3.0e-06	0.68	0.85	0.47
PGSC0003DMG200006035	K12394	ko04142	Lysosome	936	8.6e-46	0.73	0.88	0.90
PGSC0003DMG200006047	K10755	ko03030	DNA replication	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMG200006047	K10755	ko03420	Nucleotide excision repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMG200006047	K10755	ko03430	Mismatch repair	2509	1.5e-132	0.88	0.95	0.99
PGSC0003DMG200006051	K03070	ko03060	Protein export	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	3685	2.1e-197	0.80	0.86	0.99
PGSC0003DMG200006051	K03070	ko03060	Protein export	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	4837	6.0e-261	0.81	0.90	1.00
PGSC0003DMG200006051	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMG200006051	K03070	ko03060	Protein export	7055	0.	0.80	0.89	1.00
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	7055	0.	0.80	0.89	1.00
PGSC0003DMG200006051	K03070	ko03060	Protein export	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	3326	1.3e-177	0.86	0.95	0.95
PGSC0003DMG200006051	K03070	ko03060	Protein export	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMG200006051	K03070	ko03070	Bacterial secretion system	2728	1.3e-144	0.85	0.94	0.95
PGSC0003DMG200000639	K00507	ko01040	Biosynthesis of unsaturated fatty acids	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMG200000639	K00507	ko03320	PPAR signaling pathway	2228	4.7e-117	0.66	0.79	0.99
PGSC0003DMG200000641	K06666	ko04111	Cell cycle - yeast	318	9.8e-09	0.27	0.42	0.52
PGSC0003DMG200000650	K01757	ko00901	Indole alkaloid biosynthesis	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMG200000650	K01757	ko01100	Metabolic pathways	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMG200000650	K01757	ko01110	Biosynthesis of secondary metabolites	680	1.1e-31	0.39	0.54	0.95
PGSC0003DMG200000651	K05280	ko00941	Flavonoid biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMG200000651	K05280	ko00944	Flavone and flavonol biosynthesis	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMG200000651	K05280	ko01100	Metabolic pathways	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMG200000651	K05280	ko01110	Biosynthesis of secondary metabolites	1260	1.2e-63	0.37	0.56	0.98
PGSC0003DMG200000653	K10536	ko00330	Arginine and proline metabolism	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMG200000653	K10536	ko01100	Metabolic pathways	2602	1.1e-137	0.79	0.87	0.99
PGSC0003DMG200042343	K12356	ko00940	Phenylpropanoid biosynthesis	596	4.9e-27	0.33	0.49	0.95
PGSC0003DMG200042349	K11816	ko00380	Tryptophan metabolism	1143	3.3e-57	0.42	0.60	0.98
PGSC0003DMG200042364	K03681	ko03018	RNA degradation	503	6.6e-22	0.67	0.80	0.59
PGSC0003DMG200034845	K04705	ko04144	Endocytosis	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMG200034845	K04705	ko04630	Jak-STAT signaling pathway	248	3.5e-07	0.32	0.42	0.56
PGSC0003DMG200034852	K11294	ko05130	Pathogenic Escherichia coli infection	245	4.7e-07	0.53	0.59	0.81
PGSC0003DMG200034859	K04733	ko04210	Apoptosis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMG200034859	K04733	ko04620	Toll-like receptor signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMG200034859	K04733	ko04722	Neurotrophin signaling pathway	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMG200034859	K04733	ko05140	Leishmaniasis	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMG200034859	K04733	ko05142	Chagas disease	455	9.2e-19	0.37	0.57	0.43
PGSC0003DMG200019413	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.89
PGSC0003DMG200019413	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.75
PGSC0003DMG200019413	K05747	ko04062	Chemokine signaling pathway	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko04520	Adherens junction	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko04666	Fc gamma R-mediated phagocytosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko04810	Regulation of actin cytoskeleton	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko05100	Bacterial invasion of epithelial cells	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko05130	Pathogenic Escherichia coli infection	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019413	K05747	ko05131	Shigellosis	268	1.0e-08	0.44	0.46	0.31
PGSC0003DMG200019416	K04733	ko04210	Apoptosis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMG200019416	K04733	ko04620	Toll-like receptor signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMG200019416	K04733	ko04722	Neurotrophin signaling pathway	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMG200019416	K04733	ko05140	Leishmaniasis	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMG200019416	K04733	ko05142	Chagas disease	861	1.2e-41	0.37	0.53	0.92
PGSC0003DMG200019419	K02635	ko00195	Photosynthesis	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMG200019419	K02635	ko01100	Metabolic pathways	466	7.2e-20	0.82	0.88	0.75
PGSC0003DMG200029309	K00895	ko00051	Fructose and mannose metabolism	4420	6.0e-238	0.83	0.92	1.00
PGSC0003DMG200029316	K05868	ko04110	Cell cycle	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMG200029316	K05868	ko04115	p53 signaling pathway	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMG200029316	K05868	ko04914	Progesterone-mediated oocyte maturation	1509	2.1e-77	0.77	0.89	0.98
PGSC0003DMG200029319	K10591	ko04120	Ubiquitin mediated proteolysis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMG200029319	K10591	ko04144	Endocytosis	3010	3.5e-160	0.49	0.67	0.99
PGSC0003DMG200029322	K10526	ko00592	alpha-Linolenic acid metabolism	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMG200029322	K10526	ko01100	Metabolic pathways	3410	3.0e-182	0.75	0.87	0.98
PGSC0003DMG200029325	K00423	ko00053	Ascorbate and aldarate metabolism	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMG200029325	K00423	ko01100	Metabolic pathways	2413	3.0e-127	0.55	0.68	0.99
PGSC0003DMG200029325	K00423	ko00053	Ascorbate and aldarate metabolism	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMG200029325	K00423	ko01100	Metabolic pathways	314	2.8e-11	0.57	0.68	0.95
PGSC0003DMG200022789	K01099	ko00562	Inositol phosphate metabolism	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMG200022789	K01099	ko01100	Metabolic pathways	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMG200022789	K01099	ko04070	Phosphatidylinositol signaling system	728	2.6e-34	0.43	0.60	0.95
PGSC0003DMG200022795	K08241	ko00592	alpha-Linolenic acid metabolism	529	2.4e-23	0.36	0.51	0.83
PGSC0003DMG200022796	K00133	ko00260	Glycine, serine and threonine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMG200022796	K00133	ko00270	Cysteine and methionine metabolism	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMG200022796	K00133	ko00300	Lysine biosynthesis	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMG200022796	K00133	ko01100	Metabolic pathways	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMG200022796	K00133	ko01110	Biosynthesis of secondary metabolites	2528	1.3e-133	0.82	0.89	0.97
PGSC0003DMG200037026	K00797	ko00270	Cysteine and methionine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMG200037026	K00797	ko00330	Arginine and proline metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMG200037026	K00797	ko00410	beta-Alanine metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMG200037026	K00797	ko00480	Glutathione metabolism	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMG200037026	K00797	ko01100	Metabolic pathways	1595	3.9e-82	0.64	0.79	0.88
PGSC0003DMG200010117	K13065	ko00940	Phenylpropanoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMG200010117	K13065	ko00941	Flavonoid biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMG200010117	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMG200010117	K13065	ko01110	Biosynthesis of secondary metabolites	619	2.6e-28	0.30	0.50	0.97
PGSC0003DMG200010117	K13065	ko00940	Phenylpropanoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMG200010117	K13065	ko00941	Flavonoid biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMG200010117	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMG200010117	K13065	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.30	0.49	0.97
PGSC0003DMG200010125	K08008	ko04145	Phagosome	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMG200010125	K08008	ko04670	Leukocyte transendothelial migration	318	4.8e-10	0.29	0.49	0.45
PGSC0003DMG200010125	K08008	ko04145	Phagosome	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMG200010125	K08008	ko04670	Leukocyte transendothelial migration	393	1.3e-16	0.28	0.47	0.55
PGSC0003DMG200003023	K08008	ko04145	Phagosome	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMG200003023	K08008	ko04670	Leukocyte transendothelial migration	1171	9.4e-59	0.35	0.50	0.62
PGSC0003DMG200003023	K08008	ko04145	Phagosome	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMG200003023	K08008	ko04670	Leukocyte transendothelial migration	310	4.5e-11	0.43	0.60	0.97
PGSC0003DMG200003025	K02084	ko04115	p53 signaling pathway	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko04210	Apoptosis	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko05010	Alzheimer's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko05012	Parkinson's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko05016	Huntington's disease	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003025	K02084	ko05222	Small cell lung cancer	277	3.6e-06	0.27	0.46	0.52
PGSC0003DMG200003032	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMG200003032	K00517	ko00626	Naphthalene and anthracene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMG200003032	K00517	ko00903	Limonene and pinene degradation	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMG200003032	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMG200003032	K00517	ko01110	Biosynthesis of secondary metabolites	1434	2.9e-73	0.42	0.60	0.95
PGSC0003DMG200003032	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMG200003032	K00517	ko00626	Naphthalene and anthracene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMG200003032	K00517	ko00903	Limonene and pinene degradation	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMG200003032	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMG200003032	K00517	ko01110	Biosynthesis of secondary metabolites	760	4.4e-36	0.50	0.69	0.97
PGSC0003DMG200003033	K05293	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMG200003033	K05293	ko01100	Metabolic pathways	693	2.2e-32	0.33	0.50	0.88
PGSC0003DMG200003034	K09843	ko00906	Carotenoid biosynthesis	385	2.1e-15	0.34	0.58	0.82
PGSC0003DMG200003034	K09587	ko00905	Brassinosteroid biosynthesis	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMG200003034	K09587	ko01100	Metabolic pathways	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMG200003034	K09587	ko01110	Biosynthesis of secondary metabolites	740	5.6e-35	0.43	0.60	0.96
PGSC0003DMG200003035	K04424	ko04010	MAPK signaling pathway	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMG200003035	K04424	ko04530	Tight junction	1304	4.4e-66	0.49	0.67	0.50
PGSC0003DMG200008007	K00759	ko00230	Purine metabolism	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMG200008007	K00759	ko01100	Metabolic pathways	283	9.0e-10	0.81	0.91	0.64
PGSC0003DMG200008011	K09054	ko05010	Alzheimer's disease	288	9.7e-08	0.31	0.47	0.48
PGSC0003DMG200008011	K09054	ko05010	Alzheimer's disease	280	3.0e-07	0.31	0.47	0.46
PGSC0003DMG200008018	K09756	ko00940	Phenylpropanoid biosynthesis	694	1.8e-40	0.45	0.67	0.88
PGSC0003DMG200008018	K09756	ko00940	Phenylpropanoid biosynthesis	1585	1.4e-81	0.45	0.62	0.99
PGSC0003DMG200004325	K01728	ko00040	Pentose and glucuronate interconversions	1359	4.0e-69	0.61	0.77	0.85
PGSC0003DMG200004326	K02704	ko00195	Photosynthesis	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMG200004326	K02704	ko01100	Metabolic pathways	404	3.7e-26	0.76	0.87	0.98
PGSC0003DMG200004334	K00162	ko00010	Glycolysis / Gluconeogenesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko00020	Citrate cycle (TCA cycle)	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko00620	Pyruvate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko00650	Butanoate metabolism	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko01100	Metabolic pathways	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko01110	Biosynthesis of secondary metabolites	2537	4.3e-134	0.83	0.88	1.00
PGSC0003DMG200004334	K00162	ko00010	Glycolysis / Gluconeogenesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko00020	Citrate cycle (TCA cycle)	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko00620	Pyruvate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko00650	Butanoate metabolism	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko01100	Metabolic pathways	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200004334	K00162	ko01110	Biosynthesis of secondary metabolites	2664	4.2e-141	0.90	0.96	0.95
PGSC0003DMG200039274	K05282	ko00904	Diterpenoid biosynthesis	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMG200039274	K05282	ko01100	Metabolic pathways	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMG200039274	K05282	ko01110	Biosynthesis of secondary metabolites	268	1.5e-20	0.57	0.71	0.70
PGSC0003DMG200037775	K00901	ko00561	Glycerolipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMG200037775	K00901	ko00564	Glycerophospholipid metabolism	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMG200037775	K00901	ko01100	Metabolic pathways	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMG200037775	K00901	ko04070	Phosphatidylinositol signaling system	250	5.4e-06	0.31	0.59	0.28
PGSC0003DMG200024745	K08065	ko04612	Antigen processing and presentation	470	4.3e-20	0.53	0.76	0.76
PGSC0003DMG200024746	K11984	ko03040	Spliceosome	1080	9.9e-54	0.51	0.64	0.93
PGSC0003DMG200024746	K11984	ko03040	Spliceosome	869	4.3e-42	0.52	0.64	0.93
PGSC0003DMG200024748	K11251	ko05322	Systemic lupus erythematosus	999	2.9e-49	0.79	0.86	0.99
PGSC0003DMG200024752	K00799	ko00480	Glutathione metabolism	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMG200024752	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMG200024752	K00799	ko00982	Drug metabolism - cytochrome P450	639	2.1e-29	0.44	0.63	0.90
PGSC0003DMG200024754	K08008	ko04145	Phagosome	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMG200024754	K08008	ko04670	Leukocyte transendothelial migration	1224	1.1e-61	0.33	0.50	0.63
PGSC0003DMG200024757	K02947	ko03010	Ribosome	1488	3.1e-76	0.92	0.96	0.98
PGSC0003DMG200024759	K12890	ko03040	Spliceosome	1333	1.1e-67	0.85	0.91	0.54
PGSC0003DMG200024759	K12890	ko03040	Spliceosome	1629	5.2e-84	0.73	0.79	0.98
PGSC0003DMG200024759	K12890	ko03040	Spliceosome	1464	6.5e-75	0.67	0.74	0.87
PGSC0003DMG200021035	K02965	ko03010	Ribosome	520	7.6e-23	0.68	0.80	0.96
PGSC0003DMG200001972	K02703	ko00195	Photosynthesis	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMG200001972	K02703	ko01100	Metabolic pathways	274	2.8e-09	0.76	0.80	0.45
PGSC0003DMG200001976	K00469	ko00053	Ascorbate and aldarate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMG200001976	K00469	ko00562	Inositol phosphate metabolism	1991	5.6e-104	0.79	0.88	0.51
PGSC0003DMG200001976	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.68
PGSC0003DMG200001976	K08311	ko03018	RNA degradation	637	2.7e-29	0.50	0.64	0.96
PGSC0003DMG200001977	K02183	ko04020	Calcium signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04070	Phosphatidylinositol signaling system	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04114	Oocyte meiosis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04270	Vascular smooth muscle contraction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04626	Plant-pathogen interaction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04720	Long-term potentiation	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04722	Neurotrophin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04740	Olfactory transduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04744	Phototransduction	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04745	Phototransduction - fly	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04910	Insulin signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04912	GnRH signaling pathway	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04916	Melanogenesis	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04970	Salivary secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko04971	Gastric acid secretion	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko05010	Alzheimer's disease	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001977	K02183	ko05214	Glioma	238	2.7e-07	0.36	0.61	0.97
PGSC0003DMG200001978	K00365	ko00230	Purine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMG200001978	K00365	ko00232	Caffeine metabolism	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMG200001978	K00365	ko01100	Metabolic pathways	1984	1.4e-103	0.76	0.86	1.00
PGSC0003DMG200001978	K03885	ko00190	Oxidative phosphorylation	474	3.4e-20	0.33	0.45	0.90
PGSC0003DMG200001979	K02084	ko04115	p53 signaling pathway	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko04210	Apoptosis	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko05010	Alzheimer's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko05012	Parkinson's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko05016	Huntington's disease	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001979	K02084	ko05222	Small cell lung cancer	301	4.3e-07	0.27	0.45	0.50
PGSC0003DMG200001981	K02084	ko04115	p53 signaling pathway	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko04210	Apoptosis	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko05010	Alzheimer's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko05012	Parkinson's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko05016	Huntington's disease	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001981	K02084	ko05222	Small cell lung cancer	279	3.3e-06	0.25	0.46	0.69
PGSC0003DMG200001982	K02084	ko04115	p53 signaling pathway	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko04210	Apoptosis	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko05010	Alzheimer's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko05012	Parkinson's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko05016	Huntington's disease	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001982	K02084	ko05222	Small cell lung cancer	260	1.2e-06	0.28	0.41	0.98
PGSC0003DMG200001983	K02084	ko04115	p53 signaling pathway	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko04210	Apoptosis	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko05010	Alzheimer's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko05012	Parkinson's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko05016	Huntington's disease	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001983	K02084	ko05222	Small cell lung cancer	286	2.7e-06	0.26	0.45	0.51
PGSC0003DMG200001984	K02084	ko04115	p53 signaling pathway	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko04210	Apoptosis	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko05010	Alzheimer's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko05012	Parkinson's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko05016	Huntington's disease	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K02084	ko05222	Small cell lung cancer	322	2.7e-08	0.26	0.47	0.47
PGSC0003DMG200001984	K12198	ko04144	Endocytosis	1692	1.7e-87	0.86	0.94	1.00
PGSC0003DMG200001988	K01081	ko00230	Purine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko00240	Pyrimidine metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko00760	Nicotinate and nicotinamide metabolism	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko01100	Metabolic pathways	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200001988	K01081	ko01110	Biosynthesis of secondary metabolites	304	6.2e-11	0.41	0.62	0.86
PGSC0003DMG200005498	K10527	ko00592	alpha-Linolenic acid metabolism	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMG200005498	K10527	ko01100	Metabolic pathways	3423	5.8e-183	0.63	0.79	0.98
PGSC0003DMG200005499	K10527	ko00592	alpha-Linolenic acid metabolism	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMG200005499	K10527	ko01100	Metabolic pathways	2974	3.4e-158	0.64	0.81	0.99
PGSC0003DMG200005499	K10527	ko00592	alpha-Linolenic acid metabolism	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMG200005499	K10527	ko01100	Metabolic pathways	3654	1.1e-195	0.62	0.80	1.00
PGSC0003DMG200005499	K10527	ko00592	alpha-Linolenic acid metabolism	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMG200005499	K10527	ko01100	Metabolic pathways	3679	4.4e-197	0.63	0.80	1.00
PGSC0003DMG200005500	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko04144	Endocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko04666	Fc gamma R-mediated phagocytosis	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005500	K01528	ko05100	Bacterial invasion of epithelial cells	366	1.7e-11	0.25	0.42	0.94
PGSC0003DMG200005507	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMG200005507	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2771	5.3e-147	0.79	0.90	0.99
PGSC0003DMG200005508	K01199	ko00500	Starch and sucrose metabolism	707	3.7e-33	0.34	0.54	0.67
PGSC0003DMG200005515	K00423	ko00053	Ascorbate and aldarate metabolism	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMG200005515	K00423	ko01100	Metabolic pathways	1224	1.1e-61	0.45	0.61	1.00
PGSC0003DMG200005515	K00423	ko00053	Ascorbate and aldarate metabolism	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMG200005515	K00423	ko01100	Metabolic pathways	2237	1.5e-117	0.47	0.64	0.95
PGSC0003DMG200008575	K01593	ko00340	Histidine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00350	Tyrosine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00360	Phenylalanine metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00380	Tryptophan metabolism	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00901	Indole alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00965	Betalain biosynthesis	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko01100	Metabolic pathways	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko01110	Biosynthesis of secondary metabolites	1631	4.0e-84	0.79	0.89	0.86
PGSC0003DMG200008575	K01593	ko00340	Histidine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00350	Tyrosine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00360	Phenylalanine metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00380	Tryptophan metabolism	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00901	Indole alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00950	Isoquinoline alkaloid biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00965	Betalain biosynthesis	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko01100	Metabolic pathways	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko01110	Biosynthesis of secondary metabolites	3367	7.1e-180	0.82	0.92	0.98
PGSC0003DMG200008575	K01593	ko00340	Histidine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00350	Tyrosine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00360	Phenylalanine metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00380	Tryptophan metabolism	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00901	Indole alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko00965	Betalain biosynthesis	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko01100	Metabolic pathways	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008575	K01593	ko01110	Biosynthesis of secondary metabolites	1770	8.6e-92	0.83	0.91	0.97
PGSC0003DMG200008576	K05666	ko02010	ABC transporters	3248	2.6e-173	0.37	0.56	0.89
PGSC0003DMG200008576	K05666	ko02010	ABC transporters	3310	9.9e-177	0.36	0.55	0.91
PGSC0003DMG200008576	K05673	ko02010	ABC transporters	1972	6.2e-103	0.36	0.54	0.78
PGSC0003DMG200008576	K05666	ko02010	ABC transporters	484	7.4e-20	0.35	0.52	0.94
PGSC0003DMG200008576	K05666	ko02010	ABC transporters	1473	2.1e-75	0.47	0.70	0.96
PGSC0003DMG200008577	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko00190	Oxidative phosphorylation	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko01100	Metabolic pathways	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05010	Alzheimer's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05012	Parkinson's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008577	K03953	ko05016	Huntington's disease	2665	3.7e-141	0.78	0.89	1.00
PGSC0003DMG200008580	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.50
PGSC0003DMG200008580	K03707	ko00730	Thiamine metabolism	422	1.9e-17	0.34	0.53	0.40
PGSC0003DMG200008582	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	465	2.5e-19	0.37	0.49	0.85
PGSC0003DMG200008585	K08903	ko00195	Photosynthesis	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMG200008585	K08903	ko01100	Metabolic pathways	1066	5.8e-53	0.72	0.82	0.99
PGSC0003DMG200008588	K01768	ko00230	Purine metabolism	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMG200008588	K01768	ko04113	Meiosis - yeast	361	1.5e-08	0.30	0.46	0.54
PGSC0003DMG200047110	K03094	ko04110	Cell cycle	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04111	Cell cycle - yeast	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04114	Oocyte meiosis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04120	Ubiquitin mediated proteolysis	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04310	Wnt signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04350	TGF-beta signaling pathway	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047110	K03094	ko04710	Circadian rhythm - mammal	364	3.1e-14	0.72	0.82	0.90
PGSC0003DMG200047121	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMG200047121	K00517	ko00626	Naphthalene and anthracene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMG200047121	K00517	ko00903	Limonene and pinene degradation	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMG200047121	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMG200047121	K00517	ko01110	Biosynthesis of secondary metabolites	1427	7.2e-73	0.43	0.59	1.00
PGSC0003DMG200047128	K01754	ko00260	Glycine, serine and threonine metabolism	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMG200047128	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMG200047128	K01754	ko01100	Metabolic pathways	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMG200047128	K01754	ko01110	Biosynthesis of secondary metabolites	3140	2.4e-167	0.64	0.79	0.99
PGSC0003DMG200047133	K10760	ko00908	Zeatin biosynthesis	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMG200047133	K10760	ko01100	Metabolic pathways	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMG200047133	K10760	ko01110	Biosynthesis of secondary metabolites	250	5.9e-08	0.71	0.93	0.79
PGSC0003DMG200041923	K12836	ko03040	Spliceosome	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMG200041923	K12836	ko05131	Shigellosis	877	1.5e-42	0.76	0.83	0.92
PGSC0003DMG200041935	K01051	ko00040	Pentose and glucuronate interconversions	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMG200041935	K01051	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMG200041935	K01051	ko01100	Metabolic pathways	418	3.2e-17	0.44	0.60	0.59
PGSC0003DMG200020034	K01853	ko00100	Steroid biosynthesis	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMG200020034	K01853	ko01100	Metabolic pathways	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMG200020034	K01853	ko01110	Biosynthesis of secondary metabolites	4653	8.4e-251	0.69	0.82	0.98
PGSC0003DMG200020034	K01853	ko00100	Steroid biosynthesis	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMG200020034	K01853	ko01100	Metabolic pathways	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMG200020034	K01853	ko01110	Biosynthesis of secondary metabolites	4640	4.4e-250	0.69	0.82	0.99
PGSC0003DMG200020035	K01590	ko00340	Histidine metabolism	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMG200020035	K01590	ko01100	Metabolic pathways	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMG200020035	K01590	ko01110	Biosynthesis of secondary metabolites	388	2.3e-33	0.53	0.72	0.80
PGSC0003DMG200020045	K12621	ko03018	RNA degradation	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMG200020045	K12621	ko03040	Spliceosome	660	1.4e-30	0.93	0.96	0.99
PGSC0003DMG200020045	K12621	ko03018	RNA degradation	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMG200020045	K12621	ko03040	Spliceosome	346	3.0e-13	0.89	0.96	0.73
PGSC0003DMG200020053	K04120	ko00904	Diterpenoid biosynthesis	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMG200020053	K04120	ko01100	Metabolic pathways	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMG200020053	K04120	ko01110	Biosynthesis of secondary metabolites	3767	6.2e-202	0.63	0.79	1.00
PGSC0003DMG200020055	K02974	ko03010	Ribosome	1060	1.2e-52	0.95	0.98	0.99
PGSC0003DMG200023640	K04733	ko04210	Apoptosis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMG200023640	K04733	ko04620	Toll-like receptor signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMG200023640	K04733	ko04722	Neurotrophin signaling pathway	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMG200023640	K04733	ko05140	Leishmaniasis	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMG200023640	K04733	ko05142	Chagas disease	693	2.2e-32	0.36	0.58	0.88
PGSC0003DMG200023644	K03035	ko03050	Proteasome	3171	4.6e-169	0.86	0.94	1.00
PGSC0003DMG200023645	K02084	ko04115	p53 signaling pathway	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko04210	Apoptosis	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko05010	Alzheimer's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko05012	Parkinson's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko05016	Huntington's disease	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200023645	K02084	ko05222	Small cell lung cancer	296	6.3e-07	0.26	0.43	0.70
PGSC0003DMG200026627	K03405	ko00860	Porphyrin and chlorophyll metabolism	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMG200026627	K03405	ko01100	Metabolic pathways	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMG200026627	K03405	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.67	0.72	0.99
PGSC0003DMG200026627	K03405	ko00860	Porphyrin and chlorophyll metabolism	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMG200026627	K03405	ko01100	Metabolic pathways	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMG200026627	K03405	ko01110	Biosynthesis of secondary metabolites	2981	1.4e-158	0.86	0.91	1.00
PGSC0003DMG200026629	K13065	ko00940	Phenylpropanoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMG200026629	K13065	ko00941	Flavonoid biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMG200026629	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMG200026629	K13065	ko01110	Biosynthesis of secondary metabolites	306	1.7e-09	0.25	0.43	0.91
PGSC0003DMG200026632	K13065	ko00940	Phenylpropanoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMG200026632	K13065	ko00941	Flavonoid biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMG200026632	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMG200026632	K13065	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.28	0.42	0.93
PGSC0003DMG200026648	K03178	ko04120	Ubiquitin mediated proteolysis	7544	0.	0.80	0.90	1.00
PGSC0003DMG200026648	K03178	ko05012	Parkinson's disease	7544	0.	0.80	0.90	1.00
PGSC0003DMG200026649	K08059	ko04612	Antigen processing and presentation	802	2.1e-38	0.48	0.67	0.84
PGSC0003DMG200026649	K08059	ko04612	Antigen processing and presentation	442	1.5e-18	0.43	0.63	0.90
PGSC0003DMG200029204	K04382	ko04111	Cell cycle - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04113	Meiosis - yeast	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04114	Oocyte meiosis	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04310	Wnt signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04350	TGF-beta signaling pathway	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04530	Tight junction	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko04730	Long-term depression	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029204	K04382	ko05142	Chagas disease	2522	2.9e-133	0.94	0.96	0.99
PGSC0003DMG200029208	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMG200029208	K00517	ko00626	Naphthalene and anthracene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMG200029208	K00517	ko00903	Limonene and pinene degradation	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMG200029208	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMG200029208	K00517	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.56	0.74	0.91
PGSC0003DMG200029212	K01728	ko00040	Pentose and glucuronate interconversions	1586	1.2e-81	0.67	0.83	0.82
PGSC0003DMG200029213	K09755	ko00940	Phenylpropanoid biosynthesis	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMG200029213	K09755	ko01100	Metabolic pathways	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMG200029213	K09755	ko01110	Biosynthesis of secondary metabolites	1303	4.9e-66	0.39	0.60	0.98
PGSC0003DMG200029215	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMG200029215	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.71
PGSC0003DMG200029215	K07748	ko00100	Steroid biosynthesis	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMG200029215	K07748	ko01100	Metabolic pathways	1211	5.9e-61	0.55	0.71	0.97
PGSC0003DMG200029215	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMG200029215	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMG200029215	K07748	ko00100	Steroid biosynthesis	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMG200029215	K07748	ko01100	Metabolic pathways	1507	2.8e-77	0.52	0.69	0.65
PGSC0003DMG200043125	K02155	ko00190	Oxidative phosphorylation	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko01100	Metabolic pathways	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko04142	Lysosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko04145	Phagosome	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko04966	Collecting duct acid secretion	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko05110	Vibrio cholerae infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043125	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	264	1.0e-08	0.70	0.74	0.55
PGSC0003DMG200043144	K03094	ko04110	Cell cycle	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04111	Cell cycle - yeast	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04114	Oocyte meiosis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04120	Ubiquitin mediated proteolysis	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04310	Wnt signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04350	TGF-beta signaling pathway	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200043144	K03094	ko04710	Circadian rhythm - mammal	749	1.8e-35	0.61	0.73	0.99
PGSC0003DMG200002651	K05581	ko00190	Oxidative phosphorylation	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMG200002651	K05581	ko01100	Metabolic pathways	744	3.4e-35	0.93	0.96	0.87
PGSC0003DMG200002660	K09054	ko05010	Alzheimer's disease	276	5.5e-07	0.30	0.44	0.65
PGSC0003DMG200002661	K03531	ko04112	Cell cycle - Caulobacter	2227	5.4e-117	0.79	0.88	0.97
PGSC0003DMG200002661	K03531	ko04112	Cell cycle - Caulobacter	1025	1.1e-50	0.89	0.94	0.99
PGSC0003DMG200002661	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMG200002661	K03531	ko04112	Cell cycle - Caulobacter	3230	2.6e-172	0.82	0.90	1.00
PGSC0003DMG200009219	K00627	ko00010	Glycolysis / Gluconeogenesis	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMG200009219	K00627	ko00020	Citrate cycle (TCA cycle)	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMG200009219	K00627	ko00620	Pyruvate metabolism	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMG200009219	K00627	ko01100	Metabolic pathways	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMG200009219	K00627	ko01110	Biosynthesis of secondary metabolites	2890	1.5e-153	0.76	0.85	1.00
PGSC0003DMG200009224	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMG200009224	K03434	ko01100	Metabolic pathways	1130	1.7e-56	0.55	0.70	1.00
PGSC0003DMG200009224	K03434	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMG200009224	K03434	ko01100	Metabolic pathways	1514	1.1e-77	0.68	0.84	1.00
PGSC0003DMG200009228	K01190	ko00052	Galactose metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMG200009228	K01190	ko00511	Other glycan degradation	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMG200009228	K01190	ko00600	Sphingolipid metabolism	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMG200009228	K01190	ko01100	Metabolic pathways	2190	5.9e-115	0.44	0.59	0.84
PGSC0003DMG200009228	K01190	ko00052	Galactose metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMG200009228	K01190	ko00511	Other glycan degradation	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMG200009228	K01190	ko00600	Sphingolipid metabolism	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMG200009228	K01190	ko01100	Metabolic pathways	2097	8.0e-110	0.42	0.57	0.97
PGSC0003DMG200009228	K01190	ko00052	Galactose metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMG200009228	K01190	ko00511	Other glycan degradation	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMG200009228	K01190	ko00600	Sphingolipid metabolism	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMG200009228	K01190	ko01100	Metabolic pathways	412	1.4e-16	0.62	0.74	0.87
PGSC0003DMG200009228	K01190	ko00052	Galactose metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMG200009228	K01190	ko00511	Other glycan degradation	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMG200009228	K01190	ko00600	Sphingolipid metabolism	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMG200009228	K01190	ko01100	Metabolic pathways	1977	3.3e-103	0.46	0.62	0.97
PGSC0003DMG200009228	K01190	ko00052	Galactose metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMG200009228	K01190	ko00511	Other glycan degradation	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMG200009228	K01190	ko00600	Sphingolipid metabolism	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMG200009228	K01190	ko01100	Metabolic pathways	565	2.5e-25	0.42	0.60	0.84
PGSC0003DMG200006144	K11644	ko05016	Huntington's disease	236	3.8e-06	0.27	0.47	0.65
PGSC0003DMG200006147	K04079	ko04612	Antigen processing and presentation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko04621	NOD-like receptor signaling pathway	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko04626	Plant-pathogen interaction	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko04914	Progesterone-mediated oocyte maturation	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko05200	Pathways in cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko05215	Prostate cancer	5509	5.1e-298	0.82	0.91	1.00
PGSC0003DMG200006147	K04079	ko04612	Antigen processing and presentation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K04079	ko04621	NOD-like receptor signaling pathway	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K04079	ko04626	Plant-pathogen interaction	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K04079	ko04914	Progesterone-mediated oocyte maturation	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K04079	ko05200	Pathways in cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K04079	ko05215	Prostate cancer	752	1.2e-35	0.71	0.86	0.99
PGSC0003DMG200006147	K00059	ko00061	Fatty acid biosynthesis	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMG200006147	K00059	ko01040	Biosynthesis of unsaturated fatty acids	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMG200006147	K00059	ko01100	Metabolic pathways	497	1.4e-21	0.33	0.53	0.94
PGSC0003DMG200006149	K08913	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMG200006149	K08913	ko01100	Metabolic pathways	2019	1.6e-105	0.87	0.92	1.00
PGSC0003DMG200011767	K01213	ko00040	Pentose and glucuronate interconversions	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMG200011767	K01213	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMG200011767	K01213	ko01100	Metabolic pathways	459	1.8e-19	0.38	0.60	0.65
PGSC0003DMG200011767	K01213	ko00040	Pentose and glucuronate interconversions	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMG200011767	K01213	ko00500	Starch and sucrose metabolism	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMG200011767	K01213	ko01100	Metabolic pathways	914	1.4e-44	0.36	0.57	0.74
PGSC0003DMG200011772	K01809	ko00051	Fructose and mannose metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMG200011772	K01809	ko00520	Amino sugar and nucleotide sugar metabolism	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMG200011772	K01809	ko01100	Metabolic pathways	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMG200011772	K01809	ko01110	Biosynthesis of secondary metabolites	2291	1.6e-120	0.65	0.82	0.98
PGSC0003DMG200011774	K12929	ko00904	Diterpenoid biosynthesis	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMG200011774	K12929	ko01110	Biosynthesis of secondary metabolites	326	7.9e-12	0.48	0.66	0.93
PGSC0003DMG200011775	K12929	ko00904	Diterpenoid biosynthesis	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMG200011775	K12929	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.38	0.57	0.94
PGSC0003DMG200011775	K12929	ko00904	Diterpenoid biosynthesis	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMG200011775	K12929	ko01110	Biosynthesis of secondary metabolites	1077	1.4e-53	0.44	0.64	0.98
PGSC0003DMG200011776	K05933	ko00270	Cysteine and methionine metabolism	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMG200011776	K05933	ko01110	Biosynthesis of secondary metabolites	1852	2.6e-96	0.69	0.81	0.99
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.43	0.64	0.98
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.45	0.67	0.98
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	537	8.8e-24	0.39	0.62	0.98
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	358	9.4e-14	0.37	0.60	0.90
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1366	1.7e-69	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko00904	Diterpenoid biosynthesis	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMG200011777	K12929	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.44	0.66	0.99
PGSC0003DMG200011778	K10756	ko03030	DNA replication	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMG200011778	K10756	ko03420	Nucleotide excision repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMG200011778	K10756	ko03430	Mismatch repair	2477	8.7e-131	0.82	0.91	1.00
PGSC0003DMG200019316	K00547	ko00270	Cysteine and methionine metabolism	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko01100	Metabolic pathways	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko01110	Biosynthesis of secondary metabolites	2241	9.1e-118	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko00270	Cysteine and methionine metabolism	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko01100	Metabolic pathways	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko01110	Biosynthesis of secondary metabolites	2259	9.2e-119	0.80	0.91	0.96
PGSC0003DMG200019316	K00547	ko00270	Cysteine and methionine metabolism	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMG200019316	K00547	ko01100	Metabolic pathways	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMG200019316	K00547	ko01110	Biosynthesis of secondary metabolites	321	7.2e-12	0.76	0.93	0.85
PGSC0003DMG200019319	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019319	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019319	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019319	K01099	ko00562	Inositol phosphate metabolism	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019319	K01099	ko01100	Metabolic pathways	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019319	K01099	ko04070	Phosphatidylinositol signaling system	675	7.3e-43	0.37	0.56	0.67
PGSC0003DMG200019320	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMG200019320	K00517	ko00626	Naphthalene and anthracene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMG200019320	K00517	ko00903	Limonene and pinene degradation	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMG200019320	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMG200019320	K00517	ko01110	Biosynthesis of secondary metabolites	1317	8.4e-67	0.41	0.61	0.97
PGSC0003DMG200025981	K01509	ko00230	Purine metabolism	1308	2.6e-66	0.42	0.58	0.91
PGSC0003DMG200025986	K08332	ko04140	Regulation of autophagy	376	5.2e-12	0.30	0.46	0.47
PGSC0003DMG200025990	K12585	ko03018	RNA degradation	239	1.6e-06	0.54	0.62	0.82
PGSC0003DMG200022890	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMG200022890	K11517	ko01100	Metabolic pathways	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMG200022890	K11517	ko04146	Peroxisome	1699	7.1e-88	0.56	0.75	0.99
PGSC0003DMG200022890	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMG200022890	K11517	ko01100	Metabolic pathways	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMG200022890	K11517	ko04146	Peroxisome	1408	8.0e-72	0.56	0.75	1.00
PGSC0003DMG200022891	K09458	ko00061	Fatty acid biosynthesis	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMG200022891	K09458	ko01100	Metabolic pathways	3098	4.9e-165	0.72	0.86	0.96
PGSC0003DMG200022891	K09458	ko00061	Fatty acid biosynthesis	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMG200022891	K09458	ko01100	Metabolic pathways	3514	5.6e-188	0.74	0.87	0.98
PGSC0003DMG200022891	K09458	ko00061	Fatty acid biosynthesis	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMG200022891	K09458	ko01100	Metabolic pathways	436	3.3e-18	0.48	0.67	0.92
PGSC0003DMG200022892	K05280	ko00941	Flavonoid biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMG200022892	K05280	ko00944	Flavone and flavonol biosynthesis	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMG200022892	K05280	ko01100	Metabolic pathways	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMG200022892	K05280	ko01110	Biosynthesis of secondary metabolites	1230	5.3e-62	0.39	0.56	0.99
PGSC0003DMG200022892	K05280	ko00941	Flavonoid biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMG200022892	K05280	ko00944	Flavone and flavonol biosynthesis	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMG200022892	K05280	ko01100	Metabolic pathways	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMG200022892	K05280	ko01110	Biosynthesis of secondary metabolites	847	7.0e-41	0.39	0.59	0.95
PGSC0003DMG200022893	K05280	ko00941	Flavonoid biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMG200022893	K05280	ko00944	Flavone and flavonol biosynthesis	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMG200022893	K05280	ko01100	Metabolic pathways	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMG200022893	K05280	ko01110	Biosynthesis of secondary metabolites	1681	7.0e-87	0.43	0.63	0.98
PGSC0003DMG200022894	K00454	ko00591	Linoleic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMG200022894	K00454	ko00592	alpha-Linolenic acid metabolism	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMG200022894	K00454	ko01100	Metabolic pathways	2129	1.4e-111	0.77	0.90	1.00
PGSC0003DMG200022894	K00454	ko00591	Linoleic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMG200022894	K00454	ko00592	alpha-Linolenic acid metabolism	5702	0.	0.72	0.84	1.00
PGSC0003DMG200022894	K00454	ko01100	Metabolic pathways	5702	0.	0.72	0.84	1.00
PGSC0003DMG200022894	K00454	ko00591	Linoleic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMG200022894	K00454	ko00592	alpha-Linolenic acid metabolism	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMG200022894	K00454	ko01100	Metabolic pathways	3106	1.8e-165	0.78	0.90	1.00
PGSC0003DMG200022899	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMG200022899	K07195	ko04910	Insulin signaling pathway	3490	1.2e-186	0.68	0.81	1.00
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1617	2.4e-83	0.57	0.72	0.98
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1606	9.6e-83	0.55	0.73	0.92
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1663	6.9e-86	0.59	0.71	0.98
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	1799	2.2e-93	0.61	0.77	0.98
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	878	1.4e-42	0.63	0.81	0.92
PGSC0003DMG200022901	K11517	ko00630	Glyoxylate and dicarboxylate metabolism	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMG200022901	K11517	ko01100	Metabolic pathways	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMG200022901	K11517	ko04146	Peroxisome	737	8.2e-35	0.75	0.87	0.91
PGSC0003DMG200038064	K05350	ko00460	Cyanoamino acid metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMG200038064	K05350	ko00500	Starch and sucrose metabolism	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMG200038064	K05350	ko00940	Phenylpropanoid biosynthesis	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMG200038064	K05350	ko01110	Biosynthesis of secondary metabolites	418	3.2e-17	0.41	0.63	0.96
PGSC0003DMG200017082	K08269	ko04140	Regulation of autophagy	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMG200017082	K08269	ko04150	mTOR signaling pathway	531	1.9e-23	0.35	0.52	0.91
PGSC0003DMG200017083	K08269	ko04140	Regulation of autophagy	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMG200017083	K08269	ko04150	mTOR signaling pathway	528	2.8e-23	0.35	0.52	0.91
PGSC0003DMG200017084	K02183	ko04020	Calcium signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04070	Phosphatidylinositol signaling system	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04114	Oocyte meiosis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04270	Vascular smooth muscle contraction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04626	Plant-pathogen interaction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04720	Long-term potentiation	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04722	Neurotrophin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04740	Olfactory transduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04744	Phototransduction	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04745	Phototransduction - fly	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04910	Insulin signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04912	GnRH signaling pathway	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04916	Melanogenesis	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04970	Salivary secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko04971	Gastric acid secretion	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko05010	Alzheimer's disease	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017084	K02183	ko05214	Glioma	240	2.1e-07	0.33	0.54	0.78
PGSC0003DMG200017088	K03456	ko04111	Cell cycle - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04113	Meiosis - yeast	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04114	Oocyte meiosis	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04310	Wnt signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04350	TGF-beta signaling pathway	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04530	Tight junction	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko04730	Long-term depression	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017088	K03456	ko05142	Chagas disease	333	2.6e-12	0.78	0.87	0.71
PGSC0003DMG200017095	K00849	ko00052	Galactose metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMG200017095	K00849	ko00520	Amino sugar and nucleotide sugar metabolism	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMG200017095	K00849	ko01100	Metabolic pathways	3561	1.4e-190	0.83	0.92	1.00
PGSC0003DMG200017096	K00001	ko00010	Glycolysis / Gluconeogenesis	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00071	Fatty acid metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00350	Tyrosine metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00624	1- and 2-Methylnaphthalene degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00641	3-Chloroacrylic acid degradation	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00830	Retinol metabolism	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko00982	Drug metabolism - cytochrome P450	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko01100	Metabolic pathways	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200017096	K00001	ko01110	Biosynthesis of secondary metabolites	255	3.1e-08	0.51	0.67	0.93
PGSC0003DMG200003628	K03544	ko04112	Cell cycle - Caulobacter	299	1.5e-14	0.48	0.67	0.88
PGSC0003DMG200003629	K02155	ko00190	Oxidative phosphorylation	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko01100	Metabolic pathways	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko04142	Lysosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko04145	Phagosome	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko04966	Collecting duct acid secretion	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko05110	Vibrio cholerae infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003629	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1325	3.0e-67	0.99	0.99	0.99
PGSC0003DMG200003633	K01711	ko00051	Fructose and mannose metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMG200003633	K01711	ko00520	Amino sugar and nucleotide sugar metabolism	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMG200003633	K01711	ko01100	Metabolic pathways	2751	6.7e-146	0.86	0.93	1.00
PGSC0003DMG200003636	K01179	ko00500	Starch and sucrose metabolism	388	1.4e-15	0.47	0.72	0.88
PGSC0003DMG200003636	K01179	ko00500	Starch and sucrose metabolism	1027	8.3e-51	0.46	0.63	0.96
PGSC0003DMG200003636	K01179	ko00500	Starch and sucrose metabolism	674	2.4e-31	0.44	0.60	0.90
PGSC0003DMG200003636	K01179	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.44	0.62	0.95
PGSC0003DMG200003636	K01179	ko00500	Starch and sucrose metabolism	1001	2.2e-49	0.47	0.64	0.89
PGSC0003DMG200007261	K10875	ko03440	Homologous recombination	4786	3.9e-258	0.69	0.79	0.91
PGSC0003DMG200007261	K10875	ko03440	Homologous recombination	5464	1.6e-295	0.74	0.84	0.92
PGSC0003DMG200007268	K01823	ko00900	Terpenoid backbone biosynthesis	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMG200007268	K01823	ko01100	Metabolic pathways	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMG200007268	K01823	ko01110	Biosynthesis of secondary metabolites	1894	1.3e-98	0.80	0.85	0.96
PGSC0003DMG200007277	K04751	ko02020	Two-component system	512	2.1e-22	0.59	0.78	0.55
PGSC0003DMG200020394	K01184	ko00040	Pentose and glucuronate interconversions	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMG200020394	K01184	ko00500	Starch and sucrose metabolism	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMG200020394	K01184	ko01100	Metabolic pathways	2006	8.3e-105	0.61	0.76	1.00
PGSC0003DMG200020395	K01184	ko00040	Pentose and glucuronate interconversions	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMG200020395	K01184	ko00500	Starch and sucrose metabolism	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMG200020395	K01184	ko01100	Metabolic pathways	1112	1.7e-55	0.55	0.72	0.98
PGSC0003DMG200020396	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMG200020396	K01873	ko00970	Aminoacyl-tRNA biosynthesis	4033	1.3e-216	0.82	0.91	0.96
PGSC0003DMG200020396	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMG200020396	K01873	ko00970	Aminoacyl-tRNA biosynthesis	2444	5.8e-129	0.77	0.87	0.99
PGSC0003DMG200020396	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMG200020396	K01873	ko00970	Aminoacyl-tRNA biosynthesis	6621	0.	0.82	0.91	0.94
PGSC0003DMG200020396	K01873	ko00290	Valine, leucine and isoleucine biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMG200020396	K01873	ko00970	Aminoacyl-tRNA biosynthesis	735	1.1e-34	0.76	0.91	0.94
PGSC0003DMG200020398	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMG200020398	K02367	ko01100	Metabolic pathways	324	1.5e-11	0.29	0.45	0.62
PGSC0003DMG200020400	K01239	ko00230	Purine metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMG200020400	K01239	ko00760	Nicotinate and nicotinamide metabolism	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMG200020400	K01239	ko01100	Metabolic pathways	1151	1.2e-57	0.53	0.70	0.83
PGSC0003DMG200020400	K01239	ko00230	Purine metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMG200020400	K01239	ko00760	Nicotinate and nicotinamide metabolism	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMG200020400	K01239	ko01100	Metabolic pathways	1269	3.7e-64	0.57	0.75	0.84
PGSC0003DMG200020416	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00270	Cysteine and methionine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00330	Arginine and proline metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00350	Tyrosine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00360	Phenylalanine metabolism	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00401	Novobiocin biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00710	Carbon fixation in photosynthetic organisms	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko01100	Metabolic pathways	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020416	K00813	ko01110	Biosynthesis of secondary metabolites	3168	6.7e-169	0.88	0.95	0.97
PGSC0003DMG200020418	K10712	ko00430	Taurine and hypotaurine metabolism	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMG200020418	K10712	ko01100	Metabolic pathways	444	1.2e-18	0.33	0.47	0.89
PGSC0003DMG200021738	K11820	ko00380	Tryptophan metabolism	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMG200021738	K11820	ko00966	Glucosinolate biosynthesis	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMG200021738	K11820	ko01110	Biosynthesis of secondary metabolites	660	1.4e-30	0.43	0.61	0.94
PGSC0003DMG200021739	K01501	ko00380	Tryptophan metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko00460	Cyanoamino acid metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko00632	Benzoate degradation via CoA ligation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko00643	Styrene degradation	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko00910	Nitrogen metabolism	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko01100	Metabolic pathways	528	2.8e-23	0.67	0.83	0.58
PGSC0003DMG200021739	K01501	ko00380	Tryptophan metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko00460	Cyanoamino acid metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko00632	Benzoate degradation via CoA ligation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko00643	Styrene degradation	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko00910	Nitrogen metabolism	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko01100	Metabolic pathways	1089	3.1e-54	0.50	0.67	0.92
PGSC0003DMG200021739	K01501	ko00380	Tryptophan metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021739	K01501	ko00460	Cyanoamino acid metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021739	K01501	ko00632	Benzoate degradation via CoA ligation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021739	K01501	ko00643	Styrene degradation	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021739	K01501	ko00910	Nitrogen metabolism	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021739	K01501	ko01100	Metabolic pathways	908	3.0e-44	0.55	0.71	0.90
PGSC0003DMG200021741	K04424	ko04010	MAPK signaling pathway	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMG200021741	K04424	ko04530	Tight junction	626	1.1e-28	0.33	0.50	0.85
PGSC0003DMG200021744	K02950	ko03010	Ribosome	639	2.1e-29	0.64	0.81	0.78
PGSC0003DMG200021746	K08803	ko05200	Pathways in cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMG200021746	K08803	ko05219	Bladder cancer	324	1.6e-09	0.36	0.49	0.44
PGSC0003DMG200021747	K08064	ko04612	Antigen processing and presentation	557	6.9e-25	0.61	0.79	0.53
PGSC0003DMG200021747	K08064	ko04612	Antigen processing and presentation	669	4.6e-31	0.45	0.65	0.70
PGSC0003DMG200021752	K00797	ko00270	Cysteine and methionine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMG200021752	K00797	ko00330	Arginine and proline metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMG200021752	K00797	ko00410	beta-Alanine metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMG200021752	K00797	ko00480	Glutathione metabolism	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMG200021752	K00797	ko01100	Metabolic pathways	1927	1.9e-100	0.77	0.89	0.87
PGSC0003DMG200021752	K00797	ko00270	Cysteine and methionine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMG200021752	K00797	ko00330	Arginine and proline metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMG200021752	K00797	ko00410	beta-Alanine metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMG200021752	K00797	ko00480	Glutathione metabolism	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMG200021752	K00797	ko01100	Metabolic pathways	2221	1.2e-116	0.81	0.91	0.99
PGSC0003DMG200021753	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMG200021753	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMG200021753	K02985	ko03010	Ribosome	1785	1.3e-92	0.92	0.95	1.00
PGSC0003DMG200021753	K02985	ko03010	Ribosome	1798	2.5e-93	0.92	0.95	1.00
PGSC0003DMG200025407	K00162	ko00010	Glycolysis / Gluconeogenesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko00020	Citrate cycle (TCA cycle)	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko00620	Pyruvate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko00650	Butanoate metabolism	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko01100	Metabolic pathways	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko01110	Biosynthesis of secondary metabolites	2461	6.7e-130	0.83	0.92	0.94
PGSC0003DMG200025407	K00162	ko00010	Glycolysis / Gluconeogenesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko00020	Citrate cycle (TCA cycle)	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko00620	Pyruvate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko00650	Butanoate metabolism	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko01100	Metabolic pathways	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko01110	Biosynthesis of secondary metabolites	1509	2.1e-77	0.86	0.94	0.99
PGSC0003DMG200025407	K00162	ko00010	Glycolysis / Gluconeogenesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko00020	Citrate cycle (TCA cycle)	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko00620	Pyruvate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko00650	Butanoate metabolism	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko01100	Metabolic pathways	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025407	K00162	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.79	0.88	0.95
PGSC0003DMG200025410	K01692	ko00071	Fatty acid metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00280	Valine, leucine and isoleucine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00281	Geraniol degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00310	Lysine degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00380	Tryptophan metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00410	beta-Alanine metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00632	Benzoate degradation via CoA ligation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00640	Propanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00650	Butanoate metabolism	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00903	Limonene and pinene degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko00930	Caprolactam degradation	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko01100	Metabolic pathways	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025410	K01692	ko01110	Biosynthesis of secondary metabolites	1698	8.1e-88	0.75	0.87	1.00
PGSC0003DMG200025414	K12135	ko04712	Circadian rhythm - plant	316	1.4e-11	0.38	0.57	0.21
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	2345	1.7e-123	0.63	0.76	0.94
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	4503	1.6e-242	0.60	0.76	1.00
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	1799	2.2e-93	0.48	0.64	0.94
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	3061	5.4e-163	0.74	0.88	0.99
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMG200025422	K03654	ko03018	RNA degradation	809	8.7e-39	0.43	0.63	1.00
PGSC0003DMG200028518	K05933	ko00270	Cysteine and methionine metabolism	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMG200028518	K05933	ko01110	Biosynthesis of secondary metabolites	260	1.7e-08	0.38	0.53	0.73
PGSC0003DMG200028521	K09753	ko00940	Phenylpropanoid biosynthesis	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMG200028521	K09753	ko01100	Metabolic pathways	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMG200028521	K09753	ko01110	Biosynthesis of secondary metabolites	1493	1.6e-76	0.71	0.86	1.00
PGSC0003DMG200028521	K09753	ko00940	Phenylpropanoid biosynthesis	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMG200028521	K09753	ko01100	Metabolic pathways	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMG200028521	K09753	ko01110	Biosynthesis of secondary metabolites	2101	4.8e-110	0.73	0.87	0.99
PGSC0003DMG200028521	K09753	ko00940	Phenylpropanoid biosynthesis	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMG200028521	K09753	ko01100	Metabolic pathways	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMG200028521	K09753	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.78	0.88	1.00
PGSC0003DMG200028524	K02937	ko03010	Ribosome	1389	8.9e-71	0.67	0.83	1.00
PGSC0003DMG200018428	K12796	ko04621	NOD-like receptor signaling pathway	369	8.8e-11	0.31	0.46	0.40
PGSC0003DMG200018434	K08901	ko00195	Photosynthesis	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMG200018434	K08901	ko01100	Metabolic pathways	559	5.4e-25	0.44	0.57	0.99
PGSC0003DMG200018434	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMG200018434	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMG200018434	K08901	ko00195	Photosynthesis	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMG200018434	K08901	ko01100	Metabolic pathways	743	3.8e-35	0.52	0.67	0.99
PGSC0003DMG200018437	K03349	ko04110	Cell cycle	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018437	K03349	ko04111	Cell cycle - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018437	K03349	ko04113	Meiosis - yeast	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018437	K03349	ko04114	Oocyte meiosis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018437	K03349	ko04120	Ubiquitin mediated proteolysis	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018437	K03349	ko04914	Progesterone-mediated oocyte maturation	5395	1.0e-291	0.74	0.84	1.00
PGSC0003DMG200018443	K13030	ko00460	Cyanoamino acid metabolism	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMG200018443	K13030	ko01110	Biosynthesis of secondary metabolites	1389	8.9e-71	0.38	0.62	0.99
PGSC0003DMG200018443	K13030	ko00460	Cyanoamino acid metabolism	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMG200018443	K13030	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.37	0.62	0.97
PGSC0003DMG200027289	K12356	ko00940	Phenylpropanoid biosynthesis	732	1.5e-34	0.32	0.51	0.95
PGSC0003DMG200027289	K12356	ko00940	Phenylpropanoid biosynthesis	647	7.5e-30	0.41	0.62	0.69
PGSC0003DMG200027291	K12356	ko00940	Phenylpropanoid biosynthesis	755	8.3e-36	0.36	0.52	0.84
PGSC0003DMG200027301	K13066	ko00940	Phenylpropanoid biosynthesis	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMG200027301	K13066	ko01110	Biosynthesis of secondary metabolites	307	4.3e-11	0.50	0.63	0.94
PGSC0003DMG200027303	K05849	ko04020	Calcium signaling pathway	422	4.9e-17	0.34	0.55	0.50
PGSC0003DMG200027309	K03006	ko00230	Purine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMG200027309	K03006	ko00240	Pyrimidine metabolism	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMG200027309	K03006	ko01100	Metabolic pathways	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMG200027309	K03006	ko03020	RNA polymerase	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMG200027309	K03006	ko05016	Huntington's disease	349	3.3e-12	0.31	0.43	0.92
PGSC0003DMG200020679	K10418	ko04962	Vasopressin-regulated water reabsorption	327	3.4e-12	0.54	0.69	0.34
PGSC0003DMG200020680	K12929	ko00904	Diterpenoid biosynthesis	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMG200020680	K12929	ko01110	Biosynthesis of secondary metabolites	1494	1.4e-76	0.38	0.62	1.00
PGSC0003DMG200020688	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko00440	Phosphonate and phosphinate metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko00564	Glycerophospholipid metabolism	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko01100	Metabolic pathways	2878	6.7e-153	0.80	0.90	1.00
PGSC0003DMG200020688	K00967	ko00440	Phosphonate and phosphinate metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMG200020688	K00967	ko00564	Glycerophospholipid metabolism	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMG200020688	K00967	ko01100	Metabolic pathways	1446	6.4e-74	0.65	0.78	0.88
PGSC0003DMG200020689	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	302	8.0e-11	0.59	0.69	0.66
PGSC0003DMG200020690	K10352	ko04530	Tight junction	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMG200020690	K10352	ko05416	Viral myocarditis	369	2.9e-13	0.27	0.48	0.98
PGSC0003DMG200031428	K08504	ko04130	SNARE interactions in vesicular transport	784	2.1e-37	0.81	0.93	0.62
PGSC0003DMG200031435	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00561	Glycerolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00564	Glycerophospholipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00565	Ether lipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko00600	Sphingolipid metabolism	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko01100	Metabolic pathways	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031435	K01080	ko04666	Fc gamma R-mediated phagocytosis	590	1.0e-26	0.37	0.51	0.90
PGSC0003DMG200031436	K01184	ko00040	Pentose and glucuronate interconversions	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMG200031436	K01184	ko00500	Starch and sucrose metabolism	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMG200031436	K01184	ko01100	Metabolic pathways	1236	2.5e-62	0.43	0.59	0.85
PGSC0003DMG200031437	K11778	ko00900	Terpenoid backbone biosynthesis	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMG200031437	K11778	ko01110	Biosynthesis of secondary metabolites	766	2.1e-36	0.44	0.61	0.99
PGSC0003DMG200031437	K00806	ko00900	Terpenoid backbone biosynthesis	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMG200031437	K00806	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.65	0.65
PGSC0003DMG200031441	K12929	ko00904	Diterpenoid biosynthesis	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMG200031441	K12929	ko01110	Biosynthesis of secondary metabolites	314	3.9e-11	0.40	0.63	0.59
PGSC0003DMG200031445	K12192	ko04144	Endocytosis	1021	1.8e-50	0.77	0.92	0.89
PGSC0003DMG200031445	K12192	ko04144	Endocytosis	1275	1.7e-64	0.75	0.91	0.99
PGSC0003DMG200010436	K01937	ko00240	Pyrimidine metabolism	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMG200010436	K01937	ko01100	Metabolic pathways	549	1.9e-24	0.75	0.84	0.95
PGSC0003DMG200010437	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMG200010437	K02907	ko03010	Ribosome	746	2.6e-35	0.82	0.89	0.97
PGSC0003DMG200010441	K00286	ko00330	Arginine and proline metabolism	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMG200010441	K00286	ko01100	Metabolic pathways	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMG200010441	K00286	ko01110	Biosynthesis of secondary metabolites	1566	1.5e-80	0.74	0.86	1.00
PGSC0003DMG200010441	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko00330	Arginine and proline metabolism	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko01100	Metabolic pathways	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko01110	Biosynthesis of secondary metabolites	1718	6.4e-89	0.76	0.89	1.00
PGSC0003DMG200010441	K00286	ko00330	Arginine and proline metabolism	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMG200010441	K00286	ko01100	Metabolic pathways	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMG200010441	K00286	ko01110	Biosynthesis of secondary metabolites	1074	2.1e-53	0.66	0.85	0.88
PGSC0003DMG200010445	K04424	ko04010	MAPK signaling pathway	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMG200010445	K04424	ko04530	Tight junction	706	1.7e-32	0.35	0.55	0.25
PGSC0003DMG200010448	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMG200010448	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMG200010448	K00972	ko00520	Amino sugar and nucleotide sugar metabolism	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMG200010448	K00972	ko01100	Metabolic pathways	3604	6.0e-193	0.86	0.96	0.99
PGSC0003DMG200014722	K00213	ko00100	Steroid biosynthesis	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMG200014722	K00213	ko01100	Metabolic pathways	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMG200014722	K00213	ko01110	Biosynthesis of secondary metabolites	3179	1.7e-169	0.82	0.90	1.00
PGSC0003DMG200014725	K00430	ko00360	Phenylalanine metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMG200014725	K00430	ko00680	Methane metabolism	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMG200014725	K00430	ko00940	Phenylpropanoid biosynthesis	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMG200014725	K00430	ko01100	Metabolic pathways	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMG200014725	K00430	ko01110	Biosynthesis of secondary metabolites	559	5.4e-25	0.46	0.60	0.74
PGSC0003DMG200014726	K00430	ko00360	Phenylalanine metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMG200014726	K00430	ko00680	Methane metabolism	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMG200014726	K00430	ko00940	Phenylpropanoid biosynthesis	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMG200014726	K00430	ko01100	Metabolic pathways	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMG200014726	K00430	ko01110	Biosynthesis of secondary metabolites	905	4.4e-44	0.51	0.63	0.96
PGSC0003DMG200014727	K00430	ko00360	Phenylalanine metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMG200014727	K00430	ko00680	Methane metabolism	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMG200014727	K00430	ko00940	Phenylpropanoid biosynthesis	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMG200014727	K00430	ko01100	Metabolic pathways	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMG200014727	K00430	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.53	0.69	0.81
PGSC0003DMG200014728	K00430	ko00360	Phenylalanine metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMG200014728	K00430	ko00680	Methane metabolism	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMG200014728	K00430	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMG200014728	K00430	ko01100	Metabolic pathways	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMG200014728	K00430	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.42	0.58	0.81
PGSC0003DMG200014731	K01590	ko00340	Histidine metabolism	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200014731	K01590	ko01100	Metabolic pathways	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200014731	K01590	ko01110	Biosynthesis of secondary metabolites	1126	2.9e-56	0.59	0.75	0.98
PGSC0003DMG200044483	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMG200044483	K00517	ko00626	Naphthalene and anthracene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMG200044483	K00517	ko00903	Limonene and pinene degradation	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMG200044483	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMG200044483	K00517	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.43	0.63	0.98
PGSC0003DMG200044494	K11816	ko00380	Tryptophan metabolism	1300	7.2e-66	0.47	0.64	0.95
PGSC0003DMG200018984	K03936	ko00190	Oxidative phosphorylation	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMG200018984	K03936	ko01100	Metabolic pathways	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMG200018984	K03936	ko05010	Alzheimer's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMG200018984	K03936	ko05012	Parkinson's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMG200018984	K03936	ko05016	Huntington's disease	743	3.8e-35	0.88	0.92	0.82
PGSC0003DMG200018993	K01051	ko00040	Pentose and glucuronate interconversions	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMG200018993	K01051	ko00500	Starch and sucrose metabolism	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMG200018993	K01051	ko01100	Metabolic pathways	2579	2.1e-136	0.57	0.74	0.96
PGSC0003DMG200029692	K02152	ko00190	Oxidative phosphorylation	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029692	K02152	ko01100	Metabolic pathways	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029692	K02152	ko04145	Phagosome	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029692	K02152	ko04966	Collecting duct acid secretion	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029692	K02152	ko05110	Vibrio cholerae infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029692	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	637	2.7e-29	0.71	0.88	0.97
PGSC0003DMG200029693	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMG200029693	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMG200029693	K04424	ko04010	MAPK signaling pathway	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMG200029693	K04424	ko04530	Tight junction	710	1.0e-32	0.35	0.59	0.54
PGSC0003DMG200029701	K12821	ko03040	Spliceosome	247	4.8e-07	0.31	0.40	0.79
PGSC0003DMG200029703	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMG200029703	K03130	ko03022	Basal transcription factors	286	1.3e-09	0.33	0.50	0.28
PGSC0003DMG200029704	K02988	ko03010	Ribosome	1806	8.9e-94	0.72	0.83	1.00
PGSC0003DMG200036557	K12854	ko03040	Spliceosome	440	2.7e-17	0.84	0.90	0.95
PGSC0003DMG200036559	K00588	ko00360	Phenylalanine metabolism	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036559	K00588	ko00940	Phenylpropanoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036559	K00588	ko00941	Flavonoid biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036559	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036559	K00588	ko01100	Metabolic pathways	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036559	K00588	ko01110	Biosynthesis of secondary metabolites	474	2.6e-20	0.53	0.69	0.99
PGSC0003DMG200036569	K10760	ko00908	Zeatin biosynthesis	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMG200036569	K10760	ko01100	Metabolic pathways	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMG200036569	K10760	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.43	0.55	0.87
PGSC0003DMG200026225	K00492	ko00340	Histidine metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00363	Bisphenol A degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00622	Toluene and xylene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00624	1- and 2-Methylnaphthalene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00626	Naphthalene and anthracene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00627	1,4-Dichlorobenzene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00680	Methane metabolism	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko00903	Limonene and pinene degradation	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko01100	Metabolic pathways	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026225	K00492	ko01110	Biosynthesis of secondary metabolites	484	7.3e-21	0.29	0.49	0.81
PGSC0003DMG200026228	K01692	ko00071	Fatty acid metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00280	Valine, leucine and isoleucine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00281	Geraniol degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00310	Lysine degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00380	Tryptophan metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00410	beta-Alanine metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00632	Benzoate degradation via CoA ligation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00640	Propanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00650	Butanoate metabolism	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00903	Limonene and pinene degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00930	Caprolactam degradation	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko01100	Metabolic pathways	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko01110	Biosynthesis of secondary metabolites	1226	8.7e-62	0.66	0.79	0.80
PGSC0003DMG200026228	K01692	ko00071	Fatty acid metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00280	Valine, leucine and isoleucine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00281	Geraniol degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00310	Lysine degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00380	Tryptophan metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00410	beta-Alanine metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00632	Benzoate degradation via CoA ligation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00640	Propanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00650	Butanoate metabolism	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00903	Limonene and pinene degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00930	Caprolactam degradation	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko01100	Metabolic pathways	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.68	0.83	0.99
PGSC0003DMG200026228	K01692	ko00071	Fatty acid metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00280	Valine, leucine and isoleucine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00281	Geraniol degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00310	Lysine degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00380	Tryptophan metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00410	beta-Alanine metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00632	Benzoate degradation via CoA ligation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00640	Propanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00650	Butanoate metabolism	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00903	Limonene and pinene degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00930	Caprolactam degradation	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko01100	Metabolic pathways	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko01110	Biosynthesis of secondary metabolites	1476	1.4e-75	0.78	0.90	1.00
PGSC0003DMG200026228	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00310	Lysine degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026228	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.77	0.92	0.98
PGSC0003DMG200026236	K01074	ko00062	Fatty acid elongation in mitochondria	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMG200026236	K01074	ko01100	Metabolic pathways	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMG200026236	K01074	ko04142	Lysosome	1979	2.6e-103	0.67	0.80	0.97
PGSC0003DMG200004982	K09841	ko00906	Carotenoid biosynthesis	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMG200004982	K09841	ko01100	Metabolic pathways	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMG200004982	K09841	ko01110	Biosynthesis of secondary metabolites	1018	2.6e-50	0.51	0.69	0.90
PGSC0003DMG200004986	K06689	ko04120	Ubiquitin mediated proteolysis	1241	1.3e-62	0.86	0.88	0.99
PGSC0003DMG200004986	K06689	ko04120	Ubiquitin mediated proteolysis	1290	2.6e-65	0.98	0.99	0.99
PGSC0003DMG200004990	K01178	ko00500	Starch and sucrose metabolism	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMG200004990	K01178	ko01100	Metabolic pathways	482	7.7e-20	0.26	0.41	0.98
PGSC0003DMG200004992	K01179	ko00500	Starch and sucrose metabolism	1397	3.2e-71	0.41	0.57	0.75
PGSC0003DMG200004993	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMG200004993	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMG200004993	K00771	ko01100	Metabolic pathways	391	3.6e-15	0.28	0.48	0.79
PGSC0003DMG200004996	K01784	ko00052	Galactose metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMG200004996	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMG200004996	K01784	ko01100	Metabolic pathways	359	5.8e-14	0.73	0.84	0.87
PGSC0003DMG200004996	K01784	ko00052	Galactose metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMG200004996	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMG200004996	K01784	ko01100	Metabolic pathways	1953	7.0e-102	0.79	0.90	0.94
PGSC0003DMG200004996	K01784	ko00052	Galactose metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMG200004996	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMG200004996	K01784	ko01100	Metabolic pathways	2379	2.2e-125	0.79	0.90	0.99
PGSC0003DMG200004996	K01784	ko00052	Galactose metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMG200004996	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMG200004996	K01784	ko01100	Metabolic pathways	386	1.9e-15	0.79	0.90	0.91
PGSC0003DMG200002375	K01918	ko00410	beta-Alanine metabolism	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMG200002375	K01918	ko00770	Pantothenate and CoA biosynthesis	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMG200002375	K01918	ko01100	Metabolic pathways	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMG200002375	K01918	ko01110	Biosynthesis of secondary metabolites	1908	2.1e-99	0.71	0.84	0.99
PGSC0003DMG200002376	K12843	ko03040	Spliceosome	3543	1.4e-189	0.76	0.84	0.69
PGSC0003DMG200002387	K00588	ko00360	Phenylalanine metabolism	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko00940	Phenylpropanoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko00941	Flavonoid biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko01100	Metabolic pathways	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko01110	Biosynthesis of secondary metabolites	957	6.0e-47	0.61	0.80	0.99
PGSC0003DMG200002387	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.92
PGSC0003DMG200002387	K00588	ko00360	Phenylalanine metabolism	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko00940	Phenylpropanoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko00941	Flavonoid biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko01100	Metabolic pathways	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko01110	Biosynthesis of secondary metabolites	1145	2.6e-57	0.61	0.80	0.80
PGSC0003DMG200002387	K00588	ko00360	Phenylalanine metabolism	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200002387	K00588	ko00940	Phenylpropanoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200002387	K00588	ko00941	Flavonoid biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200002387	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200002387	K00588	ko01100	Metabolic pathways	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200002387	K00588	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.63	0.80	0.80
PGSC0003DMG200012945	K12580	ko03018	RNA degradation	5263	1.9e-284	0.71	0.82	1.00
PGSC0003DMG200012945	K12580	ko03018	RNA degradation	5252	7.7e-284	0.71	0.81	1.00
PGSC0003DMG200012947	K05280	ko00941	Flavonoid biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMG200012947	K05280	ko00944	Flavone and flavonol biosynthesis	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMG200012947	K05280	ko01100	Metabolic pathways	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMG200012947	K05280	ko01110	Biosynthesis of secondary metabolites	1592	5.7e-82	0.43	0.62	0.99
PGSC0003DMG200012953	K09755	ko00940	Phenylpropanoid biosynthesis	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMG200012953	K09755	ko01100	Metabolic pathways	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMG200012953	K09755	ko01110	Biosynthesis of secondary metabolites	882	8.2e-43	0.53	0.72	0.98
PGSC0003DMG200012953	K09755	ko00940	Phenylpropanoid biosynthesis	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMG200012953	K09755	ko01100	Metabolic pathways	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMG200012953	K09755	ko01110	Biosynthesis of secondary metabolites	932	1.4e-45	0.52	0.71	0.93
PGSC0003DMG200012957	K02974	ko03010	Ribosome	378	5.2e-15	0.83	0.93	0.96
PGSC0003DMG200009457	K01464	ko00240	Pyrimidine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMG200009457	K01464	ko00410	beta-Alanine metabolism	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMG200009457	K01464	ko00770	Pantothenate and CoA biosynthesis	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMG200009457	K01464	ko00983	Drug metabolism - other enzymes	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMG200009457	K01464	ko01100	Metabolic pathways	2995	2.3e-159	0.71	0.81	0.97
PGSC0003DMG200009457	K01464	ko00240	Pyrimidine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMG200009457	K01464	ko00410	beta-Alanine metabolism	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMG200009457	K01464	ko00770	Pantothenate and CoA biosynthesis	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMG200009457	K01464	ko00983	Drug metabolism - other enzymes	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMG200009457	K01464	ko01100	Metabolic pathways	3603	6.9e-193	0.81	0.91	0.97
PGSC0003DMG200015669	K01199	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.38	0.58	0.53
PGSC0003DMG200015669	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMG200015669	K01199	ko00500	Starch and sucrose metabolism	804	1.6e-38	0.37	0.56	0.66
PGSC0003DMG200015671	K10838	ko03420	Nucleotide excision repair	3553	3.9e-190	0.52	0.68	0.97
PGSC0003DMG200015673	K00795	ko00900	Terpenoid backbone biosynthesis	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMG200015673	K00795	ko01100	Metabolic pathways	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMG200015673	K00795	ko01110	Biosynthesis of secondary metabolites	1752	8.5e-91	0.63	0.79	0.93
PGSC0003DMG200000110	K00635	ko00561	Glycerolipid metabolism	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMG200000110	K00635	ko01100	Metabolic pathways	317	7.9e-10	0.28	0.44	0.76
PGSC0003DMG200000114	K08770	ko03320	PPAR signaling pathway	324	8.0e-12	0.30	0.49	0.52
PGSC0003DMG200000114	K08770	ko03320	PPAR signaling pathway	324	4.9e-12	0.30	0.49	0.64
PGSC0003DMG200000122	K12132	ko04712	Circadian rhythm - plant	1860	9.4e-97	0.54	0.70	0.62
PGSC0003DMG200001003	K08738	ko04115	p53 signaling pathway	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko04210	Apoptosis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05010	Alzheimer's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05012	Parkinson's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05014	Amyotrophic lateral sclerosis (ALS)	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05016	Huntington's disease	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05200	Pathways in cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05210	Colorectal cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05222	Small cell lung cancer	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001003	K08738	ko05416	Viral myocarditis	910	2.3e-44	0.94	0.96	0.99
PGSC0003DMG200001008	K01066	ko00623	2,4-Dichlorobenzoate degradation	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMG200001008	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1363	2.4e-69	0.79	0.92	0.93
PGSC0003DMG200001008	K01066	ko00623	2,4-Dichlorobenzoate degradation	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMG200001008	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	2080	6.9e-109	0.72	0.86	0.96
PGSC0003DMG200040461	K10591	ko04120	Ubiquitin mediated proteolysis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMG200040461	K10591	ko04144	Endocytosis	409	3.8e-16	0.31	0.40	0.76
PGSC0003DMG200040467	K03260	ko05416	Viral myocarditis	316	1.0e-08	0.25	0.41	0.93
PGSC0003DMG200040470	K12183	ko04144	Endocytosis	254	9.6e-08	0.37	0.45	0.61
PGSC0003DMG200022430	K00422	ko00350	Tyrosine metabolism	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMG200022430	K00422	ko00950	Isoquinoline alkaloid biosynthesis	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMG200022430	K00422	ko01100	Metabolic pathways	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMG200022430	K00422	ko01110	Biosynthesis of secondary metabolites	2452	2.1e-129	0.54	0.71	0.99
PGSC0003DMG200022432	K12829	ko03040	Spliceosome	4163	8.9e-224	0.84	0.91	0.98
PGSC0003DMG200022433	K01988	ko00603	Glycosphingolipid biosynthesis - globo series	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMG200022433	K01988	ko01100	Metabolic pathways	454	3.3e-19	0.33	0.50	0.56
PGSC0003DMG200022438	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMG200022438	K12837	ko03040	Spliceosome	1395	4.2e-71	0.61	0.76	0.97
PGSC0003DMG200022438	K12837	ko03040	Spliceosome	2403	1.1e-126	0.57	0.70	0.99
PGSC0003DMG200030407	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMG200030407	K08332	ko04140	Regulation of autophagy	310	8.7e-09	0.30	0.52	0.46
PGSC0003DMG200030407	K08332	ko04140	Regulation of autophagy	310	1.1e-08	0.30	0.52	0.44
PGSC0003DMG200030413	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMG200030413	K00517	ko00626	Naphthalene and anthracene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMG200030413	K00517	ko00903	Limonene and pinene degradation	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMG200030413	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMG200030413	K00517	ko01110	Biosynthesis of secondary metabolites	1765	1.6e-91	0.46	0.66	1.00
PGSC0003DMG200030414	K01199	ko00500	Starch and sucrose metabolism	761	3.9e-36	0.35	0.57	0.70
PGSC0003DMG200030416	K03006	ko00230	Purine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMG200030416	K03006	ko00240	Pyrimidine metabolism	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMG200030416	K03006	ko01100	Metabolic pathways	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMG200030416	K03006	ko03020	RNA polymerase	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMG200030416	K03006	ko05016	Huntington's disease	607	6.1e-26	0.36	0.43	0.45
PGSC0003DMG200030419	K00368	ko00910	Nitrogen metabolism	1682	6.2e-87	0.43	0.58	0.94
PGSC0003DMG200030421	K03122	ko03022	Basal transcription factors	2033	2.7e-106	0.65	0.73	0.83
PGSC0003DMG200030421	K03122	ko03022	Basal transcription factors	2369	7.9e-125	0.70	0.79	1.00
PGSC0003DMG200030422	K07750	ko00100	Steroid biosynthesis	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMG200030422	K07750	ko01100	Metabolic pathways	1696	1.0e-87	0.77	0.85	0.95
PGSC0003DMG200030422	K07750	ko00100	Steroid biosynthesis	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMG200030422	K07750	ko01100	Metabolic pathways	2104	3.3e-110	0.87	0.94	1.00
PGSC0003DMG200030423	K03006	ko00230	Purine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMG200030423	K03006	ko00240	Pyrimidine metabolism	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMG200030423	K03006	ko01100	Metabolic pathways	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMG200030423	K03006	ko03020	RNA polymerase	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMG200030423	K03006	ko05016	Huntington's disease	956	4.7e-46	0.38	0.48	0.93
PGSC0003DMG200030424	K06269	ko04113	Meiosis - yeast	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04114	Oocyte meiosis	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04270	Vascular smooth muscle contraction	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04510	Focal adhesion	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04720	Long-term potentiation	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04810	Regulation of actin cytoskeleton	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200030424	K06269	ko04910	Insulin signaling pathway	2324	2.4e-122	0.86	0.92	1.00
PGSC0003DMG200019701	K03035	ko03050	Proteasome	3109	1.2e-165	0.81	0.88	1.00
PGSC0003DMG200019701	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMG200019701	K03035	ko03050	Proteasome	3176	2.4e-169	0.87	0.93	1.00
PGSC0003DMG200019709	K00454	ko00591	Linoleic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMG200019709	K00454	ko00592	alpha-Linolenic acid metabolism	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMG200019709	K00454	ko01100	Metabolic pathways	397	1.9e-15	0.65	0.77	0.97
PGSC0003DMG200019712	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko04210	Apoptosis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko04620	Toll-like receptor signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko04722	Neurotrophin signaling pathway	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko05140	Leishmaniasis	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200019712	K04733	ko05142	Chagas disease	401	1.1e-15	0.47	0.65	0.84
PGSC0003DMG200035365	K08233	ko00901	Indole alkaloid biosynthesis	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMG200035365	K08233	ko01110	Biosynthesis of secondary metabolites	349	2.1e-13	0.60	0.72	0.94
PGSC0003DMG200035370	K12356	ko00940	Phenylpropanoid biosynthesis	766	2.1e-36	0.32	0.50	0.95
PGSC0003DMG200026909	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3734	4.1e-200	0.79	0.87	0.97
PGSC0003DMG200026909	K04567	ko00970	Aminoacyl-tRNA biosynthesis	402	2.4e-16	0.90	0.98	0.77
PGSC0003DMG200026910	K02940	ko03010	Ribosome	1358	4.6e-69	0.88	0.93	0.99
PGSC0003DMG200026911	K02901	ko03010	Ribosome	1053	3.0e-52	0.90	0.98	0.99
PGSC0003DMG200026913	K01784	ko00052	Galactose metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMG200026913	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMG200026913	K01784	ko01100	Metabolic pathways	1287	3.8e-65	0.48	0.65	0.85
PGSC0003DMG200026913	K01784	ko00052	Galactose metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMG200026913	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMG200026913	K01784	ko01100	Metabolic pathways	1358	4.6e-69	0.53	0.71	0.84
PGSC0003DMG200026914	K02183	ko04020	Calcium signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04070	Phosphatidylinositol signaling system	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04114	Oocyte meiosis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04270	Vascular smooth muscle contraction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04626	Plant-pathogen interaction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04720	Long-term potentiation	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04722	Neurotrophin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04740	Olfactory transduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04744	Phototransduction	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04745	Phototransduction - fly	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04910	Insulin signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04912	GnRH signaling pathway	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04916	Melanogenesis	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04970	Salivary secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04971	Gastric acid secretion	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko05010	Alzheimer's disease	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko05214	Glioma	297	1.5e-10	0.49	0.68	0.90
PGSC0003DMG200026914	K02183	ko04020	Calcium signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04070	Phosphatidylinositol signaling system	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04114	Oocyte meiosis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04270	Vascular smooth muscle contraction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04626	Plant-pathogen interaction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04720	Long-term potentiation	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04722	Neurotrophin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04740	Olfactory transduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04744	Phototransduction	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04745	Phototransduction - fly	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04910	Insulin signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04912	GnRH signaling pathway	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04916	Melanogenesis	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04970	Salivary secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko04971	Gastric acid secretion	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko05010	Alzheimer's disease	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026914	K02183	ko05214	Glioma	462	1.2e-19	0.37	0.57	0.73
PGSC0003DMG200026916	K00847	ko00051	Fructose and mannose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMG200026916	K00847	ko00500	Starch and sucrose metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMG200026916	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMG200026916	K00847	ko01100	Metabolic pathways	2315	7.5e-122	0.86	0.92	0.99
PGSC0003DMG200026923	K00475	ko00941	Flavonoid biosynthesis	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMG200026923	K00475	ko01100	Metabolic pathways	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMG200026923	K00475	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.37	0.59	0.95
PGSC0003DMG200026923	K00475	ko00941	Flavonoid biosynthesis	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMG200026923	K00475	ko01100	Metabolic pathways	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMG200026923	K00475	ko01110	Biosynthesis of secondary metabolites	697	1.3e-32	0.38	0.59	0.95
PGSC0003DMG200047267	K00021	ko00900	Terpenoid backbone biosynthesis	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200047267	K00021	ko01100	Metabolic pathways	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200047267	K00021	ko01110	Biosynthesis of secondary metabolites	627	9.5e-29	0.50	0.65	0.92
PGSC0003DMG200000352	K02111	ko00190	Oxidative phosphorylation	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMG200000352	K02111	ko00195	Photosynthesis	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMG200000352	K02111	ko01100	Metabolic pathways	305	6.5e-11	0.75	0.81	0.95
PGSC0003DMG200000354	K01199	ko00500	Starch and sucrose metabolism	962	3.2e-47	0.39	0.61	0.67
PGSC0003DMG200000355	K01887	ko00970	Aminoacyl-tRNA biosynthesis	2133	8.2e-112	0.82	0.93	0.99
PGSC0003DMG200000355	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMG200000355	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMG200000355	K01887	ko00970	Aminoacyl-tRNA biosynthesis	3928	8.1e-211	0.78	0.88	1.00
PGSC0003DMG200000360	K00029	ko00620	Pyruvate metabolism	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMG200000360	K00029	ko00710	Carbon fixation in photosynthetic organisms	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMG200000360	K00029	ko01100	Metabolic pathways	4078	4.3e-219	0.81	0.92	1.00
PGSC0003DMG200012274	K01784	ko00052	Galactose metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMG200012274	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMG200012274	K01784	ko01100	Metabolic pathways	2422	9.4e-128	0.81	0.90	0.99
PGSC0003DMG200012274	K01784	ko00052	Galactose metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMG200012274	K01784	ko00520	Amino sugar and nucleotide sugar metabolism	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMG200012274	K01784	ko01100	Metabolic pathways	2247	4.2e-118	0.82	0.92	1.00
PGSC0003DMG200012276	K00940	ko00230	Purine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMG200012276	K00940	ko00240	Pyrimidine metabolism	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMG200012276	K00940	ko01100	Metabolic pathways	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMG200012276	K00940	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.81	0.91	1.00
PGSC0003DMG200012284	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012284	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012284	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012284	K00655	ko00561	Glycerolipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012284	K00655	ko00564	Glycerophospholipid metabolism	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012284	K00655	ko01100	Metabolic pathways	1013	4.9e-50	0.41	0.60	0.92
PGSC0003DMG200012288	K01179	ko00500	Starch and sucrose metabolism	1878	9.5e-98	0.48	0.64	0.79
PGSC0003DMG200001690	K02921	ko03010	Ribosome	782	2.7e-37	1.00	1.00	0.99
PGSC0003DMG200001692	K10717	ko00908	Zeatin biosynthesis	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMG200001692	K10717	ko01100	Metabolic pathways	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMG200001692	K10717	ko01110	Biosynthesis of secondary metabolites	1257	1.7e-63	0.36	0.58	0.98
PGSC0003DMG200001692	K10717	ko00908	Zeatin biosynthesis	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMG200001692	K10717	ko01100	Metabolic pathways	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMG200001692	K10717	ko01110	Biosynthesis of secondary metabolites	455	2.9e-19	0.33	0.54	0.98
PGSC0003DMG200001692	K10717	ko00908	Zeatin biosynthesis	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMG200001692	K10717	ko01100	Metabolic pathways	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMG200001692	K10717	ko01110	Biosynthesis of secondary metabolites	734	1.2e-34	0.38	0.61	0.99
PGSC0003DMG200001694	K11294	ko05130	Pathogenic Escherichia coli infection	320	1.4e-11	0.28	0.45	0.97
PGSC0003DMG200001702	K10742	ko03030	DNA replication	5770	0.	0.60	0.74	0.84
PGSC0003DMG200001702	K10742	ko03030	DNA replication	3296	5.9e-176	0.69	0.81	0.99
PGSC0003DMG200008847	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMG200008847	K01469	ko00480	Glutathione metabolism	9222	0.	0.85	0.93	1.00
PGSC0003DMG200008850	K11153	ko00830	Retinol metabolism	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMG200008850	K11153	ko01100	Metabolic pathways	682	8.8e-32	0.48	0.66	0.88
PGSC0003DMG200008850	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00051	Fructose and mannose metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00363	Bisphenol A degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00591	Linoleic acid metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00625	Tetrachloroethene degradation	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko00650	Butanoate metabolism	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K00100	ko01100	Metabolic pathways	333	1.6e-12	0.46	0.63	0.91
PGSC0003DMG200008850	K11153	ko00830	Retinol metabolism	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMG200008850	K11153	ko01100	Metabolic pathways	924	4.0e-45	0.45	0.63	0.91
PGSC0003DMG200008852	K00620	ko00330	Arginine and proline metabolism	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMG200008852	K00620	ko01100	Metabolic pathways	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMG200008852	K00620	ko01110	Biosynthesis of secondary metabolites	2815	2.0e-149	0.76	0.83	1.00
PGSC0003DMG200016402	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016402	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016402	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016402	K05917	ko00100	Steroid biosynthesis	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016402	K05917	ko01100	Metabolic pathways	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016402	K05917	ko01110	Biosynthesis of secondary metabolites	3683	2.7e-197	0.88	0.95	0.99
PGSC0003DMG200016404	K03469	ko03030	DNA replication	296	6.8e-10	0.35	0.51	0.21
PGSC0003DMG200016404	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.61
PGSC0003DMG200016404	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMG200016404	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMG200016404	K03469	ko03030	DNA replication	360	5.1e-14	0.37	0.59	0.52
PGSC0003DMG200016404	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.40
PGSC0003DMG200016404	K03469	ko03030	DNA replication	349	2.1e-13	0.40	0.63	0.48
PGSC0003DMG200017691	K00599	ko00340	Histidine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMG200017691	K00599	ko00350	Tyrosine metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMG200017691	K00599	ko00450	Selenoamino acid metabolism	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMG200017691	K00599	ko00626	Naphthalene and anthracene degradation	1188	1.1e-59	0.37	0.53	0.98
PGSC0003DMG200017691	K00599	ko00340	Histidine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMG200017691	K00599	ko00350	Tyrosine metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMG200017691	K00599	ko00450	Selenoamino acid metabolism	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMG200017691	K00599	ko00626	Naphthalene and anthracene degradation	1254	2.5e-63	0.40	0.56	0.98
PGSC0003DMG200017700	K02183	ko04020	Calcium signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04070	Phosphatidylinositol signaling system	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04114	Oocyte meiosis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04270	Vascular smooth muscle contraction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04626	Plant-pathogen interaction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04720	Long-term potentiation	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04722	Neurotrophin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04740	Olfactory transduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04744	Phototransduction	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04745	Phototransduction - fly	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04910	Insulin signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04912	GnRH signaling pathway	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04916	Melanogenesis	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04970	Salivary secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko04971	Gastric acid secretion	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko05010	Alzheimer's disease	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017700	K02183	ko05214	Glioma	288	4.8e-10	0.48	0.66	0.91
PGSC0003DMG200017702	K01491	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMG200017702	K01491	ko00670	One carbon pool by folate	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMG200017702	K01491	ko01100	Metabolic pathways	473	3.0e-20	0.53	0.74	0.76
PGSC0003DMG200027873	K00658	ko00020	Citrate cycle (TCA cycle)	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMG200027873	K00658	ko00310	Lysine degradation	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMG200027873	K00658	ko01100	Metabolic pathways	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMG200027873	K00658	ko01110	Biosynthesis of secondary metabolites	2604	8.6e-138	0.83	0.90	0.88
PGSC0003DMG200027873	K00658	ko00020	Citrate cycle (TCA cycle)	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMG200027873	K00658	ko00310	Lysine degradation	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMG200027873	K00658	ko01100	Metabolic pathways	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMG200027873	K00658	ko01110	Biosynthesis of secondary metabolites	2979	1.8e-158	0.77	0.86	1.00
PGSC0003DMG200027873	K00658	ko00020	Citrate cycle (TCA cycle)	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMG200027873	K00658	ko00310	Lysine degradation	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMG200027873	K00658	ko01100	Metabolic pathways	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMG200027873	K00658	ko01110	Biosynthesis of secondary metabolites	2650	2.5e-140	0.86	0.92	1.00
PGSC0003DMG200027873	K00658	ko00020	Citrate cycle (TCA cycle)	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMG200027873	K00658	ko00310	Lysine degradation	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMG200027873	K00658	ko01100	Metabolic pathways	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMG200027873	K00658	ko01110	Biosynthesis of secondary metabolites	2789	5.4e-148	0.84	0.92	0.96
PGSC0003DMG200027874	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMG200027874	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMG200027874	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.71
PGSC0003DMG200027874	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMG200027874	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMG200027874	K00734	ko01100	Metabolic pathways	374	8.6e-15	0.31	0.47	0.66
PGSC0003DMG200027875	K02115	ko00190	Oxidative phosphorylation	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMG200027875	K02115	ko00195	Photosynthesis	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMG200027875	K02115	ko01100	Metabolic pathways	2027	5.8e-106	0.70	0.85	0.99
PGSC0003DMG200027878	K10373	ko04260	Cardiac muscle contraction	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMG200027878	K10373	ko05410	Hypertrophic cardiomyopathy (HCM)	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMG200027878	K10373	ko05414	Dilated cardiomyopathy	240	8.5e-07	0.31	0.50	0.39
PGSC0003DMG200033138	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMG200033138	K02367	ko01100	Metabolic pathways	317	6.6e-09	0.27	0.45	0.61
PGSC0003DMG200033139	K13230	ko00402	Benzoxazinoid biosynthesis	895	1.6e-43	0.36	0.57	0.97
PGSC0003DMG200033142	K01193	ko00052	Galactose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMG200033142	K01193	ko00500	Starch and sucrose metabolism	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMG200033142	K01193	ko01100	Metabolic pathways	1967	1.2e-102	0.57	0.73	1.00
PGSC0003DMG200033142	K01193	ko00052	Galactose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMG200033142	K01193	ko00500	Starch and sucrose metabolism	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMG200033142	K01193	ko01100	Metabolic pathways	2624	6.8e-139	0.60	0.74	1.00
PGSC0003DMG200033142	K01193	ko00052	Galactose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMG200033142	K01193	ko00500	Starch and sucrose metabolism	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMG200033142	K01193	ko01100	Metabolic pathways	2627	4.7e-139	0.60	0.75	1.00
PGSC0003DMG200033143	K02877	ko03010	Ribosome	1694	1.3e-87	0.95	0.96	1.00
PGSC0003DMG200033148	K13230	ko00402	Benzoxazinoid biosynthesis	496	1.6e-21	0.33	0.51	0.94
PGSC0003DMG200033153	K02084	ko04115	p53 signaling pathway	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko04210	Apoptosis	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko05010	Alzheimer's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko05012	Parkinson's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko05016	Huntington's disease	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200033153	K02084	ko05222	Small cell lung cancer	312	6.5e-08	0.28	0.46	0.45
PGSC0003DMG200045667	K13065	ko00940	Phenylpropanoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMG200045667	K13065	ko00941	Flavonoid biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMG200045667	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMG200045667	K13065	ko01110	Biosynthesis of secondary metabolites	487	5.0e-21	0.28	0.49	0.91
PGSC0003DMG200045696	K07424	ko00140	Steroid hormone biosynthesis	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00591	Linoleic acid metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00830	Retinol metabolism	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00982	Drug metabolism - cytochrome P450	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko00983	Drug metabolism - other enzymes	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200045696	K07424	ko01100	Metabolic pathways	1004	1.5e-49	0.39	0.60	1.00
PGSC0003DMG200011132	K00131	ko00010	Glycolysis / Gluconeogenesis	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMG200011132	K00131	ko01100	Metabolic pathways	3868	1.7e-207	0.91	0.96	1.00
PGSC0003DMG200011133	K12126	ko04712	Circadian rhythm - plant	338	2.2e-12	0.51	0.76	0.18
PGSC0003DMG200011135	K10255	ko01040	Biosynthesis of unsaturated fatty acids	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMG200011135	K10255	ko02020	Two-component system	2921	2.8e-155	0.81	0.90	0.87
PGSC0003DMG200011138	K00655	ko00561	Glycerolipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMG200011138	K00655	ko00564	Glycerophospholipid metabolism	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMG200011138	K00655	ko01100	Metabolic pathways	1774	5.2e-92	0.58	0.72	1.00
PGSC0003DMG200011138	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K00655	ko00561	Glycerolipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K00655	ko00564	Glycerophospholipid metabolism	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K00655	ko01100	Metabolic pathways	1835	2.2e-95	0.61	0.77	1.00
PGSC0003DMG200011138	K05391	ko04626	Plant-pathogen interaction	4777	1.2e-257	0.79	0.87	0.98
PGSC0003DMG200009904	K09561	ko04120	Ubiquitin mediated proteolysis	253	1.4e-07	0.35	0.51	0.25
PGSC0003DMG200009906	K03781	ko00380	Tryptophan metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMG200009906	K03781	ko00680	Methane metabolism	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMG200009906	K03781	ko01100	Metabolic pathways	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMG200009906	K03781	ko04146	Peroxisome	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMG200009906	K03781	ko05014	Amyotrophic lateral sclerosis (ALS)	4052	1.2e-217	0.91	0.96	1.00
PGSC0003DMG200003314	K01136	ko00531	Glycosaminoglycan degradation	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMG200003314	K01136	ko01100	Metabolic pathways	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMG200003314	K01136	ko04142	Lysosome	243	6.8e-07	0.27	0.42	0.92
PGSC0003DMG200003317	K01199	ko00500	Starch and sucrose metabolism	738	7.2e-35	0.35	0.56	0.69
PGSC0003DMG200003318	K00860	ko00230	Purine metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMG200003318	K00860	ko00450	Selenoamino acid metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMG200003318	K00860	ko00920	Sulfur metabolism	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMG200003318	K00860	ko01100	Metabolic pathways	1442	1.1e-73	0.62	0.78	0.90
PGSC0003DMG200003318	K00860	ko00230	Purine metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMG200003318	K00860	ko00450	Selenoamino acid metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMG200003318	K00860	ko00920	Sulfur metabolism	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMG200003318	K00860	ko01100	Metabolic pathways	1373	6.8e-70	0.75	0.91	1.00
PGSC0003DMG200003322	K01684	ko00052	Galactose metabolism	273	3.2e-09	0.31	0.45	0.83
PGSC0003DMG200003323	K12741	ko03040	Spliceosome	667	5.9e-31	0.46	0.67	0.31
PGSC0003DMG200003324	K00511	ko00100	Steroid biosynthesis	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMG200003324	K00511	ko01100	Metabolic pathways	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMG200003324	K00511	ko01110	Biosynthesis of secondary metabolites	2568	8.4e-136	0.75	0.86	0.97
PGSC0003DMG200003324	K00511	ko00100	Steroid biosynthesis	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMG200003324	K00511	ko01100	Metabolic pathways	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMG200003324	K00511	ko01110	Biosynthesis of secondary metabolites	3521	2.3e-188	0.79	0.89	0.98
PGSC0003DMG200003325	K01762	ko00270	Cysteine and methionine metabolism	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMG200003325	K01762	ko01110	Biosynthesis of secondary metabolites	2971	5.0e-158	0.76	0.85	1.00
PGSC0003DMG200003327	K02918	ko03010	Ribosome	553	1.1e-24	0.89	0.91	0.86
PGSC0003DMG200014052	K01593	ko00340	Histidine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00350	Tyrosine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00360	Phenylalanine metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00380	Tryptophan metabolism	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00901	Indole alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko00965	Betalain biosynthesis	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko01100	Metabolic pathways	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014052	K01593	ko01110	Biosynthesis of secondary metabolites	2359	2.8e-124	0.56	0.75	0.95
PGSC0003DMG200014055	K00430	ko00360	Phenylalanine metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMG200014055	K00430	ko00680	Methane metabolism	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMG200014055	K00430	ko00940	Phenylpropanoid biosynthesis	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMG200014055	K00430	ko01100	Metabolic pathways	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMG200014055	K00430	ko01110	Biosynthesis of secondary metabolites	1921	4.1e-100	0.72	0.82	1.00
PGSC0003DMG200010161	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMG200010161	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.17
PGSC0003DMG200010161	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.19
PGSC0003DMG200010161	K03116	ko03060	Protein export	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMG200010161	K03116	ko03070	Bacterial secretion system	423	1.7e-17	0.84	0.92	0.22
PGSC0003DMG200010162	K12842	ko03040	Spliceosome	6229	0.	0.77	0.88	1.00
PGSC0003DMG200010162	K12842	ko03040	Spliceosome	5627	0.	0.77	0.88	1.00
PGSC0003DMG200010162	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMG200010162	K12842	ko03040	Spliceosome	5621	0.	0.77	0.88	1.00
PGSC0003DMG200014863	K01593	ko00340	Histidine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00350	Tyrosine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00360	Phenylalanine metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00380	Tryptophan metabolism	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00901	Indole alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko00965	Betalain biosynthesis	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko01100	Metabolic pathways	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014863	K01593	ko01110	Biosynthesis of secondary metabolites	2372	5.4e-125	0.57	0.76	0.95
PGSC0003DMG200014867	K00430	ko00360	Phenylalanine metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMG200014867	K00430	ko00680	Methane metabolism	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMG200014867	K00430	ko00940	Phenylpropanoid biosynthesis	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMG200014867	K00430	ko01100	Metabolic pathways	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMG200014867	K00430	ko01110	Biosynthesis of secondary metabolites	1904	3.5e-99	0.69	0.79	1.00
PGSC0003DMG200014869	K05741	ko04810	Regulation of actin cytoskeleton	653	1.9e-28	0.29	0.43	0.60
PGSC0003DMG200014870	K00001	ko00010	Glycolysis / Gluconeogenesis	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00071	Fatty acid metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00350	Tyrosine metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00624	1- and 2-Methylnaphthalene degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00641	3-Chloroacrylic acid degradation	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00830	Retinol metabolism	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko00982	Drug metabolism - cytochrome P450	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko01100	Metabolic pathways	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00001	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.46	0.65	0.96
PGSC0003DMG200014870	K00121	ko00010	Glycolysis / Gluconeogenesis	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00071	Fatty acid metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00350	Tyrosine metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00641	3-Chloroacrylic acid degradation	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00680	Methane metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00830	Retinol metabolism	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00982	Drug metabolism - cytochrome P450	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko01100	Metabolic pathways	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko01110	Biosynthesis of secondary metabolites	1014	4.3e-50	0.44	0.65	0.99
PGSC0003DMG200014870	K00121	ko00010	Glycolysis / Gluconeogenesis	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00071	Fatty acid metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00350	Tyrosine metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00641	3-Chloroacrylic acid degradation	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00680	Methane metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00830	Retinol metabolism	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00982	Drug metabolism - cytochrome P450	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko01100	Metabolic pathways	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko01110	Biosynthesis of secondary metabolites	1083	6.7e-54	0.45	0.66	0.96
PGSC0003DMG200014870	K00121	ko00010	Glycolysis / Gluconeogenesis	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00071	Fatty acid metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00350	Tyrosine metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00641	3-Chloroacrylic acid degradation	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00680	Methane metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00830	Retinol metabolism	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko00982	Drug metabolism - cytochrome P450	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko01100	Metabolic pathways	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014870	K00121	ko01110	Biosynthesis of secondary metabolites	1319	6.5e-67	0.46	0.67	0.98
PGSC0003DMG200014871	K00121	ko00010	Glycolysis / Gluconeogenesis	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00071	Fatty acid metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00350	Tyrosine metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00641	3-Chloroacrylic acid degradation	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00680	Methane metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00830	Retinol metabolism	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko00982	Drug metabolism - cytochrome P450	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko01100	Metabolic pathways	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014871	K00121	ko01110	Biosynthesis of secondary metabolites	1020	2.0e-50	0.44	0.66	0.98
PGSC0003DMG200014872	K00121	ko00010	Glycolysis / Gluconeogenesis	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00071	Fatty acid metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00350	Tyrosine metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00641	3-Chloroacrylic acid degradation	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00680	Methane metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00830	Retinol metabolism	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko00982	Drug metabolism - cytochrome P450	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko01100	Metabolic pathways	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014872	K00121	ko01110	Biosynthesis of secondary metabolites	1005	1.3e-49	0.40	0.57	0.98
PGSC0003DMG200014873	K12846	ko03040	Spliceosome	792	7.6e-38	0.33	0.51	0.97
PGSC0003DMG200014875	K04733	ko04210	Apoptosis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMG200014875	K04733	ko04620	Toll-like receptor signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMG200014875	K04733	ko04722	Neurotrophin signaling pathway	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMG200014875	K04733	ko05140	Leishmaniasis	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMG200014875	K04733	ko05142	Chagas disease	1828	5.5e-95	0.40	0.56	0.99
PGSC0003DMG200014875	K04733	ko04210	Apoptosis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMG200014875	K04733	ko04620	Toll-like receptor signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMG200014875	K04733	ko04722	Neurotrophin signaling pathway	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMG200014875	K04733	ko05140	Leishmaniasis	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMG200014875	K04733	ko05142	Chagas disease	1887	3.0e-98	0.37	0.53	0.98
PGSC0003DMG200014876	K03097	ko04310	Wnt signaling pathway	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMG200014876	K03097	ko04520	Adherens junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMG200014876	K03097	ko04530	Tight junction	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMG200014876	K03097	ko04712	Circadian rhythm - plant	2799	1.5e-148	0.95	1.00	1.00
PGSC0003DMG200044956	K10760	ko00908	Zeatin biosynthesis	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMG200044956	K10760	ko01100	Metabolic pathways	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMG200044956	K10760	ko01110	Biosynthesis of secondary metabolites	765	2.3e-36	0.43	0.66	0.90
PGSC0003DMG200028284	K11584	ko04113	Meiosis - yeast	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMG200028284	K11584	ko04114	Oocyte meiosis	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMG200028284	K11584	ko04310	Wnt signaling pathway	3276	7.5e-175	0.79	0.88	0.99
PGSC0003DMG200028287	K00789	ko00270	Cysteine and methionine metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMG200028287	K00789	ko00450	Selenoamino acid metabolism	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMG200028287	K00789	ko01100	Metabolic pathways	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMG200028287	K00789	ko01110	Biosynthesis of secondary metabolites	3215	1.7e-171	0.95	0.97	1.00
PGSC0003DMG200018350	K00793	ko00740	Riboflavin metabolism	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMG200018350	K00793	ko01100	Metabolic pathways	1326	2.7e-67	0.81	0.89	1.00
PGSC0003DMG200018351	K00218	ko00860	Porphyrin and chlorophyll metabolism	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMG200018351	K00218	ko01100	Metabolic pathways	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMG200018351	K00218	ko01110	Biosynthesis of secondary metabolites	1980	2.3e-103	0.81	0.90	0.99
PGSC0003DMG200018351	K00218	ko00860	Porphyrin and chlorophyll metabolism	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMG200018351	K00218	ko01100	Metabolic pathways	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMG200018351	K00218	ko01110	Biosynthesis of secondary metabolites	2299	5.7e-121	0.71	0.82	0.99
PGSC0003DMG200018357	K01593	ko00340	Histidine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00350	Tyrosine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00360	Phenylalanine metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00380	Tryptophan metabolism	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00901	Indole alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00950	Isoquinoline alkaloid biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko00965	Betalain biosynthesis	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko01100	Metabolic pathways	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018357	K01593	ko01110	Biosynthesis of secondary metabolites	1973	5.5e-103	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00340	Histidine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00350	Tyrosine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00360	Phenylalanine metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00380	Tryptophan metabolism	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00901	Indole alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko00965	Betalain biosynthesis	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko01100	Metabolic pathways	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018358	K01593	ko01110	Biosynthesis of secondary metabolites	2027	5.8e-106	0.57	0.75	0.99
PGSC0003DMG200018359	K01593	ko00340	Histidine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00350	Tyrosine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00360	Phenylalanine metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00380	Tryptophan metabolism	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00901	Indole alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00950	Isoquinoline alkaloid biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko00965	Betalain biosynthesis	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko01100	Metabolic pathways	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018359	K01593	ko01110	Biosynthesis of secondary metabolites	2267	3.3e-119	0.57	0.76	0.99
PGSC0003DMG200018360	K08902	ko00195	Photosynthesis	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMG200018360	K08902	ko01100	Metabolic pathways	824	1.3e-39	0.66	0.76	0.98
PGSC0003DMG200018362	K10352	ko04530	Tight junction	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMG200018362	K10352	ko05416	Viral myocarditis	356	2.5e-10	0.25	0.44	0.99
PGSC0003DMG200018363	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMG200018363	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMG200018363	K00771	ko01100	Metabolic pathways	404	8.9e-16	0.28	0.47	0.84
PGSC0003DMG200018363	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMG200018363	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMG200018363	K00771	ko01100	Metabolic pathways	430	2.3e-17	0.31	0.48	0.69
PGSC0003DMG200027517	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	380	2.6e-14	0.29	0.43	0.97
PGSC0003DMG200027518	K10569	ko03410	Base excision repair	412	6.9e-17	0.42	0.56	0.42
PGSC0003DMG200027520	K01188	ko00460	Cyanoamino acid metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMG200027520	K01188	ko00500	Starch and sucrose metabolism	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMG200027520	K01188	ko00940	Phenylpropanoid biosynthesis	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMG200027520	K01188	ko01110	Biosynthesis of secondary metabolites	1513	1.3e-77	0.58	0.73	0.89
PGSC0003DMG200027520	K01188	ko00460	Cyanoamino acid metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMG200027520	K01188	ko00500	Starch and sucrose metabolism	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMG200027520	K01188	ko00940	Phenylpropanoid biosynthesis	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMG200027520	K01188	ko01110	Biosynthesis of secondary metabolites	2908	1.5e-154	0.59	0.74	0.93
PGSC0003DMG200031756	K03801	ko00785	Lipoic acid metabolism	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMG200031756	K03801	ko01100	Metabolic pathways	1459	1.2e-74	0.79	0.89	0.97
PGSC0003DMG200031758	K01066	ko00623	2,4-Dichlorobenzoate degradation	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMG200031758	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	296	1.7e-10	0.28	0.43	0.75
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	313	2.0e-11	0.30	0.46	0.60
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	319	9.3e-12	0.31	0.46	0.60
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	312	2.3e-11	0.30	0.46	0.60
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	308	3.7e-11	0.28	0.44	0.73
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	315	1.5e-11	0.28	0.44	0.73
PGSC0003DMG200031759	K01066	ko00623	2,4-Dichlorobenzoate degradation	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMG200031759	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	307	4.3e-11	0.30	0.46	0.71
PGSC0003DMG200031765	K00688	ko00500	Starch and sucrose metabolism	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMG200031765	K00688	ko04910	Insulin signaling pathway	2098	7.0e-110	0.83	0.93	1.00
PGSC0003DMG200004744	K00759	ko00230	Purine metabolism	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMG200004744	K00759	ko01100	Metabolic pathways	1066	5.8e-53	0.87	0.93	0.76
PGSC0003DMG200004744	K00759	ko00230	Purine metabolism	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMG200004744	K00759	ko01100	Metabolic pathways	1327	2.3e-67	0.86	0.94	0.99
PGSC0003DMG200002574	K00599	ko00340	Histidine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMG200002574	K00599	ko00350	Tyrosine metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMG200002574	K00599	ko00450	Selenoamino acid metabolism	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMG200002574	K00599	ko00626	Naphthalene and anthracene degradation	531	1.9e-23	0.54	0.74	0.65
PGSC0003DMG200002574	K00599	ko00340	Histidine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMG200002574	K00599	ko00350	Tyrosine metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMG200002574	K00599	ko00450	Selenoamino acid metabolism	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMG200002574	K00599	ko00626	Naphthalene and anthracene degradation	527	3.1e-23	0.54	0.74	0.60
PGSC0003DMG200002574	K00599	ko00340	Histidine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMG200002574	K00599	ko00350	Tyrosine metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMG200002574	K00599	ko00450	Selenoamino acid metabolism	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMG200002574	K00599	ko00626	Naphthalene and anthracene degradation	828	7.8e-40	0.56	0.73	0.62
PGSC0003DMG200002577	K08959	ko04340	Hedgehog signaling pathway	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMG200002577	K08959	ko04540	Gap junction	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMG200002577	K08959	ko04710	Circadian rhythm - mammal	329	2.6e-12	0.53	0.67	0.83
PGSC0003DMG200002577	K02218	ko04340	Hedgehog signaling pathway	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMG200002577	K02218	ko04711	Circadian rhythm - fly	3005	6.6e-160	0.77	0.87	0.98
PGSC0003DMG200002577	K02218	ko04340	Hedgehog signaling pathway	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMG200002577	K02218	ko04711	Circadian rhythm - fly	1904	3.5e-99	0.93	0.98	0.96
PGSC0003DMG200002580	K03787	ko00230	Purine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMG200002580	K03787	ko00240	Pyrimidine metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMG200002580	K03787	ko00760	Nicotinate and nicotinamide metabolism	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMG200002580	K03787	ko01100	Metabolic pathways	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMG200002580	K03787	ko01110	Biosynthesis of secondary metabolites	2381	1.7e-125	0.74	0.86	1.00
PGSC0003DMG200002581	K00020	ko00280	Valine, leucine and isoleucine degradation	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMG200002581	K00020	ko01100	Metabolic pathways	1341	4.0e-68	0.60	0.75	0.83
PGSC0003DMG200002581	K00020	ko00280	Valine, leucine and isoleucine degradation	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMG200002581	K00020	ko01100	Metabolic pathways	767	1.8e-36	0.61	0.75	0.66
PGSC0003DMG200002582	K12741	ko03040	Spliceosome	1112	1.7e-55	0.49	0.64	0.97
PGSC0003DMG200002582	K12741	ko03040	Spliceosome	1331	1.4e-67	0.51	0.66	0.99
PGSC0003DMG200002582	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMG200002582	K12741	ko03040	Spliceosome	1586	1.2e-81	0.52	0.67	0.98
PGSC0003DMG200002583	K01193	ko00052	Galactose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMG200002583	K01193	ko00500	Starch and sucrose metabolism	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMG200002583	K01193	ko01100	Metabolic pathways	2807	5.5e-149	0.58	0.74	0.98
PGSC0003DMG200002585	K04077	ko03018	RNA degradation	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMG200002585	K04077	ko04940	Type I diabetes mellitus	3176	2.4e-169	0.78	0.90	0.99
PGSC0003DMG200002587	K08248	ko00460	Cyanoamino acid metabolism	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMG200002587	K08248	ko01100	Metabolic pathways	529	2.4e-23	0.48	0.65	0.65
PGSC0003DMG200002587	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMG200002587	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMG200002587	K08248	ko00460	Cyanoamino acid metabolism	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMG200002587	K08248	ko01100	Metabolic pathways	1800	1.9e-93	0.46	0.62	0.92
PGSC0003DMG200002590	K01190	ko00052	Galactose metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMG200002590	K01190	ko00511	Other glycan degradation	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMG200002590	K01190	ko00600	Sphingolipid metabolism	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMG200002590	K01190	ko01100	Metabolic pathways	579	4.2e-26	0.76	0.87	0.42
PGSC0003DMG200013088	K01193	ko00052	Galactose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMG200013088	K01193	ko00500	Starch and sucrose metabolism	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMG200013088	K01193	ko01100	Metabolic pathways	780	3.5e-37	0.36	0.53	0.62
PGSC0003DMG200013088	K01193	ko00052	Galactose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMG200013088	K01193	ko00500	Starch and sucrose metabolism	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMG200013088	K01193	ko01100	Metabolic pathways	1046	7.4e-52	0.37	0.53	0.63
PGSC0003DMG200013088	K01193	ko00052	Galactose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMG200013088	K01193	ko00500	Starch and sucrose metabolism	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMG200013088	K01193	ko01100	Metabolic pathways	380	4.0e-15	0.38	0.52	0.46
PGSC0003DMG200013089	K04125	ko00904	Diterpenoid biosynthesis	689	3.6e-32	0.51	0.66	0.93
PGSC0003DMG200013098	K06260	ko04512	ECM-receptor interaction	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMG200013098	K06260	ko04640	Hematopoietic cell lineage	262	6.6e-06	0.31	0.48	0.51
PGSC0003DMG200006233	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMG200006233	K12567	ko05414	Dilated cardiomyopathy	743	1.4e-32	0.40	0.53	0.87
PGSC0003DMG200006235	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMG200006235	K12567	ko05414	Dilated cardiomyopathy	409	3.6e-14	0.38	0.52	0.79
PGSC0003DMG200006236	K03110	ko03060	Protein export	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMG200006236	K03110	ko03070	Bacterial secretion system	289	5.6e-10	0.43	0.51	0.98
PGSC0003DMG200006237	K03110	ko03060	Protein export	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMG200006237	K03110	ko03070	Bacterial secretion system	340	6.4e-13	0.42	0.55	0.98
PGSC0003DMG200006237	K12567	ko05410	Hypertrophic cardiomyopathy (HCM)	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMG200006237	K12567	ko05414	Dilated cardiomyopathy	462	4.3e-17	0.41	0.52	0.99
PGSC0003DMG200006238	K03110	ko03060	Protein export	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMG200006238	K03110	ko03070	Bacterial secretion system	286	8.5e-10	0.43	0.50	0.69
PGSC0003DMG200006239	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.86
PGSC0003DMG200006239	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMG200006239	K03063	ko03050	Proteasome	483	8.3e-21	0.83	0.86	0.66
PGSC0003DMG200006240	K01115	ko00564	Glycerophospholipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko00565	Ether lipid metabolism	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko01100	Metabolic pathways	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko04144	Endocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko04666	Fc gamma R-mediated phagocytosis	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko04912	GnRH signaling pathway	6722	0.	0.79	0.90	0.97
PGSC0003DMG200006240	K01115	ko00564	Glycerophospholipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006240	K01115	ko00565	Ether lipid metabolism	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006240	K01115	ko01100	Metabolic pathways	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006240	K01115	ko04144	Endocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006240	K01115	ko04666	Fc gamma R-mediated phagocytosis	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006240	K01115	ko04912	GnRH signaling pathway	7548	0.	0.78	0.88	1.00
PGSC0003DMG200006243	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.71
PGSC0003DMG200006243	K02156	ko04320	Dorso-ventral axis formation	294	2.2e-09	0.27	0.40	0.72
PGSC0003DMG200015382	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMG200015382	K12741	ko03040	Spliceosome	721	6.2e-34	0.35	0.49	0.83
PGSC0003DMG200015383	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.68
PGSC0003DMG200015383	K12841	ko03040	Spliceosome	390	7.4e-15	0.40	0.48	0.40
PGSC0003DMG200015385	K01595	ko00620	Pyruvate metabolism	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMG200015385	K01595	ko00710	Carbon fixation in photosynthetic organisms	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMG200015385	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMG200015385	K01595	ko01100	Metabolic pathways	5102	1.4e-275	0.90	0.96	1.00
PGSC0003DMG200015385	K01595	ko00620	Pyruvate metabolism	5747	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00710	Carbon fixation in photosynthetic organisms	5747	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	5747	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko01100	Metabolic pathways	5747	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00620	Pyruvate metabolism	7521	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00710	Carbon fixation in photosynthetic organisms	7521	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	7521	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko01100	Metabolic pathways	7521	0.	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00620	Pyruvate metabolism	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00710	Carbon fixation in photosynthetic organisms	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko00720	Reductive carboxylate cycle (CO2 fixation)	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMG200015385	K01595	ko01100	Metabolic pathways	3408	3.9e-182	0.91	0.96	1.00
PGSC0003DMG200015389	K03353	ko04110	Cell cycle	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015389	K03353	ko04111	Cell cycle - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015389	K03353	ko04113	Meiosis - yeast	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015389	K03353	ko04114	Oocyte meiosis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015389	K03353	ko04120	Ubiquitin mediated proteolysis	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015389	K03353	ko04914	Progesterone-mediated oocyte maturation	4081	3.0e-219	0.87	0.93	0.99
PGSC0003DMG200015390	K06636	ko04110	Cell cycle	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMG200015390	K06636	ko04111	Cell cycle - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMG200015390	K06636	ko04113	Meiosis - yeast	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMG200015390	K06636	ko04114	Oocyte meiosis	380	2.9e-14	0.29	0.49	0.74
PGSC0003DMG200015392	K02871	ko03010	Ribosome	1513	1.3e-77	0.74	0.85	1.00
PGSC0003DMG200015402	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMG200015402	K00517	ko00626	Naphthalene and anthracene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMG200015402	K00517	ko00903	Limonene and pinene degradation	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMG200015402	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMG200015402	K00517	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.50	0.69	0.97
PGSC0003DMG200015403	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMG200015403	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMG200015403	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMG200015403	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMG200015403	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.51	0.70	0.99
PGSC0003DMG200015404	K06627	ko04110	Cell cycle	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMG200015404	K06627	ko04914	Progesterone-mediated oocyte maturation	1900	5.8e-99	0.68	0.80	0.85
PGSC0003DMG200015404	K06627	ko04110	Cell cycle	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMG200015404	K06627	ko04914	Progesterone-mediated oocyte maturation	2016	2.3e-105	0.68	0.80	0.99
PGSC0003DMG200015404	K06627	ko04110	Cell cycle	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMG200015404	K06627	ko04914	Progesterone-mediated oocyte maturation	2008	6.4e-105	0.67	0.80	1.00
PGSC0003DMG200015404	K06627	ko04110	Cell cycle	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMG200015404	K06627	ko04914	Progesterone-mediated oocyte maturation	2015	2.7e-105	0.71	0.81	0.99
PGSC0003DMG200015405	K10577	ko04120	Ubiquitin mediated proteolysis	1262	9.0e-64	0.86	0.96	0.99
PGSC0003DMG200001152	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMG200001152	K10592	ko04120	Ubiquitin mediated proteolysis	360	2.1e-12	0.36	0.49	0.78
PGSC0003DMG200001155	K12493	ko04144	Endocytosis	2515	7.0e-133	0.74	0.87	1.00
PGSC0003DMG200001179	K01066	ko00623	2,4-Dichlorobenzoate degradation	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMG200001179	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	363	3.5e-14	0.32	0.51	0.64
PGSC0003DMG200001179	K01066	ko00623	2,4-Dichlorobenzoate degradation	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMG200001179	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	389	1.3e-15	0.32	0.52	0.56
PGSC0003DMG200043233	K08242	ko00100	Steroid biosynthesis	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMG200043233	K08242	ko01110	Biosynthesis of secondary metabolites	2206	7.7e-116	0.76	0.89	0.99
PGSC0003DMG200019219	K03469	ko03030	DNA replication	253	4.0e-08	0.42	0.61	0.41
PGSC0003DMG200019224	K05581	ko00190	Oxidative phosphorylation	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMG200019224	K05581	ko01100	Metabolic pathways	616	3.9e-28	0.78	0.86	0.96
PGSC0003DMG200019228	K00754	ko00051	Fructose and mannose metabolism	1372	7.7e-70	0.41	0.59	0.81
PGSC0003DMG200019229	K05740	ko04510	Focal adhesion	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMG200019229	K05740	ko04810	Regulation of actin cytoskeleton	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMG200019229	K05740	ko05131	Shigellosis	813	1.1e-38	0.31	0.45	0.64
PGSC0003DMG200019235	K05350	ko00460	Cyanoamino acid metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMG200019235	K05350	ko00500	Starch and sucrose metabolism	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMG200019235	K05350	ko00940	Phenylpropanoid biosynthesis	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMG200019235	K05350	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.58	0.73	0.96
PGSC0003DMG200019235	K01188	ko00460	Cyanoamino acid metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMG200019235	K01188	ko00500	Starch and sucrose metabolism	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMG200019235	K01188	ko00940	Phenylpropanoid biosynthesis	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMG200019235	K01188	ko01110	Biosynthesis of secondary metabolites	1130	1.7e-56	0.60	0.75	0.96
PGSC0003DMG200029824	K12356	ko00940	Phenylpropanoid biosynthesis	657	2.1e-30	0.45	0.63	0.98
PGSC0003DMG200029824	K12356	ko00940	Phenylpropanoid biosynthesis	216	9.7e-06	0.37	0.58	0.87
PGSC0003DMG200029825	K12356	ko00940	Phenylpropanoid biosynthesis	584	2.2e-26	0.42	0.60	0.96
PGSC0003DMG200029830	K01199	ko00500	Starch and sucrose metabolism	1489	2.7e-76	0.57	0.74	0.96
PGSC0003DMG200029833	K02183	ko04020	Calcium signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04070	Phosphatidylinositol signaling system	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04114	Oocyte meiosis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04270	Vascular smooth muscle contraction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04626	Plant-pathogen interaction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04720	Long-term potentiation	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04722	Neurotrophin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04740	Olfactory transduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04744	Phototransduction	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04745	Phototransduction - fly	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04910	Insulin signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04912	GnRH signaling pathway	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04916	Melanogenesis	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04970	Salivary secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko04971	Gastric acid secretion	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko05010	Alzheimer's disease	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029833	K02183	ko05214	Glioma	372	1.1e-14	0.36	0.55	0.80
PGSC0003DMG200029835	K06677	ko04111	Cell cycle - yeast	8161	0.	0.76	0.85	0.98
PGSC0003DMG200029836	K01760	ko00270	Cysteine and methionine metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko00450	Selenoamino acid metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko00910	Nitrogen metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko00920	Sulfur metabolism	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko01100	Metabolic pathways	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko01110	Biosynthesis of secondary metabolites	2885	2.7e-153	0.76	0.86	0.97
PGSC0003DMG200029836	K01760	ko00270	Cysteine and methionine metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200029836	K01760	ko00450	Selenoamino acid metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200029836	K01760	ko00910	Nitrogen metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200029836	K01760	ko00920	Sulfur metabolism	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200029836	K01760	ko01100	Metabolic pathways	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200029836	K01760	ko01110	Biosynthesis of secondary metabolites	440	2.0e-18	0.73	0.87	0.66
PGSC0003DMG200036067	K02992	ko03010	Ribosome	636	3.0e-29	0.99	0.99	0.22
PGSC0003DMG200036075	K05282	ko00904	Diterpenoid biosynthesis	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMG200036075	K05282	ko01100	Metabolic pathways	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMG200036075	K05282	ko01110	Biosynthesis of secondary metabolites	346	3.0e-13	0.61	0.74	0.67
PGSC0003DMG200036082	K02995	ko03010	Ribosome	1268	4.2e-64	0.74	0.80	0.97
PGSC0003DMG200036086	K03094	ko04110	Cell cycle	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04111	Cell cycle - yeast	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04114	Oocyte meiosis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04120	Ubiquitin mediated proteolysis	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04310	Wnt signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04350	TGF-beta signaling pathway	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036086	K03094	ko04710	Circadian rhythm - mammal	282	1.0e-09	0.47	0.67	0.99
PGSC0003DMG200036091	K13230	ko00402	Benzoxazinoid biosynthesis	381	3.5e-15	0.35	0.49	0.99
PGSC0003DMG200022981	K11423	ko00310	Lysine degradation	770	1.2e-36	0.39	0.56	0.89
PGSC0003DMG200022985	K02959	ko03010	Ribosome	429	7.9e-18	0.55	0.78	0.78
PGSC0003DMG200022992	K01866	ko00970	Aminoacyl-tRNA biosynthesis	1800	1.9e-93	0.76	0.88	1.00
PGSC0003DMG200022992	K01866	ko00970	Aminoacyl-tRNA biosynthesis	2707	1.8e-143	0.66	0.79	1.00
PGSC0003DMG200022994	K11423	ko00310	Lysine degradation	735	1.1e-34	0.36	0.53	0.95
PGSC0003DMG200047044	K00795	ko00900	Terpenoid backbone biosynthesis	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMG200047044	K00795	ko01100	Metabolic pathways	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMG200047044	K00795	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.70	0.81	1.00
PGSC0003DMG200042026	K02947	ko03010	Ribosome	315	1.5e-11	0.74	0.79	0.56
PGSC0003DMG200042033	K02866	ko03010	Ribosome	243	3.4e-07	0.59	0.78	0.54
PGSC0003DMG200000481	K00031	ko00020	Citrate cycle (TCA cycle)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko00480	Glutathione metabolism	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko01100	Metabolic pathways	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko01110	Biosynthesis of secondary metabolites	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko04146	Peroxisome	3017	1.4e-160	0.88	0.95	0.99
PGSC0003DMG200000481	K00031	ko00020	Citrate cycle (TCA cycle)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000481	K00031	ko00480	Glutathione metabolism	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000481	K00031	ko00720	Reductive carboxylate cycle (CO2 fixation)	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000481	K00031	ko01100	Metabolic pathways	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000481	K00031	ko01110	Biosynthesis of secondary metabolites	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000481	K00031	ko04146	Peroxisome	246	1.6e-07	0.51	0.64	0.85
PGSC0003DMG200000486	K08232	ko00053	Ascorbate and aldarate metabolism	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMG200000486	K08232	ko01100	Metabolic pathways	3218	1.2e-171	0.78	0.88	1.00
PGSC0003DMG200000486	K08232	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMG200000486	K08232	ko01100	Metabolic pathways	1723	3.4e-89	0.85	0.93	0.98
PGSC0003DMG200000486	K08232	ko00053	Ascorbate and aldarate metabolism	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMG200000486	K08232	ko01100	Metabolic pathways	1507	2.8e-77	0.71	0.84	1.00
PGSC0003DMG200000487	K02935	ko03010	Ribosome	1061	1.1e-52	0.72	0.85	0.99
PGSC0003DMG200000488	K02935	ko03010	Ribosome	1059	1.4e-52	0.73	0.87	0.99
PGSC0003DMG200000489	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200000489	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200000489	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200000489	K04728	ko04110	Cell cycle	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200000489	K04728	ko04115	p53 signaling pathway	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200000489	K04728	ko04210	Apoptosis	548	8.7e-21	0.26	0.43	0.90
PGSC0003DMG200012419	K00979	ko00540	Lipopolysaccharide biosynthesis	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMG200012419	K00979	ko01100	Metabolic pathways	1615	3.1e-83	0.71	0.77	0.93
PGSC0003DMG200012425	K10615	ko04120	Ubiquitin mediated proteolysis	609	1.0e-27	0.32	0.49	0.76
PGSC0003DMG200012425	K10614	ko04120	Ubiquitin mediated proteolysis	290	2.7e-09	0.39	0.58	0.94
PGSC0003DMG200012428	K00790	ko00520	Amino sugar and nucleotide sugar metabolism	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMG200012428	K00790	ko00550	Peptidoglycan biosynthesis	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMG200012428	K00790	ko01100	Metabolic pathways	1522	4.1e-78	0.50	0.68	0.93
PGSC0003DMG200012430	K07819	ko00601	Glycosphingolipid biosynthesis - lacto and neolacto series	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMG200012430	K07819	ko01100	Metabolic pathways	241	3.0e-07	0.27	0.49	0.63
PGSC0003DMG200012430	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMG200012430	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMG200012430	K00734	ko01100	Metabolic pathways	288	4.8e-10	0.30	0.45	0.68
PGSC0003DMG200012431	K10603	ko04120	Ubiquitin mediated proteolysis	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMG200012431	K10603	ko05340	Primary immunodeficiency	255	3.7e-07	0.40	0.48	0.15
PGSC0003DMG200012431	K10603	ko04120	Ubiquitin mediated proteolysis	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMG200012431	K10603	ko05340	Primary immunodeficiency	255	2.1e-06	0.40	0.48	0.06
PGSC0003DMG200012432	K12843	ko03040	Spliceosome	1511	1.7e-77	0.36	0.55	0.96
PGSC0003DMG200001903	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMG200001903	K00517	ko00626	Naphthalene and anthracene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMG200001903	K00517	ko00903	Limonene and pinene degradation	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMG200001903	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMG200001903	K00517	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.46	0.63	0.91
PGSC0003DMG200001903	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMG200001903	K00517	ko00626	Naphthalene and anthracene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMG200001903	K00517	ko00903	Limonene and pinene degradation	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMG200001903	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMG200001903	K00517	ko01110	Biosynthesis of secondary metabolites	992	7.0e-49	0.57	0.76	0.97
PGSC0003DMG200001903	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMG200001903	K00517	ko00626	Naphthalene and anthracene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMG200001903	K00517	ko00903	Limonene and pinene degradation	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMG200001903	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMG200001903	K00517	ko01110	Biosynthesis of secondary metabolites	2017	2.1e-105	0.50	0.68	0.98
PGSC0003DMG200001908	K04424	ko04010	MAPK signaling pathway	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMG200001908	K04424	ko04530	Tight junction	355	4.4e-13	0.45	0.65	0.64
PGSC0003DMG200001908	K04424	ko04010	MAPK signaling pathway	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMG200001908	K04424	ko04530	Tight junction	679	1.3e-31	0.36	0.53	0.83
PGSC0003DMG200001912	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMG200001912	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMG200001912	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMG200001912	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.83
PGSC0003DMG200001912	K01840	ko00051	Fructose and mannose metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMG200001912	K01840	ko00520	Amino sugar and nucleotide sugar metabolism	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMG200001912	K01840	ko01100	Metabolic pathways	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMG200001912	K01840	ko01110	Biosynthesis of secondary metabolites	1863	6.4e-97	0.51	0.66	0.94
PGSC0003DMG200001912	K01835	ko00010	Glycolysis / Gluconeogenesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00030	Pentose phosphate pathway	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00052	Galactose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00230	Purine metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00500	Starch and sucrose metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko00521	Streptomycin biosynthesis	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko01100	Metabolic pathways	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001912	K01835	ko01110	Biosynthesis of secondary metabolites	1615	3.1e-83	0.51	0.68	0.98
PGSC0003DMG200001914	K12929	ko00904	Diterpenoid biosynthesis	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMG200001914	K12929	ko01110	Biosynthesis of secondary metabolites	1527	2.2e-78	0.37	0.61	0.73
PGSC0003DMG200001915	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMG200001915	K00517	ko00626	Naphthalene and anthracene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMG200001915	K00517	ko00903	Limonene and pinene degradation	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMG200001915	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMG200001915	K00517	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.43	0.65	0.99
PGSC0003DMG200001916	K04371	ko04010	MAPK signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04012	ErbB signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04013	MAPK signaling pathway - fly	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04062	Chemokine signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04114	Oocyte meiosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04150	mTOR signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04270	Vascular smooth muscle contraction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04320	Dorso-ventral axis formation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04350	TGF-beta signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04360	Axon guidance	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04370	VEGF signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04510	Focal adhesion	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04520	Adherens junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04540	Gap junction	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04620	Toll-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04621	NOD-like receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04650	Natural killer cell mediated cytotoxicity	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04660	T cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04662	B cell receptor signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04664	Fc epsilon RI signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04666	Fc gamma R-mediated phagocytosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04720	Long-term potentiation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04722	Neurotrophin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04730	Long-term depression	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04810	Regulation of actin cytoskeleton	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04910	Insulin signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04912	GnRH signaling pathway	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04914	Progesterone-mediated oocyte maturation	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04916	Melanogenesis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04930	Type II diabetes mellitus	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko04960	Aldosterone-regulated sodium reabsorption	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05010	Alzheimer's disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05020	Prion diseases	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05131	Shigellosis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05140	Leishmaniasis	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05142	Chagas disease	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05200	Pathways in cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05210	Colorectal cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05211	Renal cell carcinoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05212	Pancreatic cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05213	Endometrial cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05214	Glioma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05215	Prostate cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05216	Thyroid cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05218	Melanoma	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05219	Bladder cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05220	Chronic myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05221	Acute myeloid leukemia	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001916	K04371	ko05223	Non-small cell lung cancer	318	1.8e-11	0.47	0.71	0.49
PGSC0003DMG200001917	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMG200001917	K02551	ko01100	Metabolic pathways	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMG200001917	K02551	ko01110	Biosynthesis of secondary metabolites	1265	6.2e-64	0.39	0.55	0.71
PGSC0003DMG200001917	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMG200001917	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMG200001917	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.80
PGSC0003DMG200001917	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMG200001917	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMG200001917	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.55
PGSC0003DMG200001917	K02551	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMG200001917	K02551	ko01100	Metabolic pathways	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMG200001917	K02551	ko01110	Biosynthesis of secondary metabolites	1486	4.0e-76	0.38	0.57	0.45
PGSC0003DMG200001917	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMG200001917	K08680	ko01100	Metabolic pathways	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMG200001917	K08680	ko01110	Biosynthesis of secondary metabolites	638	2.4e-29	0.39	0.57	0.96
PGSC0003DMG200001918	K12126	ko04712	Circadian rhythm - plant	341	5.7e-13	0.25	0.41	0.89
PGSC0003DMG200005587	K12929	ko00904	Diterpenoid biosynthesis	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMG200005587	K12929	ko01110	Biosynthesis of secondary metabolites	374	1.2e-14	0.52	0.69	0.96
PGSC0003DMG200005592	K00059	ko00061	Fatty acid biosynthesis	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMG200005592	K00059	ko01040	Biosynthesis of unsaturated fatty acids	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMG200005592	K00059	ko01100	Metabolic pathways	603	2.0e-27	0.62	0.82	0.99
PGSC0003DMG200005594	K10577	ko04120	Ubiquitin mediated proteolysis	437	2.9e-18	0.98	1.00	0.53
PGSC0003DMG200005595	K12929	ko00904	Diterpenoid biosynthesis	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMG200005595	K12929	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.40	0.63	0.98
PGSC0003DMG200005598	K12929	ko00904	Diterpenoid biosynthesis	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMG200005598	K12929	ko01110	Biosynthesis of secondary metabolites	598	3.8e-27	0.29	0.46	0.87
PGSC0003DMG200005606	K06215	ko00750	Vitamin B6 metabolism	1732	1.1e-89	0.68	0.81	0.98
PGSC0003DMG200016133	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMG200016133	K11644	ko05016	Huntington's disease	284	2.5e-06	0.28	0.43	0.46
PGSC0003DMG200016133	K11644	ko05016	Huntington's disease	284	4.1e-06	0.28	0.43	0.36
PGSC0003DMG200016135	K10703	ko01040	Biosynthesis of unsaturated fatty acids	715	1.3e-33	0.56	0.61	0.94
PGSC0003DMG200016138	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1515	1.0e-77	0.33	0.49	0.95
PGSC0003DMG200016138	K05310	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	584	5.2e-26	0.42	0.62	0.93
PGSC0003DMG200016141	K06630	ko04110	Cell cycle	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMG200016141	K06630	ko04114	Oocyte meiosis	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMG200016141	K06630	ko04722	Neurotrophin signaling pathway	1550	1.2e-79	0.76	0.91	0.97
PGSC0003DMG200016142	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMG200016142	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMG200016142	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.70
PGSC0003DMG200016142	K04503	ko04110	Cell cycle	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko04115	p53 signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko04310	Wnt signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko04510	Focal adhesion	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko04630	Jak-STAT signaling pathway	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05200	Pathways in cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05210	Colorectal cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05212	Pancreatic cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05213	Endometrial cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05214	Glioma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05215	Prostate cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05216	Thyroid cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05218	Melanoma	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05219	Bladder cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05220	Chronic myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05221	Acute myeloid leukemia	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05222	Small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05223	Non-small cell lung cancer	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K04503	ko05416	Viral myocarditis	320	8.2e-12	0.32	0.53	0.77
PGSC0003DMG200016142	K05868	ko04110	Cell cycle	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMG200016142	K05868	ko04115	p53 signaling pathway	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMG200016142	K05868	ko04914	Progesterone-mediated oocyte maturation	329	2.6e-12	0.27	0.49	0.80
PGSC0003DMG200022188	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.93
PGSC0003DMG200022188	K12132	ko04712	Circadian rhythm - plant	1535	7.9e-79	0.65	0.79	0.94
PGSC0003DMG200022188	K12132	ko04712	Circadian rhythm - plant	862	1.0e-41	0.64	0.80	0.94
PGSC0003DMG200022188	K12132	ko04712	Circadian rhythm - plant	531	1.9e-23	0.66	0.82	0.84
PGSC0003DMG200022192	K02995	ko03010	Ribosome	1666	4.7e-86	0.90	0.95	0.99
PGSC0003DMG200022194	K03714	ko00510	N-Glycan biosynthesis	2686	2.6e-142	0.60	0.72	1.00
PGSC0003DMG200022195	K08272	ko04150	mTOR signaling pathway	1325	3.0e-67	0.81	0.92	0.85
PGSC0003DMG200022195	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMG200022195	K08272	ko04150	mTOR signaling pathway	1997	2.6e-104	0.71	0.84	0.82
PGSC0003DMG200022195	K08272	ko04150	mTOR signaling pathway	1000	2.5e-49	0.82	0.93	0.81
PGSC0003DMG200022199	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMG200022199	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMG200022199	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMG200022199	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMG200022199	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.85
PGSC0003DMG200022199	K00680	ko00350	Tyrosine metabolism	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMG200022199	K00680	ko00624	1- and 2-Methylnaphthalene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMG200022199	K00680	ko00632	Benzoate degradation via CoA ligation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMG200022199	K00680	ko00642	Ethylbenzene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMG200022199	K00680	ko00903	Limonene and pinene degradation	234	9.1e-07	0.33	0.48	0.68
PGSC0003DMG200030547	K08332	ko04140	Regulation of autophagy	297	3.1e-10	0.26	0.51	1.00
PGSC0003DMG200030547	K08332	ko04140	Regulation of autophagy	308	1.8e-08	0.28	0.49	0.48
PGSC0003DMG200030555	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMG200030555	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMG200030555	K00771	ko01100	Metabolic pathways	396	2.0e-15	0.30	0.47	0.72
PGSC0003DMG200019933	K09578	ko04622	RIG-I-like receptor signaling pathway	782	2.7e-37	0.77	0.91	0.93
PGSC0003DMG200019934	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.72
PGSC0003DMG200019934	K11294	ko05130	Pathogenic Escherichia coli infection	634	1.2e-28	0.27	0.44	0.73
PGSC0003DMG200019936	K11088	ko03040	Spliceosome	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMG200019936	K11088	ko05322	Systemic lupus erythematosus	1050	4.4e-52	0.92	0.99	0.99
PGSC0003DMG200019946	K13082	ko00941	Flavonoid biosynthesis	1125	3.2e-56	0.46	0.66	0.95
PGSC0003DMG200019946	K13082	ko00941	Flavonoid biosynthesis	973	7.9e-48	0.45	0.68	0.95
PGSC0003DMG200023725	K12586	ko03018	RNA degradation	1683	5.4e-87	0.83	0.91	0.76
PGSC0003DMG200023725	K12586	ko03018	RNA degradation	2015	2.7e-105	0.82	0.90	1.00
PGSC0003DMG200023732	K12356	ko00940	Phenylpropanoid biosynthesis	645	9.7e-30	0.37	0.55	0.95
PGSC0003DMG200010859	K00454	ko00591	Linoleic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMG200010859	K00454	ko00592	alpha-Linolenic acid metabolism	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMG200010859	K00454	ko01100	Metabolic pathways	3811	2.3e-204	0.72	0.86	1.00
PGSC0003DMG200010859	K00454	ko00591	Linoleic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMG200010859	K00454	ko00592	alpha-Linolenic acid metabolism	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMG200010859	K00454	ko01100	Metabolic pathways	5126	6.8e-277	0.70	0.83	0.99
PGSC0003DMG200010071	K05280	ko00941	Flavonoid biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMG200010071	K05280	ko00944	Flavone and flavonol biosynthesis	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMG200010071	K05280	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMG200010071	K05280	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.64	0.90
PGSC0003DMG200010071	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMG200010071	K00517	ko00626	Naphthalene and anthracene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMG200010071	K00517	ko00903	Limonene and pinene degradation	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMG200010071	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMG200010071	K00517	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.46	0.66	0.98
PGSC0003DMG200010071	K05280	ko00941	Flavonoid biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMG200010071	K05280	ko00944	Flavone and flavonol biosynthesis	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMG200010071	K05280	ko01100	Metabolic pathways	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMG200010071	K05280	ko01110	Biosynthesis of secondary metabolites	745	3.0e-35	0.47	0.66	0.99
PGSC0003DMG200010072	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMG200010072	K00517	ko00626	Naphthalene and anthracene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMG200010072	K00517	ko00903	Limonene and pinene degradation	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMG200010072	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMG200010072	K00517	ko01110	Biosynthesis of secondary metabolites	1400	2.2e-71	0.43	0.64	1.00
PGSC0003DMG200010073	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMG200010073	K00517	ko00626	Naphthalene and anthracene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMG200010073	K00517	ko00903	Limonene and pinene degradation	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMG200010073	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMG200010073	K00517	ko01110	Biosynthesis of secondary metabolites	1140	4.8e-57	0.43	0.63	0.96
PGSC0003DMG200010073	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMG200010073	K00517	ko00626	Naphthalene and anthracene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMG200010073	K00517	ko00903	Limonene and pinene degradation	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMG200010073	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMG200010073	K00517	ko01110	Biosynthesis of secondary metabolites	1610	5.8e-83	0.45	0.65	0.97
PGSC0003DMG200014191	K02937	ko03010	Ribosome	1363	2.4e-69	0.65	0.83	1.00
PGSC0003DMG200014199	K07192	ko04910	Insulin signaling pathway	1395	4.2e-71	0.41	0.61	0.98
PGSC0003DMG200014200	K07192	ko04910	Insulin signaling pathway	1399	2.5e-71	0.41	0.61	0.98
PGSC0003DMG200014202	K02906	ko03010	Ribosome	1559	3.8e-80	0.71	0.84	0.81
PGSC0003DMG200017626	K01176	ko00500	Starch and sucrose metabolism	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMG200017626	K01176	ko01100	Metabolic pathways	1586	1.2e-81	0.48	0.65	0.44
PGSC0003DMG200017626	K01176	ko00500	Starch and sucrose metabolism	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMG200017626	K01176	ko01100	Metabolic pathways	1217	2.7e-61	0.50	0.68	0.37
PGSC0003DMG200017626	K01728	ko00040	Pentose and glucuronate interconversions	1759	3.5e-91	0.57	0.73	0.77
PGSC0003DMG200017626	K01728	ko00040	Pentose and glucuronate interconversions	604	1.8e-27	0.53	0.72	0.95
PGSC0003DMG200017626	K01728	ko00040	Pentose and glucuronate interconversions	1291	2.3e-65	0.55	0.71	1.00
PGSC0003DMG200017636	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko00230	Purine metabolism	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko01100	Metabolic pathways	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko01110	Biosynthesis of secondary metabolites	971	1.0e-47	0.81	0.90	0.99
PGSC0003DMG200017636	K01490	ko00230	Purine metabolism	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMG200017636	K01490	ko01100	Metabolic pathways	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMG200017636	K01490	ko01110	Biosynthesis of secondary metabolites	4653	5.4e-255	0.68	0.79	0.95
PGSC0003DMG200017638	K10615	ko04120	Ubiquitin mediated proteolysis	610	2.3e-27	0.32	0.47	0.93
PGSC0003DMG200017638	K10615	ko04120	Ubiquitin mediated proteolysis	615	1.2e-27	0.32	0.48	0.94
PGSC0003DMG200027588	K03015	ko00230	Purine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMG200027588	K03015	ko00240	Pyrimidine metabolism	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMG200027588	K03015	ko01100	Metabolic pathways	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMG200027588	K03015	ko03020	RNA polymerase	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMG200027588	K03015	ko05016	Huntington's disease	915	1.2e-44	0.68	0.87	0.97
PGSC0003DMG200027589	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027589	K00261	ko00330	Arginine and proline metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027589	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027589	K00261	ko00910	Nitrogen metabolism	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027589	K00261	ko01100	Metabolic pathways	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027589	K00261	ko04964	Proximal tubule bicarbonate reclamation	3118	3.9e-166	0.87	0.95	1.00
PGSC0003DMG200027590	K02134	ko00190	Oxidative phosphorylation	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMG200027590	K02134	ko01100	Metabolic pathways	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMG200027590	K02134	ko05010	Alzheimer's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMG200027590	K02134	ko05012	Parkinson's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMG200027590	K02134	ko05016	Huntington's disease	1235	2.8e-62	0.79	0.90	0.97
PGSC0003DMG200027594	K01069	ko00620	Pyruvate metabolism	1683	5.4e-87	0.75	0.85	0.99
PGSC0003DMG200027596	K08233	ko00901	Indole alkaloid biosynthesis	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMG200027596	K08233	ko01110	Biosynthesis of secondary metabolites	626	1.1e-28	0.38	0.53	0.92
PGSC0003DMG200027597	K03413	ko02020	Two-component system	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMG200027597	K03413	ko02030	Bacterial chemotaxis	315	1.5e-11	0.41	0.58	0.73
PGSC0003DMG200027598	K01874	ko00450	Selenoamino acid metabolism	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMG200027598	K01874	ko00970	Aminoacyl-tRNA biosynthesis	618	3.0e-28	0.38	0.51	0.67
PGSC0003DMG200027598	K01874	ko00450	Selenoamino acid metabolism	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMG200027598	K01874	ko00970	Aminoacyl-tRNA biosynthesis	615	4.4e-28	0.50	0.69	0.99
PGSC0003DMG200027598	K01874	ko00450	Selenoamino acid metabolism	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMG200027598	K01874	ko00970	Aminoacyl-tRNA biosynthesis	691	2.8e-32	0.43	0.58	0.64
PGSC0003DMG200027602	K01599	ko00860	Porphyrin and chlorophyll metabolism	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMG200027602	K01599	ko01110	Biosynthesis of secondary metabolites	2547	1.2e-134	0.83	0.90	0.83
PGSC0003DMG200033657	K01061	ko00361	gamma-Hexachlorocyclohexane degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMG200033657	K01061	ko00364	Fluorobenzoate degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMG200033657	K01061	ko00627	1,4-Dichlorobenzene degradation	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMG200033657	K01061	ko01100	Metabolic pathways	1743	2.7e-90	0.73	0.83	0.99
PGSC0003DMG200033659	K01509	ko00230	Purine metabolism	1626	1.0e-117	0.40	0.57	0.80
PGSC0003DMG200033661	K04421	ko04010	MAPK signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMG200033661	K04421	ko04722	Neurotrophin signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMG200033661	K04421	ko04912	GnRH signaling pathway	582	2.9e-26	0.41	0.58	0.95
PGSC0003DMG200033681	K04631	ko04744	Phototransduction	745	3.0e-35	0.33	0.55	0.45
PGSC0003DMG200037286	K02639	ko00195	Photosynthesis	517	1.1e-22	0.58	0.81	0.97
PGSC0003DMG200033565	K02183	ko04020	Calcium signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04070	Phosphatidylinositol signaling system	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04114	Oocyte meiosis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04270	Vascular smooth muscle contraction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04626	Plant-pathogen interaction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04720	Long-term potentiation	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04722	Neurotrophin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04740	Olfactory transduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04744	Phototransduction	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04745	Phototransduction - fly	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04910	Insulin signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04912	GnRH signaling pathway	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04916	Melanogenesis	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04970	Salivary secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko04971	Gastric acid secretion	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko05010	Alzheimer's disease	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033565	K02183	ko05214	Glioma	816	3.6e-39	0.66	0.89	0.99
PGSC0003DMG200033566	K05933	ko00270	Cysteine and methionine metabolism	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMG200033566	K05933	ko01110	Biosynthesis of secondary metabolites	438	2.5e-18	0.40	0.60	0.87
PGSC0003DMG200033567	K00475	ko00941	Flavonoid biosynthesis	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMG200033567	K00475	ko01100	Metabolic pathways	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMG200033567	K00475	ko01110	Biosynthesis of secondary metabolites	369	1.6e-14	0.48	0.70	0.89
PGSC0003DMG200033567	K05277	ko00941	Flavonoid biosynthesis	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMG200033567	K05277	ko01100	Metabolic pathways	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMG200033567	K05277	ko01110	Biosynthesis of secondary metabolites	596	4.9e-27	0.34	0.51	0.95
PGSC0003DMG200033567	K05277	ko00941	Flavonoid biosynthesis	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMG200033567	K05277	ko01100	Metabolic pathways	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMG200033567	K05277	ko01110	Biosynthesis of secondary metabolites	515	1.4e-22	0.44	0.62	0.88
PGSC0003DMG200033567	K05277	ko00941	Flavonoid biosynthesis	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMG200033567	K05277	ko01100	Metabolic pathways	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMG200033567	K05277	ko01110	Biosynthesis of secondary metabolites	752	1.2e-35	0.36	0.52	0.92
PGSC0003DMG200024705	K10901	ko03440	Homologous recombination	707	1.9e-32	0.32	0.44	0.91
PGSC0003DMG200024705	K03654	ko03018	RNA degradation	763	3.0e-36	0.34	0.47	0.95
PGSC0003DMG200024705	K03654	ko03018	RNA degradation	1044	9.5e-52	0.32	0.46	0.73
PGSC0003DMG200024705	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMG200024705	K03654	ko03018	RNA degradation	719	8.0e-34	0.31	0.43	0.87
PGSC0003DMG200024706	K05745	ko04810	Regulation of actin cytoskeleton	432	3.7e-17	0.30	0.48	0.83
PGSC0003DMG200024706	K05740	ko04510	Focal adhesion	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMG200024706	K05740	ko04810	Regulation of actin cytoskeleton	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMG200024706	K05740	ko05131	Shigellosis	632	1.8e-26	0.29	0.44	0.57
PGSC0003DMG200024707	K09490	ko03060	Protein export	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMG200024707	K09490	ko05020	Prion diseases	4326	9.1e-233	0.78	0.91	0.97
PGSC0003DMG200020706	K12598	ko03018	RNA degradation	6767	0.	0.81	0.90	1.00
PGSC0003DMG200020706	K12598	ko03018	RNA degradation	6959	0.	0.83	0.92	1.00
PGSC0003DMG200020707	K06638	ko04110	Cell cycle	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMG200020707	K06638	ko04914	Progesterone-mediated oocyte maturation	4080	3.4e-219	0.70	0.80	1.00
PGSC0003DMG200020707	K06638	ko04110	Cell cycle	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMG200020707	K06638	ko04914	Progesterone-mediated oocyte maturation	4169	4.2e-224	0.74	0.85	1.00
PGSC0003DMG200020713	K12839	ko03040	Spliceosome	1797	2.8e-93	0.74	0.85	0.99
PGSC0003DMG200020713	K12839	ko03040	Spliceosome	582	2.9e-26	0.69	0.79	0.98
PGSC0003DMG200020713	K12839	ko03040	Spliceosome	1413	4.2e-72	0.74	0.85	0.98
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	499	1.1e-21	0.55	0.69	0.99
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	233	1.1e-06	0.42	0.55	0.88
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	2945	1.3e-156	0.62	0.74	0.91
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	1377	4.1e-70	0.68	0.82	1.00
PGSC0003DMG200020715	K03544	ko04112	Cell cycle - Caulobacter	1134	1.0e-56	0.53	0.63	0.77
PGSC0003DMG200020717	K11294	ko05130	Pathogenic Escherichia coli infection	285	4.8e-07	0.30	0.48	0.24
PGSC0003DMG200020717	K11294	ko05130	Pathogenic Escherichia coli infection	285	1.7e-08	0.30	0.48	0.54
PGSC0003DMG200003215	K02112	ko00190	Oxidative phosphorylation	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMG200003215	K02112	ko00195	Photosynthesis	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMG200003215	K02112	ko01100	Metabolic pathways	700	9.0e-33	0.99	0.99	0.86
PGSC0003DMG200003218	K12890	ko03040	Spliceosome	1651	3.2e-85	0.87	0.94	0.66
PGSC0003DMG200003218	K12890	ko03040	Spliceosome	1850	3.3e-96	0.80	0.88	0.98
PGSC0003DMG200003218	K12890	ko03040	Spliceosome	1847	4.9e-96	0.81	0.89	0.98
PGSC0003DMG200007911	K02144	ko00190	Oxidative phosphorylation	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007911	K02144	ko01100	Metabolic pathways	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007911	K02144	ko04142	Lysosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007911	K02144	ko04145	Phagosome	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007911	K02144	ko05110	Vibrio cholerae infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007911	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3032	2.1e-161	0.80	0.90	0.99
PGSC0003DMG200007913	K01507	ko00190	Oxidative phosphorylation	5827	0.	0.91	0.96	1.00
PGSC0003DMG200007914	K01613	ko00564	Glycerophospholipid metabolism	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMG200007914	K01613	ko01100	Metabolic pathways	283	7.6e-09	0.35	0.52	0.84
PGSC0003DMG200007914	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMG200007914	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMG200007914	K01613	ko00564	Glycerophospholipid metabolism	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMG200007914	K01613	ko01100	Metabolic pathways	370	9.1e-14	0.29	0.46	0.73
PGSC0003DMG200004043	K11423	ko00310	Lysine degradation	451	7.8e-18	0.29	0.47	0.83
PGSC0003DMG200004047	K02150	ko00190	Oxidative phosphorylation	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004047	K02150	ko01100	Metabolic pathways	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004047	K02150	ko04145	Phagosome	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004047	K02150	ko04966	Collecting duct acid secretion	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004047	K02150	ko05110	Vibrio cholerae infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004047	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1398	2.8e-71	0.77	0.88	0.98
PGSC0003DMG200004048	K02866	ko03010	Ribosome	292	4.7e-10	0.70	0.85	0.87
PGSC0003DMG200004050	K03902	ko04610	Complement and coagulation cascades	373	1.8e-13	0.38	0.46	0.97
PGSC0003DMG200014108	K01081	ko00230	Purine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMG200014108	K01081	ko00240	Pyrimidine metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMG200014108	K01081	ko00760	Nicotinate and nicotinamide metabolism	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMG200014108	K01081	ko01100	Metabolic pathways	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMG200014108	K01081	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.38	0.58	0.91
PGSC0003DMG200014108	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014110	K00430	ko00360	Phenylalanine metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMG200014110	K00430	ko00680	Methane metabolism	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMG200014110	K00430	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMG200014110	K00430	ko01100	Metabolic pathways	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMG200014110	K00430	ko01110	Biosynthesis of secondary metabolites	665	7.6e-31	0.39	0.50	0.62
PGSC0003DMG200014115	K01915	ko00250	Alanine, aspartate and glutamate metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMG200014115	K01915	ko00330	Arginine and proline metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMG200014115	K01915	ko00910	Nitrogen metabolism	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMG200014115	K01915	ko01100	Metabolic pathways	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMG200014115	K01915	ko02020	Two-component system	454	3.3e-19	0.73	0.77	0.85
PGSC0003DMG200014121	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMG200014121	K12581	ko03018	RNA degradation	2099	6.2e-110	0.88	0.96	1.00
PGSC0003DMG200014128	K01535	ko00190	Oxidative phosphorylation	4939	1.4e-266	0.85	0.92	1.00
PGSC0003DMG200030465	K03843	ko00510	N-Glycan biosynthesis	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMG200030465	K03843	ko01100	Metabolic pathways	2800	1.3e-148	0.79	0.91	1.00
PGSC0003DMG200030469	K00487	ko00360	Phenylalanine metabolism	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00940	Phenylpropanoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00941	Flavonoid biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01100	Metabolic pathways	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01110	Biosynthesis of secondary metabolites	3935	3.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00360	Phenylalanine metabolism	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko00940	Phenylpropanoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko00941	Flavonoid biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko01100	Metabolic pathways	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko01110	Biosynthesis of secondary metabolites	2514	8.0e-133	0.91	0.96	1.00
PGSC0003DMG200030469	K00487	ko00360	Phenylalanine metabolism	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00940	Phenylpropanoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00941	Flavonoid biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01100	Metabolic pathways	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01110	Biosynthesis of secondary metabolites	3927	9.3e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00360	Phenylalanine metabolism	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00940	Phenylpropanoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00941	Flavonoid biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01100	Metabolic pathways	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030469	K00487	ko01110	Biosynthesis of secondary metabolites	3928	8.1e-211	0.90	0.96	1.00
PGSC0003DMG200030473	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMG200030473	K06689	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMG200030476	K03063	ko03050	Proteasome	3214	2.0e-171	0.93	0.95	0.99
PGSC0003DMG200023772	K00941	ko00730	Thiamine metabolism	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMG200023772	K00941	ko01100	Metabolic pathways	2158	3.4e-113	0.72	0.85	0.99
PGSC0003DMG200023772	K00941	ko00730	Thiamine metabolism	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMG200023772	K00941	ko01100	Metabolic pathways	2302	3.9e-121	0.73	0.84	0.99
PGSC0003DMG200023772	K00941	ko00730	Thiamine metabolism	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMG200023772	K00941	ko01100	Metabolic pathways	2947	1.0e-156	0.72	0.85	0.89
PGSC0003DMG200023772	K00941	ko00730	Thiamine metabolism	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMG200023772	K00941	ko01100	Metabolic pathways	765	2.3e-36	0.74	0.88	0.97
PGSC0003DMG200023775	K02365	ko04110	Cell cycle	7297	0.	0.46	0.63	1.00
PGSC0003DMG200023775	K02365	ko04111	Cell cycle - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMG200023775	K02365	ko04113	Meiosis - yeast	7297	0.	0.46	0.63	1.00
PGSC0003DMG200023775	K02365	ko04114	Oocyte meiosis	7297	0.	0.46	0.63	1.00
PGSC0003DMG200026852	K02873	ko03010	Ribosome	954	8.8e-47	0.81	0.91	0.99
PGSC0003DMG200026853	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1802	1.5e-93	0.70	0.80	0.91
PGSC0003DMG200026854	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.82	0.98
PGSC0003DMG200026855	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	2036	1.8e-106	0.71	0.80	0.98
PGSC0003DMG200026856	K00012	ko00040	Pentose and glucuronate interconversions	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026856	K00012	ko00053	Ascorbate and aldarate metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026856	K00012	ko00500	Starch and sucrose metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026856	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026856	K00012	ko01100	Metabolic pathways	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026856	K00012	ko01110	Biosynthesis of secondary metabolites	1355	6.7e-69	0.86	0.91	0.99
PGSC0003DMG200026857	K12829	ko03040	Spliceosome	3879	4.1e-208	0.80	0.88	1.00
PGSC0003DMG200026857	K12829	ko03040	Spliceosome	2509	1.5e-132	0.90	0.97	1.00
PGSC0003DMG200026857	K12829	ko03040	Spliceosome	4097	3.9e-220	0.83	0.91	1.00
PGSC0003DMG200026858	K02184	ko04320	Dorso-ventral axis formation	490	8.6e-19	0.30	0.43	0.56
PGSC0003DMG200026858	K05740	ko04510	Focal adhesion	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMG200026858	K05740	ko04810	Regulation of actin cytoskeleton	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMG200026858	K05740	ko05131	Shigellosis	540	6.8e-21	0.30	0.41	0.56
PGSC0003DMG200026862	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.61
PGSC0003DMG200026862	K12831	ko03040	Spliceosome	302	8.0e-11	0.40	0.71	0.43
PGSC0003DMG200026863	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMG200026863	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.85
PGSC0003DMG200026863	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMG200026863	K11422	ko00310	Lysine degradation	263	1.3e-07	0.29	0.47	0.73
PGSC0003DMG200026863	K11422	ko00310	Lysine degradation	260	1.7e-07	0.31	0.48	0.86
PGSC0003DMG200026867	K04733	ko04210	Apoptosis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMG200026867	K04733	ko04620	Toll-like receptor signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMG200026867	K04733	ko04722	Neurotrophin signaling pathway	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMG200026867	K04733	ko05140	Leishmaniasis	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMG200026867	K04733	ko05142	Chagas disease	1256	1.9e-63	0.49	0.66	0.91
PGSC0003DMG200026869	K01657	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMG200026869	K01657	ko01100	Metabolic pathways	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMG200026869	K01657	ko01110	Biosynthesis of secondary metabolites	2688	2.0e-142	0.63	0.76	0.90
PGSC0003DMG200028907	K04079	ko04612	Antigen processing and presentation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko04621	NOD-like receptor signaling pathway	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko04626	Plant-pathogen interaction	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko04914	Progesterone-mediated oocyte maturation	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko05200	Pathways in cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko05215	Prostate cancer	2338	4.1e-123	0.95	0.98	0.96
PGSC0003DMG200028907	K04079	ko04612	Antigen processing and presentation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04621	NOD-like receptor signaling pathway	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04626	Plant-pathogen interaction	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04914	Progesterone-mediated oocyte maturation	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko05200	Pathways in cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko05215	Prostate cancer	2793	3.3e-148	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04612	Antigen processing and presentation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko04621	NOD-like receptor signaling pathway	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko04626	Plant-pathogen interaction	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko04914	Progesterone-mediated oocyte maturation	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko05200	Pathways in cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko05215	Prostate cancer	724	4.3e-34	0.96	0.99	0.69
PGSC0003DMG200028907	K04079	ko04612	Antigen processing and presentation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04621	NOD-like receptor signaling pathway	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04626	Plant-pathogen interaction	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko04914	Progesterone-mediated oocyte maturation	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko05200	Pathways in cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028907	K04079	ko05215	Prostate cancer	3200	1.2e-170	0.94	0.98	1.00
PGSC0003DMG200028919	K08008	ko04145	Phagosome	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	983	2.2e-48	0.33	0.50	0.59
PGSC0003DMG200028919	K08008	ko04145	Phagosome	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	973	7.9e-48	0.33	0.49	0.59
PGSC0003DMG200028919	K08008	ko04145	Phagosome	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMG200028919	K08008	ko04670	Leukocyte transendothelial migration	250	1.7e-07	0.35	0.50	0.72
PGSC0003DMG200012332	K10843	ko03420	Nucleotide excision repair	5489	6.5e-297	0.89	0.93	0.98
PGSC0003DMG200012332	K10843	ko03420	Nucleotide excision repair	5851	0.	0.90	0.94	0.99
PGSC0003DMG200012334	K02202	ko03420	Nucleotide excision repair	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMG200012334	K02202	ko04110	Cell cycle	2922	2.5e-155	0.81	0.89	1.00
PGSC0003DMG200012336	K11153	ko00830	Retinol metabolism	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMG200012336	K11153	ko01100	Metabolic pathways	848	6.2e-41	0.44	0.60	0.92
PGSC0003DMG200012338	K01928	ko00300	Lysine biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMG200012338	K01928	ko00550	Peptidoglycan biosynthesis	1541	3.7e-79	0.43	0.60	0.66
PGSC0003DMG200005640	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMG200005640	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMG200005640	K02874	ko03010	Ribosome	1003	1.7e-49	0.74	0.85	0.99
PGSC0003DMG200005640	K02874	ko03010	Ribosome	853	3.3e-41	0.87	0.94	0.99
PGSC0003DMG200005642	K02993	ko03010	Ribosome	1467	4.5e-75	0.90	0.97	0.99
PGSC0003DMG200005643	K11866	ko04144	Endocytosis	365	2.7e-14	0.76	0.88	0.94
PGSC0003DMG200005643	K11866	ko04144	Endocytosis	1417	2.5e-72	0.55	0.69	0.92
PGSC0003DMG200005643	K11866	ko04144	Endocytosis	2742	2.1e-145	0.65	0.78	0.99
PGSC0003DMG200005643	K11866	ko04144	Endocytosis	2432	2.7e-128	0.65	0.77	1.00
PGSC0003DMG200005646	K01892	ko00970	Aminoacyl-tRNA biosynthesis	2067	3.6e-108	0.83	0.95	1.00
PGSC0003DMG200005647	K12396	ko04142	Lysosome	4696	3.6e-253	0.63	0.76	1.00
PGSC0003DMG200005649	K02183	ko04020	Calcium signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04070	Phosphatidylinositol signaling system	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04114	Oocyte meiosis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04270	Vascular smooth muscle contraction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04626	Plant-pathogen interaction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04720	Long-term potentiation	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04722	Neurotrophin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04740	Olfactory transduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04744	Phototransduction	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04745	Phototransduction - fly	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04910	Insulin signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04912	GnRH signaling pathway	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04916	Melanogenesis	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04970	Salivary secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04971	Gastric acid secretion	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko05010	Alzheimer's disease	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko05214	Glioma	1420	1.7e-72	0.49	0.67	0.90
PGSC0003DMG200005649	K02183	ko04020	Calcium signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04070	Phosphatidylinositol signaling system	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04114	Oocyte meiosis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04270	Vascular smooth muscle contraction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04626	Plant-pathogen interaction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04720	Long-term potentiation	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04722	Neurotrophin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04740	Olfactory transduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04744	Phototransduction	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04745	Phototransduction - fly	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04910	Insulin signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04912	GnRH signaling pathway	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04916	Melanogenesis	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04970	Salivary secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko04971	Gastric acid secretion	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko05010	Alzheimer's disease	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005649	K02183	ko05214	Glioma	1332	1.2e-67	0.50	0.68	1.00
PGSC0003DMG200005656	K05350	ko00460	Cyanoamino acid metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMG200005656	K05350	ko00500	Starch and sucrose metabolism	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMG200005656	K05350	ko00940	Phenylpropanoid biosynthesis	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMG200005656	K05350	ko01110	Biosynthesis of secondary metabolites	2876	8.6e-153	0.76	0.89	0.90
PGSC0003DMG200005656	K05350	ko00460	Cyanoamino acid metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMG200005656	K05350	ko00500	Starch and sucrose metabolism	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMG200005656	K05350	ko00940	Phenylpropanoid biosynthesis	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMG200005656	K05350	ko01110	Biosynthesis of secondary metabolites	3524	1.6e-188	0.76	0.89	0.98
PGSC0003DMG200008778	K00368	ko00910	Nitrogen metabolism	1216	3.1e-61	0.45	0.57	0.86
PGSC0003DMG200008783	K05579	ko00190	Oxidative phosphorylation	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMG200008783	K05579	ko01100	Metabolic pathways	1655	1.9e-85	0.90	0.96	0.90
PGSC0003DMG200008783	K05572	ko00190	Oxidative phosphorylation	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMG200008783	K05572	ko01100	Metabolic pathways	955	7.7e-47	0.84	0.91	0.99
PGSC0003DMG200008785	K09841	ko00906	Carotenoid biosynthesis	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMG200008785	K09841	ko01100	Metabolic pathways	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMG200008785	K09841	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.51	0.71	0.97
PGSC0003DMG200008785	K09841	ko00906	Carotenoid biosynthesis	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMG200008785	K09841	ko01100	Metabolic pathways	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMG200008785	K09841	ko01110	Biosynthesis of secondary metabolites	512	2.1e-22	0.49	0.69	0.99
PGSC0003DMG200008785	K09841	ko00906	Carotenoid biosynthesis	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMG200008785	K09841	ko01100	Metabolic pathways	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMG200008785	K09841	ko01110	Biosynthesis of secondary metabolites	676	1.9e-31	0.49	0.69	0.99
PGSC0003DMG200008787	K00522	ko00860	Porphyrin and chlorophyll metabolism	817	3.2e-39	0.59	0.74	0.67
PGSC0003DMG200008789	K13065	ko00940	Phenylpropanoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMG200008789	K13065	ko00941	Flavonoid biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMG200008789	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMG200008789	K13065	ko01110	Biosynthesis of secondary metabolites	278	2.5e-07	0.28	0.42	0.66
PGSC0003DMG200008792	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMG200008792	K02886	ko03010	Ribosome	286	6.1e-10	0.38	0.49	0.57
PGSC0003DMG200000429	K13065	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMG200000429	K13065	ko00941	Flavonoid biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMG200000429	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMG200000429	K13065	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.36	0.51	1.00
PGSC0003DMG200000431	K12356	ko00940	Phenylpropanoid biosynthesis	784	2.1e-37	0.33	0.50	0.94
PGSC0003DMG200000432	K12356	ko00940	Phenylpropanoid biosynthesis	751	1.4e-35	0.32	0.49	0.93
PGSC0003DMG200000433	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMG200000433	K12449	ko01100	Metabolic pathways	2165	1.4e-113	0.86	0.90	0.99
PGSC0003DMG200000433	K12449	ko00520	Amino sugar and nucleotide sugar metabolism	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMG200000433	K12449	ko01100	Metabolic pathways	3027	4.0e-161	0.91	0.95	0.99
PGSC0003DMG200000436	K11824	ko04144	Endocytosis	7361	0.	0.85	0.90	1.00
PGSC0003DMG200000436	K11824	ko05016	Huntington's disease	7361	0.	0.85	0.90	1.00
PGSC0003DMG200000436	K11824	ko04144	Endocytosis	7394	0.	0.87	0.92	1.00
PGSC0003DMG200000436	K11824	ko05016	Huntington's disease	7394	0.	0.87	0.92	1.00
PGSC0003DMG200000436	K11824	ko04144	Endocytosis	7426	0.	0.87	0.92	1.00
PGSC0003DMG200000436	K11824	ko05016	Huntington's disease	7426	0.	0.87	0.92	1.00
PGSC0003DMG200000439	K05692	ko04145	Phagosome	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04510	Focal adhesion	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04520	Adherens junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04530	Tight junction	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04670	Leukocyte transendothelial migration	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04745	Phototransduction - fly	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko04810	Regulation of actin cytoskeleton	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05100	Bacterial invasion of epithelial cells	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05110	Vibrio cholerae infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05130	Pathogenic Escherichia coli infection	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05131	Shigellosis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05414	Dilated cardiomyopathy	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200000439	K05692	ko05416	Viral myocarditis	3106	1.8e-165	0.96	0.99	1.00
PGSC0003DMG200041580	K10532	ko00531	Glycosaminoglycan degradation	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMG200041580	K10532	ko01100	Metabolic pathways	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMG200041580	K10532	ko04142	Lysosome	1800	1.9e-93	0.53	0.72	0.91
PGSC0003DMG200029742	K01613	ko00564	Glycerophospholipid metabolism	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMG200029742	K01613	ko01100	Metabolic pathways	3851	1.4e-206	0.75	0.86	0.98
PGSC0003DMG200029742	K01613	ko00564	Glycerophospholipid metabolism	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMG200029742	K01613	ko01100	Metabolic pathways	4038	7.0e-217	0.74	0.86	0.99
PGSC0003DMG200026180	K01768	ko00230	Purine metabolism	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMG200026180	K01768	ko04113	Meiosis - yeast	260	2.4e-06	0.34	0.50	0.28
PGSC0003DMG200026180	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMG200026180	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMG200026180	K01768	ko00230	Purine metabolism	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMG200026180	K01768	ko04113	Meiosis - yeast	260	2.7e-06	0.34	0.50	0.26
PGSC0003DMG200026181	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.85
PGSC0003DMG200026181	K12135	ko04712	Circadian rhythm - plant	240	2.1e-07	0.31	0.47	0.54
PGSC0003DMG200023058	K02997	ko03010	Ribosome	1579	3.0e-81	0.93	0.99	0.99
PGSC0003DMG200023059	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko00030	Pentose phosphate pathway	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko00040	Pentose and glucuronate interconversions	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko00710	Carbon fixation in photosynthetic organisms	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko01100	Metabolic pathways	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023059	K01783	ko01110	Biosynthesis of secondary metabolites	1169	1.2e-58	0.89	0.94	0.98
PGSC0003DMG200023061	K10594	ko04120	Ubiquitin mediated proteolysis	766	2.7e-33	0.32	0.48	0.51
PGSC0003DMG200042758	K04428	ko04010	MAPK signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMG200042758	K04428	ko04912	GnRH signaling pathway	272	3.6e-09	0.48	0.72	0.52
PGSC0003DMG200042786	K03062	ko03050	Proteasome	235	1.8e-06	0.33	0.54	0.83
PGSC0003DMG200001098	K13027	ko00460	Cyanoamino acid metabolism	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMG200001098	K13027	ko00966	Glucosinolate biosynthesis	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMG200001098	K13027	ko01100	Metabolic pathways	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMG200001098	K13027	ko01110	Biosynthesis of secondary metabolites	1865	5.0e-97	0.52	0.69	1.00
PGSC0003DMG200001104	K11594	ko04622	RIG-I-like receptor signaling pathway	4180	1.0e-224	0.78	0.87	1.00
PGSC0003DMG200001105	K04717	ko00600	Sphingolipid metabolism	484	7.3e-21	0.30	0.46	0.91
PGSC0003DMG200001110	K12124	ko04712	Circadian rhythm - plant	367	1.6e-13	0.49	0.68	0.84
PGSC0003DMG200000035	K12862	ko03040	Spliceosome	3273	1.1e-174	0.78	0.87	1.00
PGSC0003DMG200000037	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2537	4.3e-134	0.69	0.84	0.99
PGSC0003DMG200000037	K01068	ko01040	Biosynthesis of unsaturated fatty acids	417	3.6e-17	0.66	0.85	0.95
PGSC0003DMG200000048	K13034	ko00270	Cysteine and methionine metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMG200000048	K13034	ko00450	Selenoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMG200000048	K13034	ko00460	Cyanoamino acid metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMG200000048	K13034	ko00920	Sulfur metabolism	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMG200000048	K13034	ko01100	Metabolic pathways	2092	1.5e-109	0.85	0.91	0.99
PGSC0003DMG200000048	K13034	ko00270	Cysteine and methionine metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMG200000048	K13034	ko00450	Selenoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMG200000048	K13034	ko00460	Cyanoamino acid metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMG200000048	K13034	ko00920	Sulfur metabolism	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMG200000048	K13034	ko01100	Metabolic pathways	2514	8.0e-133	0.85	0.92	1.00
PGSC0003DMG200000048	K13034	ko00270	Cysteine and methionine metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMG200000048	K13034	ko00450	Selenoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMG200000048	K13034	ko00460	Cyanoamino acid metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMG200000048	K13034	ko00920	Sulfur metabolism	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMG200000048	K13034	ko01100	Metabolic pathways	1941	3.2e-101	0.92	0.99	1.00
PGSC0003DMG200000049	K12604	ko03018	RNA degradation	1434	3.7e-73	0.45	0.61	0.97
PGSC0003DMG200000049	K12604	ko03018	RNA degradation	365	4.5e-13	0.54	0.79	0.86
PGSC0003DMG200012994	K05714	ko00360	Phenylalanine metabolism	214	5.7e-06	0.36	0.54	0.45
PGSC0003DMG200012994	K10702	ko00642	Ethylbenzene degradation	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMG200012994	K10702	ko01100	Metabolic pathways	318	1.1e-11	0.29	0.48	0.82
PGSC0003DMG200009407	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMG200009407	K12858	ko03040	Spliceosome	4458	4.8e-240	0.79	0.86	0.97
PGSC0003DMG200009409	K13068	ko00940	Phenylpropanoid biosynthesis	673	2.8e-31	0.29	0.49	0.99
PGSC0003DMG200009410	K13068	ko00940	Phenylpropanoid biosynthesis	750	1.6e-35	0.30	0.51	0.97
PGSC0003DMG200009411	K13068	ko00940	Phenylpropanoid biosynthesis	592	8.1e-27	0.28	0.49	0.98
PGSC0003DMG200009412	K13068	ko00940	Phenylpropanoid biosynthesis	699	1.0e-32	0.30	0.49	0.97
PGSC0003DMG200009415	K00558	ko00270	Cysteine and methionine metabolism	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMG200009415	K00558	ko01100	Metabolic pathways	276	2.0e-06	0.49	0.64	0.19
PGSC0003DMG200006283	K05666	ko02010	ABC transporters	2647	3.7e-140	0.34	0.53	0.86
PGSC0003DMG200006283	K05666	ko02010	ABC transporters	3378	1.8e-180	0.39	0.61	0.88
PGSC0003DMG200006283	K05666	ko02010	ABC transporters	1802	5.5e-97	0.31	0.53	0.87
PGSC0003DMG200006287	K01239	ko00230	Purine metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMG200006287	K01239	ko00760	Nicotinate and nicotinamide metabolism	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMG200006287	K01239	ko01100	Metabolic pathways	317	6.0e-11	0.28	0.46	0.69
PGSC0003DMG200006287	K01239	ko00230	Purine metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMG200006287	K01239	ko00760	Nicotinate and nicotinamide metabolism	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMG200006287	K01239	ko01100	Metabolic pathways	265	3.9e-08	0.32	0.49	0.65
PGSC0003DMG200006288	K02084	ko04115	p53 signaling pathway	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko04210	Apoptosis	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko05010	Alzheimer's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko05012	Parkinson's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko05016	Huntington's disease	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006288	K02084	ko05222	Small cell lung cancer	372	7.3e-11	0.29	0.46	0.30
PGSC0003DMG200006289	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMG200006289	K01870	ko00970	Aminoacyl-tRNA biosynthesis	6961	0.	0.74	0.83	0.97
PGSC0003DMG200006289	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMG200006289	K01870	ko00970	Aminoacyl-tRNA biosynthesis	5900	0.	0.80	0.89	0.97
PGSC0003DMG200006289	K01870	ko00290	Valine, leucine and isoleucine biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMG200006289	K01870	ko00970	Aminoacyl-tRNA biosynthesis	7264	0.	0.79	0.88	0.97
PGSC0003DMG200006291	K02706	ko00195	Photosynthesis	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMG200006291	K02706	ko01100	Metabolic pathways	505	5.1e-22	0.81	0.87	0.63
PGSC0003DMG200011506	K00817	ko00340	Histidine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00350	Tyrosine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00360	Phenylalanine metabolism	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00401	Novobiocin biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko01100	Metabolic pathways	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko01110	Biosynthesis of secondary metabolites	218	3.4e-06	0.63	0.69	0.27
PGSC0003DMG200011506	K00817	ko00340	Histidine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko00350	Tyrosine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko00360	Phenylalanine metabolism	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko00401	Novobiocin biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko01100	Metabolic pathways	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011506	K00817	ko01110	Biosynthesis of secondary metabolites	222	3.0e-06	0.40	0.52	0.65
PGSC0003DMG200011512	K11753	ko00740	Riboflavin metabolism	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMG200011512	K11753	ko01100	Metabolic pathways	322	6.3e-12	0.35	0.50	0.48
PGSC0003DMG200011512	K11753	ko00740	Riboflavin metabolism	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMG200011512	K11753	ko01100	Metabolic pathways	264	1.0e-08	0.33	0.53	0.69
PGSC0003DMG200011517	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko04115	p53 signaling pathway	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko04210	Apoptosis	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05010	Alzheimer's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05012	Parkinson's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05016	Huntington's disease	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011517	K02084	ko05222	Small cell lung cancer	316	5.2e-08	0.27	0.49	0.38
PGSC0003DMG200011518	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.10
PGSC0003DMG200011518	K01803	ko00010	Glycolysis / Gluconeogenesis	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011518	K01803	ko00051	Fructose and mannose metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011518	K01803	ko00562	Inositol phosphate metabolism	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011518	K01803	ko00710	Carbon fixation in photosynthetic organisms	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011518	K01803	ko01100	Metabolic pathways	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011518	K01803	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.82	0.91	0.11
PGSC0003DMG200011520	K02084	ko04115	p53 signaling pathway	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko04210	Apoptosis	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko05010	Alzheimer's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko05012	Parkinson's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko05016	Huntington's disease	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200011520	K02084	ko05222	Small cell lung cancer	290	1.6e-06	0.26	0.45	0.58
PGSC0003DMG200020593	K01897	ko00071	Fatty acid metabolism	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMG200020593	K01897	ko01100	Metabolic pathways	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMG200020593	K01897	ko03320	PPAR signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMG200020593	K01897	ko04146	Peroxisome	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMG200020593	K01897	ko04920	Adipocytokine signaling pathway	3918	2.9e-210	0.68	0.82	0.95
PGSC0003DMG200020595	K12929	ko00904	Diterpenoid biosynthesis	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMG200020595	K12929	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.40	0.63	0.98
PGSC0003DMG200020603	K01176	ko00500	Starch and sucrose metabolism	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMG200020603	K01176	ko01100	Metabolic pathways	434	4.2e-18	0.56	0.83	0.65
PGSC0003DMG200020603	K01176	ko00500	Starch and sucrose metabolism	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMG200020603	K01176	ko01100	Metabolic pathways	1929	1.5e-100	0.66	0.78	0.90
PGSC0003DMG200020603	K01176	ko00500	Starch and sucrose metabolism	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMG200020603	K01176	ko01100	Metabolic pathways	2334	6.7e-123	0.64	0.77	0.93
PGSC0003DMG200020603	K01176	ko00500	Starch and sucrose metabolism	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMG200020603	K01176	ko01100	Metabolic pathways	324	4.9e-12	0.61	0.70	0.84
PGSC0003DMG200020603	K01176	ko00500	Starch and sucrose metabolism	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMG200020603	K01176	ko01100	Metabolic pathways	2092	1.5e-109	0.66	0.80	0.93
PGSC0003DMG200031501	K08241	ko00592	alpha-Linolenic acid metabolism	675	2.1e-31	0.33	0.51	0.89
PGSC0003DMG200031502	K01590	ko00340	Histidine metabolism	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMG200031502	K01590	ko01100	Metabolic pathways	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMG200031502	K01590	ko01110	Biosynthesis of secondary metabolites	1554	7.1e-80	0.52	0.67	0.70
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	6.8e-07	0.27	0.44	0.78
PGSC0003DMG200021470	K02602	ko04114	Oocyte meiosis	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04320	Dorso-ventral axis formation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200021470	K02602	ko04914	Progesterone-mediated oocyte maturation	286	2.0e-06	0.27	0.44	0.50
PGSC0003DMG200025346	K05862	ko04020	Calcium signaling pathway	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMG200025346	K05862	ko05012	Parkinson's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMG200025346	K05862	ko05016	Huntington's disease	323	5.6e-12	0.46	0.58	0.85
PGSC0003DMG200025346	K05862	ko04020	Calcium signaling pathway	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMG200025346	K05862	ko05012	Parkinson's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMG200025346	K05862	ko05016	Huntington's disease	706	4.2e-33	0.39	0.54	1.00
PGSC0003DMG200025346	K05862	ko04020	Calcium signaling pathway	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMG200025346	K05862	ko05012	Parkinson's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMG200025346	K05862	ko05016	Huntington's disease	348	2.3e-13	0.44	0.67	0.59
PGSC0003DMG200025346	K05862	ko04020	Calcium signaling pathway	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMG200025346	K05862	ko05012	Parkinson's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMG200025346	K05862	ko05016	Huntington's disease	391	9.9e-16	0.36	0.51	0.99
PGSC0003DMG200025348	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025348	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025348	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025348	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025348	K10591	ko04120	Ubiquitin mediated proteolysis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025348	K10591	ko04144	Endocytosis	275	7.9e-06	0.31	0.48	0.18
PGSC0003DMG200025349	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMG200025349	K01358	ko04112	Cell cycle - Caulobacter	708	3.2e-33	0.46	0.62	0.53
PGSC0003DMG200038169	K11644	ko05016	Huntington's disease	461	1.2e-18	0.35	0.50	0.73
PGSC0003DMG200038191	K03660	ko03410	Base excision repair	463	2.9e-19	0.31	0.50	0.97
PGSC0003DMG200038192	K03094	ko04110	Cell cycle	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04111	Cell cycle - yeast	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04114	Oocyte meiosis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04120	Ubiquitin mediated proteolysis	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04310	Wnt signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04350	TGF-beta signaling pathway	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038192	K03094	ko04710	Circadian rhythm - mammal	595	5.5e-27	0.60	0.73	0.99
PGSC0003DMG200038195	K02738	ko03050	Proteasome	456	2.6e-19	0.38	0.58	0.85
PGSC0003DMG200016814	K02923	ko03010	Ribosome	521	6.7e-23	0.90	0.96	0.99
PGSC0003DMG200016815	K06236	ko04510	Focal adhesion	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMG200016815	K06236	ko04512	ECM-receptor interaction	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMG200016815	K06236	ko05146	Amoebiasis	413	2.3e-16	0.39	0.56	0.69
PGSC0003DMG200016816	K01213	ko00040	Pentose and glucuronate interconversions	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMG200016816	K01213	ko00500	Starch and sucrose metabolism	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMG200016816	K01213	ko01100	Metabolic pathways	1170	1.1e-58	0.38	0.59	0.97
PGSC0003DMG200016826	K00030	ko00020	Citrate cycle (TCA cycle)	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMG200016826	K00030	ko01100	Metabolic pathways	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMG200016826	K00030	ko01110	Biosynthesis of secondary metabolites	2723	2.4e-144	0.85	0.93	1.00
PGSC0003DMG200016830	K09680	ko00770	Pantothenate and CoA biosynthesis	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMG200016830	K09680	ko01100	Metabolic pathways	856	2.2e-41	0.41	0.61	0.66
PGSC0003DMG200016830	K09680	ko00770	Pantothenate and CoA biosynthesis	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMG200016830	K09680	ko01100	Metabolic pathways	321	3.6e-11	0.57	0.72	0.91
PGSC0003DMG200003355	K01509	ko00230	Purine metabolism	264	8.2e-26	0.47	0.67	0.62
PGSC0003DMG200003357	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMG200003357	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMG200003357	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMG200003357	K08066	ko04612	Antigen processing and presentation	686	5.3e-32	0.41	0.55	0.98
PGSC0003DMG200003358	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMG200003358	K02367	ko01100	Metabolic pathways	236	1.6e-06	0.30	0.53	0.78
PGSC0003DMG200003368	K02870	ko03010	Ribosome	1326	2.7e-67	0.95	0.99	0.99
PGSC0003DMG200007192	K12815	ko03040	Spliceosome	8555	0.	0.81	0.88	0.99
PGSC0003DMG200007192	K12815	ko03040	Spliceosome	427	8.0e-17	0.96	0.98	0.95
PGSC0003DMG200007192	K12815	ko03040	Spliceosome	363	3.0e-13	0.90	0.98	0.80
PGSC0003DMG200007196	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMG200007196	K00517	ko00626	Naphthalene and anthracene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMG200007196	K00517	ko00903	Limonene and pinene degradation	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMG200007196	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMG200007196	K00517	ko01110	Biosynthesis of secondary metabolites	1522	4.1e-78	0.62	0.78	0.99
PGSC0003DMG200007196	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMG200007196	K00517	ko00626	Naphthalene and anthracene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMG200007196	K00517	ko00903	Limonene and pinene degradation	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMG200007196	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMG200007196	K00517	ko01110	Biosynthesis of secondary metabolites	2471	1.9e-130	0.60	0.75	0.99
PGSC0003DMG200007196	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMG200007196	K00517	ko00626	Naphthalene and anthracene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMG200007196	K00517	ko00903	Limonene and pinene degradation	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMG200007196	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMG200007196	K00517	ko01110	Biosynthesis of secondary metabolites	2499	5.3e-132	0.61	0.76	0.99
PGSC0003DMG200007201	K02723	ko00195	Photosynthesis	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMG200007201	K02723	ko01100	Metabolic pathways	798	3.5e-38	0.56	0.70	0.99
PGSC0003DMG200007203	K01209	ko00520	Amino sugar and nucleotide sugar metabolism	1380	2.8e-70	0.38	0.55	0.96
PGSC0003DMG200007205	K02183	ko04020	Calcium signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04070	Phosphatidylinositol signaling system	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04114	Oocyte meiosis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04270	Vascular smooth muscle contraction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04626	Plant-pathogen interaction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04720	Long-term potentiation	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04722	Neurotrophin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04740	Olfactory transduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04744	Phototransduction	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04745	Phototransduction - fly	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04910	Insulin signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04912	GnRH signaling pathway	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04916	Melanogenesis	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04970	Salivary secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko04971	Gastric acid secretion	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko05010	Alzheimer's disease	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007205	K02183	ko05214	Glioma	1247	6.1e-63	0.99	1.00	0.99
PGSC0003DMG200007206	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	368	4.4e-14	0.30	0.47	0.93
PGSC0003DMG200007206	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	380	8.8e-15	0.29	0.46	0.92
PGSC0003DMG200007207	K12486	ko04144	Endocytosis	285	5.8e-07	0.26	0.39	0.60
PGSC0003DMG200014788	K02218	ko04340	Hedgehog signaling pathway	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMG200014788	K02218	ko04711	Circadian rhythm - fly	1345	2.4e-68	0.64	0.75	0.97
PGSC0003DMG200014788	K02218	ko04340	Hedgehog signaling pathway	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMG200014788	K02218	ko04711	Circadian rhythm - fly	511	2.4e-22	0.49	0.63	0.98
PGSC0003DMG200014788	K02218	ko04340	Hedgehog signaling pathway	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMG200014788	K02218	ko04711	Circadian rhythm - fly	2965	1.1e-157	0.75	0.84	0.99
PGSC0003DMG200014795	K12668	ko00510	N-Glycan biosynthesis	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMG200014795	K12668	ko01100	Metabolic pathways	871	3.3e-42	0.91	0.97	0.99
PGSC0003DMG200014796	K00630	ko00561	Glycerolipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMG200014796	K00630	ko00564	Glycerophospholipid metabolism	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMG200014796	K00630	ko01100	Metabolic pathways	1185	1.6e-59	0.41	0.59	0.81
PGSC0003DMG200002952	K05894	ko00592	alpha-Linolenic acid metabolism	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMG200002952	K05894	ko01100	Metabolic pathways	1483	5.8e-76	0.51	0.67	0.98
PGSC0003DMG200002953	K05894	ko00592	alpha-Linolenic acid metabolism	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMG200002953	K05894	ko01100	Metabolic pathways	1726	2.3e-89	0.57	0.73	0.98
PGSC0003DMG200002959	K01757	ko00901	Indole alkaloid biosynthesis	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMG200002959	K01757	ko01100	Metabolic pathways	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMG200002959	K01757	ko01110	Biosynthesis of secondary metabolites	774	7.4e-37	0.38	0.57	0.84
PGSC0003DMG200002965	K11254	ko05322	Systemic lupus erythematosus	851	4.2e-41	0.99	1.00	0.99
PGSC0003DMG200002971	K02256	ko00190	Oxidative phosphorylation	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200002971	K02256	ko01100	Metabolic pathways	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200002971	K02256	ko04260	Cardiac muscle contraction	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200002971	K02256	ko05010	Alzheimer's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200002971	K02256	ko05012	Parkinson's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200002971	K02256	ko05016	Huntington's disease	2426	5.7e-128	0.97	0.97	0.99
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	1160	3.8e-58	0.73	0.85	0.98
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	1966	1.3e-102	0.71	0.84	0.99
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	2007	7.3e-105	0.73	0.86	0.99
PGSC0003DMG200005820	K12235	ko00260	Glycine, serine and threonine metabolism	1956	4.8e-102	0.72	0.85	0.99
PGSC0003DMG200005825	K01762	ko00270	Cysteine and methionine metabolism	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMG200005825	K01762	ko01110	Biosynthesis of secondary metabolites	2582	1.4e-136	0.62	0.78	0.98
PGSC0003DMG200005827	K04706	ko04120	Ubiquitin mediated proteolysis	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMG200005827	K04706	ko04630	Jak-STAT signaling pathway	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMG200005827	K04706	ko05200	Pathways in cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMG200005827	K04706	ko05222	Small cell lung cancer	412	6.3e-15	0.34	0.53	0.29
PGSC0003DMG200005827	K04706	ko04120	Ubiquitin mediated proteolysis	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMG200005827	K04706	ko04630	Jak-STAT signaling pathway	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMG200005827	K04706	ko05200	Pathways in cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMG200005827	K04706	ko05222	Small cell lung cancer	430	2.5e-16	0.27	0.45	0.45
PGSC0003DMG200005833	K02150	ko00190	Oxidative phosphorylation	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200005833	K02150	ko01100	Metabolic pathways	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200005833	K02150	ko04145	Phagosome	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200005833	K02150	ko04966	Collecting duct acid secretion	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200005833	K02150	ko05110	Vibrio cholerae infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200005833	K02150	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1598	2.6e-82	0.82	0.90	1.00
PGSC0003DMG200009525	K11820	ko00380	Tryptophan metabolism	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMG200009525	K11820	ko00966	Glucosinolate biosynthesis	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMG200009525	K11820	ko01110	Biosynthesis of secondary metabolites	1084	5.9e-54	0.41	0.55	0.98
PGSC0003DMG200009526	K11820	ko00380	Tryptophan metabolism	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMG200009526	K11820	ko00966	Glucosinolate biosynthesis	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMG200009526	K11820	ko01110	Biosynthesis of secondary metabolites	952	1.1e-46	0.42	0.59	0.94
PGSC0003DMG200009527	K11820	ko00380	Tryptophan metabolism	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMG200009527	K11820	ko00966	Glucosinolate biosynthesis	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMG200009527	K11820	ko01110	Biosynthesis of secondary metabolites	1562	2.6e-80	0.47	0.63	0.98
PGSC0003DMG200009528	K11820	ko00380	Tryptophan metabolism	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMG200009528	K11820	ko00966	Glucosinolate biosynthesis	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMG200009528	K11820	ko01110	Biosynthesis of secondary metabolites	1582	2.0e-81	0.47	0.65	0.98
PGSC0003DMG200009529	K11820	ko00380	Tryptophan metabolism	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMG200009529	K11820	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMG200009529	K11820	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.42	0.59	0.98
PGSC0003DMG200009531	K00658	ko00020	Citrate cycle (TCA cycle)	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMG200009531	K00658	ko00310	Lysine degradation	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMG200009531	K00658	ko01100	Metabolic pathways	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMG200009531	K00658	ko01110	Biosynthesis of secondary metabolites	229	2.9e-06	0.44	0.56	0.31
PGSC0003DMG200009534	K11820	ko00380	Tryptophan metabolism	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMG200009534	K11820	ko00966	Glucosinolate biosynthesis	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMG200009534	K11820	ko01110	Biosynthesis of secondary metabolites	1069	4.0e-53	0.51	0.68	0.98
PGSC0003DMG200042498	K08912	ko00196	Photosynthesis - antenna proteins	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMG200042498	K08912	ko01100	Metabolic pathways	2062	6.8e-108	0.90	0.95	1.00
PGSC0003DMG200042506	K00368	ko00910	Nitrogen metabolism	699	1.0e-32	0.36	0.54	0.83
PGSC0003DMG200046303	K02704	ko00195	Photosynthesis	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMG200046303	K02704	ko01100	Metabolic pathways	4384	5.8e-236	0.91	0.94	0.99
PGSC0003DMG200019634	K08337	ko04140	Regulation of autophagy	423	3.0e-17	0.77	0.81	0.97
PGSC0003DMG200019634	K08337	ko04140	Regulation of autophagy	4693	5.2e-253	0.77	0.87	1.00
PGSC0003DMG200019638	K01206	ko00511	Other glycan degradation	2801	1.2e-148	0.74	0.86	0.93
PGSC0003DMG200019638	K01206	ko00511	Other glycan degradation	1713	1.2e-88	0.66	0.82	0.95
PGSC0003DMG200019640	K01354	ko05142	Chagas disease	600	2.9e-27	0.37	0.59	0.80
PGSC0003DMG200019640	K01354	ko05142	Chagas disease	679	1.3e-31	0.48	0.67	0.98
PGSC0003DMG200019640	K01354	ko05142	Chagas disease	269	2.0e-08	0.56	0.69	0.91
PGSC0003DMG200019644	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.34	0.48	0.95
PGSC0003DMG200019645	K12356	ko00940	Phenylpropanoid biosynthesis	698	1.2e-32	0.33	0.48	0.97
PGSC0003DMG200019647	K04079	ko04612	Antigen processing and presentation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200019647	K04079	ko04621	NOD-like receptor signaling pathway	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200019647	K04079	ko04626	Plant-pathogen interaction	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200019647	K04079	ko04914	Progesterone-mediated oocyte maturation	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200019647	K04079	ko05200	Pathways in cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200019647	K04079	ko05215	Prostate cancer	5519	1.4e-298	0.83	0.90	1.00
PGSC0003DMG200022561	K10772	ko03410	Base excision repair	1846	5.6e-96	0.55	0.66	0.99
PGSC0003DMG200022561	K10772	ko03410	Base excision repair	2985	8.4e-159	0.61	0.72	0.99
PGSC0003DMG200022562	K00908	ko01100	Metabolic pathways	3426	4.0e-183	0.83	0.92	0.85
PGSC0003DMG200022562	K00908	ko01100	Metabolic pathways	2034	2.4e-106	0.84	0.93	0.87
PGSC0003DMG200022564	K11088	ko03040	Spliceosome	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMG200022564	K11088	ko05322	Systemic lupus erythematosus	1032	4.4e-51	0.90	0.97	0.99
PGSC0003DMG200022567	K00430	ko00360	Phenylalanine metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMG200022567	K00430	ko00680	Methane metabolism	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMG200022567	K00430	ko00940	Phenylpropanoid biosynthesis	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMG200022567	K00430	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMG200022567	K00430	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.72	0.84	0.98
PGSC0003DMG200022569	K02732	ko03050	Proteasome	1743	2.7e-90	0.91	0.96	1.00
PGSC0003DMG200022577	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMG200022577	K00224	ko00364	Fluorobenzoate degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMG200022577	K00224	ko00628	Fluorene degradation	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMG200022577	K00224	ko00640	Propanoate metabolism	1559	3.8e-80	0.62	0.78	0.99
PGSC0003DMG200022578	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.46
PGSC0003DMG200022578	K12126	ko04712	Circadian rhythm - plant	278	3.0e-09	0.38	0.61	0.44
PGSC0003DMG200022589	K04371	ko04010	MAPK signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04012	ErbB signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04013	MAPK signaling pathway - fly	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04062	Chemokine signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04114	Oocyte meiosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04150	mTOR signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04270	Vascular smooth muscle contraction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04320	Dorso-ventral axis formation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04350	TGF-beta signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04360	Axon guidance	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04370	VEGF signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04510	Focal adhesion	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04520	Adherens junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04540	Gap junction	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04620	Toll-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04621	NOD-like receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04650	Natural killer cell mediated cytotoxicity	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04660	T cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04662	B cell receptor signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04664	Fc epsilon RI signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04666	Fc gamma R-mediated phagocytosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04720	Long-term potentiation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04722	Neurotrophin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04730	Long-term depression	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04810	Regulation of actin cytoskeleton	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04910	Insulin signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04912	GnRH signaling pathway	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04914	Progesterone-mediated oocyte maturation	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04916	Melanogenesis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04930	Type II diabetes mellitus	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko04960	Aldosterone-regulated sodium reabsorption	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05010	Alzheimer's disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05020	Prion diseases	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05131	Shigellosis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05140	Leishmaniasis	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05142	Chagas disease	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05200	Pathways in cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05210	Colorectal cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05211	Renal cell carcinoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05212	Pancreatic cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05213	Endometrial cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05214	Glioma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05215	Prostate cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05216	Thyroid cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05218	Melanoma	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05219	Bladder cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05220	Chronic myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05221	Acute myeloid leukemia	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200022589	K04371	ko05223	Non-small cell lung cancer	581	3.3e-26	0.48	0.65	0.99
PGSC0003DMG200026286	K03715	ko00561	Glycerolipid metabolism	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMG200026286	K03715	ko01100	Metabolic pathways	3352	4.8e-179	0.75	0.87	0.99
PGSC0003DMG200026288	K01528	ko04144	Endocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMG200026288	K01528	ko04666	Fc gamma R-mediated phagocytosis	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMG200026288	K01528	ko05100	Bacterial invasion of epithelial cells	2451	2.4e-129	0.71	0.82	0.89
PGSC0003DMG200026288	K01528	ko04144	Endocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMG200026288	K01528	ko04666	Fc gamma R-mediated phagocytosis	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMG200026288	K01528	ko05100	Bacterial invasion of epithelial cells	3518	3.3e-188	0.58	0.72	0.98
PGSC0003DMG200026288	K01528	ko04144	Endocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMG200026288	K01528	ko04666	Fc gamma R-mediated phagocytosis	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMG200026288	K01528	ko05100	Bacterial invasion of epithelial cells	3535	3.9e-189	0.59	0.73	0.98
PGSC0003DMG200026288	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026288	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026288	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026288	K01528	ko04144	Endocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026288	K01528	ko04666	Fc gamma R-mediated phagocytosis	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026288	K01528	ko05100	Bacterial invasion of epithelial cells	846	7.9e-41	0.40	0.58	1.00
PGSC0003DMG200026297	K02956	ko03010	Ribosome	293	2.5e-10	0.30	0.46	0.84
PGSC0003DMG200026297	K02956	ko03010	Ribosome	774	7.4e-37	0.38	0.54	0.87
PGSC0003DMG200026297	K02956	ko03010	Ribosome	1118	7.9e-56	0.45	0.59	0.88
PGSC0003DMG200026300	K01590	ko00340	Histidine metabolism	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMG200026300	K01590	ko01100	Metabolic pathways	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMG200026300	K01590	ko01110	Biosynthesis of secondary metabolites	2229	4.2e-117	0.58	0.74	0.97
PGSC0003DMG200006956	K01673	ko00910	Nitrogen metabolism	865	7.1e-42	0.72	0.85	0.97
PGSC0003DMG200006956	K01673	ko00910	Nitrogen metabolism	592	8.1e-27	0.72	0.84	0.96
PGSC0003DMG200006957	K01673	ko00910	Nitrogen metabolism	217	3.9e-06	0.55	0.71	0.81
PGSC0003DMG200006957	K01673	ko00910	Nitrogen metabolism	301	9.1e-11	0.54	0.71	0.88
PGSC0003DMG200006957	K01673	ko00910	Nitrogen metabolism	292	2.9e-10	0.60	0.72	0.98
PGSC0003DMG200006959	K05289	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMG200006959	K05289	ko01100	Metabolic pathways	3097	5.6e-165	0.57	0.72	0.99
PGSC0003DMG200006962	K00876	ko00240	Pyrimidine metabolism	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMG200006962	K00876	ko00983	Drug metabolism - other enzymes	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMG200006962	K00876	ko01100	Metabolic pathways	2278	8.3e-120	0.76	0.88	0.98
PGSC0003DMG200003968	K12182	ko04144	Endocytosis	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMG200003968	K12182	ko04145	Phagosome	305	3.5e-10	0.25	0.44	0.98
PGSC0003DMG200038701	K11294	ko05130	Pathogenic Escherichia coli infection	283	2.6e-09	0.32	0.50	0.92
PGSC0003DMG200030712	K05756	ko04666	Fc gamma R-mediated phagocytosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMG200030712	K05756	ko04810	Regulation of actin cytoskeleton	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMG200030712	K05756	ko05100	Bacterial invasion of epithelial cells	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMG200030712	K05756	ko05130	Pathogenic Escherichia coli infection	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMG200030712	K05756	ko05131	Shigellosis	1326	2.7e-67	0.87	0.95	0.99
PGSC0003DMG200030713	K03715	ko00561	Glycerolipid metabolism	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMG200030713	K03715	ko01100	Metabolic pathways	2798	1.7e-148	0.87	0.95	0.99
PGSC0003DMG200030713	K03715	ko00561	Glycerolipid metabolism	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMG200030713	K03715	ko01100	Metabolic pathways	3228	3.3e-172	0.83	0.91	1.00
PGSC0003DMG200030715	K07964	ko00531	Glycosaminoglycan degradation	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMG200030715	K07964	ko01100	Metabolic pathways	571	1.2e-25	0.33	0.47	0.96
PGSC0003DMG200030715	K07964	ko00531	Glycosaminoglycan degradation	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMG200030715	K07964	ko01100	Metabolic pathways	596	4.9e-27	0.30	0.48	0.86
PGSC0003DMG200030720	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMG200030720	K00517	ko00626	Naphthalene and anthracene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMG200030720	K00517	ko00903	Limonene and pinene degradation	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMG200030720	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMG200030720	K00517	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.43	0.62	0.98
PGSC0003DMG200030723	K05864	ko04020	Calcium signaling pathway	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMG200030723	K05864	ko05012	Parkinson's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMG200030723	K05864	ko05016	Huntington's disease	281	1.1e-08	0.31	0.53	0.19
PGSC0003DMG200030723	K05864	ko04020	Calcium signaling pathway	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMG200030723	K05864	ko05012	Parkinson's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMG200030723	K05864	ko05016	Huntington's disease	281	1.0e-08	0.31	0.53	0.20
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200030729	K03183	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200030729	K03183	ko01100	Metabolic pathways	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200030729	K03183	ko01110	Biosynthesis of secondary metabolites	276	2.2e-09	0.29	0.46	0.64
PGSC0003DMG200025077	K02945	ko03010	Ribosome	321	7.2e-12	0.72	0.87	0.90
PGSC0003DMG200025077	K02945	ko03010	Ribosome	1241	1.3e-62	0.59	0.68	0.99
PGSC0003DMG200025077	K02945	ko03010	Ribosome	2631	2.8e-139	0.66	0.77	0.99
PGSC0003DMG200025079	K01528	ko04144	Endocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMG200025079	K01528	ko04666	Fc gamma R-mediated phagocytosis	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMG200025079	K01528	ko05100	Bacterial invasion of epithelial cells	634	3.9e-29	0.27	0.47	0.97
PGSC0003DMG200025080	K01528	ko04144	Endocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMG200025080	K01528	ko04666	Fc gamma R-mediated phagocytosis	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMG200025080	K01528	ko05100	Bacterial invasion of epithelial cells	851	4.2e-41	0.29	0.50	0.93
PGSC0003DMG200025081	K00866	ko00564	Glycerophospholipid metabolism	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMG200025081	K00866	ko01100	Metabolic pathways	1694	1.3e-87	0.58	0.75	0.91
PGSC0003DMG200025081	K00866	ko00564	Glycerophospholipid metabolism	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMG200025081	K00866	ko01100	Metabolic pathways	1377	4.1e-70	0.57	0.76	0.98
PGSC0003DMG200025083	K00430	ko00360	Phenylalanine metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMG200025083	K00430	ko00680	Methane metabolism	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMG200025083	K00430	ko00940	Phenylpropanoid biosynthesis	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMG200025083	K00430	ko01100	Metabolic pathways	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMG200025083	K00430	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.64	0.79	0.97
PGSC0003DMG200025083	K00430	ko00360	Phenylalanine metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMG200025083	K00430	ko00680	Methane metabolism	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMG200025083	K00430	ko00940	Phenylpropanoid biosynthesis	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMG200025083	K00430	ko01100	Metabolic pathways	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMG200025083	K00430	ko01110	Biosynthesis of secondary metabolites	1778	3.1e-92	0.63	0.79	0.95
PGSC0003DMG200025083	K00430	ko00360	Phenylalanine metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMG200025083	K00430	ko00680	Methane metabolism	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMG200025083	K00430	ko00940	Phenylpropanoid biosynthesis	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMG200025083	K00430	ko01100	Metabolic pathways	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMG200025083	K00430	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.62	0.77	0.95
PGSC0003DMG200025083	K00430	ko00360	Phenylalanine metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMG200025083	K00430	ko00680	Methane metabolism	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMG200025083	K00430	ko00940	Phenylpropanoid biosynthesis	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMG200025083	K00430	ko01100	Metabolic pathways	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMG200025083	K00430	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.61	0.79	0.98
PGSC0003DMG200025084	K00430	ko00360	Phenylalanine metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMG200025084	K00430	ko00680	Methane metabolism	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMG200025084	K00430	ko00940	Phenylpropanoid biosynthesis	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMG200025084	K00430	ko01100	Metabolic pathways	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMG200025084	K00430	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.62	0.80	0.98
PGSC0003DMG200025085	K01507	ko00190	Oxidative phosphorylation	6009	0.	0.90	0.95	1.00
PGSC0003DMG200025085	K01507	ko00190	Oxidative phosphorylation	5748	0.	0.89	0.95	1.00
PGSC0003DMG200025089	K05280	ko00941	Flavonoid biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMG200025089	K05280	ko00944	Flavone and flavonol biosynthesis	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMG200025089	K05280	ko01100	Metabolic pathways	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMG200025089	K05280	ko01110	Biosynthesis of secondary metabolites	821	1.9e-39	0.37	0.55	0.94
PGSC0003DMG200022131	K12831	ko03040	Spliceosome	214	9.1e-06	0.40	0.51	0.80
PGSC0003DMG200022135	K03553	ko03440	Homologous recombination	2643	6.1e-140	0.81	0.90	0.94
PGSC0003DMG200001394	K01231	ko00510	N-Glycan biosynthesis	7172	0.	0.71	0.83	1.00
PGSC0003DMG200001394	K01231	ko01100	Metabolic pathways	7172	0.	0.71	0.83	1.00
PGSC0003DMG200001396	K00754	ko00051	Fructose and mannose metabolism	381	3.5e-15	0.28	0.46	0.79
PGSC0003DMG200001397	K11644	ko05016	Huntington's disease	6729	0.	0.61	0.74	0.99
PGSC0003DMG200001397	K11644	ko05016	Huntington's disease	6993	0.	0.62	0.75	1.00
PGSC0003DMG200001398	K11644	ko05016	Huntington's disease	847	2.3e-40	0.38	0.54	0.96
PGSC0003DMG200001399	K11644	ko05016	Huntington's disease	1210	6.7e-61	0.46	0.58	0.96
PGSC0003DMG200001399	K11644	ko05016	Huntington's disease	1265	6.2e-64	0.47	0.60	0.96
PGSC0003DMG200001400	K05658	ko02010	ABC transporters	4157	1.9e-223	0.45	0.66	0.99
PGSC0003DMG200001401	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMG200001401	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMG200001401	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.90
PGSC0003DMG200001401	K01099	ko00562	Inositol phosphate metabolism	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMG200001401	K01099	ko01100	Metabolic pathways	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMG200001401	K01099	ko04070	Phosphatidylinositol signaling system	753	1.1e-35	0.35	0.50	0.82
PGSC0003DMG200001403	K00472	ko00330	Arginine and proline metabolism	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMG200001403	K00472	ko01100	Metabolic pathways	964	2.5e-47	0.54	0.67	0.99
PGSC0003DMG200001408	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMG200001408	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMG200001408	K00771	ko01100	Metabolic pathways	421	9.7e-17	0.29	0.50	0.67
PGSC0003DMG200039882	K01213	ko00040	Pentose and glucuronate interconversions	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMG200039882	K01213	ko00500	Starch and sucrose metabolism	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMG200039882	K01213	ko01100	Metabolic pathways	1105	4.1e-55	0.42	0.59	0.99
PGSC0003DMG200039889	K10760	ko00908	Zeatin biosynthesis	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMG200039889	K10760	ko01100	Metabolic pathways	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMG200039889	K10760	ko01110	Biosynthesis of secondary metabolites	243	1.4e-07	0.42	0.58	0.89
PGSC0003DMG200013284	K08272	ko04150	mTOR signaling pathway	2462	5.9e-130	0.88	0.94	0.99
PGSC0003DMG200013284	K08272	ko04150	mTOR signaling pathway	344	3.9e-13	0.80	0.87	0.95
PGSC0003DMG200013285	K01092	ko00521	Streptomycin biosynthesis	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMG200013285	K01092	ko00562	Inositol phosphate metabolism	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMG200013285	K01092	ko01100	Metabolic pathways	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMG200013285	K01092	ko01110	Biosynthesis of secondary metabolites	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMG200013285	K01092	ko04070	Phosphatidylinositol signaling system	1869	3.0e-97	0.82	0.91	1.00
PGSC0003DMG200013285	K01092	ko00521	Streptomycin biosynthesis	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMG200013285	K01092	ko00562	Inositol phosphate metabolism	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMG200013285	K01092	ko01100	Metabolic pathways	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMG200013285	K01092	ko01110	Biosynthesis of secondary metabolites	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMG200013285	K01092	ko04070	Phosphatidylinositol signaling system	520	7.6e-23	0.75	0.90	0.99
PGSC0003DMG200013286	K08332	ko04140	Regulation of autophagy	288	1.2e-07	0.30	0.45	0.76
PGSC0003DMG200013286	K08332	ko04140	Regulation of autophagy	288	9.6e-08	0.30	0.46	0.75
PGSC0003DMG200013288	K00857	ko00240	Pyrimidine metabolism	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMG200013288	K00857	ko00983	Drug metabolism - other enzymes	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMG200013288	K00857	ko01100	Metabolic pathways	1174	6.4e-59	0.67	0.80	0.39
PGSC0003DMG200013288	K00857	ko00240	Pyrimidine metabolism	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMG200013288	K00857	ko00983	Drug metabolism - other enzymes	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMG200013288	K00857	ko01100	Metabolic pathways	1394	4.7e-71	0.77	0.89	0.91
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1478	1.1e-75	0.49	0.65	0.47
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1749	1.2e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1729	1.6e-89	0.50	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1758	4.0e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1739	4.4e-90	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1754	6.6e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00230	Purine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko00730	Thiamine metabolism	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004666	K01516	ko01100	Metabolic pathways	1764	1.9e-91	0.51	0.67	0.95
PGSC0003DMG200004668	K12338	ko00942	Anthocyanin biosynthesis	548	2.2e-24	0.57	0.75	0.96
PGSC0003DMG200004669	K12338	ko00942	Anthocyanin biosynthesis	716	1.2e-33	0.40	0.60	0.96
PGSC0003DMG200004674	K08246	ko00100	Steroid biosynthesis	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMG200004674	K08246	ko01100	Metabolic pathways	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMG200004674	K08246	ko01110	Biosynthesis of secondary metabolites	360	5.1e-14	0.71	0.84	0.91
PGSC0003DMG200004674	K08246	ko00100	Steroid biosynthesis	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMG200004674	K08246	ko01100	Metabolic pathways	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMG200004674	K08246	ko01110	Biosynthesis of secondary metabolites	1954	6.1e-102	0.76	0.90	0.98
PGSC0003DMG200007630	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.74
PGSC0003DMG200007630	K00970	ko03018	RNA degradation	3070	1.7e-163	0.66	0.79	0.69
PGSC0003DMG200007630	K00970	ko03018	RNA degradation	2726	1.6e-144	0.68	0.81	0.72
PGSC0003DMG200007631	K01590	ko00340	Histidine metabolism	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMG200007631	K01590	ko01100	Metabolic pathways	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMG200007631	K01590	ko01110	Biosynthesis of secondary metabolites	1677	1.2e-86	0.64	0.80	0.86
PGSC0003DMG200007632	K01590	ko00340	Histidine metabolism	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMG200007632	K01590	ko01100	Metabolic pathways	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMG200007632	K01590	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.71	0.87	0.30
PGSC0003DMG200007639	K09755	ko00940	Phenylpropanoid biosynthesis	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMG200007639	K09755	ko01100	Metabolic pathways	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMG200007639	K09755	ko01110	Biosynthesis of secondary metabolites	928	2.4e-45	0.51	0.72	0.93
PGSC0003DMG200007639	K09755	ko00940	Phenylpropanoid biosynthesis	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMG200007639	K09755	ko01100	Metabolic pathways	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMG200007639	K09755	ko01110	Biosynthesis of secondary metabolites	878	1.4e-42	0.52	0.72	0.98
PGSC0003DMG200007640	K13083	ko00941	Flavonoid biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMG200007640	K13083	ko00944	Flavone and flavonol biosynthesis	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMG200007640	K13083	ko01110	Biosynthesis of secondary metabolites	228	2.2e-06	0.37	0.60	0.70
PGSC0003DMG200007640	K05280	ko00941	Flavonoid biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMG200007640	K05280	ko00944	Flavone and flavonol biosynthesis	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMG200007640	K05280	ko01100	Metabolic pathways	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMG200007640	K05280	ko01110	Biosynthesis of secondary metabolites	297	2.1e-10	0.34	0.59	0.94
PGSC0003DMG200007641	K05280	ko00941	Flavonoid biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMG200007641	K05280	ko00944	Flavone and flavonol biosynthesis	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMG200007641	K05280	ko01100	Metabolic pathways	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMG200007641	K05280	ko01110	Biosynthesis of secondary metabolites	1200	2.4e-60	0.41	0.62	0.99
PGSC0003DMG200007643	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMG200007643	K00517	ko00626	Naphthalene and anthracene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMG200007643	K00517	ko00903	Limonene and pinene degradation	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMG200007643	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMG200007643	K00517	ko01110	Biosynthesis of secondary metabolites	399	3.6e-16	0.42	0.66	0.98
PGSC0003DMG200007644	K05280	ko00941	Flavonoid biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200007644	K05280	ko00944	Flavone and flavonol biosynthesis	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200007644	K05280	ko01100	Metabolic pathways	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200007644	K05280	ko01110	Biosynthesis of secondary metabolites	1484	5.1e-76	0.41	0.61	0.99
PGSC0003DMG200007646	K13025	ko03040	Spliceosome	3032	2.1e-161	0.89	0.93	1.00
PGSC0003DMG200007646	K13025	ko03040	Spliceosome	3163	1.3e-168	0.92	0.96	1.00
PGSC0003DMG200021388	K00343	ko00190	Oxidative phosphorylation	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMG200021388	K00343	ko01100	Metabolic pathways	793	6.7e-38	0.50	0.72	0.88
PGSC0003DMG200024471	K08332	ko04140	Regulation of autophagy	266	3.5e-06	0.32	0.47	0.40
PGSC0003DMG200024472	K10773	ko03410	Base excision repair	1417	2.5e-72	0.61	0.78	0.89
PGSC0003DMG200024475	K02183	ko04020	Calcium signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04070	Phosphatidylinositol signaling system	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04114	Oocyte meiosis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04270	Vascular smooth muscle contraction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04626	Plant-pathogen interaction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04720	Long-term potentiation	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04722	Neurotrophin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04740	Olfactory transduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04744	Phototransduction	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04745	Phototransduction - fly	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04910	Insulin signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04912	GnRH signaling pathway	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04916	Melanogenesis	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04970	Salivary secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04971	Gastric acid secretion	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko05010	Alzheimer's disease	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko05214	Glioma	1410	6.2e-72	0.40	0.60	0.91
PGSC0003DMG200024475	K02183	ko04020	Calcium signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04070	Phosphatidylinositol signaling system	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04114	Oocyte meiosis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04270	Vascular smooth muscle contraction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04626	Plant-pathogen interaction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04720	Long-term potentiation	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04722	Neurotrophin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04740	Olfactory transduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04744	Phototransduction	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04745	Phototransduction - fly	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04910	Insulin signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04912	GnRH signaling pathway	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04916	Melanogenesis	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04970	Salivary secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04971	Gastric acid secretion	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko05010	Alzheimer's disease	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko05214	Glioma	1169	1.2e-58	0.50	0.72	0.95
PGSC0003DMG200024475	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04020	Calcium signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04070	Phosphatidylinositol signaling system	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04114	Oocyte meiosis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04270	Vascular smooth muscle contraction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04626	Plant-pathogen interaction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04720	Long-term potentiation	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04722	Neurotrophin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04740	Olfactory transduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04744	Phototransduction	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04745	Phototransduction - fly	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04910	Insulin signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04912	GnRH signaling pathway	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04916	Melanogenesis	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04970	Salivary secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko04971	Gastric acid secretion	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko05010	Alzheimer's disease	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024475	K02183	ko05214	Glioma	1499	7.6e-77	0.41	0.62	0.91
PGSC0003DMG200024477	K02183	ko04020	Calcium signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04070	Phosphatidylinositol signaling system	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04114	Oocyte meiosis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04270	Vascular smooth muscle contraction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04626	Plant-pathogen interaction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04720	Long-term potentiation	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04722	Neurotrophin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04740	Olfactory transduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04744	Phototransduction	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04745	Phototransduction - fly	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04910	Insulin signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04912	GnRH signaling pathway	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04916	Melanogenesis	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04970	Salivary secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko04971	Gastric acid secretion	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko05010	Alzheimer's disease	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024477	K02183	ko05214	Glioma	574	8.0e-26	0.32	0.50	0.95
PGSC0003DMG200024478	K02183	ko04020	Calcium signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04070	Phosphatidylinositol signaling system	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04114	Oocyte meiosis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04270	Vascular smooth muscle contraction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04626	Plant-pathogen interaction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04720	Long-term potentiation	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04722	Neurotrophin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04740	Olfactory transduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04744	Phototransduction	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04745	Phototransduction - fly	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04910	Insulin signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04912	GnRH signaling pathway	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04916	Melanogenesis	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04970	Salivary secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko04971	Gastric acid secretion	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko05010	Alzheimer's disease	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200024478	K02183	ko05214	Glioma	522	5.9e-23	0.33	0.49	0.79
PGSC0003DMG200041306	K00002	ko00010	Glycolysis / Gluconeogenesis	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMG200041306	K00002	ko00561	Glycerolipid metabolism	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMG200041306	K00002	ko00930	Caprolactam degradation	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMG200041306	K00002	ko01100	Metabolic pathways	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMG200041306	K00002	ko01110	Biosynthesis of secondary metabolites	1046	7.4e-52	0.45	0.63	0.98
PGSC0003DMG200002301	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002302	K00292	ko00310	Lysine degradation	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMG200002302	K00292	ko01100	Metabolic pathways	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMG200002302	K00292	ko01110	Biosynthesis of secondary metabolites	781	3.1e-37	0.54	0.66	1.00
PGSC0003DMG200002303	K01199	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.37	0.58	0.65
PGSC0003DMG200002308	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMG200002308	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMG200002308	K12617	ko03018	RNA degradation	3779	1.3e-202	0.65	0.77	0.86
PGSC0003DMG200002312	K03541	ko00195	Photosynthesis	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMG200002312	K03541	ko01100	Metabolic pathways	578	4.8e-26	0.57	0.70	0.99
PGSC0003DMG200002312	K03541	ko00195	Photosynthesis	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMG200002312	K03541	ko01100	Metabolic pathways	405	1.7e-16	0.58	0.74	0.79
PGSC0003DMG200002318	K10955	ko05110	Vibrio cholerae infection	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMG200002318	K10955	ko05146	Amoebiasis	470	1.3e-18	0.29	0.44	0.67
PGSC0003DMG200002321	K05933	ko00270	Cysteine and methionine metabolism	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMG200002321	K05933	ko01110	Biosynthesis of secondary metabolites	566	2.2e-25	0.58	0.83	0.98
PGSC0003DMG200002321	K05933	ko00270	Cysteine and methionine metabolism	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMG200002321	K05933	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.68	0.83	0.99
PGSC0003DMG200015084	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMG200015084	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1925	2.4e-100	0.68	0.79	0.99
PGSC0003DMG200015084	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1914	9.9e-100	0.68	0.79	0.99
PGSC0003DMG200015084	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1948	1.3e-101	0.69	0.79	0.99
PGSC0003DMG200015085	K04573	ko05014	Amyotrophic lateral sclerosis (ALS)	361	2.2e-13	0.37	0.52	0.91
PGSC0003DMG200015086	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	546	2.8e-24	0.74	0.79	0.97
PGSC0003DMG200015088	K04503	ko04110	Cell cycle	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko04115	p53 signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko04310	Wnt signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko04510	Focal adhesion	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko04630	Jak-STAT signaling pathway	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05200	Pathways in cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05210	Colorectal cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05212	Pancreatic cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05213	Endometrial cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05214	Glioma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05215	Prostate cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05216	Thyroid cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05218	Melanoma	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05219	Bladder cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05220	Chronic myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05221	Acute myeloid leukemia	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05222	Small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05223	Non-small cell lung cancer	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015088	K04503	ko05416	Viral myocarditis	299	1.2e-10	0.29	0.48	0.84
PGSC0003DMG200015098	K00971	ko00051	Fructose and mannose metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMG200015098	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMG200015098	K00971	ko01100	Metabolic pathways	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMG200015098	K00971	ko01110	Biosynthesis of secondary metabolites	2737	4.0e-145	0.89	0.95	1.00
PGSC0003DMG200015100	K09840	ko00906	Carotenoid biosynthesis	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMG200015100	K09840	ko01100	Metabolic pathways	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMG200015100	K09840	ko01110	Biosynthesis of secondary metabolites	3550	5.8e-190	0.73	0.82	0.98
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1815	2.8e-94	0.69	0.82	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1784	1.5e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1796	3.2e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.69	0.81	0.97
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1097	1.1e-54	0.66	0.80	0.99
PGSC0003DMG200008890	K00002	ko00010	Glycolysis / Gluconeogenesis	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko00561	Glycerolipid metabolism	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko00930	Caprolactam degradation	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko01100	Metabolic pathways	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMG200008890	K00002	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.68	0.81	0.97
PGSC0003DMG200008891	K00971	ko00051	Fructose and mannose metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMG200008891	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMG200008891	K00971	ko01100	Metabolic pathways	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMG200008891	K00971	ko01110	Biosynthesis of secondary metabolites	1511	1.7e-77	0.81	0.93	1.00
PGSC0003DMG200008891	K00971	ko00051	Fructose and mannose metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMG200008891	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMG200008891	K00971	ko01100	Metabolic pathways	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMG200008891	K00971	ko01110	Biosynthesis of secondary metabolites	2622	8.8e-139	0.84	0.94	1.00
PGSC0003DMG200008894	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMG200008894	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMG200008894	K10594	ko04120	Ubiquitin mediated proteolysis	460	6.4e-23	0.33	0.49	0.67
PGSC0003DMG200008894	K10595	ko04120	Ubiquitin mediated proteolysis	204	6.3e-06	0.39	0.51	0.58
PGSC0003DMG200008894	K10594	ko04120	Ubiquitin mediated proteolysis	460	1.7e-22	0.32	0.49	0.67
PGSC0003DMG200008895	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMG200008895	K08081	ko01100	Metabolic pathways	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMG200008895	K08081	ko01110	Biosynthesis of secondary metabolites	1172	8.3e-59	0.46	0.54	1.00
PGSC0003DMG200008895	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMG200008895	K08081	ko01100	Metabolic pathways	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMG200008895	K08081	ko01110	Biosynthesis of secondary metabolites	1282	7.1e-65	0.62	0.75	0.95
PGSC0003DMG200008898	K00368	ko00910	Nitrogen metabolism	1587	1.1e-81	0.42	0.57	0.91
PGSC0003DMG200008903	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.91
PGSC0003DMG200008903	K00368	ko00910	Nitrogen metabolism	1572	7.2e-81	0.42	0.57	0.98
PGSC0003DMG200008903	K00368	ko00910	Nitrogen metabolism	812	6.0e-39	0.40	0.54	0.88
PGSC0003DMG200005148	K10717	ko00908	Zeatin biosynthesis	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMG200005148	K10717	ko01100	Metabolic pathways	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMG200005148	K10717	ko01110	Biosynthesis of secondary metabolites	366	2.4e-14	0.35	0.55	0.98
PGSC0003DMG200005148	K07424	ko00140	Steroid hormone biosynthesis	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00591	Linoleic acid metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00830	Retinol metabolism	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00982	Drug metabolism - cytochrome P450	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko00983	Drug metabolism - other enzymes	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005148	K07424	ko01100	Metabolic pathways	1449	4.4e-74	0.40	0.61	0.95
PGSC0003DMG200005152	K00430	ko00360	Phenylalanine metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMG200005152	K00430	ko00680	Methane metabolism	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMG200005152	K00430	ko00940	Phenylpropanoid biosynthesis	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMG200005152	K00430	ko01100	Metabolic pathways	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMG200005152	K00430	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.65	0.79	0.96
PGSC0003DMG200020334	K12586	ko03018	RNA degradation	901	2.6e-43	0.45	0.62	0.68
PGSC0003DMG200020343	K13065	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMG200020343	K13065	ko00941	Flavonoid biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMG200020343	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMG200020343	K13065	ko01110	Biosynthesis of secondary metabolites	491	3.0e-21	0.30	0.47	0.86
PGSC0003DMG200020345	K00368	ko00910	Nitrogen metabolism	1706	2.9e-88	0.45	0.59	0.90
PGSC0003DMG200026981	K00059	ko00061	Fatty acid biosynthesis	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMG200026981	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMG200026981	K00059	ko01100	Metabolic pathways	1991	5.6e-104	0.78	0.87	0.99
PGSC0003DMG200026983	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMG200026983	K02880	ko03010	Ribosome	1333	1.1e-67	0.89	0.94	0.99
PGSC0003DMG200026983	K02880	ko03010	Ribosome	1341	4.0e-68	0.90	0.94	0.99
PGSC0003DMG200026983	K02880	ko03010	Ribosome	526	3.5e-23	0.90	0.96	0.93
PGSC0003DMG200026983	K02880	ko03010	Ribosome	534	1.3e-23	0.91	0.97	0.93
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.58	0.76	0.89
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	1584	1.6e-81	0.59	0.77	0.89
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	1442	1.1e-73	0.61	0.77	0.90
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.63	0.79	0.94
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.68	0.81	1.00
PGSC0003DMG200026984	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMG200026984	K00517	ko00626	Naphthalene and anthracene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMG200026984	K00517	ko00903	Limonene and pinene degradation	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMG200026984	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMG200026984	K00517	ko01110	Biosynthesis of secondary metabolites	495	1.8e-21	0.62	0.74	0.99
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	1960	2.9e-102	0.53	0.63	0.67
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	2098	7.0e-110	0.62	0.73	0.64
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	946	2.4e-46	0.49	0.67	0.51
PGSC0003DMG200026985	K12132	ko04712	Circadian rhythm - plant	437	4.2e-18	0.57	0.80	0.27
PGSC0003DMG200023334	K01889	ko00970	Aminoacyl-tRNA biosynthesis	1792	5.3e-93	0.89	0.96	1.00
PGSC0003DMG200023334	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3057	8.9e-163	0.80	0.89	1.00
PGSC0003DMG200023335	K08057	ko04145	Phagosome	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMG200023335	K08057	ko04612	Antigen processing and presentation	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMG200023335	K08057	ko05142	Chagas disease	2659	8.0e-141	0.78	0.89	1.00
PGSC0003DMG200023335	K08057	ko04145	Phagosome	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMG200023335	K08057	ko04612	Antigen processing and presentation	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMG200023335	K08057	ko05142	Chagas disease	2793	3.3e-148	0.75	0.88	0.94
PGSC0003DMG200023337	K02737	ko03050	Proteasome	2029	4.5e-106	0.89	0.93	0.99
PGSC0003DMG200023338	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023338	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023338	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023338	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko00340	Histidine metabolism	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko01100	Metabolic pathways	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.82	0.93	0.99
PGSC0003DMG200023338	K01814	ko00340	Histidine metabolism	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023338	K01814	ko01100	Metabolic pathways	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023338	K01814	ko01110	Biosynthesis of secondary metabolites	1913	1.1e-99	0.77	0.87	0.98
PGSC0003DMG200023340	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMG200023340	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMG200023340	K12666	ko00510	N-Glycan biosynthesis	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMG200023340	K12666	ko01100	Metabolic pathways	2081	6.1e-109	0.55	0.75	0.97
PGSC0003DMG200018751	K04424	ko04010	MAPK signaling pathway	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMG200018751	K04424	ko04530	Tight junction	739	9.3e-35	0.31	0.49	0.44
PGSC0003DMG200018753	K00875	ko00040	Pentose and glucuronate interconversions	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMG200018753	K00875	ko01100	Metabolic pathways	1405	1.2e-71	0.43	0.59	0.81
PGSC0003DMG200018753	K00875	ko00040	Pentose and glucuronate interconversions	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMG200018753	K00875	ko01100	Metabolic pathways	1967	1.2e-102	0.48	0.64	0.89
PGSC0003DMG200018754	K12356	ko00940	Phenylpropanoid biosynthesis	752	1.2e-35	0.36	0.55	0.70
PGSC0003DMG200018758	K08139	ko04113	Meiosis - yeast	663	9.8e-31	0.33	0.52	0.94
PGSC0003DMG200018758	K08139	ko04113	Meiosis - yeast	886	4.9e-43	0.34	0.52	0.90
PGSC0003DMG200025795	K09843	ko00906	Carotenoid biosynthesis	2395	2.9e-126	0.70	0.85	0.93
PGSC0003DMG200025795	K09843	ko00906	Carotenoid biosynthesis	2807	5.5e-149	0.71	0.85	0.96
PGSC0003DMG200025795	K09843	ko00906	Carotenoid biosynthesis	973	7.9e-48	0.69	0.85	0.98
PGSC0003DMG200025803	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMG200025803	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMG200025803	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMG200025803	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMG200025803	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.66	0.79	0.97
PGSC0003DMG200020093	K06666	ko04111	Cell cycle - yeast	508	4.3e-22	0.26	0.41	0.65
PGSC0003DMG200020094	K05279	ko00944	Flavone and flavonol biosynthesis	1379	3.2e-70	0.51	0.71	0.97
PGSC0003DMG200020095	K05279	ko00944	Flavone and flavonol biosynthesis	646	8.5e-30	0.47	0.66	0.99
PGSC0003DMG200020096	K05279	ko00944	Flavone and flavonol biosynthesis	1389	8.9e-71	0.51	0.71	0.96
PGSC0003DMG200020097	K05279	ko00944	Flavone and flavonol biosynthesis	1413	4.2e-72	0.51	0.71	0.97
PGSC0003DMG200020103	K00754	ko00051	Fructose and mannose metabolism	3078	6.2e-164	0.65	0.79	1.00
PGSC0003DMG200020105	K01495	ko00790	Folate biosynthesis	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMG200020105	K01495	ko01100	Metabolic pathways	2452	2.1e-129	0.65	0.77	0.99
PGSC0003DMG200020105	K01495	ko00790	Folate biosynthesis	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMG200020105	K01495	ko01100	Metabolic pathways	1304	4.4e-66	0.57	0.72	0.98
PGSC0003DMG200020108	K02995	ko03010	Ribosome	1432	3.8e-73	0.88	0.91	0.98
PGSC0003DMG200020108	K02995	ko03010	Ribosome	1653	2.5e-85	0.89	0.92	1.00
PGSC0003DMG200030026	K08332	ko04140	Regulation of autophagy	311	1.3e-08	0.35	0.51	0.36
PGSC0003DMG200030028	K02178	ko04110	Cell cycle	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMG200030028	K02178	ko04111	Cell cycle - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMG200030028	K02178	ko04113	Meiosis - yeast	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMG200030028	K02178	ko04114	Oocyte meiosis	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMG200030028	K02178	ko04914	Progesterone-mediated oocyte maturation	467	6.4e-20	0.39	0.62	0.26
PGSC0003DMG200027240	K01188	ko00460	Cyanoamino acid metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMG200027240	K01188	ko00500	Starch and sucrose metabolism	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMG200027240	K01188	ko00940	Phenylpropanoid biosynthesis	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMG200027240	K01188	ko01110	Biosynthesis of secondary metabolites	2875	9.8e-153	0.57	0.73	0.95
PGSC0003DMG200027240	K01188	ko00460	Cyanoamino acid metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMG200027240	K01188	ko00500	Starch and sucrose metabolism	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMG200027240	K01188	ko00940	Phenylpropanoid biosynthesis	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMG200027240	K01188	ko01110	Biosynthesis of secondary metabolites	1510	1.9e-77	0.56	0.72	0.91
PGSC0003DMG200027244	K08695	ko00941	Flavonoid biosynthesis	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMG200027244	K08695	ko01110	Biosynthesis of secondary metabolites	656	2.4e-30	0.33	0.59	0.97
PGSC0003DMG200027244	K08695	ko00941	Flavonoid biosynthesis	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMG200027244	K08695	ko01110	Biosynthesis of secondary metabolites	704	5.4e-33	0.33	0.58	0.94
PGSC0003DMG200027244	K08695	ko00941	Flavonoid biosynthesis	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMG200027244	K08695	ko01110	Biosynthesis of secondary metabolites	711	2.2e-33	0.32	0.57	0.97
PGSC0003DMG200027244	K08695	ko00941	Flavonoid biosynthesis	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMG200027244	K08695	ko01110	Biosynthesis of secondary metabolites	708	3.2e-33	0.34	0.58	0.94
PGSC0003DMG200027244	K08695	ko00941	Flavonoid biosynthesis	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMG200027244	K08695	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.34	0.60	0.92
PGSC0003DMG200027247	K01408	ko05010	Alzheimer's disease	3765	8.0e-202	0.77	0.88	0.98
PGSC0003DMG200027247	K01408	ko05010	Alzheimer's disease	6332	0.	0.76	0.88	0.99
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	2736	4.5e-145	0.73	0.85	0.99
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	3203	7.9e-171	0.64	0.80	0.98
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	5464	1.6e-295	0.67	0.81	0.99
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	2014	3.0e-105	0.68	0.78	0.94
PGSC0003DMG200027248	K01408	ko05010	Alzheimer's disease	3450	1.9e-184	0.70	0.81	0.99
PGSC0003DMG200036003	K05282	ko00904	Diterpenoid biosynthesis	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMG200036003	K05282	ko01100	Metabolic pathways	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMG200036003	K05282	ko01110	Biosynthesis of secondary metabolites	913	1.6e-44	0.74	0.84	0.92
PGSC0003DMG200036004	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2260	8.1e-119	0.65	0.80	0.99
PGSC0003DMG200002048	K04446	ko04310	Wnt signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04446	ko04360	Axon guidance	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04446	ko04370	VEGF signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04446	ko04650	Natural killer cell mediated cytotoxicity	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04446	ko04660	T cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04446	ko04662	B cell receptor signaling pathway	278	1.3e-08	0.31	0.42	0.88
PGSC0003DMG200002048	K04498	ko04110	Cell cycle	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04310	Wnt signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04330	Notch signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04350	TGF-beta signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04520	Adherens junction	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04630	Jak-STAT signaling pathway	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04720	Long-term potentiation	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko04916	Melanogenesis	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko05016	Huntington's disease	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko05200	Pathways in cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko05211	Renal cell carcinoma	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002048	K04498	ko05215	Prostate cancer	308	1.4e-07	0.29	0.43	0.58
PGSC0003DMG200002052	K03123	ko03022	Basal transcription factors	810	7.7e-39	0.92	0.94	0.99
PGSC0003DMG200002062	K06611	ko00052	Galactose metabolism	1731	1.2e-89	0.41	0.58	0.97
PGSC0003DMG200002062	K06611	ko00052	Galactose metabolism	2118	5.5e-111	0.40	0.57	0.97
PGSC0003DMG200002063	K12603	ko03018	RNA degradation	3577	1.9e-191	0.53	0.59	1.00
PGSC0003DMG200002063	K12603	ko03018	RNA degradation	4248	1.8e-228	0.82	0.91	1.00
PGSC0003DMG200002063	K12603	ko03018	RNA degradation	3263	3.9e-174	0.81	0.91	0.96
PGSC0003DMG200011900	K02084	ko04115	p53 signaling pathway	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko04210	Apoptosis	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko05010	Alzheimer's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko05012	Parkinson's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko05016	Huntington's disease	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011900	K02084	ko05222	Small cell lung cancer	297	5.2e-07	0.27	0.45	0.45
PGSC0003DMG200011913	K06130	ko00564	Glycerophospholipid metabolism	382	3.1e-15	0.36	0.50	0.79
PGSC0003DMG200011915	K12524	ko00260	Glycine, serine and threonine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMG200011915	K12524	ko00270	Cysteine and methionine metabolism	6121	0.	0.80	0.89	1.00
PGSC0003DMG200011915	K12524	ko00300	Lysine biosynthesis	6121	0.	0.80	0.89	1.00
PGSC0003DMG200011915	K12524	ko01100	Metabolic pathways	6121	0.	0.80	0.89	1.00
PGSC0003DMG200011915	K12524	ko01110	Biosynthesis of secondary metabolites	6121	0.	0.80	0.89	1.00
PGSC0003DMG200011919	K01597	ko00900	Terpenoid backbone biosynthesis	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMG200011919	K01597	ko01100	Metabolic pathways	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMG200011919	K01597	ko01110	Biosynthesis of secondary metabolites	1339	5.1e-68	0.89	0.93	0.88
PGSC0003DMG200011920	K02084	ko04115	p53 signaling pathway	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko04210	Apoptosis	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko05010	Alzheimer's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko05012	Parkinson's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko05016	Huntington's disease	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011920	K02084	ko05222	Small cell lung cancer	325	1.4e-08	0.28	0.47	0.42
PGSC0003DMG200011923	K01597	ko00900	Terpenoid backbone biosynthesis	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMG200011923	K01597	ko01100	Metabolic pathways	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMG200011923	K01597	ko01110	Biosynthesis of secondary metabolites	1042	1.2e-51	0.88	0.92	0.91
PGSC0003DMG200016746	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMG200016746	K08081	ko01100	Metabolic pathways	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMG200016746	K08081	ko01110	Biosynthesis of secondary metabolites	1576	4.3e-81	0.75	0.86	0.94
PGSC0003DMG200016753	K08065	ko04612	Antigen processing and presentation	578	4.8e-26	0.62	0.81	0.58
PGSC0003DMG200016764	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMG200016764	K00517	ko00626	Naphthalene and anthracene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMG200016764	K00517	ko00903	Limonene and pinene degradation	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMG200016764	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMG200016764	K00517	ko01110	Biosynthesis of secondary metabolites	1724	3.0e-89	0.49	0.70	0.93
PGSC0003DMG200016764	K09754	ko00360	Phenylalanine metabolism	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016764	K09754	ko00940	Phenylpropanoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016764	K09754	ko00941	Flavonoid biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016764	K09754	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016764	K09754	ko01100	Metabolic pathways	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016764	K09754	ko01110	Biosynthesis of secondary metabolites	718	9.1e-34	0.50	0.69	0.99
PGSC0003DMG200016772	K08488	ko04130	SNARE interactions in vesicular transport	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMG200016772	K08488	ko04145	Phagosome	1761	2.7e-91	0.81	0.90	1.00
PGSC0003DMG200016772	K08488	ko04130	SNARE interactions in vesicular transport	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMG200016772	K08488	ko04145	Phagosome	1625	8.6e-84	0.77	0.87	0.96
PGSC0003DMG200016772	K08488	ko04130	SNARE interactions in vesicular transport	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMG200016772	K08488	ko04145	Phagosome	1035	3.0e-51	0.79	0.85	0.99
PGSC0003DMG200009156	K02293	ko00906	Carotenoid biosynthesis	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200009156	K02293	ko01100	Metabolic pathways	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200009156	K02293	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.82	0.91	1.00
PGSC0003DMG200009156	K02293	ko00906	Carotenoid biosynthesis	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMG200009156	K02293	ko01100	Metabolic pathways	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMG200009156	K02293	ko01110	Biosynthesis of secondary metabolites	448	7.1e-19	0.70	0.89	0.85
PGSC0003DMG200009156	K02293	ko00906	Carotenoid biosynthesis	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMG200009156	K02293	ko01100	Metabolic pathways	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMG200009156	K02293	ko01110	Biosynthesis of secondary metabolites	501	8.5e-22	0.91	0.97	0.97
PGSC0003DMG200009158	K08248	ko00460	Cyanoamino acid metabolism	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMG200009158	K08248	ko01100	Metabolic pathways	3237	1.1e-172	0.68	0.84	0.99
PGSC0003DMG200009159	K00058	ko00260	Glycine, serine and threonine metabolism	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMG200009159	K00058	ko01100	Metabolic pathways	3846	2.7e-206	0.77	0.86	0.97
PGSC0003DMG200009159	K00058	ko00260	Glycine, serine and threonine metabolism	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMG200009159	K00058	ko01100	Metabolic pathways	1138	6.2e-57	0.81	0.91	0.99
PGSC0003DMG200028235	K08488	ko04130	SNARE interactions in vesicular transport	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMG200028235	K08488	ko04145	Phagosome	446	9.2e-19	0.42	0.59	0.66
PGSC0003DMG200028240	K01714	ko00300	Lysine biosynthesis	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMG200028240	K01714	ko01100	Metabolic pathways	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMG200028240	K01714	ko01110	Biosynthesis of secondary metabolites	2331	9.9e-123	0.82	0.93	0.99
PGSC0003DMG200028240	K01714	ko00300	Lysine biosynthesis	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMG200028240	K01714	ko01100	Metabolic pathways	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMG200028240	K01714	ko01110	Biosynthesis of secondary metabolites	2536	4.9e-134	0.85	0.95	0.95
PGSC0003DMG200028243	K02962	ko03010	Ribosome	971	1.0e-47	0.82	0.89	0.97
PGSC0003DMG200028246	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMG200028246	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMG200028246	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMG200028246	K12841	ko03040	Spliceosome	556	1.9e-24	0.31	0.46	0.64
PGSC0003DMG200028248	K11294	ko05130	Pathogenic Escherichia coli infection	255	3.1e-08	0.50	0.76	0.67
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1564	2.0e-80	0.53	0.75	1.00
PGSC0003DMG200017321	K07424	ko00140	Steroid hormone biosynthesis	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00591	Linoleic acid metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00830	Retinol metabolism	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00982	Drug metabolism - cytochrome P450	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko00983	Drug metabolism - other enzymes	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017321	K07424	ko01100	Metabolic pathways	1961	2.5e-102	0.47	0.70	0.98
PGSC0003DMG200017322	K07424	ko00140	Steroid hormone biosynthesis	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00591	Linoleic acid metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00830	Retinol metabolism	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00982	Drug metabolism - cytochrome P450	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko00983	Drug metabolism - other enzymes	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017322	K07424	ko01100	Metabolic pathways	986	1.5e-48	0.48	0.72	0.69
PGSC0003DMG200017323	K07424	ko00140	Steroid hormone biosynthesis	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00591	Linoleic acid metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00830	Retinol metabolism	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00982	Drug metabolism - cytochrome P450	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko00983	Drug metabolism - other enzymes	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017323	K07424	ko01100	Metabolic pathways	2055	1.6e-107	0.50	0.71	0.97
PGSC0003DMG200017324	K07424	ko00140	Steroid hormone biosynthesis	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00591	Linoleic acid metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00830	Retinol metabolism	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00982	Drug metabolism - cytochrome P450	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko00983	Drug metabolism - other enzymes	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017324	K07424	ko01100	Metabolic pathways	721	6.2e-34	0.58	0.78	0.99
PGSC0003DMG200017325	K07424	ko00140	Steroid hormone biosynthesis	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00591	Linoleic acid metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00830	Retinol metabolism	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00982	Drug metabolism - cytochrome P450	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko00983	Drug metabolism - other enzymes	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017325	K07424	ko01100	Metabolic pathways	1479	9.7e-76	0.42	0.58	0.97
PGSC0003DMG200017326	K11251	ko05322	Systemic lupus erythematosus	241	1.9e-07	0.48	0.58	0.93
PGSC0003DMG200017335	K01757	ko00901	Indole alkaloid biosynthesis	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMG200017335	K01757	ko01100	Metabolic pathways	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMG200017335	K01757	ko01110	Biosynthesis of secondary metabolites	790	9.7e-38	0.41	0.58	0.86
PGSC0003DMG200017336	K01757	ko00901	Indole alkaloid biosynthesis	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMG200017336	K01757	ko01100	Metabolic pathways	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMG200017336	K01757	ko01110	Biosynthesis of secondary metabolites	361	4.5e-14	0.30	0.46	0.87
PGSC0003DMG200017338	K01647	ko00020	Citrate cycle (TCA cycle)	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko01100	Metabolic pathways	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko00020	Citrate cycle (TCA cycle)	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko01100	Metabolic pathways	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.90	0.96	0.99
PGSC0003DMG200017338	K01647	ko00020	Citrate cycle (TCA cycle)	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMG200017338	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMG200017338	K01647	ko01100	Metabolic pathways	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMG200017338	K01647	ko01110	Biosynthesis of secondary metabolites	3680	3.9e-197	0.84	0.93	1.00
PGSC0003DMG200017338	K01647	ko00020	Citrate cycle (TCA cycle)	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMG200017338	K01647	ko00630	Glyoxylate and dicarboxylate metabolism	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMG200017338	K01647	ko01100	Metabolic pathways	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMG200017338	K01647	ko01110	Biosynthesis of secondary metabolites	2341	2.8e-123	0.89	0.96	0.99
PGSC0003DMG200017339	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMG200017339	K00591	ko01100	Metabolic pathways	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMG200017339	K00591	ko01110	Biosynthesis of secondary metabolites	1859	1.1e-96	0.77	0.85	0.90
PGSC0003DMG200017339	K00591	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMG200017339	K00591	ko01100	Metabolic pathways	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMG200017339	K00591	ko01110	Biosynthesis of secondary metabolites	944	3.1e-46	0.73	0.82	0.71
PGSC0003DMG200017340	K04460	ko04010	MAPK signaling pathway	3754	3.2e-201	0.81	0.87	1.00
PGSC0003DMG200032144	K08342	ko04140	Regulation of autophagy	1608	7.4e-83	0.66	0.79	0.98
PGSC0003DMG200032144	K08342	ko04140	Regulation of autophagy	650	5.1e-30	0.50	0.62	0.85
PGSC0003DMG200032144	K08342	ko04140	Regulation of autophagy	2369	7.9e-125	0.61	0.73	0.98
PGSC0003DMG200032144	K08342	ko04140	Regulation of autophagy	2304	3.0e-121	0.57	0.69	0.98
PGSC0003DMG200032146	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMG200032146	K01938	ko00670	One carbon pool by folate	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMG200032146	K01938	ko01100	Metabolic pathways	4811	1.6e-259	0.89	0.96	1.00
PGSC0003DMG200032146	K01938	ko00630	Glyoxylate and dicarboxylate metabolism	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMG200032146	K01938	ko00670	One carbon pool by folate	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMG200032146	K01938	ko01100	Metabolic pathways	4108	9.6e-221	0.89	0.95	0.97
PGSC0003DMG200032147	K00430	ko00360	Phenylalanine metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMG200032147	K00430	ko00680	Methane metabolism	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMG200032147	K00430	ko00940	Phenylpropanoid biosynthesis	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMG200032147	K00430	ko01100	Metabolic pathways	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMG200032147	K00430	ko01110	Biosynthesis of secondary metabolites	1364	2.1e-69	0.64	0.75	0.86
PGSC0003DMG200032150	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMG200032150	K11594	ko04622	RIG-I-like receptor signaling pathway	1093	1.9e-54	0.37	0.57	0.82
PGSC0003DMG200032152	K00208	ko00061	Fatty acid biosynthesis	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMG200032152	K00208	ko01100	Metabolic pathways	2630	3.2e-139	0.82	0.90	0.99
PGSC0003DMG200011458	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMG200011458	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMG200011458	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMG200011458	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMG200011458	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.85
PGSC0003DMG200011458	K00430	ko00360	Phenylalanine metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMG200011458	K00430	ko00680	Methane metabolism	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMG200011458	K00430	ko00940	Phenylpropanoid biosynthesis	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMG200011458	K00430	ko01100	Metabolic pathways	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMG200011458	K00430	ko01110	Biosynthesis of secondary metabolites	1307	3.0e-66	0.64	0.77	0.97
PGSC0003DMG200011461	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMG200011461	K05290	ko01100	Metabolic pathways	339	7.3e-13	0.52	0.71	0.85
PGSC0003DMG200011462	K05290	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMG200011462	K05290	ko01100	Metabolic pathways	479	1.4e-20	0.70	0.84	0.95
PGSC0003DMG200011469	K12843	ko03040	Spliceosome	4379	1.1e-235	0.75	0.85	0.99
PGSC0003DMG200011474	K02913	ko03010	Ribosome	332	1.8e-12	0.70	0.78	0.98
PGSC0003DMG200011476	K10581	ko04120	Ubiquitin mediated proteolysis	477	9.4e-20	0.28	0.39	0.63
PGSC0003DMG200006506	K13034	ko00270	Cysteine and methionine metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMG200006506	K13034	ko00450	Selenoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMG200006506	K13034	ko00460	Cyanoamino acid metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMG200006506	K13034	ko00920	Sulfur metabolism	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMG200006506	K13034	ko01100	Metabolic pathways	2584	1.1e-136	0.86	0.94	0.99
PGSC0003DMG200006513	K00228	ko00860	Porphyrin and chlorophyll metabolism	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMG200006513	K00228	ko01100	Metabolic pathways	1159	4.3e-58	0.48	0.54	0.99
PGSC0003DMG200006516	K00423	ko00053	Ascorbate and aldarate metabolism	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMG200006516	K00423	ko01100	Metabolic pathways	3276	7.5e-175	0.66	0.81	0.99
PGSC0003DMG200006518	K01692	ko00071	Fatty acid metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00280	Valine, leucine and isoleucine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00281	Geraniol degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00310	Lysine degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00380	Tryptophan metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00410	beta-Alanine metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00632	Benzoate degradation via CoA ligation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00640	Propanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00650	Butanoate metabolism	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00903	Limonene and pinene degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00930	Caprolactam degradation	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko01100	Metabolic pathways	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.78	0.89	0.79
PGSC0003DMG200006518	K01692	ko00071	Fatty acid metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00280	Valine, leucine and isoleucine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00281	Geraniol degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00310	Lysine degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00380	Tryptophan metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00410	beta-Alanine metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00632	Benzoate degradation via CoA ligation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00640	Propanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00650	Butanoate metabolism	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00903	Limonene and pinene degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00930	Caprolactam degradation	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko01100	Metabolic pathways	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko01110	Biosynthesis of secondary metabolites	1196	3.9e-60	0.68	0.83	0.95
PGSC0003DMG200006518	K01692	ko00071	Fatty acid metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00280	Valine, leucine and isoleucine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00281	Geraniol degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00310	Lysine degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00380	Tryptophan metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00410	beta-Alanine metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00632	Benzoate degradation via CoA ligation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00640	Propanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00650	Butanoate metabolism	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00903	Limonene and pinene degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko00930	Caprolactam degradation	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko01100	Metabolic pathways	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200006518	K01692	ko01110	Biosynthesis of secondary metabolites	2406	7.2e-127	0.76	0.87	0.99
PGSC0003DMG200013620	K05849	ko04020	Calcium signaling pathway	409	2.7e-16	0.35	0.51	0.51
PGSC0003DMG200013627	K06685	ko04111	Cell cycle - yeast	372	6.5e-11	0.29	0.46	0.39
PGSC0003DMG200013629	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMG200013629	K00517	ko00626	Naphthalene and anthracene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMG200013629	K00517	ko00903	Limonene and pinene degradation	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMG200013629	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMG200013629	K00517	ko01110	Biosynthesis of secondary metabolites	1373	6.8e-70	0.42	0.64	0.98
PGSC0003DMG200013631	K01246	ko03410	Base excision repair	2203	1.1e-115	0.67	0.78	1.00
PGSC0003DMG200013631	K01246	ko03410	Base excision repair	928	2.4e-45	0.58	0.68	0.88
PGSC0003DMG200013633	K02542	ko03030	DNA replication	5593	0.	0.77	0.86	1.00
PGSC0003DMG200013633	K02542	ko04110	Cell cycle	5593	0.	0.77	0.86	1.00
PGSC0003DMG200013633	K02542	ko04111	Cell cycle - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMG200013633	K02542	ko04113	Meiosis - yeast	5593	0.	0.77	0.86	1.00
PGSC0003DMG200013633	K02542	ko03030	DNA replication	5664	0.	0.80	0.89	1.00
PGSC0003DMG200013633	K02542	ko04110	Cell cycle	5664	0.	0.80	0.89	1.00
PGSC0003DMG200013633	K02542	ko04111	Cell cycle - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMG200013633	K02542	ko04113	Meiosis - yeast	5664	0.	0.80	0.89	1.00
PGSC0003DMG200013634	K01937	ko00240	Pyrimidine metabolism	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMG200013634	K01937	ko01100	Metabolic pathways	3801	8.2e-204	0.76	0.83	1.00
PGSC0003DMG200013634	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMG200013634	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMG200013634	K01937	ko00240	Pyrimidine metabolism	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMG200013634	K01937	ko01100	Metabolic pathways	4200	8.1e-226	0.82	0.89	1.00
PGSC0003DMG200045113	K00412	ko00190	Oxidative phosphorylation	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045113	K00412	ko01100	Metabolic pathways	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045113	K00412	ko04260	Cardiac muscle contraction	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045113	K00412	ko05010	Alzheimer's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045113	K00412	ko05012	Parkinson's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045113	K00412	ko05016	Huntington's disease	308	3.7e-11	0.97	0.97	0.39
PGSC0003DMG200045117	K00797	ko00270	Cysteine and methionine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMG200045117	K00797	ko00330	Arginine and proline metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMG200045117	K00797	ko00410	beta-Alanine metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMG200045117	K00797	ko00480	Glutathione metabolism	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMG200045117	K00797	ko01100	Metabolic pathways	212	7.4e-06	0.51	0.75	0.19
PGSC0003DMG200018057	K11812	ko00380	Tryptophan metabolism	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMG200018057	K11812	ko00966	Glucosinolate biosynthesis	790	9.7e-38	0.62	0.79	0.96
PGSC0003DMG200018057	K13027	ko00460	Cyanoamino acid metabolism	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMG200018057	K13027	ko00966	Glucosinolate biosynthesis	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMG200018057	K13027	ko01100	Metabolic pathways	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMG200018057	K13027	ko01110	Biosynthesis of secondary metabolites	419	2.8e-17	0.41	0.62	0.98
PGSC0003DMG200018058	K12153	ko00966	Glucosinolate biosynthesis	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMG200018058	K12153	ko01110	Biosynthesis of secondary metabolites	311	3.3e-11	0.54	0.70	0.80
PGSC0003DMG200018062	K13030	ko00460	Cyanoamino acid metabolism	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMG200018062	K13030	ko01110	Biosynthesis of secondary metabolites	949	1.7e-46	0.44	0.66	0.98
PGSC0003DMG200018063	K13030	ko00460	Cyanoamino acid metabolism	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMG200018063	K13030	ko01110	Biosynthesis of secondary metabolites	625	1.2e-28	0.41	0.65	0.98
PGSC0003DMG200018064	K05280	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMG200018064	K05280	ko00944	Flavone and flavonol biosynthesis	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMG200018064	K05280	ko01100	Metabolic pathways	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMG200018064	K05280	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.37	0.55	0.86
PGSC0003DMG200018064	K05280	ko00941	Flavonoid biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMG200018064	K05280	ko00944	Flavone and flavonol biosynthesis	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMG200018064	K05280	ko01100	Metabolic pathways	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMG200018064	K05280	ko01110	Biosynthesis of secondary metabolites	1456	1.8e-74	0.39	0.58	0.98
PGSC0003DMG200018066	K12929	ko00904	Diterpenoid biosynthesis	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMG200018066	K12929	ko01110	Biosynthesis of secondary metabolites	727	2.9e-34	0.42	0.62	0.99
PGSC0003DMG200018071	K02917	ko03010	Ribosome	430	7.0e-18	0.77	0.83	0.58
PGSC0003DMG200018080	K10712	ko00430	Taurine and hypotaurine metabolism	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMG200018080	K10712	ko01100	Metabolic pathways	368	1.8e-14	0.37	0.52	0.72
PGSC0003DMG200028861	K00889	ko00562	Inositol phosphate metabolism	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko01100	Metabolic pathways	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko04070	Phosphatidylinositol signaling system	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko04144	Endocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko04666	Fc gamma R-mediated phagocytosis	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko04810	Regulation of actin cytoskeleton	9812	0.	0.65	0.75	1.00
PGSC0003DMG200028861	K00889	ko00562	Inositol phosphate metabolism	9925	0.	0.67	0.78	1.00
PGSC0003DMG200028861	K00889	ko01100	Metabolic pathways	9925	0.	0.67	0.78	1.00
PGSC0003DMG200028861	K00889	ko04070	Phosphatidylinositol signaling system	9925	0.	0.67	0.78	1.00
PGSC0003DMG200028861	K00889	ko04144	Endocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMG200028861	K00889	ko04666	Fc gamma R-mediated phagocytosis	9925	0.	0.67	0.78	1.00
PGSC0003DMG200028861	K00889	ko04810	Regulation of actin cytoskeleton	9925	0.	0.67	0.78	1.00
PGSC0003DMG200024011	K04077	ko03018	RNA degradation	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMG200024011	K04077	ko04940	Type I diabetes mellitus	3903	1.9e-209	0.80	0.89	1.00
PGSC0003DMG200024011	K04077	ko03018	RNA degradation	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMG200024011	K04077	ko04940	Type I diabetes mellitus	3886	1.7e-208	0.80	0.89	0.99
PGSC0003DMG200024016	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko00020	Citrate cycle (TCA cycle)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko01100	Metabolic pathways	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024016	K01648	ko01110	Biosynthesis of secondary metabolites	4809	2.1e-259	0.93	0.97	1.00
PGSC0003DMG200024017	K12121	ko04712	Circadian rhythm - plant	8059	0.	0.84	0.92	0.99
PGSC0003DMG200024018	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMG200024018	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.40
PGSC0003DMG200024018	K04424	ko04010	MAPK signaling pathway	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMG200024018	K04424	ko04530	Tight junction	915	1.2e-44	0.48	0.67	0.35
PGSC0003DMG200024018	K04424	ko04010	MAPK signaling pathway	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMG200024018	K04424	ko04530	Tight junction	1437	2.0e-73	0.52	0.71	0.42
PGSC0003DMG200024019	K00430	ko00360	Phenylalanine metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMG200024019	K00430	ko00680	Methane metabolism	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMG200024019	K00430	ko00940	Phenylpropanoid biosynthesis	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMG200024019	K00430	ko01100	Metabolic pathways	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMG200024019	K00430	ko01110	Biosynthesis of secondary metabolites	968	1.5e-47	0.52	0.74	0.97
PGSC0003DMG200024029	K11251	ko05322	Systemic lupus erythematosus	945	2.8e-46	0.85	0.88	0.99
PGSC0003DMG200024030	K08773	ko05200	Pathways in cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMG200024030	K08773	ko05212	Pancreatic cancer	281	1.2e-09	0.33	0.52	0.40
PGSC0003DMG200024030	K08773	ko05200	Pathways in cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMG200024030	K08773	ko05212	Pancreatic cancer	280	1.4e-09	0.33	0.52	0.37
PGSC0003DMG200031056	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMG200031056	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMG200031056	K05391	ko04626	Plant-pathogen interaction	4066	2.0e-218	0.64	0.78	0.99
PGSC0003DMG200031057	K00654	ko00600	Sphingolipid metabolism	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMG200031057	K00654	ko01100	Metabolic pathways	3794	2.0e-203	0.90	0.96	1.00
PGSC0003DMG200031057	K00654	ko00600	Sphingolipid metabolism	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMG200031057	K00654	ko01100	Metabolic pathways	3367	7.1e-180	0.90	0.96	0.97
PGSC0003DMG200031062	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMG200031062	K00517	ko00626	Naphthalene and anthracene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMG200031062	K00517	ko00903	Limonene and pinene degradation	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMG200031062	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMG200031062	K00517	ko01110	Biosynthesis of secondary metabolites	1414	3.7e-72	0.42	0.60	0.98
PGSC0003DMG200031063	K00026	ko00020	Citrate cycle (TCA cycle)	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko00620	Pyruvate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko00710	Carbon fixation in photosynthetic organisms	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko01100	Metabolic pathways	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko01110	Biosynthesis of secondary metabolites	3038	1.0e-161	0.83	0.90	1.00
PGSC0003DMG200031063	K00026	ko00020	Citrate cycle (TCA cycle)	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031063	K00026	ko00620	Pyruvate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031063	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031063	K00026	ko00710	Carbon fixation in photosynthetic organisms	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031063	K00026	ko01100	Metabolic pathways	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031063	K00026	ko01110	Biosynthesis of secondary metabolites	473	3.0e-20	0.97	0.98	0.85
PGSC0003DMG200031064	K00423	ko00053	Ascorbate and aldarate metabolism	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMG200031064	K00423	ko01100	Metabolic pathways	1723	3.4e-89	0.44	0.62	0.52
PGSC0003DMG200031065	K01728	ko00040	Pentose and glucuronate interconversions	2086	3.2e-109	0.65	0.80	0.93
PGSC0003DMG200031065	K01728	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.63	0.79	0.78
PGSC0003DMG200031066	K01373	ko04142	Lysosome	2119	4.9e-111	0.74	0.86	0.84
PGSC0003DMG200031070	K12929	ko00904	Diterpenoid biosynthesis	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMG200031070	K12929	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.39	0.63	0.85
PGSC0003DMG200031070	K12929	ko00904	Diterpenoid biosynthesis	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMG200031070	K12929	ko01110	Biosynthesis of secondary metabolites	1177	4.4e-59	0.44	0.70	0.99
PGSC0003DMG200043900	K10760	ko00908	Zeatin biosynthesis	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMG200043900	K10760	ko01100	Metabolic pathways	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMG200043900	K10760	ko01110	Biosynthesis of secondary metabolites	507	4.0e-22	0.63	0.80	0.75
PGSC0003DMG200010802	K00036	ko00030	Pentose phosphate pathway	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko00480	Glutathione metabolism	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko01100	Metabolic pathways	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko01110	Biosynthesis of secondary metabolites	1890	2.1e-98	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko00030	Pentose phosphate pathway	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMG200010802	K00036	ko00480	Glutathione metabolism	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMG200010802	K00036	ko01100	Metabolic pathways	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMG200010802	K00036	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.77	0.84	0.95
PGSC0003DMG200010802	K00036	ko00030	Pentose phosphate pathway	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMG200010802	K00036	ko00480	Glutathione metabolism	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMG200010802	K00036	ko01100	Metabolic pathways	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMG200010802	K00036	ko01110	Biosynthesis of secondary metabolites	4047	2.2e-217	0.82	0.87	1.00
PGSC0003DMG200010802	K00036	ko00030	Pentose phosphate pathway	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko00480	Glutathione metabolism	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko01100	Metabolic pathways	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMG200010802	K00036	ko01110	Biosynthesis of secondary metabolites	1993	4.3e-104	0.91	0.97	1.00
PGSC0003DMG200010803	K00071	ko00140	Steroid hormone biosynthesis	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMG200010803	K00071	ko01100	Metabolic pathways	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMG200010803	K00071	ko04960	Aldosterone-regulated sodium reabsorption	409	1.0e-16	0.63	0.81	0.92
PGSC0003DMG200010803	K00071	ko00140	Steroid hormone biosynthesis	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMG200010803	K00071	ko01100	Metabolic pathways	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMG200010803	K00071	ko04960	Aldosterone-regulated sodium reabsorption	388	1.4e-15	0.45	0.65	0.70
PGSC0003DMG200010806	K01962	ko00061	Fatty acid biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010806	K01962	ko00253	Tetracycline biosynthesis	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010806	K01962	ko00620	Pyruvate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010806	K01962	ko00640	Propanoate metabolism	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010806	K01962	ko01100	Metabolic pathways	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010806	K01962	ko01110	Biosynthesis of secondary metabolites	422	4.5e-17	0.71	0.82	0.78
PGSC0003DMG200010809	K01051	ko00040	Pentose and glucuronate interconversions	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMG200010809	K01051	ko00500	Starch and sucrose metabolism	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMG200010809	K01051	ko01100	Metabolic pathways	341	8.8e-13	0.33	0.56	0.95
PGSC0003DMG200010812	K13030	ko00460	Cyanoamino acid metabolism	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMG200010812	K13030	ko01110	Biosynthesis of secondary metabolites	901	7.4e-44	0.33	0.54	0.94
PGSC0003DMG200010813	K01051	ko00040	Pentose and glucuronate interconversions	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMG200010813	K01051	ko00500	Starch and sucrose metabolism	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMG200010813	K01051	ko01100	Metabolic pathways	280	3.2e-09	0.29	0.50	0.94
PGSC0003DMG200014369	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014369	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014369	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014369	K00795	ko00900	Terpenoid backbone biosynthesis	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMG200014369	K00795	ko01100	Metabolic pathways	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMG200014369	K00795	ko01110	Biosynthesis of secondary metabolites	1525	2.8e-78	0.73	0.86	1.00
PGSC0003DMG200014369	K00795	ko00900	Terpenoid backbone biosynthesis	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014369	K00795	ko01100	Metabolic pathways	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014369	K00795	ko01110	Biosynthesis of secondary metabolites	1842	9.2e-96	0.71	0.85	1.00
PGSC0003DMG200014370	K06268	ko04010	MAPK signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04020	Calcium signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04114	Oocyte meiosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04210	Apoptosis	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04310	Wnt signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04360	Axon guidance	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04370	VEGF signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04650	Natural killer cell mediated cytotoxicity	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04660	T cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04662	B cell receptor signaling pathway	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04720	Long-term potentiation	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko05010	Alzheimer's disease	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	825	1.1e-39	0.80	0.91	0.85
PGSC0003DMG200014370	K06268	ko04010	MAPK signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04020	Calcium signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04114	Oocyte meiosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04210	Apoptosis	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04310	Wnt signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04360	Axon guidance	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04370	VEGF signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04650	Natural killer cell mediated cytotoxicity	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04660	T cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04662	B cell receptor signaling pathway	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04720	Long-term potentiation	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko05010	Alzheimer's disease	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	974	6.9e-48	0.83	0.90	0.75
PGSC0003DMG200014370	K06268	ko04010	MAPK signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04020	Calcium signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04114	Oocyte meiosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04210	Apoptosis	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04310	Wnt signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04360	Axon guidance	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04370	VEGF signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04650	Natural killer cell mediated cytotoxicity	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04660	T cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04662	B cell receptor signaling pathway	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko04720	Long-term potentiation	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko05010	Alzheimer's disease	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014370	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1606	9.6e-83	0.84	0.95	1.00
PGSC0003DMG200014372	K00876	ko00240	Pyrimidine metabolism	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMG200014372	K00876	ko00983	Drug metabolism - other enzymes	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMG200014372	K00876	ko01100	Metabolic pathways	2494	1.0e-131	0.80	0.93	0.99
PGSC0003DMG200014372	K00876	ko00240	Pyrimidine metabolism	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMG200014372	K00876	ko00983	Drug metabolism - other enzymes	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMG200014372	K00876	ko01100	Metabolic pathways	3031	2.4e-161	0.74	0.87	0.99
PGSC0003DMG200014372	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014372	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014372	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014372	K00876	ko00240	Pyrimidine metabolism	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014372	K00876	ko00983	Drug metabolism - other enzymes	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014372	K00876	ko01100	Metabolic pathways	875	2.0e-42	0.59	0.73	0.92
PGSC0003DMG200014373	K03141	ko03022	Basal transcription factors	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMG200014373	K03141	ko03420	Nucleotide excision repair	3348	8.0e-179	0.66	0.79	0.99
PGSC0003DMG200014373	K03141	ko03022	Basal transcription factors	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMG200014373	K03141	ko03420	Nucleotide excision repair	3199	1.3e-170	0.68	0.82	0.99
PGSC0003DMG200014373	K03141	ko03022	Basal transcription factors	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMG200014373	K03141	ko03420	Nucleotide excision repair	3421	7.5e-183	0.69	0.83	0.99
PGSC0003DMG200014373	K03141	ko03022	Basal transcription factors	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMG200014373	K03141	ko03420	Nucleotide excision repair	2699	5.0e-143	0.65	0.81	0.98
PGSC0003DMG200014374	K12616	ko03018	RNA degradation	7363	0.	0.64	0.77	1.00
PGSC0003DMG200014378	K02946	ko03010	Ribosome	1035	3.0e-51	0.67	0.78	0.99
PGSC0003DMG200014379	K00640	ko00270	Cysteine and methionine metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMG200014379	K00640	ko00920	Sulfur metabolism	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMG200014379	K00640	ko01100	Metabolic pathways	1998	2.3e-104	0.68	0.81	0.95
PGSC0003DMG200029346	K13068	ko00940	Phenylpropanoid biosynthesis	1850	3.3e-96	0.49	0.70	0.95
PGSC0003DMG200029347	K13068	ko00940	Phenylpropanoid biosynthesis	1770	8.6e-92	0.48	0.69	0.95
PGSC0003DMG200029348	K01076	ko00632	Benzoate degradation via CoA ligation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMG200029348	K01076	ko00903	Limonene and pinene degradation	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMG200029348	K01076	ko01040	Biosynthesis of unsaturated fatty acids	606	1.4e-27	0.35	0.53	0.69
PGSC0003DMG200029349	K11820	ko00380	Tryptophan metabolism	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMG200029349	K11820	ko00966	Glucosinolate biosynthesis	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMG200029349	K11820	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.51	0.73	0.97
PGSC0003DMG200029349	K11820	ko00380	Tryptophan metabolism	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMG200029349	K11820	ko00966	Glucosinolate biosynthesis	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMG200029349	K11820	ko01110	Biosynthesis of secondary metabolites	1387	1.2e-70	0.42	0.62	0.98
PGSC0003DMG200029350	K13068	ko00940	Phenylpropanoid biosynthesis	491	3.0e-21	0.55	0.73	0.79
PGSC0003DMG200029350	K11820	ko00380	Tryptophan metabolism	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMG200029350	K11820	ko00966	Glucosinolate biosynthesis	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMG200029350	K11820	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.43	0.62	0.98
PGSC0003DMG200029350	K11820	ko00380	Tryptophan metabolism	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMG200029350	K11820	ko00966	Glucosinolate biosynthesis	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMG200029350	K11820	ko01110	Biosynthesis of secondary metabolites	1378	3.6e-70	0.43	0.61	0.98
PGSC0003DMG200029350	K11820	ko00380	Tryptophan metabolism	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMG200029350	K11820	ko00966	Glucosinolate biosynthesis	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMG200029350	K11820	ko01110	Biosynthesis of secondary metabolites	428	9.0e-18	0.35	0.55	0.95
PGSC0003DMG200029352	K07512	ko00062	Fatty acid elongation in mitochondria	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMG200029352	K07512	ko01100	Metabolic pathways	439	2.2e-18	0.68	0.83	0.99
PGSC0003DMG200029354	K07512	ko00062	Fatty acid elongation in mitochondria	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMG200029354	K07512	ko01100	Metabolic pathways	1363	2.4e-69	0.57	0.72	0.99
PGSC0003DMG200029354	K07512	ko00062	Fatty acid elongation in mitochondria	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMG200029354	K07512	ko01100	Metabolic pathways	398	4.1e-16	0.47	0.58	0.83
PGSC0003DMG200029356	K01184	ko00040	Pentose and glucuronate interconversions	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMG200029356	K01184	ko00500	Starch and sucrose metabolism	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMG200029356	K01184	ko01100	Metabolic pathways	1041	1.4e-51	0.71	0.83	0.98
PGSC0003DMG200019379	K10143	ko04115	p53 signaling pathway	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMG200019379	K10143	ko04120	Ubiquitin mediated proteolysis	1322	4.4e-67	0.34	0.52	0.76
PGSC0003DMG200019379	K10143	ko04115	p53 signaling pathway	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMG200019379	K10143	ko04120	Ubiquitin mediated proteolysis	2168	9.7e-114	0.39	0.56	0.81
PGSC0003DMG200019386	K10775	ko00360	Phenylalanine metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMG200019386	K10775	ko00910	Nitrogen metabolism	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMG200019386	K10775	ko00940	Phenylpropanoid biosynthesis	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMG200019386	K10775	ko01100	Metabolic pathways	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMG200019386	K10775	ko01110	Biosynthesis of secondary metabolites	4832	1.1e-260	0.83	0.92	1.00
PGSC0003DMG200037204	K03130	ko03022	Basal transcription factors	235	7.4e-07	0.26	0.49	0.37
PGSC0003DMG200000684	K00368	ko00910	Nitrogen metabolism	2161	2.3e-113	0.51	0.66	0.92
PGSC0003DMG200000687	K02942	ko03010	Ribosome	504	5.8e-22	0.60	0.74	0.96
PGSC0003DMG200008380	K10352	ko04530	Tight junction	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMG200008380	K10352	ko05416	Viral myocarditis	292	9.1e-07	0.25	0.44	0.92
PGSC0003DMG200008384	K04424	ko04010	MAPK signaling pathway	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMG200008384	K04424	ko04530	Tight junction	570	2.0e-25	0.29	0.45	0.91
PGSC0003DMG200008384	K04424	ko04010	MAPK signaling pathway	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMG200008384	K04424	ko04530	Tight junction	1856	1.6e-96	0.39	0.54	0.94
PGSC0003DMG200008384	K04424	ko04010	MAPK signaling pathway	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMG200008384	K04424	ko04530	Tight junction	1439	1.6e-73	0.65	0.78	0.63
PGSC0003DMG200008384	K04424	ko04010	MAPK signaling pathway	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMG200008384	K04424	ko04530	Tight junction	457	7.0e-19	0.62	0.73	0.98
PGSC0003DMG200008386	K12183	ko04144	Endocytosis	2365	1.3e-124	0.69	0.81	0.99
PGSC0003DMG200008387	K01692	ko00071	Fatty acid metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00280	Valine, leucine and isoleucine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00281	Geraniol degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00310	Lysine degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00380	Tryptophan metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00410	beta-Alanine metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00632	Benzoate degradation via CoA ligation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00640	Propanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00650	Butanoate metabolism	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00903	Limonene and pinene degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko00930	Caprolactam degradation	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko01100	Metabolic pathways	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008387	K01692	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.48	0.64	0.92
PGSC0003DMG200008388	K01193	ko00052	Galactose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMG200008388	K01193	ko00500	Starch and sucrose metabolism	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMG200008388	K01193	ko01100	Metabolic pathways	3050	2.2e-162	0.69	0.82	1.00
PGSC0003DMG200012589	K00430	ko00360	Phenylalanine metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMG200012589	K00430	ko00680	Methane metabolism	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMG200012589	K00430	ko00940	Phenylpropanoid biosynthesis	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMG200012589	K00430	ko01100	Metabolic pathways	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMG200012589	K00430	ko01110	Biosynthesis of secondary metabolites	1678	1.0e-86	0.63	0.78	0.94
PGSC0003DMG200012590	K08917	ko00196	Photosynthesis - antenna proteins	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMG200012590	K08917	ko01100	Metabolic pathways	1752	8.5e-91	0.80	0.86	1.00
PGSC0003DMG200012591	K08917	ko00196	Photosynthesis - antenna proteins	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMG200012591	K08917	ko01100	Metabolic pathways	1759	3.5e-91	0.80	0.87	1.00
PGSC0003DMG200012601	K12741	ko03040	Spliceosome	1347	1.8e-68	0.50	0.57	0.94
PGSC0003DMG200012601	K12741	ko03040	Spliceosome	2122	3.3e-111	0.67	0.78	0.95
PGSC0003DMG200002712	K00700	ko00500	Starch and sucrose metabolism	5670	0.	0.75	0.84	0.98
PGSC0003DMG200002712	K00700	ko01100	Metabolic pathways	5670	0.	0.75	0.84	0.98
PGSC0003DMG200002718	K04424	ko04010	MAPK signaling pathway	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMG200002718	K04424	ko04530	Tight junction	1963	2.0e-102	0.38	0.53	0.92
PGSC0003DMG200002718	K04424	ko04010	MAPK signaling pathway	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMG200002718	K04424	ko04530	Tight junction	1301	6.4e-66	0.33	0.49	0.89
PGSC0003DMG200002719	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.68
PGSC0003DMG200002719	K10773	ko03410	Base excision repair	2136	5.6e-112	0.43	0.57	0.77
PGSC0003DMG200002719	K10773	ko03410	Base excision repair	2705	2.3e-143	0.38	0.50	0.70
PGSC0003DMG200002720	K00222	ko00100	Steroid biosynthesis	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMG200002720	K00222	ko01100	Metabolic pathways	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMG200002720	K00222	ko01110	Biosynthesis of secondary metabolites	2387	8.0e-126	0.78	0.85	0.98
PGSC0003DMG200002720	K00222	ko00100	Steroid biosynthesis	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMG200002720	K00222	ko01100	Metabolic pathways	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMG200002720	K00222	ko01110	Biosynthesis of secondary metabolites	2545	1.6e-134	0.82	0.89	0.98
PGSC0003DMG200002720	K00222	ko00100	Steroid biosynthesis	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMG200002720	K00222	ko01100	Metabolic pathways	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMG200002720	K00222	ko01110	Biosynthesis of secondary metabolites	1135	9.1e-57	0.81	0.88	0.91
PGSC0003DMG200002720	K00222	ko00100	Steroid biosynthesis	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMG200002720	K00222	ko01100	Metabolic pathways	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMG200002720	K00222	ko01110	Biosynthesis of secondary metabolites	1485	4.5e-76	0.78	0.86	0.92
PGSC0003DMG200016067	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMG200016067	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.55
PGSC0003DMG200016067	K08967	ko00270	Cysteine and methionine metabolism	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMG200016067	K08967	ko01100	Metabolic pathways	251	5.2e-08	0.70	0.89	0.66
PGSC0003DMG200016071	K02894	ko03010	Ribosome	499	1.1e-21	0.91	0.94	0.98
PGSC0003DMG200016078	K12602	ko03018	RNA degradation	1946	1.7e-101	0.70	0.84	1.00
PGSC0003DMG200016080	K02861	ko04210	Apoptosis	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMG200016080	K02861	ko04620	Toll-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMG200016080	K02861	ko04622	RIG-I-like receptor signaling pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMG200016080	K02861	ko04623	Cytosolic DNA-sensing pathway	519	8.6e-23	0.31	0.48	0.66
PGSC0003DMG200009827	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMG200009827	K02997	ko03010	Ribosome	1576	4.3e-81	0.93	0.98	0.99
PGSC0003DMG200009832	K12929	ko00904	Diterpenoid biosynthesis	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMG200009832	K12929	ko01110	Biosynthesis of secondary metabolites	291	8.3e-10	0.36	0.55	0.99
PGSC0003DMG200009833	K12929	ko00904	Diterpenoid biosynthesis	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMG200009833	K12929	ko01110	Biosynthesis of secondary metabolites	1233	3.6e-62	0.42	0.61	0.97
PGSC0003DMG200009835	K11813	ko00380	Tryptophan metabolism	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMG200009835	K11813	ko00966	Glucosinolate biosynthesis	714	1.5e-33	0.64	0.79	0.93
PGSC0003DMG200009836	K12153	ko00966	Glucosinolate biosynthesis	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMG200009836	K12153	ko01110	Biosynthesis of secondary metabolites	594	1.3e-34	0.52	0.71	0.99
PGSC0003DMG200009836	K12153	ko00966	Glucosinolate biosynthesis	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMG200009836	K12153	ko01110	Biosynthesis of secondary metabolites	358	6.5e-14	0.61	0.74	0.89
PGSC0003DMG200009838	K02908	ko03010	Ribosome	878	1.4e-42	0.90	0.98	0.99
PGSC0003DMG200009838	K02908	ko03010	Ribosome	886	4.9e-43	0.91	0.98	0.99
PGSC0003DMG200009842	K01835	ko00010	Glycolysis / Gluconeogenesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00030	Pentose phosphate pathway	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00052	Galactose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00230	Purine metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00500	Starch and sucrose metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko00521	Streptomycin biosynthesis	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko01100	Metabolic pathways	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009842	K01835	ko01110	Biosynthesis of secondary metabolites	4178	1.3e-224	0.84	0.92	1.00
PGSC0003DMG200009844	K10577	ko04120	Ubiquitin mediated proteolysis	905	4.4e-44	0.88	0.94	0.97
PGSC0003DMG200009844	K10577	ko04120	Ubiquitin mediated proteolysis	449	6.3e-19	0.94	0.98	0.50
PGSC0003DMG200009844	K10577	ko04120	Ubiquitin mediated proteolysis	901	7.4e-44	0.90	0.95	0.78
PGSC0003DMG200009848	K01810	ko00010	Glycolysis / Gluconeogenesis	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200009848	K01810	ko00030	Pentose phosphate pathway	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200009848	K01810	ko00500	Starch and sucrose metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200009848	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200009848	K01810	ko01100	Metabolic pathways	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200009848	K01810	ko01110	Biosynthesis of secondary metabolites	850	4.8e-41	0.48	0.54	0.80
PGSC0003DMG200002249	K12489	ko04144	Endocytosis	5562	6.1e-301	0.80	0.89	1.00
PGSC0003DMG200002250	K04733	ko04210	Apoptosis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMG200002250	K04733	ko04620	Toll-like receptor signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMG200002250	K04733	ko04722	Neurotrophin signaling pathway	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMG200002250	K04733	ko05140	Leishmaniasis	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMG200002250	K04733	ko05142	Chagas disease	416	1.5e-16	0.38	0.60	0.54
PGSC0003DMG200012064	K12824	ko03040	Spliceosome	483	2.5e-18	0.30	0.39	0.57
PGSC0003DMG200012066	K03260	ko05416	Viral myocarditis	313	2.4e-08	0.27	0.43	0.92
PGSC0003DMG200012068	K13030	ko00460	Cyanoamino acid metabolism	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMG200012068	K13030	ko01110	Biosynthesis of secondary metabolites	874	2.3e-42	0.33	0.50	0.89
PGSC0003DMG200012073	K06199	ko01100	Metabolic pathways	220	2.7e-06	0.35	0.51	0.42
PGSC0003DMG200012073	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMG200012073	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMG200012073	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMG200012073	K06199	ko01100	Metabolic pathways	230	1.2e-06	0.34	0.50	0.27
PGSC0003DMG200015182	K01493	ko00240	Pyrimidine metabolism	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMG200015182	K01493	ko01100	Metabolic pathways	1530	1.5e-78	0.79	0.86	1.00
PGSC0003DMG200015183	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMG200015183	K00517	ko00626	Naphthalene and anthracene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMG200015183	K00517	ko00903	Limonene and pinene degradation	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMG200015183	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMG200015183	K00517	ko01110	Biosynthesis of secondary metabolites	1067	5.1e-53	0.49	0.68	0.95
PGSC0003DMG200015184	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMG200015184	K00517	ko00626	Naphthalene and anthracene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMG200015184	K00517	ko00903	Limonene and pinene degradation	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMG200015184	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMG200015184	K00517	ko01110	Biosynthesis of secondary metabolites	1783	1.7e-92	0.49	0.68	0.99
PGSC0003DMG200015185	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMG200015185	K00517	ko00626	Naphthalene and anthracene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMG200015185	K00517	ko00903	Limonene and pinene degradation	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMG200015185	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMG200015185	K00517	ko01110	Biosynthesis of secondary metabolites	1757	4.5e-91	0.48	0.65	0.98
PGSC0003DMG200015187	K00939	ko00230	Purine metabolism	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMG200015187	K00939	ko01100	Metabolic pathways	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMG200015187	K00939	ko01110	Biosynthesis of secondary metabolites	1821	1.3e-94	0.87	0.95	1.00
PGSC0003DMG200015190	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMG200015190	K01904	ko00360	Phenylalanine metabolism	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMG200015190	K01904	ko00940	Phenylpropanoid biosynthesis	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMG200015190	K01904	ko01100	Metabolic pathways	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMG200015190	K01904	ko01110	Biosynthesis of secondary metabolites	1917	6.7e-100	0.46	0.65	0.99
PGSC0003DMG200015192	K01638	ko00620	Pyruvate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMG200015192	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMG200015192	K01638	ko01100	Metabolic pathways	4181	9.1e-225	0.84	0.92	1.00
PGSC0003DMG200015193	K01638	ko00620	Pyruvate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMG200015193	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMG200015193	K01638	ko01100	Metabolic pathways	624	1.4e-28	0.87	0.87	0.94
PGSC0003DMG200015193	K01638	ko00620	Pyruvate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMG200015193	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMG200015193	K01638	ko01100	Metabolic pathways	1022	1.6e-50	0.91	0.95	0.99
PGSC0003DMG200015194	K01638	ko00620	Pyruvate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMG200015194	K01638	ko00630	Glyoxylate and dicarboxylate metabolism	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMG200015194	K01638	ko01100	Metabolic pathways	4061	3.8e-218	0.83	0.90	0.98
PGSC0003DMG200015203	K07342	ko03060	Protein export	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMG200015203	K07342	ko04145	Phagosome	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMG200015203	K07342	ko05110	Vibrio cholerae infection	553	1.1e-24	0.96	0.99	0.97
PGSC0003DMG200016475	K00423	ko00053	Ascorbate and aldarate metabolism	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMG200016475	K00423	ko01100	Metabolic pathways	257	5.9e-08	0.52	0.63	0.97
PGSC0003DMG200016475	K00423	ko00053	Ascorbate and aldarate metabolism	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMG200016475	K00423	ko01100	Metabolic pathways	2426	5.7e-128	0.54	0.68	0.98
PGSC0003DMG200016475	K01199	ko00500	Starch and sucrose metabolism	699	1.0e-32	0.31	0.52	0.67
PGSC0003DMG200016478	K04518	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMG200016478	K04518	ko01100	Metabolic pathways	1692	1.7e-87	0.66	0.80	0.77
PGSC0003DMG200016479	K08341	ko04140	Regulation of autophagy	927	2.7e-45	0.91	0.98	0.94
PGSC0003DMG200016481	K00703	ko00500	Starch and sucrose metabolism	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMG200016481	K00703	ko01100	Metabolic pathways	272	2.5e-08	0.65	0.86	0.78
PGSC0003DMG200016481	K00703	ko00500	Starch and sucrose metabolism	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMG200016481	K00703	ko01100	Metabolic pathways	2775	3.2e-147	0.43	0.59	0.75
PGSC0003DMG200016482	K02115	ko00190	Oxidative phosphorylation	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMG200016482	K02115	ko00195	Photosynthesis	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMG200016482	K02115	ko01100	Metabolic pathways	2690	1.6e-142	0.88	0.94	0.99
PGSC0003DMG200016483	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMG200016483	K09489	ko04612	Antigen processing and presentation	3212	2.5e-171	0.52	0.69	0.97
PGSC0003DMG200005187	K03137	ko03022	Basal transcription factors	1921	4.1e-100	0.83	0.90	0.99
PGSC0003DMG200005189	K03110	ko03060	Protein export	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMG200005189	K03110	ko03070	Bacterial secretion system	384	3.5e-13	0.35	0.45	0.43
PGSC0003DMG200005192	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMG200005197	K09753	ko00940	Phenylpropanoid biosynthesis	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMG200005197	K09753	ko01100	Metabolic pathways	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMG200005197	K09753	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.40	0.58	0.98
PGSC0003DMG200005197	K09753	ko00940	Phenylpropanoid biosynthesis	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMG200005197	K09753	ko01100	Metabolic pathways	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMG200005197	K09753	ko01110	Biosynthesis of secondary metabolites	591	9.2e-27	0.36	0.56	0.97
PGSC0003DMG200005198	K08341	ko04140	Regulation of autophagy	582	2.9e-26	0.59	0.77	0.97
PGSC0003DMG200005199	K02977	ko03010	Ribosome	1314	1.2e-66	0.99	0.99	0.99
PGSC0003DMG200000166	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2576	3.0e-136	0.70	0.85	1.00
PGSC0003DMG200000166	K01068	ko01040	Biosynthesis of unsaturated fatty acids	2469	2.4e-130	0.70	0.86	0.99
PGSC0003DMG200000167	K11086	ko03040	Spliceosome	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMG200000167	K11086	ko05322	Systemic lupus erythematosus	1828	5.5e-95	0.75	0.82	1.00
PGSC0003DMG200000168	K02920	ko03010	Ribosome	867	5.5e-42	0.95	0.98	0.99
PGSC0003DMG200000169	K01177	ko00500	Starch and sucrose metabolism	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMG200000169	K01177	ko01100	Metabolic pathways	1647	5.3e-85	0.48	0.64	0.62
PGSC0003DMG200000169	K01177	ko00500	Starch and sucrose metabolism	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMG200000169	K01177	ko01100	Metabolic pathways	1212	5.2e-61	0.50	0.69	0.51
PGSC0003DMG200000174	K02607	ko04110	Cell cycle	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMG200000174	K02607	ko04111	Cell cycle - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMG200000174	K02607	ko04113	Meiosis - yeast	2533	7.1e-134	0.59	0.74	0.99
PGSC0003DMG200000177	K10576	ko04120	Ubiquitin mediated proteolysis	286	6.1e-10	0.78	0.89	0.81
PGSC0003DMG200000177	K10576	ko04120	Ubiquitin mediated proteolysis	1478	1.1e-75	0.91	0.96	0.99
PGSC0003DMG200000177	K10576	ko04120	Ubiquitin mediated proteolysis	1345	2.4e-68	0.90	0.96	0.99
PGSC0003DMG200041458	K12796	ko04621	NOD-like receptor signaling pathway	353	2.7e-10	0.33	0.51	0.32
PGSC0003DMG200025750	K02180	ko04110	Cell cycle	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMG200025750	K02180	ko04111	Cell cycle - yeast	2707	1.8e-143	0.90	0.96	0.99
PGSC0003DMG200025757	K11422	ko00310	Lysine degradation	413	7.8e-16	0.33	0.43	0.92
PGSC0003DMG200020269	K00036	ko00030	Pentose phosphate pathway	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMG200020269	K00036	ko00480	Glutathione metabolism	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMG200020269	K00036	ko01100	Metabolic pathways	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMG200020269	K00036	ko01110	Biosynthesis of secondary metabolites	3848	2.1e-206	0.87	0.93	1.00
PGSC0003DMG200020287	K03575	ko03410	Base excision repair	2302	3.9e-121	0.65	0.79	0.92
PGSC0003DMG200030167	K10872	ko04113	Meiosis - yeast	2474	1.3e-130	0.95	0.98	0.92
PGSC0003DMG200030180	K01728	ko00040	Pentose and glucuronate interconversions	2407	6.3e-127	0.83	0.92	0.97
PGSC0003DMG200030180	K01728	ko00040	Pentose and glucuronate interconversions	338	8.3e-13	0.64	0.82	0.84
PGSC0003DMG200030181	K01054	ko00561	Glycerolipid metabolism	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMG200030181	K01054	ko01100	Metabolic pathways	365	2.7e-14	0.35	0.49	0.88
PGSC0003DMG200030181	K01054	ko00561	Glycerolipid metabolism	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMG200030181	K01054	ko01100	Metabolic pathways	524	4.6e-23	0.33	0.49	0.87
PGSC0003DMG200030182	K03075	ko03060	Protein export	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMG200030182	K03075	ko03070	Bacterial secretion system	272	3.6e-09	0.39	0.47	0.40
PGSC0003DMG200030183	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMG200030183	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMG200030183	K00771	ko01100	Metabolic pathways	342	2.2e-12	0.29	0.51	0.60
PGSC0003DMG200023372	K11584	ko04113	Meiosis - yeast	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMG200023372	K11584	ko04114	Oocyte meiosis	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMG200023372	K11584	ko04310	Wnt signaling pathway	2870	1.8e-152	0.70	0.82	1.00
PGSC0003DMG200023375	K11252	ko05322	Systemic lupus erythematosus	1143	3.3e-57	0.95	0.97	0.99
PGSC0003DMG200023377	K02367	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMG200023377	K02367	ko01100	Metabolic pathways	579	4.2e-26	0.38	0.57	0.33
PGSC0003DMG200023382	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMG200023382	K00517	ko00626	Naphthalene and anthracene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMG200023382	K00517	ko00903	Limonene and pinene degradation	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMG200023382	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMG200023382	K00517	ko01110	Biosynthesis of secondary metabolites	2746	1.3e-145	0.70	0.87	0.99
PGSC0003DMG200011196	K03260	ko05416	Viral myocarditis	2361	2.2e-124	0.48	0.63	0.88
PGSC0003DMG200011197	K03283	ko03040	Spliceosome	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMG200011197	K03283	ko04010	MAPK signaling pathway	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMG200011197	K03283	ko04144	Endocytosis	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMG200011197	K03283	ko04612	Antigen processing and presentation	4435	8.9e-239	0.81	0.88	0.99
PGSC0003DMG200011204	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMG200011204	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMG200011204	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	1.00
PGSC0003DMG200011204	K10754	ko03030	DNA replication	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03420	Nucleotide excision repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03430	Mismatch repair	5088	8.5e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03030	DNA replication	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03420	Nucleotide excision repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03430	Mismatch repair	5096	3.1e-275	0.66	0.77	0.99
PGSC0003DMG200011204	K10754	ko03030	DNA replication	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMG200011204	K10754	ko03420	Nucleotide excision repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMG200011204	K10754	ko03430	Mismatch repair	4114	4.5e-221	0.66	0.76	0.99
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko04142	Lysosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko04145	Phagosome	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	744	3.4e-35	0.70	0.76	0.92
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko04142	Lysosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko04145	Phagosome	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	605	1.6e-27	0.89	0.95	0.95
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko00190	Oxidative phosphorylation	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko01100	Metabolic pathways	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04142	Lysosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko04145	Phagosome	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05110	Vibrio cholerae infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200011206	K02144	ko05120	Epithelial cell signaling in Helicobacter pylori infection	3194	2.5e-170	0.83	0.92	0.99
PGSC0003DMG200006664	K01126	ko00564	Glycerophospholipid metabolism	446	9.2e-19	0.29	0.53	0.88
PGSC0003DMG200006664	K01126	ko00564	Glycerophospholipid metabolism	302	1.8e-10	0.29	0.52	0.89
PGSC0003DMG200006664	K01126	ko00564	Glycerophospholipid metabolism	269	1.4e-08	0.27	0.54	0.90
PGSC0003DMG200013354	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.97
PGSC0003DMG200013354	K12741	ko03040	Spliceosome	1316	9.5e-67	0.44	0.59	0.98
PGSC0003DMG200013776	K12130	ko04712	Circadian rhythm - plant	266	2.3e-08	0.31	0.49	0.79
PGSC0003DMG200013777	K12130	ko04712	Circadian rhythm - plant	282	2.0e-07	0.27	0.47	0.77
PGSC0003DMG200013782	K10739	ko03030	DNA replication	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMG200013782	K10739	ko03420	Nucleotide excision repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMG200013782	K10739	ko03430	Mismatch repair	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMG200013782	K10739	ko03440	Homologous recombination	1405	1.2e-71	0.62	0.79	0.99
PGSC0003DMG200013785	K06085	ko04520	Adherens junction	527	3.1e-23	0.29	0.52	0.92
PGSC0003DMG200013800	K04733	ko04210	Apoptosis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMG200013800	K04733	ko04620	Toll-like receptor signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMG200013800	K04733	ko04722	Neurotrophin signaling pathway	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMG200013800	K04733	ko05140	Leishmaniasis	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMG200013800	K04733	ko05142	Chagas disease	277	1.9e-09	0.39	0.60	0.68
PGSC0003DMG200045585	K07466	ko03030	DNA replication	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMG200045585	K07466	ko03420	Nucleotide excision repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMG200045585	K07466	ko03430	Mismatch repair	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMG200045585	K07466	ko03440	Homologous recombination	531	1.9e-23	0.30	0.48	0.85
PGSC0003DMG200045603	K02183	ko04020	Calcium signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04070	Phosphatidylinositol signaling system	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04114	Oocyte meiosis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04270	Vascular smooth muscle contraction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04626	Plant-pathogen interaction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04720	Long-term potentiation	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04722	Neurotrophin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04740	Olfactory transduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04744	Phototransduction	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04745	Phototransduction - fly	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04910	Insulin signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04912	GnRH signaling pathway	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04916	Melanogenesis	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04970	Salivary secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko04971	Gastric acid secretion	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko05010	Alzheimer's disease	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200045603	K02183	ko05214	Glioma	307	4.3e-11	0.34	0.60	0.73
PGSC0003DMG200043341	K10760	ko00908	Zeatin biosynthesis	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMG200043341	K10760	ko01100	Metabolic pathways	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMG200043341	K10760	ko01110	Biosynthesis of secondary metabolites	600	2.9e-27	0.52	0.67	0.80
PGSC0003DMG200043356	K00650	ko00564	Glycerophospholipid metabolism	266	9.1e-09	0.27	0.45	0.88
PGSC0003DMG200001444	K00754	ko00051	Fructose and mannose metabolism	674	2.4e-31	0.51	0.67	0.95
PGSC0003DMG200001444	K00754	ko00051	Fructose and mannose metabolism	1413	4.2e-72	0.42	0.59	0.83
PGSC0003DMG200001448	K00012	ko00040	Pentose and glucuronate interconversions	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001448	K00012	ko00053	Ascorbate and aldarate metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001448	K00012	ko00500	Starch and sucrose metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001448	K00012	ko00520	Amino sugar and nucleotide sugar metabolism	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001448	K00012	ko01100	Metabolic pathways	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001448	K00012	ko01110	Biosynthesis of secondary metabolites	3771	3.7e-202	0.91	0.96	1.00
PGSC0003DMG200001450	K13068	ko00940	Phenylpropanoid biosynthesis	833	4.1e-40	0.31	0.53	0.98
PGSC0003DMG200001451	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.35
PGSC0003DMG200001451	K02935	ko03010	Ribosome	416	4.1e-17	0.44	0.65	0.67
PGSC0003DMG200001453	K12741	ko03040	Spliceosome	659	1.6e-30	0.41	0.56	0.86
PGSC0003DMG200001454	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMG200001454	K07195	ko04910	Insulin signaling pathway	2551	7.2e-135	0.50	0.69	1.00
PGSC0003DMG200027960	K01066	ko00623	2,4-Dichlorobenzoate degradation	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMG200027960	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	373	9.7e-15	0.33	0.51	0.78
PGSC0003DMG200027963	K05282	ko00904	Diterpenoid biosynthesis	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMG200027963	K05282	ko01100	Metabolic pathways	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMG200027963	K05282	ko01110	Biosynthesis of secondary metabolites	2008	6.4e-105	0.68	0.77	0.96
PGSC0003DMG200027966	K03660	ko03410	Base excision repair	951	1.3e-46	0.55	0.71	0.72
PGSC0003DMG200027977	K03876	ko04120	Ubiquitin mediated proteolysis	254	3.6e-08	0.31	0.56	0.74
PGSC0003DMG200027978	K02085	ko04310	Wnt signaling pathway	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko04810	Regulation of actin cytoskeleton	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko05200	Pathways in cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko05210	Colorectal cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko05213	Endometrial cancer	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko05217	Basal cell carcinoma	283	2.2e-07	0.24	0.44	0.91
PGSC0003DMG200027978	K02085	ko04310	Wnt signaling pathway	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200027978	K02085	ko04810	Regulation of actin cytoskeleton	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200027978	K02085	ko05200	Pathways in cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200027978	K02085	ko05210	Colorectal cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200027978	K02085	ko05213	Endometrial cancer	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200027978	K02085	ko05217	Basal cell carcinoma	271	1.6e-06	0.24	0.44	0.90
PGSC0003DMG200017249	K12356	ko00940	Phenylpropanoid biosynthesis	615	4.4e-28	0.33	0.50	0.96
PGSC0003DMG200017250	K12356	ko00940	Phenylpropanoid biosynthesis	357	7.4e-14	0.42	0.65	0.91
PGSC0003DMG200017253	K08504	ko04130	SNARE interactions in vesicular transport	530	2.1e-23	0.65	0.88	0.80
PGSC0003DMG200017253	K08504	ko04130	SNARE interactions in vesicular transport	741	4.9e-35	0.65	0.86	0.96
PGSC0003DMG200017258	K02706	ko00195	Photosynthesis	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMG200017258	K02706	ko01100	Metabolic pathways	2199	1.9e-115	0.99	1.00	0.92
PGSC0003DMG200032500	K12842	ko03040	Spliceosome	383	1.4e-14	0.55	0.65	0.69
PGSC0003DMG200032510	K00423	ko00053	Ascorbate and aldarate metabolism	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMG200032510	K00423	ko01100	Metabolic pathways	3056	1.0e-162	0.63	0.75	0.99
PGSC0003DMG200032511	K12356	ko00940	Phenylpropanoid biosynthesis	646	8.5e-30	0.34	0.53	0.93
PGSC0003DMG200032511	K12356	ko00940	Phenylpropanoid biosynthesis	653	3.5e-30	0.32	0.52	0.74
PGSC0003DMG200010517	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMG200010517	K02881	ko03010	Ribosome	227	1.1e-06	0.29	0.55	0.57
PGSC0003DMG200010518	K11752	ko00740	Riboflavin metabolism	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMG200010518	K11752	ko01100	Metabolic pathways	1259	1.3e-63	0.47	0.67	0.92
PGSC0003DMG200010518	K11752	ko00740	Riboflavin metabolism	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMG200010518	K11752	ko01100	Metabolic pathways	965	2.2e-47	0.57	0.72	0.52
PGSC0003DMG200010518	K11752	ko00740	Riboflavin metabolism	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMG200010518	K11752	ko01100	Metabolic pathways	1296	1.2e-65	0.49	0.65	0.62
PGSC0003DMG200010525	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMG200010525	K00517	ko00626	Naphthalene and anthracene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMG200010525	K00517	ko00903	Limonene and pinene degradation	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMG200010525	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMG200010525	K00517	ko01110	Biosynthesis of secondary metabolites	1634	2.7e-84	0.43	0.62	0.97
PGSC0003DMG200010525	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMG200010525	K00517	ko00626	Naphthalene and anthracene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMG200010525	K00517	ko00903	Limonene and pinene degradation	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMG200010525	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMG200010525	K00517	ko01110	Biosynthesis of secondary metabolites	894	1.8e-43	0.53	0.70	0.97
PGSC0003DMG200010527	K06685	ko04111	Cell cycle - yeast	291	1.4e-06	0.33	0.55	0.19
PGSC0003DMG200014487	K10144	ko04115	p53 signaling pathway	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMG200014487	K10144	ko04120	Ubiquitin mediated proteolysis	1600	2.1e-82	0.67	0.80	0.80
PGSC0003DMG200014487	K10144	ko04115	p53 signaling pathway	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMG200014487	K10144	ko04120	Ubiquitin mediated proteolysis	1472	2.4e-75	0.67	0.81	0.99
PGSC0003DMG200014496	K00128	ko00010	Glycolysis / Gluconeogenesis	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00053	Ascorbate and aldarate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00071	Fatty acid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00280	Valine, leucine and isoleucine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00310	Lysine degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00330	Arginine and proline metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00340	Histidine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00380	Tryptophan metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00410	beta-Alanine metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00561	Glycerolipid metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00620	Pyruvate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00631	1,2-Dichloroethane degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00640	Propanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00641	3-Chloroacrylic acid degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00650	Butanoate metabolism	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko00903	Limonene and pinene degradation	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko01100	Metabolic pathways	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014496	K00128	ko01110	Biosynthesis of secondary metabolites	3495	6.2e-187	0.77	0.87	0.88
PGSC0003DMG200014497	K12401	ko04142	Lysosome	1726	2.3e-89	0.39	0.60	0.79
PGSC0003DMG200014498	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.97
PGSC0003DMG200014498	K02899	ko03010	Ribosome	1019	2.3e-50	0.82	0.90	0.76
PGSC0003DMG200014498	K02899	ko03010	Ribosome	584	2.2e-26	0.86	0.91	0.95
PGSC0003DMG200014499	K00680	ko00350	Tyrosine metabolism	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMG200014499	K00680	ko00624	1- and 2-Methylnaphthalene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMG200014499	K00680	ko00632	Benzoate degradation via CoA ligation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMG200014499	K00680	ko00642	Ethylbenzene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMG200014499	K00680	ko00903	Limonene and pinene degradation	291	3.2e-10	0.36	0.61	0.39
PGSC0003DMG200014501	K11294	ko05130	Pathogenic Escherichia coli infection	246	2.3e-07	0.27	0.43	0.86
PGSC0003DMG200014502	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	275	1.5e-08	0.29	0.47	0.92
PGSC0003DMG200014503	K08490	ko04130	SNARE interactions in vesicular transport	2314	8.5e-122	0.82	0.90	1.00
PGSC0003DMG200017982	K13065	ko00940	Phenylpropanoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMG200017982	K13065	ko00941	Flavonoid biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMG200017982	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMG200017982	K13065	ko01110	Biosynthesis of secondary metabolites	254	4.9e-08	0.33	0.54	0.67
PGSC0003DMG200017983	K13065	ko00940	Phenylpropanoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMG200017983	K13065	ko00941	Flavonoid biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMG200017983	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMG200017983	K13065	ko01110	Biosynthesis of secondary metabolites	299	1.5e-09	0.35	0.52	0.38
PGSC0003DMG200017984	K02895	ko03010	Ribosome	396	5.2e-16	0.52	0.71	0.61
PGSC0003DMG200017985	K13065	ko00940	Phenylpropanoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMG200017985	K13065	ko00941	Flavonoid biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMG200017985	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMG200017985	K13065	ko01110	Biosynthesis of secondary metabolites	272	3.6e-07	0.24	0.42	0.96
PGSC0003DMG200017986	K08334	ko04140	Regulation of autophagy	2565	1.2e-135	0.80	0.90	0.99
PGSC0003DMG200017986	K08334	ko04140	Regulation of autophagy	2737	4.0e-145	0.81	0.90	1.00
PGSC0003DMG200017986	K08334	ko04140	Regulation of autophagy	3625	4.2e-194	0.81	0.90	1.00
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	2665	3.7e-141	0.64	0.79	0.99
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	3638	8.1e-195	0.61	0.77	0.99
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	3182	1.1e-169	0.56	0.71	0.99
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	2241	9.1e-118	0.66	0.82	0.99
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMG200017987	K05391	ko04626	Plant-pathogen interaction	1733	9.5e-90	0.68	0.86	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	1919	5.2e-100	0.61	0.79	0.85
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	513	1.8e-22	0.42	0.57	0.93
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	3798	1.2e-203	0.63	0.78	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	2823	7.2e-150	0.66	0.81	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	1819	1.7e-94	0.69	0.87	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	1670	2.8e-86	0.60	0.78	0.99
PGSC0003DMG200017989	K05391	ko04626	Plant-pathogen interaction	557	6.9e-25	0.42	0.59	0.97
PGSC0003DMG200017991	K03108	ko03060	Protein export	1014	4.3e-50	0.60	0.76	0.95
PGSC0003DMG200017992	K05277	ko00941	Flavonoid biosynthesis	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMG200017992	K05277	ko01100	Metabolic pathways	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMG200017992	K05277	ko01110	Biosynthesis of secondary metabolites	335	1.2e-12	0.32	0.51	0.80
PGSC0003DMG200017997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMG200017997	K00517	ko00626	Naphthalene and anthracene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMG200017997	K00517	ko00903	Limonene and pinene degradation	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMG200017997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMG200017997	K00517	ko01110	Biosynthesis of secondary metabolites	1412	4.8e-72	0.44	0.60	0.98
PGSC0003DMG200017997	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMG200017997	K00517	ko00626	Naphthalene and anthracene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMG200017997	K00517	ko00903	Limonene and pinene degradation	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMG200017997	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMG200017997	K00517	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.55	0.69	0.95
PGSC0003DMG200028592	K00215	ko00300	Lysine biosynthesis	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMG200028592	K00215	ko01100	Metabolic pathways	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMG200028592	K00215	ko01110	Biosynthesis of secondary metabolites	783	2.4e-37	0.74	0.89	0.99
PGSC0003DMG200028592	K00215	ko00300	Lysine biosynthesis	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMG200028592	K00215	ko01100	Metabolic pathways	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMG200028592	K00215	ko01110	Biosynthesis of secondary metabolites	1643	8.7e-85	0.67	0.81	0.87
PGSC0003DMG200028593	K11232	ko04011	MAPK signaling pathway - yeast	210	9.5e-06	0.33	0.52	0.79
PGSC0003DMG200028598	K01937	ko00240	Pyrimidine metabolism	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMG200028598	K01937	ko01100	Metabolic pathways	222	7.1e-06	0.63	0.79	0.24
PGSC0003DMG200028598	K08739	ko03430	Mismatch repair	281	1.0e-08	0.65	0.87	0.74
PGSC0003DMG200028599	K01920	ko00480	Glutathione metabolism	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMG200028599	K01920	ko01100	Metabolic pathways	2926	1.5e-155	0.73	0.84	1.00
PGSC0003DMG200028599	K01920	ko00480	Glutathione metabolism	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMG200028599	K01920	ko01100	Metabolic pathways	1488	3.1e-76	0.72	0.85	0.91
PGSC0003DMG200028599	K01920	ko00480	Glutathione metabolism	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMG200028599	K01920	ko01100	Metabolic pathways	3119	3.4e-166	0.77	0.88	1.00
PGSC0003DMG200024154	K01704	ko00290	Valine, leucine and isoleucine biosynthesis	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMG200024154	K01704	ko00660	C5-Branched dibasic acid metabolism	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMG200024154	K01704	ko01100	Metabolic pathways	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMG200024154	K01704	ko01110	Biosynthesis of secondary metabolites	1430	4.9e-73	0.69	0.79	1.00
PGSC0003DMG200024161	K00492	ko00340	Histidine metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00361	gamma-Hexachlorocyclohexane degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00363	Bisphenol A degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00622	Toluene and xylene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00624	1- and 2-Methylnaphthalene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00626	Naphthalene and anthracene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00627	1,4-Dichlorobenzene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00680	Methane metabolism	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko00903	Limonene and pinene degradation	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko01100	Metabolic pathways	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00492	ko01110	Biosynthesis of secondary metabolites	285	7.0e-10	0.32	0.47	0.79
PGSC0003DMG200024161	K00480	ko00624	1- and 2-Methylnaphthalene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMG200024161	K00480	ko00626	Naphthalene and anthracene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMG200024161	K00480	ko00628	Fluorene degradation	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMG200024161	K00480	ko01100	Metabolic pathways	482	9.5e-21	0.32	0.48	0.67
PGSC0003DMG200024168	K04952	ko04740	Olfactory transduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMG200024168	K04952	ko04744	Phototransduction	366	2.5e-11	0.29	0.54	0.42
PGSC0003DMG200030802	K02981	ko03010	Ribosome	1791	6.0e-93	0.80	0.84	1.00
PGSC0003DMG200030802	K02981	ko03010	Ribosome	1285	4.9e-65	0.90	0.93	0.84
PGSC0003DMG200030804	K13030	ko00460	Cyanoamino acid metabolism	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMG200030804	K13030	ko01110	Biosynthesis of secondary metabolites	1449	4.4e-74	0.41	0.60	0.95
PGSC0003DMG200030805	K13030	ko00460	Cyanoamino acid metabolism	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMG200030805	K13030	ko01110	Biosynthesis of secondary metabolites	485	6.5e-21	0.38	0.56	0.97
PGSC0003DMG200030805	K13068	ko00940	Phenylpropanoid biosynthesis	426	1.2e-17	0.46	0.60	0.83
PGSC0003DMG200030805	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMG200030805	K12356	ko00940	Phenylpropanoid biosynthesis	501	8.5e-22	0.42	0.58	0.89
PGSC0003DMG200030806	K13030	ko00460	Cyanoamino acid metabolism	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMG200030806	K13030	ko01110	Biosynthesis of secondary metabolites	956	6.8e-47	0.34	0.48	0.88
PGSC0003DMG200030812	K01626	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMG200030812	K01626	ko01100	Metabolic pathways	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMG200030812	K01626	ko01110	Biosynthesis of secondary metabolites	3808	3.4e-204	0.82	0.89	0.99
PGSC0003DMG200030814	K06630	ko04110	Cell cycle	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMG200030814	K06630	ko04114	Oocyte meiosis	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMG200030814	K06630	ko04722	Neurotrophin signaling pathway	1942	2.8e-101	0.91	0.97	0.99
PGSC0003DMG200030815	K00121	ko00010	Glycolysis / Gluconeogenesis	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00071	Fatty acid metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00350	Tyrosine metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00641	3-Chloroacrylic acid degradation	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00680	Methane metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00830	Retinol metabolism	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko00982	Drug metabolism - cytochrome P450	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko01100	Metabolic pathways	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200030815	K00121	ko01110	Biosynthesis of secondary metabolites	1866	4.4e-97	0.72	0.86	0.94
PGSC0003DMG200031189	K08233	ko00901	Indole alkaloid biosynthesis	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMG200031189	K08233	ko01110	Biosynthesis of secondary metabolites	267	6.8e-09	0.39	0.56	0.74
PGSC0003DMG200031189	K08233	ko00901	Indole alkaloid biosynthesis	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMG200031189	K08233	ko01110	Biosynthesis of secondary metabolites	666	6.7e-31	0.39	0.59	0.73
PGSC0003DMG200031192	K01199	ko00500	Starch and sucrose metabolism	529	2.4e-23	0.35	0.58	0.59
PGSC0003DMG200031192	K01199	ko00500	Starch and sucrose metabolism	289	4.2e-10	0.37	0.64	0.54
PGSC0003DMG200042640	K02878	ko03010	Ribosome	379	4.5e-15	0.51	0.76	0.74
PGSC0003DMG200000825	K13081	ko00941	Flavonoid biosynthesis	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMG200000825	K13081	ko01110	Biosynthesis of secondary metabolites	1266	5.4e-64	0.52	0.66	0.91
PGSC0003DMG200000827	K00754	ko00051	Fructose and mannose metabolism	423	1.7e-17	0.27	0.47	0.81
PGSC0003DMG200000835	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMG200000835	K12874	ko03040	Spliceosome	2078	8.9e-109	0.66	0.74	1.00
PGSC0003DMG200000835	K12874	ko03040	Spliceosome	8844	0.	0.84	0.91	0.99
PGSC0003DMG200008317	K09647	ko03060	Protein export	837	2.5e-40	0.64	0.80	0.94
PGSC0003DMG200008317	K09647	ko03060	Protein export	863	9.2e-42	0.59	0.77	0.99
PGSC0003DMG200008322	K00703	ko00500	Starch and sucrose metabolism	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMG200008322	K00703	ko01100	Metabolic pathways	1905	3.1e-99	0.49	0.66	0.49
PGSC0003DMG200008329	K03107	ko03060	Protein export	3995	1.6e-214	0.80	0.91	0.98
PGSC0003DMG200012718	K00279	ko00908	Zeatin biosynthesis	2036	1.8e-106	0.67	0.82	0.91
PGSC0003DMG200012722	K01001	ko00510	N-Glycan biosynthesis	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMG200012722	K01001	ko01100	Metabolic pathways	2842	6.5e-151	0.79	0.89	1.00
PGSC0003DMG200012723	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMG200012723	K01142	ko03410	Base excision repair	966	1.9e-47	0.89	0.96	0.99
PGSC0003DMG200012723	K01142	ko03410	Base excision repair	808	9.9e-39	0.42	0.60	0.96
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	832	4.7e-40	0.47	0.62	0.94
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	1580	2.6e-81	0.47	0.64	0.97
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.92
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	2068	3.2e-108	0.51	0.66	0.89
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	1301	6.4e-66	0.59	0.74	0.79
PGSC0003DMG200012724	K01930	ko00790	Folate biosynthesis	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMG200012724	K01930	ko01100	Metabolic pathways	1211	5.9e-61	0.50	0.66	0.95
PGSC0003DMG200012724	K13030	ko00460	Cyanoamino acid metabolism	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMG200012724	K13030	ko01110	Biosynthesis of secondary metabolites	432	5.4e-18	0.46	0.72	0.82
PGSC0003DMG200002898	K01051	ko00040	Pentose and glucuronate interconversions	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMG200002898	K01051	ko00500	Starch and sucrose metabolism	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMG200002898	K01051	ko01100	Metabolic pathways	320	1.5e-11	0.33	0.57	0.91
PGSC0003DMG200002901	K08908	ko00196	Photosynthesis - antenna proteins	1717	7.2e-89	0.75	0.82	1.00
PGSC0003DMG200002901	K08908	ko00196	Photosynthesis - antenna proteins	1130	1.7e-56	0.81	0.88	0.99
PGSC0003DMG200002904	K02730	ko03050	Proteasome	1922	3.6e-100	0.91	0.98	1.00
PGSC0003DMG200002905	K02634	ko00195	Photosynthesis	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMG200002905	K02634	ko01100	Metabolic pathways	1245	7.8e-63	0.88	0.96	0.93
PGSC0003DMG200002913	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	464	5.4e-19	0.30	0.47	1.00
PGSC0003DMG200015744	K12338	ko00942	Anthocyanin biosynthesis	1378	3.6e-70	0.41	0.62	0.98
PGSC0003DMG200015745	K00600	ko00260	Glycine, serine and threonine metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015745	K00600	ko00460	Cyanoamino acid metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015745	K00600	ko00670	One carbon pool by folate	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015745	K00600	ko00680	Methane metabolism	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015745	K00600	ko01100	Metabolic pathways	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015745	K00600	ko01110	Biosynthesis of secondary metabolites	3781	1.0e-202	0.93	0.96	1.00
PGSC0003DMG200015746	K08679	ko00500	Starch and sucrose metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMG200015746	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMG200015746	K08679	ko01100	Metabolic pathways	2794	2.9e-148	0.75	0.88	1.00
PGSC0003DMG200015747	K11984	ko03040	Spliceosome	509	1.5e-21	0.28	0.48	0.83
PGSC0003DMG200015747	K11984	ko03040	Spliceosome	508	1.7e-21	0.30	0.51	0.78
PGSC0003DMG200015748	K04711	ko00600	Sphingolipid metabolism	1519	6.0e-78	0.69	0.78	1.00
PGSC0003DMG200015748	K04711	ko00600	Sphingolipid metabolism	1728	1.8e-89	0.76	0.87	1.00
PGSC0003DMG200015753	K10866	ko03440	Homologous recombination	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMG200015753	K10866	ko03450	Non-homologous end-joining	1807	7.9e-94	0.95	0.98	0.99
PGSC0003DMG200015753	K10866	ko03440	Homologous recombination	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMG200015753	K10866	ko03450	Non-homologous end-joining	4839	4.6e-261	0.60	0.68	1.00
PGSC0003DMG200005881	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMG200005881	K02865	ko03010	Ribosome	1642	9.9e-85	0.92	0.95	1.00
PGSC0003DMG200005881	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMG200005881	K02639	ko00195	Photosynthesis	971	1.0e-47	0.77	0.88	0.99
PGSC0003DMG200005885	K08515	ko04130	SNARE interactions in vesicular transport	1384	1.7e-70	0.83	0.92	0.86
PGSC0003DMG200005885	K08515	ko04130	SNARE interactions in vesicular transport	1595	3.9e-82	0.86	0.94	1.00
PGSC0003DMG200005886	K06443	ko00906	Carotenoid biosynthesis	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMG200005886	K06443	ko01100	Metabolic pathways	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMG200005886	K06443	ko01110	Biosynthesis of secondary metabolites	3073	1.2e-163	0.72	0.83	1.00
PGSC0003DMG200005888	K12655	ko04622	RIG-I-like receptor signaling pathway	820	2.2e-39	0.39	0.57	0.61
PGSC0003DMG200005888	K12655	ko04622	RIG-I-like receptor signaling pathway	914	1.4e-44	0.36	0.55	0.64
PGSC0003DMG200005888	K12655	ko04622	RIG-I-like receptor signaling pathway	842	1.3e-40	0.39	0.57	0.62
PGSC0003DMG200005888	K12655	ko04622	RIG-I-like receptor signaling pathway	456	2.6e-19	0.34	0.50	0.57
PGSC0003DMG200005889	K12611	ko03018	RNA degradation	577	5.5e-26	0.29	0.51	0.95
PGSC0003DMG200005891	K10352	ko04530	Tight junction	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMG200005891	K10352	ko05416	Viral myocarditis	294	7.1e-07	0.28	0.44	0.91
PGSC0003DMG200029470	K02183	ko04020	Calcium signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04070	Phosphatidylinositol signaling system	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04114	Oocyte meiosis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04270	Vascular smooth muscle contraction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04626	Plant-pathogen interaction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04720	Long-term potentiation	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04722	Neurotrophin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04740	Olfactory transduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04744	Phototransduction	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04745	Phototransduction - fly	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04910	Insulin signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04912	GnRH signaling pathway	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04916	Melanogenesis	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04970	Salivary secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko04971	Gastric acid secretion	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko05010	Alzheimer's disease	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029470	K02183	ko05214	Glioma	536	1.0e-23	0.49	0.67	0.85
PGSC0003DMG200029474	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMG200029474	K00517	ko00626	Naphthalene and anthracene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMG200029474	K00517	ko00903	Limonene and pinene degradation	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMG200029474	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMG200029474	K00517	ko01110	Biosynthesis of secondary metabolites	782	2.7e-37	0.39	0.56	0.89
PGSC0003DMG200029474	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMG200029474	K00517	ko00626	Naphthalene and anthracene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMG200029474	K00517	ko00903	Limonene and pinene degradation	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMG200029474	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMG200029474	K00517	ko01110	Biosynthesis of secondary metabolites	1731	1.2e-89	0.44	0.63	0.96
PGSC0003DMG200029474	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMG200029474	K00517	ko00626	Naphthalene and anthracene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMG200029474	K00517	ko00903	Limonene and pinene degradation	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMG200029474	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMG200029474	K00517	ko01110	Biosynthesis of secondary metabolites	906	3.9e-44	0.54	0.76	0.98
PGSC0003DMG200029476	K01199	ko00500	Starch and sucrose metabolism	733	1.4e-34	0.35	0.55	0.66
PGSC0003DMG200019592	K02894	ko03010	Ribosome	573	9.1e-26	0.93	0.96	0.97
PGSC0003DMG200019600	K04506	ko04115	p53 signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMG200019600	K04506	ko04120	Ubiquitin mediated proteolysis	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMG200019600	K04506	ko04310	Wnt signaling pathway	2443	6.6e-129	0.84	0.90	1.00
PGSC0003DMG200019601	K06268	ko04010	MAPK signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04020	Calcium signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04114	Oocyte meiosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04210	Apoptosis	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04310	Wnt signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04360	Axon guidance	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04370	VEGF signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04650	Natural killer cell mediated cytotoxicity	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04660	T cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04662	B cell receptor signaling pathway	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04720	Long-term potentiation	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko05010	Alzheimer's disease	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1131	1.5e-56	0.71	0.89	0.98
PGSC0003DMG200019601	K06268	ko04010	MAPK signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04020	Calcium signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04114	Oocyte meiosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04210	Apoptosis	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04310	Wnt signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04360	Axon guidance	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04370	VEGF signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04650	Natural killer cell mediated cytotoxicity	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04660	T cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04662	B cell receptor signaling pathway	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04720	Long-term potentiation	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko05010	Alzheimer's disease	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	651	4.5e-30	0.68	0.86	0.96
PGSC0003DMG200019601	K06268	ko04010	MAPK signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04020	Calcium signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04114	Oocyte meiosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04210	Apoptosis	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04310	Wnt signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04360	Axon guidance	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04370	VEGF signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04650	Natural killer cell mediated cytotoxicity	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04660	T cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04662	B cell receptor signaling pathway	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04720	Long-term potentiation	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko05010	Alzheimer's disease	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1218	2.4e-61	0.68	0.85	0.98
PGSC0003DMG200019601	K06268	ko04010	MAPK signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04020	Calcium signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04114	Oocyte meiosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04210	Apoptosis	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04310	Wnt signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04360	Axon guidance	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04370	VEGF signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04650	Natural killer cell mediated cytotoxicity	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04660	T cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04662	B cell receptor signaling pathway	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko04720	Long-term potentiation	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko05010	Alzheimer's disease	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019601	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1105	4.1e-55	0.67	0.84	0.99
PGSC0003DMG200019602	K07466	ko03030	DNA replication	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMG200019602	K07466	ko03420	Nucleotide excision repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMG200019602	K07466	ko03430	Mismatch repair	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMG200019602	K07466	ko03440	Homologous recombination	297	4.0e-08	0.24	0.42	0.86
PGSC0003DMG200019602	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03030	DNA replication	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03420	Nucleotide excision repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03430	Mismatch repair	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200019602	K07466	ko03440	Homologous recombination	291	9.8e-08	0.24	0.41	0.86
PGSC0003DMG200022622	K00799	ko00480	Glutathione metabolism	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMG200022622	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMG200022622	K00799	ko00982	Drug metabolism - cytochrome P450	440	2.0e-18	0.55	0.76	0.94
PGSC0003DMG200022623	K00799	ko00480	Glutathione metabolism	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMG200022623	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMG200022623	K00799	ko00982	Drug metabolism - cytochrome P450	511	2.4e-22	0.52	0.75	0.98
PGSC0003DMG200022624	K00799	ko00480	Glutathione metabolism	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMG200022624	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMG200022624	K00799	ko00982	Drug metabolism - cytochrome P450	830	6.1e-40	0.47	0.64	0.97
PGSC0003DMG200022624	K00799	ko00480	Glutathione metabolism	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMG200022624	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMG200022624	K00799	ko00982	Drug metabolism - cytochrome P450	810	7.7e-39	0.47	0.62	0.99
PGSC0003DMG200036708	K03065	ko03050	Proteasome	528	2.8e-23	0.62	0.65	0.75
PGSC0003DMG200036713	K05298	ko00710	Carbon fixation in photosynthetic organisms	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMG200036713	K05298	ko01100	Metabolic pathways	1210	6.7e-61	0.65	0.74	1.00
PGSC0003DMG200036714	K12126	ko04712	Circadian rhythm - plant	303	1.0e-10	0.27	0.44	0.95
PGSC0003DMG200029425	K01186	ko00511	Other glycan degradation	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMG200029425	K01186	ko00600	Sphingolipid metabolism	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMG200029425	K01186	ko04142	Lysosome	436	1.9e-17	0.30	0.43	0.87
PGSC0003DMG200029439	K03963	ko00190	Oxidative phosphorylation	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMG200029439	K03963	ko01100	Metabolic pathways	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMG200029439	K03963	ko05010	Alzheimer's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMG200029439	K03963	ko05012	Parkinson's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMG200029439	K03963	ko05016	Huntington's disease	717	1.0e-33	0.84	0.90	0.98
PGSC0003DMG200022703	K00919	ko00900	Terpenoid backbone biosynthesis	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMG200022703	K00919	ko01100	Metabolic pathways	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMG200022703	K00919	ko01110	Biosynthesis of secondary metabolites	2507	1.9e-132	0.77	0.86	0.94
PGSC0003DMG200022703	K00919	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMG200022703	K00919	ko01100	Metabolic pathways	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMG200022703	K00919	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.76	0.91	0.90
PGSC0003DMG200022703	K00919	ko00900	Terpenoid backbone biosynthesis	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMG200022703	K00919	ko01100	Metabolic pathways	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMG200022703	K00919	ko01110	Biosynthesis of secondary metabolites	1497	9.9e-77	0.75	0.83	0.89
PGSC0003DMG200022710	K05396	ko00270	Cysteine and methionine metabolism	362	3.9e-14	0.29	0.49	0.73
PGSC0003DMG200022713	K00423	ko00053	Ascorbate and aldarate metabolism	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMG200022713	K00423	ko01100	Metabolic pathways	2431	3.0e-128	0.54	0.68	0.98
PGSC0003DMG200022713	K00423	ko00053	Ascorbate and aldarate metabolism	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMG200022713	K00423	ko01100	Metabolic pathways	3063	4.2e-163	0.63	0.78	0.96
PGSC0003DMG200022715	K01114	ko00562	Inositol phosphate metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMG200022715	K01114	ko00564	Glycerophospholipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMG200022715	K01114	ko00565	Ether lipid metabolism	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMG200022715	K01114	ko01100	Metabolic pathways	3454	1.1e-184	0.74	0.85	1.00
PGSC0003DMG200026485	K00071	ko00140	Steroid hormone biosynthesis	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMG200026485	K00071	ko01100	Metabolic pathways	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMG200026485	K00071	ko04960	Aldosterone-regulated sodium reabsorption	952	1.1e-46	0.44	0.60	0.88
PGSC0003DMG200026491	K03087	ko05111	Vibrio cholerae pathogenic cycle	687	4.7e-32	0.40	0.64	0.95
PGSC0003DMG200012669	K10717	ko00908	Zeatin biosynthesis	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMG200012669	K10717	ko01100	Metabolic pathways	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMG200012669	K10717	ko01110	Biosynthesis of secondary metabolites	2900	4.1e-154	0.73	0.87	1.00
PGSC0003DMG200012669	K10717	ko00908	Zeatin biosynthesis	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMG200012669	K10717	ko01100	Metabolic pathways	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMG200012669	K10717	ko01110	Biosynthesis of secondary metabolites	2892	1.1e-153	0.72	0.87	1.00
PGSC0003DMG200012669	K10717	ko00908	Zeatin biosynthesis	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMG200012669	K10717	ko01100	Metabolic pathways	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMG200012669	K10717	ko01110	Biosynthesis of secondary metabolites	3134	5.1e-167	0.70	0.86	0.99
PGSC0003DMG200012669	K10717	ko00908	Zeatin biosynthesis	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMG200012669	K10717	ko01100	Metabolic pathways	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMG200012669	K10717	ko01110	Biosynthesis of secondary metabolites	2897	6.0e-154	0.73	0.87	0.99
PGSC0003DMG200012670	K00660	ko00941	Flavonoid biosynthesis	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMG200012670	K00660	ko01100	Metabolic pathways	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMG200012670	K00660	ko01110	Biosynthesis of secondary metabolites	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMG200012670	K00660	ko04712	Circadian rhythm - plant	293	6.6e-09	0.26	0.46	0.60
PGSC0003DMG200012671	K03848	ko00510	N-Glycan biosynthesis	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMG200012671	K03848	ko01100	Metabolic pathways	2563	1.6e-135	0.70	0.83	0.96
PGSC0003DMG200012671	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMG200012671	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMG200012671	K03848	ko00510	N-Glycan biosynthesis	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMG200012671	K03848	ko01100	Metabolic pathways	2969	6.4e-158	0.67	0.81	0.99
PGSC0003DMG200012671	K03848	ko00510	N-Glycan biosynthesis	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMG200012671	K03848	ko01100	Metabolic pathways	818	2.8e-39	0.70	0.78	0.87
PGSC0003DMG200012674	K01066	ko00623	2,4-Dichlorobenzoate degradation	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMG200012674	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	376	6.7e-15	0.31	0.51	0.73
PGSC0003DMG200005958	K00889	ko00562	Inositol phosphate metabolism	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko01100	Metabolic pathways	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko04070	Phosphatidylinositol signaling system	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko04144	Endocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko04666	Fc gamma R-mediated phagocytosis	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko04810	Regulation of actin cytoskeleton	4215	1.2e-226	0.60	0.72	0.97
PGSC0003DMG200005958	K00889	ko00562	Inositol phosphate metabolism	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005958	K00889	ko01100	Metabolic pathways	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005958	K00889	ko04070	Phosphatidylinositol signaling system	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005958	K00889	ko04144	Endocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005958	K00889	ko04666	Fc gamma R-mediated phagocytosis	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005958	K00889	ko04810	Regulation of actin cytoskeleton	7831	0.	0.60	0.72	0.99
PGSC0003DMG200005961	K01807	ko00030	Pentose phosphate pathway	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMG200005961	K01807	ko00710	Carbon fixation in photosynthetic organisms	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMG200005961	K01807	ko01100	Metabolic pathways	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMG200005961	K01807	ko01110	Biosynthesis of secondary metabolites	1702	4.9e-88	0.78	0.87	1.00
PGSC0003DMG200009742	K11866	ko04144	Endocytosis	1149	1.5e-57	0.62	0.76	0.94
PGSC0003DMG200009742	K11866	ko04144	Endocytosis	935	9.8e-46	0.54	0.65	0.93
PGSC0003DMG200009742	K11866	ko04144	Endocytosis	432	5.4e-18	0.69	0.78	0.99
PGSC0003DMG200009744	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMG200009744	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.89
PGSC0003DMG200009744	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko00051	Fructose and mannose metabolism	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko01100	Metabolic pathways	277	1.9e-09	0.31	0.46	0.73
PGSC0003DMG200009744	K00846	ko00051	Fructose and mannose metabolism	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMG200009744	K00846	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.44	0.54
PGSC0003DMG200009744	K00847	ko00051	Fructose and mannose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMG200009744	K00847	ko00500	Starch and sucrose metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMG200009744	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMG200009744	K00847	ko01100	Metabolic pathways	213	6.5e-06	0.34	0.51	0.92
PGSC0003DMG200009750	K05849	ko04020	Calcium signaling pathway	312	9.2e-11	0.36	0.54	0.60
PGSC0003DMG200000726	K03941	ko00190	Oxidative phosphorylation	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMG200000726	K03941	ko01100	Metabolic pathways	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMG200000726	K03941	ko05010	Alzheimer's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMG200000726	K03941	ko05012	Parkinson's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMG200000726	K03941	ko05016	Huntington's disease	1657	1.5e-85	0.87	0.91	0.99
PGSC0003DMG200000732	K01055	ko00362	Benzoate degradation via hydroxylation	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMG200000732	K01055	ko01100	Metabolic pathways	222	2.1e-06	0.28	0.45	0.82
PGSC0003DMG200000733	K08486	ko04130	SNARE interactions in vesicular transport	1400	2.2e-71	0.59	0.79	0.99
PGSC0003DMG200000735	K00975	ko00500	Starch and sucrose metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMG200000735	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMG200000735	K00975	ko01100	Metabolic pathways	3299	4.0e-176	0.74	0.85	1.00
PGSC0003DMG200000735	K00975	ko00500	Starch and sucrose metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMG200000735	K00975	ko00520	Amino sugar and nucleotide sugar metabolism	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMG200000735	K00975	ko01100	Metabolic pathways	2444	5.8e-129	0.74	0.87	0.87
PGSC0003DMG200000736	K00560	ko00240	Pyrimidine metabolism	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMG200000736	K00560	ko00670	One carbon pool by folate	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMG200000736	K00560	ko01100	Metabolic pathways	3464	3.2e-185	0.78	0.89	0.96
PGSC0003DMG200000736	K00560	ko00240	Pyrimidine metabolism	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMG200000736	K00560	ko00670	One carbon pool by folate	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMG200000736	K00560	ko01100	Metabolic pathways	518	9.8e-23	0.63	0.80	0.85
PGSC0003DMG200000737	K01586	ko00300	Lysine biosynthesis	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMG200000737	K01586	ko01100	Metabolic pathways	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMG200000737	K01586	ko01110	Biosynthesis of secondary metabolites	3442	5.2e-184	0.83	0.91	1.00
PGSC0003DMG200000740	K05391	ko04626	Plant-pathogen interaction	1253	2.8e-63	0.83	0.89	0.92
PGSC0003DMG200000740	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMG200000741	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMG200000741	K00517	ko00626	Naphthalene and anthracene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMG200000741	K00517	ko00903	Limonene and pinene degradation	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMG200000741	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMG200000741	K00517	ko01110	Biosynthesis of secondary metabolites	1721	4.4e-89	0.47	0.65	0.99
PGSC0003DMG200042147	K10760	ko00908	Zeatin biosynthesis	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMG200042147	K10760	ko01100	Metabolic pathways	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMG200042147	K10760	ko01110	Biosynthesis of secondary metabolites	498	1.2e-21	0.42	0.59	0.99
PGSC0003DMG200046796	K04427	ko04010	MAPK signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04310	Wnt signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04520	Adherens junction	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04620	Toll-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04621	NOD-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04622	RIG-I-like receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko04660	T cell receptor signaling pathway	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046796	K04427	ko05140	Leishmaniasis	386	1.9e-15	0.33	0.44	0.62
PGSC0003DMG200046805	K05282	ko00904	Diterpenoid biosynthesis	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMG200046805	K05282	ko01100	Metabolic pathways	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMG200046805	K05282	ko01110	Biosynthesis of secondary metabolites	375	7.6e-15	0.49	0.63	0.79
PGSC0003DMG200024053	K00430	ko00360	Phenylalanine metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMG200024053	K00430	ko00680	Methane metabolism	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMG200024053	K00430	ko00940	Phenylpropanoid biosynthesis	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMG200024053	K00430	ko01100	Metabolic pathways	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMG200024053	K00430	ko01110	Biosynthesis of secondary metabolites	1627	6.7e-84	0.65	0.79	0.93
PGSC0003DMG200024059	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMG200024059	K12184	ko04144	Endocytosis	1543	2.9e-79	0.87	0.95	1.00
PGSC0003DMG200024063	K02291	ko00906	Carotenoid biosynthesis	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMG200024063	K02291	ko01100	Metabolic pathways	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMG200024063	K02291	ko01110	Biosynthesis of secondary metabolites	2501	4.1e-132	0.71	0.80	0.99
PGSC0003DMG200024063	K02291	ko00906	Carotenoid biosynthesis	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMG200024063	K02291	ko01100	Metabolic pathways	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMG200024063	K02291	ko01110	Biosynthesis of secondary metabolites	2695	8.3e-143	0.74	0.84	1.00
PGSC0003DMG200030851	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMG200030851	K01358	ko04112	Cell cycle - Caulobacter	892	2.3e-43	0.45	0.63	0.91
PGSC0003DMG200030860	K07466	ko03030	DNA replication	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMG200030860	K07466	ko03420	Nucleotide excision repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMG200030860	K07466	ko03430	Mismatch repair	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMG200030860	K07466	ko03440	Homologous recombination	460	1.5e-19	0.40	0.57	0.63
PGSC0003DMG200030860	K07466	ko03030	DNA replication	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMG200030860	K07466	ko03420	Nucleotide excision repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMG200030860	K07466	ko03430	Mismatch repair	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMG200030860	K07466	ko03440	Homologous recombination	3358	2.2e-179	0.51	0.68	0.94
PGSC0003DMG200025005	K00059	ko00061	Fatty acid biosynthesis	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMG200025005	K00059	ko01040	Biosynthesis of unsaturated fatty acids	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMG200025005	K00059	ko01100	Metabolic pathways	687	4.7e-32	0.64	0.79	0.99
PGSC0003DMG200025007	K00218	ko00860	Porphyrin and chlorophyll metabolism	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMG200025007	K00218	ko01100	Metabolic pathways	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMG200025007	K00218	ko01110	Biosynthesis of secondary metabolites	2423	8.3e-128	0.73	0.83	0.99
PGSC0003DMG200025010	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3119	3.4e-166	0.76	0.84	0.98
PGSC0003DMG200025010	K01889	ko00970	Aminoacyl-tRNA biosynthesis	3534	4.4e-189	0.83	0.92	0.98
PGSC0003DMG200025012	K11251	ko05322	Systemic lupus erythematosus	1045	8.4e-52	0.98	0.98	0.99
PGSC0003DMG200025013	K02895	ko03010	Ribosome	1088	3.6e-54	0.57	0.65	1.00
PGSC0003DMG200025013	K02895	ko03010	Ribosome	1223	1.3e-61	0.77	0.88	0.99
PGSC0003DMG200021805	K13082	ko00941	Flavonoid biosynthesis	827	8.9e-40	0.41	0.61	0.97
PGSC0003DMG200021806	K11251	ko05322	Systemic lupus erythematosus	505	5.1e-22	0.98	0.98	0.78
PGSC0003DMG200021806	K11251	ko05322	Systemic lupus erythematosus	1026	9.4e-51	0.96	0.97	0.99
PGSC0003DMG200021809	K11228	ko04011	MAPK signaling pathway - yeast	317	5.7e-11	0.30	0.47	0.77
PGSC0003DMG200021810	K13082	ko00941	Flavonoid biosynthesis	823	1.5e-39	0.41	0.61	0.97
PGSC0003DMG200021810	K03083	ko04012	ErbB signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04062	Chemokine signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04110	Cell cycle	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04310	Wnt signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04340	Hedgehog signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04360	Axon guidance	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04510	Focal adhesion	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04660	T cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04662	B cell receptor signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04711	Circadian rhythm - fly	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04722	Neurotrophin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko04916	Melanogenesis	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05010	Alzheimer's disease	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05200	Pathways in cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05210	Colorectal cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05213	Endometrial cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05215	Prostate cancer	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K03083	ko05217	Basal cell carcinoma	228	9.7e-07	0.41	0.62	0.36
PGSC0003DMG200021810	K13082	ko00941	Flavonoid biosynthesis	1017	2.9e-50	0.42	0.62	0.97
PGSC0003DMG200021811	K11294	ko05130	Pathogenic Escherichia coli infection	239	3.5e-07	0.36	0.55	0.68
PGSC0003DMG200021812	K02938	ko03010	Ribosome	2196	2.8e-115	0.96	0.99	0.99
PGSC0003DMG200021813	K11866	ko04144	Endocytosis	459	9.1e-19	0.28	0.43	0.85
PGSC0003DMG200021813	K11866	ko04144	Endocytosis	481	5.2e-20	0.29	0.43	0.90
PGSC0003DMG200021814	K08099	ko00860	Porphyrin and chlorophyll metabolism	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMG200021814	K08099	ko01100	Metabolic pathways	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMG200021814	K08099	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.42	0.56	0.86
PGSC0003DMG200031136	K04713	ko00600	Sphingolipid metabolism	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMG200031136	K04713	ko01100	Metabolic pathways	865	7.1e-42	0.45	0.61	0.86
PGSC0003DMG200031148	K00212	ko00980	Metabolism of xenobiotics by cytochrome P450	460	1.5e-19	0.32	0.47	0.94
PGSC0003DMG200014442	K09755	ko00940	Phenylpropanoid biosynthesis	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMG200014442	K09755	ko01100	Metabolic pathways	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMG200014442	K09755	ko01110	Biosynthesis of secondary metabolites	1472	2.4e-75	0.39	0.61	0.98
PGSC0003DMG200014442	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMG200014442	K00517	ko00626	Naphthalene and anthracene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMG200014442	K00517	ko00903	Limonene and pinene degradation	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMG200014442	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMG200014442	K00517	ko01110	Biosynthesis of secondary metabolites	737	8.2e-35	0.36	0.60	0.95
PGSC0003DMG200014450	K12489	ko04144	Endocytosis	3346	1.0e-178	0.56	0.67	0.96
PGSC0003DMG200014450	K12489	ko04144	Endocytosis	1727	2.0e-89	0.62	0.72	0.99
PGSC0003DMG200014450	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMG200014450	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMG200014450	K12489	ko04144	Endocytosis	905	4.4e-44	0.50	0.63	0.97
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1238	1.9e-62	0.91	0.93	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	970	1.2e-47	0.76	0.82	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200014451	K02949	ko03010	Ribosome	1282	7.1e-65	0.93	0.95	0.99
PGSC0003DMG200014454	K01915	ko00250	Alanine, aspartate and glutamate metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMG200014454	K01915	ko00330	Arginine and proline metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMG200014454	K01915	ko00910	Nitrogen metabolism	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMG200014454	K01915	ko01100	Metabolic pathways	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMG200014454	K01915	ko02020	Two-component system	2348	1.1e-123	0.82	0.90	1.00
PGSC0003DMG200006876	K01136	ko00531	Glycosaminoglycan degradation	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMG200006876	K01136	ko01100	Metabolic pathways	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMG200006876	K01136	ko04142	Lysosome	250	2.7e-07	0.26	0.44	0.94
PGSC0003DMG200006877	K12867	ko03040	Spliceosome	6303	0.	0.81	0.89	1.00
PGSC0003DMG200006896	K05862	ko04020	Calcium signaling pathway	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMG200006896	K05862	ko05012	Parkinson's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMG200006896	K05862	ko05016	Huntington's disease	1906	2.7e-99	0.79	0.93	1.00
PGSC0003DMG200006899	K00472	ko00330	Arginine and proline metabolism	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMG200006899	K00472	ko01100	Metabolic pathways	1610	5.8e-83	0.72	0.86	1.00
PGSC0003DMG200006899	K00472	ko00330	Arginine and proline metabolism	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMG200006899	K00472	ko01100	Metabolic pathways	1076	1.6e-53	0.66	0.80	0.91
PGSC0003DMG200003686	K10955	ko05110	Vibrio cholerae infection	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMG200003686	K10955	ko05146	Amoebiasis	613	2.7e-26	0.31	0.44	0.58
PGSC0003DMG200003687	K01051	ko00040	Pentose and glucuronate interconversions	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMG200003687	K01051	ko00500	Starch and sucrose metabolism	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMG200003687	K01051	ko01100	Metabolic pathways	865	7.1e-42	0.43	0.56	0.81
PGSC0003DMG200003690	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00364	Fluorobenzoate degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00628	Fluorene degradation	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00640	Propanoate metabolism	1735	7.4e-90	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMG200003690	K00224	ko00364	Fluorobenzoate degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMG200003690	K00224	ko00628	Fluorene degradation	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMG200003690	K00224	ko00640	Propanoate metabolism	1469	3.5e-75	0.74	0.85	0.88
PGSC0003DMG200003690	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMG200003690	K00224	ko00364	Fluorobenzoate degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMG200003690	K00224	ko00628	Fluorene degradation	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMG200003690	K00224	ko00640	Propanoate metabolism	720	7.1e-34	0.69	0.78	0.79
PGSC0003DMG200003690	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMG200003690	K00224	ko00364	Fluorobenzoate degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMG200003690	K00224	ko00628	Fluorene degradation	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMG200003690	K00224	ko00640	Propanoate metabolism	327	3.4e-12	0.73	0.88	0.96
PGSC0003DMG200003690	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00364	Fluorobenzoate degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00628	Fluorene degradation	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMG200003690	K00224	ko00640	Propanoate metabolism	1726	2.3e-89	0.69	0.81	0.99
PGSC0003DMG200003691	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00364	Fluorobenzoate degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00628	Fluorene degradation	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00640	Propanoate metabolism	1790	6.8e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMG200003691	K00224	ko00364	Fluorobenzoate degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMG200003691	K00224	ko00628	Fluorene degradation	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMG200003691	K00224	ko00640	Propanoate metabolism	1777	3.6e-92	0.70	0.82	0.97
PGSC0003DMG200003691	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00364	Fluorobenzoate degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00628	Fluorene degradation	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00640	Propanoate metabolism	1791	6.0e-93	0.69	0.82	0.99
PGSC0003DMG200003691	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMG200003691	K00224	ko00364	Fluorobenzoate degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMG200003691	K00224	ko00628	Fluorene degradation	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMG200003691	K00224	ko00640	Propanoate metabolism	1073	2.4e-53	0.68	0.79	0.98
PGSC0003DMG200003692	K00680	ko00350	Tyrosine metabolism	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMG200003692	K00680	ko00624	1- and 2-Methylnaphthalene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMG200003692	K00680	ko00632	Benzoate degradation via CoA ligation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMG200003692	K00680	ko00642	Ethylbenzene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMG200003692	K00680	ko00903	Limonene and pinene degradation	547	2.5e-24	0.42	0.63	0.64
PGSC0003DMG200003693	K00847	ko00051	Fructose and mannose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMG200003693	K00847	ko00500	Starch and sucrose metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMG200003693	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMG200003693	K00847	ko01100	Metabolic pathways	453	3.8e-19	0.33	0.52	0.75
PGSC0003DMG200003696	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.72
PGSC0003DMG200003696	K02909	ko03010	Ribosome	376	6.7e-15	0.53	0.69	0.87
PGSC0003DMG200003698	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMG200003698	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMG200003698	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.33	0.46	0.92
PGSC0003DMG200003698	K10572	ko00562	Inositol phosphate metabolism	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMG200003698	K10572	ko01100	Metabolic pathways	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMG200003698	K10572	ko04070	Phosphatidylinositol signaling system	660	1.4e-30	0.32	0.47	0.99
PGSC0003DMG200003698	K10572	ko00562	Inositol phosphate metabolism	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko01100	Metabolic pathways	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko04070	Phosphatidylinositol signaling system	568	1.7e-25	0.32	0.46	0.94
PGSC0003DMG200003698	K10572	ko00562	Inositol phosphate metabolism	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMG200003698	K10572	ko01100	Metabolic pathways	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMG200003698	K10572	ko04070	Phosphatidylinositol signaling system	518	9.8e-23	0.34	0.46	0.92
PGSC0003DMG200003700	K04371	ko04010	MAPK signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04012	ErbB signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04013	MAPK signaling pathway - fly	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04062	Chemokine signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04114	Oocyte meiosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04150	mTOR signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04270	Vascular smooth muscle contraction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04320	Dorso-ventral axis formation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04350	TGF-beta signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04360	Axon guidance	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04370	VEGF signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04510	Focal adhesion	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04520	Adherens junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04540	Gap junction	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04620	Toll-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04621	NOD-like receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04650	Natural killer cell mediated cytotoxicity	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04660	T cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04662	B cell receptor signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04664	Fc epsilon RI signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04666	Fc gamma R-mediated phagocytosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04720	Long-term potentiation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04722	Neurotrophin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04730	Long-term depression	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04810	Regulation of actin cytoskeleton	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04910	Insulin signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04912	GnRH signaling pathway	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04914	Progesterone-mediated oocyte maturation	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04916	Melanogenesis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04930	Type II diabetes mellitus	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko04960	Aldosterone-regulated sodium reabsorption	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05010	Alzheimer's disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05020	Prion diseases	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05131	Shigellosis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05140	Leishmaniasis	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05142	Chagas disease	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05200	Pathways in cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05210	Colorectal cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05211	Renal cell carcinoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05212	Pancreatic cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05213	Endometrial cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05214	Glioma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05215	Prostate cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05216	Thyroid cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05218	Melanoma	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05219	Bladder cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05220	Chronic myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05221	Acute myeloid leukemia	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200003700	K04371	ko05223	Non-small cell lung cancer	2929	1.0e-155	0.92	0.96	0.98
PGSC0003DMG200038824	K10773	ko03410	Base excision repair	1542	3.2e-79	0.32	0.46	0.82
PGSC0003DMG200021104	K06093	ko04144	Endocytosis	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMG200021104	K06093	ko04530	Tight junction	241	8.2e-07	0.34	0.47	0.43
PGSC0003DMG200024389	K02152	ko00190	Oxidative phosphorylation	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024389	K02152	ko01100	Metabolic pathways	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024389	K02152	ko04145	Phagosome	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024389	K02152	ko04966	Collecting duct acid secretion	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024389	K02152	ko05110	Vibrio cholerae infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024389	K02152	ko05120	Epithelial cell signaling in Helicobacter pylori infection	689	3.6e-32	0.78	0.89	0.99
PGSC0003DMG200024392	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMG200024392	K01736	ko01100	Metabolic pathways	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMG200024392	K01736	ko01110	Biosynthesis of secondary metabolites	3042	6.0e-162	0.82	0.90	0.99
PGSC0003DMG200032246	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko00562	Inositol phosphate metabolism	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko01100	Metabolic pathways	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032246	K01099	ko04070	Phosphatidylinositol signaling system	695	3.3e-42	0.38	0.58	0.53
PGSC0003DMG200032248	K02734	ko03050	Proteasome	1533	1.0e-78	0.87	0.94	0.99
PGSC0003DMG200032256	K01371	ko04142	Lysosome	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMG200032256	K01371	ko04620	Toll-like receptor signaling pathway	232	5.8e-07	0.46	0.61	0.83
PGSC0003DMG200001531	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1479	9.7e-76	0.67	0.80	0.91
PGSC0003DMG200040020	K01087	ko00500	Starch and sucrose metabolism	1190	8.4e-60	0.54	0.70	0.98
PGSC0003DMG200040021	K12338	ko00942	Anthocyanin biosynthesis	910	2.3e-44	0.46	0.65	0.96
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	383	2.7e-15	0.45	0.69	0.87
PGSC0003DMG200006579	K05275	ko00750	Vitamin B6 metabolism	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMG200006579	K05275	ko01100	Metabolic pathways	284	7.9e-10	0.62	0.76	0.98
PGSC0003DMG200006579	K05275	ko00750	Vitamin B6 metabolism	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMG200006579	K05275	ko01100	Metabolic pathways	460	1.5e-19	0.48	0.67	0.84
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	733	1.4e-34	0.48	0.67	0.96
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K05275	ko00750	Vitamin B6 metabolism	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMG200006579	K05275	ko01100	Metabolic pathways	696	1.5e-32	0.49	0.68	0.93
PGSC0003DMG200006579	K00100	ko00051	Fructose and mannose metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00363	Bisphenol A degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00591	Linoleic acid metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00625	Tetrachloroethene degradation	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko00650	Butanoate metabolism	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K00100	ko01100	Metabolic pathways	428	9.0e-18	0.51	0.71	0.96
PGSC0003DMG200006579	K05275	ko00750	Vitamin B6 metabolism	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMG200006579	K05275	ko01100	Metabolic pathways	286	6.1e-10	0.62	0.76	0.98
PGSC0003DMG200013411	K08912	ko00196	Photosynthesis - antenna proteins	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMG200013411	K08912	ko01100	Metabolic pathways	2003	1.2e-104	0.89	0.94	1.00
PGSC0003DMG200013412	K08912	ko00196	Photosynthesis - antenna proteins	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMG200013412	K08912	ko01100	Metabolic pathways	1981	2.0e-103	0.88	0.93	1.00
PGSC0003DMG200013413	K08912	ko00196	Photosynthesis - antenna proteins	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMG200013413	K08912	ko01100	Metabolic pathways	1287	3.8e-65	0.65	0.69	0.99
PGSC0003DMG200013413	K08912	ko00196	Photosynthesis - antenna proteins	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMG200013413	K08912	ko01100	Metabolic pathways	1259	1.3e-63	0.93	0.95	0.99
PGSC0003DMG200013414	K08912	ko00196	Photosynthesis - antenna proteins	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMG200013414	K08912	ko01100	Metabolic pathways	2045	5.9e-107	0.90	0.93	1.00
PGSC0003DMG200013415	K08912	ko00196	Photosynthesis - antenna proteins	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMG200013415	K08912	ko01100	Metabolic pathways	2019	1.6e-105	0.90	0.94	1.00
PGSC0003DMG200013416	K08912	ko00196	Photosynthesis - antenna proteins	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMG200013416	K08912	ko01100	Metabolic pathways	1998	2.3e-104	0.89	0.94	1.00
PGSC0003DMG200013417	K08912	ko00196	Photosynthesis - antenna proteins	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMG200013417	K08912	ko01100	Metabolic pathways	2041	9.8e-107	0.89	0.94	1.00
PGSC0003DMG200013418	K08912	ko00196	Photosynthesis - antenna proteins	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMG200013418	K08912	ko01100	Metabolic pathways	757	6.4e-36	0.90	0.92	0.99
PGSC0003DMG200013418	K08912	ko00196	Photosynthesis - antenna proteins	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMG200013418	K08912	ko01100	Metabolic pathways	769	1.4e-36	0.92	0.94	0.99
PGSC0003DMG200013418	K08912	ko00196	Photosynthesis - antenna proteins	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMG200013418	K08912	ko01100	Metabolic pathways	970	1.2e-47	0.86	0.92	0.99
PGSC0003DMG200013419	K07441	ko00510	N-Glycan biosynthesis	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMG200013419	K07441	ko01100	Metabolic pathways	1034	3.4e-51	0.59	0.70	0.99
PGSC0003DMG200013419	K07441	ko00510	N-Glycan biosynthesis	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMG200013419	K07441	ko01100	Metabolic pathways	901	7.4e-44	0.90	0.97	0.99
PGSC0003DMG200013419	K07441	ko00510	N-Glycan biosynthesis	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMG200013419	K07441	ko01100	Metabolic pathways	923	4.5e-45	0.86	0.94	0.91
PGSC0003DMG200013419	K07441	ko00510	N-Glycan biosynthesis	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMG200013419	K07441	ko01100	Metabolic pathways	1401	1.9e-71	0.75	0.88	0.99
PGSC0003DMG200013420	K05658	ko02010	ABC transporters	6882	0.	0.67	0.83	1.00
PGSC0003DMG200013421	K03259	ko04150	mTOR signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMG200013421	K03259	ko04910	Insulin signaling pathway	1369	1.1e-69	0.74	0.87	0.88
PGSC0003DMG200013421	K03259	ko04150	mTOR signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMG200013421	K03259	ko04910	Insulin signaling pathway	374	8.6e-15	0.59	0.67	0.85
PGSC0003DMG200013424	K00599	ko00340	Histidine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMG200013424	K00599	ko00350	Tyrosine metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMG200013424	K00599	ko00450	Selenoamino acid metabolism	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMG200013424	K00599	ko00626	Naphthalene and anthracene degradation	2022	1.1e-105	0.54	0.64	0.94
PGSC0003DMG200013424	K00599	ko00340	Histidine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMG200013424	K00599	ko00350	Tyrosine metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMG200013424	K00599	ko00450	Selenoamino acid metabolism	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMG200013424	K00599	ko00626	Naphthalene and anthracene degradation	2386	9.1e-126	0.70	0.82	0.96
PGSC0003DMG200013721	K06685	ko04111	Cell cycle - yeast	536	3.5e-20	0.25	0.42	0.82
PGSC0003DMG200013725	K02140	ko00190	Oxidative phosphorylation	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMG200013725	K02140	ko01100	Metabolic pathways	869	4.3e-42	0.83	0.90	0.99
PGSC0003DMG200013729	K11247	ko04144	Endocytosis	1697	9.2e-88	0.58	0.76	0.99
PGSC0003DMG200013729	K11247	ko04144	Endocytosis	1070	3.5e-53	0.59	0.76	0.98
PGSC0003DMG200013729	K11247	ko04144	Endocytosis	578	4.8e-26	0.53	0.74	0.81
PGSC0003DMG200013731	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200004374	K08517	ko04130	SNARE interactions in vesicular transport	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMG200004374	K08517	ko04145	Phagosome	1470	3.0e-75	0.91	0.95	0.77
PGSC0003DMG200004374	K08517	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMG200004374	K08517	ko04145	Phagosome	1668	3.6e-86	0.90	0.94	1.00
PGSC0003DMG200004383	K12349	ko00600	Sphingolipid metabolism	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMG200004383	K12349	ko01100	Metabolic pathways	3082	3.7e-164	0.53	0.68	0.97
PGSC0003DMG200004391	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	541	5.3e-24	0.63	0.74	0.80
PGSC0003DMG200004392	K05033	ko02010	ABC transporters	684	4.7e-31	0.54	0.75	0.89
PGSC0003DMG200004392	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMG200004392	K05665	ko02010	ABC transporters	1643	8.7e-85	0.36	0.55	0.84
PGSC0003DMG200007571	K02695	ko00195	Photosynthesis	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMG200007571	K02695	ko01100	Metabolic pathways	954	8.8e-47	0.79	0.88	0.99
PGSC0003DMG200007572	K00058	ko00260	Glycine, serine and threonine metabolism	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMG200007572	K00058	ko01100	Metabolic pathways	1057	1.8e-52	0.48	0.65	0.94
PGSC0003DMG200007572	K00100	ko00051	Fructose and mannose metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007572	K00100	ko00363	Bisphenol A degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007572	K00100	ko00591	Linoleic acid metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007572	K00100	ko00625	Tetrachloroethene degradation	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007572	K00100	ko00650	Butanoate metabolism	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007572	K00100	ko01100	Metabolic pathways	682	8.8e-32	0.51	0.68	0.87
PGSC0003DMG200007573	K00058	ko00260	Glycine, serine and threonine metabolism	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMG200007573	K00058	ko01100	Metabolic pathways	1027	8.3e-51	0.49	0.65	0.93
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04115	p53 signaling pathway	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko04210	Apoptosis	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05010	Alzheimer's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05012	Parkinson's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05016	Huntington's disease	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200007575	K02084	ko05222	Small cell lung cancer	295	5.7e-07	0.30	0.47	0.36
PGSC0003DMG200030112	K01590	ko00340	Histidine metabolism	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMG200030112	K01590	ko01100	Metabolic pathways	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMG200030112	K01590	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.56	0.74	0.93
PGSC0003DMG200030115	K02087	ko04110	Cell cycle	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMG200030115	K02087	ko04114	Oocyte meiosis	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMG200030115	K02087	ko04115	p53 signaling pathway	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMG200030115	K02087	ko04540	Gap junction	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMG200030115	K02087	ko04914	Progesterone-mediated oocyte maturation	1666	4.7e-86	0.73	0.79	0.94
PGSC0003DMG200030115	K02087	ko04110	Cell cycle	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMG200030115	K02087	ko04114	Oocyte meiosis	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMG200030115	K02087	ko04115	p53 signaling pathway	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMG200030115	K02087	ko04540	Gap junction	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMG200030115	K02087	ko04914	Progesterone-mediated oocyte maturation	2213	3.2e-116	0.87	0.94	1.00
PGSC0003DMG200030121	K00029	ko00620	Pyruvate metabolism	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMG200030121	K00029	ko00710	Carbon fixation in photosynthetic organisms	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMG200030121	K00029	ko01100	Metabolic pathways	4258	5.1e-229	0.84	0.95	1.00
PGSC0003DMG200027156	K00382	ko00010	Glycolysis / Gluconeogenesis	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko00020	Citrate cycle (TCA cycle)	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko00260	Glycine, serine and threonine metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko00280	Valine, leucine and isoleucine degradation	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko00620	Pyruvate metabolism	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko01100	Metabolic pathways	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027156	K00382	ko01110	Biosynthesis of secondary metabolites	3664	3.0e-196	0.86	0.93	1.00
PGSC0003DMG200027161	K02905	ko03010	Ribosome	469	4.9e-20	0.87	0.95	0.98
PGSC0003DMG200027163	K12356	ko00940	Phenylpropanoid biosynthesis	510	2.7e-22	0.44	0.60	0.91
PGSC0003DMG200027165	K04077	ko03018	RNA degradation	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMG200027165	K04077	ko04940	Type I diabetes mellitus	4242	3.9e-228	0.90	0.96	1.00
PGSC0003DMG200027165	K00878	ko00730	Thiamine metabolism	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMG200027165	K00878	ko01100	Metabolic pathways	471	3.8e-20	0.71	0.88	0.99
PGSC0003DMG200027166	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMG200027166	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMG200027166	K00771	ko01100	Metabolic pathways	414	2.2e-16	0.31	0.50	0.67
PGSC0003DMG200027166	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMG200027166	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMG200027166	K00771	ko01100	Metabolic pathways	265	4.8e-08	0.34	0.55	0.59
PGSC0003DMG200027168	K00368	ko00910	Nitrogen metabolism	1934	7.8e-101	0.48	0.62	0.89
PGSC0003DMG200027172	K01510	ko00230	Purine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMG200027172	K01510	ko00240	Pyrimidine metabolism	658	1.9e-30	0.29	0.47	0.68
PGSC0003DMG200027173	K04646	ko04142	Lysosome	10939	0.	0.79	0.82	1.00
PGSC0003DMG200027173	K04646	ko04144	Endocytosis	10939	0.	0.79	0.82	1.00
PGSC0003DMG200027173	K04646	ko05016	Huntington's disease	10939	0.	0.79	0.82	1.00
PGSC0003DMG200027173	K04646	ko05100	Bacterial invasion of epithelial cells	10939	0.	0.79	0.82	1.00
PGSC0003DMG200027173	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMG200027173	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMG200027173	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMG200027173	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMG200027175	K01179	ko00500	Starch and sucrose metabolism	1723	3.4e-89	0.47	0.65	0.97
PGSC0003DMG200023446	K00166	ko00280	Valine, leucine and isoleucine degradation	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMG200023446	K00166	ko01100	Metabolic pathways	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMG200023446	K00166	ko01110	Biosynthesis of secondary metabolites	1455	2.0e-74	0.75	0.87	0.99
PGSC0003DMG200023446	K00166	ko00280	Valine, leucine and isoleucine degradation	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMG200023446	K00166	ko01100	Metabolic pathways	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMG200023446	K00166	ko01110	Biosynthesis of secondary metabolites	2762	1.7e-146	0.68	0.81	1.00
PGSC0003DMG200023454	K02160	ko00061	Fatty acid biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023454	K02160	ko00253	Tetracycline biosynthesis	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023454	K02160	ko00620	Pyruvate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023454	K02160	ko00640	Propanoate metabolism	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023454	K02160	ko01100	Metabolic pathways	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023454	K02160	ko01110	Biosynthesis of secondary metabolites	1244	8.9e-63	0.58	0.67	1.00
PGSC0003DMG200023456	K03955	ko00190	Oxidative phosphorylation	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMG200023456	K03955	ko01100	Metabolic pathways	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMG200023456	K03955	ko05010	Alzheimer's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMG200023456	K03955	ko05012	Parkinson's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMG200023456	K03955	ko05016	Huntington's disease	771	1.1e-36	0.75	0.83	0.99
PGSC0003DMG200023456	K03955	ko00190	Oxidative phosphorylation	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMG200023456	K03955	ko01100	Metabolic pathways	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMG200023456	K03955	ko05010	Alzheimer's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMG200023456	K03955	ko05012	Parkinson's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMG200023456	K03955	ko05016	Huntington's disease	449	6.3e-19	0.90	0.97	0.87
PGSC0003DMG200018674	K05868	ko04110	Cell cycle	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMG200018674	K05868	ko04115	p53 signaling pathway	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMG200018674	K05868	ko04914	Progesterone-mediated oocyte maturation	1606	9.6e-83	0.81	0.91	0.98
PGSC0003DMG200018679	K00021	ko00900	Terpenoid backbone biosynthesis	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMG200018679	K00021	ko01100	Metabolic pathways	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMG200018679	K00021	ko01110	Biosynthesis of secondary metabolites	3481	3.7e-186	0.71	0.84	1.00
PGSC0003DMG200018685	K10802	ko03410	Base excision repair	684	6.8e-32	0.72	0.82	0.68
PGSC0003DMG200018685	K10802	ko03410	Base excision repair	819	2.5e-39	0.70	0.79	0.99
PGSC0003DMG200018687	K00588	ko00360	Phenylalanine metabolism	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018687	K00588	ko00940	Phenylpropanoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018687	K00588	ko00941	Flavonoid biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018687	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018687	K00588	ko01100	Metabolic pathways	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018687	K00588	ko01110	Biosynthesis of secondary metabolites	631	5.7e-29	0.56	0.77	0.99
PGSC0003DMG200018688	K00588	ko00360	Phenylalanine metabolism	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200018688	K00588	ko00940	Phenylpropanoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200018688	K00588	ko00941	Flavonoid biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200018688	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200018688	K00588	ko01100	Metabolic pathways	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200018688	K00588	ko01110	Biosynthesis of secondary metabolites	608	1.1e-27	0.54	0.77	0.99
PGSC0003DMG200040951	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	273	3.2e-09	0.53	0.72	0.70
PGSC0003DMG200012001	K05681	ko02010	ABC transporters	888	1.0e-44	0.34	0.53	0.48
PGSC0003DMG200012002	K00634	ko00650	Butanoate metabolism	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMG200012002	K00634	ko01100	Metabolic pathways	317	1.2e-11	0.34	0.53	0.88
PGSC0003DMG200012007	K06626	ko04110	Cell cycle	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K06626	ko04114	Oocyte meiosis	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K06626	ko04115	p53 signaling pathway	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K06626	ko05200	Pathways in cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K06626	ko05215	Prostate cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K06626	ko05222	Small cell lung cancer	270	4.7e-09	0.31	0.48	0.63
PGSC0003DMG200012007	K02220	ko04111	Cell cycle - yeast	291	3.9e-10	0.34	0.55	0.47
PGSC0003DMG200012010	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMG200012010	K11424	ko00310	Lysine degradation	372	2.1e-11	0.43	0.54	0.18
PGSC0003DMG200012010	K01178	ko00500	Starch and sucrose metabolism	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMG200012010	K01178	ko01100	Metabolic pathways	399	1.1e-12	0.25	0.39	0.72
PGSC0003DMG200012012	K01623	ko00010	Glycolysis / Gluconeogenesis	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012012	K01623	ko00030	Pentose phosphate pathway	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012012	K01623	ko00051	Fructose and mannose metabolism	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012012	K01623	ko00710	Carbon fixation in photosynthetic organisms	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012012	K01623	ko01100	Metabolic pathways	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012012	K01623	ko01110	Biosynthesis of secondary metabolites	2988	5.7e-159	0.89	0.95	1.00
PGSC0003DMG200012021	K08332	ko04140	Regulation of autophagy	294	8.3e-08	0.25	0.48	0.62
PGSC0003DMG200012023	K13230	ko00402	Benzoxazinoid biosynthesis	702	7.0e-33	0.34	0.52	0.96
PGSC0003DMG200012024	K13230	ko00402	Benzoxazinoid biosynthesis	645	9.7e-30	0.38	0.54	0.96
PGSC0003DMG200012024	K13230	ko00402	Benzoxazinoid biosynthesis	668	5.2e-31	0.39	0.55	0.96
PGSC0003DMG200015242	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMG200015242	K00517	ko00626	Naphthalene and anthracene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMG200015242	K00517	ko00903	Limonene and pinene degradation	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMG200015242	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMG200015242	K00517	ko01110	Biosynthesis of secondary metabolites	1813	3.7e-94	0.48	0.67	0.99
PGSC0003DMG200015245	K02880	ko03010	Ribosome	1347	1.8e-68	0.91	0.95	0.99
PGSC0003DMG200015246	K07199	ko04910	Insulin signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMG200015246	K07199	ko04920	Adipocytokine signaling pathway	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMG200015246	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	2.0e-06	0.41	0.57	0.17
PGSC0003DMG200015246	K07199	ko04910	Insulin signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMG200015246	K07199	ko04920	Adipocytokine signaling pathway	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMG200015246	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	228	9.7e-07	0.41	0.57	0.22
PGSC0003DMG200015249	K00059	ko00061	Fatty acid biosynthesis	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMG200015249	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMG200015249	K00059	ko01100	Metabolic pathways	1346	2.1e-68	0.82	0.88	0.82
PGSC0003DMG200015253	K00134	ko00010	Glycolysis / Gluconeogenesis	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMG200015253	K00134	ko01100	Metabolic pathways	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMG200015253	K00134	ko01110	Biosynthesis of secondary metabolites	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMG200015253	K00134	ko05010	Alzheimer's disease	2626	5.3e-139	0.91	0.97	1.00
PGSC0003DMG200015254	K00940	ko00230	Purine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMG200015254	K00940	ko00240	Pyrimidine metabolism	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMG200015254	K00940	ko01100	Metabolic pathways	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMG200015254	K00940	ko01110	Biosynthesis of secondary metabolites	1033	3.9e-51	0.92	0.98	0.79
PGSC0003DMG200015257	K02970	ko03010	Ribosome	215	5.0e-06	0.51	0.70	0.22
PGSC0003DMG200015257	K02970	ko03010	Ribosome	219	3.0e-06	0.51	0.69	0.33
PGSC0003DMG200009081	K01051	ko00040	Pentose and glucuronate interconversions	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMG200009081	K01051	ko00500	Starch and sucrose metabolism	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMG200009081	K01051	ko01100	Metabolic pathways	479	1.4e-20	0.32	0.51	0.91
PGSC0003DMG200009081	K01051	ko00040	Pentose and glucuronate interconversions	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMG200009081	K01051	ko00500	Starch and sucrose metabolism	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMG200009081	K01051	ko01100	Metabolic pathways	1162	3.0e-58	0.62	0.76	0.99
PGSC0003DMG200009089	K01228	ko00510	N-Glycan biosynthesis	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMG200009089	K01228	ko01100	Metabolic pathways	1193	5.8e-60	0.65	0.80	0.81
PGSC0003DMG200009091	K07297	ko04920	Adipocytokine signaling pathway	1096	1.3e-54	0.75	0.87	0.99
PGSC0003DMG200009091	K07297	ko04920	Adipocytokine signaling pathway	2314	8.5e-122	0.66	0.80	0.97
PGSC0003DMG200009093	K05862	ko04020	Calcium signaling pathway	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMG200009093	K05862	ko05012	Parkinson's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMG200009093	K05862	ko05016	Huntington's disease	437	2.9e-18	0.67	0.78	0.94
PGSC0003DMG200009093	K05862	ko04020	Calcium signaling pathway	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMG200009093	K05862	ko05012	Parkinson's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMG200009093	K05862	ko05016	Huntington's disease	1128	2.2e-56	0.52	0.68	0.99
PGSC0003DMG200009095	K05033	ko02010	ABC transporters	415	5.2e-16	0.51	0.67	0.84
PGSC0003DMG200009095	K05666	ko02010	ABC transporters	3162	1.4e-168	0.38	0.59	0.82
PGSC0003DMG200009095	K05666	ko02010	ABC transporters	1344	2.7e-68	0.44	0.66	0.97
PGSC0003DMG200005274	K01509	ko00230	Purine metabolism	194	1.1e-09	0.50	0.71	0.40
PGSC0003DMG200005279	K00430	ko00360	Phenylalanine metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMG200005279	K00430	ko00680	Methane metabolism	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMG200005279	K00430	ko00940	Phenylpropanoid biosynthesis	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMG200005279	K00430	ko01100	Metabolic pathways	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMG200005279	K00430	ko01110	Biosynthesis of secondary metabolites	1786	1.1e-92	0.67	0.82	0.97
PGSC0003DMG200005284	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMG200005284	K03785	ko01100	Metabolic pathways	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMG200005284	K03785	ko01110	Biosynthesis of secondary metabolites	648	6.6e-30	0.56	0.74	0.99
PGSC0003DMG200005284	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMG200005284	K03785	ko01100	Metabolic pathways	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMG200005284	K03785	ko01110	Biosynthesis of secondary metabolites	1970	8.0e-103	0.50	0.69	1.00
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	771	1.1e-36	0.74	0.91	0.96
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	770	1.2e-36	0.74	0.90	0.96
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	1313	1.4e-66	0.58	0.73	0.90
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	1332	1.2e-67	0.61	0.75	0.88
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	1321	5.0e-67	0.60	0.75	0.88
PGSC0003DMG200011095	K11778	ko00900	Terpenoid backbone biosynthesis	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMG200011095	K11778	ko01110	Biosynthesis of secondary metabolites	1342	3.5e-68	0.61	0.75	0.88
PGSC0003DMG200011096	K11778	ko00900	Terpenoid backbone biosynthesis	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMG200011096	K11778	ko01110	Biosynthesis of secondary metabolites	1359	4.0e-69	0.68	0.85	0.74
PGSC0003DMG200011098	K05933	ko00270	Cysteine and methionine metabolism	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMG200011098	K05933	ko01110	Biosynthesis of secondary metabolites	221	2.4e-06	0.42	0.54	0.95
PGSC0003DMG200011098	K05277	ko00941	Flavonoid biosynthesis	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMG200011098	K05277	ko01100	Metabolic pathways	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMG200011098	K05277	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.38	0.59	0.96
PGSC0003DMG200011105	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMG200011105	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMG200011105	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.86
PGSC0003DMG200011105	K01921	ko00473	D-Alanine metabolism	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMG200011105	K01921	ko00550	Peptidoglycan biosynthesis	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMG200011105	K01921	ko01100	Metabolic pathways	951	1.3e-46	0.27	0.44	0.91
PGSC0003DMG200011105	K01921	ko00473	D-Alanine metabolism	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMG200011105	K01921	ko00550	Peptidoglycan biosynthesis	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMG200011105	K01921	ko01100	Metabolic pathways	507	4.0e-22	0.31	0.51	0.74
PGSC0003DMG200009877	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMG200009877	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.88
PGSC0003DMG200009877	K05309	ko00590	Arachidonic acid metabolism	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMG200009877	K05309	ko01100	Metabolic pathways	983	2.2e-48	0.45	0.60	0.91
PGSC0003DMG200009882	K08766	ko00071	Fatty acid metabolism	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMG200009882	K08766	ko03320	PPAR signaling pathway	351	8.0e-13	0.38	0.58	0.53
PGSC0003DMG200009882	K08766	ko00071	Fatty acid metabolism	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMG200009882	K08766	ko03320	PPAR signaling pathway	335	6.4e-12	0.39	0.56	0.56
PGSC0003DMG200007989	K00510	ko00860	Porphyrin and chlorophyll metabolism	981	2.8e-48	0.49	0.68	0.58
PGSC0003DMG200007991	K13289	ko04142	Lysosome	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMG200007991	K13289	ko04614	Renin-angiotensin system	1767	1.3e-91	0.52	0.64	0.67
PGSC0003DMG200007991	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007991	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007991	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007991	K01719	ko00860	Porphyrin and chlorophyll metabolism	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007991	K01719	ko01100	Metabolic pathways	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007991	K01719	ko01110	Biosynthesis of secondary metabolites	1302	5.6e-66	0.66	0.76	0.96
PGSC0003DMG200007997	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMG200007997	K02954	ko03010	Ribosome	638	2.4e-29	0.76	0.91	0.87
PGSC0003DMG200007999	K02084	ko04115	p53 signaling pathway	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko04210	Apoptosis	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko05010	Alzheimer's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko05012	Parkinson's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko05016	Huntington's disease	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko05222	Small cell lung cancer	313	5.1e-09	0.25	0.49	0.38
PGSC0003DMG200007999	K02084	ko04115	p53 signaling pathway	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko04210	Apoptosis	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko05010	Alzheimer's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko05012	Parkinson's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko05016	Huntington's disease	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200007999	K02084	ko05222	Small cell lung cancer	313	3.9e-09	0.25	0.49	0.43
PGSC0003DMG200008001	K06627	ko04110	Cell cycle	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMG200008001	K06627	ko04914	Progesterone-mediated oocyte maturation	289	4.2e-10	0.27	0.46	0.83
PGSC0003DMG200008003	K01136	ko00531	Glycosaminoglycan degradation	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMG200008003	K01136	ko01100	Metabolic pathways	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMG200008003	K01136	ko04142	Lysosome	237	1.5e-06	0.32	0.47	0.74
PGSC0003DMG200014093	K05278	ko00941	Flavonoid biosynthesis	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMG200014093	K05278	ko01100	Metabolic pathways	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMG200014093	K05278	ko01110	Biosynthesis of secondary metabolites	1791	6.0e-93	0.63	0.77	0.95
PGSC0003DMG200014094	K00059	ko00061	Fatty acid biosynthesis	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMG200014094	K00059	ko01040	Biosynthesis of unsaturated fatty acids	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMG200014094	K00059	ko01100	Metabolic pathways	482	9.5e-21	0.68	0.79	0.99
PGSC0003DMG200014095	K00059	ko00061	Fatty acid biosynthesis	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMG200014095	K00059	ko01040	Biosynthesis of unsaturated fatty acids	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMG200014095	K00059	ko01100	Metabolic pathways	860	1.3e-41	0.58	0.80	0.97
PGSC0003DMG200014095	K00059	ko00061	Fatty acid biosynthesis	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMG200014095	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMG200014095	K00059	ko01100	Metabolic pathways	1328	2.1e-67	0.59	0.79	1.00
PGSC0003DMG200014098	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014098	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014098	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014098	K05740	ko04510	Focal adhesion	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014098	K05740	ko04810	Regulation of actin cytoskeleton	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014098	K05740	ko05131	Shigellosis	267	6.8e-09	0.28	0.44	0.92
PGSC0003DMG200014100	K04725	ko04120	Ubiquitin mediated proteolysis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014100	K04725	ko04210	Apoptosis	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014100	K04725	ko04510	Focal adhesion	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014100	K04725	ko04621	NOD-like receptor signaling pathway	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014100	K04725	ko05200	Pathways in cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014100	K04725	ko05222	Small cell lung cancer	213	7.1e-06	0.44	0.61	0.16
PGSC0003DMG200014108	K01081	ko00230	Purine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMG200014108	K01081	ko00240	Pyrimidine metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMG200014108	K01081	ko00760	Nicotinate and nicotinamide metabolism	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMG200014108	K01081	ko01100	Metabolic pathways	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMG200014108	K01081	ko01110	Biosynthesis of secondary metabolites	454	3.3e-19	0.43	0.65	0.92
PGSC0003DMG200014108	K01081	ko00230	Purine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko00240	Pyrimidine metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko00760	Nicotinate and nicotinamide metabolism	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko01100	Metabolic pathways	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200014108	K01081	ko01110	Biosynthesis of secondary metabolites	297	1.5e-10	0.40	0.62	0.86
PGSC0003DMG200027831	K00249	ko00071	Fatty acid metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko00280	Valine, leucine and isoleucine degradation	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko00410	beta-Alanine metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko00640	Propanoate metabolism	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko01100	Metabolic pathways	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko01110	Biosynthesis of secondary metabolites	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko03320	PPAR signaling pathway	5107	7.6e-276	0.72	0.83	1.00
PGSC0003DMG200027831	K00249	ko00071	Fatty acid metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko00280	Valine, leucine and isoleucine degradation	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko00410	beta-Alanine metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko00640	Propanoate metabolism	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko01100	Metabolic pathways	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko01110	Biosynthesis of secondary metabolites	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027831	K00249	ko03320	PPAR signaling pathway	418	9.8e-17	0.89	0.95	0.95
PGSC0003DMG200027833	K01051	ko00040	Pentose and glucuronate interconversions	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMG200027833	K01051	ko00500	Starch and sucrose metabolism	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMG200027833	K01051	ko01100	Metabolic pathways	2287	2.6e-120	0.51	0.67	0.99
PGSC0003DMG200027835	K11253	ko05322	Systemic lupus erythematosus	282	1.0e-09	0.97	0.97	0.67
PGSC0003DMG200027840	K01051	ko00040	Pentose and glucuronate interconversions	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMG200027840	K01051	ko00500	Starch and sucrose metabolism	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMG200027840	K01051	ko01100	Metabolic pathways	1935	6.9e-101	0.45	0.63	0.98
PGSC0003DMG200027845	K11253	ko05322	Systemic lupus erythematosus	787	1.4e-37	0.92	0.94	0.95
PGSC0003DMG200017725	K01507	ko00190	Oxidative phosphorylation	489	3.9e-21	0.59	0.66	0.73
PGSC0003DMG200017728	K04733	ko04210	Apoptosis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMG200017728	K04733	ko04620	Toll-like receptor signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMG200017728	K04733	ko04722	Neurotrophin signaling pathway	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMG200017728	K04733	ko05140	Leishmaniasis	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMG200017728	K04733	ko05142	Chagas disease	741	4.9e-35	0.38	0.59	0.80
PGSC0003DMG200033341	K02870	ko03010	Ribosome	1315	1.1e-66	0.94	0.99	0.99
PGSC0003DMG200033349	K11090	ko05322	Systemic lupus erythematosus	260	1.7e-08	0.31	0.50	0.39
PGSC0003DMG200024735	K01514	ko00230	Purine metabolism	827	8.9e-40	0.35	0.54	0.93
PGSC0003DMG200024735	K01514	ko00230	Purine metabolism	903	5.7e-44	0.35	0.54	0.87
PGSC0003DMG200024735	K01514	ko00230	Purine metabolism	942	4.0e-46	0.34	0.53	0.96
PGSC0003DMG200024737	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMG200024737	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMG200024737	K01192	ko00511	Other glycan degradation	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMG200024737	K01192	ko04142	Lysosome	1140	4.8e-57	0.29	0.43	0.95
PGSC0003DMG200024737	K01192	ko00511	Other glycan degradation	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMG200024737	K01192	ko04142	Lysosome	751	1.4e-35	0.28	0.42	0.98
PGSC0003DMG200024741	K00454	ko00591	Linoleic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMG200024741	K00454	ko00592	alpha-Linolenic acid metabolism	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMG200024741	K00454	ko01100	Metabolic pathways	2892	1.1e-153	0.67	0.82	1.00
PGSC0003DMG200024742	K07200	ko04910	Insulin signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMG200024742	K07200	ko04920	Adipocytokine signaling pathway	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMG200024742	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	1172	8.3e-59	0.37	0.54	0.98
PGSC0003DMG200024743	K10609	ko03420	Nucleotide excision repair	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMG200024743	K10609	ko04120	Ubiquitin mediated proteolysis	282	7.8e-09	0.29	0.47	0.94
PGSC0003DMG200000376	K10527	ko00592	alpha-Linolenic acid metabolism	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMG200000376	K10527	ko01100	Metabolic pathways	3304	2.1e-176	0.74	0.87	1.00
PGSC0003DMG200000378	K03100	ko03060	Protein export	1729	1.6e-89	0.67	0.76	0.98
PGSC0003DMG200000379	K00558	ko00270	Cysteine and methionine metabolism	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMG200000379	K00558	ko01100	Metabolic pathways	2435	1.8e-128	0.51	0.61	0.93
PGSC0003DMG200000386	K02184	ko04320	Dorso-ventral axis formation	1261	1.0e-63	0.42	0.46	0.48
PGSC0003DMG200000393	K12471	ko04144	Endocytosis	344	3.9e-13	0.33	0.57	0.63
PGSC0003DMG200000393	K12471	ko04144	Endocytosis	226	3.4e-06	0.33	0.56	0.87
PGSC0003DMG200000396	K08332	ko04140	Regulation of autophagy	304	3.3e-08	0.29	0.52	0.45
PGSC0003DMG200000396	K08332	ko04140	Regulation of autophagy	304	1.2e-10	0.29	0.52	0.96
PGSC0003DMG200001646	K10352	ko04530	Tight junction	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMG200001646	K10352	ko05416	Viral myocarditis	562	5.7e-24	0.26	0.48	0.96
PGSC0003DMG200001662	K01583	ko00330	Arginine and proline metabolism	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMG200001662	K01583	ko01100	Metabolic pathways	4221	5.6e-227	0.71	0.82	0.98
PGSC0003DMG200001672	K02257	ko00190	Oxidative phosphorylation	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMG200001672	K02257	ko00860	Porphyrin and chlorophyll metabolism	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMG200001672	K02257	ko01100	Metabolic pathways	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMG200001672	K02257	ko01110	Biosynthesis of secondary metabolites	2216	2.2e-116	0.61	0.72	0.99
PGSC0003DMG200001672	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMG200001672	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMG200001672	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMG200001672	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.95
PGSC0003DMG200001672	K02257	ko00190	Oxidative phosphorylation	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMG200001672	K02257	ko00860	Porphyrin and chlorophyll metabolism	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMG200001672	K02257	ko01100	Metabolic pathways	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMG200001672	K02257	ko01110	Biosynthesis of secondary metabolites	2279	7.3e-120	0.65	0.76	0.99
PGSC0003DMG200001672	K02257	ko00190	Oxidative phosphorylation	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMG200001672	K02257	ko00860	Porphyrin and chlorophyll metabolism	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMG200001672	K02257	ko01100	Metabolic pathways	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMG200001672	K02257	ko01110	Biosynthesis of secondary metabolites	786	1.6e-37	0.56	0.68	0.98
PGSC0003DMG200012309	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMG200012309	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMG200012309	K00734	ko01100	Metabolic pathways	319	9.3e-12	0.28	0.48	0.69
PGSC0003DMG200012312	K10456	ko04120	Ubiquitin mediated proteolysis	301	3.5e-08	0.30	0.47	0.42
PGSC0003DMG200012312	K10456	ko04120	Ubiquitin mediated proteolysis	301	1.5e-08	0.30	0.47	0.50
PGSC0003DMG200012316	K08008	ko04145	Phagosome	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMG200012316	K08008	ko04670	Leukocyte transendothelial migration	372	1.1e-14	0.37	0.59	0.79
PGSC0003DMG200012316	K08008	ko04145	Phagosome	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMG200012316	K08008	ko04670	Leukocyte transendothelial migration	1203	1.6e-60	0.34	0.53	0.58
PGSC0003DMG200012321	K01762	ko00270	Cysteine and methionine metabolism	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMG200012321	K01762	ko01110	Biosynthesis of secondary metabolites	2618	1.5e-138	0.64	0.80	0.98
PGSC0003DMG200012322	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMG200012322	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMG200012322	K08232	ko00053	Ascorbate and aldarate metabolism	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMG200012322	K08232	ko01100	Metabolic pathways	2977	2.3e-158	0.71	0.84	1.00
PGSC0003DMG200012324	K01213	ko00040	Pentose and glucuronate interconversions	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMG200012324	K01213	ko00500	Starch and sucrose metabolism	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMG200012324	K01213	ko01100	Metabolic pathways	588	1.3e-26	0.38	0.56	0.76
PGSC0003DMG200012324	K01213	ko00040	Pentose and glucuronate interconversions	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMG200012324	K01213	ko00500	Starch and sucrose metabolism	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMG200012324	K01213	ko01100	Metabolic pathways	955	7.7e-47	0.37	0.57	0.75
PGSC0003DMG200016366	K04498	ko04110	Cell cycle	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04310	Wnt signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04330	Notch signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04350	TGF-beta signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04520	Adherens junction	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04630	Jak-STAT signaling pathway	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04720	Long-term potentiation	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04916	Melanogenesis	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05016	Huntington's disease	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05200	Pathways in cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05211	Renal cell carcinoma	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05215	Prostate cancer	9728	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04110	Cell cycle	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04310	Wnt signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04330	Notch signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04350	TGF-beta signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04520	Adherens junction	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04630	Jak-STAT signaling pathway	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04720	Long-term potentiation	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04916	Melanogenesis	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05016	Huntington's disease	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05200	Pathways in cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05211	Renal cell carcinoma	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05215	Prostate cancer	9222	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04110	Cell cycle	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04310	Wnt signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04330	Notch signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04350	TGF-beta signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04520	Adherens junction	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04630	Jak-STAT signaling pathway	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04720	Long-term potentiation	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04916	Melanogenesis	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05016	Huntington's disease	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05200	Pathways in cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05211	Renal cell carcinoma	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05215	Prostate cancer	9557	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04110	Cell cycle	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04310	Wnt signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04330	Notch signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04350	TGF-beta signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04520	Adherens junction	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04630	Jak-STAT signaling pathway	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04720	Long-term potentiation	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko04916	Melanogenesis	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05016	Huntington's disease	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05200	Pathways in cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05211	Renal cell carcinoma	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016366	K04498	ko05215	Prostate cancer	9549	0.	0.66	0.78	1.00
PGSC0003DMG200016367	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMG200016367	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMG200016367	K02978	ko03010	Ribosome	733	1.4e-34	0.97	0.98	0.99
PGSC0003DMG200016367	K02978	ko03010	Ribosome	734	1.2e-34	0.97	0.99	0.99
PGSC0003DMG200016370	K01046	ko00561	Glycerolipid metabolism	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMG200016370	K01046	ko01100	Metabolic pathways	562	3.7e-25	0.31	0.49	0.80
PGSC0003DMG200016370	K01046	ko00561	Glycerolipid metabolism	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMG200016370	K01046	ko01100	Metabolic pathways	225	1.9e-06	0.26	0.43	0.89
PGSC0003DMG200016371	K00430	ko00360	Phenylalanine metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMG200016371	K00430	ko00680	Methane metabolism	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMG200016371	K00430	ko00940	Phenylpropanoid biosynthesis	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMG200016371	K00430	ko01100	Metabolic pathways	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMG200016371	K00430	ko01110	Biosynthesis of secondary metabolites	921	5.8e-45	0.41	0.59	0.68
PGSC0003DMG200016372	K02084	ko04115	p53 signaling pathway	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko04210	Apoptosis	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko05010	Alzheimer's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko05012	Parkinson's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko05016	Huntington's disease	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016372	K02084	ko05222	Small cell lung cancer	284	4.3e-06	0.29	0.45	0.34
PGSC0003DMG200016373	K00814	ko00250	Alanine, aspartate and glutamate metabolism	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMG200016373	K00814	ko00710	Carbon fixation in photosynthetic organisms	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMG200016373	K00814	ko01100	Metabolic pathways	631	5.7e-29	0.87	0.92	0.99
PGSC0003DMG200016375	K13065	ko00940	Phenylpropanoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMG200016375	K13065	ko00941	Flavonoid biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMG200016375	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMG200016375	K13065	ko01110	Biosynthesis of secondary metabolites	556	7.9e-25	0.29	0.47	0.95
PGSC0003DMG200016380	K03531	ko04112	Cell cycle - Caulobacter	308	1.5e-10	0.28	0.48	0.32
PGSC0003DMG200016380	K03531	ko04112	Cell cycle - Caulobacter	304	2.6e-10	0.27	0.49	0.32
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	489	3.9e-21	0.32	0.48	0.96
PGSC0003DMG200022400	K01107	ko00562	Inositol phosphate metabolism	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01107	ko01100	Metabolic pathways	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01107	ko04070	Phosphatidylinositol signaling system	652	4.0e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko00562	Inositol phosphate metabolism	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01107	ko01100	Metabolic pathways	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01107	ko04070	Phosphatidylinositol signaling system	656	2.4e-30	0.35	0.50	0.86
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	521	6.7e-23	0.34	0.48	0.96
PGSC0003DMG200022400	K01107	ko00562	Inositol phosphate metabolism	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko01100	Metabolic pathways	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko04070	Phosphatidylinositol signaling system	549	1.9e-24	0.37	0.53	0.66
PGSC0003DMG200022400	K01107	ko00562	Inositol phosphate metabolism	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMG200022400	K01107	ko01100	Metabolic pathways	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMG200022400	K01107	ko04070	Phosphatidylinositol signaling system	601	2.6e-27	0.35	0.49	0.94
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	387	1.6e-15	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	664	8.7e-31	0.36	0.51	0.87
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	244	1.3e-07	0.41	0.56	0.79
PGSC0003DMG200022400	K01082	ko00920	Sulfur metabolism	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMG200022400	K01082	ko01100	Metabolic pathways	515	1.4e-22	0.35	0.50	0.97
PGSC0003DMG200022402	K08139	ko04113	Meiosis - yeast	994	5.5e-49	0.37	0.56	0.87
PGSC0003DMG200022405	K03885	ko00190	Oxidative phosphorylation	3993	2.1e-214	0.79	0.90	1.00
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1347	1.8e-68	0.71	0.82	0.98
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1313	1.4e-66	0.80	0.90	0.94
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMG200022409	K00861	ko00740	Riboflavin metabolism	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMG200022409	K00861	ko01100	Metabolic pathways	1453	2.6e-74	0.79	0.89	0.95
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019668	K11817	ko00380	Tryptophan metabolism	253	4.6e-07	0.69	0.81	0.72
PGSC0003DMG200019673	K01528	ko04144	Endocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMG200019673	K01528	ko04666	Fc gamma R-mediated phagocytosis	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMG200019673	K01528	ko05100	Bacterial invasion of epithelial cells	712	2.0e-33	0.36	0.54	0.57
PGSC0003DMG200019678	K04663	ko04340	Hedgehog signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMG200019678	K04663	ko04350	TGF-beta signaling pathway	225	2.0e-06	0.40	0.59	0.35
PGSC0003DMG200030450	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMG200030450	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMG200030450	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.44
PGSC0003DMG200030450	K05743	ko04360	Axon guidance	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMG200030450	K05743	ko04666	Fc gamma R-mediated phagocytosis	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMG200030450	K05743	ko04810	Regulation of actin cytoskeleton	459	9.6e-19	0.32	0.54	0.58
PGSC0003DMG200030452	K01188	ko00460	Cyanoamino acid metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMG200030452	K01188	ko00500	Starch and sucrose metabolism	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMG200030452	K01188	ko00940	Phenylpropanoid biosynthesis	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMG200030452	K01188	ko01110	Biosynthesis of secondary metabolites	791	8.6e-38	0.41	0.54	0.98
PGSC0003DMG200030454	K13030	ko00460	Cyanoamino acid metabolism	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMG200030454	K13030	ko01110	Biosynthesis of secondary metabolites	531	1.9e-23	0.29	0.51	0.97
PGSC0003DMG200030454	K13068	ko00940	Phenylpropanoid biosynthesis	662	1.1e-30	0.27	0.50	0.98
PGSC0003DMG200030455	K13068	ko00940	Phenylpropanoid biosynthesis	695	1.7e-32	0.27	0.50	0.98
PGSC0003DMG200030456	K01955	ko00240	Pyrimidine metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMG200030456	K01955	ko00250	Alanine, aspartate and glutamate metabolism	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMG200030456	K01955	ko01100	Metabolic pathways	708	1.5e-32	0.53	0.66	0.98
PGSC0003DMG200030459	K11094	ko03040	Spliceosome	435	3.7e-18	0.77	0.97	0.98
PGSC0003DMG200030459	K11094	ko03040	Spliceosome	1491	2.1e-76	0.73	0.87	0.99
PGSC0003DMG200030461	K01955	ko00240	Pyrimidine metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMG200030461	K01955	ko00250	Alanine, aspartate and glutamate metabolism	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMG200030461	K01955	ko01100	Metabolic pathways	542	3.3e-23	0.52	0.70	0.58
PGSC0003DMG200030461	K01955	ko00240	Pyrimidine metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMG200030461	K01955	ko00250	Alanine, aspartate and glutamate metabolism	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMG200030461	K01955	ko01100	Metabolic pathways	561	2.8e-24	0.53	0.71	0.58
PGSC0003DMG200030463	K12132	ko04712	Circadian rhythm - plant	1349	1.4e-68	0.41	0.55	0.93
PGSC0003DMG200030463	K12132	ko04712	Circadian rhythm - plant	1826	7.0e-95	0.58	0.70	0.84
PGSC0003DMG200030463	K12132	ko04712	Circadian rhythm - plant	1990	6.3e-104	0.46	0.60	0.93
PGSC0003DMG200030465	K03843	ko00510	N-Glycan biosynthesis	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMG200030465	K03843	ko01100	Metabolic pathways	2316	6.6e-122	0.68	0.81	1.00
PGSC0003DMG200030465	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMG200030465	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMG200030465	K03843	ko00510	N-Glycan biosynthesis	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMG200030465	K03843	ko01100	Metabolic pathways	1120	6.1e-56	0.74	0.87	0.99
PGSC0003DMG200004949	K00826	ko00280	Valine, leucine and isoleucine degradation	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMG200004949	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMG200004949	K00826	ko00770	Pantothenate and CoA biosynthesis	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMG200004949	K00826	ko01100	Metabolic pathways	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMG200004949	K00826	ko01110	Biosynthesis of secondary metabolites	2182	1.6e-114	0.73	0.87	0.93
PGSC0003DMG200004951	K00826	ko00280	Valine, leucine and isoleucine degradation	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMG200004951	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMG200004951	K00826	ko00770	Pantothenate and CoA biosynthesis	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMG200004951	K00826	ko01100	Metabolic pathways	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMG200004951	K00826	ko01110	Biosynthesis of secondary metabolites	2219	1.5e-116	0.66	0.82	1.00
PGSC0003DMG200004962	K07374	ko04145	Phagosome	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMG200004962	K07374	ko04540	Gap junction	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMG200004962	K07374	ko05130	Pathogenic Escherichia coli infection	1517	7.8e-78	0.95	0.98	0.99
PGSC0003DMG200004962	K07374	ko04145	Phagosome	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMG200004962	K07374	ko04540	Gap junction	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMG200004962	K07374	ko05130	Pathogenic Escherichia coli infection	1998	2.3e-104	0.96	0.98	0.97
PGSC0003DMG200012979	K10588	ko04120	Ubiquitin mediated proteolysis	1646	6.0e-85	0.31	0.48	0.98
PGSC0003DMG200012979	K10588	ko04120	Ubiquitin mediated proteolysis	1613	3.9e-83	0.42	0.59	0.67
PGSC0003DMG200012979	K10588	ko04120	Ubiquitin mediated proteolysis	1693	1.5e-87	0.32	0.48	0.98
PGSC0003DMG200012985	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMG200012985	K02366	ko01100	Metabolic pathways	351	5.0e-13	0.32	0.48	0.87
PGSC0003DMG200012985	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMG200012985	K02366	ko01100	Metabolic pathways	370	1.5e-12	0.31	0.47	0.58
PGSC0003DMG200012987	K01754	ko00260	Glycine, serine and threonine metabolism	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMG200012987	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMG200012987	K01754	ko01100	Metabolic pathways	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMG200012987	K01754	ko01110	Biosynthesis of secondary metabolites	2365	1.3e-124	0.58	0.76	0.84
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	712	2.0e-33	0.52	0.68	0.92
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	718	9.1e-34	0.48	0.62	0.99
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	956	6.8e-47	0.50	0.64	0.94
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	1296	1.2e-65	0.50	0.66	1.00
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.52	0.70	1.00
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	939	5.9e-46	0.51	0.66	0.93
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	701	7.9e-33	0.49	0.65	0.98
PGSC0003DMG200002339	K01199	ko00500	Starch and sucrose metabolism	829	6.9e-40	0.51	0.68	0.85
PGSC0003DMG200002340	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMG200002340	K00517	ko00626	Naphthalene and anthracene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMG200002340	K00517	ko00903	Limonene and pinene degradation	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMG200002340	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMG200002340	K00517	ko01110	Biosynthesis of secondary metabolites	1285	4.9e-65	0.41	0.55	0.97
PGSC0003DMG200002341	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMG200002341	K00517	ko00626	Naphthalene and anthracene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMG200002341	K00517	ko00903	Limonene and pinene degradation	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMG200002341	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMG200002341	K00517	ko01110	Biosynthesis of secondary metabolites	972	8.9e-48	0.43	0.62	1.00
PGSC0003DMG200002342	K01199	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.46	0.67	0.97
PGSC0003DMG200002342	K01199	ko00500	Starch and sucrose metabolism	1161	3.4e-58	0.45	0.67	0.94
PGSC0003DMG200002342	K01199	ko00500	Starch and sucrose metabolism	1155	7.2e-58	0.47	0.68	0.96
PGSC0003DMG200002345	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMG200002345	K00517	ko00626	Naphthalene and anthracene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMG200002345	K00517	ko00903	Limonene and pinene degradation	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMG200002345	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMG200002345	K00517	ko01110	Biosynthesis of secondary metabolites	606	1.4e-27	0.56	0.70	0.96
PGSC0003DMG200002345	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMG200002345	K00517	ko00626	Naphthalene and anthracene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMG200002345	K00517	ko00903	Limonene and pinene degradation	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMG200002345	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMG200002345	K00517	ko01110	Biosynthesis of secondary metabolites	872	2.9e-42	0.53	0.70	0.95
PGSC0003DMG200002351	K07424	ko00140	Steroid hormone biosynthesis	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00591	Linoleic acid metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00830	Retinol metabolism	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00982	Drug metabolism - cytochrome P450	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00983	Drug metabolism - other enzymes	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko01100	Metabolic pathways	2160	2.7e-113	0.52	0.73	0.97
PGSC0003DMG200002351	K07424	ko00140	Steroid hormone biosynthesis	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00591	Linoleic acid metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00830	Retinol metabolism	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00982	Drug metabolism - cytochrome P450	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00983	Drug metabolism - other enzymes	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko01100	Metabolic pathways	1601	1.8e-82	0.56	0.77	1.00
PGSC0003DMG200002351	K07424	ko00140	Steroid hormone biosynthesis	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00591	Linoleic acid metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00830	Retinol metabolism	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00982	Drug metabolism - cytochrome P450	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00983	Drug metabolism - other enzymes	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko01100	Metabolic pathways	1207	9.7e-61	0.55	0.76	0.99
PGSC0003DMG200002351	K07424	ko00140	Steroid hormone biosynthesis	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00591	Linoleic acid metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00830	Retinol metabolism	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00982	Drug metabolism - cytochrome P450	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko00983	Drug metabolism - other enzymes	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002351	K07424	ko01100	Metabolic pathways	712	2.0e-33	0.60	0.77	0.99
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	1833	2.9e-95	0.50	0.65	0.96
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	1637	1.9e-84	0.63	0.79	0.90
PGSC0003DMG200002352	K01930	ko00790	Folate biosynthesis	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMG200002352	K01930	ko01100	Metabolic pathways	1766	1.4e-91	0.62	0.77	0.94
PGSC0003DMG200015637	K00813	ko00250	Alanine, aspartate and glutamate metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00270	Cysteine and methionine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00330	Arginine and proline metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00350	Tyrosine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00360	Phenylalanine metabolism	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00401	Novobiocin biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00710	Carbon fixation in photosynthetic organisms	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00950	Isoquinoline alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko01100	Metabolic pathways	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015637	K00813	ko01110	Biosynthesis of secondary metabolites	3091	1.2e-164	0.90	0.96	0.99
PGSC0003DMG200015641	K02906	ko03010	Ribosome	1689	2.5e-87	0.73	0.83	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	2727	1.4e-144	0.89	0.95	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	2265	4.3e-119	0.87	0.95	1.00
PGSC0003DMG200015645	K00971	ko00051	Fructose and mannose metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMG200015645	K00971	ko00520	Amino sugar and nucleotide sugar metabolism	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMG200015645	K00971	ko01100	Metabolic pathways	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMG200015645	K00971	ko01110	Biosynthesis of secondary metabolites	1573	6.3e-81	0.85	0.94	1.00
PGSC0003DMG200015648	K04646	ko04142	Lysosome	11637	0.	0.83	0.87	1.00
PGSC0003DMG200015648	K04646	ko04144	Endocytosis	11637	0.	0.83	0.87	1.00
PGSC0003DMG200015648	K04646	ko05016	Huntington's disease	11637	0.	0.83	0.87	1.00
PGSC0003DMG200015648	K04646	ko05100	Bacterial invasion of epithelial cells	11637	0.	0.83	0.87	1.00
PGSC0003DMG200015648	K04646	ko04142	Lysosome	13580	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko04144	Endocytosis	13580	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko05016	Huntington's disease	13580	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko05100	Bacterial invasion of epithelial cells	13580	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko04142	Lysosome	12750	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko04144	Endocytosis	12750	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko05016	Huntington's disease	12750	0.	0.94	0.97	1.00
PGSC0003DMG200015648	K04646	ko05100	Bacterial invasion of epithelial cells	12750	0.	0.94	0.97	1.00
PGSC0003DMG200015650	K13065	ko00940	Phenylpropanoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMG200015650	K13065	ko00941	Flavonoid biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMG200015650	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMG200015650	K13065	ko01110	Biosynthesis of secondary metabolites	575	7.0e-26	0.29	0.50	0.96
PGSC0003DMG200040408	K03094	ko04110	Cell cycle	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04111	Cell cycle - yeast	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04114	Oocyte meiosis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04120	Ubiquitin mediated proteolysis	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04310	Wnt signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04350	TGF-beta signaling pathway	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200040408	K03094	ko04710	Circadian rhythm - mammal	341	5.7e-13	0.48	0.67	0.98
PGSC0003DMG200001048	K01696	ko00260	Glycine, serine and threonine metabolism	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMG200001048	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMG200001048	K01696	ko01100	Metabolic pathways	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMG200001048	K01696	ko01110	Biosynthesis of secondary metabolites	2769	6.9e-147	0.82	0.89	1.00
PGSC0003DMG200001048	K01696	ko00260	Glycine, serine and threonine metabolism	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMG200001048	K01696	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMG200001048	K01696	ko01100	Metabolic pathways	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMG200001048	K01696	ko01110	Biosynthesis of secondary metabolites	3224	5.5e-172	0.84	0.90	1.00
PGSC0003DMG200001056	K07203	ko04012	ErbB signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko04150	mTOR signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko04910	Insulin signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko04920	Adipocytokine signaling pathway	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko04930	Type II diabetes mellitus	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko05200	Pathways in cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko05214	Glioma	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko05215	Prostate cancer	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001056	K07203	ko05221	Acute myeloid leukemia	526	7.0e-22	0.47	0.52	0.60
PGSC0003DMG200001058	K00660	ko00941	Flavonoid biosynthesis	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMG200001058	K00660	ko01100	Metabolic pathways	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMG200001058	K00660	ko01110	Biosynthesis of secondary metabolites	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMG200001058	K00660	ko04712	Circadian rhythm - plant	340	6.4e-13	0.28	0.44	0.66
PGSC0003DMG200001060	K07424	ko00140	Steroid hormone biosynthesis	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00591	Linoleic acid metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00830	Retinol metabolism	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00982	Drug metabolism - cytochrome P450	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko00983	Drug metabolism - other enzymes	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001060	K07424	ko01100	Metabolic pathways	1489	2.7e-76	0.38	0.61	0.98
PGSC0003DMG200001061	K06130	ko00564	Glycerophospholipid metabolism	587	1.5e-26	0.38	0.55	0.87
PGSC0003DMG200029725	K02888	ko03010	Ribosome	520	7.6e-23	0.41	0.57	0.81
PGSC0003DMG200029738	K05349	ko00460	Cyanoamino acid metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMG200029738	K05349	ko00500	Starch and sucrose metabolism	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMG200029738	K05349	ko00940	Phenylpropanoid biosynthesis	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMG200029738	K05349	ko01110	Biosynthesis of secondary metabolites	1629	5.2e-84	0.62	0.74	0.96
PGSC0003DMG200029738	K05349	ko00460	Cyanoamino acid metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMG200029738	K05349	ko00500	Starch and sucrose metabolism	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMG200029738	K05349	ko00940	Phenylpropanoid biosynthesis	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMG200029738	K05349	ko01110	Biosynthesis of secondary metabolites	2820	1.1e-149	0.59	0.73	0.97
PGSC0003DMG200029738	K05349	ko00460	Cyanoamino acid metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMG200029738	K05349	ko00500	Starch and sucrose metabolism	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMG200029738	K05349	ko00940	Phenylpropanoid biosynthesis	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMG200029738	K05349	ko01110	Biosynthesis of secondary metabolites	2911	1.0e-154	0.56	0.73	1.00
PGSC0003DMG200029739	K06027	ko04962	Vasopressin-regulated water reabsorption	895	1.6e-43	0.49	0.59	0.93
PGSC0003DMG200029739	K06027	ko04962	Vasopressin-regulated water reabsorption	4721	1.5e-254	0.73	0.84	1.00
PGSC0003DMG200029739	K06027	ko04962	Vasopressin-regulated water reabsorption	4994	1.3e-269	0.80	0.91	1.00
PGSC0003DMG200018934	K13065	ko00940	Phenylpropanoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMG200018934	K13065	ko00941	Flavonoid biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMG200018934	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMG200018934	K13065	ko01110	Biosynthesis of secondary metabolites	469	4.9e-20	0.30	0.44	0.99
PGSC0003DMG200018937	K08242	ko00100	Steroid biosynthesis	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMG200018937	K08242	ko01110	Biosynthesis of secondary metabolites	2554	4.9e-135	0.80	0.90	0.99
PGSC0003DMG200018939	K04424	ko04010	MAPK signaling pathway	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMG200018939	K04424	ko04530	Tight junction	880	1.1e-42	0.37	0.61	0.56
PGSC0003DMG200018943	K00958	ko00230	Purine metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMG200018943	K00958	ko00450	Selenoamino acid metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMG200018943	K00958	ko00920	Sulfur metabolism	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMG200018943	K00958	ko01100	Metabolic pathways	3301	3.1e-176	0.82	0.90	1.00
PGSC0003DMG200018944	K02950	ko03010	Ribosome	280	1.3e-09	0.65	0.87	0.65
PGSC0003DMG200018947	K03144	ko03022	Basal transcription factors	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMG200018947	K03144	ko03420	Nucleotide excision repair	222	2.1e-06	0.34	0.61	0.44
PGSC0003DMG200018947	K03144	ko03022	Basal transcription factors	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMG200018947	K03144	ko03420	Nucleotide excision repair	308	3.7e-11	0.35	0.57	0.45
PGSC0003DMG200018950	K12126	ko04712	Circadian rhythm - plant	768	1.6e-36	0.35	0.48	0.85
PGSC0003DMG200018950	K12126	ko04712	Circadian rhythm - plant	301	1.3e-10	0.28	0.42	0.97
PGSC0003DMG200018950	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.76
PGSC0003DMG200018950	K12126	ko04712	Circadian rhythm - plant	785	1.8e-37	0.35	0.48	0.80
PGSC0003DMG200036514	K00235	ko00020	Citrate cycle (TCA cycle)	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko00190	Oxidative phosphorylation	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko01100	Metabolic pathways	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko05010	Alzheimer's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko05012	Parkinson's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200036514	K00235	ko05016	Huntington's disease	1613	3.9e-83	0.64	0.78	0.97
PGSC0003DMG200010408	K12343	ko00140	Steroid hormone biosynthesis	384	2.4e-15	0.29	0.49	0.82
PGSC0003DMG200010410	K02183	ko04020	Calcium signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04070	Phosphatidylinositol signaling system	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04114	Oocyte meiosis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04270	Vascular smooth muscle contraction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04626	Plant-pathogen interaction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04720	Long-term potentiation	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04722	Neurotrophin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04740	Olfactory transduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04744	Phototransduction	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04745	Phototransduction - fly	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04910	Insulin signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04912	GnRH signaling pathway	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04916	Melanogenesis	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04970	Salivary secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko04971	Gastric acid secretion	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko05010	Alzheimer's disease	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010410	K02183	ko05214	Glioma	463	1.1e-19	0.44	0.65	0.97
PGSC0003DMG200010411	K04733	ko04210	Apoptosis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMG200010411	K04733	ko04620	Toll-like receptor signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMG200010411	K04733	ko04722	Neurotrophin signaling pathway	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMG200010411	K04733	ko05140	Leishmaniasis	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMG200010411	K04733	ko05142	Chagas disease	424	5.4e-17	0.38	0.58	0.48
PGSC0003DMG200010411	K04733	ko04210	Apoptosis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMG200010411	K04733	ko04620	Toll-like receptor signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMG200010411	K04733	ko04722	Neurotrophin signaling pathway	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMG200010411	K04733	ko05140	Leishmaniasis	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMG200010411	K04733	ko05142	Chagas disease	668	5.2e-31	0.41	0.61	0.53
PGSC0003DMG200010415	K00227	ko00100	Steroid biosynthesis	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMG200010415	K00227	ko01100	Metabolic pathways	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMG200010415	K00227	ko01110	Biosynthesis of secondary metabolites	1916	7.7e-100	0.77	0.87	0.99
PGSC0003DMG200010417	K01054	ko00561	Glycerolipid metabolism	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMG200010417	K01054	ko01100	Metabolic pathways	467	6.4e-20	0.33	0.54	0.98
PGSC0003DMG200010417	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMG200010417	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMG200010417	K01054	ko00561	Glycerolipid metabolism	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMG200010417	K01054	ko01100	Metabolic pathways	556	7.9e-25	0.35	0.55	0.81
PGSC0003DMG200010417	K01054	ko00561	Glycerolipid metabolism	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMG200010417	K01054	ko01100	Metabolic pathways	391	9.9e-16	0.32	0.54	0.98
PGSC0003DMG200007243	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMG200007243	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMG200007243	K03660	ko03410	Base excision repair	253	2.3e-07	0.32	0.56	0.96
PGSC0003DMG200007247	K10746	ko03430	Mismatch repair	2508	1.7e-132	0.47	0.62	1.00
PGSC0003DMG200014770	K00680	ko00350	Tyrosine metabolism	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMG200014770	K00680	ko00624	1- and 2-Methylnaphthalene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMG200014770	K00680	ko00632	Benzoate degradation via CoA ligation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMG200014770	K00680	ko00642	Ethylbenzene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMG200014770	K00680	ko00903	Limonene and pinene degradation	241	1.9e-07	0.32	0.47	0.56
PGSC0003DMG200014771	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMG200014771	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMG200014771	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMG200014771	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMG200014771	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.28	0.42	0.82
PGSC0003DMG200014772	K00680	ko00350	Tyrosine metabolism	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMG200014772	K00680	ko00624	1- and 2-Methylnaphthalene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMG200014772	K00680	ko00632	Benzoate degradation via CoA ligation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMG200014772	K00680	ko00642	Ethylbenzene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMG200014772	K00680	ko00903	Limonene and pinene degradation	261	1.5e-08	0.27	0.41	0.83
PGSC0003DMG200014774	K00680	ko00350	Tyrosine metabolism	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMG200014774	K00680	ko00624	1- and 2-Methylnaphthalene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMG200014774	K00680	ko00632	Benzoate degradation via CoA ligation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMG200014774	K00680	ko00642	Ethylbenzene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMG200014774	K00680	ko00903	Limonene and pinene degradation	226	1.2e-06	0.32	0.48	0.38
PGSC0003DMG200014776	K00680	ko00350	Tyrosine metabolism	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMG200014776	K00680	ko00624	1- and 2-Methylnaphthalene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMG200014776	K00680	ko00632	Benzoate degradation via CoA ligation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMG200014776	K00680	ko00642	Ethylbenzene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMG200014776	K00680	ko00903	Limonene and pinene degradation	243	1.4e-07	0.27	0.42	0.81
PGSC0003DMG200014778	K00680	ko00350	Tyrosine metabolism	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMG200014778	K00680	ko00624	1- and 2-Methylnaphthalene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMG200014778	K00680	ko00632	Benzoate degradation via CoA ligation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMG200014778	K00680	ko00642	Ethylbenzene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMG200014778	K00680	ko00903	Limonene and pinene degradation	254	3.6e-08	0.27	0.42	0.83
PGSC0003DMG200014779	K01590	ko00340	Histidine metabolism	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMG200014779	K01590	ko01100	Metabolic pathways	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMG200014779	K01590	ko01110	Biosynthesis of secondary metabolites	516	1.3e-22	0.51	0.70	0.70
PGSC0003DMG200014779	K01590	ko00340	Histidine metabolism	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMG200014779	K01590	ko01100	Metabolic pathways	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMG200014779	K01590	ko01110	Biosynthesis of secondary metabolites	2243	7.0e-118	0.61	0.79	0.88
PGSC0003DMG200014779	K01590	ko00340	Histidine metabolism	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMG200014779	K01590	ko01100	Metabolic pathways	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMG200014779	K01590	ko01110	Biosynthesis of secondary metabolites	1094	1.7e-54	0.67	0.83	0.95
PGSC0003DMG200044546	K07188	ko04910	Insulin signaling pathway	306	1.9e-10	0.28	0.47	0.91
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	1.0e-06	0.27	0.46	0.33
PGSC0003DMG200018462	K02084	ko04115	p53 signaling pathway	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko04210	Apoptosis	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko05010	Alzheimer's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko05012	Parkinson's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko05016	Huntington's disease	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018462	K02084	ko05222	Small cell lung cancer	295	9.3e-07	0.27	0.46	0.35
PGSC0003DMG200018464	K02084	ko04115	p53 signaling pathway	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko04210	Apoptosis	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05010	Alzheimer's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05012	Parkinson's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05016	Huntington's disease	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05222	Small cell lung cancer	282	4.8e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko04115	p53 signaling pathway	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko04210	Apoptosis	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05010	Alzheimer's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05012	Parkinson's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05016	Huntington's disease	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05222	Small cell lung cancer	282	6.4e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko04115	p53 signaling pathway	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko04210	Apoptosis	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05010	Alzheimer's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05012	Parkinson's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05016	Huntington's disease	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko05222	Small cell lung cancer	282	4.9e-06	0.25	0.44	0.56
PGSC0003DMG200018464	K02084	ko04115	p53 signaling pathway	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko04210	Apoptosis	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05010	Alzheimer's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05012	Parkinson's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05016	Huntington's disease	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018464	K02084	ko05222	Small cell lung cancer	282	6.3e-06	0.25	0.44	0.48
PGSC0003DMG200018473	K04121	ko00904	Diterpenoid biosynthesis	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMG200018473	K04121	ko01100	Metabolic pathways	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMG200018473	K04121	ko01110	Biosynthesis of secondary metabolites	473	7.6e-27	0.45	0.63	0.61
PGSC0003DMG200018475	K09843	ko00906	Carotenoid biosynthesis	2995	2.3e-159	0.76	0.87	0.99
PGSC0003DMG200018475	K09843	ko00906	Carotenoid biosynthesis	2598	1.9e-137	0.80	0.90	0.99
PGSC0003DMG200028497	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMG200028497	K12581	ko03018	RNA degradation	2084	4.1e-109	0.90	0.94	0.99
PGSC0003DMG200028502	K01881	ko00970	Aminoacyl-tRNA biosynthesis	3834	1.2e-205	0.87	0.95	0.96
PGSC0003DMG200028503	K10841	ko03420	Nucleotide excision repair	278	2.4e-08	0.34	0.52	0.49
PGSC0003DMG200028505	K05278	ko00941	Flavonoid biosynthesis	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMG200028505	K05278	ko01100	Metabolic pathways	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMG200028505	K05278	ko01110	Biosynthesis of secondary metabolites	496	1.6e-21	0.30	0.45	0.93
PGSC0003DMG200028505	K05278	ko00941	Flavonoid biosynthesis	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMG200028505	K05278	ko01100	Metabolic pathways	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMG200028505	K05278	ko01110	Biosynthesis of secondary metabolites	686	5.3e-32	0.33	0.52	0.94
PGSC0003DMG200028505	K05277	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028505	K05277	ko01100	Metabolic pathways	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028505	K05277	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.36	0.55	0.74
PGSC0003DMG200028505	K05277	ko00941	Flavonoid biosynthesis	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMG200028505	K05277	ko01100	Metabolic pathways	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMG200028505	K05277	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.33	0.54	0.70
PGSC0003DMG200028505	K05278	ko00941	Flavonoid biosynthesis	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMG200028505	K05278	ko01100	Metabolic pathways	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMG200028505	K05278	ko01110	Biosynthesis of secondary metabolites	698	1.2e-32	0.34	0.52	0.94
PGSC0003DMG200027259	K12356	ko00940	Phenylpropanoid biosynthesis	674	2.4e-31	0.43	0.63	0.89
PGSC0003DMG200027261	K12356	ko00940	Phenylpropanoid biosynthesis	711	2.2e-33	0.33	0.51	0.88
PGSC0003DMG200027263	K08249	ko00460	Cyanoamino acid metabolism	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMG200027263	K08249	ko01100	Metabolic pathways	1191	7.4e-60	0.85	0.94	0.99
PGSC0003DMG200027263	K08249	ko00460	Cyanoamino acid metabolism	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMG200027263	K08249	ko01100	Metabolic pathways	3050	2.2e-162	0.75	0.86	1.00
PGSC0003DMG200027265	K03955	ko00190	Oxidative phosphorylation	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMG200027265	K03955	ko01100	Metabolic pathways	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMG200027265	K03955	ko05010	Alzheimer's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMG200027265	K03955	ko05012	Parkinson's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMG200027265	K03955	ko05016	Huntington's disease	788	1.3e-37	0.74	0.85	0.99
PGSC0003DMG200031484	K10879	ko03440	Homologous recombination	332	1.8e-12	0.35	0.43	0.93
PGSC0003DMG200031484	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.76
PGSC0003DMG200031484	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.92
PGSC0003DMG200031484	K10879	ko03440	Homologous recombination	614	5.0e-28	0.67	0.84	0.80
PGSC0003DMG200031485	K04733	ko04210	Apoptosis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMG200031485	K04733	ko04620	Toll-like receptor signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMG200031485	K04733	ko04722	Neurotrophin signaling pathway	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMG200031485	K04733	ko05140	Leishmaniasis	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMG200031485	K04733	ko05142	Chagas disease	725	3.7e-34	0.39	0.60	0.45
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	1059	1.4e-52	0.67	0.83	0.96
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	537	8.8e-24	0.61	0.75	0.70
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	323	5.6e-12	0.65	0.86	0.75
PGSC0003DMG200025391	K10869	ko03440	Homologous recombination	349	2.1e-13	0.65	0.78	0.97
PGSC0003DMG200025394	K10955	ko05110	Vibrio cholerae infection	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMG200025394	K10955	ko05146	Amoebiasis	241	3.1e-06	0.31	0.44	0.44
PGSC0003DMG200025398	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMG200025400	K01955	ko00240	Pyrimidine metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMG200025400	K01955	ko00250	Alanine, aspartate and glutamate metabolism	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMG200025400	K01955	ko01100	Metabolic pathways	577	3.6e-25	0.66	0.77	0.99
PGSC0003DMG200025400	K01955	ko00240	Pyrimidine metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMG200025400	K01955	ko00250	Alanine, aspartate and glutamate metabolism	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMG200025400	K01955	ko01100	Metabolic pathways	1082	7.6e-54	0.76	0.84	0.79
PGSC0003DMG200018371	K11423	ko00310	Lysine degradation	273	8.3e-06	0.26	0.44	0.76
PGSC0003DMG200018380	K00901	ko00561	Glycerolipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMG200018380	K00901	ko00564	Glycerophospholipid metabolism	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMG200018380	K00901	ko01100	Metabolic pathways	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMG200018380	K00901	ko04070	Phosphatidylinositol signaling system	1132	1.3e-56	0.40	0.59	0.80
PGSC0003DMG200018380	K00901	ko00561	Glycerolipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMG200018380	K00901	ko00564	Glycerophospholipid metabolism	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMG200018380	K00901	ko01100	Metabolic pathways	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMG200018380	K00901	ko04070	Phosphatidylinositol signaling system	418	3.2e-17	0.42	0.60	0.64
PGSC0003DMG200018380	K00901	ko00561	Glycerolipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMG200018380	K00901	ko00564	Glycerophospholipid metabolism	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMG200018380	K00901	ko01100	Metabolic pathways	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMG200018380	K00901	ko04070	Phosphatidylinositol signaling system	740	5.6e-35	0.41	0.61	0.84
PGSC0003DMG200018382	K00889	ko00562	Inositol phosphate metabolism	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko01100	Metabolic pathways	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko04070	Phosphatidylinositol signaling system	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko04144	Endocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko04666	Fc gamma R-mediated phagocytosis	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko04810	Regulation of actin cytoskeleton	679	1.3e-31	0.80	0.92	0.86
PGSC0003DMG200018382	K00889	ko00562	Inositol phosphate metabolism	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko01100	Metabolic pathways	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko04070	Phosphatidylinositol signaling system	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko04144	Endocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko04666	Fc gamma R-mediated phagocytosis	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko04810	Regulation of actin cytoskeleton	2119	4.9e-111	0.79	0.89	0.99
PGSC0003DMG200018382	K00889	ko00562	Inositol phosphate metabolism	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018382	K00889	ko01100	Metabolic pathways	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018382	K00889	ko04070	Phosphatidylinositol signaling system	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018382	K00889	ko04144	Endocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018382	K00889	ko04666	Fc gamma R-mediated phagocytosis	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018382	K00889	ko04810	Regulation of actin cytoskeleton	4716	2.8e-254	0.72	0.84	1.00
PGSC0003DMG200018386	K08490	ko04130	SNARE interactions in vesicular transport	1723	3.4e-89	0.64	0.77	0.99
PGSC0003DMG200020365	K04714	ko00600	Sphingolipid metabolism	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMG200020365	K04714	ko01100	Metabolic pathways	267	6.8e-09	0.31	0.44	0.68
PGSC0003DMG200020370	K01425	ko00250	Alanine, aspartate and glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K01425	ko00330	Arginine and proline metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K01425	ko00471	D-Glutamine and D-glutamate metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K01425	ko00910	Nitrogen metabolism	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K01425	ko01100	Metabolic pathways	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K01425	ko04964	Proximal tubule bicarbonate reclamation	279	2.4e-09	0.35	0.53	0.94
PGSC0003DMG200020370	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMG200020370	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.55
PGSC0003DMG200020370	K04424	ko04010	MAPK signaling pathway	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMG200020370	K04424	ko04530	Tight junction	572	1.5e-25	0.33	0.57	0.59
PGSC0003DMG200020370	K04424	ko04010	MAPK signaling pathway	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMG200020370	K04424	ko04530	Tight junction	505	1.2e-21	0.37	0.61	0.54
PGSC0003DMG200020370	K04424	ko04010	MAPK signaling pathway	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMG200020370	K04424	ko04530	Tight junction	370	6.2e-14	0.40	0.64	0.43
PGSC0003DMG200020370	K04424	ko04010	MAPK signaling pathway	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMG200020370	K04424	ko04530	Tight junction	513	4.2e-22	0.36	0.59	0.79
PGSC0003DMG200020371	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko00650	Butanoate metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko00660	C5-Branched dibasic acid metabolism	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko00770	Pantothenate and CoA biosynthesis	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko01100	Metabolic pathways	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko01110	Biosynthesis of secondary metabolites	1311	1.8e-66	0.61	0.77	0.70
PGSC0003DMG200020371	K01653	ko00290	Valine, leucine and isoleucine biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020371	K01653	ko00650	Butanoate metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020371	K01653	ko00660	C5-Branched dibasic acid metabolism	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020371	K01653	ko00770	Pantothenate and CoA biosynthesis	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020371	K01653	ko01100	Metabolic pathways	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020371	K01653	ko01110	Biosynthesis of secondary metabolites	2029	4.5e-106	0.66	0.81	0.86
PGSC0003DMG200020372	K01184	ko00040	Pentose and glucuronate interconversions	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMG200020372	K01184	ko00500	Starch and sucrose metabolism	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMG200020372	K01184	ko01100	Metabolic pathways	2078	8.9e-109	0.62	0.77	0.96
PGSC0003DMG200020373	K01184	ko00040	Pentose and glucuronate interconversions	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMG200020373	K01184	ko00500	Starch and sucrose metabolism	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMG200020373	K01184	ko01100	Metabolic pathways	1691	2.0e-87	0.52	0.69	0.99
PGSC0003DMG200020374	K01184	ko00040	Pentose and glucuronate interconversions	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMG200020374	K01184	ko00500	Starch and sucrose metabolism	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMG200020374	K01184	ko01100	Metabolic pathways	1783	1.7e-92	0.54	0.72	0.99
PGSC0003DMG200020375	K01099	ko00562	Inositol phosphate metabolism	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMG200020375	K01099	ko01100	Metabolic pathways	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMG200020375	K01099	ko04070	Phosphatidylinositol signaling system	747	4.4e-35	0.28	0.46	0.45
PGSC0003DMG200025449	K12831	ko03040	Spliceosome	350	1.8e-13	0.45	0.53	0.73
PGSC0003DMG200025455	K00850	ko00010	Glycolysis / Gluconeogenesis	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko00030	Pentose phosphate pathway	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko00051	Fructose and mannose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko00052	Galactose metabolism	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko01100	Metabolic pathways	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko01110	Biosynthesis of secondary metabolites	3201	1.0e-170	0.79	0.89	0.98
PGSC0003DMG200025455	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00010	Glycolysis / Gluconeogenesis	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00030	Pentose phosphate pathway	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00052	Galactose metabolism	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko01100	Metabolic pathways	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko01110	Biosynthesis of secondary metabolites	1353	8.6e-69	0.74	0.86	0.95
PGSC0003DMG200025455	K00850	ko00010	Glycolysis / Gluconeogenesis	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko00030	Pentose phosphate pathway	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko00051	Fructose and mannose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko00052	Galactose metabolism	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko01100	Metabolic pathways	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko01110	Biosynthesis of secondary metabolites	590	1.0e-26	0.76	0.92	0.93
PGSC0003DMG200025455	K00850	ko00010	Glycolysis / Gluconeogenesis	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025455	K00850	ko00030	Pentose phosphate pathway	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025455	K00850	ko00051	Fructose and mannose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025455	K00850	ko00052	Galactose metabolism	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025455	K00850	ko01100	Metabolic pathways	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025455	K00850	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.90	0.98	0.61
PGSC0003DMG200025456	K07195	ko04910	Insulin signaling pathway	2559	2.6e-135	0.53	0.69	0.99
PGSC0003DMG200025457	K00654	ko00600	Sphingolipid metabolism	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMG200025457	K00654	ko01100	Metabolic pathways	1733	9.5e-90	0.78	0.88	0.97
PGSC0003DMG200025457	K00654	ko00600	Sphingolipid metabolism	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMG200025457	K00654	ko01100	Metabolic pathways	3135	4.5e-167	0.77	0.89	0.99
PGSC0003DMG200025460	K05759	ko04810	Regulation of actin cytoskeleton	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMG200025460	K05759	ko05131	Shigellosis	962	3.2e-47	0.82	0.93	0.98
PGSC0003DMG200025461	K11481	ko04114	Oocyte meiosis	2035	2.1e-106	0.88	0.93	0.99
PGSC0003DMG200025461	K11481	ko04114	Oocyte meiosis	1409	7.0e-72	0.86	0.90	0.98
PGSC0003DMG200025461	K11481	ko04114	Oocyte meiosis	2258	1.0e-118	0.87	0.93	0.99
PGSC0003DMG200021697	K13228	ko00402	Benzoxazinoid biosynthesis	602	2.3e-27	0.35	0.53	0.85
PGSC0003DMG200021708	K06236	ko04510	Focal adhesion	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMG200021708	K06236	ko04512	ECM-receptor interaction	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMG200021708	K06236	ko05146	Amoebiasis	462	3.7e-19	0.38	0.52	0.88
PGSC0003DMG200021713	K07385	ko00902	Monoterpenoid biosynthesis	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMG200021713	K07385	ko01100	Metabolic pathways	312	4.5e-11	0.66	0.83	0.98
PGSC0003DMG200021713	K07385	ko00902	Monoterpenoid biosynthesis	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMG200021713	K07385	ko01100	Metabolic pathways	562	3.7e-25	0.59	0.75	0.96
PGSC0003DMG200045045	K01087	ko00500	Starch and sucrose metabolism	739	6.3e-35	0.43	0.53	0.93
PGSC0003DMG200038004	K12338	ko00942	Anthocyanin biosynthesis	415	4.7e-17	0.38	0.61	0.99
PGSC0003DMG200017049	K10846	ko03420	Nucleotide excision repair	395	1.8e-26	0.43	0.55	0.96
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	410	8.9e-17	0.34	0.45	1.00
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	1.00
PGSC0003DMG200017052	K12893	ko03040	Spliceosome	412	6.9e-17	0.35	0.46	0.93
PGSC0003DMG200017052	K12897	ko03040	Spliceosome	287	5.4e-10	0.35	0.48	0.90
PGSC0003DMG200017057	K06677	ko04111	Cell cycle - yeast	291	6.7e-11	0.49	0.58	0.63
PGSC0003DMG200017058	K06671	ko04110	Cell cycle	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMG200017058	K06671	ko04111	Cell cycle - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMG200017058	K06671	ko04113	Meiosis - yeast	275	2.2e-08	0.52	0.61	0.49
PGSC0003DMG200017060	K02084	ko04115	p53 signaling pathway	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko04210	Apoptosis	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko05010	Alzheimer's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko05012	Parkinson's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko05016	Huntington's disease	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200017060	K02084	ko05222	Small cell lung cancer	290	2.2e-06	0.26	0.42	0.59
PGSC0003DMG200007306	K01213	ko00040	Pentose and glucuronate interconversions	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMG200007306	K01213	ko00500	Starch and sucrose metabolism	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMG200007306	K01213	ko01100	Metabolic pathways	711	2.2e-33	0.36	0.53	0.81
PGSC0003DMG200007306	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007306	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007306	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007306	K01213	ko00040	Pentose and glucuronate interconversions	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMG200007306	K01213	ko00500	Starch and sucrose metabolism	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMG200007306	K01213	ko01100	Metabolic pathways	887	4.4e-43	0.36	0.54	0.80
PGSC0003DMG200007306	K01213	ko00040	Pentose and glucuronate interconversions	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007306	K01213	ko00500	Starch and sucrose metabolism	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007306	K01213	ko01100	Metabolic pathways	331	2.0e-12	0.34	0.50	0.76
PGSC0003DMG200007307	K04733	ko04210	Apoptosis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMG200007307	K04733	ko04620	Toll-like receptor signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMG200007307	K04733	ko04722	Neurotrophin signaling pathway	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMG200007307	K04733	ko05140	Leishmaniasis	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMG200007307	K04733	ko05142	Chagas disease	2462	5.9e-130	0.42	0.58	0.99
PGSC0003DMG200007308	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMG200007308	K02728	ko03050	Proteasome	1917	6.7e-100	0.92	0.96	0.99
PGSC0003DMG200007309	K07748	ko00100	Steroid biosynthesis	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMG200007309	K07748	ko01100	Metabolic pathways	1476	1.4e-75	0.52	0.69	0.86
PGSC0003DMG200007310	K13065	ko00940	Phenylpropanoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMG200007310	K13065	ko00941	Flavonoid biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMG200007310	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMG200007310	K13065	ko01110	Biosynthesis of secondary metabolites	400	3.2e-16	0.26	0.46	0.80
PGSC0003DMG200007312	K13065	ko00940	Phenylpropanoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMG200007312	K13065	ko00941	Flavonoid biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMG200007312	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMG200007312	K13065	ko01110	Biosynthesis of secondary metabolites	312	2.3e-11	0.27	0.43	0.95
PGSC0003DMG200007314	K13065	ko00940	Phenylpropanoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMG200007314	K13065	ko00941	Flavonoid biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMG200007314	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMG200007314	K13065	ko01110	Biosynthesis of secondary metabolites	393	7.7e-16	0.26	0.44	0.96
PGSC0003DMG200003594	K04424	ko04010	MAPK signaling pathway	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMG200003594	K04424	ko04530	Tight junction	823	5.0e-42	0.38	0.59	0.67
PGSC0003DMG200003596	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMG200003596	K12399	ko04142	Lysosome	739	6.3e-35	0.60	0.74	0.99
PGSC0003DMG200003596	K12399	ko04142	Lysosome	251	5.2e-08	0.60	0.81	0.98
PGSC0003DMG200003596	K12399	ko04142	Lysosome	895	1.6e-43	0.74	0.89	0.89
PGSC0003DMG200003596	K12399	ko04142	Lysosome	939	5.9e-46	0.70	0.86	0.98
PGSC0003DMG200003603	K08486	ko04130	SNARE interactions in vesicular transport	1591	6.4e-82	0.64	0.84	1.00
PGSC0003DMG200003605	K13082	ko00941	Flavonoid biosynthesis	2077	1.0e-108	0.73	0.87	0.85
PGSC0003DMG200003606	K07252	ko00510	N-Glycan biosynthesis	327	3.4e-12	0.40	0.57	0.69
PGSC0003DMG200003606	K07252	ko00510	N-Glycan biosynthesis	332	1.8e-12	0.37	0.54	0.66
PGSC0003DMG200003606	K07252	ko00510	N-Glycan biosynthesis	310	2.9e-11	0.38	0.54	0.74
PGSC0003DMG200003606	K07252	ko00510	N-Glycan biosynthesis	325	4.3e-12	0.36	0.53	0.54
PGSC0003DMG200003606	K07252	ko00510	N-Glycan biosynthesis	323	5.6e-12	0.36	0.53	0.47
PGSC0003DMG200003607	K08241	ko00592	alpha-Linolenic acid metabolism	614	5.0e-28	0.48	0.67	0.85
PGSC0003DMG200003607	K08241	ko00592	alpha-Linolenic acid metabolism	1032	4.4e-51	0.40	0.60	0.95
PGSC0003DMG200003608	K04123	ko00904	Diterpenoid biosynthesis	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMG200003608	K04123	ko01100	Metabolic pathways	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMG200003608	K04123	ko01110	Biosynthesis of secondary metabolites	814	4.6e-39	0.32	0.53	0.89
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	907	3.4e-44	0.46	0.65	0.99
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	925	3.5e-45	0.47	0.65	0.99
PGSC0003DMG200022920	K08233	ko00901	Indole alkaloid biosynthesis	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMG200022920	K08233	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.46	0.65	0.99
PGSC0003DMG200022921	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMG200022921	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.96
PGSC0003DMG200022921	K08233	ko00901	Indole alkaloid biosynthesis	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMG200022921	K08233	ko01110	Biosynthesis of secondary metabolites	641	1.6e-29	0.48	0.67	0.79
PGSC0003DMG200022924	K02183	ko04020	Calcium signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04070	Phosphatidylinositol signaling system	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04114	Oocyte meiosis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04270	Vascular smooth muscle contraction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04626	Plant-pathogen interaction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04720	Long-term potentiation	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04722	Neurotrophin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04740	Olfactory transduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04744	Phototransduction	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04745	Phototransduction - fly	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04910	Insulin signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04912	GnRH signaling pathway	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04916	Melanogenesis	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04970	Salivary secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko04971	Gastric acid secretion	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko05010	Alzheimer's disease	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K02183	ko05214	Glioma	408	1.1e-16	0.39	0.65	0.74
PGSC0003DMG200022924	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko00521	Streptomycin biosynthesis	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko00562	Inositol phosphate metabolism	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko01100	Metabolic pathways	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko01110	Biosynthesis of secondary metabolites	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022924	K01092	ko04070	Phosphatidylinositol signaling system	1792	5.3e-93	0.78	0.88	1.00
PGSC0003DMG200022929	K10206	ko00300	Lysine biosynthesis	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMG200022929	K10206	ko01110	Biosynthesis of secondary metabolites	2346	1.5e-123	0.65	0.79	0.97
PGSC0003DMG200022931	K09054	ko05010	Alzheimer's disease	246	4.8e-06	0.34	0.48	0.52
PGSC0003DMG200022931	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMG200022931	K09054	ko05010	Alzheimer's disease	253	3.1e-06	0.33	0.48	0.53
PGSC0003DMG200022933	K05349	ko00460	Cyanoamino acid metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMG200022933	K05349	ko00500	Starch and sucrose metabolism	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMG200022933	K05349	ko00940	Phenylpropanoid biosynthesis	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMG200022933	K05349	ko01110	Biosynthesis of secondary metabolites	823	1.5e-39	0.51	0.68	0.97
PGSC0003DMG200022933	K05349	ko00460	Cyanoamino acid metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMG200022933	K05349	ko00500	Starch and sucrose metabolism	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMG200022933	K05349	ko00940	Phenylpropanoid biosynthesis	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMG200022933	K05349	ko01110	Biosynthesis of secondary metabolites	4400	7.5e-237	0.67	0.80	0.99
PGSC0003DMG200022934	K03514	ko03018	RNA degradation	257	2.4e-08	0.31	0.48	0.85
PGSC0003DMG200025936	K03006	ko00230	Purine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMG200025936	K03006	ko00240	Pyrimidine metabolism	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMG200025936	K03006	ko01100	Metabolic pathways	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMG200025936	K03006	ko03020	RNA polymerase	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMG200025936	K03006	ko05016	Huntington's disease	702	7.4e-32	0.44	0.49	0.91
PGSC0003DMG200025960	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMG200025963	K06636	ko04110	Cell cycle	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMG200025963	K06636	ko04111	Cell cycle - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMG200025963	K06636	ko04113	Meiosis - yeast	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMG200025963	K06636	ko04114	Oocyte meiosis	563	1.5e-24	0.31	0.50	0.94
PGSC0003DMG200043190	K05282	ko00904	Diterpenoid biosynthesis	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMG200043190	K05282	ko01100	Metabolic pathways	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMG200043190	K05282	ko01110	Biosynthesis of secondary metabolites	389	1.3e-15	0.29	0.50	0.97
PGSC0003DMG200043199	K04508	ko04310	Wnt signaling pathway	2067	3.6e-108	0.65	0.79	1.00
PGSC0003DMG200006175	K00434	ko00053	Ascorbate and aldarate metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMG200006175	K00434	ko00480	Glutathione metabolism	2066	4.1e-108	0.85	0.90	1.00
PGSC0003DMG200006177	K02731	ko03050	Proteasome	1362	2.8e-69	0.85	0.90	0.99
PGSC0003DMG200006184	K03094	ko04110	Cell cycle	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04111	Cell cycle - yeast	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04114	Oocyte meiosis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04120	Ubiquitin mediated proteolysis	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04310	Wnt signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04350	TGF-beta signaling pathway	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006184	K03094	ko04710	Circadian rhythm - mammal	1081	8.7e-54	0.84	0.91	0.99
PGSC0003DMG200006185	K03094	ko04110	Cell cycle	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04111	Cell cycle - yeast	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04114	Oocyte meiosis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04120	Ubiquitin mediated proteolysis	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04310	Wnt signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04350	TGF-beta signaling pathway	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04710	Circadian rhythm - mammal	493	2.3e-21	0.88	0.92	0.99
PGSC0003DMG200006185	K03094	ko04110	Cell cycle	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04111	Cell cycle - yeast	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04114	Oocyte meiosis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04120	Ubiquitin mediated proteolysis	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04310	Wnt signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04350	TGF-beta signaling pathway	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006185	K03094	ko04710	Circadian rhythm - mammal	1023	1.4e-50	0.80	0.87	0.99
PGSC0003DMG200006186	K00015	ko00630	Glyoxylate and dicarboxylate metabolism	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMG200006186	K00015	ko01100	Metabolic pathways	869	4.3e-42	0.42	0.59	0.87
PGSC0003DMG200006189	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04010	MAPK signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04062	Chemokine signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04145	Phagosome	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04310	Wnt signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04360	Axon guidance	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04370	VEGF signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04510	Focal adhesion	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04520	Adherens junction	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04620	Toll-like receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04650	Natural killer cell mediated cytotoxicity	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04662	B cell receptor signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04664	Fc epsilon RI signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04666	Fc gamma R-mediated phagocytosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04670	Leukocyte transendothelial migration	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04722	Neurotrophin signaling pathway	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko04810	Regulation of actin cytoskeleton	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05100	Bacterial invasion of epithelial cells	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05131	Shigellosis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05200	Pathways in cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05210	Colorectal cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05211	Renal cell carcinoma	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05212	Pancreatic cancer	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006189	K04392	ko05416	Viral myocarditis	1593	5.0e-82	0.94	0.98	0.99
PGSC0003DMG200006191	K01190	ko00052	Galactose metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMG200006191	K01190	ko00511	Other glycan degradation	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMG200006191	K01190	ko00600	Sphingolipid metabolism	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMG200006191	K01190	ko01100	Metabolic pathways	2304	3.0e-121	0.44	0.60	0.83
PGSC0003DMG200009187	K02135	ko00190	Oxidative phosphorylation	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMG200009187	K02135	ko01100	Metabolic pathways	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMG200009187	K02135	ko05010	Alzheimer's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMG200009187	K02135	ko05012	Parkinson's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMG200009187	K02135	ko05016	Huntington's disease	535	1.1e-23	0.83	0.97	0.97
PGSC0003DMG200009189	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009189	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009189	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009189	K01230	ko00510	N-Glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMG200009189	K01230	ko00513	High-mannose type N-glycan biosynthesis	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMG200009189	K01230	ko01100	Metabolic pathways	3484	2.5e-186	0.72	0.84	0.99
PGSC0003DMG200009189	K01230	ko00510	N-Glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009189	K01230	ko00513	High-mannose type N-glycan biosynthesis	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009189	K01230	ko01100	Metabolic pathways	1622	1.3e-83	0.74	0.86	0.98
PGSC0003DMG200009195	K12828	ko03040	Spliceosome	1790	6.8e-93	0.76	0.82	0.85
PGSC0003DMG200011728	K07407	ko00052	Galactose metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMG200011728	K07407	ko00561	Glycerolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMG200011728	K07407	ko00600	Sphingolipid metabolism	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMG200011728	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	511	2.4e-22	0.31	0.50	0.56
PGSC0003DMG200011729	K03517	ko00760	Nicotinate and nicotinamide metabolism	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMG200011729	K03517	ko01100	Metabolic pathways	799	3.1e-38	0.59	0.70	0.91
PGSC0003DMG200011729	K03517	ko00760	Nicotinate and nicotinamide metabolism	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMG200011729	K03517	ko01100	Metabolic pathways	861	1.2e-41	0.46	0.57	0.99
PGSC0003DMG200011729	K03517	ko00760	Nicotinate and nicotinamide metabolism	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMG200011729	K03517	ko01100	Metabolic pathways	858	1.7e-41	0.46	0.57	0.98
PGSC0003DMG200011731	K00799	ko00480	Glutathione metabolism	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMG200011731	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMG200011731	K00799	ko00982	Drug metabolism - cytochrome P450	718	9.1e-34	0.45	0.65	0.90
PGSC0003DMG200011735	K11099	ko03040	Spliceosome	444	1.2e-18	0.88	0.94	0.79
PGSC0003DMG200011741	K02901	ko03010	Ribosome	1046	7.4e-52	0.90	0.96	0.99
PGSC0003DMG200026586	K07424	ko00140	Steroid hormone biosynthesis	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00591	Linoleic acid metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00830	Retinol metabolism	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00982	Drug metabolism - cytochrome P450	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko00983	Drug metabolism - other enzymes	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026586	K07424	ko01100	Metabolic pathways	1765	1.6e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00140	Steroid hormone biosynthesis	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00591	Linoleic acid metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00830	Retinol metabolism	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00982	Drug metabolism - cytochrome P450	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko00983	Drug metabolism - other enzymes	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026594	K07424	ko01100	Metabolic pathways	1760	3.1e-91	0.43	0.63	1.00
PGSC0003DMG200026596	K00948	ko00030	Pentose phosphate pathway	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMG200026596	K00948	ko00230	Purine metabolism	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMG200026596	K00948	ko01100	Metabolic pathways	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMG200026596	K00948	ko01110	Biosynthesis of secondary metabolites	2270	2.3e-119	0.70	0.80	0.99
PGSC0003DMG200026596	K00948	ko00030	Pentose phosphate pathway	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMG200026596	K00948	ko00230	Purine metabolism	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMG200026596	K00948	ko01100	Metabolic pathways	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMG200026596	K00948	ko01110	Biosynthesis of secondary metabolites	2414	2.6e-127	0.72	0.83	1.00
PGSC0003DMG200026603	K02132	ko00190	Oxidative phosphorylation	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMG200026603	K02132	ko01100	Metabolic pathways	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMG200026603	K02132	ko05010	Alzheimer's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMG200026603	K02132	ko05012	Parkinson's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMG200026603	K02132	ko05016	Huntington's disease	427	2.5e-17	0.90	0.91	0.98
PGSC0003DMG200023683	K01939	ko00230	Purine metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMG200023683	K01939	ko00250	Alanine, aspartate and glutamate metabolism	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMG200023683	K01939	ko01100	Metabolic pathways	3284	2.7e-175	0.83	0.92	0.90
PGSC0003DMG200023686	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMG200023686	K11422	ko00310	Lysine degradation	979	4.8e-47	0.32	0.46	0.96
PGSC0003DMG200023687	K00559	ko00100	Steroid biosynthesis	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMG200023687	K00559	ko01100	Metabolic pathways	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMG200023687	K00559	ko01110	Biosynthesis of secondary metabolites	2084	4.1e-109	0.72	0.88	0.40
PGSC0003DMG200023687	K02996	ko03010	Ribosome	1992	4.9e-104	0.63	0.74	1.00
PGSC0003DMG200029172	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMG200029172	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMG200029172	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMG200029172	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMG200029172	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.90
PGSC0003DMG200029172	K01563	ko00361	gamma-Hexachlorocyclohexane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMG200029172	K01563	ko00626	Naphthalene and anthracene degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMG200029172	K01563	ko00631	1,2-Dichloroethane degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMG200029172	K01563	ko00641	3-Chloroacrylic acid degradation	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMG200029172	K01563	ko01100	Metabolic pathways	582	2.9e-26	0.37	0.56	0.65
PGSC0003DMG200029179	K01648	ko00020	Citrate cycle (TCA cycle)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMG200029179	K01648	ko00720	Reductive carboxylate cycle (CO2 fixation)	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMG200029179	K01648	ko01100	Metabolic pathways	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMG200029179	K01648	ko01110	Biosynthesis of secondary metabolites	3007	5.1e-160	0.89	0.96	0.99
PGSC0003DMG200029180	K08233	ko00901	Indole alkaloid biosynthesis	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMG200029180	K08233	ko01110	Biosynthesis of secondary metabolites	282	1.0e-09	0.47	0.66	0.72
PGSC0003DMG200008545	K12118	ko04712	Circadian rhythm - plant	3105	2.0e-165	0.85	0.94	0.91
PGSC0003DMG200008545	K12118	ko04712	Circadian rhythm - plant	4157	1.9e-223	0.83	0.91	0.99
PGSC0003DMG200008545	K12118	ko04712	Circadian rhythm - plant	502	7.5e-22	0.68	0.77	0.95
PGSC0003DMG200008551	K11262	ko00061	Fatty acid biosynthesis	14832	0.	0.80	0.87	1.00
PGSC0003DMG200008551	K11262	ko00620	Pyruvate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMG200008551	K11262	ko00640	Propanoate metabolism	14832	0.	0.80	0.87	1.00
PGSC0003DMG200008551	K11262	ko01100	Metabolic pathways	14832	0.	0.80	0.87	1.00
PGSC0003DMG200008551	K11262	ko04910	Insulin signaling pathway	14832	0.	0.80	0.87	1.00
PGSC0003DMG200008551	K11262	ko00061	Fatty acid biosynthesis	16040	0.	0.84	0.92	0.99
PGSC0003DMG200008551	K11262	ko00620	Pyruvate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMG200008551	K11262	ko00640	Propanoate metabolism	16040	0.	0.84	0.92	0.99
PGSC0003DMG200008551	K11262	ko01100	Metabolic pathways	16040	0.	0.84	0.92	0.99
PGSC0003DMG200008551	K11262	ko04910	Insulin signaling pathway	16040	0.	0.84	0.92	0.99
PGSC0003DMG200008553	K01210	ko00500	Starch and sucrose metabolism	2599	1.6e-137	0.64	0.77	0.92
PGSC0003DMG200008557	K13030	ko00460	Cyanoamino acid metabolism	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMG200008557	K13030	ko01110	Biosynthesis of secondary metabolites	1570	9.3e-81	0.43	0.63	0.98
PGSC0003DMG200005540	K02183	ko04020	Calcium signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04070	Phosphatidylinositol signaling system	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04114	Oocyte meiosis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04270	Vascular smooth muscle contraction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04626	Plant-pathogen interaction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04720	Long-term potentiation	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04722	Neurotrophin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04740	Olfactory transduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04744	Phototransduction	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04745	Phototransduction - fly	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04910	Insulin signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04912	GnRH signaling pathway	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04916	Melanogenesis	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04970	Salivary secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko04971	Gastric acid secretion	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko05010	Alzheimer's disease	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005540	K02183	ko05214	Glioma	857	2.0e-41	0.77	0.84	0.92
PGSC0003DMG200005545	K07199	ko04910	Insulin signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMG200005545	K07199	ko04920	Adipocytokine signaling pathway	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMG200005545	K07199	ko05410	Hypertrophic cardiomyopathy (HCM)	1296	1.2e-65	0.73	0.80	0.98
PGSC0003DMG200005553	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMG200005553	K00517	ko00626	Naphthalene and anthracene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMG200005553	K00517	ko00903	Limonene and pinene degradation	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMG200005553	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMG200005553	K00517	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.46	0.67	0.98
PGSC0003DMG200005553	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMG200005553	K00517	ko00626	Naphthalene and anthracene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMG200005553	K00517	ko00903	Limonene and pinene degradation	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMG200005553	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMG200005553	K00517	ko01110	Biosynthesis of secondary metabolites	1587	1.1e-81	0.46	0.68	0.99
PGSC0003DMG200005553	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMG200005553	K00517	ko00626	Naphthalene and anthracene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMG200005553	K00517	ko00903	Limonene and pinene degradation	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMG200005553	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMG200005553	K00517	ko01110	Biosynthesis of secondary metabolites	1802	1.5e-93	0.47	0.67	1.00
PGSC0003DMG200005553	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMG200005553	K00517	ko00626	Naphthalene and anthracene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMG200005553	K00517	ko00903	Limonene and pinene degradation	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMG200005553	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMG200005553	K00517	ko01110	Biosynthesis of secondary metabolites	1134	1.0e-56	0.45	0.66	0.99
PGSC0003DMG200005553	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMG200005553	K00517	ko00626	Naphthalene and anthracene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMG200005553	K00517	ko00903	Limonene and pinene degradation	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMG200005553	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMG200005553	K00517	ko01110	Biosynthesis of secondary metabolites	1790	6.8e-93	0.47	0.68	0.98
PGSC0003DMG200005554	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMG200005554	K00517	ko00626	Naphthalene and anthracene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMG200005554	K00517	ko00903	Limonene and pinene degradation	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMG200005554	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMG200005554	K00517	ko01110	Biosynthesis of secondary metabolites	542	4.6e-24	0.42	0.59	0.86
PGSC0003DMG200005557	K01178	ko00500	Starch and sucrose metabolism	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMG200005557	K01178	ko01100	Metabolic pathways	356	3.3e-10	0.24	0.39	0.83
PGSC0003DMG200041977	K11229	ko04011	MAPK signaling pathway - yeast	572	7.9e-25	0.35	0.57	0.79
PGSC0003DMG200041983	K00799	ko00480	Glutathione metabolism	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMG200041983	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMG200041983	K00799	ko00982	Drug metabolism - cytochrome P450	958	5.3e-47	0.51	0.73	0.99
PGSC0003DMG200042005	K00059	ko00061	Fatty acid biosynthesis	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMG200042005	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMG200042005	K00059	ko01100	Metabolic pathways	1410	6.2e-72	0.65	0.80	1.00
PGSC0003DMG200037693	K10781	ko00061	Fatty acid biosynthesis	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMG200037693	K10781	ko01100	Metabolic pathways	1173	7.3e-59	0.49	0.65	0.78
PGSC0003DMG200037698	K12338	ko00942	Anthocyanin biosynthesis	489	3.9e-21	0.49	0.63	0.83
PGSC0003DMG200017641	K04618	ko00052	Galactose metabolism	474	9.6e-20	0.28	0.43	1.00
PGSC0003DMG200017653	K06666	ko04111	Cell cycle - yeast	459	2.0e-19	0.25	0.39	0.89
PGSC0003DMG200017653	K06666	ko04111	Cell cycle - yeast	496	2.1e-21	0.27	0.43	0.68
PGSC0003DMG200020993	K09839	ko00906	Carotenoid biosynthesis	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMG200020993	K09839	ko01100	Metabolic pathways	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMG200020993	K09839	ko01110	Biosynthesis of secondary metabolites	871	3.3e-42	0.54	0.60	0.96
PGSC0003DMG200024779	K02342	ko00230	Purine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko00240	Pyrimidine metabolism	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko01100	Metabolic pathways	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko03030	DNA replication	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko03430	Mismatch repair	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko03440	Homologous recombination	360	6.3e-14	0.36	0.53	0.63
PGSC0003DMG200024779	K02342	ko00230	Purine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024779	K02342	ko00240	Pyrimidine metabolism	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024779	K02342	ko01100	Metabolic pathways	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024779	K02342	ko03030	DNA replication	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024779	K02342	ko03430	Mismatch repair	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024779	K02342	ko03440	Homologous recombination	305	1.1e-10	0.32	0.47	0.66
PGSC0003DMG200024782	K00754	ko00051	Fructose and mannose metabolism	367	2.1e-14	0.29	0.47	0.74
PGSC0003DMG200002993	K02183	ko04020	Calcium signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04070	Phosphatidylinositol signaling system	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04114	Oocyte meiosis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04270	Vascular smooth muscle contraction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04626	Plant-pathogen interaction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04720	Long-term potentiation	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04722	Neurotrophin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04740	Olfactory transduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04744	Phototransduction	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04745	Phototransduction - fly	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04910	Insulin signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04912	GnRH signaling pathway	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04916	Melanogenesis	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04970	Salivary secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko04971	Gastric acid secretion	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko05010	Alzheimer's disease	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002993	K02183	ko05214	Glioma	323	5.6e-12	0.34	0.60	0.73
PGSC0003DMG200002994	K02183	ko04020	Calcium signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04070	Phosphatidylinositol signaling system	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04114	Oocyte meiosis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04270	Vascular smooth muscle contraction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04626	Plant-pathogen interaction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04720	Long-term potentiation	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04722	Neurotrophin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04740	Olfactory transduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04744	Phototransduction	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04745	Phototransduction - fly	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04910	Insulin signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04912	GnRH signaling pathway	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04916	Melanogenesis	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04970	Salivary secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko04971	Gastric acid secretion	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko05010	Alzheimer's disease	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200002994	K02183	ko05214	Glioma	320	8.2e-12	0.35	0.60	0.70
PGSC0003DMG200004283	K13065	ko00940	Phenylpropanoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMG200004283	K13065	ko00941	Flavonoid biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMG200004283	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMG200004283	K13065	ko01110	Biosynthesis of secondary metabolites	611	7.3e-28	0.33	0.49	0.84
PGSC0003DMG200004285	K00558	ko00270	Cysteine and methionine metabolism	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMG200004285	K00558	ko01100	Metabolic pathways	4541	1.3e-244	0.59	0.72	1.00
PGSC0003DMG200004288	K04506	ko04115	p53 signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMG200004288	K04506	ko04120	Ubiquitin mediated proteolysis	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMG200004288	K04506	ko04310	Wnt signaling pathway	2112	1.2e-110	0.76	0.88	0.99
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	854	2.9e-41	0.55	0.68	0.88
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	819	2.5e-39	0.49	0.62	0.95
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMG200004289	K11424	ko00310	Lysine degradation	1175	5.7e-59	0.45	0.56	0.86
PGSC0003DMG200004299	K08065	ko04612	Antigen processing and presentation	639	2.1e-29	0.62	0.78	0.79
PGSC0003DMG200008032	K11228	ko04011	MAPK signaling pathway - yeast	967	1.7e-47	0.36	0.50	0.73
PGSC0003DMG200008032	K11228	ko04011	MAPK signaling pathway - yeast	893	2.0e-43	0.34	0.48	0.73
PGSC0003DMG200008032	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMG200008032	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMG200008032	K04428	ko04010	MAPK signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMG200008032	K04428	ko04912	GnRH signaling pathway	328	3.0e-12	0.54	0.67	0.35
PGSC0003DMG200008032	K04420	ko04010	MAPK signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMG200008032	K04420	ko04540	Gap junction	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMG200008032	K04420	ko04912	GnRH signaling pathway	629	7.4e-29	0.32	0.47	0.85
PGSC0003DMG200008046	K05681	ko02010	ABC transporters	905	4.4e-44	0.31	0.51	0.55
PGSC0003DMG200046254	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMG200046254	K00224	ko00364	Fluorobenzoate degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMG200046254	K00224	ko00628	Fluorene degradation	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMG200046254	K00224	ko00640	Propanoate metabolism	276	2.2e-09	0.49	0.62	0.83
PGSC0003DMG200039199	K08243	ko00941	Flavonoid biosynthesis	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMG200039199	K08243	ko01110	Biosynthesis of secondary metabolites	386	1.9e-15	0.52	0.71	0.88
PGSC0003DMG200039211	K10760	ko00908	Zeatin biosynthesis	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMG200039211	K10760	ko01100	Metabolic pathways	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMG200039211	K10760	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.44	0.60	0.94
PGSC0003DMG200038227	K10591	ko04120	Ubiquitin mediated proteolysis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMG200038227	K10591	ko04144	Endocytosis	251	1.2e-15	0.58	0.72	0.86
PGSC0003DMG200038230	K00079	ko00590	Arachidonic acid metabolism	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMG200038230	K00079	ko01100	Metabolic pathways	278	1.7e-09	0.37	0.58	0.92
PGSC0003DMG200038234	K01358	ko04112	Cell cycle - Caulobacter	487	5.0e-21	0.75	0.89	0.96
PGSC0003DMG200038238	K06268	ko04010	MAPK signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04020	Calcium signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04114	Oocyte meiosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04210	Apoptosis	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04310	Wnt signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04360	Axon guidance	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04370	VEGF signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04650	Natural killer cell mediated cytotoxicity	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04660	T cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04662	B cell receptor signaling pathway	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko04720	Long-term potentiation	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko05010	Alzheimer's disease	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038238	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1298	9.3e-66	0.73	0.84	0.97
PGSC0003DMG200038249	K12338	ko00942	Anthocyanin biosynthesis	303	7.1e-11	0.33	0.62	0.87
PGSC0003DMG200016850	K09841	ko00906	Carotenoid biosynthesis	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMG200016850	K09841	ko01100	Metabolic pathways	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMG200016850	K09841	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.46	0.60	0.91
PGSC0003DMG200010484	K04733	ko04210	Apoptosis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko04620	Toll-like receptor signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko04722	Neurotrophin signaling pathway	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko05140	Leishmaniasis	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010484	K04733	ko05142	Chagas disease	758	5.7e-36	0.37	0.59	0.93
PGSC0003DMG200010485	K00858	ko00760	Nicotinate and nicotinamide metabolism	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMG200010485	K00858	ko01100	Metabolic pathways	3276	7.5e-175	0.76	0.87	0.99
PGSC0003DMG200010485	K00858	ko00760	Nicotinate and nicotinamide metabolism	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMG200010485	K00858	ko01100	Metabolic pathways	3414	1.8e-182	0.76	0.87	0.99
PGSC0003DMG200010485	K00858	ko00760	Nicotinate and nicotinamide metabolism	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMG200010485	K00858	ko01100	Metabolic pathways	1815	2.8e-94	0.69	0.81	0.93
PGSC0003DMG200010485	K00858	ko00760	Nicotinate and nicotinamide metabolism	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMG200010485	K00858	ko01100	Metabolic pathways	1330	1.6e-67	0.74	0.87	0.88
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	1015	3.8e-50	0.47	0.69	0.91
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.50	0.72	0.98
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	1247	6.1e-63	0.50	0.71	0.98
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	1237	2.2e-62	0.49	0.71	0.98
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.45	0.70	0.98
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	497	1.4e-21	0.47	0.69	0.93
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	450	5.5e-19	0.45	0.66	0.97
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	407	1.3e-16	0.46	0.68	0.85
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	274	2.8e-09	0.51	0.72	0.80
PGSC0003DMG200010486	K09753	ko00940	Phenylpropanoid biosynthesis	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMG200010486	K09753	ko01100	Metabolic pathways	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMG200010486	K09753	ko01110	Biosynthesis of secondary metabolites	1254	2.5e-63	0.51	0.71	0.95
PGSC0003DMG200010487	K03066	ko03050	Proteasome	3166	8.7e-169	0.90	0.92	1.00
PGSC0003DMG200010487	K03066	ko03050	Proteasome	3211	2.9e-171	0.93	0.96	1.00
PGSC0003DMG200010490	K01199	ko00500	Starch and sucrose metabolism	449	6.3e-19	0.54	0.78	0.99
PGSC0003DMG200010491	K01199	ko00500	Starch and sucrose metabolism	459	1.8e-19	0.55	0.79	0.99
PGSC0003DMG200010492	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMG200010492	K01199	ko00500	Starch and sucrose metabolism	1335	8.5e-68	0.51	0.70	0.98
PGSC0003DMG200010492	K01199	ko00500	Starch and sucrose metabolism	1342	3.5e-68	0.51	0.68	1.00
PGSC0003DMG200010492	K01199	ko00500	Starch and sucrose metabolism	1174	6.4e-59	0.52	0.71	1.00
PGSC0003DMG200007155	K13065	ko00940	Phenylpropanoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMG200007155	K13065	ko00941	Flavonoid biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMG200007155	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMG200007155	K13065	ko01110	Biosynthesis of secondary metabolites	849	5.4e-41	0.35	0.50	0.98
PGSC0003DMG200007158	K11252	ko05322	Systemic lupus erythematosus	1039	1.8e-51	0.89	0.92	0.99
PGSC0003DMG200007159	K11252	ko05322	Systemic lupus erythematosus	1055	2.4e-52	0.89	0.94	0.99
PGSC0003DMG200007163	K00902	ko00510	N-Glycan biosynthesis	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMG200007163	K00902	ko01100	Metabolic pathways	1781	2.1e-92	0.58	0.73	0.76
PGSC0003DMG200007163	K00902	ko00510	N-Glycan biosynthesis	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMG200007163	K00902	ko01100	Metabolic pathways	1009	8.1e-50	0.85	0.94	0.99
PGSC0003DMG200007163	K00902	ko00510	N-Glycan biosynthesis	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMG200007163	K00902	ko01100	Metabolic pathways	1985	1.2e-103	0.64	0.80	0.66
PGSC0003DMG200007169	K00059	ko00061	Fatty acid biosynthesis	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMG200007169	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMG200007169	K00059	ko01100	Metabolic pathways	1422	1.4e-72	0.60	0.80	1.00
PGSC0003DMG200007169	K00059	ko00061	Fatty acid biosynthesis	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMG200007169	K00059	ko01040	Biosynthesis of unsaturated fatty acids	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMG200007169	K00059	ko01100	Metabolic pathways	925	3.5e-45	0.59	0.80	0.85
PGSC0003DMG200007169	K00059	ko00061	Fatty acid biosynthesis	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMG200007169	K00059	ko01040	Biosynthesis of unsaturated fatty acids	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMG200007169	K00059	ko01100	Metabolic pathways	673	2.8e-31	0.60	0.79	0.89
PGSC0003DMG200007171	K13065	ko00940	Phenylpropanoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMG200007171	K13065	ko00941	Flavonoid biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMG200007171	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMG200007171	K13065	ko01110	Biosynthesis of secondary metabolites	395	6.0e-16	0.28	0.44	0.97
PGSC0003DMG200007172	K05868	ko04110	Cell cycle	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMG200007172	K05868	ko04115	p53 signaling pathway	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMG200007172	K05868	ko04914	Progesterone-mediated oocyte maturation	2306	2.4e-121	0.64	0.78	0.99
PGSC0003DMG200007173	K06027	ko04962	Vasopressin-regulated water reabsorption	2042	8.6e-107	0.46	0.64	0.77
PGSC0003DMG200007173	K06027	ko04962	Vasopressin-regulated water reabsorption	2109	1.7e-110	0.44	0.61	0.79
PGSC0003DMG200007173	K06027	ko04962	Vasopressin-regulated water reabsorption	1386	1.3e-70	0.45	0.63	0.98
PGSC0003DMG200003395	K03950	ko00190	Oxidative phosphorylation	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMG200003395	K03950	ko01100	Metabolic pathways	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMG200003395	K03950	ko05010	Alzheimer's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMG200003395	K03950	ko05012	Parkinson's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMG200003395	K03950	ko05016	Huntington's disease	221	2.4e-06	0.52	0.80	0.41
PGSC0003DMG200003406	K04733	ko04210	Apoptosis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMG200003406	K04733	ko04620	Toll-like receptor signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMG200003406	K04733	ko04722	Neurotrophin signaling pathway	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMG200003406	K04733	ko05140	Leishmaniasis	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMG200003406	K04733	ko05142	Chagas disease	2150	9.5e-113	0.39	0.57	0.96
PGSC0003DMG200003408	K00801	ko00100	Steroid biosynthesis	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMG200003408	K00801	ko01100	Metabolic pathways	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMG200003408	K00801	ko01110	Biosynthesis of secondary metabolites	2458	9.8e-130	0.75	0.85	0.99
PGSC0003DMG200003408	K00801	ko00100	Steroid biosynthesis	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMG200003408	K00801	ko01100	Metabolic pathways	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMG200003408	K00801	ko01110	Biosynthesis of secondary metabolites	1789	7.7e-93	0.75	0.87	0.98
PGSC0003DMG200003408	K00801	ko00100	Steroid biosynthesis	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMG200003408	K00801	ko01100	Metabolic pathways	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMG200003408	K00801	ko01110	Biosynthesis of secondary metabolites	2752	5.9e-146	0.77	0.88	1.00
PGSC0003DMG200003412	K10643	ko03018	RNA degradation	1666	4.7e-86	0.39	0.53	0.98
PGSC0003DMG200028566	K01695	ko00260	Glycine, serine and threonine metabolism	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMG200028566	K01695	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMG200028566	K01695	ko01100	Metabolic pathways	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMG200028566	K01695	ko01110	Biosynthesis of secondary metabolites	1834	2.5e-95	0.82	0.91	0.99
PGSC0003DMG200028569	K01834	ko00010	Glycolysis / Gluconeogenesis	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMG200028569	K01834	ko01100	Metabolic pathways	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMG200028569	K01834	ko01110	Biosynthesis of secondary metabolites	354	1.1e-13	0.40	0.54	0.79
PGSC0003DMG200028569	K01834	ko00010	Glycolysis / Gluconeogenesis	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMG200028569	K01834	ko01100	Metabolic pathways	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMG200028569	K01834	ko01110	Biosynthesis of secondary metabolites	475	2.3e-20	0.37	0.53	0.71
PGSC0003DMG200028570	K01834	ko00010	Glycolysis / Gluconeogenesis	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMG200028570	K01834	ko01100	Metabolic pathways	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMG200028570	K01834	ko01110	Biosynthesis of secondary metabolites	249	6.7e-08	0.34	0.49	0.87
PGSC0003DMG200028570	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko00010	Glycolysis / Gluconeogenesis	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMG200028570	K01834	ko01100	Metabolic pathways	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMG200028570	K01834	ko01110	Biosynthesis of secondary metabolites	301	9.1e-11	0.31	0.47	0.78
PGSC0003DMG200028570	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.33	0.49	0.66
PGSC0003DMG200028570	K01834	ko00010	Glycolysis / Gluconeogenesis	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMG200028570	K01834	ko01100	Metabolic pathways	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMG200028570	K01834	ko01110	Biosynthesis of secondary metabolites	300	1.0e-10	0.32	0.48	0.66
PGSC0003DMG200020636	K02866	ko03010	Ribosome	638	2.4e-29	0.44	0.57	0.91
PGSC0003DMG200020636	K02866	ko03010	Ribosome	1447	5.6e-74	0.92	0.95	0.99
PGSC0003DMG200020637	K02995	ko03010	Ribosome	1676	1.3e-86	0.89	0.94	0.99
PGSC0003DMG200020640	K11820	ko00380	Tryptophan metabolism	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMG200020640	K11820	ko00966	Glucosinolate biosynthesis	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMG200020640	K11820	ko01110	Biosynthesis of secondary metabolites	1548	1.5e-79	0.44	0.66	0.98
PGSC0003DMG200020642	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMG200020642	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2201	1.5e-115	0.84	0.91	0.96
PGSC0003DMG200020642	K11518	ko05014	Amyotrophic lateral sclerosis (ALS)	2306	2.4e-121	0.85	0.92	1.00
PGSC0003DMG200020646	K10949	ko05110	Vibrio cholerae infection	466	7.2e-20	0.31	0.54	0.82
PGSC0003DMG200020646	K10949	ko05110	Vibrio cholerae infection	511	2.4e-22	0.34	0.58	0.81
PGSC0003DMG200025298	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00010	Glycolysis / Gluconeogenesis	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00230	Purine metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00620	Pyruvate metabolism	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko00710	Carbon fixation in photosynthetic organisms	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko01100	Metabolic pathways	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko01110	Biosynthesis of secondary metabolites	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025298	K00873	ko04930	Type II diabetes mellitus	3888	1.3e-208	0.91	0.96	1.00
PGSC0003DMG200025299	K07407	ko00052	Galactose metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMG200025299	K07407	ko00561	Glycerolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMG200025299	K07407	ko00600	Sphingolipid metabolism	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMG200025299	K07407	ko00603	Glycosphingolipid biosynthesis - globo series	1861	8.3e-97	0.56	0.68	0.99
PGSC0003DMG200025301	K12832	ko03040	Spliceosome	617	3.4e-28	0.97	1.00	0.92
PGSC0003DMG200025301	K12832	ko03040	Spliceosome	750	1.6e-35	0.98	0.99	0.99
PGSC0003DMG200025302	K01929	ko00300	Lysine biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMG200025302	K01929	ko00550	Peptidoglycan biosynthesis	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMG200025302	K01929	ko01100	Metabolic pathways	839	1.9e-40	0.40	0.57	0.97
PGSC0003DMG200025302	K01929	ko00300	Lysine biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMG200025302	K01929	ko00550	Peptidoglycan biosynthesis	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMG200025302	K01929	ko01100	Metabolic pathways	949	1.7e-46	0.38	0.55	0.89
PGSC0003DMG200025304	K10802	ko03410	Base excision repair	493	2.3e-21	0.43	0.61	0.73
PGSC0003DMG200025304	K10802	ko03410	Base excision repair	507	4.0e-22	0.45	0.69	0.66
PGSC0003DMG200025305	K02976	ko03010	Ribosome	989	1.0e-48	0.88	0.91	0.99
PGSC0003DMG200025307	K13082	ko00941	Flavonoid biosynthesis	1070	3.5e-53	0.45	0.64	0.94
PGSC0003DMG200025309	K00872	ko00260	Glycine, serine and threonine metabolism	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMG200025309	K00872	ko01100	Metabolic pathways	2337	4.6e-123	0.77	0.86	0.99
PGSC0003DMG200025311	K12824	ko03040	Spliceosome	4375	1.8e-235	0.65	0.78	1.00
PGSC0003DMG200025311	K12824	ko03040	Spliceosome	4842	3.2e-261	0.58	0.71	1.00
PGSC0003DMG200025311	K12824	ko03040	Spliceosome	4853	7.8e-262	0.58	0.71	1.00
PGSC0003DMG200025314	K11423	ko00310	Lysine degradation	2609	4.6e-138	0.54	0.67	0.47
PGSC0003DMG200021498	K08486	ko04130	SNARE interactions in vesicular transport	293	2.5e-10	0.62	0.75	0.76
PGSC0003DMG200021498	K08486	ko04130	SNARE interactions in vesicular transport	1668	3.6e-86	0.88	0.94	0.50
PGSC0003DMG200021498	K08486	ko04130	SNARE interactions in vesicular transport	2079	7.8e-109	0.82	0.90	1.00
PGSC0003DMG200021499	K01937	ko00240	Pyrimidine metabolism	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMG200021499	K01937	ko01100	Metabolic pathways	3679	4.4e-197	0.75	0.82	0.86
PGSC0003DMG200021499	K01937	ko00240	Pyrimidine metabolism	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMG200021499	K01937	ko01100	Metabolic pathways	3754	3.2e-201	0.85	0.93	1.00
PGSC0003DMG200021499	K01937	ko00240	Pyrimidine metabolism	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMG200021499	K01937	ko01100	Metabolic pathways	3417	1.2e-182	0.86	0.93	0.96
PGSC0003DMG200021499	K01937	ko00240	Pyrimidine metabolism	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMG200021499	K01937	ko01100	Metabolic pathways	4189	3.3e-225	0.82	0.90	1.00
PGSC0003DMG200021510	K03129	ko03022	Basal transcription factors	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMG200021510	K03129	ko05016	Huntington's disease	381	9.1e-13	0.25	0.43	0.81
PGSC0003DMG200021510	K04446	ko04310	Wnt signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200021510	K04446	ko04360	Axon guidance	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200021510	K04446	ko04370	VEGF signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200021510	K04446	ko04650	Natural killer cell mediated cytotoxicity	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200021510	K04446	ko04660	T cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200021510	K04446	ko04662	B cell receptor signaling pathway	339	1.3e-09	0.26	0.42	0.89
PGSC0003DMG200040538	K02183	ko04020	Calcium signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04070	Phosphatidylinositol signaling system	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04114	Oocyte meiosis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04270	Vascular smooth muscle contraction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04626	Plant-pathogen interaction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04720	Long-term potentiation	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04722	Neurotrophin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04740	Olfactory transduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04744	Phototransduction	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04745	Phototransduction - fly	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04910	Insulin signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04912	GnRH signaling pathway	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04916	Melanogenesis	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04970	Salivary secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko04971	Gastric acid secretion	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko05010	Alzheimer's disease	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040538	K02183	ko05214	Glioma	301	9.1e-11	0.33	0.59	0.83
PGSC0003DMG200040541	K11251	ko05322	Systemic lupus erythematosus	594	6.3e-27	0.59	0.71	0.94
PGSC0003DMG200040563	K10875	ko03440	Homologous recombination	290	1.6e-09	0.30	0.49	0.78
PGSC0003DMG200004997	K00166	ko00280	Valine, leucine and isoleucine degradation	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMG200004997	K00166	ko01100	Metabolic pathways	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMG200004997	K00166	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.70	0.84	0.87
PGSC0003DMG200004997	K00166	ko00280	Valine, leucine and isoleucine degradation	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMG200004997	K00166	ko01100	Metabolic pathways	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMG200004997	K00166	ko01110	Biosynthesis of secondary metabolites	899	9.5e-44	0.61	0.82	0.97
PGSC0003DMG200004997	K00166	ko00280	Valine, leucine and isoleucine degradation	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMG200004997	K00166	ko01100	Metabolic pathways	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMG200004997	K00166	ko01110	Biosynthesis of secondary metabolites	919	7.5e-45	0.65	0.81	0.96
PGSC0003DMG200004997	K00166	ko00280	Valine, leucine and isoleucine degradation	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMG200004997	K00166	ko01100	Metabolic pathways	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMG200004997	K00166	ko01110	Biosynthesis of secondary metabolites	2409	4.9e-127	0.70	0.84	1.00
PGSC0003DMG200004997	K00166	ko00280	Valine, leucine and isoleucine degradation	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMG200004997	K00166	ko01100	Metabolic pathways	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMG200004997	K00166	ko01110	Biosynthesis of secondary metabolites	670	4.0e-31	0.80	0.92	0.99
PGSC0003DMG200004998	K00166	ko00280	Valine, leucine and isoleucine degradation	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMG200004998	K00166	ko01100	Metabolic pathways	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMG200004998	K00166	ko01110	Biosynthesis of secondary metabolites	1216	3.1e-61	0.48	0.62	0.90
PGSC0003DMG200004999	K01507	ko00190	Oxidative phosphorylation	1594	4.4e-82	0.86	0.94	1.00
PGSC0003DMG200005008	K01762	ko00270	Cysteine and methionine metabolism	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMG200005008	K01762	ko01110	Biosynthesis of secondary metabolites	2434	2.1e-128	0.66	0.82	0.88
PGSC0003DMG200005010	K10852	ko00311	Penicillin and cephalosporin biosynthesis	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMG200005010	K10852	ko01100	Metabolic pathways	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMG200005010	K10852	ko01110	Biosynthesis of secondary metabolites	218	3.8e-06	0.32	0.50	0.65
PGSC0003DMG200005011	K12869	ko03040	Spliceosome	4306	1.2e-231	0.51	0.64	1.00
PGSC0003DMG200005011	K12869	ko03040	Spliceosome	5274	4.7e-285	0.86	0.93	1.00
PGSC0003DMG200006258	K07385	ko00902	Monoterpenoid biosynthesis	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMG200006258	K07385	ko01100	Metabolic pathways	2295	9.5e-121	0.52	0.72	0.95
PGSC0003DMG200006258	K07385	ko00902	Monoterpenoid biosynthesis	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMG200006258	K07385	ko01100	Metabolic pathways	1691	2.0e-87	0.44	0.60	0.94
PGSC0003DMG200009432	K00968	ko00440	Phosphonate and phosphinate metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMG200009432	K00968	ko00564	Glycerophospholipid metabolism	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMG200009432	K00968	ko01100	Metabolic pathways	1743	2.7e-90	0.72	0.85	0.90
PGSC0003DMG200009435	K12847	ko03040	Spliceosome	3713	5.9e-199	0.78	0.86	1.00
PGSC0003DMG200009435	K12847	ko03040	Spliceosome	738	7.2e-35	0.98	0.99	0.93
PGSC0003DMG200015711	K11866	ko04144	Endocytosis	329	1.8e-11	0.37	0.55	0.77
PGSC0003DMG200015711	K11866	ko04144	Endocytosis	601	8.0e-27	0.31	0.48	0.89
PGSC0003DMG200015711	K11866	ko04144	Endocytosis	435	2.0e-17	0.38	0.55	0.68
PGSC0003DMG200015717	K12603	ko03018	RNA degradation	388	1.4e-15	0.34	0.45	0.94
PGSC0003DMG200015717	K12603	ko03018	RNA degradation	629	7.4e-29	0.33	0.47	0.98
PGSC0003DMG200015718	K11866	ko04144	Endocytosis	380	7.6e-16	0.33	0.49	0.66
PGSC0003DMG200015718	K11866	ko04144	Endocytosis	427	5.7e-17	0.34	0.50	0.90
PGSC0003DMG200015718	K11866	ko04144	Endocytosis	545	1.2e-23	0.32	0.48	0.97
PGSC0003DMG200000065	K01259	ko00330	Arginine and proline metabolism	946	2.4e-46	0.47	0.65	0.79
PGSC0003DMG200000065	K01259	ko00330	Arginine and proline metabolism	1607	8.4e-83	0.48	0.67	0.85
PGSC0003DMG200000065	K01259	ko00330	Arginine and proline metabolism	1128	2.2e-56	0.46	0.65	0.81
PGSC0003DMG200000073	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1635	2.4e-84	0.64	0.76	0.99
PGSC0003DMG200000074	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	1642	9.9e-85	0.64	0.76	0.99
PGSC0003DMG200036653	K05765	ko04360	Axon guidance	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMG200036653	K05765	ko04666	Fc gamma R-mediated phagocytosis	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMG200036653	K05765	ko04810	Regulation of actin cytoskeleton	262	1.3e-08	0.52	0.76	0.20
PGSC0003DMG200036656	K10760	ko00908	Zeatin biosynthesis	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMG200036656	K10760	ko01100	Metabolic pathways	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMG200036656	K10760	ko01110	Biosynthesis of secondary metabolites	504	5.8e-22	0.42	0.61	0.98
PGSC0003DMG200023002	K08679	ko00500	Starch and sucrose metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMG200023002	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMG200023002	K08679	ko01100	Metabolic pathways	1410	6.2e-72	0.79	0.88	0.94
PGSC0003DMG200023002	K08679	ko00500	Starch and sucrose metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMG200023002	K08679	ko00520	Amino sugar and nucleotide sugar metabolism	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMG200023002	K08679	ko01100	Metabolic pathways	981	2.8e-48	0.80	0.89	0.98
PGSC0003DMG200023013	K02953	ko03010	Ribosome	1229	6.0e-62	0.96	0.99	0.99
PGSC0003DMG200023014	K02183	ko04020	Calcium signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04070	Phosphatidylinositol signaling system	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04114	Oocyte meiosis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04270	Vascular smooth muscle contraction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04626	Plant-pathogen interaction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04720	Long-term potentiation	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04722	Neurotrophin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04740	Olfactory transduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04744	Phototransduction	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04745	Phototransduction - fly	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04910	Insulin signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04912	GnRH signaling pathway	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04916	Melanogenesis	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04970	Salivary secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko04971	Gastric acid secretion	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko05010	Alzheimer's disease	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023014	K02183	ko05214	Glioma	1051	3.9e-52	0.84	0.93	0.99
PGSC0003DMG200023019	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.94
PGSC0003DMG200023019	K01509	ko00230	Purine metabolism	1516	8.8e-78	0.43	0.57	0.94
PGSC0003DMG200023019	K01509	ko00230	Purine metabolism	1554	7.1e-80	0.32	0.46	0.96
PGSC0003DMG200026214	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMG200026214	K10848	ko03420	Nucleotide excision repair	3244	4.3e-173	0.71	0.82	1.00
PGSC0003DMG200026214	K10848	ko03420	Nucleotide excision repair	5254	6.0e-284	0.67	0.79	1.00
PGSC0003DMG200026214	K10848	ko03420	Nucleotide excision repair	3551	5.1e-190	0.69	0.80	0.95
PGSC0003DMG200026219	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMG200026219	K01358	ko04112	Cell cycle - Caulobacter	1790	6.8e-93	0.72	0.82	0.99
PGSC0003DMG200026219	K01358	ko04112	Cell cycle - Caulobacter	1399	2.5e-71	0.71	0.80	0.94
PGSC0003DMG200008815	K00901	ko00561	Glycerolipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMG200008815	K00901	ko00564	Glycerophospholipid metabolism	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMG200008815	K00901	ko01100	Metabolic pathways	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMG200008815	K00901	ko04070	Phosphatidylinositol signaling system	243	1.4e-06	0.32	0.43	0.66
PGSC0003DMG200008823	K12813	ko03040	Spliceosome	860	1.3e-41	0.60	0.64	0.99
PGSC0003DMG200008826	K00368	ko00910	Nitrogen metabolism	1576	4.3e-81	0.42	0.57	0.91
PGSC0003DMG200008827	K01673	ko00910	Nitrogen metabolism	1395	4.2e-71	0.60	0.71	0.99
PGSC0003DMG200008827	K01673	ko00910	Nitrogen metabolism	509	3.1e-22	0.66	0.83	0.87
PGSC0003DMG200008827	K01673	ko00910	Nitrogen metabolism	1342	3.5e-68	0.67	0.80	0.98
PGSC0003DMG200008827	K01673	ko00910	Nitrogen metabolism	618	3.0e-28	0.68	0.76	0.98
PGSC0003DMG200005611	K01054	ko00561	Glycerolipid metabolism	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMG200005611	K01054	ko01100	Metabolic pathways	558	6.1e-25	0.35	0.52	0.80
PGSC0003DMG200005622	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMG200005622	K03128	ko03022	Basal transcription factors	2277	9.4e-120	0.47	0.60	0.99
PGSC0003DMG200005622	K03128	ko03022	Basal transcription factors	6464	0.	0.62	0.73	1.00
PGSC0003DMG200005622	K03128	ko03022	Basal transcription factors	1211	5.9e-61	0.38	0.52	0.99
PGSC0003DMG200005624	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04120	Ubiquitin mediated proteolysis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04210	Apoptosis	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04510	Focal adhesion	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko04621	NOD-like receptor signaling pathway	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko05200	Pathways in cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200005624	K04725	ko05222	Small cell lung cancer	251	6.1e-06	0.36	0.49	0.26
PGSC0003DMG200016436	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMG200016436	K01869	ko00970	Aminoacyl-tRNA biosynthesis	4857	4.7e-262	0.80	0.89	0.99
PGSC0003DMG200016436	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMG200016436	K01869	ko00970	Aminoacyl-tRNA biosynthesis	2995	2.3e-159	0.80	0.89	0.95
PGSC0003DMG200016436	K01869	ko00290	Valine, leucine and isoleucine biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMG200016436	K01869	ko00970	Aminoacyl-tRNA biosynthesis	6545	0.	0.78	0.87	0.99
PGSC0003DMG200016439	K01728	ko00040	Pentose and glucuronate interconversions	1981	2.0e-103	0.64	0.74	0.98
PGSC0003DMG200016440	K01728	ko00040	Pentose and glucuronate interconversions	1811	4.7e-94	0.57	0.72	0.96
PGSC0003DMG200016444	K00605	ko00260	Glycine, serine and threonine metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMG200016444	K00605	ko00670	One carbon pool by folate	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMG200016444	K00605	ko00910	Nitrogen metabolism	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMG200016444	K00605	ko01100	Metabolic pathways	3168	6.7e-169	0.90	0.96	1.00
PGSC0003DMG200041508	K00804	ko00900	Terpenoid backbone biosynthesis	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMG200041508	K00804	ko01100	Metabolic pathways	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMG200041508	K00804	ko01110	Biosynthesis of secondary metabolites	1709	2.0e-88	0.60	0.78	0.95
PGSC0003DMG200022438	K12837	ko03040	Spliceosome	2004	1.1e-104	0.69	0.83	0.99
PGSC0003DMG200022438	K12837	ko03040	Spliceosome	551	1.5e-24	0.60	0.79	0.80
PGSC0003DMG200022440	K03144	ko03022	Basal transcription factors	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMG200022440	K03144	ko03420	Nucleotide excision repair	332	1.8e-12	0.50	0.65	0.82
PGSC0003DMG200022440	K03144	ko03022	Basal transcription factors	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMG200022440	K03144	ko03420	Nucleotide excision repair	475	2.3e-20	0.56	0.69	0.51
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	379	4.5e-15	0.76	0.89	0.93
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	710	2.5e-33	0.82	0.93	0.94
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	2138	4.4e-112	0.76	0.90	0.96
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	2018	1.8e-105	0.82	0.94	0.99
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	3041	6.8e-162	0.77	0.91	1.00
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMG200022441	K03144	ko03022	Basal transcription factors	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMG200022441	K03144	ko03420	Nucleotide excision repair	934	1.1e-45	0.73	0.86	0.84
PGSC0003DMG200022454	K01955	ko00240	Pyrimidine metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMG200022454	K01955	ko00250	Alanine, aspartate and glutamate metabolism	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMG200022454	K01955	ko01100	Metabolic pathways	495	1.4e-20	0.41	0.59	0.64
PGSC0003DMG200022455	K06096	ko04530	Tight junction	350	1.8e-13	0.27	0.44	0.98
PGSC0003DMG200035440	K10760	ko00908	Zeatin biosynthesis	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMG200035440	K10760	ko01100	Metabolic pathways	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMG200035440	K10760	ko01110	Biosynthesis of secondary metabolites	730	2.0e-34	0.45	0.64	0.64
PGSC0003DMG200035459	K03347	ko04110	Cell cycle	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04111	Cell cycle - yeast	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04114	Oocyte meiosis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04120	Ubiquitin mediated proteolysis	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04310	Wnt signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04350	TGF-beta signaling pathway	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200035459	K03347	ko04710	Circadian rhythm - mammal	246	5.3e-07	0.32	0.54	0.76
PGSC0003DMG200026890	K12356	ko00940	Phenylpropanoid biosynthesis	526	3.5e-23	0.48	0.60	0.87
PGSC0003DMG200026892	K11294	ko05130	Pathogenic Escherichia coli infection	403	2.2e-16	0.36	0.50	0.70
PGSC0003DMG200026895	K01692	ko00071	Fatty acid metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00280	Valine, leucine and isoleucine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00281	Geraniol degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00310	Lysine degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00380	Tryptophan metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00410	beta-Alanine metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00632	Benzoate degradation via CoA ligation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00640	Propanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00650	Butanoate metabolism	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00903	Limonene and pinene degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko00930	Caprolactam degradation	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko01100	Metabolic pathways	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026895	K01692	ko01110	Biosynthesis of secondary metabolites	1041	1.4e-51	0.47	0.68	0.98
PGSC0003DMG200026900	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMG200026900	K00517	ko00626	Naphthalene and anthracene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMG200026900	K00517	ko00903	Limonene and pinene degradation	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMG200026900	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMG200026900	K00517	ko01110	Biosynthesis of secondary metabolites	1764	1.9e-91	0.46	0.63	0.96
PGSC0003DMG200026901	K00253	ko00280	Valine, leucine and isoleucine degradation	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMG200026901	K00253	ko01100	Metabolic pathways	2868	2.4e-152	0.81	0.92	1.00
PGSC0003DMG200026904	K01012	ko00780	Biotin metabolism	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMG200026904	K01012	ko01100	Metabolic pathways	2681	4.9e-142	0.84	0.94	0.99
PGSC0003DMG200026905	K00432	ko00480	Glutathione metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMG200026905	K00432	ko00590	Arachidonic acid metabolism	1159	4.3e-58	0.82	0.90	0.84
PGSC0003DMG200026906	K10773	ko03410	Base excision repair	840	1.7e-40	0.90	0.91	0.99
PGSC0003DMG200026906	K10773	ko03410	Base excision repair	242	1.6e-07	0.42	0.64	0.77
PGSC0003DMG200026906	K10773	ko03410	Base excision repair	665	7.6e-31	0.53	0.66	0.98
PGSC0003DMG200026909	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3866	2.1e-207	0.78	0.87	0.96
PGSC0003DMG200023742	K11229	ko04011	MAPK signaling pathway - yeast	867	3.0e-43	0.43	0.59	0.97
PGSC0003DMG200023742	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMG200023742	K11228	ko04011	MAPK signaling pathway - yeast	924	4.0e-45	0.38	0.57	0.58
PGSC0003DMG200023752	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMG200023752	K02942	ko03010	Ribosome	702	7.0e-33	0.75	0.85	0.99
PGSC0003DMG200028942	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMG200028942	K12403	ko04142	Lysosome	1173	7.3e-59	0.98	0.98	0.99
PGSC0003DMG200028944	K12194	ko04144	Endocytosis	1453	2.6e-74	0.93	0.97	0.99
PGSC0003DMG200028944	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMG200028944	K12194	ko04144	Endocytosis	1647	5.3e-85	0.92	0.96	1.00
PGSC0003DMG200028947	K12868	ko03040	Spliceosome	585	2.0e-26	0.86	0.95	0.72
PGSC0003DMG200028950	K12591	ko03018	RNA degradation	899	9.5e-44	0.37	0.51	0.49
PGSC0003DMG200028951	K01681	ko00020	Citrate cycle (TCA cycle)	7302	0.	0.86	0.92	1.00
PGSC0003DMG200028951	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	7302	0.	0.86	0.92	1.00
PGSC0003DMG200028951	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	7302	0.	0.86	0.92	1.00
PGSC0003DMG200028951	K01681	ko01100	Metabolic pathways	7302	0.	0.86	0.92	1.00
PGSC0003DMG200028951	K01681	ko01110	Biosynthesis of secondary metabolites	7302	0.	0.86	0.92	1.00
PGSC0003DMG200028953	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMG200028953	K00517	ko00626	Naphthalene and anthracene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMG200028953	K00517	ko00903	Limonene and pinene degradation	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMG200028953	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMG200028953	K00517	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.63	0.97
PGSC0003DMG200011179	K05745	ko04810	Regulation of actin cytoskeleton	545	1.7e-23	0.30	0.57	0.99
PGSC0003DMG200011179	K04512	ko04310	Wnt signaling pathway	545	1.4e-23	0.31	0.58	0.96
PGSC0003DMG200011179	K02184	ko04320	Dorso-ventral axis formation	1304	6.8e-66	0.30	0.42	0.76
PGSC0003DMG200011179	K02184	ko04320	Dorso-ventral axis formation	1051	2.0e-51	0.31	0.41	0.69
PGSC0003DMG200003254	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMG200003254	K00224	ko00364	Fluorobenzoate degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMG200003254	K00224	ko00628	Fluorene degradation	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMG200003254	K00224	ko00640	Propanoate metabolism	422	1.9e-17	0.56	0.68	0.19
PGSC0003DMG200003254	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMG200003254	K00224	ko00364	Fluorobenzoate degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMG200003254	K00224	ko00628	Fluorene degradation	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMG200003254	K00224	ko00640	Propanoate metabolism	282	1.0e-09	0.65	0.87	0.86
PGSC0003DMG200003257	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMG200003257	K00517	ko00626	Naphthalene and anthracene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMG200003257	K00517	ko00903	Limonene and pinene degradation	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMG200003257	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMG200003257	K00517	ko01110	Biosynthesis of secondary metabolites	1034	3.4e-51	0.37	0.56	0.93
PGSC0003DMG200003257	K09843	ko00906	Carotenoid biosynthesis	344	3.9e-13	0.49	0.62	0.81
PGSC0003DMG200003270	K05756	ko04666	Fc gamma R-mediated phagocytosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMG200003270	K05756	ko04810	Regulation of actin cytoskeleton	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMG200003270	K05756	ko05100	Bacterial invasion of epithelial cells	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMG200003270	K05756	ko05130	Pathogenic Escherichia coli infection	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMG200003270	K05756	ko05131	Shigellosis	616	3.9e-28	0.80	0.90	0.78
PGSC0003DMG200003271	K01126	ko00564	Glycerophospholipid metabolism	400	8.6e-16	0.30	0.47	0.40
PGSC0003DMG200003273	K01126	ko00564	Glycerophospholipid metabolism	455	4.6e-19	0.32	0.50	0.60
PGSC0003DMG200003273	K01126	ko00564	Glycerophospholipid metabolism	455	4.4e-19	0.32	0.50	0.61
PGSC0003DMG200004070	K01379	ko04142	Lysosome	288	1.3e-08	0.26	0.42	0.86
PGSC0003DMG200004070	K01379	ko04142	Lysosome	273	3.2e-09	0.28	0.43	0.94
PGSC0003DMG200004071	K08735	ko03430	Mismatch repair	6438	0.	0.80	0.92	0.99
PGSC0003DMG200004071	K08735	ko05200	Pathways in cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMG200004071	K08735	ko05210	Colorectal cancer	6438	0.	0.80	0.92	0.99
PGSC0003DMG200007884	K04460	ko04010	MAPK signaling pathway	433	3.0e-22	0.36	0.51	0.73
PGSC0003DMG200007889	K01535	ko00190	Oxidative phosphorylation	6457	0.	0.83	0.91	0.99
PGSC0003DMG200007890	K12834	ko03040	Spliceosome	1004	1.5e-49	1.00	1.00	0.99
PGSC0003DMG200007895	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMG200007895	K02193	ko02010	ABC transporters	565	2.5e-25	0.40	0.60	0.88
PGSC0003DMG200007896	K00754	ko00051	Fructose and mannose metabolism	982	2.5e-48	0.35	0.55	0.94
PGSC0003DMG200007896	K00754	ko00051	Fructose and mannose metabolism	1378	3.6e-70	0.38	0.56	0.86
PGSC0003DMG200007896	K00754	ko00051	Fructose and mannose metabolism	1376	4.7e-70	0.38	0.57	0.96
PGSC0003DMG200007896	K00754	ko00051	Fructose and mannose metabolism	1353	8.6e-69	0.42	0.60	0.91
PGSC0003DMG200039453	K12356	ko00940	Phenylpropanoid biosynthesis	737	8.2e-35	0.43	0.58	1.00
PGSC0003DMG200037338	K04454	ko04010	MAPK signaling pathway	230	1.1e-06	0.32	0.52	0.91
PGSC0003DMG200037344	K00771	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMG200037344	K00771	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMG200037344	K00771	ko01100	Metabolic pathways	371	6.4e-14	0.29	0.47	0.85
PGSC0003DMG200037355	K13065	ko00940	Phenylpropanoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMG200037355	K13065	ko00941	Flavonoid biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMG200037355	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMG200037355	K13065	ko01110	Biosynthesis of secondary metabolites	1203	1.6e-60	0.39	0.55	0.99
PGSC0003DMG200027914	K00423	ko00053	Ascorbate and aldarate metabolism	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMG200027914	K00423	ko01100	Metabolic pathways	1664	6.1e-86	0.46	0.63	1.00
PGSC0003DMG200027914	K00423	ko00053	Ascorbate and aldarate metabolism	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMG200027914	K00423	ko01100	Metabolic pathways	1240	1.5e-62	0.47	0.63	1.00
PGSC0003DMG200027916	K01858	ko00521	Streptomycin biosynthesis	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMG200027916	K01858	ko00562	Inositol phosphate metabolism	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMG200027916	K01858	ko01100	Metabolic pathways	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMG200027916	K01858	ko01110	Biosynthesis of secondary metabolites	4067	1.8e-218	0.93	0.97	1.00
PGSC0003DMG200027918	K02342	ko00230	Purine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027918	K02342	ko00240	Pyrimidine metabolism	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027918	K02342	ko01100	Metabolic pathways	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027918	K02342	ko03030	DNA replication	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027918	K02342	ko03430	Mismatch repair	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027918	K02342	ko03440	Homologous recombination	267	1.8e-08	0.35	0.50	0.55
PGSC0003DMG200027919	K00812	ko00250	Alanine, aspartate and glutamate metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00270	Cysteine and methionine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00330	Arginine and proline metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00350	Tyrosine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00360	Phenylalanine metabolism	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00401	Novobiocin biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00710	Carbon fixation in photosynthetic organisms	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00950	Isoquinoline alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko01100	Metabolic pathways	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027919	K00812	ko01110	Biosynthesis of secondary metabolites	1851	2.9e-96	0.57	0.74	0.84
PGSC0003DMG200027925	K01193	ko00052	Galactose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMG200027925	K01193	ko00500	Starch and sucrose metabolism	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMG200027925	K01193	ko01100	Metabolic pathways	1226	8.7e-62	0.57	0.73	0.95
PGSC0003DMG200027936	K00696	ko00500	Starch and sucrose metabolism	7380	0.	0.81	0.91	1.00
PGSC0003DMG200027936	K00696	ko01100	Metabolic pathways	7380	0.	0.81	0.91	1.00
PGSC0003DMG200027937	K07297	ko04920	Adipocytokine signaling pathway	759	5.0e-36	0.68	0.87	0.98
PGSC0003DMG200027937	K07297	ko04920	Adipocytokine signaling pathway	1944	2.2e-101	0.60	0.74	0.98
PGSC0003DMG200020741	K02084	ko04115	p53 signaling pathway	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko04210	Apoptosis	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko05010	Alzheimer's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko05012	Parkinson's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko05016	Huntington's disease	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200020741	K02084	ko05222	Small cell lung cancer	342	1.7e-09	0.30	0.46	0.42
PGSC0003DMG200024662	K10352	ko04530	Tight junction	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMG200024662	K10352	ko05416	Viral myocarditis	428	1.4e-16	0.27	0.48	0.95
PGSC0003DMG200024665	K04733	ko04210	Apoptosis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMG200024665	K04733	ko04620	Toll-like receptor signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMG200024665	K04733	ko04722	Neurotrophin signaling pathway	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMG200024665	K04733	ko05140	Leishmaniasis	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMG200024665	K04733	ko05142	Chagas disease	2093	1.3e-109	0.41	0.58	0.98
PGSC0003DMG200024679	K08901	ko00195	Photosynthesis	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMG200024679	K08901	ko01100	Metabolic pathways	243	1.4e-07	0.31	0.56	0.68
PGSC0003DMG200024685	K01897	ko00071	Fatty acid metabolism	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMG200024685	K01897	ko01100	Metabolic pathways	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMG200024685	K01897	ko03320	PPAR signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMG200024685	K01897	ko04146	Peroxisome	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMG200024685	K01897	ko04920	Adipocytokine signaling pathway	4745	7.1e-256	0.78	0.91	1.00
PGSC0003DMG200024685	K01897	ko00071	Fatty acid metabolism	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMG200024685	K01897	ko01100	Metabolic pathways	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMG200024685	K01897	ko03320	PPAR signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMG200024685	K01897	ko04146	Peroxisome	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMG200024685	K01897	ko04920	Adipocytokine signaling pathway	449	7.9e-19	0.60	0.65	0.99
PGSC0003DMG200024688	K00454	ko00591	Linoleic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMG200024688	K00454	ko00592	alpha-Linolenic acid metabolism	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMG200024688	K00454	ko01100	Metabolic pathways	4798	8.4e-259	0.65	0.80	1.00
PGSC0003DMG200024688	K00454	ko00591	Linoleic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMG200024688	K00454	ko00592	alpha-Linolenic acid metabolism	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMG200024688	K00454	ko01100	Metabolic pathways	5044	2.3e-272	0.68	0.82	1.00
PGSC0003DMG200024688	K00454	ko00591	Linoleic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMG200024688	K00454	ko00592	alpha-Linolenic acid metabolism	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMG200024688	K00454	ko01100	Metabolic pathways	4980	7.7e-269	0.67	0.82	1.00
PGSC0003DMG200024688	K00454	ko00591	Linoleic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMG200024688	K00454	ko00592	alpha-Linolenic acid metabolism	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMG200024688	K00454	ko01100	Metabolic pathways	1484	5.1e-76	0.65	0.82	0.91
PGSC0003DMG200037840	K12356	ko00940	Phenylpropanoid biosynthesis	577	5.5e-26	0.50	0.63	0.91
PGSC0003DMG200037844	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMG200037844	K00517	ko00626	Naphthalene and anthracene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMG200037844	K00517	ko00903	Limonene and pinene degradation	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMG200037844	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMG200037844	K00517	ko01110	Biosynthesis of secondary metabolites	1706	2.9e-88	0.46	0.65	0.90
PGSC0003DMG200037864	K06611	ko00052	Galactose metabolism	311	1.1e-10	0.48	0.66	0.83
PGSC0003DMG200027631	K04125	ko00904	Diterpenoid biosynthesis	480	1.2e-20	0.51	0.64	0.99
PGSC0003DMG200027631	K04125	ko00904	Diterpenoid biosynthesis	1094	1.7e-54	0.56	0.70	0.92
PGSC0003DMG200027631	K04125	ko00904	Diterpenoid biosynthesis	1001	2.2e-49	0.65	0.79	0.98
PGSC0003DMG200027631	K04125	ko00904	Diterpenoid biosynthesis	1516	8.8e-78	0.59	0.73	0.99
PGSC0003DMG200027632	K04125	ko00904	Diterpenoid biosynthesis	1076	1.6e-53	0.54	0.71	0.90
PGSC0003DMG200027632	K04125	ko00904	Diterpenoid biosynthesis	1521	4.7e-78	0.57	0.73	0.98
PGSC0003DMG200027632	K04125	ko00904	Diterpenoid biosynthesis	446	9.2e-19	0.48	0.65	0.99
PGSC0003DMG200027632	K04125	ko00904	Diterpenoid biosynthesis	1036	2.6e-51	0.65	0.78	0.97
PGSC0003DMG200027633	K09840	ko00906	Carotenoid biosynthesis	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMG200027633	K09840	ko01100	Metabolic pathways	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMG200027633	K09840	ko01110	Biosynthesis of secondary metabolites	3483	2.9e-186	0.79	0.89	0.99
PGSC0003DMG200027636	K00799	ko00480	Glutathione metabolism	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMG200027636	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMG200027636	K00799	ko00982	Drug metabolism - cytochrome P450	968	1.5e-47	0.54	0.73	0.96
PGSC0003DMG200027637	K00799	ko00480	Glutathione metabolism	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMG200027637	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMG200027637	K00799	ko00982	Drug metabolism - cytochrome P450	944	3.1e-46	0.53	0.75	0.94
PGSC0003DMG200017592	K10352	ko04530	Tight junction	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMG200017592	K10352	ko05416	Viral myocarditis	452	6.3e-18	0.28	0.48	0.95
PGSC0003DMG200017592	K10352	ko04530	Tight junction	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMG200017592	K10352	ko05416	Viral myocarditis	398	6.5e-15	0.28	0.47	0.98
PGSC0003DMG200017593	K02973	ko03010	Ribosome	1191	7.4e-60	0.99	1.00	0.99
PGSC0003DMG200017595	K12129	ko04712	Circadian rhythm - plant	1893	1.4e-98	0.43	0.59	0.98
PGSC0003DMG200017595	K12129	ko04712	Circadian rhythm - plant	2125	2.3e-111	0.45	0.62	0.98
PGSC0003DMG200017601	K01710	ko00521	Streptomycin biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMG200017601	K01710	ko00523	Polyketide sugar unit biosynthesis	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMG200017601	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMG200017601	K01710	ko01100	Metabolic pathways	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMG200017601	K01710	ko01110	Biosynthesis of secondary metabolites	1680	8.0e-87	0.86	0.94	0.98
PGSC0003DMG200017601	K01710	ko00521	Streptomycin biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMG200017601	K01710	ko00523	Polyketide sugar unit biosynthesis	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMG200017601	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMG200017601	K01710	ko01100	Metabolic pathways	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMG200017601	K01710	ko01110	Biosynthesis of secondary metabolites	439	2.2e-18	0.69	0.78	0.90
PGSC0003DMG200017604	K01754	ko00260	Glycine, serine and threonine metabolism	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMG200017604	K01754	ko00290	Valine, leucine and isoleucine biosynthesis	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMG200017604	K01754	ko01100	Metabolic pathways	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMG200017604	K01754	ko01110	Biosynthesis of secondary metabolites	2934	5.4e-156	0.65	0.78	0.97
PGSC0003DMG200017608	K02930	ko03010	Ribosome	2911	1.0e-154	0.84	0.92	1.00
PGSC0003DMG200033634	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2432	2.7e-128	0.69	0.84	0.99
PGSC0003DMG200033636	K09755	ko00940	Phenylpropanoid biosynthesis	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMG200033636	K09755	ko01100	Metabolic pathways	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMG200033636	K09755	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.40	0.61	0.98
PGSC0003DMG200033639	K12823	ko03040	Spliceosome	2249	3.3e-118	0.91	0.95	0.91
PGSC0003DMG200033639	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMG200033639	K12823	ko03040	Spliceosome	1134	1.0e-56	0.77	0.91	0.85
PGSC0003DMG200033639	K12823	ko03040	Spliceosome	3780	1.2e-202	0.87	0.93	1.00
PGSC0003DMG200021056	K11818	ko00380	Tryptophan metabolism	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMG200021056	K11818	ko00966	Glucosinolate biosynthesis	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMG200021056	K11818	ko01110	Biosynthesis of secondary metabolites	1013	4.9e-50	0.54	0.73	0.95
PGSC0003DMG200021057	K11818	ko00380	Tryptophan metabolism	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMG200021057	K11818	ko00966	Glucosinolate biosynthesis	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMG200021057	K11818	ko01110	Biosynthesis of secondary metabolites	1743	2.7e-90	0.52	0.70	0.99
PGSC0003DMG200021057	K11818	ko00380	Tryptophan metabolism	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMG200021057	K11818	ko00966	Glucosinolate biosynthesis	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMG200021057	K11818	ko01110	Biosynthesis of secondary metabolites	1674	1.7e-86	0.47	0.68	0.96
PGSC0003DMG200021058	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMG200021058	K00517	ko00626	Naphthalene and anthracene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMG200021058	K00517	ko00903	Limonene and pinene degradation	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMG200021058	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMG200021058	K00517	ko01110	Biosynthesis of secondary metabolites	825	1.1e-39	0.54	0.71	0.96
PGSC0003DMG200021068	K02183	ko04020	Calcium signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04070	Phosphatidylinositol signaling system	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04114	Oocyte meiosis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04270	Vascular smooth muscle contraction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04626	Plant-pathogen interaction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04720	Long-term potentiation	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04722	Neurotrophin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04740	Olfactory transduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04744	Phototransduction	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04745	Phototransduction - fly	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04910	Insulin signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04912	GnRH signaling pathway	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04916	Melanogenesis	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04970	Salivary secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko04971	Gastric acid secretion	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko05010	Alzheimer's disease	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021068	K02183	ko05214	Glioma	918	8.5e-45	0.75	0.85	0.99
PGSC0003DMG200021070	K09658	ko00510	N-Glycan biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMG200021070	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMG200021070	K09658	ko01100	Metabolic pathways	544	3.6e-24	0.80	0.91	0.62
PGSC0003DMG200021075	K01692	ko00071	Fatty acid metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00280	Valine, leucine and isoleucine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00281	Geraniol degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00310	Lysine degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00380	Tryptophan metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00410	beta-Alanine metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00632	Benzoate degradation via CoA ligation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00640	Propanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00650	Butanoate metabolism	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00903	Limonene and pinene degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko00930	Caprolactam degradation	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko01100	Metabolic pathways	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021075	K01692	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.46	0.65	0.80
PGSC0003DMG200021081	K09755	ko00940	Phenylpropanoid biosynthesis	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMG200021081	K09755	ko01100	Metabolic pathways	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMG200021081	K09755	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.53	0.73	0.92
PGSC0003DMG200046095	K10760	ko00908	Zeatin biosynthesis	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMG200046095	K10760	ko01100	Metabolic pathways	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMG200046095	K10760	ko01110	Biosynthesis of secondary metabolites	1011	6.3e-50	0.51	0.69	0.97
PGSC0003DMG200046105	K03012	ko00230	Purine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMG200046105	K03012	ko00240	Pyrimidine metabolism	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMG200046105	K03012	ko01100	Metabolic pathways	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMG200046105	K03012	ko03020	RNA polymerase	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMG200046105	K03012	ko05016	Huntington's disease	616	3.9e-28	0.62	0.75	0.98
PGSC0003DMG200046106	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMG200046106	K00517	ko00626	Naphthalene and anthracene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMG200046106	K00517	ko00903	Limonene and pinene degradation	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMG200046106	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMG200046106	K00517	ko01110	Biosynthesis of secondary metabolites	1026	9.4e-51	0.44	0.63	0.98
PGSC0003DMG200046107	K00059	ko00061	Fatty acid biosynthesis	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMG200046107	K00059	ko01040	Biosynthesis of unsaturated fatty acids	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMG200046107	K00059	ko01100	Metabolic pathways	1091	2.4e-54	0.56	0.68	1.00
PGSC0003DMG200046112	K03122	ko03022	Basal transcription factors	335	1.2e-12	0.35	0.52	0.90
PGSC0003DMG200039349	K01051	ko00040	Pentose and glucuronate interconversions	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMG200039349	K01051	ko00500	Starch and sucrose metabolism	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMG200039349	K01051	ko01100	Metabolic pathways	384	2.4e-15	0.59	0.80	0.96
PGSC0003DMG200039364	K03094	ko04110	Cell cycle	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04111	Cell cycle - yeast	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04114	Oocyte meiosis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04120	Ubiquitin mediated proteolysis	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04310	Wnt signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04350	TGF-beta signaling pathway	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200039364	K03094	ko04710	Circadian rhythm - mammal	372	1.1e-14	0.47	0.65	0.98
PGSC0003DMG200010886	K02084	ko04115	p53 signaling pathway	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko04210	Apoptosis	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko05010	Alzheimer's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko05012	Parkinson's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko05016	Huntington's disease	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko05222	Small cell lung cancer	320	8.0e-09	0.28	0.46	0.71
PGSC0003DMG200010886	K02084	ko04115	p53 signaling pathway	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko04210	Apoptosis	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko05010	Alzheimer's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko05012	Parkinson's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko05016	Huntington's disease	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010886	K02084	ko05222	Small cell lung cancer	312	2.1e-10	0.27	0.46	0.98
PGSC0003DMG200010893	K08504	ko04130	SNARE interactions in vesicular transport	815	4.1e-39	0.85	0.92	0.99
PGSC0003DMG200010893	K08504	ko04130	SNARE interactions in vesicular transport	835	3.2e-40	0.83	0.92	0.99
PGSC0003DMG200010895	K02084	ko04115	p53 signaling pathway	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko04210	Apoptosis	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko05010	Alzheimer's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko05012	Parkinson's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko05016	Huntington's disease	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010895	K02084	ko05222	Small cell lung cancer	334	6.7e-09	0.29	0.50	0.31
PGSC0003DMG200010897	K01553	ko00230	Purine metabolism	529	1.3e-20	0.25	0.43	0.95
PGSC0003DMG200010898	K08065	ko04612	Antigen processing and presentation	395	6.0e-16	0.55	0.75	0.84
PGSC0003DMG200010899	K01528	ko04144	Endocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMG200010899	K01528	ko04666	Fc gamma R-mediated phagocytosis	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMG200010899	K01528	ko05100	Bacterial invasion of epithelial cells	1347	1.8e-68	0.51	0.70	0.99
PGSC0003DMG200010899	K01528	ko04144	Endocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMG200010899	K01528	ko04666	Fc gamma R-mediated phagocytosis	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMG200010899	K01528	ko05100	Bacterial invasion of epithelial cells	1333	2.0e-78	0.39	0.59	0.95
PGSC0003DMG200010088	K00754	ko00051	Fructose and mannose metabolism	300	1.9e-10	0.30	0.48	0.56
PGSC0003DMG200010091	K04498	ko04110	Cell cycle	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04310	Wnt signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04330	Notch signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04350	TGF-beta signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04520	Adherens junction	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04630	Jak-STAT signaling pathway	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04720	Long-term potentiation	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko04916	Melanogenesis	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko05016	Huntington's disease	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko05200	Pathways in cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko05211	Renal cell carcinoma	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010091	K04498	ko05215	Prostate cancer	3215	7.4e-174	0.40	0.57	0.76
PGSC0003DMG200010092	K09753	ko00940	Phenylpropanoid biosynthesis	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMG200010092	K09753	ko01100	Metabolic pathways	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMG200010092	K09753	ko01110	Biosynthesis of secondary metabolites	323	5.6e-12	0.37	0.53	0.69
PGSC0003DMG200010092	K09753	ko00940	Phenylpropanoid biosynthesis	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMG200010092	K09753	ko01100	Metabolic pathways	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMG200010092	K09753	ko01110	Biosynthesis of secondary metabolites	437	2.9e-18	0.37	0.51	0.82
PGSC0003DMG200010092	K09753	ko00940	Phenylpropanoid biosynthesis	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMG200010092	K09753	ko01100	Metabolic pathways	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMG200010092	K09753	ko01110	Biosynthesis of secondary metabolites	511	2.4e-22	0.34	0.48	0.88
PGSC0003DMG200010093	K00558	ko00270	Cysteine and methionine metabolism	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMG200010093	K00558	ko01100	Metabolic pathways	1887	3.0e-98	0.46	0.58	0.84
PGSC0003DMG200010100	K10872	ko04113	Meiosis - yeast	245	4.1e-07	0.32	0.50	0.55
PGSC0003DMG200004341	K13230	ko00402	Benzoxazinoid biosynthesis	687	4.7e-32	0.38	0.54	0.99
PGSC0003DMG200004341	K13230	ko00402	Benzoxazinoid biosynthesis	410	8.9e-17	0.45	0.62	0.95
PGSC0003DMG200004341	K13230	ko00402	Benzoxazinoid biosynthesis	683	7.8e-32	0.47	0.64	0.97
PGSC0003DMG200004341	K13230	ko00402	Benzoxazinoid biosynthesis	640	1.8e-29	0.48	0.63	0.93
PGSC0003DMG200004342	K13230	ko00402	Benzoxazinoid biosynthesis	382	3.1e-15	0.53	0.70	0.76
PGSC0003DMG200004342	K13230	ko00402	Benzoxazinoid biosynthesis	380	4.0e-15	0.56	0.71	0.98
PGSC0003DMG200004350	K00526	ko00230	Purine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMG200004350	K00526	ko00240	Pyrimidine metabolism	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMG200004350	K00526	ko01100	Metabolic pathways	2174	4.5e-114	0.72	0.83	1.00
PGSC0003DMG200004350	K00526	ko00230	Purine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMG200004350	K00526	ko00240	Pyrimidine metabolism	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMG200004350	K00526	ko01100	Metabolic pathways	2213	3.2e-116	0.76	0.88	1.00
PGSC0003DMG200014160	K07750	ko00100	Steroid biosynthesis	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMG200014160	K07750	ko01100	Metabolic pathways	286	1.8e-09	0.27	0.44	0.39
PGSC0003DMG200014166	K11092	ko03040	Spliceosome	1739	4.4e-90	0.75	0.84	1.00
PGSC0003DMG200014167	K10798	ko03410	Base excision repair	6008	0.	0.71	0.84	1.00
PGSC0003DMG200014168	K08008	ko04145	Phagosome	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMG200014168	K08008	ko04670	Leukocyte transendothelial migration	1150	1.4e-57	0.34	0.50	0.60
PGSC0003DMG200014170	K07200	ko04910	Insulin signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMG200014170	K07200	ko04920	Adipocytokine signaling pathway	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMG200014170	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	648	6.6e-30	0.34	0.50	0.98
PGSC0003DMG200014170	K07200	ko04910	Insulin signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMG200014170	K07200	ko04920	Adipocytokine signaling pathway	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMG200014170	K07200	ko05410	Hypertrophic cardiomyopathy (HCM)	671	3.6e-31	0.38	0.52	0.89
PGSC0003DMG200014177	K12489	ko04144	Endocytosis	3022	7.6e-161	0.63	0.74	1.00
PGSC0003DMG200014177	K12489	ko04144	Endocytosis	1744	2.3e-90	0.73	0.85	0.96
PGSC0003DMG200014177	K12489	ko04144	Endocytosis	3901	2.5e-209	0.70	0.81	0.97
PGSC0003DMG200014177	K12489	ko04144	Endocytosis	4336	2.6e-233	0.66	0.77	0.99
PGSC0003DMG200022215	K01681	ko00020	Citrate cycle (TCA cycle)	6607	0.	0.78	0.87	1.00
PGSC0003DMG200022215	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	6607	0.	0.78	0.87	1.00
PGSC0003DMG200022215	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	6607	0.	0.78	0.87	1.00
PGSC0003DMG200022215	K01681	ko01100	Metabolic pathways	6607	0.	0.78	0.87	1.00
PGSC0003DMG200022215	K01681	ko01110	Biosynthesis of secondary metabolites	6607	0.	0.78	0.87	1.00
PGSC0003DMG200022215	K01681	ko00020	Citrate cycle (TCA cycle)	5900	0.	0.78	0.87	0.99
PGSC0003DMG200022215	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	5900	0.	0.78	0.87	0.99
PGSC0003DMG200022215	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	5900	0.	0.78	0.87	0.99
PGSC0003DMG200022215	K01681	ko01100	Metabolic pathways	5900	0.	0.78	0.87	0.99
PGSC0003DMG200022215	K01681	ko01110	Biosynthesis of secondary metabolites	5900	0.	0.78	0.87	0.99
PGSC0003DMG200022215	K01681	ko00020	Citrate cycle (TCA cycle)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMG200022215	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMG200022215	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMG200022215	K01681	ko01100	Metabolic pathways	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMG200022215	K01681	ko01110	Biosynthesis of secondary metabolites	2696	7.3e-143	0.88	0.96	0.99
PGSC0003DMG200022215	K01681	ko00020	Citrate cycle (TCA cycle)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMG200022215	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMG200022215	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMG200022215	K01681	ko01100	Metabolic pathways	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMG200022215	K01681	ko01110	Biosynthesis of secondary metabolites	2481	5.3e-131	0.86	0.93	0.99
PGSC0003DMG200022223	K09843	ko00906	Carotenoid biosynthesis	806	1.3e-38	0.41	0.61	0.98
PGSC0003DMG200022223	K09588	ko01100	Metabolic pathways	325	4.3e-12	0.35	0.53	0.77
PGSC0003DMG200022224	K09843	ko00906	Carotenoid biosynthesis	1028	7.3e-51	0.35	0.55	1.00
PGSC0003DMG200022228	K02978	ko03010	Ribosome	534	1.3e-23	0.78	0.84	0.85
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.54
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	294	2.2e-10	0.39	0.56	0.87
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.54
PGSC0003DMG200022230	K05868	ko04110	Cell cycle	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMG200022230	K05868	ko04115	p53 signaling pathway	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMG200022230	K05868	ko04914	Progesterone-mediated oocyte maturation	1663	6.9e-86	0.65	0.76	0.82
PGSC0003DMG200019969	K01408	ko05010	Alzheimer's disease	2201	2.1e-120	0.37	0.57	0.93
PGSC0003DMG200019971	K12116	ko04712	Circadian rhythm - plant	4269	1.3e-229	0.85	0.91	0.91
PGSC0003DMG200019972	K01528	ko04144	Endocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMG200019972	K01528	ko04666	Fc gamma R-mediated phagocytosis	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMG200019972	K01528	ko05100	Bacterial invasion of epithelial cells	1042	5.8e-59	0.39	0.58	0.82
PGSC0003DMG200019973	K12343	ko00140	Steroid hormone biosynthesis	232	5.8e-07	0.34	0.49	0.89
PGSC0003DMG200019973	K12343	ko00140	Steroid hormone biosynthesis	356	8.4e-14	0.32	0.52	0.85
PGSC0003DMG200019973	K12343	ko00140	Steroid hormone biosynthesis	372	1.1e-14	0.29	0.50	0.81
PGSC0003DMG200019974	K10352	ko04530	Tight junction	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMG200019974	K10352	ko05416	Viral myocarditis	321	2.6e-08	0.26	0.44	0.84
PGSC0003DMG200019982	K11866	ko04144	Endocytosis	350	1.2e-12	0.50	0.59	0.77
PGSC0003DMG200019982	K11866	ko04144	Endocytosis	479	6.7e-20	0.31	0.44	0.96
PGSC0003DMG200019982	K11866	ko04144	Endocytosis	414	3.1e-16	0.40	0.52	0.79
PGSC0003DMG200019982	K11866	ko04144	Endocytosis	366	1.5e-13	0.30	0.44	0.96
PGSC0003DMG200030519	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMG200030519	K00478	ko00904	Diterpenoid biosynthesis	678	1.5e-31	0.40	0.59	0.65
PGSC0003DMG200030520	K00970	ko03018	RNA degradation	3056	1.0e-162	0.71	0.81	0.72
PGSC0003DMG200030520	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.72
PGSC0003DMG200030520	K00970	ko03018	RNA degradation	3302	2.7e-176	0.75	0.86	0.71
PGSC0003DMG200030527	K04715	ko00600	Sphingolipid metabolism	405	1.7e-16	0.43	0.63	0.47
PGSC0003DMG200030527	K04715	ko00600	Sphingolipid metabolism	932	1.4e-45	0.32	0.47	0.79
PGSC0003DMG200030527	K04715	ko00600	Sphingolipid metabolism	504	5.8e-22	0.34	0.48	0.91
PGSC0003DMG200030528	K01080	ko00561	Glycerolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko00564	Glycerophospholipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko00565	Ether lipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko00600	Sphingolipid metabolism	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko01100	Metabolic pathways	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko04666	Fc gamma R-mediated phagocytosis	331	2.0e-12	0.37	0.55	0.66
PGSC0003DMG200030528	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.84
PGSC0003DMG200030528	K01080	ko00561	Glycerolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030528	K01080	ko00564	Glycerophospholipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030528	K01080	ko00565	Ether lipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030528	K01080	ko00600	Sphingolipid metabolism	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030528	K01080	ko01100	Metabolic pathways	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030528	K01080	ko04666	Fc gamma R-mediated phagocytosis	641	1.6e-29	0.38	0.56	0.73
PGSC0003DMG200030529	K12816	ko03040	Spliceosome	2118	5.5e-111	0.84	0.92	0.98
PGSC0003DMG200034947	K00021	ko00900	Terpenoid backbone biosynthesis	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMG200034947	K00021	ko01100	Metabolic pathways	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMG200034947	K00021	ko01110	Biosynthesis of secondary metabolites	396	7.2e-16	0.51	0.68	0.88
PGSC0003DMG200029265	K01184	ko00040	Pentose and glucuronate interconversions	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMG200029265	K01184	ko00500	Starch and sucrose metabolism	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMG200029265	K01184	ko01100	Metabolic pathways	2044	6.7e-107	0.61	0.76	0.99
PGSC0003DMG200029266	K02940	ko03010	Ribosome	1401	1.9e-71	0.90	0.96	0.99
PGSC0003DMG200029270	K11090	ko05322	Systemic lupus erythematosus	338	8.3e-13	0.35	0.56	0.32
PGSC0003DMG200029273	K00794	ko00740	Riboflavin metabolism	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMG200029273	K00794	ko01100	Metabolic pathways	1125	3.2e-56	0.70	0.79	0.85
PGSC0003DMG200029274	K02947	ko03010	Ribosome	1482	6.6e-76	0.92	0.95	0.98
PGSC0003DMG200029278	K03134	ko03022	Basal transcription factors	979	3.7e-48	0.79	0.91	0.99
PGSC0003DMG200029280	K12811	ko03040	Spliceosome	335	2.4e-11	0.27	0.45	0.97
PGSC0003DMG200000444	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko03040	Spliceosome	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04010	MAPK signaling pathway	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04144	Endocytosis	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04612	Antigen processing and presentation	5112	4.0e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko03040	Spliceosome	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04010	MAPK signaling pathway	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04144	Endocytosis	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMG200000444	K03283	ko04612	Antigen processing and presentation	5107	7.6e-276	0.94	0.96	1.00
PGSC0003DMG200000449	K12193	ko04144	Endocytosis	1587	1.1e-81	0.87	0.93	1.00
PGSC0003DMG200000449	K12193	ko04144	Endocytosis	747	2.3e-35	0.83	0.91	0.99
PGSC0003DMG200000451	K12272	ko03060	Protein export	944	3.1e-46	0.71	0.86	0.97
PGSC0003DMG200000451	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMG200000451	K12272	ko03060	Protein export	1622	1.3e-83	0.75	0.86	0.98
PGSC0003DMG200000452	K10747	ko03030	DNA replication	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMG200000452	K10747	ko03410	Base excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMG200000452	K10747	ko03420	Nucleotide excision repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMG200000452	K10747	ko03430	Mismatch repair	4356	2.0e-234	0.70	0.80	0.99
PGSC0003DMG200000452	K10747	ko03030	DNA replication	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMG200000452	K10747	ko03410	Base excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMG200000452	K10747	ko03420	Nucleotide excision repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMG200000452	K10747	ko03430	Mismatch repair	4414	1.3e-237	0.73	0.83	0.99
PGSC0003DMG200000453	K10747	ko03030	DNA replication	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMG200000453	K10747	ko03410	Base excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMG200000453	K10747	ko03420	Nucleotide excision repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMG200000453	K10747	ko03430	Mismatch repair	282	4.0e-09	0.41	0.62	0.90
PGSC0003DMG200000456	K02939	ko03010	Ribosome	1143	3.3e-57	0.73	0.88	0.98
PGSC0003DMG200047106	K10760	ko00908	Zeatin biosynthesis	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMG200047106	K10760	ko01100	Metabolic pathways	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMG200047106	K10760	ko01110	Biosynthesis of secondary metabolites	572	1.0e-25	0.39	0.55	0.97
PGSC0003DMG200001940	K09564	ko03040	Spliceosome	465	8.2e-20	0.58	0.74	0.47
PGSC0003DMG200001940	K09564	ko03040	Spliceosome	520	7.6e-23	0.48	0.65	0.80
PGSC0003DMG200001941	K12153	ko00966	Glucosinolate biosynthesis	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMG200001941	K12153	ko01110	Biosynthesis of secondary metabolites	1858	1.2e-96	0.53	0.68	1.00
PGSC0003DMG200001941	K11812	ko00380	Tryptophan metabolism	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMG200001941	K11812	ko00966	Glucosinolate biosynthesis	1010	7.2e-50	0.61	0.75	1.00
PGSC0003DMG200001941	K11812	ko00380	Tryptophan metabolism	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMG200001941	K11812	ko00966	Glucosinolate biosynthesis	1103	5.3e-55	0.60	0.75	0.99
PGSC0003DMG200001942	K12153	ko00966	Glucosinolate biosynthesis	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMG200001942	K12153	ko01110	Biosynthesis of secondary metabolites	804	1.6e-38	0.46	0.61	0.99
PGSC0003DMG200001943	K12153	ko00966	Glucosinolate biosynthesis	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMG200001943	K12153	ko01110	Biosynthesis of secondary metabolites	446	9.2e-19	0.55	0.69	0.72
PGSC0003DMG200001944	K12153	ko00966	Glucosinolate biosynthesis	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMG200001944	K12153	ko01110	Biosynthesis of secondary metabolites	1218	4.1e-68	0.55	0.71	0.99
PGSC0003DMG200001944	K13027	ko00460	Cyanoamino acid metabolism	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMG200001944	K13027	ko00966	Glucosinolate biosynthesis	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMG200001944	K13027	ko01100	Metabolic pathways	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMG200001944	K13027	ko01110	Biosynthesis of secondary metabolites	1424	1.0e-72	0.53	0.69	0.98
PGSC0003DMG200001946	K01246	ko03410	Base excision repair	529	2.4e-23	0.73	0.92	0.99
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2647	3.7e-140	0.52	0.70	0.93
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2865	3.5e-152	0.49	0.68	0.95
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	2134	7.2e-112	0.49	0.65	0.97
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	1349	1.4e-68	0.45	0.65	0.98
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	810	7.7e-39	0.40	0.59	0.97
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	422	5.9e-17	0.41	0.60	0.93
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	1707	2.6e-88	0.47	0.63	0.98
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	1468	3.9e-75	0.46	0.62	0.98
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	1490	2.4e-76	0.56	0.76	0.79
PGSC0003DMG200001948	K04120	ko00904	Diterpenoid biosynthesis	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMG200001948	K04120	ko01100	Metabolic pathways	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMG200001948	K04120	ko01110	Biosynthesis of secondary metabolites	1860	9.4e-97	0.56	0.75	0.84
PGSC0003DMG200012388	K03846	ko00510	N-Glycan biosynthesis	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMG200012388	K03846	ko01100	Metabolic pathways	1098	1.0e-54	0.76	0.85	0.97
PGSC0003DMG200012388	K03846	ko00510	N-Glycan biosynthesis	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMG200012388	K03846	ko01100	Metabolic pathways	305	1.0e-10	0.67	0.84	0.96
PGSC0003DMG200012390	K10580	ko04120	Ubiquitin mediated proteolysis	1294	1.6e-65	0.99	0.99	0.99
PGSC0003DMG200012393	K12741	ko03040	Spliceosome	337	9.4e-13	0.29	0.47	0.85
PGSC0003DMG200012395	K00026	ko00020	Citrate cycle (TCA cycle)	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012395	K00026	ko00620	Pyruvate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012395	K00026	ko00630	Glyoxylate and dicarboxylate metabolism	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012395	K00026	ko00710	Carbon fixation in photosynthetic organisms	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012395	K00026	ko01100	Metabolic pathways	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012395	K00026	ko01110	Biosynthesis of secondary metabolites	2454	1.6e-129	0.86	0.94	0.99
PGSC0003DMG200012398	K01681	ko00020	Citrate cycle (TCA cycle)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMG200012398	K01681	ko00630	Glyoxylate and dicarboxylate metabolism	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMG200012398	K01681	ko00720	Reductive carboxylate cycle (CO2 fixation)	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMG200012398	K01681	ko01100	Metabolic pathways	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMG200012398	K01681	ko01110	Biosynthesis of secondary metabolites	283	3.8e-06	0.48	0.59	0.09
PGSC0003DMG200012401	K06027	ko04962	Vasopressin-regulated water reabsorption	939	4.0e-45	0.45	0.63	0.16
PGSC0003DMG200012405	K02968	ko03010	Ribosome	310	2.9e-11	0.53	0.66	0.46
PGSC0003DMG200016162	K01838	ko00500	Starch and sucrose metabolism	306	1.8e-13	0.39	0.54	0.52
PGSC0003DMG200016162	K01838	ko00500	Starch and sucrose metabolism	266	2.6e-11	0.39	0.58	0.45
PGSC0003DMG200016168	K00297	ko00670	One carbon pool by folate	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMG200016168	K00297	ko00680	Methane metabolism	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMG200016168	K00297	ko01100	Metabolic pathways	4273	7.6e-230	0.81	0.92	1.00
PGSC0003DMG200016169	K01179	ko00500	Starch and sucrose metabolism	1024	1.2e-50	0.54	0.69	0.94
PGSC0003DMG200016169	K01179	ko00500	Starch and sucrose metabolism	3033	1.9e-161	0.57	0.72	0.99
PGSC0003DMG200016169	K01179	ko00500	Starch and sucrose metabolism	2257	1.2e-118	0.55	0.71	0.95
PGSC0003DMG200016170	K01099	ko00562	Inositol phosphate metabolism	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMG200016170	K01099	ko01100	Metabolic pathways	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMG200016170	K01099	ko04070	Phosphatidylinositol signaling system	550	9.4e-23	0.32	0.50	0.33
PGSC0003DMG200016170	K01099	ko00562	Inositol phosphate metabolism	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMG200016170	K01099	ko01100	Metabolic pathways	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMG200016170	K01099	ko04070	Phosphatidylinositol signaling system	775	5.9e-39	0.30	0.47	0.56
PGSC0003DMG200016170	K01099	ko00562	Inositol phosphate metabolism	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMG200016170	K01099	ko01100	Metabolic pathways	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMG200016170	K01099	ko04070	Phosphatidylinositol signaling system	741	1.2e-34	0.29	0.45	0.45
PGSC0003DMG200016174	K06670	ko04110	Cell cycle	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMG200016174	K06670	ko04111	Cell cycle - yeast	2803	9.1e-149	0.40	0.51	1.00
PGSC0003DMG200029803	K12741	ko03040	Spliceosome	1428	6.3e-73	0.46	0.59	0.99
PGSC0003DMG200019252	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200019252	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200019252	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200019252	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200019252	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200019253	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMG200019253	K05929	ko00564	Glycerophospholipid metabolism	243	1.4e-07	0.37	0.54	0.38
PGSC0003DMG200019255	K01051	ko00040	Pentose and glucuronate interconversions	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMG200019255	K01051	ko00500	Starch and sucrose metabolism	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMG200019255	K01051	ko01100	Metabolic pathways	1589	8.3e-82	0.59	0.76	0.97
PGSC0003DMG200019255	K01051	ko00040	Pentose and glucuronate interconversions	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMG200019255	K01051	ko00500	Starch and sucrose metabolism	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMG200019255	K01051	ko01100	Metabolic pathways	1771	7.6e-92	0.48	0.65	0.99
PGSC0003DMG200019256	K01051	ko00040	Pentose and glucuronate interconversions	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMG200019256	K01051	ko00500	Starch and sucrose metabolism	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMG200019256	K01051	ko01100	Metabolic pathways	1776	4.0e-92	0.50	0.64	0.91
PGSC0003DMG200019259	K05658	ko02010	ABC transporters	3935	3.3e-211	0.42	0.62	0.99
PGSC0003DMG200019262	K12844	ko03040	Spliceosome	2375	3.7e-125	0.65	0.77	0.98
PGSC0003DMG200019266	K02895	ko03010	Ribosome	1113	1.5e-55	0.74	0.83	0.99
PGSC0003DMG200019266	K02895	ko03010	Ribosome	1190	8.4e-60	0.76	0.86	0.99
PGSC0003DMG200036129	K13065	ko00940	Phenylpropanoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMG200036129	K13065	ko00941	Flavonoid biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMG200036129	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMG200036129	K13065	ko01110	Biosynthesis of secondary metabolites	449	6.3e-19	0.28	0.45	0.97
PGSC0003DMG200036131	K00797	ko00270	Cysteine and methionine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMG200036131	K00797	ko00330	Arginine and proline metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMG200036131	K00797	ko00410	beta-Alanine metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMG200036131	K00797	ko00480	Glutathione metabolism	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMG200036131	K00797	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.81	0.82
PGSC0003DMG200036132	K10760	ko00908	Zeatin biosynthesis	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMG200036132	K10760	ko01100	Metabolic pathways	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMG200036132	K10760	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.62	0.80	0.85
PGSC0003DMG200036150	K01509	ko00230	Purine metabolism	688	4.1e-32	0.35	0.55	0.89
PGSC0003DMG200004769	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMG200004769	K02366	ko01100	Metabolic pathways	322	6.3e-12	0.28	0.46	0.74
PGSC0003DMG200004769	K02366	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMG200004769	K02366	ko01100	Metabolic pathways	322	7.7e-12	0.28	0.46	0.63
PGSC0003DMG200004771	K12844	ko03040	Spliceosome	3586	5.9e-192	0.89	0.96	1.00
PGSC0003DMG200004772	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMG200004772	K00852	ko00030	Pentose phosphate pathway	248	7.6e-08	0.31	0.52	0.97
PGSC0003DMG200004772	K00852	ko00030	Pentose phosphate pathway	318	1.1e-11	0.30	0.47	0.62
PGSC0003DMG200004775	K05280	ko00941	Flavonoid biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMG200004775	K05280	ko00944	Flavone and flavonol biosynthesis	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMG200004775	K05280	ko01100	Metabolic pathways	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMG200004775	K05280	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.42	0.61	0.90
PGSC0003DMG200004776	K05280	ko00941	Flavonoid biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMG200004776	K05280	ko00944	Flavone and flavonol biosynthesis	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMG200004776	K05280	ko01100	Metabolic pathways	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMG200004776	K05280	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.41	0.60	0.82
PGSC0003DMG200004777	K05280	ko00941	Flavonoid biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMG200004777	K05280	ko00944	Flavone and flavonol biosynthesis	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMG200004777	K05280	ko01100	Metabolic pathways	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMG200004777	K05280	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.41	0.60	0.91
PGSC0003DMG200004778	K05280	ko00941	Flavonoid biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMG200004778	K05280	ko00944	Flavone and flavonol biosynthesis	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMG200004778	K05280	ko01100	Metabolic pathways	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMG200004778	K05280	ko01110	Biosynthesis of secondary metabolites	1463	7.4e-75	0.40	0.58	0.95
PGSC0003DMG200004779	K05280	ko00941	Flavonoid biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMG200004779	K05280	ko00944	Flavone and flavonol biosynthesis	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMG200004779	K05280	ko01100	Metabolic pathways	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMG200004779	K05280	ko01110	Biosynthesis of secondary metabolites	1360	9.8e-72	0.42	0.62	0.89
PGSC0003DMG200004779	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMG200004779	K00517	ko00626	Naphthalene and anthracene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMG200004779	K00517	ko00903	Limonene and pinene degradation	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMG200004779	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMG200004779	K00517	ko01110	Biosynthesis of secondary metabolites	1465	5.7e-75	0.41	0.59	0.96
PGSC0003DMG200004779	K05280	ko00941	Flavonoid biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMG200004779	K05280	ko00944	Flavone and flavonol biosynthesis	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMG200004779	K05280	ko01100	Metabolic pathways	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMG200004779	K05280	ko01110	Biosynthesis of secondary metabolites	1293	1.8e-65	0.39	0.59	0.94
PGSC0003DMG200004779	K05280	ko00941	Flavonoid biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMG200004779	K05280	ko00944	Flavone and flavonol biosynthesis	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMG200004779	K05280	ko01100	Metabolic pathways	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMG200004779	K05280	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.49	0.67	0.99
PGSC0003DMG200004779	K05280	ko00941	Flavonoid biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMG200004779	K05280	ko00944	Flavone and flavonol biosynthesis	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMG200004779	K05280	ko01100	Metabolic pathways	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMG200004779	K05280	ko01110	Biosynthesis of secondary metabolites	1206	1.1e-60	0.42	0.61	0.99
PGSC0003DMG200004784	K09553	ko05020	Prion diseases	3875	6.8e-208	0.78	0.88	1.00
PGSC0003DMG200013040	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.66
PGSC0003DMG200013040	K03366	ko00650	Butanoate metabolism	413	6.1e-17	0.35	0.53	0.69
PGSC0003DMG200002612	K00029	ko00620	Pyruvate metabolism	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMG200002612	K00029	ko00710	Carbon fixation in photosynthetic organisms	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMG200002612	K00029	ko01100	Metabolic pathways	3652	1.4e-195	0.80	0.90	1.00
PGSC0003DMG200002612	K00029	ko00620	Pyruvate metabolism	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMG200002612	K00029	ko00710	Carbon fixation in photosynthetic organisms	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMG200002612	K00029	ko01100	Metabolic pathways	1611	5.1e-83	0.85	0.93	1.00
PGSC0003DMG200002612	K00029	ko00620	Pyruvate metabolism	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMG200002612	K00029	ko00710	Carbon fixation in photosynthetic organisms	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMG200002612	K00029	ko01100	Metabolic pathways	1823	1.0e-94	0.85	0.93	0.99
PGSC0003DMG200002612	K00029	ko00620	Pyruvate metabolism	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMG200002612	K00029	ko00710	Carbon fixation in photosynthetic organisms	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMG200002612	K00029	ko01100	Metabolic pathways	4392	2.1e-236	0.81	0.91	1.00
PGSC0003DMG200002612	K00029	ko00620	Pyruvate metabolism	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMG200002612	K00029	ko00710	Carbon fixation in photosynthetic organisms	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMG200002612	K00029	ko01100	Metabolic pathways	2572	5.0e-136	0.78	0.89	0.99
PGSC0003DMG200015429	K04508	ko04310	Wnt signaling pathway	394	6.8e-16	0.74	0.88	0.98
PGSC0003DMG200015430	K04508	ko04310	Wnt signaling pathway	2724	2.1e-144	0.63	0.79	0.67
PGSC0003DMG200015431	K04508	ko04310	Wnt signaling pathway	2907	1.7e-154	0.66	0.80	0.94
PGSC0003DMG200015432	K01136	ko00531	Glycosaminoglycan degradation	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMG200015432	K01136	ko01100	Metabolic pathways	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMG200015432	K01136	ko04142	Lysosome	223	9.1e-06	0.33	0.50	0.44
PGSC0003DMG200015433	K04503	ko04110	Cell cycle	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko04115	p53 signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko04310	Wnt signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko04510	Focal adhesion	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko04630	Jak-STAT signaling pathway	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05200	Pathways in cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05210	Colorectal cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05212	Pancreatic cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05213	Endometrial cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05214	Glioma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05215	Prostate cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05216	Thyroid cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05218	Melanoma	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05219	Bladder cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05220	Chronic myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05221	Acute myeloid leukemia	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05222	Small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05223	Non-small cell lung cancer	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015433	K04503	ko05416	Viral myocarditis	317	1.2e-11	0.29	0.51	0.72
PGSC0003DMG200015444	K00091	ko00941	Flavonoid biosynthesis	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMG200015444	K00091	ko01100	Metabolic pathways	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMG200015444	K00091	ko01110	Biosynthesis of secondary metabolites	691	2.8e-32	0.33	0.53	0.98
PGSC0003DMG200011811	K02641	ko00195	Photosynthesis	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMG200011811	K02641	ko01100	Metabolic pathways	2718	4.5e-144	0.82	0.92	1.00
PGSC0003DMG200011813	K04708	ko00600	Sphingolipid metabolism	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMG200011813	K04708	ko01100	Metabolic pathways	817	3.2e-39	0.39	0.60	0.97
PGSC0003DMG200011813	K04708	ko00600	Sphingolipid metabolism	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMG200011813	K04708	ko01100	Metabolic pathways	391	9.9e-16	0.39	0.57	0.90
PGSC0003DMG200011813	K12420	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.42	0.59	0.75
PGSC0003DMG200011816	K02692	ko00195	Photosynthesis	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMG200011816	K02692	ko01100	Metabolic pathways	1393	5.4e-71	0.80	0.85	1.00
PGSC0003DMG200011820	K02992	ko03010	Ribosome	1163	2.6e-58	0.97	0.99	0.99
PGSC0003DMG200011823	K03787	ko00230	Purine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMG200011823	K03787	ko00240	Pyrimidine metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMG200011823	K03787	ko00760	Nicotinate and nicotinamide metabolism	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMG200011823	K03787	ko01100	Metabolic pathways	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMG200011823	K03787	ko01110	Biosynthesis of secondary metabolites	1684	4.8e-87	0.66	0.82	0.99
PGSC0003DMG200011823	K03787	ko00230	Purine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMG200011823	K03787	ko00240	Pyrimidine metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMG200011823	K03787	ko00760	Nicotinate and nicotinamide metabolism	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMG200011823	K03787	ko01100	Metabolic pathways	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMG200011823	K03787	ko01110	Biosynthesis of secondary metabolites	411	7.8e-17	0.55	0.74	0.98
PGSC0003DMG200011823	K03787	ko00230	Purine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMG200011823	K03787	ko00240	Pyrimidine metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMG200011823	K03787	ko00760	Nicotinate and nicotinamide metabolism	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMG200011823	K03787	ko01100	Metabolic pathways	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMG200011823	K03787	ko01110	Biosynthesis of secondary metabolites	1065	6.6e-53	0.65	0.79	0.94
PGSC0003DMG200011824	K03787	ko00230	Purine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMG200011824	K03787	ko00240	Pyrimidine metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMG200011824	K03787	ko00760	Nicotinate and nicotinamide metabolism	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMG200011824	K03787	ko01100	Metabolic pathways	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMG200011824	K03787	ko01110	Biosynthesis of secondary metabolites	1416	2.9e-72	0.60	0.72	0.97
PGSC0003DMG200011824	K03787	ko00230	Purine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMG200011824	K03787	ko00240	Pyrimidine metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMG200011824	K03787	ko00760	Nicotinate and nicotinamide metabolism	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMG200011824	K03787	ko01100	Metabolic pathways	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMG200011824	K03787	ko01110	Biosynthesis of secondary metabolites	1495	1.3e-76	0.61	0.74	0.97
PGSC0003DMG200040636	K00799	ko00480	Glutathione metabolism	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMG200040636	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMG200040636	K00799	ko00982	Drug metabolism - cytochrome P450	781	3.1e-37	0.45	0.66	0.91
PGSC0003DMG200040648	K03026	ko00230	Purine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMG200040648	K03026	ko00240	Pyrimidine metabolism	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMG200040648	K03026	ko01100	Metabolic pathways	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMG200040648	K03026	ko03020	RNA polymerase	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMG200040648	K03026	ko04623	Cytosolic DNA-sensing pathway	144	1.1e-07	0.42	0.57	0.72
PGSC0003DMG200001117	K00231	ko00860	Porphyrin and chlorophyll metabolism	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMG200001117	K00231	ko01100	Metabolic pathways	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMG200001117	K00231	ko01110	Biosynthesis of secondary metabolites	1699	7.1e-88	0.81	0.90	1.00
PGSC0003DMG200001117	K00231	ko00860	Porphyrin and chlorophyll metabolism	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMG200001117	K00231	ko01100	Metabolic pathways	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMG200001117	K00231	ko01110	Biosynthesis of secondary metabolites	3398	1.4e-181	0.73	0.83	1.00
PGSC0003DMG200001117	K00231	ko00860	Porphyrin and chlorophyll metabolism	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMG200001117	K00231	ko01100	Metabolic pathways	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMG200001117	K00231	ko01110	Biosynthesis of secondary metabolites	2125	2.3e-111	0.82	0.90	1.00
PGSC0003DMG200001117	K00231	ko00860	Porphyrin and chlorophyll metabolism	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMG200001117	K00231	ko01100	Metabolic pathways	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMG200001117	K00231	ko01110	Biosynthesis of secondary metabolites	1613	3.9e-83	0.68	0.78	1.00
PGSC0003DMG200001118	K00680	ko00350	Tyrosine metabolism	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMG200001118	K00680	ko00624	1- and 2-Methylnaphthalene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMG200001118	K00680	ko00632	Benzoate degradation via CoA ligation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMG200001118	K00680	ko00642	Ethylbenzene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMG200001118	K00680	ko00903	Limonene and pinene degradation	298	7.5e-08	0.50	0.67	0.14
PGSC0003DMG200001119	K11253	ko05322	Systemic lupus erythematosus	1117	9.0e-56	0.99	1.00	0.99
PGSC0003DMG200001121	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001121	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001121	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001121	K04127	ko00311	Penicillin and cephalosporin biosynthesis	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001121	K04127	ko01100	Metabolic pathways	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001121	K04127	ko01110	Biosynthesis of secondary metabolites	720	7.1e-34	0.33	0.52	0.86
PGSC0003DMG200001123	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMG200001123	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMG200001123	K03070	ko03060	Protein export	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMG200001123	K03070	ko03070	Bacterial secretion system	4558	1.5e-245	0.86	0.93	1.00
PGSC0003DMG200001128	K02958	ko03010	Ribosome	514	1.6e-22	0.88	0.94	0.95
PGSC0003DMG200001128	K02958	ko03010	Ribosome	1198	3.1e-60	0.91	0.97	0.99
PGSC0003DMG200001129	K03015	ko00230	Purine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMG200001129	K03015	ko00240	Pyrimidine metabolism	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMG200001129	K03015	ko01100	Metabolic pathways	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMG200001129	K03015	ko03020	RNA polymerase	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMG200001129	K03015	ko05016	Huntington's disease	579	4.2e-26	0.46	0.66	0.89
PGSC0003DMG200001130	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200001130	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200001130	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200001130	K00981	ko00564	Glycerophospholipid metabolism	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200001130	K00981	ko01100	Metabolic pathways	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200001130	K00981	ko04070	Phosphatidylinositol signaling system	710	2.5e-33	0.71	0.85	0.99
PGSC0003DMG200018320	K00603	ko00340	Histidine metabolism	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMG200018320	K00603	ko00670	One carbon pool by folate	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMG200018320	K00603	ko01100	Metabolic pathways	427	1.0e-17	0.32	0.49	0.95
PGSC0003DMG200018320	K00603	ko00340	Histidine metabolism	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMG200018320	K00603	ko00670	One carbon pool by folate	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMG200018320	K00603	ko01100	Metabolic pathways	228	9.7e-07	0.34	0.50	0.60
PGSC0003DMG200018321	K00603	ko00340	Histidine metabolism	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMG200018321	K00603	ko00670	One carbon pool by folate	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMG200018321	K00603	ko01100	Metabolic pathways	408	1.1e-16	0.33	0.50	0.74
PGSC0003DMG200018323	K03644	ko00785	Lipoic acid metabolism	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMG200018323	K03644	ko01100	Metabolic pathways	2738	3.5e-145	0.84	0.88	0.99
PGSC0003DMG200018325	K03885	ko00190	Oxidative phosphorylation	1973	5.5e-103	0.73	0.87	0.99
PGSC0003DMG200018333	K03006	ko00230	Purine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMG200018333	K03006	ko00240	Pyrimidine metabolism	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMG200018333	K03006	ko01100	Metabolic pathways	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMG200018333	K03006	ko03020	RNA polymerase	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMG200018333	K03006	ko05016	Huntington's disease	2411	3.8e-127	0.59	0.77	0.22
PGSC0003DMG200028322	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMG200028322	K00517	ko00626	Naphthalene and anthracene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMG200028322	K00517	ko00903	Limonene and pinene degradation	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMG200028322	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMG200028322	K00517	ko01110	Biosynthesis of secondary metabolites	1801	1.7e-93	0.49	0.66	0.98
PGSC0003DMG200028324	K08509	ko04130	SNARE interactions in vesicular transport	1215	3.5e-61	0.59	0.73	1.00
PGSC0003DMG200028324	K08509	ko04130	SNARE interactions in vesicular transport	1240	1.5e-62	0.60	0.73	1.00
PGSC0003DMG200028325	K07964	ko00531	Glycosaminoglycan degradation	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMG200028325	K07964	ko01100	Metabolic pathways	607	1.2e-27	0.29	0.48	0.89
PGSC0003DMG200028325	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	349	1.0e-12	0.32	0.46	0.85
PGSC0003DMG200028325	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	360	3.7e-13	0.27	0.44	0.95
PGSC0003DMG200027535	K02975	ko03010	Ribosome	614	5.0e-28	0.91	0.97	0.98
PGSC0003DMG200027542	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko00770	Pantothenate and CoA biosynthesis	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko01100	Metabolic pathways	439	2.2e-18	0.53	0.66	0.92
PGSC0003DMG200027542	K01922	ko00770	Pantothenate and CoA biosynthesis	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMG200027542	K01922	ko01100	Metabolic pathways	600	2.9e-27	0.46	0.67	0.86
PGSC0003DMG200027554	K00850	ko00010	Glycolysis / Gluconeogenesis	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200027554	K00850	ko00030	Pentose phosphate pathway	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200027554	K00850	ko00051	Fructose and mannose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200027554	K00850	ko00052	Galactose metabolism	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200027554	K00850	ko01100	Metabolic pathways	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200027554	K00850	ko01110	Biosynthesis of secondary metabolites	2986	7.4e-159	0.76	0.85	0.95
PGSC0003DMG200031696	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMG200031696	K00517	ko00626	Naphthalene and anthracene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMG200031696	K00517	ko00903	Limonene and pinene degradation	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMG200031696	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMG200031696	K00517	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.55	0.68	0.92
PGSC0003DMG200031714	K05391	ko04626	Plant-pathogen interaction	1520	5.3e-78	0.77	0.84	1.00
PGSC0003DMG200031725	K03064	ko03050	Proteasome	941	4.6e-46	0.93	0.97	0.99
PGSC0003DMG200031730	K10747	ko03030	DNA replication	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03410	Base excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03420	Nucleotide excision repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03430	Mismatch repair	498	7.4e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03030	DNA replication	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMG200031730	K10747	ko03410	Base excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMG200031730	K10747	ko03420	Nucleotide excision repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMG200031730	K10747	ko03430	Mismatch repair	528	1.5e-22	0.29	0.47	0.98
PGSC0003DMG200031730	K10747	ko03030	DNA replication	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03410	Base excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03420	Nucleotide excision repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMG200031730	K10747	ko03430	Mismatch repair	507	2.3e-21	0.28	0.47	0.99
PGSC0003DMG200031731	K13065	ko00940	Phenylpropanoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMG200031731	K13065	ko00941	Flavonoid biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMG200031731	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMG200031731	K13065	ko01110	Biosynthesis of secondary metabolites	1027	8.3e-51	0.36	0.56	0.97
PGSC0003DMG200031731	K13065	ko00940	Phenylpropanoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMG200031731	K13065	ko00941	Flavonoid biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMG200031731	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMG200031731	K13065	ko01110	Biosynthesis of secondary metabolites	663	9.8e-31	0.35	0.56	0.99
PGSC0003DMG200021781	K06102	ko04530	Tight junction	355	1.0e-10	0.26	0.45	0.99
PGSC0003DMG200021781	K06102	ko04530	Tight junction	328	2.6e-09	0.26	0.46	0.97
PGSC0003DMG200017144	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMG200017144	K00135	ko00350	Tyrosine metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMG200017144	K00135	ko00650	Butanoate metabolism	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMG200017144	K00135	ko01100	Metabolic pathways	3490	1.2e-186	0.84	0.94	0.99
PGSC0003DMG200017144	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko00250	Alanine, aspartate and glutamate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko00350	Tyrosine metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko00650	Butanoate metabolism	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017144	K00135	ko01100	Metabolic pathways	3512	7.2e-188	0.81	0.91	1.00
PGSC0003DMG200017145	K00797	ko00270	Cysteine and methionine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMG200017145	K00797	ko00330	Arginine and proline metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMG200017145	K00797	ko00410	beta-Alanine metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMG200017145	K00797	ko00480	Glutathione metabolism	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMG200017145	K00797	ko01100	Metabolic pathways	244	1.4e-07	0.29	0.41	0.63
PGSC0003DMG200017147	K12587	ko03018	RNA degradation	330	2.6e-11	0.35	0.54	0.45
PGSC0003DMG200017148	K12127	ko04712	Circadian rhythm - plant	223	7.5e-08	0.34	0.50	0.63
PGSC0003DMG200017150	K11420	ko00310	Lysine degradation	610	4.0e-27	0.35	0.47	0.48
PGSC0003DMG200017151	K02894	ko03010	Ribosome	1184	1.8e-59	0.99	1.00	0.99
PGSC0003DMG200017152	K02866	ko03010	Ribosome	609	9.4e-28	0.40	0.59	0.83
PGSC0003DMG200017153	K03259	ko04150	mTOR signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMG200017153	K03259	ko04910	Insulin signaling pathway	1387	1.2e-70	0.78	0.87	1.00
PGSC0003DMG200017153	K03259	ko04150	mTOR signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMG200017153	K03259	ko04910	Insulin signaling pathway	407	1.3e-16	0.72	0.79	0.97
PGSC0003DMG200017156	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMG200017156	K12741	ko03040	Spliceosome	2971	5.0e-158	0.72	0.81	1.00
PGSC0003DMG200017157	K00276	ko00260	Glycine, serine and threonine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00350	Tyrosine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00360	Phenylalanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00410	beta-Alanine metabolism	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00950	Isoquinoline alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko01100	Metabolic pathways	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko01110	Biosynthesis of secondary metabolites	806	1.3e-38	0.35	0.53	0.93
PGSC0003DMG200017157	K00276	ko00260	Glycine, serine and threonine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko00350	Tyrosine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko00360	Phenylalanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko00410	beta-Alanine metabolism	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko01100	Metabolic pathways	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017157	K00276	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.35	0.51	0.96
PGSC0003DMG200017160	K01725	ko00910	Nitrogen metabolism	1087	4.1e-54	0.82	0.92	0.97
PGSC0003DMG200010196	K04424	ko04010	MAPK signaling pathway	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMG200010196	K04424	ko04530	Tight junction	1149	1.5e-57	0.33	0.49	0.89
PGSC0003DMG200010196	K04424	ko04010	MAPK signaling pathway	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMG200010196	K04424	ko04530	Tight junction	384	4.6e-13	0.27	0.45	0.86
PGSC0003DMG200010196	K04424	ko04010	MAPK signaling pathway	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMG200010196	K04424	ko04530	Tight junction	1135	9.1e-57	0.33	0.51	0.89
PGSC0003DMG200003645	K00434	ko00053	Ascorbate and aldarate metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMG200003645	K00434	ko00480	Glutathione metabolism	550	1.7e-24	0.39	0.47	0.95
PGSC0003DMG200003645	K00434	ko00053	Ascorbate and aldarate metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMG200003645	K00434	ko00480	Glutathione metabolism	786	1.6e-37	0.45	0.56	0.96
PGSC0003DMG200003646	K00434	ko00053	Ascorbate and aldarate metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMG200003646	K00434	ko00480	Glutathione metabolism	1972	6.2e-103	0.82	0.90	0.99
PGSC0003DMG200003647	K06662	ko04111	Cell cycle - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMG200003647	K06662	ko04113	Meiosis - yeast	1340	4.5e-68	0.56	0.70	0.92
PGSC0003DMG200003647	K06662	ko04111	Cell cycle - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMG200003647	K06662	ko04113	Meiosis - yeast	2243	7.0e-118	0.56	0.73	1.00
PGSC0003DMG200003647	K06662	ko04111	Cell cycle - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMG200003647	K06662	ko04113	Meiosis - yeast	805	1.4e-38	0.57	0.71	0.99
PGSC0003DMG200003647	K06662	ko04111	Cell cycle - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMG200003647	K06662	ko04113	Meiosis - yeast	1385	1.5e-70	0.56	0.74	0.99
PGSC0003DMG200003654	K00430	ko00360	Phenylalanine metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMG200003654	K00430	ko00680	Methane metabolism	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMG200003654	K00430	ko00940	Phenylpropanoid biosynthesis	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMG200003654	K00430	ko01100	Metabolic pathways	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMG200003654	K00430	ko01110	Biosynthesis of secondary metabolites	1006	1.2e-49	0.63	0.72	0.98
PGSC0003DMG200003654	K00430	ko00360	Phenylalanine metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMG200003654	K00430	ko00680	Methane metabolism	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMG200003654	K00430	ko00940	Phenylpropanoid biosynthesis	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMG200003654	K00430	ko01100	Metabolic pathways	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMG200003654	K00430	ko01110	Biosynthesis of secondary metabolites	514	1.6e-22	0.55	0.70	0.97
PGSC0003DMG200003654	K00430	ko00360	Phenylalanine metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMG200003654	K00430	ko00680	Methane metabolism	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMG200003654	K00430	ko00940	Phenylpropanoid biosynthesis	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMG200003654	K00430	ko01100	Metabolic pathways	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMG200003654	K00430	ko01110	Biosynthesis of secondary metabolites	1630	4.6e-84	0.64	0.76	0.96
PGSC0003DMG200003654	K00430	ko00360	Phenylalanine metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMG200003654	K00430	ko00680	Methane metabolism	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMG200003654	K00430	ko00940	Phenylpropanoid biosynthesis	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMG200003654	K00430	ko01100	Metabolic pathways	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMG200003654	K00430	ko01110	Biosynthesis of secondary metabolites	1600	2.1e-82	0.62	0.74	0.99
PGSC0003DMG200003654	K00430	ko00360	Phenylalanine metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMG200003654	K00430	ko00680	Methane metabolism	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMG200003654	K00430	ko00940	Phenylpropanoid biosynthesis	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMG200003654	K00430	ko01100	Metabolic pathways	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMG200003654	K00430	ko01110	Biosynthesis of secondary metabolites	1729	1.6e-89	0.67	0.82	0.95
PGSC0003DMG200014832	K00734	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMG200014832	K00734	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMG200014832	K00734	ko01100	Metabolic pathways	313	2.0e-11	0.32	0.47	0.56
PGSC0003DMG200038156	K01535	ko00190	Oxidative phosphorylation	6228	0.	0.78	0.88	0.99
PGSC0003DMG200038158	K05391	ko04626	Plant-pathogen interaction	3510	9.2e-188	0.64	0.78	0.99
PGSC0003DMG200038162	K00599	ko00340	Histidine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMG200038162	K00599	ko00350	Tyrosine metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMG200038162	K00599	ko00450	Selenoamino acid metabolism	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMG200038162	K00599	ko00626	Naphthalene and anthracene degradation	534	1.3e-23	0.30	0.48	0.84
PGSC0003DMG200000707	K12399	ko04142	Lysosome	704	5.4e-33	0.57	0.72	0.99
PGSC0003DMG200000707	K12399	ko04142	Lysosome	999	2.9e-49	0.73	0.87	0.98
PGSC0003DMG200000707	K12399	ko04142	Lysosome	411	7.8e-17	0.69	0.89	0.99
PGSC0003DMG200000710	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMG200000710	K08680	ko01100	Metabolic pathways	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMG200000710	K08680	ko01110	Biosynthesis of secondary metabolites	228	9.7e-07	0.28	0.50	0.83
PGSC0003DMG200000710	K08680	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMG200000710	K08680	ko01100	Metabolic pathways	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMG200000710	K08680	ko01110	Biosynthesis of secondary metabolites	241	1.9e-07	0.26	0.46	0.80
PGSC0003DMG200000711	K12126	ko04712	Circadian rhythm - plant	319	1.9e-10	0.30	0.46	0.62
PGSC0003DMG200000711	K12126	ko04712	Circadian rhythm - plant	319	2.8e-10	0.30	0.46	0.60
PGSC0003DMG200000712	K01051	ko00040	Pentose and glucuronate interconversions	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMG200000712	K01051	ko00500	Starch and sucrose metabolism	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMG200000712	K01051	ko01100	Metabolic pathways	1152	1.1e-57	0.50	0.65	0.87
PGSC0003DMG200000720	K07897	ko04144	Endocytosis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMG200000720	K07897	ko04145	Phagosome	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMG200000720	K07897	ko05146	Amoebiasis	1697	9.2e-88	0.97	0.98	1.00
PGSC0003DMG200000722	K04536	ko04062	Chemokine signaling pathway	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMG200000722	K04536	ko04742	Taste transduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMG200000722	K04536	ko04744	Phototransduction	2940	2.5e-156	0.90	0.94	1.00
PGSC0003DMG200000722	K01199	ko00500	Starch and sucrose metabolism	869	4.3e-42	0.38	0.57	0.71
PGSC0003DMG200046810	K03094	ko04110	Cell cycle	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04111	Cell cycle - yeast	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04114	Oocyte meiosis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04120	Ubiquitin mediated proteolysis	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04310	Wnt signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04350	TGF-beta signaling pathway	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046810	K03094	ko04710	Circadian rhythm - mammal	714	1.5e-33	0.59	0.75	0.99
PGSC0003DMG200046813	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMG200046813	K00517	ko00626	Naphthalene and anthracene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMG200046813	K00517	ko00903	Limonene and pinene degradation	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMG200046813	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMG200046813	K00517	ko01110	Biosynthesis of secondary metabolites	3259	6.5e-174	0.79	0.90	0.97
PGSC0003DMG200046829	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	350	7.7e-11	0.26	0.44	0.69
PGSC0003DMG200008413	K01179	ko00500	Starch and sucrose metabolism	1467	4.5e-75	0.60	0.73	0.93
PGSC0003DMG200008413	K01179	ko00500	Starch and sucrose metabolism	2482	4.6e-131	0.62	0.77	0.95
PGSC0003DMG200008413	K01179	ko00500	Starch and sucrose metabolism	1060	1.2e-52	0.56	0.70	0.99
PGSC0003DMG200008416	K00817	ko00340	Histidine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko00350	Tyrosine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko00360	Phenylalanine metabolism	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko00401	Novobiocin biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko01100	Metabolic pathways	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008416	K00817	ko01110	Biosynthesis of secondary metabolites	593	7.1e-27	0.57	0.65	0.91
PGSC0003DMG200008417	K08735	ko03430	Mismatch repair	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMG200008417	K08735	ko05200	Pathways in cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMG200008417	K08735	ko05210	Colorectal cancer	895	1.6e-43	0.55	0.66	0.93
PGSC0003DMG200008418	K08735	ko03430	Mismatch repair	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMG200008418	K08735	ko05200	Pathways in cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMG200008418	K08735	ko05210	Colorectal cancer	608	1.3e-27	0.50	0.59	0.82
PGSC0003DMG200008422	K02929	ko03010	Ribosome	840	1.7e-40	0.92	0.95	0.36
PGSC0003DMG200002687	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko00900	Terpenoid backbone biosynthesis	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01100	Metabolic pathways	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002687	K00804	ko01110	Biosynthesis of secondary metabolites	1079	1.1e-53	0.45	0.62	0.94
PGSC0003DMG200002688	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMG200002688	K00517	ko00626	Naphthalene and anthracene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMG200002688	K00517	ko00903	Limonene and pinene degradation	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMG200002688	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMG200002688	K00517	ko01110	Biosynthesis of secondary metabolites	1758	4.0e-91	0.45	0.65	0.97
PGSC0003DMG200002688	K05280	ko00941	Flavonoid biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMG200002688	K05280	ko00944	Flavone and flavonol biosynthesis	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMG200002688	K05280	ko01100	Metabolic pathways	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMG200002688	K05280	ko01110	Biosynthesis of secondary metabolites	875	2.0e-42	0.51	0.71	0.99
PGSC0003DMG200002690	K00873	ko00010	Glycolysis / Gluconeogenesis	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko00230	Purine metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko00620	Pyruvate metabolism	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko00710	Carbon fixation in photosynthetic organisms	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko01100	Metabolic pathways	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko01110	Biosynthesis of secondary metabolites	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002690	K00873	ko04930	Type II diabetes mellitus	3465	2.8e-185	0.86	0.96	0.95
PGSC0003DMG200002694	K12626	ko03018	RNA degradation	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMG200002694	K12626	ko03040	Spliceosome	772	9.6e-37	0.94	0.96	0.99
PGSC0003DMG200012624	K00235	ko00020	Citrate cycle (TCA cycle)	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko00190	Oxidative phosphorylation	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko01100	Metabolic pathways	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko01110	Biosynthesis of secondary metabolites	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko05010	Alzheimer's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko05012	Parkinson's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012624	K00235	ko05016	Huntington's disease	2003	1.2e-104	0.82	0.90	0.99
PGSC0003DMG200012625	K12386	ko04142	Lysosome	807	1.1e-38	0.82	0.88	0.88
PGSC0003DMG200012625	K12386	ko04142	Lysosome	1685	4.2e-87	0.76	0.84	0.97
PGSC0003DMG200012629	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012629	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012629	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012629	K01955	ko00240	Pyrimidine metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012629	K01955	ko00250	Alanine, aspartate and glutamate metabolism	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012629	K01955	ko01100	Metabolic pathways	543	2.9e-23	0.54	0.71	0.75
PGSC0003DMG200012631	K06665	ko04111	Cell cycle - yeast	295	1.6e-09	0.27	0.44	0.87
PGSC0003DMG200016016	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMG200016016	K01736	ko01100	Metabolic pathways	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMG200016016	K01736	ko01110	Biosynthesis of secondary metabolites	2972	4.4e-158	0.82	0.90	0.97
PGSC0003DMG200016016	K01736	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMG200016016	K01736	ko01100	Metabolic pathways	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMG200016016	K01736	ko01110	Biosynthesis of secondary metabolites	2118	5.5e-111	0.89	0.95	0.96
PGSC0003DMG200016018	K01187	ko00052	Galactose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMG200016018	K01187	ko00500	Starch and sucrose metabolism	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMG200016018	K01187	ko01100	Metabolic pathways	1016	3.3e-50	0.53	0.67	0.99
PGSC0003DMG200016018	K01187	ko00052	Galactose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMG200016018	K01187	ko00500	Starch and sucrose metabolism	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMG200016018	K01187	ko01100	Metabolic pathways	3388	5.0e-181	0.67	0.80	0.92
PGSC0003DMG200016018	K01187	ko00052	Galactose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMG200016018	K01187	ko00500	Starch and sucrose metabolism	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMG200016018	K01187	ko01100	Metabolic pathways	4870	9.0e-263	0.64	0.78	0.98
PGSC0003DMG200016018	K01187	ko00052	Galactose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMG200016018	K01187	ko00500	Starch and sucrose metabolism	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMG200016018	K01187	ko01100	Metabolic pathways	2982	1.2e-158	0.66	0.78	0.99
PGSC0003DMG200016018	K01187	ko00052	Galactose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMG200016018	K01187	ko00500	Starch and sucrose metabolism	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMG200016018	K01187	ko01100	Metabolic pathways	2838	1.1e-150	0.65	0.78	0.92
PGSC0003DMG200016019	K12501	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1759	3.5e-91	0.50	0.67	0.91
PGSC0003DMG200016038	K01213	ko00040	Pentose and glucuronate interconversions	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMG200016038	K01213	ko00500	Starch and sucrose metabolism	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMG200016038	K01213	ko01100	Metabolic pathways	812	6.0e-39	0.36	0.54	0.73
PGSC0003DMG200019347	K08099	ko00860	Porphyrin and chlorophyll metabolism	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMG200019347	K08099	ko01100	Metabolic pathways	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMG200019347	K08099	ko01110	Biosynthesis of secondary metabolites	835	3.2e-40	0.45	0.61	0.89
PGSC0003DMG200019352	K01968	ko00280	Valine, leucine and isoleucine degradation	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMG200019352	K01968	ko01100	Metabolic pathways	510	2.7e-22	0.66	0.81	0.99
PGSC0003DMG200019352	K01968	ko00280	Valine, leucine and isoleucine degradation	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMG200019352	K01968	ko01100	Metabolic pathways	3665	2.6e-196	0.74	0.86	1.00
PGSC0003DMG200019352	K01968	ko00280	Valine, leucine and isoleucine degradation	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMG200019352	K01968	ko01100	Metabolic pathways	4587	3.7e-247	0.74	0.86	0.99
PGSC0003DMG200029378	K02937	ko03010	Ribosome	1803	1.3e-93	0.87	0.94	1.00
PGSC0003DMG200029380	K06001	ko00260	Glycine, serine and threonine metabolism	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMG200029380	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMG200029380	K06001	ko01100	Metabolic pathways	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMG200029380	K06001	ko01110	Biosynthesis of secondary metabolites	2496	7.8e-132	0.88	0.95	0.98
PGSC0003DMG200029380	K06001	ko00260	Glycine, serine and threonine metabolism	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMG200029380	K06001	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMG200029380	K06001	ko01100	Metabolic pathways	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMG200029380	K06001	ko01110	Biosynthesis of secondary metabolites	3392	3.0e-181	0.81	0.90	0.99
PGSC0003DMG200029381	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMG200029381	K02873	ko03010	Ribosome	1560	3.3e-80	0.88	0.95	1.00
PGSC0003DMG200029389	K00600	ko00260	Glycine, serine and threonine metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko00460	Cyanoamino acid metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko00670	One carbon pool by folate	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko00680	Methane metabolism	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko01100	Metabolic pathways	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko01110	Biosynthesis of secondary metabolites	702	7.0e-33	0.83	0.90	0.99
PGSC0003DMG200029389	K00600	ko00260	Glycine, serine and threonine metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200029389	K00600	ko00460	Cyanoamino acid metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200029389	K00600	ko00670	One carbon pool by folate	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200029389	K00600	ko00680	Methane metabolism	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200029389	K00600	ko01100	Metabolic pathways	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200029389	K00600	ko01110	Biosynthesis of secondary metabolites	2530	1.0e-133	0.87	0.92	0.97
PGSC0003DMG200043962	K01051	ko00040	Pentose and glucuronate interconversions	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMG200043962	K01051	ko00500	Starch and sucrose metabolism	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMG200043962	K01051	ko01100	Metabolic pathways	1157	5.6e-58	0.42	0.60	0.97
PGSC0003DMG200043977	K01178	ko00500	Starch and sucrose metabolism	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMG200043977	K01178	ko01100	Metabolic pathways	271	4.6e-08	0.27	0.43	0.94
PGSC0003DMG200043984	K01051	ko00040	Pentose and glucuronate interconversions	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMG200043984	K01051	ko00500	Starch and sucrose metabolism	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMG200043984	K01051	ko01100	Metabolic pathways	580	3.7e-26	0.47	0.62	0.92
PGSC0003DMG200010746	K04733	ko04210	Apoptosis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMG200010746	K04733	ko04620	Toll-like receptor signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMG200010746	K04733	ko04722	Neurotrophin signaling pathway	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMG200010746	K04733	ko05140	Leishmaniasis	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMG200010746	K04733	ko05142	Chagas disease	1058	1.6e-52	0.41	0.58	0.47
PGSC0003DMG200010749	K00850	ko00010	Glycolysis / Gluconeogenesis	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko00030	Pentose phosphate pathway	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko00051	Fructose and mannose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko00052	Galactose metabolism	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko01100	Metabolic pathways	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko01110	Biosynthesis of secondary metabolites	3286	2.1e-175	0.70	0.80	1.00
PGSC0003DMG200010749	K00850	ko00010	Glycolysis / Gluconeogenesis	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010749	K00850	ko00030	Pentose phosphate pathway	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010749	K00850	ko00051	Fructose and mannose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010749	K00850	ko00052	Galactose metabolism	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010749	K00850	ko01100	Metabolic pathways	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010749	K00850	ko01110	Biosynthesis of secondary metabolites	3383	9.3e-181	0.76	0.86	1.00
PGSC0003DMG200010771	K01728	ko00040	Pentose and glucuronate interconversions	2645	4.7e-140	0.74	0.86	0.99
PGSC0003DMG200014401	K00754	ko00051	Fructose and mannose metabolism	1386	1.3e-70	0.39	0.59	0.98
PGSC0003DMG200014401	K00754	ko00051	Fructose and mannose metabolism	1383	1.9e-70	0.42	0.60	0.83
PGSC0003DMG200014402	K08901	ko00195	Photosynthesis	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMG200014402	K08901	ko01100	Metabolic pathways	928	2.4e-45	0.53	0.72	1.00
PGSC0003DMG200014402	K08901	ko00195	Photosynthesis	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMG200014402	K08901	ko01100	Metabolic pathways	759	5.0e-36	0.52	0.70	0.96
PGSC0003DMG200014402	K08901	ko00195	Photosynthesis	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMG200014402	K08901	ko01100	Metabolic pathways	485	6.5e-21	0.69	0.88	0.92
PGSC0003DMG200014403	K11238	ko04011	MAPK signaling pathway - yeast	498	1.6e-20	0.38	0.44	0.38
PGSC0003DMG200014405	K04079	ko04612	Antigen processing and presentation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko04621	NOD-like receptor signaling pathway	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko04626	Plant-pathogen interaction	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko04914	Progesterone-mediated oocyte maturation	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko05200	Pathways in cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko05215	Prostate cancer	4832	1.1e-260	0.93	0.98	1.00
PGSC0003DMG200014405	K04079	ko04612	Antigen processing and presentation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200014405	K04079	ko04621	NOD-like receptor signaling pathway	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200014405	K04079	ko04626	Plant-pathogen interaction	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200014405	K04079	ko04914	Progesterone-mediated oocyte maturation	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200014405	K04079	ko05200	Pathways in cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200014405	K04079	ko05215	Prostate cancer	5494	3.4e-297	0.94	0.98	1.00
PGSC0003DMG200006899	K00472	ko00330	Arginine and proline metabolism	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMG200006899	K00472	ko01100	Metabolic pathways	1779	2.8e-92	0.66	0.79	1.00
PGSC0003DMG200006900	K00599	ko00340	Histidine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMG200006900	K00599	ko00350	Tyrosine metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMG200006900	K00599	ko00450	Selenoamino acid metabolism	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMG200006900	K00599	ko00626	Naphthalene and anthracene degradation	325	4.3e-12	0.30	0.56	0.56
PGSC0003DMG200006900	K00599	ko00340	Histidine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMG200006900	K00599	ko00350	Tyrosine metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMG200006900	K00599	ko00450	Selenoamino acid metabolism	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMG200006900	K00599	ko00626	Naphthalene and anthracene degradation	252	4.6e-08	0.33	0.58	0.49
PGSC0003DMG200006902	K11644	ko05016	Huntington's disease	6353	0.	0.60	0.73	0.95
PGSC0003DMG200006902	K11644	ko05016	Huntington's disease	7395	0.	0.64	0.78	1.00
PGSC0003DMG200006902	K11644	ko05016	Huntington's disease	7378	0.	0.64	0.77	1.00
PGSC0003DMG200006902	K11644	ko05016	Huntington's disease	7304	0.	0.64	0.77	1.00
PGSC0003DMG200006909	K01184	ko00040	Pentose and glucuronate interconversions	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMG200006909	K01184	ko00500	Starch and sucrose metabolism	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMG200006909	K01184	ko01100	Metabolic pathways	1185	1.6e-59	0.66	0.81	0.98
PGSC0003DMG200006909	K01184	ko00040	Pentose and glucuronate interconversions	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMG200006909	K01184	ko00500	Starch and sucrose metabolism	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMG200006909	K01184	ko01100	Metabolic pathways	2005	9.4e-105	0.60	0.77	0.99
PGSC0003DMG200006909	K01184	ko00040	Pentose and glucuronate interconversions	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMG200006909	K01184	ko00500	Starch and sucrose metabolism	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMG200006909	K01184	ko01100	Metabolic pathways	1610	5.8e-83	0.51	0.66	0.99
PGSC0003DMG200006911	K10846	ko03420	Nucleotide excision repair	5547	4.1e-300	0.50	0.64	1.00
PGSC0003DMG200006914	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200006914	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200006914	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200006914	K01955	ko00240	Pyrimidine metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200006914	K01955	ko00250	Alanine, aspartate and glutamate metabolism	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200006914	K01955	ko01100	Metabolic pathways	550	1.2e-23	0.59	0.75	0.62
PGSC0003DMG200028829	K01213	ko00040	Pentose and glucuronate interconversions	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMG200028829	K01213	ko00500	Starch and sucrose metabolism	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMG200028829	K01213	ko01100	Metabolic pathways	1426	8.1e-73	0.48	0.63	0.95
PGSC0003DMG200028829	K01213	ko00040	Pentose and glucuronate interconversions	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMG200028829	K01213	ko00500	Starch and sucrose metabolism	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMG200028829	K01213	ko01100	Metabolic pathways	1506	3.1e-77	0.48	0.64	0.93
PGSC0003DMG200028829	K01213	ko00040	Pentose and glucuronate interconversions	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMG200028829	K01213	ko00500	Starch and sucrose metabolism	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMG200028829	K01213	ko01100	Metabolic pathways	1465	5.7e-75	0.48	0.64	0.97
PGSC0003DMG200028829	K01213	ko00040	Pentose and glucuronate interconversions	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMG200028829	K01213	ko00500	Starch and sucrose metabolism	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMG200028829	K01213	ko01100	Metabolic pathways	1502	5.2e-77	0.48	0.65	0.97
PGSC0003DMG200028829	K01213	ko00040	Pentose and glucuronate interconversions	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMG200028829	K01213	ko00500	Starch and sucrose metabolism	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMG200028829	K01213	ko01100	Metabolic pathways	1499	7.6e-77	0.49	0.65	0.97
PGSC0003DMG200028835	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMG200028835	K12741	ko03040	Spliceosome	1306	3.4e-66	0.43	0.57	0.98
PGSC0003DMG200028839	K02145	ko00190	Oxidative phosphorylation	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028839	K02145	ko01100	Metabolic pathways	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028839	K02145	ko04145	Phagosome	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028839	K02145	ko04966	Collecting duct acid secretion	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028839	K02145	ko05110	Vibrio cholerae infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028839	K02145	ko05120	Epithelial cell signaling in Helicobacter pylori infection	5056	5.0e-273	0.95	0.98	1.00
PGSC0003DMG200028841	K07195	ko04910	Insulin signaling pathway	2138	4.4e-112	0.43	0.64	0.97
PGSC0003DMG200028842	K02135	ko00190	Oxidative phosphorylation	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMG200028842	K02135	ko01100	Metabolic pathways	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMG200028842	K02135	ko05010	Alzheimer's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMG200028842	K02135	ko05012	Parkinson's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMG200028842	K02135	ko05016	Huntington's disease	543	4.1e-24	0.86	0.97	0.97
PGSC0003DMG200018097	K00766	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMG200018097	K00766	ko01100	Metabolic pathways	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMG200018097	K00766	ko01110	Biosynthesis of secondary metabolites	664	8.7e-31	0.60	0.70	0.53
PGSC0003DMG200018101	K04733	ko04210	Apoptosis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMG200018101	K04733	ko04620	Toll-like receptor signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMG200018101	K04733	ko04722	Neurotrophin signaling pathway	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMG200018101	K04733	ko05140	Leishmaniasis	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMG200018101	K04733	ko05142	Chagas disease	779	3.9e-37	0.42	0.59	0.41
PGSC0003DMG200018109	K06611	ko00052	Galactose metabolism	3566	7.5e-191	0.68	0.82	0.97
PGSC0003DMG200018111	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMG200018111	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMG200018111	K12272	ko03060	Protein export	1619	1.8e-83	0.75	0.86	0.98
PGSC0003DMG200018111	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMG200018111	K12272	ko03060	Protein export	1149	1.5e-57	0.78	0.90	0.99
PGSC0003DMG200018112	K01955	ko00240	Pyrimidine metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMG200018112	K01955	ko00250	Alanine, aspartate and glutamate metabolism	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMG200018112	K01955	ko01100	Metabolic pathways	567	1.3e-24	0.52	0.66	0.62
PGSC0003DMG200018114	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMG200018114	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMG200018114	K08008	ko04145	Phagosome	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMG200018114	K08008	ko04670	Leukocyte transendothelial migration	463	1.5e-27	0.32	0.47	0.52
PGSC0003DMG200018114	K08008	ko04145	Phagosome	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMG200018114	K08008	ko04670	Leukocyte transendothelial migration	197	2.2e-10	0.32	0.54	0.53
PGSC0003DMG200024041	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko01100	Metabolic pathways	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko01110	Biosynthesis of secondary metabolites	429	7.9e-18	0.64	0.77	0.93
PGSC0003DMG200024041	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMG200024041	K03785	ko01100	Metabolic pathways	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMG200024041	K03785	ko01110	Biosynthesis of secondary metabolites	920	6.6e-45	0.60	0.74	0.95
PGSC0003DMG200024041	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMG200024041	K03785	ko01100	Metabolic pathways	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMG200024041	K03785	ko01110	Biosynthesis of secondary metabolites	1754	6.6e-91	0.48	0.67	0.97
PGSC0003DMG200024041	K03785	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMG200024041	K03785	ko01100	Metabolic pathways	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMG200024041	K03785	ko01110	Biosynthesis of secondary metabolites	685	6.0e-32	0.36	0.59	0.95
PGSC0003DMG200024044	K10144	ko04115	p53 signaling pathway	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMG200024044	K10144	ko04120	Ubiquitin mediated proteolysis	1379	3.2e-70	0.69	0.86	0.90
PGSC0003DMG200024044	K10144	ko04115	p53 signaling pathway	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMG200024044	K10144	ko04120	Ubiquitin mediated proteolysis	427	1.0e-17	0.66	0.89	0.98
PGSC0003DMG200024045	K03869	ko04120	Ubiquitin mediated proteolysis	1769	9.8e-92	0.36	0.56	0.99
PGSC0003DMG200024045	K03869	ko04120	Ubiquitin mediated proteolysis	1809	6.1e-94	0.36	0.57	0.99
PGSC0003DMG200024049	K01051	ko00040	Pentose and glucuronate interconversions	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMG200024049	K01051	ko00500	Starch and sucrose metabolism	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMG200024049	K01051	ko01100	Metabolic pathways	1791	6.0e-93	0.43	0.60	0.99
PGSC0003DMG200024051	K06672	ko04111	Cell cycle - yeast	236	6.6e-06	0.46	0.59	0.80
PGSC0003DMG200025015	K02938	ko03010	Ribosome	836	2.8e-40	0.99	1.00	0.99
PGSC0003DMG200025015	K02938	ko03010	Ribosome	2210	4.7e-116	0.96	0.99	1.00
PGSC0003DMG200025027	K05391	ko04626	Plant-pathogen interaction	1999	2.0e-104	0.79	0.89	1.00
PGSC0003DMG200025027	K05391	ko04626	Plant-pathogen interaction	3466	2.5e-185	0.65	0.77	0.90
PGSC0003DMG200025029	K12486	ko04144	Endocytosis	434	4.2e-18	0.61	0.75	0.93
PGSC0003DMG200025029	K12486	ko04144	Endocytosis	2301	4.5e-121	0.60	0.73	1.00
PGSC0003DMG200025030	K04733	ko04210	Apoptosis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMG200025030	K04733	ko04620	Toll-like receptor signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMG200025030	K04733	ko04722	Neurotrophin signaling pathway	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMG200025030	K04733	ko05140	Leishmaniasis	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMG200025030	K04733	ko05142	Chagas disease	2167	1.1e-113	0.43	0.60	1.00
PGSC0003DMG200025030	K04733	ko04210	Apoptosis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMG200025030	K04733	ko04620	Toll-like receptor signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMG200025030	K04733	ko04722	Neurotrophin signaling pathway	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMG200025030	K04733	ko05140	Leishmaniasis	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMG200025030	K04733	ko05142	Chagas disease	2347	1.3e-123	0.39	0.56	0.99
PGSC0003DMG200031091	K00799	ko00480	Glutathione metabolism	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMG200031091	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMG200031091	K00799	ko00982	Drug metabolism - cytochrome P450	1009	8.1e-50	0.55	0.75	0.97
PGSC0003DMG200031092	K00799	ko00480	Glutathione metabolism	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMG200031092	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMG200031092	K00799	ko00982	Drug metabolism - cytochrome P450	936	8.6e-46	0.56	0.75	0.97
PGSC0003DMG200031093	K00799	ko00480	Glutathione metabolism	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMG200031093	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMG200031093	K00799	ko00982	Drug metabolism - cytochrome P450	1035	3.0e-51	0.58	0.75	0.94
PGSC0003DMG200031094	K00799	ko00480	Glutathione metabolism	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMG200031094	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMG200031094	K00799	ko00982	Drug metabolism - cytochrome P450	1050	4.4e-52	0.55	0.77	0.98
PGSC0003DMG200011427	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko04115	p53 signaling pathway	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko04210	Apoptosis	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05010	Alzheimer's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05012	Parkinson's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05016	Huntington's disease	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko05222	Small cell lung cancer	306	1.9e-08	0.30	0.49	0.61
PGSC0003DMG200011427	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko04115	p53 signaling pathway	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko04210	Apoptosis	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05010	Alzheimer's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05012	Parkinson's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05016	Huntington's disease	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200011427	K02084	ko05222	Small cell lung cancer	331	7.3e-09	0.31	0.46	0.41
PGSC0003DMG200006555	K03869	ko04120	Ubiquitin mediated proteolysis	5531	3.1e-299	0.89	0.95	1.00
PGSC0003DMG200006556	K04713	ko00600	Sphingolipid metabolism	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMG200006556	K04713	ko01100	Metabolic pathways	884	6.4e-43	0.44	0.60	0.93
PGSC0003DMG200006563	K04733	ko04210	Apoptosis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMG200006563	K04733	ko04620	Toll-like receptor signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMG200006563	K04733	ko04722	Neurotrophin signaling pathway	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMG200006563	K04733	ko05140	Leishmaniasis	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMG200006563	K04733	ko05142	Chagas disease	1035	3.0e-51	0.37	0.53	0.49
PGSC0003DMG200006563	K04733	ko04210	Apoptosis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMG200006563	K04733	ko04620	Toll-like receptor signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMG200006563	K04733	ko04722	Neurotrophin signaling pathway	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMG200006563	K04733	ko05140	Leishmaniasis	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMG200006563	K04733	ko05142	Chagas disease	1027	8.3e-51	0.39	0.56	0.87
PGSC0003DMG200006563	K04733	ko04210	Apoptosis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMG200006563	K04733	ko04620	Toll-like receptor signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMG200006563	K04733	ko04722	Neurotrophin signaling pathway	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMG200006563	K04733	ko05140	Leishmaniasis	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMG200006563	K04733	ko05142	Chagas disease	1060	1.2e-52	0.34	0.49	0.90
PGSC0003DMG200013652	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMG200013652	K00517	ko00626	Naphthalene and anthracene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMG200013652	K00517	ko00903	Limonene and pinene degradation	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMG200013652	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMG200013652	K00517	ko01110	Biosynthesis of secondary metabolites	1258	1.5e-63	0.40	0.60	0.98
PGSC0003DMG200013654	K00430	ko00360	Phenylalanine metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMG200013654	K00430	ko00680	Methane metabolism	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMG200013654	K00430	ko00940	Phenylpropanoid biosynthesis	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMG200013654	K00430	ko01100	Metabolic pathways	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMG200013654	K00430	ko01110	Biosynthesis of secondary metabolites	1362	2.8e-69	0.57	0.68	0.93
PGSC0003DMG200013661	K04460	ko04010	MAPK signaling pathway	790	9.7e-38	0.40	0.55	0.73
PGSC0003DMG200013663	K00021	ko00900	Terpenoid backbone biosynthesis	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMG200013663	K00021	ko01100	Metabolic pathways	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMG200013663	K00021	ko01110	Biosynthesis of secondary metabolites	624	1.4e-28	0.43	0.63	0.87
PGSC0003DMG200013663	K00021	ko00900	Terpenoid backbone biosynthesis	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMG200013663	K00021	ko01100	Metabolic pathways	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMG200013663	K00021	ko01110	Biosynthesis of secondary metabolites	2930	9.0e-156	0.81	0.94	0.99
PGSC0003DMG200013665	K11594	ko04622	RIG-I-like receptor signaling pathway	244	1.3e-07	0.36	0.47	0.82
PGSC0003DMG200013669	K12585	ko03018	RNA degradation	6391	0.	0.80	0.89	1.00
PGSC0003DMG200007577	K10418	ko04962	Vasopressin-regulated water reabsorption	332	1.8e-12	0.49	0.67	0.94
PGSC0003DMG200007582	K07424	ko00140	Steroid hormone biosynthesis	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00591	Linoleic acid metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00830	Retinol metabolism	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00982	Drug metabolism - cytochrome P450	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko00983	Drug metabolism - other enzymes	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007582	K07424	ko01100	Metabolic pathways	1461	9.5e-75	0.42	0.61	0.94
PGSC0003DMG200007585	K01528	ko04144	Endocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMG200007585	K01528	ko04666	Fc gamma R-mediated phagocytosis	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMG200007585	K01528	ko05100	Bacterial invasion of epithelial cells	4731	4.2e-255	0.71	0.83	0.98
PGSC0003DMG200007585	K01528	ko04144	Endocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMG200007585	K01528	ko04666	Fc gamma R-mediated phagocytosis	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMG200007585	K01528	ko05100	Bacterial invasion of epithelial cells	766	2.1e-36	0.75	0.82	0.88
PGSC0003DMG200045169	K10591	ko04120	Ubiquitin mediated proteolysis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMG200045169	K10591	ko04144	Endocytosis	466	2.1e-19	0.56	0.72	0.96
PGSC0003DMG200017367	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00010	Glycolysis / Gluconeogenesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00030	Pentose phosphate pathway	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00052	Galactose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00230	Purine metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00500	Starch and sucrose metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00520	Amino sugar and nucleotide sugar metabolism	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko00521	Streptomycin biosynthesis	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko01100	Metabolic pathways	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017367	K01835	ko01110	Biosynthesis of secondary metabolites	4160	1.3e-223	0.84	0.92	1.00
PGSC0003DMG200017374	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMG200017374	K02892	ko03010	Ribosome	244	1.3e-07	0.84	0.97	0.57
PGSC0003DMG200017380	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00071	Fatty acid metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00072	Synthesis and degradation of ketone bodies	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00280	Valine, leucine and isoleucine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00310	Lysine degradation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00380	Tryptophan metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00620	Pyruvate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00632	Benzoate degradation via CoA ligation	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00640	Propanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00650	Butanoate metabolism	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko00900	Terpenoid backbone biosynthesis	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko01100	Metabolic pathways	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko01110	Biosynthesis of secondary metabolites	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200017380	K00626	ko02020	Two-component system	2873	1.3e-152	0.86	0.94	1.00
PGSC0003DMG200028203	K02183	ko04020	Calcium signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04070	Phosphatidylinositol signaling system	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04114	Oocyte meiosis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04270	Vascular smooth muscle contraction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04626	Plant-pathogen interaction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04720	Long-term potentiation	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04722	Neurotrophin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04740	Olfactory transduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04744	Phototransduction	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04745	Phototransduction - fly	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04910	Insulin signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04912	GnRH signaling pathway	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04916	Melanogenesis	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04970	Salivary secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko04971	Gastric acid secretion	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko05010	Alzheimer's disease	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028203	K02183	ko05214	Glioma	1253	2.8e-63	1.00	1.00	0.99
PGSC0003DMG200028205	K04505	ko04310	Wnt signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMG200028205	K04505	ko04330	Notch signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMG200028205	K04505	ko04722	Neurotrophin signaling pathway	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMG200028205	K04505	ko05010	Alzheimer's disease	916	1.1e-44	0.37	0.56	0.94
PGSC0003DMG200028209	K11294	ko05130	Pathogenic Escherichia coli infection	383	2.7e-15	0.31	0.49	0.62
PGSC0003DMG200028214	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMG200028214	K00326	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.83	0.90	0.99
PGSC0003DMG200028218	K02146	ko00190	Oxidative phosphorylation	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028218	K02146	ko01100	Metabolic pathways	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028218	K02146	ko04142	Lysosome	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028218	K02146	ko04966	Collecting duct acid secretion	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028218	K02146	ko05110	Vibrio cholerae infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028218	K02146	ko05120	Epithelial cell signaling in Helicobacter pylori infection	2881	4.6e-153	0.95	0.99	1.00
PGSC0003DMG200028220	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMG200028220	K00517	ko00626	Naphthalene and anthracene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMG200028220	K00517	ko00903	Limonene and pinene degradation	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMG200028220	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMG200028220	K00517	ko01110	Biosynthesis of secondary metabolites	1964	1.7e-102	0.49	0.67	0.96
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	390	1.1e-15	0.58	0.71	0.92
PGSC0003DMG200028221	K08081	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMG200028221	K08081	ko01100	Metabolic pathways	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMG200028221	K08081	ko01110	Biosynthesis of secondary metabolites	478	1.6e-20	0.63	0.80	0.87
PGSC0003DMG200024400	K07424	ko00140	Steroid hormone biosynthesis	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00591	Linoleic acid metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00830	Retinol metabolism	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00982	Drug metabolism - cytochrome P450	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko00983	Drug metabolism - other enzymes	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024400	K07424	ko01100	Metabolic pathways	691	2.8e-32	0.45	0.68	0.91
PGSC0003DMG200024401	K07424	ko00140	Steroid hormone biosynthesis	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00591	Linoleic acid metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00830	Retinol metabolism	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko00983	Drug metabolism - other enzymes	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024401	K07424	ko01100	Metabolic pathways	523	5.2e-23	0.44	0.66	0.99
PGSC0003DMG200024410	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024410	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024410	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024410	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024410	K03859	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024410	K03859	ko01100	Metabolic pathways	1834	2.5e-95	0.72	0.86	1.00
PGSC0003DMG200024414	K02976	ko03010	Ribosome	564	2.8e-25	0.73	0.83	0.86
PGSC0003DMG200024419	K12929	ko00904	Diterpenoid biosynthesis	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMG200024419	K12929	ko01110	Biosynthesis of secondary metabolites	1632	3.5e-84	0.45	0.65	0.96
PGSC0003DMG200024420	K12929	ko00904	Diterpenoid biosynthesis	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMG200024420	K12929	ko01110	Biosynthesis of secondary metabolites	798	3.5e-38	0.41	0.62	0.99
PGSC0003DMG200032166	K04567	ko00970	Aminoacyl-tRNA biosynthesis	674	2.4e-31	0.79	0.90	0.99
PGSC0003DMG200032166	K04567	ko00970	Aminoacyl-tRNA biosynthesis	2006	8.3e-105	0.82	0.91	1.00
PGSC0003DMG200032166	K04567	ko00970	Aminoacyl-tRNA biosynthesis	3907	1.2e-209	0.80	0.89	0.99
PGSC0003DMG200032180	K04382	ko04111	Cell cycle - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04113	Meiosis - yeast	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04114	Oocyte meiosis	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04310	Wnt signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04350	TGF-beta signaling pathway	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04530	Tight junction	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko04730	Long-term depression	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200032180	K04382	ko05142	Chagas disease	2637	1.3e-139	0.95	0.97	1.00
PGSC0003DMG200011945	K04392	ko04010	MAPK signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04062	Chemokine signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04145	Phagosome	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04310	Wnt signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04360	Axon guidance	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04370	VEGF signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04510	Focal adhesion	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04520	Adherens junction	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04620	Toll-like receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04650	Natural killer cell mediated cytotoxicity	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04662	B cell receptor signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04664	Fc epsilon RI signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04666	Fc gamma R-mediated phagocytosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04670	Leukocyte transendothelial migration	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04722	Neurotrophin signaling pathway	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04810	Regulation of actin cytoskeleton	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05100	Bacterial invasion of epithelial cells	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05131	Shigellosis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05200	Pathways in cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05210	Colorectal cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05211	Renal cell carcinoma	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05212	Pancreatic cancer	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko05416	Viral myocarditis	799	3.1e-38	0.94	0.98	0.94
PGSC0003DMG200011945	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04010	MAPK signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04062	Chemokine signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04145	Phagosome	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04310	Wnt signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04360	Axon guidance	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04370	VEGF signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04510	Focal adhesion	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04520	Adherens junction	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04620	Toll-like receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04650	Natural killer cell mediated cytotoxicity	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04662	B cell receptor signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04664	Fc epsilon RI signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04666	Fc gamma R-mediated phagocytosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04670	Leukocyte transendothelial migration	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04722	Neurotrophin signaling pathway	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04810	Regulation of actin cytoskeleton	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05100	Bacterial invasion of epithelial cells	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05131	Shigellosis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05200	Pathways in cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05210	Colorectal cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05211	Renal cell carcinoma	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05212	Pancreatic cancer	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko05416	Viral myocarditis	1557	4.8e-80	0.91	0.97	0.99
PGSC0003DMG200011945	K04392	ko04010	MAPK signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04062	Chemokine signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04145	Phagosome	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04310	Wnt signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04360	Axon guidance	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04370	VEGF signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04510	Focal adhesion	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04520	Adherens junction	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04620	Toll-like receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04650	Natural killer cell mediated cytotoxicity	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04662	B cell receptor signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04664	Fc epsilon RI signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04666	Fc gamma R-mediated phagocytosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04670	Leukocyte transendothelial migration	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04722	Neurotrophin signaling pathway	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko04810	Regulation of actin cytoskeleton	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05014	Amyotrophic lateral sclerosis (ALS)	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05100	Bacterial invasion of epithelial cells	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05120	Epithelial cell signaling in Helicobacter pylori infection	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05131	Shigellosis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05200	Pathways in cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05210	Colorectal cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05211	Renal cell carcinoma	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05212	Pancreatic cancer	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011945	K04392	ko05416	Viral myocarditis	595	5.5e-27	0.89	0.95	0.95
PGSC0003DMG200011946	K10590	ko04120	Ubiquitin mediated proteolysis	6211	0.	0.73	0.83	0.99
PGSC0003DMG200011946	K10590	ko04120	Ubiquitin mediated proteolysis	5226	2.1e-282	0.77	0.86	0.97
PGSC0003DMG200011946	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMG200011946	K10590	ko04120	Ubiquitin mediated proteolysis	11437	0.	0.74	0.84	1.00
PGSC0003DMG200011948	K00430	ko00360	Phenylalanine metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMG200011948	K00430	ko00680	Methane metabolism	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMG200011948	K00430	ko00940	Phenylpropanoid biosynthesis	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMG200011948	K00430	ko01100	Metabolic pathways	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMG200011948	K00430	ko01110	Biosynthesis of secondary metabolites	1354	7.6e-69	0.57	0.71	0.99
PGSC0003DMG200011950	K02639	ko00195	Photosynthesis	859	1.5e-41	0.70	0.86	0.98
PGSC0003DMG200002011	K00606	ko00770	Pantothenate and CoA biosynthesis	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMG200002011	K00606	ko01100	Metabolic pathways	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMG200002011	K00606	ko01110	Biosynthesis of secondary metabolites	887	4.4e-43	0.73	0.87	0.97
PGSC0003DMG200002011	K00606	ko00770	Pantothenate and CoA biosynthesis	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMG200002011	K00606	ko01100	Metabolic pathways	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMG200002011	K00606	ko01110	Biosynthesis of secondary metabolites	2470	2.1e-130	0.82	0.92	1.00
PGSC0003DMG200002011	K00606	ko00770	Pantothenate and CoA biosynthesis	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMG200002011	K00606	ko01100	Metabolic pathways	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMG200002011	K00606	ko01110	Biosynthesis of secondary metabolites	1594	4.4e-82	0.87	0.95	0.98
PGSC0003DMG200002018	K00799	ko00480	Glutathione metabolism	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMG200002018	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMG200002018	K00799	ko00982	Drug metabolism - cytochrome P450	978	4.2e-48	0.61	0.75	0.89
PGSC0003DMG200002018	K00799	ko00480	Glutathione metabolism	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMG200002018	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMG200002018	K00799	ko00982	Drug metabolism - cytochrome P450	351	1.6e-13	0.57	0.71	0.78
PGSC0003DMG200002019	K01426	ko00330	Arginine and proline metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K01426	ko00360	Phenylalanine metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K01426	ko00380	Tryptophan metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K01426	ko00460	Cyanoamino acid metabolism	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K01426	ko00632	Benzoate degradation via CoA ligation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K01426	ko00643	Styrene degradation	1003	1.7e-49	0.37	0.51	0.90
PGSC0003DMG200002019	K02433	ko00970	Aminoacyl-tRNA biosynthesis	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMG200002019	K02433	ko01100	Metabolic pathways	487	5.0e-21	0.42	0.64	0.96
PGSC0003DMG200016714	K05933	ko00270	Cysteine and methionine metabolism	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMG200016714	K05933	ko01110	Biosynthesis of secondary metabolites	2271	2.0e-119	0.83	0.90	0.99
PGSC0003DMG200016714	K05933	ko00270	Cysteine and methionine metabolism	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMG200016714	K05933	ko01110	Biosynthesis of secondary metabolites	707	3.7e-33	0.73	0.83	0.89
PGSC0003DMG200016714	K05933	ko00270	Cysteine and methionine metabolism	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMG200016714	K05933	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.92	0.96	0.92
PGSC0003DMG200016717	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-34	0.31	0.49	0.54
PGSC0003DMG200016717	K10595	ko04120	Ubiquitin mediated proteolysis	747	9.2e-32	0.31	0.49	0.47
PGSC0003DMG200016719	K02016	ko02010	ABC transporters	326	3.8e-12	0.26	0.44	0.92
PGSC0003DMG200016719	K02016	ko02010	ABC transporters	310	2.9e-11	0.28	0.45	0.86
PGSC0003DMG200016720	K12858	ko03040	Spliceosome	5141	1.0e-277	0.86	0.92	1.00
PGSC0003DMG200016721	K02291	ko00906	Carotenoid biosynthesis	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMG200016721	K02291	ko01100	Metabolic pathways	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMG200016721	K02291	ko01110	Biosynthesis of secondary metabolites	2669	2.2e-141	0.75	0.83	1.00
PGSC0003DMG200016721	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016721	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016721	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016721	K02291	ko00906	Carotenoid biosynthesis	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016721	K02291	ko01100	Metabolic pathways	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016721	K02291	ko01110	Biosynthesis of secondary metabolites	2857	9.6e-152	0.78	0.87	1.00
PGSC0003DMG200016722	K00799	ko00480	Glutathione metabolism	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMG200016722	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMG200016722	K00799	ko00982	Drug metabolism - cytochrome P450	925	3.5e-45	0.53	0.72	0.91
PGSC0003DMG200016726	K00895	ko00051	Fructose and mannose metabolism	3888	1.3e-208	0.82	0.90	0.99
PGSC0003DMG200025823	K00366	ko00910	Nitrogen metabolism	4199	9.2e-226	0.82	0.92	1.00
PGSC0003DMG200025825	K08233	ko00901	Indole alkaloid biosynthesis	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMG200025825	K08233	ko01110	Biosynthesis of secondary metabolites	716	1.2e-33	0.41	0.56	0.76
PGSC0003DMG200025825	K08233	ko00901	Indole alkaloid biosynthesis	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMG200025825	K08233	ko01110	Biosynthesis of secondary metabolites	553	1.1e-24	0.53	0.73	0.57
PGSC0003DMG200025825	K08233	ko00901	Indole alkaloid biosynthesis	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMG200025825	K08233	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.46	0.65	0.69
PGSC0003DMG200025825	K08233	ko00901	Indole alkaloid biosynthesis	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMG200025825	K08233	ko01110	Biosynthesis of secondary metabolites	884	6.4e-43	0.46	0.62	0.80
PGSC0003DMG200025826	K01692	ko00071	Fatty acid metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00280	Valine, leucine and isoleucine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00281	Geraniol degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00310	Lysine degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00380	Tryptophan metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00410	beta-Alanine metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00632	Benzoate degradation via CoA ligation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00640	Propanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00650	Butanoate metabolism	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00903	Limonene and pinene degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00930	Caprolactam degradation	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko01100	Metabolic pathways	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko01110	Biosynthesis of secondary metabolites	543	4.1e-24	0.70	0.84	0.66
PGSC0003DMG200025826	K01692	ko00071	Fatty acid metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00280	Valine, leucine and isoleucine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00281	Geraniol degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00310	Lysine degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00380	Tryptophan metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00410	beta-Alanine metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00632	Benzoate degradation via CoA ligation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00640	Propanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00650	Butanoate metabolism	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00903	Limonene and pinene degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00930	Caprolactam degradation	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko01100	Metabolic pathways	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko01110	Biosynthesis of secondary metabolites	453	3.8e-19	0.41	0.62	0.94
PGSC0003DMG200025826	K01692	ko00071	Fatty acid metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00280	Valine, leucine and isoleucine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00281	Geraniol degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00310	Lysine degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00380	Tryptophan metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00410	beta-Alanine metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00632	Benzoate degradation via CoA ligation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00640	Propanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00650	Butanoate metabolism	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00903	Limonene and pinene degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko00930	Caprolactam degradation	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko01100	Metabolic pathways	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025826	K01692	ko01110	Biosynthesis of secondary metabolites	336	1.1e-12	0.40	0.57	0.96
PGSC0003DMG200025827	K01692	ko00071	Fatty acid metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00280	Valine, leucine and isoleucine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00281	Geraniol degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00310	Lysine degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00380	Tryptophan metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00410	beta-Alanine metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00632	Benzoate degradation via CoA ligation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00640	Propanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00650	Butanoate metabolism	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00903	Limonene and pinene degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00930	Caprolactam degradation	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko01100	Metabolic pathways	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko01110	Biosynthesis of secondary metabolites	234	4.0e-10	0.34	0.46	0.86
PGSC0003DMG200025827	K01692	ko00071	Fatty acid metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00280	Valine, leucine and isoleucine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00281	Geraniol degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00310	Lysine degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00380	Tryptophan metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00410	beta-Alanine metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00632	Benzoate degradation via CoA ligation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00640	Propanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00650	Butanoate metabolism	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00903	Limonene and pinene degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko00930	Caprolactam degradation	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko01100	Metabolic pathways	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025827	K01692	ko01110	Biosynthesis of secondary metabolites	215	5.0e-06	0.57	0.75	0.58
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	843	1.2e-40	0.57	0.72	0.76
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.53	0.70	0.81
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	325	4.3e-12	0.74	0.83	0.52
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	210	9.5e-06	0.54	0.63	0.75
PGSC0003DMG200025828	K01692	ko00071	Fatty acid metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00280	Valine, leucine and isoleucine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00281	Geraniol degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00310	Lysine degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00380	Tryptophan metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00410	beta-Alanine metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00632	Benzoate degradation via CoA ligation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00640	Propanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00650	Butanoate metabolism	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00903	Limonene and pinene degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko00930	Caprolactam degradation	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko01100	Metabolic pathways	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200025828	K01692	ko01110	Biosynthesis of secondary metabolites	675	2.1e-31	0.59	0.73	0.74
PGSC0003DMG200030063	K00434	ko00053	Ascorbate and aldarate metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMG200030063	K00434	ko00480	Glutathione metabolism	1635	2.4e-84	0.87	0.94	1.00
PGSC0003DMG200030063	K00434	ko00053	Ascorbate and aldarate metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMG200030063	K00434	ko00480	Glutathione metabolism	1868	3.4e-97	0.86	0.93	1.00
PGSC0003DMG200030067	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMG200030067	K11247	ko04144	Endocytosis	653	3.5e-30	0.59	0.79	0.71
PGSC0003DMG200030067	K11247	ko04144	Endocytosis	1121	5.4e-56	0.59	0.77	1.00
PGSC0003DMG200030067	K11247	ko04144	Endocytosis	539	6.8e-24	0.58	0.75	0.99
PGSC0003DMG200030067	K11247	ko04144	Endocytosis	1744	2.3e-90	0.59	0.76	0.99
PGSC0003DMG200030070	K10798	ko03410	Base excision repair	3038	1.2e-167	0.54	0.70	0.98
PGSC0003DMG200030070	K10798	ko03410	Base excision repair	2868	2.4e-152	0.61	0.72	0.99
PGSC0003DMG200030077	K11419	ko00310	Lysine degradation	634	3.9e-29	0.37	0.51	0.38
PGSC0003DMG200020072	K12819	ko03040	Spliceosome	4030	1.9e-216	0.86	0.93	1.00
PGSC0003DMG200020072	K12819	ko03040	Spliceosome	3478	5.4e-186	0.88	0.94	0.97
PGSC0003DMG200020072	K12819	ko03040	Spliceosome	2602	1.1e-137	0.85	0.92	0.99
PGSC0003DMG200020079	K11816	ko00380	Tryptophan metabolism	2650	2.5e-140	0.73	0.86	0.99
PGSC0003DMG200020080	K00384	ko00240	Pyrimidine metabolism	222	9.6e-13	0.45	0.58	0.48
PGSC0003DMG200035945	K01760	ko00270	Cysteine and methionine metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200035945	K01760	ko00450	Selenoamino acid metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200035945	K01760	ko00910	Nitrogen metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200035945	K01760	ko00920	Sulfur metabolism	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200035945	K01760	ko01100	Metabolic pathways	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200035945	K01760	ko01110	Biosynthesis of secondary metabolites	890	3.0e-43	0.75	0.89	0.98
PGSC0003DMG200018735	K00627	ko00010	Glycolysis / Gluconeogenesis	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMG200018735	K00627	ko00020	Citrate cycle (TCA cycle)	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMG200018735	K00627	ko00620	Pyruvate metabolism	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMG200018735	K00627	ko01100	Metabolic pathways	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMG200018735	K00627	ko01110	Biosynthesis of secondary metabolites	3219	1.0e-171	0.71	0.81	1.00
PGSC0003DMG200018736	K00833	ko00780	Biotin metabolism	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMG200018736	K00833	ko01100	Metabolic pathways	1896	9.7e-99	0.63	0.74	0.91
PGSC0003DMG200018736	K00833	ko00780	Biotin metabolism	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMG200018736	K00833	ko01100	Metabolic pathways	4705	1.1e-253	0.68	0.79	0.98
PGSC0003DMG200018736	K00833	ko00780	Biotin metabolism	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMG200018736	K00833	ko01100	Metabolic pathways	2617	1.7e-138	0.72	0.83	0.96
PGSC0003DMG200018737	K03125	ko03022	Basal transcription factors	7537	0.	0.53	0.67	1.00
PGSC0003DMG200018737	K03125	ko03022	Basal transcription factors	6049	0.	0.58	0.73	0.98
PGSC0003DMG200018737	K03125	ko03022	Basal transcription factors	5968	0.	0.59	0.74	0.99
PGSC0003DMG200018737	K03125	ko03022	Basal transcription factors	7634	0.	0.54	0.69	1.00
PGSC0003DMG200018737	K03125	ko03022	Basal transcription factors	7627	0.	0.54	0.69	1.00
PGSC0003DMG200018738	K02183	ko04020	Calcium signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04070	Phosphatidylinositol signaling system	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04114	Oocyte meiosis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04270	Vascular smooth muscle contraction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04626	Plant-pathogen interaction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04720	Long-term potentiation	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04722	Neurotrophin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04740	Olfactory transduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04744	Phototransduction	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04745	Phototransduction - fly	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04910	Insulin signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04912	GnRH signaling pathway	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04916	Melanogenesis	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04970	Salivary secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04971	Gastric acid secretion	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko05010	Alzheimer's disease	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko05214	Glioma	4103	1.8e-220	0.77	0.88	1.00
PGSC0003DMG200018738	K02183	ko04020	Calcium signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04070	Phosphatidylinositol signaling system	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04114	Oocyte meiosis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04270	Vascular smooth muscle contraction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04626	Plant-pathogen interaction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04720	Long-term potentiation	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04722	Neurotrophin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04740	Olfactory transduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04744	Phototransduction	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04745	Phototransduction - fly	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04910	Insulin signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04912	GnRH signaling pathway	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04916	Melanogenesis	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04970	Salivary secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko04971	Gastric acid secretion	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko05010	Alzheimer's disease	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018738	K02183	ko05214	Glioma	1074	2.1e-53	0.70	0.84	0.97
PGSC0003DMG200018744	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMG200018744	K00517	ko00626	Naphthalene and anthracene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMG200018744	K00517	ko00903	Limonene and pinene degradation	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMG200018744	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMG200018744	K00517	ko01110	Biosynthesis of secondary metabolites	1665	5.3e-86	0.45	0.63	0.99
PGSC0003DMG200025767	K00083	ko00940	Phenylpropanoid biosynthesis	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMG200025767	K00083	ko01100	Metabolic pathways	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMG200025767	K00083	ko01110	Biosynthesis of secondary metabolites	2419	1.4e-127	0.78	0.88	0.99
PGSC0003DMG200023358	K03553	ko03440	Homologous recombination	2528	1.3e-133	0.69	0.77	1.00
PGSC0003DMG200023358	K03553	ko03440	Homologous recombination	2623	7.7e-139	0.76	0.85	1.00
PGSC0003DMG200023359	K01823	ko00900	Terpenoid backbone biosynthesis	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMG200023359	K01823	ko01100	Metabolic pathways	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMG200023359	K01823	ko01110	Biosynthesis of secondary metabolites	1830	4.2e-95	0.91	0.96	0.99
PGSC0003DMG200023361	K00297	ko00670	One carbon pool by folate	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMG200023361	K00297	ko00680	Methane metabolism	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMG200023361	K00297	ko01100	Metabolic pathways	3890	1.0e-208	0.77	0.85	0.99
PGSC0003DMG200023361	K00297	ko00670	One carbon pool by folate	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMG200023361	K00297	ko00680	Methane metabolism	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMG200023361	K00297	ko01100	Metabolic pathways	3379	1.6e-180	0.85	0.92	0.99
PGSC0003DMG200023361	K00297	ko00670	One carbon pool by folate	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMG200023361	K00297	ko00680	Methane metabolism	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMG200023361	K00297	ko01100	Metabolic pathways	4285	1.7e-230	0.83	0.91	0.99
PGSC0003DMG200023367	K00599	ko00340	Histidine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMG200023367	K00599	ko00350	Tyrosine metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMG200023367	K00599	ko00450	Selenoamino acid metabolism	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMG200023367	K00599	ko00626	Naphthalene and anthracene degradation	509	3.1e-22	0.37	0.56	0.41
PGSC0003DMG200023367	K00599	ko00340	Histidine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMG200023367	K00599	ko00350	Tyrosine metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMG200023367	K00599	ko00450	Selenoamino acid metabolism	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMG200023367	K00599	ko00626	Naphthalene and anthracene degradation	988	1.2e-48	0.39	0.55	0.51
PGSC0003DMG200026943	K00162	ko00010	Glycolysis / Gluconeogenesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko00020	Citrate cycle (TCA cycle)	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko00290	Valine, leucine and isoleucine biosynthesis	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko00620	Pyruvate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko00650	Butanoate metabolism	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko01100	Metabolic pathways	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026943	K00162	ko01110	Biosynthesis of secondary metabolites	2624	6.8e-139	0.92	0.96	0.94
PGSC0003DMG200026946	K02904	ko03010	Ribosome	761	3.9e-36	0.80	0.91	0.69
PGSC0003DMG200026949	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMG200026949	K01078	ko00740	Riboflavin metabolism	1719	5.6e-89	0.61	0.76	0.97
PGSC0003DMG200026956	K01099	ko00562	Inositol phosphate metabolism	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMG200026956	K01099	ko01100	Metabolic pathways	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMG200026956	K01099	ko04070	Phosphatidylinositol signaling system	642	1.4e-29	0.37	0.52	0.89
PGSC0003DMG200026956	K01099	ko00562	Inositol phosphate metabolism	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMG200026956	K01099	ko01100	Metabolic pathways	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMG200026956	K01099	ko04070	Phosphatidylinositol signaling system	687	3.1e-34	0.42	0.56	0.90
PGSC0003DMG200026957	K00863	ko00561	Glycerolipid metabolism	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMG200026957	K00863	ko01100	Metabolic pathways	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMG200026957	K00863	ko04622	RIG-I-like receptor signaling pathway	1666	4.7e-86	0.45	0.61	0.71
PGSC0003DMG200026957	K00863	ko00561	Glycerolipid metabolism	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMG200026957	K00863	ko01100	Metabolic pathways	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMG200026957	K00863	ko04622	RIG-I-like receptor signaling pathway	1520	5.3e-78	0.46	0.60	0.99
PGSC0003DMG200026957	K00863	ko00561	Glycerolipid metabolism	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMG200026957	K00863	ko01100	Metabolic pathways	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMG200026957	K00863	ko04622	RIG-I-like receptor signaling pathway	1875	1.4e-97	0.46	0.61	0.98
PGSC0003DMG200026961	K00654	ko00600	Sphingolipid metabolism	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMG200026961	K00654	ko01100	Metabolic pathways	3831	1.8e-205	0.92	0.96	1.00
PGSC0003DMG200018783	K02132	ko00190	Oxidative phosphorylation	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMG200018783	K02132	ko01100	Metabolic pathways	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMG200018783	K02132	ko05010	Alzheimer's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMG200018783	K02132	ko05012	Parkinson's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMG200018783	K02132	ko05016	Huntington's disease	438	5.7e-18	0.81	0.88	0.97
PGSC0003DMG200018784	K05894	ko00592	alpha-Linolenic acid metabolism	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMG200018784	K05894	ko01100	Metabolic pathways	2456	1.3e-129	0.76	0.86	0.99
PGSC0003DMG200018784	K05894	ko00592	alpha-Linolenic acid metabolism	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMG200018784	K05894	ko01100	Metabolic pathways	1198	3.1e-60	0.76	0.88	0.99
PGSC0003DMG200018785	K01046	ko00561	Glycerolipid metabolism	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMG200018785	K01046	ko01100	Metabolic pathways	319	9.3e-12	0.35	0.54	0.87
PGSC0003DMG200018785	K01046	ko00561	Glycerolipid metabolism	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMG200018785	K01046	ko01100	Metabolic pathways	858	1.7e-41	0.36	0.55	0.88
PGSC0003DMG200018789	K01066	ko00623	2,4-Dichlorobenzoate degradation	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMG200018789	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	345	3.4e-13	0.32	0.48	0.88
PGSC0003DMG200018791	K12124	ko04712	Circadian rhythm - plant	6214	0.	0.77	0.87	1.00
PGSC0003DMG200018791	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMG200018791	K12124	ko04712	Circadian rhythm - plant	7526	0.	0.77	0.87	1.00
PGSC0003DMG200018791	K12124	ko04712	Circadian rhythm - plant	5479	2.3e-296	0.75	0.85	1.00
PGSC0003DMG200018791	K12124	ko04712	Circadian rhythm - plant	536	5.1e-23	0.86	0.89	0.53
PGSC0003DMG200018795	K05658	ko02010	ABC transporters	3664	3.0e-196	0.45	0.65	1.00
PGSC0003DMG200041347	K12639	ko00905	Brassinosteroid biosynthesis	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMG200041347	K12639	ko01100	Metabolic pathways	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMG200041347	K12639	ko01110	Biosynthesis of secondary metabolites	1720	4.9e-89	0.53	0.72	0.99
PGSC0003DMG200041375	K04428	ko04010	MAPK signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMG200041375	K04428	ko04912	GnRH signaling pathway	275	2.5e-09	0.39	0.50	0.74
PGSC0003DMG200015127	K01522	ko00230	Purine metabolism	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMG200015127	K01522	ko05222	Small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMG200015127	K01522	ko05223	Non-small cell lung cancer	1043	1.1e-51	0.77	0.86	0.99
PGSC0003DMG200015127	K01522	ko00230	Purine metabolism	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMG200015127	K01522	ko05222	Small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMG200015127	K01522	ko05223	Non-small cell lung cancer	279	1.5e-09	0.67	0.76	0.53
PGSC0003DMG200015134	K10756	ko03030	DNA replication	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMG200015134	K10756	ko03420	Nucleotide excision repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMG200015134	K10756	ko03430	Mismatch repair	2650	2.5e-140	0.87	0.94	1.00
PGSC0003DMG200015138	K00901	ko00561	Glycerolipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMG200015138	K00901	ko00564	Glycerophospholipid metabolism	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMG200015138	K00901	ko01100	Metabolic pathways	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMG200015138	K00901	ko04070	Phosphatidylinositol signaling system	831	5.3e-40	0.39	0.57	0.85
PGSC0003DMG200015149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMG200015149	K00517	ko00626	Naphthalene and anthracene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMG200015149	K00517	ko00903	Limonene and pinene degradation	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMG200015149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMG200015149	K00517	ko01110	Biosynthesis of secondary metabolites	1616	2.7e-83	0.48	0.66	1.00
PGSC0003DMG200015150	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMG200015150	K00517	ko00626	Naphthalene and anthracene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMG200015150	K00517	ko00903	Limonene and pinene degradation	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMG200015150	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMG200015150	K00517	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.49	0.67	1.00
PGSC0003DMG200015151	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMG200015151	K00517	ko00626	Naphthalene and anthracene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMG200015151	K00517	ko00903	Limonene and pinene degradation	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMG200015151	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMG200015151	K00517	ko01110	Biosynthesis of secondary metabolites	1585	1.4e-81	0.47	0.66	0.99
PGSC0003DMG200005174	K02084	ko04115	p53 signaling pathway	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko04210	Apoptosis	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko05010	Alzheimer's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko05012	Parkinson's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko05016	Huntington's disease	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005174	K02084	ko05222	Small cell lung cancer	269	3.7e-06	0.28	0.45	0.83
PGSC0003DMG200005179	K08233	ko00901	Indole alkaloid biosynthesis	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMG200005179	K08233	ko01110	Biosynthesis of secondary metabolites	657	2.1e-30	0.39	0.57	0.73
PGSC0003DMG200005179	K08233	ko00901	Indole alkaloid biosynthesis	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMG200005179	K08233	ko01110	Biosynthesis of secondary metabolites	286	6.1e-10	0.45	0.68	0.45
PGSC0003DMG200005179	K08233	ko00901	Indole alkaloid biosynthesis	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMG200005179	K08233	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.39	0.55	0.74
PGSC0003DMG200005180	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00380	Tryptophan metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko00460	Cyanoamino acid metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko00632	Benzoate degradation via CoA ligation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko00643	Styrene degradation	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko00910	Nitrogen metabolism	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko01100	Metabolic pathways	213	6.5e-06	0.48	0.65	0.96
PGSC0003DMG200005180	K01501	ko00380	Tryptophan metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko00460	Cyanoamino acid metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko00632	Benzoate degradation via CoA ligation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko00643	Styrene degradation	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko00910	Nitrogen metabolism	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko01100	Metabolic pathways	576	6.2e-26	0.43	0.67	0.85
PGSC0003DMG200005180	K01501	ko00380	Tryptophan metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko00460	Cyanoamino acid metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko00632	Benzoate degradation via CoA ligation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko00643	Styrene degradation	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko00910	Nitrogen metabolism	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko01100	Metabolic pathways	714	1.5e-33	0.44	0.66	0.82
PGSC0003DMG200005180	K01501	ko00380	Tryptophan metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00460	Cyanoamino acid metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00632	Benzoate degradation via CoA ligation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00643	Styrene degradation	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko00910	Nitrogen metabolism	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200005180	K01501	ko01100	Metabolic pathways	678	1.5e-31	0.42	0.64	0.90
PGSC0003DMG200008865	K02955	ko03010	Ribosome	1201	2.1e-60	0.95	0.97	0.99
PGSC0003DMG200008866	K10609	ko03420	Nucleotide excision repair	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMG200008866	K10609	ko04120	Ubiquitin mediated proteolysis	1622	1.3e-83	0.35	0.56	0.98
PGSC0003DMG200008867	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMG200008867	K02935	ko03010	Ribosome	363	3.5e-14	0.59	0.74	0.42
PGSC0003DMG200008868	K13229	ko00402	Benzoxazinoid biosynthesis	951	1.3e-46	0.44	0.61	0.95
PGSC0003DMG200008871	K03106	ko03060	Protein export	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMG200008871	K03106	ko03070	Bacterial secretion system	3871	1.1e-207	0.84	0.92	1.00
PGSC0003DMG200008871	K03106	ko03060	Protein export	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMG200008871	K03106	ko03070	Bacterial secretion system	2330	1.1e-122	0.93	0.97	1.00
PGSC0003DMG200017314	K07424	ko00140	Steroid hormone biosynthesis	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00591	Linoleic acid metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00830	Retinol metabolism	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00982	Drug metabolism - cytochrome P450	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko00983	Drug metabolism - other enzymes	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017314	K07424	ko01100	Metabolic pathways	2116	7.1e-111	0.52	0.70	0.96
PGSC0003DMG200017317	K06685	ko04111	Cell cycle - yeast	417	1.6e-13	0.29	0.47	0.36
PGSC0003DMG200017319	K07424	ko00140	Steroid hormone biosynthesis	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00591	Linoleic acid metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00830	Retinol metabolism	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00982	Drug metabolism - cytochrome P450	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko00983	Drug metabolism - other enzymes	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017319	K07424	ko01100	Metabolic pathways	416	4.1e-17	0.49	0.74	0.93
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	985	1.7e-48	0.43	0.65	0.95
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1970	8.0e-103	0.48	0.70	0.99
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1553	8.0e-80	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	2017	2.1e-105	0.48	0.70	0.97
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1722	3.8e-89	0.52	0.74	1.00
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	910	2.3e-44	0.56	0.79	0.99
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1749	1.2e-90	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1591	6.4e-82	0.53	0.75	1.00
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.70	0.94
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	938	6.7e-46	0.58	0.80	0.99
PGSC0003DMG200017320	K07424	ko00140	Steroid hormone biosynthesis	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00591	Linoleic acid metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00830	Retinol metabolism	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00982	Drug metabolism - cytochrome P450	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko00983	Drug metabolism - other enzymes	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200017320	K07424	ko01100	Metabolic pathways	1034	3.4e-51	0.45	0.67	0.95
PGSC0003DMG200024499	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko01100	Metabolic pathways	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko01110	Biosynthesis of secondary metabolites	1223	1.3e-61	0.88	0.95	0.99
PGSC0003DMG200024499	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMG200024499	K06125	ko01100	Metabolic pathways	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMG200024499	K06125	ko01110	Biosynthesis of secondary metabolites	2268	2.9e-119	0.88	0.95	0.74
PGSC0003DMG200024499	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMG200024499	K06125	ko01100	Metabolic pathways	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMG200024499	K06125	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.88	0.95	0.73
PGSC0003DMG200024499	K06125	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMG200024499	K06125	ko01100	Metabolic pathways	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMG200024499	K06125	ko01110	Biosynthesis of secondary metabolites	1100	7.8e-55	0.88	0.96	0.98
PGSC0003DMG200024500	K04424	ko04010	MAPK signaling pathway	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMG200024500	K04424	ko04530	Tight junction	795	2.6e-39	0.37	0.58	0.91
PGSC0003DMG200024503	K00099	ko00900	Terpenoid backbone biosynthesis	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMG200024503	K00099	ko01100	Metabolic pathways	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMG200024503	K00099	ko01110	Biosynthesis of secondary metabolites	3247	3.0e-173	0.80	0.88	1.00
PGSC0003DMG200024503	K00099	ko00900	Terpenoid backbone biosynthesis	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMG200024503	K00099	ko01100	Metabolic pathways	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMG200024503	K00099	ko01110	Biosynthesis of secondary metabolites	3504	2.0e-187	0.87	0.95	1.00
PGSC0003DMG200024503	K00099	ko00900	Terpenoid backbone biosynthesis	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMG200024503	K00099	ko01100	Metabolic pathways	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMG200024503	K00099	ko01110	Biosynthesis of secondary metabolites	3374	2.9e-180	0.89	0.96	0.96
PGSC0003DMG200021347	K12356	ko00940	Phenylpropanoid biosynthesis	824	1.3e-39	0.33	0.49	0.92
PGSC0003DMG200045608	K10760	ko00908	Zeatin biosynthesis	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMG200045608	K10760	ko01100	Metabolic pathways	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMG200045608	K10760	ko01110	Biosynthesis of secondary metabolites	254	3.6e-08	0.41	0.59	0.92
PGSC0003DMG200045615	K08233	ko00901	Indole alkaloid biosynthesis	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMG200045615	K08233	ko01110	Biosynthesis of secondary metabolites	347	2.6e-13	0.57	0.71	0.86
PGSC0003DMG200039821	K06063	ko03040	Spliceosome	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMG200039821	K06063	ko04330	Notch signaling pathway	2088	2.5e-109	0.58	0.70	0.97
PGSC0003DMG200001438	K01850	ko00400	Phenylalanine, tyrosine and tryptophan biosynthesis	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMG200001438	K01850	ko01100	Metabolic pathways	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMG200001438	K01850	ko01110	Biosynthesis of secondary metabolites	1735	7.4e-90	0.66	0.78	0.97
PGSC0003DMG200001439	K12356	ko00940	Phenylpropanoid biosynthesis	494	2.1e-21	0.31	0.52	0.92
PGSC0003DMG200001440	K10597	ko04120	Ubiquitin mediated proteolysis	1181	2.6e-59	0.80	0.93	0.94
PGSC0003DMG200001440	K10597	ko04120	Ubiquitin mediated proteolysis	3905	1.5e-209	0.88	0.95	0.98
PGSC0003DMG200001440	K10597	ko04120	Ubiquitin mediated proteolysis	6972	0.	0.81	0.89	0.99
PGSC0003DMG200001440	K10597	ko04120	Ubiquitin mediated proteolysis	5800	0.	0.80	0.88	1.00
PGSC0003DMG200001441	K05391	ko04626	Plant-pathogen interaction	1757	4.5e-91	0.75	0.85	1.00
PGSC0003DMG200001441	K05391	ko04626	Plant-pathogen interaction	4645	2.3e-250	0.75	0.84	1.00
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	3878	4.7e-208	0.69	0.82	1.00
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	3087	2.0e-164	0.72	0.84	1.00
PGSC0003DMG200013310	K06171	ko04330	Notch signaling pathway	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMG200013310	K06171	ko05010	Alzheimer's disease	1645	6.8e-85	0.66	0.80	0.99
PGSC0003DMG200013327	K00735	ko00532	Glycosaminoglycan biosynthesis - chondroitin sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMG200013327	K00735	ko00534	Glycosaminoglycan biosynthesis - heparan sulfate	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMG200013327	K00735	ko01100	Metabolic pathways	336	1.1e-12	0.30	0.45	0.56
PGSC0003DMG200007679	K01046	ko00561	Glycerolipid metabolism	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMG200007679	K01046	ko01100	Metabolic pathways	380	4.0e-15	0.41	0.57	0.68
PGSC0003DMG200007679	K01046	ko00561	Glycerolipid metabolism	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMG200007679	K01046	ko01100	Metabolic pathways	541	5.3e-24	0.31	0.47	0.83
PGSC0003DMG200007679	K01046	ko00561	Glycerolipid metabolism	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMG200007679	K01046	ko01100	Metabolic pathways	545	3.2e-24	0.32	0.46	0.83
PGSC0003DMG200007679	K01046	ko00561	Glycerolipid metabolism	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMG200007679	K01046	ko01100	Metabolic pathways	214	8.4e-06	0.30	0.43	0.71
PGSC0003DMG200007685	K02984	ko03010	Ribosome	1934	7.8e-101	0.88	0.94	1.00
PGSC0003DMG200007686	K09553	ko05020	Prion diseases	265	1.3e-08	0.28	0.50	0.63
PGSC0003DMG200007686	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.38
PGSC0003DMG200007686	K09553	ko05020	Prion diseases	395	6.0e-16	0.42	0.65	0.73
PGSC0003DMG200004630	K10527	ko00592	alpha-Linolenic acid metabolism	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMG200004630	K10527	ko01100	Metabolic pathways	4770	3.0e-257	0.77	0.89	0.99
PGSC0003DMG200004632	K01710	ko00521	Streptomycin biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMG200004632	K01710	ko00523	Polyketide sugar unit biosynthesis	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMG200004632	K01710	ko01055	Biosynthesis of vancomycin group antibiotics	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMG200004632	K01710	ko01100	Metabolic pathways	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMG200004632	K01710	ko01110	Biosynthesis of secondary metabolites	1691	2.0e-87	0.86	0.94	0.97
PGSC0003DMG200004642	K03644	ko00785	Lipoic acid metabolism	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMG200004642	K03644	ko01100	Metabolic pathways	2408	5.6e-127	0.90	0.96	0.98
PGSC0003DMG200004647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMG200004647	K00517	ko00626	Naphthalene and anthracene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMG200004647	K00517	ko00903	Limonene and pinene degradation	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMG200004647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMG200004647	K00517	ko01110	Biosynthesis of secondary metabolites	865	7.1e-42	0.40	0.59	0.98
PGSC0003DMG200004647	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMG200004647	K00517	ko00626	Naphthalene and anthracene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMG200004647	K00517	ko00903	Limonene and pinene degradation	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMG200004647	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMG200004647	K00517	ko01110	Biosynthesis of secondary metabolites	975	6.1e-48	0.40	0.61	0.95
PGSC0003DMG200018037	K01051	ko00040	Pentose and glucuronate interconversions	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMG200018037	K01051	ko00500	Starch and sucrose metabolism	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMG200018037	K01051	ko01100	Metabolic pathways	2680	5.6e-142	0.62	0.78	1.00
PGSC0003DMG200018038	K01051	ko00040	Pentose and glucuronate interconversions	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMG200018038	K01051	ko00500	Starch and sucrose metabolism	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMG200018038	K01051	ko01100	Metabolic pathways	2111	1.3e-110	0.51	0.69	0.99
PGSC0003DMG200018040	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00230	Purine metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00250	Alanine, aspartate and glutamate metabolism	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko01100	Metabolic pathways	828	7.8e-40	0.82	0.92	0.97
PGSC0003DMG200018040	K01939	ko00230	Purine metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMG200018040	K01939	ko00250	Alanine, aspartate and glutamate metabolism	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMG200018040	K01939	ko01100	Metabolic pathways	835	3.2e-40	0.82	0.93	0.94
PGSC0003DMG200018046	K02084	ko04115	p53 signaling pathway	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko04210	Apoptosis	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko05010	Alzheimer's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko05012	Parkinson's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko05016	Huntington's disease	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018046	K02084	ko05222	Small cell lung cancer	246	1.0e-06	0.31	0.50	0.65
PGSC0003DMG200018048	K07195	ko04910	Insulin signaling pathway	576	6.2e-26	0.88	0.97	0.61
PGSC0003DMG200018048	K07195	ko04910	Insulin signaling pathway	424	1.5e-17	0.83	0.92	0.97
PGSC0003DMG200030758	K02343	ko00230	Purine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030758	K02343	ko00240	Pyrimidine metabolism	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030758	K02343	ko01100	Metabolic pathways	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030758	K02343	ko03030	DNA replication	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030758	K02343	ko03430	Mismatch repair	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030758	K02343	ko03440	Homologous recombination	247	6.7e-07	0.32	0.40	0.61
PGSC0003DMG200030761	K01046	ko00561	Glycerolipid metabolism	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMG200030761	K01046	ko01100	Metabolic pathways	512	2.1e-22	0.32	0.46	0.82
PGSC0003DMG200030761	K01046	ko00561	Glycerolipid metabolism	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMG200030761	K01046	ko01100	Metabolic pathways	516	1.3e-22	0.32	0.47	0.83
PGSC0003DMG200030762	K10144	ko04115	p53 signaling pathway	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMG200030762	K10144	ko04120	Ubiquitin mediated proteolysis	2052	2.4e-107	0.85	0.93	1.00
PGSC0003DMG200030762	K10144	ko04115	p53 signaling pathway	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMG200030762	K10144	ko04120	Ubiquitin mediated proteolysis	387	1.6e-15	0.86	0.86	0.98
PGSC0003DMG200030764	K00430	ko00360	Phenylalanine metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMG200030764	K00430	ko00680	Methane metabolism	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMG200030764	K00430	ko00940	Phenylpropanoid biosynthesis	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMG200030764	K00430	ko01100	Metabolic pathways	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMG200030764	K00430	ko01110	Biosynthesis of secondary metabolites	1433	3.3e-73	0.59	0.74	0.96
PGSC0003DMG200030766	K01611	ko00270	Cysteine and methionine metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMG200030766	K01611	ko00330	Arginine and proline metabolism	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMG200030766	K01611	ko01100	Metabolic pathways	2094	1.2e-109	0.72	0.85	0.98
PGSC0003DMG200022098	K03364	ko04110	Cell cycle	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMG200022098	K03364	ko04111	Cell cycle - yeast	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMG200022098	K03364	ko04120	Ubiquitin mediated proteolysis	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMG200022098	K03364	ko04914	Progesterone-mediated oocyte maturation	306	5.1e-10	0.31	0.51	0.94
PGSC0003DMG200022099	K03469	ko03030	DNA replication	245	1.1e-07	0.36	0.53	0.52
PGSC0003DMG200022103	K09756	ko00940	Phenylpropanoid biosynthesis	1419	2.0e-72	0.42	0.59	0.99
PGSC0003DMG200022104	K01184	ko00040	Pentose and glucuronate interconversions	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMG200022104	K01184	ko00500	Starch and sucrose metabolism	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMG200022104	K01184	ko01100	Metabolic pathways	799	3.1e-38	0.43	0.58	0.98
PGSC0003DMG200022104	K01184	ko00040	Pentose and glucuronate interconversions	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMG200022104	K01184	ko00500	Starch and sucrose metabolism	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMG200022104	K01184	ko01100	Metabolic pathways	1282	7.1e-65	0.47	0.62	0.93
PGSC0003DMG200022109	K01757	ko00901	Indole alkaloid biosynthesis	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMG200022109	K01757	ko01100	Metabolic pathways	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMG200022109	K01757	ko01110	Biosynthesis of secondary metabolites	916	1.1e-44	0.43	0.61	0.96
PGSC0003DMG200022114	K04121	ko00904	Diterpenoid biosynthesis	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMG200022114	K04121	ko01100	Metabolic pathways	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMG200022114	K04121	ko01110	Biosynthesis of secondary metabolites	784	2.1e-37	0.57	0.74	0.93
PGSC0003DMG200022114	K04121	ko00904	Diterpenoid biosynthesis	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMG200022114	K04121	ko01100	Metabolic pathways	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMG200022114	K04121	ko01110	Biosynthesis of secondary metabolites	1438	1.8e-73	0.60	0.75	0.95
PGSC0003DMG200025106	K02114	ko00190	Oxidative phosphorylation	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMG200025106	K02114	ko00195	Photosynthesis	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMG200025106	K02114	ko01100	Metabolic pathways	983	2.2e-48	0.91	0.95	0.99
PGSC0003DMG200025117	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMG200025117	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMG200025117	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.26
PGSC0003DMG200025117	K00876	ko00240	Pyrimidine metabolism	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMG200025117	K00876	ko00983	Drug metabolism - other enzymes	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMG200025117	K00876	ko01100	Metabolic pathways	448	7.1e-19	0.38	0.60	0.34
PGSC0003DMG200025118	K03011	ko00230	Purine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMG200025118	K03011	ko00240	Pyrimidine metabolism	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMG200025118	K03011	ko01100	Metabolic pathways	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMG200025118	K03011	ko03020	RNA polymerase	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMG200025118	K03011	ko05016	Huntington's disease	2284	3.9e-120	0.79	0.86	0.65
PGSC0003DMG200025118	K01859	ko00941	Flavonoid biosynthesis	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMG200025118	K01859	ko01100	Metabolic pathways	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMG200025118	K01859	ko01110	Biosynthesis of secondary metabolites	1162	3.0e-58	0.65	0.78	0.41
PGSC0003DMG200025118	K00430	ko00360	Phenylalanine metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMG200025118	K00430	ko00680	Methane metabolism	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMG200025118	K00430	ko00940	Phenylpropanoid biosynthesis	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMG200025118	K00430	ko01100	Metabolic pathways	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMG200025118	K00430	ko01110	Biosynthesis of secondary metabolites	1741	3.4e-90	0.70	0.84	1.00
PGSC0003DMG200003936	K00276	ko00260	Glycine, serine and threonine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00350	Tyrosine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00360	Phenylalanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00410	beta-Alanine metabolism	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00950	Isoquinoline alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko01100	Metabolic pathways	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko01110	Biosynthesis of secondary metabolites	1025	1.1e-50	0.31	0.46	0.86
PGSC0003DMG200003936	K00276	ko00260	Glycine, serine and threonine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko00350	Tyrosine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko00360	Phenylalanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko00410	beta-Alanine metabolism	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko00950	Isoquinoline alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko01100	Metabolic pathways	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003936	K00276	ko01110	Biosynthesis of secondary metabolites	618	3.0e-28	0.41	0.53	0.98
PGSC0003DMG200003941	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.60
PGSC0003DMG200003941	K01515	ko00230	Purine metabolism	276	2.2e-09	0.40	0.53	0.46
PGSC0003DMG200003941	K01515	ko00230	Purine metabolism	253	4.0e-08	0.41	0.54	0.50
PGSC0003DMG200006976	K02970	ko03010	Ribosome	228	9.7e-07	0.51	0.71	0.32
PGSC0003DMG200006986	K05582	ko00190	Oxidative phosphorylation	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMG200006986	K05582	ko01100	Metabolic pathways	1626	7.6e-84	0.90	0.93	0.99
PGSC0003DMG200006987	K12870	ko03040	Spliceosome	2149	1.1e-112	0.85	0.92	1.00
PGSC0003DMG200006991	K02953	ko03010	Ribosome	1220	1.9e-61	0.95	0.99	0.99
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	845	9.0e-41	0.35	0.46	0.95
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	1606	9.6e-83	0.49	0.65	0.98
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200006992	K00485	ko00982	Drug metabolism - cytochrome P450	560	4.7e-25	0.57	0.74	0.97
PGSC0003DMG200044417	K11251	ko05322	Systemic lupus erythematosus	713	1.7e-33	0.68	0.81	0.94
PGSC0003DMG200044420	K07466	ko03030	DNA replication	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMG200044420	K07466	ko03420	Nucleotide excision repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMG200044420	K07466	ko03430	Mismatch repair	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMG200044420	K07466	ko03440	Homologous recombination	812	6.0e-39	0.71	0.79	0.90
PGSC0003DMG200044432	K12581	ko03018	RNA degradation	470	4.3e-20	0.54	0.70	0.68
PGSC0003DMG200034447	K12843	ko03040	Spliceosome	1707	2.6e-88	0.39	0.55	0.94
PGSC0003DMG200034473	K10760	ko00908	Zeatin biosynthesis	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMG200034473	K10760	ko01100	Metabolic pathways	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMG200034473	K10760	ko01110	Biosynthesis of secondary metabolites	557	6.9e-25	0.43	0.57	0.98
PGSC0003DMG200026265	K00846	ko00051	Fructose and mannose metabolism	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMG200026265	K00846	ko01100	Metabolic pathways	248	7.6e-08	0.32	0.47	0.78
PGSC0003DMG200026265	K00847	ko00051	Fructose and mannose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMG200026265	K00847	ko00500	Starch and sucrose metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMG200026265	K00847	ko00520	Amino sugar and nucleotide sugar metabolism	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMG200026265	K00847	ko01100	Metabolic pathways	215	5.0e-06	0.42	0.57	0.78
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	336	1.1e-12	0.30	0.45	0.85
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	226	1.2e-06	0.38	0.59	0.71
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.94
PGSC0003DMG200026265	K00846	ko00051	Fructose and mannose metabolism	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMG200026265	K00846	ko01100	Metabolic pathways	234	4.5e-07	0.33	0.47	0.85
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	349	2.1e-13	0.31	0.45	0.85
PGSC0003DMG200026265	K00852	ko00030	Pentose phosphate pathway	346	3.0e-13	0.31	0.45	0.94
PGSC0003DMG200022617	K02963	ko03010	Ribosome	783	2.4e-37	0.94	0.96	0.99
PGSC0003DMG200022617	K01358	ko04112	Cell cycle - Caulobacter	422	1.9e-17	0.77	0.90	0.94
PGSC0003DMG200022618	K10676	ko00627	1,4-Dichlorobenzene degradation	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMG200022618	K10676	ko01100	Metabolic pathways	1056	2.1e-52	0.48	0.64	0.95
PGSC0003DMG200022618	K10676	ko00627	1,4-Dichlorobenzene degradation	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMG200022618	K10676	ko01100	Metabolic pathways	904	5.0e-44	0.47	0.62	0.94
PGSC0003DMG200022618	K10676	ko00627	1,4-Dichlorobenzene degradation	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMG200022618	K10676	ko01100	Metabolic pathways	622	1.8e-28	0.36	0.52	0.95
PGSC0003DMG200022618	K10676	ko00627	1,4-Dichlorobenzene degradation	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMG200022618	K10676	ko01100	Metabolic pathways	1646	6.0e-85	0.40	0.56	0.90
PGSC0003DMG200022618	K10676	ko00627	1,4-Dichlorobenzene degradation	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMG200022618	K10676	ko01100	Metabolic pathways	707	3.7e-33	0.43	0.60	0.88
PGSC0003DMG200008334	K00236	ko00020	Citrate cycle (TCA cycle)	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko00190	Oxidative phosphorylation	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko01100	Metabolic pathways	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko01110	Biosynthesis of secondary metabolites	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko05010	Alzheimer's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko05012	Parkinson's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008334	K00236	ko05016	Huntington's disease	414	5.3e-17	0.60	0.68	0.90
PGSC0003DMG200008336	K03657	ko03420	Nucleotide excision repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMG200008336	K03657	ko03430	Mismatch repair	1184	1.8e-59	0.32	0.52	0.58
PGSC0003DMG200008336	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMG200008336	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.59
PGSC0003DMG200008336	K03657	ko03420	Nucleotide excision repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMG200008336	K03657	ko03430	Mismatch repair	1238	1.9e-62	0.33	0.53	0.62
PGSC0003DMG200008342	K02354	ko04310	Wnt signaling pathway	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMG200008342	K02354	ko04916	Melanogenesis	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMG200008342	K02354	ko05200	Pathways in cancer	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMG200008342	K02354	ko05217	Basal cell carcinoma	271	3.5e-06	0.30	0.52	0.35
PGSC0003DMG200008344	K00261	ko00250	Alanine, aspartate and glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko00330	Arginine and proline metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko00471	D-Glutamine and D-glutamate metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko00910	Nitrogen metabolism	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko01100	Metabolic pathways	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko04964	Proximal tubule bicarbonate reclamation	3164	1.1e-168	0.88	0.96	1.00
PGSC0003DMG200008344	K00261	ko00250	Alanine, aspartate and glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200008344	K00261	ko00330	Arginine and proline metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200008344	K00261	ko00471	D-Glutamine and D-glutamate metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200008344	K00261	ko00910	Nitrogen metabolism	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200008344	K00261	ko01100	Metabolic pathways	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200008344	K00261	ko04964	Proximal tubule bicarbonate reclamation	440	2.0e-18	0.88	0.96	0.98
PGSC0003DMG200009482	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMG200009482	K01101	ko00361	gamma-Hexachlorocyclohexane degradation	470	4.3e-20	0.35	0.51	0.71
PGSC0003DMG200009484	K05349	ko00460	Cyanoamino acid metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMG200009484	K05349	ko00500	Starch and sucrose metabolism	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMG200009484	K05349	ko00940	Phenylpropanoid biosynthesis	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMG200009484	K05349	ko01110	Biosynthesis of secondary metabolites	3057	8.9e-163	0.50	0.67	0.99
PGSC0003DMG200009485	K05349	ko00460	Cyanoamino acid metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMG200009485	K05349	ko00500	Starch and sucrose metabolism	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMG200009485	K05349	ko00940	Phenylpropanoid biosynthesis	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMG200009485	K05349	ko01110	Biosynthesis of secondary metabolites	2810	3.8e-149	0.45	0.64	0.99
PGSC0003DMG200009485	K05349	ko00460	Cyanoamino acid metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMG200009485	K05349	ko00500	Starch and sucrose metabolism	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMG200009485	K05349	ko00940	Phenylpropanoid biosynthesis	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMG200009485	K05349	ko01110	Biosynthesis of secondary metabolites	2833	2.0e-150	0.46	0.65	0.98
PGSC0003DMG200009487	K05349	ko00460	Cyanoamino acid metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMG200009487	K05349	ko00500	Starch and sucrose metabolism	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMG200009487	K05349	ko00940	Phenylpropanoid biosynthesis	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMG200009487	K05349	ko01110	Biosynthesis of secondary metabolites	2524	2.2e-133	0.46	0.67	0.99
PGSC0003DMG200009494	K08008	ko04145	Phagosome	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMG200009494	K08008	ko04670	Leukocyte transendothelial migration	415	1.8e-16	0.30	0.50	0.35
PGSC0003DMG200009494	K09540	ko03060	Protein export	2534	6.3e-134	0.72	0.86	0.97
PGSC0003DMG200009494	K09540	ko03060	Protein export	2272	1.8e-119	0.64	0.78	0.99
PGSC0003DMG200005858	K01507	ko00190	Oxidative phosphorylation	1477	1.3e-75	0.90	0.95	0.98
PGSC0003DMG200005862	K02927	ko03010	Ribosome	1015	3.8e-50	0.99	1.00	0.92
PGSC0003DMG200005862	K02927	ko03010	Ribosome	1080	9.9e-54	1.00	1.00	0.99
PGSC0003DMG200005863	K01761	ko00270	Cysteine and methionine metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMG200005863	K01761	ko00450	Selenoamino acid metabolism	2783	1.2e-147	0.77	0.87	1.00
PGSC0003DMG200005870	K00028	ko00620	Pyruvate metabolism	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMG200005870	K00028	ko00710	Carbon fixation in photosynthetic organisms	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMG200005870	K00028	ko01100	Metabolic pathways	3154	4.0e-168	0.62	0.74	0.97
PGSC0003DMG200005870	K00028	ko00620	Pyruvate metabolism	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMG200005870	K00028	ko00710	Carbon fixation in photosynthetic organisms	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMG200005870	K00028	ko01100	Metabolic pathways	3275	8.5e-175	0.65	0.78	0.98
PGSC0003DMG200005872	K00430	ko00360	Phenylalanine metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMG200005872	K00430	ko00680	Methane metabolism	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMG200005872	K00430	ko00940	Phenylpropanoid biosynthesis	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMG200005872	K00430	ko01100	Metabolic pathways	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMG200005872	K00430	ko01110	Biosynthesis of secondary metabolites	1447	5.6e-74	0.54	0.71	0.95
PGSC0003DMG200005875	K13228	ko00402	Benzoxazinoid biosynthesis	309	3.3e-11	0.44	0.69	0.95
PGSC0003DMG200042569	K13230	ko00402	Benzoxazinoid biosynthesis	220	2.9e-06	0.45	0.62	0.86
PGSC0003DMG200046374	K02489	ko02020	Two-component system	264	5.4e-08	0.42	0.58	0.83
PGSC0003DMG200040894	K10760	ko00908	Zeatin biosynthesis	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMG200040894	K10760	ko01100	Metabolic pathways	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMG200040894	K10760	ko01110	Biosynthesis of secondary metabolites	630	6.5e-29	0.55	0.73	0.99
PGSC0003DMG200015205	K00680	ko00350	Tyrosine metabolism	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMG200015205	K00680	ko00624	1- and 2-Methylnaphthalene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMG200015205	K00680	ko00632	Benzoate degradation via CoA ligation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMG200015205	K00680	ko00642	Ethylbenzene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMG200015205	K00680	ko00903	Limonene and pinene degradation	389	1.3e-15	0.34	0.52	0.76
PGSC0003DMG200015209	K04368	ko04010	MAPK signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04012	ErbB signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04013	MAPK signaling pathway - fly	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04062	Chemokine signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04114	Oocyte meiosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04270	Vascular smooth muscle contraction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04320	Dorso-ventral axis formation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04370	VEGF signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04510	Focal adhesion	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04540	Gap junction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04620	Toll-like receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04626	Plant-pathogen interaction	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04650	Natural killer cell mediated cytotoxicity	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04660	T cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04662	B cell receptor signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04664	Fc epsilon RI signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04666	Fc gamma R-mediated phagocytosis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04720	Long-term potentiation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04722	Neurotrophin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04730	Long-term depression	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04810	Regulation of actin cytoskeleton	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04910	Insulin signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04912	GnRH signaling pathway	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04914	Progesterone-mediated oocyte maturation	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04916	Melanogenesis	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05020	Prion diseases	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05200	Pathways in cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05210	Colorectal cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05211	Renal cell carcinoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05212	Pancreatic cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05213	Endometrial cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05214	Glioma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05215	Prostate cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05216	Thyroid cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05218	Melanoma	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05219	Bladder cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05220	Chronic myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05221	Acute myeloid leukemia	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko05223	Non-small cell lung cancer	740	2.1e-37	0.47	0.63	0.87
PGSC0003DMG200015209	K04368	ko04010	MAPK signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04012	ErbB signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04013	MAPK signaling pathway - fly	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04062	Chemokine signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04114	Oocyte meiosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04270	Vascular smooth muscle contraction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04320	Dorso-ventral axis formation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04370	VEGF signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04510	Focal adhesion	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04540	Gap junction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04620	Toll-like receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04626	Plant-pathogen interaction	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04650	Natural killer cell mediated cytotoxicity	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04660	T cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04662	B cell receptor signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04664	Fc epsilon RI signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04666	Fc gamma R-mediated phagocytosis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04720	Long-term potentiation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04722	Neurotrophin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04730	Long-term depression	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04810	Regulation of actin cytoskeleton	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04910	Insulin signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04912	GnRH signaling pathway	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04914	Progesterone-mediated oocyte maturation	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04916	Melanogenesis	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05020	Prion diseases	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05200	Pathways in cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05210	Colorectal cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05211	Renal cell carcinoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05212	Pancreatic cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05213	Endometrial cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05214	Glioma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05215	Prostate cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05216	Thyroid cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05218	Melanoma	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05219	Bladder cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05220	Chronic myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05221	Acute myeloid leukemia	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko05223	Non-small cell lung cancer	914	6.5e-47	0.48	0.64	0.85
PGSC0003DMG200015209	K04368	ko04010	MAPK signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04012	ErbB signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04013	MAPK signaling pathway - fly	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04062	Chemokine signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04114	Oocyte meiosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04270	Vascular smooth muscle contraction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04320	Dorso-ventral axis formation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04370	VEGF signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04510	Focal adhesion	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04540	Gap junction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04620	Toll-like receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04626	Plant-pathogen interaction	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04650	Natural killer cell mediated cytotoxicity	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04660	T cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04662	B cell receptor signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04664	Fc epsilon RI signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04666	Fc gamma R-mediated phagocytosis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04720	Long-term potentiation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04722	Neurotrophin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04730	Long-term depression	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04810	Regulation of actin cytoskeleton	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04910	Insulin signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04912	GnRH signaling pathway	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04914	Progesterone-mediated oocyte maturation	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04916	Melanogenesis	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05020	Prion diseases	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05200	Pathways in cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05210	Colorectal cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05211	Renal cell carcinoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05212	Pancreatic cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05213	Endometrial cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05214	Glioma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05215	Prostate cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05216	Thyroid cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05218	Melanoma	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05219	Bladder cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05220	Chronic myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05221	Acute myeloid leukemia	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko05223	Non-small cell lung cancer	1024	1.2e-50	0.47	0.65	0.55
PGSC0003DMG200015209	K04368	ko04010	MAPK signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04012	ErbB signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04013	MAPK signaling pathway - fly	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04062	Chemokine signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04114	Oocyte meiosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04270	Vascular smooth muscle contraction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04320	Dorso-ventral axis formation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04370	VEGF signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04510	Focal adhesion	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04540	Gap junction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04620	Toll-like receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04626	Plant-pathogen interaction	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04650	Natural killer cell mediated cytotoxicity	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04660	T cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04662	B cell receptor signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04664	Fc epsilon RI signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04666	Fc gamma R-mediated phagocytosis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04720	Long-term potentiation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04722	Neurotrophin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04730	Long-term depression	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04810	Regulation of actin cytoskeleton	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04910	Insulin signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04912	GnRH signaling pathway	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04914	Progesterone-mediated oocyte maturation	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko04916	Melanogenesis	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05020	Prion diseases	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05200	Pathways in cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05210	Colorectal cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05211	Renal cell carcinoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05212	Pancreatic cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05213	Endometrial cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05214	Glioma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05215	Prostate cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05216	Thyroid cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05218	Melanoma	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05219	Bladder cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05220	Chronic myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05221	Acute myeloid leukemia	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015209	K04368	ko05223	Non-small cell lung cancer	256	2.8e-08	0.54	0.67	0.59
PGSC0003DMG200015211	K01190	ko00052	Galactose metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMG200015211	K01190	ko00511	Other glycan degradation	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMG200015211	K01190	ko00600	Sphingolipid metabolism	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMG200015211	K01190	ko01100	Metabolic pathways	3056	1.0e-162	0.53	0.66	0.81
PGSC0003DMG200015211	K01190	ko00052	Galactose metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMG200015211	K01190	ko00511	Other glycan degradation	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMG200015211	K01190	ko00600	Sphingolipid metabolism	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMG200015211	K01190	ko01100	Metabolic pathways	3279	5.1e-175	0.56	0.69	0.84
PGSC0003DMG200015215	K01893	ko00970	Aminoacyl-tRNA biosynthesis	3843	4.0e-206	0.78	0.88	1.00
PGSC0003DMG200015215	K01893	ko00970	Aminoacyl-tRNA biosynthesis	2285	3.4e-120	0.72	0.82	0.97
PGSC0003DMG200015220	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMG200015220	K00517	ko00626	Naphthalene and anthracene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMG200015220	K00517	ko00903	Limonene and pinene degradation	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMG200015220	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMG200015220	K00517	ko01110	Biosynthesis of secondary metabolites	1575	4.9e-81	0.47	0.68	0.98
PGSC0003DMG200016772	K04499	ko04310	Wnt signaling pathway	3478	5.4e-186	0.92	0.96	1.00
PGSC0003DMG200016773	K12356	ko00940	Phenylpropanoid biosynthesis	681	1.0e-31	0.31	0.48	0.94
PGSC0003DMG200016775	K05282	ko00904	Diterpenoid biosynthesis	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMG200016775	K05282	ko01100	Metabolic pathways	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMG200016775	K05282	ko01110	Biosynthesis of secondary metabolites	436	3.3e-18	0.30	0.48	0.94
PGSC0003DMG200016776	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMG200016776	K00517	ko00626	Naphthalene and anthracene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMG200016776	K00517	ko00903	Limonene and pinene degradation	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMG200016776	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMG200016776	K00517	ko01110	Biosynthesis of secondary metabolites	1184	1.8e-59	0.41	0.60	0.97
PGSC0003DMG200016776	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMG200016776	K00517	ko00626	Naphthalene and anthracene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMG200016776	K00517	ko00903	Limonene and pinene degradation	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMG200016776	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMG200016776	K00517	ko01110	Biosynthesis of secondary metabolites	1500	6.7e-77	0.40	0.61	0.99
PGSC0003DMG200016777	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMG200016777	K00517	ko00626	Naphthalene and anthracene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMG200016777	K00517	ko00903	Limonene and pinene degradation	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMG200016777	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMG200016777	K00517	ko01110	Biosynthesis of secondary metabolites	1128	2.2e-56	0.44	0.61	0.98
PGSC0003DMG200016778	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMG200016778	K00517	ko00626	Naphthalene and anthracene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMG200016778	K00517	ko00903	Limonene and pinene degradation	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMG200016778	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMG200016778	K00517	ko01110	Biosynthesis of secondary metabolites	816	3.6e-39	0.52	0.74	0.94
PGSC0003DMG200016778	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMG200016778	K00517	ko00626	Naphthalene and anthracene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMG200016778	K00517	ko00903	Limonene and pinene degradation	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMG200016778	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMG200016778	K00517	ko01110	Biosynthesis of secondary metabolites	1843	8.1e-96	0.48	0.69	0.96
PGSC0003DMG200016780	K00938	ko00900	Terpenoid backbone biosynthesis	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMG200016780	K00938	ko01100	Metabolic pathways	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMG200016780	K00938	ko01110	Biosynthesis of secondary metabolites	2431	3.0e-128	0.63	0.71	1.00
PGSC0003DMG200016783	K00224	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMG200016783	K00224	ko00364	Fluorobenzoate degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMG200016783	K00224	ko00628	Fluorene degradation	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMG200016783	K00224	ko00640	Propanoate metabolism	238	2.7e-07	0.56	0.68	0.98
PGSC0003DMG200016784	K09658	ko00510	N-Glycan biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMG200016784	K09658	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMG200016784	K09658	ko01100	Metabolic pathways	529	2.4e-23	0.76	0.90	0.99
PGSC0003DMG200016785	K00485	ko00982	Drug metabolism - cytochrome P450	1703	4.3e-88	0.60	0.75	0.96
PGSC0003DMG200016785	K00485	ko00982	Drug metabolism - cytochrome P450	2268	2.9e-119	0.59	0.75	0.97
PGSC0003DMG200016785	K00485	ko00982	Drug metabolism - cytochrome P450	1006	1.2e-49	0.58	0.72	0.91
PGSC0003DMG200016793	K11253	ko05322	Systemic lupus erythematosus	1128	2.2e-56	1.00	1.00	0.99
PGSC0003DMG200005240	K07195	ko04910	Insulin signaling pathway	2471	1.9e-130	0.50	0.67	0.99
PGSC0003DMG200005247	K04564	ko04146	Peroxisome	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMG200005247	K04564	ko05016	Huntington's disease	1813	3.7e-94	0.71	0.81	0.99
PGSC0003DMG200005247	K04564	ko04146	Peroxisome	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMG200005247	K04564	ko05016	Huntington's disease	1857	1.4e-96	0.71	0.82	1.00
PGSC0003DMG200005250	K01046	ko00561	Glycerolipid metabolism	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMG200005250	K01046	ko01100	Metabolic pathways	213	6.5e-06	0.45	0.59	0.25
PGSC0003DMG200005250	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00903	Limonene and pinene degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00930	Caprolactam degradation	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko01100	Metabolic pathways	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.1e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00351	1,1,1-Trichloro-2,2-bis(4-chlorophenyl)ethane (DDT) degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00362	Benzoate degradation via hydroxylation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00632	Benzoate degradation via CoA ligation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00903	Limonene and pinene degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko00930	Caprolactam degradation	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko01100	Metabolic pathways	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200005250	K01559	ko01110	Biosynthesis of secondary metabolites	203	1.0e-07	0.36	0.50	0.38
PGSC0003DMG200009119	K00264	ko00250	Alanine, aspartate and glutamate metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMG200009119	K00264	ko00910	Nitrogen metabolism	16388	0.	0.87	0.94	1.00
PGSC0003DMG200009119	K00264	ko01100	Metabolic pathways	16388	0.	0.87	0.94	1.00
PGSC0003DMG200009119	K00264	ko01110	Biosynthesis of secondary metabolites	16388	0.	0.87	0.94	1.00
PGSC0003DMG200009121	K11422	ko00310	Lysine degradation	644	1.0e-28	0.39	0.54	0.92
PGSC0003DMG200009121	K11422	ko00310	Lysine degradation	605	5.0e-27	0.51	0.67	0.14
PGSC0003DMG200009125	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMG200009125	K08770	ko03320	PPAR signaling pathway	330	3.8e-12	0.36	0.57	0.29
PGSC0003DMG200009127	K06268	ko04010	MAPK signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04020	Calcium signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04114	Oocyte meiosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04210	Apoptosis	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04310	Wnt signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04360	Axon guidance	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04370	VEGF signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04650	Natural killer cell mediated cytotoxicity	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04660	T cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04662	B cell receptor signaling pathway	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04720	Long-term potentiation	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko05010	Alzheimer's disease	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	668	5.2e-31	0.65	0.82	0.95
PGSC0003DMG200009127	K06268	ko04010	MAPK signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04020	Calcium signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04114	Oocyte meiosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04210	Apoptosis	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04310	Wnt signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04360	Axon guidance	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04370	VEGF signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04650	Natural killer cell mediated cytotoxicity	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04660	T cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04662	B cell receptor signaling pathway	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko04720	Long-term potentiation	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko05010	Alzheimer's disease	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009127	K06268	ko05014	Amyotrophic lateral sclerosis (ALS)	1199	2.7e-60	0.69	0.84	0.98
PGSC0003DMG200009128	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMG200009128	K02951	ko03010	Ribosome	1030	5.6e-51	0.86	0.94	0.99
PGSC0003DMG200009129	K04506	ko04115	p53 signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMG200009129	K04506	ko04120	Ubiquitin mediated proteolysis	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMG200009129	K04506	ko04310	Wnt signaling pathway	2535	5.5e-134	0.88	0.93	1.00
PGSC0003DMG200009130	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMG200009130	K03544	ko04112	Cell cycle - Caulobacter	3495	6.2e-187	0.75	0.85	1.00
PGSC0003DMG200023417	K12373	ko00511	Other glycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko00520	Amino sugar and nucleotide sugar metabolism	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko00531	Glycosaminoglycan degradation	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko00603	Glycosphingolipid biosynthesis - globo series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko00604	Glycosphingolipid biosynthesis - ganglio series	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko01100	Metabolic pathways	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023417	K12373	ko04142	Lysosome	3409	3.4e-182	0.74	0.82	0.97
PGSC0003DMG200023419	K04733	ko04210	Apoptosis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMG200023419	K04733	ko04620	Toll-like receptor signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMG200023419	K04733	ko04722	Neurotrophin signaling pathway	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMG200023419	K04733	ko05140	Leishmaniasis	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMG200023419	K04733	ko05142	Chagas disease	2162	2.1e-113	0.41	0.57	0.97
PGSC0003DMG200023422	K01874	ko00450	Selenoamino acid metabolism	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMG200023422	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3772	3.3e-202	0.70	0.80	1.00
PGSC0003DMG200023422	K01874	ko00450	Selenoamino acid metabolism	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMG200023422	K01874	ko00970	Aminoacyl-tRNA biosynthesis	1707	2.6e-88	0.76	0.86	1.00
PGSC0003DMG200023422	K01874	ko00450	Selenoamino acid metabolism	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMG200023422	K01874	ko00970	Aminoacyl-tRNA biosynthesis	3833	1.4e-205	0.73	0.84	1.00
PGSC0003DMG200023424	K02941	ko03010	Ribosome	2342	2.4e-123	0.88	0.95	1.00
PGSC0003DMG200023428	K10258	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.85	0.95	1.00
PGSC0003DMG200023429	K05692	ko04145	Phagosome	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04510	Focal adhesion	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04520	Adherens junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04530	Tight junction	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04670	Leukocyte transendothelial migration	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04745	Phototransduction - fly	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko04810	Regulation of actin cytoskeleton	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05100	Bacterial invasion of epithelial cells	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05110	Vibrio cholerae infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05130	Pathogenic Escherichia coli infection	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05131	Shigellosis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05414	Dilated cardiomyopathy	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200023429	K05692	ko05416	Viral myocarditis	3160	1.9e-168	0.98	1.00	1.00
PGSC0003DMG200027193	K01930	ko00790	Folate biosynthesis	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMG200027193	K01930	ko01100	Metabolic pathways	1439	1.6e-73	0.56	0.68	1.00
PGSC0003DMG200027193	K01930	ko00790	Folate biosynthesis	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMG200027193	K01930	ko01100	Metabolic pathways	1872	2.0e-97	0.61	0.72	1.00
PGSC0003DMG200027194	K10594	ko04120	Ubiquitin mediated proteolysis	487	3.1e-28	0.33	0.50	0.88
PGSC0003DMG200027200	K12356	ko00940	Phenylpropanoid biosynthesis	500	9.6e-22	0.47	0.62	0.83
PGSC0003DMG200027201	K03039	ko03050	Proteasome	2840	8.3e-151	0.88	0.95	1.00
PGSC0003DMG200036009	K12338	ko00942	Anthocyanin biosynthesis	259	2.4e-08	0.48	0.62	0.47
PGSC0003DMG200036023	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMG200036023	K00517	ko00626	Naphthalene and anthracene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMG200036023	K00517	ko00903	Limonene and pinene degradation	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMG200036023	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMG200036023	K00517	ko01110	Biosynthesis of secondary metabolites	997	3.7e-49	0.40	0.58	0.99
PGSC0003DMG200018646	K05279	ko00944	Flavone and flavonol biosynthesis	795	5.2e-38	0.40	0.56	0.85
PGSC0003DMG200018646	K05279	ko00944	Flavone and flavonol biosynthesis	668	5.2e-31	0.37	0.53	0.86
PGSC0003DMG200018650	K00423	ko00053	Ascorbate and aldarate metabolism	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMG200018650	K00423	ko01100	Metabolic pathways	2442	7.4e-129	0.56	0.71	0.99
PGSC0003DMG200018657	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.57
PGSC0003DMG200018657	K00356	ko00190	Oxidative phosphorylation	236	3.5e-07	0.28	0.45	0.55
PGSC0003DMG200018659	K00485	ko00982	Drug metabolism - cytochrome P450	703	6.1e-33	0.33	0.47	0.85
PGSC0003DMG200018659	K00485	ko00982	Drug metabolism - cytochrome P450	743	3.8e-35	0.31	0.49	0.98
PGSC0003DMG200018659	K00485	ko00982	Drug metabolism - cytochrome P450	523	5.2e-23	0.38	0.52	0.91
PGSC0003DMG200018659	K00485	ko00982	Drug metabolism - cytochrome P450	517	1.1e-22	0.38	0.52	0.87
PGSC0003DMG200018659	K00485	ko00982	Drug metabolism - cytochrome P450	680	1.1e-31	0.29	0.47	0.94
PGSC0003DMG200040064	K10760	ko00908	Zeatin biosynthesis	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMG200040064	K10760	ko01100	Metabolic pathways	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMG200040064	K10760	ko01110	Biosynthesis of secondary metabolites	551	1.5e-24	0.43	0.68	0.97
PGSC0003DMG200040066	K04733	ko04210	Apoptosis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200040066	K04733	ko04620	Toll-like receptor signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200040066	K04733	ko04722	Neurotrophin signaling pathway	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200040066	K04733	ko05140	Leishmaniasis	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200040066	K04733	ko05142	Chagas disease	2275	1.2e-119	0.42	0.58	0.99
PGSC0003DMG200040081	K00600	ko00260	Glycine, serine and threonine metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200040081	K00600	ko00460	Cyanoamino acid metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200040081	K00600	ko00670	One carbon pool by folate	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200040081	K00600	ko00680	Methane metabolism	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200040081	K00600	ko01100	Metabolic pathways	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200040081	K00600	ko01110	Biosynthesis of secondary metabolites	279	2.4e-09	0.51	0.62	0.37
PGSC0003DMG200001500	K08737	ko03430	Mismatch repair	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMG200001500	K08737	ko05200	Pathways in cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMG200001500	K08737	ko05210	Colorectal cancer	481	1.1e-20	0.36	0.55	0.52
PGSC0003DMG200001501	K08497	ko04130	SNARE interactions in vesicular transport	1337	6.6e-68	0.52	0.61	1.00
PGSC0003DMG200001501	K08497	ko04130	SNARE interactions in vesicular transport	1252	3.2e-63	0.73	0.83	0.99
PGSC0003DMG200001501	K08497	ko04130	SNARE interactions in vesicular transport	1523	3.6e-78	0.67	0.79	1.00
PGSC0003DMG200001509	K08852	ko05010	Alzheimer's disease	2230	3.7e-117	0.50	0.64	0.92
PGSC0003DMG200001509	K08852	ko05010	Alzheimer's disease	2813	2.6e-149	0.53	0.67	0.94
PGSC0003DMG200001509	K08852	ko05010	Alzheimer's disease	3432	1.9e-183	0.57	0.71	0.99
PGSC0003DMG200001509	K08852	ko05010	Alzheimer's disease	3789	3.8e-203	0.57	0.70	0.94
PGSC0003DMG200001512	K10615	ko04120	Ubiquitin mediated proteolysis	644	1.1e-29	0.33	0.50	0.94
PGSC0003DMG200001513	K02867	ko03010	Ribosome	516	1.3e-22	0.46	0.66	0.90
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	2798	1.7e-148	0.39	0.53	1.00
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	845	9.0e-41	0.31	0.45	0.98
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	761	6.8e-36	0.31	0.44	0.98
PGSC0003DMG200001517	K08739	ko03430	Mismatch repair	399	4.0e-13	0.28	0.40	0.95
PGSC0003DMG200011482	K12843	ko03040	Spliceosome	4554	2.4e-245	0.75	0.85	0.99
PGSC0003DMG200011492	K12356	ko00940	Phenylpropanoid biosynthesis	472	3.4e-20	0.29	0.46	0.68
PGSC0003DMG200011492	K12356	ko00940	Phenylpropanoid biosynthesis	479	1.4e-20	0.29	0.47	0.92
PGSC0003DMG200011493	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMG200011493	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMG200011493	K03133	ko03022	Basal transcription factors	1259	1.3e-63	0.83	0.90	0.99
PGSC0003DMG200013379	K00939	ko00230	Purine metabolism	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMG200013379	K00939	ko01100	Metabolic pathways	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMG200013379	K00939	ko01110	Biosynthesis of secondary metabolites	674	2.4e-31	0.43	0.57	0.87
PGSC0003DMG200013379	K00939	ko00230	Purine metabolism	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMG200013379	K00939	ko01100	Metabolic pathways	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMG200013379	K00939	ko01110	Biosynthesis of secondary metabolites	226	1.2e-06	0.42	0.61	0.70
PGSC0003DMG200013380	K11584	ko04113	Meiosis - yeast	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMG200013380	K11584	ko04114	Oocyte meiosis	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMG200013380	K11584	ko04310	Wnt signaling pathway	1247	6.1e-63	0.71	0.81	0.98
PGSC0003DMG200013388	K01183	ko00520	Amino sugar and nucleotide sugar metabolism	251	7.6e-08	0.36	0.54	0.86
PGSC0003DMG200013389	K12502	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMG200013389	K12502	ko01100	Metabolic pathways	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMG200013389	K12502	ko01110	Biosynthesis of secondary metabolites	2389	6.2e-126	0.79	0.88	1.00
PGSC0003DMG200013390	K02183	ko04020	Calcium signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04070	Phosphatidylinositol signaling system	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04114	Oocyte meiosis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04270	Vascular smooth muscle contraction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04626	Plant-pathogen interaction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04720	Long-term potentiation	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04722	Neurotrophin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04740	Olfactory transduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04744	Phototransduction	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04745	Phototransduction - fly	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04910	Insulin signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04912	GnRH signaling pathway	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04916	Melanogenesis	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04970	Salivary secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko04971	Gastric acid secretion	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko05010	Alzheimer's disease	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013390	K02183	ko05214	Glioma	931	1.6e-45	0.75	0.87	0.99
PGSC0003DMG200013393	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMG200013393	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMG200013393	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.24
PGSC0003DMG200013393	K12126	ko04712	Circadian rhythm - plant	309	4.4e-11	0.47	0.85	0.33
PGSC0003DMG200007523	K04371	ko04010	MAPK signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04012	ErbB signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04013	MAPK signaling pathway - fly	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04062	Chemokine signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04114	Oocyte meiosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04150	mTOR signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04270	Vascular smooth muscle contraction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04320	Dorso-ventral axis formation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04350	TGF-beta signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04360	Axon guidance	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04370	VEGF signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04510	Focal adhesion	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04520	Adherens junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04540	Gap junction	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04620	Toll-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04621	NOD-like receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04650	Natural killer cell mediated cytotoxicity	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04660	T cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04662	B cell receptor signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04664	Fc epsilon RI signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04666	Fc gamma R-mediated phagocytosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04720	Long-term potentiation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04722	Neurotrophin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04730	Long-term depression	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04810	Regulation of actin cytoskeleton	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04910	Insulin signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04912	GnRH signaling pathway	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04914	Progesterone-mediated oocyte maturation	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04916	Melanogenesis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04930	Type II diabetes mellitus	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko04960	Aldosterone-regulated sodium reabsorption	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05010	Alzheimer's disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05020	Prion diseases	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05131	Shigellosis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05140	Leishmaniasis	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05142	Chagas disease	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05200	Pathways in cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05210	Colorectal cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05211	Renal cell carcinoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05212	Pancreatic cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05213	Endometrial cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05214	Glioma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05215	Prostate cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05216	Thyroid cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05218	Melanoma	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05219	Bladder cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05220	Chronic myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05221	Acute myeloid leukemia	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007523	K04371	ko05223	Non-small cell lung cancer	319	1.6e-11	0.43	0.68	0.57
PGSC0003DMG200007536	K02721	ko00195	Photosynthesis	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMG200007536	K02721	ko01100	Metabolic pathways	634	3.9e-29	0.64	0.76	0.99
PGSC0003DMG200007537	K00383	ko00480	Glutathione metabolism	3788	4.3e-203	0.82	0.90	1.00
PGSC0003DMG200007540	K10532	ko00531	Glycosaminoglycan degradation	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMG200007540	K10532	ko01100	Metabolic pathways	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMG200007540	K10532	ko04142	Lysosome	632	5.0e-29	0.66	0.76	0.90
PGSC0003DMG200007541	K10532	ko00531	Glycosaminoglycan degradation	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMG200007541	K10532	ko01100	Metabolic pathways	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMG200007541	K10532	ko04142	Lysosome	1275	1.7e-64	0.62	0.73	0.58
PGSC0003DMG200007541	K12623	ko03018	RNA degradation	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMG200007541	K12623	ko03040	Spliceosome	447	8.1e-19	0.93	0.94	0.55
PGSC0003DMG200007541	K12623	ko03018	RNA degradation	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMG200007541	K12623	ko03040	Spliceosome	1127	2.5e-56	0.86	0.93	0.99
PGSC0003DMG200004414	K00799	ko00480	Glutathione metabolism	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMG200004414	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMG200004414	K00799	ko00982	Drug metabolism - cytochrome P450	356	8.4e-14	0.35	0.53	0.96
PGSC0003DMG200004415	K12132	ko04712	Circadian rhythm - plant	895	1.6e-43	0.36	0.53	0.99
PGSC0003DMG200004415	K12132	ko04712	Circadian rhythm - plant	1964	1.7e-102	0.46	0.61	0.97
PGSC0003DMG200004419	K08139	ko04113	Meiosis - yeast	986	1.5e-48	0.35	0.56	0.95
PGSC0003DMG200004422	K02155	ko00190	Oxidative phosphorylation	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko01100	Metabolic pathways	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko04142	Lysosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko04145	Phagosome	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko04966	Collecting duct acid secretion	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko05110	Vibrio cholerae infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004422	K02155	ko05120	Epithelial cell signaling in Helicobacter pylori infection	1305	3.8e-66	0.98	0.99	0.99
PGSC0003DMG200004423	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMG200004423	K06685	ko04111	Cell cycle - yeast	341	9.7e-10	0.28	0.44	0.71
PGSC0003DMG200028251	K01528	ko04144	Endocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMG200028251	K01528	ko04666	Fc gamma R-mediated phagocytosis	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMG200028251	K01528	ko05100	Bacterial invasion of epithelial cells	539	6.8e-24	0.24	0.45	0.90
PGSC0003DMG200028252	K01193	ko00052	Galactose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMG200028252	K01193	ko00500	Starch and sucrose metabolism	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMG200028252	K01193	ko01100	Metabolic pathways	3247	3.0e-173	0.71	0.83	0.96
PGSC0003DMG200028252	K01193	ko00052	Galactose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMG200028252	K01193	ko00500	Starch and sucrose metabolism	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMG200028252	K01193	ko01100	Metabolic pathways	3206	5.4e-171	0.72	0.84	0.99
PGSC0003DMG200028252	K01193	ko00052	Galactose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMG200028252	K01193	ko00500	Starch and sucrose metabolism	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMG200028252	K01193	ko01100	Metabolic pathways	3463	3.6e-185	0.70	0.81	0.97
PGSC0003DMG200028257	K10591	ko04120	Ubiquitin mediated proteolysis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMG200028257	K10591	ko04144	Endocytosis	1774	5.2e-92	0.48	0.65	0.97
PGSC0003DMG200028257	K10591	ko04120	Ubiquitin mediated proteolysis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMG200028257	K10591	ko04144	Endocytosis	3303	2.4e-176	0.53	0.70	1.00
PGSC0003DMG200028257	K10591	ko04120	Ubiquitin mediated proteolysis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMG200028257	K10591	ko04144	Endocytosis	2826	4.9e-150	0.52	0.69	0.99
PGSC0003DMG200028261	K01623	ko00010	Glycolysis / Gluconeogenesis	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko00030	Pentose phosphate pathway	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko00051	Fructose and mannose metabolism	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko00710	Carbon fixation in photosynthetic organisms	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko01100	Metabolic pathways	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko01110	Biosynthesis of secondary metabolites	1963	2.0e-102	0.88	0.93	1.00
PGSC0003DMG200028261	K01623	ko00010	Glycolysis / Gluconeogenesis	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028261	K01623	ko00030	Pentose phosphate pathway	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028261	K01623	ko00051	Fructose and mannose metabolism	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028261	K01623	ko00710	Carbon fixation in photosynthetic organisms	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028261	K01623	ko01100	Metabolic pathways	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028261	K01623	ko01110	Biosynthesis of secondary metabolites	2656	1.2e-140	0.88	0.94	1.00
PGSC0003DMG200028263	K04424	ko04010	MAPK signaling pathway	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMG200028263	K04424	ko04530	Tight junction	1894	1.3e-98	0.38	0.56	0.89
PGSC0003DMG200028264	K10773	ko03410	Base excision repair	2266	1.1e-125	0.33	0.47	0.85
PGSC0003DMG200028264	K10773	ko03410	Base excision repair	2728	4.4e-151	0.34	0.48	0.80
PGSC0003DMG200028265	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200028265	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200028265	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200028265	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200028265	K12836	ko03040	Spliceosome	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200028265	K12836	ko05131	Shigellosis	1459	1.2e-74	0.68	0.76	0.97
PGSC0003DMG200024342	K00490	ko00590	Arachidonic acid metabolism	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMG200024342	K00490	ko01100	Metabolic pathways	1093	1.9e-54	0.53	0.72	0.73
PGSC0003DMG200024342	K00490	ko00590	Arachidonic acid metabolism	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMG200024342	K00490	ko01100	Metabolic pathways	2242	8.0e-118	0.55	0.73	0.86
PGSC0003DMG200024346	K00001	ko00010	Glycolysis / Gluconeogenesis	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00071	Fatty acid metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00350	Tyrosine metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00624	1- and 2-Methylnaphthalene degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00641	3-Chloroacrylic acid degradation	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00830	Retinol metabolism	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00980	Metabolism of xenobiotics by cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko00982	Drug metabolism - cytochrome P450	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko01100	Metabolic pathways	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024346	K00001	ko01110	Biosynthesis of secondary metabolites	1506	3.1e-77	0.59	0.74	0.98
PGSC0003DMG200024351	K00826	ko00280	Valine, leucine and isoleucine degradation	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMG200024351	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMG200024351	K00826	ko00770	Pantothenate and CoA biosynthesis	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMG200024351	K00826	ko01100	Metabolic pathways	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMG200024351	K00826	ko01110	Biosynthesis of secondary metabolites	1658	1.3e-85	0.78	0.90	0.99
PGSC0003DMG200024351	K00826	ko00280	Valine, leucine and isoleucine degradation	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMG200024351	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMG200024351	K00826	ko00770	Pantothenate and CoA biosynthesis	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMG200024351	K00826	ko01100	Metabolic pathways	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMG200024351	K00826	ko01110	Biosynthesis of secondary metabolites	2145	1.8e-112	0.66	0.80	1.00
PGSC0003DMG200024351	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko00280	Valine, leucine and isoleucine degradation	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko00290	Valine, leucine and isoleucine biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko00770	Pantothenate and CoA biosynthesis	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko01100	Metabolic pathways	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K00826	ko01110	Biosynthesis of secondary metabolites	1825	8.0e-95	0.75	0.89	0.99
PGSC0003DMG200024351	K02918	ko03010	Ribosome	326	3.8e-12	0.90	0.90	0.51
PGSC0003DMG200024356	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMG200024356	K12893	ko03040	Spliceosome	781	3.1e-37	0.35	0.49	0.46
PGSC0003DMG200024356	K11093	ko03040	Spliceosome	273	4.5e-09	0.30	0.45	0.96
PGSC0003DMG200021133	K01187	ko00052	Galactose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMG200021133	K01187	ko00500	Starch and sucrose metabolism	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMG200021133	K01187	ko01100	Metabolic pathways	4702	1.7e-253	0.62	0.78	0.99
PGSC0003DMG200021133	K01187	ko00052	Galactose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMG200021133	K01187	ko00500	Starch and sucrose metabolism	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMG200021133	K01187	ko01100	Metabolic pathways	3046	3.6e-162	0.63	0.80	0.99
PGSC0003DMG200021135	K01807	ko00030	Pentose phosphate pathway	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMG200021135	K01807	ko00710	Carbon fixation in photosynthetic organisms	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMG200021135	K01807	ko01100	Metabolic pathways	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMG200021135	K01807	ko01110	Biosynthesis of secondary metabolites	1328	2.1e-67	0.57	0.72	0.91
PGSC0003DMG200021135	K01807	ko00030	Pentose phosphate pathway	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMG200021135	K01807	ko00710	Carbon fixation in photosynthetic organisms	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMG200021135	K01807	ko01100	Metabolic pathways	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMG200021135	K01807	ko01110	Biosynthesis of secondary metabolites	943	3.5e-46	0.71	0.90	0.94
PGSC0003DMG200021135	K01807	ko00030	Pentose phosphate pathway	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMG200021135	K01807	ko00710	Carbon fixation in photosynthetic organisms	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMG200021135	K01807	ko01100	Metabolic pathways	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMG200021135	K01807	ko01110	Biosynthesis of secondary metabolites	1460	1.1e-74	0.63	0.79	0.94
PGSC0003DMG200021136	K09843	ko00906	Carotenoid biosynthesis	777	5.1e-37	0.32	0.51	0.99
PGSC0003DMG200021138	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMG200021138	K12448	ko01100	Metabolic pathways	3031	2.4e-161	0.85	0.93	1.00
PGSC0003DMG200021138	K12448	ko00520	Amino sugar and nucleotide sugar metabolism	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMG200021138	K12448	ko01100	Metabolic pathways	1992	4.9e-104	0.86	0.93	1.00
PGSC0003DMG200021139	K01514	ko00230	Purine metabolism	378	5.7e-14	0.36	0.54	0.13
PGSC0003DMG200021142	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko00100	Steroid biosynthesis	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko01100	Metabolic pathways	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko01110	Biosynthesis of secondary metabolites	3756	2.5e-201	0.75	0.87	0.99
PGSC0003DMG200021142	K09828	ko00100	Steroid biosynthesis	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMG200021142	K09828	ko01100	Metabolic pathways	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMG200021142	K09828	ko01110	Biosynthesis of secondary metabolites	844	1.0e-40	0.76	0.84	0.96
PGSC0003DMG200021144	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMG200021144	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMG200021144	K02694	ko00195	Photosynthesis	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMG200021144	K02694	ko01100	Metabolic pathways	1531	1.3e-78	0.81	0.88	1.00
PGSC0003DMG200021144	K02694	ko00195	Photosynthesis	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMG200021144	K02694	ko01100	Metabolic pathways	1536	7.0e-79	0.81	0.88	1.00
PGSC0003DMG200010819	K00660	ko00941	Flavonoid biosynthesis	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMG200010819	K00660	ko01100	Metabolic pathways	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMG200010819	K00660	ko01110	Biosynthesis of secondary metabolites	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMG200010819	K00660	ko04712	Circadian rhythm - plant	230	9.3e-07	0.39	0.58	0.57
PGSC0003DMG200010824	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04020	Calcium signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04070	Phosphatidylinositol signaling system	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04114	Oocyte meiosis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04270	Vascular smooth muscle contraction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04626	Plant-pathogen interaction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04720	Long-term potentiation	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04722	Neurotrophin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04740	Olfactory transduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04744	Phototransduction	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04745	Phototransduction - fly	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04910	Insulin signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04912	GnRH signaling pathway	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04916	Melanogenesis	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04970	Salivary secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04971	Gastric acid secretion	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05010	Alzheimer's disease	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko05214	Glioma	1339	5.1e-68	0.54	0.67	0.99
PGSC0003DMG200010824	K02183	ko04020	Calcium signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04070	Phosphatidylinositol signaling system	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04114	Oocyte meiosis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04270	Vascular smooth muscle contraction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04626	Plant-pathogen interaction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04720	Long-term potentiation	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04722	Neurotrophin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04740	Olfactory transduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04744	Phototransduction	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04745	Phototransduction - fly	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04910	Insulin signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04912	GnRH signaling pathway	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04916	Melanogenesis	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04970	Salivary secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko04971	Gastric acid secretion	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko05010	Alzheimer's disease	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200010824	K02183	ko05214	Glioma	3410	3.0e-182	0.68	0.78	1.00
PGSC0003DMG200003724	K10352	ko04530	Tight junction	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMG200003724	K10352	ko05416	Viral myocarditis	586	7.8e-23	0.24	0.44	0.87
PGSC0003DMG200003724	K10352	ko04530	Tight junction	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMG200003724	K10352	ko05416	Viral myocarditis	570	6.1e-22	0.24	0.44	0.85
PGSC0003DMG200003725	K12619	ko03018	RNA degradation	6361	0.	0.68	0.78	1.00
PGSC0003DMG200006846	K02863	ko03010	Ribosome	1169	1.2e-58	0.59	0.79	0.69
PGSC0003DMG200006855	K00559	ko00100	Steroid biosynthesis	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMG200006855	K00559	ko01100	Metabolic pathways	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMG200006855	K00559	ko01110	Biosynthesis of secondary metabolites	2417	1.8e-127	0.80	0.89	0.99
PGSC0003DMG200006859	K12900	ko03040	Spliceosome	258	1.6e-07	0.37	0.53	0.16
PGSC0003DMG200006859	K12900	ko03040	Spliceosome	258	2.0e-07	0.37	0.53	0.14
PGSC0003DMG200038880	K12606	ko03018	RNA degradation	422	1.9e-17	0.33	0.49	0.66
PGSC0003DMG200038882	K13065	ko00940	Phenylpropanoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMG200038882	K13065	ko00941	Flavonoid biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMG200038882	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMG200038882	K13065	ko01110	Biosynthesis of secondary metabolites	295	2.0e-10	0.28	0.44	0.87
PGSC0003DMG200028883	K00423	ko00053	Ascorbate and aldarate metabolism	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMG200028883	K00423	ko01100	Metabolic pathways	1924	2.8e-100	0.49	0.67	0.86
PGSC0003DMG200028883	K00423	ko00053	Ascorbate and aldarate metabolism	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMG200028883	K00423	ko01100	Metabolic pathways	1012	5.5e-50	0.49	0.67	0.97
PGSC0003DMG200028883	K00423	ko00053	Ascorbate and aldarate metabolism	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMG200028883	K00423	ko01100	Metabolic pathways	2142	2.6e-112	0.49	0.67	0.91
PGSC0003DMG200028883	K00423	ko00053	Ascorbate and aldarate metabolism	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMG200028883	K00423	ko01100	Metabolic pathways	282	2.1e-09	0.46	0.73	0.48
PGSC0003DMG200028884	K01148	ko03018	RNA degradation	494	2.1e-21	0.30	0.48	0.57
PGSC0003DMG200028884	K01148	ko03018	RNA degradation	528	2.8e-23	0.30	0.47	0.61
PGSC0003DMG200028885	K03153	ko00730	Thiamine metabolism	300	1.0e-10	0.32	0.50	0.78
PGSC0003DMG200028885	K00303	ko00260	Glycine, serine and threonine metabolism	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMG200028885	K00303	ko01100	Metabolic pathways	470	4.3e-20	0.28	0.46	0.83
PGSC0003DMG200028887	K00454	ko00591	Linoleic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMG200028887	K00454	ko00592	alpha-Linolenic acid metabolism	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMG200028887	K00454	ko01100	Metabolic pathways	2164	1.6e-113	0.57	0.73	1.00
PGSC0003DMG200028887	K00454	ko00591	Linoleic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMG200028887	K00454	ko00592	alpha-Linolenic acid metabolism	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMG200028887	K00454	ko01100	Metabolic pathways	559	6.8e-25	0.65	0.79	0.99
PGSC0003DMG200028888	K00454	ko00591	Linoleic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMG200028888	K00454	ko00592	alpha-Linolenic acid metabolism	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMG200028888	K00454	ko01100	Metabolic pathways	817	3.2e-39	0.37	0.57	0.88
PGSC0003DMG200030815	K00121	ko00010	Glycolysis / Gluconeogenesis	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00071	Fatty acid metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00350	Tyrosine metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00624	1- and 2-Methylnaphthalene degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00641	3-Chloroacrylic acid degradation	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00680	Methane metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00830	Retinol metabolism	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00982	Drug metabolism - cytochrome P450	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko01100	Metabolic pathways	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko01110	Biosynthesis of secondary metabolites	1315	1.1e-66	0.70	0.84	0.97
PGSC0003DMG200030815	K00121	ko00010	Glycolysis / Gluconeogenesis	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00071	Fatty acid metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00350	Tyrosine metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00624	1- and 2-Methylnaphthalene degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00641	3-Chloroacrylic acid degradation	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00680	Methane metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00830	Retinol metabolism	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00980	Metabolism of xenobiotics by cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko00982	Drug metabolism - cytochrome P450	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko01100	Metabolic pathways	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K00121	ko01110	Biosynthesis of secondary metabolites	2326	1.9e-122	0.69	0.84	1.00
PGSC0003DMG200030815	K02267	ko00190	Oxidative phosphorylation	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030815	K02267	ko01100	Metabolic pathways	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030815	K02267	ko04260	Cardiac muscle contraction	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030815	K02267	ko05010	Alzheimer's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030815	K02267	ko05012	Parkinson's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030815	K02267	ko05016	Huntington's disease	985	1.7e-48	0.63	0.72	0.97
PGSC0003DMG200030816	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2152	7.4e-113	0.73	0.83	0.89
PGSC0003DMG200030816	K01875	ko00970	Aminoacyl-tRNA biosynthesis	1108	2.8e-55	0.84	0.92	0.97
PGSC0003DMG200030816	K01875	ko00970	Aminoacyl-tRNA biosynthesis	2726	1.6e-144	0.85	0.92	0.99
PGSC0003DMG200030816	K01875	ko00970	Aminoacyl-tRNA biosynthesis	3338	2.8e-178	0.78	0.87	0.99
PGSC0003DMG200030822	K13030	ko00460	Cyanoamino acid metabolism	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMG200030822	K13030	ko01110	Biosynthesis of secondary metabolites	1028	7.3e-51	0.42	0.63	0.97
PGSC0003DMG200030822	K13030	ko00460	Cyanoamino acid metabolism	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMG200030822	K13030	ko01110	Biosynthesis of secondary metabolites	1633	3.1e-84	0.42	0.63	0.98
PGSC0003DMG200030822	K13030	ko00460	Cyanoamino acid metabolism	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMG200030822	K13030	ko01110	Biosynthesis of secondary metabolites	1620	1.6e-83	0.42	0.65	0.97
PGSC0003DMG200030823	K13030	ko00460	Cyanoamino acid metabolism	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMG200030823	K13030	ko01110	Biosynthesis of secondary metabolites	622	1.8e-28	0.45	0.64	0.98
PGSC0003DMG200030823	K13030	ko00460	Cyanoamino acid metabolism	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMG200030823	K13030	ko01110	Biosynthesis of secondary metabolites	1666	4.7e-86	0.44	0.65	0.97
PGSC0003DMG200030824	K13030	ko00460	Cyanoamino acid metabolism	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMG200030824	K13030	ko01110	Biosynthesis of secondary metabolites	1116	1.0e-55	0.43	0.64	0.99
PGSC0003DMG200030824	K13030	ko00460	Cyanoamino acid metabolism	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMG200030824	K13030	ko01110	Biosynthesis of secondary metabolites	1705	3.3e-88	0.44	0.65	0.98
PGSC0003DMG200021842	K04733	ko04210	Apoptosis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMG200021842	K04733	ko04620	Toll-like receptor signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMG200021842	K04733	ko04722	Neurotrophin signaling pathway	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMG200021842	K04733	ko05140	Leishmaniasis	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMG200021842	K04733	ko05142	Chagas disease	2784	1.0e-147	0.46	0.62	0.98
PGSC0003DMG200021848	K01199	ko00500	Starch and sucrose metabolism	916	1.1e-44	0.44	0.59	0.93
PGSC0003DMG200021853	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko00071	Fatty acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko00592	alpha-Linolenic acid metabolism	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko01100	Metabolic pathways	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko03320	PPAR signaling pathway	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko04146	Peroxisome	1711	1.6e-88	0.67	0.86	0.99
PGSC0003DMG200021853	K00232	ko00071	Fatty acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021853	K00232	ko00592	alpha-Linolenic acid metabolism	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021853	K00232	ko01040	Biosynthesis of unsaturated fatty acids	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021853	K00232	ko01100	Metabolic pathways	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021853	K00232	ko03320	PPAR signaling pathway	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021853	K00232	ko04146	Peroxisome	1001	2.2e-49	0.77	0.90	0.99
PGSC0003DMG200021854	K13230	ko00402	Benzoxazinoid biosynthesis	973	7.9e-48	0.39	0.56	0.97
PGSC0003DMG200024963	K03955	ko00190	Oxidative phosphorylation	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMG200024963	K03955	ko01100	Metabolic pathways	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMG200024963	K03955	ko05010	Alzheimer's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMG200024963	K03955	ko05012	Parkinson's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMG200024963	K03955	ko05016	Huntington's disease	768	1.6e-36	0.74	0.84	0.99
PGSC0003DMG200024965	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMG200024965	K01455	ko00910	Nitrogen metabolism	1356	5.9e-69	0.87	0.93	0.92
PGSC0003DMG200024965	K01455	ko00630	Glyoxylate and dicarboxylate metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMG200024965	K01455	ko00910	Nitrogen metabolism	3299	4.0e-176	0.83	0.92	0.97
PGSC0003DMG200024967	K00430	ko00360	Phenylalanine metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMG200024967	K00430	ko00680	Methane metabolism	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMG200024967	K00430	ko00940	Phenylpropanoid biosynthesis	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMG200024967	K00430	ko01100	Metabolic pathways	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMG200024967	K00430	ko01110	Biosynthesis of secondary metabolites	614	5.0e-28	0.74	0.83	0.98
PGSC0003DMG200024967	K00430	ko00360	Phenylalanine metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMG200024967	K00430	ko00680	Methane metabolism	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMG200024967	K00430	ko00940	Phenylpropanoid biosynthesis	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMG200024967	K00430	ko01100	Metabolic pathways	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMG200024967	K00430	ko01110	Biosynthesis of secondary metabolites	1837	1.7e-95	0.66	0.78	1.00
PGSC0003DMG200024973	K00235	ko00020	Citrate cycle (TCA cycle)	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko00190	Oxidative phosphorylation	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko01100	Metabolic pathways	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko01110	Biosynthesis of secondary metabolites	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko05010	Alzheimer's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko05012	Parkinson's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024973	K00235	ko05016	Huntington's disease	902	6.5e-44	0.91	0.94	0.99
PGSC0003DMG200024976	K12347	ko04142	Lysosome	3012	2.7e-160	0.80	0.89	0.93
PGSC0003DMG200024976	K12347	ko04142	Lysosome	3273	1.1e-174	0.77	0.89	0.97
PGSC0003DMG200016094	K01610	ko00010	Glycolysis / Gluconeogenesis	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016094	K01610	ko00020	Citrate cycle (TCA cycle)	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016094	K01610	ko00620	Pyruvate metabolism	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016094	K01610	ko00710	Carbon fixation in photosynthetic organisms	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016094	K01610	ko01100	Metabolic pathways	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016094	K01610	ko01110	Biosynthesis of secondary metabolites	4601	6.2e-248	0.83	0.91	0.98
PGSC0003DMG200016095	K13065	ko00940	Phenylpropanoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMG200016095	K13065	ko00941	Flavonoid biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMG200016095	K13065	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMG200016095	K13065	ko01110	Biosynthesis of secondary metabolites	421	2.2e-17	0.27	0.45	0.95
PGSC0003DMG200016101	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMG200016101	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	385	9.0e-15	0.36	0.46	0.98
PGSC0003DMG200016107	K13289	ko04142	Lysosome	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMG200016107	K13289	ko04614	Renin-angiotensin system	330	2.3e-12	0.53	0.65	0.73
PGSC0003DMG200009767	K12606	ko03018	RNA degradation	236	3.5e-07	0.49	0.56	0.96
PGSC0003DMG200009772	K02738	ko03050	Proteasome	1695	1.2e-87	0.85	0.94	0.97
PGSC0003DMG200009774	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMG200009774	K12446	ko01100	Metabolic pathways	2182	1.6e-114	0.79	0.91	0.97
PGSC0003DMG200009774	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMG200009774	K12446	ko01100	Metabolic pathways	4308	9.0e-232	0.74	0.87	0.96
PGSC0003DMG200009774	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMG200009774	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMG200009774	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMG200009774	K12446	ko01100	Metabolic pathways	3021	8.6e-161	0.72	0.86	0.95
PGSC0003DMG200009774	K12446	ko00520	Amino sugar and nucleotide sugar metabolism	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMG200009774	K12446	ko01100	Metabolic pathways	1772	6.7e-92	0.71	0.85	0.98
PGSC0003DMG200009777	K01665	ko00790	Folate biosynthesis	2272	1.8e-119	0.43	0.55	0.90
PGSC0003DMG200009777	K01665	ko00790	Folate biosynthesis	1635	2.4e-84	0.49	0.62	0.84
PGSC0003DMG200009777	K01665	ko00790	Folate biosynthesis	1156	6.3e-58	0.63	0.74	0.91
PGSC0003DMG200009777	K01665	ko00790	Folate biosynthesis	794	5.9e-38	0.65	0.76	0.96
PGSC0003DMG200005923	K00419	ko00190	Oxidative phosphorylation	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko01100	Metabolic pathways	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko04260	Cardiac muscle contraction	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko05010	Alzheimer's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko05012	Parkinson's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko05016	Huntington's disease	447	8.1e-19	0.77	0.89	0.96
PGSC0003DMG200005923	K00419	ko00190	Oxidative phosphorylation	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005923	K00419	ko01100	Metabolic pathways	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005923	K00419	ko04260	Cardiac muscle contraction	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005923	K00419	ko05010	Alzheimer's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005923	K00419	ko05012	Parkinson's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005923	K00419	ko05016	Huntington's disease	331	2.0e-12	0.70	0.85	0.91
PGSC0003DMG200005925	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMG200005925	K00517	ko00626	Naphthalene and anthracene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMG200005925	K00517	ko00903	Limonene and pinene degradation	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMG200005925	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMG200005925	K00517	ko01110	Biosynthesis of secondary metabolites	1685	4.2e-87	0.44	0.63	0.99
PGSC0003DMG200005926	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMG200005926	K00517	ko00626	Naphthalene and anthracene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMG200005926	K00517	ko00903	Limonene and pinene degradation	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMG200005926	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMG200005926	K00517	ko01110	Biosynthesis of secondary metabolites	1697	9.2e-88	0.43	0.62	0.99
PGSC0003DMG200005932	K06620	ko04110	Cell cycle	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05200	Pathways in cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05212	Pancreatic cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05214	Glioma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05215	Prostate cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05218	Melanoma	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05219	Bladder cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05220	Chronic myeloid leukemia	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05222	Small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko05223	Non-small cell lung cancer	727	2.9e-34	0.36	0.52	0.90
PGSC0003DMG200005932	K06620	ko04110	Cell cycle	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05200	Pathways in cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05212	Pancreatic cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05214	Glioma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05215	Prostate cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05218	Melanoma	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05219	Bladder cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05220	Chronic myeloid leukemia	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05222	Small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005932	K06620	ko05223	Non-small cell lung cancer	728	2.6e-34	0.36	0.52	0.89
PGSC0003DMG200005937	K01757	ko00901	Indole alkaloid biosynthesis	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMG200005937	K01757	ko01100	Metabolic pathways	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMG200005937	K01757	ko01110	Biosynthesis of secondary metabolites	482	9.5e-21	0.31	0.44	0.79
PGSC0003DMG200005937	K01757	ko00901	Indole alkaloid biosynthesis	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMG200005937	K01757	ko01100	Metabolic pathways	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMG200005937	K01757	ko01110	Biosynthesis of secondary metabolites	717	1.0e-33	0.37	0.53	0.82
PGSC0003DMG200042079	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMG200042079	K00517	ko00626	Naphthalene and anthracene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMG200042079	K00517	ko00903	Limonene and pinene degradation	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMG200042079	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMG200042079	K00517	ko01110	Biosynthesis of secondary metabolites	372	1.1e-14	0.41	0.51	0.56
PGSC0003DMG200046743	K05692	ko04145	Phagosome	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04510	Focal adhesion	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04520	Adherens junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04530	Tight junction	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04670	Leukocyte transendothelial migration	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04745	Phototransduction - fly	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko04810	Regulation of actin cytoskeleton	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05100	Bacterial invasion of epithelial cells	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05110	Vibrio cholerae infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05130	Pathogenic Escherichia coli infection	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05131	Shigellosis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05410	Hypertrophic cardiomyopathy (HCM)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05414	Dilated cardiomyopathy	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046743	K05692	ko05416	Viral myocarditis	259	3.4e-11	0.70	0.82	0.75
PGSC0003DMG200046746	K12356	ko00940	Phenylpropanoid biosynthesis	1279	1.0e-64	0.58	0.74	0.97
PGSC0003DMG200034574	K05279	ko00944	Flavone and flavonol biosynthesis	410	8.9e-17	0.42	0.58	0.98
PGSC0003DMG200034585	K10760	ko00908	Zeatin biosynthesis	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMG200034585	K10760	ko01100	Metabolic pathways	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMG200034585	K10760	ko01110	Biosynthesis of secondary metabolites	457	2.3e-19	0.42	0.63	0.71
PGSC0003DMG200034591	K02261	ko00190	Oxidative phosphorylation	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034591	K02261	ko01100	Metabolic pathways	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034591	K02261	ko04260	Cardiac muscle contraction	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034591	K02261	ko05010	Alzheimer's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034591	K02261	ko05012	Parkinson's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034591	K02261	ko05016	Huntington's disease	602	2.3e-27	0.54	0.67	0.73
PGSC0003DMG200034593	K10760	ko00908	Zeatin biosynthesis	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMG200034593	K10760	ko01100	Metabolic pathways	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMG200034593	K10760	ko01110	Biosynthesis of secondary metabolites	1170	1.1e-58	0.55	0.72	1.00
PGSC0003DMG200034594	K00430	ko00360	Phenylalanine metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMG200034594	K00430	ko00680	Methane metabolism	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMG200034594	K00430	ko00940	Phenylpropanoid biosynthesis	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMG200034594	K00430	ko01100	Metabolic pathways	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMG200034594	K00430	ko01110	Biosynthesis of secondary metabolites	1080	9.9e-54	0.71	0.81	0.91
PGSC0003DMG200026513	K12117	ko04712	Circadian rhythm - plant	319	1.9e-11	0.34	0.50	0.93
PGSC0003DMG200026513	K12115	ko04712	Circadian rhythm - plant	622	1.8e-28	0.33	0.48	0.91
PGSC0003DMG200026515	K12135	ko04712	Circadian rhythm - plant	210	9.5e-06	0.35	0.53	0.30
PGSC0003DMG200022676	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	337	6.5e-12	0.33	0.49	0.94
PGSC0003DMG200022678	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMG200022678	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMG200022678	K00356	ko00190	Oxidative phosphorylation	324	4.9e-12	0.32	0.47	0.61
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1307	3.0e-66	0.33	0.52	0.97
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1310	2.0e-66	0.33	0.53	0.97
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMG200022679	K10609	ko03420	Nucleotide excision repair	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMG200022679	K10609	ko04120	Ubiquitin mediated proteolysis	331	2.0e-12	0.49	0.65	0.97
PGSC0003DMG200022679	K10609	ko03420	Nucleotide excision repair	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMG200022679	K10609	ko04120	Ubiquitin mediated proteolysis	849	5.4e-41	0.43	0.61	1.00
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	221	3.1e-06	0.36	0.62	0.92
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1601	1.8e-82	0.33	0.52	0.98
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1557	4.8e-80	0.33	0.52	0.97
PGSC0003DMG200022679	K03869	ko04120	Ubiquitin mediated proteolysis	1293	1.8e-65	0.33	0.53	0.97
PGSC0003DMG200022680	K08065	ko04612	Antigen processing and presentation	547	2.5e-24	0.59	0.78	0.80
PGSC0003DMG200037214	K07466	ko03030	DNA replication	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMG200037214	K07466	ko03420	Nucleotide excision repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMG200037214	K07466	ko03430	Mismatch repair	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMG200037214	K07466	ko03440	Homologous recombination	297	2.8e-10	0.27	0.49	0.69
PGSC0003DMG200037226	K00799	ko00480	Glutathione metabolism	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMG200037226	K00799	ko00980	Metabolism of xenobiotics by cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMG200037226	K00799	ko00982	Drug metabolism - cytochrome P450	331	2.0e-12	0.48	0.69	0.82
PGSC0003DMG200037227	K01087	ko00500	Starch and sucrose metabolism	313	9.7e-11	0.80	0.90	0.63
PGSC0003DMG200037233	K07466	ko03030	DNA replication	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMG200037233	K07466	ko03420	Nucleotide excision repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMG200037233	K07466	ko03430	Mismatch repair	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMG200037233	K07466	ko03440	Homologous recombination	481	1.1e-20	0.29	0.47	0.88
PGSC0003DMG200037235	K12356	ko00940	Phenylpropanoid biosynthesis	524	4.6e-23	0.41	0.59	0.66
PGSC0003DMG200019618	K12581	ko03018	RNA degradation	1200	2.4e-60	0.56	0.73	0.94
PGSC0003DMG200019620	K01591	ko00240	Pyrimidine metabolism	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMG200019620	K01591	ko01100	Metabolic pathways	3203	7.9e-171	0.80	0.90	1.00
PGSC0003DMG200019627	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko04115	p53 signaling pathway	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko04210	Apoptosis	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05010	Alzheimer's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05012	Parkinson's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05016	Huntington's disease	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019627	K02084	ko05222	Small cell lung cancer	292	1.3e-06	0.27	0.46	0.42
PGSC0003DMG200019629	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.85
PGSC0003DMG200019629	K06620	ko04110	Cell cycle	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05200	Pathways in cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05212	Pancreatic cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05214	Glioma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05215	Prostate cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05218	Melanoma	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05219	Bladder cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05220	Chronic myeloid leukemia	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05222	Small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K06620	ko05223	Non-small cell lung cancer	752	1.2e-35	0.43	0.59	0.92
PGSC0003DMG200019629	K04682	ko04110	Cell cycle	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMG200019629	K04682	ko04350	TGF-beta signaling pathway	304	6.2e-11	0.34	0.50	0.94
PGSC0003DMG200019629	K06620	ko04110	Cell cycle	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05200	Pathways in cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05212	Pancreatic cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05214	Glioma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05215	Prostate cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05218	Melanoma	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05219	Bladder cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05220	Chronic myeloid leukemia	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05222	Small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019629	K06620	ko05223	Non-small cell lung cancer	786	1.6e-37	0.38	0.54	0.86
PGSC0003DMG200019631	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMG200019631	K02899	ko03010	Ribosome	1157	5.6e-58	0.77	0.88	0.97
PGSC0003DMG200029447	K12356	ko00940	Phenylpropanoid biosynthesis	565	2.5e-25	0.50	0.62	0.99
PGSC0003DMG200029449	K01078	ko00361	gamma-Hexachlorocyclohexane degradation	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMG200029449	K01078	ko00740	Riboflavin metabolism	787	1.4e-37	0.64	0.85	0.91
PGSC0003DMG200036760	K08233	ko00901	Indole alkaloid biosynthesis	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMG200036760	K08233	ko01110	Biosynthesis of secondary metabolites	402	2.4e-16	0.47	0.71	0.96
PGSC0003DMG200036768	K06237	ko04510	Focal adhesion	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMG200036768	K06237	ko04512	ECM-receptor interaction	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMG200036768	K06237	ko05146	Amoebiasis	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMG200036768	K06237	ko05200	Pathways in cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMG200036768	K06237	ko05222	Small cell lung cancer	1395	4.2e-71	0.37	0.46	0.94
PGSC0003DMG200036773	K01509	ko00230	Purine metabolism	255	2.1e-07	0.74	0.83	0.70
PGSC0003DMG200000785	K01590	ko00340	Histidine metabolism	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMG200000785	K01590	ko01100	Metabolic pathways	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMG200000785	K01590	ko01110	Biosynthesis of secondary metabolites	2032	3.1e-106	0.80	0.88	0.94
PGSC0003DMG200000785	K01590	ko00340	Histidine metabolism	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMG200000785	K01590	ko01100	Metabolic pathways	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMG200000785	K01590	ko01110	Biosynthesis of secondary metabolites	1188	1.1e-59	0.82	0.93	0.98
PGSC0003DMG200000787	K05681	ko02010	ABC transporters	1191	7.4e-60	0.33	0.53	0.86
PGSC0003DMG200000792	K10595	ko04120	Ubiquitin mediated proteolysis	752	7.2e-32	0.34	0.51	0.43
PGSC0003DMG200000796	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMG200000796	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMG200000796	K04424	ko04010	MAPK signaling pathway	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMG200000796	K04424	ko04530	Tight junction	723	4.8e-34	0.43	0.64	0.80
PGSC0003DMG200000796	K04424	ko04010	MAPK signaling pathway	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMG200000796	K04424	ko04530	Tight junction	481	3.0e-20	0.43	0.60	0.40
PGSC0003DMG200000796	K04424	ko04010	MAPK signaling pathway	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMG200000796	K04424	ko04530	Tight junction	840	1.7e-40	0.41	0.62	0.53
PGSC0003DMG200000798	K09843	ko00906	Carotenoid biosynthesis	1068	4.5e-53	0.37	0.57	0.94
PGSC0003DMG200000798	K09843	ko00906	Carotenoid biosynthesis	260	2.9e-08	0.40	0.65	0.88
PGSC0003DMG200008285	K02882	ko03010	Ribosome	1469	3.5e-75	0.94	0.98	0.99
PGSC0003DMG200008292	K02084	ko04115	p53 signaling pathway	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko04210	Apoptosis	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko05010	Alzheimer's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko05012	Parkinson's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko05014	Amyotrophic lateral sclerosis (ALS)	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko05016	Huntington's disease	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200008292	K02084	ko05222	Small cell lung cancer	308	1.3e-07	0.28	0.46	0.41
PGSC0003DMG200002931	K01213	ko00040	Pentose and glucuronate interconversions	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMG200002931	K01213	ko00500	Starch and sucrose metabolism	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMG200002931	K01213	ko01100	Metabolic pathways	866	6.3e-42	0.42	0.59	0.60
PGSC0003DMG200002931	K01213	ko00040	Pentose and glucuronate interconversions	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMG200002931	K01213	ko00500	Starch and sucrose metabolism	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMG200002931	K01213	ko01100	Metabolic pathways	518	9.8e-23	0.39	0.58	0.71
PGSC0003DMG200002935	K03868	ko03420	Nucleotide excision repair	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04110	Cell cycle	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04111	Cell cycle - yeast	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04114	Oocyte meiosis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04120	Ubiquitin mediated proteolysis	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04310	Wnt signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04350	TGF-beta signaling pathway	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko04710	Circadian rhythm - mammal	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko05200	Pathways in cancer	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko05211	Renal cell carcinoma	621	2.0e-28	0.89	0.93	0.94
PGSC0003DMG200002935	K03868	ko03420	Nucleotide excision repair	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04110	Cell cycle	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04111	Cell cycle - yeast	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04114	Oocyte meiosis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04120	Ubiquitin mediated proteolysis	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04310	Wnt signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04350	TGF-beta signaling pathway	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko04710	Circadian rhythm - mammal	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko05200	Pathways in cancer	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002935	K03868	ko05211	Renal cell carcinoma	943	3.5e-46	0.88	0.91	0.99
PGSC0003DMG200002943	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2186	9.8e-115	0.63	0.78	0.99
PGSC0003DMG200002945	K12130	ko04712	Circadian rhythm - plant	267	1.4e-08	0.31	0.46	0.92
PGSC0003DMG200012679	K10525	ko00592	alpha-Linolenic acid metabolism	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMG200012679	K10525	ko01100	Metabolic pathways	1113	1.5e-55	0.57	0.71	1.00
PGSC0003DMG200012685	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMG200012685	K12837	ko03040	Spliceosome	3856	7.6e-207	0.80	0.89	0.99
PGSC0003DMG200012685	K12837	ko03040	Spliceosome	2768	7.8e-147	0.89	0.95	0.99
PGSC0003DMG200012693	K12356	ko00940	Phenylpropanoid biosynthesis	651	4.5e-30	0.47	0.63	0.93
PGSC0003DMG200012694	K12356	ko00940	Phenylpropanoid biosynthesis	769	1.4e-36	0.50	0.63	0.93
PGSC0003DMG200015775	K02897	ko03010	Ribosome	1284	5.5e-65	0.75	0.87	0.88
PGSC0003DMG200028620	K02295	ko04710	Circadian rhythm - mammal	3588	4.6e-192	0.76	0.86	0.99
PGSC0003DMG200028620	K02295	ko04710	Circadian rhythm - mammal	3802	7.3e-204	0.80	0.90	0.99
PGSC0003DMG200028620	K02295	ko04710	Circadian rhythm - mammal	1409	7.0e-72	0.76	0.90	0.98
PGSC0003DMG200028621	K02265	ko00190	Oxidative phosphorylation	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028621	K02265	ko01100	Metabolic pathways	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028621	K02265	ko04260	Cardiac muscle contraction	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028621	K02265	ko05010	Alzheimer's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028621	K02265	ko05012	Parkinson's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028621	K02265	ko05016	Huntington's disease	997	3.7e-49	0.70	0.81	0.98
PGSC0003DMG200028622	K06130	ko00564	Glycerophospholipid metabolism	567	1.9e-25	0.36	0.55	0.87
PGSC0003DMG200028629	K03106	ko03060	Protein export	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMG200028629	K03106	ko03070	Bacterial secretion system	3957	2.0e-212	0.94	0.97	1.00
PGSC0003DMG200028629	K03106	ko03060	Protein export	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMG200028629	K03106	ko03070	Bacterial secretion system	582	2.9e-26	0.80	0.85	0.94
PGSC0003DMG200028629	K03106	ko03060	Protein export	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMG200028629	K03106	ko03070	Bacterial secretion system	1596	3.4e-82	0.93	0.96	0.99
PGSC0003DMG200028631	K02951	ko03010	Ribosome	1021	1.8e-50	0.86	0.92	0.99
PGSC0003DMG200028632	K12356	ko00940	Phenylpropanoid biosynthesis	779	3.9e-37	0.33	0.50	0.97
PGSC0003DMG200028634	K03283	ko03040	Spliceosome	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMG200028634	K03283	ko04010	MAPK signaling pathway	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMG200028634	K03283	ko04144	Endocytosis	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMG200028634	K03283	ko04612	Antigen processing and presentation	3948	6.4e-212	0.76	0.80	1.00
PGSC0003DMG200028634	K03283	ko03040	Spliceosome	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMG200028634	K03283	ko04010	MAPK signaling pathway	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMG200028634	K03283	ko04144	Endocytosis	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMG200028634	K03283	ko04612	Antigen processing and presentation	4917	2.3e-265	0.89	0.95	1.00
PGSC0003DMG200017948	K04564	ko04146	Peroxisome	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMG200017948	K04564	ko05016	Huntington's disease	950	1.5e-46	0.51	0.69	0.80
PGSC0003DMG200017953	K08991	ko03440	Homologous recombination	3168	6.7e-169	0.60	0.74	1.00
PGSC0003DMG200017956	K01509	ko00230	Purine metabolism	2112	1.2e-110	0.42	0.60	0.88
PGSC0003DMG200017957	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMG200017957	K11433	ko00310	Lysine degradation	545	3.2e-24	0.34	0.52	0.73
PGSC0003DMG200024109	K03841	ko00010	Glycolysis / Gluconeogenesis	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko00030	Pentose phosphate pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko00051	Fructose and mannose metabolism	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko00710	Carbon fixation in photosynthetic organisms	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko01100	Metabolic pathways	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko01110	Biosynthesis of secondary metabolites	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko04910	Insulin signaling pathway	2487	2.5e-131	0.85	0.90	0.99
PGSC0003DMG200024109	K03841	ko00010	Glycolysis / Gluconeogenesis	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko00030	Pentose phosphate pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko00051	Fructose and mannose metabolism	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko00710	Carbon fixation in photosynthetic organisms	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko01100	Metabolic pathways	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko01110	Biosynthesis of secondary metabolites	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko04910	Insulin signaling pathway	1820	1.5e-94	0.92	0.97	0.91
PGSC0003DMG200024109	K03841	ko00010	Glycolysis / Gluconeogenesis	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko00030	Pentose phosphate pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko00051	Fructose and mannose metabolism	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko00710	Carbon fixation in photosynthetic organisms	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko01100	Metabolic pathways	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko01110	Biosynthesis of secondary metabolites	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko04910	Insulin signaling pathway	2666	3.3e-141	0.91	0.96	0.99
PGSC0003DMG200024109	K03841	ko00010	Glycolysis / Gluconeogenesis	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko00030	Pentose phosphate pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko00051	Fructose and mannose metabolism	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko00710	Carbon fixation in photosynthetic organisms	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko01100	Metabolic pathways	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko01110	Biosynthesis of secondary metabolites	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko04910	Insulin signaling pathway	715	1.3e-33	0.94	0.97	0.98
PGSC0003DMG200024109	K03841	ko00010	Glycolysis / Gluconeogenesis	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko00030	Pentose phosphate pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko00051	Fructose and mannose metabolism	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko00710	Carbon fixation in photosynthetic organisms	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko01100	Metabolic pathways	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko01110	Biosynthesis of secondary metabolites	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024109	K03841	ko04910	Insulin signaling pathway	459	1.8e-19	0.78	0.82	0.96
PGSC0003DMG200024111	K10842	ko03420	Nucleotide excision repair	1036	2.6e-51	0.66	0.78	0.99
PGSC0003DMG200024124	K03108	ko03060	Protein export	1275	1.7e-64	0.76	0.86	0.99
PGSC0003DMG200024124	K03108	ko03060	Protein export	2544	1.8e-134	0.75	0.88	1.00
PGSC0003DMG200024124	K03108	ko03060	Protein export	2075	1.3e-108	0.74	0.85	1.00
PGSC0003DMG200024126	K03108	ko03060	Protein export	1194	5.1e-60	0.68	0.84	0.99
PGSC0003DMG200024128	K03108	ko03060	Protein export	1140	4.8e-57	0.75	0.87	0.50
PGSC0003DMG200024129	K05277	ko00941	Flavonoid biosynthesis	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMG200024129	K05277	ko01100	Metabolic pathways	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMG200024129	K05277	ko01110	Biosynthesis of secondary metabolites	773	8.4e-37	0.36	0.57	0.90
PGSC0003DMG200022169	K01148	ko03018	RNA degradation	1654	2.2e-85	0.47	0.65	0.67
PGSC0003DMG200022169	K01148	ko03018	RNA degradation	909	2.7e-44	0.45	0.66	0.60
PGSC0003DMG200022169	K01148	ko03018	RNA degradation	1601	1.8e-82	0.48	0.65	0.86
PGSC0003DMG200022169	K01148	ko03018	RNA degradation	648	6.6e-30	0.49	0.63	0.75
PGSC0003DMG200022169	K01148	ko03018	RNA degradation	1231	4.6e-62	0.51	0.67	0.83
PGSC0003DMG200022170	K00952	ko00760	Nicotinate and nicotinamide metabolism	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMG200022170	K00952	ko01100	Metabolic pathways	838	2.2e-40	0.72	0.81	0.94
PGSC0003DMG200022170	K00952	ko00760	Nicotinate and nicotinamide metabolism	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMG200022170	K00952	ko01100	Metabolic pathways	831	5.3e-40	0.72	0.81	0.93
PGSC0003DMG200022170	K00952	ko00760	Nicotinate and nicotinamide metabolism	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMG200022170	K00952	ko01100	Metabolic pathways	854	2.9e-41	0.68	0.81	0.97
PGSC0003DMG200022170	K00952	ko00760	Nicotinate and nicotinamide metabolism	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMG200022170	K00952	ko01100	Metabolic pathways	1292	2.0e-65	0.71	0.82	0.95
PGSC0003DMG200022172	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMG200022172	K08065	ko04612	Antigen processing and presentation	636	3.0e-29	0.58	0.75	0.73
PGSC0003DMG200022175	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMG200022175	K10878	ko04113	Meiosis - yeast	1167	1.6e-58	0.75	0.89	0.97
PGSC0003DMG200022177	K01692	ko00071	Fatty acid metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00280	Valine, leucine and isoleucine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00281	Geraniol degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00310	Lysine degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00380	Tryptophan metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00410	beta-Alanine metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00632	Benzoate degradation via CoA ligation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00640	Propanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00650	Butanoate metabolism	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00903	Limonene and pinene degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00930	Caprolactam degradation	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko01100	Metabolic pathways	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko01110	Biosynthesis of secondary metabolites	601	2.6e-27	0.41	0.57	0.90
PGSC0003DMG200022177	K01692	ko00071	Fatty acid metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00280	Valine, leucine and isoleucine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00281	Geraniol degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00310	Lysine degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00380	Tryptophan metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00410	beta-Alanine metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00632	Benzoate degradation via CoA ligation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00640	Propanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00650	Butanoate metabolism	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00903	Limonene and pinene degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00930	Caprolactam degradation	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko01100	Metabolic pathways	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko01110	Biosynthesis of secondary metabolites	1189	9.6e-60	0.43	0.62	0.90
PGSC0003DMG200022177	K01692	ko00071	Fatty acid metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00280	Valine, leucine and isoleucine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00281	Geraniol degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00310	Lysine degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00380	Tryptophan metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00410	beta-Alanine metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00632	Benzoate degradation via CoA ligation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00640	Propanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00650	Butanoate metabolism	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00903	Limonene and pinene degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko00930	Caprolactam degradation	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko01100	Metabolic pathways	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200022177	K01692	ko01110	Biosynthesis of secondary metabolites	1109	2.5e-55	0.42	0.60	0.90
PGSC0003DMG200031163	K02492	ko00860	Porphyrin and chlorophyll metabolism	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMG200031163	K02492	ko01100	Metabolic pathways	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMG200031163	K02492	ko01110	Biosynthesis of secondary metabolites	2542	2.3e-134	0.70	0.84	0.99
PGSC0003DMG200031166	K00940	ko00230	Purine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMG200031166	K00940	ko00240	Pyrimidine metabolism	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMG200031166	K00940	ko01100	Metabolic pathways	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMG200031166	K00940	ko01110	Biosynthesis of secondary metabolites	1102	6.0e-55	0.87	0.93	0.99
PGSC0003DMG200031168	K06654	ko04111	Cell cycle - yeast	344	3.9e-13	0.33	0.50	0.83
PGSC0003DMG200038720	K08770	ko03320	PPAR signaling pathway	3748	6.9e-201	1.00	1.00	1.00
PGSC0003DMG200010554	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00140	Steroid hormone biosynthesis	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00591	Linoleic acid metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00830	Retinol metabolism	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00982	Drug metabolism - cytochrome P450	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00983	Drug metabolism - other enzymes	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko01100	Metabolic pathways	1967	1.2e-102	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00140	Steroid hormone biosynthesis	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00361	gamma-Hexachlorocyclohexane degradation	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00591	Linoleic acid metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00830	Retinol metabolism	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00980	Metabolism of xenobiotics by cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00982	Drug metabolism - cytochrome P450	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko00983	Drug metabolism - other enzymes	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010554	K07424	ko01100	Metabolic pathways	1983	1.5e-103	0.46	0.69	0.98
PGSC0003DMG200010556	K01087	ko00500	Starch and sucrose metabolism	5434	7.0e-294	0.69	0.82	0.98
PGSC0003DMG200010556	K01087	ko00500	Starch and sucrose metabolism	5444	2.0e-294	0.75	0.89	0.98
PGSC0003DMG200010557	K01723	ko00592	alpha-Linolenic acid metabolism	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMG200010557	K01723	ko01100	Metabolic pathways	2102	4.2e-110	0.51	0.73	0.96
PGSC0003DMG200010558	K02868	ko03010	Ribosome	1458	1.4e-74	0.96	0.98	0.99
PGSC0003DMG200014457	K01199	ko00500	Starch and sucrose metabolism	756	7.3e-36	0.34	0.55	0.74
PGSC0003DMG200014458	K01613	ko00564	Glycerophospholipid metabolism	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMG200014458	K01613	ko01100	Metabolic pathways	229	6.9e-06	0.41	0.56	0.54
PGSC0003DMG200014458	K01613	ko00564	Glycerophospholipid metabolism	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMG200014458	K01613	ko01100	Metabolic pathways	248	6.0e-07	0.39	0.54	0.58
PGSC0003DMG200014459	K05929	ko00564	Glycerophospholipid metabolism	753	1.1e-35	0.39	0.58	0.53
PGSC0003DMG200014460	K00059	ko00061	Fatty acid biosynthesis	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMG200014460	K00059	ko01040	Biosynthesis of unsaturated fatty acids	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMG200014460	K00059	ko01100	Metabolic pathways	325	4.3e-12	0.61	0.74	0.94
PGSC0003DMG200014461	K10256	ko01040	Biosynthesis of unsaturated fatty acids	2414	2.6e-127	0.68	0.83	0.99
PGSC0003DMG200014462	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMG200014462	K05287	ko01100	Metabolic pathways	362	3.9e-14	0.47	0.60	0.93
PGSC0003DMG200014462	K05287	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMG200014462	K05287	ko01100	Metabolic pathways	404	1.9e-16	0.37	0.56	0.68
PGSC0003DMG200014465	K08243	ko00941	Flavonoid biosynthesis	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMG200014465	K08243	ko01110	Biosynthesis of secondary metabolites	489	3.9e-21	0.52	0.75	0.86
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	3414	1.8e-182	0.74	0.86	0.99
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	2796	2.2e-148	0.75	0.86	1.00
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	1940	3.6e-101	0.70	0.83	0.97
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	1464	6.5e-75	0.82	0.91	1.00
PGSC0003DMG200014466	K01904	ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMG200014466	K01904	ko00360	Phenylalanine metabolism	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMG200014466	K01904	ko00940	Phenylpropanoid biosynthesis	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMG200014466	K01904	ko01100	Metabolic pathways	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMG200014466	K01904	ko01110	Biosynthesis of secondary metabolites	2936	4.2e-156	0.74	0.85	0.99
PGSC0003DMG200014467	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMG200014467	K00328	ko00562	Inositol phosphate metabolism	408	1.1e-16	0.32	0.48	0.67
PGSC0003DMG200004011	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.61
PGSC0003DMG200004011	K12126	ko04712	Circadian rhythm - plant	515	1.4e-22	0.41	0.54	0.57
PGSC0003DMG200004012	K00763	ko00760	Nicotinate and nicotinamide metabolism	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMG200004012	K00763	ko01100	Metabolic pathways	3902	2.2e-209	0.82	0.92	0.97
PGSC0003DMG200004016	K01046	ko00561	Glycerolipid metabolism	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMG200004016	K01046	ko01100	Metabolic pathways	367	2.1e-14	0.35	0.49	0.60
PGSC0003DMG200004017	K01046	ko00561	Glycerolipid metabolism	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMG200004017	K01046	ko01100	Metabolic pathways	354	1.1e-13	0.34	0.47	0.59
PGSC0003DMG200004019	K12741	ko03040	Spliceosome	549	1.9e-24	0.32	0.45	0.96
PGSC0003DMG200004019	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMG200004019	K12741	ko03040	Spliceosome	589	1.2e-26	0.33	0.46	0.96
PGSC0003DMG200017227	K06269	ko04113	Meiosis - yeast	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04114	Oocyte meiosis	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04270	Vascular smooth muscle contraction	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04510	Focal adhesion	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04720	Long-term potentiation	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04810	Regulation of actin cytoskeleton	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017227	K06269	ko04910	Insulin signaling pathway	2424	7.3e-128	0.89	0.95	0.94
PGSC0003DMG200017228	K05746	ko04810	Regulation of actin cytoskeleton	702	7.0e-33	0.34	0.43	0.76
PGSC0003DMG200017236	K13229	ko00402	Benzoxazinoid biosynthesis	798	3.5e-38	0.42	0.60	0.91
PGSC0003DMG200028008	K00558	ko00270	Cysteine and methionine metabolism	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMG200028008	K00558	ko01100	Metabolic pathways	303	4.5e-10	0.40	0.56	0.74
PGSC0003DMG200028014	K04420	ko04010	MAPK signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMG200028014	K04420	ko04540	Gap junction	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMG200028014	K04420	ko04912	GnRH signaling pathway	478	1.6e-20	0.36	0.53	0.77
PGSC0003DMG200028018	K05894	ko00592	alpha-Linolenic acid metabolism	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMG200028018	K05894	ko01100	Metabolic pathways	531	1.9e-23	0.66	0.81	0.64
PGSC0003DMG200021430	K06123	ko00564	Glycerophospholipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMG200021430	K06123	ko00565	Ether lipid metabolism	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMG200021430	K06123	ko01100	Metabolic pathways	899	9.5e-44	0.44	0.61	0.94
PGSC0003DMG200021431	K04371	ko04010	MAPK signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04012	ErbB signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04013	MAPK signaling pathway - fly	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04062	Chemokine signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04114	Oocyte meiosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04150	mTOR signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04270	Vascular smooth muscle contraction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04320	Dorso-ventral axis formation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04350	TGF-beta signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04360	Axon guidance	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04370	VEGF signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04510	Focal adhesion	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04520	Adherens junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04540	Gap junction	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04620	Toll-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04621	NOD-like receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04650	Natural killer cell mediated cytotoxicity	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04660	T cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04662	B cell receptor signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04664	Fc epsilon RI signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04666	Fc gamma R-mediated phagocytosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04720	Long-term potentiation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04722	Neurotrophin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04730	Long-term depression	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04810	Regulation of actin cytoskeleton	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04910	Insulin signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04912	GnRH signaling pathway	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04914	Progesterone-mediated oocyte maturation	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04916	Melanogenesis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04930	Type II diabetes mellitus	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko04960	Aldosterone-regulated sodium reabsorption	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05010	Alzheimer's disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05020	Prion diseases	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05131	Shigellosis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05140	Leishmaniasis	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05142	Chagas disease	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05200	Pathways in cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05210	Colorectal cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05211	Renal cell carcinoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05212	Pancreatic cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05213	Endometrial cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05214	Glioma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05215	Prostate cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05216	Thyroid cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05218	Melanoma	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05219	Bladder cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05220	Chronic myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05221	Acute myeloid leukemia	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021431	K04371	ko05223	Non-small cell lung cancer	292	5.9e-10	0.42	0.64	0.41
PGSC0003DMG200021438	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMG200021438	K07297	ko04920	Adipocytokine signaling pathway	2532	8.1e-134	0.75	0.87	0.95
PGSC0003DMG200021439	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMG200021439	K00517	ko00626	Naphthalene and anthracene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMG200021439	K00517	ko00903	Limonene and pinene degradation	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMG200021439	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMG200021439	K00517	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.51	0.69	0.96
PGSC0003DMG200021439	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00626	Naphthalene and anthracene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00903	Limonene and pinene degradation	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021439	K00517	ko01110	Biosynthesis of secondary metabolites	1599	2.3e-82	0.44	0.65	0.96
PGSC0003DMG200021440	K03937	ko00190	Oxidative phosphorylation	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMG200021440	K03937	ko01100	Metabolic pathways	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMG200021440	K03937	ko05010	Alzheimer's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMG200021440	K03937	ko05012	Parkinson's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMG200021440	K03937	ko05016	Huntington's disease	282	1.0e-09	0.62	0.80	0.98
PGSC0003DMG200021441	K02935	ko03010	Ribosome	364	3.1e-14	0.41	0.62	0.80
PGSC0003DMG200021445	K10598	ko04120	Ubiquitin mediated proteolysis	4215	1.2e-226	0.81	0.90	1.00
PGSC0003DMG200021446	K00860	ko00230	Purine metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMG200021446	K00860	ko00450	Selenoamino acid metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMG200021446	K00860	ko00920	Sulfur metabolism	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMG200021446	K00860	ko01100	Metabolic pathways	1283	6.3e-65	0.60	0.72	0.93
PGSC0003DMG200021446	K00860	ko00230	Purine metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMG200021446	K00860	ko00450	Selenoamino acid metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMG200021446	K00860	ko00920	Sulfur metabolism	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMG200021446	K00860	ko01100	Metabolic pathways	1176	5.0e-59	0.72	0.81	0.74
PGSC0003DMG200032264	K01738	ko00270	Cysteine and methionine metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMG200032264	K01738	ko00450	Selenoamino acid metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMG200032264	K01738	ko00920	Sulfur metabolism	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMG200032264	K01738	ko01100	Metabolic pathways	489	3.9e-21	0.90	0.97	0.97
PGSC0003DMG200032264	K01738	ko00270	Cysteine and methionine metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMG200032264	K01738	ko00450	Selenoamino acid metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMG200032264	K01738	ko00920	Sulfur metabolism	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMG200032264	K01738	ko01100	Metabolic pathways	2010	5.0e-105	0.89	0.95	0.93
PGSC0003DMG200032264	K01738	ko00270	Cysteine and methionine metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMG200032264	K01738	ko00450	Selenoamino acid metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMG200032264	K01738	ko00920	Sulfur metabolism	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMG200032264	K01738	ko01100	Metabolic pathways	2403	1.1e-126	0.89	0.95	1.00
PGSC0003DMG200011224	K05286	ko00563	Glycosylphosphatidylinositol(GPI)-anchor biosynthesis	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMG200011224	K05286	ko01100	Metabolic pathways	1084	5.9e-54	0.65	0.80	0.99
PGSC0003DMG200006621	K05857	ko00562	Inositol phosphate metabolism	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMG200006621	K05857	ko01100	Metabolic pathways	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMG200006621	K05857	ko04020	Calcium signaling pathway	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMG200006621	K05857	ko04070	Phosphatidylinositol signaling system	2874	1.1e-152	0.69	0.80	0.97
PGSC0003DMG200006621	K05857	ko00562	Inositol phosphate metabolism	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMG200006621	K05857	ko01100	Metabolic pathways	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMG200006621	K05857	ko04020	Calcium signaling pathway	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMG200006621	K05857	ko04070	Phosphatidylinositol signaling system	3521	2.3e-188	0.70	0.82	1.00
PGSC0003DMG200006622	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko00562	Inositol phosphate metabolism	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko01100	Metabolic pathways	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko04020	Calcium signaling pathway	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko04070	Phosphatidylinositol signaling system	3150	6.6e-168	0.74	0.86	0.96
PGSC0003DMG200006622	K05857	ko00562	Inositol phosphate metabolism	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMG200006622	K05857	ko01100	Metabolic pathways	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMG200006622	K05857	ko04020	Calcium signaling pathway	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMG200006622	K05857	ko04070	Phosphatidylinositol signaling system	822	1.7e-39	0.73	0.91	0.99
PGSC0003DMG200006628	K06675	ko04111	Cell cycle - yeast	862	1.5e-41	0.52	0.61	0.93
PGSC0003DMG200013731	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMG200013731	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMG200013731	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMG200013731	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMG200013731	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.87
PGSC0003DMG200013731	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04210	Apoptosis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04620	Toll-like receptor signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko04722	Neurotrophin signaling pathway	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05140	Leishmaniasis	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013731	K04733	ko05142	Chagas disease	768	1.6e-36	0.34	0.50	0.83
PGSC0003DMG200013736	K01768	ko00230	Purine metabolism	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMG200013736	K01768	ko04113	Meiosis - yeast	286	1.7e-06	0.29	0.46	0.36
PGSC0003DMG200004713	K10595	ko04120	Ubiquitin mediated proteolysis	857	7.9e-40	0.33	0.49	0.80
PGSC0003DMG200004715	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMG200004715	K03260	ko05416	Viral myocarditis	247	8.7e-07	0.26	0.46	0.88
PGSC0003DMG200004717	K03109	ko03060	Protein export	775	6.5e-37	0.87	0.93	0.99
PGSC0003DMG200004717	K03109	ko03060	Protein export	780	3.5e-37	0.87	0.94	0.99
PGSC0003DMG200045524	K03094	ko04110	Cell cycle	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04111	Cell cycle - yeast	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04114	Oocyte meiosis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04120	Ubiquitin mediated proteolysis	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04310	Wnt signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04350	TGF-beta signaling pathway	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045524	K03094	ko04710	Circadian rhythm - mammal	602	2.3e-27	0.49	0.72	0.94
PGSC0003DMG200045527	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMG200045527	K00517	ko00626	Naphthalene and anthracene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMG200045527	K00517	ko00903	Limonene and pinene degradation	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMG200045527	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMG200045527	K00517	ko01110	Biosynthesis of secondary metabolites	612	6.4e-28	0.53	0.70	0.60
PGSC0003DMG200043267	K00804	ko00900	Terpenoid backbone biosynthesis	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMG200043267	K00804	ko01100	Metabolic pathways	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMG200043267	K00804	ko01110	Biosynthesis of secondary metabolites	1660	1.0e-85	0.58	0.77	0.97
PGSC0003DMG200043272	K10760	ko00908	Zeatin biosynthesis	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMG200043272	K10760	ko01100	Metabolic pathways	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMG200043272	K10760	ko01110	Biosynthesis of secondary metabolites	623	1.6e-28	0.37	0.51	0.98
PGSC0003DMG200043288	K06675	ko04111	Cell cycle - yeast	243	3.0e-16	0.46	0.62	0.95
PGSC0003DMG200039917	K12356	ko00940	Phenylpropanoid biosynthesis	693	2.2e-32	0.31	0.49	0.96
PGSC0003DMG200039919	K11821	ko00380	Tryptophan metabolism	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMG200039919	K11821	ko00966	Glucosinolate biosynthesis	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMG200039919	K11821	ko01110	Biosynthesis of secondary metabolites	775	6.5e-37	0.43	0.63	0.98
PGSC0003DMG200025701	K08008	ko04145	Phagosome	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMG200025701	K08008	ko04670	Leukocyte transendothelial migration	403	2.2e-16	0.30	0.45	0.56
PGSC0003DMG200025728	K08233	ko00901	Indole alkaloid biosynthesis	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMG200025728	K08233	ko01110	Biosynthesis of secondary metabolites	857	2.0e-41	0.44	0.62	0.99
PGSC0003DMG200025729	K00120	ko00361	gamma-Hexachlorocyclohexane degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko00363	Bisphenol A degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko00624	1- and 2-Methylnaphthalene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko00626	Naphthalene and anthracene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko00632	Benzoate degradation via CoA ligation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko00903	Limonene and pinene degradation	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko01100	Metabolic pathways	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025729	K00120	ko01110	Biosynthesis of secondary metabolites	914	1.4e-44	0.69	0.82	0.85
PGSC0003DMG200025733	K07203	ko04012	ErbB signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko04150	mTOR signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko04910	Insulin signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko04920	Adipocytokine signaling pathway	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko04930	Type II diabetes mellitus	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko05200	Pathways in cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko05214	Glioma	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko05215	Prostate cancer	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko05221	Acute myeloid leukemia	17462	0.	0.84	0.91	1.00
PGSC0003DMG200025733	K07203	ko04012	ErbB signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko04150	mTOR signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko04910	Insulin signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko04920	Adipocytokine signaling pathway	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko04930	Type II diabetes mellitus	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko05200	Pathways in cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko05214	Glioma	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko05215	Prostate cancer	17695	0.	0.85	0.92	1.00
PGSC0003DMG200025733	K07203	ko05221	Acute myeloid leukemia	17695	0.	0.85	0.92	1.00
PGSC0003DMG200030123	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.82
PGSC0003DMG200030123	K01513	ko00230	Purine metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00500	Starch and sucrose metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00740	Riboflavin metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00760	Nicotinate and nicotinamide metabolism	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko00770	Pantothenate and CoA biosynthesis	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030123	K01513	ko01100	Metabolic pathways	1173	7.3e-59	0.42	0.59	0.81
PGSC0003DMG200030124	K01513	ko00230	Purine metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030124	K01513	ko00500	Starch and sucrose metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030124	K01513	ko00740	Riboflavin metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030124	K01513	ko00760	Nicotinate and nicotinamide metabolism	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030124	K01513	ko00770	Pantothenate and CoA biosynthesis	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030124	K01513	ko01100	Metabolic pathways	1189	9.6e-60	0.41	0.59	0.82
PGSC0003DMG200030128	K01810	ko00010	Glycolysis / Gluconeogenesis	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030128	K01810	ko00030	Pentose phosphate pathway	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030128	K01810	ko00500	Starch and sucrose metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030128	K01810	ko00520	Amino sugar and nucleotide sugar metabolism	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030128	K01810	ko01100	Metabolic pathways	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030128	K01810	ko01110	Biosynthesis of secondary metabolites	493	2.3e-21	0.52	0.55	0.75
PGSC0003DMG200030131	K00588	ko00360	Phenylalanine metabolism	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030131	K00588	ko00940	Phenylpropanoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030131	K00588	ko00941	Flavonoid biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030131	K00588	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030131	K00588	ko01100	Metabolic pathways	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030131	K00588	ko01110	Biosynthesis of secondary metabolites	1076	1.6e-53	0.87	0.94	0.86
PGSC0003DMG200030137	K03506	ko00230	Purine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030137	K03506	ko00240	Pyrimidine metabolism	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030137	K03506	ko01100	Metabolic pathways	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030137	K03506	ko03030	DNA replication	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030137	K03506	ko03410	Base excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030137	K03506	ko03420	Nucleotide excision repair	454	3.3e-19	0.36	0.55	0.50
PGSC0003DMG200030138	K06170	ko04330	Notch signaling pathway	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMG200030138	K06170	ko05010	Alzheimer's disease	706	4.2e-33	0.59	0.77	0.98
PGSC0003DMG200020317	K06119	ko00561	Glycerolipid metabolism	1021	1.8e-50	0.76	0.87	0.96
PGSC0003DMG200020323	K02882	ko03010	Ribosome	1442	1.1e-73	0.92	0.97	0.99
PGSC0003DMG200020323	K02882	ko03010	Ribosome	705	4.8e-33	0.93	0.98	0.99
PGSC0003DMG200020325	K01962	ko00061	Fatty acid biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko00253	Tetracycline biosynthesis	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko00620	Pyruvate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko00640	Propanoate metabolism	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko01100	Metabolic pathways	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko01110	Biosynthesis of secondary metabolites	2375	3.7e-125	0.87	0.93	0.99
PGSC0003DMG200020325	K01962	ko00061	Fatty acid biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200020325	K01962	ko00253	Tetracycline biosynthesis	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200020325	K01962	ko00620	Pyruvate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200020325	K01962	ko00640	Propanoate metabolism	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200020325	K01962	ko01100	Metabolic pathways	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200020325	K01962	ko01110	Biosynthesis of secondary metabolites	4464	2.2e-240	0.71	0.85	0.98
PGSC0003DMG200035573	K12356	ko00940	Phenylpropanoid biosynthesis	665	7.6e-31	0.31	0.52	0.96
PGSC0003DMG200035578	K04574	ko05014	Amyotrophic lateral sclerosis (ALS)	408	4.5e-16	0.33	0.44	0.92
PGSC0003DMG200012027	K12338	ko00942	Anthocyanin biosynthesis	869	4.3e-42	0.38	0.58	0.97
PGSC0003DMG200012032	K03110	ko03060	Protein export	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMG200012032	K03110	ko03070	Bacterial secretion system	258	3.8e-08	0.42	0.50	0.80
PGSC0003DMG200012033	K02689	ko00195	Photosynthesis	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMG200012033	K02689	ko01100	Metabolic pathways	620	2.3e-28	0.97	1.00	0.66
PGSC0003DMG200012040	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMG200012040	K00517	ko00626	Naphthalene and anthracene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMG200012040	K00517	ko00903	Limonene and pinene degradation	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMG200012040	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMG200012040	K00517	ko01110	Biosynthesis of secondary metabolites	1029	6.4e-51	0.36	0.56	0.96
PGSC0003DMG200002291	K01046	ko00561	Glycerolipid metabolism	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMG200002291	K01046	ko01100	Metabolic pathways	254	6.3e-08	0.36	0.47	0.33
PGSC0003DMG200002294	K05355	ko00900	Terpenoid backbone biosynthesis	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMG200002294	K05355	ko01110	Biosynthesis of secondary metabolites	1191	7.4e-60	0.45	0.67	0.83
PGSC0003DMG200002294	K05355	ko00900	Terpenoid backbone biosynthesis	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMG200002294	K05355	ko01110	Biosynthesis of secondary metabolites	1381	2.5e-70	0.50	0.73	0.84
PGSC0003DMG200002301	K00290	ko00300	Lysine biosynthesis	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMG200002301	K00290	ko00310	Lysine degradation	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMG200002301	K00290	ko01100	Metabolic pathways	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMG200002301	K00290	ko01110	Biosynthesis of secondary metabolites	611	1.0e-27	0.52	0.68	0.85
PGSC0003DMG200002301	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00300	Lysine biosynthesis	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00310	Lysine degradation	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01100	Metabolic pathways	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko01110	Biosynthesis of secondary metabolites	836	2.8e-40	0.44	0.60	0.99
PGSC0003DMG200002301	K00290	ko00300	Lysine biosynthesis	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMG200002301	K00290	ko00310	Lysine degradation	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMG200002301	K00290	ko01100	Metabolic pathways	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMG200002301	K00290	ko01110	Biosynthesis of secondary metabolites	696	1.5e-32	0.46	0.62	0.93
PGSC0003DMG200002301	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00291	ko00300	Lysine biosynthesis	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMG200002301	K00291	ko00310	Lysine degradation	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMG200002301	K00291	ko01100	Metabolic pathways	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMG200002301	K00291	ko01110	Biosynthesis of secondary metabolites	247	2.2e-07	0.30	0.49	0.70
PGSC0003DMG200002301	K00292	ko00310	Lysine degradation	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01100	Metabolic pathways	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200002301	K00292	ko01110	Biosynthesis of secondary metabolites	903	5.7e-44	0.61	0.74	0.97
PGSC0003DMG200016504	K02695	ko00195	Photosynthesis	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMG200016504	K02695	ko01100	Metabolic pathways	961	3.6e-47	0.77	0.88	0.99
PGSC0003DMG200016511	K10803	ko03410	Base excision repair	605	1.6e-27	0.60	0.69	0.88
PGSC0003DMG200016511	K10803	ko03410	Base excision repair	1008	9.2e-50	0.55	0.71	0.94
PGSC0003DMG200016511	K10803	ko03410	Base excision repair	1458	1.4e-74	0.53	0.68	0.95
PGSC0003DMG200016511	K10803	ko03410	Base excision repair	1129	2.0e-56	0.53	0.70	0.96
PGSC0003DMG200016516	K04124	ko00904	Diterpenoid biosynthesis	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMG200016516	K04124	ko01110	Biosynthesis of secondary metabolites	1644	7.7e-85	0.56	0.74	0.94
PGSC0003DMG200000138	K00970	ko03018	RNA degradation	537	5.1e-22	0.32	0.50	0.48
PGSC0003DMG200000139	K01066	ko00623	2,4-Dichlorobenzoate degradation	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMG200000139	K01066	ko00960	Tropane, piperidine and pyridine alkaloid biosynthesis	362	3.9e-14	0.36	0.55	0.82
PGSC0003DMG200000139	K01046	ko00561	Glycerolipid metabolism	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMG200000139	K01046	ko01100	Metabolic pathways	389	1.3e-15	0.31	0.49	0.83
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	613	5.6e-28	0.40	0.59	0.86
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1346	2.1e-68	0.44	0.63	0.95
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1397	3.2e-71	0.42	0.61	0.91
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1409	7.0e-72	0.41	0.60	0.97
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	376	6.7e-15	0.48	0.66	0.99
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1363	2.4e-69	0.42	0.60	0.93
PGSC0003DMG200000143	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMG200000143	K00517	ko00626	Naphthalene and anthracene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMG200000143	K00517	ko00903	Limonene and pinene degradation	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMG200000143	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMG200000143	K00517	ko01110	Biosynthesis of secondary metabolites	1410	6.2e-72	0.41	0.61	0.97
PGSC0003DMG200000144	K11821	ko00380	Tryptophan metabolism	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMG200000144	K11821	ko00966	Glucosinolate biosynthesis	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMG200000144	K11821	ko01110	Biosynthesis of secondary metabolites	922	5.1e-45	0.45	0.64	0.94
PGSC0003DMG200000145	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000145	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000145	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000145	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000145	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000146	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMG200000146	K00517	ko00626	Naphthalene and anthracene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMG200000146	K00517	ko00903	Limonene and pinene degradation	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMG200000146	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMG200000146	K00517	ko01110	Biosynthesis of secondary metabolites	1382	2.2e-70	0.44	0.65	0.95
PGSC0003DMG200000147	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000147	K00517	ko00626	Naphthalene and anthracene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000147	K00517	ko00903	Limonene and pinene degradation	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000147	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000147	K00517	ko01110	Biosynthesis of secondary metabolites	1122	4.8e-56	0.41	0.56	0.95
PGSC0003DMG200000148	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMG200000148	K00517	ko00626	Naphthalene and anthracene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMG200000148	K00517	ko00903	Limonene and pinene degradation	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMG200000148	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMG200000148	K00517	ko01110	Biosynthesis of secondary metabolites	1367	1.5e-69	0.42	0.63	0.84
PGSC0003DMG200000149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00626	Naphthalene and anthracene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00903	Limonene and pinene degradation	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko01110	Biosynthesis of secondary metabolites	1365	1.9e-69	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00626	Naphthalene and anthracene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00903	Limonene and pinene degradation	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko01110	Biosynthesis of secondary metabolites	1383	1.9e-70	0.40	0.61	0.95
PGSC0003DMG200000149	K00517	ko00361	gamma-Hexachlorocyclohexane degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00626	Naphthalene and anthracene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00903	Limonene and pinene degradation	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko00945	Stilbenoid, diarylheptanoid and gingerol biosynthesis	1390	7.9e-71	0.40	0.62	0.95
PGSC0003DMG200000149	K00517	ko01110	Biosynthesis of secondary metabolites	1390	7.9e-71	0.40	0.62	0.95
